PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Daubeuf, F; Hachet-Haas, M; Gizzi, P; Gasparik, V; Bonnet, D; Utard, V; Hibert, M; Frossard, N; Galzi, JL				Daubeuf, Francois; Hachet-Haas, Muriel; Gizzi, Patrick; Gasparik, Vincent; Bonnet, Dominique; Utard, Valerie; Hibert, Marcel; Frossard, Nelly; Galzi, Jean-Luc			An Antedrug of the CXCL12 Neutraligand Blocks Experimental Allergic Asthma without Systemic Effect in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; HEMATOPOIETIC PROGENITOR CELLS; T-LYMPHOCYTES; WHIM SYNDROME; RAPID MOBILIZATION; ANTAGONIST AMD3100; IN-VITRO; G-CSF; EXPRESSION; CANCER	The chemokine receptor CXCR4 and its chemokine CXCL12 are involved in normal tissue patterning but also in tumor cell growth and survival as well as in the recruitment of immune and inflammatory cells, as successfully demonstrated using agents that block either CXCL12 or CXCR4. In order to achieve selectivity in drug action on the CXCR4/CXCL12 pair, in particular in the airways, drugs should be delivered as selectively as possible in the treated tissue and should not diffuse in the systemic circulation, where it may reach undesired organs. To this end, we used a previously unexploited Knoevenagel reaction to create a short lived drug, or soft drug, based on the CXCL12-neutralizing small molecule, chalcone 4, which blocks binding of CXCL12 to CXCR4. We show that the compound, carbonitrile-chalcone 4, blocks the recruitment of eosinophils to the airways in ovalbumin-sensitized and challenged mice in vivo when administered directly to the airways by the intranasal route, but not when administered systemically by the intraperitoneal route. We show that the lack of effect at a distant site is due to the rapid degradation of the molecule to inactive fragments. This approach allows selective action of the CXCL12 neutraligands although the target protein is widely distributed in the organism.	[Daubeuf, Francois; Gasparik, Vincent; Bonnet, Dominique; Hibert, Marcel; Frossard, Nelly] Univ Strasbourg, Lab Innovat Therapeut, Fac Pharm, UMR 7200,CNRS, F-67401 Illkirch Graffenstaden, France; [Hachet-Haas, Muriel; Gizzi, Patrick; Utard, Valerie; Galzi, Jean-Luc] Univ Strasbourg, Ecole Super Biotechnol, Lab Biotechnol & Signalisat Cellulaire, UMR 7242,CNRS,Ecole Biotechnol Strasbourg, F-67412 Illkirch Graffenstaden, France; [Daubeuf, Francois; Hachet-Haas, Muriel; Gizzi, Patrick; Gasparik, Vincent; Bonnet, Dominique; Utard, Valerie; Hibert, Marcel; Frossard, Nelly; Galzi, Jean-Luc] Univ Strasbourg, Lab Excellence MEDALIS, F-67400 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Galzi, JL (corresponding author), Univ Strasbourg, Lab Excellence MEDALIS, F-67400 Illkirch Graffenstaden, France.	galzi@unistra.fr	Bonnet, Dominique/N-7275-2014; Frossard, Nelly/F-8301-2013	Bonnet, Dominique/0000-0002-8252-9199; 	CNRS; Institut National pour la Sante et la Recherche Medicale; Agence Nationale pour la Recherche (ANR); Fonds de Recherche en Sante Respiratoire from Societe de Pneumologie de langue francaise (SPLF); Region Alsace	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National pour la Sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Fonds de Recherche en Sante Respiratoire from Societe de Pneumologie de langue francaise (SPLF); Region Alsace(Region Grand-Est)	This work was supported by funds from CNRS, the Institut National pour la Sante et la Recherche Medicale, and the Agence Nationale pour la Recherche (ANR).; Supported by a fellowship from the Fonds de Recherche en Sante Respiratoire from Societe de Pneumologie de langue francaise (SPLF) and the Region Alsace.	Bachelerie F, 2010, DIS MARKERS, V29, P189, DOI [10.3233/DMA-2010-0736, 10.1155/2010/475104]; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balabanian K, 2012, BLOOD, V119, P5722, DOI 10.1182/blood-2012-01-403378; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bouchery T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034971; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chow KYC, 2010, CELL HOST MICROBE, V8, P523, DOI 10.1016/j.chom.2010.11.006; Cinamon G, 2001, NAT IMMUNOL, V2, P515, DOI 10.1038/88710; Negrete-Garcia MC, 2010, CHEST, V138, P100, DOI 10.1378/chest.09-2104; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Devine SM, 2004, J CLIN ONCOL, V22, P1095, DOI 10.1200/JCO.2004.07.131; Eddleston J, 2002, J IMMUNOL, V169, P6445, DOI 10.4049/jimmunol.169.11.6445; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Flomenberg N, 2005, BLOOD, V106, P1867, DOI 10.1182/blood-2005-02-0468; Flomenberg N, 2005, ACTA HAEMATOL-BASEL, V114, P198, DOI 10.1159/000088410; Fulkerson PC, 2004, J IMMUNOL, V173, P7565, DOI 10.4049/jimmunol.173.12.7565; Galzi JL, 2010, PHARMACOL THERAPEUT, V126, P39, DOI 10.1016/j.pharmthera.2009.12.003; Gasparik V, 2012, ACS MED CHEM LETT, V3, P10, DOI 10.1021/ml200017d; Gerrits H, 2008, GENESIS, V46, P235, DOI 10.1002/dvg.20387; Gonzalo JA, 2000, J IMMUNOL, V165, P499, DOI 10.4049/jimmunol.165.1.499; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; GUTHRIE JP, 1983, CAN J CHEM, V61, P2621, DOI 10.1139/v83-449; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Johnson Z, 2005, TRENDS IMMUNOL, V26, P268, DOI 10.1016/j.it.2005.03.001; Jourdan P, 1998, J IMMUNOL, V160, P4153; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Khan MOF, 2008, CHEM REV, V108, P5131, DOI 10.1021/cr068203e; Khan MOF, 2005, CURR MED CHEM, V12, P2227, DOI 10.2174/0929867054864840; Kim HY, 2010, CANCER RES TREAT, V42, P225, DOI 10.4143/crt.2010.42.4.225; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liles WC, 2005, TRANSFUSION, V45, P295, DOI 10.1111/j.1537-2995.2005.04222.x; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Maillet EL, 2007, FASEB J, V21, P2124, DOI 10.1096/fj.06-7683com; McDermott DH, 2011, BLOOD, V118, P4957, DOI 10.1182/blood-2011-07-368084; McDermott DH, 2011, J CELL MOL MED, V15, P2071, DOI 10.1111/j.1582-4934.2010.01210.x; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagase H, 2000, J IMMUNOL, V164, P5935, DOI 10.4049/jimmunol.164.11.5935; Nagase H, 2000, J ALLERGY CLIN IMMUN, V106, P1132; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Rajasekaran K, 2008, J CHEM SCI, V120, P475, DOI 10.1007/s12039-008-0074-4; ROBERTS DL, 1962, J ORG CHEM, V27, P3989, DOI 10.1021/jo01058a056; Rusconi S, 2009, MOLECULES, V14, P1927, DOI 10.3390/molecules14051927; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640; Thomas SY, 2007, J IMMUNOL, V179, P1901, DOI 10.4049/jimmunol.179.3.1901; Trent JO, 2003, J BIOL CHEM, V278, P47136, DOI 10.1074/jbc.M307850200; Waldhauser KM, 2008, BRIT J PHARMACOL, V155, P585, DOI 10.1038/bjp.2008.287; Wang JB, 1998, J LEUKOCYTE BIOL, V64, P642, DOI 10.1002/jlb.64.5.642; Wells TNC, 1999, INFLAMM RES, V48, P353, DOI 10.1007/s000110050472; WETZLER M, 1990, AM J MED, V89, P663, DOI 10.1016/0002-9343(90)90187-I; Xu JG, 2008, J HEART LUNG TRANSPL, V27, P1302, DOI 10.1016/j.healun.2008.08.010; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	67	29	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11865	11876		10.1074/jbc.M112.449348	http://dx.doi.org/10.1074/jbc.M112.449348			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23449983	Green Published, hybrid			2022-12-25	WOS:000318157600022
J	Kulik, HJ; Drennan, CL				Kulik, Heather J.; Drennan, Catherine L.			Substrate Placement Influences Reactivity in Non-heme Fe(II) Halogenases and Hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; TAURINE/ALPHA-KETOGLUTARATE DIOXYGENASE; FATTY-ACID SYNTHASE; STRUCTURAL BASIS; IRON; BIOSYNTHESIS; ENZYMES; SYRB2; SYRINGOMYCIN; ACTIVATION	We employ error-corrected density functional theory methods to map out the dependence of reactivity on substrate position for SyrB2, a member of a family of non-heme iron halogenases and hydroxylases that are only reactive toward amino acid substrates delivered via prosthetic phosphopantetheine arms. For the initial hydrogen abstraction step, the inherent flexibility of the phosphopantetheine molecule weakens the position dependence for both the native substrate (threonine for SyrB2) and alternative substrates. Over a 5 angstrom window of substrate positions, the tethered hydrogen abstraction step proceeds with nearly identical activation energies and donor-acceptor distances in the transition state. The propensity of a particular substrate toward halogenation or hydroxylation is found to depend strongly on the substrate placement following hydrogen abstraction, with deeper substrate delivery into the active (for native substrates) site favoring halogenation and shallower substrate delivery favoring hydroxylation.	[Kulik, Heather J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Drennan, Catherine L.] MIT, Dept Biol & Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kulik, HJ (corresponding author), Stanford Univ, Dept Chem, 333 Campus Dr,Mudd Bldg,Rm 121, Stanford, CA 94305 USA.	hkulik@stanford.edu			Burroughs Wellcome Fund	Burroughs Wellcome Fund(Burroughs Wellcome Fund)	Recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. To whom correspondence should be addressed: Dept. of Chemistry, Stanford University, 333 Campus Dr., Mudd Bldg., Rm. 121, Stanford, CA, 94305. E-mail: hkulik@stanford.edu.	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Borowski T, 2010, J AM CHEM SOC, V132, P12887, DOI 10.1021/ja101877a; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Cho KB, 2012, CHEM COMMUN, V48, P2189, DOI 10.1039/c2cc17610f; Comba P, 2010, CHEM-EUR J, V16, P7293, DOI 10.1002/chem.201000092; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; de Visser SP, 2006, J AM CHEM SOC, V128, P9813, DOI 10.1021/ja061581g; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GRGURINA I, 1994, EXPERIENTIA, V50, P130, DOI 10.1007/BF01984950; Gribble GW, 2004, J CHEM EDUC, V81, P1441, DOI 10.1021/ed081p1441; Grzyska PK, 2007, J INORG BIOCHEM, V101, P797, DOI 10.1016/j.jinorgbio.2007.01.011; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; Janardanan D, 2010, ANGEW CHEM INT EDIT, V49, P3342, DOI 10.1002/anie.201000004; Joshi AK, 2005, BIOCHEMISTRY-US, V44, P4100, DOI 10.1021/bi047856r; Klinker EJ, 2009, ANGEW CHEM INT EDIT, V48, P1291, DOI 10.1002/anie.200804029; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Kulik HJ, 2009, J AM CHEM SOC, V131, P14426, DOI 10.1021/ja905206k; Lai JR, 2006, P NATL ACAD SCI USA, V103, P5314, DOI 10.1073/pnas.0601038103; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Liu HN, 2009, J PHYS CHEM B, V113, P4887, DOI 10.1021/jp810715t; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Lowe JR, 2011, POLYM CHEM-UK, V2, P702, DOI 10.1039/c0py00283f; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; MCMILLEN DF, 1982, ANNU REV PHYS CHEM, V33, P493, DOI 10.1146/annurev.pc.33.100182.002425; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Nagel ZD, 2006, CHEM REV, V106, P3095, DOI 10.1021/cr050301x; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pandian S, 2009, DALTON T, P6201, DOI 10.1039/b906866j; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Seo MS, 2011, CHEM SCI, V2, P1039, DOI 10.1039/c1sc00062d; Shaik S, 2010, NAT CHEM, V2, P347, DOI 10.1038/nchem.638; Sheppard D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2841941; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Tran L, 2010, CHEM BIOL, V17, P705, DOI 10.1016/j.chembiol.2010.05.017; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wagner C, 2009, J NAT PROD, V72, P540, DOI 10.1021/np800651m; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v; Wong C, 2009, J AM CHEM SOC, V131, P4872, DOI 10.1021/ja8097355; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497	53	41	42	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11233	11241		10.1074/jbc.M112.415570	http://dx.doi.org/10.1074/jbc.M112.415570			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449977	Green Published, hybrid			2022-12-25	WOS:000317915500026
J	Ruiz, J; Macias, D; Rincon, MM; Pascual, A; Catalan, IA; Navarro, G				Ruiz, Javier; Macias, Diego; Rincon, Margarita M.; Pascual, Ananda; Catalan, Ignacio A.; Navarro, Gabriel			Recruiting at the Edge: Kinetic Energy Inhibits Anchovy Populations in the Western Mediterranean	PLOS ONE			English	Article							SARDINE SARDINA-PILCHARDUS; EARLY-LIFE-HISTORY; ALBORAN SEA; ENGRAULIS-ENCRASICOLUS; SEASONAL VARIABILITY; VERTICAL MOTION; CAMARINAL SILL; FISH LARVAE; IN-SITU; STRAIT	The Strait of Gibraltar replenishes the Mediterranean with Atlantic waters through an intense eastward current known as the Atlantic Jet (AJ). The AJ fertilizes the southwestern Mediterranean and is considered to be the ultimate factor responsible for the comparatively high fish production of this region. Here, we perform an analysis of the available historical catches and catch per unit effort (CPUE), together with a long series of surface currents, kinetic energy and chlorophyll concentration. We show that the high kinetic energy of the AJ increases primary production but also negatively impacts the recruitment of anchovy. We contend that anchovy recruitment in the region is inhibited by the advection and dispersion of larvae and post-larvae during periods of strong advection by the AJ. The inhibitory impact of kinetic energy on anchovy landings is not a transient but rather a persistent state of the system. An exceptional combination of events creates an outbreak of this species in the Alboran Sea. These events depend on the Mediterranean-Atlantic exchange of water masses and, therefore, are highly sensitive to climate changes that are projected, though not always negatively, for fish landings.	[Ruiz, Javier; Macias, Diego; Rincon, Margarita M.; Navarro, Gabriel] CSIC, Dept Coastal Ecol & Management, Inst Ciencias Marinas Andalucia, Cadiz, Spain; [Pascual, Ananda; Catalan, Ignacio A.] Inst Mediterrani Estudis Avancats IMEDEA CSIC UIB, Esporles, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Ruiz, J (corresponding author), CSIC, Dept Coastal Ecol & Management, Inst Ciencias Marinas Andalucia, Campus Rio San Pedro, Cadiz, Spain.	javier.ruiz@csic.es	Ruiz, Javier/G-3184-2016; Navarro, Gabriel/AAA-9528-2020; Pascual, Ananda/H-8214-2013; Catalan, Ignacio/C-5382-2011; Macías, Diego/G-1972-2010	Ruiz, Javier/0000-0002-3375-2327; Navarro, Gabriel/0000-0002-8919-0060; Catalan, Ignacio/0000-0002-6496-9182; Macías, Diego/0000-0002-7772-255X; Pascual, Ananda/0000-0001-9476-9272; Rincon Hidalgo, Margarita/0000-0002-2866-3178	project ECOKNOWS [FP7-244706]; project MEDEX [CTM2008-04036-E]; project PERSEUS [FP7-287600]; project G2Coupling [CTM2011-22580]; Junta de Andalucia [P09-RNM-5358]; JaeDOC contract of the Spanish Science and Technology Council (CSIC) [X0SC000087]	project ECOKNOWS; project MEDEX; project PERSEUS; project G2Coupling; Junta de Andalucia(Junta de Andalucia); JaeDOC contract of the Spanish Science and Technology Council (CSIC)	This work was supported by projects ECOKNOWS (FP7-244706), MEDEX (CTM2008-04036-E), PERSEUS (FP7-287600) and G2Coupling (CTM2011-22580). Margarita M. Rincon was funded by P09-RNM-5358 of the Junta de Andalucia. D. Macias was supported by a JaeDOC contract (X0SC000087) of the Spanish Science and Technology Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R., 1990, INF TEC I ESP OCEANO, V86, P48; Abad R, 1997, DATOS RESUMENES I ES, V4, P41; Agostini VN, 2002, FISH OCEANOGR, V11, P129, DOI 10.1046/j.1365-2419.2002.00201.x; Aldanondo N, 2010, FISH OCEANOGR, V19, P196, DOI 10.1111/j.1365-2419.2010.00537.x; Beranger K, 2005, PROG OCEANOGR, V66, P341, DOI 10.1016/j.pocean.2004.07.013; BLAXTER JHS, 1982, ADV MAR BIOL, V20, P3; Bruno M, 2002, DEEP-SEA RES PT II, V49, P4097, DOI 10.1016/S0967-0645(02)00144-3; CADDY JF, 1995, OCEAN COAST MANAGE, V26, P1, DOI 10.1016/0964-5691(95)00015-T; CANDELA J, 1989, J GEOPHYS RES-OCEANS, V94, P12667, DOI 10.1029/JC094iC09p12667; Catalan IA, 2010, ESTUAR COAST SHELF S, V86, P299, DOI 10.1016/j.ecss.2009.11.033; Cole J, 1998, REV FISH BIOL FISHER, V8, P445, DOI 10.1023/A:1008861224731; CopeMed-II, 2011, COPEMED 2 ARTFIMED N; Crepon M, 1965, CAH OCEANOGR, V1, P15; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Erzini K, 2005, FISH OCEANOGR, V14, P195, DOI 10.1111/j.1365-2419.2005.00332.x; Flexas MM, 2006, PROG OCEANOGR, V70, P486, DOI 10.1016/j.pocean.2006.03.017; Freon P, 2005, B MAR SCI, V76, P385; Furnestin J., 1959, Revue des Travaux de l'Office des Peches Maritimes, V23, P79; Garcia A, 1996, SCI MAR, V60, P155; Garcia A, 2003, SCI MAR, V67, P155; Garcia-Lafuente J, 2002, J GEOPHYS RES, V107, P321, DOI DOI 10.1029/2001JC0011004; GARRETT C, 1990, NATO ADV SCI I C-MAT, V318, P271; Giraldez A, 2002, TECHNICAL REPORT; Giraldez A., 1991, INF TEC I ESP OCEANO, V105, P31; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; ICES, 2012, REP WORK GROUP SMALL; Lafuente JG, 1998, DEEP-SEA RES PT I, V45, P39, DOI 10.1016/S0967-0637(97)00216-1; Le Traon P.-Y., 2001, SATELLITE ALTIMETRY, P171; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Leggett WC, 2008, OCEANOGR MAR BIOL, V46, P331; Lloret J, 2004, FISH OCEANOGR, V13, P102, DOI 10.1046/j.1365-2419.2003.00279.x; Macias D, 2008, ESTUAR COAST SHELF S, V78, P250, DOI 10.1016/j.ecss.2007.12.008; Macias D, 2007, J MAR RES, V65, P523, DOI 10.1357/002224007782689085; Macias D, 2006, J MARINE SYST, V60, P177, DOI 10.1016/j.jmarsys.2005.12.003; Macias D, 2011, DEEP-SEA RES PT I, V58, P1175, DOI 10.1016/j.dsr.2011.08.013; Macias D, 2009, ESTUAR COAST SHELF S, V83, P197, DOI 10.1016/j.ecss.2009.03.032; Mafalda P, 2008, REV BIOL MAR OCEANOG, V43, P41; Maritorena S, 2005, REMOTE SENS ENVIRON, V94, P429, DOI 10.1016/j.rse.2004.08.014; Maritorena S, 2010, REMOTE SENS ENVIRON, V114, P1791, DOI 10.1016/j.rse.2010.04.002; Mercado J, 2009, PROGR OCEANOGR, V74, P273; Mercado JM, 2005, SCI MAR, V69, P451, DOI 10.3989/scimar.2005.69n4451; Millan M, 1999, FISH RES, V41, P73, DOI 10.1016/S0165-7836(99)00010-7; Morote E, 2010, ICES J MAR SCI, V67, P897, DOI 10.1093/icesjms/fsp302; Navarro G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049708; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; Parrish R.H., 1983, FAO FISHERIES REPORT, V2, P731; Pascual A, 2007, J MARINE SYST, V65, P190, DOI 10.1016/j.jmarsys.2004.12.004; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Pujol MI, 2005, J MARINE SYST, V58, P121, DOI 10.1016/j.jmarsys.2005.07.005; Rio MH, 2007, J MARINE SYST, V65, P484, DOI 10.1016/j.jmarsys.2005.02.006; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; RODRIGUEZ J M, 1990, Boletin Instituto Espanol de Oceanografia, V6, P1; Rubin J, 2006, B I ESP OCEANOGR, V22, P1; Ruiz J, 2001, J MARINE SYST, V29, P277, DOI 10.1016/S0924-7963(01)00020-3; Ruiz J, 2005, CIESM WORKSHOP MONOG, V27, P87; Ruiz J, 2006, DEEP SEA RES 2, V53; Ruiz J, 2009, FISH OCEANOGR, V18, P62, DOI 10.1111/j.1365-2419.2008.00497.x; Sarhan T, 2000, J MARINE SYST, V23, P317, DOI 10.1016/S0924-7963(99)00068-8; TINTORE J, 1991, J PHYS OCEANOGR, V21, P811, DOI 10.1175/1520-0485(1991)021<0811:MDAVMI>2.0.CO;2; Vargas-Yanez M, 2002, J MARINE SYST, V35, P229, DOI 10.1016/S0924-7963(02)00128-8; Vargas-Yanez M, 2008, GLOBAL PLANET CHANGE, V63, P177, DOI 10.1016/j.gloplacha.2007.09.001; Vargas-Yanez M, 2007, J MARINE SYST, V68, P421, DOI 10.1016/j.jmarsys.2007.01.004; Vazquez J, 1998, NOAA NASA AVHRR OCEA; Velez-Belchi P, 2005, PROG OCEANOGR, V66, P190, DOI 10.1016/j.pocean.2004.09.006	66	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55523	10.1371/journal.pone.0055523	http://dx.doi.org/10.1371/journal.pone.0055523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451027	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500002
J	Wei, CY; Thatcher, EJ; Olena, AF; Cha, DJ; Perdigoto, AL; Marshall, AF; Carter, BD; Broadie, K; Patton, JG				Wei, Chunyao; Thatcher, Elizabeth J.; Olena, Abigail F.; Cha, Diana J.; Perdigoto, Ana L.; Marshall, Andrew F.; Carter, Bruce D.; Broadie, Kendal; Patton, James G.			miR-153 Regulates SNAP-25, Synaptic Transmission, and Neuronal Development	PLOS ONE			English	Article							PROTEIN-RECEPTOR COMPLEX; T-SNARE SNAP-25; IDENTIFIED MOTONEURONS; BOTULINUM NEUROTOXIN; GENE-EXPRESSION; MEMBRANE-FUSION; AXONAL GROWTH; ZEBRAFISH DEVELOPMENT; NEURITE OUTGROWTH; PLASTICITY	SNAP-25 is a core component of the trimeric SNARE complex mediating vesicle exocytosis during membrane addition for neuronal growth, neuropeptide/growth factor secretion, and neurotransmitter release during synaptic transmission. Here, we report a novel microRNA mechanism of SNAP-25 regulation controlling motor neuron development, neurosecretion, synaptic activity, and movement in zebrafish. Loss of miR-153 causes overexpression of SNAP-25 and consequent hyperactive movement in early zebrafish embryos. Conversely, overexpression of miR-153 causes SNAP-25 down regulation resulting in near complete paralysis, mimicking the effects of treatment with Botulinum neurotoxin. miR-153-dependent changes in synaptic activity at the neuromuscular junction are consistent with the observed movement defects. Underlying the movement defects, perturbation of miR-153 function causes dramatic developmental changes in motor neuron patterning and branching. Together, our results indicate that precise control of SNAP-25 expression by miR-153 is critically important for proper neuronal patterning as well as neurotransmission.	[Wei, Chunyao; Thatcher, Elizabeth J.; Olena, Abigail F.; Cha, Diana J.; Marshall, Andrew F.; Broadie, Kendal; Patton, James G.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA; [Wei, Chunyao; Thatcher, Elizabeth J.; Olena, Abigail F.; Cha, Diana J.; Perdigoto, Ana L.; Marshall, Andrew F.; Carter, Bruce D.; Broadie, Kendal; Patton, James G.] Sch Med, Nashville, TN USA; [Perdigoto, Ana L.; Carter, Bruce D.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Patton, JG (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37212 USA.	James.G.Patton@Vanderbilt.edu			National Institutes of Health (NIH) [GM 075790, EY019759, GM 54544, NS038220, T32 GM08556, F30 NS061403, T32 GM07347]; Zebrafish International Resource Center NIH-NCRR [RR12546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012546] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY019759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544, T32GM007347, R01GM075790, T32GM008554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS061403, R01NS038220] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zebrafish International Resource Center NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) to JGP (GM 075790 and EY019759), KB (GM 54544), and BDC (NS038220) and by training fellowships to EJT (T32 GM08556) and ALP (F30 NS061403 and T32 GM07347). Antibodies were obtained from the Zebrafish International Resource Center NIH-NCRR, grant RR12546. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Appel B, 1995, DEVELOPMENT, V121, P4117; Asakura T, 2010, GENETICS, V185, P573, DOI 10.1534/genetics.110.116293; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Atouf F, 1997, J BIOL CHEM, V272, P1929, DOI 10.1074/jbc.272.3.1929; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Bicker S, 2008, J CELL MOL MED, V12, P1466, DOI 10.1111/j.1582-4934.2008.00400.x; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Choi UB, 2010, NAT STRUCT MOL BIOL, V17, P318, DOI 10.1038/nsmb.1763; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Dessi F, 1997, NEUROREPORT, V8, P3685, DOI 10.1097/00001756-199712010-00006; Doxakis E, 2010, J BIOL CHEM, V285, P12726, DOI 10.1074/jbc.M109.086827; EISEN JS, 1991, J NEUROSCI, V11, P311; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Gray LJ, 2010, PSYCHIAT RES, V178, P374, DOI 10.1016/j.psychres.2008.07.012; Greenlee MHW, 2002, SEMIN CELL DEV BIOL, V13, P99, DOI 10.1016/S1084-9521(02)00015-0; Grosse G, 1999, J NEUROSCI RES, V56, P539, DOI 10.1002/(SICI)1097-4547(19990601)56:5<539::AID-JNR9>3.0.CO;2-Y; Hepp R, 2001, CELL TISSUE RES, V305, P247, DOI 10.1007/s004410100359; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Igarashi M, 1997, J NEUROSCI, V17, P1460; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jao LE, 2012, DEVELOPMENT, V139, P1316, DOI 10.1242/dev.074344; Kannenberg K, 2007, J NEUROENDOCRINOL, V19, P882, DOI 10.1111/j.1365-2826.2007.01602.x; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Keller JE, 2004, BIOCHEMISTRY-US, V43, P526, DOI 10.1021/bi0356698; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Li WY, 2003, J NEUROSCI, V23, P10467; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Matteoli M, 2009, NEUROSCIENCE, V158, P223, DOI 10.1016/j.neuroscience.2008.03.014; McKee AG, 2010, J NEUROCHEM, V112, P991, DOI 10.1111/j.1471-4159.2009.06516.x; MYERS PZ, 1986, J NEUROSCI, V6, P2278; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Qureshi IA, 2009, NEUROSCI LETT, V466, P73, DOI 10.1016/j.neulet.2009.07.093; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Risinger C, 1998, J NEUROSCI RES, V54, P563; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tafoya LCR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-105; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Tsuji M, 2001, J BIOL CHEM, V276, P32779, DOI 10.1074/jbc.M101403200; Tsurudome K, 2010, NEURON, V68, P879, DOI 10.1016/j.neuron.2010.11.016; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Vo NK, 2010, CURR OPIN NEUROBIOL; Vrljic M, 2010, NAT STRUCT MOL BIOL, V17, P325, DOI 10.1038/nsmb.1764; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wei CY, 2012, RNA, V18, P915, DOI 10.1261/rna.029090.111; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Zhou Q, 2000, J NEUROSCI RES, V61, P321, DOI 10.1002/1097-4547(20000801)61:3<321::AID-JNR10>3.0.CO;2-L	84	48	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57080	10.1371/journal.pone.0057080	http://dx.doi.org/10.1371/journal.pone.0057080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451149	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500063
J	Goudy, S; Angel, P; Jacobs, B; Hill, C; Mainini, V; Smith, AL; Kousa, YA; Caprioli, R; Prince, LS; Baldwin, S; Schutte, BC				Goudy, Steven; Angel, Peggi; Jacobs, Britni; Hill, Cynthia; Mainini, Veronica; Smith, Arianna L.; Kousa, Youssef A.; Caprioli, Richard; Prince, Lawrence S.; Baldwin, Scott; Schutte, Brian C.			Cell-Autonomous and Non-Cell-Autonomous Roles for Irf6 during Development of the Tongue	PLOS ONE			English	Article							TASTE PAPILLA DEVELOPMENT; ORBICULARIS-ORIS MUSCLE; CRANIAL NEURAL CREST; SKELETAL-MUSCLE; CLEFT-LIP; CRANIOFACIAL DEVELOPMENT; EXPRESSION PATTERNS; MASS-SPECTROMETRY; PALATE; DIFFERENTIATION	Interferon regulatory factor 6 (IRF6) encodes a highly conserved helix-turn-helix DNA binding protein and is a member of the interferon regulatory family of DNA transcription factors. Mutations in IRF6 lead to isolated and syndromic forms of cleft lip and palate, most notably Van der Woude syndrome (VWS) and Popliteal Ptyerigium Syndrome (PPS). Mice lacking both copies of Irf6 have severe limb, skin, palatal and esophageal abnormalities, due to significantly altered and delayed epithelial development. However, a recent report showed that MCS9.7, an enhancer near Irf6, is active in the tongue, suggesting that Irf6 may also be expressed in the tongue. Indeed, we detected Irf6 staining in the mesoderm-derived muscle during development of the tongue. Dual labeling experiments demonstrated that Irf6 was expressed only in the Myf5+ cell lineage, which originates from the segmental paraxial mesoderm and gives rise to the muscles of the tongue. Fate mapping of the segmental paraxial mesoderm cells revealed a cell-autonomous Irf6 function with reduced and poorly organized Myf5+ cell lineage in the tongue. Molecular analyses showed that the Irf6-/- embryos had aberrant cytoskeletal formation of the segmental paraxial mesoderm in the tongue. Fate mapping of the cranial neural crest cells revealed non-cell-autonomous Irf6 function with the loss of the inter-molar eminence. Loss of Irf6 function altered Bmp2, Bmp4, Shh, and Fgf10 signaling suggesting that these genes are involved in Irf6 signaling. Based on these data, Irf6 plays important cell-autonomous and non-cell-autonomous roles in muscular differentiation and cytoskeletal formation in the tongue.	[Goudy, Steven; Jacobs, Britni; Hill, Cynthia] Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA; [Angel, Peggi; Caprioli, Richard] Vanderbilt Univ, Dept Imaging Biophys, Nashville, TN USA; [Mainini, Veronica] Univ Milano Bicocca, Dept Hlth Sci, Milan, Italy; [Smith, Arianna L.; Schutte, Brian C.] Michigan State Univ, Genet PhD Program, E Lansing, MI 48824 USA; [Kousa, Youssef A.; Schutte, Brian C.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Prince, Lawrence S.] Vanderbilt Univ, Div Neonatol, Nashville, TN USA; [Prince, Lawrence S.; Baldwin, Scott] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN USA; [Prince, Lawrence S.; Baldwin, Scott] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Baldwin, Scott] Vanderbilt Univ, Div Cardiol, Nashville, TN 37232 USA; [Schutte, Brian C.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Schutte, Brian C.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Vanderbilt University; Vanderbilt University; University of Milano-Bicocca; Michigan State University; Michigan State University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Michigan State University; Michigan State University	Goudy, S (corresponding author), Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37235 USA.	steven.goudy@vanderbilt.edu		Kousa, MS, DO, PhD, Youssef A/0000-0001-6049-8144	National Institutes of Health; National Institute of Dental and Craniofacial Research (NIDCR) [K08 DE017953]; National Heart, Lung, and Blood Institute (NHLBI) [HL097195, HL086324, DK078640, HL086964, HL092551, HL105334, DE13413]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK058404]; National Institute of General Medical Sciences (NIGMS) [GM058008, GM103391]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027396] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086964, R01HL086324, RL1HL092551, T32HL105334, R01HL116358, R01HL097195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE017953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078640, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058008, P41GM103391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Here are the funding sources from National Institutes of Health: This work was supported by National Institute of Dental and Craniofacial Research (NIDCR) K08 DE017953 (SG), National Heart, Lung, and Blood Institute (NHLBI) HL097195 (LP), HL086324 (LP), DK078640 (SB), HL086964 (SB), HL092551 (SB), and HL105334 (SB), DE13413 (SG), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK058404 (RC), National Institute of General Medical Sciences (NIGMS) GM058008 (RC), GM103391 (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CM, 2009, DEV GROWTH DIFFER, V51, P473, DOI 10.1111/j.1440-169X.2009.01110.x; Barron F, 2011, DEVELOPMENT, V138, P2249, DOI 10.1242/dev.056929; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Chai Y, 2000, DEVELOPMENT, V127, P1671; Fakhouri WD, 2012, DEV DYNAM, V241, P340, DOI 10.1002/dvdy.22786; GORLIN RJ, 1968, PEDIATRICS, V41, P503; Han D, 2012, DEVELOPMENT, V139, P1640, DOI 10.1242/dev.076653; Hill CR, 2012, CELL SIGNAL, V24, P1012, DOI 10.1016/j.cellsig.2011.12.022; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Jones JLP, 2010, J CRANIOFAC SURG, V21, P1350, DOI 10.1097/SCS.0b013e3181ec6aad; Jung HS, 1999, MECH DEVELOP, V81, P179, DOI 10.1016/S0925-4773(98)00234-2; Kablar B, 1997, DEVELOPMENT, V124, P4729; Kim JY, 2003, EXP CELL RES, V290, P217, DOI 10.1016/S0014-4827(03)00319-7; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Liu HX, 2004, DEV BIOL, V276, P280, DOI 10.1016/j.ydbio.2004.07.042; Neiswanger K, 2007, AM J MED GENET A, V143A, P1143, DOI 10.1002/ajmg.a.31760; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; Parada C, 2012, J DENT RES, V91, P528, DOI 10.1177/0022034511434055; PAULSON RB, 1985, J CRAN GENET DEV BIO, V5, P59; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rice R, 2006, GENE EXPR PATTERNS, V6, P206, DOI 10.1016/j.modgep.2005.06.005; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Richardson RJ, 2009, HUM MOL GENET, V18, P2632, DOI 10.1093/hmg/ddp201; Rogers CR, 2008, CLEFT PALATE-CRAN J, V45, P518, DOI 10.1597/07-115.1; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Saadi I, 2011, AM J HUM GENET, V89, P44, DOI 10.1016/j.ajhg.2011.05.023; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Smart Nicola, 2007, Angiogenesis, V10, P229, DOI 10.1007/s10456-007-9077-x; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Weinberg SM, 2007, CLEFT PALATE-CRAN J, V44, P683, DOI 10.1597/07-104.1; Yamane A, 2005, CELL TISSUE RES, V322, P183, DOI 10.1007/s00441-005-0019-x; Yang JH, 2011, ANAL CHEM, V83, P5728, DOI 10.1021/ac200998a; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	39	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56270	10.1371/journal.pone.0056270	http://dx.doi.org/10.1371/journal.pone.0056270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451037	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800007
J	Puig, F; Fuster, G; Adda, M; Blanch, L; Farre, R; Navajas, D; Artigas, A				Puig, Ferranda; Fuster, Gemma; Adda, Melanie; Blanch, Lluis; Farre, Ramon; Navajas, Daniel; Artigas, Antonio			Barrier-Protective Effects of Activated Protein C in Human Alveolar Epithelial Cells	PLOS ONE			English	Article							ACUTE LUNG INJURY; THROMBIN; PERMEABILITY; PULMONARY; ZO-1; THROMBOMODULIN; COAGULATION; CONTRACTION; RECEPTOR-1; MICROSCOPY	Acute lung injury (ALI) is a clinical manifestation of respiratory failure, caused by lung inflammation and the disruption of the alveolar-capillary barrier. Preservation of the physical integrity of the alveolar epithelial monolayer is of critical importance to prevent alveolar edema. Barrier integrity depends largely on the balance between physical forces on cell-cell and cell-matrix contacts, and this balance might be affected by alterations in the coagulation cascade in patients with ALI. We aimed to study the effects of activated protein C (APC) on mechanical tension and barrier integrity in human alveolar epithelial cells (A549) exposed to thrombin. Cells were pretreated for 3 h with APC (50 mu g/ml) or vehicle (control). Subsequently, thrombin (50 nM) or medium was added to the cell culture. APC significantly reduced thrombin-induced cell monolayer permeability, cell stiffening, and cell contraction, measured by electrical impedance, optical magnetic twisting cytometry, and traction microscopy, respectively, suggesting a barrier-protective response. The dynamics of the barrier integrity was also assessed by western blotting and immunofluorescence analysis of the tight junction ZO-1. Thrombin resulted in more elongated ZO-1 aggregates at cell-cell interface areas and induced an increase in ZO-1 membrane protein content. APC attenuated the length of these ZO-1 aggregates and reduced the ZO-1 membrane protein levels induced by thrombin. In conclusion, pretreatment with APC reduced the disruption of barrier integrity induced by thrombin, thus contributing to alveolar epithelial barrier protection.	[Puig, Ferranda; Fuster, Gemma; Blanch, Lluis; Farre, Ramon; Navajas, Daniel; Artigas, Antonio] CIBER Enfermedades Resp, Bunyola, Spain; [Adda, Melanie; Blanch, Lluis; Artigas, Antonio] Univ Autonoma Barcelona, Crit Care Ctr, Hosp Sabadell, Inst Univ Parc Tauli, Sabadell, Spain; [Farre, Ramon; Navajas, Daniel] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Farre, Ramon] IDIBAPS, Barcelona, Spain; [Navajas, Daniel] Inst Bioengn Catalunya IBEC, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya	Artigas, A (corresponding author), CIBER Enfermedades Resp, Bunyola, Spain.	aartigas@tauli.cat	Fuster, Gemma/B-5468-2019; Fuster, Gemma/ACH-5814-2022; Navajas, Daniel/E-4233-2010; Farre, Ramon/L-2664-2017	Fuster, Gemma/0000-0002-4501-2422; Navajas, Daniel/0000-0001-7150-9363; antonio, artigas/0000-0002-8029-1017; Farre, Ramon/0000-0002-9084-7824	Ministerio de Ciencia e Innovacion [FISPI080646, FISPI081908, SAF200802991]; Fundacio Parc Tauli; CIBER de Enfermedades Respiratorias; Eli Lilly and Company; Eli Lilly	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Parc Tauli; CIBER de Enfermedades Respiratorias; Eli Lilly and Company(Eli Lilly); Eli Lilly(Eli Lilly)	This study was supported by grants from the Ministerio de Ciencia e Innovacion (FISPI080646, FISPI081908, and SAF200802991), from the Fundacio Parc Tauli, and from CIBER de Enfermedades Respiratorias; it was partially funded by Eli Lilly and Company. The funders had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.; This project was partially funded by the commercial company Eli Lilly and Company. Professor Antonio Artigas, the corresponding author, have received travel support, lecture fees and support patient recruitment (through his institution) from Eli Lilly. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adda M, 2009, CURR RESPIR MED REV, V5, P149, DOI 10.2174/157339809788922342; Birukova AA, 2009, NANOMED-NANOTECHNOL, V5, P30, DOI 10.1016/j.nano.2008.07.002; Borbiev T, 2003, AM J PHYSIOL-LUNG C, V285, pL43, DOI 10.1152/ajplung.00460.2001; Brevier J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.268101; Brevier J, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/016005; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Fabry B, 2001, J APPL PHYSIOL, V91, P986, DOI 10.1152/jappl.2001.91.2.986; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Gavara N, 2006, J APPL PHYSIOL, V101, P512, DOI 10.1152/japplphysiol.00185.2006; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hataji O, 2002, LUNG, V180, P47, DOI 10.1007/s004080000080; Hofstra JJ, 2010, J AEROSOL MED PULM D, V23, P105, DOI 10.1089/jamp.2009.0779; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; KOBAYASHI S, 1995, PHARMACEUT RES, V12, P1115, DOI 10.1023/A:1016295406473; Kotanidou A, 2006, VASC PHARMACOL, V45, P134, DOI 10.1016/j.vph.2006.06.016; Laterre PF, 2003, CRIT CARE MED, V31, pS329, DOI 10.1097/01.CCM.0000057912.71499.A5; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Maniatis NA, 2010, CRIT CARE, V14, DOI 10.1186/cc8976; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Puig F, 2009, EXP MECH, V49, P47, DOI 10.1007/s11340-007-9072-6; Ragsdale GK, 1997, BIOPHYS J, V73, P2798, DOI 10.1016/S0006-3495(97)78309-7; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shimizu S, 2003, AM J RESP CRIT CARE, V167, P1416, DOI 10.1164/rccm.200206-515OC; STEVENSON BR, 1989, BIOCHEM J, V263, P597, DOI 10.1042/bj2630597; Trepat X, 2005, J APPL PHYSIOL, V98, P1567, DOI 10.1152/japplphysiol.00925.2004; Waerhaug K, 2009, CRIT CARE, V13, DOI 10.1186/cc7777; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Ware LB, 2003, AM J PHYSIOL-LUNG C, V285, pL514, DOI 10.1152/ajplung.00442.2002; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Winton HL, 1998, CLIN EXP ALLERGY, V28, P1273, DOI 10.1046/j.1365-2222.1998.00354.x; Zeng W, 2004, CRIT CARE MED, V32, pS302, DOI 10.1097/01.CCM.0000128038.49201.8C	38	18	20	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56965	10.1371/journal.pone.0056965	http://dx.doi.org/10.1371/journal.pone.0056965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451122	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800055
J	Lane, DJR; Saletta, F; Rahmanto, YS; Kovacevic, Z; Richardson, DR				Lane, Darius J. R.; Saletta, Federica; Rahmanto, Yohan Suryo; Kovacevic, Zaklina; Richardson, Des R.			N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion	PLOS ONE			English	Article							PYRIDOXAL ISONICOTINOYL HYDRAZONE; EFFECTIVE ANTIPROLIFERATIVE AGENTS; METASTASIS SUPPRESSOR GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RIBONUCLEOTIDE REDUCTASE; ENDOTHELIAL-CELLS; MOLECULAR TARGETS; TUMOR-METASTASIS; FACTOR 1-ALPHA; EXPRESSION	Iron is critical for cellular proliferation and its depletion leads to a suppression of both DNA synthesis and global translation. These observations suggest that iron depletion may trigger a cellular "stress response". A canonical response of cells to stress is the formation of stress granules, which are dynamic cytoplasmic aggregates containing stalled pre-initiation complexes that function as mRNA triage centers. By differentially prioritizing mRNA translation, stress granules allow for the continued and selective translation of stress response proteins. Although the multi-subunit eukaryotic initiation factor 3 (eIF3) is required for translation initiation, its largest subunit, eIF3a, may not be essential for this activity. Instead, eIF3a is a vital constituent of stress granules and appears to act, in part, by differentially regulating specific mRNAs during iron depletion. Considering this, we investigated eIF3a's role in modulating iron-regulated genes/proteins that are critically involved in proliferation and metastasis. In this study, eIF3a was down-regulated and recruited into stress granules by iron depletion as well as by the classical stress-inducers, hypoxia and tunicamycin. Iron depletion also increased expression of the metastasis suppressor, N-myc downstream regulated gene-1 (NDRG1), and a known downstream repressed target of eIF3a, namely the cyclin-dependent kinase inhibitor, p27(kip1). To determine if eIF3a regulates NDRG1 expression, eIF3a was inducibly over-expressed or ablated. Importantly, eIF3a positively regulated NDRG1 expression and negatively regulated p27(kip1) expression during iron depletion. This activity of eIF3a could be due to its recruitment to stress granules and/or its ability to differentially regulate mRNA translation during cellular stress. Additionally, eIF3a positively regulated proliferation, but negatively regulated cell motility and invasion, which may be due to the eIF3a-dependent changes in expression of NDRG1 and p27(kip1) observed under these conditions.	[Lane, Darius J. R.] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Lane, DJR (corresponding author), Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia.	darius.lane@sydney.edu.au	Suryo Rahmanto, Yohan/K-8043-2018; Kovacevic, Zaklina/ABD-9581-2021	Suryo Rahmanto, Yohan/0000-0003-1453-7872; Kovacevic, Zaklina/0000-0002-4742-4690; Lane, Darius/0000-0001-8725-6903; Richardson, Des/0000-0002-5506-3274; Saletta, Federica/0000-0003-0598-3504; Richardson, Des/0000-0003-0960-6415	Cancer Institute NSW (CINSW) [10/ECF/2-18]; NHMRC; CINSW [07/RSA/1-22]; University of Sydney; CINSW Early Career Fellowship [08/ECF/1-36]; National Health and Medical Research Council (NHMRC)	Cancer Institute NSW (CINSW); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CINSW; University of Sydney(University of Sydney); CINSW Early Career Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	DJRL kindly thanks the Cancer Institute NSW (CINSW) for an Early Career Fellowship [10/ECF/2-18] and the NHMRC for an Early Career Postdoctoral Fellowship. FS thanks the CINSW for a Research Scholar Award [07/RSA/1-22] and the University of Sydney for a PhD Scholarship and University Postgraduate Award. YSR appreciates the support of a CINSW Early Career Fellowship [08/ECF/1-36]. ZK kindly thanks the National Health and Medical Research Council (NHMRC) or Australia for an Early Career Postdoctoral Fellowship. DRR thanks the NHMRC for a Senior Principal Research Fellowship and Project Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Angst E, 2006, BRIT J CANCER, V95, P307, DOI 10.1038/sj.bjc.6603256; Bachmann F, 1997, CANCER RES, V57, P988; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Chaudhuri J, 1997, J BIOL CHEM, V272, P30975, DOI 10.1074/jbc.272.49.30975; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Damoc E, 2007, MOL CELL PROTEOMICS, V6, P1135, DOI 10.1074/mcp.M600399-MCP200; Darnell G, 1999, BLOOD, V94, P781, DOI 10.1182/blood.V94.2.781.414k32_781_792; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2006, CRIT REV ONCOL HEMAT, V59, P169, DOI 10.1016/j.critrevonc.2006.03.005; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Farley J, 2011, GYNECOL ONCOL, V121, P395, DOI 10.1016/j.ygyno.2010.11.023; Fu D, 2007, BLOOD, V110, P752, DOI 10.1182/blood-2007-03-076737; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOTO Y, 1983, J BIOL CHEM, V258, P5248; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Guang RJ, 2000, CANCER RES, V60, P749; Inagaki Y, 2009, DIGEST LIVER DIS, V41, P96, DOI 10.1016/j.dld.2008.04.003; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Jiang H, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-2; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Kovacevic Z, 2008, BBA-MOL CELL RES, V1783, P1981, DOI 10.1016/j.bbamcr.2008.05.016; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Leber MF, 2009, INT J ONCOL, V34, P881, DOI 10.3892/ijo_00000214; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu YL, 2011, TUMOR BIOL, V32, P99, DOI 10.1007/s13277-010-0103-z; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; MAITRA U, 1982, ANNU REV BIOCHEM, V51, P869, DOI 10.1146/annurev.bi.51.070182.004253; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Park H, 2000, BIOCHEM BIOPH RES CO, V276, P321, DOI 10.1006/bbrc.2000.3475; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; PONKA P, 1982, BIOCHIM BIOPHYS ACTA, V718, P151, DOI 10.1016/0304-4165(82)90213-6; Rahmanto YS, 2007, CARCINOGENESIS, V28, P2172, DOI 10.1093/carcin/bgm096; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Richardson DR, 1999, J BIOL INORG CHEM, V4, P266, DOI 10.1007/s007750050312; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; Ryan HE, 2000, CANCER RES, V60, P4010; Saletta F, 2011, J BIOL CHEM, V286, P35396, DOI 10.1074/jbc.M111.273060; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Saletta F, 2010, MOL PHARMACOL, V77, P443, DOI 10.1124/mol.109.061028; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Salnikow K, 2000, CANCER RES, V60, P38; Salnikow K, 2008, CARCINOGENESIS, V29, P1493, DOI 10.1093/carcin/bgn088; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Simpson J, 2011, MOL VIS, V17, P2212; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Van de Putte G, 2003, GYNECOL ONCOL, V89, P140, DOI 10.1016/S0090-8258(03)00010-6; vanBelzen N, 1997, LAB INVEST, V77, P85; Vengellur A, 2003, GENE EXPRESSION, V11, P181, DOI 10.3727/000000003108749062; Wang G, 2003, J CELL BIOCHEM, V90, P548, DOI 10.1002/jcb.10621; Wang G, 2004, BIOMETALS, V17, P15, DOI 10.1023/A:1024417309370; WRIGHT JA, 1990, BIOCHEM CELL BIOL, V68, P1364, DOI 10.1139/o90-199; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591; Zhou DJ, 1998, CANCER RES, V58, P2182	82	56	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57273	10.1371/journal.pone.0057273	http://dx.doi.org/10.1371/journal.pone.0057273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437357	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000092
J	Brandt, ME; Smith, TB; Correa, AMS; Vega-Thurber, R				Brandt, Marilyn E.; Smith, Tyler B.; Correa, Adrienne M. S.; Vega-Thurber, Rebecca			Disturbance Driven Colony Fragmentation as a Driver of a Coral Disease Outbreak	PLOS ONE			English	Article							MULTIPLE STABLE STATES; NATIONAL-PARK; REEF; FLORIDA; CONSERVATION; POPULATIONS; THRESHOLDS; MACROALGAE; PATTERNS; BAHAMAS	In September of 2010, Brewer's Bay reef, located in St. Thomas (U.S. Virgin Islands), was simultaneously affected by abnormally high temperatures and the passage of a hurricane that resulted in the mass bleaching and fragmentation of its coral community. An outbreak of a rapid tissue loss disease among coral colonies was associated with these two disturbances. Gross lesion signs and lesion progression rates indicated that the disease was most similar to the Caribbean coral disease white plague type 1. Experiments indicated that the disease was transmissible through direct contact between colonies, and five-meter radial transects showed a clustered spatial distribution of disease, with diseased colonies being concentrated within the first meter of other diseased colonies. Disease prevalence and the extent to which colonies were bleached were both significantly higher on unattached colony fragments than on attached colonies, and disease occurred primarily on fragments found in direct contact with sediment. In contrast to other recent studies, disease presence was not related to the extent of bleaching on colonies. The results of this study suggest that colony fragmentation and contact with sediment played primary roles in the initial appearance of disease, but that the disease was capable of spreading among colonies, which suggests secondary transmission is possible through some other, unidentified mechanism.	[Brandt, Marilyn E.; Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Correa, Adrienne M. S.; Vega-Thurber, Rebecca] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Correa, Adrienne M. S.; Vega-Thurber, Rebecca] Florida Int Univ, Dept Biol Sci, N Miami, FL USA; [Correa, Adrienne M. S.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA	University of the Virgin Islands; Oregon State University; State University System of Florida; Florida International University; Rice University	Brandt, ME (corresponding author), Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA.	mbrandt@uvi.edu			Virgin Islands Experimental Program to Stimulate Competitive Research (VI-EPSCoR)	Virgin Islands Experimental Program to Stimulate Competitive Research (VI-EPSCoR)	Funding was provided by an incubator grant from the Virgin Islands Experimental Program to Stimulate Competitive Research (VI-EPSCoR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2006, MAR ECOL PROG SER, V318, P103, DOI 10.3354/meps318103; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Borger JL, 2003, REV BIOL TROP, V51, P25; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Brandt ME, 2012, B MAR SCI, V88, P1035, DOI 10.5343/bms.2011.1104; Brandt ME, 2009, DIS AQUAT ORGAN, V87, P117, DOI 10.3354/dao02137; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruckner AW, 1997, CORAL REEFS, V16, P260, DOI 10.1007/s003380050081; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Crabbe MJC, 2009, MAR ENVIRON RES, V67, P189, DOI 10.1016/j.marenvres.2009.01.003; Croquer A, 2005, CARIBB J SCI, V41, P815; Diggle PJ, 1983, STAT ANAL SPATIAL PO; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; DUSTAN P, 1977, ENVIRON GEOL, V2, P51, DOI 10.1007/BF02430665; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Knowlton N, 2004, PROG OCEANOGR, V60, P387, DOI 10.1016/j.pocean.2004.02.011; KNOWLTON N, 1992, AM ZOOL, V32, P674; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Manzello DP, 2007, MAR POLLUT BULL, V54, P1923, DOI 10.1016/j.marpolbul.2007.08.009; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; MEESTERS EH, 1993, MAR ECOL PROG SER, V96, P189, DOI 10.3354/meps096189; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Miller J, 2012, 2012 INT COR REEF S; Miller MW, 2007, CORAL REEFS, V26, P97, DOI 10.1007/s00338-006-0165-y; Morrow KM, 2011, CORAL REEFS, V30, P309, DOI 10.1007/s00338-011-0747-1; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; NOAA, 2012, COR REEF WATCH COR B; NPS, 2012, 2181494 NPS; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pollock FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002183; Richardson LL, 1998, REV BIOL TROP, V46, P187; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Richardson LL, 2001, HYDROBIOLOGIA, V460, P71, DOI 10.1023/A:1013187723831; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Vega-Thurber R., 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044246, DOI 10.1371/JOURNAL.PONE.00442463434190]; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Widder EA, 2005, DEEP-SEA RES PT I, V52, P2077, DOI 10.1016/j.dsr.2005.06.007; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155	50	46	46	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57164	10.1371/journal.pone.0057164	http://dx.doi.org/10.1371/journal.pone.0057164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437335	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200224
J	Nieminen, L; Webb, S; Smith, MCM; Hoskisson, PA				Nieminen, Leena; Webb, Steven; Smith, Margaret C. M.; Hoskisson, Paul A.			A Flexible Mathematical Model Platform for Studying Branching Networks: Experimentally Validated Using the Model Actinomycete, Streptomyces coelicolor	PLOS ONE			English	Article							MORPHOLOGICALLY STRUCTURED MODEL; FILAMENTOUS MICROORGANISMS; ANTIBIOTIC PRODUCTION; SUBMERGED CULTURES; MYCELIAL NETWORKS; GROWTH; ANGIOGENESIS; A3(2); DESIGN; ENVIRONMENTS	Branching networks are ubiquitous in nature and their growth often responds to environmental cues dynamically. Using the antibiotic-producing soil bacterium Streptomyces as a model we have developed a flexible mathematical model platform for the study of branched biological networks. Streptomyces form large aggregates in liquid culture that can impair industrial antibiotic fermentations. Understanding the features of these could aid improvement of such processes. The model requires relatively few experimental values for parameterisation, yet delivers realistic simulations of Streptomyces pellet and is able to predict features, such as the density of hyphae, the number of growing tips and the location of antibiotic production within a pellet in response to pellet size and external nutrient supply. The model is scalable and will find utility in a range of branched biological networks such as angiogenesis, plant root growth and fungal hyphal networks.	[Nieminen, Leena; Hoskisson, Paul A.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Nieminen, Leena] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Webb, Steven] Univ Liverpool, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England; [Smith, Margaret C. M.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Strathclyde; University of Strathclyde; University of Liverpool; University of York - UK	Webb, S (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Liverpool L69 3BX, Merseyside, England.	steven.webb@liverpool.ac.uk; Paul.hoskisson@strath.ac.uk	Kerr, Leena/AAY-8332-2020	Kerr, Leena/0000-0003-0811-3264; Hoskisson, Paul/0000-0003-4332-1640; Smith, Maggie/0000-0002-4150-0496	Scottish Universities Life Science Alliance (SULSA)	Scottish Universities Life Science Alliance (SULSA)	The authors would like to thank the Scottish Universities Life Science Alliance (SULSA) for PhD studentship funding to LN (http://www.sulsa.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-202; ALLAN EJ, 1983, J GEN MICROBIOL, V129, P2029; Bastian P, 2008, J THEOR BIOL, V254, P99, DOI 10.1016/j.jtbi.2008.04.014; Bebber DP, 2007, P ROY SOC B-BIOL SCI, V274, P2307, DOI 10.1098/rspb.2007.0459; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Birol G, 2002, BIOTECHNOL BIOENG, V77, P538, DOI 10.1002/bit.10115; Boswell GP, 2002, J THEOR BIOL, V217, P459, DOI 10.1006/jtbi.2002.3048; Boswell GP, 2008, MYCOL RES, V112, P1015, DOI 10.1016/j.mycres.2008.02.006; Boswell Graeme P., 2012, Fungal Biology Reviews, V26, P30, DOI 10.1016/j.fbr.2012.02.002; Celler K, 2012, ANTON LEEUW INT J G, V102, P409, DOI 10.1007/s10482-012-9760-9; Davidson FA, 1998, J THEOR BIOL, V195, P281, DOI 10.1006/jtbi.1998.0739; Dupuy L, 2010, J EXP BOT, V61, P2131, DOI 10.1093/jxb/erp389; Fricker MD, 2008, J MICROSC-OXFORD, V231, P317, DOI 10.1111/j.1365-2818.2008.02043.x; Heaton Luke, 2012, Fungal Biology Reviews, V26, P12, DOI 10.1016/j.fbr.2012.02.001; Hille A, 2005, BIOTECHNOL BIOENG, V92, P614, DOI 10.1002/bit.20628; Jones Pamela F., 2006, Angiogenesis, V9, P127, DOI 10.1007/s10456-006-9039-8; Jyothikumar V, 2008, APPL ENVIRON MICROB, V74, P6774, DOI 10.1128/AEM.01233-08; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Lejeune R, 1997, BIOTECHNOL BIOENG, V53, P139, DOI 10.1002/(SICI)1097-0290(19970120)53:2<139::AID-BIT3>3.0.CO;2-P; LEJEUNE R, 1995, BIOTECHNOL BIOENG, V47, P609, DOI 10.1002/bit.260470513; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Manteca A, 2008, APPL ENVIRON MICROB, V74, P3877, DOI 10.1128/AEM.02715-07; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Melzoch K, 1997, BIOTECHNOL BIOENG, V54, P577; MEYERHOFF J, 1995, BIOPROCESS ENG, V12, P305; MEYERHOFF J, 1995, J BIOTECHNOL, V38, P201, DOI 10.1016/0168-1656(94)00121-R; Murray J.D., 2001, MATH BIOL; NIELSEN J, 1993, BIOTECHNOL BIOENG, V41, P715, DOI 10.1002/bit.260410706; OBERT M, 1990, J BACTERIOL, V172, P1180, DOI 10.1128/jb.172.3.1180-1185.1990; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Plank MJ, 2004, B MATH BIOL, V66, P1785, DOI 10.1016/j.bulm.2004.04.001; PROSSER JI, 1991, CRIT REV BIOTECHNOL, V10, P253, DOI 10.3109/07388559109038211; PROSSER JI, 1979, J GEN MICROBIOL, V111, P153, DOI 10.1099/00221287-111-1-153; Richards DM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002423; Shahab N, 1996, MICROBIOL-SGM, V142, P1927, DOI 10.1099/13500872-142-8-1927; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; STOKES CL, 1991, J CELL SCI, V99, P419; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Tough AJ, 1996, MICROBIOL-UK, V142, P639, DOI 10.1099/13500872-142-3-639; Traag BA, 2007, APPL ENVIRON MICROB, V73, P2085, DOI 10.1128/AEM.02755-06; van Wezel GP, 2006, APPL ENVIRON MICROB, V72, P5283, DOI 10.1128/AEM.00808-06; Wardell JN, 2002, BIOTECHNOL BIOENG, V78, P141, DOI 10.1002/bit.10210; WILKE CR, 1955, AICHE J, V1, P264, DOI 10.1002/aic.690010222; YANG H, 1992, BIOTECHNOL BIOENG, V39, P44, DOI 10.1002/bit.260390108; YANG H, 1992, BIOTECHNOL BIOENG, V39, P49, DOI 10.1002/bit.260390109	45	17	17	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e54316	10.1371/journal.pone.0054316	http://dx.doi.org/10.1371/journal.pone.0054316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441147	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200005
J	Norais, C; Servant, P; Bouthier-de-la-Tour, C; Coureux, PD; Ithurbide, S; Vannier, F; Guerin, PP; Dulberger, CL; Satyshur, KA; Keck, JL; Armengaud, J; Cox, MM; Sommer, S				Norais, Cedric; Servant, Pascale; Bouthier-de-la-Tour, Claire; Coureux, Pierre-Damien; Ithurbide, Solenne; Vannier, Francoise; Guerin, Philippe P.; Dulberger, Charles L.; Satyshur, Kenneth A.; Keck, James L.; Armengaud, Jean; Cox, Michael M.; Sommer, Suzanne			The Deinococcus radiodurans DR1245 Protein, a DdrB Partner Homologous to YbjN Proteins and Reminiscent of Type III Secretion System Chaperones	PLOS ONE			English	Article							STRAND BREAK REPAIR; CRYSTAL-STRUCTURE; VIRULENCE FACTORS; ESCHERICHIA-COLI; BINDING; RADIATION; REVEALS; COMPLEX; RESISTANCE; PEPTIDE	The bacterium Deinococcus radiodurans exhibits an extreme resistance to ionizing radiation. A small subset of Deinococcus genus-specific genes were shown to be up-regulated upon exposure to ionizing radiation and to play a role in genome reconstitution. These genes include an SSB-like protein called DdrB. Here, we identified a novel protein encoded by the dr1245 gene as an interacting partner of DdrB. A strain devoid of the DR1245 protein is impaired in growth, exhibiting a generation time approximately threefold that of the wild type strain while radioresistance is not affected. We determined the three-dimensional structure of DR1245, revealing a relationship with type III secretion system chaperones and YbjN family proteins. Thus, DR1245 may display some chaperone activity towards DdrB and possibly other substrates.	[Norais, Cedric; Dulberger, Charles L.; Cox, Michael M.] Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI USA; [Norais, Cedric; Coureux, Pierre-Damien] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [Servant, Pascale; Bouthier-de-la-Tour, Claire; Ithurbide, Solenne; Vannier, Francoise; Sommer, Suzanne] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Servant, Pascale; Bouthier-de-la-Tour, Claire; Ithurbide, Solenne; Vannier, Francoise; Sommer, Suzanne] CNRS, F-91405 Orsay, France; [Guerin, Philippe P.; Armengaud, Jean] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Environm & Biotechnol, Lab Biochim Syst Perturb, Bagnols Sur Ceze, France; [Satyshur, Kenneth A.; Keck, James L.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CEA; University of Wisconsin System; University of Wisconsin Madison	Sommer, S (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, Bat 409, F-91405 Orsay, France.	suzanne.sommer@igmors.u-psud.fr	Ithurbide, Solenne/AAV-3999-2020; Servant, pascale/V-9016-2017	Keck, James/0000-0002-5961-0220; Satyshur, Kenneth/0000-0001-9371-2493; ARMENGAUD, Jean/0000-0003-1589-445X; Ithurbide, Solenne/0000-0002-1533-8472	Centre National de la Recherche Scientifique; University Paris-Sud, Electricite de France [RB2007-11]; Agence Nationale de la Recherche [ANR-07-BLAN-0106]; United States National Institutes of Health [GM32335, GM068061]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM032335, R01GM067085, R01GM068061] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud, Electricite de France; Agence Nationale de la Recherche(French National Research Agency (ANR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Centre National de la Recherche Scientifique, the University Paris-Sud, Electricite de France (RB2007-11 to SS), the Agence Nationale de la Recherche (ANR-07-BLAN-0106 to SS), and the United States National Institutes of Health (GM32335 and GM068061 to MMC and JLK, respectively). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bentchikou E, 2007, J BACTERIOL, V189, P4784, DOI 10.1128/JB.00452-07; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blasius M, 2008, CRIT REV BIOCHEM MOL, V43, P221, DOI [10.1080/10409230802122274, 10.1080/10409230802122274 ]; Buttner CR, 2005, PROTEIN SCI, V14, P1993, DOI 10.1110/ps.051474605; Chen XN, 2006, BIOCHEM BIOPH RES CO, V345, P834, DOI 10.1016/j.bbrc.2006.04.101; Clair G, 2010, MOL CELL PROTEOMICS, V9, P1486, DOI 10.1074/mcp.M000027-MCP201; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; de la Tour CB, 2009, EXTREMOPHILES, V13, P827, DOI 10.1007/s00792-009-0270-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Gabant G, 2008, J MASS SPECTROM, V43, P360, DOI 10.1002/jms.1328; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Izore T, 2011, STRUCTURE, V19, P603, DOI 10.1016/j.str.2011.03.015; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; Narumi I, 2004, MOL MICROBIOL, V54, P278, DOI 10.1111/j.1365-2958.2004.04272.x; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Schreiner M, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-13; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Toueille M, 2012, J PROTEOMICS, V75, P2588, DOI 10.1016/j.jprot.2012.03.002; Vogelaar NJ, 2010, BIOCHEMISTRY-US, V49, P5870, DOI 10.1021/bi100432e; Wang DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045038; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025293; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003; Xu GZ, 2010, DNA REPAIR, V9, P805, DOI 10.1016/j.dnarep.2010.04.006; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	49	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56558	10.1371/journal.pone.0056558	http://dx.doi.org/10.1371/journal.pone.0056558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441204	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200061
J	Triulzi, T; Casalini, P; Sandri, M; Ratti, M; Carcangiu, ML; Colombo, MP; Balsari, A; Menard, S; Orlandi, R; Tagliabue, E				Triulzi, Tiziana; Casalini, Patrizia; Sandri, Marco; Ratti, Manuela; Carcangiu, Maria L.; Colombo, Mario P.; Balsari, Andrea; Menard, Sylvie; Orlandi, Rosaria; Tagliabue, Elda			Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR; INVASION; SIGNATURE; SPARC; MIGRATION; OVEREXPRESSION; METAANALYSIS; MACROPHAGES; FIBROBLASTS	We recently showed that differential expression of extracellular matrix (ECM) genes delineates four subgroups of breast carcinomas (ECM1, -2, -3- and -4) with different clinical outcome. To further investigate the characteristics of ECM signature and its impact on tumor progression, we conducted unsupervised clustering analyses in 6 additional independent datasets of invasive breast tumors from different platforms for a total of 643 samples. Use of four different clustering algorithms identified ECM3 tumors as an independent group in all datasets tested. ECM3 showed a homogeneous gene pattern, consisting of 58 genes encoding 43 structural ECM proteins. From 26 to 41% of the cases were ECM3-enriched, and analysis of datasets relevant to gene expression in neoplastic or corresponding stromal cells showed that both stromal and breast carcinoma cells can coordinately express ECM3 genes. In in vitro experiments, beta-estradiol induced ECM3 gene production in ER-positive breast carcinoma cell lines, whereas TGF beta induced upregulation of the genes leading to ECM3 gene classification, especially in ER-negative breast carcinoma cells and in fibroblasts. Multivariate analysis of distant metastasis-free survival in untreated breast tumor patients revealed a significant interaction between ECM3 and histological grade (p = 0.001). Cox models, estimated separately in grade I-II and grade III tumors, indicated a highly significant association between ECM3 and worse survival probability only in grade III tumors (HR = 3.0, 95% CI = 1.3-7.0, p = 0.0098). Gene Set Enrichment analysis of ECM3 compared to non-ECM3 tumors revealed significant enrichment of epithelial-mesenchymal transition (EMT) genes in both grade I-II and grade III subsets of ECM3 tumors. Thus, ECM3 is a robust cluster that identifies breast carcinomas with EMT features but with accelerated metastatic potential only in the undifferentiated (grade III) phenotype. These findings support the key relevance of neoplastic and stroma interaction in breast cancer progression.	[Triulzi, Tiziana; Casalini, Patrizia; Sandri, Marco; Ratti, Manuela; Menard, Sylvie; Orlandi, Rosaria; Tagliabue, Elda] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Targeting Unit, Milan, Italy; [Carcangiu, Maria L.] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Anat Pathol Unit A, Milan, Italy; [Colombo, Mario P.] Fdn IRCCS Ist Nazl Tumori, Mol Immunol Unit, Dept Expt Oncol & Mol Med, Milan, Italy; [Balsari, Andrea] Univ Milan, Dipartimento Sci Biomed Salute, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan	Tagliabue, E (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Targeting Unit, Milan, Italy.	elda.tagliabue@istitutotumori.mi.it	Tagliabue, Elda/B-9377-2017; Sandri, Marco/L-2875-2013; Colombo, Mario P./V-7166-2017; Triulzi, Tiziana/C-1070-2017; balsari, andrea/M-5657-2016; Orlandi, Rosaria/C-1182-2017	Tagliabue, Elda/0000-0001-9877-2903; Sandri, Marco/0000-0002-1422-5695; Colombo, Mario P./0000-0003-0042-7955; Triulzi, Tiziana/0000-0003-3050-8676; balsari, andrea/0000-0002-3250-2668; Orlandi, Rosaria/0000-0002-0533-9041	Associazione Italiana per la Ricerca sul Cancro (AIRC) [5496, 12162]; Cassa di Risparmio delle Provincie Lombarde (CARIPLO); Italian Bureau of Health	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Cassa di Risparmio delle Provincie Lombarde (CARIPLO)(Fondazione Cariplo); Italian Bureau of Health	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC) (Grants No. 5496 and No. 12162), Cassa di Risparmio delle Provincie Lombarde (CARIPLO) and Italian Bureau of Health (Alleanza contro il Cancro and funds obtained through a law by the Italian government which allowed Italian citizens to allocate the 5x1000 share of their tax payment to support a research or charitable institution of their choice). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Casey TM, 2008, BREAST CANCER RES TR, V110, P39, DOI 10.1007/s10549-007-9684-7; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cox D. R., 1984, ANAL SURVIVAL DATA; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; HajianTilaki KO, 1997, MED DECIS MAKING, V17, P94, DOI 10.1177/0272989X9701700111; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Ilic D, 1998, J CELL BIOL, V143, P547; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; McCready J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2578; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Myhre S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014002; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; Pupa SM, 2002, J CELL PHYSIOL, V192, P259, DOI 10.1002/jcp.10142; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Sangaletti S, 2005, J CELL SCI, V118, P3685, DOI 10.1242/jcs.02474; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Shabalin AA, 2009, ANN APPL STAT, V3, P985, DOI 10.1214/09-AOAS239; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; StataCorp, 2009, STAT STAT SOFTW REL; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Wang WG, 2002, CANCER RES, V62, P6278; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yan DJ, 2010, BIOSCI BIOTECH BIOCH, V74, P2103, DOI 10.1271/bbb.100286	55	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56761	10.1371/journal.pone.0056761	http://dx.doi.org/10.1371/journal.pone.0056761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441215	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200072
J	Kosaka, N; Iguchi, H; Hagiwara, K; Yoshioka, Y; Takeshita, F; Ochiya, T				Kosaka, Nobuyoshi; Iguchi, Haruhisa; Hagiwara, Keitaro; Yoshioka, Yusuke; Takeshita, Fumitaka; Ochiya, Takahiro			Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISMS; HYPOXIA; RNA	The release of humoral factors between cancer cells and the microenvironmental cells is critical for metastasis; however, the roles of secreted miRNAs in non-cell autonomous cancer progression against microenvironmental cells remain largely unknown. Here, we demonstrate that the neutral sphyngomyelinase 2 (nSMase2) regulates exosomal microRNA (miRNA) secretion and promotes angiogenesis within the tumor microenvironment as well as metastasis. We demonstrate a requirement for nSMase2-mediated cancer cell exosomal miRNAs in the regulation of metastasis through the induction of angiogenesis in inoculated tumors. In addition, miR-210, released by metastatic cancer cells, was shown to transport to endothelial cells and suppress the expression of specific target genes, which resulted in enhanced angiogenesis. These findings suggest that the horizontal transfer of exosomal miRNAs from cancer cells can dictate the microenviromental niche for the benefit of the cancer cell, like "on demand system" for cancer cells.	[Kosaka, Nobuyoshi; Iguchi, Haruhisa; Hagiwara, Keitaro; Yoshioka, Yusuke; Takeshita, Fumitaka; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, Tokyo 1040045, Japan; [Iguchi, Haruhisa] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Konohana Ku, Osaka 5540022, Japan; [Hagiwara, Keitaro] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	National Cancer Center - Japan; Dainippon Sumitomo Pharmaceutical Company; Tokyo Institute of Technology	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Chuo Ku, 1-1 Tsukiji,5 Chome, Tokyo 1040045, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019		Ministry of Education, Culture, Sports, Science, and Technology; National Institute of Biomedical Innovation (NiBio); Japan Society for the Promotion of Science initiated by the Council for Science and Technology Policy; Japanese Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NiBio)(National Institute of Biomedical Innovation); Japan Society for the Promotion of Science initiated by the Council for Science and Technology Policy(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for the third term comprehensive 10-year strategy for cancer control, a grant-in-aid for scientific research on priority areas cancer from the Ministry of Education, Culture, Sports, Science, and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NiBio), and the Japan Society for the Promotion of Science through the Funding Program for world leading innovative R&D on science and technology (FIRST Program) initiated by the Council for Science and Technology Policy, and a grant-in-aid for Scientific Research on Innovative Areas (functional machinery for non-coding RNAs) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bobrie A, 2012, CANCER RES, V72, P4920, DOI 10.1158/0008-5472.CAN-12-0925; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; GALAND P, 1966, EXP CELL RES, V43, P391, DOI 10.1016/0014-4827(66)90066-8; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Jung EJ, 2012, CANCER-AM CANCER SOC, V118, P2603, DOI 10.1002/cncr.26565; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka Nobuyoshi, 2012, Frontiers in Genetics, V2, P97, DOI 10.3389/fgene.2011.00097; Kosaka N, 2012, J BIOL CHEM, V287, P1397, DOI 10.1074/jbc.M111.288662; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Maupas-Schwalm F, 2009, CELL SIGNAL, V21, P1925, DOI 10.1016/j.cellsig.2009.08.010; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; STROUN M, 1978, CANCER RES, V38, P3546; Takeshita F, 2010, MOL THER, V18, P181, DOI 10.1038/mt.2009.207; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yamamoto Y, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-135; Yang M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-117; Yoshioka Y, 2012, J BIOL CHEM, V287, P34110, DOI 10.1074/jbc.M112.356717	31	501	530	1	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10849	10859		10.1074/jbc.M112.446831	http://dx.doi.org/10.1074/jbc.M112.446831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439645	Green Published, hybrid			2022-12-25	WOS:000317565000062
J	D'Souza, AJ; Desai, SD; Rudner, XL; Kelly, MN; Ruan, S; Shellito, JE				D'Souza, Alain J.; Desai, Shyamal D.; Rudner, Xiaowen L.; Kelly, Michelle N.; Ruan, SanBao; Shellito, Judd E.			Suppression of the Macrophage Proteasome by Ethanol Impairs MHC Class I Antigen Processing and Presentation	PLOS ONE			English	Article							IMMUNE-SYSTEM; PROTEIN-DEGRADATION; UBIQUITIN SYSTEM; 26S PROTEASOMES; HOST-DEFENSE; 2 PARTS; ALCOHOL; EXPOSURE; ALPHA; ACTIVATION	Alcohol binge-drinking (acute ethanol consumption) is immunosuppressive and alters both the innate and adaptive arms of the immune system. Antigen presentation by macrophages (and other antigen presenting cells) represents an important function of the innate immune system that, in part, determines the outcome of the host immune response. Ethanol has been shown to suppress antigen presentation in antigen presenting cells though mechanisms of this impairment are not well understood. The constitutive and immunoproteasomes are important components of the cellular proteolytic machinery responsible for the initial steps critical to the generation of MHC Class I peptides for antigen presentation. In this study, we used an in-vitro cell culture model of acute alcohol exposure to study the effect of ethanol on the proteasome function in RAW 264.7 cells. Additionally, primary murine peritoneal macrophages obtained by peritoneal lavage from C57BL/6 mice were used to confirm our cell culture findings. We demonstrate that ethanol impairs proteasome function in peritoneal macrophages through suppression of chymotrypsin-like (Cht-L) proteasome activity as well as composition of the immunoproteasome subunit LMP7. Using primary murine peritoneal macrophages, we have further demonstrated that, ethanol-induced impairment of the proteasome function suppresses processing of antigenic proteins and peptides by the macrophage and in turn suppresses the presentation of these antigens to cells of adaptive immunity. The results of this study provide an important mechanism to explain the immunosuppressive effects of acute ethanol exposure.	[D'Souza, Alain J.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Desai, Shyamal D.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [D'Souza, Alain J.; Rudner, Xiaowen L.; Kelly, Michelle N.; Ruan, SanBao; Shellito, Judd E.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Pulmonary Crit Care Med, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Desai, SD (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA.	sdesai@lsuhsc.edu; jshell@lsuhsc.edu		D'Souza, Alain/0000-0003-1851-5638	Public Health Service Grant [HL076100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076100] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Public Health Service Grant HL076100 (JES) (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; BALLARD HS, 1989, ALCOHOL CLIN EXP RES, V13, P706, DOI 10.1111/j.1530-0277.1989.tb00408.x; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Crabbe JC, 2011, ANN NY ACAD SCI, V1216, P24, DOI 10.1111/j.1749-6632.2010.05895.x; Craiu A, 1997, J BIOL CHEM, V272, P13437, DOI 10.1074/jbc.272.20.13437; Delves PJ, 2000, NEW ENGL J MED, V343, P37, DOI 10.1056/NEJM200007063430107; Delves PJ, 2000, NEW ENGL J MED, V343, P108, DOI 10.1056/NEJM200007133430207; Donohue TM, 2007, ALCOHOL CLIN EXP RES, V31, P1446, DOI 10.1111/j.1530-0277.2007.00454.x; Donohue TM, 2006, INT J BIOCHEM CELL B, V38, P92, DOI 10.1016/j.biocel.2005.07.010; GACZYNSKA M, 1993, ENZYME PROTEIN, V47, P354, DOI 10.1159/000468693; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Goral J, 2005, J IMMUNOL, V174, P456, DOI 10.4049/jimmunol.174.1.456; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Haorah J, 2004, CELL IMMUNOL, V229, P139, DOI 10.1016/j.cellimm.2004.07.005; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Mandrekar P, 2002, ALCOHOL CLIN EXP RES, V26, P1609, DOI 10.1097/01.ALC.0000036926.46632.57; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Osna NA, HEPATOLOGY, V49, P1308; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Rivett AJ, 2004, CURR PROTEIN PEPT SC, V5, P153, DOI 10.2174/1389203043379774; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Stoltz DA, 2000, AM J RESP CRIT CARE, V161, P135, DOI 10.1164/ajrccm.161.1.9905016; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; SZABO G, 1993, J LEUKOCYTE BIOL, V54, P534, DOI 10.1002/jlb.54.6.534; Szabo G, 1996, ALCOHOL CLIN EXP RES, V20, P900, DOI 10.1111/j.1530-0277.1996.tb05269.x; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173	32	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56890	10.1371/journal.pone.0056890	http://dx.doi.org/10.1371/journal.pone.0056890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451104	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500040
J	Huang, YD; Ochieng, JK; Buscop-van Kempen, M; Boerema-de Munck, A; Swagemakers, S; van Ijcken, W; Grosveld, F; Tibboel, D; Rottier, RJ				Huang, Yadi; Ochieng, Joshua Kapere; Buscop-van Kempen, Marjon; Boerema-de Munck, Anne; Swagemakers, Sigrid; van Ijcken, Wilfred; Grosveld, Frank; Tibboel, Dick; Rottier, Robbert J.			Hypoxia Inducible Factor 3 alpha Plays a Critical Role in Alveolarization and Distal Epithelial Cell Differentiation during Mouse Lung Development	PLOS ONE			English	Article							PAS DOMAIN PROTEIN; TUMOR-SUPPRESSOR PROTEIN; HIGH-ALTITUDE ADAPTATION; FACTOR 2-ALPHA PLAYS; GENE-EXPRESSION; TRANSCRIPTION FACTOR; FACTOR 1-ALPHA; PROLYL HYDROXYLATION; FACTOR (HIF)-1-ALPHA; NEGATIVE REGULATOR	Lung development occurs under relative hypoxia and the most important oxygen-sensitive response pathway is driven by Hypoxia Inducible Factors (HIF). HIFs are heterodimeric transcription factors of an oxygen-sensitive subunit, HIF alpha, and a constitutively expressed subunit, HIF1 beta. HIF1 alpha and HIF2 alpha, encoded by two separate genes, contribute to the activation of hypoxia inducible genes. A third HIF alpha gene, HIF3 alpha, is subject to alternative promoter usage and splicing, leading to three major isoforms, HIF3 alpha, NEPAS and IPAS. HIF3 alpha gene products add to the complexity of the hypoxia response as they function as dominant negative inhibitors (IPAS) or weak transcriptional activators (HIF3 alpha/NEPAS). Previously, we and others have shown the importance of the Hif1 alpha and Hif2 alpha factors in lung development, and here we investigated the role of Hif3 alpha during pulmonary development. Therefore, HIF3 alpha was conditionally expressed in airway epithelial cells during gestation and although HIF3 alpha transgenic mice were born alive and appeared normal, their lungs showed clear abnormalities, including a post-pseudoglandular branching defect and a decreased number of alveoli. The HIF3 alpha expressing lungs displayed reduced numbers of Clara cells, alveolar epithelial type I and type II cells. As a result of HIF3 alpha expression, the level of Hif2 alpha was reduced, but that of Hif1 alpha was not affected. Two regulatory genes, Rarb, involved in alveologenesis, and Foxp2, a transcriptional repressor of the Clara cell specific Ccsp gene, were significantly upregulated in the HIF3 alpha expressing lungs. In addition, aberrant basal cells were observed distally as determined by the expression of Sox2 and p63. We show that Hif3 alpha binds a conserved HRE site in the Sox2 promoter and weakly transactivated a reporter construct containing the Sox2 promoter region. Moreover, Hif3 alpha affected the expression of genes not typically involved in the hypoxia response, providing evidence for a novel function of Hif3 alpha beyond the hypoxia response.	[Huang, Yadi; Ochieng, Joshua Kapere; Buscop-van Kempen, Marjon; Boerema-de Munck, Anne; Tibboel, Dick; Rottier, Robbert J.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Swagemakers, Sigrid] Erasmus MC, Dept Genet, Rotterdam, Netherlands; [van Ijcken, Wilfred] Erasmus MC, Dept Biom, Rotterdam, Netherlands; [Grosveld, Frank; Rottier, Robbert J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Rottier, RJ (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Rotterdam, Netherlands.	r.rottier@erasmusmc.nl	van ijcken, willem/N-9805-2018	van ijcken, willem/0000-0002-0421-8301; Rottier, Robbert/0000-0002-9291-4971	Sophia Foundation for Medical Research, SSWO [482]	Sophia Foundation for Medical Research, SSWO	This work was supported in part by the Sophia Foundation for Medical Research, SSWO nr. 482 (YH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Augstein A, 2011, CELL MOL LIFE SCI, V68, P2627, DOI 10.1007/s00018-010-0575-4; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Brahimi-Horn MC, 2011, CURR OPIN GENET DEV, V21, P67, DOI 10.1016/j.gde.2010.10.006; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hara S, 2001, BIOCHEM BIOPH RES CO, V287, P808, DOI 10.1006/bbrc.2001.5659; Heidbreder M, 2003, FASEB J, V17, P1541, DOI 10.1096/fj.02-0963fje; Hirche TO, 2004, J BIOL CHEM, V279, P27688, DOI 10.1074/jbc.M402936200; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENOMICS, V52, P159, DOI 10.1006/geno.1998.5416; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2001, P NATL ACAD SCI USA, V98, P6692, DOI 10.1073/pnas.121494298; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Lisy K, 2008, CELL DEATH DIFFER, V15, P642, DOI 10.1038/sj.cdd.4402315; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Londhe VA, 2011, AM J RESP CELL MOL, V44, P804, DOI 10.1165/rcmb.2009-0429OC; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Makino Y, 2002, J BIOL CHEM, V277, P32405, DOI 10.1074/jbc.C200328200; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Malpel S, 2000, DEVELOPMENT, V127, P3057; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Massaro GD, 2000, PHYSIOL GENOMICS, V4, P51, DOI 10.1152/physiolgenomics.2000.4.1.51; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Raghoebir L, 2012, J MOL CELL BIOL; Rajatapiti P, 2008, PEDIATR DEVEL PATHOL, V11, P193, DOI 10.2350/07-04-0257.1; Rawlins EL, 2010, DEV DYN; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sowter HM, 2003, CANCER RES, V63, P6130; Stahlman MT, 2007, J HISTOCHEM CYTOCHEM, V55, P71, DOI 10.1369/jhc.6A6962.2006; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Torii S, 2011, CELL DEATH DIFFER, V18, P1711, DOI 10.1038/cdd.2011.47; van Tuyl M, 2005, AM J PHYSIOL-LUNG C, V288, pL167, DOI 10.1152/ajplung.00185.2004; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wongtrakool C, 2003, J BIOL CHEM, V278, P46911, DOI 10.1074/jbc.M307977200; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yamashita T, 2008, MOL CELL BIOL, V28, P1285, DOI 10.1128/MCB.01332-07; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yoshida T, 2001, EXP TOXICOL PATHOL, V53, P123, DOI 10.1078/0940-2993-00183; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang FJ, 2004, AM J RESP CELL MOL, V30, P174, DOI 10.1165/rcmb.2003-0235OC; Zhou BY, 2008, AM J RESP CELL MOL, V38, P750, DOI 10.1165/rcmb.2007-0350OC	95	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57695	10.1371/journal.pone.0057695	http://dx.doi.org/10.1371/journal.pone.0057695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451260	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500127
J	Rahman, MM; Gilmour, S; Saito, E; Sultana, P; Shibuya, K				Rahman, Md Mizanur; Gilmour, Stuart; Saito, Eiko; Sultana, Papia; Shibuya, Kenji			Health-Related Financial Catastrophe, Inequality and Chronic Illness in Bangladesh	PLOS ONE			English	Article							OF-POCKET PAYMENTS; LOW-INCOME SOCIETY; CARE EXPENDITURE; HOUSEHOLDS; POOR; DETERMINANTS; PROTECTION; FAMILIES; VIETNAM; IMPACT	Background: Bangladesh has a high proportion of households incurring catastrophic health expenditure, and very limited risk sharing mechanisms. Identifying determinants of out-of-pocket (OOP) payments and catastrophic health expenditure may reveal opportunities to reduce costs and protect households from financial risk. Objective: This study investigates the determinants of high healthcare expenditure and healthcare- related financial catastrophe. Methods: A cross-sectional household survey was conducted in Rajshahi city, Bangladesh, in 2011. Catastrophic health expenditure was estimated separately based on capacity to pay and proportion of non-food expenditure. Determinants of OOP payments and financial catastrophe were estimated using double hurdle and Poisson regression models respectively. Results: On average households spent 11% of their total budgets on health, half the residents spent 7% of the monthly per capita consumption expenditure for one illness, and nearly 9% of households faced financial catastrophe. The poorest households spent less on health but had a four times higher risk of catastrophe than the richest households. The risk of financial catastrophe and the level of OOP payments were higher for users of inpatient, outpatient public and private facilities respectively compared to using self-medication or traditional healers. Other determinants of OOP payments and catastrophic expenses were economic status, presence of chronic illness in the household, and illness among children and adults. Conclusion: Households that received inpatient or outpatient private care experienced the highest burden of health expenditure. The poorest members of the community also face large, often catastrophic expenses. Chronic illness management is crucial to reducing the total burden of disease in a household and its associated increased risk of level of OOP payments and catastrophic expenses. Households can only be protected from these situations by reducing the health system's dependency on OOP payments and providing more financial risk protection.	[Rahman, Md Mizanur; Gilmour, Stuart; Saito, Eiko; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Rahman, Md Mizanur] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Sultana, Papia] Rajshahi Univ, Dept Stat, Rajshahi 6205, Bangladesh	University of Tokyo; University of Rajshahi; University of Rajshahi	Rahman, MM (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	mizanur_rub@yahoo.com	Sultana, Papia/GRS-6420-2022	Shibuya, Kenji/0000-0003-2528-7530	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan [24030401]; University of Tokyo; Asian Development Bank (ADB)	Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan(Ministry of Health, Labour and Welfare, Japan); University of Tokyo; Asian Development Bank (ADB)	This study was supported in part by Grants for Scientific Research (24030401) from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan. An Overseas Research Grant from the University of Tokyo and grants from the Asian Development Bank (ADB) were used to conduct this survey. The funders had no role in the study design, data collection, data analysis, interpretation or write up.	Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Ahmed SM, 2006, SOC SCI MED, V63, P2899, DOI 10.1016/j.socscimed.2006.07.024; Alamgir NI, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-622; Lara JLA, 2011, INT J HEALTH CARE FI, V11, P83, DOI 10.1007/s10754-011-9089-3; Aristei D, 2008, EMPIR ECON, V35, P29, DOI 10.1007/s00181-007-0142-5; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Bangladesh Bureau of Statistics (BBS), 2005, HOUS INC EXP SURV HI; Bangladesh Bureau of Statistics (BBS), 2006, EC CENS 2001 2003 ZI; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Binnendijk E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-23; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Bredenkamp C, 2011, HEALTH POLICY PLANN, V26, P349, DOI 10.1093/heapol/czq070; Brinda EM RA, 2012, INT PSYCHOGERIATR, V22, P1; CRAGG JG, 1971, ECONOMETRICA, V39, P829, DOI 10.2307/1909582; Dror DM, 2008, INDIAN J MED RES, V127, P347; Ekman B, 2008, HEALTH POLICY PLANN, V23, P252, DOI 10.1093/heapol/czn009; Engelgau MM, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-9; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Grosh M., 2000, DESIGNING HOUSEHOLD; Hotchkiss DR, 1998, HEALTH POLICY PLANN, V13, P371, DOI 10.1093/heapol/13.4.371; JONES AM, 1989, J APPL ECONOM, V4, P23, DOI 10.1002/jae.3950040103; Kavosi Z, 2012, HEALTH POLICY PLANN, V27, P613, DOI 10.1093/heapol/czs001; Killingsworth JR, 1999, HEALTH POLICY PLANN, V14, P152, DOI 10.1093/heapol/14.2.152; Kim Y, 2011, HEALTH POLICY, V100, P239, DOI 10.1016/j.healthpol.2010.08.008; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Leive A, 2008, B WORLD HEALTH ORGAN, V86, P849, DOI 10.2471/BLT.07.049403; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Murray CJL, 2003, ASSESSING DISTRIBUTI, P513; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; O'Donnell O, 2007, WORLD BANK ECON REV, V21, P93, DOI 10.1093/wber/lhl009; Okunade AA, 2010, HEALTH ECON, V19, P365, DOI 10.1002/hec.1471; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Rous JJ, 2003, HEALTH ECON, V12, P431, DOI 10.1002/hec.727; Shahrawat R, 2012, HEALTH POLICY PLANN, V27, P213, DOI 10.1093/heapol/czr029; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Thuan NBT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-283; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Waters HR, 2004, HEALTH POLICY, V69, P339, DOI 10.1016/j.healthpol.2004.01.003; WHO, 2012, WHO GLOB HLTH EXP AT; World Health Organization, 2011, WORLD HLTH STAT 2011; World Health Organization, 2000, WORLD HLTH REP 2000; WYSZEWIANSKI L, 1986, HEALTH SERV RES, V21, P617; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2006, SOC SCI MED, V62, P866, DOI 10.1016/j.socscimed.2005.07.004; Xu K, 2005, DISTRIBUTION HLTH PA, V2, P2; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006; Zaidi S., 2002, GUIDELINES CONSTRUCT; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	55	75	78	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56873	10.1371/journal.pone.0056873	http://dx.doi.org/10.1371/journal.pone.0056873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451102	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500037
J	Khatibzadeh, N; Spector, AA; Brownell, WE; Anvari, B				Khatibzadeh, Nima; Spector, Alexander A.; Brownell, William E.; Anvari, Bahman			Effects of Plasma Membrane Cholesterol Level and Cytoskeleton F-Actin on Cell Protrusion Mechanics	PLOS ONE			English	Article							P-SELECTIN DETACHMENT; LEUKOCYTE INTERFACES; MICROSCALE DYNAMICS; OPTICAL TWEEZERS; LIVING CELLS; TETHERS; BEHAVIOR; MODEL; POLYMERIZATION; SEPARATION	Protrusions are deformations that form at the surface of living cells during biological activities such as cell migration. Using combined optical tweezers and fluorescent microscopy, we quantified the mechanical properties of protrusions in adherent human embryonic kidney cells in response to application of an external force at the cell surface. The mechanical properties of protrusions were analyzed by obtaining the associated force-length plots during protrusion formation, and force relaxation at constant length. Protrusion mechanics were interpretable by a standard linear solid (Kelvin) model, consisting of two stiffness parameters, k(0) and k(1) (with k(0)>k(1)), and a viscous coefficient. While both stiffness parameters contribute to the time-dependant mechanical behavior of the protrusions, k(0) and k(1) in particular dominated the early and late stages of the protrusion formation and elongation process, respectively. Lowering the membrane cholesterol content by 25% increased the k(0) stiffness by 74%, and shortened the protrusion length by almost half. Enhancement of membrane cholesterol content by nearly two-fold increased the protrusion length by 30%, and decreased the k(0) stiffness by nearly two-and-half-fold as compared with control cells. Cytoskeleton integrity was found to make a major contribution to protrusion mechanics as evidenced by the effects of F-actin disruption on the resulting mechanical parameters. Viscoelastic behavior of protrusions was further characterized by hysteresis and force relaxation after formation. The results of this study elucidate the coordination of plasma membrane composition and cytoskeleton during protrusion formation.	[Khatibzadeh, Nima] Univ Calif Riverside, Dept Mech Engn, Riverside, CA 92521 USA; [Spector, Alexander A.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Brownell, William E.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Anvari, Bahman] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA	University of California System; University of California Riverside; Johns Hopkins University; Baylor College of Medicine; University of California System; University of California Riverside	Anvari, B (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	anvarib@ucr.edu	Spector, Alexander/A-3330-2010	Anvari, Bahman/0000-0002-2511-5854	National Science Foundation [NSF-BES-0522862]; National Institute of Deafness and Other Communication Disorders [NIH 2R01-DC02775]; Bourns College of Engineering and Bioengineering Center at University of California, Riverside; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002775] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Bourns College of Engineering and Bioengineering Center at University of California, Riverside; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding came from the National Science Foundation (NSF-BES-0522862) and the National Institute of Deafness and Other Communication Disorders (NIH 2R01-DC02775). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge support provided by Bourns College of Engineering and Bioengineering Center at University of California, Riverside.	Allena R, 2012, J THEOR BIOL, V306, P15, DOI 10.1016/j.jtbi.2012.03.041; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Borghi N, 2007, BIOPHYS J, V93, P1369, DOI 10.1529/biophysj.106.087908; Byfield FJ, 2006, ACTA PHYSIOL, V187, P285, DOI 10.1111/j.1748-1716.2006.01555.x; Byfield FJ, 2004, BIOPHYS J, V87, P3336, DOI 10.1529/biophysj.104.040634; Chen Y, 2007, AM J PHYSIOL-CELL PH, V292, pC1272, DOI 10.1152/ajpcell.00251.2006; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Enculescu M, 2010, BIOPHYS J, V98, P1571, DOI [10.1016/j.bpj.2009.12.4311, 10.1016/j.bpj.2009.12.431]; Ermilov SA, 2007, J BIOMECH, V40, P476, DOI 10.1016/j.jbiomech.2005.12.006; EVANS E, 1990, PHYS REV LETT, V64, P2094, DOI 10.1103/PhysRevLett.64.2094; Evans E, 2005, BIOPHYS J, V88, P2288, DOI 10.1529/biophysj.104.051698; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Gracia RS, 2010, SOFT MATTER, V6, P1472, DOI 10.1039/b920629a; Heinrich V, 2005, BIOPHYS J, V88, P2299, DOI 10.1529/biophysj.104.051706; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Khatibzadeh N, 2012, SOFT MATTER, V8, P8350, DOI 10.1039/c2sm25263e; Li ZW, 2002, BIOPHYS J, V82, P1386, DOI 10.1016/S0006-3495(02)75493-3; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Marcus WD, 2002, ANN BIOMED ENG, V30, P1273, DOI 10.1114/1.1528614; Marion S, 2004, J CELL SCI, V117, P3271, DOI 10.1242/jcs.01178; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Murdock DR, 2005, BIOPHYS J, V89, P4090, DOI 10.1529/biophysj.105.069872; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Oh H, 2009, ARTERIOSCL THROM VAS, V29, P1290, DOI 10.1161/ATVBAHA.109.189571; Pan JJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021931; Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103; Qian F, 2004, REV SCI INSTRUM, V75, P2937, DOI 10.1063/1.1781382; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Ramachandran V, 2004, P NATL ACAD SCI USA, V101, P13519, DOI 10.1073/pnas.0403608101; Roy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037667; Schmidtke DW, 2000, J CELL BIOL, V149, P719, DOI 10.1083/jcb.149.3.719; Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289; Schwan C, 2011, J BIOL CHEM, V286, P29356, DOI 10.1074/jbc.M111.261925; Sfondouris J, 2008, J BIOL CHEM, V283, P22473, DOI 10.1074/jbc.M803722200; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Stamenovic D, 2007, BIOPHYS J, V93, pL39, DOI 10.1529/biophysj.107.116582; Sun MZ, 2005, BIOPHYS J, V89, P4320, DOI 10.1529/biophysj.104.058180; Tatavarty V, 2012, MOL BIOL CELL, V23, P3167, DOI 10.1091/mbc.E12-02-0165; Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775; TSAI MA, 1994, BIOPHYS J, V66, P2166, DOI 10.1016/S0006-3495(94)81012-4; WAUGH RE, 1995, ANN BIOMED ENG, V23, P308, DOI 10.1007/BF02584431; Xu G, 2008, AM J PHYSIOL-CELL PH, V295, pC1434, DOI 10.1152/ajpcell.00136.2008; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; YC F, 1993, BIOMECHANICS MECH PR; Zhang XY, 2011, AM J PHYSIOL-CELL PH, V301, pC451, DOI 10.1152/ajpcell.00458.2010; Zhou EH, 2012, BIOMECH MODEL MECHAN, V11, P1075, DOI 10.1007/s10237-012-0374-y; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	50	47	47	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57147	10.1371/journal.pone.0057147	http://dx.doi.org/10.1371/journal.pone.0057147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451167	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800079
J	Luisi, I; Pavan, S; Fontanive, G; Tossi, A; Benedetti, F; Savoini, A; Maurizio, E; Sgarra, R; Sblattero, D; Berti, F				Luisi, Immacolata; Pavan, Silvia; Fontanive, Giampaolo; Tossi, Alessandro; Benedetti, Fabio; Savoini, Adriano; Maurizio, Elisa; Sgarra, Riccardo; Sblattero, Daniele; Berti, Federico			An Albumin-Derived Peptide Scaffold Capable of Binding and Catalysis	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; GLUTATHIONE-S-TRANSFERASE; 3 RECOMBINANT DOMAINS; SCHISTOSOMA-JAPONICUM; PROTON-TRANSFER; PROTEINS; SPECIFICITY; SITE; NEOCARZINOSTATIN; EFAVIRENZ	We have identified a 101-amino-acid polypeptide derived from the sequence of the IIA binding site of human albumin. The polypeptide contains residues that make contact with IIA ligands in the parent protein, and eight cysteine residues to form disulfide bridges, that stabilize the polypeptide structure. Seventy-four amino acids are located in six alpha-helical regions, while the remaining thirty-seven amino acids form six connecting coil/loop regions. A soluble GST fusion protein was expressed in E. coli in yields as high as 4 mg/l. This protein retains the IIA fragment's capacity to bind typical ligands such as warfarin and efavirenz and other albumin's functional properties such as aldolase activity and the ability to direct the stereochemical outcome of a diketone reduction. This newly cloned polypeptide thus represents a valuable starting point for the construction of libraries of binders and catalysts with improved proficiency.	[Luisi, Immacolata; Pavan, Silvia; Fontanive, Giampaolo; Benedetti, Fabio; Berti, Federico] Univ Trieste, Dipartimento Sci Chim & Farmaceut, Trieste, Italy; [Luisi, Immacolata; Tossi, Alessandro; Maurizio, Elisa; Sgarra, Riccardo] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Savoini, Adriano] T&B Associati Srl, Trieste, Italy; [Sblattero, Daniele] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Salute, Novara, Italy	University of Trieste; University of Trieste; University of Eastern Piedmont Amedeo Avogadro	Sblattero, D (corresponding author), Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Sci Salute, Novara, Italy.	sblatter@med.unipmn.it; fberti@units.it	Tossi, Alessandro/U-2474-2017; Benedetti, Fabio/G-4787-2012; Tossi, Alessandro/ABC-9061-2020	Tossi, Alessandro/0000-0001-9087-5764; Benedetti, Fabio/0000-0002-8773-7413; Berti, Federico/0000-0001-5608-3798; Sblattero, Daniele/0000-0003-4309-242X; Sgarra, Riccardo/0000-0002-4496-2856	Commissariato del Governo nella Regione Friuli - Venezia Giulia (Fondo Trieste Grant) [597/08]; Regione Piemonte "Piattaforma ImmOnc"	Commissariato del Governo nella Regione Friuli - Venezia Giulia (Fondo Trieste Grant); Regione Piemonte "Piattaforma ImmOnc"	Commissariato del Governo nella Regione Friuli - Venezia Giulia (Fondo Trieste Grant 597/08 "Piccoli peptidi per lo sviluppo di biosensori'') has funded this research project and has granted Immacolata Luisi, Silvia Pavan and Giampaolo Fontanive. Regione Piemonte "Piattaforma ImmOnc'' has funded Daniele Sblattero. The funders (Commissariato del Governo nella regione Friuli - Venezia Giulia, fondo Trieste, grant 597/08; Regione Piemonte, piattaforma ImmunOc) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badalassi F, 2000, ANGEW CHEM INT EDIT, V39, P4067, DOI 10.1002/1521-3773(20001117)39:22<4067::AID-ANIE4067>3.0.CO;2-9; Benedetti F, 2002, CHEM COMMUN, P828, DOI 10.1039/b200474g; Benedetti F, 2011, ORG BIOMOL CHEM, V9, P4417, DOI 10.1039/c0ob01219j; Berti F, 2011, ORG BIOMOL CHEM, V9, P1987, DOI 10.1039/c0ob00648c; Binz HK, 2005, CURR OPIN BIOTECH, V16, P459, DOI 10.1016/j.copbio.2005.06.005; Bocedi A, 2004, IUBMB LIFE, V56, P609, DOI 10.1080/15216540400016286; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Di Niro R, 2009, METHODS MOL BIOL, V570, P353, DOI 10.1007/978-1-60327-394-7_20; Ding F, 2010, J MOL STRUCT, V975, P256, DOI 10.1016/j.molstruc.2010.04.033; Dockal M, 1999, J BIOL CHEM, V274, P29303, DOI 10.1074/jbc.274.41.29303; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Drevelle A, 2006, J MOL BIOL, V358, P455, DOI 10.1016/j.jmb.2006.02.002; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Heyd B, 2003, BIOCHEMISTRY-US, V42, P5674, DOI 10.1021/bi0273664; Hollfelder F, 2000, J AM CHEM SOC, V122, P1022, DOI 10.1021/ja993471y; Kaplan W, 1997, PROTEIN SCI, V6, P399; Kaur N, 2008, MOL PHARMACEUT, V5, P294, DOI 10.1021/mp700096e; Kikuchi K, 1996, J AM CHEM SOC, V118, P8184, DOI 10.1021/ja9617395; Klein G, 1998, BIOORG MED CHEM LETT, V8, P1113, DOI 10.1016/S0960-894X(98)00165-6; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; LIM K, 1994, PROTEIN SCI, V3, P2233, DOI 10.1002/pro.5560031209; Matsushita S, 2004, PHARM RES-DORDR, V21, P1924, DOI 10.1023/B:PHAM.0000045248.03337.0e; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Peters T., 1996, ALL ALBUMIN BIOCH GE; Pierce ME, 1998, J ORG CHEM, V63, P8536, DOI 10.1021/jo981170l; Revell JD, 2007, CURR OPIN CHEM BIOL, V11, P269, DOI 10.1016/j.cbpa.2007.05.015; Rich RL, 2001, ANAL BIOCHEM, V296, P197, DOI 10.1006/abio.2001.5314; Roucairol C, 2007, ANAL CHIM ACTA, V589, P142, DOI 10.1016/j.aca.2007.02.045; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; Sheedy C, 2007, BIOTECHNOL ADV, V25, P333, DOI 10.1016/j.biotechadv.2007.02.003; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Tanaka F, 2001, CHEM COMMUN, P769, DOI 10.1039/b100479b; Tanaka F, 2005, BIOCHEMISTRY-US, V44, P7583, DOI 10.1021/bi050216j; Tavirani M. Rezaei, 2006, J BIOCHEM MOL BIOL, V39, P530, DOI DOI 10.5483/BMBREP.2006.39.5.530; Twine SM, 2003, ARCH BIOCHEM BIOPHYS, V414, P83, DOI 10.1016/S0003-9861(03)00173-5; YVON M, 1988, FEBS LETT, V239, P237, DOI 10.1016/0014-5793(88)80924-4; Zhang QL, 2010, J PHARMACEUT BIOMED, V52, P280, DOI 10.1016/j.jpba.2010.01.006	46	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56469	10.1371/journal.pone.0056469	http://dx.doi.org/10.1371/journal.pone.0056469			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451052	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800015
J	Zhang, LJ; Wang, GQ; Liu, QH; Chen, CF; Li, J; Long, B; Yu, H; Zhang, ZL; He, J; Qu, ZY; Yu, JG; Liu, YN; Dong, T; Yao, N; Wang, Y; Cheng, XQ; Xu, JG				Zhang, Lijuan; Wang, Guiqiang; Liu, Qinghui; Chen, Chuangfu; Li, Jun; Long, Bo; Yu, Hong; Zhang, Zhilun; He, Jing; Qu, Zhangyi; Yu, Jiguang; Liu, Yuanni; Dong, Tuo; Yao, Na; Wang, Yong; Cheng, Xueqin; Xu, Jianguo			Molecular Analysis of Anaplasma phagocytophilum Isolated from Patients with Febrile Diseases of Unknown Etiology in China	PLOS ONE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; EHRLICHIA-CHAFFEENSIS; PHYLOGENETIC ANALYSIS; INFECTION; TICKS; SEQUENCE; OUTCOMES; JAPAN	Although anaplasmosis cases have been nationally identified in China, no human isolates of A. phagocytophilum have been obtained, which limits the analysis of any molecular and genetic contributions to patients' severe clinical manifestations and the study of the bacteria's pathogeneses in China. Given this situation, a joint project was conducted in 2009-2010. A total of 421 febrile cases of unknown etiology were collected and the patients' blood samples were collected for laboratory diagnoses including serologic diagnosis based on the four-fold rise in the anti- A. phagocytophilum IgG titer by indirect micro-immunofluorescence assay (IFA), positive PCR assay and confirmation of A. phagocytophilum DNA and positive culture of A. phagocytophilum and confirmed by amplification and sequencing of the 16S rRNA and ank A genes of the A. phagocytophilum isolates. A total of 570 ticks were collected from the patients' domestic animals (456) and from wild fields (114) for culturing and amplifying and sequencing the 16S rRNA gene of A. phagocytophilum. Phylogenetic analyses were performed on the 16S rRNA and ank A gene sequences of the isolates and the ticks tested in the study. A total of 46 (10.9%) confirmed and 16 (3.8%) probable cases were diagnosed and severe clinical features and higher mortality rates were observed in these Chinese patients. Five isolates were obtained and the 16S rRNA genes of the 5 isolates were conserved but variety for ank A genes. Two human isolates and 1 tick isolate from Shandong Peninsula, where all patients exhibited severe clinical manifestations, were grouped as one clan based on the phylogenetic analyses, while 2 other human isolates were clustered in a second clan. 43.5% of H. longicornis were infected with A. phagocytophilum. The present study is the first to obtain clinical isolates of A. phagocytophilum in China. The diversity of the ank A genes of Chinese isolates will help us to further discern the relationship between the variations in the ank A genes and the severity of the disease's clinical manifestations in China.	[Zhang, Lijuan; Dong, Tuo; Yao, Na; Wang, Yong; Cheng, Xueqin; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Rickettsiol, Beijing, Peoples R China; [Wang, Guiqiang; Li, Jun] Peking Univ First Hosp, Dept Infect Dis, Beijing, Peoples R China; [Liu, Qinghui] Shandong Laizhou Peoples Hosp, Dept Intens Care, Laizhou, Shandong, Peoples R China; [Chen, Chuangfu; Yao, Na; Wang, Yong] Shihezi Univ, Anim Sci & Technol Coll, Shihezi, Xinjiang Provin, Peoples R China; [Long, Bo; Yu, Hong; Yu, Jiguang; Liu, Yuanni] Yantai Infect Dis Hosp, Dept Infect Dis, Yantai, Shandong, Peoples R China; [Zhang, Zhilun] Tianjin Ctr Dis Control & Prevent, Dept Epidemiol, Tianjin, Peoples R China; [He, Jing] 302 Hosp PLA, Dept Infect Dis, Beijing, Peoples R China; [Qu, Zhangyi; Dong, Tuo] Harbin Med Univ, Sch Publ Hlth, Harbin, Heilongjiang Pr, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University; Shihezi University; Tianjin Center for Disease Control & Prevention; Fifth Medical Center of Chinese PLA General Hospital; Harbin Medical University	Zhang, LJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Rickettsiol, Beijing, Peoples R China.	zhanglijuan@icdc.cn; wanggq@hotmail.com	yao, na/HDL-8772-2022		National Basic Research Program of China (973 Program) [2010CB530206]; National Natural Science Foundation of China [30771854]; China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases [1U2GGH000018-01]; China Mega-Project for Infectious Disease [2011ZX10004-001]; National Key Science and Technology Projects of China [20122X10004215]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases; China Mega-Project for Infectious Disease; National Key Science and Technology Projects of China	This study was supported by the National Basic Research Program of China (973 Program) 2010CB530206, the National Natural Science Foundation of China (No. 30771854), and the China-U.S. Collaborative Program on Emerging and Re-emerging Infectious Diseases (No. 1U2GGH000018-01) and China Mega-Project for Infectious Disease (2011ZX10004-001) and National Key Science and Technology Projects of China ( Project no. 20122X10004215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chapes SK, 2008, VET PARASITOL, V158, P344, DOI 10.1016/j.vetpar.2008.09.028; Domingos MC, 2011, VET CLIN PATH, V40, P215, DOI 10.1111/j.1939-165X.2011.00321.x; Dumler JS, 2012, FEMS IMMUNOL MED MIC, V64, P13, DOI 10.1111/j.1574-695X.2011.00909.x; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; EREMEEVA ME, 1994, CLIN DIAGN LAB IMMUN, V1, P318, DOI 10.1128/CDLI.1.3.318-324.1994; Garcia-Garcia JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000488; Ge Y, 2006, CELL MICROBIOL, V8, P1406, DOI 10.1111/j.1462-5822.2006.00720.x; Guero-Rosenfeld M. E., 2003, MANUAL CLIN MICROBIO, P1015; Katargina O, 2012, CLIN MICROBIOL INFEC, V18, P40, DOI 10.1111/j.1469-0691.2010.03457.x; Kawahara M, 2006, APPL ENVIRON MICROB, V72, P1102, DOI 10.1128/AEM.72.2.1102-1109.2006; Li HY, 2011, INT J INFECT DIS, V15, pE859, DOI 10.1016/j.ijid.2011.09.008; 오재영, 2009, Journal of Bacteriology and Virology, V39, P257; Ohashi N, 2005, EMERG INFECT DIS, V11, P1780, DOI 10.3201/eid1111.050407; Pan L, 2011, J CLIN MICROBIOL, V49, P4117, DOI 10.1128/JCM.01085-11; Rejmanek D, 2012, MICROBIOL; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Rikihisa Y, 2010, CELL MICROBIOL, V12, P1213, DOI 10.1111/j.1462-5822.2010.01500.x; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; ROUX V, 1995, RES MICROBIOL, V146, P385, DOI 10.1016/0923-2508(96)80284-1; Schaarschmidt-Kiener D, 2009, SCHWEIZ ARCH TIERH, V151, P336, DOI 10.1024/0036-7281.151.7.336; Scharf W, 2011, J CLIN MICROBIOL, V49, P790, DOI 10.1128/JCM.02051-10; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; WALKER DH, 1994, NEW ENGL J MED, V331, P1651, DOI 10.1056/NEJM199412153312410; Wang SW, 2011, DIS SURVEIL, V26, P12; Wen BH, 2002, J CLIN MICROBIOL, V40, P3286, DOI 10.1128/JCM.40.9.3286-3290.2002; Yu Q, 2012, CLIN VACCINE IMMUNOL, V19, P919, DOI 10.1128/CVI.05709-11; Yu Qiang, 2012, Chinese Journal of Zoonoses, V28, P323; Zhan L, 2010, VET MICROBIOL, V144, P405, DOI 10.1016/j.vetmic.2010.02.018; Zhan L, 2010, EMERG INFECT DIS, V16, P764, DOI [10.3201/eid1605.021293, 10.3201/eid1605.091293]; Zhan L, 2009, EMERG INFECT DIS, V15, P1904, DOI 10.3201/eid1512.081141; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; Zhang LJ, 2008, EMERG INFECT DIS, V14, P938, DOI 10.3201/eid1406.071502; Zhang LJ, 2012, AM J TROP MED HYG, V87, P185, DOI 10.4269/ajtmh.2012.12-0005; Zhang LJ, 2011, ASIAN PAC J TROP MED, V4, P568, DOI 10.1016/S1995-7645(11)60148-X; Zhou ZY, 2010, RES VET SCI, V89, P262, DOI 10.1016/j.rvsc.2010.02.009	37	30	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57155	10.1371/journal.pone.0057155	http://dx.doi.org/10.1371/journal.pone.0057155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451170	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800081
J	Pernice, MC; Logares, R; Guillou, L; Massana, R				Pernice, Massimo C.; Logares, Ramiro; Guillou, Laure; Massana, Ramon			General Patterns of Diversity in Major Marine Microeukaryote Lineages	PLOS ONE			English	Article							OPERATIONAL TAXONOMIC UNITS; SEQUENCE ALIGNMENT; COMMUNITY; DIVERSIFICATION; PICOEUKARYOTES; CLASSIFICATION; EUKARYOTES; PHYLOGENY; PROTISTS; RATES	Microeukaryotes have vital roles for the functioning of marine ecosystems, but still some general characteristics of their current diversity and phylogeny remain unclear. Here we investigated both aspects in major oceanic microeukaryote lineages using 18S rDNA (V4-V5 hypervariable regions) sequences from public databases that derive from various marine environmental surveys. A very carefully and manually curated dataset of 8291 Sanger sequences was generated and subsequently split into 65 taxonomic groups (roughly to Class level based on KeyDNATools) prior to downstream analyses. First, we calculated genetic distances and clustered sequences into Operational Taxonomic Units (OTUs) using different distance cut-off levels. We found that most taxonomic groups had a maximum pairwise genetic distance of 0.25. Second, we used phylogenetic trees to study general evolutionary patterns. These trees confirmed our taxonomic classification and served to run Lineage Through Time (LTT) plots. LTT results indicated different cladogenesis dynamics across groups, with some displaying an early diversification and others a more recent one. Overall, our study provides an improved description of the microeukaryote diversity in the oceans in terms of genetic differentiation within groups as well as in the general phylogenetic structure. These results will be important to interpret the large amount of sequence data that is currently generated by High Throughput Sequencing technologies.	[Pernice, Massimo C.; Logares, Ramiro; Massana, Ramon] CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Catalonia, Spain; [Guillou, Laure] Univ Paris 06, Stn Biol Roscoff, Roscoff, France; [Guillou, Laure] CNRS, Lab Adaptat & Diversite Milieu Marin, UMR 7144, Roscoff, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Pernice, MC (corresponding author), CSIC, Inst Ciencies Mar, Dept Marine Biol & Oceanog, Barcelona, Catalonia, Spain.	pernice@icm.csic.es; ramonm@icm.csic.es	Logares, Ramiro/D-5920-2011; Logares, Ramiro/AAI-2306-2019; Pernice, Massimo C./AAE-6214-2019; Massana, Ramon/F-4205-2016	Logares, Ramiro/0000-0002-8213-0604; Pernice, Massimo Ciro/0000-0001-6917-8999; Massana, Ramon/0000-0001-9172-5418; Guillou, Laure/0000-0003-1032-7958	FLAME (MICINN, Spain) [CGL2010-16304]; BioMarKs (ERA-net Biodiversa, EU) [2008-6530]; project GEMMA (MEC, Spain) [CTM2007-63753-C02-01/MAR]; Spanish Ministry of Education and Science; Marie Curie Intra-European Fellowship grant [PIEF-GA-2009-235365]; Barcelona Supercomputing Center at the MareNostrum [BCV-2011-2-0003, BCV-2011-3-0005]	FLAME (MICINN, Spain); BioMarKs (ERA-net Biodiversa, EU); project GEMMA (MEC, Spain); Spanish Ministry of Education and Science(Spanish Government); Marie Curie Intra-European Fellowship grant; Barcelona Supercomputing Center at the MareNostrum	Funding has been provided by projects FLAME (CGL2010-16304, MICINN, Spain) and BioMarKs (2008-6530, ERA-net Biodiversa, EU) to RM, by project GEMMA (CTM2007-63753-C02-01/MAR, MEC, Spain) to Carlos Pedros-375 Alio, by a FPI fellowship from the Spanish Ministry of Education and Science to MCP, and by a Marie Curie Intra-European Fellowship grant PIEF-GA-2009-235365 to RL. Original sequence database was built under the frame of the French ANR-Biodiversite project AQUAPARADOX. High-performance computing resources were provided by the Barcelona Supercomputing Center at the MareNostrum (grants BCV-2011-2-0003 & BCV-2011-3-0005) to RM and RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Brate J, 2010, ISME J, V4, P1144, DOI 10.1038/ismej.2010.39; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Dunthorn M, 2012, J EUKARYOT MICROBIOL, V59, P185, DOI 10.1111/j.1550-7408.2011.00602.x; Epstein S, 2008, BIODIVERS CONSERV, V17, P261, DOI 10.1007/s10531-007-9250-y; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guillou L, 2008, ENVIRON MICROBIOL, V10, P397; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jeon S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-222; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIRKPATRICK M, 1993, EVOLUTION, V47, P1171, DOI [10.2307/2409983, 10.1111/j.1558-5646.1993.tb02144.x]; Krabberod AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023526; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Martin AP, 2004, EVOLUTION, V58, P946; Massana R, 2004, APPL ENVIRON MICROB, V70, P3528, DOI 10.1128/AEM.70.6.3528-3534.2004; Massana R, 2008, CURR OPIN MICROBIOL, V11, P213, DOI 10.1016/j.mib.2008.04.004; Massana R, 2011, ISME J, V5, P184, DOI 10.1038/ismej.2010.104; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Moreira D, 2004, INT J SYST EVOL MICR, V54, P1861, DOI 10.1099/ijs.0.63081-0; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Not F, 2007, ENVIRON MICROBIOL, V9, P1233, DOI 10.1111/j.1462-2920.2007.01247.x; Not F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007143; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; PURVIS A, 1995, P ROY SOC B-BIOL SCI, V260, P329, DOI 10.1098/rspb.1995.0100; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Terrado R, 2009, AQUAT MICROB ECOL, V56, P25, DOI 10.3354/ame01327; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vaulot D, 2008, FEMS MICROBIOL REV, V32, P795, DOI 10.1111/j.1574-6976.2008.00121.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	48	42	43	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57170	10.1371/journal.pone.0057170	http://dx.doi.org/10.1371/journal.pone.0057170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437337	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000082
J	Zhang, B; Wang, ZJ; Wu, LL; Zhang, M; Li, W; Ding, JH; Zhu, J; Wei, HF; Zhao, K				Zhang, Bin; Wang, Zhijun; Wu, Liangliang; Zhang, Meng; Li, Wei; Ding, Jianhua; Zhu, Jun; Wei, Huafeng; Zhao, Ke			Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma	PLOS ONE			English	Article							CLINICAL-RELEVANCE; IMMUNE CELLS; T-CELLS; SUBSETS; INFLAMMATION; DOXORUBICIN; POPULATION; EXPANSION; CORRELATE; STAGE	Myeloid-derived suppressor cells (MDSCs) are a heterogeneous family of myeloid cells that suppress T cell immunity in tumor-bearing hosts. In patients with colon cancer, MDSCs have recently been described as Lin(-/low)HLA-DR(-)CD11b(+)CD33(+) cells correlating with cancer stage, metastasis and chemotherapy response. To learn in more detail the dynamic change and clinical relevance of circulating and tumor-infiltrating Lin(-)/lowHLA-DR(-)CD11b(+)CD33(+) MDSC in colorectal cancer, we harvested the blood from 64 patients with varying stage of colorectal cancer and tumor and matched paraneoplastic tissues from 5 patients with advanced colorectal cancer, subjected them to multicolor flow cytometric analysis of percentage, absolute number and phenotype of MDSC and finally characterized their immunosuppressive functions. Our results demonstrate that peripheral blood from colorectal cancer patients contains markedly increased percentage and absolute number of Lin(-/low)HLA-DR(-)CD11b(+)CD33(+) MDSCs compared with healthy individuals, and this increase is closely correlated with clinical cancer stage and tumor metastasis but not primary tumor size and serum concentrations of cancer biomarker. A similar increase of MDSCs was also observed in the tumor tissues. Phenotyping MDSCs shows that they express high CD13 and CD39, low CD115, CD117, CD124 and PD-L1, and devoid of CD14, CD15 and CD66b, reminiscent of precursor myeloid cells. MDSCs from cancer patients but not healthy donors have the immunosuppressive activity and were able to inhibit in vitro autologous T-cell proliferation. Collectively, this study substantiates the presence of increased immunosuppressive circulating and tumor-resident Lin(-/low)HLA-DR(-)CD11b(+)C33(+) MDSCs in patients with colorectal cancers correlating with cancer stage and metastasis, and suggests that pharmacologic blockade of MDSCs should be considered in future clinical trials.	[Zhang, Bin; Zhang, Meng; Ding, Jianhua; Zhu, Jun; Zhao, Ke] Second Artillery Gen Hosp, Dept Colorectal Dis Surg, Beijing, Peoples R China; [Wang, Zhijun] Peoples Liberat Army Gen Hosp, Dept Intervent Radiol, Beijing, Peoples R China; [Wu, Liangliang] Peoples Liberat Army Gen Hosp, Canc Ctr Lab, Beijing, Peoples R China; [Li, Wei] Nanjing Med Univ, Brain Hosp, Dept Geriatr Neurol, Nanjing, Jiangsu, Peoples R China; [Wei, Huafeng] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Nanjing Medical University; Naval Medical University	Wei, HF (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China.	foxp3_smmu@163.com; thalarus@126.com	Ding, Jian-Hua/AAK-4129-2020	Ding, Jian-Hua/0000-0002-0858-1941	Beijing Natural Science Foundation [7133254]; Beijing Nova Program; National Natural Science Foundation of China [30901380/C081501]; Shanghai Morning Light Program [09CG36]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Morning Light Program	This work was supported by the the Beijing Natural Science Foundation (7133254 to BZ), the Beijing Nova Program (to ZJW), the National Natural Science Foundation of China (No. 30901380/C081501 to HFW) and the Shanghai Morning Light Program (09CG36 to HFW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergamin LS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/959848; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Duffy A, 2012, CANC IMMUNOLOGY IMMU; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Eruslanov E, 2012, INT J CANCER, V130, P1109, DOI 10.1002/ijc.26123; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng PH, 2012, AM J RESP CRIT CARE, V186, P1025, DOI 10.1164/rccm.201204-0636OC; Fujimura T, 2010, J DERMATOL SCI, V59, P1, DOI 10.1016/j.jdermsci.2010.05.001; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ghiringhelli F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/473712; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Melani C, 2003, BLOOD, V102, P2138, DOI 10.1182/blood-2003-01-0190; Montero AJ, 2012, BREAST CANCER RES TR, V132, P215, DOI 10.1007/s10549-011-1889-0; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Mundy-Bosse BL, 2011, CANCER IMMUNOL IMMUN, V60, P1269, DOI 10.1007/s00262-011-1029-z; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Poschke I, 2010, CANCER RES, V70, P4335, DOI 10.1158/0008-5472.CAN-09-3767; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Sun HL, 2012, WORLD J GASTROENTERO, V18, P3303, DOI 10.3748/wjg.v18.i25.3303; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Walter S., 2012, NAT MED; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Younos IH, 2012, INT IMMUNOPHARMACOL, V13, P245, DOI 10.1016/j.intimp.2012.05.002; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	45	185	200	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57114	10.1371/journal.pone.0057114	http://dx.doi.org/10.1371/journal.pone.0057114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437326	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200219
J	Zou, SQ; Tian, C; Ge, SC; Hu, B				Zou, Suqi; Tian, Chen; Ge, Shuchao; Hu, Bing			Neurogenesis of Retinal Ganglion Cells Is Not Essential to Visual Functional Recovery after Optic Nerve Injury in Adult Zebrafish	PLOS ONE			English	Article							TIME-COURSE ANALYSIS; RETINOTECTAL PROJECTION; INTRAVITREAL INJECTION; AXONAL REGENERATION; ALBINO ZEBRAFISH; GENE-EXPRESSION; MULLER GLIA; STEM-CELLS; SYSTEM; DEATH	Zebrafish central nervous system (CNS) possesses a strong neural regeneration ability to restore visual function completely after optic nerve injury (ONI). However, whether neurogenesis of retinal ganglion cell (RGC) contributes to functional recovery remains controversial. Our quantitative analysis of RGCs in different ONI models showed that almost all RGCs survived in optic nerve crush (ONC) model; while over 90% of RGCs survived in the first 2 weeks with 75% remaining after 7 weeks in optic nerve transection (ONT) model. Retrograde labeling from tectum revealed a surprising regeneration rate, with over 90% and over 50% of RGCs regrowing axons to tectum at the first week in ONC and ONT model respectively. In the latter one, the number of regenerative RGCs after 4 weeks had no significant difference from the control group. As for neurogenesis, newborn RGCs were rarely detected either by double retrograde labeling or BrdU marker. Since few RGCs died, microglia number showed a temporary increase at 3 days post injury (dpi) and a decrease at 14 dpi. Finally, myelin structure within retina kept integrity and optomotor response (OMR) test demonstrated visual functional restoration at 5 weeks post injury (wpi). In conclusion, our results have directly shown that RGC survival and axon regrowth are responsible for functional recovery after ONI in adult zebrafish.	[Zou, Suqi; Tian, Chen; Ge, Shuchao; Hu, Bing] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Hu, B (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230026, Anhui, Peoples R China.	bhu@ustc.edu.cn	zou, suqi/AAI-9868-2021; hu, bing/B-1030-2010	hu, bing/0000-0001-8627-5272; Zou, Suqi/0000-0001-6816-6400; Ge, Shuchao/0000-0002-6590-9050	973 MOST grant [2011CB504402]; National Natural Science Foundation of China [30870950]; "Hundred Talents Project" of the Chinese Academy of Science	973 MOST grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Project" of the Chinese Academy of Science	This project is supported by 973 MOST grant (Grant No. 2011CB504402), National Natural Science Foundation of China (Grant No. 30870950) and the "Hundred Talents Project" of the Chinese Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo M, 2008, MOL VIS, V14, P1050; Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; Bakken TE, 2012, J COMP NEUROL, V520, P142, DOI 10.1002/cne.22704; Beaver RS, 2001, VISION RES, V41, P1765, DOI 10.1016/S0042-6989(01)00053-0; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2007, J NEUROSCI RES, V85, P2793, DOI 10.1002/jnr.21121; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; Callahan MP, 2007, VISUAL NEUROSCI, V24, P309, DOI 10.1017/S0952523807070289; Comyn O, 2010, CURR OPIN NEUROL, V23, P4, DOI 10.1097/WCO.0b013e3283352f96; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fimbel SM, 2007, J NEUROSCI, V27, P1712, DOI 10.1523/JNEUROSCI.5317-06.2007; Germain F, 2004, EXP EYE RES, V78, P95, DOI 10.1016/j.exer.2003.09.012; Huang Yu-Bin, 2012, Yichuan, V34, P1193, DOI 10.3724/SP.J.1005.2012.01193; HUMPHREY MF, 1985, J COMP NEUROL, V236, P382, DOI 10.1002/cne.902360307; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Jeon GS, 2004, BRAIN RES, V1023, P15, DOI 10.1016/j.brainres.2004.01.093; Kaneda M, 2008, NEUROSCI RES, V61, P281, DOI 10.1016/j.neures.2008.03.008; Kassen SC, 2007, DEV NEUROBIOL, V67, P1009, DOI 10.1002/dneu.20362; Kato S, 1999, NEUROSCIENCE, V93, P907, DOI 10.1016/S0306-4522(99)00202-X; Kustermann S, 2008, CELL TISSUE RES, V332, P195, DOI 10.1007/s00441-008-0589-5; Lang DM, 2002, J NEUROBIOL, V52, P322, DOI 10.1002/neu.10099; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li L, 2000, J NEUROSCI, V20, P1883; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Lillo C, 2002, J HISTOCHEM CYTOCHEM, V50, P1289, DOI 10.1177/002215540205001002; Liu Q., 2003, Methods in Cell Science, V25, P71, DOI 10.1023/B:MICS.0000006854.18378.fc; Mack AF, 2007, NEUROSCIENCE, V144, P1004, DOI 10.1016/j.neuroscience.2006.10.029; Marcus RC, 1999, VISUAL NEUROSCI, V16, P417, DOI 10.1017/S095252389916303X; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Montgomery JE, 2010, J COMP NEUROL, V518, P800, DOI 10.1002/cne.22243; Morcos Y, 1997, GLIA, V21, P163, DOI 10.1002/(SICI)1098-1136(199710)21:2<163::AID-GLIA1>3.3.CO;2-N; MUCHNICK N, 1980, EXP NEUROL, V68, P205, DOI 10.1016/0014-4886(80)90079-5; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Munderloh C, 2009, J NEUROSCI, V29, P6607, DOI 10.1523/JNEUROSCI.0870-09.2009; Paulsen UJ, 2010, EXP EYE RES, V90, P514, DOI 10.1016/j.exer.2010.01.002; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Rodger J, 2005, MOL CELL NEUROSCI, V30, P452, DOI 10.1016/j.mcn.2005.08.009; SCALIA F, 1985, BRAIN RES, V344, P267, DOI 10.1016/0006-8993(85)90804-2; SCHWALB JM, 1995, J NEUROSCI, V15, P5514; Schweitzer J, 2007, MOL CELL NEUROSCI, V35, P194, DOI 10.1016/j.mcn.2007.02.018; Seo JH, 2001, J NEUROSCI RES, V65, P173, DOI 10.1002/jnr.1140; Sherpa T, 2008, DEV NEUROBIOL, V68, P166, DOI 10.1002/dneu.20568; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Tokuoka H, 2002, J NEUROSCI, V22, P10324; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Vihtelic TS, 2006, EXP EYE RES, V82, P558, DOI 10.1016/j.exer.2005.08.015; Watanabe M, 2001, VISUAL NEUROSCI, V18, P137, DOI 10.1017/S0952523801181137; Wyatt C, 2010, J NEUROSCI, V30, P13838, DOI 10.1523/JNEUROSCI.3846-10.2010; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yin YQ, 2003, J NEUROSCI, V23, P2284; You SW, 2000, INVEST OPHTH VIS SCI, V41, P3165; Yurco P, 2005, VISION RES, V45, P991, DOI 10.1016/j.visres.2004.10.022; Zhou Lan Xia, 2002, Shi Yan Sheng Wu Xue Bao, V35, P159; Zou Su-Qi, 2010, J Vis Exp, DOI 10.3791/1742	62	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57280	10.1371/journal.pone.0057280	http://dx.doi.org/10.1371/journal.pone.0057280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437359	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200235
J	Gritton, HJ; Stasiak, AM; Sarter, M; Lee, TM				Gritton, Howard J.; Stasiak, Ashley M.; Sarter, Martin; Lee, Theresa M.			Cognitive Performance as a Zeitgeber: Cognitive Oscillators and Cholinergic Modulation of the SCN Entrain Circadian Rhythms	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; ANTICIPATORY ACTIVITY; FEEDING SCHEDULES; RECEPTOR-IMMUNOREACTIVITY; PALATABLE MEAL; WATER ACCESS; C-FOS; RATS; ACETYLCHOLINE; EXPRESSION	The suprachiasmatic nucleus (SCN) is the primary circadian pacemaker in mammals that can synchronize or entrain to environmental cues. Although light exerts powerful influences on SCN output, other non-photic stimuli can modulate the SCN as well. We recently demonstrated that daily performance of a cognitive task requiring sustained periods of attentional effort that relies upon basal forebrain (BF) cholinergic activity dramatically alters circadian rhythms in rats. In particular, normally nocturnal rats adopt a robust diurnal activity pattern that persists for several days in the absence of cognitive training. Although anatomical and pharmacological data from non-performing animals support a relationship between cholinergic signaling and circadian rhythms, little is known about how endogenous cholinergic signaling influences SCN function in behaving animals. Here we report that BF cholinergic projections to the SCN provide the principal signal allowing for the expression of cognitive entrainment in light-phase trained animals. We also reveal that oscillator(s) outside of the SCN drive cognitive entrainment as daily timed cognitive training robustly entrains SCN-lesioned arrhythmic animals. Ablation of the SCN, however, resulted in significant impairments in task acquisition, indicating that SCN-mediated timekeeping benefits new learning and cognitive performance. Taken together, we conclude that cognition entrains non-photic oscillators, and cholinergic signaling to the SCN serves as a temporal timestamp attenuating SCN photic-driven rhythms, thereby permitting cognitive demands to modulate behavior.	[Gritton, Howard J.; Stasiak, Ashley M.; Sarter, Martin; Lee, Theresa M.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Gritton, Howard J.; Sarter, Martin; Lee, Theresa M.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lee, TM (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	terrilee@umich.edu		Lee, Theresa/0000-0002-9508-6382	National Institutes of Health: PHS Grant [RO1 MH079084]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007281, T32DA007268] Funding Source: NIH RePORTER	National Institutes of Health: PHS Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health: PHS Grant RO1 MH079084. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Angeles-Castellanos M, 2007, NEUROSCIENCE, V144, P344, DOI 10.1016/j.neuroscience.2006.08.064; Angeles-Castellanos M, 2010, NEUROSCIENCE, V165, P1115, DOI 10.1016/j.neuroscience.2009.11.061; Antoniadis EA, 2000, BEHAV BRAIN RES, V114, P219, DOI 10.1016/S0166-4328(00)00290-4; Arnold HM, 2002, NEUROSCIENCE, V114, P451, DOI 10.1016/S0306-4522(02)00292-0; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Beaule C, 2001, BRAIN RES, V894, P301, DOI 10.1016/S0006-8993(01)02021-2; BIELLO SM, 2009, AGE DORDR; Bina KG, 1996, BRAIN RES, V743, P202, DOI 10.1016/S0006-8993(96)01043-8; BINA KG, 1993, J COMP NEUROL, V335, P295, DOI 10.1002/cne.903350212; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Daan S, 2000, J BIOL RHYTHM, V15, P296, DOI 10.1177/074873000129001396; EARNEST DJ, 1983, SCIENCE, V219, P77, DOI 10.1126/science.6849121; Erhardt C, 2004, EUR J NEUROSCI, V19, P1773, DOI 10.1111/j.1460-9568.2004.03281.x; Gillette MU, 2001, LIFE SCI, V68, P2467, DOI 10.1016/S0024-3205(01)01040-2; Gritton HJ, 2012, LEARNING ME IN PRESS; Gritton HJ, 2009, BEHAV NEUROSCI, V123, P937, DOI 10.1037/a0017128; Haus E, 2006, CANCER CAUSE CONTROL, V17, P489, DOI 10.1007/s10552-005-9015-4; HECKERS S, 1994, J NEUROSCI, V14, P1271, DOI 10.1523/JNEUROSCI.14-03-01271.1994; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; Hut RA, 2010, BEHAV BRAIN RES; Lee TM, 2010, TIMED SUSTAINED ATTE, P203; Madeira MD, 2004, NEUROSCIENCE, V125, P889, DOI 10.1016/j.neuroscience.2004.03.005; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; McGaughy J, 1996, BEHAV NEUROSCI, V110, P247, DOI 10.1037/0735-7044.110.2.247; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; MISTLBERGER RE, 1985, PHYSIOL BEHAV, V34, P17, DOI 10.1016/0031-9384(85)90070-8; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; MISTLBERGER RE, 1992, J BIOL RHYTHM, V7, P149, DOI 10.1177/074873049200700206; MISTLBERGER RE, 1993, AM J PHYSIOL, V264, pR22, DOI 10.1152/ajpregu.1993.264.1.R22; MOORE RY, 1983, FED PROC, V42, P2783; Paolone G, 2012, J NEUROSCI, V32, P12115, DOI 10.1523/JNEUROSCI.2271-12.2012; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; Reid KJ, 2004, MED CLIN N AM, V88, P631, DOI 10.1016/j.mcna.2004.01.010; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; Salgado-Delgado R, 2010, J BIOL RHYTHM, V25, P421, DOI 10.1177/0748730410383403; Scheer FAJL, 2005, NEUROSCIENCE, V132, P465, DOI 10.1016/j.neuroscience.2004.12.012; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Van der Zee EA, 2004, J NEUROSCI RES, V78, P508, DOI 10.1002/jnr.20300; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; Van Someren EJW, 2000, EXP GERONTOL, V35, P1229, DOI 10.1016/S0531-5565(00)00191-1; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Yoshihara T, 1997, NEUROSCI LETT, V222, P95, DOI 10.1016/S0304-3940(97)13353-5	48	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56206	10.1371/journal.pone.0056206	http://dx.doi.org/10.1371/journal.pone.0056206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441168	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200025
J	Lim, SG; Venkatraman, SS; Burnett, JC; Chen, HH				Lim, Soo Ghim; Venkatraman, Subbu S.; Burnett, John C., Jr.; Chen, Horng H.			In-Vivo Evaluation of an In Situ Polymer Precipitation Delivery System for a Novel Natriuretic Peptide	PLOS ONE			English	Article							PHASE INVERSION DYNAMICS; DRUG-DELIVERY; ATRIAL; NESIRITIDE; LEUPROLIDE; EFFICACY; IMPLANT	This study reports on the release of a novel natriuretic peptide, CD-NP, from an in situ polymer precipitation delivery system. Following extensive screening of in-vitro release profiles, an in-vivo evaluation of the efficacy of the delivery system was carried out in Wistar rats. Gel injection was performed subcutaneously on the back of the rats. A secondary messenger, cyclic Guanosine 3'5' Monophosphate (cGMP), was tested for verification of CD-NP bioactivity, in addition to direct measurements of CD-NP levels in plasma and urine using a radio-immuno assay. Plasma evaluation showed an elevated level of CD-NP over 3 weeks' duration. Unexpectedly, plasma cGMP level followed a decreasing trend over the same duration despite high CD-NP level. Loss of drug bioactivity was ruled out as a high level of CD-NP and cGMP excretion was observed in the treatment group as compared to baseline readings. This unexpected low-plasma cGMP levels and high-urinary cGMP excretion suggest that there might be other compensatory responses to regulation of the CDNP bioactivity as a result of the high drug dosing. The results stress the importance of assessing the overall bioactivity of released drug (in-vivo) concurrently in addition to measuring its concentrations, to determine the correct release profile.	[Lim, Soo Ghim; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Burnett, John C., Jr.; Chen, Horng H.] Mayo Clin, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Mayo Clinic	Chen, HH (corresponding author), Mayo Clin, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA.	chen.horng@mayo.edu	Venkatraman, Subramanian/A-2228-2011	Venkatraman, Subramanian/0000-0002-8693-1070	National Institute of Health [RO1 HL36634, R01 HL83231, HL101439, PO1 HL76611]; Mayo Foundation; National Research Foundation - Competitive Research Programme; Singapore Economic Development Board - The Strategic Attachment and Training Programme; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101439, P01HL076611, R01HL036634, R01HL083231] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; National Research Foundation - Competitive Research Programme; Singapore Economic Development Board - The Strategic Attachment and Training Programme; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following grants: The National Institute of Health, http://www.nih.gov/(RO1 HL36634, R01 HL83231, HL101439-and PO1 HL76611); The Mayo Foundation, http://www.mayoclinic.com/; The National Research Foundation - Competitive Research Programme, http://www.nrf.gov.sg/; Singapore Economic Development Board - The Strategic Attachment and Training Programme, www.edb.gov.sg/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson B, 1994, ARBETE OCH HALSA, P1; Andersen F, 2003, INT J TOXICOLOGY; Arora RR, 2006, AM HEART J, V152, P1084, DOI 10.1016/j.ahj.2006.07.002; Brodbeck KJ, 1999, J CONTROL RELEASE, V62, P333, DOI 10.1016/S0168-3659(99)00159-5; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; CLAVELL AL, 1993, AM J PHYSIOL, V264, pR290, DOI 10.1152/ajpregu.1993.264.2.R290; Del Ry S, 2005, CLIN CHEM LAB MED, V43, P641, DOI 10.1515/CCLM.2005.110; Dickey DM, 2008, J BIOL CHEM, V283, P35003, DOI 10.1074/jbc.M804538200; Dunn R.L., 1990, US Patent, Patent No. [4 938 763, 4938763, US patent no. 4,938,763]; Evans D, 2012, US Patent, Patent No. [us 20120178689, 20120178689]; Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8; Horio T, 2003, ENDOCRINOLOGY, V144, P2279, DOI 10.1210/en.2003-0128; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Igaki T, 1998, HYPERTENS RES-CLIN E, V21, P7, DOI 10.1291/hypres.21.7; Kim TK, 2002, J PHARM PHARMACOL, V54, P897, DOI 10.1211/002235702760089009; Kohzu H, 2007, J CARD FAIL, V13, pS40; La Villa G, 1998, CLIN SCI, V95, P595; Lee CYW, 2007, HEART FAIL REV, V12, P131, DOI 10.1007/s10741-007-9016-3; LEE KP, 1987, FUND APPL TOXICOL, V9, P222, DOI 10.1016/0272-0590(87)90045-5; Lisy O, 2003, J AM COLL CARDIOL, V41, p312A; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McKie Paul M, 2010, Curr Heart Fail Rep, V7, P93, DOI 10.1007/s11897-010-0016-6; MISONO KS, 1984, BIOCHEM BIOPH RES CO, V123, P444, DOI 10.1016/0006-291X(84)90250-X; Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/j.ejpb.2004.03.003; Peacock WF, 2004, J CARD FAIL, V10, P120, DOI 10.1016/j.cardfail.2003.08.012; Ravivarapu HB, 2000, INT J PHARM, V194, P181, DOI 10.1016/S0378-5173(99)00371-3; Royals MA, 1999, J BIOMED MATER RES, V45, P231, DOI 10.1002/(SICI)1097-4636(19990605)45:3<231::AID-JBM11>3.0.CO;2-H; Sartor O, 2003, UROLOGY, V61, P25, DOI 10.1016/S0090-4295(02)02396-8; Sartor O, 2006, EUR UROL SUPPL, V5, P905, DOI 10.1016/j.eursup.2006.08.006; Shah SJ, 2010, J CARD FAIL, V16, P720, DOI 10.1016/j.cardfail.2010.04.008; Socki T, 2005, J AM COLL CARDIOL, V45, P608, DOI 10.1016/j.jacc.2004.10.067; Wei CM, 1993, AM J PHYSL HEART CIR, P264	33	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e52484	10.1371/journal.pone.0052484	http://dx.doi.org/10.1371/journal.pone.0052484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441143	gold, Green Published			2022-12-25	WOS:000315159200001
J	Romagnoli, PA; Premenko-Lanier, MF; Loria, GD; Altman, JD				Romagnoli, Pablo A.; Premenko-Lanier, Mary F.; Loria, Gilbert D.; Altman, John D.			CD8 T Cell Memory Recall Is Enhanced by Novel Direct Interactions with CD4 T Cells Enabled by MHC Class II Transferred from APCs	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; DENDRITIC CELL; LYMPHOCYTIC CHORIOMENINGITIS; SECONDARY EXPANSION; CD8-T-CELL MEMORY; VIRAL-INFECTIONS; CD4-T-CELL HELP; CUTTING EDGE; IN-VIVO; EXPRESSION	Protection against many intracellular pathogens is provided by CD8 T cells, which are thought to need CD4 T cell help to develop into effective memory CD8 T cells. Because murine CD8 T cells do not transcribe MHC class II (MHC-II) genes, several models have proposed antigen presenting cells (APCs) as intermediaries required for CD4 T cells to deliver their help to CD8 T cells. Here, we demonstrate the presence of MHC-II molecules on activated murine CD8 T cells in vitro as well as in vivo. These MHC-II molecules are acquired via trogocytosis by CD8 T cells from their activating APCs, particularly CD11c positive dendritic cells (DCs). Transferred MHC-II molecules on activated murine CD8 T cells were functionally competent in stimulating specific indicator CD4 T cells. CD8 T cells that were "helped" in vitro and subsequently allowed to rest in vivo showed enhanced recall responses upon challenge compared to "helpless" CD8 T cells; in contrast, no differences were seen upon immediate challenge. These data indicate that direct CD8:CD4 T cell interactions may significantly contribute to help for CD8 T cells. Furthermore, this mechanism may enable CD8 T cells to communicate with different subsets of interacting CD4 T cells that could modulate immune responses.	[Romagnoli, Pablo A.; Loria, Gilbert D.; Altman, John D.] Emory Vaccine Ctr, Atlanta, GA USA; [Romagnoli, Pablo A.; Loria, Gilbert D.; Altman, John D.] Yerkes Natl Primate Res Ctr, Dept Microbiol & Immunol, Atlanta, GA USA; [Romagnoli, Pablo A.; Loria, Gilbert D.; Altman, John D.] Emory Univ, Sch Med, Atlanta, GA USA; [Premenko-Lanier, Mary F.] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Premenko-Lanier, Mary F.] San Francisco Gen Hosp, San Francisco, CA 94110 USA	Emory University; Emory University; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Altman, JD (corresponding author), Emory Vaccine Ctr, Atlanta, GA USA.	jaltman@emory.edu	Romagnoli, Pablo Alberto/AAF-4719-2019	Romagnoli, Pablo Alberto/0000-0002-6328-9070	National Institutes of Health (USA) [1RO1AI042373]; Emory Vaccine Center Flow Cytometry Core Facility, Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042373, P30AI050409] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Vaccine Center Flow Cytometry Core Facility, Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this research came from National Institutes of Health (USA), grant 1RO1AI042373, and the Emory Vaccine Center Flow Cytometry Core Facility, Emory Center for AIDS Research (P30 AI050409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2007, J IMMUNOL, V178, P5465, DOI 10.4049/jimmunol.178.9.5465; AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208; Bahcheli D, 2011, AUTOIMMUNITY, V44, P607, DOI 10.3109/08916934.2011.571730; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; BENNUN A, 1985, IMMUNOGENETICS, V22, P123, DOI 10.1007/BF00563509; Beuneu H, 2006, J IMMUNOL, V177, P1406, DOI 10.4049/jimmunol.177.3.1406; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; BURNET FM, 1968, LANCET, V2, P610; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; CHANG CH, 1995, INT IMMUNOL, V7, P1515, DOI 10.1093/intimm/7.9.1515; Curtsinger JM, 1999, J IMMUNOL, V162, P3256; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; FRELINGER JA, 1974, J EXP MED, V140, P1273, DOI 10.1084/jem.140.5.1273; FU SM, 1978, J EXP MED, V148, P1423, DOI 10.1084/jem.148.5.1423; GIORGI JV, 1989, CLIN IMMUNOL IMMUNOP, V52, P10, DOI 10.1016/0090-1229(89)90188-8; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; HUDSON L, 1974, NATURE, V251, P60, DOI 10.1038/251060a0; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; KRAMMER PH, 1975, J EXP MED, V142, P1403, DOI 10.1084/jem.142.6.1403; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Lanzavecchia A, 1998, NATURE, V393, P413, DOI 10.1038/30845; LORBER MI, 1982, J IMMUNOL, V128, P2798; Mannie MD, 1996, J IMMUNOL, V157, P1062; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; MAURI D, 1995, J IMMUNOL, V155, P118; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; MITCHISON NA, 1987, EUR J IMMUNOL, V17, P1579, DOI 10.1002/eji.1830171109; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Northrop JK, 2006, J IMMUNOL, V177, P1062, DOI 10.4049/jimmunol.177.2.1062; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Osborne DG, 2012, J IMMUNOL, V189, P4728, DOI 10.4049/jimmunol.1201507; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rosenits K, 2010, EUR J IMMUNOL, V40, P3450, DOI 10.1002/eji.201040743; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schooten E, 2005, IMMUNOGENETICS, V57, P795, DOI 10.1007/s00251-005-0051-8; SHARROW SO, 1981, J IMMUNOL, V126, P1327; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Thomas DB, 1996, J IMMUNOL, V157, P2386; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; YU DTY, 1980, J EXP MED, V151, P91, DOI 10.1084/jem.151.1.91; Zajac P, 1998, CANCER RES, V58, P4567; Zhou G, 2011, J IMMUNOL, V186, P2148, DOI 10.4049/jimmunol.1002917; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0	69	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56999	10.1371/journal.pone.0056999	http://dx.doi.org/10.1371/journal.pone.0056999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441229	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200086
J	Deka, RK; Brautigam, CA; Liu, WZ; Tomchick, DR; Norgard, MV				Deka, Ranjit K.; Brautigam, Chad A.; Liu, Wei Z.; Tomchick, Diana R.; Norgard, Michael V.			The TP0796 Lipoprotein of Treponema pallidum Is a Bimetal-dependent FAD Pyrophosphatase with a Potential Role in Flavin Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; ADENINE GLYCOSYLASE MUTY; COMPLETE GENOME SEQUENCE; CRYSTAL-STRUCTURE; CATALYTIC MECHANISMS; FMN PHOSPHOHYDROLASE; THIAMINE SYNTHESIS; CHORISMATE LYASE; MEMBRANE-PROTEIN; IN-VIVO	Treponema pallidum, an obligate parasite of humans and the causative agent of syphilis, has evolved the capacity to exploit host-derived metabolites for its survival. Flavin-containing compounds are essential cofactors that are required for metabolic processes in all living organisms, and riboflavin is a direct precursor of the cofactors FMN and FAD. Unlike many pathogenic bacteria, Treponema pallidum cannot synthesize riboflavin; we recently described a flavin-uptake mechanism composed of an ABC-type transporter. However, there is a paucity of information about flavin utilization in bacterial periplasms. Using a discovery-driven approach, we have identified the TP0796 lipoprotein as a previously uncharacterized Mg2+-dependent FAD pyrophosphatase within the ApbE superfamily. TP0796 probably plays a central role in flavin turnover by hydrolyzing exogenously acquired FAD, yielding AMP and FMN. Biochemical and structural investigations revealed that the enzyme has a unique bimetal Mg2+ catalytic center. Furthermore, the pyrophosphatase activity is product-inhibited by AMP, indicating a possible role for this molecule in modulating FMN and FAD levels in the treponemal periplasm. The ApbE superfamily was previously thought to be involved in thiamine biosynthesis, but our characterization of TP0796 prompts a renaming of this superfamily as a periplasmic flavin-trafficking protein (Ftp). TP0796 is the first structurally and biochemically characterized FAD pyrophosphate enzyme in bacteria. This new paradigm for a bacterial flavin utilization pathway may prove to be useful for future inhibitor design.	[Deka, Ranjit K.; Liu, Wei Z.; Norgard, Michael V.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Brautigam, Chad A.; Tomchick, Diana R.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tomchick, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Diana.Tomchick@UTSouthwestern.edu; Michael.Norgard@UTSouthwestern.edu	Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643; Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [AI056305]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI056305 (to M. V. N.).; We thank Martin Goldberg for technical assistance and the scientists in the University of Texas Southwestern Protein Chemistry Core for protein sequence and mass analyses. The structures shown in this report are derived from work performed on beamline 19-ID at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand A, 2012, J BACTERIOL, V194, P2321, DOI 10.1128/JB.00101-12; Backiel J, 2008, BIOCHEMISTRY-US, V47, P11273, DOI 10.1021/bi800920j; Barile M, 1997, EUR J BIOCHEM, V249, P777, DOI 10.1111/j.1432-1033.1997.00777.x; Beck BJ, 1999, J BACTERIOL, V181, P7285, DOI 10.1128/JB.181.23.7285-7290.1999; Beck BJ, 1998, J BACTERIOL, V180, P885, DOI 10.1128/JB.180.4.885-891.1998; Besteiro S, 2002, J BIOL CHEM, V277, P38001, DOI 10.1074/jbc.M201759200; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; BRENNAN S, 1992, REV SCI INSTRUM, V63, P850, DOI 10.1063/1.1142625; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Covington ED, 2010, MOL MICROBIOL, V78, P519, DOI 10.1111/j.1365-2958.2010.07353.x; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Deka RK, 2007, J BIOL CHEM, V282, P5944, DOI 10.1074/jbc.M610215200; Deka RK, 2013, MBIO, V4, DOI 10.1128/mBio.00615-12; Deka RK, 2012, J MOL BIOL, V416, P678, DOI 10.1016/j.jmb.2012.01.015; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Deka RK, 2004, J BIOL CHEM, V279, P55644, DOI 10.1074/jbc.M409263200; Deka RK, 2004, J BACTERIOL, V186, P2303, DOI 10.1128/JB.186.8.2303-2308.2004; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORTI G, 1968, EUR J BIOCHEM, V3, P461, DOI 10.1111/j.1432-1033.1967.tb19553.x; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Gallagher DT, 2001, PROTEINS, V44, P304, DOI 10.1002/prot.1095; Garavaglia S, 2012, BIOCHEM J, V441, P131, DOI 10.1042/BJ20111263; Gorelik M, 2006, PROTEIN SCI, V15, P1506, DOI 10.1110/ps.062146906; Han C, 2011, STAND GENOMIC SCI, V4, P361, DOI 10.4056/sigs.1984594; Han GW, 2006, PROTEINS, V64, P1083, DOI 10.1002/prot.20950; Herguedas B, 2010, J MOL BIOL, V400, P218, DOI 10.1016/j.jmb.2010.05.018; HINKSON JW, 1968, BIOCHEMISTRY-US, V7, P2666, DOI 10.1021/bi00847a033; Holden MJ, 2002, BBA-PROTEIN STRUCT M, V1594, P160, DOI 10.1016/S0167-4838(01)00302-8; Hustad S, 2002, CLIN CHEM, V48, P1571; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knapp K, 2012, STRUCTURE, V20, P2161, DOI 10.1016/j.str.2012.10.001; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEE RSF, 1988, J BIOL CHEM, V263, P14878; Lee RSF, 1997, METHOD ENZYMOL, V280, P424; Luthra A, 2011, J BIOL CHEM, V286, P41656, DOI 10.1074/jbc.M111.305284; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Machius M, 2007, J MOL BIOL, V373, P681, DOI 10.1016/j.jmb.2007.08.018; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Maruta T, 2012, PLANT CELL PHYSIOL, V53, P1106, DOI 10.1093/pcp/pcs054; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mitic N, 2006, CHEM REV, V106, P3338, DOI 10.1021/cr050318f; Norris SJ, 2001, J MOL MICROB BIOTECH, V3, P37; Pallotta ML, 2011, YEAST, V28, P693, DOI 10.1002/yea.1897; Pingoud A, 2005, CELL MOL LIFE SCI, V62, P685, DOI 10.1007/s00018-004-4513-1; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Reidl J, 2000, MOL MICROBIOL, V35, P1573, DOI 10.1046/j.1365-2958.2000.01829.x; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; Robinson Jr W. N., 1993, SYPHILIS HIST, P334; Saier MH, 2000, J MOL MICROB BIOTECH, V2, P393; Sandoval FJ, 2008, J BIOL CHEM, V283, P30890, DOI 10.1074/jbc.M803416200; Schmidt-Brauns J, 2001, INT J MED MICROBIOL, V291, P219, DOI 10.1078/1438-4221-00122; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SELL S, 1983, INT REV EXP PATHOL, V24, P203; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; SKARE JT, 1993, J BIOL CHEM, V268, P16302; Strauss EJ, 1997, SCIENCE, V276, P707, DOI 10.1126/science.276.5313.707; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; Wallden K, 2007, J BIOL CHEM, V282, P17828, DOI 10.1074/jbc.M700917200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	80	21	24	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11106	11121		10.1074/jbc.M113.449975	http://dx.doi.org/10.1074/jbc.M113.449975			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23447540	Green Published, hybrid			2022-12-25	WOS:000317915500016
J	Hertel, P; Daniel, J; Stegehake, D; Vaupel, H; Kailayangiri, S; Gruel, C; Woltersdorf, C; Liebau, E				Hertel, Patrick; Daniel, Jens; Stegehake, Dirk; Vaupel, Hannah; Kailayangiri, Sareetha; Gruel, Clio; Woltersdorf, Christian; Liebau, Eva			The Ubiquitin-fold Modifier 1 (Ufm1) Cascade of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CRYSTAL-STRUCTURE; C-ELEGANS; SYSTEM; ENZYME; CALCINEURIN; INTERACT; BINDING; LIGASE	Ufm1 (ubiquitin-fold modifier 1) is the most recently identified member of the ubiquitin-like protein family. We characterized the Ufm1 cascade of the model organism Caenorhabditis elegans in terms of function and analyzed interactions of the involved proteins in vitro and in vivo. Furthermore, we investigated the phenotypes of the deletion mutants uba5(ok3364) (activating enzyme of Ufm1) and ufc1(tm4888) (conjugating enzyme of Ufm1). The viable deletion mutants showed a decrease in reproduction, development, life span, and a reduced survival under heavy metal stress. However, an increased survival rate under pathogenic, oxidative, heat, and endoplasmic reticulum stress was observed. We propose that the Ufm1 cascade negatively regulates the IRE1-mediated unfolded protein response.	[Hertel, Patrick; Daniel, Jens; Stegehake, Dirk; Vaupel, Hannah; Kailayangiri, Sareetha; Gruel, Clio; Woltersdorf, Christian; Liebau, Eva] Univ Munster, Dept Mol Physiol, Inst Anim Physiol, D-48143 Munster, Germany	University of Munster	Liebau, E (corresponding author), Univ Munster, Dept Mol Physiol, Inst Anim Physiol, Schlosspl 8, D-48143 Munster, Germany.	liebaue@uni-muenster.de						Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Bacik JP, 2010, J BIOL CHEM, V285, P20273, DOI 10.1074/jbc.M110.102921; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Blanchard D, 2006, MOL CELL PROTEOMICS, V5, P2175, DOI 10.1074/mcp.T600025-MCP200; BRENNER S, 1974, GENETICS, V77, P71; CARDENAS ME, 1994, EMBO J, V13, P5944, DOI 10.1002/j.1460-2075.1994.tb06940.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Corsi AK, 2006, ANAL BIOCHEM, V359, P1, DOI 10.1016/j.ab.2006.07.033; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Einarson M. B., 2007, CSH PROTOC, V2007; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; Ha BH, 2011, J BIOL CHEM, V286, P10248, DOI 10.1074/jbc.M110.172171; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Kim SS, 1997, J MOL NEUROSCI, V9, P49, DOI 10.1007/BF02789394; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Mizushima T, 2007, BIOCHEM BIOPH RES CO, V362, P1079, DOI 10.1016/j.bbrc.2007.08.129; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Nam S, 2009, J BIOL CHEM, V284, P8192, DOI 10.1074/jbc.M808230200; Neziri D, 2010, BBA-GEN SUBJECTS, V1800, P430, DOI 10.1016/j.bbagen.2009.12.004; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Richardson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002391; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619; Zhang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048587	44	25	30	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10661	10671		10.1074/jbc.M113.458000	http://dx.doi.org/10.1074/jbc.M113.458000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23449979	hybrid, Green Published			2022-12-25	WOS:000317565000044
J	Ahn, KH; Mahmoud, MM; Shim, JY; Kendall, DA				Ahn, Kwang H.; Mahmoud, Mariam M.; Shim, Joong-Youn; Kendall, Debra A.			Distinct Roles of beta-Arrestin 1 and beta-Arrestin 2 in ORG27569-induced Biased Signaling and Internalization of the Cannabinoid Receptor 1 (CB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ALLOSTERIC MODULATION; KINASE ACTIVATION; REGULATED KINASES; DOWN-REGULATION; 7TM RECEPTORS; HELIX 8; AGONIST; MECHANISM; PATHWAY	The cannabinoid receptor 1 (CB1) is a G protein-coupled receptor primarily expressed in brain tissue that has been implicated in several disease states. CB1 allosteric compounds, such as ORG27569, offer enormous potential as drugs over orthosteric ligands, but their mechanistic, structural, and downstream effects upon receptor binding have not been established. Previously, we showed that ORG27569 enhances agonist binding affinity to CB1 but inhibits G protein-dependent agonist signaling efficacy in HEK293 cells and rat brain expressing the CB1 receptor (Ahn, K. H., Mahmoud, M. M., and Kendall, D. A. (2012) J. Biol. Chem. 287, 12070-12082). Here, we identify the mediators of CB1 receptor internalization and ORG27569-induced G protein-independent signaling. Using siRNA technology, we elucidate an ORG27569-induced signaling mechanism for CB1 wherein beta-arrestin 1 mediates short term signaling to ERK1/2 with a peak at 5 min and other upstream kinase components including MEK1/2 and c-Src. Consistent with these findings, we demonstrate co-localization of CB1-GFP with red fluorescent protein-beta-arrestin 1 upon ORG27569 treatment using confocal microscopy. In contrast, we show the critical role of beta-arrestin 2 in CB1 receptor internalization upon treatment with CP55940 (agonist) or treatment with ORG27569. These results demonstrate for the first time the involvement of beta-arrestin in CB1-biased signaling by a CB1 allosteric modulator and also define the differential role of the two beta-arrestin isoforms in CB1 signaling and internalization.	[Ahn, Kwang H.; Kendall, Debra A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Mahmoud, Mariam M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Shim, Joong-Youn] N Carolina Cent Univ, JL Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA	University of Connecticut; University of Connecticut; University of North Carolina; North Carolina Central University	Kendall, DA (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, 69 N Eagleville Rd, Storrs, CT 06269 USA.	debra.kendall@uconn.edu		Mahmoud, Mariam/0000-0002-0491-1544	National Institutes of Health [DA020763]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA020763 (to D. A. K.).	Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Ahn KH, 2010, BIOCHEMISTRY-US, V49, P502, DOI 10.1021/bi901619r; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Baillie GL, 2013, MOL PHARMACOL, V83, P322, DOI 10.1124/mol.112.080879; Barlic J, 2000, NAT IMMUNOL, V1, P227, DOI 10.1038/79767; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Davis AA, 2010, ACS CHEM NEUROSCI, V1, P542, DOI 10.1021/cn100011e; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dowal L, 2011, P NATL ACAD SCI USA, V108, P2951, DOI 10.1073/pnas.1014863108; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Horswill JG, 2007, BRIT J PHARMACOL, V152, P805, DOI 10.1038/sj.bjp.0707347; Howlett AC, 2000, CHEM PHYS LIPIDS, V108, P53, DOI 10.1016/S0009-3084(00)00187-0; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Imamura T, 2001, J BIOL CHEM, V276, P43663, DOI 10.1074/jbc.M105364200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Klaasse EC, 2005, EUR J PHARMACOL, V522, P1, DOI 10.1016/j.ejphar.2005.08.052; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Langmead CJ, 2006, MOL PHARMACOL, V69, P236, DOI 10.1124/mol.105.017814; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lim CS, 2008, CELL SIGNAL, V20, P825, DOI 10.1016/j.cellsig.2007.12.013; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Miller WE, 2000, J BIOL CHEM, V275, P11312, DOI 10.1074/jbc.275.15.11312; Navarro HA, 2009, BRIT J PHARMACOL, V156, P1178, DOI 10.1111/j.1476-5381.2009.00124.x; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Palanche T, 2001, J BIOL CHEM, V276, P34853, DOI 10.1074/jbc.M104363200; Pelkey KA, 2007, NEUROPHARMACOLOGY, V52, P108, DOI 10.1016/j.neuropharm.2006.07.020; Perez DM, 1996, MOL PHARMACOL, V49, P112; Povsic TJ, 2003, J BIOL CHEM, V278, P51334, DOI 10.1074/jbc.M309968200; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Zhang YQ, 2005, J PHARMACOL EXP THER, V315, P1212, DOI 10.1124/jpet.105.090308	57	100	101	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9790	9800		10.1074/jbc.M112.438804	http://dx.doi.org/10.1074/jbc.M112.438804			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23449980	Green Published, hybrid			2022-12-25	WOS:000317114000020
J	Fujii, Y; Kitaura, K; Matsutani, T; Shirai, K; Suzuki, S; Takasaki, T; Kumagai, K; Kametani, Y; Shiina, T; Takabayashi, S; Katoh, H; Hamada, Y; Kurane, I; Suzuki, R				Fujii, Yoshiki; Kitaura, Kazutaka; Matsutani, Takaji; Shirai, Kenji; Suzuki, Satsuki; Takasaki, Tomohiko; Kumagai, Kenichi; Kametani, Yoshie; Shiina, Takashi; Takabayashi, Shuji; Katoh, Hideki; Hamada, Yoshiki; Kurane, Ichiro; Suzuki, Ryuji			Immune-Related Gene Expression Profile in Laboratory Common Marmosets Assessed by an Accurate Quantitative Real-Time PCR Using Selected Reference Genes	PLOS ONE			English	Article							CLASS-I EXPRESSION; MHC CLASS-I; T-CELLS; CALLITHRIX-JACCHUS; BIOMEDICAL-RESEARCH; VIRUS; TH1; MODEL; LYMPHOCYTES; CYTOKINES	The common marmoset (Callithrix jacchus) is considered a novel experimental animal model of non-human primates. However, due to antibody unavailability, immunological and pathological studies have not been adequately conducted in various disease models of common marmoset. Quantitative real-time PCR (qPCR) is a powerful tool to examine gene expression levels. Recent reports have shown that selection of internal reference housekeeping genes are required for accurate normalization of gene expression. To develop a reliable qPCR method in common marmoset, we used geNorm applets to evaluate the expression stability of eight candidate reference genes (GAPDH, ACTB, rRNA, B2M, UBC, HPRT, SDHA and TBP) in various tissues from laboratory common marmosets. geNorm analysis showed that GAPDH, ACTB, SDHA and TBP were generally ranked high in stability followed by UBC. In contrast, HPRT, rRNA and B2M exhibited lower expression stability than other genes in most tissues analyzed. Furthermore, by using the improved qPCR with selected reference genes, we analyzed the expression levels of CD antigens (CD3 epsilon, CD4, CD8 alpha and CD20) and cytokines (IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 beta, IL-13, IFN-gamma and TNF-alpha) in peripheral blood leukocytes and compared them between common marmosets and humans. The expression levels of CD4 and IL-4 were lower in common marmosets than in humans whereas those of IL-10, IL-12 beta and IFN-gamma were higher in the common marmoset. The ratio of Th1-related gene expression level to that of Th2-related genes was inverted in common marmosets. We confirmed the inverted ratio of CD4 to CD8 in common marmosets by flow cytometric analysis. Therefore, the difference in Th1/Th2 balance between common marmosets and humans may affect host defense and/or disease susceptibility, which should be carefully considered when using common marmoset as an experimental model for biomedical research.	[Fujii, Yoshiki; Kitaura, Kazutaka; Shirai, Kenji; Kumagai, Kenichi; Suzuki, Ryuji] Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Allergy & Rheumatol, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan; [Fujii, Yoshiki; Kitaura, Kazutaka; Shirai, Kenji; Takasaki, Tomohiko; Kurane, Ichiro] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Matsutani, Takaji] Wakayama Med Univ, Lab Immune Regulat, Osaka, Japan; [Suzuki, Satsuki] Nippon Dent Univ Tokyo, Sect Biol Sci, Res Ctr Odontol, Sch Life Dent, Tokyo, Japan; [Kumagai, Kenichi; Hamada, Yoshiki] Tsurumi Univ, Dept Oral & Maxillofacial Surg, Sch Dent Med, Yokohama, Kanagawa, Japan; [Kametani, Yoshie] Tokai Univ, Sch Med, Dept Immunol, Div Basic Med Sci & Mol Med, Hiratsuka, Kanagawa 25912, Japan; [Shiina, Takashi] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Hiratsuka, Kanagawa 25912, Japan; [Takabayashi, Shuji; Katoh, Hideki] Hamamatsu Univ Sch Med, Expt Anim Inst, Shizuoka, Japan; [Katoh, Hideki] Cent Inst Expt Anim, Lab Anim Breeding & Genet, Kawasaki, Kanagawa, Japan	National Institute of Infectious Diseases (NIID); Wakayama Medical University; Nippon Dental University; Tsurumi University; Tokai University; Tokai University; Hamamatsu University School of Medicine	Suzuki, R (corresponding author), Natl Hosp Org, Dept Rheumatol & Clin Immunol, Clin Res Ctr Allergy & Rheumatol, Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan.	r-suzuki@sagamihara-hosp.gr.jp	高林, 秀次/ABC-9307-2021; Suzuki, Satsuki/ABE-1283-2020; Fujii, Yoshiki/GOE-3566-2022	Shiina, Takashi/0000-0002-2067-6708	Ministry of Health, Labor, and Welfare, Japan [H20-shinkou-ippan-013, H23-shinkou-ippan-010]; Japan Society for the Promotion of Science [23659237]	Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labor, and Welfare, Japan (Grants H20-shinkou-ippan-013 and H23-shinkou-ippan-010) as well as by Grant-in-Aid for Challenging Exploratory Research 23659237 from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Abbott DH, 2003, COMPARATIVE MED, V53, P339; Adams AP, 2008, J VIROL, V82, P9035, DOI 10.1128/JVI.00674-08; Ando K, 2008, PSYCHOPHARMACOLOGY, V195, P509, DOI 10.1007/s00213-007-0929-2; Bentwich Z, 1996, CLIN EXP IMMUNOL, V103, P239, DOI 10.1046/j.1365-2249.1996.d01-612.x; Bostik Pavel, 2004, Clin Dev Immunol, V11, P35, DOI 10.1080/10446670410001670472; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; DAAR AS, 1984, TRANSPLANTATION, V38, P287, DOI 10.1097/00007890-198409000-00018; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; DREZEN JM, 1993, J IMMUNOL, V150, P2805; Fukuoka T, 2010, NEUROSCI RES, V66, P62, DOI 10.1016/j.neures.2009.09.1709; Genain CP, 1997, J MOL MED, V75, P187, DOI 10.1007/s001090050103; GENAIN CP, 1994, J CLIN INVEST, V94, P1339, DOI 10.1172/JCI117454; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jeong AR, 2008, J MED PRIMATOL, V37, P290, DOI 10.1111/j.1600-0684.2008.00289.x; Kametani Y, 2009, EXP HEMATOL, V37, P1318, DOI 10.1016/j.exphem.2009.08.003; Keskinen P, 1997, IMMUNOLOGY, V91, P421, DOI 10.1046/j.1365-2567.1997.00258.x; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KLUG S, 1994, ARCH TOXICOL, V68, P619, DOI 10.1007/BF03208341; LAMPSON LA, 1995, MICROSC RES TECHNIQ, V32, P267, DOI 10.1002/jemt.1070320402; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Matrai Z, 2009, CLIN CHEM LAB MED, V47, P585, DOI 10.1515/CCLM.2009.137; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; QUINT DJ, 1990, IMMUNOLOGY, V69, P616; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Solanas M, 2001, ANAL BIOCHEM, V288, P99, DOI 10.1006/abio.2000.4889; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; Yaguchi M, 2009, NEUROSCI RES, V65, P384, DOI 10.1016/j.neures.2009.08.016; Zuhlke U, 2003, Toxicol Pathol, V31 Suppl, P123, DOI 10.1080/01926230309767	37	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56296	10.1371/journal.pone.0056296	http://dx.doi.org/10.1371/journal.pone.0056296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451040	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500011
J	Griessenberger, H; Heib, DPJ; Lechinger, J; Luketina, N; Petzka, M; Moeckel, T; Hoedlmoser, K; Schabus, M				Griessenberger, Hermann; Heib, Dominik P. J.; Lechinger, Julia; Luketina, Nikolina; Petzka, Marit; Moeckel, Tina; Hoedlmoser, Kerstin; Schabus, Manuel			Susceptibility to Declarative Memory Interference Is Pronounced in Primary Insomnia	PLOS ONE			English	Article							LEARNING-DEPENDENT CHANGES; SLOW-WAVE SLEEP; REM-SLEEP; TIME-COURSE; EARLY BOOST; CONSOLIDATION; SPINDLES; PERFORMANCE; RIPPLES; CLASSIFICATION	Sleep has been shown to stabilize memory traces and to protect against competing interference in both the procedural and declarative memory domain. Here, we focused on an interference learning paradigm by testing patients with primary insomnia (N = 27) and healthy control subjects (N = 21). In two separate experimental nights with full polysomnography it was revealed that after morning interference procedural memory performance (using a finger tapping task) was not impaired in insomnia patients while declarative memory (word pair association) was decreased following interference. More specifically, we demonstrate robust associations of central sleep spindles (in N3) with motor memory susceptibility to interference as well as (cortically more widespread) fast spindle associations with declarative memory susceptibility. In general the results suggest that insufficient sleep quality does not necessarily show up in worse overnight consolidation in insomnia but may only become evident (in the declarative memory domain) when interference is imposed.	[Griessenberger, Hermann; Heib, Dominik P. J.; Lechinger, Julia; Luketina, Nikolina; Petzka, Marit; Moeckel, Tina; Hoedlmoser, Kerstin; Schabus, Manuel] Salzburg Univ, Dept Psychol, Lab Sleep Cognit & Consciousness Res, A-5020 Salzburg, Austria	Salzburg University	Schabus, M (corresponding author), Salzburg Univ, Dept Psychol, Lab Sleep Cognit & Consciousness Res, A-5020 Salzburg, Austria.	manuel.schabus@sbg.ac.at	Hoedlmoser, Kerstin/E-8236-2010; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; Schabus, Manuel/C-1704-2010	Hoedlmoser, Kerstin/0000-0001-5177-4389; Schabus, Manuel/0000-0001-5899-8772; Lechinger, Julia/0000-0002-6325-1988; Heib, Dominik/0000-0002-7977-8557	Austrian Science Fund (FWF) [P-21154-B18]; Doctoral College "Imaging the Mind" by the Austrian Science Fund [FWF-W1233]; Austrian Science Fund (FWF) [P 21154] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Doctoral College "Imaging the Mind" by the Austrian Science Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Research was supported by a research grant (P-21154-B18) from the Austrian Science Fund (FWF; http://www.fwf.ac.at/). DPJH was financially supported by the Doctoral College "Imaging the Mind" by the Austrian Science Fund (FWF-W1233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anderer P, 2005, NEUROPSYCHOBIOLOGY, V51, P115, DOI 10.1159/000085205; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Broman Jan-Erik, 1992, Scandinavian Journal of Behaviour Therapy, V21, P115; Clemens Z, 2005, NEUROSCIENCE, V132, P529, DOI 10.1016/j.neuroscience.2005.01.011; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Espie CA, 2008, SLEEP, V31, P591, DOI 10.1093/sleep/31.5.591; Fischer S, 2005, J NEUROSCI, V25, P11248, DOI 10.1523/JNEUROSCI.1743-05.2005; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Fogel SM, 2006, J SLEEP RES, V15, P250, DOI 10.1111/j.1365-2869.2006.00522.x; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Hotermans C, 2008, EUR J NEUROSCI, V28, P1216, DOI 10.1111/j.1460-9568.2008.06421.x; Hotermans C, 2006, LEARN MEMORY, V13, P580, DOI 10.1101/lm.239406; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Molle M, 2011, SLEEP, V34, P1411, DOI 10.5665/SLEEP.1290; Molle M, 2009, EUR J NEUROSCI, V29, P1071, DOI 10.1111/j.1460-9568.2009.06654.x; Morin A, 2008, SLEEP, V31, P1149; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Nissen C, 2011, J SLEEP RES, V20, P129, DOI 10.1111/j.1365-2869.2010.00872.x; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Orff HJ, 2007, SLEEP, V30, P1205, DOI 10.1093/sleep/30.9.1205; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2005, BEHAV BRAIN SCI, V28, P78, DOI 10.1017/S0140525X05350023; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rasch B, 2009, NAT NEUROSCI, V12, P396, DOI 10.1038/nn.2206; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rosanova M, 2005, J NEUROSCI, V25, P9398, DOI 10.1523/JNEUROSCI.2149-05.2005; Roth T, 1999, SLEEP, V22, pS354; Schabus M, 2007, P NATL ACAD SCI USA, V104, P13164, DOI 10.1073/pnas.0703084104; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schabus M, 2009, SLEEP, V32, P291, DOI 10.1093/sleep/32.3.291; Shekleton JA, 2009, SLEEP MED REV; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siegel JM, 2001, SCIENCE, V294, P1058, DOI 10.1126/science.1063049; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Steyer R., 1997, HANDANWEISUNG; Tamaki M, 2008, SLEEP, V31, P204, DOI 10.1093/sleep/31.2.204; Tamaki M, 2009, CLIN NEUROPHYSIOL, V120, P878, DOI 10.1016/j.clinph.2009.03.006; van Dongen EV, 2012, P NATL ACAD SCI USA, V109, P10575, DOI 10.1073/pnas.1201072109; Varkevisser Michael, 2007, Behav Sleep Med, V5, P279; Vertes RP, 2004, NEURON, V44, P135, DOI 10.1016/j.neuron.2004.08.034; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Walsh JK, 2004, J CLIN PSYCHIAT, V65, P13	61	16	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57394	10.1371/journal.pone.0057394	http://dx.doi.org/10.1371/journal.pone.0057394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451218	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500097
J	Tehrani, FR; Moslehi, N; Asghari, G; Gholami, R; Mirmiran, P; Azizi, F				Tehrani, Fahimeh Ramezani; Moslehi, Nazanin; Asghari, Golaleh; Gholami, Roya; Mirmiran, Parvin; Azizi, Fereidoun			Intake of Dairy Products, Calcium, Magnesium, and Phosphorus in Childhood and Age at Menarche in the Tehran Lipid and Glucose Study	PLOS ONE			English	Article							GROWTH-FACTOR-I; PROSPECTIVE COHORT; BONE MASS; INTERVENTION TRIAL; BODY-COMPOSITION; NUTRIENT INTAKE; IGF-I; GIRLS; MILK; CHILDREN	Purpose: Studies indicate that milk intake is associated with insulin-like growth factor 1 (IGF-1) concentrations and height in childhood, whether milk and other dairy products promote puberty remains unclear. This study aimed to investigate influences of pre-pubertal intakes of milk, yogurt and cheese on menarcheal age in Tehranian girls. The associations of total dietary calcium (Ca), magnesium (Mg), and phosphorus (P) with menarcheal age were also examined. Methods: This prospective study was conducted on 134 pre-pubertal girls, aged 4-12 years at baseline, who participated in the Tehran Lipid and Glucose Study (TLGS), and were followed for a median of 6.5 years. Dietary intakes were determined at initiation of the study using two non-consecutive 24-h dietary recalls and the age of menarche was documented during the follow-up. Logistic regression was used to calculate the risk of reaching menarche <= 12 years according to pre-pubertal levels of dairy or mineral intakes. Results: The risk of earlier menarche was higher in girls with higher intakes of milk [OR: 2.28 (95% CI: 1.03-5.05)], Ca [OR: 3.20 (95%CI: 1.39-7.42)], Mg [OR: 2.43 (95% CI: 1.12-5.27)] and P [OR: 3.37 (95 % CI: 1.44-7.87) after controlling for energy and protein intake, interval between the age at study initiation and the age of menarche, and maternal age at menarche (Model 1). Girls in the middle tertile of cheese intakes had a lower risk of reaching menarche <= 12 years than those in the lowest tertile after controlling for covariates in model 1. These associations remained significant after further adjustment of BMI Z-score at baseline. The relationship of Ca, Mg, and P with menarche remained after further adjustment for height Z-score at baseline, whereas the association between milk and cheese intakes became non-significant. Conclusions: Pre-pubertal intake of milk, but not cheese and yogurt, may hasten age at menarche.	[Tehrani, Fahimeh Ramezani; Gholami, Roya] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Reprod Endocrinol Res Ctr, Tehran, Iran; [Moslehi, Nazanin; Asghari, Golaleh] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Obes Res Ctr, Tehran, Iran; [Mirmiran, Parvin] Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Mirmiran, P (corresponding author), Shahid Beheshti Univ Med Sci, Natl Nutr & Food Technol Res Inst, Fac Nutr Sci & Food Technol, Dept Clin Nutr & Dietet, Tehran, Iran.	mirmiran@endocrine.ac.ir	Gholami, Roya/D-7584-2019; Azizi, Fereidoun/ABD-4136-2021; Moslehi, Nazanin/R-8154-2019; Tehrani, Fahimeh Ramezani/H-6133-2017; asghari, golaleh/N-4521-2013; Mirmiran, Parvin/V-1433-2019	Gholami, Roya/0000-0002-7322-182X; Azizi, Fereidoun/0000-0002-6470-2517; Moslehi, Nazanin/0000-0001-8441-5200; Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; asghari, golaleh/0000-0002-7925-5158; Mirmiran, Parvin/0000-0003-2391-4924	National Research Council of the Islamic Republic of Iran [121]; Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences	National Research Council of the Islamic Republic of Iran; Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences	This study was supported by grant no. 121 from National Research Council of the Islamic Republic of Iran and Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayatollahi SMT, 2002, ANN HUM BIOL, V29, P355, DOI 10.1080/03014460110086817; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Berkey CS, 2009, CANCER EPIDEM BIOMAR, V18, P1881, DOI 10.1158/1055-9965.EPI-08-1163; Berkey CS, 1999, CANCER-AM CANCER SOC, V85, P2400, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2400::AID-CNCR15>3.0.CO;2-O; Berkey CS, 2000, AM J EPIDEMIOL, V152, P446, DOI 10.1093/aje/152.5.446; Bonofiglio D, 2004, J BONE MINER METAB, V22, P64, DOI 10.1007/s00774-003-0451-5; Boyne MS, 2010, J CLIN ENDOCR METAB, V95, P3194, DOI 10.1210/jc.2010-0080; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255; Chagas CEA, 2012, NUTR REV, V70, P294, DOI 10.1111/j.1753-4887.2012.00464.x; Cheng G, 2012, NUTR REV, V70, P133, DOI 10.1111/j.1753-4887.2011.00461.x; Chevalley T, 2005, J CLIN ENDOCR METAB, V90, P44, DOI 10.1210/jc.2004-1043; Collier RJ, 2008, DOMEST ANIM ENDOCRIN, V35, P16, DOI 10.1016/j.domaniend.2008.01.003; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Esterle L, 2009, OSTEOPOROSIS INT, V20, P567, DOI 10.1007/s00198-008-0708-x; Farahmand M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1064; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Frontini MG, 2003, INT J OBESITY, V27, P1398, DOI 10.1038/sj.ijo.0802422; Gerdhem P, 2004, J BONE MINER METAB, V22, P372, DOI 10.1007/s00774-004-0497-z; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Gunther ALB, 2010, J NUTR, V140, P565, DOI 10.3945/jn.109.114934; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Holmes MD, 2002, CANCER EPIDEM BIOMAR, V11, P852; Hoppe C, 2004, EUR J CLIN NUTR, V58, P1211, DOI 10.1038/sj.ejcn.1601948; Karapanou O, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-115; KISSINGER DG, 1987, NUTR RES, V7, P471, DOI 10.1016/S0271-5317(87)80003-9; Koo MM, 2002, PUBLIC HEALTH NUTR, V5, P353, DOI 10.1079/PHN2002261; Kwok MK, 2012, PEDIATRICS, V130, pE631, DOI 10.1542/peds.2011-3697; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; MACLURE M, 1991, AM J CLIN NUTR, V54, P649, DOI 10.1093/ajcn/54.4.649; Maggio M, 2011, INT J ANDROL, V34, pE594, DOI 10.1111/j.1365-2605.2011.01193.x; Remer T, 1999, J CLIN ENDOCR METAB, V84, P3936, DOI 10.1210/jc.84.11.3936; Rogers IS, 2010, PUBLIC HEALTH NUTR, V13, P2052, DOI 10.1017/S1368980010001461; Singer MR, 1995, AM J PUBLIC HEALTH, V85, P1673, DOI 10.2105/AJPH.85.12.1673; Tehrani F. R., 2010, Eastern Mediterranean Health Journal, V16, P391; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; Velie Ellen M, 2005, Breast Dis, V24, P17; Wang YF, 2002, J NUTR, V132, P430, DOI 10.1093/jn/132.3.430; Wiley AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014685; Wiley AS, 2009, ANN HUM BIOL, V36, P125, DOI 10.1080/03014460802680466; Zhu K, 2006, AM J CLIN NUTR, V83, P714, DOI 10.1093/ajcn.83.3.714	42	34	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57696	10.1371/journal.pone.0057696	http://dx.doi.org/10.1371/journal.pone.0057696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451261	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500128
J	Yassin, A; Orgogozo, V				Yassin, Amir; Orgogozo, Virginie			Coevolution between Male and Female Genitalia in the Drosophila melanogaster Species Subgroup	PLOS ONE			English	Article							MORPHOLOGICAL SHAPE DIFFERENCE; ANTAGONISTIC COEVOLUTION; SEXUAL SELECTION; GENETIC-ANALYSIS; PHOLCID SPIDERS; EVOLUTION; SPERM; DIVERGENCE; COPULATION; SANTOMEA	In contrast to male genitalia that typically exhibit patterns of rapid and divergent evolution among internally fertilizing animals, female genitalia have been less well studied and are generally thought to evolve slowly among closely-related species. As a result, few cases of male-female genital coevolution have been documented. In Drosophila, female copulatory structures have been claimed to be mostly invariant compared to male structures. Here, we re-examined male and female genitalia in the nine species of the D. melanogaster subgroup. We describe several new species-specific female genital structures that appear to coevolve with male genital structures, and provide evidence that the coevolving structures contact each other during copulation. Several female structures might be defensive shields against apparently harmful male structures, such as cercal teeth, phallic hooks and spines. Evidence for male-female morphological coevolution in Drosophila has previously been shown at the post-copulatory level (e.g., sperm length and sperm storage organ size), and our results provide support for male-female coevolution at the copulatory level.	[Yassin, Amir; Orgogozo, Virginie] Univ Paris Diderot, CNRS, Inst Jacques Monod, Unite Mixte Rech 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Yassin, A (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Unite Mixte Rech 7592, Paris, France.	yassin@legs.cnrs-gif.fr	Yassin, Amir/N-7957-2018; Yassin, Amir/P-5915-2019	Yassin, Amir/0000-0002-2590-5434; Courtier-Orgogozo, Virginie/0000-0002-9297-9230	CNRS ATIP-AVENIR	CNRS ATIP-AVENIR	This work has been funded by a CNRS ATIP-AVENIR research grant to VO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Acebes A, 2003, J EXP BIOL, V206, P3095, DOI 10.1242/jeb.00522; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2010, GENETICS, V186, P595, DOI 10.1534/genetics.110.119735; Bachli G., 2004, FAUNA ENTOMOL SCAD, V39; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennan PLR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000418; Carayon J, 1966, ENTOMOL SOC AM, P88; Cariou ML, 2001, MOL ECOL, V10, P649, DOI 10.1046/j.1365-294x.2001.01225.x; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; COYNE JA, 1991, GENET RES, V57, P113, DOI 10.1017/S0016672300029177; Dalmasso C, 2005, BIOINFORMATICS, V21, P660, DOI 10.1093/bioinformatics/bti063; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dufour, 1844, ANN SCI NAT, V1, P224, DOI DOI 10.1111/J.1420-9101.2007.01323.X; Eberhard WG, 2004, EVOLUTION, V58, P1947; Eberhard WG, 2004, ANN ENTOMOL SOC AM, V97, P1007, DOI 10.1603/0013-8746(2004)097[1007:FMOTMG]2.0.CO;2; Eberhard WG, 1985, SEXUAL SELECTION ANI; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Evans JP, 2011, P ROY SOC B-BIOL SCI, V278, P2611, DOI 10.1098/rspb.2010.2453; Grieshop K, 2012, EVOLUTION, V66, P2637, DOI 10.1111/j.1558-5646.2012.01638.x; Hosken DJ, 2009, ANNU REV ENTOMOL, V54, P361, DOI 10.1146/annurev.ento.54.110807.090608; Hruskova-Martisova M, 2010, J ZOOL, V282, P91, DOI 10.1111/j.1469-7998.2010.00718.x; Huber BA, 2003, ZOOL J LINN SOC-LOND, V139, P477, DOI 10.1046/j.0024-4082.2003.00082.x; Huber BA, 1999, J ARACHNOL, V27, P135; Huber Bernhard A., 2005, Zoologica (Stuttgart), V155, P1; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Joly D, 2010, GENETICA, V138, P105, DOI 10.1007/s10709-009-9392-9; Joly D, 2010, GENETICA, V138, P139, DOI 10.1007/s10709-009-9423-6; Kamimura Y, 2007, BIOL LETTERS, V3, P401, DOI 10.1098/rsbl.2007.0192; Kamimura Y, 2012, BEHAV ECOL SOCIOBIOL, V66, P1107, DOI 10.1007/s00265-012-1361-0; Kamimura Y, 2012, ENTOMOL SCI, V15, P197, DOI 10.1111/j.1479-8298.2011.00490.x; Kamimura Y, 2011, ENTOMOL SCI, V14, P399, DOI 10.1111/j.1479-8298.2011.00467.x; Kamimura Y, 2010, ZOOMORPHOLOGY, V129, P163, DOI 10.1007/s00435-010-0109-5; Kulkarni C. V., 1940, Records of the Indian Museum, V42, P379; LACHAISE D, 1981, AM NAT, V117, P600, DOI 10.1086/283745; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lachaise D, 2004, EVOLUTION OF POPULATION BIOLOGY, P315, DOI 10.1017/CBO9780511542619.019; Lang M, 2012, CONTRIB ZOOL, V81, P87, DOI 10.1163/18759866-08102003; Liu J, 1996, GENETICS, V142, P1129; Llopart A, 2005, EVOLUTION, V59, P2602, DOI 10.1111/j.0014-3820.2005.tb00972.x; Lung O, 1999, INSECT BIOCHEM MOLEC, V29, P1043, DOI 10.1016/S0965-1748(99)00078-8; Macdonald SJ, 1999, GENETICS, V153, P1683; Maddison W. P., 2012, MESQUITE MODULAR SYS; Masly John P., 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/247352; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; Mueller JL, 2007, GENETICS, V175, P777, DOI 10.1534/genetics.106.065318; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; Ottiger M, 2000, J NEUROBIOL, V44, P57; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Peretti AV, 2007, J ETHOL, V25, P29, DOI 10.1007/s10164-006-0201-y; Pitnick S, 1999, EVOLUTION, V53, P1804, DOI [10.2307/2640442, 10.1111/j.1558-5646.1999.tb04564.x]; Polak M, 2010, P ROY SOC B-BIOL SCI, V277, P1371, DOI 10.1098/rspb.2009.1720; PRATT HL, 1979, FISH B-NOAA, V77, P445; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; ROBERTSON H M, 1988, Pacific Science, V42, P72; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; Sanchez L, 1997, GENETICS, V147, P231; Simmons LW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1379; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tsacas L., 1971, Bull Soc Ent France, V76, P35; TSACAS L, 1978, Beitraege zur Entomologie, V28, P179; TSACAS L, 1974, Annales de l'Universite d'Abidjan Serie E Ecologie, V7, P193; Tsacas L., 1974, Bulletin Soc Ent France, V79, P42; TSACAS L, 1981, Revue Francaise d'Entomologie (Nouvelle Serie), V3, P146; Vahed K, 2002, ETHOLOGY, V108, P1065, DOI 10.1046/j.1439-0310.2002.00838.x; Zeng ZB, 2000, GENETICS, V154, P299	68	65	66	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57158	10.1371/journal.pone.0057158	http://dx.doi.org/10.1371/journal.pone.0057158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451172	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500071
J	Dada, J; Pinder, AG; Lang, D; James, PE				Dada, Jessica; Pinder, Andrew G.; Lang, Derek; James, Philip E.			Oxygen Mediates Vascular Smooth Muscle Relaxation in Hypoxia	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; RED-BLOOD-CELLS; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; CARBON-MONOXIDE; RADICAL GENERATION; NO; HEMOGLOBIN; HEME; VASODILATION	The activation of soluble guanylate cyclase (sGC) by nitric oxide (NO) and other ligands has been extensively investigated for many years. In the present study we considered the effect of molecular oxygen (O-2) on sGC both as a direct ligand and its affect on other ligands by measuring cyclic guanosine monophosphate (cGMP) production, as an index of activity, as well as investigating smooth muscle relaxation under hypoxic conditions. Our isolated enzyme studies confirm the function of sGC is impaired under hypoxic conditions and produces cGMP in the presence of O-2, importantly in the absence of NO. We also show that while O-2 could partially affect the magnitude of sGC stimulation by NO when the latter was present in excess, activation by the NO independent, haem-dependent sGC stimulator 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) was unaffected. Our in vitro investigation of smooth muscle relaxation confirmed that O-2 alone in the form of a buffer bolus (equilibrated at 95% O-2/5% CO2) had the ability to dilate vessels under hypoxic conditions and that this was dependent upon sGC and independent of eNOS. Our studies confirm that O-2 can be a direct and important mediator of vasodilation through an increase in cGMP production. In the wider context, these observations are key to understanding the relative roles of O-2 versus NO-induced sGC activation.	[Dada, Jessica; Pinder, Andrew G.; Lang, Derek; James, Philip E.] Cardiff Univ, Sch Med, Wales Heart Res Inst, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	James, PE (corresponding author), Cardiff Univ, Sch Med, Wales Heart Res Inst, Inst Mol & Expt Med, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	jamespp@cardiff.ac.uk			British Heart Foundation [FS/10/007/28077]	British Heart Foundation(British Heart Foundation)	This work was funded by the British Heart Foundation (PhD Studentship) [FS/10/007/28077]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BW, 2006, AM J PHYSIOL-HEART C, V291, pH1507, DOI 10.1152/ajpheart.00310.2006; Angelos MG, 2006, AM J PHYSIOL-HEART C, V290, pH341, DOI 10.1152/ajpheart.00223.2005; Berg JM, 2002, BIOCHEMISTY; BERGFELD GR, 1992, CARDIOVASC RES, V26, P40, DOI 10.1093/cvr/26.1.40; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BRUNE B, 1990, EUR J BIOCHEM, V192, P683, DOI 10.1111/j.1432-1033.1990.tb19276.x; BRUNORI M, 1967, J BIOL CHEM, V242, P2295; Chen KJ, 2008, ANTIOXID REDOX SIGN, V10, P1185, DOI 10.1089/ars.2007.1959; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; Derbyshire Emily R., 2009, V191, P17, DOI 10.1007/978-3-540-68964-5_2; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; Ellsworth ML, 1995, AM J PHYSIOL-HEART C, V269, pH2155, DOI 10.1152/ajpheart.1995.269.6.H2155; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Friebe A, 1998, BIOCHEM J, V335, P527, DOI 10.1042/bj3350527; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1998, MOL PHARMACOL, V53, P123, DOI 10.1124/mol.53.1.123; Galle J, 1999, BRIT J PHARMACOL, V127, P195, DOI 10.1038/sj.bjp.0702495; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; JAMES PE, 1995, FREE RADICAL BIO MED, V18, P641, DOI 10.1016/0891-5849(94)00179-N; James PE, 2004, CIRC RES, V94, P976, DOI 10.1161/01.RES.0000122044.21787.01; Kim-Shapiro DB, 2005, J INORG BIOCHEM, V99, P237, DOI 10.1016/j.jinorgbio.2004.10.034; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Makino R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177576; Martin E, 2003, P NATL ACAD SCI USA, V100, P9208, DOI 10.1073/pnas.1633590100; Martin E, 2006, J BIOL CHEM, V281, P27836, DOI 10.1074/jbc.M601078200; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Patel AJ, 2001, EUR RESPIR J, V18, P221, DOI 10.1183/09031936.01.00204001; Patel RP, 2011, CARDIOVASC RES, V89, P507, DOI 10.1093/cvr/cvq323; Pinder AG, 2009, CIRC RES, V104, pE25, DOI 10.1161/CIRCRESAHA.108.191569; Pinder AG, 2009, ADV EXP MED BIOL, V645, P13, DOI 10.1007/978-0-387-85998-9_3; POST JM, 1992, AM J PHYSIOL, V262, pC882, DOI 10.1152/ajpcell.1992.262.4.C882; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Schrammel A, 1996, MOL PHARMACOL, V50, P1; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stone JR, 1995, BIOCHEMISTRY-US, V34, P16397, DOI 10.1021/bi00050a021; Yasmin W, 1997, CARDIOVASC RES, V33, P422, DOI 10.1016/S0008-6363(96)00254-4; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404	47	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57162	10.1371/journal.pone.0057162	http://dx.doi.org/10.1371/journal.pone.0057162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451175	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000316658800083
J	Fossati-Jimack, L; Ling, GS; Cortini, A; Szajna, M; Malik, TH; McDonald, JU; Pickering, MC; Cook, HT; Taylor, PR; Botto, M				Fossati-Jimack, Liliane; Ling, Guang Sheng; Cortini, Andrea; Szajna, Marta; Malik, Talat H.; McDonald, Jacqueline U.; Pickering, Matthew C.; Cook, H. Terence; Taylor, Philip R.; Botto, Marina			Phagocytosis Is the Main CR3-Mediated Function Affected by the Lupus-Associated Variant of CD11b in Human Myeloid Cells	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; T-CELLS; LEUKOCYTE ADHESION; SCAVENGER RECEPTOR; DISEASE-ACTIVITY; APOPTOTIC CELLS; IMPAIRED UPTAKE; ERYTHEMATOSUS; ITGAM; MACROPHAGES	The CD11b/CD18 integrin (complement receptor 3, CR3) is a surface receptor on monocytes, neutrophils, macrophages and dendritic cells that plays a crucial role in several immunological processes including leukocyte extravasation and phagocytosis. The minor allele of a non-synonymous CR3 polymorphism (rs1143679, conversation of arginine to histidine at position 77: R77H) represents one of the strongest genetic risk factor in human systemic lupus erythematosus, with heterozygosity (77R/H) being the most common disease associated genotype. Homozygosity for the 77H allele has been reported to reduce adhesion and phagocytosis in human monocytes and monocyte-derived macrophages, respectively, without affecting surface expression of CD11b. Herein we comprehensively assessed the influence of R77H on different CR3-mediated activities in monocytes, neutrophils, macrophages and dendritic cells. R77H did not alter surface expression of CD11b including its active form in any of these cell types. Using two different iC3b-coated targets we found that the uptake by heterozygous 77R/H macrophages, monocytes and neutrophils was significantly reduced compared to 77R/R cells. Allele-specific transduced immortalized macrophage cell lines demonstrated that the minor allele, 77H, was responsible for the impaired phagocytosis. R77H did not affect neutrophil adhesion, neutrophil transmigration in vivo or Toll-like receptor 7/8-mediated cytokine release by monocytes or dendritic cells with or without CR3 pre-engagement by iC3b-coated targets. Our findings demonstrate that the reduction in CR3-mediated phagocytosis associated with the 77H CD11b variant is not macrophage-restricted but demonstrable in other CR3-expressing professional phagocytic cells. The association between 77H and susceptibility to systemic lupus erythematosus most likely relates to impaired waste disposal, a key component of lupus pathogenesis.	[Fossati-Jimack, Liliane; Ling, Guang Sheng; Cortini, Andrea; Szajna, Marta; Malik, Talat H.; Pickering, Matthew C.; Cook, H. Terence; Botto, Marina] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Immunol & Inflammat, Ctr Complement & Inflammat Res, London, England; [McDonald, Jacqueline U.; Taylor, Philip R.] Cardiff Univ, Sch Med, Cardiff Inst Infect & Immun, Cardiff CF10 3AX, S Glam, Wales	Imperial College London; Cardiff University	Botto, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Immunol & Inflammat, Ctr Complement & Inflammat Res, London, England.	m.botto@imperial.ac.uk		Taylor, Philip/0000-0003-0163-1421; Pickering, Matthew/0000-0002-1153-0192	Wellcome Trust [088517]; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant number 088517) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya JM, 2012, AUTOIMMUN REV, V11, P276, DOI 10.1016/j.autrev.2011.07.007; ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000; BUYON JP, 1988, CLIN IMMUNOL IMMUNOP, V46, P141, DOI 10.1016/0090-1229(88)90014-1; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Coustet B, 2011, J RHEUMATOL, V38, P1033, DOI 10.3899/jrheum.101053; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DAGATI VD, 1986, KIDNEY INT, V30, P573, DOI 10.1038/ki.1986.223; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; DIAMOND MS, 1993, J CELL BIOL, V120, P1031, DOI 10.1083/jcb.120.4.1031; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Green MRJ, 2007, ARTHRITIS RHEUM-US, V56, P303, DOI 10.1002/art.22326; Griffin DO, 2011, J EXP MED, V208, P2591, DOI 10.1084/jem.20110978; Hajishengallis G, 2007, J IMMUNOL, V179, P2359, DOI 10.4049/jimmunol.179.4.2359; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Han SZ, 2009, HUM MOL GENET, V18, P1171, DOI 10.1093/hmg/ddp007; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; HASLETT C, 1985, AM J PATHOL, V119, P101; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Huynh L, 2012, J IMMUNOL, V188, P3447, DOI 10.4049/jimmunol.1102211; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; LHOTTA K, 1991, CLIN SCI, V81, P477, DOI 10.1042/cs0810477; Li Y, 2003, J BIOL CHEM, V278, P34395, DOI 10.1074/jbc.M304190200; MacPherson M, 2011, J BIOL CHEM, V286, P17303, DOI 10.1074/jbc.M110.182998; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Marth T, 1997, J EXP MED, V185, P1987, DOI 10.1084/jem.185.11.1987; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Munoz LE, 2005, RHEUMATOLOGY, V44, P1101, DOI 10.1093/rheumatology/keh693; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Rhodes B, 2012, ANN RHEUM DIS; Rosas M, 2011, EUR J IMMUNOL, V41, P356, DOI 10.1002/eji.201040962; Sachs UJH, 2004, BLOOD, V104, P727, DOI 10.1182/blood-2003-11-3809; Schaer CA, 2007, J LEUKOCYTE BIOL, V82, P106, DOI 10.1189/jlb.0706453; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Skoberne M, 2006, BLOOD, V108, P947, DOI 10.1182/blood-2005-12-4812; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Tas SW, 2006, ANN RHEUM DIS, V65, P216, DOI 10.1136/ard.2005.037143; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876; Yang WL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000841; Yoshida Y, 1998, J IMMUNOL, V161, P5873	55	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57082	10.1371/journal.pone.0057082	http://dx.doi.org/10.1371/journal.pone.0057082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451151	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000316658800069
J	Iyer, RP; Gu, SM; Nicholson, BJ; Jiang, JX				Iyer, Rugmani Padmanabhan; Gu, Sumin; Nicholson, Bruce J.; Jiang, Jean X.			Identification of a Disulfide Bridge Important for Transport Function of SNAT4 Neutral Amino Acid Transporter	PLOS ONE			English	Article							CYSTEINE RESIDUES; SYSTEM-A; NEUROTRANSMITTER TRANSPORTERS; SEROTONIN TRANSPORTER; ACTIVE-SITE; MEMBRANE; PROTEIN; LIVER; TRAFFICKING; ISOFORM	SNAT4 is a member of system N/A amino acid transport family that primarily expresses in liver and muscles and mediates the transport of L-alanine. However, little is known about the structure and function of the SNAT family of transporters. In this study, we showed a dose-dependent inhibition in transporter activity of SNAT4 with the treatment of reducing agents, dithiothreitol (DTT) and Tris(2-carboxyethyl) phosphine (TCEP), indicating the possible involvement of disulfide bridge(s). Mutation of residue Cys-232, and the two highly conserved residues Cys-249 and Cys-321, compromised the transport function of SNAT4. However, this reduction was not caused by the decrease of SNAT4 on the cell surface since the cysteine-null mutant generated by replacing all five cysteines with alanine was equally capable of being expressed on the cell surface as wild-type SNAT4. Interestingly, by retaining two cysteine residues, 249 and 321, a significant level of L-alanine uptake was restored, indicating the possible formation of disulfide bond between these two conserved residues. Biotinylation crosslinking of free thiol groups with MTSEA-biotin provided direct evidence for the existence of a disulfide bridge between Cys-249 and Cys-321. Moreover, in the presence of DTT or TCEP, transport activity of the mutant retaining Cys-249 and Cys-321 was reduced in a dose-dependent manner and this reduction is gradually recovered with increased concentration of H2O2. Disruption of the disulfide bridge also decreased the transport of L-arginine, but to a lesser degree than that of L-alanine. Together, these results suggest that cysteine residues 249 and 321 form a disulfide bridge, which plays an important role in substrate transport but has no effect on trafficking of SNAT4 to the cell surface.	[Iyer, Rugmani Padmanabhan; Gu, Sumin; Nicholson, Bruce J.; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu		Jiang, Jean/0000-0002-2185-5716; Nicholson, Bruce/0000-0003-1649-7173	National Institute of Health [EY012085]; The Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R01EY012085, R29EY012085] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by: 1. National Institute of Health (EY012085) URL: www.nih.gov; 2. The Welch Foundation (AQ-1507) URL: www.welch1.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen R, 2007, MOL CELL BIOCHEM, V298, P41, DOI 10.1007/s11010-006-9348-7; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Desforges M, 2009, J PHYSIOL-LONDON, V587, P61, DOI 10.1113/jphysiol.2008.161331; Dorn M, 2009, J BIOL CHEM, V284, P22123, DOI 10.1074/jbc.M109.023713; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Gruarin P, 1997, BIOCHEM J, V328, P635, DOI 10.1042/bj3280635; Gu SM, 2003, BIOCHEM J, V371, P721, DOI 10.1042/BJ20030049; Gu SM, 2001, GENOMICS, V74, P262, DOI 10.1006/geno.2001.6567; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; Hu LA, 1998, J BIOL CHEM, V273, P20162, DOI 10.1074/jbc.273.32.20162; Kudou D, 2008, BIOSCI BIOTECH BIOCH, V72, P1722, DOI 10.1271/bbb.80015; Lambert G, 2000, J MEMBRANE BIOL, V176, P133, DOI 10.1007/s002320001082; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Nissen-Meyer LSH, 2011, J NEUROSCI, V31, P6565, DOI 10.1523/JNEUROSCI.3694-10.2011; Palmada Monica, 1998, Frontiers in Bioscience, V3, pD701; Robinson MB, 2002, J NEUROCHEM, V80, P1, DOI 10.1046/j.0022-3042.2001.00698.x; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Shi Q, 2011, J BIOL CHEM, V286, P38086, DOI 10.1074/jbc.M111.220277; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; SUBBARAMAIAH K, 1991, J BIOL CHEM, V266, P19023; Sugawara M, 2000, BBA-BIOMEMBRANES, V1509, P7, DOI 10.1016/S0005-2736(00)00349-7; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Sur C, 1997, BIOCHEM BIOPH RES CO, V241, P68, DOI 10.1006/bbrc.1997.7771; Tanaka K, 2004, BIOCHEM J, V380, P283, DOI 10.1042/BJ20031724; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhao RB, 2011, BBA-BIOMEMBRANES, V1808, P1140, DOI 10.1016/j.bbamem.2011.01.008; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	35	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56792	10.1371/journal.pone.0056792	http://dx.doi.org/10.1371/journal.pone.0056792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451088	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800037
J	Molina-Rueda, JJ; Tsai, CJ; Kirby, EG				Molina-Rueda, Juan Jesus; Tsai, Chung Jui; Kirby, Edward G.			The Populus Superoxide Dismutase Gene Family and Its Responses to Drought Stress in Transgenic Poplar Overexpressing a Pine Cytosolic Glutamine Synthetase (GS1a)	PLOS ONE			English	Article							OXIDATIVE STRESS; DIFFERENTIAL EXPRESSION; COPPER HOMEOSTASIS; ENHANCED TOLERANCE; ECTOPIC EXPRESSION; HYDROGEN-PEROXIDE; PLANTS; ARABIDOPSIS; INDUCTION; PROTEINS	Background: Glutamine synthetase (GS) plays a central role in plant nitrogen assimilation, a process intimately linked to soil water availability. We previously showed that hybrid poplar (Populus tremula X alba, INRA 717-1B4) expressing ectopically a pine cytosolic glutamine synthetase gene (GS1a) display enhanced tolerance to drought. Preliminary transcriptome profiling revealed that during drought, members of the superoxide dismutase (SOD) family were reciprocally regulated in GS poplar when compared with the wild-type control, in all tissues examined. SOD was the only gene family found to exhibit such patterns. Results: In silico analysis of the Populus genome identified 12 SOD genes and two genes encoding copper chaperones for SOD (CCSs). The poplar SODs form three phylogenetic clusters in accordance with their distinct metal co-factor requirements and gene structure. Nearly all poplar SODs and CCSs are present in duplicate derived from whole genome duplication, in sharp contrast to their predominantly single-copy Arabidopsis orthologs. Drought stress triggered plant-wide down-regulation of the plastidic copper SODs (CSDs), with concomitant up-regulation of plastidic iron SODs (FSDs) in GS poplar relative to the wild type; this was confirmed at the activity level. We also found evidence for coordinated down-regulation of other copper proteins, including plastidic CCSs and polyphenol oxidases, in GS poplar under drought conditions. Conclusions: Both gene duplication and expression divergence have contributed to the expansion and transcriptional diversity of the Populus SOD/CCS families. Coordinated down-regulation of major copper proteins in drought-tolerant GS poplars supports the copper cofactor economy model where copper supply is preferentially allocated for plastocyanins to sustain photosynthesis during drought. Our results also extend previous findings on the compensatory regulation between chloroplastic CSDs and FSDs, and suggest that this copper-mediated mechanism represents a common response to oxidative stress and other genetic manipulations, as in GS poplars, that affect photosynthesis.	[Molina-Rueda, Juan Jesus; Kirby, Edward G.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Tsai, Chung Jui] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Tsai, Chung Jui] Univ Georgia, Dept Genet, Athens, GA 30602 USA	Rutgers State University Newark; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Kirby, EG (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA.	ekirby@andromeda.rutgers.edu	Tsai, CJ/C-2450-2009	Tsai, CJ/0000-0002-9282-7704; Molina Rueda, Juan Jesus/0000-0003-1143-7008	US Department of Energy through the Consortium for Plant Biotechnology Research [GO12026-314]; ArborGen LLC (USA); ArborGen LLC	US Department of Energy through the Consortium for Plant Biotechnology Research(United States Department of Energy (DOE)); ArborGen LLC (USA); ArborGen LLC	This work was supported by a grant from the US Department of Energy through the Consortium for Plant Biotechnology Research (GO12026-314) (URL: www.cpbr.org) and by a grant from ArborGen LLC (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded in part through a commercial source, ArborGen LLC. This funding arrangement does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdel-Ghany SE, 2005, FEBS LETT, V579, P2307, DOI 10.1016/j.febslet.2005.03.025; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; BOWLER C, 1989, EMBO J, V8, P31, DOI 10.1002/j.1460-2075.1989.tb03345.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cohu CM, 2007, PHYSIOL PLANTARUM, V129, P747, DOI 10.1111/j.1399-3054.2007.00879.x; Cohu CM, 2009, MOL PLANT, V2, P1336, DOI 10.1093/mp/ssp084; Coleman HD, 2012, PLANT BIOTE IN PRESS, P1; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; de Hoon MJL, 2002, BIOINFORMATICS, V18, P1477, DOI 10.1093/bioinformatics/18.11.1477; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; El-Khatib RT, 2004, TREE PHYSIOL, V24, P729, DOI 10.1093/treephys/24.7.729; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Gallardo F, 1999, PLANTA, V210, P19, DOI 10.1007/s004250050649; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Molina-Rueda JJ, 2010, PLANTA, V232, P1471, DOI 10.1007/s00425-010-1268-9; Jia XY, 2009, PLANT MOL BIOL, V71, P51, DOI 10.1007/s11103-009-9508-8; Jiang Ke, 2011, BMC Res Notes, V4, P52, DOI 10.1186/1756-0500-4-52; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jing ZP, 2004, NEW PHYTOL, V164, P137, DOI 10.1111/j.1469-8137.2004.01173.x; Kathiresan A, 1997, PLANT PHYSIOL, V115, P129, DOI 10.1104/pp.115.1.129; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Kurepa J, 1997, PLANT CELL PHYSIOL, V38, P463, DOI 10.1093/oxfordjournals.pcp.a029190; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei YB, 2006, PHYSIOL PLANTARUM, V127, P182, DOI 10.1111/j.1399-3054.2006.00638.x; Liao ZH, 2004, PREP BIOCHEM BIOTECH, V34, P209, DOI 10.1081/PB-200026790; Lower SS, 2003, ENTOMOL EXP APPL, V107, P69, DOI 10.1046/j.1570-7458.2003.00037.x; Lu YZ, 2011, FUNCT PLANT BIOL, V38, P44, DOI 10.1071/FP10178; Man HM, 2005, NEW PHYTOL, V167, P31, DOI 10.1111/j.1469-8137.2005.01461.x; Man HM, 2011, J EXP BOT, V62, P4423, DOI 10.1093/jxb/err026; Marron N, 2006, ANN FOREST SCI, V63, P323, DOI 10.1051/forest:2006012; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Myouga F, 2008, PLANT CELL, V20, P3148, DOI 10.1105/tpc.108.061341; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; PARKER MW, 1988, FEBS LETT, V229, P377, DOI 10.1016/0014-5793(88)81160-8; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pradedova EV, 2009, BIOCHEM MOSC SUPPL S, V3, P24, DOI 10.1134/S1990747809010048; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Quaye A. K., 2009, J FORESTRY HORT SOIL, V3, P1; Ravet K, 2011, PLANT PHYSIOL, V157, P1300, DOI 10.1104/pp.111.183350; Roberts MR, 2007, PLANT SIGNAL BEHAV, V2, P408, DOI 10.4161/psb.2.5.4335; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; SANDALIO LM, 1988, PLANT PHYSIOL, V88, P1215, DOI 10.1104/pp.88.4.1215; Solomon S, 2007, CLIMATE CHANGE 2007, V4; Srivastava V, 2009, PLANT PHYSIOL, V149, P1848, DOI 10.1104/pp.108.133371; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tewari RK, 2006, PLANTA, V223, P1145, DOI 10.1007/s00425-005-0160-5; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; TSANG EWT, 1991, PLANT CELL, V3, P783, DOI 10.1105/tpc.3.8.783; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VANCAMP W, 1990, P NATL ACAD SCI USA, V87, P9903, DOI 10.1073/pnas.87.24.9903; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang F, 2006, PLANT CELL REP, V24, P734, DOI 10.1007/s00299-005-0030-4; Wang FZ, 2005, J PLANT PHYSIOL, V162, P465, DOI 10.1016/j.jplph.2004.09.009; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Wang YC, 2010, MOL BIOL REP, V37, P1119, DOI 10.1007/s11033-009-9884-9; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wilkins MR, 1999, METH MOL B, V112, P531; Wintz H, 2002, BIOCHEM SOC T, V30, P732, DOI 10.1042/bst0300732; Wu GH, 1999, PLANT PHYSIOL, V120, P513, DOI 10.1104/pp.120.2.513; YAMAKURA F, 1984, BIOCHEM BIOPH RES CO, V122, P635, DOI 10.1016/S0006-291X(84)80080-7; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200	74	42	50	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56421	10.1371/journal.pone.0056421	http://dx.doi.org/10.1371/journal.pone.0056421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451045	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800011
J	Yang, FM; Wang, N; Shi, F; Ljungqvist, FC; Wang, SG; Fan, ZX; Lu, JW				Yang, Fengmei; Wang, Naiang; Shi, Feng; Ljungqvist, Fredrik Charpentier; Wang, Shigong; Fan, Zexin; Lu, Junwei			Multi-Proxy Temperature Reconstruction from the West Qinling Mountains, China, for the Past 500 Years	PLOS ONE			English	Article							TREE-RING RECORD; TIBETAN PLATEAU; CLIMATE VARIABILITY; QILIAN MOUNTAINS; DROUGHT; RESOLUTION; GROWTH; REGION; SERIES; WIDTH	A total of 290 tree-ring samples, collected from six sites in the West Qinling Mountains of China, were used to develop six new standard tree-ring chronologies. In addition, 73 proxy records were assembled in collaboration with Chinese and international scholars, from 27 publically available proxy records and 40 tree-ring chronologies that are not available in public datasets. These records were used to reconstruct annual mean temperature variability in the West Qinling Mountains over the past 500 years (AD 1500-1995), using a modified point-by-point regression (hybrid PPR) method. The results demonstrate that the hybrid PPR method successfully integrates the temperature signals from different types of proxies, and that the method preserves a high degree of low-frequency variability. The reconstruction shows greater temperature variability in the West Qinling Mountains than has been found in previous studies. Our temperature reconstruction for this region shows: 1) five distinct cold periods, at approximately AD 1520-1535, AD 1560-1575, AD 1610-1620, AD 1850-1875 and AD 1965-1985, and four warm periods, at approximately AD 1645-1660, AD 1705-1725, AD 1785-1795 and AD 19201945; 2) that in this region, the 20th century was not the warmest period of the past 500 years; and 3) that a dominant and persistent oscillation of ca. 64 years is significantly identified in the 1640-1790 period.	[Yang, Fengmei; Wang, Shigong] Lanzhou Univ, Key Lab Semiarid Climate Change, Minist Educ, Coll Atmospher Sci, Lanzhou 730000, Peoples R China; [Yang, Fengmei] China Meteorol Adm Training Ctr, Beijing, Peoples R China; [Wang, Naiang; Lu, Junwei] Lanzhou Univ, Ctr Climate Change & Hydrol Cycle Arid Reg, Coll Earth & Environm Sci, Lanzhou 730000, Peoples R China; [Shi, Feng] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modelling Atmospher Sci & Geo, Beijing, Peoples R China; [Shi, Feng] Chinese Acad Sci, Key Lab Desert & Desertificat, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China; [Ljungqvist, Fredrik Charpentier] Stockholm Univ, Dept Hist, S-10691 Stockholm, Sweden; [Fan, Zexin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Kunming, Peoples R China	Lanzhou University; Lanzhou University; Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Stockholm University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Shi, F (corresponding author), Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Numer Modelling Atmospher Sci & Geo, Beijing, Peoples R China.	shifeng@lasg.iap.ac.cn	Shi, Feng/AAG-6973-2020; Fan, Ze-Xin/ABG-7176-2020; Charpentier Ljungqvist, Fredrik/I-5770-2012; Fan, Zexin/E-2344-2016; Wang, Yuesi/AAF-3317-2019	Shi, Feng/0000-0003-3963-1822; Fan, Ze-Xin/0000-0003-4623-6783; Charpentier Ljungqvist, Fredrik/0000-0003-0220-3947; Fan, Zexin/0000-0003-4623-6783; 	CAS Strategic Priority Research Program Grant [XDA05080801]; National Basic Research Program of China ( 973 Program) [2012CB957804]; Specialized Research Fund for the Doctoral Program of Higher Education [20090211110025]; Forty-ninth batch of China Postdoctoral Science Foundation [2012T50829]; China Meteorological Administration Drought Research Fund [IAM201109, IAM201213]; West Light Program for Talent Cultivation of Chinese Academy of Sciences	CAS Strategic Priority Research Program Grant; National Basic Research Program of China ( 973 Program)(National Basic Research Program of China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Forty-ninth batch of China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Meteorological Administration Drought Research Fund; West Light Program for Talent Cultivation of Chinese Academy of Sciences	The study was jointly funded by the CAS Strategic Priority Research Program Grant (XDA05080801), the National Basic Research Program of China (973 Program) (2012CB957804) and the Specialized Research Fund for the Doctoral Program of Higher Education (20090211110025). Fengmei Yang was supported by the Forty-ninth batch of China Postdoctoral Science Foundation (2012T50829) and the China Meteorological Administration Drought Research Fund (IAM201109). Feng Shi was supported by the China Meteorological Administration Drought Research Fund (IAM201213) and the West Light Program for Talent Cultivation of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley R. S., 1999, PALEOCLIMATOLOGY REC; Bradley RS, 2011, DEV PALEOENVIRON RES, V11, P3, DOI 10.1007/978-1-4020-5725-0_1; Brauning A, 2006, J GEOL SOC INDIA, V68, P485; Briffa KR, 2008, PHILOS T R SOC B, V363, P2271, DOI 10.1098/rstb.2007.2199; Briffa KR, 2011, DEV PALEOENVIRON RES, V11, P113, DOI 10.1007/978-1-4020-5725-0_5; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Cook ER, 2007, EARTH-SCI REV, V81, P93, DOI 10.1016/j.earscirev.2006.12.002; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 1999, J CLIMATE, V12, P1145, DOI 10.1175/1520-0442(1999)012<1145:DRFTCU>2.0.CO;2; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; D'Arrigo R, 2006, INT J CLIMATOL, V26, P1607, DOI 10.1002/joc.1326; Fan ZX, 2010, PALAEOGEOGR PALAEOCL, V296, P94, DOI 10.1016/j.palaeo.2010.06.017; Fan ZX, 2009, GLOBAL PLANET CHANGE, V65, P1, DOI 10.1016/j.gloplacha.2008.10.001; Fang KY, 2012, CLIM DYNAM, V39, P1697, DOI 10.1007/s00382-012-1371-7; Fang KY, 2012, GLOBAL PLANET CHANGE, V80-81, P190, DOI 10.1016/j.gloplacha.2011.10.009; Fang KY, 2011, J CLIMATE, V24, P3457, DOI 10.1175/2011JCLI3911.1; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Feng S, 2013, J CLIMATE, V26, P2192, DOI 10.1175/JCLI-D-12-00099.1; Fritts H. C., 1976, TREE RINGS CLIMATE; Ge QS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041281; GILMAN DL, 1963, J ATMOS SCI, V20, P182, DOI 10.1175/1520-0469(1963)020<0182:OTPSON>2.0.CO;2; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; Grudd H, 2008, CLIM DYNAM, V31, P843, DOI 10.1007/s00382-007-0358-2; He MH, 2013, HOLOCENE, V23, P36, DOI 10.1177/0959683612450198; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hughes MK, 2011, DEV PALEOENVIRON RES, V11, P17, DOI 10.1007/978-1-4020-5725-0_2; Jones PD, 2009, HOLOCENE, V19, P3, DOI 10.1177/0959683608098952; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; Li JB, 2011, NAT CLIM CHANGE, V1, P114, DOI [10.1038/nclimate1086, 10.1038/NCLIMATE1086]; Li ZS, 2012, CLIMATIC CHANGE, V110, P455, DOI 10.1007/s10584-011-0111-z; Liang EY, 2009, THEOR APPL CLIMATOL, V98, P9, DOI 10.1007/s00704-008-0085-6; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Linderholm HW, 2005, GEOGR ANN A, V87A, P231, DOI 10.1111/j.0435-3676.2005.00255.x; Liu H.B., 2000, ACTA METEOROL SIN, V58, P223, DOI [10.11676/qxxb2000.023, DOI 10.11676/QXXB2000.023]; Liu JJ, 2011, QUATERN INT, V236, P75, DOI 10.1016/j.quaint.2010.03.020; Liu X, 2007, ARCT ANTARCT ALP RES, V39, P651, DOI 10.1657/1523-0430(07-506)[LIU-X]2.0.CO;2; Liu Y, 2009, SCI CHINA SER D, V52, P348, DOI 10.1007/s11430-009-0025-z; Mann ME, 2005, J CLIMATE, V18, P4097, DOI 10.1175/JCLI3564.1; Mann ME, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008272; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Qin C, 2011, GLOBAL PLANET CHANGE, V75, P143, DOI 10.1016/j.gloplacha.2010.10.013; Riedwyl N, 2009, CLIM DYNAM, V32, P381, DOI 10.1007/s00382-008-0395-5; Rutherford S, 2005, J CLIMATE, V18, P2308, DOI 10.1175/JCLI3351.1; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schneider T, 2001, J CLIMATE, V14, P853, DOI 10.1175/1520-0442(2001)014<0853:AOICDE>2.0.CO;2; Shao XM., 1999, QUATERNARY SCI, V19, P81, DOI DOI 10.3321/j.issn:1001-7410.1999.01.010; Shao XM, 2009, IAWA J, V30, P379, DOI 10.1163/22941932-90000226; Shi F, 2012, SCI CHINA EARTH SCI, V55, P2058, DOI 10.1007/s11430-012-4374-7; Shi F, 2012, THEOR APPL CLIMATOL, V109, P233, DOI 10.1007/s00704-011-0576-8; Smerdon JE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047372; Smerdon JE, 2011, J CLIMATE, V24, P1284, DOI 10.1175/2010JCLI4110.1; Sontakke NA, 2008, HOLOCENE, V18, P1055, DOI 10.1177/0959683608095576; Thompson LG, 2003, CLIMATIC CHANGE, V59, P137, DOI 10.1023/A:1024472313775; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Ting MF, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048712; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vaganov EA, 2011, DEV PALEOENVIRON RES, V11, P37, DOI 10.1007/978-1-4020-5725-0_3; Wahl ER, 2007, CLIMATIC CHANGE, V85, P33, DOI 10.1007/s10584-006-9105-7; Wang SW, 2007, CHINESE SCI BULL, V52, P3272, DOI 10.1007/s11434-007-0425-4; Wang XC, 2011, J ATMOS SOL-TERR PHY, V73, P1959, DOI 10.1016/j.jastp.2011.06.001; Wei W, 2012, J CLIMATE, V25, P6989, DOI 10.1175/JCLI-D-11-00667.1; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wu GX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00404; [杨保 Yang Bao], 2012, [第四纪研究, Quaternary Sciences], V32, P81; Yang B, 2012, HOLOCENE, V22, P773, DOI 10.1177/0959683611430411; Yang B, 2011, INT J CLIMATOL, V31, P1166, DOI 10.1002/joc.2143; Yang B, 2010, HOLOCENE, V20, P1235, DOI 10.1177/0959683610371997; Yang F, 2009, RES TOURISM GEOGRAPH; Zhang QB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017425; Zhang Y, 2009, IAWA J, V30, P407, DOI 10.1163/22941932-90000228	77	17	21	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57638	10.1371/journal.pone.0057638	http://dx.doi.org/10.1371/journal.pone.0057638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451254	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800114
J	Lubis, DU; Jaya, ES; Arjadi, R; Hanum, L; Astri, K; Decha, M; Putri, D				Lubis, Dharmayati Utoyo; Jaya, Edo Sebastian; Arjadi, Retha; Hanum, Lathifah; Astri, Kresna; Decha, Maha; Putri, Dwi			Preliminary Study on the Effectiveness of Short Group Cognitive Behavioral Therapy (GCBT) on Indonesian Older Adults	PLOS ONE			English	Article							CHRONIC PAIN; CRITERION VALIDITY; CES-D; DEPRESSION; INSOMNIA; ANXIETY; ACCEPTANCE; SAMPLE; SCALE; QUESTIONNAIRE	This research aims to develop evidence based affordable psychological therapy for Indonesian older adults. An affordable psychological therapy is important as there is virtually no managed care or health insurance that covers psychological therapy in Indonesia. Multicomponent group cognitive behavior therapy (GCBGT) was chosen as a starting point due to its extensive evidence, short sessions, and success for a wide range of psychological problems. The group format was chosen to address both the economic and the cultural context of Indonesia. Then, the developed treatment is tested to common psychological problems in older adults' population (anxiety, chronic pain, depression, and insomnia). The treatment consists of 8 sessions with twice a week meetings for 2.5 hours. There are similarities and differences among the techniques used in the treatment for the different psychological problems. The final participants are 38 older adults that are divided into the treatment groups; 8 participants joined the anxiety treatment, 10 participants for the chronic pain treatment, 10 participants for depression treatment, and lastly, 10 participants joined the insomnia treatment. The research design is pre-test post-test with within group analysis. We used principal outcome measure that is specific for each treatment group, as well as additional outcome measures. Overall, the result shows statistical significance change with large effect size for the principal outcome measure. In addition, the result for the additional measures varies from slight improvement with small effect size to statistically significant improvement with large effect size. The result indicates that short multicomponent GCBT is effective in alleviating various common psychological problems in Indonesian older adults. Therefore, multicomponent GCBT may be a good starting point to develop an effective and affordable psychological therapy for Indonesian older adults. Lastly, this result adds to the accumulating body of evidence on the effectiveness of multicomponent GCBT outside western context.	[Lubis, Dharmayati Utoyo; Jaya, Edo Sebastian; Arjadi, Retha; Hanum, Lathifah; Astri, Kresna; Decha, Maha; Putri, Dwi] Univ Indonesia, Fac Psychol, Depok, Indonesia	University of Indonesia	Jaya, ES (corresponding author), Univ Indonesia, Fac Psychol, Depok, Indonesia.	edojaya@hotmail.com	Jaya, Edo S./K-8961-2016	Jaya, Edo S./0000-0002-7232-6312; Hanum, Lathifah/0000-0003-1771-335X	Research and Public Service Directorate, University of Indonesia	Research and Public Service Directorate, University of Indonesia	This study is funded by the Research and Public Service Directorate, University of Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Badan Pusat Statistik, 2010, STAT PEND LANJ US IN, p[36, 186]; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck J.S., 2011, COGNITIVE BEHAV THER; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Boswell E B, 1996, Am J Med, V101, p3S, DOI 10.1016/S0002-9343(96)00392-0; Butler AC, 2000, J NORWEGIAN PSYCHOL, V37, P1; Carvalho JP, 2011, J BEHAV THER EXP PSY, V42, P154, DOI 10.1016/j.jbtep.2010.10.001; Cohen CI, 2006, PSYCHIAT SERV, V57, P1719, DOI 10.1176/appi.ps.57.12.1719; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Efron B, 2003, STAT SCI, V18, P135, DOI 10.1214/ss/1063994968; Fish RA, 2010, PAIN, V149, P435, DOI 10.1016/j.pain.2009.12.016; FOLEY DJ, 1995, SLEEP, V18, P425, DOI 10.1093/sleep/18.6.425; Fujisawa D, 2010, BMC RES NOTES, V3; Goodwin R, 2003, J CROSS CULT PSYCHOL, V34, P240, DOI 10.1177/0022022102250227; Greenhoot AF, 2003, HDB RES METHODS CLIN; Hamilton NA, 2007, J CONSULT CLIN PSYCH, V75, P939, DOI 10.1037/0022-006X.75.6.939; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Jansson-Frojmark M, 2008, J PSYCHOSOM RES, V64, P443, DOI 10.1016/j.jpsychores.2007.10.016; Jeon ST, 2010, J EXP CHILD PSYCHOL, V107, P423, DOI 10.1016/j.jecp.2010.05.009; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Karlson CW, 2012, HLTH PSYCHO IN PRESS; Kley H, 2012, J BEHAV THER EXP PSY, V43, P548, DOI 10.1016/j.jbtep.2011.07.008; Knight BG, 2006, HDB PSYCHOL AGING; Laidlaw K., 2003, COGNITIVE BEHAV THER; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McCracken LM, 2004, PAIN, V107, P159, DOI 10.1016/j.pain.2003.10.012; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CME, 2004, INSOMNIA CLIN GUIDE; Mukhtar F, 2011, ASEAN J PSYCHIATR, V12, P50; Naeem F, 2011, BEHAV COGN PSYCHOTH, V39, P165, DOI 10.1017/S1352465810000822; Poedjiastutie D, 2009, TEFLIN J, V20, P25, DOI DOI 10.15639/TEFLINJOURNAL.V20I1/25-36; Pomerantz AM, 2011, CLIN PSYCHOL SCI PRA; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Slade M, 2010, BMC HLTH SERVICES RE, V10; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Suseno FM, 1988, ETIKA JAWA SEBUAH AN; Suwantara JR, 2005, BECK DEPRESSION INVE, V12, P69; Taylor DJ, 2005, SLEEP, V28, P1457, DOI 10.1093/sleep/28.11.1457; Tluczek A, 2009, J NURS MEAS, V17, P19, DOI 10.1891/1061-3749.17.1.19; Vowles KE, 2008, J CONSULT CLIN PSYCH, V76, P397, DOI 10.1037/0022-006X.76.3.397; Weingarden H, 2011, INT J COGN THER, V4, P381, DOI 10.1521/ijct.2011.4.4.381; Won AB, 2004, J AM GERIATR SOC, V52, P867, DOI 10.1111/j.1532-5415.2004.52251.x; Wong DFK, 2008, DEPRESS ANXIETY, V25, P142, DOI 10.1002/da.20286; Wright D.B., 2011, J EXPER PSYCHOPATHOL, V2, P252, DOI [10.5127/jep.013611, DOI 10.5127/JEP.013611]	54	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57198	10.1371/journal.pone.0057198	http://dx.doi.org/10.1371/journal.pone.0057198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437339	Green Published, gold			2022-12-25	WOS:000315186000083
J	Rolo, D; Simoes, AS; Domenech, A; Fenoll, A; Linares, J; de Lencastre, H; Ardanuy, C; Sa-Leao, R				Rolo, Dora; Simoes, Alexandra S.; Domenech, Arnau; Fenoll, Asuncion; Linares, Josefina; de Lencastre, Herminia; Ardanuy, Carmen; Sa-Leao, Raquel			Disease Isolates of Streptococcus pseudopneumoniae and Non-Typeable S. pneumoniae Presumptively Identified as Atypical S. pneumoniae in Spain	PLOS ONE			English	Article							VIRIDANS GROUP STREPTOCOCCI; PNEUMOCOCCAL STRAINS; MITIS; SEROTYPES; SEQUENCE; SAMPLES; GENE; LYTA; DISCRIMINATION; RESISTANCE	We aimed to obtain insights on the nature of a collection of isolates presumptively identified as atypical Streptococcus pneumoniae recovered from invasive and non-invasive infections in Spain. One-hundred and thirty-two isolates were characterized by: optochin susceptibility in ambient and CO2-enriched atmosphere; bile solubility; PCR-based assays targeting pneumococcal genes lytA, ply, pspA, cpsA, Spn9802, aliB-like ORF2, and a specific 16S rRNA region; multilocus sequence analysis; and antimicrobial susceptibility. By multilocus sequence analysis, 61 isolates were S. pseudopneumoniae, 34 were pneumococci, 13 were S. mitis, and 24 remained unclassified as non-pneumococci. Among S. pseudopneumoniae isolates, 51 (83.6%) were collected from respiratory tract samples; eight isolates were obtained from sterile sources. High frequency of non-susceptibility to penicillin (60.7%) and erythromycin (42.6%) was found. Only 50.8% of the S. pseudopneumoniae isolates displayed the typical optochin phenotype originally described for this species. None harbored the cpsA gene or the pneumococcal typical lytA restriction fragment length polymorphism. The Spn9802 and the specific 16S rRNA regions were detected among the majority of the S. pseudopneumoniae isolates (n = 59 and n = 49, respectively). The ply and pspA genes were rarely found. A high genetic diversity was found and 59 profiles were identified. Among the S. pneumoniae, 23 were capsulated and 11 were non-typeable. Three non-typeable isolates, associated to international non-capsulated lineages, were recovered from invasive disease sources. In conclusion, half of the atypical pneumococcal clinical isolates were, in fact, S. pseudopneumoniae and one-fourth were other streptococci. We identified S. pseudopneumoniae and non-typeable pneumococci as cause of disease in Spain including invasive disease.	[Rolo, Dora; Domenech, Arnau; Linares, Josefina; Ardanuy, Carmen] Univ Barcelona, Dept Microbiol, Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Rolo, Dora; Domenech, Arnau; Linares, Josefina; Ardanuy, Carmen] Inst Salud Carlos III, Ctr Inves Red Enfermedades Resp, Madrid, Spain; [Simoes, Alexandra S.; de Lencastre, Herminia; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Simoes, Alexandra S.; Sa-Leao, Raquel] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Mol Microbiol Human Pathogens, P-2780156 Oeiras, Portugal; [Fenoll, Asuncion] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Rockefeller University	Sa-Leao, R (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	rsaleao@itqb.unl.pt	Ardanuy, Carmen/C-4463-2015; Simões, Alexandra S/G-4884-2013; Rolo, Dora/G-4236-2015; Sá-Leão, Raquel/A-9341-2011; Rolo, Dora/AAI-4326-2021; Liñares, Josefina/N-9450-2014	Simões, Alexandra S/0000-0002-3234-7522; Sá-Leão, Raquel/0000-0001-9804-827X; Domenech, Arnau/0000-0002-0829-511X; /0000-0001-6816-8932; Rolo, Dora/0000-0003-4327-2279; Ardanuy, Carmen/0000-0003-0225-607X; Rolo, Dora/0000-0003-2704-8648	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI060647, PI090104]; Plan Nacional de I+D+I of Spain's Ministerio de Ciencia e Innovacion [BIO2008-02154]; Centro de investigacion en red de enfermedades respiratorias [CB06/06/0037]; Fundacao para a Ciencia e Tecnologia, Portugal [PDTC/BIA-MIC/64010/2006, PTDC/BIA-BEC/098289/2008, Pest-OE/EQB/LA004/2011]; Institut d'Investigacio Biomedica de Bellvitge; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/27325/2006]; Formacion de Profesorado Universitario (Ministerio de Educacion, Spain); Wellcome Trust	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); Plan Nacional de I+D+I of Spain's Ministerio de Ciencia e Innovacion; Centro de investigacion en red de enfermedades respiratorias; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Institut d'Investigacio Biomedica de Bellvitge; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Formacion de Profesorado Universitario (Ministerio de Educacion, Spain); Wellcome Trust(Wellcome Trust)	This work was supported by a grants from the Fondo de Investigaciones Sanitarias de la Seguridad Social (PI060647 and PI090104), Plan Nacional de I+D+I of Spain's Ministerio de Ciencia e Innovacion (BIO2008-02154), Centro de investigacion en red de enfermedades respiratorias (CB06/06/0037) run by the Instituto de Salud Carlos III (Madrid, Spain), Fundacao para a Ciencia e Tecnologia, Portugal (PDTC/BIA-MIC/64010/2006, PTDC/BIA-BEC/098289/2008 and Pest-OE/EQB/LA004/2011). DR was supported by a grant from Institut d'Investigacio Biomedica de Bellvitge. ASS was supported by a grant from Fundacao para a Ciencia e a Tecnologia (SFRH/BD/27325/2006). AD was supported by a grant from Formacion de Profesorado Universitario (Ministerio de Educacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the use of the pneumococcal MLST database, which is located at Imperial College London and is funded by the Wellcome Trust.	Abdeldaim G, 2010, CLIN MICROBIOL INFEC, V16, P1135, DOI 10.1111/j.1469-0691.2009.03069.x; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Balsalobre L, 2012, ANTIMICROB AGENTS CH; Balsalobre L, 2006, J CLIN MICROBIOL, V44, P4163, DOI 10.1128/JCM.01137-06; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Berron S, 2005, J CLIN MICROBIOL, V43, P1694, DOI 10.1128/JCM.43.4.1694-1698.2005; Bishop CJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-3; Blasi F, 2012, CLIN MICROBIOL INFEC, V18, P7, DOI 10.1111/j.1469-0691.2012.03937.x; Chi F, 2007, INT J MED MICROBIOL, V297, P503, DOI 10.1016/j.ijmm.2007.02.009; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; El Aila NA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-104; FENOLL A, 1994, MOL MICROBIOL, V12, P587, DOI 10.1111/j.1365-2958.1994.tb01045.x; Hanage WP, 2005, J BACTERIOL, V187, P6223, DOI 10.1128/JB.187.17.6223-6230.2005; Harf-Monteil C, 2006, J CLIN MICROBIOL, V44, P2240, DOI 10.1128/JCM.02643-05; Hathaway LJ, 2004, J BACTERIOL, V186, P3721, DOI 10.1128/JB.186.12.3721-3729.2004; Ing J, 2012, J CLIN MICROBIOL, V50, P1326, DOI 10.1128/JCM.05182-11; Ioannidou S, 2001, INT J ANTIMICROB AG, V17, P195, DOI 10.1016/S0924-8579(00)00338-1; Jefferies JMC, 2007, J INFECT DIS, V196, P936, DOI 10.1086/520091; Johnston C, 2010, J CLIN MICROBIOL, V48, P2762, DOI 10.1128/JCM.01746-09; Keith ER, 2008, ANTIMICROB AGENTS CH, V52, P2998, DOI 10.1128/AAC.01526-07; Keith ER, 2006, J CLIN MICROBIOL, V44, P923, DOI 10.1128/JCM.44.3.923-927.2006; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Laurens C, 2012, ANTIMICROB AGENTS CH, V56, P4504, DOI 10.1128/AAC.06374-11; Leegaard TM, 2010, MICROBIOL-SGM, V156, P838, DOI 10.1099/mic.0.035345-0; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Martin M, 2003, NEW ENGL J MED, V348, P1112, DOI 10.1056/NEJMoa022521; Melchiorre S, 2012, MICROBIOL-SGM, V158, P338, DOI 10.1099/mic.0.054270-0; MUNOZ R, 1990, DIAGN MICR INFEC DIS, V13, P63, DOI 10.1016/0732-8893(90)90056-2; Nunes S, 2008, J CLIN MICROBIOL, V46, P321, DOI 10.1128/JCM.02097-07; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obregon V, 2002, J CLIN MICROBIOL, V40, P2545, DOI 10.1128/JCM.40.7.2545-2554.2002; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Park HK, 2010, J MED MICROBIOL, V59, P1146, DOI 10.1099/jmm.0.017798-0; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; Ruoff KL, 2003, MANUAL CLIN MICROBIO, P405; Sa-Leao R, 2006, MICROBIOL-SGM, V152, P367, DOI 10.1099/mic.0.28596-0; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Scott JR, 2012, J INFECT DIS, V206, P73, DOI 10.1093/infdis/jis307; Shahinas D, 2011, J BACTERIOL, V193, P6102, DOI 10.1128/JB.06075-11; Simoes AS, 2011, DIAGN MICR INFEC DIS, V71, P208, DOI 10.1016/j.diagmicrobio.2011.07.009; Simoes AS, 2010, J CLIN MICROBIOL, V48, P238, DOI 10.1128/JCM.01313-09; Suzuki N, 2005, J CLIN MICROBIOL, V43, P4528, DOI 10.1128/JCM.43.9.4528-4534.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wessels E, 2012, J CLIN MICROBIOL, V50, P1171, DOI 10.1128/JCM.06609-11; Whatmore AM, 2000, INFECT IMMUN, V68, P1374, DOI 10.1128/IAI.68.3.1374-1382.2000; Xu QF, 2011, DIAGN MICR INFEC DIS, V69, P200, DOI 10.1016/j.diagmicrobio.2010.09.019	49	38	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57047	10.1371/journal.pone.0057047	http://dx.doi.org/10.1371/journal.pone.0057047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437306	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000070
J	Christie, GJ; Cook, CM; Ward, BJ; Tata, MS; Sutherland, J; Sutherland, RJ; Saucier, DM				Christie, Gregory J.; Cook, Charles M.; Ward, Brian J.; Tata, Matthew S.; Sutherland, Janice; Sutherland, Robert J.; Saucier, Deborah M.			Mental Rotational Ability Is Correlated with Spatial but Not Verbal Working Memory Performance and P300 Amplitude in Males	PLOS ONE			English	Article							SEX-DIFFERENCES; INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; COGNITIVE-ABILITIES; ACTIVATION PATTERNS; BRAIN ACTIVATION; OBJECT LOCATION; NEURAL ACTIVITY; TASK; DIFFERENCE	This study investigated how both sex and individual differences in a mental rotation test (MRT) influence performance on working memory (WM). To identify the neural substrate supporting these differences, brain electrical activity was measured using the event-related potential technique. No significant sex differences were observed in a test of verbal WM, however males were significantly faster than females to respond to probe stimuli in a test of spatial WM. This difference was no longer significant after controlling for differences in MRT score, suggesting that rotational ability mediates performance in the spatial memory task for both sexes. A posterior P300 was observed in both tasks as participants encoded information into memory, however the amplitude of the P300 correlated with RT in the spatial task but not in the verbal task. Individual differences in the MRT also correlated with RT and with the amplitude of the P300, but again only in the spatial task. After splitting the analysis by sex, partial correlations controlling for MRT revealed that for males, individual differences in rotational ability completely mediated the correlation between the P300 and RT in the spatial task. This mediating effect was not observed for the female participants. The results therefore suggest a relatively stronger association in males between innate mental rotational ability, spatial memory performance, and brain electrophysiological processes supporting spatial memory.	[Christie, Gregory J.; Cook, Charles M.; Ward, Brian J.; Tata, Matthew S.; Sutherland, Janice; Sutherland, Robert J.; Saucier, Deborah M.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Christie, Gregory J.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Saucier, Deborah M.] Univ Ontario, Fac Sci, Inst Technol, Oshawa, ON, Canada	University of Lethbridge; Simon Fraser University; Ontario Tech University	Saucier, DM (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	Debsaucier@mac.com			Natural Sciences and Engineering Research Council (NSERC); NSERC; Canada Research Chairs program; Canadian Foundation Innovation grant; Alberta Heritage Foundation for Medical Research	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation Innovation grant; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This research was supported by discovery grants from the Natural Sciences and Engineering Research Council (NSERC) to DMS, MST, and RJS; by an NSERC postdoctoral fellowship to CMC; by the Canada Research Chairs program and by a Canadian Foundation Innovation grant to DMS; and by an operating grant and a scientist award from the Alberta Heritage Foundation for Medical Research to RJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Baddeley A, 1974, PSYCHOL LEARN MOTIV, V8; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Beste C, 2010, BRAIN COGNITION, V72, P238, DOI 10.1016/j.bandc.2009.09.005; CAPITANI E, 1991, ITAL J NEUROL SCI, V12, P461, DOI 10.1007/BF02335507; Christova PS, 2008, EXP BRAIN RES, V189, P79, DOI 10.1007/s00221-008-1405-x; Clements AM, 2006, BRAIN LANG, V98, P150, DOI 10.1016/j.bandl.2006.04.007; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; Cook CM, 2010, PERS INDIV DIFFER, V49, P712, DOI 10.1016/j.paid.2010.06.010; Cowan Nelson, 1999, MODELS WORKING MEMOR; Dien J, 1998, BEHAV RES METH INS C, V30, P34, DOI 10.3758/BF03209414; Duff SJ, 2001, BRAIN COGNITION, V47, P470, DOI 10.1006/brcg.2001.1326; FABIANI M, 1986, PSYCHOPHYSIOLOGY, V23, P298, DOI 10.1111/j.1469-8986.1986.tb00636.x; Felix MC, 2011, PERCEPT MOTOR SKILL, V113, P38, DOI 10.2466/03.22.PMS.113.4.38-50; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; FISCHER SC, 1988, BRAIN COGNITION, V7, P1, DOI 10.1016/0278-2626(88)90017-6; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Geiger J. F., 2005, J INSTR PSYCHOL, V32, P49; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Halpern DF, 2000, EDUC PSYCHOL REV, V12, P229, DOI 10.1023/A:1009027516424; Halpern DF, 1997, AM PSYCHOL, V52, P1091, DOI 10.1037/0003-066X.52.10.1091; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; HARSHMAN RA, 1983, CAN J PSYCHOL, V37, P144, DOI 10.1037/h0080690; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P414, DOI 10.1017/S0048577202001105; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; Hoesing JM, 1998, EVALUATION SEX DIFFE; Hoesing JM, 1994, SOC NEUR ABSTR, V20; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; James TW, 1997, EVOL HUM BEHAV, V18, P155, DOI 10.1016/S1090-5138(97)00004-4; Jansen-Osmann P, 2007, BRAIN COGNITION, V64, P217, DOI 10.1016/j.bandc.2007.03.002; Jennings JR, 2006, BRAIN RES, V1092, P177, DOI 10.1016/j.brainres.2006.03.077; Jordan K, 2002, NEUROPSYCHOLOGIA, V40, P2397, DOI 10.1016/S0028-3932(02)00076-3; JUST MA, 1985, PSYCHOL REV, V92, P137, DOI 10.1037/0033-295X.92.2.137; Kaiser S, 2008, NEUROPSYCHOLOGIA, V46, P2524, DOI 10.1016/j.neuropsychologia.2008.04.013; Kaufman SB, 2007, INTELLIGENCE, V35, P211, DOI 10.1016/j.intell.2006.07.009; Kimura Doreen, 1999, SEX COGNITION; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Kosslyn SM, 2001, NEUROREPORT, V12, P2519, DOI 10.1097/00001756-200108080-00046; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Loehlin J.C., 2000, HDB INTELLIGENCE, P176, DOI [10.1017/cbo9780511807947.010, DOI 10.1017/CBO9780511807947]; Lycke C, 2008, SCAND J PSYCHOL, V49, P393, DOI 10.1111/j.1467-9450.2008.00672.x; LYNN R, 1994, PERS INDIV DIFFER, V17, P257, DOI 10.1016/0191-8869(94)90030-2; Mackintosh NJ, 2005, INTELLIGENCE, V33, P663, DOI 10.1016/j.intell.2005.03.004; MANN VA, 1990, NEUROPSYCHOLOGIA, V28, P1063, DOI 10.1016/0028-3932(90)90141-A; MASTERS MS, 1993, BEHAV GENET, V23, P337, DOI 10.1007/BF01067434; McBurney DH, 1997, EVOL HUM BEHAV, V18, P165, DOI 10.1016/S1090-5138(97)00001-9; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; Mecklinger A, 1996, COGNITIVE BRAIN RES, V4, P211, DOI 10.1016/S0926-6410(96)00034-1; Mecklinger A, 1998, MEM COGNITION, V26, P1068, DOI 10.3758/BF03201184; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; Neubauer AC, 2010, INTELLIGENCE, V38, P529, DOI 10.1016/j.intell.2010.06.001; Nittono H, 1999, PSYCHOPHYSIOLOGY, V36, P745; ORSINI A, 1986, PERCEPT MOTOR SKILL, V63, P727, DOI 10.2466/pms.1986.63.2.727; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; OWEN K, 1993, J BIOSOC SCI, V25, P557, DOI 10.1017/S0021932000021933; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Postma A, 1999, PSYCHONEUROENDOCRINO, V24, P175, DOI 10.1016/S0306-4530(98)00073-0; Postma A, 1998, BRAIN COGNITION, V36, P334, DOI 10.1006/brcg.1997.0974; Postma A, 2004, BRAIN COGNITION, V54, P24, DOI 10.1016/S0278-2626(03)00238-0; Prime DJ, 2010, J COGNITIVE NEUROSCI, V22, P2437, DOI 10.1162/jocn.2009.21337; ROSSER RA, 1984, CHILD DEV, V55, P2204, DOI 10.2307/1129792; RUCHKIN DS, 1992, COGNITIVE BRAIN RES, V1, P53, DOI 10.1016/0926-6410(92)90005-C; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Silverman I., 1992, ADAPTED MIND EVOLUTI, P533; Simon-Thomas ER, 2003, COGNITIVE BRAIN RES, V16, P457, DOI 10.1016/S0926-6410(03)00060-0; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Thomsen T, 2000, Med Sci Monit, V6, P1186; Unterrainer JM, 2005, NEUROIMAGE, V24, P586, DOI 10.1016/j.neuroimage.2004.09.020; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Vecchi T, 1998, ACTA PSYCHOL, V99, P1, DOI 10.1016/S0001-6918(97)00052-8; VERLEGER R, 1994, COGNITIVE BRAIN RES, V2, P103, DOI 10.1016/0926-6410(94)90007-8; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Walter H, 2003, CORTEX, V39, P897, DOI 10.1016/S0010-9452(08)70869-4; WATSON NV, 1991, PERS INDIV DIFFER, V12, P375, DOI 10.1016/0191-8869(91)90053-E; WIJERS AA, 1989, PSYCHOPHYSIOLOGY, V26, P452, DOI 10.1111/j.1469-8986.1989.tb01951.x; Yu QB, 2009, NEUROREPORT, V20, P43, DOI 10.1097/WNR.0b013e32831c50f4; Zurowski B, 2002, NEUROIMAGE, V15, P45, DOI 10.1006/nimg.2001.0968	85	18	19	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57390	10.1371/journal.pone.0057390	http://dx.doi.org/10.1371/journal.pone.0057390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437381	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200252
J	Jang, CW; Magnuson, T				Jang, Chuan-Wei; Magnuson, Terry			A Novel Selection Marker for Efficient DNA Cloning and Recombineering in E. coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESISTANCE GENE; EXPRESSION; SEQUENCE; PBR322	Production of recombinant DNA in bacterial cells is an essential technique in molecular biology. Plasmids are usually maintained in an E. coli host by antibiotic selection. However, there are only a few antibiotic-resistance markers available in common use. Here we report the adoption of a novel selection marker, mfabl (mutant fabl) for plasmid propagation in E. coli. mfabl expands the limited repertoire of selection markers and allows for more efficient molecular manipulation and plasmid propagation in E. coli. We show that mfabl is not only an efficient plasmid selection marker, but it also possesses unique activity that may facilitate molecular manipulation of unstable sequences. Furthermore, we have incorporated mfabl in the recombineering tool kit for generating mouse gene targeting vectors and demonstrate the advantage of using mfabl-containing recombineering vectors.	[Jang, Chuan-Wei; Magnuson, Terry] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Jang, Chuan-Wei; Magnuson, Terry] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Jang, Chuan-Wei; Magnuson, Terry] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Magnuson, T (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	terry_magnuson@med.unc.edu			United States National Institutes of Health [R01GM101974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101974] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health [grant number R01GM101974]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; BOCHNER BR, 1980, J BACTERIOL, V143, P926, DOI 10.1128/JB.143.2.926-933.1980; DROCOURT D, 1990, NUCLEIC ACIDS RES, V18, P4009, DOI 10.1093/nar/18.13.4009; Goh S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-61; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; HERSHFIE.V, 1974, P NATL ACAD SCI USA, V71, P3455, DOI 10.1073/pnas.71.9.3455; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; OCONNOR M, 1989, SCIENCE, V244, P1307, DOI 10.1126/science.2660262; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SUTCLIFFE JG, 1978, P NATL ACAD SCI USA, V75, P3737, DOI 10.1073/pnas.75.8.3737; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100	20	14	17	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57075	10.1371/journal.pone.0057075	http://dx.doi.org/10.1371/journal.pone.0057075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437314	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200210
J	Neaux, D; Guy, F; Gilissen, E; Coudyzer, W; Vignaud, P; Ducrocq, S				Neaux, Dimitri; Guy, Franck; Gilissen, Emmanuel; Coudyzer, Walter; Vignaud, Patrick; Ducrocq, Stephane			Facial Orientation and Facial Shape in Extant Great Apes: A Geometric Morphometric Analysis of Covariation	PLOS ONE			English	Article							RELATIVE BRAIN SIZE; CRANIAL BASE ANGULATION; PARTIAL LEAST-SQUARES; PLATE SPLINE ANALYSIS; MORPHOLOGICAL INTEGRATION; DEVELOPMENTAL INTEGRATION; BASICRANIAL FLEXION; SEXUAL DIMORPHISM; AFRICAN APES; MODULARITY	The organization of the bony face is complex, its morphology being influenced in part by the rest of the cranium. Characterizing the facial morphological variation and craniofacial covariation patterns in extant hominids is fundamental to the understanding of their evolutionary history. Numerous studies on hominid facial shape have proposed hypotheses concerning the relationship between the anterior facial shape, facial block orientation and basicranial flexion. In this study we test these hypotheses in a sample of adult specimens belonging to three extant hominid genera (Homo, Pan and Gorilla). Intraspecific variation and covariation patterns are analyzed using geometric morphometric methods and multivariate statistics, such as partial least squared on three-dimensional landmarks coordinates. Our results indicate significant intraspecific covariation between facial shape, facial block orientation and basicranial flexion. Hominids share similar characteristics in the relationship between anterior facial shape and facial block orientation. Modern humans exhibit a specific pattern in the covariation between anterior facial shape and basicranial flexion. This peculiar feature underscores the role of modern humans' highly-flexed basicranium in the overall integration of the cranium. Furthermore, our results are consistent with the hypothesis of a relationship between the reduction of the value of the cranial base angle and a downward rotation of the facial block in modern humans, and to a lesser extent in chimpanzees.	[Neaux, Dimitri; Guy, Franck; Vignaud, Patrick; Ducrocq, Stephane] Univ Poitiers, CNRS UMR 7262, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Poitiers, France; [Gilissen, Emmanuel] Royal Museum Cent Africa, Dept African Zool, Tervuren, Belgium; [Gilissen, Emmanuel] Univ Libre Bruxelles, Lab Histol & Neuropathol, Brussels, Belgium; [Gilissen, Emmanuel] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Coudyzer, Walter] Katholieke Univ Leuven Hosp, Dept Radiol, B-3000 Louvain, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Royal Museum for Central Africa; Universite Libre de Bruxelles; University of Arkansas System; University of Arkansas Fayetteville; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Neaux, D (corresponding author), Univ Poitiers, CNRS UMR 7262, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, Poitiers, France.	dimitri.neaux@univ-poitiers.fr	Neaux, Dimitri/V-2606-2019	GUY, Franck/0000-0001-7032-7963; Coudyzer, Walter/0000-0002-6406-7496; Neaux, Dimitri/0000-0001-9465-220X	Minisere Francais de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche [ANR-09-BLAN-0238]; Ministere Francais des Affaires Etrangeres et Europeennes	Minisere Francais de l'Enseignement Superieur et de la Recherche; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere Francais des Affaires Etrangeres et Europeennes	This work was supported by Minisere Francais de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche (ANR-09-BLAN-0238), and Ministere Francais des Affaires Etrangeres et Europeennes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1994, AM J PHYS ANTHROPOL, V95, P409, DOI 10.1002/ajpa.1330950405; Baab KL, 2010, AM J PHYS ANTHROPOL, V141, P97, DOI 10.1002/ajpa.21120; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; Bastir M, 2004, AM J PHYS ANTHROPOL, V123, P340, DOI 10.1002/ajpa.10313; Bastir M, 2008, ARCH ORAL BIOL, V53, P295, DOI 10.1016/j.archoralbio.2007.09.011; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bastir M, 2010, J HUM EVOL, V58, P424, DOI 10.1016/j.jhevol.2010.03.001; Bastir M, 2009, EVOL BIOL, V36, P57, DOI 10.1007/s11692-008-9037-4; Bastir M, 2008, J ANTHROPOL SCI, V86, P37; Berge C, 2004, AM J PHYS ANTHROPOL, V124, P124, DOI 10.1002/ajpa.10333; Biegert J., 1963, CLASSIFICATION HUMAN, P77; Bienvenu T, 2011, AM J PHYS ANTHROPOL, V145, P231, DOI 10.1002/ajpa.21488; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; Bookstein FL., 1991, MORPHOMETRICS TOOLS; BROMAGE TG, 1992, J HUM EVOL, V23, P235, DOI 10.1016/S0047-2484(05)80002-8; Bruner E, 2010, J ANAT, V216, P589, DOI 10.1111/j.1469-7580.2010.01221.x; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Chernoff B., 1999, MORPHOLOGICAL INTEGR, P319; Cheverud JM, 1996, AM ZOOL, V36, P44; Claude J, 2008, MORPHOMETRICS R; Cobb SN, 2004, J EXP ZOOL PART B, V302B, P302, DOI 10.1002/jez.b.21005; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; Enlow D H, 1975, Birth Defects Orig Artic Ser, V11, P217; Enlow DH, 1996, ESSENTIALS FACIAL GR; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Gkantidis N, 2011, J ANAT, V218, P426, DOI 10.1111/j.1469-7580.2011.01346.x; Goswami A, 2010, PALEONTOLOGICAL SOC, V16, P213; Gould SJ, 1966, BIOL REV CAMB PHILOS, V41, P87; Guy F, 2005, P NATL ACAD SCI USA, V102, P18836, DOI 10.1073/pnas.0509564102; Guy F, 2003, AM J PHYS ANTHROPOL, V121, P198, DOI 10.1002/ajpa.10261; Hallgrimsson B, 2007, EVOL DEV, V9, P76, DOI 10.1111/j.1525-142X.2006.00139.x; Hallgrimsson B, 2004, J EXP ZOOL PART B, V302B, P207, DOI 10.1002/jez.b.21002; Hallgrimsson B, 2009, EVOL BIOL, V36, P355, DOI 10.1007/s11692-009-9076-5; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Kuroe K, 2004, EUR J ORTHODONT, V26, P201, DOI 10.1093/ejo/26.2.201; Laffont R, 2009, EVOL DEV, V11, P302, DOI 10.1111/j.1525-142X.2009.00332.x; Lieberman DE, 2008, J ANAT, V212, P720, DOI 10.1111/j.1469-7580.2008.00900.x; Lieberman DE, 2007, J HUM EVOL, V52, P647, DOI 10.1016/j.jhevol.2006.12.005; Lieberman Daniel E., 2000, Linnean Society Symposium Series, V20, P85; Lieberman DE, 2000, J HUM EVOL, V38, P291, DOI 10.1006/jhev.1999.0335; Lieberman DE, 1999, J HUM EVOL, V36, P487, DOI 10.1006/jhev.1998.0287; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Lieberman DE, 1998, NATURE, V393, P158, DOI 10.1038/30227; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; McCarthy RC, 2001, J HUM EVOL, V40, P41, DOI 10.1006/jhev.2000.0446; McCarthy RC, 2001, ANAT REC, V264, P247, DOI 10.1002/ar.1167; McCollum MA, 1997, AM J PHYS ANTHROPOL, V102, P377, DOI 10.1002/(SICI)1096-8644(199703)102:3<377::AID-AJPA7>3.0.CO;2-S; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; OHIGGINS P, 1993, J HUM EVOL, V24, P183, DOI 10.1006/jhev.1993.1014; OHiggins P., 2006, TOOLS STAT SHAPE ANA; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Parsons TE, 2011, DEV DYNAM, V240, P2233, DOI 10.1002/dvdy.22729; Pavlicev M, 2009, EVOL BIOL, V36, P157, DOI 10.1007/s11692-008-9042-7; Penin X, 2001, CR ACAD SCI III-VIE, V324, P87, DOI 10.1016/S0764-4469(00)01260-9; Penin X, 1999, C R ACAD SCI 3, P322; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1996, ADV MORPHOMETRICS, P131; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Rosas A, 2008, ARCH ORAL BIOL, V53, P826, DOI 10.1016/j.archoralbio.2008.02.005; ROSS C, 1995, AM J PHYS ANTHROPOL, V98, P575, DOI 10.1002/ajpa.1330980413; ROSS CF, 1993, AM J PHYS ANTHROPOL, V91, P305, DOI 10.1002/ajpa.1330910306; ROSS CF, 1995, J HUM EVOL, V29, P201, DOI 10.1006/jhev.1995.1057; SHEA BT, 1983, AM J PHYS ANTHROPOL, V62, P275, DOI 10.1002/ajpa.1330620307; SHEA BT, 1985, AM J PHYS ANTHROPOL, V68, P329, DOI 10.1002/ajpa.1330680304; Singh N, 2012, J HUM EVOL, V62, P155, DOI 10.1016/j.jhevol.2011.11.006; Spoor F, 1997, S AFR J SCI, V93, P182; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; WAGNER GP, 1990, Z ZOOL SYST EVOL, V28, P48; Weidenreich F., 1941, T AM PHILOS SOC, V31, P320, DOI DOI 10.2307/1005610; Wiley D. F., 2005, P IEEE VIS 2005; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	82	10	10	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57026	10.1371/journal.pone.0057026	http://dx.doi.org/10.1371/journal.pone.0057026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441232	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200089
J	Weibel, S; Basse-Luesebrink, TC; Hess, M; Hofmann, E; Seubert, C; Langbein-Laugwitz, J; Gentschev, I; Sturm, VJF; Ye, YX; Kampf, T; Jakob, PM; Szalay, AA				Weibel, Stephanie; Basse-Luesebrink, Thomas Christian; Hess, Michael; Hofmann, Elisabeth; Seubert, Carolin; Langbein-Laugwitz, Johanna; Gentschev, Ivaylo; Sturm, Volker Joerg Friedrich; Ye, Yuxiang; Kampf, Thomas; Jakob, Peter Michael; Szalay, Aladar A.			Imaging of Intratumoral Inflammation during Oncolytic Virotherapy of Tumors by F-19-Magnetic Resonance Imaging (MRI)	PLOS ONE			English	Article							IN-VIVO; VACCINIA VIRUS; F-19 MRI; NONINVASIVE DETECTION; CANCER-THERAPY; NUDE-MICE; MACROPHAGES; MICROENVIRONMENTS; TOMOGRAPHY; PROGRESS	Background: Oncolytic virotherapy of tumors is an up-coming, promising therapeutic modality of cancer therapy. Unfortunately, non-invasive techniques to evaluate the inflammatory host response to treatment are rare. Here, we evaluate F-19 magnetic resonance imaging (MRI) which enables the non-invasive visualization of inflammatory processes in pathological conditions by the use of perfluorocarbon nanoemulsions (PFC) for monitoring of oncolytic virotherapy. Methodology/Principal Findings: The Vaccinia virus strain GLV-1h68 was used as an oncolytic agent for the treatment of different tumor models. Systemic application of PFC emulsions followed by H-1/F-19 MRI of mock-infected and GLV-1h68-infected tumor-bearing mice revealed a significant accumulation of the F-19 signal in the tumor rim of virus-treated mice. Histological examination of tumors confirmed a similar spatial distribution of the F-19 signal hot spots and CD68(+)-macrophages. Thereby, the CD68(+)-macrophages encapsulate the GFP-positive viral infection foci. In multiple tumor models, we specifically visualized early inflammatory cell recruitment in Vaccinia virus colonized tumors. Furthermore, we documented that the F-19 signal correlated with the extent of viral spreading within tumors. Conclusions/Significance: These results suggest F-19 MRI as a non-invasive methodology to document the tumor-associated host immune response as well as the extent of intratumoral viral replication. Thus, F-19 MRI represents a new platform to non-invasively investigate the role of the host immune response for therapeutic outcome of oncolytic virotherapy and individual patient response.	[Weibel, Stephanie; Basse-Luesebrink, Thomas Christian; Hess, Michael; Hofmann, Elisabeth; Seubert, Carolin; Langbein-Laugwitz, Johanna; Gentschev, Ivaylo; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany; [Basse-Luesebrink, Thomas Christian; Sturm, Volker Joerg Friedrich; Ye, Yuxiang; Kampf, Thomas; Jakob, Peter Michael] Univ Wurzburg, Dept Expt Phys 5, D-97070 Wurzburg, Germany; [Basse-Luesebrink, Thomas Christian; Jakob, Peter Michael] Res Ctr Magnet Resonance Bavaria EV, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr, Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Calif San Diego Hlth Syst, Dept Radiat Med & Appl Sci, La Jolla, CA USA; [Gentschev, Ivaylo; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego	Szalay, AA (corresponding author), Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/F-9454-2011; Gentschev, Ivaylo/AAJ-5819-2021	Gentschev, Ivaylo/0000-0003-3743-6329; Jakob, Peter/0000-0002-3481-5545	Genelux Corporation (RAMP;D facility in San Diego, CA, USA); Genelux Corporation	Genelux Corporation (RAMP;D facility in San Diego, CA, USA); Genelux Corporation	This work was supported by a research grant and a service grant from Genelux Corporation (R&D facility in San Diego, CA, USA) awarded to the University of Wuerzburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from Genelux Corporation (R&D facility in San Diego, CA, USA). SW, TCBL, EH, and CS received a postdoctoral fellowship, MH received a graduate fellowship by Genelux Corporation awarded to the University of Wuerzburg, Germany. IG and AAS are salaried employees of Genelux Corporation and have personal financial interests in Genelux Corporation. All authors fully adhere to all the PLOS ONE ploicies on sharing data and materials.	Advani SJ, 2012, CLIN CANCER RES, V18, P2579, DOI 10.1158/1078-0432.CCR-11-2394; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bourke MG, 2011, CANCER TREAT REV, V37, P618, DOI 10.1016/j.ctrv.2010.12.003; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Donat U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045942; Ebner B, 2010, CIRC-CARDIOVASC IMAG, V3, P202, DOI 10.1161/CIRCIMAGING.109.902312; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Flogel U, 2011, AM J TRANSPLANT, V11, P235, DOI 10.1111/j.1600-6143.2010.03372.x; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Fulci G, 2007, CANCER RES, V67, P9398, DOI 10.1158/0008-5472.CAN-07-1063; Fulci G, 2006, P NATL ACAD SCI USA, V103, P12873, DOI 10.1073/pnas.0605496103; Gentschev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022069; Greer S, 2001, INT J RADIAT ONCOL, V51, P791, DOI 10.1016/S0360-3016(01)01706-0; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; HURST J, 1993, BRIT J CANCER, V68, P274, DOI 10.1038/bjc.1993.327; Hyafil F, 2007, NAT MED, V13, P636, DOI 10.1038/nm1571; Kadayakkara DK, 2012, LAB INVEST, V92, P636, DOI 10.1038/labinvest.2012.7; Kleijn A, 2011, CLIN CANCER RES, V17, P4484, DOI 10.1158/1078-0432.CCR-11-0575; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu TC, 2007, NAT CLIN PRACT ONCOL, V4, P101, DOI 10.1038/ncponc0736; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meadowcroft MD, 2007, MAGN RESON MED, V57, P835, DOI 10.1002/mrm.21213; Miller Janet C, 2004, J Am Coll Radiol, V1, P4, DOI 10.1016/S1546-1440(03)00025-5; Morchel P, 2010, RADIOTHER ONCOL, V96, P123, DOI 10.1016/j.radonc.2010.05.006; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Parato KA, 2005, NAT REV CANCER, V5, P965, DOI 10.1038/nrc1750; Prestwich RJ, 2008, EXPERT REV ANTICANC, V8, P1581, DOI 10.1586/14737140.8.10.1581; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Rowan K, 2010, J NATL CANCER I, V102, P590, DOI 10.1093/jnci/djq165; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sabatino M, 2008, CANCER RES, V68, P122, DOI 10.1158/0008-5472.CAN-07-1939; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Srinivas M, 2009, MAGN RESON MED, V62, P747, DOI 10.1002/mrm.22063; Stoll G, 2012, WIRES NANOMED NANOBI, V4, P438, DOI 10.1002/wnan.1168; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Temme S, 2012, WIRES NANOMED NANOBI, V4, P329, DOI 10.1002/wnan.1163; Thorne SH, 2011, IMMUNOL RES, V50, P286, DOI 10.1007/s12026-011-8211-4; Urruticoechea A, 2010, CURR PHARM DESIGN, V16, P3, DOI 10.2174/138161210789941847; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Weibel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-68; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146	46	22	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56317	10.1371/journal.pone.0056317	http://dx.doi.org/10.1371/journal.pone.0056317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441176	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200033
J	Kan, CY; Petti, C; Bracken, L; Maritz, M; Xu, N; O'Brien, R; Yang, C; Liu, T; Yuan, J; Lock, RB; MacKenzie, KL				Kan, Chin-Yi; Petti, Carlotta; Bracken, Lauryn; Maritz, Michelle; Xu, Ning; O'Brien, Rosemary; Yang, Chen; Liu, Tao; Yuan, Jun; Lock, Richard B.; MacKenzie, Karen L.			Up-regulation of Survivin during Immortalization of Human Myofibroblasts Is Linked to Repression of Tumor Suppressor p16(INK4a) Protein and Confers Resistance to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERASE ACTIVITY; HUMAN-CELLS; DNA-DAMAGE; LIFE-SPAN; MALIGNANT-TRANSFORMATION; HYDROGEN-PEROXIDE; GROWTH ARREST; SENESCENCE; FIBROBLASTS; APOPTOSIS	Survivin is an essential component of the chromosomal passenger complex and a member of the inhibitor of apoptosis family. It is expressed at high levels in a large variety of malignancies, where it has been implicated in drug resistance. It was also shown previously that survivin is up-regulated during telomerase-mediated immortalization, which occurs at a relatively early stage during carcinogenesis. This study shows that up-regulation of survivin during immortalization of human myofibroblasts is an indirect consequence of the repression of p16(INK4a). Survivin and p16(INK4a) were functionally linked by assays that showed that either the up-regulation of survivin or repression of p16(INK4a) rendered telomerase-transduced MRC-5 myofibroblasts resistant to oxidative stress. Conversely, siRNA-mediated down-regulation of survivin activated caspases and enhanced the sensitivity of immortal MRC-5 cells to oxidative stress. The E2F1 transcription factor, which is negatively regulated by the pRB/p16(INK4a) tumor suppressor pathway, was implicated in the up-regulation of survivin. Using the ChIP assay, it was shown that E2F1 directly interacted with the survivin gene (BIRC5) promoter in cells that spontaneously silenced p16(INK4a) during telomerase-mediated immortalization. E2F1 binding to the BIRC5 was also enhanced in telomerase-transduced cells subjected to shRNA-mediated repression of p16(INK4a). Together, these data show that repression of p16(INK4a) contributes to the up-regulation of survivin and thereby provides a survival advantage to cells exposed to oxidative stress during immortalization. The up-regulation of survivin during immortalization likely contributes to the vulnerability of immortal cells to transformation by oncogenes that alter intracellular redox state.	[Kan, Chin-Yi; Petti, Carlotta; Bracken, Lauryn; Maritz, Michelle; O'Brien, Rosemary; Yang, Chen; Yuan, Jun; MacKenzie, Karen L.] Univ New S Wales, Canc Cell Dev Grp, Childrens Canc Inst Australia, Lowy Canc Res Ctr, Randwick, NSW 2031, Australia; [Xu, Ning; Liu, Tao] Univ New S Wales, Histone Modificat Grp, Childrens Canc Inst Australia, Lowy Canc Res Ctr, Randwick, NSW 2031, Australia; [Lock, Richard B.] Univ New S Wales, Leukaemia Biol Program, Childrens Canc Inst Australia, Lowy Canc Res Ctr, Randwick, NSW 2031, Australia	Children's Cancer Institute; University of New South Wales Sydney; Children's Cancer Institute; University of New South Wales Sydney; Children's Cancer Institute; University of New South Wales Sydney	MacKenzie, KL (corresponding author), Childrens Canc Inst Australia Med Res, POB 81, Randwick, NSW 2031, Australia.	k.mackenzie@unsw.edu.au	MacKenzie, Karen/N-5849-2019; Mackenzie, Karen/F-1310-2011; Lock, Richard/G-4253-2013; Liu, Tao/A-3922-2015	Liu, Tao/0000-0001-6244-7316; Lock, Richard/0000-0002-3436-9071; Maritz, Michelle Frances/0000-0001-6345-4446; MacKenzie, Karen/0000-0003-2996-1617	National Health and Medical Research Council (NHMRC) [510378, 568704]; Cancer Institute New South Wales Career Development and Support Fellowship [07-CDF-1/23]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales Career Development and Support Fellowship	This work was supported by National Health and Medical Research Council (NHMRC) Career Development Award 510378 (to K. L. M.), by a senior research fellowship (to R. B. L.), by NHMRC Project Grant 568704, and by Cancer Institute New South Wales Career Development and Support Fellowship 07-CDF-1/23 (to K. L. M.).	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Ausserlechner MJ, 2001, J BIOL CHEM, V276, P10984, DOI 10.1074/jbc.M008188200; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Duan JM, 2001, J BIOL CHEM, V276, P48325, DOI 10.1074/jbc.M104814200; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; Franco S, 2001, EXP CELL RES, V268, P14, DOI 10.1006/excr.2001.5264; Frost M, 2002, AM J CLIN PATHOL, V117, P738; Gianani R, 2001, HUM PATHOL, V32, P119, DOI 10.1053/hupa.2001.21897; Guha M, 2009, CANCER RES, V69, P4954, DOI 10.1158/0008-5472.CAN-09-0584; Guidarelli A, 1997, FREE RADICAL RES, V26, P537, DOI 10.3109/10715769709097825; Guidarelli A, 1997, EXP CELL RES, V237, P176, DOI 10.1006/excr.1997.3779; Gurbuxani S, 2005, P NATL ACAD SCI USA, V102, P11480, DOI 10.1073/pnas.0500303102; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Huschtscha LI, 1998, CANCER RES, V58, P3508; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kan CY, 2012, ONCOGENE, V31, P4815, DOI 10.1038/onc.2011.645; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Ksiazek K, 2007, BIOCHEM BIOPH RES CO, V362, P707, DOI 10.1016/j.bbrc.2007.08.047; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Liu T, 2007, P NATL ACAD SCI USA, V104, P18682, DOI 10.1073/pnas.0705524104; MacKenzie KL, 2002, ONCOGENE, V21, P4200, DOI 10.1038/sj.onc.1205425; MacKenzie KL, 2000, EXP CELL RES, V259, P336, DOI 10.1006/excr.2000.4982; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Milyavsky M, 2003, CANCER RES, V63, P7147; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Napier CE, 2010, BBA-MOL CELL RES, V1803, P1142, DOI 10.1016/j.bbamcr.2010.06.010; Obexer P, 2009, J BIOL CHEM, V284, P30933, DOI 10.1074/jbc.M109.051441; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Pennati M, 2007, CARCINOGENESIS, V28, P1133, DOI 10.1093/carcin/bgm047; RICEEVANS C, 1985, BIOCHIM BIOPHYS ACTA, V815, P426, DOI 10.1016/0005-2736(85)90370-0; Rincheval V, 2012, CELL BIOL TOXICOL, V28, P239, DOI 10.1007/s10565-012-9219-9; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taylor LM, 2004, J BIOL CHEM, V279, P43634, DOI 10.1074/jbc.M402388200; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vaziri SAJ, 2005, MOL CANCER THER, V4, P1880, DOI 10.1158/1535-7163.MCT-05-0222; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; WHITAKER NJ, 1995, ONCOGENE, V11, P971; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; XIONG Y, 1993, GENE DEV, V7, P1572, DOI 10.1101/gad.7.8.1572; Xu JH, 2009, ONCOL RES, V18, P377, DOI 10.3727/096504010X12644422320663; Yuan J, 2009, ONCOGENE, V28, P2678, DOI 10.1038/onc.2009.136	61	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12032	12041		10.1074/jbc.M112.447821	http://dx.doi.org/10.1074/jbc.M112.447821			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23449974	Green Published, hybrid			2022-12-25	WOS:000318157600037
J	Ritter, E; Piwowarski, P; Hegemann, P; Bartl, FJ				Ritter, Eglof; Piwowarski, Patrick; Hegemann, Peter; Bartl, Franz J.			Light-dark Adaptation of Channelrhodopsin C128T Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; METARHODOPSIN-II; RESONANCE RAMAN; BACTERIORHODOPSIN; RHODOPSIN; SPECTROSCOPY; PHOTOCYCLES; CHROMOPHORE; MEMBRANE; PEPTIDES	Channelrhodopsins are microbial type rhodopsins that operate as light-gated ion channels. Largely prolonged lifetimes of the conducting state of channelrhodopsin-2 may be achieved by mutations of crucial single amino acids, i.e. cysteine 128. Such mutants are of great scientific interest in the field of neurophysiology because they allow neurons to be switched on and off on demand (step function rhodopsins). Due to their slow photocycle, structural alterations of these proteins can be studied by vibrational spectroscopy in more detail than possible with wild type. Here, we present spectroscopic evidence that the photocycle of the C128T mutant involves three different dark-adapted states that are populated according to the wavelength and duration of the preceding illumination. Our results suggest an important role of multiphoton reactions and the previously described side reaction for dark state regeneration. Structural changes that cause formation and depletion of the assumed ion conducting state P520 are only small and follow larger changes that occur early and late in the photocycle, respectively. They require only minor structural rearrangements of amino acids near the retinal binding pocket and are triggered by all-trans/13-cis retinal isomerization, although additional isomerizations are also involved in the photocycle. We will discuss an extended photocycle model of this mutant on the basis of spectroscopic and electrophysiological data.	[Ritter, Eglof; Piwowarski, Patrick; Bartl, Franz J.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Hegemann, Peter] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Ritter, E (corresponding author), Charite, Inst Med Phys & Biophys, Charitepl 1, D-10117 Berlin, Germany.	eglof.ritter@charite.de; franz.bartl@charite.de			Deutsche Forschungsgemeinschaft [BA 2242/2-1, SFB 1078]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grants BA 2242/2-1 (to F. J. B.) and SFB 1078.	ATON B, 1977, BIOCHEMISTRY-US, V16, P2995, DOI 10.1021/bi00632a029; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; Berndt A, 2010, BIOPHYS J, V98, P753, DOI 10.1016/j.bpj.2009.10.052; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bruun S, 2011, FEBS LETT, V585, P3998, DOI 10.1016/j.febslet.2011.11.007; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; MARCUS MA, 1978, BIOCHEMISTRY-US, V17, P4722, DOI 10.1021/bi00615a019; MARRERO H, 1987, BIOPHYS J, V52, P629, DOI 10.1016/S0006-3495(87)83254-X; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nack M, 2009, FEBS LETT, V583, P3676, DOI 10.1016/j.febslet.2009.10.052; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nikolic K, 2009, PHOTOCHEM PHOTOBIOL, V85, P400, DOI 10.1111/j.1751-1097.2008.00460.x; Patzelt H, 2002, P NATL ACAD SCI USA, V99, P9765, DOI 10.1073/pnas.132253899; Radu I, 2009, J AM CHEM SOC, V131, P7313, DOI 10.1021/ja8084274; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; SCHERRER P, 1989, BIOCHEMISTRY-US, V28, P829, DOI 10.1021/bi00428a063; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Stehfest K, 2010, CHEMPHYSCHEM, V11, P1120, DOI 10.1002/cphc.200900980; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	30	42	44	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10451	10458		10.1074/jbc.M112.446427	http://dx.doi.org/10.1074/jbc.M112.446427			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439646	Green Published, hybrid			2022-12-25	WOS:000317565000025
J	Ibarra, JA; Garcia-Zacarias, CM; Lara-Ochoa, C; Carabarin-Lima, A; Tecpanecatl-Xihuitl, JS; Perez-Rueda, E; Martinez-Laguna, Y; Puente, JL				Antonio Ibarra, J.; Garcia-Zacarias, Claudia M.; Lara-Ochoa, Cristina; Carabarin-Lima, Alejandro; Sergio Tecpanecatl-Xihuitl, J.; Perez-Rueda, Ernesto; Martinez-Laguna, Ygnacio; Puente, Jose L.			Further Characterization of Functional Domains of PerA, Role of Amino and Carboxy Terminal Domains in DNA Binding	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; ALANINE-SCANNING MUTAGENESIS; BUNDLE-FORMING PILUS; TRANSCRIPTIONAL ACTIVATOR; ARAC/XYLS FAMILY; RNA-POLYMERASE; REGULATOR; VIRULENCE; PROTEIN; EXPRESSION	PerA is a key regulator of virulence genes in enteropathogenic E. coli. PerA is a member of the AraC/XylS family of transcriptional regulators that directly regulates the expression of the bfp and per operons in response to different environmental cues. Here, we characterized mutants in both the amino (NTD) and carboxy (CTD) terminal domains of PerA that affect its ability to activate the expression of the bfp and per promoters. Mutants at residues predicted to be important for DNA binding within the CTD had a significant defect in their ability to bind to the regulatory regions of the bfp and per operons and, consequently, in transcriptional activation. Notably, mutants in specific NTD residues were also impaired to bind to DNA suggesting that this domain is involved in structuring the protein for correct DNA recognition. Mutations in residues E116 and D168, located in the vicinity of the putative linker region, significantly affected the activation of the perA promoter, without affecting PerA binding to the per or bfp regulatory sequences. Overall these results provide additional evidence of the importance of the N-terminal domain in PerA activity and suggest that the activation of these promoters involves differential interactions with the transcriptional machinery. This study further contributes to the characterization of the functional domains of PerA by identifying critical residues involved in DNA binding, differential promoter activation and, potentially, in the possible response to environmental cues.	[Antonio Ibarra, J.; Lara-Ochoa, Cristina; Puente, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62191, Morelos, Mexico; [Garcia-Zacarias, Claudia M.; Lara-Ochoa, Cristina; Carabarin-Lima, Alejandro; Sergio Tecpanecatl-Xihuitl, J.; Martinez-Laguna, Ygnacio] Benemerita Univ Autonoma Puebla, Ctr Invest Ciencias Microbiol, Puebla, Mexico; [Perez-Rueda, Ernesto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Benemerita Universidad Autonoma de Puebla; Universidad Nacional Autonoma de Mexico	Ibarra, JA (corresponding author), Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	ibarraj@usf.edu; puente@ibt.unam.mx	Perez-Rueda, Ernesto/F-8337-2013; Ibarra, J. Antonio/R-2030-2018; lima, Alejandro carabarin-/J-4004-2013; Garcia-Zacarias, Claudia Maria/AAX-9639-2020; Perez-Rueda, Ernesto/D-7468-2016	Ibarra, J. Antonio/0000-0002-5016-0622; lima, Alejandro carabarin-/0000-0002-0162-4929; Garcia-Zacarias, Claudia Maria/0000-0002-8909-6744; Puente, Jose/0000-0002-8411-4974; Perez-Rueda, Ernesto/0000-0002-6879-0673	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [60796, 154287, 36477-N]; Direccion General de Asuntos del Personal Academico (DGAPA) [IN227410, IN-209511]; CONACyT [86036, 165332, 180540]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico (DGAPA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia (CONACyT, www.conacyt.gob.mx) (60796 and 154287 to JLP and 36477-N to YML), and from Direccion General de Asuntos del Personal Academico (DGAPA, www.http://dgapa.unam.mx/) (IN227410 to JLP and IN-209511 for EPR). JAI, CLO and ACL were supported by fellowships from CONACyT (86036, 165332 and 180540 respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basturea GN, 2008, J BACTERIOL, V190, P2279, DOI 10.1128/JB.01705-07; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Bustamante VH, 1998, J BACTERIOL, V180, P3013, DOI 10.1128/JB.180.11.3013-3016.1998; Bustamante VH, 2011, MOL MICROBIOL, V82, P398, DOI 10.1111/j.1365-2958.2011.07819.x; Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5; Chen HD, 2005, FEMS MICROBIOL REV, V29, P83, DOI 10.1016/j.femsre.2004.07.002; Childers BM, 2007, J MOL BIOL, V367, P1413, DOI 10.1016/j.jmb.2007.01.061; Childers BM, 2011, J BIOL CHEM, V286, P28644, DOI 10.1074/jbc.M111.258780; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; DONNENBERG MS, 1992, MOL MICROBIOL, V6, P3427, DOI 10.1111/j.1365-2958.1992.tb02210.x; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; Furnham N, 2006, STRUCTURE, V14, P1313, DOI 10.1016/j.str.2006.06.014; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gillette WK, 2000, J MOL BIOL, V299, P1245, DOI 10.1006/jmbi.2000.3827; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; GOMEZDUARTE OG, 1995, INFECT IMMUN, V63, P1767; Griffith KL, 2002, J MOL BIOL, V322, P237, DOI 10.1016/S0022-2836(02)00782-9; Humphries RM, 2010, FUTURE MICROBIOL, V5, P1645, DOI 10.2217/FMB.10.124; Ibarra JA, 2008, GENETICA, V133, P65, DOI 10.1007/s10709-007-9185-y; Ibarra JA, 2003, J BACTERIOL, V185, P2835, DOI 10.1128/JB.185.9.2835-2847.2003; Iida M, 2010, MICROBIOL IMMUNOL, V54, P184, DOI 10.1111/j.1348-0421.2010.00212.x; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Mahon V, 2010, MICROBIOL-SGM, V156, P2796, DOI 10.1099/mic.0.038521-0; Martinez-Laguna Y, 1999, MOL MICROBIOL, V33, P153, DOI 10.1046/j.1365-2958.1999.01460.x; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Okeke IN, 2001, INFECT IMMUN, V69, P5553, DOI 10.1128/IAI.69.9.5553-5564.2001; Porter ME, 2004, MOL MICROBIOL, V54, P1117, DOI 10.1111/j.1365-2958.2004.04333.x; Porter ME, 2002, J BACTERIOL, V184, P531, DOI 10.1128/JB.184.2.531-539.2002; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Ruiz R, 2002, J BIOL CHEM, V277, P7282, DOI 10.1074/jbc.M110226200; Ruiz R, 2001, BIOCHEM BIOPH RES CO, V287, P519, DOI 10.1006/bbrc.2001.5615; Sambrook J, 2001, MOL CLONING LAB MANU; SOHEL I, 1993, MOL MICROBIOL, V7, P563, DOI 10.1111/j.1365-2958.1993.tb01147.x; Sohel I, 1996, J BACTERIOL, V178, P2613, DOI 10.1128/jb.178.9.2613-2628.1996; Stone KD, 1996, MOL MICROBIOL, V20, P325, DOI 10.1111/j.1365-2958.1996.tb02620.x; Tobe T, 1999, MOL MICROBIOL, V33, P741, DOI 10.1046/j.1365-2958.1999.01522.x; Tobe T, 1996, MOL MICROBIOL, V21, P963, DOI 10.1046/j.1365-2958.1996.531415.x	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56977	10.1371/journal.pone.0056977	http://dx.doi.org/10.1371/journal.pone.0056977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451127	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500050
J	Dukart, J; Perneczky, R; Forster, S; Barthel, H; Diehl-Schmid, J; Draganski, B; Obrig, H; Santarnecchi, E; Drzezga, A; Fellgiebel, A; Frackowiak, R; Kurz, A; Muller, K; Sabri, O; Schroeter, ML; Yakushev, I				Dukart, Juergen; Perneczky, Robert; Foerster, Stefan; Barthel, Henryk; Diehl-Schmid, Janine; Draganski, Bogdan; Obrig, Hellmuth; Santarnecchi, Emiliano; Drzezga, Alexander; Fellgiebel, Andreas; Frackowiak, Richard; Kurz, Alexander; Mueller, Karsten; Sabri, Osama; Schroeter, Matthias L.; Yakushev, Igor			Reference Cluster Normalization Improves Detection of Frontotemporal Lobar Degeneration by Means of FDG-PET	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; F-18-FDG PET; PARKINSONS-DISEASE; PATHOLOGICAL HETEROGENEITY; GLUCOSE-METABOLISM; DEMENTIA; METAANALYSIS; BRAIN	Positron emission tomography with [18F] fluorodeoxyglucose (FDG-PET) plays a well-established role in assisting early detection of frontotemporal lobar degeneration (FTLD). Here, we examined the impact of intensity normalization to different reference areas on accuracy of FDG-PET to discriminate between patients with mild FTLD and healthy elderly subjects. FDG-PET was conducted at two centers using different acquisition protocols: 41 FTLD patients and 42 controls were studied at center 1, 11 FTLD patients and 13 controls were studied at center 2. All PET images were intensity normalized to the cerebellum, primary sensorimotor cortex (SMC), cerebral global mean (CGM), and a reference cluster with most preserved FDG uptake in the aforementioned patients group of center 1. Metabolic deficits in the patient group at center 1 appeared 1.5, 3.6, and 4.6 times greater in spatial extent, when tracer uptake was normalized to the reference cluster rather than to the cerebellum, SMC, and CGM, respectively. Logistic regression analyses based on normalized values from FTLD-typical regions showed that at center 1, cerebellar, SMC, CGM, and cluster normalizations differentiated patients from controls with accuracies of 86%, 76%, 75% and 90%, respectively. A similar order of effects was found at center 2. Cluster normalization leads to a significant increase of statistical power in detecting early FTLD-associated metabolic deficits. The established FTLD-specific cluster can be used to improve detection of FTLD on a single case basis at independent centers - a decisive step towards early diagnosis and prediction of FTLD syndromes enabling specific therapies in the future.	[Dukart, Juergen; Draganski, Bogdan; Frackowiak, Richard] Univ Lausanne, LREN, Dept Neurosci Clin, CHUV, Lausanne, Switzerland; [Obrig, Hellmuth; Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, D-04109 Leipzig, Germany; [Dukart, Juergen; Obrig, Hellmuth; Mueller, Karsten; Schroeter, Matthias L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Barthel, Henryk; Sabri, Osama; Schroeter, Matthias L.] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany; [Draganski, Bogdan] Charite, Mind Brain Inst, Berlin, Germany; [Draganski, Bogdan] Humboldt Univ, D-10099 Berlin, Germany; [Barthel, Henryk; Sabri, Osama] Univ Leipzig, Dept Nucl Med, D-04109 Leipzig, Germany; [Perneczky, Robert; Diehl-Schmid, Janine; Kurz, Alexander] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-80290 Munich, Germany; [Foerster, Stefan; Drzezga, Alexander; Yakushev, Igor] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany; [Santarnecchi, Emiliano] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Fellgiebel, Andreas; Yakushev, Igor] Univ Med Ctr Mainz, Mainz, Germany; [Perneczky, Robert] Univ London Imperial Coll Sci Technol & Med, Neuroepidemiol & Ageing Res Unit, Sch Publ Hlth, Fac Med, London, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Leipzig University; Max Planck Society; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Leipzig University; Technical University of Munich; University of Munich; Technical University of Munich; University of Munich; University of Siena; Johannes Gutenberg University of Mainz; Imperial College London	Dukart, J (corresponding author), Univ Lausanne, LREN, Dept Neurosci Clin, CHUV, Lausanne, Switzerland.	dukart@cbs.mpg.de	Draganski, Bogdan/C-3096-2016; Frackowiak, Richard S/I-1809-2013; Perneczky, Robert/AAJ-2550-2020; Frackowiak, Richard/H-4383-2011; Santarnecchi, Emiliano/H-7528-2017	Draganski, Bogdan/0000-0002-5159-5919; Frackowiak, Richard/0000-0002-3151-822X; Santarnecchi, Emiliano/0000-0002-6533-7427; Dukart, Juergen/0000-0003-0492-5644; Diehl-Schmid, Janine/0000-0002-7745-1382; Drzezga, Alexander/0000-0001-6018-716X; Yakushev, Igor/0000-0003-4764-798X; Perneczky, Robert/0000-0003-1981-7435	Leipzig Research Center for Civilization Diseases (LIFE) at the University of Leipzig; European Union; European Regional Development Fund (ERFD); Free State of Saxony within the framework of the excellence initiative; German consortium; German Federal Ministry of Education and Research	Leipzig Research Center for Civilization Diseases (LIFE) at the University of Leipzig; European Union(European Commission); European Regional Development Fund (ERFD)(European Commission); Free State of Saxony within the framework of the excellence initiative; German consortium; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Henryk Barthel, Osama Sabri and Matthias L. Schroeter are supported by the Leipzig Research Center for Civilization Diseases (LIFE) at the University of Leipzig. LIFE is funded by the European Union, the European Regional Development Fund (ERFD) and the Free State of Saxony within the framework of the excellence initiative. Matthias L. Schroeter, Robert Perneczky, Alexander Kurz and Janine Diehl-Schmid are also supported by the German consortium for frontotemporal lobar degeneration, funded by the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Berti V, 2012, Q J NUCL MED MOL IM, V56, P299; Borghammer P, 2012, ACTA NEUROL SCAND, V125, P303, DOI 10.1111/j.1600-0404.2011.01556.x; Borghammer P, 2012, J NEUROL SCI, V313, P123, DOI 10.1016/j.jns.2011.09.010; Borghammer P, 2009, NEUROIMAGE, V47, P1514, DOI 10.1016/j.neuroimage.2009.05.040; Borghammer P, 2009, NEUROIMAGE, V46, P981, DOI 10.1016/j.neuroimage.2009.03.021; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl-Schmid J, 2007, NEUROBIOL AGING, V28, P42, DOI 10.1016/j.neurobiolaging.2005.11.002; Dukart J, 2012, PSYCHIAT RES, DOI DOI 10.1016/J.PSCYCHRESNS.2012.1004.1007; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018111; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Gavrilescu M, 2002, NEUROIMAGE, V17, P532, DOI 10.1006/nimg.2002.1226; Harvey RJ, 2003, J NEUROL NEUROSUR PS, V74, P1206, DOI 10.1136/jnnp.74.9.1206; Ibach B, 2004, NEUROIMAGE, V23, P739, DOI 10.1016/j.neuroimage.2004.06.041; Ishii K, 1998, J NUCL MED, V39, P293; Jeong Y, 2005, J NUCL MED, V46, P233; Kipps CM, 2009, BRAIN, V132, P2566, DOI 10.1093/brain/awp077; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MINOSHIMA S, 1995, J COMPUT ASSIST TOMO, V19, P541, DOI 10.1097/00004728-199507000-00006; Mosconi L, 2004, NEUROLOGY, V63, P2332, DOI 10.1212/01.WNL.0000147469.18313.3B; Mosconi L, 2008, J NUCL MED, V49, P390, DOI 10.2967/jnumed.107.045385; Mukherjee O, 2006, ANN NEUROL, V60, P314, DOI 10.1002/ana.20963; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Perneczky R, 2006, AM J GERIAT PSYCHIAT, V14, P139, DOI 10.1097/01.JGP.0000192478.82189.a8; Perneczky R, 2008, EUR J NUCL MED MOL I, V35, P605, DOI 10.1007/s00259-007-0626-8; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Poljansky S, 2011, EUR ARCH PSY CLIN N, V261, P433, DOI 10.1007/s00406-010-0184-0; Rostomian AH, 2011, J NUCL MED, V52, P173, DOI 10.2967/jnumed.110.082057; Sadeghi N, 2008, I S BIOMED IMAGING, P408, DOI 10.1109/ISBI.2008.4541019; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Samuraki M, 2007, EUR J NUCL MED MOL I, V34, P1658, DOI 10.1007/s00259-007-0454-x; Santens P, 2001, EUR NEUROL, V45, P19, DOI 10.1159/000052084; Schroeter ML, 2008, NEUROBIOL AGING, V29, P418, DOI 10.1016/j.neurobiolaging.2006.10.023; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schroeter ML, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00010; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Silverman DHS, 2004, J NUCL MED, V45, P594; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; TIEN RD, 1992, AM J ROENTGENOL, V158, P1155, DOI 10.2214/ajr.158.5.1566683; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Yakushev I, 2009, NEUROIMAGE, V44, P43, DOI 10.1016/j.neuroimage.2008.07.015; Yakushev I, 2008, PSYCHIAT RES-NEUROIM, V164, P143, DOI 10.1016/j.pscychresns.2007.11.004	47	25	26	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55415	10.1371/journal.pone.0055415	http://dx.doi.org/10.1371/journal.pone.0055415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451025	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500001
J	Aparisi, MJ; Garcia-Garcia, G; Aller, E; Sequedo, MD; de la Camara, CMF; Rodrigo, R; Armengot, M; Cortijo, J; Milara, J; Diaz-LLopis, M; Jaijo, T; Millan, JM				Jose Aparisi, Maria; Garcia-Garcia, Gema; Aller, Elena; Dolores Sequedo, Maria; Martinez-Fernandez de la Camara, Cristina; Rodrigo, Regina; Armengot, Miguel; Cortijo, Julio; Milara, Javier; Diaz-LLopis, Manuel; Jaijo, Teresa; Maria Millan, Jose			Study of USH1 Splicing Variants through Minigenes and Transcript Analysis from Nasal Epithelial Cells	PLOS ONE			English	Article							MUTATION; GENE; FAMILIES; FREQUENCY; PROFILE; MYO7A	Usher syndrome type I (USH1) is an autosomal recessive disorder characterized by congenital profound deafness, vestibular areflexia and prepubertal retinitis pigmentosa. The first purpose of this study was to determine the pathologic nature of eighteen USH1 putative splicing variants found in our series and their effect in the splicing process by minigene assays. These variants were selected according to bioinformatic analysis. The second aim was to analyze the USH1 transcripts, obtained from nasal epithelial cells samples of our patients, in order to corroborate the observed effect of mutations by minigenes in patient's tissues. The last objective was to evaluate the nasal ciliary beat frequency in patients with USH1 and compare it with control subjects. In silico analysis were performed using four bioinformatic programs: NNSplice, Human Splicing Finder, NetGene2 and Spliceview. Afterward, minigenes based on the pSPL3 vector were used to investigate the implication of selected changes in the mRNA processing. To observe the effect of mutations in the patient's tissues, RNA was extracted from nasal epithelial cells and RT-PCR analyses were performed. Four MYO7A (c.470G>A, c.1342_1343delAG, c.5856G>A and c.3652G>A), three CDH23 (c.2289+1G>A, c.6049G. A and c.8722+1delG) and one PCDH15 (c.3717+2dupTT) variants were observed to affect the splicing process by minigene assays and/or transcripts analysis obtained from nasal cells. Based on our results, minigenes are a good approach to determine the implication of identified variants in the mRNA processing, and the analysis of RNA obtained from nasal epithelial cells is an alternative method to discriminate neutral Usher variants from those with a pathogenic effect on the splicing process. In addition, we could observe that the nasal ciliated epithelium of USH1 patients shows a lower ciliary beat frequency than control subjects.	[Jose Aparisi, Maria; Garcia-Garcia, Gema; Aller, Elena; Dolores Sequedo, Maria; Martinez-Fernandez de la Camara, Cristina; Rodrigo, Regina; Jaijo, Teresa; Maria Millan, Jose] Inst Invest Sanitaria La Fe, Res Grp Sensorineural Dis, Valencia, Spain; [Aller, Elena; Jaijo, Teresa; Maria Millan, Jose] Biomed Network Res Ctr Rare Dis, Valencia, Spain; [Armengot, Miguel] Univ Valencia, Sch Med, Gen & Univ Hosp, Rhinol Unit, Valencia, Spain; [Cortijo, Julio] Univ Gen Hosp Valencia, Res Fdn, Valencia, Spain; [Cortijo, Julio; Milara, Javier] Biomed Network Res Ctr Resp Dis, Valencia, Spain; [Cortijo, Julio] Univ Valencia, Valencia, Spain; [Milara, Javier] Univ Clin Hosp, Clin Pharmacol Unit, Valencia, Spain; [Milara, Javier] Univ Gen Hosp Consortium, Res Unit, Valencia, Spain; [Diaz-LLopis, Manuel] Univ Valencia, La Fe Univ Hosp, Sch Med, Dept Ophthalmol, Valencia, Spain; [Maria Millan, Jose] La Fe Univ Hosp, Genet Unit, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Valencia; University of Valencia; University of Valencia	Jaijo, T (corresponding author), Inst Invest Sanitaria La Fe, Res Grp Sensorineural Dis, Valencia, Spain.	tjaijo@gmail.com	Garcia, Gema/AEN-8767-2022; Martinez, Cristina/ABH-7295-2020; Rodrigo, Regina/I-1868-2015; Armengot, Miguel/E-4664-2016; García-García, Gema/J-9387-2015; Jaijo, Teresa/A-4801-2010; Aller, Elena/A-4803-2010	Martinez, Cristina/0000-0002-6612-6162; Rodrigo, Regina/0000-0001-5875-986X; Armengot, Miguel/0000-0001-8258-6292; García-García, Gema/0000-0002-2113-0600; Aller, Elena/0000-0001-7973-5250; MILARA, JAVIER/0000-0001-6033-4211; Jaijo, Teresa/0000-0003-0973-9146; Aparisi, Maria Jose/0000-0002-6778-4415	Spanish Ministry of Science and Innovation [SAF2011-26443, FIS CP11/00293, PI11/02618, ADE10/00020, PI10/01825]; Regional Government (Generalitat Valenciana) [Prometeo/2008/045, GV/2012/028]; PROMIS from the Instituto de Salud Carlos III [II12/00023]; Ministerio de Educacion [AP2099-3344, AP2008-02760]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF)); PROMIS from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Educacion	This work was supported by grants SAF2011-26443, FIS CP11/00293, PI11/02618, ADE10/00020 and PI10/01825 from Spanish Ministry of Science and Innovation and grants Prometeo/2008/045 and GV/2012/028 from Regional Government (Generalitat Valenciana). CIBERER (CB/06/07/1030) and CIBERES (CB06/06/0027) are an initiative of the Institute of Health Carlos III from the Spanish Ministry of Science and Innovation. The bioanalyzer ABI3500xl was purchased with the grant PROMIS (II12/00023) from the Instituto de Salud Carlos III. MJA and GGG are recipient of a fellowship from the Ministerio de Educacion (REF: AP2099-3344 and AP2008-02760, respectively). RR has a Contrato-Investigador SNS Miguel Servet (CP09/118) from Instituto de Salud Carlos III, Ministerio Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Armengot M, 2012, INVEST OPHTH VIS SCI, V53, P2076, DOI 10.1167/iovs.11-8666; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; BONNEAU D, 1993, J MED GENET, V30, P253, DOI 10.1136/jmg.30.3.253; Bottillo I, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-4; Cohn E, 2006, 1 INT S USH SYNDR RE, P22; Davenport SHL, 1977, AMST EXC MED FDN INT, P87; Espinos C, 1998, Community Genet, V1, P223, DOI 10.1159/000016167; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Jaijo T, 2006, Hum Mutat, V27, P290, DOI 10.1002/humu.9404; Jaijo T, 2011, CLIN GENET, V79, P282, DOI 10.1111/j.1399-0004.2010.01454.x; Jaijo T, 2012, MOL VIS, V18, P1719; Jaijo T, 2010, INVEST OPHTH VIS SCI, V51, P1311, DOI 10.1167/iovs.09-4085; Jaworek TJ, 2012, J HUM GENET, V57, P633, DOI 10.1038/jhg.2012.79; Aparisi MJ, 2010, MOL VIS, V16, P2948; KIMBERLING WJ, 1995, AM J HUM GENET, V56, P216; Le Gueard-Mereuze S, 2010, HUM MUTAT, V31, P347, DOI 10.1002/humu.21193; Millan Jose M, 2011, J Ophthalmol, V2011, P417217, DOI 10.1155/2011/417217; Najera C., 1999, HUM MUTAT, V14, P181, DOI [3.0.CO;2-3, 10.1002/(SICI)1098-1004(1999)14:2&lt;181::AID-HUMU11&gt;3.0.CO;2-3]; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; Vache C, 2010, HUM MUTAT, V31, P734, DOI 10.1002/humu.21255; VERNON M, 1969, J SPEECH HEAR RES, V12, P541, DOI 10.1044/jshr.1203.541	26	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57506	10.1371/journal.pone.0057506	http://dx.doi.org/10.1371/journal.pone.0057506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451239	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500111
J	Lin, YW; Yu, SL; Shao, HY; Lin, HY; Liu, CC; Hsiao, KN; Chitra, E; Tsou, YL; Chang, HW; Sia, C; Chong, PL; Chow, YH				Lin, Yi-Wen; Yu, Shu-Ling; Shao, Hsiao-Yun; Lin, Hsiang-Yin; Liu, Chia-Chyi; Hsiao, Kuang-Nan; Chitra, Ebenezer; Tsou, Yueh-Liang; Chang, Hsuen-Wen; Sia, Charles; Chong, Pele; Chow, Yen-Hung			Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SELECTIN GLYCOPROTEIN LIGAND-1; BRAIN-STEM ENCEPHALITIS; P-SELECTIN; MOUTH-DISEASE; NEUROLOGICAL DISEASE; CEREBROSPINAL-FLUID; VACCINE DEVELOPMENT; CYNOMOLGUS MONKEYS; CELL-CULTURE	Enterovirus 71 (EV71) and coxsackievirus (CVA) are the most common causative factors for hand, foot, and mouth disease (HFMD) and neurological disorders in children. Lack of a reliable animal model is an issue in investigating EV71-induced disease manifestation in humans, and the current clinical therapies are symptomatic. We generated a novel EV71-infectious model with hSCARB2-transgenic mice expressing the discovered receptor human SCARB2 (hSCARB2). The challenge of hSCARB2-transgenic mice with clinical isolates of EV71 and CVA16 resulted in HFMD-like and neurological syndromes caused by E59 (B4) and N2838 (B5) strains, and lethal paralysis caused by 5746 (C2), N3340 (C4), and CVA16. EV71 viral loads were evident in the tissues and CNS accompanied the upregulated pro-inflammatory mediators (CXCL10, CCL3, TNF-alpha, and IL-6), correlating to recruitment of the infiltrated T lymphocytes that result in severe diseases. Transgenic mice pre-immunized with live E59 or the FI-E59 vaccine was able to resist the subsequent lethal challenge with EV71. These results indicate that hSCARB2-transgenic mice are a useful model for assessing anti-EV71 medications and for studying the pathogenesis induced by EV71.	[Lin, Yi-Wen; Yu, Shu-Ling; Shao, Hsiao-Yun; Lin, Hsiang-Yin; Liu, Chia-Chyi; Hsiao, Kuang-Nan; Chitra, Ebenezer; Tsou, Yueh-Liang; Chang, Hsuen-Wen; Sia, Charles; Chong, Pele; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Sia, Charles; Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan	Chong, PL (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan.	pelechong@nhri.org.tw; choeyenh@nhri.org.tw	Chitra, Ebenezer/F-5984-2019; Chow, Yen-Hung/E-3863-2010; Chong, Pele/E-3855-2010; Sia, Dwo-Yuan/E-3860-2010; Liu, Chia-Chyi/A-8215-2012	Chitra, Ebenezer/0000-0002-5818-6587; Liu, Chia-Chyi/0000-0002-6257-0389	Taiwan National Science Council [99-2323-B-400-014-, 100-2311-B-400-003]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants (99-2323-B-400-014- and 100-2311-B-400-003) from the Taiwan National Science Council (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; APPELBERG R, 1992, J LEUKOCYTE BIOL, V52, P303, DOI 10.1002/jlb.52.3.303; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chen YC, 2004, J GEN VIROL, V85, P69, DOI 10.1099/vir.0.19423-0; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; de Villiers WJS, 1999, J LEUKOCYTE BIOL, V66, P740, DOI 10.1002/jlb.66.5.740; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; HASHIMOTO I, 1978, ARCH VIROL, V56, P257, DOI 10.1007/BF01317855; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lane TE, 1998, J IMMUNOL, V160, P970; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Lin YW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030507, 10.1371/journal.pone.0052490]; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu JN, 2012, ARCH VIROL, V157, P539, DOI 10.1007/s00705-011-1198-2; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; Melnick J L, 1980, Intervirology, V12, P297; Muse M, 2008, VIROLOGY, V382, P132, DOI 10.1016/j.virol.2008.09.032; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; Shih SR, 2000, VIRUS RES, V68, P127, DOI 10.1016/S0168-1702(00)00162-3; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Tani M, 1996, J CLIN INVEST, V98, P529, DOI 10.1172/JCI118821; Trifilo MJ, 2004, J VIROL, V78, P585, DOI 10.1128/JVI.78.2.585-594.2004; Wang SM, 2007, CLIN MICROBIOL INFEC, V13, P677, DOI 10.1111/j.1469-0691.2007.01729.x; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; WATANABE K, 1989, J BIOL CHEM, V264, P19559; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	52	71	75	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57591	10.1371/journal.pone.0057591	http://dx.doi.org/10.1371/journal.pone.0057591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451246	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500117
J	Valiente-Echeverria, F; Vallejos, M; Monette, A; Pino, K; Letelier, A; Huidobro-Toro, JP; Mouland, AJ; Lopez-Lastra, M				Valiente-Echeverria, Fernando; Vallejos, Maricarmen; Monette, Anne; Pino, Karla; Letelier, Alejandro; Pablo Huidobro-Toro, J.; Mouland, Andrew J.; Lopez-Lastra, Marcelo			A cis-Acting Element Present within the gag Open Reading Frame Negatively Impacts on the Activity of the HIV-1 IRES	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; STRUCTURAL GENE-EXPRESSION; RIBOSOMAL ENTRY SITE; ENV MESSENGER-RNA; HEPATITIS-C VIRUS; TRANSLATION INITIATION; HNRNP A1; REV PROTEIN; LEADER RNA; 5-UNTRANSLATED REGION	Translation initiation from the human immunodeficiency virus type-1 (HIV-1) mRNA can occur through a cap or an IRES dependent mechanism. Cap-dependent translation initiation of the HIV-1 mRNA can be inhibited by the instability element (INS)-1, a cis-acting regulatory element present within the gag open reading frame (ORF). In this study we evaluated the impact of the INS-1 on HIV-1 IRES-mediated translation initiation. Using heterologous bicistronic mRNAs, we show that the INS-1 negatively impact on HIV-1 IRES-driven translation in in vitro and in cell-based experiments. Additionally, our results show that the inhibitory effect of the INS-1 is not general to all IRESes since it does not hinder translation driven by the HCV IRES. The inhibition by the INS-1 was partially rescued in cells by the overexpression of the viral Rev protein or hnRNPA1.	[Valiente-Echeverria, Fernando; Vallejos, Maricarmen; Pino, Karla; Letelier, Alejandro; Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Santiago, Chile; [Monette, Anne; Mouland, Andrew J.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, HIV Trafficking Lab 1, Montreal, PQ H3T 1E2, Canada; [Monette, Anne; Mouland, Andrew J.] McGill Univ, Dept Expt Med, Montreal, PQ, Canada; [Mouland, Andrew J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Pablo Huidobro-Toro, J.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Ctr Envejecimiento & Regenerac,CARE, Santiago, Chile	Pontificia Universidad Catolica de Chile; Lady Davis Institute; McGill University; McGill University; McGill University; Pontificia Universidad Catolica de Chile	Lopez-Lastra, M (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Inst Milenio Inmunol & Inmunoterapia, Lab Virol Mol,Ctr Invest Med, Alameda 340, Santiago, Chile.	malopez@med.puc.cl	Valiente-Echeverria, Fernando/I-6881-2018; Lopez-Lastra, Marcelo/HHM-9832-2022	Valiente-Echeverria, Fernando/0000-0001-9156-2516; Lopez-Lastra, Marcelo/0000-0002-7936-8478	CONICYT; predoctoral CIHR studentship; VRAID; PUC; Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT) [1090318]; Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo [P09/016-F]; FONDECYT [1110672]; Proyecto Basal CARE [12/2007]; Canadian Institutes of Health Research (CIHR) [MOP-56974]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); predoctoral CIHR studentship(Canadian Institutes of Health Research (CIHR)); VRAID; PUC; Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Basal CARE(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	FV-E and MV conducted this work as part of their PhD Thesis and were supported by a CONICYT doctoral fellowship, AM was supported by a predoctoral CIHR studentship, and AL, who also participated in this study as part of his PhD Thesis, was supported by a VRAID, PUC fellowship and by a CONICYT beca de extension. This study was supported by grants from the Fondo Nacional de Ciencia y Tecnologia del Gobierno de Chile (FONDECYT) 1090318, Proyecto P09/016-F de la Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo to MLL, partial support from FONDECYT 1110672 and Proyecto Basal CARE 12/2007 to JPH-T, and the Canadian Institutes of Health Research (CIHR, MOP-56974) to AJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina E, 1997, J BIOL CHEM, V272, P2307, DOI 10.1074/jbc.272.4.2307; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 2011, NUCLEIC ACIDS RES, V39, P5232, DOI 10.1093/nar/gkr113; Black AC, 1996, VIRUS GENES, V12, P275, DOI 10.1007/BF00284648; Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Buck CB, 2001, J VIROL, V75, P181, DOI 10.1128/JVI.75.1.181-191.2001; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; Cheunim T, 2008, VIRUS RES, V131, P189, DOI 10.1016/j.virusres.2007.09.006; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; COCHRANE AW, 1991, J VIROL, V65, P5305, DOI 10.1128/JVI.65.10.5305-5313.1991; COCHRANE AW, 1990, P NATL ACAD SCI USA, V87, P1198, DOI 10.1073/pnas.87.3.1198; de Breyne S, 2012, VIRUS RES IN PRESS; DILLON PJ, 1990, J VIROL, V64, P4428, DOI 10.1128/JVI.64.9.4428-4437.1990; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Gallego J, 2003, J BIOL CHEM, V278, P40385, DOI 10.1074/jbc.M301041200; GEBALLE AP, 1992, NUCLEIC ACIDS RES, V20, P4291, DOI 10.1093/nar/20.16.4291; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Groom HCT, 2009, J GEN VIROL, V90, P1141, DOI 10.1099/vir.0.007963-0; HADZOPOULOUCLADARAS M, 1989, J VIROL, V63, P1265, DOI 10.1128/JVI.63.3.1265-1274.1989; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Huffman KM, 1997, VIROLOGY, V234, P253, DOI 10.1006/viro.1997.8655; Barria MI, 2009, NUCLEIC ACIDS RES, V37, P957, DOI 10.1093/nar/gkn1022; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Ka WH, 2012, BIOCHEM BIOPH RES CO, V417, P501, DOI 10.1016/j.bbrc.2011.11.149; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim CS, 2007, J VIROL, V81, P3852, DOI 10.1128/JVI.01311-06; Kolupaeva VG, 2000, J VIROL, V74, P6242, DOI 10.1128/JVI.74.14.6242-6250.2000; Kress E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-8; Lin JY, 2009, J VIROL, V83, P6106, DOI 10.1128/JVI.02476-08; Liu JF, 2011, J NEUROIMMUNE PHARM, V6, P308, DOI 10.1007/s11481-011-9265-8; MALDARELLI F, 1991, J VIROL, V65, P5732, DOI 10.1128/JVI.65.11.5732-5743.1991; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; Monette A, 2011, J CELL BIOL, V193, P619, DOI 10.1083/jcb.201008064; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Najera I, 1999, J MOL BIOL, V285, P1951, DOI 10.1006/jmbi.1998.2473; NASIOULAS G, 1994, J VIROL, V68, P2986, DOI 10.1128/JVI.68.5.2986-2993.1994; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; OLSEN HS, 1992, VIROLOGY, V191, P709, DOI 10.1016/0042-6822(92)90246-L; Otto GA, 2004, CELL, V119, P369, DOI 10.1016/j.cell.2004.09.038; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; PARKIN N, 1988, MOL CELL BIOL, V8, P2875, DOI 10.1128/MCB.8.7.2875; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Ricci EP, 2008, BIOCHEM SOC T, V36, P690, DOI 10.1042/BST0360690; Rivas-Aravena A, 2009, VIROLOGY, V392, P178, DOI 10.1016/j.virol.2009.06.050; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; SILVERMAN R H, 1990, Journal of Experimental Pathology (New York), V5, P69; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soto-Rifo R, 2012, NUCL ACIDS RES; Vallejos M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035031; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Vallejos M, 2010, NUCLEIC ACIDS RES, V38, P618, DOI 10.1093/nar/gkp890; Wolff H, 2003, NUCLEIC ACIDS RES, V31, P2839, DOI 10.1093/nar/gkg390; Wolff H, 2006, BIOTECHNIQUES, V41, P688, DOI 10.2144/000112291; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	64	13	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56962	10.1371/journal.pone.0056962	http://dx.doi.org/10.1371/journal.pone.0056962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451120	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500047
J	Kollers, S; Rodemann, B; Ling, J; Korzun, V; Ebmeyer, E; Argillier, O; Hinze, M; Plieske, J; Kulosa, D; Ganal, MW; Roder, MS				Kollers, Sonja; Rodemann, Bernd; Ling, Jie; Korzun, Viktor; Ebmeyer, Erhard; Argillier, Odile; Hinze, Maike; Plieske, Joerg; Kulosa, Dagmar; Ganal, Martin W.; Roeder, Marion S.			Whole Genome Association Mapping of Fusarium Head Blight Resistance in European Winter Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; SPRING WHEAT; GENETIC-STRUCTURE; QTL ANALYSIS; MAJOR QTL; POPULATION; QUALITY; IDENTIFICATION; COMPONENTS; SELECTION	A total of 358 recent European winter wheat varieties plus 14 spring wheat varieties were evaluated for resistance to Fusarium head blight (FHB) caused by Fusarium graminearum and Fusarium culmorum in four separate environments. The FHB scores based on FHB incidence (Type I resistance) x FHB severity (Type II resistance) indicated a wide phenotypic variation of the varieties with BLUE (best linear unbiased estimation) values ranging from 0.07 to 33.67. Genotyping with 732 microsatellite markers resulted in 782 loci of which 620 were placed on the ITMI map. The resulting average marker distance of 6.8 cM allowed genome wide association mapping employing a mixed model. Though no clear population structure was discovered, a kinship matrix was used for stratification. A total of 794 significant (-log(10)(p)-value >= 3.0) associations between SSR-loci and environment-specific FHB scores or BLUE values were detected, which included 323 SSR alleles. For FHB incidence and FHB severity a total of 861 and 877 individual marker-trait associations (MTA) were detected, respectively. Associations for both traits co-located with FHB score in most cases. Consistent associations detected in three or more environments were found on all chromosomes except chromosome 6B, and with the highest number of MTA on chromosome 5B. The dependence of the number of favourable and unfavourable alleles within a variety to the respective FHB scores indicated an additive effect of favourable and unfavourable alleles, i.e. genotypes with more favourable or less unfavourable alleles tended to show greater resistance to FHB. Assessment of a marker specific for the dwarfing gene Rht-D1 resulted in strong effects. The results provide a prerequisite for designing genome wide breeding strategies for FHB resistance.	[Kollers, Sonja; Ling, Jie; Roeder, Marion S.] Leibniz Inst Plant Genet & Crop Plant Resesarch I, Gatersleben, Germany; [Rodemann, Bernd] JKI, Braunschweig, Germany; [Kollers, Sonja; Korzun, Viktor; Ebmeyer, Erhard] KWS LOCHOW GMBH, Bergen, Germany; [Argillier, Odile] Syngenta Seeds SAS, Toulouse, France; [Hinze, Maike] Syngenta Seeds GmbH, Bad Salzuflen, Germany; [Plieske, Joerg; Kulosa, Dagmar; Ganal, Martin W.] TraitGenetics GmbH, Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Julius Kuhn-Institut; KWS Saat AG; Syngenta; Syngenta	Roder, MS (corresponding author), Leibniz Inst Plant Genet & Crop Plant Resesarch I, Gatersleben, Germany.	roder@ipk-gatersleben.de	Korzun, Viktor/U-6352-2019	Korzun, Viktor/0000-0003-0760-8249; Roder, Marion/0000-0002-9313-0650; Ling, Jie/0000-0001-7054-5119	project GABI-Wheat [0315067]; German Federal Ministry of Education and Research (BMBF)	project GABI-Wheat; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was conducted within the frame of the project GABI-Wheat (project No. 0315067) funded by the German Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Anderson JA, 2001, THEOR APPL GENET, V102, P1164, DOI 10.1007/s001220000509; Anderson JA, 2007, CROP SCI, V47, pS112, DOI 10.2135/cropsci2007.04.0006IPBS; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bonin CM, 2009, CROP SCI, V49, P1304, DOI 10.2135/cropsci2008.08.0459; Bordes J, 2011, J CEREAL SCI, V54, P137, DOI 10.1016/j.jcs.2011.03.004; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Buerstmayr H, 2003, THEOR APPL GENET, V107, P503, DOI 10.1007/s00122-003-1272-6; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Chao SM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-727; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Draeger R, 2007, THEOR APPL GENET, V115, P617, DOI 10.1007/s00122-007-0592-3; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Haberle J, 2009, THEOR APPL GENET, V119, P325, DOI 10.1007/s00122-009-1041-2; Hamblin MT, 2011, TRENDS GENET, V27, P98, DOI 10.1016/j.tig.2010.12.003; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Holzapfel J, 2008, THEOR APPL GENET, V117, P1119, DOI 10.1007/s00122-008-0850-z; Jayatilake D, 2011, THEOR APPL GENET, V122, P1189, DOI 10.1007/s00122-010-1523-2; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kulwal P, 2012, THEOR APPL GENET, V125, P793, DOI 10.1007/s00122-012-1872-0; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Le Couviour F, 2011, THEOR APPL GENET, V123, P715, DOI 10.1007/s00122-011-1621-9; Le Gouis J, 2012, THEOR APPL GENET, V124, P597, DOI 10.1007/s00122-011-1732-3; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Loffler M, 2009, MOL BREEDING, V23, P473, DOI 10.1007/s11032-008-9250-y; Ma HX, 2006, PHYTOPATHOLOGY, V96, P534, DOI 10.1094/PHYTO-96-0534; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Mardi M, 2006, PLANT BREEDING, V125, P313, DOI 10.1111/j.1439-0523.2006.01228.x; Massman J, 2011, MOL BREEDING, V27, P439, DOI 10.1007/s11032-010-9442-0; Matthies IE, 2012, MOL BREEDING, V30, P951, DOI 10.1007/s11032-011-9678-3; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2008, CROP SCI, V48, P2115, DOI 10.2135/cropsci2008.02.0107; Miedaner T, 2006, THEOR APPL GENET, V112, P562, DOI 10.1007/s00122-005-0163-4; Miedaner T, 2012, MOL BREEDING, V29, P731, DOI 10.1007/s11032-011-9586-6; Miedaner T, 2011, MOL BREEDING, V28, P647, DOI 10.1007/s11032-010-9516-z; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Paillard S, 2004, THEOR APPL GENET, V109, P323, DOI 10.1007/s00122-004-1628-6; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2011, THEOR APPL GENET, V123, P283, DOI 10.1007/s00122-011-1583-y; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Salameh A, 2011, MOL BREEDING, V28, P485, DOI 10.1007/s11032-010-9498-x; Schmolke M, 2005, THEOR APPL GENET, V111, P747, DOI 10.1007/s00122-005-2060-2; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Srinivasachary, 2008, THEOR APPL GENET, V116, P1145, DOI 10.1007/s00122-008-0742-2; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Steed A, 2005, THEOR APPL GENET, V111, P521, DOI 10.1007/s00122-005-2043-3; Steiner B, 2004, THEOR APPL GENET, V109, P215, DOI 10.1007/s00122-004-1620-1; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wilde F, 2008, THEOR APPL GENET, V117, P29, DOI 10.1007/s00122-008-0749-8; WRIGHT S, 1978, EVOLUTION GENETICS P, V4, P91; Yang ZP, 2005, GENOME, V48, P187, DOI [10.1139/G04-104, 10.1139/g04-104]; Yu LX, 2012, THEOR APPL GENET, V125, P749, DOI 10.1007/s00122-012-1867-x; Yu LX, 2011, THEOR APPL GENET, V123, P1257, DOI 10.1007/s00122-011-1664-y	60	114	120	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57500	10.1371/journal.pone.0057500	http://dx.doi.org/10.1371/journal.pone.0057500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451238	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800110
J	Reinwald, M; Buchheidt, D; Hummel, M; Duerken, M; Bertz, H; Schwerdtfeger, R; Reuter, S; Kiehl, MG; Barreto-Miranda, M; Hofmann, WK; Spiess, B				Reinwald, Mark; Buchheidt, Dieter; Hummel, Margit; Duerken, Matthias; Bertz, Hartmut; Schwerdtfeger, Rainer; Reuter, Stefan; Kiehl, Michael G.; Barreto-Miranda, Manuel; Hofmann, Wolf-Karsten; Spiess, Birgit			Diagnostic Performance of an Aspergillus-Specific Nested PCR Assay in Cerebrospinal Fluid Samples of Immunocompromised Patients for Detection of Central Nervous System Aspergillosis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BRONCHOALVEOLAR LAVAGE SAMPLES; REAL-TIME PCR; INVASIVE ASPERGILLOSIS; CEREBRAL-ASPERGILLOSIS; FUNGAL-INFECTIONS; GALACTOMANNAN; VORICONAZOLE; MENINGITIS; MANAGEMENT	Central nervous system (CNS) invasive aspergillosis (IA) is a fatal complication in immunocompromised patients. Confirming the diagnosis is rarely accomplished as invasive procedures are impaired by neutropenia and low platelet count. Cerebrospinal fluid (CSF) cultures or galactomannan (GM) regularly yield negative results thus suggesting the need for improving diagnostic procedures. Therefore the performance of an established Aspergillus-specific nested polymerase chain reaction assay (PCR) in CSF samples of immunocompromised patients with suspicion of CNS IA was evaluated. We identified 113 CSF samples from 55 immunocompromised patients for whom CNS aspergillosis was suspected. Of these patients 8/55 were identified as having proven/probable CNS IA while the remaining 47 patients were classified as having either possible (n = 22) or no CNS IA (n = 25). PCR positivity in CSF was observed for 8/8 proven/probable, in 4/22 possible CNS IA patients and in 2/25 NoIA patients yielding sensitivity and specificity values of 1.0 (95% CI 0.68-1) and 0.93 (95% CI 0.77-0.98) and a positive likelihood ratio of 14 and negative likelihood ratio of 0.0, respectively, thus resulting in a diagnostic odds ratio of infinity. The retrospective analysis of CSF samples from patients with suspected CNS IA yielded a high sensitivity of the nested PCR assay. PCR testing of CSF samples is recommended for patients for whom CNS IA is suspected, especially for those whose clinical condition does not allow invasive procedures as a positive PCR result makes the presence of CNS IA in that patient population highly likely.	[Reinwald, Mark; Buchheidt, Dieter; Hummel, Margit; Barreto-Miranda, Manuel; Hofmann, Wolf-Karsten; Spiess, Birgit] Heidelberg Univ, Dept Hematol & Oncol, Mannheim Univ Hosp, Mannheim, Germany; [Duerken, Matthias] Heidelberg Univ, Dept Pediat, Mannheim Univ Hosp, Mannheim, Germany; [Bertz, Hartmut] Heidelberg Univ, Freiburg Univ Hosp, Mannheim, Germany; [Schwerdtfeger, Rainer] Bone Marrow Transplantat Ctr Wiesbaden, Wiesbaden, Germany; [Reuter, Stefan] Univ Ulm, Ulm Univ Hosp, D-89069 Ulm, Germany; [Kiehl, Michael G.] Frankfurt Oder Gen Hosp, Frankfurt, Oder, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University	Buchheidt, D (corresponding author), Heidelberg Univ, Dept Hematol & Oncol, Mannheim Univ Hosp, Mannheim, Germany.	dieter.buchheidt@umm.de		Buchheidt, Dieter/0000-0002-4425-6134; Barreto Miranda, Manuel/0000-0003-2435-1326; Reinwald, Mark/0000-0002-6506-2136	Faculty of Medicine, Mannheim, University of Heidelberg	Faculty of Medicine, Mannheim, University of Heidelberg	The study was supported by internal funding of the Faculty of Medicine, Mannheim, University of Heidelberg. The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiee P, 2011, ARCH IRAN MED, V14, P381, DOI 011146/AIM.005; Boes B, 1994, J Neuroimaging, V4, P123; Buchheidt D, 2002, BRIT J HAEMATOL, V116, P803, DOI 10.1046/j.0007-1048.2002.03337.x; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Finelli PF, 2010, NEUROLOGIST, V16, P364, DOI 10.1097/NRL.0b013e3181b47001; Hori A, 2002, J HOSP INFECT, V50, P175, DOI 10.1053/jhin.2001.1170; Howard SC, 2000, JAMA-J AM MED ASSOC, V284, P2222, DOI 10.1001/jama.284.17.2222; Hummel M, 2006, J CLIN MICROBIOL, V44, P3989, DOI 10.1128/JCM.00466-06; Kami M, 1999, BRIT J HAEMATOL, V106, P536, DOI 10.1046/j.1365-2141.1999.01542.x; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Marchetti O, 2011, BONE MARROW TRANSPLA; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Mennink-Kersten MASH, 2004, LANCET INFECT DIS, V4, P349, DOI 10.1016/S1473-3099(04)01045-X; Morton CO, 2011, J MED MICROBIOL, V60, P913, DOI 10.1099/jmm.0.028399-0; Offiah CE, 2006, CLIN RADIOL, V61, P393, DOI 10.1016/j.crad.2006.01.008; Ruhnke M, 2012, ANN ONCOL, V23, P823, DOI 10.1093/annonc/mdr407; Schmidt-Hieber M, 2009, LEUKEMIA LYMPHOMA, V50, P24, DOI 10.1080/10428190802517740; Schwartz S, 2005, BLOOD, V106, P2641, DOI 10.1182/blood-2005-02-0733; Schwartz S, 2011, INFECTION, V39, P201, DOI 10.1007/s15010-011-0108-6; Skladny H, 1999, J CLIN MICROBIOL, V37, P3865, DOI 10.1128/JCM.37.12.3865-3871.1999; Steinbach WJ, 2003, CLIN INFECT DIS, V37, pS188, DOI 10.1086/376524; Tuon Felipe Francisco, 2007, Revista Iberoamericana de Micologia, V24, P89; Verweij PE, 1999, J CLIN MICROBIOL, V37, P1186, DOI 10.1128/JCM.37.4.1186-1189.1999; Viscoli C, 2002, J CLIN MICROBIOL, V40, P1496, DOI 10.1128/JCM.40.4.1496-1499.2002	24	45	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56706	10.1371/journal.pone.0056706	http://dx.doi.org/10.1371/journal.pone.0056706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451071	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800028
J	Voulgaridou, GP; Mantso, T; Chlichlia, K; Panayiotidis, MI; Pappa, A				Voulgaridou, Georgia-Persephoni; Mantso, Theodora; Chlichlia, Katerina; Panayiotidis, Mihalis I.; Pappa, Aglaia			Efficient E. coli Expression Strategies for Production of Soluble Human Crystallin ALDH3A1	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; HIGH-LEVEL PRODUCTION; ESCHERICHIA-COLI; ALDEHYDE DEHYDROGENASES; PROTEIN EXPRESSION; OXIDATIVE DAMAGE; PURIFICATION; AUTOINDUCTION; COEXPRESSION; CHAPERONES	Aldehyde dehydrogenase 3A1 (ALDH3A1) is a recently characterized corneal crystallin with its exact functions still being unclear. Expressing recombinant human ALDH3A1 has been difficult in Escherichia coli (E. coli) because of low solubility, yield and insufficient purity issues. In this report, we compared different E. coli expression strategies (namely the maltose binding protein; MBP- and the 6-his-tagged expression systems) under conditions of auto-induction and co-expression with E. coli's molecular chaperones where appropriate. Thus, we aimed to screen the efficiency of these expression strategies in order to improve solubility of recombinant ALDH3A1 when expressed in E. coli. We showed that the MBP- tagged expression in combination with lower-temperature culture conditions resulted in active soluble recombinant ALDH3A1. Expression of the fused 6-his tagged-ALDH3A1 protein resulted in poor solubility and neither lowering temperature culture conditions nor the auto-induction strategy improved its solubility. Furthermore, higher yield of soluble, active native form of 6-his tagged-ALDH3A1 was facilitated through co-expression of the two groups of E. coli's molecular chaperones, GroES/GroEL and DnaK/DnaJ/GrpE. Convenient one step immobilized affinity chromatography methods were utilized to purify the fused ALDH3A1 hybrids. Both fusion proteins retained their biological activity and could be used directly without removing the fusion tags. Taken together, our results provide a rational option for producing sufficient amounts of soluble and active recombinant ALDH3A1 using the E. coli expression system for conducting functional studies towards elucidating the biological role(s) of this interesting corneal crystallin.	[Voulgaridou, Georgia-Persephoni; Mantso, Theodora; Chlichlia, Katerina; Pappa, Aglaia] Democritus Univ Thrace, Dept Mol Biol & Genet, Dragana, Alexandroupolis, Greece; [Panayiotidis, Mihalis I.] Univ Ioannina, Sch Med, Anat Pathol Lab, GR-45110 Ioannina, Greece	Democritus University of Thrace; University of Ioannina	Pappa, A (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Univ Campus, Dragana, Alexandroupolis, Greece.	apappa@mbg.duth.gr	Panagiotidis, Mihalis/AAG-6274-2020; Pappa, Aglaia/E-8663-2011; Chlichlia, Katerina/Q-3948-2019; Voulgaridou, Georgia/AAB-5203-2021; Pappa, Aglaia/P-4663-2019	Panagiotidis, Mihalis/0000-0002-1450-3552; Voulgaridou, Georgia/0000-0003-0173-8560; Pappa, Aglaia/0000-0003-0913-4315; Panagiotidis, Mihalis/0000-0002-1130-5972; Chlichlia, Katerina/0000-0003-4952-0675	European Union (European Social Fund-ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	European Union (European Social Fund-ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	This research has been co-financed by the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton SJ, 1999, PHOTOCHEM PHOTOBIOL, V70, P823, DOI 10.1111/j.1751-1097.1999.tb08289.x; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Black W, 2012, FREE RADICAL BIO MED, V52, P1937, DOI 10.1016/j.freeradbiomed.2012.02.050; Bunting KD, 1996, J BIOL CHEM, V271, P11891, DOI 10.1074/jbc.271.20.11891; Choi MS, 2010, BIOCHEM BIOPH RES CO, V393, P509, DOI 10.1016/j.bbrc.2010.02.036; Chou CP, 2007, APPL MICROBIOL BIOT, V76, P521, DOI 10.1007/s00253-007-1039-0; de Marco A, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-32; Estey T, 2007, J BIOL CHEM, V282, P4382, DOI 10.1074/jbc.M607546200; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; Georgiou G, 1996, CURR OPIN BIOTECH, V7, P190, DOI 10.1016/S0958-1669(96)80012-7; Goenka S, 2001, PROTEIN EXPRES PURIF, V21, P260, DOI 10.1006/prep.2000.1359; Guo WH, 2011, PROTEIN EXPRES PURIF, V77, P185, DOI 10.1016/j.pep.2011.01.015; Harnois T, 2009, ARTIF CELL BLOOD SUB, V37, P106, DOI 10.1080/10731190902908445; HARTL FU, 1995, CURR OPIN STRUC BIOL, V5, P92; Islam RS, 2007, BIOTECHNOL PROGR, V23, P785, DOI 10.1021/bp070059a; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Lu ZS, 2010, PROTEIN EXPRES PURIF, V74, P217, DOI 10.1016/j.pep.2010.06.010; Ma N, 2012, PROTEIN EXPRES PURIF, V82, P263, DOI 10.1016/j.pep.2012.01.013; Nishi K, 2010, PROTEIN EXPRES PURIF, V69, P34, DOI 10.1016/j.pep.2009.09.013; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Oganesyan N, 2007, PROTEIN EXPRES PURIF, V52, P280, DOI 10.1016/j.pep.2006.09.015; Pappa A, 2005, J BIOL CHEM, V280, P27998, DOI 10.1074/jbc.M503698200; Pappa A, 2003, BIOCHEM J, V376, P615, DOI 10.1042/BJ20030810; Pappa A, 2003, FREE RADICAL BIO MED, V34, P1178, DOI 10.1016/S0891-5849(03)00070-4; Pappa A, 2001, CHEM-BIOL INTERACT, V130, P181, DOI 10.1016/S0009-2797(00)00233-7; Piatigorsky J, 2000, J OCUL PHARMACOL TH, V16, P173, DOI 10.1089/jop.2000.16.173; Piatigorsky J, 2001, CORNEA, V20, P853, DOI 10.1097/00003226-200111000-00015; Ray M, 2012, J BIOTECHNOL, V157, P12, DOI 10.1016/j.jbiotec.2011.09.022; Renner JN, 2011, PROTEIN EXPR PURIF; Sahdev S, 2008, MOL CELL BIOCHEM, V307, P249, DOI 10.1007/s11010-007-9603-6; Sahu SK, 2009, BIOTECHNOL LETT, V31, P1745, DOI 10.1007/s10529-009-0073-7; Semba H, 2010, METHODS MOL BIOL, V643, P133, DOI 10.1007/978-1-60761-723-5_10; Siurkus J, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-65; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tait AR, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-51; Tu W, 2009, PROTEIN EXPRES PURIF, V67, P169, DOI 10.1016/j.pep.2009.05.005; Uma L, 1996, EXP EYE RES, V63, P117, DOI 10.1006/exer.1996.0098; Wang XL, 2010, PROTEIN EXPRES PURIF, V71, P179, DOI 10.1016/j.pep.2010.01.011; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu SJ, 2009, PROTEIN EXPRES PURIF, V68, P49, DOI 10.1016/j.pep.2009.06.009	42	24	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56582	10.1371/journal.pone.0056582	http://dx.doi.org/10.1371/journal.pone.0056582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451057	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800019
J	Zucchi, FCR; Yao, YL; Ward, ID; Ilnytskyy, Y; Olson, DM; Benzies, K; Kovalchuk, I; Kovalchuk, O; Metz, GAS				Zucchi, Fabiola C. R.; Yao, Youli; Ward, Isaac D.; Ilnytskyy, Yaroslav; Olson, David M.; Benzies, Karen; Kovalchuk, Igor; Kovalchuk, Olga; Metz, Gerlinde A. S.			Maternal Stress Induces Epigenetic Signatures of Psychiatric and Neurological Diseases in the Offspring	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PRENATAL STRESS; MICRORNA EXPRESSION; GENE-EXPRESSION; MULTIPLE-SCLEROSIS; PROTEIN; RAT; GLUCOCORTICOIDS; MOUSE; SCHIZOPHRENIA	The gestational state is a period of particular vulnerability to diseases that affect maternal and fetal health. Stress during gestation may represent a powerful influence on maternal mental health and offspring brain plasticity and development. Here we show that the fetal transcriptome, through microRNA (miRNA) regulation, responds to prenatal stress in association with epigenetic signatures of psychiatric and neurological diseases. Pregnant Long-Evans rats were assigned to stress from gestational days 12 to 18 while others served as handled controls. Gestational stress in the dam disrupted parturient maternal behaviour and was accompanied by characteristic brain miRNA profiles in the mother and her offspring, and altered transcriptomic brain profiles in the offspring. In the offspring brains, prenatal stress upregulated miR-103, which is involved in brain pathologies, and downregulated its potential gene target Ptplb. Prenatal stress downregulated miR-145, a marker of multiple sclerosis in humans. Prenatal stress also upregulated miR-323 and miR-98, which may alter inflammatory responses in the brain. Furthermore, prenatal stress upregulated miR-219, which targets the gene Dazap1. Both miR-219 and Dazap1 are putative markers of schizophrenia and bipolar affective disorder in humans. Offspring transcriptomic changes included genes related to development, axonal guidance and neuropathology. These findings indicate that prenatal stress modifies epigenetic signatures linked to disease during critical periods of fetal brain development. These observations provide a new mechanistic association between environmental and genetic risk factors in psychiatric and neurological disease.	[Zucchi, Fabiola C. R.; Yao, Youli; Ward, Isaac D.; Metz, Gerlinde A. S.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Zucchi, Fabiola C. R.] Univ Mato Grosso State, Dept Biol Sci, Caceres, MG, Brazil; [Yao, Youli; Ilnytskyy, Yaroslav; Kovalchuk, Igor; Kovalchuk, Olga] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Olson, David M.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Olson, David M.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Benzies, Karen] Univ Calgary, Fac Nursing, Calgary, AB, Canada	University of Lethbridge; Universidade Estadual de Mato Grosso do Sul; University of Lethbridge; University of Alberta; University of Alberta; University of Alberta; University of Calgary	Metz, GAS (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca	Benzies, Karen/E-1452-2016; Zucchi, Fabiola/K-1296-2017	Benzies, Karen/0000-0002-9090-2395; Zucchi, Fabiola/0000-0002-2252-613X; Metz, Gerlinde/0000-0002-5801-7716	Alberta Innovates-Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant [200700595]; Canadian Institutes of Health Research; Hotchkiss Brain Institute; Norlien Foundation	Alberta Innovates-Health Solutions (AI-HS); Preterm Birth and Healthy Outcomes; AI-HS Interdisciplinary Team Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hotchkiss Brain Institute; Norlien Foundation	This research was supported by Alberta Innovates-Health Solutions (AI-HS; FZ and GM), Preterm Birth and Healthy Outcomes funded by the AI-HS Interdisciplinary Team Grant #200700595 (DMO, KB and GM), the Canadian Institutes of Health Research (GM), Hotchkiss Brain Institute (FZ), and the Norlien Foundation (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikmese B, 2012, BEHAV PHARMACOL, V23, P215, DOI 10.1097/FBP.0b013e3283512c6d; Aisa B, 2009, PSYCHONEUROENDOCRINO, V34, P1495, DOI 10.1016/j.psyneuen.2009.05.003; Andersson L, 2004, AM J EPIDEMIOL, V159, P872, DOI 10.1093/aje/kwh122; Babenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029441; Babenko O, 2012, BRAIN RES, V1444, P96, DOI 10.1016/j.brainres.2012.01.038; Bell JT, 2012, INT J EPIDEMIOL, V41, P140, DOI 10.1093/ije/dyr179; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; Boksa P, 2008, J PSYCHIATR NEUROSCI, V33, P183; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buss C, 2010, PSYCHONEUROENDOCRINO, V35, P141, DOI 10.1016/j.psyneuen.2009.07.010; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Cohen JE, 2011, P NATL ACAD SCI USA, V108, P11650, DOI 10.1073/pnas.1017576108; Connolly M, 2011, ARTHRITIS RHEUM-US, V63, pS654; Corcoran C, 2009, SCHIZOPHRENIA BULL, V35, P596, DOI 10.1093/schbul/sbn089; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Dave RS, 2010, J CELL BIOCHEM, V110, P834, DOI 10.1002/jcb.22592; de Rooij SR, 2012, EARLY HUM DEV, V88, P321, DOI 10.1016/j.earlhumdev.2011.09.002; de Weerth C, 2005, NEUROSCI BIOBEHAV R, V29, P207, DOI 10.1016/j.neubiorev.2004.10.011; DENENBER.VH, 1969, BEHAVIOUR, V34, P1, DOI 10.1163/156853969X00369; Dinan TG, 2010, INT J NEUROPSYCHOPH, V13, P395, DOI 10.1017/S1461145709990800; Diz-Chaves Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-71; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellenbogen MA, 2011, J AFFECT DISORDERS, V132, P265, DOI 10.1016/j.jad.2011.01.007; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Fitzpatrick CJ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00047; Frankfurt M, 2011, SYNAPSE, V65, P955, DOI 10.1002/syn.20918; Gardiner E, 2012, MOL PSYCHIATR, V17, P827, DOI 10.1038/mp.2011.78; Goyal R, 2011, REPROD SCI, V18, P180, DOI 10.1177/1933719110385134; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Ilnytskyy Y, 2008, BIOCHEM BIOPH RES CO, V377, P41, DOI 10.1016/j.bbrc.2008.09.080; Kaminsky Z, 2008, TWIN RES HUM GENET, V11, P1, DOI 10.1375/twin.11.1.1; Keller A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007440; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kinnunen AK, 2003, J NEUROCHEM, V86, P736, DOI 10.1046/j.1471-4159.2003.01873.x; Kirkland SW, 2008, BRAIN RES, V1201, P151, DOI 10.1016/j.brainres.2008.01.032; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kovalchuk I, 2007, MUTAT RES-FUND MOL M, V624, P101, DOI 10.1016/j.mrfmmm.2007.04.009; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lenroot RK, 2009, HUM BRAIN MAPP, V30, P163, DOI 10.1002/hbm.20494; Lim SH, 2009, EMBO J, V28, P3564, DOI 10.1038/emboj.2009.289; Lindsay DG, 2005, NUTR RES REV, V18, P249, DOI 10.1079/NRR2005110; Liu Y, 2011, FEBS LETT, V585, P1963, DOI 10.1016/j.febslet.2011.05.029; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Markham JA, 2011, PSYCHOPHARMACOLOGY, V214, P89, DOI 10.1007/s00213-010-2035-0; Matrisciano F, 2012, NEUROPSYCHOPHARMACOL, V37, P929, DOI 10.1038/npp.2011.274; Matthews SG, 2012, EXP NEUROL, V233, P95, DOI 10.1016/j.expneurol.2011.01.009; Meaney MJ, 2010, NAT NEUROSCI, V13, P1313, DOI 10.1038/nn1110-1313; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Merlot E, 2008, BRAIN BEHAV IMMUN, V22, P42, DOI 10.1016/j.bbi.2007.05.007; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GAS, 2001, PHYSIOL BEHAV, V72, P29, DOI 10.1016/S0031-9384(00)00371-1; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Migicovsky Zoe, 2011, Frontiers in Genetics, V2, P28, DOI 10.3389/fgene.2011.00028; Miller SM, 2011, BRAIN RES BULL, V86, P60, DOI 10.1016/j.brainresbull.2011.05.013; Mody N, 2011, DIABETOLOGIA, V54, P2143, DOI 10.1007/s00125-011-2160-2; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Munk-Olsen T, 2011, ARCH GEN PSYCHIAT; Nelson EE, 1998, NEUROSCI BIOBEHAV R, V22, P437, DOI 10.1016/S0149-7634(97)00052-3; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; Ostiguy CS, 2011, PSYCHOL MED, V41, P2447, DOI 10.1017/S0033291711000523; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Owen D, 2005, NEUROSCI BIOBEHAV R, V29, P209, DOI 10.1016/j.neubiorev.2004.10.004; Pandis I, 2012, ANN RHEUM DIS, V71, P1716, DOI 10.1136/annrheumdis-2011-200803; Pereira M, 2011, J NEUROENDOCRINOL, V23, P1020, DOI 10.1111/j.1365-2826.2011.02200.x; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pogribny IP, 2007, TOXICOL APPL PHARM, V225, P61, DOI 10.1016/j.taap.2007.07.001; Pogribny IP, 2007, MUTAT RES-FUND MOL M, V619, P30, DOI 10.1016/j.mrfmmm.2006.12.006; Rassoulzadegan M, 2007, BIOCHEM SOC T, V35, P623, DOI 10.1042/BST0350623; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schulz H., 1888, PFLUGERS ARCH GES PH, V42, P517, DOI DOI 10.1007/BF01669373; Schulz LC, 2010, P NATL ACAD SCI USA, V107, P16757, DOI 10.1073/pnas.1012911107; Seckl JR, 2006, ANN NY ACAD SCI, V1071, P351, DOI 10.1196/annals.1364.027; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Takahashi N, 2011, BIOL PSYCHIAT, V70, P626, DOI 10.1016/j.biopsych.2011.06.016; Thamilarasan M, 2012, AUTOIMMUN REV, V11, P174, DOI 10.1016/j.autrev.2011.05.009; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; van Hasselt FN, 2012, HIPPOCAMPUS, V22, P255, DOI 10.1002/hipo.20892; Voineskos AN, 2011, ARCH GEN PSYCHIAT, V68, P198, DOI 10.1001/archgenpsychiatry.2010.194; Vyas A, 2002, J NEUROSCI, V22, P6810; Ward ID, BMC PREGNAN IN PRESS; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Whishaw IQ, 2001, DEV PSYCHOBIOL, V39, P151, DOI 10.1002/dev.1041; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546; Yehuda R, 2008, J PSYCHIATR RES, V42, P1104, DOI 10.1016/j.jpsychires.2008.01.002; Yehuda R, 2009, PSYCHONEUROENDOCRINO, V34, P1304, DOI 10.1016/j.psyneuen.2009.03.018; Yorty JL, 2004, AM J PHYSIOL-REG I, V287, pR1316, DOI 10.1152/ajpregu.00685.2003; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096; Zucchi FCR, 2009, BEHAV BRAIN RES, V205, P67, DOI 10.1016/j.bbr.2009.06.030	100	126	130	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56967	10.1371/journal.pone.0056967	http://dx.doi.org/10.1371/journal.pone.0056967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451123	Green Submitted, gold, Green Published			2022-12-25	WOS:000316658800056
J	Brown, NJ; Higham, SE; Perunovic, B; Arafa, M; Balasubramanian, S; Rehman, I				Brown, Nicola J.; Higham, Sue E.; Perunovic, Branko; Arafa, Mohammad; Balasubramanian, Sabapathy; Rehman, Ishtiaq			Lactate Dehydrogenase-B Is Silenced by Promoter Methylation in a High Frequency of Human Breast Cancers	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; STROMAL CELLS; HYPOXIA; HYPERMETHYLATION; METASTASIS; INHIBITION; GLYCOLYSIS; CARCINOMAS; ISOZYMES; PATHWAY	Objective: Under normoxia, non-malignant cells rely on oxidative phosphorylation for their ATP production, whereas cancer cells rely on Glycolysis; a phenomenon known as the Warburg effect. We aimed to elucidate the mechanisms contributing to the Warburg effect in human breast cancer. Experimental design: Lactate Dehydrogenase (LDH) isoenzymes were profiled using zymography. LDH-B subunit expression was assessed by reverse transcription PCR in cells, and by Immunohistochemistry in breast tissues. LDH-B promoter methylation was assessed by sequencing bisulfite modified DNA. Results: Absent or decreased expression of LDH isoenzymes 1-4, were seen in T-47D and MCF7 cells. Absence of LDH-B mRNA was seen in T-47D cells, and its expression was restored following treatment with the demethylating agent 5'Azacytadine. LDH-B promoter methylation was identified in T-47D and MCF7 cells, and in 25/ 25 cases of breast cancer tissues, but not in 5/ 5 cases of normal breast tissues. Absent immuno-expression of LDH-B protein (<10% cells stained), was seen in 23/ 26 (88%) breast cancer cases, and in 4/8 cases of adjacent ductal carcinoma in situ lesions. Exposure of breast cancer cells to hypoxia (1% O-2), for 48 hours resulted in significant increases in lactate levels in both MCF7 (14.0 fold, p = 0.002), and T-47D cells (2.9 fold, p = 0.009), but not in MDA-MB-436 (-0.9 fold, p = 0.229), or MCF10AT (1.2 fold, p = 0.09) cells. Conclusions: Loss of LDH-B expression is an early and frequent event in human breast cancer occurring due to promoter methylation, and is likely to contribute to an enhanced glycolysis of cancer cells under hypoxia.	[Brown, Nicola J.; Higham, Sue E.; Balasubramanian, Sabapathy] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Perunovic, Branko; Arafa, Mohammad] Royal Hallamshire Hosp, Dept Histopathol, Sheffield S10 2JF, S Yorkshire, England; [Rehman, Ishtiaq] Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Rehman, I (corresponding author), Univ Sheffield, Sch Med, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England.	i.rehman@sheffield.ac.uk	Perunovic, Branko/R-5570-2019; balasubramanian, saba prakash/H-2830-2019	balasubramanian, saba prakash/0000-0001-5953-2843; Brown, Nicola/0000-0002-2100-1905	Sheffield Breast Cancer [X/001592]	Sheffield Breast Cancer	Sheffield Breast Cancer support group funding to NJB is acknowledged (Grant code X/001592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antone PD, 2012, MED HYPOTHESES, V79, P388, DOI 10.1016/j.mehy.2012.06.002; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Biswas S, 2012, CANC METASTASIS REV; BURKE RE, 1978, CANCER RES, V38, P2773; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Dhup S, 2012, CURR PHARM DESIGN, V18, P1319, DOI 10.2174/138161212799504902; Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kolev Y, 2008, ANN SURG ONCOL, V15, P2336, DOI 10.1245/s10434-008-9955-5; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Koukourakis MI, 2003, TUMOR BIOL, V24, P199, DOI 10.1159/000074430; Koukourakis MI, 2005, CLIN EXP METASTAS, V22, P25, DOI 10.1007/s10585-005-2343-7; Koukourakis MI, 2009, GYNECOL OBSTET INVES, V67, P162, DOI 10.1159/000183250; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Leiblich A, 2006, ONCOGENE, V25, P2953, DOI 10.1038/sj.onc.1209262; Liao AC, 2011, PATHOLOGY, V43, P707, DOI 10.1097/PAT.0b013e32834bf67a; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; Maekawa M, 2003, CLIN CHEM, V49, P1518, DOI 10.1373/49.9.1518; MARKERT CL, 1963, SCIENCE, V140, P1329, DOI 10.1126/science.140.3573.1329; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Montcourrier P, 1997, CLIN EXP METASTAS, V15, P382, DOI 10.1023/A:1018446104071; Ong ES, 2010, MOL CELL PROTEOMICS, P1, DOI DOI 10.1074/MCP.M900551-MCP200; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Rehman I, 1996, ONCOGENE, V12, P2483; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Tsoi SCM, 2001, PLACENTA, V22, P317, DOI 10.1053/plac.2000.0620; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang ZY, 2012, BREAST CANCER RES TR, V131, P791, DOI 10.1007/s10549-011-1466-6; Ward RA, 2012, J MED CHEM, V55, P3285, DOI 10.1021/jm201734r; YOSHIKUNI K, 1986, ARCH DERMATOL, V122, P1420, DOI 10.1001/archderm.122.12.1420; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33; Zhou WD, 2012, ELECTROPHORESIS, V33, P1850, DOI 10.1002/elps.201200017	45	42	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57697	10.1371/journal.pone.0057697	http://dx.doi.org/10.1371/journal.pone.0057697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437403	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000315186000116
J	Othman, A; Ahmad, S; Megyerdi, S; Mussell, R; Choksi, K; Maddipati, KR; Elmarakby, A; Rizk, N; Al-Shabrawey, M				Othman, Amira; Ahmad, Saif; Megyerdi, Sylvia; Mussell, Rene; Choksi, Karishma; Maddipati, Krishna Rao; Elmarakby, Ahmed; Rizk, Nasser; Al-Shabrawey, Mohamed			12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; VASCULAR NAD(P)H OXIDASE; DIABETIC-RETINOPATHY; GROWTH-FACTOR; ADHESION MOLECULES; OXIDATIVE STRESS; ANGIOTENSIN-II; MOUSE MODEL; EXPRESSION; KINASE	The purpose of the current study was to evaluate the effect of 12/15-lipoxygenase (12/15-LOX) metabolites on retinal endothelial cell (REC) barrier function. FITC-dextran flux across the REC monolayers and electrical cell-substrate impedance sensing (ECIS) were used to evaluate the effect of 12- and 15-hydroxyeicosatetreanoic acids (HETE) on REC permeability and transcellular electrical resistance (TER). Effect of 12- or 15-HETE on the levels of zonula occludens protein 1 (ZO-1), reactive oxygen species (ROS), NOX2, pVEGF-R2 and pSHP1 was examined in the presence or absence of inhibitors of NADPH oxidase. In vivo studies were performed using Ins2(Akita) mice treated with or without the 12/15-LOX inhibitor baicalein. Levels of HETE and inflammatory mediators were examined by LC/MS and Multiplex Immunoassay respectively. ROS generation and NOX2 expression were also measured in mice retinas. 12- and 15-HETE significantly increased permeability and reduced TER and ZO-1expression in REC. VEGF-R2 inhibitor reduced the permeability effect of 12-HETE. Treatment of REC with HETE also increased ROS generation and expression of NOX2 and pVEGF-R2 and decreased pSHP1 expression. Treatment of diabetic mice with baicalein significantly decreased retinal HETE, ICAM-1, VCAM-1, IL-6, ROS generation, and NOX2 expression. Baicalein also reduced pVEGF-R2 while restored pSHP1 levels in diabetic retina. Our findings suggest that 12/15-LOX contributes to vascular hyperpermeability during DR via NADPH oxidase dependent mechanism which involves suppression of protein tyrosine phosphatase and activation of VEGF-R2 signal pathway.	[Othman, Amira; Megyerdi, Sylvia; Mussell, Rene; Choksi, Karishma; Elmarakby, Ahmed; Al-Shabrawey, Mohamed] GRU, Coll Dent Med, Dept Oral Biol Anat, Augusta, GA USA; [Othman, Amira; Al-Shabrawey, Mohamed] Mansoura Univ, Dept Anat, Mansoura, Egypt; [Ahmad, Saif; Al-Shabrawey, Mohamed] GRU, Med Coll Georgia, Dept Ophthalmol, Augusta, GA USA; [Ahmad, Saif; Al-Shabrawey, Mohamed] GRU, Med Coll Georgia, Vis Discovery Inst, Augusta, GA USA; [Maddipati, Krishna Rao] Wayne States Univ, Dept Pathol, Detroit, MI USA; [Elmarakby, Ahmed; Al-Shabrawey, Mohamed] GRU, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA; [Rizk, Nasser] Qatar Univ, Coll Sci, Dept Hlth Sci, Doha, Qatar	University System of Georgia; Augusta University; Egyptian Knowledge Bank (EKB); Mansoura University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Qatar University	Al-Shabrawey, M (corresponding author), GRU, Coll Dent Med, Dept Oral Biol Anat, Augusta, GA USA.	malshabrawey@gru.edu	Rizk, Nasser/AAE-4660-2022; Maddipati, Krishna Rao/H-3569-2019; Rizk, Nasser M/C-5174-2015; Maddipati, Krishna Rao/G-1859-2011; Elmarakby, Ahmed/ABF-5055-2021; Ahmad, Saif/K-5075-2013; Al-Shabrawey, Mohamed/P-9570-2018	Rizk, Nasser/0000-0002-6288-3609; Maddipati, Krishna Rao/0000-0003-1445-791X; Rizk, Nasser M/0000-0002-6288-3609; Maddipati, Krishna Rao/0000-0003-1445-791X; Othman, Amira/0000-0002-2437-8564; Al-Shabrawey, Mohamed/0000-0001-5362-7972; Rizk, Nasser/0000-0001-7629-1332	Qatar National Research Fund [NPRP 4 - 1046 - 3 " 284]; American Heart Association [AHA00104]; Vision Discovery Institute [VDI002010]; Bridge Fund from the Georgia Health Sciences University [BFP00018]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027926] Funding Source: NIH RePORTER	Qatar National Research Fund(Qatar National Research Fund (QNRF)); American Heart Association(American Heart Association); Vision Discovery Institute; Bridge Fund from the Georgia Health Sciences University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Qatar National Research Fund (NPRP 4 - 1046 - 3 " 284), American Heart Association (AHA00104) and Vision Discovery Institute (VDI002010) and Bridge Fund (BFP00018) from the Georgia Health Sciences University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Behzadian MA, 1998, GLIA, V24, P216, DOI 10.1002/(SICI)1098-1136(199810)24:2<216::AID-GLIA6>3.3.CO;2-D; Bhatia S, 2003, CLIN BIOCHEM, V36, P557, DOI 10.1016/S0009-9120(03)00094-8; Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P2301, DOI 10.1161/01.ATV.0000186181.19909.a6; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Cao RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002748; Chen WQ, 2003, INVEST OPHTH VIS SCI, V44, P5016, DOI 10.1167/iovs.03-0418; CHEN XS, 1994, J BIOL CHEM, V269, P13979; Cheung CMG, 2012, MOL VIS, V18, P830; Choi JA, 2008, FREE RADICAL BIO MED, V44, P624, DOI 10.1016/j.freeradbiomed.2007.10.041; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Cui LL, 2010, PHARMACOL BIOCHEM BE, V96, P469, DOI 10.1016/j.pbb.2010.07.007; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Endo A, 2003, J RECEPT SIG TRANSD, V23, P239, DOI 10.1081/RRS-120025567; Funk CD, 1996, J BIOL CHEM, V271, P23338, DOI 10.1074/jbc.271.38.23338; GAITS F, 1995, BIOCHEM J, V311, P97, DOI 10.1042/bj3110097; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Guo DQ, 2000, J BIOL CHEM, V275, P11216, DOI 10.1074/jbc.275.15.11216; Haneda M, 1997, DIABETES, V46, P847, DOI 10.2337/diabetes.46.5.847; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Inoguchi T, 2003, CURR MED CHEM, V10, P1759, DOI 10.2174/0929867033457133; Kang SW, 2003, J AM SOC NEPHROL, V14, P3178, DOI 10.1097/01.ASN.0000099702.16315.DE; Khalfaoui T, 2008, J MOL HISTOL, V39, P243, DOI 10.1007/s10735-007-9159-5; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Li JM, 2010, DIABETES, V59, P1528, DOI 10.2337/db09-1057; Ma J, 2005, PROSTAG LEUKOTR ESS, V72, P13, DOI 10.1016/j.plefa.2004.06.004; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Natarajan R, 2003, FRONT BIOSCI-LANDMRK, V8, pS783, DOI 10.2741/1144; NOZAWA K, 1990, AM J PHYSIOL, V259, pH1774, DOI 10.1152/ajpheart.1990.259.6.H1774; Rojas M, 2010, INVEST OPHTH VIS SCI, V51, P1709, DOI 10.1167/iovs.09-3375; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; Tabet F, 2008, CIRC RES, V103, P149, DOI 10.1161/CIRCRESAHA.108.178608; Talahalli R, 2010, INVEST OPHTH VIS SCI, V51, P1699, DOI 10.1167/iovs.09-3557; Tawfik A, 2009, INVEST OPHTH VIS SCI, V50, P878, DOI 10.1167/iovs.08-2005; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Wen YH, 2008, AM J PHYSIOL-HEART C, V294, pH1933, DOI 10.1152/ajpheart.00260.2007; Whittles CE, 2002, MICROCIRCULATION, V9, P513, DOI 10.1038/sj.mn.7800164; Woo CH, 2000, BIOCHEM J, V348, P525, DOI 10.1042/0264-6021:3480525; YAMAMOTO S, 1992, BIOCHIM BIOPHYS ACTA, V1128, P117, DOI 10.1016/0005-2760(92)90297-9; Yang LP, 2009, INVEST OPHTH VIS SCI, V50, P2319, DOI 10.1167/iovs.08-2642; Young BA, 2003, AM J PHYSIOL-LUNG C, V285, pL63, DOI 10.1152/ajplung.00423.2002; Zarbock A, 2009, J IMMUNOL, V183, P4715, DOI 10.4049/jimmunol.0802592	56	67	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57254	10.1371/journal.pone.0057254	http://dx.doi.org/10.1371/journal.pone.0057254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437353	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200231
J	Bronnum, H; Andersen, DC; Schneider, M; Sandberg, MB; Eskildsen, T; Nielsen, SB; Kalluri, R; Sheikh, SP				Bronnum, Hasse; Andersen, Ditte C.; Schneider, Mikael; Sandberg, Maria B.; Eskildsen, Tilde; Nielsen, Solveig B.; Kalluri, Raghu; Sheikh, Soren P.			miR-21 Promotes Fibrogenic Epithelial-to-Mesenchymal Transition of Epicardial Mesothelial Cells Involving Programmed Cell Death 4 and Sprouty-1	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; HEART-FAILURE; MICRORNA EXPRESSION; CARDIAC-HYPERTROPHY; PROGENITOR CELLS; DISEASE; PLASTICITY; CONTRIBUTE; FIBROSIS	The lining of the adult heart contains epicardial mesothelial cells (EMCs) that have the potential to undergo fibrogenic Epithelial-to-Mesenchymal Transition (EMT) during cardiac injury. EMT of EMCs has therefore been suggested to contribute to the heterogeneous fibroblast pool that mediates cardiac fibrosis. However, the molecular basis of this process is poorly understood. Recently, microRNAs (miRNAs) have been shown to regulate a number of sub-cellular events in cardiac disease. Hence, we hypothesized that miRNAs regulate fibrogenic EMT in the adult heart. Indeed pro-fibrogenic stimuli, especially TGF-beta, promoted EMT progression in EMC cultures, which resulted in differential expression of numerous miRNAs, especially the pleiotropic miR-21. Accordingly, ectopic expression of miR-21 substantially promoted the fibroblast-like phenotype arising from fibrogenic EMT, whereas an antagonist that targeted miR-21 blocked this effect, as assessed on the E-cadherin/alpha-smooth muscle actin balance, cell viability, matrix activity, and cell motility, thus making miR-21 a relevant target of EMC-derived fibrosis. Several mRNA targets of miR-21 was differentially regulated during fibrogenic EMT of EMCs and miR-21-dependent targeting of Programmed Cell Death 4 (PDCD4) and Sprouty Homolog 1 (SPRY1) significantly contributed to the development of a fibroblastoid phenotype. However, PDCD4- and SPRY1-targeting was not entirely ascribable to all phenotypic effects from miR-21, underscoring the pleiotropic biological role of miR-21 and the increasing number of recognized miR-21 targets.	[Bronnum, Hasse; Andersen, Ditte C.; Schneider, Mikael; Sandberg, Maria B.; Eskildsen, Tilde; Nielsen, Solveig B.; Sheikh, Soren P.] Univ So Denmark, Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Lab Mol & Cellular Cardiol, Odense, Denmark; [Bronnum, Hasse; Andersen, Ditte C.; Schneider, Mikael; Sandberg, Maria B.; Eskildsen, Tilde; Nielsen, Solveig B.; Sheikh, Soren P.] Univ So Denmark, Dept Cardiovasc & Renal Res, Odense, Denmark; [Bronnum, Hasse; Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Bronnum, Hasse; Kalluri, Raghu] Harvard Univ, Sch Med, Boston, MA USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Sheikh, SP (corresponding author), Univ So Denmark, Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Lab Mol & Cellular Cardiol, Odense, Denmark.	soeren.sheikh@ouh.regionsyddanmark.dk	Schneider, Mikael/GLN-7716-2022; Andersen, Ditte Caroline/AAA-8774-2021; Andersen, Ditte/P-4523-2014; Schneider, Mikael/AAC-2742-2019; Sandberg, Maria Boysen/AAE-6889-2019; Schneider, Mikael/C-2036-2008; Kalluri, Raghu/E-2677-2015	Schneider, Mikael/0000-0002-3379-0235; Andersen, Ditte Caroline/0000-0003-4940-7912; Andersen, Ditte/0000-0003-4940-7912; Schneider, Mikael/0000-0002-3379-0235; Kalluri, Raghu/0000-0002-2190-547X	Odense University Hospital; John and Birthe Meyer Foundation; King Chr. X Foundation; Danish Heart Association, National Institutes of Health [DK 55001]; Danish National Research Council [09-073648]; Lundbeck Foundation; Hertha Christensens Foundation; Eva and Henry Fraenkels Foundation; Danish Ministry of Science, Technology and Innovation	Odense University Hospital; John and Birthe Meyer Foundation; King Chr. X Foundation; Danish Heart Association, National Institutes of Health; Danish National Research Council(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Hertha Christensens Foundation; Eva and Henry Fraenkels Foundation; Danish Ministry of Science, Technology and Innovation	This work was supported by Odense University Hospital, The John and Birthe Meyer Foundation, The King Chr. X Foundation, The Danish Heart Association, National Institutes of Health DK 55001, The Danish National Research Council (#09-073648), The Lundbeck Foundation, Hertha Christensens Foundation, Eva and Henry Fraenkels Foundation, and The Danish Ministry of Science, Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bujak M, 2009, ARCH IMMUNOL THER EX, V57, P165, DOI 10.1007/s00005-009-0024-y; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Cheng YH, 2010, CARDIOVASC RES, V87, P431, DOI 10.1093/cvr/cvq082; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Cottonham CL, 2010, J BIOL CHEM; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Di Meglio F, 2010, J MOL CELL CARDIOL; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kleinbongard P, 2011, HEART FAIL REV, V16, P49, DOI 10.1007/s10741-010-9180-8; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Manner J, 1999, ANAT RECORD, V255, P212; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c; Patrick DM, 2010, J CLIN INVEST, V120, P3912, DOI 10.1172/JCI43604; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Penna Aubin, 2007, J Vis Exp, P264, DOI 10.3791/264; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2010, J BIOL CHEM, V285, P20281, DOI 10.1074/jbc.M110.109207; Smart N, 2009, CURR PROTOC STEM CEL; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2011, J CLIN INVEST, V121, P461, DOI 10.1172/JCI45938; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Tuyn J, 2007, STEM CELLS, V25, P271, DOI 10.1634/stemcells.2006-0366; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wada AM, 2003, CIRC RES, V92, P525, DOI 10.1161/01.RES.0000060484.11032.0B; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Xia H, 2010, J BIOL CHEM; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	60	75	77	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56280	10.1371/journal.pone.0056280	http://dx.doi.org/10.1371/journal.pone.0056280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441172	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200029
J	Jausoro, I; Mestres, I; Quassollo, G; Masseroni, L; Heredia, F; Caceres, A				Jausoro, Ignacio; Mestres, Ivan; Quassollo, Gonzalo; Masseroni, Lujan; Heredia, Florencia; Caceres, Alfredo			Regulation of Spine Density and Morphology by IQGAP1 Protein Domains	PLOS ONE			English	Article							DENDRITIC SPINES; CELL POLARIZATION; ARP2/3 COMPLEX; SMALL GTPASES; ACTIN; CDC42; DYNAMICS; ROLES; RAC1; RHO	IQGAP1 is a scaffolding protein that regulates spine number. We now show a differential role for IQGAP1 domains in spine morphogenesis, in which a region of the N-terminus that promotes Arp2/3-mediated actin polymerization and branching stimulates spine head formation while a region that binds to Cdc42 and Rac is required for stalk extension. Conversely, IQGAP1 rescues spine deficiency induced by expression of dominant negative Cdc42 by stimulating formation of stubby spines. Together, our observations place IQGAP1 as a crucial regulator of spine number and shape acting through the N-Wasp Arp2/3 complex, as well as upstream and downstream of Cdc42.	[Jausoro, Ignacio; Mestres, Ivan; Quassollo, Gonzalo; Masseroni, Lujan; Heredia, Florencia; Caceres, Alfredo] INIMEC CONICET, Inst Mercedes & Martin Ferreyra, Neurobiol Lab, Cordoba, Argentina; [Jausoro, Ignacio; Mestres, Ivan; Quassollo, Gonzalo; Masseroni, Lujan; Heredia, Florencia; Caceres, Alfredo] Univ Nacl Cordoba, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Caceres, A (corresponding author), INIMEC CONICET, Inst Mercedes & Martin Ferreyra, Neurobiol Lab, Cordoba, Argentina.	acaceres@immf.uncor.edu		Quassollo, Gonzalo/0000-0003-3298-9688	MINCyT; CONICET; Agencia Cordoba Ciencia	MINCyT; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Cordoba Ciencia	This work was supported by grants from MINCyT, CONICET and Agencia Cordoba Ciencia to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Conde C, 2010, J NEUROSCI, V30, P6793, DOI 10.1523/JNEUROSCI.5420-09.2010; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hoogenraad CC, 2009, TRENDS CELL BIOL, V19, P669, DOI 10.1016/j.tcb.2009.08.006; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Jausoro I, 2012, HISTOL HISTOPATHOL, V27, P1385, DOI 10.14670/HH-27.1385; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Svitkina T, 2010, J NEUROSCI, V30, P14937, DOI 10.1523/JNEUROSCI.4276-10.2010; Swiech L, 2011, J NEUROSCI, V31, P4555, DOI 10.1523/JNEUROSCI.6582-10.2011; Szebenyi G, 2005, CURR BIOL, V15, P1820, DOI 10.1016/j.cub.2005.08.069; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Wang SJ, 2007, J CELL SCI, V120, P567, DOI 10.1242/jcs.03356; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Watanabe Takashi, 2005, Novartis Found Symp, V269, P92; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; Weissbach L, 1994, J BIOL CHEM, V278, P9630	43	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56574	10.1371/journal.pone.0056574	http://dx.doi.org/10.1371/journal.pone.0056574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441206	Green Published, gold			2022-12-25	WOS:000315159200063
J	Lund, H; Krakauer, M; Skimminge, A; Sellebjerg, F; Garde, E; Siebner, HR; Paulson, OB; Hesse, D; Hanson, LG				Lund, Henrik; Krakauer, Martin; Skimminge, Arnold; Sellebjerg, Finn; Garde, Ellen; Siebner, Hartwig R.; Paulson, Olaf B.; Hesse, Dan; Hanson, Lars G.			Blood-Brain Barrier Permeability of Normal Appearing White Matter in Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							STATUS SCALE EDSS; COGNITIVE IMPAIRMENT; TIME MEASUREMENTS; RELAXATION-TIMES; AXONAL LOSS; MRI; DISABILITY; LESIONS; ABNORMALITIES; DEMYELINATION	Background: Multiple sclerosis (MS) affects the integrity of the blood-brain barrier (BBB). Contrast-enhanced T1 weighted magnetic resonance imaging (MRI) is widely used to characterize location and extent of BBB disruptions in focal MS lesions. We employed quantitative T1 measurements before and after the intravenous injection of a paramagnetic contrast agent to assess BBB permeability in the normal appearing white matter (NAWM) in patients with relapsing-remitting MS (RR-MS). Methodology/Principal Findings: Fifty-nine patients (38 females) with RR-MS undergoing immunomodulatory treatment and nine healthy controls (4 females) underwent quantitative T1 measurements at 3 tesla before and after injection of a paramagnetic contrast agent (0.2 mmol/kg Gd-DTPA). Mean T1 values were calculated for NAWM in patients and total cerebral white matter in healthy subjects for the T1 measurements before and after injection of Gd-DTPA. The pre-injection baseline T1 of NAWM (945 +/- 55 [SD] ms) was prolonged in RR-MS relative to healthy controls (903 +/- 23 ms, p = 0.028). Gd-DTPA injection shortened T1 to a similar extent in both groups. Mean T1 of NAWM was 866 +/- 47 ms in the NAWM of RR-MS patients and 824 +/- 13 ms in the white matter of healthy controls. The regional variability of T1 values expressed as the coefficient of variation (CV) was comparable between the two groups at baseline, but not after injection of the contrast agent. After intravenous Gd-DTPA injection, T1 values in NAWM were more variable in RR-MS patients (CV = 0.198 +/- 0.046) compared to cerebral white matter of healthy controls (CV = 0.166 +/- 0.018, p = 0.046). Conclusions/Significance: We found no evidence of a global BBB disruption within the NAWM of RR-MS patients undergoing immunomodulatory treatment. However, the increased variation of T1 values in NAWM after intravenous GdDTPA injection points to an increased regional inhomogeneity of BBB function in NAWM in relapsing-remitting MS.	[Lund, Henrik; Skimminge, Arnold; Garde, Ellen; Siebner, Hartwig R.; Paulson, Olaf B.; Hanson, Lars G.] Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark; [Krakauer, Martin; Sellebjerg, Finn; Hesse, Dan] Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Res Ctr, Dept Neurol, Hvidovre, Denmark; [Paulson, Olaf B.] Copenhagen Univ Hosp, Neurobiol Res Unit, Hvidovre, Denmark; [Hanson, Lars G.] Tech Univ Denmark, Biomed Engn Grp, DK-2800 Lyngby, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Lund, H (corresponding author), Copenhagen Univ Hosp, Danish Res Ctr Magnet Resonance, Hvidovre, Denmark.	hlund@drcmr.dk	Hanson, Lars/GRS-0733-2022; Krakauer, Martin/M-4657-2019; Siebner, Hartwig R/G-4052-2016; Paulson, Olaf B./N-6924-2016; Hanson, Lars G/E-8562-2010	Krakauer, Martin/0000-0002-2191-1861; Paulson, Olaf B./0000-0001-7712-8596; Hanson, Lars G/0000-0002-8204-6912; Garde, Ellen/0000-0002-9906-6880; Sellebjerg, Finn/0000-0002-1333-9623; Hesse, Dan/0000-0002-9670-6037	Danish Multiple Sclerosis Society [9007]; Henry Hansen og Hustrus Legat [2009]; Biogen Idec/HRS; Biogen Idec; Merck Serono; Sanofi-Aventis; Lundbeck Foundation [R59-2010-5399] Funding Source: researchfish	Danish Multiple Sclerosis Society; Henry Hansen og Hustrus Legat; Biogen Idec/HRS(Biogen); Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); Lundbeck Foundation(Lundbeckfonden)	The work was supported by Danish Multiple Sclerosis Society (www.scleroseforeningen.dk): grant 9007, and by Henry Hansen og Hustrus Legat (www.jpb.dk): grant; HL - no competing interests/MK - no competing interests/AS - no competing interests/FS - no competing interests/EG - received honoraria for lecturing and travel expenses for attending meetings from Biogen Idec/HRS - received honoraria as Reviewing Editor for Neuroimage, as speaker for Biogen Idec Denmark A/S, and scientific Advisor from Lundbeck A/S, Valby, Denmark/OBP - no competing interests/DH - received funding for travel from Biogen Idec, Merck Serono, and Sanofi-Aventis and has received speaker honoraria from Biogen Idec and Sanofi-Aventis/LGH - no competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN IV, 1979, J NEUROL SCI, V41, P81, DOI 10.1016/0022-510X(79)90142-4; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; Barkhof F, 2002, J NEUROL, V249, P1451, DOI 10.1007/s00415-002-0835-9; Calabresi PA, 1997, NEUROLOGY, V48, P1446, DOI 10.1212/WNL.48.5.1446; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; CLAUDIO L, 1995, ACTA NEUROPATHOL, V90, P228; Comi G, 1999, J NEUROL SCI, V171, P135, DOI 10.1016/S0022-510X(99)00266-X; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Davies GR, 2005, J NEUROL, V252, P1037, DOI 10.1007/s00415-005-0808-x; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Filippi M, 2000, J NEUROL NEUROSUR PS, V68, P157, DOI 10.1136/jnnp.68.2.157; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; FRAHM J, 1985, J MAGN RESON, V64, P81, DOI 10.1016/0022-2364(85)90033-2; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gaitan MI, 2011, ANN NEUROL, V70, P22, DOI 10.1002/ana.22472; Gold Ralf, 2010, Ther Adv Neurol Disord, V3, P351, DOI 10.1177/1756285610385608; GROSSMAN RI, 1986, RADIOLOGY, V161, P721, DOI 10.1148/radiology.161.3.3786722; Hanson LG, 1998, P INT SOC MAGN RESON; Hanson LG, 2005, P INT SOC MAGN RESON; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Holman DW, 2011, BBA-MOL BASIS DIS, V1812, P220, DOI 10.1016/j.bbadis.2010.07.019; Iannucci G, 2000, AM J NEURORADIOL, V21, P1034; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Lund H, 2012, ACTA NEUROL SCAND, V125, P338, DOI 10.1111/j.1600-0404.2011.01574.x; Mathiesen HK, 2006, ARCH NEUROL-CHICAGO, V63, P533, DOI 10.1001/archneur.63.4.533; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mottershead JP, 2003, J NEUROL, V250, P1293, DOI 10.1007/s00415-003-0192-3; Parry A, 2002, J NEUROL, V249, P1279, DOI 10.1007/s00415-002-0837-7; Rovaris M, 2011, MULT SCLER J, V17, P319, DOI 10.1177/1352458510388824; Sarchielli P, 1999, BRAIN, V122, P513, DOI 10.1093/brain/122.3.513; Schmierer K, 2004, MULT SCLER J, V10, P182, DOI 10.1191/1352458504ms996oa; Silver NC, 2001, MULT SCLER J, V7, P75, DOI 10.1177/135245850100700201; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Topakian R, 2010, J NEUROL NEUROSUR PS, V81, P192, DOI 10.1136/jnnp.2009.172072; Topp S, 1997, P INT SOC MAGN RESON; Vaithianathar L, 2002, J NEUROL SCI, V197, P45, DOI 10.1016/S0022-510X(02)00044-8; van Waesberghe JHTM, 1999, ANN NEUROL, V46, P747; van Walderveen MAA, 2003, J MAGN RESON IMAGING, V18, P656, DOI 10.1002/jmri.10417; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Vrenken H, 2006, AM J NEURORADIOL, V27, P868; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zivadinov R, 2001, NEURORADIOLOGY, V43, P272, DOI 10.1007/s002340000500	48	25	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56375	10.1371/journal.pone.0056375	http://dx.doi.org/10.1371/journal.pone.0056375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441184	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200041
J	Muller, R; Daniel, C; Hugo, C; Amann, K; Mielenz, D; Endlich, K; Braun, T; van der Veen, B; Heeringa, P; Schett, G; Zwerina, J				Mueller, Ralf; Daniel, Christoph; Hugo, Christian; Amann, Kerstin; Mielenz, Dirk; Endlich, Karlhans; Braun, Tobias; van der Veen, Betty; Heeringa, Peter; Schett, Georg; Zwerina, Jochen			The Mitogen-Activated Protein Kinase p38 alpha Regulates Tubular Damage in Murine Anti-Glomerular Basement Membrane Nephritis	PLOS ONE			English	Article							P38 MAP KINASE; CRESCENTIC GLOMERULONEPHRITIS; SELECTIVE INHIBITOR; LOCALIZATION; CYTOSKELETON; EXPRESSION; EVOLUTION; ENDOTOXIN; PATHWAYS; MEMBER	p38 mitogen-activated protein kinase (MAPK) is thought to play a central role in acute and chronic inflammatory responses. Whether p38MAPK plays a pathogenic role in crescentic GN (GN) and which of its four isoforms is preferentially involved in kidney inflammation is not definitely known. We thus examined expression and activation of p38MAPK isoforms during antiglomerular basement membrane (GBM) nephritis. Therefore, p38 alpha conditional knockout mice (MxCre-p38 alpha(Delta/Delta)) were used to examine the role of p38 alpha in anti-GBM induced nephritis. Both wild type and MxCre-p38 alpha(Delta/Delta) mice developed acute renal failure over time. Histological examinations revealed a reduced monocyte influx and less tubular damage in MxCre-p38 alpha(Delta/Delta) mice, whereas glomerular crescent formation and renal fibrosis was similar. Likewise, the levels of pro-and anti-inflammatory cytokines such as TNF, IL-1 and IL-10 were similar, but IL-8 was even up-regulated in MxCre-p38 alpha(Delta/Delta) mice. In contrast, we could detect strong down-regulation of chemotactic cytokines such as CCL-2, -5 and -7, in the kidneys of MxCre-p38 alpha(Delta/Delta) mice. In conclusion, p38 alpha is the primary p38MAPK isoform expressed in anti-GBM nephritis and selectively affects inflammatory cell influx and tubular damage. Full protection from nephritis is however not achieved as renal failure and structural damage still occurs.	[Mueller, Ralf; Mielenz, Dirk; Braun, Tobias; Schett, Georg; Zwerina, Jochen] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Bavaria, Germany; [Daniel, Christoph] Univ Erlangen Nurnberg, Dept Internal Med 4, D-91054 Erlangen, Bavaria, Germany; [Hugo, Christian] Tech Univ Dresden, Med Clin 3, D-01062 Dresden, Saxony, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Bavaria, Germany; [Endlich, Karlhans] Ernst Moritz Arndt Univ Greifswald, Inst Anat & Cell Biol, Mecklenburg W Pomerania, Germany; [van der Veen, Betty; Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Technische Universitat Dresden; University of Erlangen Nuremberg; Ernst Moritz Arndt Universitat Greifswald; University of Groningen	Zwerina, J (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Bavaria, Germany.	jochen.zwerina@uk-erlangen.de	Endlich, Karlhans/G-5485-2013; Heeringa, Peter/A-6008-2009; Daniel, Christoph/AAK-2136-2021	Heeringa, Peter/0000-0001-8684-763X; Daniel, Christoph/0000-0002-6803-4755; Endlich, Karlhans/0000-0001-6052-6061	Deutsche Forschungsgemeinschaft (DFG) [SFB 423]; European Union; Interdisciplinary Centre for Clinical Research Erlangen (IZKF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); Interdisciplinary Centre for Clinical Research Erlangen (IZKF)	This work was supported by the grant SFB 423 of the Deutsche Forschungsgemeinschaft (DFG, projects A34 and Z2), the KINACEPT project of the European Union and the Interdisciplinary Centre for Clinical Research Erlangen (IZKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Asgeirdottir SA, 2007, MOL PHARMACOL, V72, P121, DOI 10.1124/mol.107.034140; Badger AM, 2000, ARTHRITIS RHEUM, V43, P175, DOI 10.1002/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S; Bariety J, 2005, KIDNEY INT, V68, P1109, DOI 10.1111/j.1523-1755.2005.00503.x; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Bohm C, 2009, J IMMUNOL, V183, P5938, DOI 10.4049/jimmunol.0901026; COBB BS, 1991, MOL CELL BIOL, V11, P5832, DOI 10.1128/MCB.11.12.5832; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Floege J, 1999, AM J KIDNEY DIS, V33, P434, DOI 10.1016/S0272-6386(99)70179-4; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; HAN JH, 1993, J BIOL CHEM, V268, P25009; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; LAN HY, 1991, KIDNEY INT, V40, P425, DOI 10.1038/ki.1991.229; Lechner C, 1996, P NATL ACAD SCI USA, V93, P4355, DOI 10.1073/pnas.93.9.4355; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Nick JA, 2000, J IMMUNOL, V164, P2151, DOI 10.4049/jimmunol.164.4.2151; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Polzer K, 2008, ANN RHEUM DIS, V67, P602, DOI 10.1136/ard.2007.077263; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Sheryanna A, 2007, J AM SOC NEPHROL, V18, P1167, DOI 10.1681/ASN.2006010050; Song GY, 2001, SHOCK, V15, P42, DOI 10.1097/00024382-200115010-00007; Stambe C, 2004, J AM SOC NEPHROL, V15, P370, DOI 10.1097/01.ASN.0000109669.23650.56; Stambe C, 2004, J AM SOC NEPHROL, V15, P326, DOI 10.1097/01.ASN.0000108520.63445.E0; Stambe C, 2003, J AM SOC NEPHROL, V14, P338, DOI 10.1097/01.ASN.0000048715.12315.FD; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Underwood DC, 2000, AM J PHYSIOL-LUNG C, V279, pL895, DOI 10.1152/ajplung.2000.279.5.L895; van der Veen BS, 2011, ANN RHEUM DIS, V70, P356, DOI 10.1136/ard.2010.129106	41	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56316	10.1371/journal.pone.0056316	http://dx.doi.org/10.1371/journal.pone.0056316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441175	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200032
J	Perony, N; Townsend, SW				Perony, Nicolas; Townsend, Simon W.			Why Did the Meerkat Cross the Road? Flexible Adaptation of Phylogenetically-Old Behavioural Strategies to Modern-Day Threats	PLOS ONE			English	Article							SELFISH HERD; PROGRESSIONS	Risk-sensitive adaptive spatial organisation during group movement has been shown to efficiently minimise the risks associated with external ecological threats. Whether animals can draw on such behaviours when confronted with man-made threats is generally less clear. We studied road-crossing in a wild, but habituated, population of meerkats living in the Kalahari Desert, South Africa. We found that dominant females, the core member in meerkat social systems, led groups to the road significantly more often than subordinates, yet were consistently less likely to cross first. Our results suggest that a reshuffling occurs in progression order when meerkat groups reach the road. By employing a simple model of collective movement, we have shown that risk aversion alone may be sufficient to explain this reshuffling, but that the risk aversion of dominant females toward road crossing is significantly higher than that of subordinates. It seems that by not crossing first, dominant females avoid occupying the most risky, exposed locations, such as at the front of the group - a potential selfish strategy that also promotes the long-term stability and hence reproductive output of their family groups. We argue that our findings support the idea that animals can flexibly apply phylogenetically-old behavioural strategies to deal with emerging modern-day problems.	[Perony, Nicolas] Swiss Fed Inst Technol, Chair Syst Design, Zurich, Switzerland; [Townsend, Simon W.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Townsend, Simon W.] Kuruman River Reserve, Kalahari Meerkat Project, No Cape, South Africa	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Townsend, SW (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	simon.townsend@ieu.uzh.ch		Perony, Nicolas/0000-0002-2918-163X	University of Zurich; ETH Zurich; NERC [NE/H004912/1] Funding Source: UKRI; Natural Environment Research Council [NE/H004912/1] Funding Source: researchfish	University of Zurich; ETH Zurich(ETH Zurich); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by University of Zurich and ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN SA, 1979, ANIM BEHAV, V27, P46, DOI 10.1016/0003-3472(79)90128-3; Clutton-Brock TH, 2005, ANIM BEHAV, V69, P1273, DOI 10.1016/j.anbehav.2004.10.006; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Kerth G, 2009, BIOL CONSERV, V142, P270, DOI 10.1016/j.biocon.2008.10.022; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Quinn JL, 2006, P R SOC B, V273, P2521, DOI 10.1098/rspb.2006.3612; RHINE RJ, 1985, INT J PRIMATOL, V6, P115, DOI 10.1007/BF02693649; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viscido SV, 2002, ANIM BEHAV, V63, P735, DOI 10.1006/anbe.2001.1935	14	6	6	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e52834	10.1371/journal.pone.0052834	http://dx.doi.org/10.1371/journal.pone.0052834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441144	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000315159200002
J	Prakash, R; Johnson, M; Fagan, SC; Ergul, A				Prakash, Roshini; Johnson, Maribeth; Fagan, Susan C.; Ergul, Adviye			Cerebral Neovascularization and Remodeling Patterns in Two Different Models of Type 2 Diabetes	PLOS ONE			English	Article							GLYCEMIC CONTROL; VASCULAR TREES; BLOOD-FLOW; BRAIN; ANGIOGENESIS; REACTIVITY; STROKE; RATS; QUANTIFICATION; PEROXYNITRITE	We previously reported intense pial cerebral collateralization and arteriogenesis in a mild and lean model of type 2 diabetes (T2D), Goto-Kakizaki (GK) rats. Increased cerebral neovascularization differed regionally and was associated with poor vessel wall maturity. Building upon these findings, the goals of this study were to determine whether a) glycemic control prevents this erratic cerebral neovascularization in the GK model, and b) this pathological neovascularization pattern occurs in Lepr(db/db) model, which is the most commonly used model of T2D for studies involving cerebral complications of diabetes. Vascular volume, surface area and structural parameters including microvessel/macrovessel ratio, non-FITC (fluorescein) perfusing vessel abundance, vessel tortuosity, and branch density were measured by 3D reconstruction of FITC stained vasculature in GK rats or Lepr(db/db) mice. GK rats exhibited an increase in all of these parameters, which were prevented by glycemic control with metformin. In Lepr(db/db) mice, microvascular density was increased but there was no change in nonFITC-perfusing vessels. Increased PA branch density was associated with reduced branch diameter. These results suggest that T2D leads to cerebral neovascularization and remodeling but some structural characteristics of newly formed vessels differ between these models of T2D. The prevention of dysfunctional cerebral neovascularization by early glucose control suggests that hyperglycemia is a mediator of this response.	[Prakash, Roshini; Fagan, Susan C.; Ergul, Adviye] Univ Georgia, Coll Pharm, Charlie Norwood Vet Adm Med Ctr, Augusta, GA USA; [Prakash, Roshini; Fagan, Susan C.; Ergul, Adviye] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA USA; [Johnson, Maribeth] Georgia Hlth Sci Univ, Dept Biostat, Augusta, GA USA; [Ergul, Adviye] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA	University System of Georgia; University of Georgia; US Department of Veterans Affairs; Veterans Health Administration (VHA); University System of Georgia; University of Georgia; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Ergul, A (corresponding author), Univ Georgia, Coll Pharm, Charlie Norwood Vet Adm Med Ctr, Augusta, GA USA.	aergul@georgiahealth.edu		Prakash, Roshini/0000-0003-4309-3078	VA Merit Awards [BX000891, BX000347]; National Institutes of Health [NS063965, NS054688]; American Heart Association [EIA 0740002N, 10PRE4030037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083559, R01NS063965, R21NS070239, R03NS054688] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000347] Funding Source: NIH RePORTER	VA Merit Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by VA Merit Awards to Susan C. Fagan (BX000891) and Adviye Ergul (BX000347), grants from the National Institutes of Health to Susan C. Fagan (NS063965) and to Adviye Ergul (NS054688), and grants from the American Heart Association to Adviye Ergul (EIA 0740002N) and Roshini Prakash (10PRE4030037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2006, CURR OPIN INVEST DR, V7, P619; BOROWSKY IW, 1989, J COMP NEUROL, V288, P401, DOI 10.1002/cne.902880304; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Dockery P, 2007, EXP MOL PATHOL, V82, P110, DOI 10.1016/j.yexmp.2006.12.011; Dore-Duffy P, 2007, ANTIOXID REDOX SIGN, V9, P1363, DOI 10.1089/ars.2007.1713; DUCKROW RB, 1987, STROKE, V18, P52, DOI 10.1161/01.STR.18.1.52; Elgebaly MM, 2010, J CEREBR BLOOD F MET, V30, P1928, DOI 10.1038/jcbfm.2010.120; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Faure P, 2008, CLIN SCI, V114, P251, DOI 10.1042/CS20070276; Heinzer S, 2008, NEUROIMAGE, V39, P1549, DOI 10.1016/j.neuroimage.2007.10.054; Kassab GS, 2006, AM J PHYSIOL-HEART C, V290, pH894, DOI 10.1152/ajpheart.00579.2005; Kelly-Cobbs AI, 2012, J PHARMACOL EXP THER, V342, P407, DOI 10.1124/jpet.111.191296; Lechuga-Sancho AM, 2006, ENDOCRINOLOGY, V147, P5314, DOI 10.1210/en.2006-0766; Li WG, 2010, DIABETES, V59, P228, DOI 10.2337/db09-0902; Lokkegaard A, 2001, HIPPOCAMPUS, V11, P726, DOI 10.1002/hipo.1088; Macia I, 2012, KNOWL INF SYST, V30, P457, DOI 10.1007/s10115-010-0377-x; Mankovsky BN, 1996, J DIABETES COMPLICAT, V10, P228, DOI 10.1016/S1056-8727(96)90006-9; MCCALL AL, 1992, DIABETES, V41, P557, DOI 10.2337/diabetes.41.5.557; MCCUSKEY PA, 1984, MICROCIRC ENDOTH LYM, V1, P221; Muranyi M, 2006, DIABETES, V55, P349, DOI 10.2337/diabetes.55.02.06.db05-0654; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Prakash R, 2012, DIABETES, V61, P1533, DOI 10.2337/db11-1528; Risser L, 2009, INT J DEV NEUROSCI, V27, P185, DOI 10.1016/j.ijdevneu.2008.10.006; Rosen P, 2006, DIABETES-METAB RES, V22, P323, DOI 10.1002/dmrr.623; Rungger-Brandle E, 2000, INVEST OPHTH VIS SCI, V41, P1971; Sachidanandam K, 2009, AM J PHYSIOL-REG I, V296, pR952, DOI 10.1152/ajpregu.90537.2008; Saravia FE, 2002, BRAIN RES, V957, P345, DOI 10.1016/S0006-8993(02)03675-2; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Secomb T W, 1995, Symp Soc Exp Biol, V49, P305; Silvestre JS, 2006, CIRC RES, V98, P4, DOI 10.1161/01.RES.0000200396.90220.41; Skyler J S, 1998, J Fla Med Assoc, V85, P7; Skyler JS, 2004, CLIN DIABETES, V22; Soltanian-Zadeh H, 2005, COMPUT BIOL MED, V35, P791, DOI 10.1016/j.compbiomed.2004.06.009; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016/j.pathophys.2008.04.007; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	37	59	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56264	10.1371/journal.pone.0056264	http://dx.doi.org/10.1371/journal.pone.0056264			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441170	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200027
J	Shields, RC; Mokhtar, N; Ford, M; Hall, MJ; Burgess, JG; ElBadawey, MR; Jakubovics, NS				Shields, Robert C.; Mokhtar, Norehan; Ford, Michael; Hall, Michael J.; Burgess, J. Grant; ElBadawey, Mohamed Reda; Jakubovics, Nicholas S.			Efficacy of a Marine Bacterial Nuclease against Biofilm Forming Microorganisms Isolated from Chronic Rhinosinusitis	PLOS ONE			English	Article							EXTRACELLULAR DNA; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; CHRONIC SINUSITIS; IDENTIFICATION; EPIDEMIOLOGY; DIAGNOSIS; SURGERY; MUCOSA; MATRIX	Background: The persistent colonization of paranasal sinus mucosa by microbial biofilms is a major factor in the pathogenesis of chronic rhinosinusitis (CRS). Control of microorganisms within biofilms is hampered by the presence of viscous extracellular polymers of host or microbial origin, including nucleic acids. The aim of this study was to investigate the role of extracellular DNA in biofilm formation by bacteria associated with CRS. Methods/Principal Findings: Obstructive mucin was collected from patients during functional endoscopic sinus surgery. Examination of the mucous by transmission electron microscopy revealed an acellular matrix punctuated occasionally with host cells in varying states of degradation. Bacteria were observed in biofilms on mucosal biopsies, and between two and six different species were isolated from each of 20 different patient samples. In total, 16 different bacterial genera were isolated, of which the most commonly identified organisms were coagulase-negative staphylococci, Staphylococcus aureus and alpha-haemolytic streptococci. Twenty-four fresh clinical isolates were selected for investigation of biofilm formation in vitro using a microplate model system. Biofilms formed by 14 strains, including all 9 extracellular nuclease-producing bacteria, were significantly disrupted by treatment with a novel bacterial deoxyribonuclease, NucB, isolated from a marine strain of Bacillus licheniformis. Extracellular biofilm matrix was observed in untreated samples but not in those treated with NucB and extracellular DNA was purified from in vitro biofilms. Conclusion/Significance: Our data demonstrate that bacteria associated with CRS form robust biofilms which can be reduced by treatment with matrix-degrading enzymes such as NucB. The dispersal of bacterial biofilms with NucB may offer an additional therapeutic target for CRS sufferers.	[Shields, Robert C.; Mokhtar, Norehan; Jakubovics, Nicholas S.] Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Mokhtar, Norehan] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia; [Ford, Michael] Freeman Rd Hosp, Dept Microbiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Hall, Michael J.] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Burgess, J. Grant] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [ElBadawey, Mohamed Reda] Freeman Rd Hosp, Dept Otolaryngol & Head & Neck Surg, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [ElBadawey, Mohamed Reda] Tanta Univ, Dept Otolaryngol, Tanta, Egypt	Newcastle University - UK; Universiti Sains Malaysia; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK; Egyptian Knowledge Bank (EKB); Tanta University	Jakubovics, NS (corresponding author), Newcastle Univ, Sch Dent Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	nick.jakubovics@ncl.ac.uk	Jakubovics, Nicholas S/B-1938-2010; Hall, Michael/N-2458-2019; Hall, Michael J/A-4126-2012; Shields, Robert C./I-7890-2019	Jakubovics, Nicholas S/0000-0001-6667-0515; Hall, Michael/0000-0001-6475-9161; Hall, Michael J/0000-0001-6475-9161; Shields, Robert C./0000-0002-8823-9504; Mokhtar, Norehan/0000-0002-8851-1539	NERC [NE/I01523X/1]; Centre for Oral Health Research at Newcastle University	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre for Oral Health Research at Newcastle University	This study was supported by an NERC follow-on-fund grant NE/I01523X/1 awarded to JGB, and by a PhD studentship to RS from the Centre for Oral Health Research at Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Araujo Elisabeth, 2007, Braz J Otorhinolaryngol, V73, P549; Bassiouni A, 2012, LARYNGOSCOPE, V122, P460, DOI 10.1002/lary.22461; Beenken KE, 2012, INFECT IMMU IN PRESS; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Benninger MS, 2003, OTOLARYNG HEAD NECK, V129, pS1, DOI 10.1016/S0194-5998(03)01397-4; Berne C, 2010, MOL MICROBIOL, V77, P815, DOI 10.1111/j.1365-2958.2010.07267.x; Brook I, 2005, J CLIN MICROBIOL, V43, P3479, DOI 10.1128/JCM.43.7.3479-3480.2005; Brook I, 2006, ARCH OTOLARYNGOL, V132, P1099, DOI 10.1001/archotol.132.10.1099; CATLIN BW, 1956, SCIENCE, V124, P441, DOI 10.1126/science.124.3219.441; Cerqueira L, 2008, INT J MOL SCI, V9, P1944, DOI 10.3390/ijms9101944; Chakrabarti A, 2009, MED MYCOL, V47, pS299, DOI 10.1080/13693780802213357; Clement S, 2005, J INFECT DIS, V192, P1023, DOI 10.1086/432735; Diez-Garcia M, 2012, FOOD MICROBIOL, V31, P173, DOI 10.1016/j.fm.2012.03.012; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; Dominiak DM, 2011, ENVIRON MICROBIOL, V13, P710, DOI 10.1111/j.1462-2920.2010.02375.x; DOYLE PW, 1991, J CLIN MICROBIOL, V29, P2396, DOI 10.1128/JCM.29.11.2396-2400.1991; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Foreman A, 2012, CURR ALLERGY ASTHM R, V12, P127, DOI 10.1007/s11882-012-0246-7; Gilbert P, 1997, Adv Dent Res, V11, P160; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; Hastan D, 2011, ALLERGY, V66, P1216, DOI 10.1111/j.1398-9995.2011.02646.x; Healy DY, 2008, OTOLARYNG HEAD NECK, V138, P641, DOI 10.1016/j.otohns.2008.02.002; Hochstim CJ, 2010, OTOLARYNG HEAD NECK, V143, P697, DOI 10.1016/j.otohns.2010.07.017; JOUSIMIESSOMER HR, 1989, J CLIN MICROBIOL, V27, P2736, DOI 10.1128/JCM.27.12.2736-2743.1989; Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403; Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113; Khalil HS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004458.pub2; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Kreth J, 2009, J BACTERIOL, V191, P6281, DOI 10.1128/JB.00906-09; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lara JF, 2001, ARCH PATHOL LAB MED, V125, P1442; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lim M, 2008, AM J RHINOL, V22, P381, DOI 10.2500/ajr.2008.22.3189; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Martins M, 2010, MYCOPATHOLOGIA, V169, P323, DOI 10.1007/s11046-009-9264-y; Matthews PC, 2011, J CLIN MICROBIOL, V49, P2740, DOI 10.1128/JCM.00722-11; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Njoroge J, 2009, EMBO MOL MED, V1, P201, DOI 10.1002/emmm.200900032; Palmer LJ, 2012, J PERIODONTAL RES, V47, P439, DOI 10.1111/j.1600-0765.2011.01451.x; Pimenta P, 2008, LETT APPL MICROBIOL, V46, P307, DOI 10.1111/j.1472-765X.2007.02310.x; Piromchai P, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008233.pub2; Ponikau JU, 1999, MAYO CLIN PROC, V74, P877, DOI 10.4065/74.9.877; Prince AA, 2008, AM J RHINOL, V22, P239, DOI 10.2500/ajr.2008.22.3180; Ramadan HH, 2005, OTOLARYNG HEAD NECK, V132, P414, DOI 10.1016/j.otohns.2004.11.011; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seper A, 2011, MOL MICROBIOL, V82, P1015, DOI 10.1111/j.1365-2958.2011.07867.x; Steichen CT, 2011, INFECT IMMUN, V79, P1504, DOI 10.1128/IAI.01162-10; Steinberger RE, 2005, APPL ENVIRON MICROB, V71, P5404, DOI 10.1128/AEM.71.9.5404-5410.2005; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; SYED SA, 1972, APPL MICROBIOL, V24, P638, DOI 10.1128/AEM.24.4.638-644.1972; Taylor MJ, 2002, OTOLARYNG HEAD NECK, V127, P377, DOI 10.1067/mhn.2002.128896; Tetz VV, 2010, DNA CELL BIOL, V29, P399, DOI 10.1089/dna.2009.1011; Thompson GR, 2012, J ALLERGY CLIN IMMUN, V129, P321, DOI 10.1016/j.jaci.2011.11.039; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Zhang Z, 2011, OTOLARYNG HEAD NECK, V144, P457, DOI 10.1177/0194599810394302	64	55	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55339	10.1371/journal.pone.0055339	http://dx.doi.org/10.1371/journal.pone.0055339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441151	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200009
J	Lehner, J; Berendt, S; Dorsam, B; Perez, R; Forchhammer, K; Maldener, I				Lehner, Josef; Berendt, Susanne; Doersam, Bastian; Perez, Rebeca; Forchhammer, Karl; Maldener, Iris			Prokaryotic multicellularity: a nanopore array for bacterial cell communication	FASEB JOURNAL			English	Article						cyanobacteria; amidase	SP-STRAIN PCC-7120; HETEROCYST-FORMING CYANOBACTERIUM; INTERCELLULAR MOLECULAR-EXCHANGE; BLUE-GREEN-ALGAE; ANABAENA SP; ESCHERICHIA-COLI; FILAMENT INTEGRITY; NOSTOC-PUNCTIFORME; MUREIN HYDROLASES; PATTERN-FORMATION	The transition from unicellular to multicellular life, which occurred several times during evolution, requires tight interaction and communication of neighboring cells. The multicellular cyanobacterium Nostoc punctiforme ATCC 29133 forms filaments of hundreds of interacting cells exchanging metabolites and signal molecules and is able to differentiate specialized cells in response to environmental stimuli. Mutation of cell wall amidase AmiC2 leads to a severe phenotype with formation of aberrant septa in the distorted filaments, which completely lack cell communication and potential for cell differentiation. Here we demonstrate the function of the amidase AmiC2 in formation of cell-joining structures. The AmiC2 protein localizes to the young septum between cells and shows bona fide amidase activity in vivo and in vitro. Vancomycin staining identified the overall septum morphology in living cells. By electron microscopy of isolated peptidoglycan sacculi, the submicroscopic structure of the cell junctions could be visualized, revealing a novel function for a cell wall amidase: AmiC2 drills holes into the cross-walls, forming an array of similar to 155 nanopores with a diameter of similar to 20 nm each. These nanopores seem to constitute a framework for cell-joining proteins, penetrating the cell wall. The entire array of junctional nanopores appears as a novel bacterial organelle, establishing multicellularity in a filamentous prokaryote.-Lehner, J., Berendt, S., Dorsam, B., Perez, R., Forchhammer, K., Maldener, I. Prokaryotic multicellularity: a nanopore array for bacterial cell communication.	[Lehner, Josef; Berendt, Susanne; Doersam, Bastian; Perez, Rebeca; Forchhammer, Karl; Maldener, Iris] Univ Tubingen, Dept Microbiol Organism Interact, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Forchhammer, K (corresponding author), Univ Tubingen, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de; iris.maldener@uni-tuebingen.de		Perez, Rebeca/0000-0002-0402-8356	Deutsche Forschungsgemeinschaft [SFB766, GRK1708]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Miguel de Pedro, Klaus Hantke, Markus Kroog, Claudia Menzel, York Stierhof, and Waldemar Vollmer for help and the Deutsche Forschungsgemeinschaft (SFB766) for financial support. R.P. was supported by a grant from Deutsche Forschungsgemeinschaft (GRK1708).	Berendt S, 2012, J BACTERIOL, V194, P5218, DOI 10.1128/JB.00912-12; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bonner JT., 2000, 1 SIGNALS EVOLUTION; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; CAIOLA MG, 1985, CYTOBIOS, V42, P171; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; Drews G., 1982, BIOL CYANOBACTERIA, P333; DUNN JH, 1970, J BACTERIOL, V103, P153, DOI 10.1128/JB.103.1.153-158.1970; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; Firczuk M, 2007, FEMS MICROBIOL REV, V31, P676, DOI 10.1111/j.1574-6976.2007.00084.x; Flores E, 2007, J BACTERIOL, V189, P3884, DOI 10.1128/JB.00085-07; Flores E, 2006, TRENDS MICROBIOL, V14, P439, DOI 10.1016/j.tim.2006.08.007; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; GIDDINGS TH, 1978, CYTOBIOLOGIE, V16, P235; GIDDINGS TH, 1981, ARCH MICROBIOL, V129, P295, DOI 10.1007/BF00414700; Haselkorn R, 2008, MOL MICROBIOL, V70, P783, DOI 10.1111/j.1365-2958.2008.06475.x; Heidrich C, 2002, J BACTERIOL, V184, P6093, DOI 10.1128/JB.184.22.6093-6099.2002; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Hoiczyk E, 2000, J BACTERIOL, V182, P1191, DOI 10.1128/JB.182.5.1191-1199.2000; Hoiczyk E, 2000, ARCH MICROBIOL, V174, P11, DOI 10.1007/s002030000187; HOLTJE JV, 1995, ARCH MICROBIOL, V164, P243, DOI 10.1007/s002030050261; Jost M., 1965, ARCH MIKROBIOL, V50, P211; Kaplan-Levy RN, 2010, TOP CURR GENET, V21, P5, DOI 10.1007/978-3-642-12422-8_2; Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; LANG NJ, 1971, PROC R SOC SER B-BIO, V178, P193, DOI 10.1098/rspb.1971.0061; Leganes F, 2005, ARCH MICROBIOL, V184, P234, DOI 10.1007/s00203-005-0046-8; Lehner J, 2011, MOL MICROBIOL, V79, P1655, DOI 10.1111/j.1365-2958.2011.07554.x; Mariscal V, 2011, MOL MICROBIOL, V79, P1077, DOI 10.1111/j.1365-2958.2010.07508.x; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Mella-Herrera RA, 2011, MICROBIOL-SGM, V157, P617, DOI 10.1099/mic.0.046128-0; Merino-Puerto V, 2011, J BACTERIOL, V193, P6815, DOI 10.1128/JB.05995-11; Merino-Puerto V, 2011, MOL MICROBIOL, V82, P87, DOI 10.1111/j.1365-2958.2011.07797.x; Merino-Puerto V, 2010, MOL MICROBIOL, V75, P1159, DOI 10.1111/j.1365-2958.2009.07031.x; Mullineaux CW, 2008, EMBO J, V27, P1299, DOI 10.1038/emboj.2008.66; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; Nayar AS, 2007, MICROBIOL-SGM, V153, P601, DOI 10.1099/mic.0.2006/002535-0; Palinska KA, 2000, J PHYCOL, V36, P139, DOI 10.1046/j.1529-8817.2000.99040.x; Pinho MG, 2003, MOL MICROBIOL, V50, P871, DOI 10.1046/j.1365-2958.2003.03719.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schneider D, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-39; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; WILDON DC, 1963, ARCH MIKROBIOL, V47, P19, DOI 10.1007/BF00408286; Wilk L, 2011, CELL MICROBIOL, V13, P1744, DOI 10.1111/j.1462-5822.2011.01655.x; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhu JS, 2001, J BACTERIOL, V183, P6841, DOI 10.1128/JB.183.23.6841-6851.2001	51	44	44	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2293	2300		10.1096/fj.12-225854	http://dx.doi.org/10.1096/fj.12-225854			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23444428				2022-12-25	WOS:000319667600019
J	Sommerville, C; Richardson, JM; Williams, RAM; Mottram, JC; Roberts, CW; Alexander, J; Henriquez, FL				Sommerville, Caroline; Richardson, Julia M.; Williams, Roderick A. M.; Mottram, Jeremy C.; Roberts, Craig W.; Alexander, James; Henriquez, Fiona L.			Biochemical and Immunological Characterization of Toxoplasma gondii Macrophage Migration Inhibitory Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAUTOMERASE ACTIVE-SITE; FACTOR MIF; DENDRITIC CELLS; FUNCTIONAL-CHARACTERIZATION; PARASITIC NEMATODE; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; REGULATORY ROLE; ACTIVATION; INFECTION	Macrophage migration inhibitory factor (MIF) is a proinflammatory molecule in mammals that, unusually for a cytokine, exhibits tautomerase and oxidoreductase enzymatic activities. Homologues of this well conserved protein are found within diverse phyla including a number of parasitic organisms. Herein, we produced recombinant histidine-tagged Toxoplasma gondii MIF (TgMIF), a 12-kDa protein that lacks oxidoreductase activity but exhibits tautomerase activity with a specific activity of 19.3 mu mol/min/mg that cannot be inhibited by the human MIF inhibitor ISO-1. The crystal structure of the TgMIF homotrimer has been determined to 1.82 angstrom, and although it has close structural homology with mammalian MIFs, it has critical differences in the tautomerase active site that account for the different inhibitor sensitivity. We also demonstrate that TgMIF can elicit IL-8 production from human peripheral blood mononuclear cells while also activating ERK MAPK pathways in murine bone marrow-derived macrophages. TgMIF may therefore play an immunomodulatory role during T. gondii infection in mammals.	[Sommerville, Caroline; Williams, Roderick A. M.; Roberts, Craig W.; Alexander, James] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Richardson, Julia M.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Williams, Roderick A. M.; Henriquez, Fiona L.] Univ West Scotland, Sch Sci, Inst Biomed & Environm Hlth Res, Paisley PA1 2BE, Renfrew, Scotland	University of Strathclyde; University of Edinburgh; University of Glasgow; University of West Scotland	Henriquez, FL (corresponding author), Univ West Scotland, Sch Sci, 1 High St, Paisley PA1 2BE, Renfrew, Scotland.	fiona.henriquez@uws.ac.uk	Williams, Roderick/V-4317-2019; Richardson, Julia/D-1808-2013; Roberts, Craig William/B-8016-2008; Alexander, James/A-4238-2009	Williams, Roderick/0000-0001-5065-9768; Richardson, Julia/0000-0002-1547-3009; Roberts, Craig William/0000-0002-0653-835X; Mottram, Jeremy/0000-0001-5574-3766; Henriquez, Fiona/0000-0002-5534-1019	Leverhulme Trust	Leverhulme Trust(Leverhulme Trust)	This work was supported by the Leverhulme Trust.	Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Augustijn KD, 2007, INFECT IMMUN, V75, P1116, DOI 10.1128/IAI.00902-06; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bierly AL, 2008, J IMMUNOL, V181, P8485, DOI 10.4049/jimmunol.181.12.8485; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Denkers EY, 2008, CELL HOST MICROBE, V3, P61, DOI 10.1016/j.chom.2008.01.003; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Denney CF, 1999, INFECT IMMUN, V67, P1547; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Ibrahim HM, 2009, INFECT IMMUN, V77, P3686, DOI 10.1128/IAI.00361-09; Jang SI, 2011, VACCINE, V29, P8998, DOI 10.1016/j.vaccine.2011.09.038; Kamir D, 2008, J IMMUNOL, V180, P8250, DOI 10.4049/jimmunol.180.12.8250; KAMIYAMA T, 1982, INFECT IMMUN, V36, P628; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kleemann R, 2000, EUR J BIOCHEM, V267, P7183, DOI 10.1046/j.1432-1327.2000.01823.x; Kudrin A, 2008, IMMUNOL CELL BIOL, V86, P232, DOI 10.1038/sj.icb.7100133; Kudrin A, 2006, J BIOL CHEM, V281, P29641, DOI 10.1074/jbc.M601103200; Kurosaka K, 2003, BIOCHEM BIOPH RES CO, V306, P1070, DOI 10.1016/S0006-291X(03)01105-7; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lang C, 2007, PARASITOL RES, V100, P191, DOI 10.1007/s00436-006-0306-9; Larson DF, 2006, CRIT CARE, V10, DOI 10.1186/cc4899; LEONARD EJ, 1990, AM J RESP CELL MOL, V2, P479, DOI 10.1165/ajrcmb/2.6.479; LIU DY, 1985, CELL IMMUNOL, V90, P539, DOI 10.1016/0008-8749(85)90218-7; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Pennock JL, 1998, BIOCHEM J, V331, P905, DOI 10.1042/bj3310905; Ren Y, 2004, ONCOGENE, V23, P4146, DOI 10.1038/sj.onc.1207490; Richardson JM, 2009, BIOCHEM BIOPH RES CO, V380, P442, DOI 10.1016/j.bbrc.2009.01.030; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; RYTEL MW, 1966, P SOC EXP BIOL MED, V123, P859, DOI 10.3181/00379727-123-31624; Sakai Y, 2003, GASTROENTEROLOGY, V124, P725, DOI 10.1053/gast.2003.50099; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Stojanovic I, 2009, IMMUNOLOGY, V126, P74, DOI 10.1111/j.1365-2567.2008.02879.x; Sun HW, 1996, P NATL ACAD SCI USA, V93, P5191, DOI 10.1073/pnas.93.11.5191; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Tan THP, 2001, BIOCHEM J, V357, P373, DOI 10.1042/0264-6021:3570373; Zang XX, 2002, J BIOL CHEM, V277, P44261, DOI 10.1074/jbc.M204655200	51	31	33	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2013	288	18					12733	12741		10.1074/jbc.M112.419911	http://dx.doi.org/10.1074/jbc.M112.419911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	139AZ	23443656	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000318555100030
J	Liu, L; Xu, YX; Caradonna, KL; Kruzel, EK; Burleigh, BA; Bangs, JD; Hirschberg, CB				Liu, Li; Xu, Yu-Xin; Caradonna, Kacey L.; Kruzel, Emilia K.; Burleigh, Barbara A.; Bangs, James D.; Hirschberg, Carlos B.			Inhibition of Nucleotide Sugar Transport in Trypanosoma brucei Alters Surface Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; UDP-GLUCOSE 4'-EPIMERASE; POLY-N-ACETYLLACTOSAMINE; ENDOPLASMIC-RETICULUM; STRUCTURAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; BIOCHEMICAL-PROPERTIES; AFRICAN TRYPANOSOMES; GALACTOSE METABOLISM; MEMBRANE-PROTEINS	Nucleotide sugar transporters (NSTs) are indispensible for the biosynthesis of glycoproteins by providing the nucleotide sugars needed for glycosylation in the lumen of the Golgi apparatus. Mutations in NST genes cause human and cattle diseases and impaired cell walls of yeast and fungi. Information regarding their function in the protozoan parasite, Trypanosoma brucei, a causative agent of African trypanosomiasis, is unknown. Here, we characterized the substrate specificities of four NSTs, TbNST1-4, which are expressed in both the insect procyclic form (PCF) and mammalian bloodstream form (BSF) stages. TbNST1/2 transports UDP-Gal/UDP-GlcNAc, TbNST3 transports GDP-Man, and TbNST4 transports UDP-GlcNAc, UDP-GalNAc, and GDP-Man. TbNST4 is the first NST shown to transport both pyrimidine and purine nucleotide sugars and is demonstrated here to be localized at the Golgi apparatus. RNAi-mediated silencing of TbNST4 in the procyclic form caused underglycosylated surface glycoprotein EP-procyclin. Similarly, defective glycosylation of the variant surface glycoprotein (VSG221) as well as the lysosomal membrane protein p67 was observed in Delta tbnst4 BSF T. brucei. Relative infectivity analysis showed that defects in glycosylation of the surface coat resulting from tbnst4 deletion were insufficient to impact the ability of this parasite to infect mice. Notably, the fact that inactivation of a single NST gene results in measurable defects in surface glycoproteins in different life cycle stages of the parasite highlights the essential role of NST(s) in glycosylation of T. brucei. Thus, results presented in this study provide a framework for conducting functional analyses of other NSTs identified in T. brucei.	[Liu, Li; Xu, Yu-Xin; Hirschberg, Carlos B.] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Caradonna, Kacey L.; Burleigh, Barbara A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kruzel, Emilia K.; Bangs, James D.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hirschberg, CB (corresponding author), Evans 438,72 East Concord St, Boston, MA 02118 USA.	chirschb@bu.edu		Hirschberg, Carlos/0000-0003-2299-7721; Xu, Yu-Xin/0000-0002-0200-4633	National Institutes of Health [R01 GM30365, R01 AI35739, AI090366]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035739, R21AI090366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM30365 (to C. B. H.), R01 AI35739 (to J. D. B.), and AI090366 (to B. B.).	Abeijon C, 1996, J BIOL CHEM, V271, P8851, DOI 10.1074/jbc.271.15.8851; ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Alexander DL, 2002, J CELL SCI, V115, P3253; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; Bangs JD, 2011, MOL MICROBIOL, V82, P1433, DOI 10.1111/j.1365-2958.2011.07900.x; BANGS JD, 1988, J BIOL CHEM, V263, P17697; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Borst P, 1998, ANNU REV MICROBIOL, V52, P745, DOI 10.1146/annurev.micro.52.1.745; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; BRUN R, 1979, ACTA TROP, V36, P387; Caffaro CE, 2007, J BIOL CHEM, V282, P27970, DOI 10.1074/jbc.M704485200; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; Dean N, 1996, GLYCOBIOLOGY, V6, P73, DOI 10.1093/glycob/6.1.73; DECARVALHO LCP, 1993, J EXP MED, V177, P465, DOI 10.1084/jem.177.2.465; DESCOTEAUX A, 1995, SCIENCE, V269, P1869, DOI 10.1126/science.7569927; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Ellerton S. S., 2008, J BIOL SCI, V8, P1211; Gao XD, 2001, J BIOL CHEM, V276, P4424, DOI 10.1074/jbc.M009114200; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; HIRUMI H, 1980, PARASITOLOGY, V80, P371, DOI 10.1017/S0031182000000822; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; Hwa KY, 1999, GLYCOBIOLOGY, V9, P181, DOI 10.1093/glycob/9.2.181; Ishikawa HO, 2010, J BIOL CHEM, V285, P4122, DOI 10.1074/jbc.M109.016964; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; Kuettel S, 2012, MOL MICROBIOL, V84, P340, DOI 10.1111/j.1365-2958.2012.08026.x; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Liu L, 2013, GLYCOCONJUGATE J, V30, P5, DOI 10.1007/s10719-012-9375-4; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Marino K, 2011, EUKARYOT CELL, V10, P985, DOI 10.1128/EC.05025-11; Marino K, 2010, GLYCOBIOLOGY, V20, P1619, DOI 10.1093/glycob/cwq115; MBAWA ZR, 1991, EUR J CELL BIOL, V56, P243; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Mehlert A, 2010, MOL BIOCHEM PARASIT, V174, P74, DOI 10.1016/j.molbiopara.2010.06.007; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Nishikawa A, 2002, YEAST, V19, P691, DOI 10.1002/yea.854; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; PEREZ M, 1987, METHOD ENZYMOL, V138, P709; Roditi I, 1999, MOL BIOCHEM PARASIT, V103, P99, DOI 10.1016/S0166-6851(99)00124-3; Roper JR, 2003, MOL BIOCHEM PARASIT, V132, P47, DOI 10.1016/j.molbiopara.2003.07.002; Roper JR, 2005, J BIOL CHEM, V280, P19728, DOI 10.1074/jbc.M502370200; Roper JR, 2002, P NATL ACAD SCI USA, V99, P5884, DOI 10.1073/pnas.092669999; Rudenko G, 2011, ESSAYS BIOCHEM, V51, P47, DOI [10.1042/BSE0510047, 10.1042/bse0510047]; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Schwartz KJ, 2013, EUKARYOT CELL, V12, P132, DOI 10.1128/EC.00293-12; Schwartz KJ, 2005, J CELL SCI, V118, P5499, DOI 10.1242/jcs.02667; Schwede A, 2010, PARASITOLOGY, V137, P2029, DOI 10.1017/S0031182009992034; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Stokes MJ, 2008, J BIOL CHEM, V283, P16147, DOI 10.1074/jbc.M709581200; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thoden JB, 2001, J BIOL CHEM, V276, P15131, DOI 10.1074/jbc.M100220200; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Turnock DC, 2007, J BIOL CHEM, V282, P28853, DOI 10.1074/jbc.M704742200; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; Urbaniak MD, 2006, EUKARYOT CELL, V5, P1906, DOI 10.1128/EC.00156-06; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Xu YX, 2010, J BIOL CHEM, V285, P24600, DOI 10.1074/jbc.M110.134544; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244	78	11	11	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10599	10615		10.1074/jbc.M113.453597	http://dx.doi.org/10.1074/jbc.M113.453597			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443657	Green Published, hybrid			2022-12-25	WOS:000317565000039
J	Halova, I; Draberova, L; Bambouskova, M; Machyna, M; Stegurova, L; Smrz, D; Draber, P				Halova, Ivana; Draberova, Lubica; Bambouskova, Monika; Machyna, Martin; Stegurova, Lucie; Smrz, Daniel; Draber, Petr			Cross-talk between Tetraspanin CD9 and Transmembrane Adaptor Protein Non-T Cell Activation Linker (NTAL) in Mast Cell Activation and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; ANTI-CD9 MONOCLONAL-ANTIBODY; FC-EPSILON RECEPTOR; GAMMA-II RECEPTOR; NEGATIVE REGULATION; PLATELET ACTIVATION; IMMUNOGLOBULIN-E; TERMINAL DOMAIN; LIPID RAFTS; MAJOR CD9	Chemotaxis, a process leading to movement of cells toward increasing concentrations of chemoattractants, is essential, among others, for recruitment of mast cells within target tissues where they play an important role in innate and adaptive immunity. Chemotaxis is driven by chemoattractants, produced by various cell types, as well as by intrinsic cellular regulators, which are poorly understood. In this study we prepared a new mAb specific for the tetraspanin CD9. Binding of the antibody to bone marrow-derived mast cells triggered activation events that included cell degranulation, Ca2+ response, dephosphorylation of ezrin/radixin/moesin (ERM) family proteins, and potent tyrosine phosphorylation of the non-T cell activation linker (NTAL) but only weak phosphorylation of the linker for activation of T cells (LAT). Phosphorylation of the NTAL was observed with whole antibody but not with its F(ab)(2) or Fab fragments. This indicated involvement of the Fc gamma receptors. As documented by electron microscopy of isolated plasma membrane sheets, CD9 colocalized with the high-affinity IgE receptor (Fc epsilon RI) and NTAL but not with LAT. Further tests showed that both anti-CD9 antibody and its F(ab)(2) fragment inhibited mast cell chemotaxis toward antigen. Experiments with bone marrow-derived mast cells deficient in NTAL and/or LAT revealed different roles of these two adaptors in antigen-driven chemotaxis. The combined data indicate that chemotaxis toward antigen is controlled in mast cells by a cross-talk among Fc epsilon RI, tetraspanin CD9, transmembrane adaptor proteins NTAL and LAT, and cytoskeleton-regulatory proteins of the ERM family.	[Halova, Ivana; Draberova, Lubica; Bambouskova, Monika; Machyna, Martin; Stegurova, Lucie; Smrz, Daniel; Draber, Petr] Acad Sci Czech Republ, Inst Mol Genet, Dept Signal Transduct, CZ-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Draber, P (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Lab Signal Transduct, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	draberpe@img.cas.cz	Draber, Petr/G-3412-2014; Draber, Petr/E-1119-2018; Smrz, Daniel/D-4853-2014; Draberova, Lubica/G-3505-2014; Halova, Ivana/G-3512-2014	Draber, Petr/0000-0002-3986-2025; Draber, Petr/0000-0002-3986-2025; Smrz, Daniel/0000-0003-0143-8744; Draberova, Lubica/0000-0002-2459-4435; Halova, Ivana/0000-0003-3078-7986; Machyna, Martin/0000-0002-3624-3472	Grant Agency of the Czech Republic [301/09/1826, P302/10/1759, P302/12/G101, 204/09/H084]; European Cooperation in Science and Technology [Action BM1007]; Technology Agency of the Czech Republic [LD12073 COST-CZ-MAST, TA01010436]; Ministry of Industry and Trade of the Czech Republic [FR-TI3/067]; Faculty of Science, Charles University, Prague, Czech Republic;  [RVO 68378050]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Technology Agency of the Czech Republic; Ministry of Industry and Trade of the Czech Republic; Faculty of Science, Charles University, Prague, Czech Republic(Czech Republic Government); 	This work was supported in part by the Projects 301/09/1826, P302/10/1759 and P302/12/G101, 204/09/H084 from Grant Agency of the Czech Republic, Action BM1007 from the European Cooperation in Science and Technology. Project LD12073 COST-CZ-MAST, Project TA01010436 of the Technology Agency of the Czech Republic, Project FR-TI3/067 of the Ministry of Industry and Trade of the Czech Republic, and Institutional Support Grant RVO 68378050.; Supported in part by the Faculty of Science, Charles University, Prague, Czech Republic.	BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Berditchevski F, 1999, J CELL BIOL, V146, P477, DOI 10.1083/jcb.146.2.477; Berditchevski F, 2001, J CELL SCI, V114, P4143; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; DRABER P, 1980, J IMMUNOGENET, V7, P455; Draber P, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00095; Draberova L, 1996, IMMUNOLOGY, V87, P141; Draberova L, 2007, J IMMUNOL, V179, P5169, DOI 10.4049/jimmunol.179.8.5169; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Fleming TJ, 1997, J EXP MED, V186, P1307, DOI 10.1084/jem.186.8.1307; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gonzalez-Espinosa C, 2003, J EXP MED, V197, P1453, DOI 10.1084/jem.20021806; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Halova I, 2002, INT IMMUNOL, V14, P213, DOI 10.1093/intimm/14.2.213; Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 1996, BBA-REV CANCER, V1287, P67, DOI 10.1016/0304-419X(96)00007-8; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Kimura T, 2001, IMMUNOL LETT, V75, P123, DOI 10.1016/S0165-2478(00)00295-9; Kotha J, 2008, EXP CELL RES, V314, P1811, DOI 10.1016/j.yexcr.2008.01.024; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kramer B, 2009, EUR J IMMUNOL, V39, P3447, DOI 10.1002/eji.200939234; KURODA K, 1995, J IMMUNOL, V155, P4427; Lebduska P, 2007, J IMMUNOL METHODS, V328, P139, DOI 10.1016/j.jim.2007.08.015; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Linnekin D, 1999, INT J BIOCHEM CELL B, V31, P1053, DOI 10.1016/S1357-2725(99)00078-3; Little KD, 2004, MOL BIOL CELL, V15, P2375, DOI 10.1091/mbc.E03-12-0886; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; ORTEGA E, 1988, EMBO J, V7, P4101, DOI 10.1002/j.1460-2075.1988.tb03304.x; Parameswaran N, 2011, J IMMUNOL, V186, P4088, DOI 10.4049/jimmunol.1001139; Philimonenko AA, 2000, J STRUCT BIOL, V132, P201, DOI 10.1006/jsbi.2000.4326; Qi JC, 2006, BLOOD, V107, P135, DOI 10.1182/blood-2005-03-1312; Qi RM, 1996, J IMMUNOL, V157, P5638; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; Rivera J, 2005, TRENDS IMMUNOL, V26, P119, DOI 10.1016/j.it.2005.01.001; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Simeoni L, 2008, IMMUNOL REV, V224, P215, DOI 10.1111/j.1600-065X.2008.00656.x; Smrz D, 2008, J BIOL CHEM, V283, P10904, DOI 10.1074/jbc.M710386200; Staser K, 2013, EXP HEMATOL, V41, P56, DOI 10.1016/j.exphem.2012.10.001; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; Tolar P, 2001, FOLIA BIOL-PRAGUE, V47, P215; Treanor B, 2011, J EXP MED, V208, P1055, DOI 10.1084/jem.20101125; Tumova M, 2010, EUR J IMMUNOL, V40, P3235, DOI 10.1002/eji.201040403; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Wedemeyer J, 2000, BRIT MED BULL, V56, P936, DOI 10.1258/0007142001903616; WORTHINGTON RE, 1990, BRIT J HAEMATOL, V74, P216, DOI 10.1111/j.1365-2141.1990.tb02568.x; Xu DS, 2009, FASEB J, V23, P3674, DOI 10.1096/fj.09-133462; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	64	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9801	9814		10.1074/jbc.M112.449231	http://dx.doi.org/10.1074/jbc.M112.449231			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23443658	hybrid, Green Published			2022-12-25	WOS:000317114000021
J	Belderok, SM; van den Hoek, A; Roeffen, W; Sauerwein, R; Sonder, GJB				Belderok, Sanne-Meike; van den Hoek, Anneke; Roeffen, Will; Sauerwein, Robert; Sonder, Gerard J. B.			Adherence to Chemoprophylaxis and Plasmodium falciparum Anti-Circumsporozoite Seroconversion in a Prospective Cohort Study of Dutch Short-Term Travelers	PLOS ONE			English	Article							MALARIA CHEMOPROPHYLAXIS; ATOVAQUONE-PROGUANIL; NONIMMUNE TRAVELERS; IMPORTED MALARIA; DECLINING INCIDENCE; NORTH-AMERICAN; RISK; PROPHYLAXIS; DETERMINANTS; TRANSMISSION	Background: We conducted a prospective study in a cohort of short-term travelers assessing the incidence rate of anti-circumsporozoite seroconversion, adherence to chemoprophylaxis, symptoms of malaria during travel, and malaria treatment abroad. Methods: Adults were recruited from the travel clinic of the Public Health Service Amsterdam. They kept a structured daily travel diary and donated blood samples before and after travel. Blood samples were serologically tested for the presence of Plasmodium falciparum anti-circumsporozoite antibodies. Results: Overall, the incidence rate (IR) of anti-circumsporozoite seroconversion was 0.8 per 100 person-months. Of 945 travelers, 620 (66%) visited high-endemic areas and were advised about both chemoprophylaxis and preventive measures against mosquito bites. Most subjects (520/620 = 84%) took at least 75% of recommended prophylaxis during travel. Travel to Africa, use of mefloquine, travel duration of 14-29 days in endemic areas, and concurrent use of DEET (N,N-diethyl-metatoluamide) were associated with good adherence practices. Four travelers without fever seroconverted, becoming anti-circumsporozoite antibody-positive. All four had been adherent to chemoprophylaxis; two visited Africa, one Suriname, one India. Ten subjects with fever were tested for malaria while abroad and of these, three received treatment. All three were adherent to chemoprophylaxis and tested negative for anti-circumsporozoite antibodies. Conclusion: Travel to Africa, using mefloquine, travel duration of 14-29 days in endemic areas, and use of DEET were associated with good adherence to chemoprophylaxis. The combination of chemoprophylaxis and other preventive measures were sufficient to protect seroconverting travelers from clinical malaria. Travelers who were treated for malaria abroad did not seroconvert.	[Belderok, Sanne-Meike; van den Hoek, Anneke; Sonder, Gerard J. B.] Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands; [Belderok, Sanne-Meike; van den Hoek, Anneke; Sonder, Gerard J. B.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Roeffen, Will; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Sonder, Gerard J. B.] Natl Coordinat Ctr Travellers Hlth Advice LCR, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Belderok, SM (corresponding author), Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.	sbelderok@ggd.amsterdam.nl	Sauerwein, Robert/C-8519-2013; Roeffen, W.F.G./L-4607-2015		the Netherlands Organization for Health Research and Development (ZonMw) [7115 0001]	the Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was conducted within the Amsterdam Academic Collaborative Center on Public Health: a collaboration between the Public Health Service of Amsterdam & the Academic Medical Center of the University of Amsterdam, the Netherlands. The Amsterdam Academic Collaborative Center on Public Health is financially supported by the Netherlands Organization for Health Research and Development (ZonMw; grant number 7115 0001, http://www.zonmw.nl/nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens RH, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-114; Behrens RH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-266; Behrens RH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-235; Chen LH, 2005, INFECT DIS CLIN N AM, V19, P185, DOI 10.1016/j.idc.2004.10.006; Cobelens FGJ, 1998, AM J TROP MED HYG, V58, P75, DOI 10.4269/ajtmh.1998.58.75; Cobelens FGJ, 1997, TROP MED INT HEALTH, V2, P705, DOI 10.1046/j.1365-3156.1997.d01-357.x; DePetrillo JC, 2010, J TRAVEL MED, V17, P217, DOI 10.1111/j.1708-8305.2010.00426.x; DRUILHE P, 1986, INFECT IMMUN, V53, P393, DOI 10.1128/IAI.53.2.393-397.1986; Goodyer L, 2011, J TRAVEL MED, V18, P245, DOI 10.1111/j.1708-8305.2011.00534.x; GYORKOS TW, 1995, AM J TROP MED HYG, V53, P511, DOI 10.4269/ajtmh.1995.53.511; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hogh B, 2000, LANCET, V356, P1888, DOI 10.1016/S0140-6736(00)03260-8; Huzly, 1996, J Travel Med, V3, P148, DOI 10.1111/j.1708-8305.1996.tb00729.x; Jelinek T, 1998, AM J TROP MED HYG, V59, P35, DOI 10.4269/ajtmh.1998.59.35; Jelinek T., 2008, Eurosurveillance, V13, P19077; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616; Knappik M, 2002, TROP MED INT HEALTH, V7, P652, DOI 10.1046/j.1365-3156.2002.00906.x; Lalloo DG, 2008, BMJ-BRIT MED J, V336, P1362, DOI 10.1136/bmj.a153; [Landelijk Cordinatiecentrum Reizigersadvisering National Coordination Centre for Traveller's Health Advice], 2007, NAT COORD CTR TRAV H; Leder K, 2008, J TRAVEL MED, V15, P263, DOI 10.1111/j.1708-8305.2008.00218.x; LOBEL HO, 1990, B WORLD HEALTH ORGAN, V68, P209; Lobel HO, 2001, J TRAVEL MED, V8, P167, DOI 10.2310/7060.2001.22206; Neave PE, 2010, J TRAVEL MED, V17, P346, DOI 10.1111/j.1708-8305.2010.00440.x; Nothdurft HD, 1999, CLIN INFECT DIS, V28, P641, DOI 10.1086/515155; Orlandi-Pradines E, 2006, AM J TROP MED HYG, V74, P979; Overbosch D, 2001, CLIN INFECT DIS, V33, P1015, DOI 10.1086/322694; Petersen E, 2000, J TRAVEL MED, V7, P79; Resseguier N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-41; Robert V, 2000, PARASITE IMMUNOL, V22, P589, DOI 10.1046/j.1365-3024.2000.00340.x; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Ropers G, 2008, J TRAVEL MED, V15, P162, DOI 10.1111/j.1708-8305.2008.00188.x; Sagui E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-232; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Schlagenhauf P, 2008, CLIN MICROBIOL REV, V21, P466, DOI 10.1128/CMR.00059-07; United Nations Statistics Division, 2011, COMP MACR CONT REG G; van Rijckevorsel GGC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-300; WEBSTER HK, 1987, J CLIN MICROBIOL, V25, P1002, DOI 10.1128/JCM.25.6.1002-1008.1987; Williams Christopher J, 2007, Travel Med Infect Dis, V5, P295, DOI 10.1016/j.tmaid.2007.05.001; World Health Organization, 2012, MAL FACTSH	39	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56863	10.1371/journal.pone.0056863	http://dx.doi.org/10.1371/journal.pone.0056863			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451100	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500036
J	Henderson, WR; Ye, X; Lai, Y; Ni, ZL; Bollinger, JG; Tien, YT; Chi, EY; Gelb, MH				Henderson, William R., Jr.; Ye, Xin; Lai, Ying; Ni, Zhanglin; Bollinger, James G.; Tien, Ying-Tzang; Chi, Emil Y.; Gelb, Michael H.			Key Role of Group V Secreted Phospholipase A(2) in Th2 Cytokine and Dendritic Cell-Driven Airway Hyperresponsiveness and Remodeling	PLOS ONE			English	Article							MOUSE ASTHMA MODEL; ALLERGIC PULMONARY INFLAMMATION; ARACHIDONIC-ACID RELEASE; GROUP-X; CYSTEINYL LEUKOTRIENES; IMMUNE-RESPONSES; PERITONEAL-MACROPHAGES; PROSTAGLANDIN E-2; HUMAN NEUTROPHILS; RECEPTOR	Background: Previous work has shown that disruption of the gene for group X secreted phospholipase A(2) (sPLA(2)-X) markedly diminishes airway hyperresponsiveness and remodeling in a mouse asthma model. With the large number of additional sPLA(2)s in the mammalian genome, the involvement of other sPLA(2)s in the asthma model is possible - in particular, the group V sPLA(2) (sPLA(2)-V) that like sPLA(2)-X is highly active at hydrolyzing membranes of mammalian cells. Methodology and Principal Findings: The allergen-driven asthma phenotype was significantly reduced in sPLA(2)-V-deficient mice but to a lesser extent than observed previously in sPLA(2)-X-deficient mice. The most striking difference observed between the sPLA(2)-V and sPLA(2)-X knockouts was the significant impairment of the primary immune response to the allergen ovalbumin (OVA) in the sPLA(2)-V-/- mice. The impairment in eicosanoid generation and dendritic cell activation in sPLA(2)-V-/- mice diminishes Th2 cytokine responses in the airways. Conclusions: This paper illustrates the diverse roles of sPLA(2)s in the immunopathogenesis of the asthma phenotype and directs attention to developing specific inhibitors of sPLA(2)-V as a potential new therapy to treat asthma and other allergic disorders.	[Henderson, William R., Jr.; Ye, Xin] Univ Washington, Dept Med, UW Med South Lake Union, Ctr Allergy & Inflammat, Seattle, WA 98195 USA; [Lai, Ying; Ni, Zhanglin; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Tien, Ying-Tzang; Chi, Emil Y.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Henderson, WR (corresponding author), Univ Washington, Dept Med, UW Med South Lake Union, Ctr Allergy & Inflammat, Seattle, WA 98195 USA.	wrhchem@u.washington.edu; gelb@chem.washington.edu		gelb, michael/0000-0001-7000-5219	National Institutes of Health [RO1 AI 42989, HL 73722, R37 HL36235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R01HL073722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health grants RO1 AI 42989 and HL 73722 (WRH) and R37 HL36235 (MHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Barrett NA, 2012, J IMMUNOL, V189, P4556, DOI 10.4049/jimmunol.1201865; BARTOLI F, 1994, J BIOL CHEM, V269, P15625; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Chizzolini C, 2009, IMMUNOL CELL BIOL, V87, P510, DOI 10.1038/icb.2009.56; Dannull J, 2012, BLOOD, V119, P3113, DOI 10.1182/blood-2011-10-385930; de Faudeur G, 2008, IMMUNOL LETT, V118, P21, DOI 10.1016/j.imlet.2008.02.006; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; Del Prete A, 2007, BLOOD, V109, P626, DOI 10.1182/blood-2006-02-003665; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Ghomashchi F, 2001, BBA-BIOMEMBRANES, V1513, P160, DOI 10.1016/S0005-2736(01)00349-2; Giannattasio G, 2010, J IMMUNOL, V185, P4430, DOI 10.4049/jimmunol.1001384; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Hallstrand TS, 2011, CLIN EXP ALLERGY, V41, P801, DOI 10.1111/j.1365-2222.2010.03676.x; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2000, J IMMUNOL, V164, P1086, DOI 10.4049/jimmunol.164.2.1086; Henderson WR, 2006, AM J RESP CRIT CARE, V173, P718, DOI 10.1164/rccm.200501-088OC; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Leigh R, 2002, AM J RESP CELL MOL, V27, P526, DOI 10.1165/rcmb.2002-0048OC; Machida I, 2004, J IMMUNOL, V172, P1833, DOI 10.4049/jimmunol.172.3.1833; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Okunishi K, 2004, J IMMUNOL, V173, P6393, DOI 10.4049/jimmunol.173.10.6393; Parameswaran K, 2004, J ALLERGY CLIN IMMUN, V114, P73, DOI 10.1016/j.jaci.2004.03.054; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Radhakrishnan S, 2005, P NATL ACAD SCI USA, V102, P11438, DOI 10.1073/pnas.0501420102; RIENDEAU D, 1994, J BIOL CHEM, V269, P15619; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Saiga A, 2001, BBA-MOL CELL BIOL L, V1530, P67, DOI 10.1016/S1388-1981(00)00167-0; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Shin EH, 2006, BIOCHEM BIOPH RES CO, V348, P606, DOI 10.1016/j.bbrc.2006.07.084; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Singh P, 2012, BLOOD, V119, P1671, DOI 10.1182/blood-2011-03-342428; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Thivierge M, 2006, J ALLERGY CLIN IMMUN, V117, P1155, DOI 10.1016/j.jaci.2005.12.1342; Thivierge M, 2009, J IMMUNOL, V183, P6778, DOI 10.4049/jimmunol.0901800; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Woszczek G, 2008, J IMMUNOL, V180, P7597, DOI 10.4049/jimmunol.180.11.7597; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	53	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56172	10.1371/journal.pone.0056172	http://dx.doi.org/10.1371/journal.pone.0056172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451035	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500007
J	Matic, M; Bryzgalova, G; Gao, H; Antonson, P; Humire, P; Omoto, Y; Portwood, N; Pramfalk, C; Efendic, S; Berggren, PO; Gustafsson, JA; Dahlman-Wright, K				Matic, Marko; Bryzgalova, Galyna; Gao, Hui; Antonson, Per; Humire, Patricia; Omoto, Yoko; Portwood, Neil; Pramfalk, Camilla; Efendic, Suad; Berggren, Per-Olof; Gustafsson, Jan-Ake; Dahlman-Wright, Karin			Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action	PLOS ONE			English	Article							LONG-TERM CONTROL; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; OVARIAN HORMONES; OB/OB MICE; MECHANISMS; RESISTANCE; SPECIFICITY; ACTIVATION; EXPRESSION	An increasing body of evidence now links estrogenic signalling with the metabolic syndrome (MS). Despite the beneficial estrogenic effects in reversing some of the MS symptoms, the underlying mechanisms remain largely undiscovered. We have previously shown that total estrogen receptor alpha (ER alpha) knockout (KO) mice exhibit hepatic insulin resistance. To determine whether liver-selective ablation of ER alpha recapitulates metabolic phenotypes of ERKO mice we generated a liver-selective ER alpha KO mouse model, LERKO. We demonstrate that LERKO mice have efficient reduction of ER alpha selectively within the liver. However, LERKO and wild type control mice do not differ in body weight, and have a comparable hormone profile as well as insulin and glucose response, even when challenged with a high fat diet. Furthermore, LERKO mice display very minor changes in their hepatic transcript profile. Collectively, our findings indicate that hepatic ER alpha action may not be the responsible factor for the previously identified hepatic insulin resistance in ER alpha KO mice.	[Matic, Marko; Gao, Hui; Antonson, Per; Humire, Patricia; Omoto, Yoko; Gustafsson, Jan-Ake; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Bryzgalova, Galyna; Portwood, Neil; Efendic, Suad; Berggren, Per-Olof] Karolinska Inst, Karolinska Univ Hosp L1, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signalling, Houston, TX USA; [Pramfalk, Camilla] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston; Karolinska Institutet	Dahlman-Wright, K (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.	karin.dahlman-wright@ki.se	Gao, Hui/AAF-9770-2019	Pramfalk, Camilla/0000-0003-4928-1256; Berggren, Per-Olof/0000-0001-8991-413X; Antonson, Per/0000-0001-9335-9941	Swedish Research Council; Cancerfonden [080482, 090678, 100404, 110588]; Novo Nordisk Foundation; Strategic Research Area in Diabetes at the Karolinska Institute; Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; BioCrine AB; Karolinska Bioinformatics and Expression Analysis core facility; Swedish Cancer Society; Robert A. Welch Foundation [E-0004];  [K2009-54X-21122-01-3];  [K2008-54X-20640-01-3];  [K2011-54X-20640-04-6]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Strategic Research Area in Diabetes at the Karolinska Institute; Center for Biosciences; KI Endomet network; King Gustaf V and Queen Victoria's Freemason's Foundation; BioCrine AB(HOGANAS ABStatisticon AB); Karolinska Bioinformatics and Expression Analysis core facility; Swedish Cancer Society(Swedish Cancer Society); Robert A. Welch Foundation(The Welch Foundation); ; ; 	This work is supported by the Swedish Research Council (http://www.vr.se/; The involvement of estrogen receptor signaling in insulin resistance and type 2 diabetes (project # K2009-54X-21122-01-3), Estrogen signaling in metabolic disease; a functional genomics approach (project # K2008-54X-20640-01-3) and Tissue-specific estrogen signaling - new insights in metabolic disease development (project # K2011-54X-20640-04-6)), Cancerfonden (http://www.cancerfonden.se; grant # 080482, 090678, 100404 and 110588), Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en/; Estrogen signaling in metabolic disease (2006), Molecular mechanisms underlying the regulation of body weight and the anti-diabetic effects of estrogen (2008), Genetic dissection of estrogen signaling in mice (2009), Genetic dissection of estrogen signaling in metabolic disease (2011)), the Strategic Research Area in Diabetes at the Karolinska Institute (http://ki.se/srp-diabetes; SFO/TM Diabetes (2010)), Center for Biosciences (http://ki.se/cb; grant # n/a (2009-2011)), the KI Endomet network (http://researchnetworks.ki.se/converis/; grant details n/a), King Gustaf V and Queen Victoria's Freemason's Foundation (http://www.frimurarorden.se; Molecular Mechanisms Underlying the Antidiabetic Effects of Estrogen (2008, 2009, 2010, 2011)); and BioCrine AB (website and grant details n/a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by BioCrine AB. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; The authors gratefully acknowledge the support and technical expertise of the Karolinska Bioinformatics and Expression Analysis core facility (www.bea.ki.se), and Dr. Rongrong Fan. J-A G is grateful to the Swedish Cancer Society and the Robert A. Welch Foundation (E-0004) for support.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AHLBORG G, 1986, J CLIN INVEST, V77, P690, DOI 10.1172/JCI112363; AHMEDSOROUR H, 1980, HORM RES, V13, P396, DOI 10.1159/000179307; Antonson P, 2012, BIOCHEM BIOPH RES CO, V424, P710, DOI 10.1016/j.bbrc.2012.07.016; Aragno M, 2009, FREE RADICAL BIO MED, V47, P1067, DOI 10.1016/j.freeradbiomed.2009.07.016; Aronoff S.L, 2004, DIABETES SPECTR, V17, P183, DOI [DOI 10.2337/DIASPECT.17.3.183, 10.2337/diaspect.17.3.183]; BAILEY CJ, 1980, DIABETOLOGIA, V19, P475, DOI 10.1007/BF00281829; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; D'Eon TM, 2005, J BIOL CHEM, V280, P35983, DOI 10.1074/jbc.M507339200; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Della Torre S, 2011, CELL METAB, V13, P205, DOI 10.1016/j.cmet.2011.01.002; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eshtiaghi R, 2010, MATURITAS, V65, P262, DOI 10.1016/j.maturitas.2009.11.004; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734; Jones MEE, 2007, NAT CLIN PRACT ENDOC, V3, P414, DOI 10.1038/ncpendmet0477; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Jones MEE, 2006, TRENDS ENDOCRIN MET, V17, P53, DOI 10.1016/j.tem.2006.01.004; Katzenellenbogen BS, 2000, J STEROID BIOCHEM, V74, P279, DOI 10.1016/S0960-0760(00)00104-7; Kendall DM, 2002, AM J MANAG CARE, V8, pS635; Knebel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031812; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Lindberg MK, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740167; Lundholm L, 2008, J ENDOCRINOL, V199, P275, DOI [10.1677/JOE-08-0192, 10.1530/JOE-08-0192e]; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Munoz J, 2002, OBES RES, V10, P424, DOI 10.1038/oby.2002.59; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Ohshiro T, 2011, ARTERIOSCL THROM VAS, V31, P1108, DOI 10.1161/ATVBAHA.111.223552; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ribas V, 2011, P NATL ACAD SCI USA; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Takeda K, 2003, J ENDOCRINOL, V176, P237, DOI 10.1677/joe.0.1760237; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009	52	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57458	10.1371/journal.pone.0057458	http://dx.doi.org/10.1371/journal.pone.0057458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451233	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500106
J	Mukherjee, J; Phillips, JJ; Zheng, SC; Wiencke, J; Ronen, SM; Pieper, RO				Mukherjee, Joydeep; Phillips, Joanna J.; Zheng, Shichun; Wiencke, John; Ronen, Sabrina M.; Pieper, Russell O.			Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma	PLOS ONE			English	Article							MESSENGER-RNA; CELL-METABOLISM; TUMOR-GROWTH; STEM-CELLS; CANCER; GLIOBLASTOMA; GLYCOLYSIS; ACTIVATION; ONCOGENES; COMPLEX	Normal tissues express the M1 isoform of pyruvate kinase (PK) that helps generate and funnel pyruvate into the mitochondria for ATP production. Tumors, in contrast, express the less active PKM2 isoform, which limits pyruvate production and spares glycolytic intermediates for the generation of macromolecules needed for proliferation. Although high PKM2 expression and low PK activity are considered defining features of tumors, very little is known about how PKM expression and PK activity change along the continuum from low grade to high grade tumors, and how these changes relate to tumor growth. To address this issue, we measured PKM isoform expression and PK activity in normal brain, neural progenitor cells, and in a series of over 100 astrocytomas ranging from benign grade I pilocytic astrocytomas to highly aggressive grade IV glioblastoma multiforme (GBM). All glioma exhibited comparably reduced levels of PKM1 expression and PK activity relative to normal brain. In contrast, while grade I-III gliomas all had modestly increased levels of PKM2 RNA and protein expression relative to normal brain, GBM, regardless of whether they arose de novo or progressed from lower grade tumors, showed a 3-5 fold further increase in PKM2 RNA and protein expression. Low levels of PKM1 expression and PK activity were important for cell growth as PKM1 over-expression and the accompanying increases in PK activity slowed the growth of GBM cells. The increased expression of PKM2, however, was also important, because shRNA-mediated PKM2 knockdown decreased total PKM2 and the already low levels of PK activity, but paradoxically also limited cell growth in vitro and in vivo. These results show that pyruvate kinase M expression, but not pyruvate kinase activity, is regulated in a grade-specific manner in glioma, but that changes in both PK activity and PKM2 expression contribute to growth of GBM.	[Mukherjee, Joydeep; Phillips, Joanna J.; Zheng, Shichun; Wiencke, John; Pieper, Russell O.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Phillips, Joanna J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Mukherjee, Joydeep; Phillips, Joanna J.; Zheng, Shichun; Wiencke, John; Ronen, Sabrina M.; Pieper, Russell O.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pieper, RO (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	rpieper@cc.ucsf.edu			National Institutes of Health [CA136774, CA097257, CA154915, NS063456]; NATIONAL CANCER INSTITUTE [R01CA136774, P50CA097257, R01CA154915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS063456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health grants CA136774 and CA097257 (SPORE) to ROP, CA154915 to SMR, and NS063456 to JJP. www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluemlein K, 2011, ONCOTARGET, V2, P393; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Chinnaiyan P, 2012, CANCER RES, V72, P5878, DOI 10.1158/0008-5472.CAN-12-1572-T; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Guminska M, 1997, ACTA BIOCHIM POL, V44, P711; Gupta V, 2010, PRO SCI, V19, P2131; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; IMAMURA K, 1986, MARKERS HUMAN NEUROE, P191; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kawaguchi T, 2006, CANCER RES, V66, P11331, DOI 10.1158/0008-5472.CAN-06-1540; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kleihues P, 2000, PATHOLOGY GENETICS T; Koss K, 2007, J CLIN PATHOL, V57, P1156; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mazurek S, 2001, BIOCHEM J, V356, P247, DOI 10.1042/0264-6021:3560247; Mirzoeva OK, 2006, MOL CANCER THER, V5, P2757, DOI 10.1158/1535-7163.MCT-06-0183; Nakamura JL, 2008, CANCER RES, V68, P6516, DOI 10.1158/0008-5472.CAN-07-6188; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Steinberg P, 1999, VIRCHOWS ARCH, V434, P213, DOI 10.1007/s004280050330; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolf A, 2010, ONCOTARGET, V1, P552, DOI 10.18632/oncotarget.190; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	40	67	70	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57610	10.1371/journal.pone.0057610	http://dx.doi.org/10.1371/journal.pone.0057610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451252	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500121
J	Stevens, RD; Tello, JS; Gavilanez, M				Stevens, Richard D.; Sebastian Tello, J.; Mercedes Gavilanez, Maria			Stronger Tests of Mechanisms Underlying Geographic Gradients of Biodiversity: Insights from the Dimensionality of Biodiversity	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; SPECIES-RICHNESS GRADIENTS; FUNCTIONAL DIVERSITY; NICHE CONSERVATISM; SPATIAL-PATTERNS; WORLD; BATS; SPECIATION; EVOLUTIONARY; SCALE	Inference involving diversity gradients typically is gathered by mechanistic tests involving single dimensions of biodiversity such as species richness. Nonetheless, because traits such as geographic range size, trophic status or phenotypic characteristics are tied to a particular species, mechanistic effects driving broad diversity patterns should manifest across numerous dimensions of biodiversity. We develop an approach of stronger inference based on numerous dimensions of biodiversity and apply it to evaluate one such putative mechanism: the mid-domain effect (MDE). Species composition of 10,000-km(2) grid cells was determined by overlaying geographic range maps of 133 noctilionoid bat taxa. We determined empirical diversity gradients in the Neotropics by calculating species richness and three indices each of phylogenetic, functional and phenetic diversity for each grid cell. We also created 1,000 simulated gradients of each examined metric of biodiversity based on a MDE model to estimate patterns expected if species distributions were randomly placed within the Neotropics. For each simulation run, we regressed the observed gradient onto the MDE-expected gradient. If a MDE drives empirical gradients, then coefficients of determination from such an analysis should be high, the intercept no different from zero and the slope no different than unity. Species richness gradients predicted by the MDE fit empirical patterns. The MDE produced strong spatially structured gradients of taxonomic, phylogenetic, functional and phenetic diversity. Nonetheless, expected values generated from the MDE for most dimensions of biodiversity exhibited poor fit to most empirical patterns. The MDE cannot account for most empirical patterns of biodiversity. Fuller understanding of latitudinal gradients will come from simultaneous examination of relative effects of random, environmental and historical mechanisms to better understand distribution and abundance of the current biota.	[Stevens, Richard D.; Sebastian Tello, J.; Mercedes Gavilanez, Maria] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Sebastian Tello, J.] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO USA; [Sebastian Tello, J.] Pontificia Univ Catolica Ecuador, Museo Zool, Pichincha, Quito, Ecuador	Louisiana State University System; Louisiana State University; Missouri Botanical Gardens; Pontificia Universidad Catolica del Ecuador	Stevens, RD (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	rstevens@lsu.edu		Tello, J. Sebastian/0000-0003-2539-6796				Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; Arita HT, 2005, J THEOR BIOL, V232, P119, DOI 10.1016/j.jtbi.2004.08.004; Baker R.J., 2003, OCCASIONAL PAPERS MU, V230, P1, DOI DOI 10.5962/BHL.TITLE.156931; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; CAMARGO JA, 1993, J THEOR BIOL, V161, P537, DOI 10.1006/jtbi.1993.1072; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; Colwell RK, 2009, EVOL ECOL RES, V11, P355; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koleff P, 2001, ECOGRAPHY, V24, P341, DOI 10.1034/j.1600-0587.2001.240312.x; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lyons SK, 1997, OIKOS, V79, P568, DOI 10.2307/3546901; McClain CR, 2007, GLOBAL ECOL BIOGEOGR, V16, P257, DOI 10.1111/j.1466-8238.2007.00286.x; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; MCNAB BK, 1969, COMP BIOCHEM PHYSIOL, V31, P227, DOI 10.1016/0010-406X(69)91651-X; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Morlon H, 2011, ECOL LETT, V14, P141, DOI 10.1111/j.1461-0248.2010.01563.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PATTERSON B. D., 2007, DIGITAL DISTRIBUTION; Patterson BD, 2003, BAT ECOLOGY, P536; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; PIELOU EC, 1975, MATH ECOLOGY; Rangel TFLVB, 2005, ECOL LETT, V8, P783, DOI 10.1111/j.1461-0248.2005.00786.x; Rangel TFLVB, 2007, AM NAT, V170, P602, DOI 10.1086/521315; Ricklefs Robert E., 1994, P13; Rosenzweig ML, 1997, EVOL ECOL, V11, P733, DOI 10.1023/A:1018490419885; SCHUM M, 1984, ECOLOGY, V65, P1315, DOI 10.2307/1938336; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V235, P1; Sokal RR, 1995, BIOMETRY; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; Stevens RD, 2004, J BIOGEOGR, V31, P665, DOI 10.1111/j.1365-2699.2003.01042.x; Stevens RD, 2006, OIKOS, V112, P41, DOI 10.1111/j.0030-1299.2006.13167.x; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2000, OIKOS, V89, P367, DOI 10.1034/j.1600-0706.2000.890218.x; Stevens RD, 2006, P ROY SOC B-BIOL SCI, V273, P2283, DOI 10.1098/rspb.2006.3596; Stevens RD, 2011, P ROY SOC B-BIOL SCI, V278, P2528, DOI 10.1098/rspb.2010.2341; Swingland Ian R., 2001, P377; Tello JS, 2012, GLOBAL ECOL BIOGEOGR, V21, P212, DOI 10.1111/j.1466-8238.2011.00661.x; Tello JS, 2010, ECOGRAPHY, V33, P796, DOI 10.1111/j.1600-0587.2009.05991.x; Tello JS, 2013, INVESTIGACI IN PRESS; Villalobos F, 2010, GLOBAL ECOL BIOGEOGR, V19, P200, DOI 10.1111/j.1466-8238.2009.00503.x; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Willig MR, 2011, SCIENCE, V333, P1709, DOI 10.1126/science.1212453; WILLIG MR, 1989, J BIOGEOGR, V16, P189, DOI 10.2307/2845093; Willig MR, 1998, OIKOS, V81, P93, DOI 10.2307/3546471; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WILSON DE, 1973, SYST ZOOL, V22, P14, DOI 10.2307/2412374; Zapata FA, 2005, AM NAT, V166, pE144, DOI 10.1086/491685; Zapata FA, 2003, J ANIM ECOL, V72, P677, DOI 10.1046/j.1365-2656.2003.00741.x	68	18	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56853	10.1371/journal.pone.0056853	http://dx.doi.org/10.1371/journal.pone.0056853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451099	Green Published, gold			2022-12-25	WOS:000316849500035
J	Verma, D; Jin, SX; Kanagaraj, A; Singh, ND; Daniel, J; Kolattukudy, PE; Miller, M; Daniell, H				Verma, Dheeraj; Jin, Shuangxia; Kanagaraj, Anderson; Singh, Nameirakpam D.; Daniel, Jaiyanth; Kolattukudy, Pappachan E.; Miller, Michael; Daniell, Henry			Expression of Fungal Cutinase and Swollenin in Tobacco Chloroplasts Reveals Novel Enzyme Functions and/or Substrates	PLOS ONE			English	Article							PLANT-CELL WALL; ECTOPIC EXPRESSION; TRANSGENIC PLANTS; THYLAKOID LIPIDS; PHOTOSYSTEM-II; ARABIDOPSIS; EXPANSINS; MEMBRANES; PROTEIN; BIOMASS	In order to produce low-cost biomass hydrolyzing enzymes, transplastomic lines were generated that expressed cutinase or swollenin within chloroplasts. While swollenin expressing plants were homoplasmic, cutinase transplastomic lines remained heteroplasmic. Both transplastomic lines showed interesting modifications in their phenotype, chloroplast structure, and functions. Ultrastructural analysis of chloroplasts from cutinase- and swollenin-expressing plants did not show typical lens shape and granal stacks. But, their thylakoid membranes showed unique scroll like structures and chloroplast envelope displayed protrusions, stretching into the cytoplasm. Unusual honeycomb structures typically observed in etioplasts were observed in mature chloroplasts expressing swollenin. Treatment of cotton fiber with chloroplast-derived swollenin showed enlarged segments and the intertwined inner fibers were irreversibly unwound and fully opened up due to expansin activity of swollenin, causing disruption of hydrogen bonds in cellulose fibers. Cutinase transplastomic plants showed esterase and lipase activity, while swollenin transplastomic lines lacked such enzyme activities. Higher plants contain two major galactolipids, monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG), in their chloroplast thylakoid membranes that play distinct roles in their structural organization. Surprisingly, purified cutinase effectively hydrolyzed DGDG to MGDG, showing alpha galactosidase activity. Such hydrolysis resulted in unstacking of granal thylakoids in chloroplasts and other structural changes. These results demonstrate DGDG as novel substrate and function for cutinase. Both MGDG and DGDG were reduced up to 47.7% and 39.7% in cutinase and 68.5% and 67.5% in swollenin expressing plants. Novel properties and functions of both enzymes reported here for the first time should lead to better understanding and enhanced biomass hydrolysis.	[Verma, Dheeraj; Jin, Shuangxia; Kanagaraj, Anderson; Singh, Nameirakpam D.; Daniel, Jaiyanth; Kolattukudy, Pappachan E.; Daniell, Henry] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Miller, Michael] Auburn Univ, Res Instrumentat Facil, Auburn, AL 36849 USA	State University System of Florida; University of Central Florida; Auburn University System; Auburn University	Daniell, H (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	Henry.Daniell@ucf.edu	Daniell, Henry/L-3655-2019; KANAGARAJ, A/GZG-4720-2022	Daniell, Henry/0000-0003-4485-1176; , Palsamy Kanagaraj/0000-0003-3297-3125; Jin, Shuangxia/0000-0002-1495-9154	United States Department of Agriculture (USDA)-Cooperative State Research, Education, and Extension Service (CSREES) [2009-39200-19972]; USDA-National Institute of Food and Agriculture (NIFA) [2010-39200-21704]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107904] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA)-Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA-National Institute of Food and Agriculture (NIFA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported in part by United States Department of Agriculture (USDA)-Cooperative State Research, Education, and Extension Service (CSREES) 2009-39200-19972 and USDA-National Institute of Food and Agriculture (NIFA) 2010-39200-21704 to Henry Daniell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; An XP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001179; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Chen S, 2008, J BIOL CHEM, V283, P25854, DOI 10.1074/jbc.M800848200; Chen XA, 2010, APPL ENVIRON MICROB, V76, P2556, DOI 10.1128/AEM.02499-09; Clarke JL, 2011, PLANT MOL BIOL, V76, P211, DOI 10.1007/s11103-011-9767-z; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2002, PLANT CELL PHYSIOL, V43, P1436, DOI 10.1093/pcp/pcf180; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Daniell H, 2001, J MOL BIOL, V311, P1001, DOI 10.1006/jmbi.2001.4921; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; DANTZIG AH, 1986, J BACTERIOL, V168, P911, DOI 10.1128/jb.168.2.911-916.1986; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Ding SY, 2012, SCIENCE, V338, P1055, DOI 10.1126/science.1227491; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; ETTINGER WF, 1987, BIOCHEMISTRY-US, V26, P7883, DOI 10.1021/bi00398a052; FETT WF, 1992, CURR MICROBIOL, V25, P165, DOI 10.1007/BF01571025; FUKS B, 1994, BIOPHYS J, V66, P1404, DOI 10.1016/S0006-3495(94)80931-2; Gray-Mitsumune M, 2008, PLANT BIOTECHNOL J, V6, P62, DOI 10.1111/j.1467-7652.2007.00295.x; Grobe K, 1999, EUR J BIOCHEM, V263, P33, DOI 10.1046/j.1432-1327.1999.00462.x; Hanus J, 2006, BIOPOLYMERS, V82, P59, DOI 10.1002/bip.20460; Jager G, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-33; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Jin SX, 2011, PLANT PHYSIOL, V155, P222, DOI 10.1104/pp.110.160754; Jones MR, 2007, PROG LIPID RES, V46, P56, DOI 10.1016/j.plipres.2006.06.001; Kalamaki MS, 2003, J AGR FOOD CHEM, V51, P7465, DOI 10.1021/jf0341666; KOLATTUKUDY PE, 1984, METHOD ENZYMOL, V106, P210; KOLATTUKUDY PE, 1981, ANNU REV PLANT PHYS, V32, P539, DOI 10.1146/annurev.pp.32.060181.002543; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; Kota Z, 2002, P NATL ACAD SCI USA, V99, P12149, DOI 10.1073/pnas.192463899; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kwon YR, 2008, BIOTECHNOL LETT, V30, P1281, DOI 10.1007/s10529-008-9678-5; Lee AG, 2000, CURR BIOL, V10, pR377, DOI 10.1016/S0960-9822(00)00477-2; Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902; Leelavathi S, 2003, MOL BREEDING, V11, P59, DOI 10.1023/A:1022168321380; LIN TS, 1980, EUR J BIOCHEM, V106, P341, DOI 10.1111/j.1432-1033.1980.tb04580.x; Maeda H, 2005, APPL MICROBIOL BIOT, V67, P778, DOI 10.1007/s00253-004-1853-6; MCQUEENMASON S, 1994, P NATL ACAD SCI USA, V91, P6574, DOI 10.1073/pnas.91.14.6574; Moon HS, 2010, ENVIRON MANAGE, V46, P531, DOI 10.1007/s00267-010-9503-5; Murphy CA, 1996, APPL ENVIRON MICROB, V62, P456, DOI 10.1128/AEM.62.2.456-460.1996; Neves Petersen MT, 1997, METHOD ENZYMOL, V284, P130; NUSSBERGER S, 1993, J MOL BIOL, V234, P347, DOI 10.1006/jmbi.1993.1591; Pali T, 2003, CELL MOL LIFE SCI, V60, P1591, DOI 10.1007/s00018-003-3173-x; Petersen K, 2011, PLANT MOL BIOL, V76, P311, DOI 10.1007/s11103-011-9742-8; Pien S, 2001, P NATL ACAD SCI USA, V98, P11812, DOI 10.1073/pnas.191380498; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2824, DOI 10.1021/bi00684a006; Ransom C, 2007, APPL BIOCHEM BIOTECH, V137, P207, DOI 10.1007/s12010-007-9053-3; Rochange SF, 2001, PLANT MOL BIOL, V46, P581, DOI 10.1023/A:1010650217100; Ruhlman T, 2010, PLANT PHYSIOL, V152, P2088, DOI 10.1104/pp.109.152017; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; SEBASTIAN J, 1987, J BACTERIOL, V169, P131, DOI 10.1128/jb.169.1.131-136.1987; SEN A, 1981, BIOCHIM BIOPHYS ACTA, V663, P380, DOI 10.1016/0005-2760(81)90167-3; Sieber P, 2000, PLANT CELL, V12, P721, DOI 10.1105/tpc.12.5.721; Simidjiev I, 1998, BIOCHEMISTRY-US, V37, P4169, DOI 10.1021/bi972726m; Singh N. Dolendro, 2009, V483, P163, DOI 10.1007/978-1-59745-407-0_10; Singh ND, 2008, PLANT CELL, V20, P3405, DOI 10.1105/tpc.108.063172; Smith M., 1991, ELECT MICROSCOPY BIO, P17; SOLIDAY CL, 1984, P NATL ACAD SCI-BIOL, V81, P3939, DOI 10.1073/pnas.81.13.3939; Stettler M, 2009, MOL PLANT, V2, P1233, DOI 10.1093/mp/ssp093; Szilagyi A, 2007, BBA-BIOMEMBRANES, V1768, P2310, DOI 10.1016/j.bbamem.2007.06.001; vanderVlugtBergmans CJB, 1997, MOL PLANT MICROBE IN, V10, P21, DOI 10.1094/MPMI.1997.10.1.21; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x; Wang GY, 2002, FUNGAL GENET BIOL, V35, P261, DOI 10.1006/fgbi.2001.1320; Wieczorek K, 2006, PLANT J, V48, P98, DOI 10.1111/j.1365-313X.2006.02856.x; Yu LX, 2007, J BIOTECHNOL, V131, P362, DOI 10.1016/j.jbiotec.2007.07.942; Ziegelhoffer T, 2009, PLANT BIOTECHNOL J, V7, P527, DOI 10.1111/j.1467-7652.2009.00421.x	73	32	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57187	10.1371/journal.pone.0057187	http://dx.doi.org/10.1371/journal.pone.0057187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451186	Green Published, gold			2022-12-25	WOS:000316849500077
J	Vigren, P; Tisell, A; Engstrom, M; Karlsson, T; Dahlqvist, OL; Lundberg, P; Landtblom, AM				Vigren, Patrick; Tisell, Anders; Engstrom, Maria; Karlsson, Thomas; Dahlqvist, Olof Leinhard; Lundberg, Peter; Landtblom, Anne-Marie			Low Thalamic NAA-Concentration Corresponds to Strong Neural Activation in Working Memory in Kleine-Levin Syndrome	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; N-ACETYLASPARTATE; BRAIN; LOAD; PATTERNS; SPECT	Background: Kleine Levin Syndrome (KLS) is a rare disorder of periodic hypersomnia and behavioural disturbances in young individuals. It has previously been shown to be associated with disturbances of working memory (WM), which, in turn, was associated with higher activation of the thalamus with increasing WM load, demonstrated with functional magnetic resonance imaging (fMRI). In this study we aimed to further elucidate how these findings are related to the metabolism of the thalamus. Methods: fMRI and magnetic resonance spectroscopy were applied while performing a WM task. Standard metabolites were examined: n-acetylaspartate (NAA), myo-inositol, choline, creatine and glutamate-glutamine. Fourteen KLS-patients and 15 healthy controls participated in the study. The patients with active disease were examined in asymptomatic periods. Results: There was a statistically significant negative correlation between thalamic fMRI-activation and thalamic NAA, i.e., high fMRI-activation corresponded to low NAA-levels. This correlation was not seen in healthy controls. Thalamic levels of NAA in patients and controls showed no significant differences between the groups. None of the other metabolites showed any co-variation with fMRI-activiation. Conclusion: This study shows negative correlation between NAA-levels and fMRI-activity in the left thalamus of KLS-patients while performing a WM task. This correlation could not be found in healthy control subjects, primarily interpreted as an effect of increased effort in the patient group upon performing the task. It might indicate a disturbance in the neuronal networks responsible for WM in KLS patients, resulting in higher effort at lower WM load, compared with healthy subjects. The general relationship between NAA and BOLD-signal is also discussed in the article.	[Vigren, Patrick; Landtblom, Anne-Marie] Linkoping Univ, Dept Clin & Expt Med IKE Neurosci, Linkoping, Sweden; [Vigren, Patrick] Cty Council Ostergotland, Dept Neurosurg, Linkoping, Sweden; [Vigren, Patrick; Tisell, Anders; Engstrom, Maria; Karlsson, Thomas; Dahlqvist, Olof Leinhard; Lundberg, Peter; Landtblom, Anne-Marie] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Tisell, Anders; Engstrom, Maria; Dahlqvist, Olof Leinhard; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Lundberg, Peter] Cty Council Ostergotland, Dept Radiat Phys UHL, Linkoping, Sweden; [Lundberg, Peter] Cty Council Ostergotland, Dept Radiol UHL, Linkoping, Sweden; [Landtblom, Anne-Marie] Cty Council Ostergotland, Dept Neurol, Linkoping, Sweden	Linkoping University; City Council Ostergotland; Linkoping University; Linkoping University; Linkoping University; City Council Ostergotland; City Council Ostergotland; City Council Ostergotland	Vigren, P (corresponding author), Linkoping Univ, Dept Clin & Expt Med IKE Neurosci, Linkoping, Sweden.	patrick.vigren@lio.se	Dahlqvist Leinhard, Olof/K-4228-2013; Lundberg, Peter/AGD-9679-2022	Dahlqvist Leinhard, Olof/0000-0002-6189-0807; Engstrom, Maria/0000-0002-2167-2450; Landtblom, Anne-Marie/0000-0001-9567-470X	County Council of Ostergotland; Swedish Research Council; KLS foundation	County Council of Ostergotland; Swedish Research Council(Swedish Research CouncilEuropean Commission); KLS foundation	Funding was obtained from the County Council of Ostergotland, the Swedish Research Council and the KLS foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arnulf I, 2005, BRAIN, V128, P2763, DOI 10.1093/brain/awh620; Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Baslow MH, 2000, J NEUROCHEM, V75, P453, DOI 10.1046/j.1471-4159.2000.0750453.x; Billings ME, 2011, SLEEP MED, V12, P532, DOI 10.1016/j.sleep.2011.01.009; Bor J, 2011, SCHIZOPHR RES, V125, P49, DOI 10.1016/j.schres.2010.10.018; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Choo WC, 2005, NEUROIMAGE, V25, P579, DOI 10.1016/j.neuroimage.2004.11.029; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Ende G, 2003, EUR ARCH PSY CLIN N, V253, P9, DOI 10.1007/s00406-003-0398-5; Engstrom M, 2009, SLEEP, V32, P681, DOI 10.1093/sleep/32.5.681; Friedman NP, 2005, BEHAV RES METHODS, V37, P581, DOI 10.3758/BF03192728; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; Hagino H, 2002, PSYCHIAT CLIN NEUROS, V56, P499, DOI 10.1046/j.1440-1819.2002.01045.x; Honma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012923; Huang YS, 2005, SLEEP, V28, P955, DOI 10.1093/sleep/28.8.955; Huang YS, 2012, SLEEP, V35, P123, DOI 10.5665/sleep.1600; Hyder F, 2001, NMR BIOMED, V14, P413, DOI 10.1002/nbm.733; Kleine W, 1925, MON PSYCHIATR NEUROL, V57, P285; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Landtblom AM, 2003, ACTA NEUROL SCAND, V108, P363, DOI 10.1034/j.1600-0404.2003.00171.x; Landtblom AM, 2002, ACTA NEUROL SCAND, V105, P318, DOI 10.1034/j.1600-0404.2002.1c162.x; Levin M, 1936, BRAIN, V59, P494, DOI 10.1093/brain/59.4.494; Lundin F, 2011, J NEUROL NEUROSUR PS, V82, P772, DOI 10.1136/jnnp.2010.223529; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Manoach DS, 2003, NEUROIMAGE, V20, P1670, DOI 10.1016/j.neuroimage.2003.08.002; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Murillo-Rodriguez E, 2009, CNS NEUROL DISORD-DR, V8, P245, DOI 10.2174/187152709788921654; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nyberg L, 2009, SCAND J PSYCHOL, V50, P41, DOI 10.1111/j.1467-9450.2008.00678.x; Poryazova R, 2007, J NEUROL, V254, P1445, DOI 10.1007/s00415-007-0531-x; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ross AJ, 2004, BRAIN RES REV, V44, P83, DOI 10.1016/j.brainresrev.2003.11.001; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Tisell AL, 2009, ABSOLUTE QUANTIFICAT; Tomasi D, 2007, BRAIN RES, V1132, P158, DOI 10.1016/j.brainres.2006.11.030; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635	40	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56279	10.1371/journal.pone.0056279	http://dx.doi.org/10.1371/journal.pone.0056279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451038	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500009
J	Andrade-Vieira, R; Xu, ZL; Colp, P; Marignani, PA				Andrade-Vieira, Rafaela; Xu, Zhaolin; Colp, Patricia; Marignani, Paola A.			Loss of lkb1 Expression Reduces the Latency of ErbB2-Mediated Mammary Gland Tumorigenesis, Promoting Changes in Metabolic Pathways	PLOS ONE			English	Article							BREAST-CANCER; TUMOR-GROWTH; KINASE LKB1; MTOR; ACTIVATION; TRASTUZUMAB; CONTRIBUTES; SUPPRESSION; DEFICIENCY; RESISTANCE	The tumor suppressor kinase LKB1 is mutated in a broad range of cancers however, the role of LKB1 mammary gland tumorigenesis is not fully understood. Evaluation of human breast cancer tissue microarrays, indicate that 31% of HER2 positive samples lacked LKB1 expression. To expand on these observations, we crossed STK11(fl/fl) mice with mice genetically engineered to express activated Neu/HER2-MMTV-Cre (NIC) under the endogenous Erbb2 promoter, to generate STK11(-/-)/NIC mice. In these mice, the loss of lkb1 expression reduced the latency of ErbB2-mediated tumorigenesis compared to the latency of tumorigenesis in NIC mice alone. Analysis of STK11(-/-)/NIC mammary tumors revealed hyperactivation of mammalian target of rapamycin (mTOR) through both mTORC1 and mTORC2 pathways as determined by the phosphorylation status of ribosomal protein S6 and AKT. Furthermore, STK11(-/-)/NIC mammary tumors had elevated ATP levels along with changes in metabolic enzymes and metabolites. The treatment of primary mammary tumor cells with specific mTOR inhibitors AZD8055 and Torin1, that target both mTOR complexes, attenuated mTOR activity and decreased expression of glycolytic enzymes. Our findings underscore the existence of a molecular interplay between LKB1-AMPK-mTORC1 and ErbB2-AKT-mTORC2 pathways with mTOR at its epicenter, suggestive that loss of LKB1 expression may serve as a marker for hyperactivated mTOR in HER2 positive breast cancer and warranting further investigation into therapeutics that target LKB1-AMPK-mTOR and glycolytic pathways.	[Andrade-Vieira, Rafaela; Marignani, Paola A.] Dalhousie Univ, Fac Med, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Xu, Zhaolin; Colp, Patricia; Marignani, Paola A.] Dalhousie Univ, Dept Pathol, Fac Med, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Marignani, PA (corresponding author), Dalhousie Univ, Fac Med, Dept Biochem & Mol Biol, Halifax, NS, Canada.	pmarigna@dal.ca		Marignani, Paola/0000-0001-8070-905X	CIHR-CRTP (Canadian Institutes of Health Research - The Cancer Research Training Program); Nova Scotia Health research Foundation; Beatrice Hunter Cancer Research Institute; CIHR-CRTP	CIHR-CRTP (Canadian Institutes of Health Research - The Cancer Research Training Program)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health research Foundation; Beatrice Hunter Cancer Research Institute; CIHR-CRTP(Canadian Institutes of Health Research (CIHR))	RA is supported by CIHR-CRTP (Canadian Institutes of Health Research - The Cancer Research Training Program). PM is supported by the Nova Scotia Health research Foundation, the Beatrice Hunter Cancer Research Institute and by private donations administered through the Dalhousie Medical Research Foundation, Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Jean Marshall and Jason Berman for their support. We thank Ria Sayat for her technical support. We thank the animal care staff in the Faculty of Medicine, Dalhousie University. RA is supported by CIHR-CRTP. PM is supported by the Nova Scotia Health Research Foundation, the Beatrice Hunter Cancer Research Institute and by private donations administered through the Dalhousie Medical Research Foundation.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Eskens F, 2008, BRIT J CANCER, V98, P80, DOI 10.1038/sj.bjc.6604108; Fenton H, 2006, APPL IMMUNOHISTO M M, V14, P146, DOI 10.1097/01.pai.0000176157.07908.20; Garcia-Martinez JM, 2011, BRIT J CANCER, V104, P1116, DOI 10.1038/bjc.2011.83; Gatenby RA, 1996, CANCER RES, V56, P5745; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Lim W, 2003, BRIT J CANCER, V89, P308, DOI 10.1038/sj.bjc.6601030; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Loden M, 2002, ONCOGENE, V21, P4680, DOI 10.1038/sj.onc.1205578; Marignani P.A., 2010, EMERGING SIGNALLING, P71; McCarthy A, 2009, J PATHOL, V219, P306, DOI 10.1002/path.2599; Mercier P, 2011, J BIOMOL NMR, V49, P307, DOI 10.1007/s10858-011-9480-x; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nath-Sain S, 2009, MOL BIOL CELL, V20, P2785, DOI 10.1091/mbc.E08-11-1138; Partanen JI, 2012, P NATL ACAD SCI USA, V109, pE388, DOI 10.1073/pnas.1120421109; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schade B, 2009, J BIOL CHEM, V284, P19018, DOI 10.1074/jbc.M109.018937; Scott KD, 2007, CANCER RES, V67, P5622, DOI 10.1158/0008-5472.CAN-07-0762; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; VARLEY JM, 1987, ONCOGENE, V1, P423; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weigelt B, 2011, ONCOGENE, V30, P3222, DOI 10.1038/onc.2011.42; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668	40	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56567	10.1371/journal.pone.0056567	http://dx.doi.org/10.1371/journal.pone.0056567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451056	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800018
J	Li, P; Li, F; Fang, YJ; Wan, DS; Pan, ZZ; Chen, G; Ma, G				Li, Pan; Li, Fen; Fang, Yujing; Wan, Desen; Pan, Zhizhong; Chen, Gong; Ma, Gang			Efficacy, Compliance and Reasons for Refusal of Postoperative Chemotherapy for Elderly Patients with Colorectal Cancer: A Retrospective Chart Review and Telephone Patient Questionnaire	PLOS ONE			English	Article							III COLON-CANCER; TRADITIONAL CHINESE MEDICINE; ADJUVANT-CHEMOTHERAPY; STAGE-II; POOLED ANALYSIS; RECTAL-CANCER; 1ST-LINE TREATMENT; THERAPY; AGE; CAPECITABINE	Background: Numerous clinical trials have demonstrated that elderly patients with colorectal cancer (CRC) can benefit from chemotherapy, yet compliance in real-world practice is low. The purpose of this study is to investigate the efficacy, compliance and reasons for refusal of postoperative chemotherapy for elderly patients with CRC and to provide corresponding strategies. Patients and methods: The clinico-pathological and biochemical data of the chemotherapy group and chemo-refusing group were compared among 386 elderly patients (>70 years old) with CRC who underwent surgery. 226 patients received chemotherapy and 160 patients refused. Follow-up of the subjective reasons for refusal was investigated using the elderly caner patients' chemo-refusal reason questionnaire (ECPCRRQ) prepared by the authors and a group of psychologists. The questionnaire is administrated by telephone. A predictive model for 5-year disease-free survival (DFS) and 5-year overall survival (OS) was constructed by using Kaplan-Meier analysis, logistic and Cox regression. Results: Among stage III patients, receiving chemotherapy was associated with a significantly higher OS (68%) compared to those who refused (OS50%) (HR: 2.05, 95%CI: 1.12-3.77, P = 0.02). The Chemo-refusal group had more female and elderly patients, significantly higher rate of severe complications, and lower body mass index (BMI). Follow-up phone questionnaire analysis showed the doctors' uncertainty of chemotherapy benefit, economic difficulties, uncomfortable feeling, superstition of Traditional Chinese Medicine, concealing information and lack of social support were the main factors for elderly CRC patients to decline chemotherapy. Conclusion: The receipt of post-operative chemotherapy in elderly patients with resected stage III CRC was associated with a more favorable survival. The low compliance rate (160/386) of postoperative chemotherapy was influenced by various subjective and objective factors.	[Li, Pan; Fang, Yujing; Wan, Desen; Pan, Zhizhong; Chen, Gong] Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Fen] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China; [Ma, Gang] Sun Yat Sen Univ, Ctr Canc, Dept Intens Care Unit, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Huazhong University of Science & Technology; Sun Yat Sen University	Chen, G (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Colorectal Surg, Guangzhou 510275, Guangdong, Peoples R China.	violet.lipan@163.com; magang@sysucc.org.com						Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224; BALDUCCI L, 2002, AM J CANC, V1, P101; Balducci L, 2005, SENIOR ADULT ONCOLOG, V1, P38; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Bouvier AM, 2005, ALIMENT PHARM THERAP, V22, P233, DOI 10.1111/j.1365-2036.2005.02559.x; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Cheung WY, 2009, DIS COLON RECTUM, V52, P1054, DOI 10.1007/DCR.0b013e3181a51173; Czaykowski P, 2007, ASCO GASTR CANC S; Faivre-Finn C, 2002, GUT, V51, P60, DOI 10.1136/gut.51.1.60; Feliu J, 2006, BRIT J CANCER, V94, P969, DOI 10.1038/sj.bjc.6603047; Feliu J, 2005, J CLIN ONCOL, V23, P3104, DOI 10.1200/JCO.2005.06.035; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; Folprecht G, 2004, ANN ONCOL, V15, P1330, DOI 10.1093/annonc/mdh344; Goldberg RM, 2006, J CLIN ONCOL, V24, P4085, DOI 10.1200/JCO.2006.06.9039; Gurney H, 1996, J CLIN ONCOL, V14, P2590, DOI 10.1200/JCO.1996.14.9.2590; Haberland J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-52; Haen E, 2011, PHARMACOPSYCHIATRY, V44, P254, DOI 10.1055/s-0031-1286285; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jensen SA, 2006, ACTA ONCOL, V45, P67, DOI 10.1080/02841860500375213; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Lima IS, 2002, CANCER, V10, P25954; Liu G, 1997, J CLIN ONCOL, V15, P110, DOI 10.1200/JCO.1997.15.1.110; Mahoney T, 2000, ARCH SURG-CHICAGO, V135, P182, DOI 10.1001/archsurg.135.2.182; National Institutes of Health, 1990, ADJ THER PAT COL REC, P1; Neugut AI, 2002, J CLIN ONCOL, V20, P2643, DOI 10.1200/JCO.2002.08.062; Pasetto LM, 2005, CRIT REV ONCOL HEMAT, V54, P145, DOI 10.1016/j.critrevonc.2004.12.003; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; REILLY JJ, 1993, CANCER CHEMOTH PHARM, V32, P411, DOI 10.1007/BF00685883; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Sasaki K, 2007, J CLIN ONCOL, V25; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; Schrag D, 2001, J CLIN ONCOL, V19, P3712, DOI 10.1200/JCO.2001.19.17.3712; Simmonds P, 2000, LANCET, V356, P968, DOI 10.1016/S0140-6736(00)02713-6; Tan KY, 2008, TECH COLOPROCTOL, V12, P1, DOI 10.1007/s10151-008-0392-z; Tao L, 2010, ARITCLE CHINESE, P1159; Yang YF, 2008, CHIN J INTEGR MED, V14, P251, DOI 10.1007/s11655-008-0251-9	38	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e55494	10.1371/journal.pone.0055494	http://dx.doi.org/10.1371/journal.pone.0055494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451026	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800003
J	Li, YB; Wang, DP; Wang, L; Yu, JH; Du, DH; Chen, Y; Gao, P; Wang, DM; Yu, J; Zhang, F; Fu, SL				Li, Yunbo; Wang, Dapeng; Wang, Lei; Yu, Jinhai; Du, Danhua; Chen, Ye; Gao, Peng; Wang, Duen-Mei; Yu, Jun; Zhang, Feng; Fu, Shuanglin			Distinct Genomic Aberrations between Low-Grade and High-Grade Gliomas of Chinese Patients	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; GENETIC ALTERATIONS; PATHWAY ACTIVATION; PROGRESSION; REVEALS; EXPRESSION; TUMORS; HYBRIDIZATION; ASTROCYTOMAS; METAANALYSIS	Background: Glioma is a type of tumor that develops in the central nerve system, mainly the brain. Alterations of genomic sequence and sequence segments (such as copy number variations or CNV and copy neutral loss of heterozygosities or cnLOH) are thought to be a major determinant of the tumor grade. Methods: We mapped genomic variations between low-grade and high-grade gliomas (LGG and HGG) in Chinese population based on Illumina's Beadchip and validated the results using real-time qPCR. Results: At the cytoband level, we discovered: (1) unique losses in LGG on 5q, 8p and 11q, and in HGG on 6q, 11p, 13q and 19q; (2) unique gains in the LGG on 1p and in HGG at 5p, 7p, 7q and 20q; and (3) cnLOH in HGG only on 3q, 8q, 10p, 14q, 15q, 17p, 17q, 18q and 21q. Subsequently, we confirmed well-characterized oncogenes among tumor-related loci (such as EGFR and KIT) and detected novel genes that gained chromosome sequences (such as AASS, HYAL4, NDUFA5 and SPAM1) in both LGG and HGG. In addition, we found gains, losses, and cnLOH in several genes, including VN1R2, VN1R4, and ZNF677, in multiple samples. Mapping grade-associated pathways and their related gene ontology (GO) terms, we classified LGG-associated functions as "arachidonic acid metabolism", "DNA binding" and "regulation of DNA-dependent transcription" and the HGG-associated as "neuroactive ligand-receptor interaction", "neuronal cell body" and "defense response to bacterium". Conclusion: LGG and HGG appear to have different molecular signatures in genomic variations and our results provide invaluable information for the diagnosis and treatment of gliomas in patients with variable duration or diverse tumor differentiation.	[Li, Yunbo; Yu, Jinhai; Du, Danhua; Gao, Peng; Fu, Shuanglin] Jilin Univ, Hosp 1, Changchun, Peoples R China; [Wang, Dapeng; Wang, Lei; Wang, Duen-Mei; Yu, Jun; Zhang, Feng] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Chen, Ye] Jilin Univ, Norman Bethune Coll Med, Changchun 130023, Peoples R China; [Li, Yunbo] Jilin Univ, Changchun 130023, Peoples R China; [Zhang, Feng] NE Normal Univ, Changchun, Peoples R China	Jilin University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Jilin University; Jilin University; Northeast Normal University - China	Wang, DP (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	wangdp@big.ac.cn; zhangf@big.ac.cn; fu.shuanglin@yahoo.com.cn	Wang, Dapeng/HGD-4818-2022		Research Fund of the Health Department of Jilin Province [2008P004]	Research Fund of the Health Department of Jilin Province	This work was supported by 2008 Research Fund of the Health Department of Jilin Province 2008P004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Arslantas A, 2007, PATHOL ONCOL RES, V13, P39, DOI 10.1007/BF02893439; Batchelor TT, 2004, CLIN CANCER RES, V10, P228, DOI 10.1158/1078-0432.CCR-0841-3; Blcuw HM, 2008, LANCET NEUROL, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Campbell BA, 2008, J NEURO-ONCOL, V89, P37, DOI 10.1007/s11060-008-9597-2; Cavaliere R, 2005, LANCET NEUROL, V4, P760, DOI 10.1016/S1474-4422(05)70222-2; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Cheng JX, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-305; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Czernicki T, 2007, INT J ONCOL, V30, P55; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Ferrer-Luna R, 2009, J NEURO-ONCOL, V95, P343, DOI 10.1007/s11060-009-9944-y; Freire P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004076; Gladson CL, 2010, ANNU REV PATHOL-MECH, V5, P33, DOI 10.1146/annurev-pathol-121808-102109; Hirose Y, 2003, CANCER GENET CYTOGEN, V142, P1, DOI 10.1016/S0165-4608(02)00791-4; Hu J, 2003, CHINESE MED J-PEKING, V116, P577; Idbaih A, 2008, J NEURO-ONCOL, V90, P133, DOI 10.1007/s11060-008-9644-z; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Jiang RC, 2006, PROTEOMICS, V6, P2964, DOI 10.1002/pmic.200500555; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koschny R, 2002, CANCER GENET CYTOGEN, V135, P147, DOI 10.1016/S0165-4608(01)00650-1; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Kotliarov Y, 2009, CANCER RES, V69, P1596, DOI 10.1158/0008-5472.CAN-08-2496; Kuga D, 2008, NEURO-ONCOLOGY, V10, P995, DOI 10.1215/15228517-2008-064; Larjavaara S, 2007, NEURO-ONCOLOGY, V9, P319, DOI 10.1215/15228517-2007-016; Liang BC, 1996, CANCER LETT, V105, P167, DOI 10.1016/0304-3835(96)04276-0; Liu FH, 2006, CANCER RES, V66, P10815, DOI 10.1158/0008-5472.CAN-06-1408; Marko NF, 2010, GENOMICS, V95, P16, DOI 10.1016/j.ygeno.2009.09.007; Misra A, 2005, CLIN CANCER RES, V11, P2907, DOI 10.1158/1078-0432.CCR-04-0708; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paugh BS, 2010, J CLIN ONCOL, V28, P3061, DOI 10.1200/JCO.2009.26.7252; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pouratian N, 2010, CURR NEUROL NEUROSCI, V10, P224, DOI 10.1007/s11910-010-0105-7; Qaddoumi I, 2009, CANCER BIOL THER, V8, P4, DOI 10.4161/cbt.8.1.7237; RADHAKRISHNAN K, 1995, ANN NEUROL, V37, P67, DOI 10.1002/ana.410370113; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Taylor LP, 2010, NEUROLOGY, V75, pS28, DOI 10.1212/WNL.0b013e3181fb3661; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Vranova V, 2007, ONCOL REP, V17, P457; Wong KK, 2006, CANCER RES, V66, P11172, DOI 10.1158/0008-5472.CAN-06-2438; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	54	80	81	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57168	10.1371/journal.pone.0057168	http://dx.doi.org/10.1371/journal.pone.0057168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451178	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800085
J	Nicholson, A; Ford, E; Davies, KA; Smith, HE; Rait, G; Tate, AR; Petersen, I; Cassell, J				Nicholson, Amanda; Ford, Elizabeth; Davies, Kevin A.; Smith, Helen E.; Rait, Greta; Tate, A. Rosemary; Petersen, Irene; Cassell, Jackie			Optimising Use of Electronic Health Records to Describe the Presentation of Rheumatoid Arthritis in Primary Care: A Strategy for Developing Code Lists	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; MEDICAL-RECORDS; OVARIAN-CANCER; PATIENT; DIAGNOSIS; DISEASE; EPIDEMIOLOGY; QUALITY	Background: Research using electronic health records (EHRs) relies heavily on coded clinical data. Due to variation in coding practices, it can be difficult to aggregate the codes for a condition in order to define cases. This paper describes a methodology to develop 'indicator markers' found in patients with early rheumatoid arthritis (RA); these are a broader range of codes which may allow a probabilistic case definition to use in cases where no diagnostic code is yet recorded. Methods: We examined EHRs of 5,843 patients in the General Practice Research Database, aged >= 30y, with a first coded diagnosis of RA between 2005 and 2008. Lists of indicator markers for RA were developed initially by panels of clinicians drawing up code-lists and then modified based on scrutiny of available data. The prevalence of indicator markers, and their temporal relationship to RA codes, was examined in patients from 3y before to 14d after recorded RA diagnosis. Findings: Indicator markers were common throughout EHRs of RA patients, with 83.5% having 2 or more markers. 34% of patients received a disease-specific prescription before RA was coded; 42% had a referral to rheumatology, and 63% had a test for rheumatoid factor. 65% had at least one joint symptom or sign recorded and in 44% this was at least 6-months before recorded RA diagnosis. Conclusion: Indicator markers of RA may be valuable for case definition in cases which do not yet have a diagnostic code. The clinical diagnosis of RA is likely to occur some months before it is coded, shown by markers frequently occurring >= 6 months before recorded diagnosis. It is difficult to differentiate delay in diagnosis from delay in recording. Information concealed in free text may be required for the accurate identification of patients and to assess the quality of care in general practice.	[Nicholson, Amanda; Ford, Elizabeth; Davies, Kevin A.; Smith, Helen E.; Cassell, Jackie] Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England; [Rait, Greta; Petersen, Irene] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Tate, A. Rosemary] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of Brighton; University of Sussex; University of London; University College London; University of Sussex	Ford, E (corresponding author), Brighton & Sussex Med Sch, Div Primary Care & Publ Hlth, Brighton, E Sussex, England.	e.m.ford@bsms.ac.uk	Smith, Helen E/M-2449-2016; Greiver, Michelle/N-8764-2015; Tate, Anne Rosemary/AAK-4512-2020; Petersen, Irene/C-5702-2009	Smith, Helen E/0000-0003-1883-6124; Greiver, Michelle/0000-0001-8957-0285; Petersen, Irene/0000-0002-0037-7524; Ford, Elizabeth/0000-0001-5613-8509; Cassell, Jackie/0000-0003-0777-0385; Rait, Greta/0000-0002-7216-7294; Davies, Kevin/0000-0003-1639-7017	Wellcome Trust - PREP (Patient Record Enhancement Project) study [086105/Z/08/Z]	Wellcome Trust - PREP (Patient Record Enhancement Project) study	The study was funded by the Wellcome Trust (http://www.wellcome.ac.uk/), grant number 086105/Z/08/Z - the PREP (Patient Record Enhancement Project) study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt U, 2007, RHEUMATOL INT, V28, P21, DOI 10.1007/s00296-007-0382-x; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Carroll Robert J, 2011, AMIA Annu Symp Proc, V2011, P189; Cassell JA, 2006, BMJ-BRIT MED J, V332, P332, DOI 10.1136/bmj.38726.404120.7C; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; DeLisle S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013377; DOLL R, 1954, BMJ-BRIT MED J, V1, P1451, DOI 10.1136/bmj.1.4877.1451; Edwards CJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P1151, DOI 10.1002/art.23003; Edwards CJ, 2005, RHEUMATOLOGY, V44, P1394, DOI 10.1093/rheumatology/kei024; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Hansen K., 2010, UK MILLENNIUM COHORT; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2007, TIME SERIES ANAL SEL; Houssien DA, 1998, SCAND J RHEUMATOL, V27, P300; Jordan K, 2006, RHEUMATOLOGY, V45, P126, DOI 10.1093/rheumatology/kei265; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Jordan K, 2006, J CLIN EPIDEMIOL, V59, P791, DOI 10.1016/j.jclinepi.2005.12.008; Koeling R., 2011, INT WORKSH HLTH TEXT, P43; Kumar K, 2007, RHEUMATOLOGY, V46, P1438, DOI 10.1093/rheumatology/kem130; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Linder JA, 2010, PHARMACOEPIDEM DR S, V19, P1211, DOI 10.1002/pds.2027; Manuel DG, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4226; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Meystre SM, 2008, YB MED INFORM, V128, P128; National Institute of Clinical Excellent (NICE), 2009, RHEUM ARTHR MAN RHEU, V79; Pakhomov SSV, 2007, AM HEART J, V153, P666, DOI 10.1016/j.ahj.2006.12.022; Pascoe SW, 2008, FAM PRACT, V25, P215, DOI 10.1093/fampra/cmn023; Sharp J, 2010, MEANINGFUL USE EHR D; Tate AR, 2010, BRIT J CANCER, V102, P947, DOI 10.1038/sj.bjc.6605593; Tate AR, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-42; Thiru K, 2003, BMJ-BRIT MED J, V326, P1070, DOI 10.1136/bmj.326.7398.1070; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van der Horst-Bruinsma IE, 1998, BRIT J RHEUMATOL, V37, P1084	36	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e54878	10.1371/journal.pone.0054878	http://dx.doi.org/10.1371/journal.pone.0054878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451024	Green Published, Green Accepted, gold			2022-12-25	WOS:000316658800002
J	Reising, A; Sambale, S; Donnerstag, F; Schmidt, JJ; Hafer, C; Schmidt, BMW; Kielstein, JT				Reising, Ansgar; Sambale, Saskia; Donnerstag, Frank; Schmidt, Julius J.; Hafer, Carsten; Schmidt, Bernhard M. W.; Kielstein, Jan T.			Effect of Isovolemic, Isothermic Hemodialysis on Cerebral Perfusion and Vascular Stiffness Using Contrast Computed Tomography and Pulse Wave Velocity	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; ARTERIAL STIFFNESS; BLOOD-FLOW; DIALYSIS; INDEX; MORTALITY; DYSFUNCTION; DECREASES; FAILURE	Background: Patients undergoing hemodialysis treatment have a six-fold increased risk for stroke relative to the general population. However, the effect of hemodialysis on cerebral blood flow is poorly studied and confounding factors like blood pressure and ultrafiltration as well as temperature changes have rarely been accounted for. The aim of our study was to use state-of-the-art technology to evaluate the effect of a single dialysis session on cerebral perfusion as well as on vascular stiffness. Methods: Chronic hemodialysis patients (7 male/3 female, mean age 58 years) were recruited. Cerebral blood flow and arterial pulse wave velocity were measured before and immediately after a hemodialysis session. To exclude effects of volume changes we kept ultrafiltration to a minimum, allowing no change in body weight. Isothermic conditions were maintained by using the GENIUS single-pass batch-dialysis system with a high-flux polysulfone dialyser. Cerebral blood flow was measured by contrast-enhanced computed tomography. Pulse wave velocity was measured using the SphygmoCor (AtCor Medical, USA) device by a single operator. Results: This study shows for the first time that isovolemic, isothermic hemodialysis neither affected blood pressure or heart rate, nor total or regional cerebral perfusion. There was also no change in pulse wave velocity. Conclusions: Mechanisms other than the dialysis procedure itself might be causative for the high incidence of ischemic strokes in this patient population. Moreover, the sole removal of uremic toxins does not lead to short-term effects on vascular stiffness, underlying the importance of volume control in this patient population.	[Reising, Ansgar; Sambale, Saskia; Schmidt, Julius J.; Hafer, Carsten; Schmidt, Bernhard M. W.; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Donnerstag, Frank] Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany	Hannover Medical School; Hannover Medical School	Kielstein, JT (corresponding author), Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany.	Kielstein@yahoo.com	Kielstein, Jan T./I-2956-2019; Donnerstag, Frank/N-6853-2017	Kielstein, Jan T./0000-0001-8110-9064; Donnerstag, Frank/0000-0002-6798-1929	Else-Kroner-Fresenius Foundation [P63/06//EKMS 06/03]; Fresenius Medical Care Germany	Else-Kroner-Fresenius Foundation; Fresenius Medical Care Germany	This study was supported by an unrestricted grant of the Else-Kroner-Fresenius Foundation (P63/06//EKMS 06/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JTK recieved unrestricted research support from Fresenius Medical Care Germany. JTK received speaker fees from Fresenius Medical Care Germany. All other authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bisdas S, 2006, EUR RADIOL, V16, P2220, DOI 10.1007/s00330-006-0209-2; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Blacher J, 2003, KIDNEY INT, V63, P1852, DOI 10.1046/j.1523-1755.2003.00932.x; Chung AWY, 2010, NEPHROL DIAL TRANSPL, V25, P4031, DOI 10.1093/ndt/gfq202; Covic A, 2004, NEPHROL DIAL TRANSPL, V19, P637, DOI 10.1093/ndt/gfg568; Di Iorio B, 2010, NEPHROL DIAL TRANSPL, V25, P1579, DOI 10.1093/ndt/gfp662; Fliser D, 2006, NAT CLIN PRACT NEPHR, V2, P32, DOI 10.1038/ncpneph0060; Flythe JE, 2011, KIDNEY INT, V79, P250, DOI 10.1038/ki.2010.383; Georgianos PI, 2011, AM J NEPHROL, V34, P407, DOI 10.1159/000331700; Gusbeth-Tatomir P, 2007, KIDNEY BLOOD PRESS R, V30, P97, DOI 10.1159/000100905; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Hogas S, 2011, INT UROL NEPHROL; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Kalantar-Zadeh K, 2009, CIRCULATION, V119, P671, DOI 10.1161/CIRCULATIONAHA.108.807362; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Kooman JP, 2006, BLOOD PURIFICAT, V24, P218, DOI 10.1159/000091015; Kosch M, 2001, NEPHROL DIAL TRANSPL, V16, P1663, DOI 10.1093/ndt/16.8.1663; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; London GM, 2004, KIDNEY INT, V65, P700, DOI 10.1111/j.1523-1755.2004.00434.x; Lonnemann G, 2000, NEPHROL DIAL TRANSPL, V15, P1189, DOI 10.1093/ndt/15.8.1189; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Metry G, 2002, AM J KIDNEY DIS, V40, P996, DOI 10.1053/ajkd.2002.36333; Prohovnik I, 2007, J CEREBR BLOOD F MET, V27, P1861, DOI 10.1038/sj.jcbfm.9600478; Regolisti G, 2013, NEPHROL DIAL TRANSPL, V28, P79, DOI 10.1093/ndt/gfs182; Selby NM, 2006, CLIN J AM SOC NEPHRO, V1, P1216, DOI 10.2215/CJN.02010606; Stefanidis I, 2005, CLIN NEPHROL, V64, P129; Su HM, 2007, HYPERTENS RES, V30, P965, DOI 10.1291/hypres.30.965; Usvyat LA, 2011, NEPHROL DIAL TRANSPL; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	29	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56396	10.1371/journal.pone.0056396	http://dx.doi.org/10.1371/journal.pone.0056396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451044	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800010
J	Rodriguez, RM; Suarez-Alvarez, B; Salvanes, R; Muro, M; Martinez-Camblor, P; Colado, E; Sanchez, MA; Diaz, MG; Fernandez, AF; Fraga, MF; Lopez-Larrea, C				Rodriguez, Ramon M.; Suarez-Alvarez, Beatriz; Salvanes, Ruben; Muro, Manuel; Martinez-Camblor, Pablo; Colado, Enrique; Alcoceba Sanchez, Miguel; Gonzalez Diaz, Marcos; Fernandez, Agustin F.; Fraga, Mario F.; Lopez-Larrea, Carlos			DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; IFN-GAMMA PROMOTER; T-HELPER-CELL; INTERFERON-GAMMA; FAS-LIGAND; GENE; DIFFERENTIATION; EPIGENETICS; EXPRESSION; CYTOKINE	Epigenetic deregulation is considered a common hallmark of cancer. Nevertheless, recent publications have demonstrated its association with a large array of human diseases. Here, we explore the DNA methylation dynamics in blood samples during hematopoietic cell transplant and how they are affected by pathophysiological events during transplant evolution. We analyzed global DNA methylation in a cohort of 47 patients with allogenic transplant up to 12 months post-transplant. Recipients stably maintained the donor's global methylation levels after transplant. Nonetheless, global methylation is affected by chimerism status. Methylation analysis of promoters revealed that methylation in more than 200 genes is altered 1 month post-transplant when compared with non-pathological methylation levels in the donor. This number decreased by 6 months post-transplant. Finally, we analyzed methylation in IFN-gamma, FASL, IL-10, and PRF1 and found association with the severity of the acute graft-versus-host disease. Our results provide strong evidence that methylation changes in blood are linked to underlying physiological events and demonstrate that DNA methylation analysis is a viable strategy for the study of transplantation and for development of biomarkers.	[Rodriguez, Ramon M.; Fernandez, Agustin F.; Fraga, Mario F.] Univ Oviedo, HUCA, IUOPA, Canc Epigenet Lab, Oviedo, Spain; [Suarez-Alvarez, Beatriz; Salvanes, Ruben; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Dept Immunol, Oviedo, Spain; [Muro, Manuel] Hosp Virgen Arrixaca, Dept Immunol, Murcia, Spain; [Martinez-Camblor, Pablo] OIB, CAIBER, Unidad Apoyo Invest, Oviedo, Spain; [Colado, Enrique] Hosp Univ Cent Asturias, Dept Hematol, Oviedo, Spain; [Alcoceba Sanchez, Miguel; Gonzalez Diaz, Marcos] Hosp Univ Salamanca, Serv Hematol & Hemoterapia, Salamanca, Spain; [Fraga, Mario F.] CSIC, Dept Immunol & Oncol, CNB, Madrid, Spain; [Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain	Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; Hospital Clinico Universitario Virgen de la Arrixaca; Central University Hospital Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Fraga, MF (corresponding author), Univ Oviedo, HUCA, IUOPA, Canc Epigenet Lab, Oviedo, Spain.	mffraga@cnb.csic.es; inmuno@hca.es	Colado, Enrique/Z-6326-2019; Alcoceba, Miguel/B-7873-2017; Alcoceba, Miguel/AAH-2784-2020; Camblor, Pablo Martinez/Z-4834-2019; Fraga, Mario F/H-7824-2017; Colado, Enrique/GXF-7705-2022; Martinez-Camblor, Pablo/Q-1715-2015; Fernandez, Agustin F./N-7302-2014; Rodriguez, Ramon Maria/AAF-9376-2019; Alcoceba, Miguel/GXH-4002-2022; RG, SMABSS/N-3322-2018	Colado, Enrique/0000-0001-8675-8207; Alcoceba, Miguel/0000-0002-3819-4846; Camblor, Pablo Martinez/0000-0001-7845-3905; Fraga, Mario F/0000-0001-8450-2603; Fernandez, Agustin F./0000-0002-3792-4085; Rodriguez, Ramon Maria/0000-0002-6770-5123; Alcoceba, Miguel/0000-0002-3819-4846; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942; Lopez-Larrea, Carlos/0000-0001-9988-1730; Martinez-Camblor, Pablo/0000-0003-3032-9598; RG, SMABSS/0000-0001-9944-3861	Red de Investigacion Renal (REDinREN); Institute "Carlos III" [FIS PI08/0566]	Red de Investigacion Renal (REDinREN); Institute "Carlos III"(Instituto de Salud Carlos III)	This work was supported by the Spanish grants from Red de Investigacion Renal (REDinREN) and the FIS PI08/0566 from Institute "Carlos III". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Im SH, 2004, J BIOL CHEM, V279, P46818, DOI 10.1074/jbc.M401722200; Jaksch M, 2004, TRANSPLANTATION, V77, P195, DOI 10.1097/01.TP.0000100465.83529.42; Janson PCJ, 2011, J IMMUNOL, V186, P92, DOI 10.4049/jimmunol.1000960; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanda Y, 1998, BONE MARROW TRANSPL, V22, P751, DOI 10.1038/sj.bmt.1701427; Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lu QJ, 2003, J IMMUNOL, V170, P5124, DOI 10.4049/jimmunol.170.10.5124; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miura Y, 2002, BLOOD, V100, P2650, DOI 10.1182/blood-2002-01-0176; Naesens M, 2010, NAT REV NEPHROL, V6, P614, DOI 10.1038/nrneph.2010.113; Narasimhan Supraja, 2009, BMC Res Notes, V2, P104, DOI 10.1186/1756-0500-2-104; Nishiyama R, 2005, MOL CANCER RES, V3, P617, DOI 10.1158/1541-7786.MCR-05-0146; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Puliaev R, 2004, J IMMUNOL, V173, P910, DOI 10.4049/jimmunol.173.2.910; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shustov A, 1998, J IMMUNOL, V161, P2848; Takatsuta H, 1999, BONE MARROW TRANSPL, V24, P1005, DOI 10.1038/sj.bmt.1702010; Tato C, 2004, J IMMUNOL, V173, P1514, DOI 10.4049/jimmunol.173.3.1514; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Volkmar M, 2010, EMBO J; Yang YG, 2005, CELL MOL IMMUNOL, V2, P323; Zediak VP, 2011, CURR OPIN GENET DEV, V21, P154, DOI 10.1016/j.gde.2011.01.016; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335	50	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56931	10.1371/journal.pone.0056931	http://dx.doi.org/10.1371/journal.pone.0056931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451113	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800049
J	Sood, R; Carrington, B; Bishop, K; Jones, M; Rissone, A; Candotti, F; Chandrasekharappa, SC; Liu, P				Sood, Raman; Carrington, Blake; Bishop, Kevin; Jones, MaryPat; Rissone, Alberto; Candotti, Fabio; Chandrasekharappa, Settara C.; Liu, Paul			Efficient Methods for Targeted Mutagenesis in Zebrafish Using Zinc-Finger Nucleases: Data from Targeting of Nine Genes Using CompoZr or CoDA ZFNs	PLOS ONE			English	Article							POOL ENGINEERING OPEN; TAL EFFECTORS; GENOME; DNA; TRANSCRIPTION; INACTIVATION; SELECTION; PROTEINS; MUTATION; PROJECT	Recently, it has been shown that targeted mutagenesis using zinc-finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) can be used to generate knockout zebrafish lines for analysis of their function and/or developing disease models. A number of different methods have been developed for the design and assembly of gene-specific ZFNs and TALENs, making them easily available to most zebrafish researchers. Regardless of the choice of targeting nuclease, the process of generating mutant fish is similar. It is a time-consuming and multi-step process that can benefit significantly from development of efficient high throughput methods. In this study, we used ZFNs assembled through either the CompoZr (Sigma-Aldrich) or the CoDA (context-dependent assembly) platforms to generate mutant zebrafish for nine genes. We report our improved high throughput methods for 1) evaluation of ZFNs activity by somatic lesion analysis using colony PCR, eliminating the need for plasmid DNA extractions from a large number of clones, and 2) a sensitive founder screening strategy using fluorescent PCR with PIG-tailed primers that eliminates the stutter bands and accurately identifies even single nucleotide insertions and deletions. Using these protocols, we have generated multiple mutant alleles for seven genes, five of which were targeted with CompoZr ZFNs and two with CoDA ZFNs. Our data also revealed that at least five-fold higher mRNA dose was required to achieve mutagenesis with CoDA ZFNs than with CompoZr ZFNs, and their somatic lesion frequency was lower (<5%) when compared to CopmoZr ZFNs (9-98%). This work provides high throughput protocols for efficient generation of zebrafish mutants using ZFNs and TALENs.	[Sood, Raman; Carrington, Blake; Bishop, Kevin] NHGRI, Zebrafish Core Facil, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Jones, MaryPat; Chandrasekharappa, Settara C.] NHGRI, Genom Core, Genome Technol Branch, Bethesda, MD 20892 USA; [Rissone, Alberto; Candotti, Fabio] NHGRI, Disorders Immun Sect, Genet & Mol Biol Branch, Bethesda, MD 20892 USA; [Liu, Paul] NHGRI, Oncogenesis & Dev Sect, Genet & Mol Biol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sood, R (corresponding author), NHGRI, Zebrafish Core Facil, Genet & Mol Biol Branch, Bethesda, MD 20892 USA.	rsood@mail.nih.gov	Liu, Paul/A-7976-2012	Liu, Paul/0000-0002-6779-025X; Candotti, Fabio/0000-0001-6399-6042	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIGHG200351, ZIAHG000102, ZIAHG000121] Funding Source: NIH RePORTER	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Ben J, 2011, DEVELOPMENT, V138, P4969, DOI 10.1242/dev.070862; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; BROWNSTEIN MJ, 1996, BIOTECHNIQUES, V20, P1008; Cade L, 2012, NUCL ACIDS RES; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Gupta A, 2011, NUCLEIC ACIDS RES, V39, P381, DOI 10.1093/nar/gkq787; Guryev V, 2006, GENOME RES, V16, P491, DOI 10.1101/gr.4791006; Haffter P, 1996, DEVELOPMENT, V123, P1; Huang P, 2012, J GENET GENOMICS, V39, P421, DOI 10.1016/j.jgg.2012.07.004; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Jao Li-En, 2008, Briefings in Functional Genomics & Proteomics, V7, P427, DOI 10.1093/bfgp/eln038; Kettleborough RNW, 2011, METHOD CELL BIOL, V104, P121, DOI 10.1016/B978-0-12-374814-0.00006-9; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sander JD, 2010, NUCLEIC ACIDS RES, V38, pW462, DOI 10.1093/nar/gkq319; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Siekmann AF, 2009, GENE DEV, V23, P2272, DOI 10.1101/gad.1813509; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Winkler S, 2011, METHODS MOL BIOL, V770, P475, DOI 10.1007/978-1-61779-210-6_19; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779	45	40	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57239	10.1371/journal.pone.0057239	http://dx.doi.org/10.1371/journal.pone.0057239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451191	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800094
J	Verleger, R; Dittmer, M; Smigasiewicz, K				Verleger, Rolf; Dittmer, Marie; Smigasiewicz, Kamila			Cooperation or Competition of the Two Hemispheres in Processing Characters Presented at Vertical Midline	PLOS ONE			English	Article							VISUAL-FIELD; CEREBRAL HEMISPHERES; SPATIAL ATTENTION; WORD RECOGNITION; MODULATION; ACTIVATION; ASYMMETRY; STIMULUS; TASK	Little is known about how the hemispheres interact in processing of stimuli presented at vertical midline. Processing might be mutually independent or cooperative. Here we measured target identification and visually evoked EEG potentials while stimulus streams containing two targets, T1 and T2, were either presented at vertical midline above and below fixation, or laterally, left and right. With left and right streams, potentials evoked by filler stimuli and by T2 were earlier at the right than the left visual cortex, and T2 was better identified left than right, confirming earlier results and suggesting better capabilities of the right hemisphere in this task. With streams above and below fixation, EEG potentials evoked by filler stimuli and by T2 were likewise earlier at the right than the left hemisphere, and T2 was generally identified as well as, but not better than left T2, in one target constellation even worse (T2 in lower stream preceded by T1 in upper stream). These results suggest right-hemisphere preference for this task even with stimuli at vertical midline, and no added value through hemispheric cooperation. Lacking asymmetry for T1 amidst asymmetries for filler stimuli and for T2 might indicate alternating access of the hemispheres to midline stimuli as one means of hemispheric division of labor.	[Verleger, Rolf; Dittmer, Marie; Smigasiewicz, Kamila] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany	University of Lubeck	Verleger, R (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	rolf.verleger@neuro.uni-luebeck.de			Deutsche Forschungsgemeinschaft, as part of the package proposal "neuro-cognitive mechanisms of conscious and unconscious visual perception" [VE110/15-2, PAK270]	Deutsche Forschungsgemeinschaft, as part of the package proposal "neuro-cognitive mechanisms of conscious and unconscious visual perception"	This research was funded by grant VE110/15-2 from the Deutsche Forschungsgemeinschaft (www.dfg.de) to the first author, as part of the package proposal "neuro-cognitive mechanisms of conscious and unconscious visual perception" (PAK270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brysbaert M, 2005, J RES READ, V28, P216, DOI 10.1111/j.1467-9817.2005.00266.x; Delvenne JF, 2012, COGNITION, V122, P258, DOI 10.1016/j.cognition.2011.10.015; Ellis AW, 2010, NEUROPSYCHOLOGIA, V48, P353, DOI 10.1016/j.neuropsychologia.2009.08.021; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Greene DJ, 2011, NEUROPSYCHOLOGIA, V49, P61, DOI 10.1016/j.neuropsychologia.2010.11.007; HELLIGE JB, 1979, J EXP PSYCHOL GEN, V108, P251, DOI 10.1037/0096-3445.108.2.251; Hollander A, 2005, NEUROPSYCHOLOGIA, V43, P35, DOI 10.1016/j.neuropsychologia.2004.06.006; Hunter ZR, 2007, J COGNITIVE NEUROSCI, V19, P1373, DOI 10.1162/jocn.2007.19.8.1373; Jaskowski P, 2002, PSYCHOL SCI, V13, P48, DOI 10.1111/1467-9280.00408; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2341, DOI 10.1016/j.neuropsychologia.2008.07.020; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kraft A, 2007, BRAIN RES, V1133, P123, DOI 10.1016/j.brainres.2006.11.043; Leff A, 2004, BRAIN LANG, V88, P268, DOI 10.1016/S0093-934X(03)00161-5; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; LUCK SJ, 1993, J COGNITIVE NEUROSCI, V5, P188, DOI 10.1162/jocn.1993.5.2.188; Marzi CA, 2009, NEUROPSYCHOLOGIA, V47, P3007, DOI 10.1016/j.neuropsychologia.2009.05.007; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Milner A. D., 1995, VISUAL BRAIN ACTION; Miniussi C, 1998, J COGNITIVE NEUROSCI, V10, P216, DOI 10.1162/089892998562663; Okon-Singer N, 2011, NEUROIMAGE, V54, P3010, DOI 10.1016/j.neuroimage.2010.10.078; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Putnam MC, 2010, J COGNITIVE NEUROSCI, V22, P1662, DOI 10.1162/jocn.2009.21290; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Scalf PE, 2007, J EXP PSYCHOL HUMAN, V33, P298, DOI 10.1037/0096-1523.33.2.298; Smigasiewicz K, 2010, NEUROPSYCHOLOGIA, V48, P2852, DOI 10.1016/j.neuropsychologia.2010.05.027; Thomas NA, 2011, BRAIN RES, V1387, P108, DOI 10.1016/j.brainres.2011.02.063; Verleger R, 2012, PSYCHOPHYSIOLOGY, V49, P1254, DOI 10.1111/j.1469-8986.2012.01408.x; Verleger R, 2012, ADV COGN PSYCHOL, V8, P19, DOI [10.5709/acp-0098-9, 10.2478/v10053-008-0098-9]; Verleger R, 2011, BRAIN COGNITION, V77, P138, DOI 10.1016/j.bandc.2011.05.004; Verleger R, 2010, EXP BRAIN RES, V203, P355, DOI 10.1007/s00221-010-2237-z; Verleger R, 2009, J COGNITIVE NEUROSCI, V21, pD; Wascher E, 2005, EXP BRAIN RES, V163, P430, DOI 10.1007/s00221-004-2198-1; Wascher E, 1996, ELECTROEN CLIN NEURO, V99, P149, DOI 10.1016/0013-4694(96)95602-3; Wyble B, 2011, J EXP PSYCHOL GEN, V140, P488, DOI 10.1037/a0023612; Zeki S., 1993, VISION BRAIN	39	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57421	10.1371/journal.pone.0057421	http://dx.doi.org/10.1371/journal.pone.0057421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451226	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800106
J	Yang, JH; Dong, SM; Jiang, QC; Kuang, TJ; Huang, WT; Yang, JX				Yang, Jianghua; Dong, Siming; Jiang, Qichen; Kuang, Tengjiao; Huang, Wenting; Yang, Jiaxin			Changes in Expression of Manganese Superoxide Dismutase, Copper and Zinc Superoxide Dismutase and Catalase in Brachionus calyciflorus during the Aging Process	PLOS ONE			English	Article							LIFE-SPAN; DIETARY RESTRICTION; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; CALORIC RESTRICTION; GENE-EXPRESSION; RESVERATROL; DROSOPHILA; EXTENSION; OVEREXPRESSION	Rotifers are useful model organisms for aging research, owing to their small body size (0.1-1 mm), short lifespan (6-14 days) and the relative easy in which aging and senescence phenotypes can be measured. Recent studies have shown that antioxidants can extend the lifespan of rotifers. In this paper, we analyzed changes in the mRNA expression level of genes encoding the antioxidants manganese superoxide dismutase (MnSOD), copper and zinc SOD (CuZnSOD) and catalase (CAT) during rotifer aging to clarify the function of these enzymes in this process. We also investigated the effects of common life-prolonging methods [dietary restriction (DR) and resveratrol] on the mRNA expression level of these genes. The results showed that the mRNA expression level of MnSOD decreased with aging, whereas that of CuZnSOD increased. The mRNA expression of CAT did not change significantly. This suggests that the ability to eliminate reactive oxygen species (ROS) in the mitochondria reduces with aging, thus aggravating the damaging effect of ROS on the mitochondria. DR significantly increased the mRNA expression level of MnSOD, CuZnSOD and CAT, which might explain why DR is able to extend rotifer lifespan. Although resveratrol also increased the mRNA expression level of MnSOD, it had significant inhibitory effects on the mRNA expression of CuZnSOD and CAT. In short, mRNA expression levels of CAT, MnSOD and CuZnSOD are likely to reflect the ability of mitochondria to eliminate ROS and delay the aging process.	[Yang, Jiaxin] Nanjing Normal Univ, Jiangsu Prov Key Lab Biodivers & Biotechnol, Sch Biol Sci, Nanjing, Jiangsu, Peoples R China; Nanjing Normal Univ, Jiangsu Prov Key Lab Aquat Live Food, Sch Biol Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Normal University	Yang, JX (corresponding author), Nanjing Normal Univ, Jiangsu Prov Key Lab Biodivers & Biotechnol, Sch Biol Sci, Nanjing, Jiangsu, Peoples R China.	yangjx@njnu.edu.cn			National Natural Science Foundation of China [31272388]; National Natural Science Foundation of China for Talents Training in Basic Science [J1103507]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China for Talents Training in Basic Science	This work was supported by the National Natural Science Foundation of China (No.: 31272388) to JXY and National Natural Science Foundation of China for Talents Training in Basic Science (J1103507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; ASTM, 2001, ANN BOOK ASTM STAND, V1105; Bauer JH, 2004, P NATL ACAD SCI USA, V101, P12980, DOI 10.1073/pnas.0403493101; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; DERCKS W, 1989, PHYSIOL MOL PLANT P, V34, P189, DOI 10.1016/0885-5765(89)90043-X; Drew B, 2002, ANN NY ACAD SCI, V959, P66, DOI 10.1111/j.1749-6632.2002.tb02084.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; FANESTIL DD, 1965, J GERONTOL, V20, P462; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIDOVICH I, 1972, ACCOUNTS CHEM RES, V5, P321, DOI 10.1021/ar50058a001; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HIRATA H, 1987, HYDROBIOLOGIA, V147, P283, DOI 10.1007/BF00025755; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kailasam M, 2011, FISHERIES SCI, V77, P403, DOI 10.1007/s12562-011-0334-y; Kaneko G, 2005, HYDROBIOLOGIA, V546, P117, DOI 10.1007/s10750-005-4107-4; Kaneko G, 2002, FISHERIES SCI, V68, P1317, DOI 10.1046/j.1444-2906.2002.00570.x; Kaneko G, 2011, FUNCT ECOL, V25, P209, DOI 10.1111/j.1365-2435.2010.01773.x; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Masoro EJ, 1996, J GERONTOL A-BIOL, V51, pB387, DOI 10.1093/gerona/51A.6.B387; MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Muller F, 2000, J AM AGING ASSOC, V23, P227, DOI 10.1007/s11357-000-0022-9; Oo AKS, 2010, J COMP PHYSIOL B, V180, P105, DOI 10.1007/s00360-009-0389-6; Orallo F, 2002, MOL PHARMACOL, V61, P294, DOI 10.1124/mol.61.2.294; Ozaki Y, 2010, HYDROBIOLOGIA, V649, P267, DOI 10.1007/s10750-010-0269-9; Ozdemir N, 2009, J ANIM VET ADV, V8, P669; Ozkan OV, 2009, TOHOKU J EXP MED, V218, P251, DOI 10.1620/tjem.218.251; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Snell TW, 2008, J EXP MAR BIOL ECOL, V363, P104, DOI 10.1016/j.jembe.2008.06.031; Snell TW, 2007, HYDROBIOLOGIA, V593, P227, DOI 10.1007/s10750-007-9045-x; Snell TW, 2012, BIOGERONTOLOGY, V13, P261, DOI 10.1007/s10522-012-9371-x; SNELL TW, 1991, ECOTOX ENVIRON SAFE, V21, P308, DOI 10.1016/0147-6513(91)90070-6; Snell TW, 1995, HYDROBIOLOGIA, V313, P231, DOI 10.1007/BF00025956; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Sun JT, 2002, GENETICS, V161, P661; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Weithoff G, 2007, OECOLOGIA, V153, P303, DOI 10.1007/s00442-007-0739-6; Wheelock CE, 2002, AQUAT TOXICOL, V61, P89, DOI 10.1016/S0166-445X(02)00044-9; WINSTON GW, 1991, COMP BIOCHEM PHYS C, V100, P173, DOI 10.1016/0742-8413(91)90148-M; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang JH, 2013, MOL BIOL REP, V40, P2927, DOI 10.1007/s11033-012-2308-2; Ye K, 2010, J RADIAT RES, V51, P473, DOI 10.1269/jrr.10009; Yoshinaga T, 2000, J EXP MAR BIOL ECOL, V253, P253, DOI 10.1016/S0022-0981(00)00268-9	61	23	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57186	10.1371/journal.pone.0057186	http://dx.doi.org/10.1371/journal.pone.0057186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451185	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800090
J	Yung, CF; Andrews, N; Hoschler, K; Miller, E				Yung, Chee-Fu; Andrews, Nick; Hoschler, Katja; Miller, Elizabeth			Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England	PLOS ONE			English	Article							IMMUNE-RESPONSE; INFLUENZA VACCINATION; INFECTION; ANTIBODY; ADULTS; VIRUS; YOUNG; AGE	In England, during pandemic 2009 H1N1, vaccine efficacy and immunogenicity population studies in priority groups were rolled out in parallel to evaluate the pandemic vaccination programme. This provided a unique opportunity to compare immunogenicity and clinical protection in the same population and thus provide insights into the correlates of protection for the pandemic H1N1 2009 vaccine in risk groups. While clinical protection from AS03-adjuvanted pandemic 2009 H1N1 vaccine was high in those aged <25 years and pregnant women, effectiveness in older adults with chronic conditions has been found to be surprisingly poor. Here we present results from the immunogenicity study derived from the same population. Individuals from priority groups eligible for pandemic vaccination attending participating general practices were recruited. Pre and post-vaccination blood samples were collected and HI antibody testing to assess immune response to vaccination performed. The final cohort consisted of 610 individuals: 60 healthy children aged <5 years; 32 healthy pregnant women; 518 individuals from risk groups. Seroconversion rate in healthy children aged <5 years (87%, 95% CI: 75% to 94%) was higher than that of risk groups combined (65%, 95% CI: 61% to 69%) (p<0.001). Multivariable analysis of risk groups showed that the size of response in those who did seroconvert was lower in those who received the 2009/10 seasonal TIV (Fold effect: 0.52, 0.35 to 0.78). Predicted immunological boosting from higher pre-vaccine titres after 2009 pandemic H1N1 vaccination only occurred in children (seroconversion rate = 92%) and not in individuals aged 10 to 39 from risk groups (seroconversion rate = 74%). The lack of clinical protection identified in the same population in older adults from risk groups could be attributed to these lower seroresponses. Current immunogenicity licensing criteria for pandemic influenza vaccine may not correlate with clinical protection in individuals with chronic disease or immunocompromised.	[Yung, Chee-Fu] Tan Tock Seng Hosp, Communicable Dis Ctr, Dept Clin Epidemiol, Singapore, Singapore; [Yung, Chee-Fu; Miller, Elizabeth] Hlth Protect Agcy, Hlth Protect Serv, Immunisat Hepatitis & Blood Safety Dept, London, England; [Andrews, Nick] Hlth Protect Agcy, Stat Unit, Hlth Protect Serv, London, England; [Hoschler, Katja] Hlth Protect Agcy, Microbiol Serv, Virus Reference Dept, Resp Virus Unit, London, England	Tan Tock Seng Hospital; Health Protection Agency; Health Protection Agency; Health Protection Agency	Yung, CF (corresponding author), Tan Tock Seng Hosp, Communicable Dis Ctr, Dept Clin Epidemiol, Singapore, Singapore.	chee_fu_yung@ttsh.com.sg			DH Research and Development Directorate grant [039/0031]; Sanofi-Pasteur; GlaxoSmithKline; CSL Australia; Baxter	DH Research and Development Directorate grant; Sanofi-Pasteur; GlaxoSmithKline(GlaxoSmithKline); CSL Australia; Baxter	DH Research and Development Directorate grant number 039/0031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; N. Andrews and E. Miller have declared that no competing interests exist. C.F. Yung has received financial assistance from Sanofi-Pasteur and GlaxoSmithKline to attend conferences. K. Hoschler has been an investigator for clinical trials sponsored by Sanofi Pasteur, CSL Australia and Baxter but received no payment for this. K. Hoschler has on one occasion received financial assistance from Sanofi-Pasteur to attend a conference. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; [Anonymous], NOT GUID HARM REQ IN; [Anonymous], SUMMARY PRODUCT CHAR; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Emborg HD, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7901; Hardelid P, 2011, EUROSURVEILLANCE, V16, P12; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Hsu JP, 2012, INT J INFECT DIS, V16, pE621, DOI 10.1016/j.ijid.2012.04.010; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nauta JJP, 2009, BIOLOGICALS, V37, P216, DOI 10.1016/j.biologicals.2009.02.002; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Peeters M, 2012, VACCINE, V30, P6483, DOI 10.1016/j.vaccine.2012.07.081; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Roman F, 2010, CLIN INFECT DIS, V51, P668, DOI 10.1086/655830; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612	23	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56844	10.1371/journal.pone.0056844	http://dx.doi.org/10.1371/journal.pone.0056844			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451097	Green Published, gold			2022-12-25	WOS:000316658800042
J	Brereton, MF; Wareing, M; Jones, RL; Greenwood, SL				Brereton, Melissa F.; Wareing, Mark; Jones, Rebecca L.; Greenwood, Susan L.			Characterisation of K+ Channels in Human Fetoplacental Vascular Smooth Muscle Cells	PLOS ONE			English	Article							HUMAN PLACENTAL ARTERIES; POTASSIUM CHANNELS; NITRIC-OXIDE; CURRENTS; EXPRESSION; VASOCONSTRICTION; INVOLVEMENT; ACTIVATION; DIVERSITY; CONDUIT	Adequate blood flow through placental chorionic plate resistance arteries (CPAs) is necessary for oxygen and nutrient transfer to the fetus and a successful pregnancy. In non-placental vascular smooth muscle cells (SMCs), K+ channels regulate contraction, vascular tone and blood flow. Previous studies showed that K+ channel modulators alter CPA tone, but did not distinguish between effects on K+ channels in endothelial cells and SMCs. In this study, we developed a preparation of freshly isolated CPASMCs of normal pregnancy and investigated K+ channel expression and function. CPASMCs were isolated from normal human term placentas using enzymatic digestion. Purity and phenotype was confirmed with immunocytochemistry. Whole-cell patch clamp was used to assess K+ channel currents, and mRNA and protein expression was determined in intact CPAs and isolated SMCs with RT-PCR and immunostaining. Isolated SMCs expressed alpha-actin but not CD31, a marker of endothelial cells. CPASMCs and intact CPAs expressed h-caldesmon and non-muscle myosin heavy chain-2; phenotypic markers of contractile and synthetic SMCs respectively. Whole-cell currents were inhibited by 4-AP, TEA, charybdotoxin and iberiotoxin implicating functional K-v and BKCa channels. 1-EBIO enhanced whole cell currents which were abolished by TRAM-34 and reduced by apamin indicating activation of IKCa and SKCa respectively. BKCa, IKCa and SK(Ca)3 mRNA and/or protein were expressed in CPASMCs and intact CPAs. This study provides the first direct evidence for functional K-v, BKCa, IKCa and SKCa channels in CPASMCs. These cells display a mixed phenotype implicating a dual role for CPASMCs in controlling both fetoplacental vascular resistance and vasculogenesis.	[Brereton, Melissa F.; Wareing, Mark; Jones, Rebecca L.; Greenwood, Susan L.] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr,Inst Human Dev, Manchester M13 0JH, Lancs, England	University of Manchester	Brereton, MF (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	melissa.brereton@dpag.ox.ac.uk	Jones, Rebecca/E-4481-2011; Wareing, Mark/J-6396-2015	Jones, Rebecca/0000-0002-8871-0589; Wareing, Mark/0000-0002-1333-0899; Greenwood, Susan/0000-0003-2867-4368	University of Manchester Medical Research Council Doctoral Training Grant [G0800127]; Tommy's the baby charity	University of Manchester Medical Research Council Doctoral Training Grant; Tommy's the baby charity	This work was supported by University of Manchester 2008-2012 Medical Research Council Doctoral Training Grant (G0800127), Tommy's the baby charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 1996, CIRC RES, V78, P431, DOI 10.1161/01.RES.78.3.431; Beech DJ, 2007, BIOCHEM SOC T, V35, P890, DOI 10.1042/BST0350890; Beech DJ, 2006, J PHYSIOL-LONDON, V570, P1, DOI 10.1113/jphysiol.2005.101873; BEECH DJ, 1989, J PHYSIOL-LONDON, V418, P293, DOI 10.1113/jphysiol.1989.sp017841; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; CLAPP LH, 1991, EXP PHYSIOL, V76, P677, DOI 10.1113/expphysiol.1991.sp003535; Corcoran J, 2008, HYPERTENS PREGNANCY, V27, P75, DOI 10.1080/10641950701826158; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Fyfe GK, 2012, J OBSTET GYNAECOL, V32, P624, DOI 10.3109/01443615.2012.709288; Gardener MJ, 1999, BRIT J PHARMACOL, V128, P1064, DOI 10.1038/sj.bjp.0702916; Garland C.J., 2010, BR J PHARM; Gollasch M, 1996, CIRC RES, V78, P676, DOI 10.1161/01.RES.78.4.676; Guiet-Bara A, 1999, BIOELECTROCH BIOENER, V48, P407, DOI 10.1016/S0302-4598(99)00020-3; Halliday FC, 1995, BRIT J PHARMACOL, V116, P3139, DOI 10.1111/j.1476-5381.1995.tb15116.x; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hampl V, 2002, AM J PHYSIOL-HEART C, V283, pH2440, DOI 10.1152/ajpheart.01033.2001; Ibrahim B, 1998, BIOELECTROCH BIOENER, V45, P131, DOI 10.1016/S0302-4598(97)00105-0; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Jackson WF, 2000, HYPERTENSION, V35, P173, DOI 10.1161/01.HYP.35.1.173; Jewsbury S, 2007, EUR J CLIN INVEST, V37, P65, DOI 10.1111/j.1365-2362.2007.01749.x; Kiernan MF, 2010, PLACENTA, V31, P553, DOI 10.1016/j.placenta.2010.03.009; Ko EA, 2007, AM J PHYSIOL-CELL PH, V293, pC928, DOI 10.1152/ajpcell.00101.2007; MAIGAARD S, 1986, ACTA PHYSIOL SCAND, V128, P23, DOI 10.1111/j.1748-1716.1986.tb07945.x; McNeish AJ, 2006, STROKE, V37, P1277, DOI 10.1161/01.STR.0000217307.71231.43; Mills TA, 2009, REPROD SCI A, V163A; MYATT L, 1991, AM J OBSTET GYNECOL, V164, P687, DOI 10.1016/S0002-9378(11)80047-5; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Neylon CB, 2002, VASC PHARMACOL, V38, P35, DOI 10.1016/S1537-1891(02)00124-6; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Platoshyn O, 2004, AM J PHYSIOL-LUNG C, V287, pL226, DOI 10.1152/ajplung.00438.2003; Reeve HL, 1998, AM J PHYSIOL-LUNG C, V275, pL1019, DOI 10.1152/ajplung.1998.275.6.L1019; Rhodes MT, 2001, AM J PHYSIOL-LUNG C, V280, pL1250, DOI 10.1152/ajplung.2001.280.6.L1250; Sampson U, 2010, P PHYSL SOC, V20, pPC4; Sand A, 2006, PLACENTA, V27, P181, DOI 10.1016/j.placenta.2004.12.013; SMIRNOV SV, 1992, J PHYSIOL-LONDON, V457, P431, DOI 10.1113/jphysiol.1992.sp019386; Smirnov SV, 2002, J PHYSIOL-LONDON, V538, P867, DOI 10.1113/jphysiol.2001.013003; Snetkov VA, 1998, PEDIATR RES, V43, P548, DOI 10.1203/00006450-199804000-00019; Sones WR, 2009, BRIT J PHARMACOL, V158, P521, DOI 10.1111/j.1476-5381.2009.00332.x; Standen NB, 1998, ACTA PHYSIOL SCAND, V164, P549; Sweeney M, 2006, PLACENTA, V27, P635, DOI 10.1016/j.placenta.2005.05.010; Wareing M, 2006, PLACENTA, V27, P660, DOI 10.1016/j.placenta.2005.05.012; Wareing M, 2011, PLACENTA, V32, pS203, DOI 10.1016/j.placenta.2010.12.022; Wareing M, 2002, PLACENTA, V23, P400, DOI 10.1053/plac.2002.0825; Wareing M, 2006, AM J PHYSIOL-REG I, V291, pR437, DOI 10.1152/ajpregu.00040.2006	45	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57451	10.1371/journal.pone.0057451	http://dx.doi.org/10.1371/journal.pone.0057451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437391	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000105
J	Costa, PR; Acencio, ML; Lemke, N				Costa, Pedro Rafael; Acencio, Marcio Luis; Lemke, Ney			Cooperative RNA Polymerase Molecules Behavior on a Stochastic Sequence-Dependent Model for Transcription Elongation	PLOS ONE			English	Article							TERMINATION; PARAMETERS; STABILITY	The transcription process is crucial to life and the enzyme RNA polymerase (RNAP) is the major component of the transcription machinery. The development of single-molecule techniques, such as magnetic and optical tweezers, atomic-force microscopy and single-molecule fluorescence, increased our understanding of the transcription process and complements traditional biochemical studies. Based on these studies, theoretical models have been proposed to explain and predict the kinetics of the RNAP during the polymerization, highlighting the results achieved by models based on the thermodynamic stability of the transcription elongation complex. However, experiments showed that if more than one RNAP initiates from the same promoter, the transcription behavior slightly changes and new phenomenona are observed. We proposed and implemented a theoretical model that considers collisions between RNAPs and predicts their cooperative behavior during multi-round transcription generalizing the Bai et al. stochastic sequence-dependent model. In our approach, collisions between elongating enzymes modify their transcription rate values. We performed the simulations in Mathematica (R) and compared the results of the single and the multiple-molecule transcription with experimental results and other theoretical models. Our multi-round approach can recover several expected behaviors, showing that the transcription process for the studied sequences can be accelerated up to 48% when collisions are allowed: the dwell times on pause sites are reduced as well as the distance that the RNAPs backtracked from backtracking sites.	[Costa, Pedro Rafael; Acencio, Marcio Luis; Lemke, Ney] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Sao Paulo, Brazil	Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista	Costa, PR (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Sao Paulo, Brazil.	costapr@ibb.unesp.br	Acencio, Marcio L/D-9264-2012; Lemke, Ney/A-8213-2008; Costa, Pedro R/J-7460-2012; Acencio, Marcio Luis/ABH-1930-2020; Lemke, Ney/L-6761-2019	Acencio, Marcio L/0000-0002-8278-240X; Lemke, Ney/0000-0001-7463-4303; Acencio, Marcio Luis/0000-0002-8278-240X; Lemke, Ney/0000-0001-7463-4303	FAPESP (The State of Sao Paulo Research Foundation) [2010/03338-4, 2010/20684-3, 2009/10382-2]; CAPES (Coordination of Improvement of Higher Education Personnel) [PNPD 2897/2011]	FAPESP (The State of Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thank FAPESP (The State of Sao Paulo Research Foundation) for the financial support through the FAPESP research grants 2010/03338-4, 2010/20684-3 and 2009/10382-2 and CAPES (Coordination of Improvement of Higher Education Personnel) research grant PNPD 2897/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bai L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068103; Bai L, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12007; BORER PN, 1974, J MOL BIOL, V86, P843, DOI 10.1016/0022-2836(74)90357-X; Ehrenberg M, 2010, BIOCHIMIE, V92, P12, DOI 10.1016/j.biochi.2009.10.002; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; FOE VE, 1977, COLD SPRING HARB SYM, V42, P723, DOI 10.1101/SQB.1978.042.01.074; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HAMMING J, 1981, NUCLEIC ACIDS RES, V9, P1339, DOI 10.1093/nar/9.6.1339; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Jin J, 2010, NAT STRUCT MOL BIOL, V17, P745, DOI 10.1038/nsmb.1798; Klumpp S, 2011, J STAT PHYS, V142, P1252, DOI 10.1007/s10955-011-0120-3; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P18159, DOI 10.1073/pnas.0806084105; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Rajala T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000704; Sahoo M, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/60004; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Shapiro BE, 2003, BIOINFORMATICS, V19, P677, DOI 10.1093/bioinformatics/btg042; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Tripathi T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011921; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032	26	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57328	10.1371/journal.pone.0057328	http://dx.doi.org/10.1371/journal.pone.0057328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437369	Green Published, gold			2022-12-25	WOS:000315186000096
J	Zhang, RX; Marshall, D; Bryan, GJ; Hornyik, C				Zhang, Runxuan; Marshall, David; Bryan, Glenn J.; Hornyik, Csaba			Identification and Characterization of miRNA Transcriptome in Potato by High-Throughput Sequencing	PLOS ONE			English	Article							PLANT SMALL RNAS; STRESS RESPONSES; SIRNA BIOGENESIS; GENOME SEQUENCE; MICRORNAS; GENES; ARABIDOPSIS; EVOLUTION; ROLES; EXPRESSION	Micro RNAs (miRNAs) represent a class of short, non-coding, endogenous RNAs which play important roles in post-transcriptional regulation of gene expression. While the diverse functions of miRNAs in model plants have been well studied, the impact of miRNAs in crop plant biology is poorly understood. Here we used high-throughput sequencing and bioinformatics analysis to analyze miRNAs in the tuber bearing crop potato (Solanum tuberosum). Small RNAs were analysed from leaf and stolon tissues. 28 conserved miRNA families were found and potato-specific miRNAs were identified and validated by RNA gel blot hybridization. The size, origin and predicted targets of conserved and potato specific miRNAs are described. The large number of miRNAs and complex population of small RNAs in potato suggest important roles for these non-coding RNAs in diverse physiological and metabolic pathways.	[Zhang, Runxuan; Marshall, David; Bryan, Glenn J.; Hornyik, Csaba] James Hutton Inst, Dundee, Scotland	James Hutton Institute	Hornyik, C (corresponding author), James Hutton Inst, Dundee, Scotland.	csaba.hornyik@hutton.ac.uk	Hornyik, Csaba/G-6279-2012; Zhang, Runxuan/F-2236-2013	Zhang, Runxuan/0000-0001-7558-765X; Bryan, Glenn/0000-0002-7752-5740; Hornyik, Csaba/0000-0003-3692-2413; Marshall, David/0000-0001-9309-2570	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); BBSRC [BB/J017213/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017213/1] Funding Source: researchfish	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda JA, 2011, CURR OPIN BIOTECH, V22, P287, DOI 10.1016/j.copbio.2010.11.013; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen X, 2012, CURR OPIN GENET DEV; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Jiao YP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-141; Kim HJ, 2011, GENOME, V54, P91, DOI 10.1139/G10-104; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lelandais-Briere C, 2010, CURR GENOMICS, V11, P14, DOI 10.2174/138920210790217918; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meng YJ, 2011, PLANT PHYSIOL, V157, P1583, DOI 10.1104/pp.111.187088; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Vazquez F, 2010, TRENDS PLANT SCI, V15, P337, DOI 10.1016/j.tplants.2010.04.001; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang WZ, 2010, MOL BIOL REP, V37, P3081, DOI 10.1007/s11033-009-9881-z; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	81	301	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57233	10.1371/journal.pone.0057233	http://dx.doi.org/10.1371/journal.pone.0057233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437348	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000089
J	Blain, A; Greally, E; Laval, S; Blamire, A; Straub, V; MacGowan, GA				Blain, Alison; Greally, Elizabeth; Laval, Steve; Blamire, Andrew; Straub, Volker; MacGowan, Guy A.			Beta-Blockers, Left and Right Ventricular Function, and In-Vivo Calcium Influx in Muscular Dystrophy Cardiomyopathy	PLOS ONE			English	Article							HEART-FAILURE; MOUSE MODEL; DILATED CARDIOMYOPATHY; MICE; INVOLVEMENT; SURVIVAL	Beta-blockers are used to treat acquired heart failure in adults, though their role in early muscular dystrophy cardiomyopathy is unclear. We treated 2 different dystrophic mouse models which have an associated cardiomyopathy (mdx: model for Duchenne Muscular Dystrophy, and Sgcd-/-: model for limb girdle muscular dystrophy type 2F) and wild type controls (C57 Bl10) with the beta blocker metoprolol or placebo for 8 weeks at an early stage in the development of the cardiomyopathy. Left and right ventricular function was assessed with cardiac magnetic resonance imaging (MRI) and in-vivo myocardial calcium influx with manganese enhanced MRI. In the mdx mice at baseline there was reduced stroke volume, cardiac index, and end-diastolic volume with preserved left ventricular ejection fraction. These abnormalities were no longer evident after treatment with beta-blockers. Right ventricular ejection fraction was reduced and right ventricular end-systolic volume increased in the mdx mice. With metoprolol there was an increase in right ventricular end-diastolic and end-systolic volumes. Left and right ventricular function was normal in the Sgcd-/- mice. Metroprolol had no significant effects on left and right ventricular function in these mice, though heart/body weight ratios increased after treatment. In-vivo myocardial calcium influx with MEMRI was significantly elevated in both models, though metoprolol had no significant effects on either. In conclusion, metoprolol treatment at an early stage in the development of cardiomyopathy has deleterious effects on right ventricular function in mdx mice and in both models no effect on increased in- vivo calcium influx. This suggests that clinical trials need to carefully monitor not just left ventricular function but also right ventricular function and other aspects of myocardial metabolism.	[Blain, Alison; Greally, Elizabeth; Laval, Steve; Straub, Volker; MacGowan, Guy A.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Blamire, Andrew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Blamire, Andrew] Newcastle Univ, Newcastle Magnet Resonance Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [MacGowan, Guy A.] Freeman Rd Hosp, Dept Cardiol, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle University - UK	MacGowan, GA (corresponding author), Newcastle Univ, Int Ctr Life, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	guy.macgowan@nuth.nhs.uk	Blamire, Andrew/AAU-6100-2021	Oliver, Alison/0000-0002-4564-9984; Straub, Volker/0000-0001-9046-3540; Blamire, Andrew/0000-0002-8749-1257	Heart Research UK grant [RG 2585]; British Heart Foundation Clinical Leave Research Fellowship [FS/11/89/29162]; British Heart Foundation [FS/11/89/29162] Funding Source: researchfish; Medical Research Council [MR/K000608/1] Funding Source: researchfish; MRC [MR/K000608/1] Funding Source: UKRI	Heart Research UK grant; British Heart Foundation Clinical Leave Research Fellowship; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded in part by Heart Research UK grant RG 2585 and British Heart Foundation Clinical Leave Research Fellowship FS/11/89/29162 (both to GMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; Bauer R, 2010, EUR J HEART FAIL, V12, P1163, DOI 10.1093/eurjhf/hfq129; Bauer R, 2010, NEUROMUSCULAR DISORD, V20, P21, DOI 10.1016/j.nmd.2009.10.003; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Bushby K, 2003, 107 ENMC INT WORKSH, V13, P166; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Fraysse B, 2010, AM J PHYSIOL-CELL PH, V299, pC706, DOI 10.1152/ajpcell.00545.2009; Greally E, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-4; Hu TCC, 2001, MAGNET RESON MED, V46, P884, DOI 10.1002/mrm.1273; Jacoby C, 2006, BASIC RES CARDIOL, V101, P87, DOI 10.1007/s00395-005-0542-7; Jefferies JL, 2005, CIRCULATION, V112, P2799, DOI 10.1161/CIRCULATIONAHA.104.528281; MacGowan GA, 2005, J APPL PHYSIOL, V98, P1163, DOI 10.1152/japplphysiol.00959.2004; MacGowan GA, 2012, CURR OPIN CARDIOL, V27, P296, DOI 10.1097/HCO.0b013e3283511e60; Melacini P, 1996, CIRCULATION, V94, P3168, DOI 10.1161/01.CIR.94.12.3168; MELACINI P, 1993, J AM COLL CARDIOL, V22, P1927, DOI 10.1016/0735-1097(93)90781-U; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Williams IA, 2007, AM J PHYSIOL-HEART C, V292, pH846, DOI 10.1152/ajpheart.00688.2006; Winter EM, 2008, ACTA PHYSIOL, V194, P111, DOI 10.1111/j.1748-1716.2008.01863.x; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844	24	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57260	10.1371/journal.pone.0057260	http://dx.doi.org/10.1371/journal.pone.0057260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437355	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200233
J	Marthin, JK; Nielsen, KG				Marthin, June Kehlet; Nielsen, Kim Gjerum			Hand-Held Tidal Breathing Nasal Nitric Oxide Measurement - A Promising Targeted Case-Finding Tool for the Diagnosis of Primary Ciliary Dyskinesia	PLOS ONE			English	Article							CLINICAL-PRACTICE; CHILDREN	Background: Nasal nitric oxide (nNO) measurement is an established first line test in the work-up for primary ciliary dyskinesia (PCD). Tidal breathing nNO (TB-nNO) measurements require minimal cooperation and are potentially useful even in young children. Hand-held NO devices are becoming increasingly widespread for asthma management. Therefore, we chose to assess whether hand-held TB-nNO measurements reliably discriminate between PCD, and Healthy Subjects (HS) and included Cystic Fibrosis (CF) patients as a disease control group known to have intermediate nNO levels. Methods: In this cross sectional, single centre, single occasion, proof-of-concept study in children and adults with PCD and CF, and in HS we compared feasibility, success rates, discriminatory capacity, repeatability and agreement between a hand-held electrochemical device equipped with a nNO software application sampling at flow rates 2 ml/s or 5 ml/s, and two stationary chemiluminescence devices, applying both tidal breathing and velum closure techniques. Results: Measurements were done in 16 PCD patients, 21 patients with CF and 20 HS aged between 3.8 and 60.9 years. Hand-held TB-nNO showed high success rate (96.5-100%) vs. velum closure nNO techniques (70.2-89.5%). Hand-held TB-nNO sampling at flow rate 5 ml/s showed equally high discriminative power (PCD vs. HS [p<0.0001] and PCD vs. CF [p<0.0001]) and reaching close to 100% sensitivity and specificity, superior repeatability (CV% = 10%) and equal limits of agreement compared to TB-nNO by stationary devices and even compared to velum closure sampling. Conclusion: Hand-held TB-nNO discriminates significantly between PCD, CF and HS and shows promising potential as a widespread targeted case-finding tool for PCD, although further studies are warranted before implementation.	[Marthin, June Kehlet; Nielsen, Kim Gjerum] Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Pediat Pulm Serv, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Nielsen, KG (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Pediat & Adolescent Med, Pediat Pulm Serv, DK-2100 Copenhagen, Denmark.	kgn@dadlnet.dk	Nielsen, KG/AAE-6575-2020	Nielsen, KG/0000-0001-5906-9449				[Anonymous], 2005, AM J RESP CRIT CARE, V171, P912; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Corbelli R, 2004, CHEST, V126, P1054, DOI 10.1378/chest.126.4.1054; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Hogg C, 2009, PAEDIATR RESPIR REV, V10, P44, DOI 10.1016/j.prrv.2008.10.001; Karadag B, 1999, EUR RESPIR J, V13, P1402, DOI 10.1034/j.1399-3003.1999.13f28.x; LUNDBERG JON, 1995, NAT MED, V1, P370, DOI 10.1038/nm0495-370; Maniscalco M, 2008, EUR J CLIN INVEST, V38, P197, DOI 10.1111/j.1365-2362.2008.01907.x; Marthin JK, 2011, EUR RESPIR J, V37, P559, DOI 10.1183/09031936.00032610; Marthin JK, 2010, AM J RESP CRIT CARE, V181, P1262, DOI 10.1164/rccm.200811-1731OC; Marthin JK, 2007, CHEST, V132, P966, DOI 10.1378/chest.06-2951; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; Menzies D, 2007, CHEST, V131, P410, DOI 10.1378/chest.06-1335; Montella S, 2011, EUR J CLIN INVEST, V41, P1063, DOI 10.1111/j.1365-2362.2011.02501.x; Narang I, 2002, THORAX, V57, P586, DOI 10.1136/thorax.57.7.586; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Santamaria F, 2008, MED SCI MONITOR, V14, pCR80; Strippoli MPF, 2012, EUR RESPIR J, V39, P1482, DOI 10.1183/09031936.00073911	19	43	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57262	10.1371/journal.pone.0057262	http://dx.doi.org/10.1371/journal.pone.0057262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437356	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200234
J	Starmans, LWE; Burdinski, D; Haex, NPM; Moonen, RPM; Strijkers, GJ; Nicolay, K; Grull, H				Starmans, Lucas W. E.; Burdinski, Dirk; Haex, Nicole P. M.; Moonen, Rik P. M.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger			Iron Oxide Nanoparticle-Micelles (ION-Micelles) for Sensitive (Molecular) Magnetic Particle Imaging and Magnetic Resonance Imaging	PLOS ONE			English	Article							IN-VIVO DETECTION; CONTRAST; SIZE	Background: Iron oxide nanoparticles (IONs) are a promising nanoplatform for contrast-enhanced MRI. Recently, magnetic particle imaging (MPI) was introduced as a new imaging modality, which is able to directly visualize magnetic particles and could serve as a more sensitive and quantitative alternative to MRI. However, MPI requires magnetic particles with specific magnetic properties for optimal use. Current commercially available iron oxide formulations perform suboptimal in MPI, which is triggering research into optimized synthesis strategies. Most synthesis procedures aim at size control of iron oxide nanoparticles rather than control over the magnetic properties. In this study, we report on the synthesis, characterization and application of a novel ION platform for sensitive MPI and MRI. Methods and Results: IONs were synthesized using a thermal-decomposition method and subsequently phase-transferred by encapsulation into lipidic micelles (ION-Micelles). Next, the material and magnetic properties of the ION-Micelles were analyzed. Most notably, vibrating sample magnetometry measurements showed that the effective magnetic core size of the IONs is 16 nm. In addition, magnetic particle spectrometry (MPS) measurements were performed. MPS is essentially zero-dimensional MPI and therefore allows to probe the potential of iron oxide formulations for MPI. ION-Micelles induced up to 200 times higher signal in MPS measurements than commercially available iron oxide formulations (Endorem, Resovist and Sinerem) and thus likely allow for significantly more sensitive MPI. In addition, the potential of the ION-Micelle platform for molecular MPI and MRI was showcased by MPS and MRI measurements of fibrin-binding peptide functionalized ION-Micelles (FibPep-ION-Micelles) bound to blood clots. Conclusions: The presented data underlines the potential of the ION-Micelle nanoplatform for sensitive (molecular) MPI and warrants further investigation of the FibPep-ION-Micelle platform for in vivo, non-invasive imaging of fibrin in preclinical disease models of thrombus-related pathologies and atherosclerosis.	[Starmans, Lucas W. E.; Moonen, Rik P. M.; Strijkers, Gustav J.; Nicolay, Klaas; Grull, Holger] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [Burdinski, Dirk; Haex, Nicole P. M.; Grull, Holger] Philips Res Eindhoven, Dept Minimally Invas Healthcare, Eindhoven, Netherlands	Eindhoven University of Technology; Philips; Philips Research	Grull, H (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.	h.gruell@tue.nl		Starmans, Luc/0000-0003-4569-1725; Strijkers, Gustav/0000-0001-6700-5058; Moonen, Rik/0000-0002-2294-0226; Nicolay, Klaas/0000-0002-4179-616X; Grull, Holger/0000-0002-0993-9300	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK [01C-202]	Center for Translational Molecular Medicine; Netherlands Heart Foundation PARISK(Netherlands Heart Foundation)	This research was supported by the Center for Translational Molecular Medicine (http://www.ctmm.nl) and the Netherlands Heart Foundation (www.hartstichting.nl): PARISK, grant 01C-202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman SC, 2011, MAGN RESON MED, V65, P564, DOI 10.1002/mrm.22613; Biederer S, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/20/205007; Briley-Saebo KC, 2011, J AM COLL CARDIOL, V57, P337, DOI 10.1016/j.jacc.2010.09.023; Burdinski D, 2012, Synthesis of high-performance iron oxide particle tracers for magnetic particle imaging (MPI), Patent No. [WO 2012/001579 A1, 2012001579]; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; Chen DX, 2009, J APPL PHYS, V106, DOI 10.1063/1.3211307; Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013; Dash R, 2011, MAGN RESON MED, V66, P1152, DOI 10.1002/mrm.22876; DIAS MHM, 1986, MAGNET RESON MED, V3, P328, DOI 10.1002/mrm.1910030218; Ferguson RM, 2011, MED PHYS, V38, P1619, DOI 10.1118/1.3554646; Ferguson RM, 2009, J MAGN MAGN MATER, V321, P1548, DOI 10.1016/j.jmmm.2009.02.083; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s; Jayapaul J, 2011, BIOMATERIALS, V32, P5863, DOI 10.1016/j.biomaterials.2011.04.056; Luigjes B, 2011, J PHYS CHEM C, V115, P14598, DOI 10.1021/jp203373f; Marinelli E., 2008, Fibrin Binding Peptide Conjugates for Diagnostic and Therapeutic Applications, Patent No. [WO 2008/071679 A1, 2008071679]; Markov DE, 2010, PHYS MED BIOL, V55, P6461, DOI 10.1088/0031-9155/55/21/008; McAteer MA, 2008, ARTERIOSCL THROM VAS, V28, P77, DOI 10.1161/ATVBAHA.107.145466; Muja N, 2011, MAGN RESON MED, V65, P1738, DOI 10.1002/mrm.22757; Mulder WJM, 2009, ANGIOGENESIS, V12, P17, DOI 10.1007/s10456-008-9124-2; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Radermacher KA, 2009, INVEST RADIOL, V44, P398, DOI 10.1097/RLI.0b013e3181a49639; REIMER P, 1995, RADIOLOGY, V195, P489, DOI 10.1148/radiology.195.2.7724772; Starmans LWE, 2011, CONTRAST MEDIA MOL I, V6, P100, DOI 10.1002/cmmi.411; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; von zur Muhlen C, 2008, CIRCULATION, V118, P258, DOI 10.1161/CIRCULATIONAHA.107.753657; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01; Wescot C. R., 2002, Fibrin Binding Moieties Useful as Imaging Agents, Patent No. [WO 02/055544 A2, 02055544]; Xu CJ, 2009, DALTON T, P5583, DOI 10.1039/b900272n; Yu WW, 2004, CHEM COMMUN, P2306, DOI 10.1039/b409601k	33	47	50	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57335	10.1371/journal.pone.0057335	http://dx.doi.org/10.1371/journal.pone.0057335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437371	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200245
J	Bornert, O; Moller, TC; Boeuf, J; Candusso, MP; Wagner, R; Martinez, KL; Simonin, F				Bornert, Olivier; Moller, Thor C.; Boeuf, Julien; Candusso, Marie-Pierre; Wagner, Renaud; Martinez, Karen L.; Simonin, Frederic			Identification of a Novel Protein-Protein Interaction Motif Mediating Interaction of GPCR-Associated Sorting Proteins with G Protein-Coupled Receptors	PLOS ONE			English	Article							DELTA-OPIOID RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; RESONANCE SPECTROSCOPY; BINDING; ARRESTIN; TOLERANCE; RHODOPSIN; SNX1; GASP	GPCR desensitization and down-regulation are considered key molecular events underlying the development of tolerance in vivo. Among the many regulatory proteins that are involved in these complex processes, GASP-1 have been shown to participate to the sorting of several receptors toward the degradation pathway. This protein belongs to the recently identified GPCR-associated sorting proteins (GASPs) family that comprises ten members for which structural and functional details are poorly documented. We present here a detailed structure-function relationship analysis of the molecular interaction between GASPs and a panel of GPCRs. In a first step, GST-pull down experiments revealed that all the tested GASPs display significant interactions with a wide range of GPCRs. Importantly, the different GASP members exhibiting the strongest interaction properties were also characterized by the presence of a small, highly conserved and repeated "GASP motif'' of 15 amino acids. We further showed using GST-pull down, surface plasmon resonance and co-immunoprecipitation experiments that the central domain of GASP-1, which contains 22 GASP motifs, is essential for the interaction with GPCRs. We then used site directed mutagenesis and competition experiments with synthetic peptides to demonstrate that the GASP motif, and particularly its highly conserved core sequence SWFW, is critically involved in the interaction with GPCRs. Overall, our data show that several members of the GASP family interact with GPCRs and highlight the presence within GASPs of a novel protein-protein interaction motif that might represent a new target to investigate the involvement of GASPs in the modulation of the activity of GPCRs.	[Bornert, Olivier; Boeuf, Julien; Candusso, Marie-Pierre; Wagner, Renaud; Simonin, Frederic] Univ Strasbourg, Inst Rech ESBS, Lab Excellence MEDALIS, CNRS,UMR 7242, Illkirch Graffenstaden, France; [Bornert, Olivier] BioXtal, St Felix, France; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Dept Chem, Bionanotechnol & Nanomed Lab, DK-2100 Copenhagen, Denmark; [Moller, Thor C.; Martinez, Karen L.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Copenhagen; University of Copenhagen	Simonin, F (corresponding author), Univ Strasbourg, Inst Rech ESBS, Lab Excellence MEDALIS, CNRS,UMR 7242, Illkirch Graffenstaden, France.	simonin@unistra.fr	Mosca, Antonella/L-2523-2018; Møller, Thor C/T-9452-2018; Boeuf, JP/H-1421-2011; Martinez, Karen/W-3709-2019; martinez, karen L/J-5933-2013	Mosca, Antonella/0000-0001-9646-7462; Møller, Thor C/0000-0002-2256-577X; Boeuf, JP/0000-0003-1023-222X; Martinez, Karen/0000-0003-0932-8080; martinez, karen L/0000-0003-0932-8080; Wagner, Renaud/0000-0002-4249-9853	Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (MENSER); Association pour la Recherche sur le Cancer [3423]; Fondation pour la Recherche Medicale; Centre National de la Recherche Scientifique; Universite Louis Pasteur; Lundbeck Foundation Center for Biomembranes and Nanomedicine; program BioScaRT; program UNIK Synthetic Biology	Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (MENSER); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Louis Pasteur; Lundbeck Foundation Center for Biomembranes and Nanomedicine; program BioScaRT; program UNIK Synthetic Biology	This work was supported by Ministere de l'Education Nationale de l'Enseignement Superieur et de la Recherche (MENSER) fellowship, Association pour la Recherche sur le Cancer (No3423), Fondation pour la Recherche Medicale, Centre National de la Recherche Scientifique, Universite Louis Pasteur, the Lundbeck Foundation Center for Biomembranes and Nanomedicine, and the programs BioScaRT and UNIK Synthetic Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Helo A, 2010, PHARMACOL THERAPEUT, V126, P244, DOI 10.1016/j.pharmthera.2010.03.004; Alves ID, 2004, J BIOL CHEM, V279, P44673, DOI 10.1074/jbc.M404713200; Alves ID, 2003, J BIOL CHEM, V278, P48890, DOI 10.1074/jbc.M306866200; Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Boeuf J, 2009, EUR J NEUROSCI, V30, P860, DOI 10.1111/j.1460-9568.2009.06865.x; Bomert O., 2012, CURR PROTOC PROTEIN; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fruh V, 2011, CHEM REV, V111, P640, DOI 10.1021/cr900088s; Georgieva T, 2008, EUR J PHARMACOL, V581, P19, DOI 10.1016/j.ejphar.2007.11.053; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; Komolov KE, 2010, ANAL BIOANAL CHEM, V397, P2967, DOI 10.1007/s00216-010-3876-4; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Martini L, 2010, NEUROPSYCHOPHARMACOL, V35, P1363, DOI 10.1038/npp.2010.6; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Tappe-Theodor A, 2007, J NEUROSCI, V27, P4165, DOI 10.1523/JNEUROSCI.5648-06.2007; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Winter EE, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-54; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	27	20	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56336	10.1371/journal.pone.0056336	http://dx.doi.org/10.1371/journal.pone.0056336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441177	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200034
J	Camp, JV; Chu, YK; Chung, DH; McAllister, RC; Adcock, RS; Gerlach, RL; Wiemken, TL; Peyrani, P; Ramirez, JA; Summersgill, JT; Jonsson, CB				Camp, Jeremy V.; Chu, Yong-Kyu; Chung, Dong-Hoon; McAllister, Ryan C.; Adcock, Robert S.; Gerlach, Rachael L.; Wiemken, Timothy L.; Peyrani, Paula; Ramirez, Julio A.; Summersgill, James T.; Jonsson, Colleen B.			Phenotypic Differences in Virulence and Immune Response in Closely Related Clinical Isolates of Influenza A 2009 H1N1 Pandemic Viruses in Mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ALVEOLAR MACROPHAGES; RECEPTOR SPECIFICITY; EPITHELIAL-CELLS; DISEASE SEVERITY; INFECTION; HEMAGGLUTININ; CYTOKINE; LUNG; NEUTROPHILS	To capture the possible genotypic and phenotypic differences of the 2009 influenza A virus H1N1 pandemic (H1N1pdm) strains circulating in adult hospitalized patients, we isolated and sequenced nine H1N1pdm viruses from patients hospitalized during 2009-2010 with severe influenza pneumonia in Kentucky. Each viral isolate was characterized in mice along with two additional H1N1 pandemic strains and one seasonal strain to assess replication and virulence. All isolates showed similar levels of replication in nasal turbinates and lung, but varied in their ability to cause morbidity. Further differences were identified in cytokine and chemokine responses. IL-6 and KC were expressed early in mice infected with strains associated with higher virulence. Strains that showed lower pathogenicity in mice had greater IFN gamma, MIG, and IL-10 responses. A principal component analysis (PCA) of the cytokine and chemokine profiles revealed 4 immune response phenotypes that correlated with the severity of disease. A/KY/180/10, which showed the greatest virulence with a rapid onset of disease progression, was compared in additional studies with A/KY/136/09, which showed low virulence in mice. Analyses comparing a low (KY/136) versus a high (KY/180) virulent isolate showed a significant difference in the kinetics of infection within the lower respiratory tract and immune responses. Notably by 4 DPI, virus titers within the lung, bronchoalveolar lavage fluid (BALf), and cells within the BAL (BALc) revealed that the KY/136 replicated in BALc, while KY/180 replication persisted in lungs and BALc. In summary, our studies suggest four phenotypic groups based on immune responses that result in different virulence outcomes in H1N1pdm isolates with a high degree of genetic similarity. In vitro studies with two of these isolates suggested that the more virulent isolate, KY/180, replicates productively in macrophages and this may be a key determinant in tipping the response toward a more severe disease progression.	[Camp, Jeremy V.; Chung, Dong-Hoon; McAllister, Ryan C.; Adcock, Robert S.; Gerlach, Rachael L.; Jonsson, Colleen B.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Chu, Yong-Kyu; Chung, Dong-Hoon; Jonsson, Colleen B.] Univ Louisville, Ctr Predict Med Biodef & Emerging Infect Dis, Louisville, KY 40292 USA; [Wiemken, Timothy L.; Peyrani, Paula; Ramirez, Julio A.; Summersgill, James T.] Univ Louisville, Dept Med, Div Infect Dis, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Jonsson, CB (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA.	cbjons01@louisville.edu	Camp, Jeremy V./AAS-6184-2020; Jonsson, Colleen/X-2360-2019; Jonsson, Colleen/GPC-4424-2022	Camp, Jeremy V./0000-0002-9040-5786; Jonsson, Colleen/0000-0002-2640-7672; Ramirez, Julio/0000-0001-7801-5374	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville	Support was provided in part by the Commonwealth of Kentucky as a Clinical and Translational Science Pilot Project Program at the University of Louisville to CBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Abed Y, 2011, J INFECT DIS, V204, P1008, DOI 10.1093/infdis/jir483; Anton A, 2010, DIAGN MICR INFEC DIS, V67, P207, DOI 10.1016/j.diagmicrobio.2010.02.002; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Blair PJ, 2010, EPIDEMIOL INFECT, V138, P199, DOI 10.1017/S095026880999063X; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Fezeu L, 2011, OBES REV, V12, P653, DOI 10.1111/j.1467-789X.2011.00864.x; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ghedin E, 2011, J INFECT DIS, V203, P168, DOI 10.1093/infdis/jiq040; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Herold S, 2006, J IMMUNOL, V177, P1817, DOI 10.4049/jimmunol.177.3.1817; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Inoue E, 2010, MICROBIOL IMMUNOL, V54, P129, DOI 10.1111/j.1348-0421.2009.00193.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Josset L, 2012, J VIROL, V86, P7192, DOI 10.1128/JVI.00563-12; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Kao CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031162; Kilander A, 2010, EUROSURVEILLANCE, V4, P15; Kim HM, 2008, J VIROL, V82, P4265, DOI 10.1128/JVI.02602-07; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kuster SP, 2010, EUR J CLIN MICROBIOL, V29, P835, DOI 10.1007/s10096-010-0935-x; Lee N, 2011, ANTIVIR THER, V16, P237, DOI 10.3851/IMP1722; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Louie JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018221; Lucker LM, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13177; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Mao HW, 2010, J VIROL, V84, P4148, DOI 10.1128/JVI.02340-09; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Patel JR, 2011, VIRAL IMMUNOL, V24, P89, DOI 10.1089/vim.2010.0122; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; PESCHKE T, 1993, IMMUNOBIOLOGY, V189, P340, DOI 10.1016/S0171-2985(11)80365-7; Pica N, 2011, J VIROL, V85, P12825, DOI 10.1128/JVI.05930-11; Reading PC, 2010, IMMUNOL CELL BIOL, V88, P641, DOI 10.1038/icb.2010.11; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; Seo SH, 2004, VIROLOGY, V329, P270, DOI 10.1016/j.virol.2004.08.019; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Srivastava B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004857; Stein-Streilein J, 1988, Reg Immunol, V1, P100; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; STEINSTREILEIN J, 1983, J IMMUNOL, V131, P2699; Suphaphiphat P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-157; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Takemae N, 2010, J GEN VIROL, V91, P938, DOI 10.1099/vir.0.016691-0; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Trammell RA, 2012, MICROBES INFECT, V14, P50, DOI 10.1016/j.micinf.2011.08.008; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; van Riel D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002099; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Watanabe T, 2011, J VIROL, V85, P13195, DOI 10.1128/JVI.00859-11; Weinheimer VK, 2012, J INFECT DIS; Wijburg OLC, 1997, J VIROL, V71, P9450, DOI 10.1128/JVI.71.12.9450-9457.1997; Wong SSY, 2006, CHEST, V129, P156, DOI 10.1378/chest.129.1.156; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020698; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145	91	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56602	10.1371/journal.pone.0056602	http://dx.doi.org/10.1371/journal.pone.0056602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441208	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200065
J	Cromer, D; Best, SE; Engwerda, C; Haque, A; Davenport, M				Cromer, Deborah; Best, Shannon E.; Engwerda, Christian; Haque, Ashraful; Davenport, Miles			Where Have All the Parasites Gone? Modelling Early Malaria Parasite Sequestration Dynamics	PLOS ONE			English	Article							CEREBRAL MALARIA; T-CELLS; IN-VIVO; HOST; BLOOD; STAGE; INFECTIONS; PATHOLOGY	Traditional approaches to measuring the level of malaria infection involve counting the proportion of parasite-infected red blood cells (iRBC) in circulating blood, known as parasitaemia. However, iRBC can also accumulate within the microvasculature of tissues and organs, a process called sequestration. Thus measurements of parasitemia do not necessarily reflect the total parasite burden (TPB). Recent experimental advances have allowed TPB measurements to be made in humans and experimental models. TPB is particularly important because it is the best current predictor of malaria disease severity and death in humans. Understanding the relationship between freely circulating iRBC versus tissue-sequestered iRBC is an important question in infection dynamics. The recent ability to experimentally measure the dynamics of iRBC in blood and tissue during murine malaria provides an exciting potential window into sequestration, but new modeling approaches are clearly required to understand these interactions. We present a model of malaria dynamics during early infection that incorporates iRBC that both circulate in the blood and sequester in tissue microvasculature. We explore the effect that perturbations to the system have on the ratio of the number of iRBC between these compartments, and consider which changes are most consistent with experimental data from mice. Using this model we predict an increase in the clearance rate of sequestered iRBCs around the time when mild symptoms become apparent, but a more pronounced increase in the rate of sequestration of iRBCs associated with the onset of severe malaria symptoms.	[Cromer, Deborah; Davenport, Miles] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Kensington, NSW 2033, Australia; [Best, Shannon E.; Engwerda, Christian; Haque, Ashraful] Queensland Inst Med Res, Immunol & Infect Lab, Brisbane, Qld 4006, Australia	University of New South Wales Sydney; QIMR Berghofer Medical Research Institute	Cromer, D (corresponding author), Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, POB 1, Kensington, NSW 2033, Australia.	d.cromer@unsw.edu.au	Haque, Ashraful/H-8697-2014; Engwerda, Christian/I-3072-2015	Haque, Ashraful/0000-0003-2260-0026; Davenport, Miles/0000-0002-4751-1831; Engwerda, Christian/0000-0003-2813-4804; Cromer, Deborah/0000-0002-5276-5094	Australian NHMRC Project Grant [613702]; NHMRC; Australian Centre for Vaccine Development	Australian NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for Vaccine Development	DC is an UNSW Vice-Chancellor's Post-Doctoral Fellow, SEB is funded by an Australian NHMRC Project Grant (Grant Number 613702), CE is a NHMRC Senior Research Fellow, AH is an Australian NHMRC Career Development Fellow and MPD is a NHMRC Senior Research Fellow. The work was funded by the NHMRC and Australian Centre for Vaccine Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Antia R, 2008, P ROY SOC B-BIOL SCI, V275, P1449, DOI 10.1098/rspb.2008.0198; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Craig AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002401; Cromer D, 2006, INT J PARASITOL, V36, P1389, DOI 10.1016/j.ijpara.2006.07.009; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Fonager J, 2011, J EXPT MED; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Gravenor MB, 1998, P NATL ACAD SCI USA, V95, P7620, DOI 10.1073/pnas.95.13.7620; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; HELLRIEGEL B, 1992, P ROY SOC B-BIOL SCI, V250, P249, DOI 10.1098/rspb.1992.0156; Hetzel C, 1996, PARASITOLOGY, V113, P25, DOI 10.1017/S0031182000066245; Hoshen MB, 2000, PARASITOLOGY, V121, P227, DOI 10.1017/S0031182099006368; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; Lovegrove FE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000068; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; Malleret B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00118; Mideo N, 2008, AM NAT, V172, pE214, DOI 10.1086/591684; Miller MR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000946; MONS B, 1985, PARASITOLOGY, V91, P423, DOI 10.1017/S0031182000062673; NEILL AL, 1992, PARASITOLOGY, V105, P165, DOI 10.1017/S0031182000074072; Newton CRJC, 2000, J NEUROL NEUROSUR PS, V69, P433, DOI 10.1136/jnnp.69.4.433; Ochola LB, 2005, PARASITOLOGY, V131, P449, DOI 10.1017/S0031182005008085; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Phillips AN, 1996, SCIENCE, V271, P497, DOI 10.1126/science.271.5248.497; SILAMUT K, 1993, T ROY SOC TROP MED H, V87, P436, DOI 10.1016/0035-9203(93)90028-O; Smith T, 2004, PARASITOLOGY, V129, P289, DOI 10.1017/S003118200400575X; WHITE NJ, 1992, T ROY SOC TROP MED H, V86, P590, DOI 10.1016/0035-9203(92)90141-X; WHO, 2010, GUID TREATM MAL, V2nd	35	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55961	10.1371/journal.pone.0055961	http://dx.doi.org/10.1371/journal.pone.0055961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441158	gold, Green Published			2022-12-25	WOS:000315159200015
J	Eriksen, KT; Raaschou-Nielsen, O; McLaughlin, JK; Lipworth, L; Tjonneland, A; Overvad, K; Sorensen, M				Eriksen, Kirsten T.; Raaschou-Nielsen, Ole; McLaughlin, Joseph K.; Lipworth, Loren; Tjonneland, Anne; Overvad, Kim; Sorensen, Mette			Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population	PLOS ONE			English	Article							FLUOROCHEMICAL PRODUCTION WORKERS; PERFLUOROOCTANOIC ACID; SERUM-LIPIDS; LIVER-ENZYMES; EXPOSURE; HEALTH; PARAMETERS; RESIDENTS; CANCER	Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) are used in a variety of consumer products and have been detected worldwide in human blood. Recent studies mainly of highly exposed populations have indicated that PFOA and PFOS may affect serum cholesterol levels, but the magnitude of the effect may be inconsistent across exposure levels. The aim of the present cross-sectional study was to investigate the association between plasma PFOA and PFOS and total cholesterol in a general, middle-aged Danish population. The study population comprised 753 individuals (663 men and 90 women), 50-65 years of age, nested within a Danish cohort of 57,053 participants. Blood samples were taken from all cohort members at enrolment (1993-1997) and stored in a biobank at -150 degrees C. Plasma levels of PFOA and PFOS and serum levels of total cholesterol were measured. The associations between plasma PFOA and PFOS levels and total cholesterol levels were analysed by generalized linear models, both crude and adjusted for potential confounders. We observed statistically significant positive associations between both perfluorinated compounds and total cholesterol, e.g. a 4.4 [95% CI = 1.1-7.8] higher concentration of total cholesterol (mg/dL) per interquartile range of PFOA plasma level. Sex and prevalent diabetes appeared to modify the association between PFOA and PFOS, respectively, and cholesterol. In conclusion, this study indicated positive associations between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population, although whether the observed pattern of results reflects a causal association is unclear.	[Eriksen, Kirsten T.; Raaschou-Nielsen, Ole; Tjonneland, Anne; Sorensen, Mette] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [McLaughlin, Joseph K.; Lipworth, Loren] Int Epidemiol Inst, Rockville, MD USA; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark	Danish Cancer Society; Aarhus University	Eriksen, KT (corresponding author), Danish Canc Soc Res Ctr, Copenhagen, Denmark.	kirsthor@cancer.dk	Raaschou-Nielsen, Ole/GOK-0338-2022	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; Sorensen, Mette/0000-0002-7302-4789	Danish Cancer Society; International Epidemiology Institute (IEI); 3M Company; International Epidemiology Institute	Danish Cancer Society(Danish Cancer Society); International Epidemiology Institute (IEI); 3M Company(3M); International Epidemiology Institute	The present project was supported by the Danish Cancer Society and by the International Epidemiology Institute (IEI), which received an unrestricted research grant from the 3M Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by the International Epidemiology Institute, which received funding from a commercial source (unrestricted research grant from the 3M Company). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Butenhoff JL, 2006, ENVIRON HEALTH PERSP, V114, P1776, DOI 10.1289/ehp.9060; Calafat AM, 2006, CHEMOSPHERE, V63, P490, DOI 10.1016/j.chemosphere.2005.08.028; Calafat AM, 2006, ENVIRON SCI TECHNOL, V40, P2128, DOI 10.1021/es0517973; Chateau-Degat ML, 2010, ENVIRON RES, V110, P710, DOI 10.1016/j.envres.2010.07.003; Costa G, 2009, J OCCUP ENVIRON MED, V51, P364, DOI 10.1097/JOM.0b013e3181965d80; Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008; Emmett EA, 2006, J OCCUP ENVIRON MED, V48, P771, DOI 10.1097/01.jom.0000233380.13087.37; Eriksen KT, 2011, ENVIRON SCI TECHNOL, V45, P8137, DOI 10.1021/es100626h; Eriksen KT, 2009, JNCI-J NATL CANCER I, V101, P605, DOI 10.1093/jnci/djp041; Frisbee SJ, 2010, ARCH PEDIAT ADOL MED, V164, P860, DOI 10.1001/archpediatrics.2010.163; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Kennedy GL, 2004, CRIT REV TOXICOL, V34, P351, DOI 10.1080/10408440490464705; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Midasch O, 2006, INT J HYG ENVIR HEAL, V209, P489, DOI 10.1016/j.ijheh.2006.06.002; Nelson JW, 2010, ENVIRON HEALTH PERSP, V118, P197, DOI 10.1289/ehp.0901165; Olsen GW, 2007, INT ARCH OCC ENV HEA, V81, P231, DOI 10.1007/s00420-007-0213-0; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2003, J OCCUP ENVIRON MED, V45, P260, DOI 10.1097/01.jom.0000052958.59271.10; Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14; Sakr CJ, 2007, J OCCUP ENVIRON MED, V49, P1086, DOI 10.1097/JOM.0b013e318156eca3; Sakr CJ, 2007, J OCCUP ENVIRON MED, V49, P872, DOI 10.1097/JOM.0b013e318124a93f; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P1100, DOI 10.1289/ehp.0901827; Steenland K, 2009, AM J EPIDEMIOL, V170, P1268, DOI 10.1093/aje/kwp279; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; U.S. Environmental Protection Agency, PERFL AC PFOA BAS IN	26	93	95	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56969	10.1371/journal.pone.0056969	http://dx.doi.org/10.1371/journal.pone.0056969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441227	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200084
J	Paproski, RJ; Yao, SYM; Favis, N; Evans, D; Young, JD; Cass, CE; Zemp, RJ				Paproski, Robert J.; Yao, Sylvia Y. M.; Favis, Nicole; Evans, David; Young, James D.; Cass, Carol E.; Zemp, Roger J.			Human Concentrative Nucleoside Transporter 3 Transfection with Ultrasound and Microbubbles in Nucleoside Transport Deficient HEK293 Cells Greatly Increases Gemcitabine Uptake	PLOS ONE			English	Article							PANCREATIC-CANCER; GENE DELIVERY; IN-VITRO; PREDICT RESPONSE; DNA TRANSFECTION; EXPRESSION; SURVIVAL; ADENOCARCINOMA; CYTOTOXICITY; THERAPY	Gemcitabine is a hydrophilic clinical anticancer drug that requires nucleoside transporters to cross plasma membranes and enter cells. Pancreatic adenocarcinomas with low levels of nucleoside transporters are generally resistant to gemcitabine and are currently a clinical problem. We tested whether transfection of human concentrative nucleoside transporter 3 (hCNT3) using ultrasound and lipid stabilized microbubbles could increase gemcitabine uptake and sensitivity in HEK293 cells made nucleoside transport deficient by pharmacologic treatment with dilazep. To our knowledge, no published data exists regarding the utility of using hCNT3 as a therapeutic gene to reverse gemcitabine resistance. Our ultrasound transfection system - capable of transfection of cell cultures, mouse muscle and xenograft CEM/araC tumors - increased hCNT3 mRNA and H-3-gemcitabine uptake by >2,000- and 3,400-fold, respectively, in dilazep-treated HEK293 cells. Interestingly, HEK293 cells with both functional human equilibrative nucleoside transporters and hCNT3 displayed 5% of H-3-gemcitabine uptake observed in cells with only functional hCNT3, suggesting that equilibrative nucleoside transporters caused significant efflux of H-3-gemcitabine. Efflux assays confirmed that dilazep could inhibit the majority of H-3-gemcitabine efflux from HEK293 cells, suggesting that hENTs were responsible for the majority of efflux from the tested cells. Oocyte uptake transport assays were also performed and provided support for our hypothesis. Gemcitabine uptake and efflux assays were also performed on pancreatic cancer AsPC-1 and MIA PaCa-2 cells with similar results to that of HEK293 cells. Using the MTS proliferation assay, dilazep-treated HEK293 cells demonstrated 13-fold greater resistance to gemcitabine compared to dilazep-untreated HEK293 cells and this resistance could be reversed by transfection of hCNT3 cDNA. We propose that transfection of hCNT3 cDNA using ultrasound and microbubbles may be a method to reverse gemcitabine resistance in pancreatic tumors that have little nucleoside transport activity which are resistant to almost all current anticancer therapies.	[Paproski, Robert J.; Zemp, Roger J.] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Yao, Sylvia Y. M.; Young, James D.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Favis, Nicole; Evans, David] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Cass, Carol E.] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada; [Yao, Sylvia Y. M.; Young, James D.; Cass, Carol E.] Univ Alberta, Membrane Prot Dis Res Grp, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Zemp, RJ (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.	rzemp@ualberta.ca	Evans, David/M-1912-2016	Evans, David/0000-0001-5871-299X	Canadian Institutes of Health Research [190869]; Natural Sciences and Engineering Research Council of Canada [355544-2008, 375340-2009, STPGP 396444]; Terry Fox Foundation; Canadian Cancer Society [TFF 019237, TFF 019240, CCS 2011-700718]; Alberta Cancer Research Institute [ACB 23728]; Canada Foundation for Innovation [NIF11625]; Leaders Opportunity Fund [18472]; Alberta Advanced Education & Technology, Small Equipment Grants Program [URSI09007SEG]; Microsystems Technology Research Initiative [MSTRI RES0003166]; Microsystems Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Terry Fox Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Research Institute; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Leaders Opportunity Fund; Alberta Advanced Education & Technology, Small Equipment Grants Program; Microsystems Technology Research Initiative; Microsystems Technology	Funding for this work was provided by Canadian Institutes of Health Research (190869), Natural Sciences and Engineering Research Council of Canada (355544-2008, 375340-2009, STPGP 396444), Terry Fox Foundation and the Canadian Cancer Society (TFF 019237, TFF 019240, CCS 2011-700718), the Alberta Cancer Research Institute (ACB 23728), the Canada Foundation for Innovation (NIF11625), Leaders Opportunity Fund (18472), Alberta Advanced Education & Technology, Small Equipment Grants Program (URSI09007SEG), and Microsystems Technology Research Initiative (MSTRI RES0003166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Although the authors have received funding from Microsystems Technology, these funds were for another research project which does not involve the work presented in the Cover Letter submitted manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Cass CE, 1998, BIOCHEM CELL BIOL, V76, P761, DOI 10.1139/bcb-76-5-761; Chen SY, 2006, P NATL ACAD SCI USA, V103, P8469, DOI 10.1073/pnas.0602921103; Damaraju VL, 2012, NUCLEOS NUCLEOT NUCL, V31, P236, DOI 10.1080/15257770.2011.652330; Del Re AM, 2005, DRUG ALCOHOL DEPEN, V78, P221, DOI 10.1016/j.drugalcdep.2004.10.005; Deshpande MC, 2007, J CONTROL RELEASE, V118, P126, DOI 10.1016/j.jconrel.2006.12.010; Farrell JJ, 2009, GASTROENTEROLOGY, V136, P187, DOI 10.1053/j.gastro.2008.09.067; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Lang TT, 2004, MOL PHARMACOL, V65, P925, DOI 10.1124/mol.65.4.925; Lang TT, 2001, MOL PHARMACOL, V60, P1143, DOI 10.1124/mol.60.5.1143; Li YS, 2009, CANCER LETT, V273, P62, DOI 10.1016/j.canlet.2008.07.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YK, 2008, J LIPOSOME RES, V18, P341, DOI [10.1080/03639040802509868, 10.1080/03639040802509868 ]; Mackey JR, 1998, CANCER RES, V58, P4349; Marechal R, 2009, CLIN CANCER RES, V15, P2913, DOI 10.1158/1078-0432.CCR-08-2080; Michalski CW, 2008, BRIT J CANCER, V99, P760, DOI 10.1038/sj.bjc.6604528; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Paproski RJ, 2010, BIOCHEM PHARMACOL, V79, P587, DOI 10.1016/j.bcp.2009.09.025; Pennycooke M, 2001, BIOCHEM BIOPH RES CO, V280, P951, DOI 10.1006/bbrc.2000.4205; Perez-Torras S, 2008, BIOCHEM PHARMACOL, V76, P322, DOI 10.1016/j.bcp.2008.05.011; Qiu YY, 2010, J CONTROL RELEASE, V145, P40, DOI 10.1016/j.jconrel.2010.04.010; Rahim AA, 2006, J GENE MED, V8, P1347, DOI 10.1002/jgm.962; Sheeran PS, 2011, LANGMUIR, V27, P10412, DOI 10.1021/la2013705; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Tlaxca JL, 2010, ULTRASOUND MED BIOL, V36, P1907, DOI 10.1016/j.ultrasmedbio.2010.05.014; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Tsunoda S, 2005, BIOCHEM BIOPH RES CO, V336, P118, DOI 10.1016/j.bbrc.2005.08.052; Veltkamp SA, 2008, MOL CANCER THER, V7, P2415, DOI 10.1158/1535-7163.MCT-08-0137	33	21	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56423	10.1371/journal.pone.0056423	http://dx.doi.org/10.1371/journal.pone.0056423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441192	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200049
J	Yu, CF; Hong, JH; Chiang, CS				Yu, Ching-Fang; Hong, Ji-Hong; Chiang, Chi-Shiun			The Roles of Macrophages and Nitric Oxide in Interleukin-3-Enhanced HSV-Sr39tk-Mediated Prodrug Therapy	PLOS ONE			English	Article							VIRUS-THYMIDINE-KINASE; GENE-THERAPY; IN-VIVO; SUICIDE GENE; PARTICULATE ANTIGEN; GANCICLOVIR SYSTEM; HSV-TK; EXPRESSION; CELLS; IL-3	The herpes simplex virus thymidine kinase/ganciclovir (HSV-sr39tk/GCV) system is a well-established prodrug system used in cancer gene therapy. However, this system is currently not effective enough to eradicate malignant tumors completely. This study aimed to evaluate whether co-expression of interleukin-3 (IL-3) could enhance the anti-tumor activity of HSV-sr39tk/GCV prodrug gene therapy using a murine TRAMP-C1 prostate tumor model. In vitro results demonstrated that HSV-sr39tk-transfected cells exhibited enhanced sensitivity to the GCV prodrug, which was not affected by co-expression of the mIL-3 gene. However, in vivo studies showed that co-expression of the mIL-3 gene significantly increased the HSV-sr39tk/GCV-induced tumor growth delay and even cured the tumor. The TRAMP-C1-specific immune response of spleen lymphocytes from mice bearing HSV-sr39tk- and IL-3-expressing TRAMP-C1 tumors was measured by ELISA. Results showed that IL-3-activated IL-4-dominant lymphocytes became IFN-gamma- dominant lymphocytes after combined HSV-sr39tk/GCV therapy. The efficacy of combined therapies on tumor regression was reduced when macrophages populations were depleted by carrageenan or NO production was inhibited by administration of the iNOS inhibitor, L-NAME. These results suggest that utilizing a bicistronic vector to express HSV-sr39tk and the IL-3 gene induced an enhanced macrophage- or NO-dependent anti-tumor effect.	[Yu, Ching-Fang; Chiang, Chi-Shiun] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Hong, Ji-Hong] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan; [Hong, Ji-Hong] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University	Chiang, CS (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	cschiang@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129	 [NHRI-EX101-10132BI];  [NSC 101-2627-N-007-001];  [NTHU101N2050E1];  [NHTU-101N2760E1]	; ; ; 	This study is supported by NHRI-EX101-10132BI, NSC 101-2627-N-007-001, NTHU101N2050E1, and NHTU-101N2760E1 grants to Chiang, C. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardiani A, 2010, CANCER GENE THER, V17, P86, DOI 10.1038/cgt.2009.60; Black ME, 2001, CANCER RES, V61, P3022; Chiang CS, 1997, CANCER RES, V57, P3899; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Elshami AA, 1996, GENE THER, V3, P85; FARIASEISNER R, 1994, P NATL ACAD SCI USA, V91, P9407, DOI 10.1073/pnas.91.20.9407; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; FREEMAN SM, 1995, CANCER LETT, V92, P167, DOI 10.1016/0304-3835(95)03771-N; FRENDL G, 1990, J IMMUNOL, V144, P3400; FRENDL G, 1990, J IMMUNOL, V144, P3392; Hanari N, 2007, ANTICANCER RES, V27, P2305; IHLE JN, 1992, CHEM IMMUNOL, V51, P65; Kagaya T, 2006, CANCER GENE THER, V13, P357, DOI 10.1038/sj.cgt.7700908; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Lord EM, 1998, J IMMUNOTHER, V21, P205, DOI 10.1097/00002371-199805000-00006; McBride WH, 1996, ANTICANCER RES, V16, P1139; MOOLTEN FL, 1986, CANCER RES, V46, P5276; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Orucevic A, 1999, INT J CANCER, V81, P889, DOI 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2; PULASKI BA, 1993, CANCER RES, V53, P2112; Pulaski BA, 1996, P NATL ACAD SCI USA, V93, P3669, DOI 10.1073/pnas.93.8.3669; Ramesh R, 1996, EXP HEMATOL, V24, P829; Ramesh R, 1996, CANCER GENE THER, V3, P373; Ramesh R, 1998, ADV EXP MED BIOL, V451, P125; Ren WH, 2004, CANCER RES, V64, P6645, DOI 10.1158/0008-5472.CAN-04-1084; SCHRADER JW, 1986, ANNU REV IMMUNOL, V4, P205, DOI 10.1146/annurev.iy.04.040186.001225; Stefani AL, 2005, J HEPATOL, V42, P728, DOI 10.1016/j.jhep.2004.12.037; Tsai CH, 2006, CANCER GENE THER, V13, P1082, DOI 10.1038/sj.cgt.7700977; Van Dillen Ingrid J., 2002, Current Gene Therapy, V2, P307, DOI 10.2174/1566523023347733; VILE RG, 1994, CANCER RES, V54, P6228; Vile RG, 1997, INT J CANCER, V71, P267; Wiewrodt R, 2003, CANCER GENE THER, V10, P353, DOI 10.1038/sj.cgt.7700589; Yamazaki M, 2004, CANCER GENE THER, V11, P8, DOI 10.1038/sj.cgt.7700636; Yeh KY, 1998, J IMMUNOL, V160, P5773; Zhang JH, 2004, WORLD J GASTROENTERO, V10, P26	35	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56508	10.1371/journal.pone.0056508	http://dx.doi.org/10.1371/journal.pone.0056508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441198	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200055
J	Zhao, B; Bohonowych, JES; Timme-Laragy, A; Jung, D; Affatato, AA; Rice, RH; Di Giulio, RT; Denison, MS				Zhao, Bin; Bohonowych, Jessica E. S.; Timme-Laragy, Alicia; Jung, Dawoon; Affatato, Alessandra A.; Rice, Robert H.; Di Giulio, Richard T.; Denison, Michael S.			Common Commercial and Consumer Products Contain Activators of the Aryl Hydrocarbon (Dioxin) Receptor	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; RECOMBINANT CELL BIOASSAYS; AH-RECEPTOR; BINDING AFFINITY; TIRE EXTRACTS; CHEMICALS; AGONISTS; PATHWAY; GENE; IDENTIFICATION	Activation of the Ah receptor (AhR) by halogenated aromatic hydrocarbons (HAHs), such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin), can produce a wide variety of toxic and biological effects. While recent studies have shown that the AhR can bind and be activated by structurally diverse chemicals, how widespread of these AhR agonists are in environmental, biological and synthetic materials remains to be determined. Using AhR-based assays, we demonstrate the presence of potent AhR agonists in a variety of common commercial and consumer items. Solvent extracts of paper, rubber and plastic products contain chemicals that can bind to and stimulate AhR DNA binding and/or AhR-dependent gene expression in hepatic cytosol, cultured cell lines, human epidermis and zebrafish embryos. In contrast to TCDD and other persistent dioxin-like HAHs, activation of AhR-dependent gene expression by these extracts was transient, suggesting that the agonists are metabolically labile. Solvent extracts of rubber products produce AhR-dependent developmental toxicity in zebrafish in vivo, and inhibition of expression of the metabolic enzyme CYP1A, significantly increased their toxic potency. Although the identity of the responsible AhR-active chemicals and their toxicological impact remain to be determined, our data demonstrate that AhR active chemicals are widely distributed in everyday products.	[Zhao, Bin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, Beijing, Peoples R China; [Zhao, Bin; Bohonowych, Jessica E. S.; Affatato, Alessandra A.; Rice, Robert H.; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Timme-Laragy, Alicia; Jung, Dawoon; Di Giulio, Richard T.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of California System; University of California Davis; Duke University	Zhao, B (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Environm Chem & Ecotoxicol, POB 934, Beijing, Peoples R China.	binzhao@rcees.ac.cn; msdenison@ucdavis.edu	Jung, Dawoon/F-9893-2010; Rice, Robert/AAP-7813-2021	Jung, Dawoon/0000-0001-5193-3626; Timme-Laragy, Alicia/0000-0002-8835-5038	National Institutes of Environmental Health Sciences [R01-ES012498, R01-ES007685, P42-ES004699, P42-ES010356, P30-ES011961]; California Agricultural Experiment Station; Chinese Academy of Sciences Key Program of Knowledge Innovation [KZCX2-EW-411]; National Natural Science Foundation of China [20921063, 21177150]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, P30ES011961, P42ES010356, R01ES012498, P42ES004699] Funding Source: NIH RePORTER	National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; Chinese Academy of Sciences Key Program of Knowledge Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Environmental Health Sciences [R01-ES012498, R01-ES007685, P42-ES004699, P42-ES010356, P30-ES011961], the California Agricultural Experiment Station, the Chinese Academy of Sciences Key Program of Knowledge Innovation (KZCX2-EW-411) and National Natural Science Foundation of China (20921063, 21177150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Andersen HH, 2002, NUCL INSTRUM METH B, V187, P1; [Anonymous], 2011, AH RECEPTOR BIOL TOX; Baston DS, 2011, TALANTA, V83, P1415, DOI 10.1016/j.talanta.2010.11.035; Behnisch PA, 2001, ENVIRON INT, V27, P413, DOI 10.1016/S0160-4120(01)00028-9; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Billiard SM, 2006, TOXICOL SCI, V92, P526, DOI 10.1093/toxsci/kfl011; Bohonowych JE, 2007, TOXICOL SCI, V98, P99, DOI 10.1093/toxsci/kfm085; Bohonowych JES, 2008, TOXICOL SCI, V102, P278, DOI 10.1093/toxsci/kfn011; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; Chou PH, 2006, WATER SCI TECHNOL, V53, P35, DOI 10.2166/wst.2006.335; Chou PH, 2007, ENVIRON SCI TECHNOL, V41, P652, DOI 10.1021/es061500g; Denison M, 1998, MOL BIOL APPROACHES, P393; Denison M.S., 2002, CURRENT PROTOCOLS TO, p(48)1; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; DENISON MS, 1986, J BIOL CHEM, V261, P3987; Denison MS, 2004, TALANTA, V63, P1123, DOI 10.1016/j.talanta.2004.05.032; Denison MS, 1998, TOXICOL APPL PHARM, V152, P406, DOI 10.1006/taap.1998.9999; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Farfan A, 1999, PROMEGA NOTES, P25; Flaveny Colin A, 2009, Mol Cell Pharmacol, V1, P119; Furness SGB, 2009, PHARMACOL THERAPEUT, V124, P336, DOI 10.1016/j.pharmthera.2009.09.004; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Han D, 2004, BIOFACTORS, V20, P11, DOI 10.1002/biof.5520200102; He GC, 2011, ENVIRON TOXICOL CHEM, V30, P1915, DOI 10.1002/etc.581; Henry EC, 2008, ARCH BIOCHEM BIOPHYS, V472, P77, DOI 10.1016/j.abb.2008.02.005; Houtman CJ, 2004, ENVIRON TOXICOL CHEM, V23, P32, DOI 10.1897/02-544; Huang RL, 2011, ENVIRON HEALTH PERSP, V119, P1142, DOI 10.1289/ehp.1002952; Jeuken A, 2003, J AGR FOOD CHEM, V51, P5478, DOI 10.1021/jf030252u; Kruger T, 2008, TOXICOLOGY, V246, P112, DOI 10.1016/j.tox.2007.12.028; Leusch FDL, 2010, ENVIRON SCI TECHNOL, V44, P3853, DOI 10.1021/es903899d; Long WP, 1998, MOL PHARMACOL, V53, P691, DOI 10.1124/mol.53.4.691; Ma Q, 2002, ARCH BIOCHEM BIOPHYS, V404, P309, DOI 10.1016/S0003-9861(02)00339-9; Mankidy R, 2012, TOXICOL LETT; Morohoshi K, 2005, TOXICOL IN VITRO, V19, P457, DOI 10.1016/j.tiv.2005.01.004; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Noguerol TN, 2006, ANAL BIOANAL CHEM, V385, P1012, DOI 10.1007/s00216-006-0476-4; Ogawa Y, 2006, FOOD ADDIT CONTAM A, V23, P422, DOI 10.1080/02652030500482371; Ozaki A, 2003, FOOD ADDIT CONTAM, V20, P92, DOI 10.1080/0265203021000014798; Petkov PI, 2010, SAR QSAR ENVIRON RES, V21, P187, DOI 10.1080/10629360903570933; Rice RH, 2009, CHEM-BIOL INTERACT, V181, P359, DOI 10.1016/j.cbi.2009.08.007; Rogers JM, 2000, IN VITRO MOL TOXICOL, V13, P67; Rogers JM, 2002, MOL PHARMACOL, V61, P1393, DOI 10.1124/mol.61.6.1393; SAFE S, 1990, CRIT REV TOXICOL, V21, P51, DOI 10.3109/10408449009089873; Satoh K, 2008, BIOL PHARM BULL, V31, P375, DOI 10.1248/bpb.31.375; Seidel SD, 2000, TOXICOL SCI, V55, P107, DOI 10.1093/toxsci/55.1.107; Seidel SD, 2001, J BIOCHEM MOL TOXIC, V15, P187; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Swedenborg E, 2010, TOXICOLOGY, V268, P132, DOI 10.1016/j.tox.2009.09.007; Wassenberg DM, 2004, ENVIRON HEALTH PERSP, V112, P1658, DOI 10.1289/ehp.7168; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Zhang QH, 2002, B ENVIRON CONTAM TOX, V69, P863, DOI 10.1007/s00128-002-0139-x; Zhao B, 2006, J BIOCHEM MOL TOXIC, V20, P103, DOI 10.1002/jbt.20126	53	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56860	10.1371/journal.pone.0056860	http://dx.doi.org/10.1371/journal.pone.0056860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441220	Green Published, gold			2022-12-25	WOS:000315159200077
J	Crowe, A; James, MJ; Lee, VMY; Smith, AB; Trojanowski, JQ; Ballatore, C; Brunden, KR				Crowe, Alex; James, Michael J.; Lee, Virginia M. -Y.; Smith, Amos B., III; Trojanowski, John Q.; Ballatore, Carlo; Brunden, Kurt R.			Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; IN-VITRO; AGGREGATION; INHIBITION; NEURODEGENERATION; DISCOVERY; PEPTIDES; DEMENTIA	Alzheimer disease and several other neurodegenerative disorders are characterized by the accumulation of intraneuronal fibrils comprised of the protein Tau. Tau is normally a soluble protein that stabilizes microtubules, with splice isoforms that contain either three (3-R) or four (4-R) microtubule binding repeats. The formation of Tau fibrils is thought to result in neuronal damage, and inhibitors of Tau fibrillization may hold promise as therapeutic agents. The process of Tau fibrillization can be replicated in vitro, and a number of small molecules have been identified that inhibit Tau fibril formation. However, little is known about how these molecules affect Tau fibrillization. Here, we examined the mechanism by which the previously described aminothieno pyridazine (ATPZ) series of compounds inhibit Tau fibrillization. Active ATPZs were found to promote the oxidation of the two cysteine residues within 4-R Tau by a redox cycling mechanism, resulting in the formation of a disulfide-containing compact monomer that was refractory to fibrillization. Moreover, the ATPZs facilitated intermolecular disulfide formation between 3-R Tau monomers, leading to dimers that were capable of fibrillization. The ATPZs also caused cysteine oxidation in molecules unrelated to Tau. Interestingly, methylene blue, an inhibitor of Tau fibrillization under evaluation in Alzheimer disease clinical trials, caused a similar oxidation of cysteines in Tau and other molecules. These findings reveal that the ATPZs and methylene blue act by a mechanism that may affect their viability as potential therapeutic agents.	[Crowe, Alex; James, Michael J.; Lee, Virginia M. -Y.; Trojanowski, John Q.; Ballatore, Carlo; Brunden, Kurt R.] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Amos B., III; Ballatore, Carlo] Univ Penn, Dept Chem, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Brunden, KR (corresponding author), Univ Penn, Ctr Neurodegenerat Dis Res, 3600 Spruce St,Maloney 3, Philadelphia, PA 19104 USA.	kbrunden@upenn.edu	Ballatore, Carlo/L-1034-2017	Ballatore, Carlo/0000-0002-2718-3850	National Institutes of Health (NIA) [AG17586]; Alzheimer Disease Research program of the American Health Assistance Foundation; Coins for Alzheimer's Research Trust; Comprehensive Neuroscience Center at the University of Pennsylvania; Marian S. Ware Alzheimer's Program; NATIONAL INSTITUTE ON AGING [P01AG017586] Funding Source: NIH RePORTER	National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer Disease Research program of the American Health Assistance Foundation; Coins for Alzheimer's Research Trust; Comprehensive Neuroscience Center at the University of Pennsylvania; Marian S. Ware Alzheimer's Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG17586 (NIA; V. M.-Y. L.). This work was also supported by grants from the Alzheimer Disease Research program of the American Health Assistance Foundation (to K. R. B.) and the Coins for Alzheimer's Research Trust (to K. R. B.), a pilot grant from the Comprehensive Neuroscience Center at the University of Pennsylvania (to C. B.), and by the Marian S. Ware Alzheimer's Program.	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; Ballatore C, 2011, CURR TOP MED CHEM, V11, P317, DOI 10.2174/156802611794072605; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Ballatore C, 2012, BIOORGAN MED CHEM, V20, P4451, DOI 10.1016/j.bmc.2012.05.027; Ballatore C, 2010, J MED CHEM, V53, P3739, DOI 10.1021/jm100138f; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; Brunden KR, 2010, EXP NEUROL, V223, P304, DOI 10.1016/j.expneurol.2009.08.031; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Chang E, 2009, J MED CHEM, V52, P3539, DOI 10.1021/jm900116d; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; Crowe A, 2009, BIOCHEMISTRY-US, V48, P7732, DOI 10.1021/bi9006435; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GORMAN JJ, 1987, ANAL BIOCHEM, V160, P376, DOI 10.1016/0003-2697(87)90064-9; Hasegawa M, 2006, NEUROPATHOLOGY, V26, P484, DOI 10.1111/j.1440-1789.2006.00666.x; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LEE VMY, 1994, NEUROBIOL AGING, V15, pS87; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Smith GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P195, DOI 10.1006/abbi.2002.2757; Soares KM, 2010, ASSAY DRUG DEV TECHN, V8, P152, DOI 10.1089/adt.2009.0247; STAFF RT, 2008, ALZHEIMERS DEMENT, V4, pT775; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wilson DM, 1997, AM J PATHOL, V150, P2181; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Zhang HQ, 2012, SEMIN CELL DEV BIOL, V23, P722, DOI 10.1016/j.semcdb.2012.03.017; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	51	105	107	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11024	11037		10.1074/jbc.M112.436006	http://dx.doi.org/10.1074/jbc.M112.436006			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443659	hybrid, Green Published			2022-12-25	WOS:000317915500009
J	Chen, YC; Hsiao, CC; Chen, KD; Hung, YC; Wu, CY; Lie, CH; Liu, SF; Sung, MT; Chen, CJ; Wang, TY; Chang, JC; Tang, P; Fang, WF; Wang, YH; Chung, YH; Chao, TY; Leung, SY; Su, MC; Wang, CC; Lin, MC				Chen, Yung-Che; Hsiao, Chang-Chun; Chen, Kuang-Den; Hung, Yu-Chiang; Wu, Ching-Yuan; Lie, Chien-Hao; Liu, Shih-Feng; Sung, Ming-Tse; Chen, Chung-Jen; Wang, Ting-Ya; Chang, Jen-Chieh; Tang, Petrus; Fang, Wen-Feng; Wang, Yi-Hsi; Chung, Yu-Hsiu; Chao, Tung-Ying; Leung, Sum-Yee; Su, Mao-Chang; Wang, Chin-Chou; Lin, Meng-Chih			Peripheral Immune Cell Gene Expression Changes in Advanced Non-Small Cell Lung Cancer Patients Treated with First Line Combination Chemotherapy	PLOS ONE			English	Article							SUPPRESSOR-CELLS; BREAST-CANCER; GEMCITABINE; MACROPHAGES; SIGNATURE; INVASION; RECEPTOR; SURVIVAL; THERAPY; CYCLOPHOSPHAMIDE	Introduction: Increasing evidence has shown that immune surveillance is compromised in a tumor-promoting microenvironment for patients with non-small cell lung cancer (NSCLC), and can be restored by appropriate chemotherapy. Methods: To test this hypothesis, we analyzed microarray gene expression profiles of peripheral blood mononuclear cells from 30 patients with newly-diagnosed advanced stage NSCLC, and 20 age-, sex-, and co-morbidity-matched healthy controls. All the patients received a median of four courses of chemotherapy with cisplatin and gemcitabine for a 28-day cycle as first line treatment. Results: Sixty-nine differentially expressed genes between the patients and controls, and 59 differentially expressed genes before and after chemotherapy were identified. The IL4 pathway was significantly enriched in both tumor progression and chemotherapy signatures. CXCR4 and IL2RG were down-regulated, while DOK2 and S100A15 were up-regulated in the patients, and expressions of all four genes were partially or totally reversed after chemotherapy. Real-time quantitative RT-PCR for the four up-regulated (S100A15, DOK2) and down-regulated (TLR7, TOP1MT) genes in the patients, and the six up-regulated (TLR7, CRISP3, TOP1MT) and down-regulated (S100A15, DOK2, IL2RG) genes after chemotherapy confirmed the validity of the microarray results. Further immunohistochemical analysis of the paraffin-embedded lung cancer tissues identified strong S100A15 nuclear staining not only in stage IV NSCLC as compared to stage IIIB NSCLC (p = 0.005), but also in patients with stable or progressive disease as compared to those with a partial response (p = 0.032). A high percentage of S100A15 nuclear stained cells (HR 1.028, p = 0.01) was the only independent factor associated with three-year overall mortality. Conclusions: Our results suggest a potential role of the IL4 pathway in immune surveillance of advanced stage NSCLC, and immune potentiation of combination chemotherapy. S100A15 may serve as a potential biomarker for tumor staging, and a predictor of poor prognosis in NSCLC.	[Chen, Yung-Che; Lie, Chien-Hao; Liu, Shih-Feng; Wang, Ting-Ya; Fang, Wen-Feng; Wang, Yi-Hsi; Chung, Yu-Hsiu; Chao, Tung-Ying; Leung, Sum-Yee; Su, Mao-Chang; Wang, Chin-Chou; Lin, Meng-Chih] Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Chen, Yung-Che; Chen, Kuang-Den; Hung, Yu-Chiang; Wu, Ching-Yuan; Lie, Chien-Hao; Liu, Shih-Feng; Sung, Ming-Tse; Chen, Chung-Jen; Wang, Ting-Ya; Chang, Jen-Chieh; Fang, Wen-Feng; Wang, Yi-Hsi; Chung, Yu-Hsiu; Chao, Tung-Ying; Leung, Sum-Yee; Su, Mao-Chang; Wang, Chin-Chou; Lin, Meng-Chih] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chen, Kuang-Den] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Hung, Yu-Chiang; Wu, Ching-Yuan] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung, Taiwan; [Liu, Shih-Feng] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan; [Sung, Ming-Tse] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chen, Chung-Jen] Kaohsiung Chang Gung Mem Hosp, Div Rheumatol, Kaohsiung, Taiwan; [Chang, Jen-Chieh] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chen, Yung-Che; Hsiao, Chang-Chun; Tang, Petrus] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, MC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan.	linmengchih@hotmail.com	Chen, Yung-Che/AAL-5167-2020; Fang, Wen-Feng/AAT-6296-2021; Hung, yu-chiang/ABE-7636-2020; Leung, Suet Yi/T-9620-2019	Chen, Yung-Che/0000-0001-8695-5227; Fang, Wen-Feng/0000-0003-0350-9059; Tang, Petrus/0000-0002-2779-0116; Chen, Chung-Jen/0000-0002-7405-2335; Hsiao, Chang-Chun/0000-0002-7275-4675; Leung, Suet Yi/0000-0001-8614-4619; Liu, Shih-Feng/0000-0003-1394-5401	Committee on Chinese Medicine and Pharmacy of the Department of Health, Executive Yuan, Taiwan [CCMP96-RD-202]; Chang Gung Memorial Hospital [CMRPG891301, CMRPG881031]	Committee on Chinese Medicine and Pharmacy of the Department of Health, Executive Yuan, Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant (CCMP96-RD-202) from the Committee on Chinese Medicine and Pharmacy of the Department of Health, Executive Yuan, Taiwan, and also supported in part by grants from the Chang Gung Memorial Hospital (CMRPG891301 to K.D. Chen, and CMRPG881031 to Y. C. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI W, 1995, BRIT MED J, V311, P899; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Berger AH, 2010, NAT GENET, V42, P216, DOI 10.1038/ng.527; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Buechau AS, 2007, J INVEST DERMATOL, V127, P2596, DOI 10.1038/sj.jid.5700946; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029; Caras I, 2004, CANCER IMMUNOL IMMUN, V53, P1146, DOI 10.1007/s00262-004-0556-2; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Cherfils-Vicini J, 2010, J CLIN INVEST, V120, P1285, DOI 10.1172/JCI36551; Dahlman A, 2010, PROSTATE CANCER P D, V13, P369, DOI 10.1038/pcan.2010.25; Dai FQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-220; Delbaldo C, 2004, JAMA-J AM MED ASSOC, V292, P470, DOI 10.1001/jama.292.4.470; Della Peruta M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-61; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dumitru CD, 2010, CANCER BIOL THER, V10, P155, DOI 10.4161/cbt.10.2.12163; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Fransson S, 2012, ONCOGENE, V31, P3277, DOI 10.1038/onc.2011.492; Grills C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014635; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Hu JT, 2005, ONCOGENE, V24, P1212, DOI 10.1038/sj.onc.1208242; Kawakami M, 2002, CLIN CANCER RES, V8, P3503; Kawashima O, 2000, ANN SURG ONCOL, V7, P239, DOI 10.1007/BF02523660; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Khodarev NN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005821; KOHN EC, 1995, CANCER RES, V55, P1856; Kossenkov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034392; Kossenkov AV, 2011, CLIN CANCER RES, V17, P5867, DOI 10.1158/1078-0432.CCR-11-0737; Lee JM, 2008, CRIT REV ONCOL HEMAT, V66, P208, DOI 10.1016/j.critrevonc.2008.01.004; Liu WM, 2010, BRIT J CANCER, V102, P115, DOI 10.1038/sj.bjc.6605465; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Mailloux AW, 2010, INT J CANCER, V127, P2598, DOI 10.1002/ijc.25281; Mazzoccoli G, 2012, CLIN EXP MED, V12, P181, DOI 10.1007/s10238-011-0153-6; Merritt RE, 2003, J THORAC CARDIOV SUR, V126, P1609, DOI 10.1016/S0022-5223(03)00707-4; Nowak AK, 2002, CANCER RES, V62, P2353; Okabe M, 2008, MOL CANCER THER, V7, P3081, DOI 10.1158/1535-7163.MCT-08-0539; Oliveras-Ferraros C, 2011, INT J ONCOL, V39, P1455, DOI 10.3892/ijo.2011.1155; Otsuka S, 2008, J THORAC ONCOL, V3, P1379, DOI 10.1097/JTO.0b013e31818dda9d; Perez-Pinera P, 2007, MOL CELL BIOCHEM, V295, P19, DOI 10.1007/s11010-006-9267-7; Plate JMD, 2005, CANCER IMMUNOL IMMUN, V54, P915, DOI 10.1007/s00262-004-0638-1; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Saviouk V, 2007, SCHIZOPHR RES, V96, P100, DOI 10.1016/j.schres.2007.07.031; Shepherd FA, 2011, J THORAC ONCOL, V6, P1763, DOI 10.1097/JTO.0b013e31822e28fc; Shojaei H, 2009, CANCER RES, V69, P8710, DOI 10.1158/0008-5472.CAN-09-1602; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sun ZF, 2008, J CLIN ONCOL, V26, P877, DOI 10.1200/JCO.2007.13.1516; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Vasievich EA, 2011, MOL PHARMACEUT, V8, P635, DOI 10.1021/mp1004228; Wolf R, 2008, J IMMUNOL, V181, P1499, DOI 10.4049/jimmunol.181.2.1499; Wolf R, 2011, AMINO ACIDS, V41, P789, DOI 10.1007/s00726-010-0666-4; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Zhang H, 2008, THORAX, V63, P352, DOI 10.1136/thx.2007.087015; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325	63	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57053	10.1371/journal.pone.0057053	http://dx.doi.org/10.1371/journal.pone.0057053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451142	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500055
J	Freeman, SL; England, GCW				Freeman, Sarah L.; England, Gary C. W.			Storage and Release of Spermatozoa from the Pre-Uterine Tube Reservoir	PLOS ONE			English	Article							OVIDUCTAL SPERM RESERVOIR; FEMALE REPRODUCTIVE-TRACT; EPITHELIAL-CELLS; DOG SPERMATOZOA; ARTIFICIAL-INSEMINATION; ACROSOME REACTION; GENITAL-TRACT; CAPACITATION; BITCH; INDUCTION	In mammals, after coitus a small number of spermatozoa enter the uterine tube and following attachment to uterine tube epithelium are arrested in a non-capacitated state until peri-ovulatory signalling induces their detachment. Whilst awaiting release low numbers of spermatozoa continually detach from the epithelium and the uterine tube reservoir risks depletion. There is evidence of attachment of spermatozoa to uterine epithelium in several species which might form a potential pre-uterine tube reservoir. In this study we demonstrate that: (1) dog spermatozoa attach to uterine epithelium and maintain flagellar activity, (2) in non-capacitating conditions spermatozoa progressively detach with a variety of motility characteristics, (3) attachment is not influenced by epithelial changes occurring around ovulation, (4) attachment to uterine epithelium slows capacitation, (5) capacitated spermatozoa have reduced ability to attach to uterine epithelium, (6) under capacitating conditions increased numbers of spermatozoa detach and exhibit transitional and hyperactive motility which differ to those seen in non-capacitating conditions, (7) detachment of spermatozoa and motility changes can be induced by post-ovulation but not pre-ovulation uterine tube flush fluid and by components of follicular fluid and solubilised zona pellucida, (8) prolonged culture does not change the nature of the progressive detachment seen in non-capacitating conditions nor the potential for increased detachment in capacitating conditions. We postulate that in some species binding of spermatozoa to uterine epithelium is an important component of the transport of spermatozoa. Before ovulation low numbers of spermatozoa continually detach, including those which are non-capacitated with fast forward progressive motility allowing the re-population of the uterine tube, whilst around the time of ovulation, signalling from as-yet unknown factors associated with follicular fluid, oocytes and uterine tube secretion promotes the detachment of large numbers of capacitated spermatozoa with hyperactive motility that may contribute to the fertilising pool.	[Freeman, Sarah L.; England, Gary C. W.] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Surg, Nottingham NG7 2RD, Leics, England	University of Nottingham	England, GCW (corresponding author), Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Surg, Sutton Bonington Campus, Nottingham NG7 2RD, Leics, England.	gary.england@nottingham.ac.uk	Freeman, Sarah/H-1228-2011; England, Gary C.W./G-5432-2011	Freeman, Sarah/0000-0002-3119-2207; England, Gary/0000-0001-5800-3106				Burgess CM, 2012, VET J, V192, P398, DOI 10.1016/j.tvjl.2011.08.026; BURKHARDT J, 1949, J AGR SCI, V39, P201, DOI 10.1017/S0021859600005025; Chatdarong K, 2004, THERIOGENOLOGY, V62, P1027, DOI 10.1016/j.theriogenology.2003.12.014; DEMOTT RP, 1992, BIOL REPROD, V46, P779, DOI 10.1095/biolreprod46.5.779; DOAK RL, 1967, J REPROD FERTIL, V13, P51, DOI 10.1530/jrf.0.0130051; Dunson DB, 2001, HUM REPROD, V16, P2278, DOI 10.1093/humrep/16.11.2278; ELLINGTON JE, 1995, VET REC, V136, P542, DOI 10.1136/vr.136.21.542; England GCW, 2006, THERIOGENOLOGY, V66, P1410, DOI 10.1016/j.theriogenology.2006.01.025; England GCW, 1999, THERIOGENOLOGY, V52, P981, DOI 10.1016/S0093-691X(99)00187-9; England GCW, 2012, VET J IN PRESS; Fazeli A, 1999, BIOL REPROD, V60, P879, DOI 10.1095/biolreprod60.4.879; Hewitt DA, 1998, ANIM REPROD SCI, V51, P321, DOI 10.1016/S0378-4320(98)00079-7; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; Karre I, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-49; Kawakami E, 1998, J VET MED SCI, V60, P197, DOI 10.1292/jvms.60.197; Kawakami E, 2000, J VET MED SCI, V62, P65, DOI 10.1292/jvms.62.65; Kawakami E, 2002, J VET MED SCI, V64, P867, DOI 10.1292/jvms.64.867; Kawakami E, 2001, ANIM REPROD SCI, V68, P121, DOI 10.1016/S0378-4320(01)00135-X; LEFEBVRE R, 1995, BIOL REPROD, V53, P1066, DOI 10.1095/biolreprod53.5.1066; Lefebvre R, 1996, BIOL REPROD, V54, P575, DOI 10.1095/biolreprod54.3.575; MAHI CA, 1978, GAMETE RES, V1, P101, DOI 10.1002/mrd.1120010203; Moxon R, 2010, VET REC, V167, P528, DOI 10.1136/vr.c5082; Murray SC, 1997, FERTIL STERIL, V68, P351, DOI 10.1016/S0015-0282(97)81528-2; Osycka-Salut C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030671; PACEY AA, 1995, HUM REPROD, V10, P2603, DOI 10.1093/oxfordjournals.humrep.a135754; Pacey AA, 2000, THERIOGENOLOGY, V54, P109, DOI 10.1016/S0093-691X(00)00329-0; PURSEL VG, 1978, BIOL REPROD, V19, P69, DOI 10.1095/biolreprod19.1.69; Rath D, 2008, REPROD DOMEST ANIM, V43, P2, DOI 10.1111/j.1439-0531.2008.01250.x; Rijsselaere T, 2004, REPRODUCTION, V128, P801, DOI 10.1530/rep.1.00273; Rodriguez-Martinez H, 2001, J REP FER S, P129; Smith SC, 2001, J REP FER S, P151; Smith SC, 1999, THESIS U LONDON; Smith TT, 1998, BIOL REPROD, V58, P1102, DOI 10.1095/biolreprod58.5.1102; SMITH TT, 1990, BIOL REPROD, V42, P450, DOI 10.1095/biolreprod42.3.450; SMITH TT, 1991, J REPROD FERTIL, V91, P567, DOI 10.1530/jrf.0.0910567; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 1998, BIOL REPROD, V58, P1105, DOI 10.1095/biolreprod58.5.1105; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Talevi R, 2001, BIOL REPROD, V64, P491, DOI 10.1095/biolreprod64.2.491; Taylor U, 2008, REPROD DOMEST ANIM, V43, P166, DOI 10.1111/j.1439-0531.2007.00872.x; Taylor U, 2009, Soc Reprod Fertil Suppl, V66, P83; TSUTSUI T, 1989, J REPROD FERTIL, P269; WILDT DE, 1979, BIOL REPROD, V20, P648, DOI 10.1095/biolreprod20.3.648	43	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57006	10.1371/journal.pone.0057006	http://dx.doi.org/10.1371/journal.pone.0057006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451135	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500053
J	Nagy, ZS; Ross, JA; Rodriguez, G; Balint, BL; Szeles, L; Nagy, L; Kirken, RA				Nagy, Zsuzsanna S.; Ross, Jeremy A.; Rodriguez, Georgialina; Balint, Balint L.; Szeles, Lajos; Nagy, Laszlo; Kirken, Robert A.			Genome Wide Mapping Reveals PDE4B as an IL-2 Induced STAT5 Target Gene in Activated Human PBMCs and Lymphoid Cancer Cells	PLOS ONE			English	Article							T-CELLS; TRANSCRIPTIONAL ACTIVATION; BINDING-SITES; APOPTOSIS; RECEPTOR; JAK; PROTEINS; CD4(+); LINE; DIFFERENTIATION	IL-2 is the primary growth factor for promoting survival and proliferation of activated T cells that occurs following engagement of the Janus Kinase (JAK)1-3/and Signal Transducer and Activator of Transcription (STAT) 5 signaling pathway. STAT5 has two isoforms: STAT5A and STAT5B ( commonly referred to as STAT5) which, in T cells, play redundant roles transcribing cell cycle and survival genes. As such, inhibition of STAT5 by a variety of mechanisms can rapidly induce apoptosis in certain lymphoid tumor cells, suggesting that it and its target genes represent therapeutic targets to control certain lymphoid diseases. To search for these molecules we aligned IL-2 regulated genes detected by Affymetrix gene expression microarrays with the STAT5 cistrome identified by chip-on-ChIP analysis in an IL-2-dependent human leukemia cell line, Kit225. Select overlapping genes were then validated using qRT(2)PCR medium-throughput arrays in human PHA-activated PBMCs. Of 19 putative genes, one key regulator of T cell receptor signaling, PDE4B, was identified as a novel target, which was readily up-regulated at the protein level (3 h) in IL-2 stimulated, activated human PBMCs. Surprisingly, only purified CD8+ primary T-cells expressed PDE4B, but not CD4+ cells. Moreover, PDE4B was found to be highly expressed in CD4+ lymphoid cancer cells, which suggests that it may represent a physiological role unique to the CD8+ and lymphoid cancer cells and thus might represent a target for pharmaceutical intervention for certain lymphoid diseases.	[Nagy, Zsuzsanna S.; Ross, Jeremy A.; Rodriguez, Georgialina; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Nagy, Zsuzsanna S.; Balint, Balint L.; Szeles, Lajos; Nagy, Laszlo] Univ Debrecen, Dept Biochem & Mol Biol, H-4012 Debrecen, Hungary; [Nagy, Zsuzsanna S.; Balint, Balint L.; Szeles, Lajos; Nagy, Laszlo] Hlth Sci Ctr, Debrecen, Hungary	University of Texas System; University of Texas El Paso; University of Debrecen	Nagy, ZS (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	nagyzsu@med.unideb.hu	Nagy, Laszlo/A-3814-2008	Nagy, Laszlo/0000-0001-6653-2155; Balint, Balint/0000-0002-6163-7190; Szeles, Lajos/0000-0003-1206-8515	National Institutes of Health (NIH) [AI053566]; NIGMS SCORE program [S06 GM008012-37]; National Center for Research Resources [5G12RR008124]; NIH; Janos Bolyai Research Felowship from the Hungarian Academy of Sciences; NKTH-OTKA-EU 7KP (Marie Curie actions) Reintegration Grant [OTKA MB08C 84630]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008012] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS SCORE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janos Bolyai Research Felowship from the Hungarian Academy of Sciences; NKTH-OTKA-EU 7KP (Marie Curie actions) Reintegration Grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant number AI053566 to RAK and a pilot project grant to ZSN (NIGMS SCORE program, grant S06 GM008012-37), and made possible by Grant Number 5G12RR008124 from the National Center for Research Resources, a component of the NIH. ZSN is the recipient of the Janos Bolyai Research Felowship from the Hungarian Academy of Sciences and is supported by the NKTH-OTKA-EU 7KP (Marie Curie actions) Reintegration Grant (OTKA MB08C 84630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barta E., 2011, EMBNET J, V17, P13, DOI DOI 10.14806/EJ.17.1.209; Behbod F, 2003, J IMMUNOL, V171, P3919, DOI 10.4049/jimmunol.171.8.3919; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; GAZDAR AF, 1980, BLOOD, V55, P409; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; HORI T, 1987, BLOOD, V70, P1069; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; KAMMER GM, 1988, P NATL ACAD SCI USA, V85, P792, DOI 10.1073/pnas.85.3.792; Kim HP, 2001, IMMUNITY, V15, P159, DOI 10.1016/S1074-7613(01)00167-4; LeBaron MJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-6; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; MANN DL, 1989, AIDS RES HUM RETROV, V5, P253, DOI 10.1089/aid.1989.5.253; Mao JN, 2006, J BIOL CHEM, V281, P12587, DOI 10.1074/jbc.M600497200; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; McGargill MA, 2004, IMMUNITY, V21, P781, DOI 10.1016/j.immuni.2004.10.008; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; MINOWADA J, 1972, J NATL CANCER I, V49, P891; MIYOSHI I, 1981, GANN, V72, P978; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nagy ZS, 2004, CRIT REV IMMUNOL, V24, P87, DOI 10.1615/CritRevImmunol.v24.i2.10; Nagy ZS, 2002, J LEUKOCYTE BIOL, V72, P819; Nagy ZS, 2006, J IMMUNOL, V177, P5032, DOI 10.4049/jimmunol.177.8.5032; Nagy ZS, 2010, FEBS LETT, V584, P1515, DOI 10.1016/j.febslet.2010.02.071; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Peter D, 2007, J IMMUNOL, V178, P4820, DOI 10.4049/jimmunol.178.8.4820; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Saeki K, 2009, J IMMUNOL, V182, P5929, DOI 10.4049/jimmunol.0802672; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; YODOI J, 1985, J IMMUNOL, V134, P1623; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	47	46	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57326	10.1371/journal.pone.0057326	http://dx.doi.org/10.1371/journal.pone.0057326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451206	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000316849500089
J	Shaner, PJL; Chen, YR; Lin, JW; Kolbe, JJ; Lin, SM				Shaner, Pei-Jen L.; Chen, Ying-Ru; Lin, Jhan-Wei; Kolbe, Jason J.; Lin, Si-Min			Sex-Specific Correlations of Individual Heterozygosity, Parasite Load, and Scalation Asymmetry in a Sexually Dichromatic Lizard	PLOS ONE			English	Article							FITNESS CORRELATIONS; MULTILOCUS HETEROZYGOSITY; MICROSATELLITE VARIATION; GENETIC-VARIATION; GALLOTIA-GALLOTI; COMMON LIZARD; MATE CHOICE; HEAD SIZE; POPULATIONS; DIMORPHISM	Heterozygosity-fitness correlations (HFCs) provide insights into the genetic bases of individual fitness variation in natural populations. However, despite decades of study, the biological significance of HFCs is still under debate. In this study, we investigated HFCs in a large population of the sexually dimorphic lizard Takydromus viridipunctatus (Lacertidae). Because of the high prevalence of parasitism from trombiculid mites in this lizard, we expect individual fitness (i.e., survival) to decrease with increasing parasite load. Furthermore, because morphological asymmetry is likely to influence individuals' mobility (i.e., limb asymmetry) and male biting ability during copulation (i.e., head asymmetry) in this species, we also hypothesize that individual fitness should decrease with increasing morphological asymmetry. Although we did not formally test the relationship between morphological asymmetry and fitness in this lizard, we demonstrated that survival decreased with increasing parasite load using a capture-mark-recapture data set. We used a separate sample of 140 lizards to test the correlations between individual heterozygosity (i.e., standardized mean d(2) and HL based on 10 microsatellite loci) and the two fitness traits (i.e., parasite load and morphological asymmetry). We also evaluated and excluded the possibility that single-locus effects produced spurious HFCs. Our results suggest male-only, negative correlations between individual heterozygosity and parasite load and between individual heterozygosity and asymmetry, suggesting sex-specific, positive HFCs. Male T. viridipunctatus with higher heterozygosity tend to have lower parasite loads (i.e., higher survival) and lower asymmetry, providing a rare example of HFC in reptiles.	[Shaner, Pei-Jen L.; Chen, Ying-Ru; Lin, Jhan-Wei; Lin, Si-Min] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Kolbe, Jason J.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	National Taiwan Normal University; University of Rhode Island	Lin, SM (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	fish@ntnu.edu.tw		Shaner, Pei-Jen/0000-0001-8112-4299	National Science Council, Taiwan [NSC96-2628-B-034-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The funding was provided by National Science Council, Taiwan (NSC96-2628-B-034-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2006, MOL ECOL, V15, P1973, DOI 10.1111/j.1365-294X.2006.02903.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; ANDERSON RA, 1990, OECOLOGIA, V84, P145, DOI 10.1007/BF00318265; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Britten HB, 1996, EVOLUTION, V50, P2158, DOI 10.1111/j.1558-5646.1996.tb03606.x; Campos JL, 2006, CONSERV GENET, V7, P515, DOI 10.1007/s10592-005-9063-z; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Christian KA, 1995, CAN J ZOOL, V73, P2302, DOI 10.1139/z95-272; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Curtis JL, 2008, HERPETOLOGICA, V64, P189, DOI 10.1655/07-052.1; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; DUNLAP KD, 1993, COPEIA, P1045; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Gemmell NJ, 1996, TRENDS GENET, V12, P338, DOI 10.1016/S0168-9525(96)80005-9; Gvozdik L, 2003, J ZOOL, V259, P7, DOI 10.1017/S0952836902003308; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Harrison XA, 2011, MOL ECOL, V20, P4786, DOI 10.1111/j.1365-294X.2011.05283.x; Harrison XA, 2010, MOL ECOL, V19, P5484, DOI 10.1111/j.1365-294X.2010.04852.x; Hedrick P, 2001, EVOLUTION, V55, P1256; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Hoffman JI, 2006, MOL ECOL, V15, P1995, DOI 10.1111/j.1365-294X.2006.02894.x; Laloi D, 2011, BEHAV PROCESS, V88, P149, DOI 10.1016/j.beproc.2011.08.011; Lappin AK, 2006, BIOL J LINN SOC, V88, P215, DOI 10.1111/j.1095-8312.2006.00615.x; LeBas NR, 2002, EVOLUTION, V56, P371, DOI 10.1111/j.0014-3820.2002.tb01347.x; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lens L, 2000, J EVOLUTION BIOL, V13, P889, DOI 10.1046/j.1420-9101.2000.00232.x; Lesbarreres D, 2005, MOL ECOL, V14, P311, DOI 10.1111/j.1365-294X.2004.02394.x; Lin SM, 2006, MOL ECOL NOTES, V6, P57, DOI 10.1111/j.1471-8286.2005.01136.x; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V52, P342, DOI 10.1007/s00265-002-0514-y; Lou CH, 2012, THESIS NATL TAIWAN N; Lue KY, 2008, HERPETOLOGICA, V64, P379, DOI 10.1655/07-030.1; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; MacDougall-Shackleton EA, 2005, BIOL LETTERS, V1, P105, DOI 10.1098/rsbl.2004.0264; Main AR, 2000, OECOLOGIA, V122, P574, DOI 10.1007/s004420050981; Martin J, 2000, P ROY SOC B-BIOL SCI, V267, P1265, DOI 10.1098/rspb.2000.1137; Miller HC, 2009, P ROY SOC B-BIOL SCI, V276, P1695, DOI 10.1098/rspb.2008.1840; Molina-Borja M, 1998, ETHOLOGY, V104, P314; Moore JA, 2009, J HERPETOL, V43, P570, DOI 10.1670/08-290.1; Pritchard JK, 2000, GENETICS, V155, P945; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Rijks JM, 2008, HEREDITY, V100, P587, DOI 10.1038/hdy.2008.18; Shine R, 2005, FUNCT ECOL, V19, P306, DOI 10.1111/j.1365-2435.2005.00963.x; SHULL GH, 1948, GENETICS, V33, P439; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Slate J, 2006, CURR BIOL, V16, pR790, DOI 10.1016/j.cub.2006.08.047; Smith AL, 2009, APPL HERPETOL, V6, P300, DOI 10.1163/157075408X386150; Sorci G, 1995, J EVOLUTION BIOL, V8, P711, DOI 10.1046/j.1420-9101.1995.8060711.x; Sorci G, 1996, OIKOS, V76, P121, DOI 10.2307/3545754; Sperry JH, 2009, J ZOOL, V278, P100, DOI 10.1111/j.1469-7998.2009.00549.x; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Ujvari B, 2006, BEHAV ECOL, V17, P20, DOI 10.1093/beheco/ari091; Vervust B, 2008, J HERPETOL, V42, P369, DOI 10.1670/07-1202.1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	54	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56720	10.1371/journal.pone.0056720	http://dx.doi.org/10.1371/journal.pone.0056720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451073	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500023
J	Tiwari, N; Meyer-Schaller, N; Arnold, P; Antoniadis, H; Pachkov, M; van Nimwegen, E; Christofori, G				Tiwari, Neha; Meyer-Schaller, Nathalie; Arnold, Phil; Antoniadis, Helena; Pachkov, Mikhail; van Nimwegen, Erik; Christofori, Gerhard			Klf4 Is a Transcriptional Regulator of Genes Critical for EMT, Including Jnk1 (Mapk8)	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR; EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER PATIENTS; TUMOR-SUPPRESSOR; STEM-CELLS; DOWN-REGULATION; PROGRESSION; EXPRESSION; GROWTH; DIFFERENTIATION	We have identified the zinc-finger transcription factor Kruppel-like factor 4 (Klf4) among the transcription factors that are significantly downregulated in their expression during epithelial-mesenchymal transition (EMT) in mammary epithelial cells and in breast cancer cells. Loss and gain of function experiments demonstrate that the down-regulation of Klf4 expression is required for the induction of EMT in vitro and for metastasis in vivo. In addition, reduced Klf4 expression correlates with shorter disease-free survival of subsets of breast cancer patients. Yet, reduced expression of Klf4 also induces apoptosis in cells undergoing TGF beta-induced EMT. Chromatin immunoprecipitation/deep-sequencing in combination with gene expression profiling reveals direct Klf4 target genes, including E-cadherin (Cdh1), N-cadherin (Cdh2), vimentin (Vim), beta-catenin (Ctnnb1), VEGF-A (Vegfa), endothelin-1 (Edn1) and Jnk1 (Mapk8). Thereby, Klf4 acts as a transcriptional activator of epithelial genes and as a repressor of mesenchymal genes. Specifically, increased expression of Jnk1 (Mapk8) upon down-regulation of its transcriptional repressor Klf4 is required for EMT cell migration and for the induction of apoptosis. The data demonstrate a central role of Klf4 in the maintenance of epithelial cell differentiation and the prevention of EMT and metastasis.	[Tiwari, Neha; Meyer-Schaller, Nathalie; Antoniadis, Helena; Christofori, Gerhard] Univ Basel, Dept Biomed, Basel, Switzerland; [Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland; [Arnold, Phil; Pachkov, Mikhail; van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland	University of Basel; University of Basel; Swiss Institute of Bioinformatics	Christofori, G (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	Gerhard.christofori@unibas.ch	van Nimwegen, Erik/ABF-1085-2021	van Nimwegen, Erik/0000-0001-6338-1312; Tiwari, Neha/0000-0001-7931-4085	Swiss National Science Foundation; SystemsX.ch RTD project Cellplasticity; Swiss Cancer League	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch RTD project Cellplasticity; Swiss Cancer League	This work was supported by the Swiss National Science Foundation, the SystemsX.ch RTD project Cellplasticity, and the Swiss Cancer League. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cellurale C, 2012, CANCER RES, V72, P472, DOI 10.1158/0008-5472.CAN-11-1628; Cellurale C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012469; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Santibanez JF, 2006, FEBS LETT, V580, P5385, DOI 10.1016/j.febslet.2006.09.003; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Strock CJ, 2006, CANCER RES, V66, P7509, DOI 10.1158/0008-5472.CAN-05-3048; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Ton-That H, 1997, FEBS LETT, V419, P239, DOI 10.1016/S0014-5793(97)01465-8; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Van der Velden JL, 2010, AM J RESP CELL MOL B, V47, P306; Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yilmaz M, 2011, EMBO J, V30, P4489, DOI 10.1038/emboj.2011.319; Yori JL, 2011, NEOPLASIA, V13, P601, DOI 10.1593/neo.11260; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067	49	82	87	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57329	10.1371/journal.pone.0057329	http://dx.doi.org/10.1371/journal.pone.0057329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451207	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500090
J	Knapp, S; Vorontsova, MS; Prohens, J				Knapp, Sandra; Vorontsova, Maria S.; Prohens, Jaime			Wild Relatives of the Eggplant (Solanum melongena L.: Solanaceae): New Understanding of Species Names in a Complex Group	PLOS ONE			English	Article							TOMATO; DEFINITION; RESISTANCE; INCANUM	Background: The common or brinjal eggplant (Solanum melongena L.) belongs to the Leptostemonum Clade (the "spiny'' solanums) of the species-rich genus Solanum (Solanaceae). Unlike most of the genus, the eggplant and its relatives are from the Old World; most eggplant wild relatives are from Africa. An informal system for naming eggplant wild relatives largely based on crossing and other biosystematics data has been in use for approximately a decade. This system recognises several forms of two broadly conceived species, S. incanum L. and S. melongena. Recent morphological and molecular work has shown that species-level differences exist between these entities, and a new species-level nomenclature has been identified as necessary for plant breeders and for the maintenance of accurately named germplasm. Methodology/Principal Findings: We examined herbarium specimens from throughout the wild species ranges as part of a larger revision of the spiny solanums of Africa. Based on these morphological and molecular studies, we delimited species in the group to which the common eggplant belongs and constructed identification keys for the group. We also examined the monophyly of the group considered as the eggplant relatives by previous authors. Conclusions/Significance: We recognise ten species in this group: S. aureitomentosum Bitter, S. campylacanthum A. Rich., S. cerasiferum Dunal, S. incanum L., S. insanum L., S. lichtensteinii Willd., S. linnaeanum Hepper & P.-M.L. Jaeger, S. melongena L., S. rigidum Lam. and S. umtuma Voronts. & S. Knapp. We review the history of naming and provide keys and character lists for all species. Ploidy level differences have not been investigated in the eggplant wild relatives; we identify this as a priority for improvement of crop wild relative use in breeding. The application of species-level names to these entities will help focus new collecting efforts for brinjal eggplant improvement and help facilitate information exchange.	[Knapp, Sandra] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Vorontsova, Maria S.] Royal Bot Gardens Kew, Herbarium, Richmond, Surrey, England; [Prohens, Jaime] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, E-46071 Valencia, Spain	Natural History Museum London; Royal Botanic Gardens, Kew; Universitat Politecnica de Valencia	Knapp, S (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk	Prohens, Jaime/H-2228-2015; Fuller, Dorian/AAF-7400-2019; Fuller, Dorian Q/C-1908-2008; Prohens, Jaime/ABF-1229-2021; Knapp, Sandra/A-4856-2011; Vorontsova, Maria S/H-9263-2015	Prohens, Jaime/0000-0003-1181-9065; Fuller, Dorian/0000-0002-4859-080X; Fuller, Dorian Q/0000-0002-4859-080X; Prohens, Jaime/0000-0003-1181-9065; Knapp, Sandra/0000-0001-7698-3945; 	National Science Foundation; Planetary Biodiversity Inventory (PBI) project "Solanum: A worldwide treatment'' [DEB-0316614]	National Science Foundation(National Science Foundation (NSF)); Planetary Biodiversity Inventory (PBI) project "Solanum: A worldwide treatment''	SK and MSV's work in Solanum taxonomy has been funded by the National Science Foundation, Planetary Biodiversity Inventory (PBI) project "Solanum: A worldwide treatment'' (DEB-0316614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaso H. U., 1989, Nucleus (Calcutta), V32, P4; ANASO H U, 1990, Cytologia (Tokyo), V55, P1, DOI 10.1508/cytologia.55.1; Bitter G, 1923, REPERTORIUM SPECIERU, V16, P1; Bohs L., 2005, MONOGRAPHS SYSTEMATI, P27, DOI DOI 10.1111/J.1365-2699.2007.01870.X; Brickell CD, 2009, SCRIPTA HORTICULTURA, V10; Cai XK, 2011, PHYTOPATHOLOGY, V101, P1074, DOI 10.1094/PHYTO-02-11-0060; Daunay M.-C., 2012, HDB VEGETABLES, P257, DOI DOI 10.1016/B978-0-08-040826-2.50028-X; Daunay Marie-Christine, 2001, P199; Daunay MC, 2007, CHRONICA HORTICULTUR, V47, P16; DEB DB, 1989, TAXON, V38, P138, DOI 10.2307/1220916; Doglanar S, 2002, GENETICS, V161, P1697; Dunal MF, 1852, PRODROMUS SYSTEMATIS, V13, P1, DOI DOI 10.5962/BHL.TITLE.286; ESHED Y, 1995, GENETICS, V141, P1147; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Goncalves AE, 2002, FLORA CABO VERDE, V71, P5; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hasan SMZ, 1986, THESIS U BIRMINGHAM; HEPPER F N, 1985, Kew Bulletin, V40, P387, DOI 10.2307/4108264; Hepper FN, 1986, KEW B, V41, P433, DOI DOI 10.2307/4102956; Hurtado M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041748; Jarvis C. E., 2007, ORDER OUT CHAOS LINN; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; KNAPP S, 1990, BOT J LINN SOC, V104, P325, DOI 10.1111/j.1095-8339.1990.tb02227.x; Knapp S, 1997, B NATURAL HIST MUSEU, V27, P31; Knapp S, 2008, BIOL J LINN SOC, V95, P17, DOI 10.1111/j.1095-8312.2008.01090.x; Knapp S, 2011, TAXON, V60, P1498, DOI 10.1002/tax.605031; Lebeau A, 2011, PHYTOPATHOLOGY, V101, P154, DOI 10.1094/PHYTO-02-10-0048; Lester R. N., 1991, SOLANACEAE, P369; LESTER RN, 1990, TAXON, V39, P521, DOI 10.2307/1223119; Linnaeus C., 1759, SYSTEMA NATURAE, V12th; Mace ES, 1999, THEOR APPL GENET, V99, P626, DOI 10.1007/s001220051277; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; Manoko M.L.K., 2007, THESIS RADBOUD U NIJ; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; McNeill J, 2012, REGNUM VEG, V154, P1; Meyer RS, 2012, MOL PHYLOGENET EVOL, V63, P685, DOI 10.1016/j.ympev.2012.02.006; Miller P, 1768, GARDENERS DICT; Moyle LC, 2010, SCIENCE, V329, P1521, DOI 10.1126/science.1193063; Ovchinnikova A, 2011, BOT J LINN SOC, V165, P107, DOI 10.1111/j.1095-8339.2010.01107.x; Peralta I. E., 2008, Systematic Botany Monographs, V84; Samuels J, 2012, KEW B, V67, P1; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scaldaferro M, 2012, GENET RESOUR CROP EV, V59, P1833, DOI 10.1007/s10722-012-9807-9; Simon R, 2010, INVAS PLANT SCI MANA, V3, P286, DOI 10.1614/IPSM-D-09-00043.1; Spooner DM, 2005, TAXON, V54, P43, DOI 10.2307/25065301; SPOONER DM, 2004, SYST BOT MONOGR, V68, P1, DOI DOI 10.2307/25027915; Stern S, 2011, TAXON, V60, P1429, DOI 10.1002/tax.605018; SZYMKOWIAK EJ, 1992, PLANT CELL, V4, P1089, DOI 10.1105/tpc.4.9.1089; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tepe EJ, 2011, SYST BOT, V36, P1068, DOI 10.1600/036364411X605074; Tumbilen Y, 2011, TURK J BIOL, V35, P125, DOI 10.3906/biy-0906-57; Vavilov N. I., 1951, ORIGIN VARIATION IMM; Vavilov N. I., 1926, B APPL BOT GEN PB, V14, P1; Vilanova S., 2010, ADV GENETICS BREEDIN, P435; Vorontsova M.S., 2012, FLORA TROPICAL E AFR, p[164, 198, 220]; Vorontsova MS, 2010, TAXON, V59, P1585, DOI 10.1002/tax.595024; Vorontsova MS, 2013, BOT J LINN IN PRESS; Wang JX, 2008, ANN BOT-LONDON, V102, P891, DOI 10.1093/aob/mcn179; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Weese TL, 2010, TAXON, V59, P49, DOI 10.1002/tax.591006; WHALEN M D, 1984, Gentes Herbarum, V12, P179; Whalen M. D., 1986, SOLANACEAE BIOL SYST, P285; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158	63	86	91	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57039	10.1371/journal.pone.0057039	http://dx.doi.org/10.1371/journal.pone.0057039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451138	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800064
J	Santha, S; Bommareddy, A; Rule, B; Guillermo, R; Kaushik, RS; Young, A; Dwivedi, C				Santha, Sreevidya; Bommareddy, Ajay; Rule, Brittny; Guillermo, Ruth; Kaushik, Radhey S.; Young, Alan; Dwivedi, Chandradhar			Antineoplastic Effects of alpha-Santalol on Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancer Cells through Cell Cycle Arrest at G2/M Phase and Induction of Apoptosis	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; SKIN TUMOR-DEVELOPMENT; SANDALWOOD OIL; FRAGMENTATION; CHECKPOINT; CARCINOMA; CLEAVAGE; DISTINCT; TARGET; DEATH	Anticancer efficacy and the mechanism of action of alpha-santalol, a terpenoid isolated from sandalwood oil, were investigated in human breast cancer cells by using p53 wild-type MCF-7 cells as a model for estrogen receptor(ER)-positive and p53 mutated MDA-MB-231 cells as a model for ER-negative breast cancer. alpha-Santalol inhibited cell viability and proliferation in a concentration and time-dependent manner in both cells regardless of their ER and/or p53 status. However, alpha-santalol produced relatively less toxic effect on normal breast epithelial cell line, MCF-10A. It induced G2/M cell cycle arrest and apoptosis in both MCF-7 and MDA-MB-231 cells. Cell cycle arrest induced by a-santalol was associated with changes in the protein levels of BRCA1, Chk1, G2/M regulatory cyclins, Cyclin dependent kinases (CDKs), Cell division cycle 25B (Cdc25B), Cdc25C and Ser-216 phosphorylation of Cdc25C. An up-regulated expression of CDK inhibitor p21 along with suppressed expression of mutated p53 was observed in MDA-MB-231 cells treated with alpha-santalol. On the contrary, alpha-santalol did not increase the expression of wild-type p53 and p21 in MCF-7 cells. In addition, alpha-santalol induced extrinsic and intrinsic pathways of apoptosis in both cells with activation of caspase-8 and caspase-9. It led to the activation of the executioner caspase-6 and caspase-7 in alpha-santalol-treated MCF-7 cells and caspase-3 and caspase-6 in MDA-MB-231 cells along with strong cleavage of poly(ADP-ribose) polymerase (PARP) in both cells. Taken together, this study for the first time identified strong anti-neoplastic effects of alpha-santalol against both ER-positive and ER-negative breast cancer cells.	[Santha, Sreevidya; Guillermo, Ruth; Dwivedi, Chandradhar] S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA; [Bommareddy, Ajay; Rule, Brittny] Wilkes Univ, Dept Pharmaceut Sci, Wilkes Barre, PA 18766 USA; [Kaushik, Radhey S.] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Kaushik, Radhey S.; Young, Alan] S Dakota State Univ, Dept Vet & Biomed Sci, Brookings, SD 57007 USA	South Dakota State University; Wilkes University; South Dakota State University; South Dakota State University	Dwivedi, C (corresponding author), S Dakota State Univ, Dept Pharmaceut Sci, Brookings, SD 57007 USA.	Chandradhar.Dwivedi@sdstate.edu	kaushik, Radhey Shyam/AAE-3773-2020		South Dakota Governor's Office of Economic Development	South Dakota Governor's Office of Economic Development	The Translational Cancer Research Center is funded by the South Dakota Governor's Office of Economic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2001, J CLIN ONCOL, V19, P18, DOI 10.1200/JCO.2001.19.1.18; Bommareddy A, 2012, PHYTOMEDICINE, V19, P804, DOI 10.1016/j.phymed.2012.04.003; Burdock GA, 2008, FOOD CHEM TOXICOL, V46, P421, DOI 10.1016/j.fct.2007.09.092; Chen JSK, 2004, J CELL PHYSIOL, V200, P223, DOI 10.1002/jcp.20014; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; CROWE JP, 1991, SURG GYNECOL OBSTET, V173, P273; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Dwivedi C, 2003, CANCER EPIDEM BIOMAR, V12, P151; Dwivedi C, 2006, CARCINOGENESIS, V27, P1917, DOI 10.1093/carcin/bgl058; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Ferreira CG, 2002, CLIN CANCER RES, V8, P2024; GAUTIER J, 1991, CELL, V67, P197, DOI 10.1016/0092-8674(91)90583-K; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Howes MJR, 2004, J CHROMATOGR A, V1028, P307, DOI 10.1016/j.chroma.2003.11.093; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kaur M, 2005, CARCINOGENESIS, V26, P369, DOI 10.1093/carcin/bgh325; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; Megyesi J, 1996, AM J PHYSIOL, V1, P1211; Michalides RJAM, 1999, J CLIN PATHOL, V52, P555, DOI 10.1136/jcp.52.8.555; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Nizamutdinova IT, 2008, INT J ONCOL, V33, P485, DOI 10.3892/ijo_00000031; OBERHAMMER F, 1993, EMBO J, V12, P3679, DOI 10.1002/j.1460-2075.1993.tb06042.x; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Park MT, 2003, J BIOCHEM MOL BIOL, V36, P60; PARL FF, 1984, CANCER, V54, P2237, DOI 10.1002/1097-0142(19841115)54:10<2237::AID-CNCR2820541029>3.0.CO;2-V; Rivera E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2573; Rochefort H, 2003, ENDOCR-RELAT CANCER, V10, P261, DOI 10.1677/erc.0.0100261; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Swerdlow AJ, 2005, JNCI-J NATL CANCER I, V97, P375, DOI 10.1093/jnci/dji057; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Yang HL, 2006, CANCER LETT, V231, P215, DOI 10.1016/j.canlet.2005.02.004; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhang Xiaoying, 2011, Front Biosci (Schol Ed), V3, P777, DOI 10.2741/s186; Zhang Xiaoying, 2010, BMC Res Notes, V3, P220, DOI 10.1186/1756-0500-3-220	45	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56982	10.1371/journal.pone.0056982	http://dx.doi.org/10.1371/journal.pone.0056982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451128	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800058
J	Zhang, YJ; Liu, QQ; Wang, D; Chen, SH; Wang, SQ				Zhang, Yingjie; Liu, Qiqi; Wang, Dou; Chen, Suhong; Wang, Shengqi			Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization	PLOS ONE			English	Article							ADAMANTANE RESISTANCE; H1N1 VIRUS; SEASON; SENSITIVITY; EMERGENCE; CHINA	Presently, the resistance of Influenza A virus isolates causes great difficulty for the prevention and treatment of influenza A virus infection. It is important to establish a drug-resistance detection method for epidemiological study and personalized medicine in the clinical setting. Consequently, a cost-effective oligonucleotide microarray visualization method, which was based on quantum dot-catalyzed silver deposition, was developed and evaluated for the simultaneous detection of neuraminidase H275Y and E119V; matrix protein 2 V27A and S31N mutations of influenza A (H3N2), seasonal influenza A (H1N1), and 2009 influenza A (H1N1). Then, 307 clinical throat swab specimens were detected and the drug-resistance results showed that 100% (17/17) of influenza A (H3N2) and 100% (259/259) of 2009 influenza A (H1N1) samples were resistant to amantadine and susceptible to oseltamivir; and 100% (5/5) of seasonal influenza A (H1N1) samples were resistant to both amantadine and oseltamivir.	[Zhang, Yingjie; Liu, Qiqi; Wang, Dou; Chen, Suhong; Wang, Shengqi] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China; [Liu, Qiqi; Wang, Shengqi] Shenzhen Puruikang Biotech Co Ltd, Shenzhen, Peoples R China	Academy of Military Medical Sciences - China	Chen, SH (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	doudoucsh@sina.com; sqwang@bmi.ac.cn	Zhang, Yingjie/HHM-3016-2022; Wang, Dou/V-4758-2019		National High Technology Research and Development Program (863 Program) of China [2010AA022803]; National Science and Technology Major Project [2012ZX09301003-005]; Cooperation Project in Industry, Education and Research of Guangdong Province and Ministry of Education of P. R. China [2011A090200071]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Science and Technology Major Project; Cooperation Project in Industry, Education and Research of Guangdong Province and Ministry of Education of P. R. China	This work was financially supported by the National High Technology Research and Development Program (863 Program) of China (No. 2010AA022803), the National Science and Technology Major Project (No. 2012ZX09301003-005), and the Cooperation Project in Industry, Education and Research of Guangdong Province and Ministry of Education of P. R. China (No.2011A090200071). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2008, ANTIVIR RES, V77, P163, DOI 10.1016/j.antiviral.2007.08.008; Alonso M, 2011, J CLIN VIROL, V50, P114, DOI 10.1016/j.jcv.2010.10.007; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Chen EC, 2011, JOVE-J VIS EXP, DOI 10.3791/2536; Crameri A, 2007, J CLIN MICROBIOL, V45, P3685, DOI 10.1128/JCM.01178-07; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Hoopes JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029778; Hurt AC, 2011, EUROSURVEILLANCE, V16, P2; Hurt AC, 2012, EMERG INFECT DIS, V18, P109, DOI 10.3201/eid1801.111079; Karthick V, 2012, PROTOPLASMA; Kim WY, 2011, ANTIMICROB AGENTS CH, V55, P5703, DOI 10.1128/AAC.05529-11; Kolquist KA, 2011, CANCER GENET-NY, V204, P603, DOI 10.1016/j.cancergen.2011.10.004; Lan Y, 2010, ANTIVIR THER, V15, P853, DOI 10.3851/IMP1656; Layne SP, 2001, SCIENCE, V293, P1729, DOI 10.1126/science.293.5536.1729; Li L, 2011, BIOSENS BIOELECTRON, V26, P3688, DOI 10.1016/j.bios.2011.01.040; Mazzatti D, 2012, ARCH PHYSL BIOCH; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Memoli MJ, 2010, CLIN INFECT DIS, V50, P1252, DOI 10.1086/651605; Nguyen JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031006; Redlberger-Fritz M, 2011, EUR J CLIN MICROBIOL; Richard M, 2011, ANTIMICROB AGENTS CH, V55, P2942, DOI 10.1128/AAC.01699-10; Sanvicens N, 2011, ANAL BIOANAL CHEM, V399, P2755, DOI 10.1007/s00216-010-4624-5; Sheu TG, 2011, J INFECT DIS, V203, P13, DOI 10.1093/infdis/jiq005; Simon P, 2011, J CLIN MICROBIOL, V49, P715, DOI 10.1128/JCM.01732-10; Townsend MB, 2008, J CLIN VIROL, V42, P117, DOI 10.1016/j.jcv.2007.12.019; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Zhou J, 2011, J CLIN MICROBIOL, V49, P2651, DOI 10.1128/JCM.00535-11	30	9	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57154	10.1371/journal.pone.0057154	http://dx.doi.org/10.1371/journal.pone.0057154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451169	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800080
J	Zhang, YM; Li, CX; Zhang, YJ; Zhu, HX; Kang, YY; Liu, HY; Wang, JY; Qin, YL; Mao, RC; Xie, Y; Huang, YX; Zhang, JM				Zhang, Yongmei; Li, Chenxiao; Zhang, Yijun; Zhu, Haoxiang; Kang, Yaoyue; Liu, Hongyan; Wang, Jinyu; Qin, Yanli; Mao, Richeng; Xie, Yi; Huang, Yuxian; Zhang, Jiming			Comparative Analysis of CpG Islands among HBV Genotypes	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CLOSED CIRCULAR DNA; PHYLOGENETIC RELATEDNESS; METHYLATION; INFECTION; SEQUENCE; SUBGENOTYPES; MECHANISMS; STRAINS; GENOME	DNA methylation is being increasingly recognized to play a role in regulation of hepatitis B virus (HBV) gene expression. The aim of this study was to compare the CpG island distribution among different HBV genotypes. We analyzed 176 full-length HBV genomic sequences obtained from the GenBank database, belonging to genotypes A through J, to identify the CpG islands in the HBV genomes. Our results showed that while 79 out of 176 sequences contained three conventional CpG islands (I-III) as previously described, 83 HBV sequences harbored only two of the three known islands. Novel CpG islands were identified in the remaining 14 HBV isolates and named as CpG island IV, V, and VI. Among the eight known HBV genotypes and two putative genotypes, while HBV genomes containing three CpG islands were predominant in genotypes A, B, D, E, and I; genotypes C, F, G, and H tended to contain only two CpG islands (II and III). In conclusion, the CpG islands, which are potential targets for DNA methylation mediated by the host functions, differ among HBV genotypes, and these genotype-specific differences in CpG island distribution could provide new insights into the understanding of epigenetic regulation of HBV gene expression and hepatitis B disease outcome.	[Zhang, Yongmei; Zhang, Yijun; Zhu, Haoxiang; Kang, Yaoyue; Liu, Hongyan; Wang, Jinyu; Qin, Yanli; Mao, Richeng; Xie, Yi; Huang, Yuxian; Zhang, Jiming] Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Jiming] Fudan Univ, Key Lab Med Mol Virol, MOH, Shanghai 200433, Peoples R China; [Zhang, Jiming] Fudan Univ, MOE, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Li, Chenxiao] Fudan Univ, Dept Basic Med Sci, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Huang, YX (corresponding author), Fudan Univ, Dept Infect Dis, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	yxhuang@fudan.edu.cn; jmzhang@fudan.edu.cn			National Natural Science Foundation of China [81071354, 81271833, 81201277, 3735636]; '973' project [2012CB519001]; Shanghai Science and Technology Committee [11DZ2291900]; National Science and Technology Major Project of China [2012ZX10002007-001-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); '973' project(National Basic Research Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Science and Technology Major Project of China	This work was supported by National Natural Science Foundation of China (81071354, 81271833, 81201277, 3735636), '973' project (2012CB519001), Shanghai Science and Technology Committee (11DZ2291900), and National Science and Technology Major Project of China (2012ZX10002007-001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Banerjee A, 2006, J MED VIROL, V78, P1164, DOI 10.1002/jmv.20677; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Block Timothy M, 2007, Clin Liver Dis, V11, P685, DOI 10.1016/j.cld.2007.08.002; Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; Cortes-Mancera F, 2011, HEPAT RES TREAT, V2011; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Denis H, 2011, EMBO REP, V12, P647, DOI 10.1038/embor.2011.110; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Grabarczyk P, 2010, J VIRAL HEPATITIS, V17, P444, DOI 10.1111/j.1365-2893.2009.01192.x; Gunther S, 2006, J CLIN VIROL, V36, pS3, DOI 10.1016/S1386-6532(06)80002-8; Guo YH, 2009, J MED VIROL, V81, P1177, DOI 10.1002/jmv.21525; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Karayiannis P, 1995, HEPATOLOGY, V22, P1628, DOI 10.1016/0270-9139(95)90183-3; Kato H, 2002, J VIROL, V76, P6131, DOI 10.1128/JVI.76.12.6131-6137.2002; Kaur P, 2010, J INFECT DIS, V202, P700, DOI 10.1086/655398; Kim JW, 2011, INTERVIROLOGY, V54, P316, DOI 10.1159/000321450; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; MILLER RH, 1983, P NATL ACAD SCI-BIOL, V80, P2534, DOI 10.1073/pnas.80.9.2534; Moolla N, 2002, J VIRAL HEPATITIS, V9, P323, DOI 10.1046/j.1365-2893.2002.00381.x; Mulyanto, 2012, VIRUS RES, V163, P129, DOI 10.1016/j.virusres.2011.09.002; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Pollicino T, 2006, GASTROENTEROLOGY, V130, P823, DOI 10.1053/j.gastro.2006.01.001; PREISLERADAMS S, 1993, ARCH VIROL, V133, P385, DOI 10.1007/BF01313777; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Shibayama T, 2005, J MED VIROL, V76, P24, DOI 10.1002/jmv.20319; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Vivekanandan P, 2008, J VIRAL HEPATITIS, V15, P103, DOI 10.1111/j.1365-2893.2007.00905.x; Vivekanandan P, 2008, CLIN INFECT DIS, V46, P1227, DOI 10.1086/529437; Vivekanandan P, 2009, J INFECT DIS, V199, P1286, DOI 10.1086/597614; Wang ZH, 2007, HEPATOL RES, V37, pS36, DOI 10.1111/j.1872-034X.2007.00102.x; Zeng G, 2005, J VIRAL HEPATITIS, V12, P609, DOI 10.1111/j.1365-2893.2005.00657.x	47	31	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56711	10.1371/journal.pone.0056711	http://dx.doi.org/10.1371/journal.pone.0056711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451072	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800029
J	Avasarala, S; Zhang, FF; Liu, GL; Wang, RX; London, SD; London, L				Avasarala, Sreedevi; Zhang, Fangfang; Liu, Guangliang; Wang, Ruixue; London, Steven D.; London, Lucille			Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							NF-KAPPA-B; ACUTE LUNG INJURY; OBLITERANS ORGANIZING PNEUMONIA; REOVIRUS 1/L INDUCTION; INDUCED PULMONARY-FIBROSIS; ACTIVATED PROTEIN-KINASE; HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX GENES; DIFFUSE ALVEOLAR DAMAGE	Acute Respiratory Distress Syndrome (ARDS) is a clinical syndrome characterized by diffuse alveolar damage usually secondary to an intense host inflammatory response of the lung to a pulmonary or extrapulmonary infectious or noninfectious insult often leading to the development of intra-alveolar and interstitial fibrosis. Curcumin, the principal curcumoid of the popular Indian spice turmeric, has been demonstrated as an anti-oxidant and anti-inflammatory agent in a broad spectrum of diseases. Using our well-established model of reovirus 1/L-induced acute viral pneumonia, which displays many of the characteristics of the human ALI/ARDS, we evaluated the anti-inflammatory and anti-fibrotic effects of curcumin. Female CBA/J mice were treated with curcumin (50 mg/kg) 5 days prior to intranasal inoculation with 10(7) PFU reovirus 1/L and daily, thereafter. Mice were evaluated for key features associated with ALI/ARDS. Administration of curcumin significantly modulated inflammation and fibrosis, as revealed by histological and biochemical analysis. The expression of IL-6, IL-10, IFN gamma, and MCP-1, key chemokines/cytokines implicated in the development of ALI/ARDS, from both the inflammatory infiltrate and whole lung tissue were modulated by curcumin potentially through a reduction in the phosphorylated form of NF kappa B p65. While the expression of TGF beta 1 was not modulated by curcumin, TGF beta Receptor II, which is required for TGF beta signaling, was significantly reduced. In addition, curcumin also significantly inhibited the expression of alpha-smooth muscle actin and Tenascin-C, key markers of myofibroblast activation. This data strongly supports a role for curcumin in modulating the pathogenesis of viral-induced ALI/ARDS in a pre-clinical model potentially manifested through the alteration of inflammation and myofibroblast differentiation.	[Avasarala, Sreedevi; Zhang, Fangfang; Liu, Guangliang; Wang, Ruixue; London, Steven D.; London, Lucille] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, L (corresponding author), SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA.	lucille.london@stonybrook.edu	Liu, Guangliang/I-8173-2013; Zhang, Fang/HHN-2153-2022	Liu, Guangliang/0000-0001-8158-5749; 	U.S. Public Health Service grant [NCCAM 5R21AT003824]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003824] Funding Source: NIH RePORTER	U.S. Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a U.S. Public Health Service grant NCCAM 5R21AT003824 (LL)(http://nccam.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CURCUMIN DERIVED TUR, P350; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Amin K, 2000, AM J RESP CRIT CARE, V162, P2295, DOI 10.1164/ajrccm.162.6.9912001; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Arnalich F, 2000, INFECT IMMUN, V68, P1942, DOI 10.1128/IAI.68.4.1942-1945.2000; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bansal S, 2010, J MED MICROBIOL, V59, P429, DOI 10.1099/jmm.0.016873-0; Bellum SC, 1997, AM J PATHOL, V150, P2243; Biswas SK, 2005, ANTIOXID REDOX SIGN, V7, P32, DOI 10.1089/ars.2005.7.32; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Budinger GRS, 2005, INTENS CARE MED, V31, P121, DOI 10.1007/s00134-004-2503-2; Chen Bi, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P257; Creagh-Brown BC, 2009, CRIT CARE, V13, DOI 10.1186/cc7734; Cutroneo KR, 2007, J CELL PHYSIOL, V211, P585, DOI 10.1002/jcp.20972; Del Sorbo L, 2011, CURR OPIN CRIT CARE, V17, P1, DOI 10.1097/MCC.0b013e3283427295; Dhainaut JF, 2003, CRIT CARE MED, V31, pS258, DOI 10.1097/01.CCM.0000057901.92381.75; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Gaedeke J, 2004, KIDNEY INT, V66, P112, DOI 10.1111/j.1523-1755.2004.00713.x; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Guzel A, 2009, PEDIATR SURG INT, V25, P83, DOI 10.1007/s00383-008-2282-x; Han W, 2009, AM J PHYSIOL-LUNG C, V296, pL320, DOI 10.1152/ajplung.90485.2008; Hsu YC, 2010, ARCH DERMATOL RES, V302, P717, DOI 10.1007/s00403-010-1075-y; Hu MW, 2005, CRIT CARE MED, V33, P2571, DOI 10.1097/01.CCM.0000186760.20502.C7; Jiang Zhen-you, 2009, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V25, P399; Jimenez SA, 2001, J CLIN INVEST, V108, P1395, DOI 10.1172/JCI200112347; Joe B, 2004, CRIT REV FOOD SCI, V44, P97, DOI 10.1080/10408690490424702; Kaarteenaho-Wiik R, 2000, J HISTOCHEM CYTOCHEM, V48, P1257, DOI 10.1177/002215540004800909; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Laitinen A, 1997, AM J RESP CRIT CARE, V156, P951, DOI 10.1164/ajrccm.156.3.9610084; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023756; Lee PJ, 2005, CRIT CARE MED, V33, P2703, DOI 10.1097/01.CCM.0000183162.61584.43; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Literat A, 2001, LIFE SCI, V70, P253, DOI 10.1016/S0024-3205(01)01398-4; Liu K, 2012, J CARDIOVASC PHARM T, V17, P395, DOI 10.1177/1074248412442002; Liu K, 2012, J SURG RES, V174, P73, DOI 10.1016/j.jss.2010.12.002; London L, 2002, EXP MOL PATHOL, V72, P24, DOI 10.1006/exmp.2001.2414; London L, 2002, CLIN IMMUNOL, V103, P284, DOI 10.1006/clim.2002.5214; Lopez AD, 2009, J IMMUNOL, V183, P8244, DOI 10.4049/jimmunol.0901958; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Majeski EI, 2003, AM J PATHOL, V163, P1467, DOI 10.1016/S0002-9440(10)63504-3; Majeski EI, 2003, AM J RESP CELL MOL, V28, P208, DOI 10.1165/rcmb.4891; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P214, DOI 10.1513/pats.200504-031AC; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Meier M, 2007, J AM SOC NEPHROL, V18, P1190, DOI 10.1681/ASN.2005070694; Moine P, 2000, SHOCK, V13, P85, DOI 10.1097/00024382-200013020-00001; Morris GF, 2010, AM J PATHOL, V176, P2595, DOI 10.2353/ajpath.2010.100272; Nahra R, 2008, CURR OPIN ANESTHESIO, V21, P98, DOI 10.1097/ACO.0b013e3282f5335c; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Oh SW, 2011, J ETHNOPHARMACOL, V136, P414, DOI 10.1016/j.jep.2010.07.026; Paakko P, 2000, AM J RESP CRIT CARE, V161, P967; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578; Punithavathi D, 2003, BRIT J PHARMACOL, V139, P1342, DOI 10.1038/sj.bjp.0705362; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; SHARMA OP, 1976, BIOCHEM PHARMACOL, V25, P1811, DOI 10.1016/0006-2952(76)90421-4; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Smith MR, 2010, AM J PHYSIOL-LUNG C, V298, pL616, DOI 10.1152/ajplung.00002.2009; Song KM, 2011, BIOCHEM BIOPH RES CO, V411, P821, DOI 10.1016/j.bbrc.2011.07.044; SRIMAL RC, 1973, J PHARM PHARMACOL, V25, P447, DOI 10.1111/j.2042-7158.1973.tb09131.x; Stengler M, 2002, NATURAL PHYS HEALING, P444; Sun DM, 2010, MOL THER, V18, P1606, DOI 10.1038/mt.2010.105; Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tham CL, 2011, EUR J PHARMACOL, V652, P136, DOI 10.1016/j.ejphar.2010.10.092; Thiemermann C, 2006, CRIT CARE MED, V34, P2009, DOI 10.1097/01.CCM.0000224230.63684.06; Thresiamma K. C., 1996, Indian Journal of Experimental Biology, V34, P845; Tourkina E, 2004, AM J RESP CELL MOL, V31, P28, DOI 10.1165/rcmb.2003-0354OC; Tourkina E, 2001, ARTHRITIS RHEUM-US, V44, P1370, DOI 10.1002/1529-0131(200106)44:6<1370::AID-ART230>3.0.CO;2-2; Tully JE, 2012, AM J RESP CELL MOL, V47, P497, DOI 10.1165/rcmb.2012-0014OC; Vachharajani V, 2010, MICROCIRCULATION, V17, P407, DOI 10.1111/j.1549-8719.2010.00039.x; VENKATESAN N, 1995, MOL CELL BIOCHEM, V142, P79, DOI 10.1007/BF00928916; Venkatesan N, 1997, LIFE SCI, V61, pPL51; Venkatesan N, 1999, LIFE SCI, V66, pPL21, DOI 10.1016/S0024-3205(99)00576-7; Wang Y, 2011, MOL CELL BIOCHEM, V357, P83, DOI 10.1007/s11010-011-0878-2; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xu M, 2007, J ETHNOPHARMACOL, V112, P292, DOI 10.1016/j.jep.2007.03.011; Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC; Zhang De-ping, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P197; Zheng SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG113, DOI 10.1152/ajpgi.00200.2006; Zheng SZ, 2006, AM J PHYSIOL-GASTR L, V290, pG883, DOI 10.1152/ajpgi.00450.2005; Zheng SZ, 2004, BIOCHEM J, V384, P149, DOI 10.1042/BJ20040928; Zhu Rui-fang, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2141	87	80	86	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57285	10.1371/journal.pone.0057285	http://dx.doi.org/10.1371/journal.pone.0057285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437361	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200237
J	Gumieiro, DN; Rafacho, BPM; Goncalves, AF; Santos, PP; Azevedo, PS; Zornoff, LAM; Pereira, GJC; Matsubara, LS; Paiva, SAR; Minicucci, MF				Gumieiro, David N.; Rafacho, Bruna P. M.; Goncalves, Andrea F.; Santos, Priscila P.; Azevedo, Paula S.; Zornoff, Leonardo A. M.; Pereira, Gilberto J. C.; Matsubara, Luiz S.; Paiva, Sergio A. R.; Minicucci, Marcos F.			Serum Metalloproteinases 2 and 9 as Predictors of Gait Status, Pressure Ulcer and Mortality after Hip Fracture	PLOS ONE			English	Article							WOUND FLUIDS; INHIBITORS; SURGERY	Introduction: The aim of this study is to evaluate the serum activity of metalloproteinases (MMPs) -2 and -9 as predictors of pressure ulcer (PU), gait status and mortality 6 months after hip fracture. Methods: Eighty-seven patients over the age of 65 admitted to the orthopedic unit from January to December 2010 with hip fracture were prospectively evaluated. Upon admission, patient demographic information, including age, gender and concomitant diseases, was recorded. Blood samples were taken for analysis of MMP -2 and -9 activity by gel zymography and for biochemical examination within the first 72 hours of the patient's admission, after clinical stabilization. The fracture pattern (neck, trochanteric or subtrochanteric), time from admission to surgery, surgery duration and length of hospital stay were also recorded. Results: Two patients were excluded due to the presence of pathological fractures (related to cancer), and three patients were excluded due to the presence of PU before admission. Eighty-two patients, with a mean age of 80.4 +/- 6 7.3 years, were included in the analysis. Among these patients, 75.6% were female, 59.8% had PU, and 13.4% died 6 months after hip fracture. All patients underwent hip fracture repair. In a univariate analysis, there were no differences in serum MMP activity between hip fracture patients with or without PU. In addition, the multiple logistic regression analysis models, which were adjusted by age, gender, length of hospital stay and C-reactive protein, showed that the pro-MMP-9 complexed with neutrophil gelatinase-associated lipocalin form (130 kDa) was associated with gait status recovery 6 months after hip fracture. Conclusions: In conclusion, serum pro-MMP-9 is a predictor of gait status recovery 6 months after hip fracture.	[Gumieiro, David N.; Pereira, Gilberto J. C.] Univ Estadual Paulista, UNESP, Botucatu Med Sch, Surg & Orthoped Dept, Botucatu, SP, Brazil; [Rafacho, Bruna P. M.; Goncalves, Andrea F.; Santos, Priscila P.; Azevedo, Paula S.; Zornoff, Leonardo A. M.; Matsubara, Luiz S.; Paiva, Sergio A. R.; Minicucci, Marcos F.] Univ Estadual Paulista, UNESP, Dept Internal Med, Botucatu Med Sch, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Minicucci, MF (corresponding author), Univ Estadual Paulista, UNESP, Dept Internal Med, Botucatu Med Sch, Botucatu, SP, Brazil.	minicucci@fmb.unesp.br	Paiva, Sergio AR/A-5101-2008; Zornoff, Leonardo/A-5612-2008; Rafacho, Bruna Paola Murino/B-5460-2013; Rafacho, Bruna Paola Murino/AGW-5794-2022; Minicucci, Marcos F/A-9094-2008; Azevedo, Paula Schmidt/S-1597-2019; Azevedo, Paula S/F-2701-2012; dos Santos, Priscila Portugal/U-5345-2018	Paiva, Sergio AR/0000-0003-4412-1990; Zornoff, Leonardo/0000-0002-9831-8820; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Minicucci, Marcos F/0000-0002-5980-4367; Azevedo, Paula Schmidt/0000-0002-5843-6232; Azevedo, Paula S/0000-0002-5843-6232; dos Santos, Priscila Portugal/0000-0003-1159-5030	Botucatu Medical School	Botucatu Medical School	This work was supported by Botucatu Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Baumgarten M, 2003, WOUND REPAIR REGEN, V11, P96, DOI 10.1046/j.1524-475X.2003.11204.x; Beloosesky Y, 2004, GERONTOLOGY, V50, P216, DOI 10.1159/000078350; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Dunbar MJ, 2009, J BONE JOINT SURG AM, V91A, P2276, DOI 10.2106/JBJS.H.01521; European Pressure Ulcer Advisory Panel (EPUAP), 1999, EPUAP REV, V1, P31; Gumieiro DN, 2012, NUTRITION, V28, P874, DOI 10.1016/j.nut.2011.11.010; GUO S, 2010, INJURY, V89, P219, DOI DOI 10.1177/0022034509359125; Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Kurtinaitis J, 2012, MEDICINA KAUNAS, V48, P145; Ladwig GP, 2002, WOUND REPAIR REGEN, V10, P26, DOI 10.1046/j.1524-475X.2002.10903.x; Lauhio A, 2011, PHARM RES, V64, P590; Lefaivre KA, 2009, J BONE JOINT SURG BR, V91B, P922, DOI 10.1302/0301-620X.91B7.22446; Lindholm C, 2008, INT WOUND J, V5, P315, DOI 10.1111/j.1742-481X.2008.00452.x; Ma GF, 2006, RISK, V54, P2928; Ngbanda AR, 2012, OSTEOPOROS INT, DOI 0.1007/s00198-012-2061-3; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Shoda N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000416; SHODA N, 2012, J DENT RES, DOI DOI 10.1177/0022034509359125; TYAGI SC, 1993, CLIN BIOCHEM, V26, P191, DOI 10.1016/0009-9120(93)90025-2; UTZ ER, 2010, PLOS ONE, V159, P633, DOI DOI 10.1016/J.JSS.2009.08.021; Utz ER, 2010, RISK, V159, P633; Vidal EI, 2012, OSTEOPOROS INT, V23, P2847; Wysocki AB, 1993, RISK, V101, P64; WYSOCKI AB, 1993, PATHOL ONCOL RES, V101, P64; Yager DR, 1996, J INVEST DERMATOL, V107, P743, DOI 10.1111/1523-1747.ep12365637; Yokohama Y, 1995, RISK, V73, P899	28	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57424	10.1371/journal.pone.0057424	http://dx.doi.org/10.1371/journal.pone.0057424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437384	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200254
J	Lee, SJ; Kang, JH; Choi, SY; Suk, KT; Kim, DJ; Kwon, OS				Lee, Su Jin; Kang, Jeong Han; Choi, Soo Young; Suk, Ki Tae; Kim, Dong Joon; Kwon, Oh-Shin			PKC delta as a Regulator for TGF beta 1-Induced alpha-SMA Production in a Murine Nonalcoholic Steatohepatitis Model	PLOS ONE			English	Article							KINASE-C-DELTA; FATTY LIVER-DISEASE; NF-KAPPA-B; TGF-BETA; HEPATIC-FIBROSIS; STELLATE CELLS; GROWTH-FACTOR; PROTEIN; EXPRESSION; MICE	The precise mechanism of TGF beta 1 signaling in the progression of non-alcoholic steatohepatitis (NASH) has remained unclear. In particular, a potential regulatory mechanism by which PKC delta affects profibrogenic gene expression had never been explored. In this study, therefore, the role of PKC delta in TGF beta 1 mediated alpha-SMA expression was investigated using NASH model mice. In preparation of the NASH model, male C57BL6/J mice were fed a methionine-choline-deficient (MCD) diet for 3 weeks, after which time they were intraperitoneally injected with lipopolysaccharide (LPS). In addition, Tlr4(Lps-d) (CH3/HeJ) mice were used to demonstrate the TGF beta 1 signaling's dependency on TLR4 induction. Liver histology and hepatic hepatitis markers were investigated, and hepatic gene expression levels were determined by real-time PCR. Acute liver injury by LPS injection specifically elevated not only alpha-SMA expression but also phospho-PKC delta in this model. In contrast, Tlr4(Lps-d) (CH3/HeJ) and blockade of TGF beta 1 receptor by SB431542 resulted in a significant reduction of PKC delta activation and alpha-SMA expression. Moreover, the TGF beta 1-induced alpha-SMA production was significantly reduced by a specific PKC delta inhibitor. These findings suggested that PKC delta plays a critical role in TGF beta 1-induced alpha-SMA production in a NASH model. Thus, this was the first demonstration of the involvement of PKC delta in the regulation of alpha-SMA expression in NASH liver tissues, and the impaired induction of PKC delta phosphorylation by LPS in a steatohepatitis condition. Interestingly, treatment by PKC delta inhibitor caused dramatic reduction of myofibroblast activation, indicating that PKC delta represents a promising target for treating NASH.	[Lee, Su Jin; Kwon, Oh-Shin] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu, South Korea; [Kang, Jeong Han] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Choi, Soo Young] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea; [Choi, Soo Young] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon, South Korea; [Suk, Ki Tae; Kim, Dong Joon] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea	Kyungpook National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hallym University; Hallym University; Hallym University	Kwon, OS (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu, South Korea.	oskwon@knu.ac.kr	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696	Basic Science Research Program through the National Research Foundation of Korea (NRF); Korean Ministry of Education, Science and Technology [2011-0014420]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Ministry of Education, Science and Technology (2011-0014420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; Brunt EM, 2005, FRONT BIOSCI-LANDMRK, V10, P1475; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dina OA, 2001, NEUROSCIENCE, V108, P507, DOI 10.1016/S0306-4522(01)00425-0; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gore-Hyer E, 2003, ARTHRITIS RHEUM-US, V48, P798, DOI 10.1002/art.10953; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Kucich U, 2000, ARCH BIOCHEM BIOPHYS, V374, P313, DOI 10.1006/abbi.1999.1625; Lee MC, 2008, J LEUKOCYTE BIOL, V84, P835, DOI 10.1189/jlb.1007691; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Page K, 2003, J IMMUNOL, V170, P5681, DOI 10.4049/jimmunol.170.11.5681; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pinzani M, 2001, SEMIN LIVER DIS, V21, P397, DOI 10.1055/s-2001-17554; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Runyan CE, 2003, AM J PHYSIOL-RENAL, V285, pF413, DOI 10.1152/ajprenal.00082.2003; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Su GL, 2000, HEPATOLOGY, V31, P932, DOI 10.1053/he.2000.5634; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Vallee S, 2004, EXP CELL RES, V297, P165, DOI 10.1016/j.yexcr.2004.03.007; Wermuth PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027110; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Yue JB, 2000, METH MOL B, V142, P125	32	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55979	10.1371/journal.pone.0055979	http://dx.doi.org/10.1371/journal.pone.0055979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441159	gold, Green Submitted, Green Published			2022-12-25	WOS:000315159200016
J	Mukaro, VR; Bylund, J; Hodge, G; Holmes, M; Jersmann, H; Reynolds, PN; Hodge, S				Mukaro, Violet R.; Bylund, Johan; Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra			Lectins Offer New Perspectives in the Development of Macrophage-Targeted Therapies for COPD/Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MANNOSE-BINDING LECTIN; T-CELL APOPTOSIS; ALVEOLAR MACROPHAGES; GALECTIN-3; EXPRESSION; AIRWAY; EFFEROCYTOSIS; PHAGOCYTOSIS; RECOGNITION	We have previously shown that the defective ability of alveolar macrophages (AM) to phagocytose apoptotic cells ('efferocytosis') in chronic obstructive pulmonary disease/emphysema (COPD) could be therapeutically improved using the C-type lectin, mannose binding lectin (MBL), although the exact mechanisms underlying this effect are unknown. An S-type lectin, galectin-3, is also known to regulate macrophage phenotype and function, via interaction with its receptor CD98. We hypothesized that defective expression of galectin/CD98 would be associated with defective efferocytosis in COPD and that mechanisms would include effects on cytoskeletal remodeling and macrophage phenotype and glutathione (GSH) availability. Galectin-3 was measured by ELISA in BAL from controls, smokers and current/ex-smokers with COPD. CD98 was measured on AM using flow cytometry. We assessed the effects of galectin-3 on efferocytosis, CD98, GSH, actin polymerisation, rac activation, and the involvement of PI3K (using beta-actin probing and wortmannin inhibition) in vitro using human AM and/or MH-S macrophage cell line. Significant decreases in BAL galectin-3 and AM CD98 were observed in BAL from both current- and ex-smoker COPD subjects vs controls. Galectin 3 increased efferocytosis via an increase in active GTP bound Rac1. This was confirmed with beta-actin probing and the role of PI3K was confirmed using wortmannin inhibition. The increased efferocytosis was associated with increases in available glutathione and expression of CD98. We provide evidence for a role of airway lectins in the failed efferocytosis in COPD, supporting their further investigation as potential macrophage-targeted therapies.	[Mukaro, Violet R.; Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia; [Mukaro, Violet R.; Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Hanson Inst, Lung Res Lab, Adelaide, SA, Australia; [Bylund, Johan] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Hodge, Greg; Holmes, Mark; Jersmann, Hubertus; Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Dept Med, Adelaide, SA 5001, Australia	Royal Adelaide Hospital; Hanson Institute; University of Gothenburg; University of Adelaide	Hodge, S (corresponding author), Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA 5000, Australia.	sandra.hodge@health.sa.gov.au	Jersmann, Hubertus/ABC-5287-2020	Jersmann, Hubertus/0000-0003-1763-2736; Mukaro, Violet/0000-0002-3968-6551	National Health and Medical Research Council Project Grant; Career Development Award; Practitioner Fellowship	National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Career Development Award; Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a National Health and Medical Research Council Project Grant and Career Development Award and Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNAI S, 1986, J BIOL CHEM, V261, P2256; Beatty WL, 2002, CELL MICROBIOL, V4, P167, DOI 10.1046/j.1462-5822.2002.00183.x; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; Dobashi K, 2001, CLIN EXP IMMUNOL, V124, P290, DOI 10.1046/j.1365-2249.2001.01535.x; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Fukumori T, 2003, CANCER RES, V63, P8302; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2008, AM J RESP CRIT CARE, V178, P139, DOI 10.1164/rccm.200711-1666OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Hodge S, 2012, RESPIROLOGY, V17, P802, DOI 10.1111/j.1440-1843.2012.02135.x; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hodge S, 2011, J HEART LUNG TRANSPL, V30, P589, DOI 10.1016/j.healun.2011.01.710; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Karlsson A, 2009, GLYCOBIOLOGY, V19, P16, DOI 10.1093/glycob/cwn104; Kohatsu L, 2006, J IMMUNOL, V177, P4718, DOI 10.4049/jimmunol.177.7.4718; Krzeslak A, 2004, CELL MOL BIOL LETT, V9, P305; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Matthews GM, 2007, CANCER BIOL THER, V6, P1051, DOI 10.4161/cbt.6.7.4318; Pilette C, 2007, EUR RESPIR J, V29, P914, DOI 10.1183/09031936.00073005; Rimaniol AC, 2001, AM J PHYSIOL-CELL PH, V281, pC1964, DOI 10.1152/ajpcell.2001.281.6.C1964; Rotshenker S, 2008, GLIA, V56, P1607, DOI 10.1002/glia.20713; Stuart LM, 2005, J IMMUNOL, V174, P3220, DOI 10.4049/jimmunol.174.6.3220; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; Theakston F, 2008, WORLD HLTH STAT; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737	31	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56147	10.1371/journal.pone.0056147	http://dx.doi.org/10.1371/journal.pone.0056147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441163	Green Published, gold			2022-12-25	WOS:000315159200020
J	Suzuki, M; Takaishi, S; Nagasaki, M; Onozawa, Y; Iino, I; Maeda, H; Komai, T; Oda, T				Suzuki, Masakatsu; Takaishi, Sachiko; Nagasaki, Miyuki; Onozawa, Yoshiko; Iino, Ikue; Maeda, Hiroaki; Komai, Tomoaki; Oda, Tomiichiro			Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; INFLAMMATORY CHANGES; INSULIN-RESISTANCE; ALPHA; ADIPOCYTES; LIPOLYSIS; GPR120; DEORPHANIZATION; CHROMATOGRAPHY; PROPIONATE	G protein-coupled receptor 84 (GPR84) is a putative receptor for medium-chain fatty acids (MCFAs), whose pathophysiological roles have not yet been clarified. Here, we show that GPR84 was activated by MCFAs with the hydroxyl group at the 2- or 3-position more effectively than nonhydroxylated MCFAs. We also identified a surrogate agonist, 6-n-octylaminouracil (6-OAU), for GPR84. These potential ligands and the surrogate agonist, 6-OAU, stimulated [S-35]GTP binding and accumulated phosphoinositides in a GPR84-dependent manner. The surrogate agonist, 6-OAU, internalized GPR84-EGFP from the cell surface. Both the potential ligands and 6-OAU elicited chemotaxis of human polymorphonuclear leukocytes (PMNs) and macrophages and amplified LPS-stimulated production of the proinflammatory cytokine IL-8 from PMNs and TNF alpha from macrophages. Furthermore, the intravenous injection of 6-OAU raised the blood CXCL1 level in rats, and the inoculation of 6-OAU into the rat air pouch accumulated PMNs and macrophages in the site. Our results indicate a proinflammatory role of GPR84, suggesting that the receptor may be a novel target to treat chronic low grade inflammation associated-disease.	[Suzuki, Masakatsu; Nagasaki, Miyuki; Onozawa, Yoshiko; Maeda, Hiroaki; Komai, Tomoaki] Daiichi Sankyo Co Ltd, Frontier Res Labs, Tokyo 140871, Japan; [Takaishi, Sachiko] Daiichi Sankyo Co Ltd, Oncol Res Labs, Tokyo 140871, Japan; [Oda, Tomiichiro] Daiichi Sankyo Co Ltd, R&D Adm & Support Dept, R&D Div, Tokyo 140871, Japan; [Iino, Ikue] Daiichi Sankyo RD Novare Co Ltd, Drug Discovery & Biomed Technol Unit, Tokyo 1408710, Japan	Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited; Daiichi Sankyo Company Limited	Suzuki, M (corresponding author), Daiichi Sankyo Co Ltd, Frontier Res Labs, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan.	suzuki.masakatsu.mr@daiichisankyo.co.jp						Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Bouchard C, 2007, GLIA, V55, P790, DOI 10.1002/glia.20506; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Costa CG, 1998, CLIN CHEM, V44, P463; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Guo L, 2012, J LIPID RES, V53, P1327, DOI 10.1194/jlr.M025742; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jones PM, 2011, BBA-MOL CELL BIOL L, V1811, P657, DOI 10.1016/j.bbalip.2011.06.026; KIMACHI T, 1991, J HETEROCYCLIC CHEM, V28, P439, DOI 10.1002/jhet.5570280244; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Nagasaki H, 2012, FEBS LETT, V586, P368, DOI 10.1016/j.febslet.2012.01.001; Nakagawa H, 1996, BIOCHEM BIOPH RES CO, V220, P945, DOI 10.1006/bbrc.1996.0511; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Oh DY, 2011, CURR OPIN CLIN NUTR, V14, P322, DOI 10.1097/MCO.0b013e3283479230; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; PARLESAK A, 1995, J CHROMATOGR A, V711, P277, DOI 10.1016/0021-9673(95)00518-R; Rodrigues HG, 2010, LIPIDS, V45, P809, DOI 10.1007/s11745-010-3461-9; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; SHIBATA F, 1995, EUR J BIOCHEM, V231, P306, DOI 10.1111/j.1432-1033.1995.tb20701.x; Soydan AS, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/64980; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Takeda S, 2003, LIFE SCI, V74, P367, DOI 10.1016/j.lfs.2003.09.030; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Venkataraman C, 2005, IMMUNOL LETT, V101, P144, DOI 10.1016/j.imlet.2005.05.010; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045	41	128	137	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10684	10691		10.1074/jbc.M112.420042	http://dx.doi.org/10.1074/jbc.M112.420042			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23449982	Green Published, hybrid			2022-12-25	WOS:000317565000046
J	Augusto, DG; Piovezan, BZ; Tsuneto, LT; Callegari-Jacques, SM; Petzl-Erler, ML				Augusto, Danillo Gardenal; Piovezan, Bruno Zagonel; Tsuneto, Luiza Tamie; Callegari-Jacques, Sidia Maria; Petzl-Erler, Maria Luiza			KIR Gene Content in Amerindians Indicates Influence of Demographic Factors	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; KILLER-CELL RECEPTOR; MHC CLASS-I; NK CELLS; HAPLOTYPES CONTAIN; GENOMIC DIVERSITY; CUTTING EDGE; PCR-SSOP; HLA; POPULATIONS	Although the KIR gene content polymorphism has been studied worldwide, only a few isolated or Amerindian populations have been analyzed. This extremely diverse gene family codifies receptors that are expressed mainly in NK cells and bind HLA class I molecules. KIR-HLA combinations have been associated to several diseases and population studies are important to comprehend their evolution and their role in immunity. Here we analyzed, by PCR-SSP (specific sequencing priming), 327 individuals from four isolated groups of two of the most important Brazilian Amerindian populations: Kaingang and Guarani. The pattern of KIR diversity among these and other ten Amerindian populations disclosed a wide range of variation for both KIR haplotypes and gene frequencies, indicating that demographic factors, such as bottleneck and founder effects, were the most important evolutionary factors in shaping the KIR polymorphism in these populations.	[Augusto, Danillo Gardenal; Piovezan, Bruno Zagonel; Petzl-Erler, Maria Luiza] Univ Fed Parana, Lab Genet Mol Humana, BR-80060000 Curitiba, Parana, Brazil; [Tsuneto, Luiza Tamie] Univ Estadual Maringa, Lab Imunogenet, Maringa, Parana, Brazil; [Callegari-Jacques, Sidia Maria] Univ Fed Rio Grande do Sul, Dept Estat, Porto Alegre, RS, Brazil	Universidade Federal do Parana; Universidade Estadual de Maringa; Universidade Federal do Rio Grande do Sul	Petzl-Erler, ML (corresponding author), Univ Fed Parana, Lab Genet Mol Humana, BR-80060000 Curitiba, Parana, Brazil.	perler@ufpr.br	Petzl-Erler, Maria Luiza/H-8221-2012; Callegari-Jacques, Sidia M/H-1774-2016; Augusto, Danillo G/H-8179-2019; Augusto, Danillo/F-3147-2013	Petzl-Erler, Maria Luiza/0000-0002-0345-5276; Augusto, Danillo G/0000-0001-5665-8547; CALLEGARI JACQUES, SIDIA M./0000-0002-2489-2539	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); PRONEX; Institutos do Milenio; Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX; Institutos do Milenio; Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PRONEX (Programa de Apoio a Nucleos de Excelencia); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project received financial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), PRONEX, Institutos do Milenio, Fundacao Araucaria, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by PRONEX (Programa de Apoio a Nucleos de Excelencia - Fundacao Araucaria and CNPq). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Augusto DG, 2012, IMMUNOGENETICS, V64, P143, DOI 10.1007/s00251-011-0565-1; Augusto DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039991; Braun-Prado K, 2000, TISSUE ANTIGENS, V56, P417, DOI 10.1034/j.1399-0039.2000.560504.x; Caggiari L, 2011, INT J BIOL MARKER, V26, P221, DOI 10.5301/JBM.2011.8903; Capittini C, 2012, GENES IMMUN, V13, P452, DOI 10.1038/gene.2012.14; Crum KA, 2000, TISSUE ANTIGENS, V56, P313, DOI 10.1034/j.1399-0039.2000.560403.x; Ewerton PD, 2007, IMMUNOGENETICS, V59, P625, DOI 10.1007/s00251-007-0229-3; Du ZY, 2007, IMMUNOGENETICS, V59, P1, DOI 10.1007/s00251-006-0168-4; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Flores AC, 2007, TISSUE ANTIGENS, V69, P568, DOI 10.1111/j.1399-0039.2007.00824.x; Foley B, 2008, INT IMMUNOL, V20, P555, DOI 10.1093/intimm/dxn013; Garcia-Leon JA, 2011, MOL IMMUNOL, V48, P1896, DOI 10.1016/j.molimm.2011.05.018; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gomez-Lozano N, 2005, EUR J IMMUNOL, V35, P16, DOI 10.1002/eji.200425493; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Goodridge JP, 2007, EUR J IMMUNOL, V37, P199, DOI 10.1002/eji.200636316; Goodridge JP, 2003, J IMMUNOL, V171, P1768, DOI 10.4049/jimmunol.171.4.1768; Gutierrez-Rodriguez ME, 2006, HUM IMMUNOL, V67, P85, DOI 10.1016/j.humimm.2005.11.007; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Kulkarni S, 2010, METHODS MOL BIOL, V612, P365, DOI 10.1007/978-1-60761-362-6_25; Long EO, 1996, IMMUNOL TODAY, V17, P100, DOI 10.1016/0167-5699(96)80590-1; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; Maxwell LD, 2002, TISSUE ANTIGENS, V60, P254, DOI 10.1034/j.1399-0039.2002.600307.x; Moesta AK, 2010, J IMMUNOL, V185, P4233, DOI 10.4049/jimmunol.1001951; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Connor GM, 2011, J IMMUNOL, V187, P2162, DOI 10.4049/jimmunol.1002906; Ordonez D, 2008, GENES IMMUN, V9, P431, DOI 10.1038/gene.2008.34; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parham P, 2004, IMMUNOL LETT, V92, P11, DOI 10.1016/j.imlet.2003.11.016; PETZLERLER ML, 1993, TISSUE ANTIGENS, V41, P227; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Rajalingam R, 2002, IMMUNOGENETICS, V53, P1009, DOI 10.1007/s00251-001-0425-5; Rajalingam R, 2008, IMMUNOGENETICS, V60, P207, DOI 10.1007/s00251-008-0286-2; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Slik ARVD, 2006, TISSUE ANTIGENS, P101; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Toneva M, 2001, TISSUE ANTIGENS, V57, P358, DOI 10.1034/j.1399-0039.2001.057004358.x; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Wende H, 1999, MAMM GENOME, V10, P154, DOI 10.1007/s003359900961; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Winter CC, 1998, J IMMUNOL, V161, P571; Witt CS, 1999, TRANSPLANTATION, V68, P1784, DOI 10.1097/00007890-199912150-00024; Yoo YJ, 2007, BIOINFORMATICS, V23, P2399, DOI 10.1093/bioinformatics/btm371; Yusa S, 2002, J IMMUNOL, V168, P5047, DOI 10.4049/jimmunol.168.10.5047; Zhi DJ, 2011, DIABETES-METAB RES, V27, P872, DOI 10.1002/dmrr.1264	56	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56755	10.1371/journal.pone.0056755	http://dx.doi.org/10.1371/journal.pone.0056755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451080	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500027
J	Koch, O; Cappel, D; Nocker, M; Jager, T; Flohe, L; Sotriffer, CA; Selzer, PM				Koch, Oliver; Cappel, Daniel; Nocker, Monika; Jaeger, Timo; Flohe, Leopold; Sotriffer, Christoph A.; Selzer, Paul M.			Molecular Dynamics Reveal Binding Mode of Glutathionylspermidine by Trypanothione Synthetase	PLOS ONE			English	Article							CRITHIDIA-FASCICULATA; TRYPANOSOMA-CRUZI; RESP MODEL; BIOSYNTHESIS; CHEMOTHERAPY; METABOLISM; BRUCEI; SYSTEM; LEISHMANIASIS; PURIFICATION	The trypanothione synthetase (TryS) catalyses the two-step biosynthesis of trypanothione from spermidine and glutathione and is an attractive new drug target for the development of trypanocidal and antileishmanial drugs, especially since the structural information of TryS from Leishmania major has become available. Unfortunately, the TryS structure was solved without any of the substrates and lacks loop regions that are mechanistically important. This contribution describes docking and molecular dynamics simulations that led to further insights into trypanothione biosynthesis and, in particular, explains the binding modes of substrates for the second catalytic step. The structural model essentially confirm previously proposed binding sites for glutathione, ATP and two Mg2+ ions, which appear identical for both catalytic steps. The analysis of an unsolved loop region near the proposed spermidine binding site revealed a new pocket that was demonstrated to bind glutathionylspermidine in an inverted orientation. For the second step of trypanothione synthesis glutathionylspermidine is bound in a way that preferentially allows N-1-glutathionylation of N-8-glutathionylspermidine, classifying N-8-glutathionylspermidine as the favoured substrate. By inhibitor docking, the binding site for N-8-glutathionylspermidine was characterised as druggable.	[Koch, Oliver; Selzer, Paul M.] MSD Anim Hlth Innovat GmbH, Schwabenheim, Germany; [Koch, Oliver; Jaeger, Timo] MOLISA GmbH, Magdeburg, Germany; [Cappel, Daniel; Nocker, Monika; Sotriffer, Christoph A.] Univ Wurzburg, Inst Pharm & Food Chem, D-97070 Wurzburg, Germany; [Flohe, Leopold] Otto von Guericke Univ, Magdeburg, Germany; [Selzer, Paul M.] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Selzer, Paul M.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Selzer, Paul M.] Univ Glasgow, Fac Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland	Merck & Company; Intervet International B.V.; University of Wurzburg; Otto von Guericke University; Eberhard Karls University of Tubingen; University of Glasgow; University of Glasgow	Koch, O (corresponding author), TU Dortmund Univ, Fac Chem, Dortmund, Germany.	oliver.koch@tu-dortmund.de; paul.selzer@msd.de	Koch, Oliver/E-4599-2018	Cappel, Daniel/0000-0002-8460-7867; Koch, Oliver/0000-0001-9228-217X	Bundesministerium fur Bildung und Forschung of the German Federal Republic [FKZ 0315814A]	Bundesministerium fur Bildung und Forschung of the German Federal Republic	The work was performed in the context of the COST Action CM0801 "New Drugs for Neglected Diseases'' and supported by the Bundesministerium fur Bildung und Forschung of the German Federal Republic (FKZ 0315814A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Castro H, 2008, ANTIOXID REDOX SIGN, V10, P1593, DOI 10.1089/ars.2008.2050; Comini M, 2003, BIOL CHEM, V384, P653, DOI 10.1515/BC.2003.072; Comini M, 2005, J BIOL CHEM, V280, P6850, DOI 10.1074/jbc.M404486200; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1986, MOL BIOCHEM PARASIT, V21, P247, DOI 10.1016/0166-6851(86)90130-1; Flohe L, 2012, BIOTECHNOL ADV, V30, P294, DOI 10.1016/j.biotechadv.2011.05.012; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Harvey SC, 1998, J COMPUT CHEM, V19, P726, DOI 10.1002/(SICI)1096-987X(199805)19:7<726::AID-JCC4>3.0.CO;2-S; HENDERSON GB, 1990, BIOCHEMISTRY-US, V29, P3924, DOI 10.1021/bi00468a019; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Korb O, 2010, J CHEMOINF, V2, P25; Krauth-Siegel Luise R., 2007, V44, P231; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Lin CH, 1997, CHEM BIOL, V4, P859, DOI 10.1016/S1074-5521(97)90118-6; McGuire JJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P140, DOI 10.1016/j.abb.2009.06.017; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oza SL, 2008, FEBS J, V275, P5408, DOI 10.1111/j.1742-4658.2008.06670.x; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Pai CH, 2006, EMBO J, V25, P5970, DOI 10.1038/sj.emboj.7601440; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shlomai J, 2010, ANTIOXID REDOX SIGN, V13, P1429, DOI 10.1089/ars.2009.3029; SMITH K, 1992, PROTEIN SCI, V1, P874, DOI 10.1002/pro.5560010705; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; WHO Expert Committee, 2010, M WHO EXP COMM CONTR; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x	45	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56788	10.1371/journal.pone.0056788	http://dx.doi.org/10.1371/journal.pone.0056788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451087	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500030
J	Kumar, NP; Sridhar, R; Banurekha, VV; Nair, D; Jawahar, MS; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Sridhar, Rathinam; Banurekha, Vaithilingam V.; Nair, Dina; Jawahar, Mohideen S.; Nutman, Thomas B.; Babu, Subash			Expansion of Pathogen-Specific Mono- and Multifunctional Th1 and Th17 Cells in Multi-Focal Tuberculous Lymphadenitis	PLOS ONE			English	Article							REGULATORY T-CELLS; ACTIVE PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; IFN-GAMMA; INTERFERON-GAMMA; IMMUNE-RESPONSES; EXPRESSION; IL-23; IL-17; DIFFERENTIATION	Background: Th1 and Th17 responses are known to play an important role in immunity to pulmonary tuberculosis (PTB), although little is known about their role in extrapulmonary forms of tuberculosis (TB). Methods: To identify the role of Th1, Th17, and Th22 cells in multi-focal TB lymphadenitis (TBL), we examined mycobacteria-specific immune responses in the whole blood of individuals with PTB (n = 20) and compared them with those with TBL (n = 25). Results: Elevated frequencies of CD4(+) T cells expressing IFN- gamma, TNF-alpha, and IL-2 were present in individuals with TBL compared with those with PTB at baseline and in response to ESAT-6 and CFP-10. Similarly, increased frequencies of CD4(+) T cells expressing IL-17A, IL-17F, and IFN-gamma were also present in individuals with TBL at baseline and following ESAT-6 and CFP-10 stimulation although no significant difference in frequency of Th22 cells was observed. Finally, frequencies of Th1 (but not Th17) cells exhibited a significantly negative correlation with natural regulatory T cell frequencies at baseline. Conclusions: Multi-focal TB lymphadenitis is therefore characterized by elevated frequencies of Th1 and Th17 cells, indicating that Th1 and Th17 responses in TB disease are probably correlates of disease severity rather than of protective immunity.	[Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Chennai, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Chennai, Tamil Nadu, India; [Banurekha, Vaithilingam V.; Nair, Dina; Jawahar, Mohideen S.] Natl Inst Res TB, Chennai, Tamil Nadu, India; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Int Ctr Excellence Res, Natl Inst Hlth, Chennai, Tamil Nadu, India.	sbabu@mail.nih.gov	Kumar, Nathella Pavan/AAU-2328-2021; Babu, Subash/GXG-4746-2022		Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000197, ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Cooper AM, 2012, CURR OPIN IMMUNOL; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handa U, 2012, J INFECT DEV COUNTR, V6, P6, DOI 10.3855/jidc.2090; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020165; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Millington KA, 2010, J INFECT DIS, V202, P1685, DOI 10.1086/656772; Mohapatra Prasanta Raghab, 2009, J Assoc Physicians India, V57, P585; Nemeth J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035290; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Peters A, 2011, CURR OPIN IMMUNOL, V23, P702, DOI 10.1016/j.coi.2011.08.007; Qiao D, 2011, SCAND J IMMUNOL, V73, P330, DOI 10.1111/j.1365-3083.2011.02512.x; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Rutz S, 2011, CURR OPIN IMMUNOL, V23, P605, DOI 10.1016/j.coi.2011.07.018; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sharma PK, 2009, AM J RESP CRIT CARE, V179, P1061, DOI 10.1164/rccm.200804-529OC; Streitz M, 2011, J INFECT DIS, V203, P378, DOI 10.1093/infdis/jiq065; Sutherland JS, 2009, EUR J IMMUNOL, V39, P723, DOI 10.1002/eji.200838693; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Torrado E, 2010, CYTOKINE GROWTH F R, V21, P455, DOI 10.1016/j.cytogfr.2010.10.004; Winkler S, 2005, MICROBES INFECT, V7, P1161, DOI 10.1016/j.micinf.2005.03.020; Ye ZJ, 2012, AM J RESP CRIT CARE, V185, P660, DOI 10.1164/rccm.201107-1198OC; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	43	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57123	10.1371/journal.pone.0057123	http://dx.doi.org/10.1371/journal.pone.0057123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451159	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500066
J	Lee, M; Kim, SE; Kim, WS; Lee, J; Yoo, HK; Park, KD; Choi, KG; Jeong, SY; Kim, BG; Lee, HW				Lee, Mina; Kim, Song E.; Kim, Won Sup; Lee, Jungyeun; Yoo, Hye Kyung; Park, Kee-Duk; Choi, Kyoung-Gyu; Jeong, Seon-Yong; Kim, Byung Gon; Lee, Hyang Woon			Interaction of Motor Training and Intermittent Theta Burst Stimulation in Modulating Motor Cortical Plasticity: Influence of BDNF Val66Met Polymorphism	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SYNAPTIC-TRANSMISSION; CORTICOSPINAL EXCITABILITY; ANTIDEPRESSANT RESPONSE; DEPENDENT PLASTICITY; BRAIN-STIMULATION; CHRONIC STROKE; CORTEX; METAPLASTICITY; RECOVERY	Cortical physiology in human motor cortex is influenced by behavioral motor training (MT) as well as repetitive transcranial magnetic stimulation protocol such as intermittent theta burst stimulation (iTBS). This study aimed to test whether MT and iTBS can interact with each other to produce additive changes in motor cortical physiology. We hypothesized that potential interaction between MT and iTBS would be dependent on BDNF Val66Met polymorphism, which is known to affect neuroplasticity in the human motor cortex. Eighty two healthy volunteers were genotyped for BDNF polymorphism. Thirty subjects were assigned for MT alone, 23 for iTBS alone, and 29 for MT + iTBS paradigms. TMS indices for cortical excitability and motor map areas were measured prior to and after each paradigm. MT alone significantly increased the motor cortical excitability and expanded the motor map areas. The iTBS alone paradigm also enhanced excitability and increased the motor map areas to a slightly greater extent than MT alone. A combination of MT and iTBS resulted in the largest increases in the cortical excitability, and the representational motor map expansion of MT + iTBS was significantly greater than MT or iTBS alone only in Val/Val genotype. As a result, the additive interaction between MT and iTBS was highly dependent on BDNF Val66Met polymorphism. Our results may have clinical relevance in designing rehabilitative strategies that combine therapeutic cortical stimulation and physical exercise for patients with motor disabilities.	[Lee, Mina; Kim, Song E.; Kim, Won Sup; Lee, Jungyeun; Yoo, Hye Kyung; Park, Kee-Duk; Choi, Kyoung-Gyu; Lee, Hyang Woon] Ewha Womans Univ, Dept Neurol, Sch Med, Seoul, South Korea; [Lee, Mina; Kim, Song E.; Kim, Won Sup; Lee, Hyang Woon] Ewha Med Res Inst, Seoul, South Korea; [Jeong, Seon-Yong] Ajou Univ, Sch Med, Dept Med Genet, Suwon 441749, South Korea; [Kim, Byung Gon] Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea	Ewha Womans University; Ewha Womans University; Ajou University; Ajou University	Kim, BG (corresponding author), Ajou Univ, Sch Med, Dept Neurol, Suwon 441749, South Korea.	kimbg@ajou.ac.kr; leeh@ewha.ac.kr	Kim, Byung Gon/L-6884-2019	Kim, Byung Gon/0000-0003-2233-9569; LEE, Jungyeun/0000-0002-3544-1098	Chronic Inflammatory Disease Research Center through the National Research Foundation of Korea; Ministry of Education, Science and Technology [2012051429, R01-2001-0015788, KRF-2009-006-5721, 2009-007-2164]; Ewha Global Top 5 Grant of Ewha Womans University; Korean Science and Engineering Foundation Grant; South Korean government (MOST) [R01-2007-000-11080-0]; Basic Science Research Program through the National Research Foundation of Korea	Chronic Inflammatory Disease Research Center through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ewha Global Top 5 Grant of Ewha Womans University; Korean Science and Engineering Foundation Grant(Korea Science and Engineering Foundation); South Korean government (MOST)(Ministry of Science & Technology (MOST), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Chronic Inflammatory Disease Research Center through the National Research Foundation of Korea (http://www.nrf.re.kr/html/en/) funded by the Ministry of Education, Science and Technology 2012051429) to BGK, and by the Ewha Global Top 5 Grant 2011 of Ewha Womans University and by the Korean Science and Engineering Foundation Grant (http://www.kosef.re.kr/) funded by the South Korean government (MOST) (R01-2007-000-11080-0), and by the Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re.kr/html/en/) funded by the Ministry of Education, Science and Technology (R01-2001-0015788, KRF-2009-006-5721 and 2009-007-2164) to HWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Butefisch CM, 2002, ANN NEUROL, V51, P59, DOI 10.1002/ana.10056; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Dobkin BH, 2008, NAT CLIN PRACT NEURO, V4, P76, DOI 10.1038/ncpneuro0709; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Green EK, 2006, BRIT J PSYCHIAT, V188, P21, DOI 10.1192/bjp.bp.105.009969; Gur RC, 2002, AM J GERIAT PSYCHIAT, V10, P72, DOI 10.1176/appi.ajgp.10.1.72; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang YZ, 2011, CLIN NEUROPHYSIOL, V122, P1011, DOI 10.1016/j.clinph.2010.08.016; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Iezzi E, 2008, J NEUROPHYSIOL, V100, P2070, DOI 10.1152/jn.90521.2008; Iezzi E, 2011, EUR J NEUROSCI, V33, P1908, DOI 10.1111/j.1460-9568.2011.07674.x; Iyer MB, 2003, J NEUROSCI, V23, P10867; Jung P, 2009, J NEUROSCI, V29, P5597, DOI 10.1523/JNEUROSCI.0222-09.2009; Kaneko K, 1996, ELECTROMYOGR MOTOR C, V101, P478, DOI 10.1016/S0921-884X(96)96021-X; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Malcolm MP, 2007, AM J PHYS MED REHAB, V86, P707, DOI 10.1097/PHM.0b013e31813e0de0; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Paulus W, 2005, NEURON, V45, P181, DOI 10.1016/j.neuron.2005.01.008; Rose CR, 2004, BIOESSAYS, V26, P1185, DOI 10.1002/bies.20118; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schwenkreis P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-35; Siebner HR, 2003, EXP BRAIN RES, V148, P1, DOI 10.1007/s00221-002-1234-2; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P333, DOI 10.1016/j.clinph.2006.10.014; Tsai SJ, 2003, AM J MED GENET B, V123B, P19, DOI 10.1002/ajmg.b.20026; Tyc F, 2006, REV NEUROSCIENCE, V17, P469; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Wu K, 2004, MOL BRAIN RES, V130, P178, DOI 10.1016/j.molbrainres.2004.07.019; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	51	35	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57690	10.1371/journal.pone.0057690	http://dx.doi.org/10.1371/journal.pone.0057690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451258	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500125
J	Xing, W; He, XZ; Kassir, MA; Chen, J; Ding, JL; Sun, J; Hu, JN; Zhang, ZS; Haacke, EM; Dai, YM				Xing, Wei; He, Xiaozhou; Kassir, Mohammad A.; Chen, Jie; Ding, Jiule; Sun, Jun; Hu, Jiani; Zhang, Zishu; Haacke, E. Mark; Dai, Yongming			Evaluating Hemorrhage in Renal Cell Carcinoma Using Susceptibility Weighted Imaging	PLOS ONE			English	Article							MRI; LESIONS; CT; EXPERIENCE; CHILDREN; SUBTYPES; TUMORS; SWI	Background: Intratumoral hemorrhage is a frequent occurrence in renal cell carcinoma and is an indicator of tumor subtype. We hypothesize that susceptibility weighted imaging (SWI) is sensitive to hemorrhage in renal cell carcinoma and can give a more diagnostic image when compared to conventional imaging techniques. Materials and Methods: A retrospective review of 32 patients with clear cell renal cell carcinoma was evaluated. All patients underwent magnetic resonance imaging (MRI) and 22 out of 32 patients also underwent a computed tomography (CT) scan. Hemorrhage was classified into 3 different categories according to shape and distribution. Histopathology was obtained from all masses by radical nephrectomy. The ability to detect the presence of hemorrhage using CT, non-contrast conventional MRI and SWI was evaluated, and the patterns of hemorrhage were compared. Results: Using pathologic results as the gold standard, the sensitivities of non-contrast conventional MRI, SWI and CT in detecting hemorrhage in clear cell renal cell carcinoma were 65.6%, 100% and 22.7%, respectively. Accuracy of non-contrast conventional MRI and SWI in evaluating hemorrhagic patterns were 31.3% and 100%, respectively. Conclusion: These results demonstrate that SWI can better reveal hemorrhage and characterize the pattern more accurately than either non-contrast conventional MRI or CT. This suggests that SWI is the technique of choice for detecting hemorrhagic lesions in patients with renal cancer.	[Xing, Wei; Chen, Jie; Ding, Jiule; Sun, Jun] Suzhou Univ, Dept Radiol, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China; [He, Xiaozhou] Suzhou Univ, Dept Urol, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China; [Kassir, Mohammad A.; Hu, Jiani; Zhang, Zishu; Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Dai, Yongming] MR Collaborat NE Asia, Siemens Healthcare China, Shanghai, Peoples R China	Wayne State University; Siemens AG	He, XZ (corresponding author), Suzhou Univ, Dept Urol, Affiliated Hosp 3, Changzhou, Jiangsu, Peoples R China.	czxiaozhouhe@sina.com						Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Casillas VJ, 2000, RADIOGRAPHICS, V20, P367, DOI 10.1148/radiographics.20.2.g00mc10367; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036454; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Grignon DJ, 2005, CLIN LAB MED, V25, P305, DOI 10.1016/j.cll.2005.01.012; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; John G, 1997, JMRI-J MAGN RESON IM, V7, P157, DOI 10.1002/jmri.1880070123; Kim JK, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781499; Kim S, 2010, J MAGN RESON IMAGING, V31, P348, DOI 10.1002/jmri.22038; Latif F, 2011, J PAK MED ASSOC, V61, P224; Leveridge MJ, 2010, NAT REV UROL, V7, P311, DOI 10.1038/nrurol.2010.63; Linehan MW, 2001, PRINCIPLES PRACTICE, P1362; LJUNGBERG B, 1995, J UROLOGY, V154, P1681, DOI 10.1016/S0022-5347(01)66749-1; Martorana G, 2006, EUR UROL SUPPL, V5, P600, DOI 10.1016/j.eursup.2006.04.002; McAninch JW, 2002, CAMPBELLS UROLOGY, V4, p3,707; MCCLENNAN BL, 1994, RADIOL CLIN N AM, V32, P55; McKinney AM, 2012, AM J NEURORADIOL, V33, P896, DOI 10.3174/ajnr.A2886; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; PAAJANEN H, 1987, INVEST RADIOL, V22, P792, DOI 10.1097/00004424-198710000-00005; Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055; Razek AAKA, 2011, J COMPUT ASSIST TOMO, V35, P332, DOI 10.1097/RCT.0b013e318219fe76; Rofsky N M, 1997, Magn Reson Imaging Clin N Am, V5, P67; ROUBIDOUX MA, 1994, RADIOGRAPHICS, V14, P1033, DOI 10.1148/radiographics.14.5.7991812; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Shinmoto H, 1998, JMRI-J MAGN RESON IM, V8, P690, DOI 10.1002/jmri.1880080327; Silverman SG, 2007, RADIOGRAPHICS, V27, P1131, DOI 10.1148/rg.274065147; Simon JW, 2000, CLIN ONCOLOGY, P1784; Thomsen TW, 2004, J EMERG MED, V26, P331, DOI 10.1016/j.jemermed.2003.12.012; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wagner B J, 1997, Magn Reson Imaging Clin N Am, V5, P13; Walsh DO, 2000, MAGNET RESON MED, V43, P682, DOI 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617	34	19	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57691	10.1371/journal.pone.0057691	http://dx.doi.org/10.1371/journal.pone.0057691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451259	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500126
J	Yoon, JH; Han, KH; Kim, EK; Moon, HJ; Kim, MJ; Suh, YJ; Choi, JS; Park, BW				Yoon, Jung Hyun; Han, Kyung Hwa; Kim, Eun-Kyung; Moon, Hee Jung; Kim, Min Jung; Suh, Young Joo; Choi, Ji Soo; Park, Byeong-Woo			Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; NEURON-SPECIFIC ENOLASE; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN-19 FRAGMENTS; NEOADJUVANT CHEMOTHERAPY; SERUM CYFRA-21-1; PLEURAL FLUID; HIGH-RISK; ULTRASOUND; BIOPSY	Introduction: To assess whether the value of CYFRA21-1 in the aspirates of ultrasonography-guided fine-needle aspiration biopsy (US-FNAB) can contribute to improving the performances of US-FNAB in the diagnosis of axillary lymph node (LN) metastasis in breast cancer patients. Methods: US-FNAB was performed in 156 axillary LNs in 152 breast cancer patients (mean age: 51.4 years, range: 17-92 years). Concentrations of CYFRA21-1 were measured from washouts of the syringe used during US-FNAB. Tumor marker concentrations, US-FNAB, intraoperative sentinel node biopsy (SNB), and surgical pathology results were reviewed and analyzed. For comparison, the values of CEA and CA15-3 were also measured from washouts. Results: Among the 156 LNs, 75 (48.1%) were benign, and 81 (51.9%) were metastases. Mean concentrations of CYFRA21-1 were significantly higher in metastasis compared to benign LNs (P<0.001). US-FNAB combined to CYFRA21-1 showed significantly higher sensitivity, NPV, and accuracy compared to US-FNAB alone (all values P<0.05). All diagnostic indices of US-FNAB combined to CYFRA21-1 were significantly higher compared to US-FNAB combined with CEA or CA15-3 (all P<0.001). Of the 28 metastatic LNs which showed metastasis on SNB, CYFRA21-1 showed higher positive rate of 75.0% (CEA or CA15-3:60.7%, P = 0.076). Conclusion: Measuring CYFRA 21-1 concentrations from US-FNAB aspirates improves sensitivity, NPV, and accuracy of US-FNAB alone, and may contribute to reducing up to 75.0% of unnecessary intraoperative SNB. Compared to CEA or CA15-3, CYFRA21-1 shows significantly higher performances when combined to US-FNAB in the preoperative diagnosis of LN metastasis in breast cancer patients.	[Yoon, Jung Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Kim, Min Jung; Suh, Young Joo] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Yoon, Jung Hyun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea; [Han, Kyung Hwa] Yonsei Univ, Coll Med, Dept Res Affairs, Seoul, South Korea; [Choi, Ji Soo] Natl Canc Ctr, Dept Radiol, Goyang, South Korea; [Park, Byeong-Woo] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System; National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Suh, Young Joo/0000-0002-2078-5832; Yoon, Jung Hyun/0000-0002-2100-3513; Moon, Hee Jung/0000-0002-5643-5885; Han, Kyunghwa/0000-0002-5687-7237; Park, Byeong-Woo/0000-0003-1353-2607	faculty research grant of Yonsei University College of Medicine [6-2010-0116]	faculty research grant of Yonsei University College of Medicine	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2010(6-2010-0116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikuwari E, 2008, CANCER CYTOPATHOL, V114, P89, DOI 10.1002/cncr.23344; Altomare V, 2007, SURG TODAY, V37, P735, DOI 10.1007/s00595-006-3366-7; Bedrosian I, 2003, ANN SURG ONCOL, V10, P1025, DOI 10.1245/ASO.2003.12.017; Bonnema J, 1997, WORLD J SURG, V21, P270, DOI 10.1007/s002689900227; Choi JS, 2012, ULTRASOUND MED BIOL, V38, P1881, DOI 10.1016/j.ultrasmedbio.2012.07.011; Ciatto S, 2007, BREAST CANCER RES TR, V103, P85, DOI 10.1007/s10549-006-9355-0; Davis JT, 2006, ANN SURG ONCOL, V13, P1545, DOI 10.1245/s10434-006-9095-8; de Kanter AY, 1999, BRIT J SURG, V86, P1459, DOI 10.1046/j.1365-2168.1999.01243.x; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Ferrer J, 1999, CANCER-AM CANCER SOC, V86, P1488, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y; Godey F, 2012, BREAST CANCER RES TR, V131, P509, DOI 10.1007/s10549-011-1808-4; Houssami N, 2011, ANN SURG, V254, P243, DOI 10.1097/SLA.0b013e31821f1564; Hughes SJ, 2006, ANN SURG, V243, P389, DOI 10.1097/01.sla.0000201541.68577.6a; Ishitobi M, 2012, CANCER-AM CANCER SOC, V118, P4385, DOI 10.1002/cncr.27377; Kim MJ, 2010, RADIOLOGY, V254, P691, DOI 10.1148/radiol.09091031; Koelliker SL, 2008, RADIOLOGY, V246, P81, DOI 10.1148/radiol.2463061463; Krishnamurthy S, 2002, CANCER, V95, P982, DOI 10.1002/cncr.10786; Kuenen-Boumeester V, 2003, EUR J CANCER, V39, P170, DOI 10.1016/S0959-8049(02)00501-4; Lee JH, 2005, CHEST, V128, P2298, DOI 10.1378/chest.128.4.2298; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mitas M, 2001, INT J CANCER, V93, P162, DOI 10.1002/ijc.1312; Moore A, 2008, BRIT J RADIOL, V81, P630, DOI 10.1259/bjr/21933846; Nakata B, 2004, BRIT J CANCER, V91, P873, DOI 10.1038/sj.bjc.6602074; Nakata B, 2000, CANCER, V89, P1285, DOI 10.1002/1097-0142(20000915)89:6<1285::AID-CNCR13>3.0.CO;2-G; NCCN, 2012, NCCN GUID ONC BREAST; Nissan A, 2006, BRIT J CANCER, V94, P681, DOI 10.1038/sj.bjc.6602992; Papa MZ, 2008, J SURG ONCOL, V98, P403, DOI 10.1002/jso.21128; Park SH, 2010, ANN SURG ONCOL; Rodriguez CA, 2002, CANCER, V95, P670, DOI 10.1002/cncr.10692; Schem C, 2009, VIRCHOWS ARCH, V454, P203, DOI 10.1007/s00428-008-0703-9; Snook KL, 2011, BRIT J SURG, V98, P527, DOI 10.1002/bjs.7347; Suh YJ, 2011, AM J ROENTGENOL, V197, pW730, DOI 10.2214/AJR.11.6713; Tamaki Y, 2012, CANCER-AM CANCER SOC, V118, P3477, DOI 10.1002/cncr.26683; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Vegue LB, 2012, DIAGN MOL PATHOL; Vilardell F, 2012, VIRCHOWS ARCH, V460, P569, DOI 10.1007/s00428-012-1241-z; Yoshihara E, 2012, BREAST; Zhang L, 2012, SURG ONCOL, V21, P252, DOI 10.1016/j.suronc.2012.06.006	38	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57248	10.1371/journal.pone.0057248	http://dx.doi.org/10.1371/journal.pone.0057248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451192	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500080
J	Oishi, K; Miyamoto, Y; Saito, H; Murase, K; Ono, K; Sawada, M; Watanabe, M; Noguchi, Y; Fujiwara, T; Hayashi, S; Noguchi, H				Oishi, Koichi; Miyamoto, Yoshitaka; Saito, Hiroaki; Murase, Katsutoshi; Ono, Kenji; Sawada, Makoto; Watanabe, Masami; Noguchi, Yasufumi; Fujiwara, Toshiyoshi; Hayashi, Shuji; Noguchi, Hirofumi			In Vivo Imaging of Transplanted Islets Labeled with a Novel Cationic Nanoparticle	PLOS ONE			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; MAGNETIC NANOPARTICLES; PANCREATIC-ISLETS; PROTEIN TRANSDUCTION; CELLS; LANGERHANS; REJECTION; TRACKING; DELIVERY; MOUSE	To monitor pancreatic islet transplantation efficiency, reliable noninvasive imaging methods, such as magnetic resonance imaging (MRI) are needed. Although an efficient uptake of MRI contrast agent is required for islet cell labeling, commercially-available magnetic nanoparticles are not efficiently transduced into cells. We herein report the in vivo detection of transplanted islets labeled with a novel cationic nanoparticle that allowed for noninvasive monitoring of islet grafts in diabetic mice in real time. The positively-charged nanoparticles were transduced into a beta-cell line, MIN6 cells, and into isolated islets for 1 hr. MRI showed a marked decrease in the signal intensity on T1- and T2-weighted images at the implantation site of the labeled MIN 6 cells or islets in the left kidneys of mice. These data suggest that the novel positively-charged nanoparticle could be useful to detect and monitor islet engraftment, which would greatly aid in the clinical management of islet transplant patients.	[Oishi, Koichi; Miyamoto, Yoshitaka; Hayashi, Shuji; Noguchi, Hirofumi] Nagoya Univ, Grad Sch Med, Dept Adv Med Biotechnol & Robot, Nagoya, Aichi 4648601, Japan; [Saito, Hiroaki; Murase, Katsutoshi] MEITO Sangyo Co Ltd, Nagoya Res Lab, Nagoya, Aichi, Japan; [Ono, Kenji; Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Div Stress Adaptat & Protect, Dept Brain Funct, Nagoya, Aichi 464, Japan; [Watanabe, Masami] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Ctr Gene & Cell Therapy, Okayama 7008530, Japan; [Noguchi, Yasufumi] Hiroshima Int Univ, Dept Socioenvironm Design, Kure, Hiroshima, Japan; [Fujiwara, Toshiyoshi; Noguchi, Hirofumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008530, Japan	Nagoya University; Nagoya University; Okayama University; Okayama University	Noguchi, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Adv Med Biotechnol & Robot, Nagoya, Aichi 4648601, Japan.	noguch-h@cc.okayama-u.ac.jp	Ono, Kenji/I-6163-2014; Miyamoto, Yoshitaka/X-6637-2018	Ono, Kenji/0000-0002-5402-6535; Miyamoto, Yoshitaka/0000-0001-6697-7453; Noguchi, Hirofumi/0000-0002-0880-6805	Ministry of Education, Science and Culture; Ministry of Health, Labour and Welfare	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by the Ministry of Education, Science and Culture, the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581; Bennet W, 2001, TRANSPLANTATION, V72, P312, DOI 10.1097/00007890-200107270-00026; Bennet W, 2000, TRANSPLANTATION, V69, P711; Eriksson O, 2009, AM J TRANSPLANT, V9, P2816, DOI 10.1111/j.1600-6143.2009.02844.x; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Evgenov NV, 2006, NAT MED, V12, P144, DOI 10.1038/nm1316; Jiao Y, 2008, TRANSPL P, V40, P3615, DOI 10.1016/j.transproceed.2008.04.026; Jirak D, 2004, MAGN RESON MED, V52, P1228, DOI 10.1002/mrm.20282; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Juang JH, 2010, TRANSPL P, V42, P2104, DOI 10.1016/j.transproceed.2010.05.103; Kim DH, 2009, J BIOMED MATER RES A, V88A, P1, DOI 10.1002/jbm.a.31775; Kriz J, 2005, TRANSPLANTATION, V80, P1596, DOI 10.1097/01.tp.0000183959.73681.b9; Lee KJ, 2012, J NANOSCI NANOTECHNO, V12, P1611, DOI 10.1166/jnn.2012.4632; Lee KJ, 2010, J NANOSCI NANOTECHNO, V10, P6962, DOI 10.1166/jnn.2010.2985; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Medarova Z, 2009, NAT REV ENDOCRINOL, V5, P444, DOI 10.1038/nrendo.2009.130; Moody JB, 2004, J MAGN RESON, V167, P36, DOI 10.1016/j.jmr.2003.11.004; Noguchi H, 2006, AM J TRANSPLANT, V6, P2476, DOI 10.1111/j.1600-6143.2006.01499.x; Noguchi H, 2005, DIABETES, V54, P2859, DOI 10.2337/diabetes.54.10.2859; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Oishi K, 2012, CELL MED, V3, P43, DOI 10.3727/215517912X639397; Oishi K, 2010, CELL TRANSPLANT, V19, P887, DOI 10.3727/096368910X509013; RICORDI C, 1990, ACTA DIABETOL LAT, V27, P185, DOI 10.1007/BF02581331; Robertson RP, 2000, DIABETES CARE, V23, P112, DOI 10.2337/diacare.23.1.112; Saudek F, 2010, TRANSPLANTATION, V90, P1602, DOI 10.1097/TP.0b013e3181ffba5e; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Tai JH, 2006, DIABETES, V55, P2931, DOI 10.2337/db06-0393; Zhang SZ, 2009, PANCREAS, V38, P293, DOI 10.1097/MPA.0b013e318190d77a	31	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57046	10.1371/journal.pone.0057046	http://dx.doi.org/10.1371/journal.pone.0057046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451139	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800065
J	Wang, Y; Chen, L; Huang, GC; He, DM; He, J; Xu, W; Zou, CY; Zong, F; Li, Y; Chen, B; Wu, SS; Zhao, WH; Wu, JQ				Wang, Yan; Chen, Lei; Huang, Guochang; He, Dongmei; He, Juan; Xu, Wei; Zou, Chunying; Zong, Feng; Li, Yan; Chen, Bo; Wu, Shuanshuan; Zhao, Weihong; Wu, Jianqing			Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway	PLOS ONE			English	Article							HUMAN OVARIAN-CANCER; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; AKT; RESISTANCE; APOPTOSIS; SURVIVAL; PROTEIN; GENE; EXPRESSION	Klotho was first identified in 1997 and has been considered as an anti-aging gene. Emerging evidence demonstrates that klotho has a close relationship with cancers, including lung cancer, breast cancer, etc, by inhibiting the proliferation and promoting apoptosis of cancer cells. Cisplatin has been the most widely used drug in the first-line chemotherapy. However, the increase in cisplatin-resistant cancer cells has become a major obstacle in clinical management of cancers. In our study, we for the first time demonstrated that klotho could attenuate the resistance of lung cancer to cisplatin based chemotherapy and the apoptosis of the resistant cells with klotho overexpression was markedly increased. However, klotho knockdown cells showed enhanced resistance to chemotherapy. Further analysis showed that inhibition of PI3K/Akt pathway with specific inhibitor (LY294002) attenuated the promotive effects on cancer growth following interfering with klotho shRNA. Moreover, we demonstrated that klotho modulated the resistance to cisplatin in a xenograft nude mice model. These observations suggested that klotho could improve the resistance of lung cancer cells to chemotherapy and may serve as a potential target for the gene therapy of lung cancers resistant to cisplatin based chemotherapy.	[Wang, Yan; Chen, Lei; He, Juan; Xu, Wei; Zou, Chunying; Zong, Feng; Li, Yan; Chen, Bo; Wu, Shuanshuan; Zhao, Weihong; Wu, Jianqing] Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Huang, Guochang] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [He, Dongmei] Nanjing Univ, Nanjing Stomatol Hosp, Dept Orthodont, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Memorial Sloan Kettering Cancer Center; Nanjing University	Wu, JQ (corresponding author), Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	jwuny@njmu.edu.cn			National Natural Science Foundation of China [30971320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 30971320). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz L, 2011, CLIN CANCER RES, V17, P4254, DOI 10.1158/1078-0432.CCR-10-2749; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Eastman A, 1991, Cancer Treat Res, V57, P233; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Galluzzi L., 2011, ONCOGENE; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Hayakawa J, 2000, CANCER RES, V60, P5988; He XH, 2004, CELL RES, V14, P487, DOI 10.1038/sj.cr.7290252; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hennenlotter J, 2011, ANTICANCER RES, V31, P3783; Iorio MV, 2009, CANCER RES, V69, P2195, DOI 10.1158/0008-5472.CAN-08-2920; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Milane L, 2011, J CONTROL RELEASE, V155, P237, DOI 10.1016/j.jconrel.2011.03.032; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; Pan J, 2011, TUMOR BIOL, V32, P729, DOI 10.1007/s13277-011-0174-5; Poh TW, 2005, CANCER RES, V65, P6264, DOI 10.1158/0008-5472.CAN-05-0152; Reed E, 2005, CLIN CANCER RES, V11, P6100, DOI 10.1158/1078-0432.CCR-05-1083; Rubinek T, 2011, BREAST CANC RES TREA; Shibata T, 2009, CANCER LETT, V283, P203, DOI 10.1016/j.canlet.2009.03.038; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Yuan Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020586; Zhao ZW, 2012, BIOCHEM J, V444, P291, DOI 10.1042/BJ20111855	39	46	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57391	10.1371/journal.pone.0057391	http://dx.doi.org/10.1371/journal.pone.0057391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437382	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000100
J	Mizokami, A; Yasutake, Y; Gao, J; Matsuda, M; Takahashi, I; Takeuchi, H; Hirata, M				Mizokami, Akiko; Yasutake, Yu; Gao, Jing; Matsuda, Miho; Takahashi, Ichiro; Takeuchi, Hiroshi; Hirata, Masato			Osteocalcin Induces Release of Glucagon-Like Peptide-1 and Thereby Stimulates Insulin Secretion in Mice	PLOS ONE			English	Article							COLLAGEN-SYNTHESIS; BETA-CELL; METABOLISM; EXENDIN-4; RECEPTOR; CYCLINS; BIOLOGY; SYSTEM	The uncarboxylated form (ucOC), but not the gamma-carboxylated form (GlaOC), of the bone-derived protein osteocalcin stimulates insulin secretion and regulates energy metabolism in insulin target tissues. Glucagon-like peptide-1 (GLP-1) is an insulin secretagogue that is released from the gut in response to food intake. We have now found that Gprc6a, a putative ucOC receptor, is expressed in epithelial cells of the mouse small intestine as well as in STC-1 enteroendocrine cells. Secretion of GLP-1 by STC-1 cells was stimulated by ucOC but not by GlaOC. The serum GLP-1 concentration in mice was increased by intraperitoneal or oral administration of ucOC, whereas GlaOC was effective in this regard only after oral application. Serum insulin levels were also increased by ucOC, and this effect was potentiated by an inhibitor of dipeptidyl peptidase IV and blocked by a GLP-1 receptor antagonist. Intravenous injection of ucOC in mice increased the serum GLP-1 concentration, and also increased the serum level of insulin. Our results suggest that ucOC acts via Gprc6a to induce GLP-1 release from the gut, and that the stimulatory effect of ucOC on insulin secretion is largely mediated by GLP-1.	[Mizokami, Akiko; Yasutake, Yu; Gao, Jing; Matsuda, Miho; Takeuchi, Hiroshi; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan; [Yasutake, Yu; Takahashi, Ichiro] Kyushu Univ, Fac Dent Sci, Div Orthodont, Fukuoka 812, Japan; [Takeuchi, Hiroshi] Kyushu Dent Coll, Div Appl Pharmacol, Kitakyushu, Fukuoka 803, Japan	Kyushu University; Kyushu University; Kyushu Dental University	Hirata, M (corresponding author), Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan.	hirata1@dent.kyushu-u.ac.jp	Mizokami, Akiko/ABC-5448-2021; Takeuchi, Hiroshi/I-8849-2019; Mizokami, Akiko/AAY-2193-2020	Takeuchi, Hiroshi/0000-0003-0033-2913; Mizokami, Akiko/0000-0002-7490-5190	KAKENHI from Japan Society for Promotion of Science [24229009, 23792127, 24592805, 24592804]	KAKENHI from Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI from Japan Society for Promotion of Science to MH (24229009), JG (23792127), HT (24592805) and MM (24592804). AM is a Research Fellow (RPD program) of Japan Society for the Promotion of Science. The Uehara Memorial Foundation (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; ENG J, 1992, J BIOL CHEM, V267, P7402; ENGELKE JA, 1991, BIOCHIM BIOPHYS ACTA, V1078, P31, DOI 10.1016/0167-4838(91)90088-H; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; GOKE R, 1993, J BIOL CHEM, V268, P19650; Green BD, 2005, J ENDOCRINOL, V185, P307, DOI 10.1677/joe.1.05876; Hauschka PV, 1989, PHYSIOL REV, V130, P287; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Humphrey MJ, 1986, DELIVERY SYSTEMS PEP; ITUARTE EA, 1989, CALCIFIED TISSUE INT, V45, P27, DOI 10.1007/BF02556657; Karsenty G, 2012, ANNU REV PHYSIOL, V74, P87, DOI 10.1146/annurev-physiol-020911-153233; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; KREAM BE, 1985, ENDOCRINOLOGY, V116, P296, DOI 10.1210/endo-116-1-296; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lim GE, 2006, DIABETES, V55, pS70, DOI 10.2337/db06-S020; Oury F, 2011, CELL, V144, P796, DOI 10.1016/j.cell.2011.02.004; Pi M, 2011, J BONE MINER RES, V26, P1680, DOI 10.1002/jbmr.390; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; ROSEN DM, 1983, ENDOCRINOLOGY, V112, P992, DOI 10.1210/endo-112-3-992; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Yang RY, 2006, CELL CYCLE, V5, P180, DOI 10.4161/cc.5.2.2306	30	105	114	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57375	10.1371/journal.pone.0057375	http://dx.doi.org/10.1371/journal.pone.0057375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437377	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200249
J	Todorova, N; Yeung, L; Hung, A; Yarovsky, I				Todorova, Nevena; Yeung, Levi; Hung, Andrew; Yarovsky, Irene			"Janus" Cyclic Peptides: A New Approach to Amyloid Fibril Inhibition?	PLOS ONE			English	Article							APOLIPOPROTEIN-C-II; SIMULATIONS; LIPIDS	Cyclic peptides are increasingly being shown as powerful inhibitors of fibril formation, and have the potential to be therapeutic agents for combating many debilitating amyloid-related diseases. One such example is a cyclic peptide derivative from the human apolipoprotein C-II, which has the ability to inhibit fibril formation by the fibrillogenic peptide apoC-II(60-70). Using classical molecular dynamics and electronic structure calculations, we were able to provide insight into the interaction between the amyloidogenic peptide apoC-II(60-70) and its cyclic derivative, cyc(60-70). Our results showed that cyc(60-70) induced increased flexibility in apoC-II(60-70), suggesting that one mechanism by which cyc(60-70) inhibits fibrillisation is by destabilising apoC-II(60-70) structure, rendering it incapable of adopting fibril favouring conformations. In contrast, cyc(60-70) shows less flexibility upon binding to apoC-II(60-70), which is predominantly mediated by hydrophobic interactions between the aromatic rings of the peptides. This effectively creates a cap around the fibril-forming region of apoC-II(60-70) and generates an outer hydrophilic shell that discourages further apoC-II(60-70) peptide self-association. We showed that apoC-II(60-70) exhibited stronger binding affinity for the hydrophobic face of cyc(60-70) and weakest binding affinity for the hydrophilic side. This suggests that cyc(60-70) can be an effective fibril inhibitor due to its amphipathic character, like that of the "Janus"-type particles. This property can be exploited in the design of specific inhibitors of amyloid fibril formation.	[Todorova, Nevena; Yarovsky, Irene] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia; [Yeung, Levi; Hung, Andrew] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Todorova, Nevena; Hung, Andrew; Yarovsky, Irene] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Yarovsky, I (corresponding author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia.	irene.yarovsky@rmit.edu.au	Todorova, Nevena/L-5190-2016	Todorova, Nevena/0000-0001-6358-2974; Yarovsky, Irene/0000-0002-4033-5150; Hung, Andrew/0000-0003-3569-2951	Australian Research Council under the Discovery Project Scheme [DP0984565]	Australian Research Council under the Discovery Project Scheme(Australian Research Council)	The authors acknowledge financial support from the Australian Research Council under the Discovery Project Scheme (DP0984565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen HJC, 1991, TRANSPORT PROPERTIES; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cole DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002096; Elstner M, 2001, J CHEM PHYS, V114, P5149, DOI 10.1063/1.1329889; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gazit E, 2005, FEBS J, V272, P5971, DOI 10.1111/j.1742-4658.2005.05022.x; Griffin MDW, 2012, J MOL BIOL, V416, P642, DOI 10.1016/j.jmb.2011.12.059; Hatters DM, 2003, BIOPHYS J, V85, P3979, DOI 10.1016/S0006-3495(03)74812-7; Hill Q, 2009, P ROY SOC A-MATH PHY, V465, P669, DOI 10.1098/rspa.2008.0398; Hine NDM, 2009, COMPUT PHYS COMMUN, V180, P1041, DOI 10.1016/j.cpc.2008.12.023; Hung A, 2008, EUR BIOPHYS J BIOPHY, V38, P99, DOI 10.1007/s00249-008-0363-3; Hung A, 2011, J MOL GRAPH MODEL, V29, P597, DOI 10.1016/j.jmgm.2010.11.001; Hung A, 2009, J PHYS CHEM B, V113, P9447, DOI 10.1021/jp901051n; Kapurniotu A, 2003, CHEM BIOL, V10, P149, DOI 10.1016/S1074-5521(03)00022-X; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Perdew JP, 1996, PHYS REV B, V54, P16533, DOI 10.1103/PhysRevB.54.16533; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Skylaris CK, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839852; Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504; Teoh CL, 2011, J MOL BIOL, V405, P1246, DOI 10.1016/j.jmb.2010.12.006; Todorova N, 2010, PHYS CHEM CHEM PHYS, V12, P14762, DOI 10.1039/c0cp00299b; Todorova N, 2010, J PHYS CHEM B, V114, P7974, DOI 10.1021/jp102142x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h	29	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57437	10.1371/journal.pone.0057437	http://dx.doi.org/10.1371/journal.pone.0057437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437387	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200255
J	De Giorgi, V; Buonaguro, L; Worschech, A; Tornesello, ML; Izzo, F; Marincola, FM; Wang, E; Buonaguro, FM				De Giorgi, Valeria; Buonaguro, Luigi; Worschech, Andrea; Tornesello, Maria Lina; Izzo, Francesco; Marincola, Francesco M.; Wang, Ena; Buonaguro, Franco M.			Molecular Signatures Associated with HCV-Induced Hepatocellular Carcinoma and Liver Metastasis	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENE-EXPRESSION; CLASS-I; MOTILE PHENOTYPE; UNITED-STATES; UP-REGULATION; TARGET; IDENTIFICATION; PATHOGENESIS; CANCER	Hepatocellular carcinomas (HCCs) are a heterogeneous group of tumors that differ in risk factors and genetic alterations. In Italy, particularly Southern Italy, chronic hepatitis C virus (HCV) infection represents the main cause of HCC. Using high-density oligoarrays, we identified consistent differences in gene-expression between HCC and normal liver tissue. Expression patterns in HCC were also readily distinguishable from those associated with liver metastases. To characterize molecular events relevant to hepatocarcinogenesis and identify biomarkers for early HCC detection, gene expression profiling of 71 liver biopsies from HCV-related primary HCC and corresponding HCV-positive non-HCC hepatic tissue, as well as gastrointestinal liver metastases paired with the apparently normal peri-tumoral liver tissue, were compared to 6 liver biopsies from healthy individuals. Characteristic gene signatures were identified when normal tissue was compared with HCV-related primary HCC, corresponding HCV-positive non-HCC as well as gastrointestinal liver metastases. Pathway analysis classified the cellular and biological functions of the genes differentially expressed as related to regulation of gene expression and post-translational modification in HCV-related primary HCC; cellular Growth and Proliferation, and Cell-To-Cell Signaling and Interaction in HCV-related non HCC samples; Cellular Growth and Proliferation and Cell Cycle in metastasis. Also characteristic gene signatures were identified of HCV-HCC progression for early HCC diagnosis. Conclusions: A diagnostic molecular signature complementing conventional pathologic assessment was identified.	[Buonaguro, Luigi; Tornesello, Maria Lina; Buonaguro, Franco M.] Ist Naz Tumori Fond G Pascale, Mol Biol & Viral Oncogenesis & AIDS Refer Ctr, Naples, Italy; [De Giorgi, Valeria; Marincola, Francesco M.; Wang, Ena] NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [De Giorgi, Valeria; Marincola, Francesco M.; Wang, Ena] NIH, Trans NIH Ctr Human Immunol CHI, Bethesda, MD 20892 USA; [Worschech, Andrea] Univ Wurzburg, Dept Biochem, Bioctr, D-97070 Wurzburg, Germany; [Izzo, Francesco] Ist Naz Tumori Fond G Pascale, Hepatobiliary Surg Dept, Naples, Italy	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Wurzburg	De Giorgi, V (corresponding author), NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	degiorgiv@mail.nih.gov; irccsvir@unina.it	Izzo, Francesco/P-3042-2019; Buonaguro, Franco M./T-6028-2019; Buonaguro, Luigi/AAV-5655-2020; De Giorgi, Valeria/D-4582-2017; Tornesello, Maria Lina/A-1964-2008; Guennoun, Andrea/AAF-5281-2020	Izzo, Francesco/0000-0003-3093-5408; Buonaguro, Franco M./0000-0002-7491-7220; Tornesello, Maria Lina/0000-0002-3523-3264; Guennoun, Andrea/0000-0002-4303-8653; Buonaguro, Luigi/0000-0002-6380-7114	Italian Ministry of Health - Ministero Italiano Salute [ACC4/2007-2012, RO 4/2007]	Italian Ministry of Health - Ministero Italiano Salute(Ministry of Health, Italy)	Italian Ministry of Health - Ministero Italiano Salute (Ricerca Corrente 2010-11; Programma Ricerca Oncologica Grant no ACC4/2007-2012; Programma Integrato Oncologia Grant no RO 4/2007 (2009-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sukhun S, 2003, CANCER, V97, P2064, DOI 10.1002/cncr.11289; Blight KJ, 1998, ANTIVIR THER, V3, P71; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Brunt EM, 2004, HUM PATHOL, V35, P1070, DOI 10.1016/j.humpath.2004.04.017; Buendia MA, 1998, BIOMED PHARMACOTHER, V52, P34, DOI 10.1016/S0753-3322(97)86239-7; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167; Davila JA, 2003, J CLIN EPIDEMIOL, V56, P487, DOI 10.1016/S0895-4356(02)00605-4; De Giorgi V, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-85; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Falk CS, 2002, J IMMUNOL, V169, P3257, DOI 10.4049/jimmunol.169.6.3257; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Groen K A, 1999, Semin Oncol Nurs, V15, P48, DOI 10.1016/S0749-2081(99)80039-4; Herzer K, 2003, J VIROL, V77, P8299, DOI 10.1128/JVI.77.15.8299-8309.2003; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; Kim JW, 2003, CARCINOGENESIS, V24, P363, DOI 10.1093/carcin/24.3.363; Koike K, 2002, J GASTROEN HEPATOL, V17, P394, DOI 10.1046/j.1440-1746.2002.02763.x; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Midorikawa Y, 2003, INT J CANCER, V103, P455, DOI 10.1002/ijc.10856; Midorikawa Y, 2010, HEPATOL RES, V40, P49, DOI 10.1111/j.1872-034X.2009.00583.x; Momburg F, 2001, J VIROL, V75, P5663, DOI 10.1128/JVI.75.12.5663-5671.2001; MULLBACHER A, 1995, IMMUNITY, V3, P207, DOI 10.1016/1074-7613(95)90090-X; Ohata K, 2007, BIOORG MED CHEM LETT, V17, P4070, DOI 10.1016/j.bmcl.2007.04.067; Okabe H, 2004, INT J ONCOL, V24, P43; Okabe H, 2003, CANCER RES, V63, P3043; Pang EYT, 2007, HEPATOLOGY, V46, P436, DOI 10.1002/hep.21691; Romeo R, 2002, TOXICOLOGY, V181, P39, DOI 10.1016/S0300-483X(02)00252-4; Rosenberg W, 1999, GUT, V44, P759, DOI 10.1136/gut.44.5.759; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sakamoto M, 2008, INTERVIROLOGY, V51, P42, DOI 10.1159/000122603; Schafer DF, 1999, LANCET, V353, P1253, DOI 10.1016/S0140-6736(98)09148-X; Silva FP, 2005, NEOPLASIA, V7, P348, DOI 10.1593/neo.04544; Sy SMH, 2006, MODERN PATHOL, V19, P1108, DOI 10.1038/modpathol.3800626; Theise Neil D, 2002, Clin Liver Dis, V6, P497, DOI 10.1016/S1089-3261(02)00006-5; Theodorescu D, 2003, HISTOL HISTOPATHOL, V18, P259, DOI 10.14670/HH-18.259; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Yagyu R, 2002, INT J ONCOL, V20, P1173; Yamane B, 2009, SURG CLIN N AM, V89, P97, DOI 10.1016/j.suc.2008.10.004; Zender L, 2008, ONKOLOGIE, V31, P550, DOI 10.1159/000151586	44	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56153	10.1371/journal.pone.0056153	http://dx.doi.org/10.1371/journal.pone.0056153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441164	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200021
J	Ertl, NG; Elizur, A; Brooks, P; Kuballa, AV; Anderson, TA; Knibb, WR				Ertl, Nicole G.; Elizur, Abigail; Brooks, Peter; Kuballa, Anna V.; Anderson, Trevor A.; Knibb, Wayne R.			Molecular Characterisation of Colour Formation in the Prawn Fenneropenaeus merguiensis	PLOS ONE			English	Article							ARGININE KINASE; STRUCTURAL CHEMISTRY; PIGMENT MOVEMENTS; BETA-CRUSTACYANIN; BINDING-PROTEIN; GENE-EXPRESSION; MOLT CYCLE; BLUE-CRAB; LIPOCALIN; LOBSTER	Introduction: Body colouration in animals can have a range of functions, with predator protection an important aspect of colour in crustaceans. Colour determination is associated with the carotenoid astaxanthin, which is taken up through the diet and stabilised in the tissues by the protein crustacyanin. As a variety of genes are found to play a role in colour formation in other systems, a holistic approach was employed in this study to determine the factors involved in Fenneropenaeus merguiensis colouration. Results: Full length F. merguiensis crustacyanin subunit A and C sequences were isolated. Crustacyanin subunit A and C were found in the F. merguiensis transcriptomes of the muscle/cuticle tissue, hepatopancreas, eye stalk and nervous system, using 454 next generation sequencing technology. Custom microarray analysis of albino, light and dark F. merguiensis cuticle tissue showed genes encoding actin, sarcoplasmic calcium-binding protein and arginine kinase to be 4-fold or greater differentially expressed (p<0.05) and down-regulated in albinos when compared to light and dark samples. QPCR expression analysis of crustacyanin and total astaxanthin pigment extraction revealed significantly (p<0.05) lower crustacyanin subunit A and C gene transcript copy numbers and total astaxanthin levels in albinos than in the light and dark samples. Additionally, crustacyanin subunit A and C expression levels correlated positively with each other. Conclusions: This study identified gene products putatively involved in crustacean colouration, such as crustacyanin, sarcoplasmic calcium-binding protein and forms of actin, and investigated differences in gene expression and astaxanthin levels between albino, light and dark coloured prawns. These genes open a path to enhance our understanding of the biology and regulation of colour formation.	[Ertl, Nicole G.; Elizur, Abigail; Brooks, Peter; Kuballa, Anna V.; Anderson, Trevor A.; Knibb, Wayne R.] Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia	University of the Sunshine Coast	Elizur, A (corresponding author), Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia.	AElizur@usc.edu.au		Brooks, Peter/0000-0003-4915-4986; Elizur, Abigail/0000-0002-2960-302X; ERTL, Nicole/0000-0002-0442-3882; Knibb, Wayne/0000-0003-2593-0303	Fisheries Research & Development Corporation (FRDC); Australian Seafood Cooperative Research Centre (CRC) [2009/724, 2009/776]; University of the Sunshine Coast, Australia; Australian Seafood CRC scholarship; University of the Sunshine Coast	Fisheries Research & Development Corporation (FRDC)(Fisheries R&D Corp); Australian Seafood Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast, Australia; Australian Seafood CRC scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast	The project was funded by the Fisheries Research & Development Corporation (FRDC - http://frdc.com.au/) and the Australian Seafood Cooperative Research Centre (CRC - http://www.seafoodcrc.com/) (2009/724 to WRK, 2009/776 to WRK and NGE), and the University of the Sunshine Coast, Australia. NGE was supported by an Australian Seafood CRC scholarship and a scholarship from the University of the Sunshine Coast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 2000, P 10 BIENN C INT I F; BECKERLE MC, 1983, J CELL BIOL, V96, P354, DOI 10.1083/jcb.96.2.354; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuckmann CT, 1996, J NEUROSCI, V16, P6119; BILLINGHAM RE, 1960, Q REV BIOL, V35, P1, DOI 10.1086/402951; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; BURNSIDE B, 1983, INVEST OPHTH VIS SCI, V24, P1; Canonaco F, 2003, BIOTECHNOL LETT, V25, P1013, DOI 10.1023/A:1024172518062; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Caro T, 2009, PHILOS T R SOC B, V364, P537, DOI 10.1098/rstb.2008.0221; Carvalho LN, 2006, NEOTROP ICHTHYOL, V4, P219, DOI 10.1590/S1679-62252006000200008; Charron JBF, 2002, FEBS LETT, V517, P129, DOI 10.1016/S0014-5793(02)02606-6; Chayen NE, 2003, ACTA CRYSTALLOGR D, V59, P2072, DOI 10.1107/S0907444903025952; Chung ACK, 1998, GEN COMP ENDOCR, V109, P375, DOI 10.1006/gcen.1997.7046; Cianci M, 2002, P NATL ACAD SCI USA, V99, P9795, DOI 10.1073/pnas.152088999; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Ejiri S, 2002, BIOSCI BIOTECH BIOCH, V66, P1, DOI 10.1271/bbb.66.1; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; FINGERMAN M, 1975, BIOL BULL, V149, P165, DOI 10.2307/1540487; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Flower DR, 1996, BIOCHEM J, V318, P1; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Garcia-Orozco KD, 2007, INT ARCH ALLERGY IMM, V144, P23, DOI 10.1159/000102610; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Healy M, 2003, ACTA BIOTECHNOL, V23, P151, DOI 10.1002/abio.200390023; Helliwell JR, 2010, CRYSTALLOGR REV, V16, P231, DOI 10.1080/08893111003747084; Holt SM, 2002, J EXP BIOL, V205, P1775; Ilagan RP, 2005, J PHYS CHEM A, V109, P3120, DOI 10.1021/jp0444161; Jiang H, 2009, PROTEOMICS, V9, P3353, DOI 10.1002/pmic.200800518; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; KEEN JN, 1991, EUR J BIOCHEM, V202, P31, DOI 10.1111/j.1432-1033.1991.tb16340.x; Kinsey ST, 2003, COMP BIOCHEM PHYS B, V135, P521, DOI 10.1016/S1096-4959(03)00121-0; KOTZ KJ, 1994, J CELL BIOL, V124, P463, DOI 10.1083/jcb.124.4.463; Kuballa AV, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-45; Kuballa AV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-575; Latscha T., 1989, ADV TROPICAL AQUACUL, V9, P319; LITTLE CC, 1958, Q REV BIOL, V33, P103, DOI 10.1086/402319; Liu YS, 2003, PLANT BIOTECHNOL J, V1, P195, DOI 10.1046/j.1467-7652.2003.00018.x; Lopez M, 2004, TALANTA, V64, P726, DOI 10.1016/j.talanta.2004.03.048; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mantiri DMH, 2004, J CRUSTACEAN BIOL, V24, P592, DOI 10.1651/C-2488; Matsukawa T, 2004, J NEUROSCI, V24, P8346, DOI 10.1523/JNEUROSCI.1809-04.2004; McArdle K, 1998, J CELL BIOL, V143, P1201, DOI 10.1083/jcb.143.5.1201; McNamara JC, 1999, J EXP ZOOL, V283, P19, DOI 10.1002/(SICI)1097-010X(19990101)283:1<19::AID-JEZ4>3.3.CO;2-Z; Mykles DL, 2000, J EXP ZOOL, V286, P329, DOI 10.1002/(SICI)1097-010X(20000301)286:4<329::AID-JEZ1>3.0.CO;2-M; Pan CH, 2010, AQUAC RES, V41, P973, DOI 10.1111/j.1365-2109.2009.02380.x; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Ponce-Palafox J.T., 2006, REV MEXICANA INGENIE, V5, P157; Qiu LH, 2008, MOL BIOL REP, V35, P431, DOI 10.1007/s11033-007-9103-5; Sachindra NM, 2005, J SCI FOOD AGR, V85, P167, DOI 10.1002/jsfa.1977; Salier JP, 2000, BBA-PROTEIN STRUCT M, V1482, P25, DOI 10.1016/S0167-4838(00)00144-8; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sanchez D, 2000, INT J DEV BIOL, V44, P349; Shih Jin-Taur, 1997, Biological Bulletin National Taiwan Normal University, V32, P53; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Tanaka M, 2007, BRAIN RES, V1153, P34, DOI 10.1016/j.brainres.2007.03.075; Tlusty MF, 2009, NEW ZEAL J MAR FRESH, V43, P247, DOI 10.1080/00288330909509998; Tuma MC, 1999, PIGM CELL RES, V12, P283, DOI 10.1111/j.1600-0749.1999.tb00762.x; Tume RK, 2009, AQUACULTURE, V296, P129, DOI 10.1016/j.aquaculture.2009.08.006; Untalan PM, 2005, INSECT BIOCHEM MOLEC, V35, P141, DOI 10.1016/j.ibmb.2004.10.009; Urade Y, 2000, BBA-PROTEIN STRUCT M, V1482, P259, DOI 10.1016/S0167-4838(00)00161-8; Wade N, 2005, COMP BIOCHEM PHYS B, V141, P307, DOI 10.1016/j.cbpc.2005.04.004; Wade NM, 2008, J EXP BIOL, V211, P1512, DOI 10.1242/jeb.012930; Wade NM, 2012, J EXP BIOL, V215, P343, DOI 10.1242/jeb.064592; Wade NM, 2009, MOL BIOL EVOL, V26, P1851, DOI 10.1093/molbev/msp092; Wade NM, 2006, CRUSTACEAN SHELL COL; Wang MR, 2007, COMP BIOCHEM PHYS B, V147, P222, DOI 10.1016/j.cbpb.2007.01.003; Weesie RJ, 1999, BIOSPECTROSCOPY, V5, P358, DOI 10.1002/(SICI)1520-6343(1999)5:6<358::AID-BSPY5>3.0.CO;2-1; Xu JY, 2008, CELL PHYSIOL BIOCHEM, V21, P473, DOI 10.1159/000129640	73	23	23	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56920	10.1371/journal.pone.0056920	http://dx.doi.org/10.1371/journal.pone.0056920			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441225	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200082
J	Hay, T; Fraud, S; Lau, CHF; Gilmour, C; Poole, K				Hay, Thomas; Fraud, Sebastien; Lau, Calvin Ho-Fung; Gilmour, Christie; Poole, Keith			Antibiotic Inducibility of the mexXY Multidrug Efflux Operon of Pseudomonas aeruginosa: Involvement of the MexZ Anti-Repressor ArmZ	PLOS ONE			English	Article							AMINOGLYCOSIDE RESISTANCE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SYSTEM; PUMP; MECHANISMS; PA5471; STRAINS; OPRM	Expression of the mexXY multidrug efflux operon in wild type Pseudomonas aeruginosa is substantially enhanced by the ribosome-targeting antimicrobial spectinomycin (18-fold) and this is wholly dependent upon the product of the PA5471 gene. In a mutant strain lacking the mexZ gene encoding a repressor of mexXY gene expression, expression of the efflux operon increases modestly (5-fold) and is still responsive (18-fold) to spectinomycin. Spectinomycin induction of mexXY expression in the mexZ mutant is, however, independent of PA5471 suggesting that PA5471 functions as an anti-repressor (dubbed ArmZ for anti-repressor MexZ) that serves only to modulate MexZ's repressor activity, with additional gene(s)/gene product(s) providing for the bulk of the antimicrobial-inducible mexXY expression. Consistent with PA5471/ArmZ functioning as a MexZ anti-repressor, an interaction between MexZ and ArmZ was confirmed using a bacterial 2-hybrid assay. Mutations compromising this interaction (P68S, G76S, R216C, R221W, R221Q, G231D and G252S) were identified and localized to one region of an ArmZ structural model that may represent a MexZ-interacting domain. Introduction of representative mutations into the chromosome of P. aeruginosa reduced (P68S, G76S) or obviated (R216C, R2211W) antimicrobial induction of mexXY gene expression, rendering the mutants pan-aminoglycoside-susceptible. These data confirm the importance of an ArmZ-MexZ interaction for antimicrobial-inducible mexXY expression and intrinsic aminoglycoside resistance in P. aeruginosa.	[Hay, Thomas; Fraud, Sebastien; Lau, Calvin Ho-Fung; Gilmour, Christie; Poole, Keith] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Poole, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall, Kingston, ON, Canada.	poolek@queensu.ca		Lau, Calvin (Ho-Fung)/0000-0003-3407-4924	Cystic Fibrosis Canada	Cystic Fibrosis Canada	This work was supported by an operating grant from Cystic Fibrosis Canada (http://www.cysticfibrosis.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; Alguel Y, 2010, J STRUCT BIOL, V172, P305, DOI 10.1016/j.jsb.2010.07.012; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Caughlan RE, 2009, ANTIMICROB AGENTS CH, V53, P5015, DOI 10.1128/AAC.00253-09; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Daigle DM, 2007, J BACTERIOL, V189, P5441, DOI 10.1128/JB.00543-07; Dmitrova M, 1998, MOL GEN GENET, V257, P205; El'Garch F, 2007, ANTIMICROB AGENTS CH, V51, P1016, DOI 10.1128/AAC.00704-06; GarinotSchneider C, 1996, J MOL BIOL, V260, P731, DOI 10.1006/jmbi.1996.0433; Henrichfreise B, 2007, ANTIMICROB AGENTS CH, V51, P4062, DOI 10.1128/AAC.00148-07; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Islam S, 2009, CLIN MICROBIOL INFEC, V15, P60, DOI 10.1111/j.1469-0691.2008.02097.x; Islam S, 2004, CLIN MICROBIOL INFEC, V10, P877, DOI 10.1111/j.1469-0691.2004.00991.x; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jo JTH, 2003, ANTIMICROB AGENTS CH, V47, P1101, DOI 10.1128/AAC.47.3.1101-1111.2003; Lau CHF, 2012, ANTIMICROB AGENTS CH, V56, P5171, DOI 10.1128/AAC.00846-12; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Martinez-Argudo I, 2004, J BACTERIOL, V186, P601, DOI 10.1128/JB.186.3.601-610.2004; Masuda N, 2000, ANTIMICROB AGENTS CH, V44, P2242, DOI 10.1128/AAC.44.9.2242-2246.2000; MASUDA N, 1992, ANTIMICROB AGENTS CH, V36, P1847, DOI 10.1128/AAC.36.9.1847; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Matsuo Y, 2004, FEMS MICROBIOL LETT, V238, P23, DOI 10.1016/j.femsle.2004.07.010; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mine T, 1999, ANTIMICROB AGENTS CH, V43, P415, DOI 10.1128/AAC.43.2.415; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Morita Y, 2009, J BACTERIOL, V191, P4966, DOI 10.1128/JB.00073-09; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Poole K, 2004, PSEUDOMONAS, VOL 1: GENOMICS, LIFE STYLE AND MOLECULAR ARCHITECTURE, P635; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Sambrook J., 2001, MOL CLONING LAB MANU, V3; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sobel ML, 2003, ANTIMICROB AGENTS CH, V47, P3202, DOI 10.1128/AAC.47.10.3202-3207.2003; Sun X, 2011, J BACTERIOL, V193, P2717, DOI 10.1128/JB.00149-11; Vettoretti L, 2009, ANTIMICROB AGENTS CH, V53, P1987, DOI 10.1128/AAC.01024-08; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975; Whitworth DE, 2001, MOL MICROBIOL, V42, P809, DOI 10.1046/j.1365-2958.2001.02679.x; Yamamoto M, 2009, MICROBIOL-SGM, V155, P3312, DOI 10.1099/mic.0.028993-0; [No title captured]	44	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56858	10.1371/journal.pone.0056858	http://dx.doi.org/10.1371/journal.pone.0056858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441219	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200076
J	Zhao, BY; Yuan, C; Li, R; Qu, D; Huang, MD; Ngo, JCK				Zhao, Baoyu; Yuan, Cai; Li, Rui; Qu, Dan; Huang, Mingdong; Ngo, Jacky Chi Ki			Crystal Structures of Matriptase in Complex with Its Inhibitor Hepatocyte Growth Factor Activator Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE MICROARRAY ANALYSIS; SERINE-PROTEASE; CATALYTIC DOMAIN; BREAST-CANCER; EXPRESSION; SURFACE; HAI-1; LOCALIZATION; PURIFICATION; PROGRESSION	Matriptase, a type II trans-membrane serine protease of the S1 trypsin-like family, is expressed on the surface of nearly all normal human epithelium and found in biological fluid-like human milk. Matriptase overexpression has been implicated in tumor progression in certain epithelium-derived cancer cells. Matriptase is tightly regulated by its cognate inhibitor hepatocyte growth factor activator inhibitor-1 (HAI-1). It has been demonstrated that the Kunitz domain I (KD1) but not Kunitz domain II (KD2) of HAI-1 is responsible for the inhibitory activity of HAI-1 against matriptase. To investigate the molecular basis of inhibition of matriptase by HAI-1, we solved several crystal structures of matriptase serine protease domain in complex with the fragments of HAI-1. Based on these structures, we found that the binding of KD1 was different from previously predicted binding mode. The P3 arginine residue occupies the S3 specificity pocket of matriptase, but not the S4 pocket as in the cases of hepatocyte growth factor activator.HAI-1 KD1 and matriptase.sunflower trypsin inhibitor-1 complexes. The long 60-loop of matriptase makes direct contact with HAI-1 but remains flexible even in the complexes, and its apex does not bind with KD1 tightly. The interactions between this unique 60-loop and KD1 may provide an opportunity to increase the specificity and inhibitory activity of KD1 for matriptase. Furthermore, comparison between KD1 and a homology model of HAI-1 KD2 rationalizes the structural basis of why KD1 but not KD2 is responsible for the inhibitory activity of HAI-1 against matriptase.	[Zhao, Baoyu; Yuan, Cai; Li, Rui; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Zhao, Baoyu; Li, Rui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhao, Baoyu; Yuan, Cai; Li, Rui; Qu, Dan; Huang, Mingdong; Ngo, Jacky Chi Ki] Danish Chinese Ctr Proteases & Canc, Shatin, Hong Kong, Peoples R China; [Qu, Dan; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese University of Hong Kong	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.	mhuang@fjirsm.ac.cn; jackyngo@cuhk.edu.hk	Ngo, Jacky C/O-8093-2017; Huang, Mingdong/J-4278-2017	Ngo, Jacky C/0000-0002-6004-7041; Huang, Mingdong/0000-0003-0085-9141; Li, Rui/0000-0001-5343-3027	Natural Science Foundation of China [31161130356, 31170707]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Grants 31161130356 and 31170707.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Cheng MF, 2006, DIS ESOPHAGUS, V19, P482, DOI 10.1111/j.1442-2050.2006.00613.x; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Jin L, 2005, ACTA CRYSTALLOGR D, V61, P1418, DOI [10.1107/S0907444905024340, 10.1107/S090744905024340]; Kang JY, 2003, CANCER RES, V63, P1101; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Lee JW, 2005, HUM PATHOL, V36, P626, DOI 10.1016/j.humpath.2005.03.003; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Santin AD, 2003, CANCER, V98, P1898, DOI 10.1002/cncr.11753; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tanimoto H, 2005, BRIT J CANCER, V92, P278, DOI 10.1038/sj.bjc.6602320; Tsai WC, 2006, HISTOPATHOLOGY, V49, P388, DOI 10.1111/j.1365-2559.2006.02516.x; Tsai WC, 2008, DIS MARKERS, V24, P89, DOI 10.1155/2008/945197; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; vandeLocht A, 1997, EMBO J, V16, P2977, DOI 10.1093/emboj/16.11.2977; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30	43	29	31	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11155	11164		10.1074/jbc.M113.454611	http://dx.doi.org/10.1074/jbc.M113.454611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443661	Green Published, hybrid			2022-12-25	WOS:000317915500020
J	Roffe, M; Hajj, GNM; Azevedo, HF; Alves, VS; Castilho, BA				Roffe, Martin; Hajj, Glaucia N. M.; Azevedo, Hatylas F.; Alves, Viviane S.; Castilho, Beatriz A.			IMPACT Is a Developmentally Regulated Protein in Neurons That Opposes the Eukaryotic Initiation Factor 2 alpha Kinase GCN2 in the modulation of Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA TRANSLATION; AMINO-ACID CONTROL; EIF2-ALPHA KINASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; PHOSPHORYLATION; ACTIVATION; BRAIN; ASSOCIATION	The product of the mouse Imprinted and Ancient gene, IMPACT, is preferentially expressed in neurons. We have previously shown that IMPACT overexpression inhibits the activation of the protein kinase GCN2, which signals amino acid starvation. GCN2 phosphorylates the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2 alpha), resulting in inhibition of general protein synthesis but increased translation of specific messages, such as ATF4. GCN2 is also involved in the regulation of neuronal functions, controlling synaptic plasticity, memory, and feeding behavior. We show here that IMPACT abundance increases during differentiation of neurons and neuron-like N2a cells, whereas GCN2 displays lowered activation levels. Upon differentiation, IMPACT associates with translating ribosomes, enhances translation initiation, and down-regulates the expression of ATF4. We further show that endogenous IMPACT promotes neurite outgrowth whereas GCN2 is a strong inhibitor of spontaneous neuritogenesis. Together, these results uncover the participation of the GCN2-IMPACT module of translational regulation in a highly controlled step in the development of the nervous system.	[Roffe, Martin; Azevedo, Hatylas F.; Alves, Viviane S.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, BR-04023062 Sao Paulo, Brazil; [Hajj, Glaucia N. M.] Hosp AC Camargo Fund Antonio Prudente, Int Res Ctr, Natl Inst Translat Neurosci, BR-01509010 Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); A.C.Camargo Cancer Center	Castilho, BA (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Escola Paulista Med, Rua Botucatu 862, BR-04023062 Sao Paulo, Brazil.	bacastilho@unifesp.br	Castilho, Beatriz A/C-2503-2012; Azevedo, Hatylas FZ/M-5332-2013; Roffe, Martin/S-1124-2019; Roffé, Martín/I-1864-2013; Alves, Viviane S/C-2776-2013; de Souza Alves, Viviane/M-8954-2019; Hajj, Glaucia N M/I-8176-2015	Castilho, Beatriz A/0000-0003-4509-5237; Azevedo, Hatylas FZ/0000-0001-9233-0696; Roffe, Martin/0000-0001-7247-3067; Roffé, Martín/0000-0001-7247-3067; de Souza Alves, Viviane/0000-0002-0625-6619; Hajj, Glaucia N M/0000-0003-2342-7384	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to B. A. C. and G. N. M. H.).; Received research fellowships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico.	Angelastro JM, 2003, J NEUROSCI, V23, P4590; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Bidinosti M, 2010, MOL CELL, V37, P797, DOI 10.1016/j.molcel.2010.02.022; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; Brenk M, 2009, J IMMUNOL, V183, P145, DOI 10.4049/jimmunol.0803277; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Donnelly N, 2013, CELL MOL LI IN PRESS; Greene LA, 2009, J NEUROCHEM, V108, P11, DOI 10.1111/j.1471-4159.2008.05749.x; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Roffe M, 2010, P NATL ACAD SCI USA, V107, P13147, DOI 10.1073/pnas.1000784107; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Waller T, 2012, FEBS J, V279, P1761, DOI 10.1111/j.1742-4658.2012.08553.x; Waters JE, 2008, J CELL SCI, V121, P2892, DOI 10.1242/jcs.030353; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	44	39	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10860	10869		10.1074/jbc.M113.461970	http://dx.doi.org/10.1074/jbc.M113.461970			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447528	hybrid, Green Published			2022-12-25	WOS:000317565000063
J	Ronchi, VP; Klein, JM; Haas, AL				Ronchi, Virginia P.; Klein, Jennifer M.; Haas, Arthur L.			E6AP/UBE3A Ubiquitin Ligase Harbors Two E2 similar to ubiquitin Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CONJUGATING ENZYME; E1-E2 INTERACTIONS; PROTEIN LIGASE; DEGRADATION; E6-AP; DETERMINANTS; MECHANISM; COMPLEX; UBE3A	By exploiting I-125-polyubiquitin chain formation as a functional readout of enzyme activity, we have quantitatively examined the mechanism of human E6AP/UBE3A for the first time. Initial rate studies identify UbcH7 as the cognate E2 carrier protein for E6AP, although related Ubc5 isoforms and the ISG15-specific UbcH8 paralog also support E6AP with reduced efficacy due to impaired binding and catalytic competence. Initial rates of polyubiquitin chain formation displayed hyperbolic kinetics with respect to UbcH7 concentration (K-m = 57.6 +/- 5.7 nM and k(cat) = 0.032 +/- 0.001 s(-1)) and substrate inhibition above 2 mu M. Competitive inhibition by an isosteric UbcH7C86S-ubiquitin oxyester substrate analog (K-i = 64 +/- 18 nM) demonstrates that Km reflects intrinsic substrate affinity. In contrast, noncompetitive inhibition by a UbcH7C86A product analog (K-i = 7 +/- 0.7 mu M) and substrate inhibition at high concentrations require two functionally distinct E2 similar to ubiquitin substrate binding sites. The kinetics of polyubiquitin chain formation reflect binding at a cryptic Site 1 not previously recognized that catalyzes E6AP similar to ubiquitin thioester formation. Subsequent binding of E2 similar to ubiquitin at the canonical Site 2 present in the extant crystal structure is responsible for polyubiquitin chain elongation. Other rate studies show that the conserved -4 Phe(849) residue is required for polyubiquitin chain formation rather than target protein conjugation as originally suggested. The present studies unambiguously preclude earlier models for the mechanism of Hect domain-catalyzed conjugation through the canonical binding site suggested by the crystal structure and define a novel two-step mechanism for formation of the polyubiquitin degradation signal.	[Ronchi, Virginia P.; Klein, Jennifer M.; Haas, Arthur L.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034009 (to A. L. H.).	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Bedard KM, 2008, J VIROL, V82, P3894, DOI 10.1128/JVI.01818-07; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cook EH, 1997, AM J HUM GENET, V60, P928; Durfee LA, 2008, J BIOL CHEM, V283, P23895, DOI 10.1074/jbc.M804069200; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Gao QS, 2001, J VIROL, V75, P4459, DOI 10.1128/JVI.75.9.4459-4466.2001; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Haas AL, 1997, FASEB J, V11, P1257; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HAAS AL, 2006, PROTEIN DEGRADATION, P103; Haas Arthur L., 2005, V301, P23; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hu Y, 2009, CANCER INVEST, V27, P298, DOI 10.1080/07357900802350798; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kumar S, 1997, J BIOL CHEM, V272, P13548, DOI 10.1074/jbc.272.21.13548; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mishra A, 2008, J BIOL CHEM, V283, P7648, DOI 10.1074/jbc.M706620200; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Ng CC, 2003, ONCOGENE, V22, P4449, DOI 10.1038/sj.onc.1206586; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Purbeck C, 2010, BIOCHEMISTRY-US, V49, P1361, DOI 10.1021/bi9014693; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; SULLIVAN ML, 1993, J BIOL CHEM, V268, P8777; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	62	32	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10349	10360		10.1074/jbc.M113.458059	http://dx.doi.org/10.1074/jbc.M113.458059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439649	Green Published, hybrid			2022-12-25	WOS:000317565000016
J	Belalov, IS; Lukashev, AN				Belalov, Ilya S.; Lukashev, Alexander N.			Causes and Implications of Codon Usage Bias in RNA Viruses	PLOS ONE			English	Article							BACKGROUND NUCLEOTIDE COMPOSITION; AMINO-ACID USAGE; TRANSLATIONAL SELECTION; MUTATIONAL BIAS; GENOMES; GENE; EVOLUTION; BACTERIA; TRANSCRIPTION; PREFERENCES	Choice of synonymous codons depends on nucleotide/dinucleotide composition of the genome (termed mutational pressure) and relative abundance of tRNAs in a cell (translational pressure). Mutational pressure is commonly simplified to genomic GC content; however mononucleotide and dinucleotide frequencies in different genomes or mRNAs may vary significantly, especially in RNA viruses. A series of in silico shuffling algorithms were developed to account for these features and analyze the relative impact of mutational pressure components on codon usage bias in RNA viruses. Total GC content was a poor descriptor of viral genome composition and causes of codon usage bias. Genomic nucleotide content was the single most important factor of synonymous codon usage. Moreover, the choice between compatible amino acids (e.g., leucine and isoleucine) was strongly affected by genomic nucleotide composition. Dinucleotide composition at codon positions 2-3 had additional effect on codon usage. Together with mononucleotide composition bias, it could explain almost the entire codon usage bias in RNA viruses. On the other hand, strong dinucleotide content bias at codon position 3-1 found in some viruses had very little effect on codon usage. A hypothetical innate immunity sensor for CpG in RNA could partially explain the codon usage bias, but due to dependence of virus translation upon biased host translation machinery, experimental studies are required to further explore the source of dinucleotide bias in RNA viruses.	[Belalov, Ilya S.; Lukashev, Alexander N.] Russian Acad Med Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia; [Lukashev, Alexander N.] Univ Bonn, Inst Virol, Med Ctr, Bonn, Germany	Chumakov Federal Scientific Center for Research & Development of Immune & Biological Products of Russian Academy of Sciences; Russian Academy of Medical Sciences; University of Bonn	Lukashev, AN (corresponding author), Russian Acad Med Sci, Chumakov Inst Poliomyelitis & Viral Encephalitide, Moscow, Russia.	alexander_lukashev@hotmail.com	Belalov, Ilya/K-2195-2016; Lukashev, Alexander/G-2777-2013	Belalov, Ilya/0000-0002-5447-4872; Lukashev, Alexander/0000-0001-7365-0352	Deutsche Forschungsgemeinschaft [DR772/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft [grant DR772/2-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2004, ARCH VIROL, V149, P113, DOI 10.1007/s00705-003-0186-6; Arora R, 1996, J MOL BIOL, V258, P433, DOI 10.1006/jmbi.1996.0260; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; Burns CC, 2010, INTRO CPG UPA DINUCL, P68; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chamary JV, 2004, MOL BIOL EVOL, V21, P1014, DOI 10.1093/molbev/msh087; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Fernandez V, 2001, PARASITOLOGY, V123, P203, DOI 10.1017/S0031182001008150; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; FRADKIN LG, 1987, MOL CELL BIOL, V7, P3880, DOI 10.1128/MCB.7.11.3880; Fuglsang A, 2006, MOL BIOL EVOL, V23, P1345, DOI 10.1093/molbev/msl009; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Gutierrez G, 1996, NUCLEIC ACIDS RES, V24, P2525, DOI 10.1093/nar/24.13.2525; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; HOEFFLER WK, 1985, CELL, V41, P955, DOI 10.1016/S0092-8674(85)80076-3; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Kleinman CL, 2012, RNA, V18, P1586, DOI 10.1261/rna.033233.112; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lukashev A, 2012, J GEN VIROL; MARSHAK A, 1950, BIOL BULL, V99, P332; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Pan A, 1998, GENE, V215, P405, DOI 10.1016/S0378-1119(98)00257-1; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Rispe C, 2004, GENOME RES, V14, P44, DOI 10.1101/gr.1358104; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; Simmonds P, 2004, RNA, V10, P1337, DOI 10.1261/rna.7640104; Singer GAC, 2000, MOL BIOL EVOL, V17, P1581, DOI 10.1093/oxfordjournals.molbev.a026257; Steil BP, 2009, VIRUS RES, V139, P240, DOI 10.1016/j.virusres.2008.07.027; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; Weill L, 2010, NUCLEIC ACIDS RES, V38, P1367, DOI 10.1093/nar/gkp1109; Woo PCY, 2007, VIROLOGY, V369, P431, DOI 10.1016/j.virol.2007.08.010; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	52	85	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56642	10.1371/journal.pone.0056642	http://dx.doi.org/10.1371/journal.pone.0056642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451064	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500020
J	Liu, YG; Liu, CC; Wang, SJ; Guo, K; Yang, J; Zhang, XS; Li, GQ				Liu, Yuguo; Liu, Changcheng; Wang, Shijie; Guo, Ke; Yang, Jun; Zhang, Xinshi; Li, Guoqing			Organic Carbon Storage in Four Ecosystem Types in the Karst Region of Southwestern China	PLOS ONE			English	Article							BRAZILIAN AMAZON; FORESTS; BIOMASS; VEGETATION; SEQUESTRATION; GRASSLANDS; GUIZHOU; POOLS	Karst ecosystems are important landscape types that cover about 12% of the world's land area. The role of karst ecosystems in the global carbon cycle remains unclear, due to the lack of an appropriate method for determining the thickness of the solum, a representative sampling of the soil and data of organic carbon stocks at the ecosystem level. The karst region in southwestern China is the largest in the world. In this study, we estimated biomass, soil quantity and ecosystem organic carbon stocks in four vegetation types typical of karst ecosystems in this region, shrub grasslands (SG), thorn shrubbery (TS), forest - shrub transition (FS) and secondary forest (F). The results showed that the biomass of SG, TS, FS, and F is 0.52, 0.85, 5.9 and 19.2 kg m(-2), respectively and the corresponding organic cabon storage is 0.26, 0.40, 2.83 and 9.09 kg m(-2), respectively. Nevertheless, soil quantity and corresponding organic carbon storage are very small in karst habitats. The quantity of fine earth overlaying the physical weathering zone of the carbonate rock of SG, TS, FS and F is 38.10, 99.24, 29.57 and 61.89 kg m(-2), respectively, while the corresponding organic carbon storage is only 3.34, 4.10, 2.37, 5.25 kg m(-2), respectively. As a whole, ecosystem organic carbon storage of SG, TS, FS, and F is 3.81, 4.72, 5.68 and 15.1 kg m(-2), respectively. These are very low levels compared to other ecosystems in non-karst areas. With the restoration of degraded vegetation, karst ecosystems in southwestern China may play active roles in mitigating the increasing CO2 concentration in the atmosphere.	[Liu, Yuguo; Liu, Changcheng; Guo, Ke; Yang, Jun; Zhang, Xinshi; Li, Guoqing] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Liu, Yuguo; Li, Guoqing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Shijie] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS	Guo, K (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	guoke@ibcas.ac.cn			National Key Basic Research Program of China [2013CB956701]; "Strategic Priority Research Program'' of the Chinese Academy of Sciences [XDA05070400]	National Key Basic Research Program of China(National Basic Research Program of China); "Strategic Priority Research Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Key Basic Research Program of China (2013CB956701) and "Strategic Priority Research Program'' of the Chinese Academy of Sciences (No. XDA05070400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Delaney M, 1997, J TROP ECOL, V13, P697, DOI 10.1017/S0266467400010877; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Dong M, 1996, OBSERVATION ANAL TER; Fan JW, 2008, CLIMATIC CHANGE, V86, P375, DOI 10.1007/s10584-007-9316-6; Fang JY, 2007, SCI CHINA SER D, V50, P1341, DOI 10.1007/s11430-007-0049-1; Fang JY, 2003, FRONT ECOL ENVIRON, V1, P293; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang S, 2007, J ENVIRON MANAGE, V85, P672, DOI 10.1016/j.jenvman.2006.09.014; Fang SZ, 2010, AGROFOREST SYST, V79, P213, DOI 10.1007/s10457-010-9307-x; Feldpausch TR, 2004, ECOL APPL, V14, pS164; Feller C, 2008, WASTE MANAGE, V28, P734, DOI 10.1016/j.wasman.2007.09.022; Golubiewski NE, 2006, ECOL APPL, V16, P555, DOI 10.1890/1051-0761(2006)016[0555:UIGCPE]2.0.CO;2; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Huang CY, 2000, PEDOLOGY, P224; Huang DZ, 2006, PROTECTION FOREST SC, V1, P16; Huang W., 1988, VEGETATION GUIZHOU; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Keller M, 2004, GLOBAL CHANGE BIOL, V10, P784, DOI 10.1111/j.1529-8817.2003.00770.x; Li ZP, 2007, GEODERMA, V138, P119, DOI 10.1016/j.geoderma.2006.11.007; Liao CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010867; Lin Fang, 2006, Acta Agriculturae Universitatis Jiangxiensis, V28, P74; Liu C.Q., 2009, BIOGEOCHEMICAL PROCE; Liu Chang-Cheng, 2009, Chinese Journal of Plant Ecology, V33, P698, DOI 10.3773/j.issn.1005-264x.2009.04.008; Liu G., 1996, SOIL PHYS CHEM ANAL; Liu T, 2009, KARST DESERTIFICATIO; Liu YG, 2011, SCI SILVAE SINICAE, V3, P82; Liu Yu-Guo, 2011, Chinese Journal of Plant Ecology, V35, P1009, DOI 10.3724/SP.J.1258.2011.01009; Lu XT, 2010, FOREST ECOL MANAG, V260, P1798, DOI 10.1016/j.foreco.2010.08.024; Luo Dong-Hui, 2010, Chinese Journal of Plant Ecology, V34, P611, DOI 10.3773/j.issn.1005-264x.2010.05.015; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Ni J, 2004, CLIMATIC CHANGE, V67, P237, DOI 10.1007/s10584-004-0070-8; Ni J, 2002, J ARID ENVIRON, V50, P205, DOI 10.1006/jare.2001.0902; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2005GB002634; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Schuur EAG, 2001, ECOLOGY, V82, P3182, DOI 10.1890/0012-9658(2001)082[3182:CCASCS]2.0.CO;2; Smith P, 2004, EUR J AGRON, V20, P229, DOI 10.1016/j.eja.2003.08.002; Soil Survey Staff, 2010, KEYS SOIL TAX; TU YL, 1995, J GUIZHOU NORMAL U N, V13, P27; Wang K.L., 1999, J MT SCI-ENGL, V17, P125; Wang SJ, 2004, LAND DEGRAD DEV, V15, P115, DOI 10.1002/ldr.592; Xia H.B., 2010, GUIZHOU FORESTRY SCI, V38, P1; Yao FengPing, 2003, Journal of Zhejiang Forestry Science and Technology, V23, P74; Yu W., 2010, J SUBTROP RESOUR ENV, V5, P25; Zhang XB, 2011, SCI CHINA EARTH SCI, V54, P431, DOI 10.1007/s11430-010-4105-x; Zhang ZH, 2010, ECOL RES, V25, P1151, DOI 10.1007/s11284-010-0740-0; Zhu S-Q, 2003, ECOLOGICAL RES KARST; Zhu SQ, 1995, ECOLOGICAL RES KARST	49	20	31	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56443	10.1371/journal.pone.0056443	http://dx.doi.org/10.1371/journal.pone.0056443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451047	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500015
J	Ruiz-Benito, P; Lines, ER; Gomez-Aparicio, L; Zavala, MA; Coomes, DA				Ruiz-Benito, Paloma; Lines, Emily R.; Gomez-Aparicio, Lorena; Zavala, Miguel A.; Coomes, David A.			Patterns and Drivers of Tree Mortality in Iberian Forests: Climatic Effects Are Modified by Competition	PLOS ONE			English	Article							PINE-OAK FORESTS; INDIVIDUAL TREES; STAND STRUCTURE; TRADE-OFFS; DROUGHT; GROWTH; MECHANISMS; SURVIVAL; DECLINE; MODELS	Tree mortality is a key process underlying forest dynamics and community assembly. Understanding how tree mortality is driven by simultaneous drivers is needed to evaluate potential effects of climate change on forest composition. Using repeat-measure information from c. 400,000 trees from the Spanish Forest Inventory, we quantified the relative importance of tree size, competition, climate and edaphic conditions on tree mortality of 11 species, and explored the combined effect of climate and competition. Tree mortality was affected by all of these multiple drivers, especially tree size and asymmetric competition, and strong interactions between climate and competition were found. All species showed L-shaped mortality patterns (i.e. showed decreasing mortality with tree size), but pines were more sensitive to asymmetric competition than broadleaved species. Among climatic variables, the negative effect of temperature on tree mortality was much larger than the effect of precipitation. Moreover, the effect of climate (mean annual temperature and annual precipitation) on tree mortality was aggravated at high competition levels for all species, but especially for broadleaved species. The significant interaction between climate and competition on tree mortality indicated that global change in Mediterranean regions, causing hotter and drier conditions and denser stands, could lead to profound effects on forest structure and composition. Therefore, to evaluate the potential effects of climatic change on tree mortality, forest structure must be considered, since two systems of similar composition but different structure could radically differ in their response to climatic conditions.	[Ruiz-Benito, Paloma] Inst Nacl Invest & Tecnol Agr & Alimentaria CIFOR, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain; [Ruiz-Benito, Paloma; Zavala, Miguel A.] Univ Alcala, Dept Life Sci, Forest Ecol & Restorat Grp, Madrid, Spain; [Ruiz-Benito, Paloma; Lines, Emily R.; Coomes, David A.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Lines, Emily R.] UCL, Dept Geog, London, England; [Gomez-Aparicio, Lorena] CSIC, Inst Recursos Nat & Agrobiol Sevilla, E-41080 Seville, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Alcala; University of Cambridge; University of London; University College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Ruiz-Benito, P (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria CIFOR, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain.	ruiz.paloma@inia.es	Zavala, Miguel A./H-3603-2015; Ruiz-Benito, Paloma/E-5833-2012; Lines, Emily/B-4646-2013; Gómez-Aparicio, Lorena/K-6905-2014	Zavala, Miguel A./0000-0003-1456-0132; Ruiz-Benito, Paloma/0000-0002-2781-5870; Coomes, David/0000-0002-8261-2582; Lines, Emily/0000-0002-5357-8741	FPU fellowship [AP2008-01325]; CARBO-Extreme [FP7-ENV-2008-1-226701]; REMEDINAL-2 [S2009/AMB-1783];  [INTERBOS3-CGL2008-04503-C03-03];  [SUM2008-00004-C03-01]	FPU fellowship(Spanish Government); CARBO-Extreme; REMEDINAL-2; ; 	Paloma Ruiz-Benito was supported by a FPU fellowship (AP2008-01325). This research was supported by INTERBOS3-CGL2008-04503-C03-03 (http://www.irnase.csic.es/users/interbos/inicio.php), SUM2008-00004-C03-01,CARBO-Extreme (FP7-ENV-2008-1-226701, http://www.carbo-extreme.eu/) and REMEDINAL-2(S2009/AMB-1783, http://www.remedinal.org/) projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], CUADERNOS SOC ESPANO; [Anonymous], 1997, BOSQUES IB RICOS INT; Ashton PMS, 1997, J APPL ECOL, V34, P915, DOI 10.2307/2405282; Barbero Marcel, 1998, P153; Begon M., 1996, ECOLOGY; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Garzon MB, 2011, GLOBAL ECOL BIOGEOGR, V20, P766, DOI 10.1111/j.1466-8238.2010.00646.x; BUCHMAN RG, 1983, CAN J FOREST RES, V13, P601, DOI 10.1139/x83-087; Linares JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P485, DOI 10.1111/j.1466-8238.2009.00465.x; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2012, J ECOL, V100, P42, DOI 10.1111/j.1365-2745.2011.01920.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Dietze MC, 2011, GLOBAL CHANGE BIOL, V17, P3312, DOI 10.1111/j.1365-2486.2011.02477.x; Eid T, 2001, FOREST ECOL MANAG, V154, P69, DOI 10.1016/S0378-1127(00)00634-4; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Galan P., 1998, ARBOLES ARBUSTOS PEN; Galiano L, 2010, ECOSYSTEMS, V13, P978, DOI 10.1007/s10021-010-9368-8; Gelman A., 2004, BAYESIAN DATA ANAL; Gil-Tena A, 2009, GLOBAL CHANGE BIOL, V15, P474, DOI 10.1111/j.1365-2486.2008.01730.x; Gomez-Aparicio L, 2011, GLOBAL CHANGE BIOL, V17, P2400, DOI 10.1111/j.1365-2486.2011.02421.x; Gomez-Aparicio L, 2009, ECOL APPL, V19, P2124, DOI 10.1890/08-1656.1; Harper J. L., 1977, POPULATION BIOL PLAN; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hurst JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026670; Kobe RK, 1996, ECOL MONOGR, V66, P181, DOI 10.2307/2963474; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LORIMER CG, 1983, FOREST ECOL MANAG, V6, P343, DOI 10.1016/0378-1127(83)90042-7; Martinez-Vilalta J, 2002, FOREST ECOL MANAG, V161, P247, DOI 10.1016/S0378-1127(01)00495-9; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; McDowell NG, 2011, PLANT PHYSIOL, V155, P1051, DOI 10.1104/pp.110.170704; Olano JM, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest:2008074; MONSERUD RA, 1976, FOREST SCI, V22, P438; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Pausas JG, 2004, PLANT ECOL, V171, P209, DOI 10.1023/B:VEGE.0000029381.63336.20; PEET RK, 1987, BIOSCIENCE, V37, P586, DOI 10.2307/1310669; PIGOTT CD, 1993, J ECOL, V81, P557, DOI 10.2307/2261534; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; R Core Team, 2021, R LANG ENV STAT COMP; Rohner B, 2012, J VEG SCI, V23, P892, DOI 10.1111/j.1654-1103.2012.01408.x; Sanchez-Gomez D, 2006, NEW PHYTOL, V170, P795, DOI 10.1111/j.1469-8137.2006.01711.x; Sanchez-Salguero R, 2012, FOREST ECOL MANAG, V271, P158, DOI 10.1016/j.foreco.2012.01.040; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Stephenson NL, 2011, ECOL MONOGR, V81, P527, DOI 10.1890/10-1077.1; Torras O, 2008, FOREST ECOL MANAG, V255, P3322, DOI 10.1016/j.foreco.2008.02.013; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Valladares F, 2002, PLANT CELL ENVIRON, V25, P749, DOI 10.1046/j.1365-3040.2002.00856.x; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Vayreda J, 2012, GLOBAL CHANGE BIOL, V18, P1028, DOI 10.1111/j.1365-2486.2011.02606.x; Vila-Cabrera A, 2011, ECOL APPL, V21, P1162, DOI 10.1890/10-0647.1; Villaescusa R., 1998, 2 INVENTARIO FORESTA; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Zavala MA, 2000, BOT REV, V66, P119, DOI 10.1007/BF02857785; Zavala MA, 2004, PLANT ECOL, V171, P197, DOI 10.1023/B:VEGE.0000029387.15947.b7; Zavala MA, 2011, CAN J FOREST RES, V41, P1432, DOI [10.1139/X11-050, 10.1139/x11-050]	68	147	149	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56843	10.1371/journal.pone.0056843	http://dx.doi.org/10.1371/journal.pone.0056843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451096	gold, Green Published			2022-12-25	WOS:000316849500034
J	Wang, HL; Kimberley, MO; Wilks, PJ				Wang, Hailong; Kimberley, Mark O.; Wilks, Peter J.			Economic Analysis of a Pine Plantation Receiving Repeated Applications of Biosolids	PLOS ONE			English	Article							SEWAGE-SLUDGE; FOREST SOIL; RADIATA PLANTATION; GROWTH-RESPONSE; MANAGEMENT; PHOSPHORUS; FERTILIZER; RESIDUALS; MUNICIPAL; ISLAND	Treated biosolids have been applied to 750-ha of a Pinus radiata forest plantation on Rabbit Island near Nelson City in New Zealand since 1996. A long-term research trial was established in 1997 to investigate the effects of the biosolids applications on the receiving environment and tree growth. An analysis of the likely economic impact of biosolids application shows that biosolids application has been beneficial. Stem volume of the high treatment (biosolids applied at 600 kg N ha(-1) every three years) was 36% greater than the control treatment (no biosolids applied), and stem volume of the standard treatment (300 kg N ha(-1)) was 27% greater than the control treatment at age 18 years of age. Biosolids treatments have effectively transformed a low productivity forest site to a medium productivity site. Although this increased productivity has been accompanied by some negative influences on wood quality attributes with reduced wood stiffness, wood density, and larger branches, an economic analysis shows that the increased stem volume and greater average log diameter in the biosolids treatments outweighs these negative effects. The high and standard biosolids treatments are predicted to increase the net stumpage value of logs by 24% and 14% respectively at harvesting, providing a large positive impact on the forest owner's economic return.	[Wang, Hailong] Zhejiang Agr & Forestry Univ, Zhejiang Prov Key Lab Carbon Cycling Forest Ecosy, Linan, Zhejiang, Peoples R China; [Wang, Hailong] Zhejiang Agr & Forestry Univ, Sch Environm & Resource Sci, Linan, Zhejiang, Peoples R China; [Wang, Hailong; Kimberley, Mark O.] Scion, Rotorua, New Zealand; [Wilks, Peter J.] PF Olsen Ltd, Nelson, New Zealand	Zhejiang A&F University; Zhejiang A&F University; Scion	Wang, HL (corresponding author), Zhejiang Agr & Forestry Univ, Zhejiang Prov Key Lab Carbon Cycling Forest Ecosy, Linan, Zhejiang, Peoples R China.	nzhailongwang@gmail.com	Wang, Hailong/C-2641-2011	Wang, Hailong/0000-0002-6107-5095	New Zealand Foundation for Research Science and Technology [C03X0902]; National Natural Science Foundation of China [41271337]; Research and Development Fund of Zhejiang A F University [2010FR097]; PF Olsen Ltd.; Tasman District Council; Nelson Regional Sewerage Business Unit	New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Development Fund of Zhejiang A F University; PF Olsen Ltd.; Tasman District Council; Nelson Regional Sewerage Business Unit	The work was supported by New Zealand Foundation for Research Science and Technology (C03X0902), National Natural Science Foundation of China (41271337), the Research and Development Fund of Zhejiang A & F University (2010FR097), PF Olsen Ltd., Tasman District Council, the Nelson Regional Sewerage Business Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Peter J. Wilks is affiliated with PF Olsen Ltd, who provided some of the funding for the study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Brown S, 2011, ENVIRON SCI TECHNOL, V45, P7451, DOI 10.1021/es2010418; Carter P., 2005, P 14 INT S NOND TEST, P161; Dunlop JD, 1995, FRI B; Ferreiro-Dominguez N, 2012, SCI TOTAL ENVIRON, V424, P39, DOI 10.1016/j.scitotenv.2012.02.042; Hamuda HEAFB, 2011, J RESIDUALS SCI TECH, V8, P143; Hewitt AE, 1998, LANDSCAPE RES SCI SE; Kimberley Mark, 2005, New Zealand Journal of Forestry, V50, P13; Kimberley MO, 2004, FOREST ECOL MANAG, V189, P345, DOI 10.1016/j.foreco.2003.09.003; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lopez-Diaz ML, 2009, FOREST ECOL MANAG, V257, P1363, DOI 10.1016/j.foreco.2008.12.001; MacLaren JP, 2005, NZ TREE GROWER, P24; Magesan GN, 2003, AUST J SOIL RES, V41, P557, DOI 10.1071/SR02134; Mosquera-Losada MR, 2012, AGR ECOSYST ENVIRON, V161, P165, DOI 10.1016/j.agee.2012.08.001; Pratt WA, 2009, J ENVIRON QUAL, V38, P2106, DOI 10.2134/jeq2008.0350; Prescott CE, 2005, CAN J FOREST RES, V35, P211, DOI 10.1139/x04-146; Su JJ, 2008, AUST J SOIL RES, V46, P502, DOI 10.1071/SR07203; Su J, 2007, ENVIRON SCI POLLUT R, V14, P529, DOI 10.1065/espr2007.08.443; Thiart J, 2012, BUSINESS PLAN 2012 1; Walker R. F., 2011, Journal of Sustainable Forestry, V30, P263, DOI 10.1080/10549811.2010.490107; Wang HL, 2008, ENVIRON SCI POLLUT R, V15, P308, DOI 10.1007/s11356-008-0012-5; Wang H, 2006, CAN J FOREST RES, V36, P1921, DOI 10.1139/X06-084; Wang HL, 2004, PLANT SOIL, V267, P255, DOI 10.1007/s11104-005-0107-4; Wilks Peter, 2009, New Zealand Journal of Forestry, V54, P33	23	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57705	10.1371/journal.pone.0057705	http://dx.doi.org/10.1371/journal.pone.0057705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451262	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500129
J	Popov, S; Jury, A; Laxton, R; Doey, L; Kandasamy, N; Al-Sarraj, S; Jurgensmeier, JM; Jones, C				Popov, Sergey; Jury, Alexa; Laxton, Ross; Doey, Lawrence; Kandasamy, Naga; Al-Sarraj, Safa; Juergensmeier, Juliane M.; Jones, Chris			IDH1-Associated Primary Glioblastoma in Young Adults Displays Differential Patterns of Tumour and Vascular Morphology	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; IDH2 MUTATIONS; MULTIFORME; CELL; DISTINCT; GLIOMA; OLIGODENDROGLIOMA; AMPLIFICATION; ANGIOGENESIS; TEMOZOLOMIDE	Glioblastoma is a highly aggressive tumour with marked heterogeneity at the morphological level in both the tumour cells and the associated highly prominent vasculature. As we begin to develop an increased biological insight into the underlying processes driving the disease, fewer attempts have thus far been made to understand these phenotypic differences. We sought to address this by carefully assessing the morphological characteristics of both the tumour cells and the associated vasculature, relating these observations to the IDH1/MGMT status, with a particular focus on the early onset population of young adults who develop primary glioblastoma. 276 primary glioblastoma specimens were classified into their predominant cell morphological type (fibrillary, gemistocytic, giant cell, small cell, oligodendroglial, sarcomatous), and assessed for specific tumour (cellularity, necrosis, palisades) and vascular features (glomeruloid structures, arcades, pericyte proliferation). IDH1 positive glioblastomas were associated with a younger age at diagnosis, better clinical outcome, prominent oligodendroglial and small cell tumour cell morphology, pallisading necrosis and glomeruloid vascular proliferation in the absence of arcade-like structures. These features widen the phenotype of IDH1 mutation-positive primary glioblastoma in young adults and provide correlative evidence for a functional role of mutant IDH1 in the differential nature of neo-angiogenesis in different subtypes of glioblastoma.	[Popov, Sergey; Jury, Alexa; Jones, Chris] Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England; [Popov, Sergey; Jury, Alexa; Jones, Chris] Inst Canc Res, Div Canc Therapeut, Sutton, Surrey, England; [Laxton, Ross; Doey, Lawrence; Al-Sarraj, Safa] Kings Coll Hosp, Dept Neuropathol, London, England; [Kandasamy, Naga] Kings Coll Hosp, Dept Neuroradiol, London, England; [Juergensmeier, Juliane M.] AstraZeneca, Macclesfield, Cheshire, England	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; King's College Hospital NHS Foundation Trust; King's College Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; AstraZeneca	Jones, C (corresponding author), Inst Canc Res, Div Mol Pathol, Sutton, Surrey, England.	chris.jones@icr.ac.uk	Juergensmeier, Juliane/I-4117-2013; Jones, Chris/ABE-6059-2021; Laxton, Ross C/G-1205-2010	Jones, Chris/0000-0001-8118-2296; Laxton, Ross C/0000-0002-3164-1201	AstraZeneca; NHS	AstraZeneca(AstraZeneca); NHS	JMJ is an employee of AstraZeneca. CJ receives research grant funding from AstraZeneca. SP, AJ, SEL, AB and CJ acknowledge NHS funding to the Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-2; De Carli E, 2009, NEW ENGL J MED, V360, P2248, DOI 10.1056/NEJMc090593; HADDAD SF, 1992, J NEUROPATH EXP NEUR, V51, P488, DOI 10.1097/00005072-199209000-00002; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2012, ACTA NEUROPATHOL; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Miyanaga T, 2008, NEUROPATHOLOGY, V28, P116, DOI 10.1111/j.1440-1789.2007.00853.x; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perry A, 2004, CANCER, V101, P2318, DOI 10.1002/cncr.20625; Quezado M, 2005, CLIN NEUROPATHOL, V24, P163; Reardon DA, 2011, J NATL COMPR CANC NE, V9, P414, DOI 10.6004/jnccn.2011.0038; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tuettenberg J, 2006, CRIT REV ONCOL HEMAT, V59, P181, DOI 10.1016/j.critrevonc.2006.01.004; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232; WESSELING P, 1995, J NEUROPATH EXP NEUR, V54, P304, DOI 10.1097/00005072-199505000-00003; Williams SC, 2011, ACTA NEUROPATHOL, V121, P279, DOI 10.1007/s00401-010-0790-y; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	27	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56328	10.1371/journal.pone.0056328	http://dx.doi.org/10.1371/journal.pone.0056328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451042	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800009
J	Aridgides, D; Salvador, R; PereiraPerrin, M				Aridgides, Daniel; Salvador, Ryan; PereiraPerrin, Mercio			Cardiomyocyte Death by Activating Nerve Growth Factor Receptor TrkA	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; TRANS-SIALIDASE; CARDIAC FIBROBLASTS; NEUROTROPHIC FACTOR; IN-VITRO; CELLS; DIFFERENTIATION; IDENTIFICATION; SURVIVAL; ANGIOGENESIS	Rationale: Cardiomyocytes neurotrophin receptor TrkA that promotes survival following nerve growth factor (NGF) ligation. Whether TrkA also resides in cardiac fibroblasts (CFs) and underlies cardioprotection is unknown. Objective: To test whether CFs express TrkA that conveys paracrine signals to neighbor cardiomyocytes using, as probe, the Chagas disease parasite Trypanosoma cruzi, which expresses a TrkA-binding neurotrophin mimetic, named PDNF. T cruzi targets the heart, causing chronic debilitating cardiomyopathy in, similar to 30% patients. Methods and Results: Basal levels of TrkA and TrkC in primary CFs are comparable to those in cardiomyocytes. However, in the myocardium, TrkA expression is significantly lower in fibroblasts than myocytes, and vice versa for TrkC. Yet T cruzi recognition of TrkA on fibroblasts, preferentially over cardiomyocytes, triggers a sharp and sustained increase in NGF, including in the heart of infected mice or of mice administered PDNF intravenously, as early as 3-h post-administration. Further, NGF-containing T cruzi-or PDNF-induced fibroblast-conditioned medium averts cardiomyocyte damage by H2O2, in agreement with the previously recognized cardioprotective role of NGF. Conclusions: TrkA residing in CFs induces an exuberant NGF production in response to T cruzi infection, enabling, in a paracrine fashion, myocytes to resist oxidative stress, a leading Chagas cardiomyopathy trigger. Thus, PDNF-TrkA interaction on CFs may be a mechanism orchestrated by T cruzi to protect its heart habitat, in concert with the long-term (decades) asymptomatic heart parasitism that characterizes Chagas disease. Moreover, as a potent booster of cardioprotective NGF in vivo, PDNF may offer a novel therapeutic opportunity against cardiomyopathies.	[Aridgides, Daniel; Salvador, Ryan; PereiraPerrin, Mercio] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA; [Aridgides, Daniel; Salvador, Ryan; PereiraPerrin, Mercio] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA	Tufts University; Tufts University	PereiraPerrin, M (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA.	Mercio.perrin@tufts.edu			NIH [NS40574, NS42960]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042960, R01NS040574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS40574 and NS42960. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1989, MOL BIOCHEM PARASIT, V34, P221, DOI 10.1016/0166-6851(89)90050-9; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; BASHEY RI, 1992, J MOL CELL CARDIOL, V24, P691, DOI 10.1016/0022-2828(92)93383-U; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Cai DQ, 2006, PHYSIOL GENOMICS, V24, P191, DOI 10.1152/physiolgenomics.00165.2005; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Caporali A, 2008, CELL DEATH DIFFER, V15, P299, DOI 10.1038/sj.cdd.4402263; Caradonna K, 2009, INFECT IMMUN, V77, P1349, DOI 10.1128/IAI.01434-08; Chuenkova M, 1999, BIOCHEM BIOPH RES CO, V262, P549, DOI 10.1006/bbrc.1999.1154; Chuenkova MV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000374; Chuenkova MV, 2004, J NEUROCHEM, V91, P385, DOI 10.1111/j.1471-4159.2004.02724.x; Chuenkova MV, 2005, BIOCHEMISTRY-US, V44, P15685, DOI 10.1021/bi0512039; Chuenkova MV, 2000, MOL BIOL CELL, V11, P1487, DOI 10.1091/mbc.11.4.1487; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; de Melo-Jorge M, 2007, CELL HOST MICROBE, V1, P251, DOI 10.1016/j.chom.2007.05.006; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ieda M, 2006, CIRCULATION, V114, P2351, DOI 10.1161/CIRCULATIONAHA.106.627588; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; KATWA LC, 1993, CARDIOVASC RES, V27, P2125, DOI 10.1093/cvr/27.12.2125; Kawaguchi-Manabe H, 2007, LIFE SCI, V81, P385, DOI 10.1016/j.lfs.2007.05.024; Manque PA, 2011, INFECT IMMUN, V79, P1855, DOI 10.1128/IAI.00643-10; Martinelli PM, 2006, AUTON NEUROSCI-BASIC, V130, P32, DOI 10.1016/j.autneu.2006.05.004; Meloni M, 2012, DIABETES, V61, P229, DOI 10.2337/db11-0763; Meloni M, 2010, CIRC RES, V106, P1275, DOI 10.1161/CIRCRESAHA.109.210088; Ottaviano FG, 2011, J CARDIOVASC PHARM, V57, P513, DOI 10.1097/FJC.0b013e31821209ee; PEREIRA MEA, 1983, SCIENCE, V219, P1444, DOI 10.1126/science.6338592; PEREIRA MEA, 1991, J EXP MED, V174, P179, DOI 10.1084/jem.174.1.179; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567; SCUDDER P, 1993, J BIOL CHEM, V268, P9886; Skaper S, 2001, METHODS MOL BIOL, V846, P1; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Sreejit P, 2008, IN VITRO CELL DEV-AN, V44, P45, DOI 10.1007/s11626-007-9079-4; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Tessarollo L, 1997, P NATL ACAD SCI USA, V94, P14776, DOI 10.1073/pnas.94.26.14776; Weinkauf C, 2009, INFECT IMMUN, V77, P1368, DOI 10.1128/IAI.01450-08; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	50	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57450	10.1371/journal.pone.0057450	http://dx.doi.org/10.1371/journal.pone.0057450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437390	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000104
J	Cillo, U; Vitale, A; Dupuis, D; Corso, S; Neri, D; D'Amico, F; Gringeri, E; Farinati, F; Vincenzi, V; Zanus, G				Cillo, Umberto; Vitale, Alessandro; Dupuis, Davide; Corso, Stefano; Neri, Daniele; D'Amico, Francesco; Gringeri, Enrico; Farinati, Fabio; Vincenzi, Valter; Zanus, Giacomo			Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; MICROWAVE COAGULATION; LOCAL RECURRENCE; MILAN CRITERIA; TRANSPLANTATION; CHEMOEMBOLIZATION; SURVIVAL; THERAPY; TUMORS; HCC	The aim of this study was to demonstrate the safety and efficacy of laparoscopic ablation for cirrhotic HCC patients. Between January 2004 and December 2009, laparoscopic ablation was applied prospectively in 169 consecutive HCC patients (median age 62 years, 43% hepatitis C positive) considered ineligible for liver resection and/or percutaneous ablation. There was clinically relevant portal hypertension in 72% of cases. A significant proportion of subjects (50%) had multinodular tumors or nodules larger than 25 mm. The main ablation techniques used were radiofrequency in 103 patients (61%), microwave ablation in 8 (5%), and ethanol injection in 58 (34%). The primary endpoint was 3-year survival. There was no perioperative mortality. The overall morbidity rate was 25%. The median postoperative hospital stay was 3 days (range 1-19 days). Patients survived a median 33 months with a 3-year survival rate of 47%. Cox's multivariate analysis identified patient age, presence of diabetes, albumin <= 37 g/l, and alpha-fetoprotein >400 mu g/l as significant preoperative predictors of survival, while the chance to undergo liver transplantation and postoperative ascites were the only independent postoperative predictor of survival. Laparoscopic ablation is a safe and effective therapeutic option for selected HCC patients ineligible for liver resection and/or percutaneous ablation.	[Cillo, Umberto; Vitale, Alessandro; Dupuis, Davide; Corso, Stefano; Neri, Daniele; D'Amico, Francesco; Gringeri, Enrico; Zanus, Giacomo] Univ Padua, Azienda Osped, Unita Chirurg Epatobiliare & Trapianto Epat, Padua, Italy; [Farinati, Fabio] Univ Padua, Azienda Osped, Div Gastroenterol, Padua, Italy; [Vincenzi, Valter] Osped San Martino, Unita Med Gen, Belluno, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; Azienda Ospedaliera - Universita di Padova; ULSS 1 Dolomiti; Ospedale di Belluno	Vitale, A (corresponding author), Univ Padua, Azienda Osped, Unita Chirurg Epatobiliare & Trapianto Epat, Padua, Italy.	alessandro.vitale@unipd.it	Farinati, Fabio/A-8267-2012; Gringeri, Enrico/K-4199-2018; GRINGERI, ENRICO/AAB-9315-2019; Cillo, Umberto/AAC-2591-2019; Vitale, Alessandro/AAA-9182-2021; Zanus, Giacomo/AIB-1093-2022	Farinati, Fabio/0000-0002-2944-1374; GRINGERI, ENRICO/0000-0002-3459-7306; Cillo, Umberto/0000-0002-2310-0245; Vitale, Alessandro/0000-0002-4548-8308				Asahina Y, 2009, DIGEST ENDOSC, V21, P67, DOI 10.1111/j.1443-1661.2009.00844.x; Ballem N, 2008, HPB, V10, P315, DOI 10.1080/13651820802247102; Belghiti J, 2009, J GASTROENTEROL, V44, P132, DOI 10.1007/s00535-008-2250-1; Belli G, 2007, SURG LAPARO ENDO PER, V17, P331, DOI 10.1097/SLE.0b013e31806d9c65; Berber E, 2007, SURG ENDOSC, V21, P613, DOI 10.1007/s00464-006-9139-y; Berber E, 2008, ANN SURG ONCOL, V15, P2757, DOI 10.1245/s10434-008-0043-7; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Buell JF, 2008, ANN SURG, V248, P475, DOI 10.1097/SLA.0b013e318185e647; Casaccia M, 2008, J LAPAROENDOSC ADV S, V18, P797, DOI 10.1089/lap.2008.0039; Cassera MA, 2011, SURG ENDOSC, V25, P1088, DOI 10.1007/s00464-010-1322-5; Cillo U, 2007, AM J TRANSPLANT, V7, P972, DOI 10.1111/j.1600-6143.2006.01719.x; Golfieri R, 2011, HEPATOLOGY, V53, P1580, DOI 10.1002/hep.24246; Ho MC, 2009, ANN SURG ONCOL, V16, P848, DOI 10.1245/s10434-008-0282-7; Hsieh CB, 2004, WORLD J GASTROENTERO, V10, P505, DOI 10.3748/wjg.v10.i4.505; Ishizawa T, 2008, GASTROENTEROLOGY, V134, P1908, DOI 10.1053/j.gastro.2008.02.091; Kawamoto C, 2005, CANCER-AM CANCER SOC, V103, P985, DOI 10.1002/cncr.20880; Kurokohchi K, 2008, WORLD J GASTROENTERO, V14, P2037, DOI 10.3748/wjg.14.2037; Lam VWT, 2008, J AM COLL SURGEONS, V207, P20, DOI 10.1016/j.jamcollsurg.2008.01.020; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Minami Y, 2010, WORLD J RADIOL, V2, P417, DOI 10.4329/wjr.v2.i11.417; Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217; N'Kontchou G, 2012, J HEPATOL, V56, P160, DOI 10.1016/j.jhep.2011.03.026; Pelletier SJ, 2009, LIVER TRANSPLANT, V15, P859, DOI 10.1002/lt.21778; Perrone F, 2000, HEPATOLOGY, V31, P840; Ramsey DE, 2002, J VASC INTERV RADIOL, V13, pS211, DOI 10.1016/S1051-0443(07)61789-8; Raoul JL, 2011, CANCER TREAT REV, V37, P212, DOI 10.1016/j.ctrv.2010.07.006; Santambrogio R, 2003, SURG ENDOSC, V17, P1826, DOI 10.1007/s00464-002-8960-1; Santambrogio R, 2009, ANN SURG ONCOL, V16, P3289, DOI 10.1245/s10434-009-0678-z; Seki S, 2005, ENDOSCOPY, V37, P1220, DOI 10.1055/s-2005-921035; Tanaka S, 2009, HEPATO-GASTROENTEROL, V56, P1169; Tangkijvanich P, 2000, J CLIN GASTROENTEROL, V31, P302, DOI 10.1097/00004836-200012000-00007; Tesche LJ, 2010, SURG LAPARO ENDO PER, V20, P404, DOI 10.1097/SLE.0b013e3181fd619b; Vitale A, 2011, LANCET ONCOL, V12, P654, DOI 10.1016/S1470-2045(11)70144-9; Vitale A, 2010, ANN SURG ONCOL, V17, P2290, DOI 10.1245/s10434-010-0993-4; Volk ML, 2008, AM J TRANSPLANT, V8, P839, DOI 10.1111/j.1600-6143.2007.02138.x	40	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57249	10.1371/journal.pone.0057249	http://dx.doi.org/10.1371/journal.pone.0057249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437351	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000091
J	Cornett, EM; O'Steen, MR; Kolpashchikov, DM				Cornett, Evan M.; O'Steen, Martin R.; Kolpashchikov, Dmitry M.			Operating Cooperatively (OC) Sensor for Highly Specific Recognition of Nucleic Acids	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MOLECULAR BEACONS; MESSENGER-RNA; SNP ANALYSIS; DNA; PROBES; HYBRIDIZATION; DIAGNOSTICS; MUTATIONS; SEQUENCE	Molecular Beacon (MB) probes have been extensively used for nucleic acid analysis because of their ability to produce fluorescent signal in solution instantly after hybridization. The indirect binding of MB probe to a target analyte offers several advantages, including: improved genotyping accuracy and the possibility to analyse folded nucleic acids. Here we report on a new design for MB-based sensor, called 'Operating Cooperatively' (OC), which takes advantage of indirect binding of MB probe to a target analyte. The sensor consists of two unmodified DNA strands, which hybridize to a universal MB probe and a nucleic acid analyte to form a fluorescent complex. OC sensors were designed to analyze two human SNPs and E.coli 16S rRNA. High specificity of the approach was demonstrated by the detection of true analyte in over 100 times excess amount of single base substituted analytes. Taking into account the flexibility in the design and the simplicity in optimization, we conclude that OC sensors may become versatile and efficient tools for instant DNA and RNA analysis in homogeneous solution.	[Cornett, Evan M.; Kolpashchikov, Dmitry M.] Univ Cent Florida, Dept Chem, Coll Sci, Orlando, FL 32816 USA; [Cornett, Evan M.; O'Steen, Martin R.; Kolpashchikov, Dmitry M.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Kolpashchikov, DM (corresponding author), Univ Cent Florida, Dept Chem, Coll Sci, Orlando, FL 32816 USA.	dmk2111@gmail.com	Kolpashchuikov, Dmitry M./AAE-2085-2019; Kolpashchikov, Dmitry/AAO-2777-2020; Cornett, Evan/M-1989-2019	Kolpashchuikov, Dmitry M./0000-0002-8682-6553; Cornett, Evan/0000-0003-1468-4506	NIHGRI [R21 HG004060]; NSF CCF [1117205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004060] Funding Source: NIH RePORTER	NIHGRI; NSF CCF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by NIHGRI (R21 HG004060) and NSF CCF (1117205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann A, 2012, HUM GENET, V131, P1541, DOI 10.1007/s00439-012-1213-z; Asanuma H, 2012, CHEM COMMUN, V48, P1760, DOI 10.1039/c2cc16812j; Balasingham SV, 2009, MOL DIAGN THER, V13, P137, DOI 10.2165/01250444-200913030-00001; Browne KA, 2005, J AM CHEM SOC, V127, P1989, DOI 10.1021/ja046369w; Chandler DP, 2003, APPL ENVIRON MICROB, V69, P2950, DOI 10.1128/AEM.69.5.2950-2958.2003; Cornett EM, 2012, ANGEW CHEM INT EDIT, V51, P9075, DOI 10.1002/anie.201203708; Demidov VV, 2004, TRENDS BIOCHEM SCI, V29, P62, DOI 10.1016/j.tibs.2003.12.007; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Gerasimova YV, 2013, BIOSENS BIOELECTRON, V41, P386, DOI 10.1016/j.bios.2012.08.058; Gerasimova YV, 2010, CHEMBIOCHEM, V11, P1762, DOI 10.1002/cbic.201000287; Grimes J, 2010, ANGEW CHEM INT EDIT, V49, P8950, DOI 10.1002/anie.201004475; Hiyari Sarah, 2011, J Dent Hyg, V85, P256; Hopkins JF, 2005, NUCLEIC ACIDS RES, V33, P5763, DOI 10.1093/nar/gki877; Huang KW, 2012, ANAL BIOANAL CHEM, V402, P3091, DOI 10.1007/s00216-011-5570-6; Kam Y, 2012, MOL PHARMACEUT, V9, P685, DOI 10.1021/mp200505k; Kim Y, 2007, NUCLEIC ACIDS RES, V35, P7279, DOI 10.1093/nar/gkm771; Kolpashchikov DM, 2006, J AM CHEM SOC, V128, P10625, DOI 10.1021/ja0628093; Kolpashchikov DM, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/928783; Kolpashchikov DM, 2011, CHEMBIOCHEM, V12, P2564, DOI 10.1002/cbic.201100545; Lane S, 2004, BIOSENS BIOELECTRON, V20, P728, DOI 10.1016/j.bios.2004.04.014; Li J, 2012, BIOSENS BIOELECTRON, V36, P142, DOI 10.1016/j.bios.2012.04.003; Li YQ, 2011, BIOSENS BIOELECTRON, V26, P2317, DOI 10.1016/j.bios.2010.10.002; Liang XW, 2012, SCI CHINA LIFE SCI, V55, P670, DOI 10.1007/s11427-012-4354-3; Lin YH, 2012, CHEM COMMUN, V48, P6262, DOI 10.1039/c2cc31382k; Liu AL, 2012, ANAL BIOANAL CHEM, V402, P805, DOI 10.1007/s00216-011-5480-7; Marras SAE, 2006, CLIN CHIM ACTA, V363, P48, DOI 10.1016/j.cccn.2005.04.037; Moschioni M, 2010, MICROB BIOTECHNOL, V3, P370, DOI 10.1111/j.1751-7915.2009.00138.x; Nagy C, 2012, EPIGENOMICS-UK, V4, P445, DOI [10.2217/EPI.12.37, 10.2217/epi.12.37]; Nguyen C, 2011, CHEM-EUR J, V17, P13052, DOI 10.1002/chem.201101987; Nogueira da Costa A, 2012, MOL ONCOL; Phillips C, 2012, TRANSFUS MED HEMOTH, V39, P202, DOI 10.1159/000338857; Qiao GM, 2011, CHEM-EUR J, V17, P11210, DOI 10.1002/chem.201100658; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Santangelo P, 2006, ANN BIOMED ENG, V34, P39, DOI 10.1007/s10439-005-9003-6; Shen ZL, 2012, CHEM COMMUN, V48, P7580, DOI 10.1039/c2cc33280a; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Slodkowska Janina, 2012, Stud Health Technol Inform, V179, P143; Starke EM, 2007, ANN NY ACAD SCI, V1098, P345, DOI 10.1196/annals.1384.007; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Wang JH, 2009, MOL BIOL REP, V36, P1903, DOI 10.1007/s11033-008-9397-y; Wang KM, 2009, ANGEW CHEM INT EDIT, V48, P856, DOI 10.1002/anie.200800370; Yang CN, 2012, CHEM COMMUN, V48, P112, DOI [10.1039/c1cc14518e, 10.3778/j.issn.1002-8331.2012.30.024]; Yoshinaga H, 2012, ANAL SCI, V28, P939, DOI 10.2116/analsci.28.939; Yu M, 2012, ADV CLIN CHEM, V57, P99, DOI 10.1016/B978-0-12-394384-2.00004-8	45	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55919	10.1371/journal.pone.0055919	http://dx.doi.org/10.1371/journal.pone.0055919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441157	Green Published, gold			2022-12-25	WOS:000315159200014
J	Hawken, ER; Delva, NJ; Beninger, RJ				Hawken, Emily R.; Delva, Nicholas J.; Beninger, Richard J.			Increased Drinking following Social Isolation Rearing: Implications for Polydipsia Associated with Schizophrenia	PLOS ONE			English	Article							SCHEDULE-INDUCED-POLYDIPSIA; OBSESSIVE-COMPULSIVE SYMPTOMS; INDIVIDUAL-DIFFERENCES; WATER-INTOXICATION; HIPPOCAMPAL-FORMATION; LOCOMOTOR-ACTIVITY; ANIMAL-MODEL; DOPAMINE; RATS; DETERMINANTS	Primary polydipsia, excessive drinking without known medical cause, is especially associated with a diagnosis of schizophrenia. We used animal models of schizophrenia-like symptoms to examine the effects on schedule-induced polydipsia: post-weaning social isolation rearing, subchronic MK-801 treatment (an NMDA-receptor antagonist) or the two combined. Male, Sprague-Dawley rats reared in groups or in isolation beginning at postnatal day 21 were further divided to receive subchronic MK-801 (0.5 mg/kg twice daily) or saline for 7 days beginning on postnatal day 62. Following a 4-day withdrawal period, all groups were trained on a schedule-induced polydipsia paradigm. Under food-restriction, animals reared in isolation and receiving food pellets at 1-min intervals developed significantly more drinking behavior than those reared with others. The addition of subchronic MK-801 treatment did not significantly augment the amount of water consumed. These findings suggest a predisposition to polydipsia is a schizophrenia-like behavioral effect of post-weaning social isolation.	[Hawken, Emily R.; Beninger, Richard J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Hawken, Emily R.; Delva, Nicholas J.; Beninger, Richard J.] Queens Univ, Dept Psychiat, Kingston, ON K7L 3N6, Canada; [Delva, Nicholas J.] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Beninger, Richard J.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Dalhousie University; Queens University - Canada	Beninger, RJ (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.	beninger@queensu.ca	Beninger, Richard/AAR-1584-2021		Ontario Ministry of Mental Health; H. Lundbeck A/S; Institut de Recherche Pierre Fabre (Boulogne, France)	Ontario Ministry of Mental Health; H. Lundbeck A/S; Institut de Recherche Pierre Fabre (Boulogne, France)	This work was funded by the Ontario Ministry of Mental Health, Type B Grant (no grant number assigned). [http://www.omhf.on.ca/home/] The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.; E.R. Hawken declares no competing interest exist. N.J. Delva has read the journal's policy and has the following conflict: he has received funding (ending in late 2009) from H. Lundbeck A/S for research unrelated to this study. R.J. Beninger has read the journal's policy and has the following conflicts: he has been compenstated as an expert witness by Kenyon and Kenyon LLP (New York, New York, USA) acting for defendants Teva Pharmaceuticals Industries Ltd. Teva Pharmaceuticals USA Inc., and has carried out research under contract for Institut de Recherche Pierre Fabre (Boulogne, France). This does not alter the author's adherence to all the PLOS ONE policies on sharing data and materials.	Alquicer G, 2008, J CHEM NEUROANAT, V35, P179, DOI 10.1016/j.jchemneu.2007.10.001; Ashby DM, 2010, BEHAV BRAIN RES, V212, P64, DOI 10.1016/j.bbr.2010.03.041; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Beninger RJ, 2009, PHARMACOL BIOCHEM BE, V91, P495, DOI 10.1016/j.pbb.2008.09.003; Braun I, 2007, SCHIZOPHR RES, V97, P254, DOI 10.1016/j.schres.2007.05.005; Byerly M, 2005, SCHIZOPHR RES, V76, P309, DOI 10.1016/j.schres.2005.02.004; Cassano GB, 1998, J CLIN PSYCHIAT, V59, P60, DOI 10.4088/JCP.v59n0204; Cunill R, 2009, J CLIN PSYCHIAT, V70, P70, DOI 10.4088/JCP.07r03618; Dawe GS, 2009, ANN ACAD MED SINGAP, V38, P425; DELEON J, 1994, BIOL PSYCHIAT, V35, P408, DOI 10.1016/0006-3223(94)90008-6; EINON DF, 1977, DEV PSYCHOBIOL, V10, P123, DOI 10.1002/dev.420100205; EINON DF, 1978, Q J EXP PSYCHOL, V30, P151, DOI 10.1080/14640747808400663; Escher T, 2006, PSYCHOPHARMACOLOGY, V187, P424, DOI 10.1007/s00213-006-0465-5; Fabricius K, 2010, NEUROSCI LETT, V482, P117, DOI 10.1016/j.neulet.2010.07.014; FALK JL, 1966, J EXP ANAL BEHAV, V9, P37, DOI 10.1901/jeab.1966.9-37; FALK JL, 1971, PHYSIOL BEHAV, V6, P577, DOI 10.1016/0031-9384(71)90209-5; FLORES P, 1995, BEHAV PHARMACOL, V6, P16; Flory RK, 1971, LEARN MOTIV, V2, P215, DOI [10.1016/0023-9690(71)90022-1, DOI 10.1016/0023-9690(71)90022-1]; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Goldman MB, 2007, HIPPOCAMPUS, V17, P554, DOI 10.1002/hipo.20292; Goldman MB, 2004, SCHIZOPHRENIA BULL, V30, P367, DOI 10.1093/oxfordjournals.schbul.a007086; Goldman MB, 2007, J CLIN ENDOCR METAB, V92, P698, DOI 10.1210/jc.2006-1131; Goldman MB, 2011, BEHAV BRAIN RES, V218, P106, DOI 10.1016/j.bbr.2010.11.025; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Harte MK, 2007, J NEURAL TRANSM, V114, P893, DOI 10.1007/s00702-007-0627-6; Hawken ER, 2011, SCHIZOPHR RES, V125, P93, DOI 10.1016/j.schres.2010.07.022; Hawken ER, 2009, SCHIZOPHR RES, V107, P128, DOI 10.1016/j.schres.2008.09.029; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Hickey AJ, 2012, PHARMACOL BIOCHEM BE, V101, P231, DOI 10.1016/j.pbb.2012.01.015; Hong SZ, 2012, PHYSIOL BEHAV, V105, P269, DOI 10.1016/j.physbeh.2011.08.036; HOOKS MS, 1994, BEHAV BRAIN RES, V60, P199, DOI 10.1016/0166-4328(94)90148-1; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; JONES GH, 1989, PHYSIOL BEHAV, V45, P71, DOI 10.1016/0031-9384(89)90167-4; Lapiz M D S, 2003, Neurosci Behav Physiol, V33, P13, DOI 10.1023/A:1021171129766; Lodge DJ, 2008, NEUROTOX RES, V14, P97, DOI 10.1007/BF03033801; Lopez-Grancha M, 2008, PSYCHOPHARMACOLOGY, V197, P487, DOI 10.1007/s00213-007-1059-6; LUCHINS DJ, 1992, SCHIZOPHR RES, V8, P119, DOI 10.1016/0920-9964(92)90027-3; Lysaker PH, 2009, EXPERT REV NEUROTHER, V9, P99, DOI 10.1586/14737175.9.1.99; Mercier-Guidez E, 2000, EUR PSYCHIAT, V15, P306, DOI 10.1016/S0924-9338(00)00399-0; MITTLEMAN G, 1994, J PHARMACOL EXP THER, V271, P638; Moreno M, 2012, PSYCHOPHARMACOLOGY, V219, P647, DOI 10.1007/s00213-011-2570-3; Nettles KW, 2000, BRAIN RES, V858, P181, DOI 10.1016/S0006-8993(99)02281-7; Pellon R, 2011, BEHAV BRAIN RES, V217, P195, DOI 10.1016/j.bbr.2010.10.010; Platt B., 2008, CURR PROTOC NEUROSCI, V43, P1, DOI [DOI 10.1002/0471142301.NS0927S43, 10.1002/0471142301.ns0927-43, DOI 10.1002/0471142301.NS0927-43]; Poirier S, 2010, SCHIZOPHR RES, V118, P285, DOI 10.1016/j.schres.2009.12.036; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Poyurovsky M, 1999, AM J PSYCHIAT, V156, P1998; Simpson SM, 2010, PHARMACOL BIOCHEM BE, V95, P72, DOI 10.1016/j.pbb.2009.12.008; Torres IJ, 2009, NEUROPSYCHOLOGY, V23, P307, DOI 10.1037/a0014481; UMBRICHT D, 1994, BIOL PSYCHIAT, V36, P709, DOI 10.1016/0006-3223(94)91183-5; van den Heuvel OA, 2010, J NEUROL SCI, V289, P55, DOI 10.1016/j.jns.2009.08.043; WALLACE M, 1976, PHARMACOL BIOCHEM BE, V5, P483, DOI 10.1016/0091-3057(76)90114-3; WILKINSON LS, 1994, NEUROPSYCHOPHARMACOL, V10, P61, DOI 10.1038/npp.1994.8; WOODS A, 1993, PSYCHOPHARMACOLOGY, V112, P195, DOI 10.1007/BF02244910	55	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56105	10.1371/journal.pone.0056105	http://dx.doi.org/10.1371/journal.pone.0056105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441161	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200018
J	Osmancik, P; Teringova, E; Tousek, P; Paulu, P; Widimsky, P				Osmancik, Pavel; Teringova, Elena; Tousek, Petr; Paulu, Petra; Widimsky, Petr			Prognostic Value of TNF-Related Apoptosis Inducing Ligand (TRAIL) in Acute Coronary Syndrome Patients	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; HUMAN ENDOTHELIAL-CELLS; HEART-FAILURE; TROPONIN-T; RECEPTORS 1; INTERVENTION; INHIBITION; EXPRESSION; MORTALITY	Background: Apoptosis plays an important role in the development of heart failure. The aim of the prospectively designed study was to assess whether the concentration of apoptotic markers apoptosis-stimulating fragment (Fas, CD95/APO-1) and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) can predict prognosis in patients with acute coronary syndromes. Methods: The concentrations of soluble Fas and TRAIL were determined in 295 patients with acute coronary syndromes. The status of all patients was evaluated at 6 months. The primary goal was a composite end-point of death and hospitalization for heart failure. The secondary end-points were re-MI, death alone and stroke alone. Results: During the median follow-up of 6 months, 26 patients experienced the composite end-point. Using multivariate logistic regression, the concentration of TRAIL was the strongest significant and independent predictor of composite endpoint (OR 0.11 (95% CI 0.03-0.45), p = 0.002). Low concentration was associated with poor prognosis of patients. Other significant predictors of composite end-point were serum creatinine (OR 7.7 (95% CI 1.1-54.5, p = 0.041) and complete revascularization (OR 0.19 (95% CI 0.05-0.78, p = 0.02). Independent significant predictors of death in the multivariate analysis were the concentration of TRAIL (OR 0.053 (95% CI 0.004-0.744), p = 0.029), older age (OR 1.20 (95% CI 1.02-1.41, p = 0.026) and serum creatinine (OR 15.1 (95% CI 1.56-145.2), p = 0.0193). Re-MI or stroke could not be predicted by any combination of obtained parameters. Conclusions: Low concentrations of soluble TRAIL represent a strong predictor of a poor prognosis in patients with acute coronary syndrome. The predictive value of TRAIL concentration is independent of age, ejection fraction, index peak troponin level, concentration of BNP or serum creatinine.	[Osmancik, Pavel] Charles Univ Prague, Med Sch 3, Dept Cardiol, Cardioctr, Prague, Czech Republic; Univ Hosp Kralovske Vinohrady, Prague, Czech Republic	Charles University Prague; University Hospital Vinohrady	Osmancik, P (corresponding author), Charles Univ Prague, Med Sch 3, Dept Cardiol, Cardioctr, Prague, Czech Republic.	pavel.osmancik@gmail.com	Widimsky, Petr/P-8088-2016; Tousek, Petr/P-3455-2016	Widimsky, Petr/0000-0001-5686-7752; Tousek, Petr/0000-0002-2598-3635	Third Faculty of Medicine, Charles University Prague [PRVOUK P35]	Third Faculty of Medicine, Charles University Prague	Third Faculty of Medicine, Charles University Prague, research project PRVOUK P35. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2003, J AM COLL CARDIOL, V41, P753, DOI 10.1016/S0735-1097(02)02959-5; Byrne RA, 2010, AM J CARDIOL, V106, P1212, DOI 10.1016/j.amjcard.2010.06.050; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Filippatos G, 2003, CURR PHARM DESIGN, V9, P707, DOI 10.2174/1381612033455477; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Goussev A, 1998, AM J PHYSIOL-HEART C, V275, pH626, DOI 10.1152/ajpheart.1998.275.2.H626; Guidez T, 2012, EMERG MED J, V29, P274, DOI 10.1136/emj.2010.104422; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Jayasankar V, 2005, J CARDIAC SURG, V20, P93, DOI 10.1111/j.0886-0440.2005.200373.x; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Landmesser U, 2005, NAT CLIN PRACT CARD, V2, P628, DOI 10.1038/ncpcardio0371; Li JH, 2003, J IMMUNOL, V171, P1526, DOI 10.4049/jimmunol.171.3.1526; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Mueller M, 2012, CLIN RES CARDIOL, V101, P837, DOI 10.1007/s00392-012-0469-6; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Oemrawsingh RM, 2011, HEART, V97, P1061, DOI 10.1136/hrt.2010.197392; Rossig L, 2004, EUR HEART J, V25, P1620, DOI 10.1016/j.ehj.2004.06.036; Schneider P, 1997, IMMUNITY, V7, P831, DOI 10.1016/S1074-7613(00)80401-X; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2010, ATHEROSCLEROSIS, V210, P274, DOI 10.1016/j.atherosclerosis.2009.11.005; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Suzuki G, 2002, CIRCULATION, V106, P2967, DOI 10.1161/01.CIR.0000039104.56479.42; Toffoli B, 2012, INVEST NEW DRUGS; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zauli G, 2003, CIRC RES, V92, P732, DOI 10.1161/01.RES.0000067928.83455.9C; Zhao L, 2009, J INVASIVE CARDIOL, V21, P493	32	37	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e53860	10.1371/journal.pone.0053860	http://dx.doi.org/10.1371/journal.pone.0053860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441146	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200004
J	Rizzetto, L; Giovannini, G; Bromley, M; Bowyer, P; Romani, L; Cavalieri, D				Rizzetto, Lisa; Giovannini, Gloria; Bromley, Michael; Bowyer, Paul; Romani, Luigina; Cavalieri, Duccio			Strain Dependent Variation of Immune Responses to A-fumigatus: Definition of Pathogenic Species	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; ASPERGILLUS-FUMIGATUS; FUNGAL-INFECTIONS; IN-VITRO; TRYPTOPHAN CATABOLISM; CANDIDA-ALBICANS; CELL-WALL; RECOGNITION; RECEPTOR; VIRULENCE	For over a century microbiologists and immunologist have categorized microorganisms as pathogenic or non-pathogenic species or genera. This definition, clearly relevant at the strain and species level for most bacteria, where differences in virulence between strains of a particular species are well known, has never been probed at the strain level in fungal species. Here, we tested the immune reactivity and the pathogenic potential of a collection of strains from Aspergillus spp, a fungus that is generally considered pathogenic in immuno-compromised hosts. Our results show a wide strain-dependent variation of the immune response elicited indicating that different isolates possess diverse virulence and infectivity. Thus, the definition of markers of inflammation or pathogenicity cannot be generalized. The profound understanding of the molecular mechanisms subtending the different immune responses will result solely from the comparative study of strains with extremely diverse properties.	[Rizzetto, Lisa; Cavalieri, Duccio] Univ Florence, Dept Neurosci Pharmacol & Childs Hlth NEUROFARBA, Florence, Italy; [Giovannini, Gloria; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Bromley, Michael; Bowyer, Paul] Univ Manchester, Univ S Manchester Hosp, Natl Aspergillosis Ctr, Manchester, Lancs, England; [Bromley, Michael; Bowyer, Paul] Univ Manchester, Univ S Manchester Hosp, Mycol Reference Ctr, Manchester, Lancs, England; [Bromley, Michael; Bowyer, Paul] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Manchester, Lancs, England; [Cavalieri, Duccio] Edmund Mach Fdn, Innovat & Res Ctr, San Michele All Adige, TN, Italy	University of Florence; University of Perugia; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Fondazione Edmund Mach	Cavalieri, D (corresponding author), Univ Florence, Dept Neurosci Pharmacol & Childs Hlth NEUROFARBA, Florence, Italy.	duccio.cavalieri@fmach.it	Rizzetto, Lisa/C-7304-2016; CAVALIERI, DUCCIO/T-3097-2017; Romani, Luigina/O-9987-2018	Rizzetto, Lisa/0000-0002-2170-9276; CAVALIERI, DUCCIO/0000-0001-6426-5719; Bromley, Michael/0000-0002-7611-0201; bowyer, paul/0000-0002-1083-9286; Romani, Luigina/0000-0002-1356-525X	European Community [242220]	European Community(European Commission)	This work was supported by funding from the European Communitys Integrative Project FP7, SYBARIS (Grant Agreement 242220, www.sybaris.eu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Beauvais A, 1997, INFECT IMMUN, V65, P3042, DOI 10.1128/IAI.65.8.3042-3047.1997; Bonifazi P, 2010, MUCOSAL IMMUNOL, V3, P193, DOI 10.1038/mi.2009.130; Bourgeois C, 2010, CURR OPIN MICROBIOL, V13, P401, DOI 10.1016/j.mib.2010.05.004; Bourgeois Christelle, 2009, V470, P125, DOI 10.1007/978-1-59745-204-5_11; Carvalho A, 2011, BEST PRACT RES CL HA, V24, P435, DOI 10.1016/j.beha.2011.04.006; Chai LYA, 2011, MICROBES INFECT, V13, P151, DOI 10.1016/j.micinf.2010.10.005; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Chai LYA, 2009, INFECT IMMUN, V77, P2184, DOI 10.1128/IAI.01455-08; Clemons KV, 2005, MED MYCOL, V43, pS101, DOI 10.1080/13693780500051919; Cramer RA, 2011, CURR OPIN INFECT DIS, V24, P315, DOI 10.1097/QCO.0b013e328348b159; De Luca A, 2012, J CLIN INVEST, V122, P1816, DOI 10.1172/JCI60862; DEnfert C, 1996, INFECT IMMUN, V64, P4401, DOI 10.1128/IAI.64.10.4401-4405.1996; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Ene IV, 2012, INFECT IMMUN; Esteban A, 2011, P NATL ACAD SCI USA, V108, P14270, DOI 10.1073/pnas.1111415108; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Foligne B, 2010, APPL ENVIRON MICROB, V76, P8259, DOI 10.1128/AEM.01976-10; Foligne B, 2010, WORLD J GASTROENTERO, V16, P2134, DOI 10.3748/wjg.v16.i17.2134; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Peran L, 2005, WORLD J GASTROENTERO, V11, P5185; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Ramaprakash H, 2009, INFECT IMMUN, V77, P108, DOI 10.1128/IAI.00998-08; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Rizzetto L, 2010, J IMMUNOL, V184, P4258, DOI 10.4049/jimmunol.0902972; Romani L, 2006, TRENDS MICROBIOL, V14, P183, DOI 10.1016/j.tim.2006.02.003; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sorrell TC, 2009, ADV EXP MED BIOL, V666, P108; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Upton A, 2007, CLIN INFECT DIS, V44, P531, DOI 10.1086/510592; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006	45	65	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56651	10.1371/journal.pone.0056651	http://dx.doi.org/10.1371/journal.pone.0056651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441211	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200068
J	Pogribny, IP; Kutanzi, K; Melnyk, S; de Conti, A; Tryndyak, V; Montgomery, B; Pogribna, M; Muskhelishvili, L; Latendresse, JR; James, SJ; Beland, FA; Rusyn, I				Pogribny, Igor P.; Kutanzi, Kristy; Melnyk, Stepan; de Conti, Aline; Tryndyak, Volodymyr; Montgomery, Beverly; Pogribna, Marta; Muskhelishvili, Levan; Latendresse, John R.; James, S. Jill; Beland, Frederick A.; Rusyn, Ivan			Strain-dependent dysregulation of one-carbon metabolism in male mice is associated with choline- and folate-deficient diet-induced liver injury	FASEB JOURNAL			English	Article						strain differences; methyl donor deficiency; gene expression; homocysteinemia; NAFLD	ENDOPLASMIC-RETICULUM STRESS; COULOMETRIC ELECTROCHEMICAL DETECTION; ALCOHOL-FED MICE; FATTY LIVER; GENE-EXPRESSION; INTERSTRAIN DIFFERENCES; COLLABORATIVE CROSS; DISEASE; METHIONINE; HYPERHOMOCYSTEINEMIA	Dysregulation of one-carbon metabolism-related metabolic processes is a major contributor to the pathogenesis of nonalcoholic fatty liver disease (NAFLD). It is well established that genetic and gender-specific variations in one-carbon metabolism contribute to the vulnerability to NAFLD in humans. To examine the role of one-carbon metabolism dysregulation in the pathogenesis and individual susceptibility to NAFLD, we used a "population-based" mouse model where male mice from 7 inbred were fed a choline-and folate-deficient (CFD) diet for 12 wk. Strain-dependent down-regulation of several key one-carbon metabolism genes, including methionine adenosyltransferase 1 alpha (Mat1a), cystathionine-beta-synthase (Cbs), methylenetetrahydrofolate reductase (Mthfr), adenosyl-homocysteinase (Ahcy), and methylenetetrahydrofolate dehydrogenase 1 (Mthfd1), was observed. These changes were strongly associated with interstrain variability in liver injury (steatosis, necrosis, inflammation, and activation of fibrogenesis) and hyperhomocysteinemia. Mechanistically, the decreased expression of Mat1a, Ahcy, and Mthfd1 was linked to a reduced level and promoter binding of transcription factor CCAAT/enhancer binding protein beta (CEBP beta), which directly regulates their transcription. The strain specificity of diet-induced dysregulation of one-carbon metabolism suggests that interstrain variation in the regulation of one-carbon metabolism may contribute to the differential vulnerability to NFLD and that correcting the imbalance may be considered as preventive and treatment strategies for NAFLD.-Pogribny, I. P., Kutanzi, K., Melnyk, S., de Conti, A., Tryndyak, V., Montgomery, B., Pogribna, M., Muskhelishvili, L., Latendresse, J. R., James, S. J., Beland, F. A., Rusyn, I. Strain-dependent dysregulation of one-carbon metabolism in male mice is associated with choline- and folate-deficient diet-induced liver injury.	[Pogribny, Igor P.; Kutanzi, Kristy; de Conti, Aline; Tryndyak, Volodymyr; Montgomery, Beverly; Pogribna, Marta; Beland, Frederick A.] US FDA, Natl Ctr Toxicol Res, Div Biochem Toxicol, Jefferson, AR 72079 USA; [Muskhelishvili, Levan; Latendresse, John R.] US FDA, Natl Ctr Toxicol Res, Toxicol Pathol Associates, Jefferson, AR 72079 USA; [Melnyk, Stepan; James, S. Jill] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Rusyn, Ivan] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); University of Arkansas System; University of Arkansas Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill	Pogribny, IP (corresponding author), NCTR, Div Biochem Toxicol, 3900 NCTR Rd, Jefferson, AR 72079 USA.	igor.pogribny@fda.hhs.gov	de Conti, Aline/I-1666-2013; Rusyn, Ivan/S-2426-2016	Rusyn, Ivan/0000-0001-9340-7384; Beland, Frederick/0000-0002-2113-6260; Tryndyak, Volodymyr/0000-0002-8319-2954				Adinolfi LE, 2005, HEPATOLOGY, V41, P995, DOI 10.1002/hep.20664; Bravo E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-60; Buchman AL, 2001, DIGEST DIS SCI, V46, P1, DOI 10.1023/A:1005628121546; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Christensen KE, 2010, J NUTR, V140, P1736, DOI 10.3945/jn.110.124917; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; Daly AK, 2011, EXPERT REV GASTROENT, V5, P253, DOI [10.1586/egh.11.18, 10.1586/EGH.11.18]; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feng QP, 2009, J NEUROCHEM, V110, P1806, DOI 10.1111/j.1471-4159.2009.06276.x; Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156; Harrill AH, 2009, GENOME RES, V19, P1507, DOI 10.1101/gr.090241.108; Harrill AH, 2009, TOXICOL SCI, V110, P235, DOI 10.1093/toxsci/kfp096; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Henkel AS, 2012, AM J PHYSIOL-GASTR L, V303, pG54, DOI 10.1152/ajpgi.00052.2012; Ikeda R, 2008, INT J BIOCHEM CELL B, V40, P1956, DOI 10.1016/j.biocel.2008.02.004; Ji C, 2008, J GASTROEN HEPATOL, V23, pS16, DOI 10.1111/j.1440-1746.2007.05276.x; Ji C, 2004, WORLD J GASTROENTERO, V10, P1699; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Lubos E, 2007, ANTIOXID REDOX SIGN, V9, P1923, DOI 10.1089/ars.2007.1771; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Medici V, 2013, MOL NUTR FOOD RES, V57, P596, DOI 10.1002/mnfr.201200077; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; Melnyk S, 2000, CLIN CHEM, V46, P265; Molloy Anne M, 2012, Subcell Biochem, V56, P105, DOI 10.1007/978-94-007-2199-9_7; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Pogribny IP, 2012, MOL NUTR FOOD RES, V56, P116, DOI 10.1002/mnfr.201100524; Pogribny IP, 2009, J HEPATOL, V51, P176, DOI 10.1016/j.jhep.2009.03.021; Powell CL, 2005, HEPATOLOGY, V42, P1137, DOI 10.1002/hep.20910; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Rusyn I, 2010, PHARMACOGENOMICS, V11, P1127, DOI [10.2217/pgs.10.100, 10.2217/PGS.10.100]; Shinohara M, 2010, HEPATOLOGY, V51, P796, DOI 10.1002/hep.23391; SHIVAPURKAR N, 1986, J NATL CANCER I, V77, P213; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Soon RK, 2010, GASTROENTEROLOGY, V139, P1730, DOI 10.1053/j.gastro.2010.07.046; Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Threadgill DW, 2012, GENETICS, V190, P291, DOI 10.1534/genetics.111.138032; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tryndyak V, 2012, FASEB J, V26, P4592, DOI 10.1096/fj.12-209569; Tryndyak VP, 2012, TOXICOL APPL PHARM, V262, P52, DOI 10.1016/j.taap.2012.04.018; Tryndyak VP, 2011, MOL NUTR FOOD RES, V55, P411, DOI 10.1002/mnfr.201000300; Tsuchiya M, 2012, HEPATOLOGY, V56, P130, DOI 10.1002/hep.25641; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045	55	24	24	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2233	2243		10.1096/fj.12-227116	http://dx.doi.org/10.1096/fj.12-227116			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23439872				2022-12-25	WOS:000319667600014
J	Goltermann, L; Good, L; Bentin, T				Goltermann, Lise; Good, Liam; Bentin, Thomas			Chaperonins Fight Aminoglycoside-induced Protein Misfolding and Promote Short-term Tolerance in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERICIDAL ACTION; ANTIBIOTICS; SHOCK; HEAT; GROE; DNAK	For almost half of a century, we have known that aminoglycoside antibiotics corrupt ribosomes, causing translational misreading, yet it remains unclear whether or not misreading triggers protein misfolding, and possible effects of chaperone action on drug susceptibilities are poorly understood. Here, we show that aminoglycosides cause cytosolic protein misfolding and that chaperonin GroEL/GroES overexpression counters this defect. During aminoglycoside exposure to exponential cultures, chaperonin overexpression protected the bacterial membrane potential, rescued cell growth, and facilitated survival, whereas inhibition of chaperonin expression sensitized bacteria. Overexpression of the DnaK/DnaJ/GrpE chaperone system similarly facilitated survival but did not promote growth of aminoglycoside-treated bacteria. Inhibition of chaperonin expression sensitized bacteria to aminoglycosides as measured by reduced minimum inhibitory concentrations, whereas GroEL/GroES overexpression did not increase minimum inhibitory concentrations. Our observations establish misfolding of cytosolic proteins as an effect of aminoglycoside action and reveal that chaperones, chaperonins in particular, help bacteria cope during early exposure to these drugs.	[Goltermann, Lise; Bentin, Thomas] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-200 Copenhagen, Denmark; [Good, Liam] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London NW1 0TU, England	University of Copenhagen; University of London; University of London Royal Veterinary College	Bentin, T (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	bentin@sund.ku.dk		Goltermann, Lise/0000-0002-6679-9762; Good, Liam/0000-0002-2798-8640	Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	This work was supported by the Carlsberg Foundation.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Cardoso K, 2010, J MED MICROBIOL, V59, P1061, DOI 10.1099/jmm.0.020339-0; DAVIES J, 1965, SCIENCE, V149, P1096, DOI 10.1126/science.149.3688.1096; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Goltermann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010104; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kindrachuk KN, 2011, ANTIMICROB AGENTS CH, V55, P1874, DOI 10.1128/AAC.00935-10; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lin JT, 2005, ANTIMICROB AGENTS CH, V49, P1915, DOI 10.1128/AAC.49.5.1915-1926.2005; Ling JQ, 2012, MOL CELL, V48, P713, DOI 10.1016/j.molcel.2012.10.001; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4	22	51	52	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10483	10489		10.1074/jbc.M112.420380	http://dx.doi.org/10.1074/jbc.M112.420380			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447537	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000317565000028
J	Zakova, L; Kletvikova, E; Veverka, V; Lepsik, M; Watson, CJ; Turkenburg, JP; Jiracek, J; Brzozowski, AM				Zakova, Lenka; Kletvikova, Emilia; Veverka, Vaclav; Lepsik, Martin; Watson, Christopher J.; Turkenburg, Johan P.; Jiracek, Jiri; Brzozowski, Andrzej M.			Structural Integrity of the B24 Site in Human Insulin Is Important for Hormone Functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENTIAL RESONANCE ASSIGNMENT; RECEPTOR-BINDING REGION; MUTANT HUMAN INSULIN; NEGATIVE COOPERATIVITY; MOLECULAR-DYNAMICS; PROTEIN; ANALOGS; CHAIN; RESIDUES; SEMISYNTHESIS	Despite the recent first structural insight into the insulin-insulin receptor complex, the role of the C terminus of the B-chain of insulin in this assembly remains unresolved. Previous studies have suggested that this part of insulin must rearrange to reveal amino acids crucial for interaction with the receptor. The role of the invariant Phe(B24), one of the key residues of the hormone, in this process remains unclear. For example, the B24 site functionally tolerates substitutions to D-amino acids but not to L-amino acids. Here, we prepared and characterized a series of B24-modified insulin analogues, also determining the structures of [D-HisB24]-insulin and [HisB24]-insulin. The inactive [HisB24]-insulin molecule is remarkably rigid due to a tight accommodation of the L-His side chain in the B24 binding pocket that results in the stronger tethering of B25-B28 residues to the protein core. In contrast, the highly active [D-HisB24]-insulin is more flexible, and the reverse chirality of the B24C(alpha) atom swayed the D-His(B24) side chain into the solvent. Furthermore, the pocket vacated by Phe(B24) is filled by Phe(B25), which mimics the Phe(B24) side and main chains. The B25 -> B24 downshift results in a subsequent downshift of Tyr(B26) into the B25 site and the departure of B26-B30 residues away from the insulin core. Our data indicate the importance of the aromatic L-amino acid at the B24 site and the structural invariance/integrity of this position for an effective binding of insulin to its receptor. Moreover, they also suggest limited, B25-B30 only, unfolding of the C terminus of the B-chain upon insulin activation.	[Zakova, Lenka; Kletvikova, Emilia; Veverka, Vaclav; Lepsik, Martin; Jiracek, Jiri] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague 6, Czech Republic; [Watson, Christopher J.; Turkenburg, Johan P.; Brzozowski, Andrzej M.] Univ York, York Struct Biol Lab, Dept Chem, York YO10 5DD, N Yorkshire, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of York - UK	Jiracek, J (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	jiracek@uochb.cas.cz; marek.brzozowski@york.ac.uk	Lepšík, Martin/X-8603-2019; Zakova, Lenka/Y-6234-2019; Jiracek, Jiri/Y-6703-2019; Lepsik, Martin/C-6614-2012; Jiracek, Jiri/A-7124-2008; Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019; Zakova, Lenka/A-7119-2008	Lepšík, Martin/0000-0003-2607-8132; Zakova, Lenka/0000-0001-6439-2574; Jiracek, Jiri/0000-0003-3848-2773; Lepsik, Martin/0000-0003-2607-8132; Jiracek, Jiri/0000-0003-3848-2773; Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Turkenburg, Johan/0000-0001-6992-6838	Grant Agency of the Czech Republic [P207/11/P430]; Ministry of Education of the Czech Republic [LK11205]; Academy of Sciences of the Czech Republic [RVO:61388963]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Diamond Light Source (Did-cot, United Kingdom); MRC [MR/K000179/1] Funding Source: UKRI; Medical Research Council [MR/K000179/1] Funding Source: researchfish	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Diamond Light Source (Did-cot, United Kingdom); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Grant Agency of the Czech Republic Grant P207/11/P430 (to L.Z.), the Ministry of Education of the Czech Republic (Program "NAVRAT" LK11205, to V. V.), Research Project of the Academy of Sciences of the Czech Republic RVO:61388963 (to the Institute of Organic Chemistry and Biochemistry), and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (a Ph.D. studentship to C.J.W.). This work was also supported by the Diamond Light Source (Did-cot, United Kingdom).	Antolikova E, 2011, J BIOL CHEM, V286, P36968, DOI 10.1074/jbc.M111.265249; ASSOIAN RK, 1982, P NATL ACAD SCI-BIOL, V79, P5147, DOI 10.1073/pnas.79.17.5147; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; CASARETTO M, 1987, BIOL CHEM H-S, V368, P709, DOI 10.1515/bchm3.1987.368.1.709; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Cosgrove MS, 2002, BIOCHEMISTRY-US, V41, P6939, DOI 10.1021/bi0255219; DEMEYTS P, 1978, NATURE, V273, P504; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; DODSON EJ, 1983, BIOPOLYMERS, V22, P281, DOI 10.1002/bip.360220137; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GATTNER HG, 1980, H-S Z PHYSIOL CHEM, V361, P1135; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Glendorf T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020288; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, 1992, BIOCHEMISTRY-US, V31, P11940, DOI 10.1021/bi00162a037; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; INOUYE K, 1981, EXPERIENTIA, V37, P811, DOI 10.1007/BF01985653; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KEEFER LM, 1981, BIOCHEM BIOPH RES CO, V100, P1229, DOI 10.1016/0006-291X(81)91955-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kurapkat G, 1999, PROTEIN SCI, V8, P499; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; LUDVIGSEN S, 1994, BIOCHEMISTRY-US, V33, P7998, DOI 10.1021/bi00192a003; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAKAGAWA SH, 1993, BIOCHEMISTRY-US, V32, P7237, DOI 10.1021/bi00079a021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SHOELSON S, 1983, P NATL ACAD SCI-BIOL, V80, P7390, DOI 10.1073/pnas.80.24.7390; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Steiner DF, 2011, J BIOL CHEM, V286, P17399, DOI 10.1074/jbc.X111.244764; SVOBODA I, 1994, BIOL CHEM H-S, V375, P373, DOI 10.1515/bchm3.1994.375.6.373; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; Tran TT, 2006, PROTEIN ENG DES SEL, V19, P401, DOI 10.1093/protein/gzl024; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; WOLLMER A, 1981, H-S Z PHYSIOL CHEM, V362, P581, DOI 10.1515/bchm2.1981.362.1.581; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yao ZP, 1999, ACTA CRYSTALLOGR D, V55, P1524, DOI 10.1107/S0907444999008562; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w; Zakova L, 2007, J PEPT SCI, V13, P334, DOI 10.1002/psc.847; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033; Zoete V, 2006, J COMPUT CHEM, V27, P1843, DOI 10.1002/jcc.20512	64	35	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10230	10240		10.1074/jbc.M112.448050	http://dx.doi.org/10.1074/jbc.M112.448050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447530	Green Published, hybrid			2022-12-25	WOS:000317565000005
J	Vaishnavi, V; Manikandan, M; Tiwary, BK; Munirajan, AK				Vaishnavi, Varadarajan; Manikandan, Mayakannan; Tiwary, Basant K.; Munirajan, Arasambattu Kannan			Insights on the Functional Impact of MicroRNAs Present in Autism-Associated Copy Number Variants	PLOS ONE			English	Article							RARE DE-NOVO; SYNAPTIC-TRANSMISSION; GENE; NETWORK; EXPRESSION; PLASTICITY; DEFICITS; MICRODELETION; DUPLICATIONS; OVERGROWTH	Autism spectrum disorder is a complex neurodevelopmental disorder that appears during the first three years of infancy and lasts throughout a person's life. Recently a large category of genomic structural variants, denoted as copy number variants (CNVs), were established to be a major contributor of the pathophysiology of autism. To date almost all studies have focussed only on the genes present in the CNV loci, but the impact of non-coding regulatory microRNAs (miRNAs) present in these regions remain largely unexplored. Hence we attempted to elucidate the biological and functional significance of miRNAs present in autism-associated CNV loci and their target genes by using a series of computational tools. We demonstrate that nearly 11% of the CNV loci harbor miRNAs and a few of these miRNAs were previously reported to be associated with autism. A systematic analysis of the CNV-miRNAs based on their interactions with the target genes enabled the identification of top 10 miRNAs namely hsa-miR-590-3p, hsa-miR-944, hsa-miR-570, hsa-miR-34a, hsa-miR-124, hsa-miR-548f, hsa-miR-429, hsa-miR-200b, hsa-miR-195 and hsa-miR-497 as hub molecules. Further, the CNV-miRNAs formed a regulatory loop with transcription factors and their downstream target genes, and annotation of these target genes indicated their functional involvement in neurodevelopment and synapse. Moreover, miRNAs present in deleted and duplicated CNV loci may explain the difference in dosage of the crucial genes controlled by them. These CNV-miRNAs can also impair the global processing and biogenesis of all miRNAs by targeting key molecules in the miRNA pathway. To our knowledge, this is the first report to highlight the significance of CNV-microRNAs and their target genes to contribute towards the genetic heterogeneity and phenotypic variability of autism.	[Vaishnavi, Varadarajan; Manikandan, Mayakannan; Munirajan, Arasambattu Kannan] Univ Madras, Dept Genet, Dr ALM PG Inst Basic Med Sci, Madras, Tamil Nadu, India; [Tiwary, Basant K.] Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Pondicherry, India	University of Madras; Pondicherry University	Munirajan, AK (corresponding author), Univ Madras, Dept Genet, Dr ALM PG Inst Basic Med Sci, Madras, Tamil Nadu, India.	akmunirajan@unom.ac.in	Munirajan, Arasambattu/S-1096-2019; MUNIRAJAN, A K/P-5953-2019; Tiwary, Basant K/A-9617-2011	MUNIRAJAN, A K/0000-0003-1337-9008; Tiwary, Basant K/0000-0002-8194-5860; Manikandan, Mayakannan/0000-0002-6659-8987	Department of Biotechnology, New Delhi, India [BT/PR10023/AGR/36/27/2007]; Council of Scientific and Industrial Research, New Delhi	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology, New Delhi, India to AKM (Grant No. BT/PR10023/AGR/36/27/2007). MM is supported by a research fellowship from the Council of Scientific and Industrial Research, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21093, DOI 10.1073/pnas.1112061109; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21099, DOI 10.1073/pnas.1112063108; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Akerblom M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00014; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bauman ML, 2010, NEUROTHERAPEUTICS, V7, P320, DOI 10.1016/j.nurt.2010.06.001; Berg JM, 2012, GENOME BIOL, V13, DOI [10.1186/gb4034, 10.1186/gb-2012-13-7-247]; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Ceman S, 2011, PHARMACOL THERAPEUT, V130, P26, DOI 10.1016/j.pharmthera.2011.01.004; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Courchesne E, 2005, INT J DEV NEUROSCI, V23, P153, DOI 10.1016/j.ijdevneu.2005.01.003; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; El Baroudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014742; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Gkogkas CG, 2012, NATURE; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hsu R, 2012, MOL CELL NEUROSCI, V50, P283, DOI 10.1016/j.mcn.2012.06.002; Jobling MA, 2008, CYTOGENET GENOME RES, V123, P253, DOI 10.1159/000184715; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee K, 2012, J NEUROSCI, V32, P5678, DOI 10.1523/JNEUROSCI.6471-11.2012; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Marshall CR, 2012, METHODS MOL BIOL, V838, P115, DOI 10.1007/978-1-61779-507-7_5; Marti E, 2010, NUCLEIC ACIDS RES, V38, P7219, DOI 10.1093/nar/gkq575; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice GM, 2011, AM J MED GENET A; Rozen SG, 2012, AM J HUM GENET, V91, P890, DOI 10.1016/j.ajhg.2012.09.003; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Santini E, 2012, NATURE; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Schofield CM, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-11; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sengupta D, 2011, MOL BIOSYST, V7, P1966, DOI 10.1039/c0mb00347f; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Van der Aa N, 2012, AUTISM RES; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Waltereit R, 2011, BEHAV GENET, V41, P364, DOI 10.1007/s10519-010-9399-0; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	67	55	58	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56781	10.1371/journal.pone.0056781	http://dx.doi.org/10.1371/journal.pone.0056781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451085	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500028
J	Bertin, A; Chanson, M; Delaveau, J; Mercerand, F; Mostl, E; Calandreau, L; Arnould, C; Leterrier, C; Collin, A				Bertin, Aline; Chanson, Marine; Delaveau, Joel; Mercerand, Frederic; Moestl, Erich; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine; Collin, Anne			Moderate Heat Challenge Increased Yolk Steroid Hormones and Shaped Offspring Growth and Behavior in Chickens	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; SPARROW PASSER-DOMESTICUS; JAPANESE-QUAIL HATCHLINGS; TONIC IMMOBILITY REACTION; GALLUS-GALLUS-DOMESTICUS; LAYING HENS; AMBIENT-TEMPERATURE; FEEDING-BEHAVIOR; MATERNAL TESTOSTERONE; DIVERGENT SELECTION	Background: Environmental challenges might affect the maternal organism and indirectly affect the later ontogeny of the progeny. We investigated the cross-generation impact of a moderate heat challenge in chickens. We hypothesized that a warm temperature-within the thermotolerance range-would affect the hormonal environment provided to embryos by mothers, and in turn, affect the morphology and behavioral phenotype of offspring. Methodology/Principal Findings: Laying hens were raised under a standard thermal condition at 21 degrees C (controls) or 30 degrees C (experimental) for 5 consecutive weeks. A significant increase was observed in the internal temperature of hens exposed to the warm treatment; however plasma corticosterone levels remained unaffected. The laying rate was not affected, but experimental hens laid lighter eggs than the controls during the treatment. As expected, the maternal thermal environment affected yolk hormone contents. Eggs laid by the experimental hens showed significantly higher concentrations of yolk progesterone, testosterone, and estradiol. All chicks were raised under standard thermal conditions. The quality of hatchlings, growth, feeding behavior and emotional reactivity of chicks were analyzed. Offspring of experimental hens (C30 chicks) were lighter but obtained better morphological quality scores at hatching than the controls (C21 chicks). C30 chicks expressed lesser distress calls when exposed to a novel food. Unlike C21 chicks, C30 chicks expressed no preference for energetic food. Conclusion/Significance: Our findings suggest that moderate heat challenge triggers maternal effects and modulate the developmental trajectory of offspring in a way that may be adaptive. This suggests that the impact of heat challenges on captive or wild populations might have a cross-generation effect.	[Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] CNRS, UMR7247, Nouzilly, France; [Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] Univ Tours, Tours, France; [Bertin, Aline; Chanson, Marine; Calandreau, Ludovic; Arnould, Cecile; Leterrier, Christine] IFCE, Nouzilly, France; [Delaveau, Joel; Mercerand, Frederic] INRA, UE1295, PEAT, F-37380 Nouzilly, France; [Moestl, Erich] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Collin, Anne] INRA, Rech Avicoles UR83, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; INRAE; University of Veterinary Medicine Vienna; INRAE	Bertin, A (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	aline.bertin@tours.inra.fr	Moreira, Nei/AAK-1357-2020; Leterrier, Christine/AAY-7201-2020	Moreira, Nei/0000-0002-9236-667X; 	Department PHASE of INRA	Department PHASE of INRA	The authors were supported by the Department PHASE of INRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DH, 2005, J EVOLUTION BIOL, V18, P884, DOI 10.1111/j.1420-9101.2005.00955.x; ARIELI A, 1980, BRIT POULTRY SCI, V21, P471, DOI 10.1080/00071668008416699; Barnagaud JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032819; Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bertin A, 2010, ETHOLOGY, V116, P1027, DOI 10.1111/j.1439-0310.2010.01820.x; Bertin A, 2009, HORM BEHAV, V56, P416, DOI 10.1016/j.yhbeh.2009.07.008; Calandreau L, 2011, BEHAV BRAIN RES, V217, P104, DOI 10.1016/j.bbr.2010.10.004; CAMPO JL, 1994, ARCH GEFLUGELKD, V58, P75; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; DONOGHUE DJ, 1989, BIOL REPROD, V41, P419, DOI 10.1095/biolreprod41.3.419; Dzialowski EM, 2004, J EXP BIOL, V207, P597, DOI 10.1242/jeb.00792; Fasenko GM, 2008, POULTRY SCI, V87, P594, DOI 10.3382/ps.2007-00352; FAURE JM, 1983, BIOL BEHAV, V8, P103; GENTLE MJ, 1972, BRIT POULTRY SCI, V13, P141, DOI 10.1080/00071667208415928; Greenberg RS, 2003, ANIMAL INNOVATION; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guesdon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023941; Guibert F, 2011, APPL ANIM BEHAV SCI, V132, P51, DOI 10.1016/j.applanim.2011.03.012; Guibert F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014069; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; Harper LV, 2005, PSYCHOL BULL, V131, P340, DOI 10.1037/0033-2909.131.3.340; Hegyi G, 2010, J AVIAN BIOL, V41, P258, DOI 10.1111/j.1600-048X.2009.04787.x; Henriksen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023824; Henriksen R, 2011, NEUROSCI BIOBEHAV R, V35, P1484, DOI 10.1016/j.neubiorev.2011.04.010; HUANG ESR, 1979, BIOL REPROD, V20, P442, DOI 10.1095/biolreprod20.3.442; Ipek A., 2007, Journal of Biological & Environmental Sciences, V1, P117; IQBAL A, 1990, J THERM BIOL, V15, P149, DOI 10.1016/0306-4565(90)90032-D; Janczak AM, 2009, ACTA AGR SCAND A-AN, V59, P80, DOI 10.1080/09064700903023348; Janczak AM, 2007, APPL ANIM BEHAV SCI, V107, P66, DOI 10.1016/j.applanim.2006.09.016; JONES RB, 1986, BEHAV PROCESS, V12, P261, DOI 10.1016/0376-6357(86)90040-9; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1986, WORLD POULTRY SCI J, V42, P82, DOI 10.1079/WPS19860008; JONSON KM, 1976, BRAIN RES BULL, V1, P133, DOI 10.1016/0361-9230(76)90056-3; Kjaer JB, 2009, PHYSIOL BEHAV, V96, P370, DOI 10.1016/j.physbeh.2008.10.023; Kyriazakis I, 1999, P NUTR SOC, V58, P765, DOI 10.1017/S0029665199001044; Lecuelle S, 2010, APPL ANIM BEHAV SCI, V125, P132, DOI 10.1016/j.applanim.2010.04.009; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; MacLeod MG, 1997, BRIT POULTRY SCI, V38, P586, DOI 10.1080/00071669708418040; Marples NM, 1999, EVOL ECOL, V13, P641, DOI 10.1023/A:1011077731153; Mashaly MM, 2004, POULTRY SCI, V83, P889, DOI 10.1093/ps/83.6.889; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; Okuliarova M., 2006, ACTA VET BRNO, V75, P325; Okuliarova M, 2010, GEN COMP ENDOCR, V165, P91, DOI 10.1016/j.ygcen.2009.06.007; Pfannkuche KA, 2011, GEN COMP ENDOCR, V172, P487, DOI 10.1016/j.ygcen.2011.04.014; Renaudeau D, 2012, ANIMAL, V6, P707, DOI 10.1017/S1751731111002448; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Rozenboim I, 2007, POULTRY SCI, V86, P1760, DOI 10.1093/ps/86.8.1760; Sauveur B., 1988, REPROD VOLAILLES PRO; SAVORY CJ, 1986, PHYSIOL BEHAV, V38, P353, DOI 10.1016/0031-9384(86)90106-X; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 2007, AM NAT, V170, P196, DOI 10.1086/519397; Sockman KW, 2001, GEN COMP ENDOCR, V122, P205, DOI 10.1006/gcen.2001.7626; Sol D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019535; Tobler M, 2007, HORM BEHAV, V52, P640, DOI 10.1016/j.yhbeh.2007.07.016; Tona K, 2003, POULTRY SCI, V82, P736, DOI 10.1093/ps/82.5.736; Vedder O, 2007, J AVIAN BIOL, V38, P625, DOI 10.1111/j.2007.0908-8857.04018.x; Verboven N, 2003, P ROY SOC B-BIOL SCI, V270, P2223, DOI 10.1098/rspb.2003.2496; Wauters AM, 2002, DEV PSYCHOBIOL, V41, P25, DOI 10.1002/dev.10042; Yahav S, 2000, AVIAN POULT BIOL REV, V11, P81; Yahav S, 2009, WORLD POULTRY SCI J, V65, P719, DOI 10.1017/S004393390900049X; Yahav S, 2000, BRIT POULTRY SCI, V41, P660, DOI 10.1080/713654988; Yo T, 1998, POULTRY SCI, V77, P502, DOI 10.1093/ps/77.4.502; ZADWORNY D, 1989, GEN COMP ENDOCR, V74, P468, DOI 10.1016/S0016-6480(89)80044-9	74	20	20	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57670	10.1371/journal.pone.0057670	http://dx.doi.org/10.1371/journal.pone.0057670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451257	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800115
J	Gabaldon, C; Montero-Pau, J; Serra, M; Carmona, MJ				Gabaldon, Carmen; Montero-Pau, Javier; Serra, Manuel; Jose Carmona, Maria			Morphological Similarity and Ecological Overlap in Two Rotifer Species	PLOS ONE			English	Article							BRACHIONUS-PLICATILIS; BODY-SIZE; RESOURCE COMPETITION; SEXUAL REPRODUCTION; NICHE CONSERVATISM; PARTICLE-SIZE; LIMITING SIMILARITY; MOLECULAR ECOLOGY; POPULATION-GROWTH; FOOD SIZE	Co-occurrence of cryptic species raises theoretically relevant questions regarding their coexistence and ecological similarity. Given their great morphological similitude and close phylogenetic relationship (i.e., niche retention), these species will have similar ecological requirements and are expected to have strong competitive interactions. This raises the problem of finding the mechanisms that may explain the coexistence of cryptic species and challenges the conventional view of coexistence based on niche differentiation. The cryptic species complex of the rotifer Brachionus plicatilis is an excellent model to study these questions and to test hypotheses regarding ecological differentiation. Rotifer species within this complex are filtering zooplankters commonly found inhabiting the same ponds across the Iberian Peninsula and exhibit an extremely similar morphology-some of them being even virtually identical. Here, we explore whether subtle differences in body size and morphology translate into ecological differentiation by comparing two extremely morphologically similar species belonging to this complex: B. plicatilis and B. manjavacas. We focus on three key ecological features related to body size: (1) functional response, expressed by clearance rates; (2) tolerance to starvation, measured by growth and reproduction; and (3) vulnerability to copepod predation, measured by the number of preyed upon neonates. No major differences between B. plicatilis and B. manjavacas were found in the response to these features. Our results demonstrate the existence of a substantial niche overlap, suggesting that the subtle size differences between these two cryptic species are not sufficient to explain their coexistence. This lack of evidence for ecological differentiation in the studied biotic niche features is in agreement with the phylogenetic limiting similarity hypothesis but requires a mechanistic explanation of the coexistence of these species not based on differentiation related to biotic niche axes.	[Gabaldon, Carmen; Montero-Pau, Javier; Serra, Manuel; Jose Carmona, Maria] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain	University of Valencia	Gabaldon, C (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	carmen.gabaldon-tebar@uv.es	Serra, Manuel/H-7817-2015; Carmona, María José/AAM-4340-2020; Montero-Pau, Javier/H-6711-2015; GABALDÓN, CARMEN/N-3245-2017; Carmona, María José/H-6452-2015	Serra, Manuel/0000-0003-1731-1529; Carmona, María José/0000-0002-4835-6933; Montero-Pau, Javier/0000-0002-0864-8157; Carmona, María José/0000-0002-4835-6933	Ministerio de Ciencia [CGL2009-07364]; Spanish Ministerio de Ciencia e Innovacion [BES2010-036384]	Ministerio de Ciencia(Spanish Government); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was founded by a grant from the Ministerio de Ciencia (CGL2009-07364) to MS. CG was supported by a fellowship from the Spanish Ministerio de Ciencia e Innovacion (BES2010-036384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1967, TREATISE LIMNOL; Barlow KE, 1997, P ROY SOC B-BIOL SCI, V264, P1695, DOI 10.1098/rspb.1997.0235; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; BOGDAN KG, 1984, P NATL ACAD SCI-BIOL, V81, P6427, DOI 10.1073/pnas.81.20.6427; Bundy MH, 2002, J PLANKTON RES, V24, P215, DOI 10.1093/plankt/24.3.215; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; Campillo S, 2009, J EVOLUTION BIOL, V22, P2542, DOI 10.1111/j.1420-9101.2009.01871.x; Carmona MJ, 1995, HYDROBIOLOGIA, V313, P365, DOI 10.1007/BF00025971; Caswell H., 2006, ENCY ENV, VSecond, DOI 10.1002/9780470057339.vam006m; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHOTIYAPUTTA C, 1978, MAR BIOL, V45, P105, DOI 10.1007/BF00390546; Ciros-Perez J, 2004, LIMNOL OCEANOGR, V49, P40, DOI 10.4319/lo.2004.49.1.0040; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Conde-Porcuna JM, 1998, J PLANKTON RES, V20, P605, DOI 10.1093/plankt/20.4.605; Cox D. R., 1984, ANAL SURVIVAL DATA; DeMott WR, 1989, PLANKTON ECOLOGY SUC; DUMONT HJ, 1977, ARCH HYDROBIOL BEIH, V8, P98; Efron B., 1981, CANADIAN J STATISTIC, V9, P139, DOI [10.1093/jtm/taab016, DOI 10.1093/jtm/taab016]; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Futuyma DJ, 1996, PHILOS T R SOC B, V351, P1361, DOI 10.1098/rstb.1996.0119; Garcia-Roger EM, 2009, LIMNOL OCEANOGR, V54, P1845, DOI 10.4319/lo.2009.54.6.1845; Garcia-Roger EM, 2006, J PLANKTON RES, V28, P257, DOI 10.1093/plankt/fbi062; Geange SW, 2011, METHODS ECOL EVOL, V2, P175, DOI 10.1111/j.2041-210X.2010.00070.x; Gilbert J.J., 1984, P97; Gilbert JJ, 2004, FRESHWATER BIOL, V49, P1505, DOI 10.1111/j.1365-2427.2004.01282.x; GILBERT JJ, 1978, OECOLOGIA, V37, P13, DOI 10.1007/BF00349987; Gomez A, 2000, MOL ECOL, V9, P203, DOI 10.1046/j.1365-294x.2000.00849.x; Gomez A, 2005, HYDROBIOLOGIA, V546, P83, DOI 10.1007/s10750-005-4104-7; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Gomez A, 1997, OECOLOGIA, V111, P350, DOI 10.1007/s004420050245; GOMEZ A, 1995, J EVOLUTION BIOL, V8, P601, DOI 10.1046/j.1420-9101.1995.8050601.x; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; GUWICZ Z. M., 1980, EVOLUTION ECOLOGY ZO, V3, P282; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; Hansen B, 1997, J EXP MAR BIOL ECOL, V215, P217, DOI 10.1016/S0022-0981(97)00053-1; HANSEN B, 1991, MAR BIOL, V111, P263, DOI 10.1007/BF01319708; HINO A, 1984, B JPN SOC SCI FISH, V50, P1139; HINO A, 1980, B JPN SOC SCI FISH, V46, P1217; Hubbell Stephen P., 2001, V32, pi; KERFOOT WC, 1977, LIMNOL OCEANOGR, V22, P316, DOI 10.4319/lo.1977.22.2.0316; Kirk KL, 1997, ECOLOGY, V78, P434, DOI 10.1890/0012-9658(1997)078[0434:LHRTVE]2.0.CO;2; Kong LF, 2009, MAR BIOL, V156, P1507, DOI 10.1007/s00227-009-1190-5; Lapesa S, 2004, FRESHWATER BIOL, V49, P1053, DOI 10.1111/j.1365-2427.2004.01249.x; Lapesa S, 2002, FRESHWATER BIOL, V47, P1685, DOI 10.1046/j.1365-2427.2002.00926.x; Lapesa S, 2004, EFECTO DEPREDACION I; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; McPeek MA, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P355; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021530; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Moore PA, 1999, LIMNOL OCEANOGR, V44, P166, DOI 10.4319/lo.1999.44.1.0166; OBRIEN WJ, 1976, ECOLOGY, V57, P1304, DOI 10.2307/1935055; PASTOROK RA, 1981, ECOLOGY, V62, P1311, DOI 10.2307/1937295; Peters R.H., 1984, MANUAL METHODS ASSES, V17, P336; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pitta Paraskevi, 1997, Hydrobiologia, V363, P97, DOI 10.1023/A:1003121704913; Pourriot R., 1977, ARCHIV F R HYDROBIOL, V8, P243; Quinn GP, 2005, EXPT DESIGN DATA ANA; Ricci C, 2006, FUNCT ECOL, V20, P340, DOI 10.1111/j.1365-2435.2006.01082.x; RIGLER FH, 1961, CAN J ZOOLOG, V39, P857, DOI 10.1139/z61-080; ROCHE K, 1990, HYDROBIOLOGIA, V198, P153, DOI 10.1007/BF00048632; ROCHE KF, 1987, HYDROBIOLOGIA, V147, P229, DOI 10.1007/BF00025747; Rodriguez-Puebla C, 1998, INT J CLIMATOL, V18, P299, DOI 10.1002/(SICI)1097-0088(19980315)18:3&lt;299::AID-JOC247&gt;3.0.CO;2-L; ROTHHAUPT KO, 1990, LIMNOL OCEANOGR, V35, P16, DOI 10.4319/lo.1990.35.1.0016; ROTHHAUPT KO, 1990, FRESHWATER BIOL, V23, P561, DOI 10.1111/j.1365-2427.1990.tb00295.x; ROTHHAUPT KO, 1990, ARCH HYDROBIOL, V118, P1; ROTHHAUPT KO, 1990, LIMNOL OCEANOGR, V35, P24, DOI 10.4319/lo.1990.35.1.0024; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SCHULZE PC, 1995, LIMNOL OCEANOGR, V40, P33, DOI 10.4319/lo.1995.40.1.0033; SERRA M, 1987, HYDROBIOLOGIA, V147, P83, DOI 10.1007/BF00025729; Snell TW, 2006, MAR BIOL, V149, P763, DOI 10.1007/s00227-006-0251-2; Sommer U., 1989, P57; Stearns S.C., 1992, pi; Stelzer CP, 2006, LIMNOL OCEANOGR, V51, P125, DOI 10.4319/lo.2006.51.1.0125; Stelzer CP, 2003, LIMNOL OCEANOGR, V48, P939, DOI 10.4319/lo.2003.48.2.0939; Stelzer CP, 2001, ECOLOGY, V82, P2521; STEMBERGER RS, 1987, ECOLOGY, V68, P181, DOI 10.2307/1938818; STEMBERGER RS, 1985, ECOLOGY, V66, P1151, DOI 10.2307/1939167; Stemberger RS, 1982, MECH CONTROLLING SEL; STEWART AJ, 1986, ARCH HYDROBIOL, V106, P1; THRELKELD ST, 1976, FRESHWATER BIOL, V6, P489, DOI 10.1111/j.1365-2427.1976.tb01640.x; Tilman D., 1982, Monographs in Population Biology, pi; Tortajada AM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-312; Turner JT, 2005, DEEP-SEA RES PT II, V52, P2801, DOI 10.1016/j.dsr2.2005.06.011; VADSTEIN O, 1993, HYDROBIOLOGIA, V255, P261, DOI 10.1007/BF00025847; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; WARE DM, 1972, J FISH RES BOARD CAN, V29, P1193, DOI 10.1139/f72-175; WARE DM, 1973, J FISH RES BOARD CAN, V30, P787, DOI 10.1139/f73-134; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; WILLIAMSON CE, 1987, LIMNOL OCEANOGR, V32, P167, DOI 10.4319/lo.1987.32.1.0167; WILSON DS, 1975, AM NAT, V109, P769, DOI 10.1086/283042; Yoshinaga T, 2003, J EXP MAR BIOL ECOL, V287, P261, DOI 10.1016/S0022-0981(02)00574-9; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x; Zhang DY, 1998, J THEOR BIOL, V193, P465, DOI 10.1006/jtbi.1998.0712; Zhou WL, 2009, CHIN J OCEANOL LIMN, V27, P473, DOI 10.1007/s00343-009-9208-x	109	28	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57087	10.1371/journal.pone.0057087	http://dx.doi.org/10.1371/journal.pone.0057087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451154	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800071
J	Kwon, N; Pyo, J; Lee, SJ; Je, JH				Kwon, Namseop; Pyo, Jaeyeon; Lee, Seung-Jae; Je, Jung Ho			3-D Worm Tracker for Freely Moving C. elegans	PLOS ONE			English	Article							NEMATODE; BEHAVIOR; SYSTEM	The manner in which the nervous system regulates animal behaviors in natural environments is a fundamental issue in biology. To address this question, C. elegans has been widely used as a model animal for the analysis of various animal behaviors. Previous behavioral assays have been limited to two-dimensional (2-D) environments, confining the worm motion to a planar substrate that does not reflect three-dimensional (3-D) natural environments such as rotting fruits or soil. Here, we develop a 3-D worm tracker (3DWT) for freely moving C. elegans in 3-D environments, based on a stereoscopic configuration. The 3DWT provides us with a quantitative trajectory, including the position and movement direction of the worm in 3-D. The 3DWT is also capable of recording and visualizing postures of the moving worm in 3-D, which are more complex than those in 2-D. Our 3DWT affords new opportunities for understanding the nervous system function that regulates animal behaviors in natural 3-D environments.	[Kwon, Namseop; Pyo, Jaeyeon; Je, Jung Ho] Pohang Univ Sci & Technol, Xray Imaging Ctr, Pohang, South Korea; [Kwon, Namseop; Lee, Seung-Jae; Je, Jung Ho] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Pyo, Jaeyeon; Je, Jung Ho] Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang, South Korea; [Lee, Seung-Jae] Pohang Univ Sci & Technol, Dept Mol & Life Sci, Pohang, South Korea; [Lee, Seung-Jae] Pohang Univ Sci & Technol, World Class Univ Informat Technol Convergence Eng, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea.	seungjaelee@postech.ac.kr; jhje@postech.ac.kr	Lee, Seung Jae V/E-2468-2019	Lee, Seung-Jae/0000-0002-6103-156X	Creative Research Initiatives (Functional X-ray Imaging) of MEST/NRF (Ministry of Education, Science and Technology/National Research Foundation)	Creative Research Initiatives (Functional X-ray Imaging) of MEST/NRF (Ministry of Education, Science and Technology/National Research Foundation)	This research was supported by the Creative Research Initiatives (Functional X-ray Imaging) of MEST/NRF (Ministry of Education, Science and Technology/National Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENNER S, 1974, GENETICS, V77, P71; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; Cronin Christopher J., 2006, V351, P241; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; GUO ZC, 1989, COMMUN ACM, V32, P359, DOI 10.1145/62065.62074; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Ronkko M, 2008, J THEOR BIOL, V253, P316, DOI 10.1016/j.jtbi.2008.03.028; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	14	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57484	10.1371/journal.pone.0057484	http://dx.doi.org/10.1371/journal.pone.0057484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437394	gold, Green Submitted, Green Published			2022-12-25	WOS:000315186000107
J	Wang, Q; Li, B; Tsang, AKL; Yi, Y; Woo, PCY; Liu, CH				Wang, Qi; Li, Bin; Tsang, Alan K. L.; Yi, Yong; Woo, Patrick C. Y.; Liu, Cui Hua			Genotypic Analysis of Klebsiella pneumoniae Isolates in a Beijing Hospital Reveals High Genetic Diversity and Clonal Population Structure of Drug-Resistant Isolates	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; RISK-FACTORS; TEL-AVIV; STRAINS; SPREAD; CARE; DISSEMINATION; CIPROFLOXACIN; INFECTION	Background: The genetic diversity and the clinical relevance of the drug-resistant Klebsiella pneumoniae isolates from hospital settings are largely unknown. We thus conducted this prospective study to analyze the molecular epidemiology of K. pneumoniae isolates from patients being treated in the 306 Hospital in Beijing, China for the period of November 1, 2010-October 31, 2011. Methodology/Principal Findings: Antibiotic susceptibility testing, PCR amplification and sequencing of the drug resistance-associated genes, and multilocus sequence typing (MLST) were conducted. A total of 163 isolates were analyzed. The percentage of MDR, XDR and PDR isolates were 63.8% (104), 20.9 (34), and 1.8% (3), respectively. MLST results showed that 60 sequence types (STs) were identified, which were further separated by eBURST into 13 clonal complexes and 18 singletons. The most dominant ST was ST15 (10.4%). Seven new alleles and 24 new STs were first identified in this study. Multiple logistic regression analysis revealed that certain clinical characteristics were associated with those prevalent STs such as: from ICU, from medical ward, from community acquired infection, from patients without heart disease, from patients with treatment success, susceptible to extended spectrum cephalosporin, susceptible to cephamycins, susceptible to fluoroquinolones, and with MDR. Conclusions/Significance: Our data indicate that certain drug-resistant K. pneumoniae clones are highly prevalent and are associated with certain clinical characteristics in hospital settings. Our study provides evidence demonstrating that intensive nosocomial infection control measures are urgently needed.	[Wang, Qi; Li, Bin; Liu, Cui Hua] Chinese Acad Sci, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Tsang, Alan K. L.; Woo, Patrick C. Y.] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Yi, Yong] 306 Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; University of Hong Kong	Woo, PCY (corresponding author), Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	pcywoo@hkucc.hku.hk; liucuihua@im.ac.cn	Woo, Patrick Chiu Yat/AAJ-6112-2020	Woo, Patrick Chiu Yat/0000-0001-9401-1832	National Basic Research Program of China [2012CB518700]; National Natural Science Foundation of China (NSFC) [30700975]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-6]; Merieux Research Grant program; Chinese Academy of Sciences; Merieux Research Grant	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Merieux Research Grant program; Chinese Academy of Sciences(Chinese Academy of Sciences); Merieux Research Grant	This study was supported by a grant from the National Basic Research Program of China (grant number 2012CB518700); a grant from National Natural Science Foundation of China (NSFC) (grant No. 30700975); a grant from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6); and the Merieux Research Grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was largely supported by research grants from National Natural Science Foundation of China and Chinese Academy of Sciences, while the Merieux Research Grant acknowledged in this manuscript only partially contributed to this study. In addition, no competing interests and any other relevant declarations relating to employment, consultancy, patents, products in development or marketed products etc. are associated with this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; [Anonymous], 2011, PERF STAND ANT SUS S; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Breurec S, 2013, CLIN MICROBIOL INFEC, V19, P349, DOI 10.1111/j.1469-0691.2012.03805.x; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; Chmelnitsky I, 2009, J ANTIMICROB CHEMOTH, V64, P718, DOI 10.1093/jac/dkp272; Chudackova E, 2010, FEMS MICROBIOL LETT, V309, P62, DOI 10.1111/j.1574-6968.2010.02016.x; Chung DR, 2012, EUR J CLIN MICROBIOL, V31, P481, DOI 10.1007/s10096-011-1334-7; Chung HC, 2012, ANTIMICROB AGENTS CH, V56, P618, DOI 10.1128/AAC.05753-11; Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10; Daikos GL, 2009, ANTIMICROB AGENTS CH, V53, P1868, DOI 10.1128/AAC.00782-08; Damjanova I, 2008, J ANTIMICROB CHEMOTH, V62, P978, DOI 10.1093/jac/dkn287; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hammerum AM, 2010, LANCET INFECT DIS, V10, P829, DOI 10.1016/S1473-3099(10)70276-0; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Jemima SA, 2008, INDIAN J MED MICROBI, V26, P365, DOI 10.4103/0255-0857.43581; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Kohlenberg A, 2012, EPIDEMIOL INFECT, V140, P528, DOI 10.1017/S0950268811000781; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lee MY, 2011, INT J ANTIMICROB AG, V38, P160, DOI 10.1016/j.ijantimicag.2011.03.020; Li B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042280; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nagano N, 2012, J ANTIMICROB CHEMOTH, V67, P849, DOI 10.1093/jac/dkr546; Nielsen JB, 2011, EUR J CLIN MICROBIOL, V30, P773, DOI 10.1007/s10096-011-1153-x; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Orsi GB, 2006, J HOSP INFECT, V64, P23, DOI 10.1016/j.jhin.2006.02.022; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Ramirez MS, 2010, DRUG RESIST UPDATE, V13, P151, DOI 10.1016/j.drup.2010.08.003; Rotariu O, 2010, EPIDEMIOL INFECT, V138, P1744, DOI 10.1017/S0950268810001457; Sanchez-Romero I, 2012, ANTIMICROB AGENTS CH, V56, P420, DOI 10.1128/AAC.05036-11; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Siu LK, 2011, J CLIN MICROBIOL, V49, P3761, DOI 10.1128/JCM.00977-11; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zimhony O, 2006, ANTIMICROB AGENTS CH, V50, P3179, DOI 10.1128/AAC.00218-06	41	27	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57091	10.1371/journal.pone.0057091	http://dx.doi.org/10.1371/journal.pone.0057091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437318	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000075
J	Paupy, C; Makanga, B; Ollomo, B; Rahola, N; Durand, P; Magnus, J; Willaume, E; Renaud, F; Fontenille, D; Prugnolle, F				Paupy, Christophe; Makanga, Boris; Ollomo, Benjamin; Rahola, Nil; Durand, Patrick; Magnus, Julie; Willaume, Eric; Renaud, Francois; Fontenille, Didier; Prugnolle, Franck			Anopheles moucheti and Anopheles vinckei Are Candidate Vectors of Ape Plasmodium Parasites, Including Plasmodium praefalciparum in Gabon	PLOS ONE			English	Article							HUMAN MALARIA; FALCIPARUM; ORIGIN; MOSQUITOS; COMPLEX; AFRICA	During the last four years, knowledge about the diversity of Plasmodium species in African great apes has considerably increased. Several new species were described in chimpanzees and gorillas, and some species that were previously considered as strictly of human interest were found to be infecting African apes. The description in gorillas of P. praefalciparum, the closest relative of P. falciparum which is the main malignant agent of human malaria, definitively changed the way we understand the evolution and origin of P. falciparum. This parasite is now considered to have appeared recently, following a cross-species transfer from gorillas to humans. However, the Plasmodium vector mosquito species that have served as bridge between these two host species remain unknown. In order to identify the vectors that ensure ape Plasmodium transmission and evaluate the risk of transfer of these parasites to humans, we carried out a field study in Gabon to capture Anopheles in areas where wild and semi-wild ape populations live. We collected 1070 Anopheles females belonging to 15 species, among which An. carnevalei, An. moucheti and An. marshallii were the most common species. Using mtDNA-based PCR tools, we discovered that An. moucheti, a major human malaria vector in Central Africa, could also ensure the natural transmission of P. praefalciparum among great apes. We also showed that, together with An. vinckei, An. moucheti was infected with P. vivax-like parasites. An. moucheti constitutes, therefore, a major candidate for the transfer of Plasmodium parasites from apes to humans.	[Paupy, Christophe; Rahola, Nil; Durand, Patrick; Renaud, Francois; Fontenille, Didier; Prugnolle, Franck] IRD Montpellier, Lab MIVEGEC, UMR CNRS IRD UM1 UM2 224 5290, Montpellier, France; [Paupy, Christophe; Makanga, Boris; Ollomo, Benjamin; Rahola, Nil; Magnus, Julie; Prugnolle, Franck] CIRMF, Franceville, Gabon; [Makanga, Boris] Inst Rech Ecol Trop, Libreville, Gabon; [Willaume, Eric] ERMAET COMILOG, Bakoumba, Gabon	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Paupy, C (corresponding author), IRD Montpellier, Lab MIVEGEC, UMR CNRS IRD UM1 UM2 224 5290, Montpellier, France.	christophe.paupy@ird.fr; franck.prugnolle@ird.fr	Paupy, Christophe/I-4847-2017; MAKANGA, Boris Kevin MBK/E-5239-2019; RAHOLA, Nil/G-2397-2019; FONTENILLE, didier/G-4091-2013	Paupy, Christophe/0000-0002-7122-2079; MAKANGA, Boris Kevin MBK/0000-0003-1172-6109; RAHOLA, Nil/0000-0003-4067-6438; Prugnolle, Franck/0000-0001-8519-1253; FONTENILLE, didier/0000-0002-0544-3885	CIRMF (Centre International de Recherches Medicales de Franceville); CNRS (Centre National de la Recherche Scientifique); IRD (Institut de Recherche pour le Developpement) through the program PPR FTH-AC (Programme Pilote Regional "Changements globaux, Biodiversite et Sante dans les Forets Tropicales Humides d' Afrique Centrale"); Agence Nationale pour la Recherche (ANR) through the project ORIGIN (Programme Jeunes Chercheurs-Jeunes Chercheuses,Sciences de la Vie, de la Sante et des Ecosystemes) [JCJC-SVSE 7-2012]	CIRMF (Centre International de Recherches Medicales de Franceville); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); IRD (Institut de Recherche pour le Developpement) through the program PPR FTH-AC (Programme Pilote Regional "Changements globaux, Biodiversite et Sante dans les Forets Tropicales Humides d' Afrique Centrale"); Agence Nationale pour la Recherche (ANR) through the project ORIGIN (Programme Jeunes Chercheurs-Jeunes Chercheuses,Sciences de la Vie, de la Sante et des Ecosystemes)(French National Research Agency (ANR))	This work was jointly funded by CIRMF (Centre International de Recherches Medicales de Franceville), CNRS (Centre National de la Recherche Scientifique), IRD (Institut de Recherche pour le Developpement) through the program PPR FTH-AC (Programme Pilote Regional "Changements globaux, Biodiversite et Sante dans les Forets Tropicales Humides d' Afrique Centrale"), and by Agence Nationale pour la Recherche (ANR) through the project ORIGIN JCJC-SVSE 7-2012 (Programme Jeunes Chercheurs-Jeunes Chercheuses,Sciences de la Vie, de la Sante et des Ecosystemes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1968, ANOPHELINAE AFR S SA; Antonio-Nkondjio C, 2009, ACTA TROP, V112, P270, DOI 10.1016/j.actatropica.2009.08.009; Culleton R, 2009, J INFECT DIS, V200, P1465, DOI 10.1086/644510; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Gautret P, 2001, ACTA TROP, V78, P177, DOI 10.1016/S0001-706X(00)00181-9; Gillies M, 1987, ANOPHELINAE AFRICA S; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Kaiser M, 2010, EMERG INFECT DIS, V16, P1956, DOI 10.3201/eid1612.100424; Kengne P, 2007, MED VET ENTOMOL, V21, P177, DOI 10.1111/j.1365-2915.2007.00681.x; Kengne P, 2003, MED VET ENTOMOL, V7, P1; Krief S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-116; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prugnolle F, 2011, P NATL ACAD SCI USA, V108, P11948, DOI 10.1073/pnas.1109368108; Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rayner JC, 2011, TRENDS PARASITOL, V27, P222, DOI 10.1016/j.pt.2011.01.006; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-117; Verhulst NO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00197	26	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57294	10.1371/journal.pone.0057294	http://dx.doi.org/10.1371/journal.pone.0057294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437363	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200238
J	Bahia, AC; Oliveira, JHM; Kubota, MS; Araujo, HRC; Lima, JBP; Rios-Velasquez, CM; Lacerda, MVG; Oliveira, PL; Traub-Cseko, YM; Pimenta, PFP				Bahia, Ana C.; Oliveira, Jose Henrique M.; Kubota, Marina S.; Araujo, Helena R. C.; Lima, Jose B. P.; Rios-Velasquez, Claudia Maria; Lacerda, Marcus Vinicius G.; Oliveira, Pedro L.; Traub-Csekoe, Yara M.; Pimenta, Paulo F. P.			The Role of Reactive Oxygen Species in Anopheles aquasalis Response to Plasmodium vivax Infection	PLOS ONE			English	Article							FAMILY NADPH OXIDASES; IMMUNE DEFENSES; INNATE IMMUNITY; DUAL OXIDASE; GAMBIAE; SUPEROXIDE; MECHANISMS; BACTERIA; PCR	Malaria affects millions of people worldwide and hundreds of thousands of people each year in Brazil. The mosquito Anopheles aquasalis is an important vector of Plasmodium vivax, the main human malaria parasite in the Americas. Reactive oxygen species (ROS) have been shown to have a role in insect innate immune responses as a potent pathogen-killing agent. We investigated the mechanisms of free radicals modulation after A. aquasalis infection with P. vivax. ROS metabolism was evaluated in the vector by studying expression and activity of three key detoxification enzymes, one catalase and two superoxide dismutases (SOD3A and SOD3B). Also, the involvement of free radicals in the mosquito immunity was measured by silencing the catalase gene followed by infection of A. aquasalis with P. vivax. Catalase, SOD3A and SOD3B expression in whole A. aquasalis were at the same levels of controls at 24 h and upregulated 36 h after ingestion of blood containing P. vivax. However, in the insect isolated midgut, the mRNA for these enzymes was not regulated by P. vivax infection, while catalase activity was reduced 24 h after the infectious meal. RNAi-mediated silencing of catalase reduced enzyme activity in the midgut, resulted in increased P. vivax infection and prevalence, and decreased bacterial load in the mosquito midgut. Our findings suggest that the interactions between A. aquasalis and P. vivax do not follow the model of ROS-induced parasite killing. It appears that P. vivax manipulates the mosquito detoxification system in order to allow its own development. This can be an indirect effect of fewer competitive bacteria present in the mosquito midgut caused by the increase of ROS after catalase silencing. These findings provide novel information on unique aspects of the main malaria parasite in the Americas interaction with one of its natural vectors.	[Bahia, Ana C.; Kubota, Marina S.; Traub-Csekoe, Yara M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil; [Oliveira, Jose Henrique M.; Oliveira, Pedro L.] Univ Fed Rio de Janeiro, Programa Biol Mol & Biotecnol, Inst Bioquim Med, Lab Bioquim Artropodes Hematofagos, Rio De Janeiro, Brazil; [Araujo, Helena R. C.; Pimenta, Paulo F. P.] Inst Rene Rachou, Lab Entomol Med, Belo Horizonte, MG, Brazil; [Lima, Jose B. P.] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, BR-21045900 Rio De Janeiro, Brazil; [Rios-Velasquez, Claudia Maria] Fiocruz MS, Lab Biodiversidade Saude, Ctr Pesquisa Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Lacerda, Marcus Vinicius G.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Oliveira, Pedro L.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Traub-Cseko, YM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Parasitas & Vetores, BR-21045900 Rio De Janeiro, Brazil.	ytraub@ioc.fiocruz.br; pimenta@cpqrr.fiocruz.br	Traub-Cseko, Yara M/F-2723-2015; Pimenta, Paulo/AAH-1502-2020; Araujo, Helena/J-9209-2015; Rios Velasquez, Claudia Maria/K-2901-2015; Nascimento, Ana Cristina Bahia/G-2372-2015; L. Oliveira, Pedro/A-9438-2010	Araujo, Helena/0000-0002-2021-2217; Nascimento, Ana Cristina Bahia/0000-0002-4584-1888; L. Oliveira, Pedro/0000-0003-0307-354X; Oliveira, Jose Henrique M./0000-0003-3814-5312	CNPq; PRONEX; FIOCRUZ; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX; FIOCRUZ; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was funded by CNPq, PRONEX, FIOCRUZ, and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Bahia AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001317; Bahia AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009795; Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Brazilian Ministry of Health, 2009, MAL DOENC A Z; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; de Lacerda MVG, 2007, REV SOC BRAS MED TRO, V40, P489, DOI 10.1590/S0037-86822007000400026; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gentile C, 2005, Mem. Inst. Oswaldo Cruz, V100, P545, DOI 10.1590/S0074-02762005000600008; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Horosko S, 1997, J AM MOSQUITO CONTR, V13, P95; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Liochev SI, 2002, REDOX REP, V7, P55, DOI 10.1179/135100002125000190; Luckhart S, 2003, INFECT IMMUN, V71, P3000, DOI 10.1128/IAI.71.6.3000-3009.2003; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Paiva CN, 2012, J CLIN INVEST, V122, P2531, DOI 10.1172/JCI58525; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; World Health Organization, 2008, 20081 WHOHTMGMP	44	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57014	10.1371/journal.pone.0057014	http://dx.doi.org/10.1371/journal.pone.0057014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441231	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200088
J	Capurro, V; Busquet, P; Lopes, JP; Bertorelli, R; Tarozzo, G; Bolognesi, ML; Piomelli, D; Reggiani, A; Cavalli, A				Capurro, Valeria; Busquet, Perrine; Lopes, Joao Pedro; Bertorelli, Rosalia; Tarozzo, Glauco; Bolognesi, Maria Laura; Piomelli, Daniele; Reggiani, Angelo; Cavalli, Andrea			Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID CASCADE HYPOTHESIS; TARGET-DIRECTED LIGANDS; MORRIS WATER MAZE; OBJECT RECOGNITION; PASSIVE-AVOIDANCE; MEMORY IMPAIRMENT; MOUSE MODEL; MICE; BETA; ACCUMULATION	Alzheimer's disease (AD) is characterized by progressive loss of cognitive function, dementia and altered behavior. Over 30 million people worldwide suffer from AD and available therapies are still palliative rather than curative. Recently, Memoquin (MQ), a quinone-bearing polyamine compound, has emerged as a promising anti-AD lead candidate, mainly thanks to its multi-target profile. MQ acts as an acetylcholinesterase and beta-secretase-1 inhibitor, and also possesses anti-amyloid and anti-oxidant properties. Despite this potential interest, in vivo behavioral studies with MQ have been limited. Here, we report on in vivo studies with MQ (acute and sub-chronic treatments; 7-15 mg/kg per os) carried out using two different mouse models: i) scopolamine- and ii) beta-amyloid peptide-(A beta-) induced amnesia. Several aspects related to memory were examined using the T-maze, the Morris water maze, the novel object recognition, and the passive avoidance tasks. At the dose of 15 mg/kg, MQ was able to rescue all tested aspects of cognitive impairment including spatial, episodic, aversive, short and long-term memory in both scopolamine-and Ab-induced amnesia models. Furthermore, when tested in primary cortical neurons, MQ was able to fully prevent the Ab-induced neurotoxicity mediated by oxidative stress. The results support the effectiveness of MQ as a cognitive enhancer, and highlight the value of a multi-target strategy to address the complex nature of cognitive dysfunction in AD.	[Capurro, Valeria; Busquet, Perrine; Lopes, Joao Pedro; Bertorelli, Rosalia; Tarozzo, Glauco; Piomelli, Daniele; Reggiani, Angelo; Cavalli, Andrea] Ist Italiano Tecnol, Genoa, Italy; [Bolognesi, Maria Laura; Cavalli, Andrea] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Istituto Italiano di Tecnologia - IIT; University of Bologna; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Cavalli, A (corresponding author), Ist Italiano Tecnol, Genoa, Italy.	andrea.cavalli@iit.it	Lopes, Joao P/A-2332-2017; Bolognesi, Maria Laura/AAL-8062-2021	Lopes, Joao P/0000-0002-5122-1802; Bolognesi, Maria Laura/0000-0002-1289-5361; BERTORELLI, Rosalia/0000-0002-7913-3564; CAVALLI, ANDREA/0000-0002-6370-1176	Fondazione Istituto Italiano di Tecnologia	Fondazione Istituto Italiano di Tecnologia	The study reported in this paper was funded by Fondazione Istituto Italiano di Tecnologia. The founders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Axelsen PH, 2011, PHYSIOLOGY, V26, P54, DOI 10.1152/physiol.00024.2010; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bolognesi ML, 2009, CURR OPIN CHEM BIOL, V13, P303, DOI 10.1016/j.cbpa.2009.04.619; Bolognesi ML, 2007, J MED CHEM, V50, P4882, DOI 10.1021/jm070559a; Bolognesi ML, 2011, CURR TOP MED CHEM, V11, P2797; Bolognesi ML, 2011, BIOORG MED CHEM LETT, V21, P2655, DOI 10.1016/j.bmcl.2010.12.093; Bolognesi ML, 2009, NEUROTHERAPEUTICS, V6, P152, DOI 10.1016/j.nurt.2008.10.042; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Bores GM, 1996, J PHARMACOL EXP THER, V277, P728; Cavalli A, 2012, MULTITARGETED DRUGS, P441; Cavalli A, 2008, J MED CHEM, V51, P347, DOI 10.1021/jm7009364; Cavalli A, 2007, ANGEW CHEM INT EDIT, V46, P3689, DOI 10.1002/anie.200700256; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Gacar N, 2011, PHARMACOL BIOCHEM BE, V99, P316, DOI 10.1016/j.pbb.2011.05.017; Gutzmann H, 1998, J NEURAL TRANSM-SUPP, P301; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kanski J, 2003, BRAIN RES, V988, P173, DOI 10.1016/S0006-8993(03)03369-9; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim DH, 2010, PHARMACOL BIOCHEM BE, V97, P239, DOI 10.1016/j.pbb.2010.08.005; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; Lau LF, 2008, TOP MED CHEM SER, V2, P1, DOI 10.1007/7355_2007_017; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Mazzola C, 2003, EUR J PHARMACOL, V477, P219, DOI 10.1016/j.ejphar.2003.08.026; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Meunier J, 2013, EUR J PHARMACOL, V698, P193, DOI 10.1016/j.ejphar.2012.10.033; Mohamed T, 2011, BIOORG MED CHEM LETT, V21, P5881, DOI 10.1016/j.bmcl.2011.07.091; Morgan D, 2008, J ALZHEIMERS DIS, V15, P605; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Palacios HH, 2011, CNS NEUROL DISORD-DR, V10, P149; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Raina AK, 1999, REDOX REP, V4, P23, DOI 10.1179/135100099101534701; Resende R, 2008, NEUROSCIENCE, V155, P725, DOI 10.1016/j.neuroscience.2008.06.036; SantaCruz KS, 2004, NEUROBIOL AGING, V25, P63, DOI 10.1016/S0197-4580(03)00117-9; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Snowden JS, 2011, BRAIN, V134, P2478, DOI 10.1093/brain/awr189; Spowart-Manning L, 2004, BEHAV BRAIN RES, V151, P37, DOI 10.1016/j.bbr.2003.08.004; Stone JG, 2011, THER ADV CHRONIC DIS, V2, P9, DOI 10.1177/2040622310382817; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Tsuji M, 2003, NEUROPSYCHOPHARMACOL, V28, P664, DOI 10.1038/sj.npp.1300080; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; Valgimigli L, 2008, J ORG CHEM, V73, P1830, DOI 10.1021/jo7024543; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang Y, 2000, NAD P H QUINONE OXID; Zhang HY, 2005, FEBS LETT, V579, P5260, DOI 10.1016/j.febslet.2005.09.006	50	67	68	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56870	10.1371/journal.pone.0056870	http://dx.doi.org/10.1371/journal.pone.0056870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441223	gold, Green Published			2022-12-25	WOS:000315159200080
J	Wang, SS; Li, EC; Gao, YH; Wang, Y; Guo, Z; He, JR; Zhang, JN; Gao, ZC; Wang, Q				Wang, Shanshan; Li, Encheng; Gao, Yanghui; Wang, Yan; Guo, Zhe; He, Jiarui; Zhang, Jianing; Gao, Zhancheng; Wang, Qi			Study on Invadopodia Formation for Lung Carcinoma Invasion with a Microfluidic 3D Culture Device	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; PERFUSION-CULTURE; CANCER-CELLS; TUMOR-CELLS; N-WASP; CORTACTIN; MIGRATION; SYSTEM; PODOSOMES	Invadopodia or invasive feet, which are actin-rich membrane protrusions with matrix degradation activity formed by invasive cancer cells, are a key determinant in the malignant invasive progression of tumors and represent an important target for cancer therapies. In this work, we presented a microfluidic 3D culture device with continuous supplement of fresh media via a syringe pump. The device mimicked tumor microenvironment in vivo and could be used to assay invadopodia formation and to study the mechanism of human lung cancer invasion. With this device, we investigated the effects of epidermal growth factor (EGF) and matrix metalloproteinase (MMP) inhibitor, GM6001 on invadopodia formation by human non-small cell lung cancer cell line A549 in 3D matrix model. This device was composed of three units that were capable of achieving the assays on one control group and two experimental groups' cells, which were simultaneously pretreated with EGF or GM6001 in parallel. Immunofluorescence analysis of invadopodia formation and extracellular matrix degradation was conducted using confocal imaging system. We observed that EGF promoted invadopodia formation by A549 cells in 3D matrix and that GM6001 inhibited the process. These results demonstrated that epidermal growth factor receptor (EGFR) signaling played a significant role in invadopodia formation and related ECM degradation activity. Meanwhile, it was suggested that MMP inhibitor (GM6001) might be a powerful therapeutic agent targeting invadopodia formation in tumor invasion. This work clearly demonstrated that the microfluidic-based 3D culture device provided an applicable platform for elucidating the mechanism of cancer invasion and could be used in testing other anti-invasion agents.	[Wang, Shanshan; Li, Encheng; Gao, Yanghui; Wang, Yan; Guo, Zhe; He, Jiarui] Dalian Med Univ, Grad Sch, Dalian, Peoples R China; [Zhang, Jianing] Dalian Med Univ, Inst Glycobiol, Dept Biochem, Dalian, Peoples R China; [Gao, Zhancheng] Peking Univ Peoples Hosp, Dept Resp, Beijing, Peoples R China; [Gao, Zhancheng] Peking Univ Peoples Hosp, Dept Crit Care Med, Beijing, Peoples R China; [Wang, Qi] Dalian Med Univ, Hosp 2, Dept Resp Med, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Peking University; Peking University; Dalian Medical University	Gao, ZC (corresponding author), Peking Univ Peoples Hosp, Dept Resp, Beijing, Peoples R China.	gaozhancheng5446@163.com; wqdmu@yahoo.com.cn	He, Jiarui/AAF-7206-2020	He, Jiarui/0000-0003-4665-2306	National High-tech R&D Program (973 Program) [2012CB822103]; National Natural Science Foundation of China [91129733, 81071228]	National High-tech R&D Program (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High-tech R&D Program (973 Program, No. 2012CB822103) and National Natural Science Foundation of China (No. 91129733 and 81071228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Corn PG, 2000, CLIN CANCER RES, V6, P4243; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Dubey S, 2009, AM J RESP CRIT CARE, V179, P860, DOI 10.1164/rccm.200902-0289UP; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elstner A, 2007, CLIN EXP METASTAS, V24, P57, DOI 10.1007/s10585-007-9057-y; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Frisk T, 2007, ELECTROPHORESIS, V28, P4705, DOI 10.1002/elps.200700342; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Hase T, 2011, CANCER SCI, V102, P1493, DOI 10.1111/j.1349-7006.2011.01973.x; Hirooka S, 2011, PATHOBIOLOGY, V78, P10, DOI 10.1159/000322734; Hwang YS, 2012, ARCH ORAL BIOL, V57, P335, DOI 10.1016/j.archoralbio.2011.08.019; Jia DS, 2010, BMC CANCER, V10, P12; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062; Kim JH, 2011, GENE DEV, V25, P730, DOI 10.1101/gad.2028611; Kim L, 2007, LAB CHIP, V7, P681, DOI 10.1039/b704602b; Kim SM, 2008, LAB CHIP, V8, P1015, DOI 10.1039/b800835c; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Li XJ, 2008, ANAL CHEM, V80, P4095, DOI 10.1021/ac800231k; Lii J, 2008, ANAL CHEM, V80, P3640, DOI 10.1021/ac8000034; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Liu D, 2007, J BIOTECHNOL, V131, P286, DOI 10.1016/j.jbiotec.2007.06.014; Liu TJ, 2009, ELECTROPHORESIS, V30, P4285, DOI 10.1002/elps.200900289; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b; McNiven MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1944, DOI 10.2741/1348; Nakahara H, 1997, P NATL ACAD SCI USA, V94, P7959, DOI 10.1073/pnas.94.15.7959; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ra GS, 2008, J NANOSCI NANOTECHNO, V8, P4588, DOI 10.1166/jnn.2008.IC83; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Tanaka Y, 2007, BIOSENS BIOELECTRON, V23, P449, DOI 10.1016/j.bios.2007.08.006; Tanaka Y, 2009, J BIOMED NANOTECHNOL, V5, P516, DOI 10.1166/jbn.2009.1057; Toh YC, 2007, LAB CHIP, V7, P302, DOI 10.1039/b614872g; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Weaver AM, 2008, AFR ARTS, V41, P89, DOI 10.1162/afar.2008.41.4.89; Wong AP, 2008, BIOMATERIALS, V29, P1853, DOI 10.1016/j.biomaterials.2007.12.044; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; Zhang LC, 2010, ELECTROPHORESIS, V31, P3763, DOI 10.1002/elps.201000265; Zhang Q, 2012, LAB CHIP, V12, P2837, DOI 10.1039/c2lc00030j; Zhao L, 2010, BIOMED MICRODEVICES, V12, P325, DOI 10.1007/s10544-009-9388-3	55	38	41	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56448	10.1371/journal.pone.0056448	http://dx.doi.org/10.1371/journal.pone.0056448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441195	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200052
J	Yu, S; Huang, H; Iliuk, A; Wang, WH; Jayasundera, KB; Tao, WA; Post, CB; Geahlen, RL				Yu, Shuai; Huang, He; Iliuk, Anton; Wang, Wen-Horng; Jayasundera, Keerthi B.; Tao, W. Andy; Post, Carol B.; Geahlen, Robert L.			Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ELEMENT-BINDING PROTEIN; BREAST-CANCER CELLS; NON-HODGKIN-LYMPHOMA; TRANSCRIPTION FACTOR; THERAPEUTIC TARGET; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TERMINAL TAIL; B-CELLS	The Syk protein-tyrosine kinase can have multiple effects on cancer cells, acting in some as a tumor suppressor by inhibiting motility and in others as a tumor promoter by enhancing survival. Phosphoproteomic analyses identified PKA as a Syk-specific substrate. Syk catalyzes the phosphorylation of the catalytic subunit of PKA (PKAc) both in vitro and in cells on Tyr-330. Tyr-330 lies within the adenosine-binding motif in the C-terminal tail of PKAc within a cluster of acidic amino acids (DDY-EEEE), which is a characteristic of Syk substrates. The phosphorylation of PKAc on Tyr-330 by Syk strongly inhibits its catalytic activity. Molecular dynamics simulations suggest that this additional negative charge prevents the C-terminal tail from interacting with the substrate and the nucleotide-binding site to stabilize the closed conformation of PKAc, thus preventing catalysis from occurring. Phosphoproteomic analyses and Western blotting studies indicate that Tyr-330 can be phosphorylated in a Syk-dependent manner in MCF7 breast cancer cells and DT40 B cells. The phosphorylation of a downstream substrate of PKAc, cAMP-responsive element-binding protein (CREB), is inhibited in cells expressing Syk but can be rescued by a selective inhibitor of Syk. Modulation of CREB activity alters the expression of the CREB-regulated gene BCL2 and modulates cellular responses to genotoxic agents. Thus, PKA is a novel substrate of Syk, and its phosphorylation on Tyr-330 inhibits its participation in downstream signaling pathways.	[Yu, Shuai; Huang, He; Wang, Wen-Horng; Tao, W. Andy; Post, Carol B.; Geahlen, Robert L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Iliuk, Anton; Jayasundera, Keerthi B.; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tao, W. Andy; Post, Carol B.; Geahlen, Robert L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu	Post, Carol/AAD-7910-2021; Jayasundera, Keerthi/AGG-1997-2022; Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020	Tao, Weiguo/0000-0002-5535-5517; Iliuk, Anton/0000-0002-2914-1363; Geahlen, Robert/0000-0001-8400-2924	National Institutes of Health from the NIAID [R01AI098132]; NCI [R01CA115465]; NIGMS [R01GM039478, R01GM088317]; National Cancer Institute [R25CA128770]; NATIONAL CANCER INSTITUTE [R01CA115465, R25CA128770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317, R01GM039478] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI098132 (to R. L. G.) from the NIAID, R01CA115465 (to R. L. G. and W. A. T.) from the NCI, and R01GM039478 (to C. B. P.) and R01GM088317 (to W. A. T. and R. L. G.) from the NIGMS.; Supported by the National Cancer Institute Cancer Prevention Internship Program Grant R25CA128770.	Aggarwal S, 2008, CANCER RES, V68, P981, DOI 10.1158/0008-5472.CAN-06-0249; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Buchner M, 2009, CANCER RES, V69, P5424, DOI 10.1158/0008-5472.CAN-08-4252; Caldwell GB, 2012, J CELL BIOCHEM, V113, P39, DOI 10.1002/jcb.23325; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Cheng JC, 2008, BLOOD, V111, P1182, DOI 10.1182/blood-blood-2007-04-083600; Chestukhin A, 1996, J BIOL CHEM, V271, P10175, DOI 10.1074/jbc.271.17.10175; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gobessi S, 2009, LEUKEMIA, V23, P686, DOI 10.1038/leu.2008.346; Goodman RH, 2000, GENE DEV, V14, P1553; Gurumurthy S, 2005, MOL CELL BIOL, V25, P1146, DOI 10.1128/MCB.25.3.1146-1161.2005; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Luo YD, 2009, CELL SIGNAL, V21, P1370, DOI 10.1016/j.cellsig.2009.04.004; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Moujalled D, 2011, EMBO REP, V12, P77, DOI 10.1038/embor.2010.190; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pugazhenthi S, 1999, J BIOL CHEM, V274, P27529, DOI 10.1074/jbc.274.39.27529; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Shankar DB, 2005, CANCER CELL, V7, P351, DOI 10.1016/j.ccr.2005.02.018; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Thompson EE, 2009, PROTEIN SCI, V18, P2016, DOI 10.1002/pro.209; Toyama T, 2003, CANCER LETT, V189, P97, DOI 10.1016/S0304-3835(02)00463-9; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Xue L, 2012, P NATL ACAD SCI USA, V109, P5615, DOI 10.1073/pnas.1119418109; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou F, 2006, MOL CELL BIOL, V26, P3478, DOI 10.1128/MCB.26.9.3478-3491.2006; Zhou Q, 2009, ONCOGENE, V28, P1348, DOI 10.1038/onc.2008.493	52	12	12	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10870	10881		10.1074/jbc.M112.426130	http://dx.doi.org/10.1074/jbc.M112.426130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447535	Green Published, hybrid			2022-12-25	WOS:000317565000064
J	Foley, RC; Gleason, CA; Anderson, JP; Hamann, T; Singh, KB				Foley, Rhonda C.; Gleason, Cynthia A.; Anderson, Jonathan P.; Hamann, Thorsten; Singh, Karam B.			Genetic and Genomic Analysis of Rhizoctonia solani Interactions with Arabidopsis; Evidence of Resistance Mediated through NADPH Oxidases	PLOS ONE			English	Article							PLANT DEFENSE; TRANSCRIPTION FACTORS; DISEASE RESISTANCE; ROOT-ROT; MEDICAGO-TRUNCATULA; ABIOTIC STRESS; SUGAR-BEET; NECROTROPHIC PATHOGENS; BIOTIC INTERACTIONS; FUSARIUM-OXYSPORUM	Rhizoctonia solani is an important soil-borne necrotrophic fungal pathogen, with a broad host range and little effective resistance in crop plants. Arabidopsis is resistant to R. solani AG8 but susceptible to R. solani AG2-1. A screen of 36 Arabidopsis ecotypes and mutants affected in the auxin, camalexin, salicylic acid, abscisic acid and ethylene/jasmonic acid pathways did not reveal any variation in response to R. solani and demonstrated that resistance to AG8 was independent of these defense pathways. The Arabidopsis Affymetrix ATH1 Genome array was used to assess global gene expression changes in plants infected with AG8 and AG2-1 at seven days post-infection. While there was considerable overlap in the response, some gene families were differentially affected by AG8 or AG2-1 and included those involved in oxidative stress, cell wall associated proteins, transcription factors and heat shock protein genes. Since a substantial proportion of the gene expression changes were associated with oxidative stress responses, we analysed the role of NADPH oxidases in resistance. While single NADPH oxidase mutants had no effect, a NADPH oxidase double mutant atrbohf atrbohd resulted in an almost complete loss of resistance to AG8, suggesting that reactive oxidative species play an important role in Arabidopsis's resistance to R. solani.	[Foley, Rhonda C.; Gleason, Cynthia A.; Anderson, Jonathan P.; Singh, Karam B.] CSIRO Plant Ind, Ctr Environm & Life Sci, Perth, WA, Australia; [Anderson, Jonathan P.; Singh, Karam B.] Univ Western Australia, Univ Western Australia Inst Agr, Perth, WA 6009, Australia; [Hamann, Thorsten] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; Imperial College London	Singh, KB (corresponding author), CSIRO Plant Ind, Ctr Environm & Life Sci, Perth, WA, Australia.	Karam.singh@csiro.au	Singh, Karam B/C-3235-2012; Anderson, Jonathan P/A-7244-2008; Foley, Rhonda C/G-6716-2012	Singh, Karam B/0000-0002-2777-7448; Anderson, Jonathan P/0000-0002-4783-5393; 	Grains Research and Development Corportation [CSP00061, CSP00114]	Grains Research and Development Corportation	Funding provided by Grains Research and Development Corportation (CSP00061 and CSP00114) (http://www.grdc.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson JP, 2010, PLANT PHYSIOL, V154, P861, DOI 10.1104/pp.110.163949; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; BANVILLE GJ, 1989, AM POTATO J, V66, P821, DOI 10.1007/BF02853963; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2008, TRENDS PLANT SCI, V13, P145, DOI 10.1016/j.tplants.2007.12.004; Bibikov SI, 2000, P NATL ACAD SCI USA, V97, P5830, DOI 10.1073/pnas.100118697; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Carling DE, 2002, PHYTOPATHOLOGY, V92, P43, DOI 10.1094/PHYTO.2002.92.1.43; Chen WQ, 1999, PLANT J, V19, P667, DOI 10.1046/j.1365-313x.1999.00560.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cook RJ, 2002, CAN J PLANT PATHOL, V24, P349; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Ferrari S, 2008, PLANT PHYSIOL, V146, P669, DOI 10.1104/pp.107.109686; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Gao LL, 2007, MOL PLANT MICROBE IN, V20, P82, DOI 10.1094/MPMI-20-0082; Geraats BPJ, 2003, PHYTOPATHOLOGY, V93, P813, DOI 10.1094/PHYTO.2003.93.7.813; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gonzalez D, 2006, MOL PHYLOGENET EVOL, V40, P459, DOI 10.1016/j.ympev.2006.03.022; Grefen C, 2004, PLANTA, V219, P733, DOI 10.1007/s00425-004-1316-4; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P283, DOI 10.1016/j.tibtech.2005.04.009; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; HIDE GA, 1992, ANN APPL BIOL, V120, P391, DOI 10.1111/j.1744-7348.1992.tb04899.x; Hoffman T, 1999, PLANT PHYSIOL, V119, P935, DOI 10.1104/pp.119.3.935; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kasajima I, 2004, PLANT MOL BIOL REP, V22, P49, DOI 10.1007/BF02773348; Keijer J, 1996, RHIZOCTONIA SPECIES: TAXONOMY, MOLECULAR BIOLOGY, ECOLOGY, PATHOLOGY AND DISEASE CONTROL, P149; Khangura RK, 1999, PLANT DIS, V83, P714, DOI 10.1094/PDIS.1999.83.8.714; Kiewnick S, 2001, PLANT DIS, V85, P718, DOI 10.1094/PDIS.2001.85.7.718; Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kluth C, 2010, CROP PROT, V29, P230, DOI 10.1016/j.cropro.2009.12.002; Knecht K, 2010, MOL PLANT MICROBE IN, V23, P446, DOI 10.1094/MPMI-23-4-0446; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kuhn J, 2009, J PLANT NUTR SOIL SC, V172, P661, DOI 10.1002/jpln.200700186; Kuninaga S, 1997, CURR GENET, V32, P237, DOI 10.1007/s002940050272; Lazniewska J, 2010, ACTA PHYSIOL PLANT, V32, P1, DOI 10.1007/s11738-009-0372-6; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; MacNish GC, 1996, PLANT DIS, V80, P965, DOI 10.1094/PD-80-0965; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; MUSHEGIAN AR, 1995, PROTEIN SCI, V4, P1243, DOI 10.1002/pro.5560040623; Okubara P, 2009, THEORETICAL APPL GEN; Okubara PA, 2005, PLANT SOIL, V274, P215, DOI 10.1007/s11104-004-7328-9; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Penmetsa RV, 2008, PLANT J, V55, P580, DOI 10.1111/j.1365-313X.2008.03531.x; Perl-Treves R, 2004, MOL PLANT MICROBE IN, V17, P70, DOI 10.1094/MPMI.2004.17.1.70; Pogany M, 2009, PLANT PHYSIOL, V151, P1459, DOI 10.1104/pp.109.141994; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Sharon M, 2011, PHYTOPATHOLOGY, V101, P828, DOI 10.1094/PHYTO-09-10-0247; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sneh B, 1996, 2 INT S RHIZ NOORDW, pxvi+589; Srinivasachary, 2011, EUPHYTICA, V178, P1, DOI 10.1007/s10681-010-0296-7; Stodart BJ, 2007, MYCOL RES, V111, P891, DOI 10.1016/j.mycres.2007.05.008; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Thatcher LF, 2005, FUNCT PLANT BIOL, V32, P1, DOI 10.1071/FP04135; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Venu RC, 2007, MOL GENET GENOMICS, V278, P421, DOI 10.1007/s00438-007-0260-y; Verma PR, 1996, PHYTOPROTECTION, V77, P99, DOI 10.7202/706106ar; VILGALYS R, 1994, ANNU REV PHYTOPATHOL, V32, P135, DOI 10.1146/annurev.py.32.090194.001031; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Wang HZ, 2011, PLANT J, V68, P1104, DOI 10.1111/j.1365-313X.2011.04764.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Weinhold AR, 1995, RHIZOCTONIA SOLANI P, P163; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427	84	45	45	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56814	10.1371/journal.pone.0056814	http://dx.doi.org/10.1371/journal.pone.0056814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451091	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500031
J	Harrington, WE; Morrison, R; Fried, M; Duffy, PE				Harrington, Whitney E.; Morrison, Robert; Fried, Michal; Duffy, Patrick E.			Intermittent Preventive Treatment in Pregnant Women Is Associated with Increased Risk of Severe Malaria in Their Offspring	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; PLACENTAL MALARIA; FACILITATION; INFECTIONS; RESISTANCE; MORBIDITY; PARASITES; EFFICACY; IMMUNITY; MODEL	Background: In areas of widespread sulfadoxine-pyrimethamine resistance, intermittent treatment in pregnancy (IPTp) fails to prevent placental malaria (PM) and may exacerbate drug resistant infections. Because PM predicts increased susceptibility to parasitemia during infancy, we hypothesized that IPTp would also increase susceptibility to malaria infection and disease in the offspring. Methods: In a birth cohort from NE Tanzania, we evaluated the association between maternal IPTp use and risk of parasitemia and severe malaria in the offspring. Using Cox Proportional Hazards Models as well as Generalized Estimating Equations, we evaluated the effects of IPTp on the entire cohort and on subgroups stratified by PM status at delivery. Results and Conclusions: Offspring of PM+ women who received IPTp had a dose-dependent decrease in time to first parasitemia (AHR = 2.13, p = 0.04 [95%CI: 1.04, 4.38]). Among all offspring, IPTp was associated with earlier first severe malaria episode (AHR = 2.32, p = 0.02 [95%CI: 1.12, 4.78]) as well as increased overall odds of severe malaria (AOR = 2.31, p = 0.03 [95%CI: 1.09, 4.88]). Cost-benefit analyses of IPTp regimens should consider the long term effects on offspring in addition to pregnancy outcomes.	[Harrington, Whitney E.] Univ Washington, Sch Med, Dept Pediat, Seattle Childrens Hosp, Seattle, WA 98195 USA; [Morrison, Robert] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Fried, Michal; Duffy, Patrick E.] NIAID, NIH, Rockville, MD USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; Center for Infectious Disease Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Duffy, PE (corresponding author), NIAID, NIH, Rockville, MD USA.	patrick.duffy@nih.gov			Bill & Melinda Gates Foundation [29202]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative [1364]; U.S. National Institutes of Health Fogarty International Center (FIC) [D43 TW005509]; National Institute of Allergy and Infectious Diseases [R01AI52059]; National Heart, Lung, and Blood Institute (NIH Fellowship) [1F30HL096298]; FOGARTY INTERNATIONAL CENTER [D43TW005509] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL096298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001134, R01AI052059, ZIAAI001056] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institutes of Health Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute (NIH Fellowship); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the Bill & Melinda Gates Foundation (Grant 29202), the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (Grant 1364), the U.S. National Institutes of Health Fogarty International Center (FIC) (Grant D43 TW005509), and the National Institute of Allergy and Infectious Diseases (R01AI52059) to PED, and by the National Heart, Lung, and Blood Institute (NIH Fellowship 1F30HL096298) to WEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not represent the official views of the funding sources.	Aitken EH, PLOS ONE, V7; [Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Brabin B., 2001, Malaria in pregnancy: deadly parasite, susceptible host, P27, DOI 10.4324/9780203302255_chapter_2; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; DESOWITZ RS, 1988, ANN TROP MED PARASIT, V82, P121, DOI 10.1080/00034983.1988.11812218; Duffy PE, 2005, CURR TOP MICROBIOL, V295, P169; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Malhotra I, 2005, INFECT IMMUN, V73, P3462, DOI 10.1128/IAI.73.6.3462-3470.2005; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; May K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007986; Milner DA, 2008, TRENDS PARASITOL, V24, P590, DOI 10.1016/j.pt.2008.09.001; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; NYIRJESY P, 1993, CLIN INFECT DIS, V16, P127, DOI 10.1093/clinids/16.1.127; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Serra-Casas E, J INFECT DIS, V201, P123; Staalsoe T, 2004, INFECT IMMUN, V72, P5027, DOI 10.1128/IAI.72.9.5027-5030.2004; Staszewski V, 2012, P ROY SOC B-BIOL SCI, V279, P2487, DOI 10.1098/rspb.2011.1563; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Wargo AR, 2007, P NATL ACAD SCI USA, V104, P19914, DOI 10.1073/pnas.0707766104	25	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56183	10.1371/journal.pone.0056183	http://dx.doi.org/10.1371/journal.pone.0056183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451036	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500008
J	Luchetti, A; Mantovani, B				Luchetti, Andrea; Mantovani, Barbara			Non-LTR R2 Element Evolutionary Patterns: Phylogenetic Incongruences, Rapid Radiation and the Maintenance of Multiple Lineages	PLOS ONE			English	Article							RETROTRANSPOSABLE ELEMENTS; TRANSPOSABLE ELEMENTS; SATELLITE DNAS; RNA; R1; IDENTIFICATION; BRANCHIOPODA; DIVERSITY; TURNOVER; DYNAMICS	Retrotransposons of the R2 superclade specifically insert within the 28S ribosomal gene. They have been isolated from a variety of metazoan genomes and were found vertically inherited even if their phylogeny does not always agree with that of the host species. This was explained with the diversification/extinction of paralogous lineages, being proved the absence of horizontal transfer. We here analyze the widest available collection of R2 sequences, either newly isolated from recently sequenced genomes or drawn from public databases, in a phylogenetic framework. Results are congruent with previous analyses, but new important issues emerge. First, the N-terminal end of the R2-B clade protein, so far unknown, presents a new zinc fingers configuration. Second, the phylogenetic pattern is consistent with an ancient, rapid radiation of R2 lineages: being the estimated time of R2 origin (850-600 Million years ago) placed just before the metazoan Cambrian explosion, the wide element diversity and the incongruence with the host phylogeny could be attributable to the sudden expansion of available niches represented by host's 28S ribosomal genes. Finally, we detect instances of coexisting multiple R2 lineages showing a non-random phylogenetic pattern, strongly similar to that of the "library" model known for tandem repeats: a collection of R2s were present in the ancestral genome and then differentially activated/repressed in the derived species. Models for activation/repression as well as mechanisms for sequence maintenance are also discussed within this framework.	[Luchetti, Andrea; Mantovani, Barbara] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy	University of Bologna	Luchetti, A (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, Bologna, Italy.	andrea.luchetti@unibo.it		Luchetti, Andrea/0000-0002-2986-721X	Canziani funds	Canziani funds	The work has been supported by Canziani funds to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BRIEF BIOINFORM, V9, P286; Bunikis J, 2005, INSECT MOL BIOL, V14, P465, DOI 10.1111/j.1365-2583.2005.00577.x; BURKE WD, 1993, MOL BIOL EVOL, V10, P163; Burke WD, 2002, MOL BIOL EVOL, V19, P619, DOI 10.1093/oxfordjournals.molbev.a004121; Burke WD, 1998, NATURE, V392, P141, DOI 10.1038/32330; Burke WD, 1999, MOL BIOL EVOL, V16, P502, DOI 10.1093/oxfordjournals.molbev.a026132; Butterfield NJ, 2007, PALAEONTOLOGY, V50, P41, DOI 10.1111/j.1475-4983.2006.00613.x; Cesari M, 2003, GENE, V312, P289, DOI 10.1016/S0378-1119(03)00625-5; Christensen SM, 2006, P NATL ACAD SCI USA, V103, P17602, DOI 10.1073/pnas.0605476103; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Dover G, 2002, TRENDS GENET, V18, P587, DOI 10.1016/S0168-9525(02)02789-0; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Eickbush DG, 2008, MOL CELL BIOL, V28, P6452, DOI 10.1128/MCB.01015-08; EICKBUSH DG, 1995, GENETICS, V139, P671; Eickbush TH, 2008, VIRUS RES, V134, P221, DOI 10.1016/j.virusres.2007.12.010; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Gentile KL, 2001, MOL BIOL EVOL, V18, P235, DOI 10.1093/oxfordjournals.molbev.a003797; Ghesini S, 2011, J MOL EVOL, V72, P296, DOI 10.1007/s00239-011-9430-y; Gladyshev EA, 2009, GENE, V448, P145, DOI 10.1016/j.gene.2009.08.016; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; JAKUBCZAK JL, 1992, GENETICS, V131, P129; Jamburuthugoda VK, 2011, J MOL BIOL, V407, P661, DOI 10.1016/j.jmb.2011.02.015; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kojima KK, 2006, MOL BIOL EVOL, V23, P1984, DOI 10.1093/molbev/msl067; Kojima KK, 2005, MOL BIOL EVOL, V22, P2157, DOI 10.1093/molbev/msi210; Kojima KK, 2004, MOL BIOL EVOL, V21, P207, DOI 10.1093/molbev/msg235; Luchetti A, 2012, GENOMICS, V100, P51, DOI 10.1016/j.ygeno.2012.04.005; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Mestrovic N, 2009, MOL PHYLOGENET EVOL, V50, P204, DOI 10.1016/j.ympev.2008.10.013; Mingazzini V, 2011, HEREDITY, V106, P567, DOI 10.1038/hdy.2010.86; Perez-Gonzalez CE, 2001, GENETICS, V158, P1557; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Stage DE, 2010, INSECT MOL BIOL, V19, P37, DOI 10.1111/j.1365-2583.2009.00949.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson Blaine K, 2011, Mob Genet Elements, V1, P29; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; Yang HP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r39; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; Zhang X, 2008, GENETICS, V180, P1617, DOI 10.1534/genetics.108.093716	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57076	10.1371/journal.pone.0057076	http://dx.doi.org/10.1371/journal.pone.0057076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451148	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500061
J	Mao, XG; He, GM; Zhang, JP; Rossiter, SJ; Zhang, SY				Mao, Xiuguang; He, Guimei; Zhang, Junpeng; Rossiter, Stephen J.; Zhang, Shuyi			Lineage Divergence and Historical Gene Flow in the Chinese Horseshoe Bat (Rhinolophus sinicus)	PLOS ONE			English	Article							DNA-SEQUENCE; POPULATION-STRUCTURE; COMPUTER-PROGRAM; MITOCHONDRIAL; PHYLOGEOGRAPHY; COALESCENT; SPECIATION; MIGRATION; INFERENCE; EVOLUTION	Closely related taxa living in sympatry provide good opportunities to investigate the origin of barriers to gene flow as well as the extent of reproductive isolation. The only two recognized subspecies of the Chinese rufous horseshoe bat Rhinolophus sinicus are characterized by unusual relative distributions in which R. s. septentrionalis is restricted to a small area within the much wider range of its sister taxon R. s. sinicus. To determine the history of lineage divergence and gene flow between these taxa, we applied phylogenetic, demographic and coalescent analyses to multi-locus datasets. MtDNA gene genealogies and microsatellite-based clustering together revealed three divergent lineages of sinicus, corresponding to Central China, East China and the offshore Hainan Island. However, the central lineage of sinicus showed a closer relationship with septentrionalis than with other lineages of R. s. sinicus, in contrary to morphological data. Paraphyly of sinicus could result from either past asymmetric mtDNA introgression between these two taxa, or could suggest septentrionalis evolved in situ from its more widespread sister subspecies. To test between these hypotheses, we applied coalescent-based phylogenetic reconstruction and Approximate Bayesian Computation (ABC). We found that septentrionalis is likely to be the ancestral taxon and therefore a recent origin of this subspecies can be ruled out. On the other hand, we found a clear signature of asymmetric mtDNA gene flow from septentrionalis into central populations of sinicus yet no nuclear gene flow, thus strongly pointing to historical mtDNA introgression. We suggest that the observed deeply divergent lineages within R. sinicus probably evolved in isolation in separate Pleistocene refugia, although their close phylogeographic correspondence with distinct eco-environmental zones suggests that divergent selection might also have promoted broad patterns of population genetic structure.	[Mao, Xiuguang; He, Guimei; Zhang, Junpeng; Zhang, Shuyi] E China Normal Univ, Inst Adv Studies Multidisciplinary Sci & Technol, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Mao, Xiuguang; Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	East China Normal University; University of London; Queen Mary University London	Rossiter, SJ (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	s.j.rossiter@qmul.ac.uk; syzhang@bio.ecnu.edu.cn	Rossiter, Stephen J/E-2111-2011	He, Guimei/0000-0002-4889-0933; Rossiter, Stephen/0000-0002-3881-4515	Key Construction Program of the National "985'' Project; Key Construction Program of the National "211'' Project; China Postdoctoral Science Foundation; Marie Curie Actions-International Incoming Fellowships (IIF); Royal Society Fellowship (UK)	Key Construction Program of the National "985'' Project; Key Construction Program of the National "211'' Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Marie Curie Actions-International Incoming Fellowships (IIF); Royal Society Fellowship (UK)(Royal Society of London)	This work was funded by a grant awarded to S. Zhang under the Key Construction Program of the National "985'' Project and "211'' Project. X. Mao was supported by China Postdoctoral Science Foundation funded project and Marie Curie Actions-International Incoming Fellowships (IIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S. Rossiter was supported by a Royal Society Fellowship (UK).	Andersen K., 1905, ANN MAGAZINE NATURAL, V16, P289; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beaumont MA, 2002, GENETICS, V162, P2025; Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Chattopadhyay B, 2012, CONSERV GENET, V13, P1435, DOI 10.1007/s10592-012-0361-y; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; CHENG J, 2001, GEOSCIENCE, V15, P290; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Coyne JA, 2004, SPECIATION, V37; Csorba G., 2003, HORSESHOE BATS WORLD; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Hulva P, 2004, MOL PHYLOGENET EVOL, V32, P1023, DOI 10.1016/j.ympev.2004.04.007; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kondo B, 2008, EVOLUTION, V62, P1182, DOI 10.1111/j.1558-5646.2008.00345.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Li G, 2006, J MAMMAL, V87, P1234, DOI 10.1644/05-MAMM-A-395R2.1; Lim BK, 2008, BIOL J LINN SOC, V93, P189; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2009, SYST BIOL, V58, P452, DOI 10.1093/sysbio/syp034; Liu WC, 2009, MOL ECOL RESOUR, V9, P183, DOI 10.1111/j.1755-0998.2008.02434.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Mao XG, 2007, CHROMOSOME RES, V15, P835, DOI 10.1007/s10577-007-1167-5; Mao XG, 2010, MOL ECOL, V19, P1352, DOI 10.1111/j.1365-294X.2010.04560.x; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nielsen R, 2001, GENETICS, V158, P885; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2007, TRACER 1 4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Stadler T, 2008, GENETICS, V178, P339, DOI 10.1534/genetics.107.081810; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su Z., 2006, QUATERNARY GLACIATIO; Swofford DL, 2002, PAUP VER 4 0 B10 PHY; Thomas NM, 1997, THESIS HARRISON ZOLL; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Xu WX, 2005, SICHUAN J ZOOL, V24, P467; Yeung CKL, 2011, MOL BIOL EVOL, V28, P473, DOI 10.1093/molbev/msq210; You YY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-208; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21; ZHANG W, 1985, Acta Theriologica Sinica, V5, P95	71	25	27	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56786	10.1371/journal.pone.0056786	http://dx.doi.org/10.1371/journal.pone.0056786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451086	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500029
J	Cutrullis, RA; Petray, PB; Schapachnik, E; Sanchez, R; Postan, M; Gonzalez, MN; Martin, V; Corral, RS				Cutrullis, Romina A.; Petray, Patricia B.; Schapachnik, Edgardo; Sanchez, Ruben; Postan, Miriam; Gonzalez, Mariela N.; Martin, Valentina; Corral, Ricardo S.			Elevated Serum Levels of Macrophage Migration Inhibitory Factor Are Associated with Progressive Chronic Cardiomyopathy in Patients with Chagas Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI ANTIGENS; IFN-GAMMA; T-CELLS; SUPPRESSOR-CELLS; FACTOR MIF; HEART; MYOCARDITIS; PATHOGENESIS; EXPRESSION; INFECTION	Clinical symptoms of chronic Chagas disease occur in around 30% of the individuals infected with Trypanosoma cruzi and are characterized by heart inflammation and dysfunction. The pathogenesis of chronic chagasic cardiomyopathy (CCC) is not completely understood yet, partially because disease evolution depends on complex host-parasite interactions. Macrophage migration inhibitory factor (MIF) is a pleiotropic proinflammatory cytokine that promotes numerous pathophysiological processes. In the current study, we investigated the link between MIF and CCC progression. Immunohistochemical analysis demonstrated MIF overexpression in the hearts from chronically T. cruzi-infected mice, particularly those showing intense inflammatory infiltration. We also found that MIF exogenously added to parasite-infected murine macrophage cultures is capable of enhancing the production of TNF-alpha and reactive oxygen species, both with pathogenic roles in CCC. Thus, the integrated action of MIF and other cytokines and chemokines may account for leukocyte influx to the infected myocardium, accompanied by enhanced local production of multiple inflammatory mediators. We further examined by ELISA the level of MIF in the sera from chronic indeterminate and cardiomyopathic chagasic patients, and healthy subjects. CCC patients displayed significantly higher MIF concentrations than those recorded in asymptomatic T. cruzi-infected and uninfected individuals. Interestingly, increased MIF levels were associated with severe progressive Chagas heart disease, in correlation with elevated serum concentration of high sensitivity C-reactive protein and also with several echocardiographic indicators of left ventricular dysfunction, one of the hallmarks of CCC. Our present findings represent the first evidence that enhanced MIF production is associated with progressive cardiac impairment in chronic human infection with T. cruzi, strengthening the relationship between inflammatory response and parasite-driven pathology. These observations contribute to unravel the elements involved in the pathogenesis of CCC and may also be helpful for the design of novel therapies aimed to control long-term morbidity in chagasic patients.	[Cutrullis, Romina A.; Petray, Patricia B.; Corral, Ricardo S.] Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol Chagas, Buenos Aires, DF, Argentina; [Schapachnik, Edgardo] Hosp Gen Agudos Dr Cosme Argerich, Serv Cardiol, Buenos Aires, DF, Argentina; [Sanchez, Ruben] Hosp Gen Agudos Dr Jose Maria Ramos Mejia, Serv Cardiol, Buenos Aires, DF, Argentina; [Postan, Miriam; Gonzalez, Mariela N.] Inst Nacl Parasitol Dr Mario Fatala Chaben ANLIS, Buenos Aires, DF, Argentina; [Martin, Valentina] Univ Nacl San Martin, ECyT, Ctr Salud & Medio Ambiente CESyMA, Lab Inmunol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; University of Buenos Aires; Hospital Ramos Mejia	Corral, RS (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Serv Parasitol Chagas, Buenos Aires, DF, Argentina.	ricardocorral56@hotmail.com		GONZALEZ, MARIELA NATACHA/0000-0002-7274-4282	CONICET; FONCyT, Argentina [PICT 2010-2148]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT, Argentina(FONCyT)	RSC, PBP, MP and VM are members of the Research Career Program from National Research Council (CONICET, Argentina). RAC and MNG thank CONICET for fellowship granted. The study was funded by CONICET and by a grant (PICT 2010-2148) to MP from FONCyT, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cutrullis RA, 2009, PATHOBIOLOGY, V76, P170, DOI 10.1159/000218333; Bergeron M, 2008, PARASITE IMMUNOL, V30, P280, DOI 10.1111/j.1365-3024.2008.01022.x; Bernhagen J, 1998, J MOL MED-JMM, V76, P151, DOI 10.1007/s001090050204; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; Biolo A, 2010, PROG CARDIOVASC DIS, V52, P300, DOI 10.1016/j.pcad.2009.11.008; Bozza FA, 2004, SHOCK, V22, P309, DOI 10.1097/01.shk.0000140305.01641.c8; Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Camargo MM, 1997, J IMMUNOL, V158, P5890; Cavalcanti MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025259; Chen PF, 2010, MOL MED, V16, P400, DOI 10.2119/molmed.2009.00128; Chuang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037613; Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928; da Silva CA, 2010, REV ESP CARDIOL, V63, P1096, DOI 10.1016/S0300-8932(10)70233-5; Rosado JD, 2011, INT J BIOL SCI, V7, P1239; Dhiman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028449; Donn RP, 2004, J ENDOCRINOL, V182, P1, DOI 10.1677/joe.0.1820001; Drigo SA, 2006, MICROBES INFECT, V8, P598, DOI 10.1016/j.micinf.2005.08.009; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Girard E, 2012, BRIT J CANCER, V107, P1498, DOI 10.1038/bjc.2012.392; Gomes JAS, 2003, INFECT IMMUN, V71, P1185, DOI 10.1128/IAI.71.3.1185-1193.2003; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2011, ADV PARASIT, V76, P153, DOI 10.1016/B978-0-12-385895-5.00007-4; Hagman S, 2011, J NEUROIMMUNOL, V234, P141, DOI 10.1016/j.jneuroim.2011.02.009; Hardison JL, 2006, INFECT IMMUN, V74, P135, DOI 10.1128/IAI.74.1.135-143.2006; Higuchi MD, 1997, AM J TROP MED HYG, V56, P485; Higuchi MD, 2003, CARDIOVASC RES, V60, P96, DOI 10.1016/S0008-6363(03)00361-4; HO JL, 1992, INFECT IMMUN, V60, P1984, DOI 10.1128/IAI.60.5.1984-1993.1992; Jain Vidhan, 2009, BMC Res Notes, V2, P36, DOI 10.1186/1756-0500-2-36; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kimura K, 2006, CLIN VACCINE IMMUNOL, V13, P415, DOI 10.1128/CVI.13.3.415-419.2006; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lorena VMB, 2010, SCAND J IMMUNOL, V72, P529, DOI 10.1111/j.1365-3083.2010.02462.x; Luo HH, 2010, CARDIOVASC RES, V85, P347, DOI 10.1093/cvr/cvp225; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Matsui Y, 2004, J MOL CELL CARDIOL, V37, P557, DOI 10.1016/j.yjmcc.2004.05.016; McDevitt MA, 2006, J EXP MED, V203, P1185, DOI 10.1084/jem.20052398; Mocelin AO, 2005, EUR J HEART FAIL, V7, P869, DOI 10.1016/j.ejheart.2004.10.014; MOLINA HA, 1988, T ROY SOC TROP MED H, V82, P241, DOI 10.1016/0035-9203(88)90432-4; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Muller II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038376; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; Paiva CN, 2007, EUR J IMMUNOL, V37, P1355, DOI 10.1002/eji.200636705; Pan American Health Organization, 2009, JOINT M SO CON CENTR; POSTAN M, 1986, T ROY SOC TROP MED H, V80, P50, DOI 10.1016/0035-9203(86)90193-8; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Regis EG, 2010, VIROLOGY, V399, P31, DOI 10.1016/j.virol.2009.12.018; REIS DD, 1993, AM J TROP MED HYG, V48, P637, DOI 10.4269/ajtmh.1993.48.637; Reyes JL, 2006, INFECT IMMUN, V74, P3170, DOI 10.1128/IAI.01648-05; Santos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Talvani A, 2000, MICROBES INFECT, V2, P851, DOI 10.1016/S1286-4579(00)00388-9; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; Terrazas CA, 2011, INT J BIOL SCI, V7, P1298, DOI 10.7150/ijbs.7.1298; Vogt J, 2008, MICROBES INFECT, V10, P781, DOI 10.1016/j.micinf.2008.04.013; Wakabayashi K, 2012, MOD RHEUMATOL, V22, P59, DOI 10.1007/s10165-011-0466-z; Wen JJ, 2006, FREE RADICAL BIO MED, V41, P270, DOI 10.1016/j.freeradbiomed.2006.04.009; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; Yamada G, 2002, CLIN IMMUNOL, V104, P123, DOI 10.1006/clim.2002.5255; Yu CM, 2003, J HISTOCHEM CYTOCHEM, V51, P625, DOI 10.1177/002215540305100508; Yu XY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016239, 10.1371/journal.pone.0028397]; Yu XH, 2012, CHINESE MED J-PEKING, V125, P50, DOI 10.3760/cma.j.issn.0366-6999.2012.01.010; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	71	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57181	10.1371/journal.pone.0057181	http://dx.doi.org/10.1371/journal.pone.0057181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451183	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800088
J	Diao, HL; Xiao, S; Li, R; Zhao, F; Ye, XQ				Diao, Honglu; Xiao, Shuo; Li, Rong; Zhao, Fei; Ye, Xiaoqin			Distinct Spatiotemporal Expression of Serine Proteases Prss23 and Prss35 in Periimplantation Mouse Uterus and Dispensable Function of Prss35 in Fertility	PLOS ONE			English	Article							EMBRYO IMPLANTATION; MICE; DECIDUALIZATION; LOCALIZATION; ENDOMETRIUM; DEFICIENT; OVARIAN; FAMILY; CYCLE; ISP2	PRSS23 and PRSS35 are homologous proteases originally identified in mouse ovaries. In the periimplantation mouse uterus, Prss23 was highly expressed in the preimplantation gestation day 3.5 (D3.5) uterine luminal epithelium (LE). It disappeared from the postimplantation LE and reappeared in the stromal compartment next to the myometrium on D6.5. It was undetectable in the embryo from D4.5 to D6.5 but highly expressed in the embryo on D7.5. Prss35 became detectable in the uterine stromal compartment surrounding the embryo on D4.5 and shifted towards the mesometrial side of the stromal compartment next to the embryo from D5.5 to D7.5. In the ovariectomized uterus, Prss23 was moderately and Prss35 was dramatically downregulated by progesterone and 17 beta-estradiol. Based on the expression of Prss35 in granulosa cells and corpus luteum of the ovary and the early pregnant uterus, we hypothesized that PRSS35 might play a role in female reproduction, especially in oocyte development, ovulation, implantation, and decidualization. This hypothesis was tested in Prss35((-/-)) mice, which proved otherwise. Between wild type (WT) and Prss35((-/-)) mice, superovulation of immature females produced comparable numbers of cumulus-oocyte complexes; there were comparable numbers of implantation sites detected on D4.5 and D7.5; there were no obvious differences in the expression of implantation and decidualization marker genes in D4.5 or D7.5 uteri. Comparable mRNA expression levels of a few known protease-related genes in the WT and Prss35((-/-)) D4.5 uteri indicated no compensatory upregulation. Comparable litter sizes from WT x WT and Prss35((-/-)) x Prss35((-/-)) crosses suggested that Prss35 gene was unessential for fertility and embryo development. Prss35 gene has been linked to cleft lip/palate in humans. However, no obvious such defects were observed in Prss35((-/-)) mice. This study demonstrates the distinct expression of Prss23 and Prss35 in the periimplantation uterus and the dispensable role of Prss35 in fertility and embryo development.	[Diao, Honglu; Xiao, Shuo; Li, Rong; Zhao, Fei; Ye, Xiaoqin] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Xiao, Shuo; Li, Rong; Zhao, Fei; Ye, Xiaoqin] Univ Georgia, Interdisciplinary Toxicol Program, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Ye, XQ (corresponding author), Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA.	ye@uga.edu	Li, Rong/O-5558-2018		National Institutes of Health [NIH R15HD066301, NIH R01HD065939]; Office of the Vice President for Research; Graduate School; Department of Physiology Pharmacology; Interdisciplinary Toxicology Program at University of Georgia, Athens, Georgia, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065939] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD066301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research; Graduate School; Department of Physiology Pharmacology; Interdisciplinary Toxicology Program at University of Georgia, Athens, Georgia, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the grants from the National Institutes of Health (NIH R15HD066301 and NIH R01HD065939 to X.Y.), and funding from the Office of the Vice President for Research, the Graduate School, the Department of Physiology & Pharmacology, and the Interdisciplinary Toxicology Program at University of Georgia, Athens, Georgia, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bany BM, 2006, DEV BIOL, V294, P445, DOI 10.1016/j.ydbio.2006.03.006; Brown N, 2004, BIOL REPROD, V71, P2003, DOI 10.1095/biolreprod.104.031864; Chan HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030397; Chen W, 2010, CELL TISSUE RES, V341, P441, DOI 10.1007/s00441-010-1013-5; Chen Y, 2006, J MOL ENDOCRINOL, V37, P147, DOI 10.1677/jme.1.02009; Curry TE, 2003, ENDOCR REV, V24, P428, DOI 10.1210/er.2002-0005; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Diao HL, 2011, FERTIL STERIL, V95, P2087, DOI 10.1016/j.fertnstert.2011.01.160; Diao HL, 2010, FERTIL STERIL, V94, P2808, DOI 10.1016/j.fertnstert.2010.06.034; FINN CA, 1967, J REPROD FERTIL, V13, P259; Forde N, 2012, BIOL REPROD; Grummer R, 1996, INT J DEV BIOL, V40, P361; Hamm ML, 2004, BIOL REPROD, V71, P66, DOI 10.1095/biolreprod.104.027292; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; KINDER JE, 1995, J REPROD FERTIL, P393; Letra A, 2010, J DENT RES, V89, P927, DOI 10.1177/0022034510370004; Liang XH, 2010, ENDOCRINOLOGY, V151, P5007, DOI 10.1210/en.2010-0170; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Liu H C, 1995, Early Pregnancy, V1, P281; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Mitko K, 2008, REPRODUCTION, V135, P225, DOI 10.1530/REP-07-0415; Miyakoshi K, 2006, BIOL REPROD, V75, P823, DOI 10.1095/biolreprod.106.052290; O'Sullivan CM, 2002, MOL REPROD DEV, V62, P328, DOI 10.1002/mrd.10142; O'Sullivan CM, 2001, REPRODUCTION, V122, P235, DOI 10.1530/rep.0.1220235; Pelch KE, 2010, FERTIL STERIL, V93, P1615, DOI 10.1016/j.fertnstert.2009.03.086; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; SAFRANSKI TJ, 1993, BIOL REPROD, V48, P669, DOI 10.1095/biolreprod48.3.669; Salamonsen LA, 2003, PLACENTA, V24, pS76, DOI 10.1053/plac.2002.0928; Salamonsen Lois A, 2002, Rev Endocr Metab Disord, V3, P133, DOI 10.1023/A:1015407012559; Wahlberg P, 2008, ENDOCRINOLOGY, V149, P5070, DOI 10.1210/en.2007-1736; Ye XQ, 2011, FERTIL STERIL, V95, P2107, DOI 10.1016/j.fertnstert.2011.02.024; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505	33	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56757	10.1371/journal.pone.0056757	http://dx.doi.org/10.1371/journal.pone.0056757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451081	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800033
J	Hamilton, SA; Tower, CL; Jones, RL				Hamilton, Sarah A.; Tower, Clare L.; Jones, Rebecca L.			Identification of Chemokines Associated with the Recruitment of Decidual Leukocytes in Human Labour: Potential Novel Targets for Preterm Labour	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; HUMAN ENDOMETRIUM; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; TERM; CELLS; SECRETION; CYTOKINES; CERVIX	Current therapies for preterm labour (PTL) focus on arresting myometrial contractions but are largely ineffective, thus alternative therapeutic targets need to be identified. Leukocytes infiltrate the uterus around the time of labour, and are in particularly abundant in decidua (maternal-fetal interface). Moreover, decidual inflammation precedes labour in rat pregnancies and thus may contribute to initiation of labour. We hypothesized that chemokines mediate decidual leukocyte trafficking during preterm labour (PTL) and term labour (TL), thus representing potential targets for preventing PTL. Women were recruited into 4 groups: TL, term not in labour (TNL), idiopathic PTL and PTL with infection (PTLI). Choriodecidual RNA was subjected to a pathway-specific PCR array for chemokines. Differential expression of 12 candidate chemokines was validated by real time RT-PCR and Bioplex assay, with immunohistochemistry to confirm cellular origin. 25 chemokines were upregulated in choriodecidua from TL compared to TNL. A similar pattern was detected in PTL, however a distinct profile was observed in PTLI consistent with differences in leukocyte infiltration. Upregulation of CCL2, CCL4, CCL5, CXCL8 and CXCL10 mRNA and protein was confirmed in TL, with CCL8 upregulated in PTL. Significant correlations were detected between these chemokines and decidual leukocyte abundance previously assessed by immunohistochemical and image analysis. Chemokines were primarily expressed by decidual stromal cells. In addition, CXCL8 and CCL5 were significantly elevated in maternal plasma during labour, suggesting chemokines contribute to peripheral inflammatory events during labour. Differences in chemokine expression patterns between TL and idiopathic PTL may be attributable to suppression of chemokine expression by betamethasone administered to women in PTL; this was supported by in vitro evidence of chemokine downregulation by clinically relevant concentrations of the steroid. The current study provides compelling evidence that chemokines regulate decidual leukocyte recruitment during labour. The 6 chemokines identified represent potential novel therapeutic targets to block PTL.	[Hamilton, Sarah A.; Tower, Clare L.; Jones, Rebecca L.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Inst Human Dev, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester	Jones, RL (corresponding author), Univ Manchester, Maternal & Fetal Hlth Res Ctr, Inst Human Dev, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	Rebecca.Lee.Jones@manchester.ac.uk	Jones, Rebecca/E-4481-2011	Jones, Rebecca/0000-0002-8871-0589; Tower, Clare/0000-0001-8532-5354	James Tudor Foundation; Tommy's the Baby Charity	James Tudor Foundation; Tommy's the Baby Charity	This study was supported by a research grant from the James Tudor Foundation and Tommy's the Baby Charity. (http://www.jamestudor.org.uk/http://www.tommys.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ofi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042217; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Anderson J, 2007, GENE THER, V14, P1287, DOI 10.1038/sj.gt.3302958; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; BERKMAN N, 1995, AM J PHYSIOL-LUNG C, V269, pL443, DOI 10.1152/ajplung.1995.269.4.L443; Bollopragada S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.032; Brown NL, 1998, J ENDOCRINOL, V159, P519, DOI 10.1677/joe.0.1590519; Carlino C, 2008, BLOOD, V111, P3108, DOI 10.1182/blood-2007-08-105965; CASEY ML, 1988, CLIN OBSTET GYNECOL, V31, P533, DOI 10.1097/00003081-198809000-00005; Chan J, 2007, J ENDOCRINOL, V195, P7, DOI 10.1677/JOE-07-0289; Critchley HOD, 1999, J CLIN ENDOCR METAB, V84, P240, DOI 10.1210/jc.84.1.240; Denison FC, 1998, HUM REPROD, V13, P3560, DOI 10.1093/humrep/13.12.3560; Dominguez F, 2008, MOL HUM REPROD, V14, P423, DOI 10.1093/molehr/gan032; Dubicke A, 2008, MOL HUM REPROD, V14, P641, DOI 10.1093/molehr/gan060; Engert S, 2007, AM J REPROD IMMUNOL, V58, P129, DOI 10.1111/j.1600-0897.2007.00498.x; Esplin MS, 2005, PLACENTA, V26, P661, DOI 10.1016/j.placenta.2004.09.012; Gibb W, 1998, ANN MED, V30, P235, DOI 10.3109/07853899809005850; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez-Lopez N, 2009, J REPROD IMMUNOL, V80, P122, DOI 10.1016/j.jri.2009.01.002; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Hamilton S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095505; Hassan SS, 2006, AM J OBSTET GYNECOL, V195, P778, DOI 10.1016/j.ajog.2006.06.021; Huang SJ, 2006, J REPROD IMMUNOL, V72, P60, DOI 10.1016/j.jri.2006.03.002; Ishihara O, 1996, PROSTAGLANDINS, V52, P199, DOI 10.1016/S0090-6980(96)00097-4; Jones RL, 2004, J CLIN ENDOCR METAB, V89, P6155, DOI 10.1210/jc.2004-0507; Jones RL, 1997, HUM REPROD, V12, P1300; Krzysiek R, 1999, J IMMUNOL, V162, P4455; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Li AH, 2004, CLIN EXP METASTAS, V21, P571; Li M, 2011, J CLIN ENDOCR METAB, V96, P2502, DOI 10.1210/jc.2011-0055; Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034707; Marret S, 2007, OBSTET GYNECOL, V110, P72, DOI 10.1097/01.AOG.0000267498.95402.bd; Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753; Marvin KW, 2002, MOL HUM REPROD, V8, P399, DOI 10.1093/molehr/8.4.399; Menzies FM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094631; MITCHELL MD, 1995, REPROD FERT DEVELOP, V7, P623, DOI 10.1071/RD9950623; Mittal P, 2008, AM J REPROD IMMUNOL, V60, P246, DOI 10.1111/j.1600-0897.2008.00620.x; Norman Jane E, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS7, DOI 10.1186/1471-2393-7-S1-S7; Osman I, 2006, J SOC GYNECOL INVEST, V13, P97, DOI 10.1016/j.jsgi.2005.12.002; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Reich ES, 2012, NATURE, V485, P20, DOI 10.1038/485020a; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Shire D, 2000, METH MOL B, V137, P59; Shynlova O, 2008, J IMMUNOL, V181, P1470, DOI 10.4049/jimmunol.181.2.1470; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Tan T. C., 2006, SMJ Singapore Medical Journal, V47, P361; Tattersall M, 2008, REPRODUCTION, V135, P569, DOI 10.1530/REP-07-0461; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-39; Tower CL, 2010, REPRODUCTION, V140, P931, DOI 10.1530/REP-10-0307; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; WILCOX MA, 1993, BRIT J OBSTET GYNAEC, V100, P342, DOI 10.1111/j.1471-0528.1993.tb12977.x; Winkler M, 2001, J PERINAT MED, V29, P519, DOI 10.1515/JPM.2001.072; Young A, 2002, BIOL REPROD, V66, P445, DOI 10.1095/biolreprod66.2.445; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	57	89	90	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56946	10.1371/journal.pone.0056946	http://dx.doi.org/10.1371/journal.pone.0056946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451115	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800050
J	Mo, WJ; Zhang, JY; Li, X; Meng, DL; Gao, Y; Yang, S; Wan, XC; Zhou, CH; Guo, FH; Huang, Y; Amente, S; Avvedimento, EV; Xie, Y; Li, Y				Mo, Wenjuan; Zhang, Jiyuan; Li, Xia; Meng, Delong; Gao, Yun; Yang, Shu; Wan, Xuechao; Zhou, Caihong; Guo, Fenghua; Huang, Yan; Amente, Stefano; Avvedimento, Enrico V.; Xie, Yi; Li, Yao			Identification of Novel AR-Targeted MicroRNAs Mediating Androgen Signalling through Critical Pathways to Regulate Cell Viability in Prostate Cancer	PLOS ONE			English	Article							EXPRESSION; GROWTH; RECEPTOR; PROTEIN; KINASE; PROSAPOSIN; PREDICTION; MECHANISM; CLUSTER; COMPLEX	MicroRNAs (miRNAs) have been recognized as significantly involved in prostate cancer (PCa). Since androgen receptor (AR) plays a central role in PCa carcinogenesis and progression, it is imperative to systematically elucidate the causal association between AR and miRNAs, focusing on the molecular mechanisms by which miRNAs mediate AR signalling. In this study, we performed a series of time-course microarrays to observe the dynamic genome-wide expressions of mRNAs and miRNAs in parallel in hormone-sensitive prostate cancer LNCaP cells stimulated by androgen. Accordingly, we introduced Response Score to identify AR target miRNAs, as well as Modulation Score to identify miRNA target mRNAs. Based on theoretical identification and experimental validation, novel mechanisms addressing cell viability in PCa were unravelled for 3 miRNAs newly recognized as AR targets. (1) miR-19a is directly up-regulated by AR, and represses SUZ12, RAB13, SC4MOL, PSAP and ABCA1, respectively. (2) miR-27a is directly up-regulated by AR, and represses ABCA1 and PDS5B. (3) miR-133b is directly upregulated by AR, and represses CDC2L5, PTPRK, RB1CC1, and CPNE3, respectively. Moreover, we found miR-133b is essential to PCa cell survival. Our study gives certain clues on miRNAs mediated AR signalling to cell viability by influencing critical pathways, especially by breaking through androgen's growth restriction effect on normal prostate tissue.	[Mo, Wenjuan; Zhang, Jiyuan; Li, Xia; Meng, Delong; Gao, Yun; Yang, Shu; Wan, Xuechao; Zhou, Caihong; Guo, Fenghua; Huang, Yan; Xie, Yi; Li, Yao] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Amente, Stefano] Univ Naples Federico II, Dept Biol, Naples, Italy; [Avvedimento, Enrico V.] Univ Naples Federico II, Dept Mol Med & Biotechnol, Naples, Italy	Fudan University; University of Naples Federico II; University of Naples Federico II	Avvedimento, EV (corresponding author), Univ Naples Federico II, Dept Mol Med & Biotechnol, Naples, Italy.	avvedim@unina.it; yaoli@fudan.edu.cn	Amente, Stefano/AAU-7605-2020; Li, Yao/AAE-3550-2019; Yang, Shu/CAG-1493-2022; Meng, Delong/K-8937-2019	Amente, Stefano/0000-0003-0612-6096; Yang, Shu/0000-0001-8909-1962; Meng, Delong/0000-0001-5183-4564	National Natural Science Foundation of China [31071142, 31171246]; Shanghai Key Laboratory of Intelligent Information Processing of China [IIPL-2010-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Intelligent Information Processing of China	This work is supported in part by two grants 31071142 and 31171246 from the National Natural Science Foundation of China, and by Shanghai Key Laboratory of Intelligent Information Processing of China (No. IIPL-2010-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Anazawa Y, 2004, ONCOGENE, V23, P7621, DOI 10.1038/sj.onc.1207270; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Caudell EG, 2000, BIOCHEMISTRY-US, V39, P13034, DOI 10.1021/bi001250v; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Crea F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-40; Culig Z, 2000, UROL RES, V28, P211, DOI 10.1007/s002400000111; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fletcher CE, 2012, HUM MOL GENET, V21, P3112, DOI 10.1093/hmg/dds139; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Hamzeh M, 2011, J ENDOCRINOL, V209, P55, DOI 10.1530/JOE-10-0223; He MA, 2011, J CLIN INVEST, V121, P976, DOI 10.1172/JCI42650; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jayaswal V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp153; Jiang M, 2009, MOL ENDOCRINOL, V23, P1927, DOI 10.1210/me.2009-0103; Kanda I, 2008, ONCOGENE, V27, P1687, DOI 10.1038/sj.onc.1210812; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Koochekpour S, 2008, J CELL BIOCHEM, V104, P2272, DOI 10.1002/jcb.21786; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Liu C, 2011, CANCER RES, V71, P5950, DOI 10.1158/0008-5472.CAN-11-1035; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Maffini MV, 2002, ENDOCRINOLOGY, V143, P2708, DOI 10.1210/en.143.7.2708; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Patron JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035345; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Snedecor GW, 1980, STAT METHODS, V7th; STABEL S, 1985, EMBO J, V4, P2329, DOI 10.1002/j.1460-2075.1985.tb03934.x; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Wang WH, 2011, HEPATOLOGY, V53, P1137, DOI 10.1002/hep.24163; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yang CM, 2012, J NUTR BIOCHEM, V23, P8, DOI 10.1016/j.jnutbio.2010.10.006	47	90	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56592	10.1371/journal.pone.0056592	http://dx.doi.org/10.1371/journal.pone.0056592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451058	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800020
J	Yongye, AB; Vivoli, M; Lindberg, I; Appel, JR; Houghten, RA; Martinez-Mayorga, K				Yongye, Austin B.; Vivoli, Mirella; Lindberg, Iris; Appel, Jon R.; Houghten, Richard A.; Martinez-Mayorga, Karina			Identification of a Small Molecule That Selectively Inhibits Mouse PC2 over Mouse PC1/3: A Computational and Experimental Study	PLOS ONE			English	Article							SYNTHETIC COMBINATORIAL LIBRARIES; PROPROTEIN CONVERTASES; PROHORMONE CONVERTASES; CRYSTAL-STRUCTURE; FURIN INHIBITORS; SPECIFICITY; PEPTIDE; 7B2; ACTIVATION; CHEMISTRY	The calcium-dependent serine endoproteases prohormone convertase 1/3 (PC1/3) and prohormone convertase 2 (PC2) play important roles in the homeostatic regulation of blood glucose levels, hence implicated in diabetes mellitus. Specifically, the absence of PC2 has been associated with chronic hypoglycemia. Since there is a reasonably good conservation of the catalytic domain between species translation of inhibitory effects is likely. In fact, similar results have been found using both mouse and human recombinant enzymes. Here, we employed computational structure-based approaches to screen 14,400 compounds from the Maybridge small molecule library towards mouse PC2. Our most remarkable finding was the identification of a potent and selective PC2 inhibitor. Kinetic data showed the compound to be an allosteric inhibitor. The compound identified is one of the few reported selective, small-molecule inhibitors of PC2. In addition, this new PC2 inhibitor is structurally different and of smaller size than those reported previously. This is advantageous for future studies where structural analogues can be built upon.	[Yongye, Austin B.; Houghten, Richard A.; Martinez-Mayorga, Karina] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Vivoli, Mirella; Lindberg, Iris] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Appel, Jon R.; Houghten, Richard A.] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Martinez-Mayorga, Karina] Univ Nacl Autonoma Mexico, Inst Quim, Mexico City, DF, Mexico	Torrey Pines Institute for Molecular Studies, Florida; University System of Maryland; University of Maryland Baltimore; Torrey Pines Institute for Molecular Studies, California; Universidad Nacional Autonoma de Mexico	Martinez-Mayorga, K (corresponding author), Torrey Pines Inst Mol Studies, Port St Lucie, FL USA.	kmartinez@tpims.org	Lindberg, Iris/Q-3825-2019	Vivoli Vega, Mirella/0000-0002-1148-5651	State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development;  [DA05084]; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA005084, R01DA005084] Funding Source: NIH RePORTER	State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development to RAH and KMM, and DA05084 to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SCHROD L GLID 5 5; [Anonymous], SOFTW OS ROCS VERS 2; [Anonymous], 2009, SCHROD L PRIM VERS 2; [Anonymous], 2008, SCHROD L LIGPREP 2 2; Apletalina E, 1998, J BIOL CHEM, V273, P26589, DOI 10.1074/jbc.273.41.26589; Apletalina EV, 2000, BIOCHEM BIOPH RES CO, V267, P940, DOI 10.1006/bbrc.1999.2060; Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Basak A, 1999, BIOCHEM J, V338, P107, DOI 10.1042/0264-6021:3380107; Becker GL, 2010, J MED CHEM, V53, P1067, DOI 10.1021/jm9012455; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Boudreault A, 1998, J BIOL CHEM, V273, P31574, DOI 10.1074/jbc.273.47.31574; BRESLIN MB, 1993, J BIOL CHEM, V268, P27084; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Cameron A, 2000, FEBS LETT, V473, P135, DOI 10.1016/S0014-5793(00)01511-8; Cameron A, 2002, ENZYMES, P291; Cornwall GA, 2003, ENDOCRINOLOGY, V144, P901, DOI 10.1210/en.2002-220997; Creemers JWM, 2012, DIABETES, V61, P383, DOI 10.2337/db11-0305; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Fugere M, 2002, CURR PHARM DESIGN, V8, P549, DOI 10.2174/1381612023395736; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; Hoshino A., 2012, C SERIES NEUROPEPTID, V1, P1; Houghten RA, 1999, J MED CHEM, V42, P3743, DOI 10.1021/jm990174v; Houghten RA, 2008, J COMB CHEM, V10, P3, DOI 10.1021/cc7001205; Hubbard S. J., 1993, NACCESS; Inc CCG, 2008, MOE 2008 10; JEAN F, 1995, J BIOL CHEM, V270, P19225, DOI 10.1074/jbc.270.33.19225; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kowalska D, 2009, MOL PHARMACOL, V75, P617, DOI 10.1124/mol.108.051334; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; LINDBERG I, 1995, BIOCHEMISTRY-US, V34, P7780, DOI 10.1021/bi00023a027; Lopez-Vallejo F, 2012, BIOORGAN MED CHEM, V20, P4462, DOI 10.1016/j.bmc.2012.05.029; Lopez-Vallejo F, 2011, COMB CHEM HIGH T SCR, V14, P475, DOI 10.2174/138620711795767866; McGann MR, 2003, BIOPOLYMERS, V68, P76, DOI 10.1002/bip.10207; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Nicholls A, 2008, J COMPUT AID MOL DES, V22, P239, DOI 10.1007/s10822-008-9170-2; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Pinilla C, 2003, NAT MED, V9, P118, DOI 10.1038/nm0103-118; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rouille Y, 1997, FEBS LETT, V413, P119, DOI 10.1016/S0014-5793(97)00892-2; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; SMEEKENS SP, 1992, P NATL ACAD SCI USA, V89, P8822, DOI 10.1073/pnas.89.18.8822; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Vivoli M, 2012, MOL PHARMACOL, V81, P440, DOI 10.1124/mol.111.077040; Yongye AB, 2011, J MOL MODEL, V17, P1473, DOI 10.1007/s00894-010-0850-1; ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509	52	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56957	10.1371/journal.pone.0056957	http://dx.doi.org/10.1371/journal.pone.0056957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451118	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800053
J	Huang, SW; Zhang, HY				Huang, Shengwei; Zhang, Hongyu			The Impact of Environmental Heterogeneity and Life Stage on the Hindgut Microbiota of Holotrichia parallela Larvae (Coleoptera: Scarabaeidae)	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; PACHNODA-EPHIPPIATA COLEOPTERA; HUMUS-FEEDING LARVA; GUT BACTERIA; COMMUNITY STRUCTURE; MANAGEMENT REGIME; AEDES-ALBOPICTUS; DIVERSITY; TEMPERATURE; VECTOR	Gut microbiota has diverse ecological and evolutionary effects on its hosts. However, the ways in which it responds to environmental heterogeneity and host physiology remain poorly understood. To this end, we surveyed intestinal microbiota of Holotrichia parallela larvae at different instars and from different geographic regions. Bacterial 16S rRNA gene clone libraries were constructed and clones were subsequently screened by DGGE and sequenced. Firmicutes and Proteobacteria were the major phyla, and bacteria belonging to Ruminococcaceae, Lachnospiraceae, Enterobacteriaceae, Desulfovibrionaceae and Rhodocyclaceae families were commonly found in all natural populations. However, bacterial diversity (Chao1 and Shannon indices) and community structure varied across host populations, and the observed variation can be explained by soil pH, organic carbon and total nitrogen, and the climate factors (e.g., mean annual temperature) of the locations where the populations were sampled. Furthermore, increases in the species richness and diversity of gut microbiota were observed during larval growth. Bacteroidetes comprised the dominant group in the first instar; however, Firmicutes composed the majority of the hindgut microbiota during the second and third instars. Our results suggest that the gut's bacterial community changes in response to environmental heterogeneity and host's physiology, possibly to meet the host's ecological needs or physiological demands.	[Huang, Shengwei; Zhang, Hongyu] Huazhong Agr Univ, Inst Urban & Hort Pests, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Huang, Shengwei; Zhang, Hongyu] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zhang, HY (corresponding author), Huazhong Agr Univ, Inst Urban & Hort Pests, State Key Lab Agr Microbiol, Wuhan, Peoples R China.; Zhang, HY (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn			National Natural Science Foundation of China [30671404, 31272378]; Special Fund for Agro-Scientific Research of the Public Interest [201003025]; earmarked fund for Modern Agro-industry Technology Research System of China [CARS-27]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200805040010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research of the Public Interest; earmarked fund for Modern Agro-industry Technology Research System of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work is partly supported by National Natural Science Foundation of China (No. 30671404 and No. 31272378), the Special Fund for Agro-Scientific Research of the Public Interest (No. 201003025), the earmarked fund for Modern Agro-industry Technology Research System of China (No. CARS-27), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 200805040010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; BAYON C, 1980, J INSECT PHYSIOL, V26, P819, DOI 10.1016/0022-1910(80)90098-0; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Behar A, 2008, ISR J ECOL EVOL, V54, P181, DOI 10.1080/15659801.2008.10639612; Bell C, 2008, MICROB ECOL, V56, P153, DOI 10.1007/s00248-007-9333-z; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Briones AM, 2008, ISME J, V2, P74, DOI 10.1038/ismej.2007.95; CAYLEY GR, 1980, PESTIC SCI, V11, P9, DOI 10.1002/ps.2780110103; Cazemier AE, 2003, ANTON LEEUW INT J G, V83, P135, DOI 10.1023/A:1023325817663; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Clark J, 2009, MICROB ECOL, V57, P248, DOI 10.1007/s00248-008-9475-7; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; de Barros HP, 2003, AQUACULTURE, V216, P165, DOI 10.1016/S0044-8486(02)00505-7; de Graaff MA, 2010, NEW PHYTOL, V188, P1055, DOI 10.1111/j.1469-8137.2010.03427.x; de Vries EJ, 2004, P ROY SOC B-BIOL SCI, V271, P2171, DOI 10.1098/rspb.2004.2817; de Vries EJ, 2001, J INVERTEBR PATHOL, V77, P120, DOI 10.1006/jipa.2001.5009; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dillon RJ, 2002, J APPL MICROBIOL, V92, P759, DOI 10.1046/j.1365-2672.2002.01581.x; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; DOWD PF, 1992, J IND MICROBIOL, V9, P149, DOI 10.1007/BF01569619; Egert M, 2005, APPL ENVIRON MICROB, V71, P4556, DOI 10.1128/AEM.71.8.4556-4566.2005; Egert M, 2003, APPL ENVIRON MICROB, V69, P6659, DOI 10.1128/AEM.69.11.6659-6668.2003; Ghiglione JF, 2008, BIOGEOSCIENCES, V5, P1751, DOI 10.5194/bg-5-1751-2008; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Hillesland H, 2008, AM J TROP MED HYG, V79, P881, DOI 10.4269/ajtmh.2008.79.881; Hong PY, 2011, ISME J, V5, P1461, DOI 10.1038/ismej.2011.33; Hongoh Y, 2006, MOL ECOL, V15, P505, DOI 10.1111/j.1365-294X.2005.02795.x; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kirk JL, 2005, ENVIRON POLLUT, V133, P455, DOI 10.1016/j.envpol.2004.06.002; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lavelle P, 1997, EUR J SOIL BIOL, V33, P159; Lemke T, 2003, APPL ENVIRON MICROB, V69, P6650, DOI 10.1128/AEM.69.11.6650-6658.2003; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Liu WT, 2002, J BIOSCI BIOENG, V93, P101, DOI 10.1263/jbb.93.101; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakatsu CH, 2000, SOIL SCI SOC AM J, V64, P1382, DOI 10.2136/sssaj2000.6441382x; Nubel U, 1996, J BACTERIOL, V178, P5636; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Panikkar P, 2002, INDIAN J FISH, V49, P29; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Penders J, 2006, CLIN EXP ALLERGY, V36, P1602, DOI 10.1111/j.1365-2222.2006.02599.x; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Pittman GW, 2008, APPL ENVIRON MICROB, V74, P762, DOI 10.1128/AEM.01831-07; Prado SS, 2010, APPL ENVIRON MICROB, V76, P1261, DOI 10.1128/AEM.02034-09; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Salles JF, 2006, MICROB ECOL, V52, P267, DOI 10.1007/s00248-006-9048-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Toth EM, 2006, MICROB ECOL, V51, P13, DOI 10.1007/s00248-005-0090-6; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Visotto LE, 2009, J INSECT PHYSIOL, V55, P185, DOI 10.1016/j.jinsphys.2008.10.017; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Yang H, 2005, ENVIRON MICROBIOL, V7, P916, DOI 10.1111/j.1462-2920.2005.00760.x; Zhang H, 2008, J APPL MICROBIOL, V105, P1277, DOI 10.1111/j.1365-2672.2008.03867.x; Zhou Li-Mei, 2009, Acta Entomologica Sinica, V52, P121; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	77	31	37	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57169	10.1371/journal.pone.0057169	http://dx.doi.org/10.1371/journal.pone.0057169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437336	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000081
J	Schnettler, S				Schnettler, Sebastian			Revisiting a Sample of US Billionaires: How Sample Selection and Timing of Maternal Condition Influence Findings on the Trivers-Willard Effect	PLOS ONE			English	Article							SEX-BIASED INVESTMENT; REPRODUCTIVE STRATEGIES; PARENTAL INVESTMENT; RATIO; BIRTH; HYPOTHESIS; DAUGHTERS; SUCCESS	Based on evolutionary theory, Trivers & Willard (TW) predicted the existence of mechanisms that lead parents with high levels of resources to bias offspring sex composition to favor sons and parents with low levels of resources to favor daughters. This hypothesis has been tested in samples of wealthy individuals but with mixed results. Here, I argue that both sample selection due to a high number of missing cases and a lacking specification of the timing of wealth accumulation contribute to this equivocal pattern. This study improves on both issues: First, analyses are based on a data set of U.S. billionaires with near-complete information on the sex of offspring. Second, subgroups of billionaires are distinguished according to the timing when they acquired their wealth. Informed by recent insights on the timing of a potential TW effect in animal studies, I state two hypotheses. First, billionaires have a higher share of male offspring than the general population. Second, this effect is larger for heirs and heiresses who are wealthy at the time of conception of all of their children than for self-made billionaires who acquired their wealth during their adult lives, that is, after some or all of their children have already been conceived. Results do not support the first hypothesis for all subgroups of billionaires. But for males, results are weakly consistent with the second hypothesis: Heirs but not self-made billionaires have a higher share of male offspring than the U.S. population. Heiresses, on the other hand, have a much lower share of male offspring than the U.S. average. This hints to a possible interplay of at least two mechanisms affecting sex composition. Implications for future research that would allow disentangling the distinct mechanisms are discussed.	Univ Konstanz, Dept Sociol, Constance, Germany	University of Konstanz	Schnettler, S (corresponding author), Univ Konstanz, Dept Sociol, Constance, Germany.	sebastian.schnettler@uni-konstanz.de						Almond D, 2007, P ROY SOC B-BIOL SCI, V274, P2491, DOI 10.1098/rspb.2007.0524; Almond D, 2011, AM ECON J-APPL ECON, V3, P56, DOI 10.1257/app.3.4.56; [Anonymous], 2009, FORBES; [Anonymous], 2009, FORBES MAGAZINE; Barkow J. H., 1992, ADAPTED MIND EVOLUTI; Bereczkei T, 1997, P ROY SOC B-BIOL SCI, V264, P17, DOI 10.1098/rspb.1997.0003; BETZIG L, 1995, POLIT LIFE SCI, V14, P61, DOI 10.1017/S0730938400011771; Brown GR, 2001, ANIM BEHAV, V61, P683, DOI 10.1006/anbe.2000.1659; Bruckner TA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-273; Cameron EZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004195; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; ChaconPuignau GC, 1996, SOC BIOL, V43, P257; CRAN, 2013, PACK MULTC; ESSOCKVITALE SM, 1984, ETHOL SOCIOBIOL, V5, P45, DOI 10.1016/0162-3095(84)90034-7; FestaBianchet M, 1996, ECOSCIENCE, V3, P42, DOI 10.1080/11956860.1996.11682313; Freese J, 2001, AM J SOCIOL, V106, P1776, DOI 10.1086/321304; Freese J, 1999, AM J SOCIOL, V104, P1704, DOI 10.1086/210221; Gelman AB, 2009, AM SCI; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Grant VJ, 2007, J THEOR BIOL, V246, P708, DOI 10.1016/j.jtbi.2007.02.005; Grant VJ, 2010, REPRODUCTION, V140, P425, DOI 10.1530/REP-10-0137; Grant VJ, 2005, J EXP ZOOL PART A, V303A, P1120, DOI 10.1002/jez.a.233; Hansen D, 1999, BRIT MED J, V319, P548, DOI 10.1136/bmj.319.7209.548; Hopcroft RL, 2005, SOC FORCES, V83, P1111, DOI 10.1353/sof.2005.0035; James WH, 2008, J ENDOCRINOL, V198, P3, DOI 10.1677/JOE-07-0446; James WH, 2012, J THEOR BIOL, V310, P183, DOI 10.1016/j.jtbi.2012.06.038; James WH, 2009, J THEOR BIOL, V257, P116, DOI 10.1016/j.jtbi.2008.09.028; Keller MC, 2001, EVOL HUM BEHAV, V22, P343, DOI 10.1016/S1090-5138(01)00075-7; KLINDWORTH H, 1995, HUM NATURE-INT BIOS, V6, P221, DOI 10.1007/BF02734140; Kolk M, 2013, J BIOSOC SCI, V45, P683, DOI 10.1017/S0021932012000557; Lazarus J, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P287, DOI 10.1017/CBO9780511542053.015; LOW BS, 1992, ETHOL SOCIOBIOL, V13, P463, DOI 10.1016/0162-3095(92)90013-T; MACKEY WC, 1987, ETHOL SOCIOBIOL, V8, P49, DOI 10.1016/0162-3095(87)90057-4; Mathews T J, 2005, Natl Vital Stat Rep, V53, P1; MEALEY L, 1990, ETHOL SOCIOBIOL, V11, P83, DOI 10.1016/0162-3095(90)90030-A; Neuhauser M, 2004, ENVIRON ECOL STAT, V11, P295, DOI 10.1023/B:EEST.0000038017.58293.c0; Norberg K, 2004, P ROY SOC B-BIOL SCI, V271, P2403, DOI 10.1098/rspb.2004.2857; ROSKAFT E, 1992, ETHOL SOCIOBIOL, V13, P443, DOI 10.1016/0162-3095(92)90012-S; Ruckstuhl KE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-269; Ryan M.K., 2009, GLASS CEILING 21 CEN, P153; Scott S, 1999, HUM NATURE-INT BIOS, V10, P85, DOI 10.1007/s12110-999-1002-0; Shackelford TK, 2005, PERS INDIV DIFFER, V39, P447, DOI 10.1016/j.paid.2005.01.023; Trivers R., 2002, NATURAL SELECTION SO; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; VOLAND E, 1995, HUMAN REPRODUCTIVE DECISIONS, P137; Woods FA, 1939, J HERED, V30, P313, DOI 10.1093/oxfordjournals.jhered.a104752; Zilko CEM, 2010, HUM REPROD UPDATE, V16, P445, DOI 10.1093/humupd/dmp059	47	6	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57446	10.1371/journal.pone.0057446	http://dx.doi.org/10.1371/journal.pone.0057446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437389	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000103
J	Cui, LQ; Wang, Y; Li, Y; He, T; Schwarz, S; Ding, YJ; Shen, JZ; Lv, Y				Cui, Lanqing; Wang, Yang; Li, Yun; He, Tao; Schwarz, Stefan; Ding, Yujing; Shen, Jianzhong; Lv, Yuan			Cfr-Mediated Linezolid-Resistance among Methicillin-Resistant Coagulase-Negative Staphylococci from Infections of Humans	PLOS ONE			English	Article							1ST REPORT; GENE CFR; CHLORAMPHENICOL; OXAZOLIDINONES; MUTATIONS	Four methicillin-resistant coagulase-negative staphylococci (MRCoNS), one Staphylococcus haemolyticus and three Staphylococcus cohnii, from infections of humans collected via the Ministry of Health National Antimicrobial Resistance Surveillance Net (Mohnarin) program in China were identified as linezolid-resistant. These four isolates were negative for the 23S rRNA mutations, but positive for the gene cfr. Mutations in the gene for the ribosomal protein L3, which resulted in the amino acid exchanges Gly152Asp and Tyr158Phe, were identified in S. haemolyticus 09D279 and S. cohnii NDM113, respectively. In each isolate, the cfr gene was located on a plasmid of ca. 35.4 kb, as shown by S1 nuclease pulsed-field gel electrophoresis and Southern blotting experiments. This plasmid was indistinguishable from the previously described plasmid pSS-02 by its size, restriction pattern, and a sequenced 14-kb cfr-carrying segment. Plasmid pSS-02 was originally identified in staphylococci isolated from pigs. This is the first time that a cfr-carrying plasmid has been detected in MRCoNS obtained from intensive care patients in China. Based on the similarities to the cfr-carrying plasmid pSS-02 from porcine coagulase-negative staphylococci, a transmission of this cfr-carrying plasmid between staphylococci from pigs and humans appears to be likely.	[Cui, Lanqing; Li, Yun; Ding, Yujing; Lv, Yuan] Peking Univ, Peking Univ Hosp 1, Inst Clin Pharmacol, Beijing 100871, Peoples R China; [Wang, Yang; He, Tao; Shen, Jianzhong] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Schwarz, Stefan] FLI, Inst Farm Anim Genet, Neustadt, Germany	Peking University; China Agricultural University; Friedrich Loeffler Institute	Shen, JZ (corresponding author), China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China.	sjz@cau.edu.cn; lyzx5857@sina.com	Wang, Yang/ABD-5983-2021; Shen, Jianzhong/AAH-8184-2019	Wang, Yang/0000-0002-5928-9377; 	National Science and Technology Major Project [2012ZX09303005-003]; National Natural Science Foundation of China [31001087]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science and Technology Major Project (No. 2012ZX09303005-003) and National Natural Science Foundation of China (No. 31001087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bongiorno D, 2010, J ANTIMICROB CHEMOTH, V65, P2336, DOI 10.1093/jac/dkq344; Bosling J, 2003, ANTIMICROB AGENTS CH, V47, P2892, DOI 10.1128/AAC.47.9.2892-2896.2003; Cai JC, 2012, J MED MICROBIOL, V61, P1568, DOI 10.1099/jmm.0.043729-0; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Hong T, 2007, J CLIN MICROBIOL, V45, P3277, DOI 10.1128/JCM.02048-06; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Kosowska-Shick K, 2010, DIAGN MICR INFEC DIS, V68, P34, DOI 10.1016/j.diagmicrobio.2010.05.007; Leach KL, 2011, ANN NY ACAD SCI, V1222, P49, DOI 10.1111/j.1749-6632.2011.05962.x; Liakopoulos A, 2009, J ANTIMICROB CHEMOTH, V64, P206, DOI 10.1093/jac/dkp167; Locke JB, 2009, ANTIMICROB AGENTS CH, V53, P5265, DOI 10.1128/AAC.00871-09; Locke JB, 2009, ANTIMICROB AGENTS CH, V53, P5275, DOI 10.1128/AAC.01032-09; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Long KS, 2012, ANTIMICROB AGENTS CH, V56, P603, DOI 10.1128/AAC.05702-11; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Mendes RE, 2010, J ANTIMICROB CHEMOTH, V65, P2329, DOI 10.1093/jac/dkq331; Mendes RE, 2010, J CLIN MICROBIOL, V48, P3041, DOI 10.1128/JCM.00880-10; Miller K, 2008, ANTIMICROB AGENTS CH, V52, P1737, DOI 10.1128/AAC.01015-07; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; de Gopegui ER, 2012, ANTIMICROB AGENTS CH, V56, P2139, DOI 10.1128/AAC.06042-11; Garcia MS, 2010, JAMA-J AM MED ASSOC, V303, P2260, DOI 10.1001/jama.2010.757; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SERAL C, 2011, J MED MICROBIOL, V301, P354, DOI DOI 10.1016/J.IJMM.2010.11.001; Shore AC, 2010, ANTIMICROB AGENTS CH, V54, P4978, DOI 10.1128/AAC.01113-10; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Wang Y, 2012, ANTIMICROB AGENTS CH, V56, P1485, DOI 10.1128/AAC.05827-11; Wolter N, 2005, ANTIMICROB AGENTS CH, V49, P3554, DOI 10.1128/AAC.49.8.3554-3557.2005	26	39	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57096	10.1371/journal.pone.0057096	http://dx.doi.org/10.1371/journal.pone.0057096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437319	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200213
J	Nambu, I; Ebisawa, M; Kogure, M; Yano, S; Hokari, H; Wada, Y				Nambu, Isao; Ebisawa, Masashi; Kogure, Masumi; Yano, Shohei; Hokari, Haruhide; Wada, Yasuhiro			Estimating the Intended Sound Direction of the User: Toward an Auditory Brain-Computer Interface Using Out-of-Head Sound Localization	PLOS ONE			English	Article							P300 SPELLING SYSTEM; MENTAL PROSTHESIS	The auditory Brain-Computer Interface (BCI) using electroencephalograms (EEG) is a subject of intensive study. As a cue, auditory BCIs can deal with many of the characteristics of stimuli such as tone, pitch, and voices. Spatial information on auditory stimuli also provides useful information for a BCI. However, in a portable system, virtual auditory stimuli have to be presented spatially through earphones or headphones, instead of loudspeakers. We investigated the possibility of an auditory BCI using the out-of-head sound localization technique, which enables us to present virtual auditory stimuli to users from any direction, through earphones. The feasibility of a BCI using this technique was evaluated in an EEG oddball experiment and offline analysis. A virtual auditory stimulus was presented to the subject from one of six directions. Using a support vector machine, we were able to classify whether the subject attended the direction of a presented stimulus from EEG signals. The mean accuracy across subjects was 70.0% in the single-trial classification. When we used trial-averaged EEG signals as inputs to the classifier, the mean accuracy across seven subjects reached 89.5% (for 10-trial averaging). Further analysis showed that the P300 event-related potential responses from 200 to 500 ms in central and posterior regions of the brain contributed to the classification. In comparison with the results obtained from a loudspeaker experiment, we confirmed that stimulus presentation by out-of-head sound localization achieved similar event-related potential responses and classification performances. These results suggest that out-of-head sound localization enables us to provide a high-performance and loudspeaker-less portable BCI system.	[Nambu, Isao; Ebisawa, Masashi; Kogure, Masumi; Hokari, Haruhide; Wada, Yasuhiro] Nagaoka Univ Technol, Nagaoka, Niigata 94021, Japan; [Yano, Shohei] Nagaoka Natl Coll Technol, Nagaoka, Niigata, Japan	Nagaoka University of Technology	Wada, Y (corresponding author), Nagaoka Univ Technol, Nagaoka, Niigata 94021, Japan.	ywada@nagaokaut.ac.jp	Isao, Nambu/S-5963-2018; Wada, Yasuhiro/D-2587-2011	Isao, Nambu/0000-0002-1705-6268; Ebisawa, Motohiro/0000-0003-4117-558X; Wada, Yasuhiro/0000-0003-0268-8921	Japan Society for the Promotion of Science (JSPS) KAKENHI [21240013, 24650104, 24300051]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (Grants in Aid for Scientific Research) grants number 21240013, 24650104, 24300051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algazi VR, 2001, IEEE WORKSH APPL SIG, V2001, P99, DOI [DOI 10.1109/ASPAA.2001.969552, 10.1155/S1463924601000141]; Bishop C.M., 2006, PATTERN RECOGNITION; Blauert J., 1997, SPATIAL HEARING PSYC, DOI [10.7551/mitpress/6391.001.0001, DOI 10.7551/MITPRESS/6391.001.0001]; Brunner P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056013; Cecotti H, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/016001; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Gao HY, 2011, IEEE ENG MED BIO, P4568, DOI 10.1109/IEMBS.2011.6091131; GARDNER WG, 1995, J ACOUST SOC AM, V97, P3907, DOI 10.1121/1.412407; Guo J, 2010, IEEE T NEUR SYS REH, V18, P230, DOI 10.1109/TNSRE.2010.2047604; Halder S, 2010, CLIN NEUROPHYSIOL, V121, P516, DOI 10.1016/j.clinph.2009.11.087; Hill NJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026011; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Jrad N, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056004; Kanoh Shin'ichiro, 2010, Journal of Biomechanical Science and Engineering, V5, P32, DOI 10.1299/jbse.5.32; Kim DW, 2011, J NEUROSCI METH, V197, P180, DOI 10.1016/j.jneumeth.2011.02.007; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Kubler A, 2009, ANN NY ACAD SCI, V1157, P90, DOI 10.1111/j.1749-6632.2008.04122.x; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Morioka S, 2012, LECT NOTES COMPUT SC, V7666, P423, DOI 10.1007/978-3-642-34478-7_52; Nijboer F, 2008, J NEUROSCI METH, V167, P43, DOI 10.1016/j.jneumeth.2007.02.009; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Schreuder M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00112; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Sellers EW, 2006, IEEE T NEUR SYS REH, V14, P221, DOI 10.1109/TNSRE.2006.875580; Shimada S, 1995, ACTA ACUST UNITED AC, V81, P267; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Yano S, 2000, IEICE T FUND ELECTR, VE83A, P877	37	21	22	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57174	10.1371/journal.pone.0057174	http://dx.doi.org/10.1371/journal.pone.0057174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437338	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200225
J	Zhang, JK; Yang, L; Meng, GL; Yuan, Z; Fan, J; Li, D; Chen, JZ; Shi, TY; Hu, HM; Wei, BY; Luo, ZJ; Liu, J				Zhang, Jin-Kang; Yang, Liu; Meng, Guo-Lin; Yuan, Zhi; Fan, Jing; Li, Dan; Chen, Jian-Zong; Shi, Tian-Yao; Hu, Hui-Min; Wei, Bo-Yuan; Luo, Zhuo-Jing; Liu, Jian			Protection by Salidroside against Bone Loss via Inhibition of Oxidative Stress and Bone-Resorbing Mediators	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; OSTEOBLASTIC DIFFERENTIATION; POSTMENOPAUSAL OSTEOPOROSIS; OSTEOCLAST FORMATION; MECHANICAL-PROPERTIES; ANTIOXIDANT SYSTEM; LIPID-PEROXIDATION; MC3T3-E1 CELLS; STROMAL CELLS	Oxidative stress is a pivotal pathogenic factor for bone loss in mouse model. Salidroside, a phenylpropanoid glycoside extracted from Rhodiola rosea L, exhibits potent antioxidative effects. In the present study, we used an in vitro oxidative stress model induced by hydrogen peroxide (H2O2) in MC3T3-E1 cells and a murine ovariectomized (OVX) osteoporosis model to investigate the protective effects of salidroside on bone loss and the related mechanisms. We demonstrated that salidroside caused a significant (P < 0.05) elevation of cell survival, alkaline phosphatase (ALP) staining and activity, calcium deposition, and the transcriptional expression of Alp, Col1a1 and Osteocalcin (Ocn) in the presence of H2O2. Moreover, salidroside decreased the production of intracellular reactive oxygen species (ROS), and osteoclast differentiation inducing factors such as receptor activator of nuclear factor-kB ligand (RANKL) and IL-6 induced by H2O2. In vivo studies further demonstrated that salidroside supplementation for 3 months caused a decrease in malondialdehyde (MDA) and an increase in reduced glutathione (GSH) concentration in blood of ovariectomized mouse (P < 0.05), it also improved trabecular bone microarchitecture and bone mineral density in the fourth lumbar vertebra and distal femur. Our study indicated that the protection provided by salidroside in alleviating bone loss was mediated, at least in part, via inhibition of the release of bone-resorbing mediators and oxidative damage to bone-forming cells, suggesting that salidroside can be used as an effective remedy in the treatment or prevention of osteoporosis.	[Zhang, Jin-Kang; Yang, Liu; Meng, Guo-Lin; Yuan, Zhi; Fan, Jing; Li, Dan; Hu, Hui-Min; Wei, Bo-Yuan; Luo, Zhuo-Jing; Liu, Jian] Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China; [Chen, Jian-Zong] Fourth Mil Med Univ, Xijing Hosp, Res Ctr Tradit Chinese Med, Xian 710032, Peoples R China; [Shi, Tian-Yao] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Luo, ZJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthoped Surg, Xian 710032, Peoples R China.	zjluo@fmmu.edu.cn; zjk1271984@21cn.com			Ministry of Science and Technology of China [2011CB964703]; National High Technology Research and Development Program 863 [2012AA020502]; China Postdoctoral Science Foundation [20100480093]; National Natural Science Foundation of China [30901504]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China (2011CB964703), National High Technology Research and Development Program 863 (2012AA020502), China Postdoctoral Science Foundation (20100480093) and National Natural Science Foundation of China (30901504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 2007, IUBMB LIFE, V59, P27, DOI 10.1080/15216540601156188; Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bai XC, 2004, BIOCHEM BIOPH RES CO, V314, P197, DOI 10.1016/j.bbrc.2003.12.073; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Fatokun AA, 2008, EUR J PHARMACOL, V587, P35, DOI 10.1016/j.ejphar.2008.03.024; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; GIRASOLE G, 1992, J CLIN INVEST, V89, P883, DOI 10.1172/JCI115668; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Isomura H, 2004, TOXICOLOGY, V197, P93, DOI 10.1016/j.tox.2003.12.006; Kazakia GJ, 2006, REV ENDOCR METAB DIS, V7, P67, DOI 10.1007/s11154-006-9004-2; Kinov P, 2006, J ORTHOP RES, V24, P55, DOI 10.1002/jor.20013; KITAZAWA R, 1994, J CLIN INVEST, V94, P2397, DOI 10.1172/JCI117606; KURIHARA N, 1990, J IMMUNOL, V144, P4226; Lean JM, 2005, ENDOCRINOLOGY, V146, P728, DOI 10.1210/en.2004-1021; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li XF, 2011, BRAIN RES, V1382, P9, DOI 10.1016/j.brainres.2011.01.015; Li Y, 2012, J BIOMED MAT RES B; Li Yongming, 2010, BMC Res Notes, V3, P309, DOI 10.1186/1756-0500-3-309; Liu AL, 2004, CELL BIOL INT, V28, P905, DOI 10.1016/j.cellbi.2004.09.004; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Mao GX, 2010, BIOMED ENVIRON SCI, V23, P161, DOI 10.1016/S0895-3988(10)60047-5; Muthusami S, 2005, CLIN CHIM ACTA, V360, P81, DOI 10.1016/j.cccn.2005.04.014; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Nielsen F, 1997, CLIN CHEM, V43, P1209; Ning J, 2000, TOXICOL IN VITRO, V14, P329, DOI 10.1016/S0887-2333(00)00024-2; Ozgocmen S, 2007, ARCH MED RES, V38, P196, DOI 10.1016/j.arcmed.2006.09.010; Ozgocmen S, 2007, MOL CELL BIOCHEM, V295, P45, DOI 10.1007/s11010-006-9270-z; Papanicolaou DA, 2000, J CLIN ENDOCR METAB, V85, P1331, DOI 10.1210/jc.85.3.1331; Peng ZQ, 1997, BONE, V20, P207, DOI 10.1016/S8756-3282(96)00369-9; Qian EW, 2012, J NAT PROD, V75, P531, DOI 10.1021/np200555s; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Sendur OF, 2009, JOINT BONE SPINE, V76, P514, DOI 10.1016/j.jbspin.2009.02.005; Shi TY, 2012, NEUROTOX RES, V21, P358, DOI 10.1007/s12640-011-9290-7; Skopinska-Rozewska E, 2008, POL J VET SCI, V11, P97; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Teo JCM, 2006, CLIN BIOMECH, V21, P235, DOI 10.1016/j.clinbiomech.2005.11.001; Wiegant FAC, 2009, BIOGERONTOLOGY, V10, P27, DOI 10.1007/s10522-008-9151-9; Yang P, 2007, J TOXICOL ENV HEAL A, V70, P976, DOI 10.1080/15287390701290832; Yu PZ, 2007, CHEM BIODIVERS, V4, P508, DOI 10.1002/cbdv.200790043; Yu S, 2008, CELL MOL NEUROBIOL, V28, P1067, DOI 10.1007/s10571-008-9284-z; Zhu Y, 2011, DNA CELL BIOL, V30, P809, DOI 10.1089/dna.2010.1183; 2001, JAMA, V285, P785	45	66	74	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57251	10.1371/journal.pone.0057251	http://dx.doi.org/10.1371/journal.pone.0057251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437352	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200230
J	Lee, Y; Song, B; Park, C; Kwon, KS				Lee, Younglang; Song, Byeongwoon; Park, Chankyu; Kwon, Ki-Sun			TRIM11 Negatively Regulates IFN beta Production and Antiviral Activity by Targeting TBK1	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; DOUBLE-STRANDED-RNA; BINDING KINASE 1; NF-KAPPA-B; I INTERFERON; RIG-I; FAMILY PROTEINS; VIRUS-INFECTION; ACTIVATION; DEGRADATION	The innate immune response is a host defense mechanism against infection by viruses and bacteria. Type I interferons (IFN alpha/beta) play a crucial role in innate immunity. If not tightly regulated under normal conditions and during immune responses, IFN production can become aberrant, leading to inflammatory and autoimmune diseases. In this study, we identified TRIM11 (tripartite motif containing 11) as a novel negative regulator of IFN beta production. Ectopic expression of TRIM11 decreased IFN beta promoter activity induced by poly (I: C) stimulation or overexpression of RIG-I (retinoic acid-inducible gene-I) signaling cascade components RIG-IN (constitutively active form of RIG-I), MAVS (mitochondrial antiviral signaling protein), or TBK1 (TANK-binding kinase-1). Conversely, TRIM11 knockdown enhanced IFN beta promoter activity induced by these stimuli. Moreover, TRIM11 overexpression inhibited the phosphorylation and dimerization of IRF3 and expression of IFN beta mRNA. By contrast, TRIM11 knockdown increased the IRF3 phosphorylation and IFN beta mRNA expression. We also found that TRIM11 and TBK1, a key kinase that phosphorylates IRF3 in the RIG-I pathway, interacted with each other through CC and CC2 domain, respectively. This interaction was enhanced in the presence of the TBK1 adaptor proteins, NAP1 (NF-kappa B activating kinase-associated protein-1), SINTBAD (similar to NAP1 TBK1 adaptor) or TANK (TRAF family member-associated NF-kappa B activator). Consistent with its inhibitory role in RIG-I-mediated IFN beta signaling, TRIM11 overexpression enhanced viral infectivity, whereas TRIM11 knockdown produced the opposite effect. Collectively, our results suggest that TRIM11 inhibits RIG-I-mediated IFN beta production by targeting the TBK1 signaling complex.	[Lee, Younglang; Park, Chankyu] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Younglang; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Lab Cell Signaling, Aging Res Ctr, Taejon, South Korea; [Song, Byeongwoon] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California Davis	Kwon, KS (corresponding author), Korea Res Inst Biosci & Biotechnol, Lab Cell Signaling, Aging Res Ctr, Taejon, South Korea.	kwonks@kribb.re.kr	Park, Chankyu/C-1936-2011	CHEN, Tsung-Chih/0000-0001-8256-6240; Huang, Hsu-Shan/0000-0001-8162-5608	KRIBB Research Initiative Program; National Research Foundation of Korea [20110027762, 20120009082, 20120005073]	KRIBB Research Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from the KRIBB Research Initiative Program and National Research Foundation of Korea (Grants 20110027762, 20120009082 and 20120005073, K.-S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BENJAMIN WR, 1982, P NATL ACAD SCI-BIOL, V79, P5379, DOI 10.1073/pnas.79.17.5379; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Charoenthongtrakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053717; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2006, FEBS LETT, V580, P4784, DOI 10.1016/j.febslet.2006.07.066; Iwamura T, 2001, GENES CELLS, V6, P375, DOI 10.1046/j.1365-2443.2001.00426.x; Jia YX, 2009, J IMMUNOL, V183, P4241, DOI 10.4049/jimmunol.0901646; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Lei CQ, 2010, IMMUNITY, V33, P878, DOI 10.1016/j.immuni.2010.11.021; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Munir M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc2; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Parodi S, 2012, J MOL MED, V90, P1025, DOI 10.1007/s00109-012-0868-1; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Sainz B, 2002, J VIROL, V76, P11541, DOI 10.1128/JVI.76.22.11541-11550.2002; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Tuoc TC, 2008, GENE DEV, V22, P1972, DOI 10.1101/gad.471708; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506	50	67	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2013	8	5							e63255	10.1371/journal.pone.0063255	http://dx.doi.org/10.1371/journal.pone.0063255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145RZ	23451039	Green Submitted, Green Published, gold			2022-12-25	WOS:000319036100031
J	Cohen, MX; Ridderinkhof, KR				Cohen, Michael X.; Ridderinkhof, K. Richard			EEG Source Reconstruction Reveals Frontal-Parietal Dynamics of Spatial Conflict Processing	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; TASK-RELATED CHANGES; EVENT-RELATED FMRI; COGNITIVE CONTROL; RESPONSE CONFLICT; NEUROCOGNITIVE MECHANISMS; CORTICAL SYNCHRONIZATION; ATTENTIONAL CONTROL; PREFRONTAL CORTEX; ACTION SELECTION	Cognitive control requires the suppression of distracting information in order to focus on task-relevant information. We applied EEG source reconstruction via time-frequency linear constrained minimum variance beamforming to help elucidate the neural mechanisms involved in spatial conflict processing. Human subjects performed a Simon task, in which conflict was induced by incongruence between spatial location and response hand. We found an early (similar to 200 ms post-stimulus) conflict modulation in stimulus-contralateral parietal gamma (30-50 Hz), followed by a later alpha-band (8-12 Hz) conflict modulation, suggesting an early detection of spatial conflict and inhibition of spatial location processing. Inter-regional connectivity analyses assessed via cross-frequency coupling of theta (4-8 Hz), alpha, and gamma power revealed conflict-induced shifts in cortical network interactions: Congruent trials (relative to incongruent trials) had stronger coupling between frontal theta and stimulus-contrahemifield parietal alpha/gamma power, whereas incongruent trials had increased theta coupling between medial frontal and lateral frontal regions. These findings shed new light into the large-scale network dynamics of spatial conflict processing, and how those networks are shaped by oscillatory interactions.	[Cohen, Michael X.; Ridderinkhof, K. Richard] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Cohen, Michael X.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Ridderinkhof, K. Richard] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Arizona; University of Amsterdam	Cohen, MX (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	mikexcohen@gmail.com	Cohen, Michael/A-3092-2016; Cohen, Michael X/H-8748-2019	Cohen, Michael/0000-0002-1879-3593; Cohen, Michael X/0000-0002-1879-3593	Organization for Scientific Research (NWO)	Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2011, P NATL ACAD SCI USA, V108, P17556, DOI 10.1073/pnas.1103475108; Appelbaum LG, 2011, J COGNITIVE NEUROSCI, V23, P2620, DOI 10.1162/jocn.2010.21575; Bardi L, 2012, J COGN NEUROSCI; Barnes GR, 2004, HUM BRAIN MAPP, V23, P120, DOI 10.1002/hbm.20047; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cavanagh JF, 2012, PSYCHOPHYSIOLOGY, V49, P220, DOI 10.1111/j.1469-8986.2011.01293.x; Cavanagh JF, 2010, NEUROIMAGE, V49, P3198, DOI 10.1016/j.neuroimage.2009.11.080; Cavanagh JF, 2009, J NEUROSCI, V29, P98, DOI 10.1523/JNEUROSCI.4137-08.2009; Cho RY, 2009, J EXP PSYCHOL HUMAN, V35, P1161, DOI 10.1037/a0014491; Cohen M. X., 2012, CEREB CORTEX; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cohen MX, 2012, HUM BRAIN MAPP, V33, P246, DOI 10.1002/hbm.21195; Cohen MX, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00030; Cohen MX, 2011, NEUROIMAGE, V55, P1373, DOI 10.1016/j.neuroimage.2010.12.072; Cohen MX, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.054.2009; Compton RJ, 2012, PSYCHOPHYSIOLOGY, V49, P583, DOI 10.1111/j.1469-8986.2012.01354.x; Compton RJ, 2011, PSYCHOPHYSIOLOGY, V48, P583, DOI 10.1111/j.1469-8986.2010.01124.x; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; Dalal SS, 2004, NEUROL CLIN NEUROPHY, V52, P2004; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding J, 2006, CEREB CORTEX, V16, P1016, DOI 10.1093/cercor/bhj044; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Gramfort A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/923703; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Green JJ, 2009, BRAIN SIGNAL ANALYSIS: ADVANCES IN NEUROELECTRIC AND NEUROMAGNETIC METHODS, P79; Hartwigsen G, 2012, J NEUROSCI, V32, P16162, DOI 10.1523/JNEUROSCI.1010-12.2012; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jin Y, 2010, EXP BRAIN RES, V205, P131, DOI 10.1007/s00221-010-2336-x; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Marco-Pallares J, 2008, J COGNITIVE NEUROSCI, V20, P1595, DOI 10.1162/jocn.2008.20117; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Mazaheri A, 2009, HUM BRAIN MAPP, V30, P1791, DOI 10.1002/hbm.20763; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Milner A. D., 1995, VISUAL BRAIN ACTION; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Nigbur R, 2011, CLIN NEUROPHYSIOL, V122, P2185, DOI 10.1016/j.clinph.2011.03.030; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Phillips S, 2009, INT J PSYCHOPHYSIOL, V73, P350, DOI 10.1016/j.ijpsycho.2009.05.011; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Ruiz MH, 2011, NEUROIMAGE, V55, P1791, DOI 10.1016/j.neuroimage.2010.12.050; Rusconi E, 2007, COGN NEUROPSYCHOL, V24, P373, DOI 10.1080/02643290701309425; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; Schiff S, 2011, J COGNITIVE NEUROSCI, V23, P3998, DOI 10.1162/jocn_a_00080; Sekihara K, 2008, SER BIOMED ENG, P1; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Singh KD, 2003, NEUROIMAGE, V19, P1589, DOI 10.1016/S1053-8119(03)00249-0; Singh KD, 2002, NEUROIMAGE, V16, P103, DOI 10.1006/nimg.2001.1050; Sturmer B, 2003, EXP BRAIN RES, V153, P35, DOI 10.1007/s00221-003-1579-1; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Taylor PCJ, 2007, J NEUROSCI, V27, P11343, DOI 10.1523/JNEUROSCI.2877-07.2007; Trujillo LT, 2007, CLIN NEUROPHYSIOL, V118, P645, DOI 10.1016/j.clinph.2006.11.009; van de Vijver I, 2011, J COGN NEUROSCI; van der Meij R, 2012, J NEUROSCI, V32, P111, DOI 10.1523/JNEUROSCI.4816-11.2012; Van Der Werf J, 2012, CEREB CORTEX; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Walsh BJ, 2011, J COGNITIVE NEUROSCI, V23, P2211, DOI 10.1162/jocn.2010.21595; Wittfoth M, 2008, BRAIN RES, V1194, P118, DOI 10.1016/j.brainres.2007.11.067; Wittfoth M, 2006, NEUROIMAGE, V32, P921, DOI 10.1016/j.neuroimage.2006.03.034; Woolrich M, 2011, NEUROIMAGE, V57, P1466, DOI 10.1016/j.neuroimage.2011.04.041; Worden MS, 2000, J NEUROSCI, V20; Wuhr P, 2005, Q J EXP PSYCHOL-A, V58, P705, DOI 10.1080/02724980443000269; Yeung N, 2007, PSYCHOPHYSIOLOGY, V44, P39, DOI 10.1111/j.1469-8986.2006.00482.x	81	77	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57293	10.1371/journal.pone.0057293	http://dx.doi.org/10.1371/journal.pone.0057293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451201	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500086
J	Coulstock, E; Sosabowski, J; Ovecka, M; Prince, R; Goodall, L; Mudd, C; Sepp, A; Davies, M; Foster, J; Burnet, J; Dunlevy, G; Walker, A				Coulstock, Edward; Sosabowski, Jane; Ovecka, Milan; Prince, Rob; Goodall, Laura; Mudd, Clare; Sepp, Armin; Davies, Marie; Foster, Julie; Burnet, Jerome; Dunlevy, Grainne; Walker, Adam			Liver-Targeting of Interferon-Alpha with Tissue-Specific Domain Antibodies	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HUMAN ASIALOGLYCOPROTEIN RECEPTOR; PLUS RIBAVIRIN; CELLS; INHIBITION; LIPOSOMES; THERAPY; BINDING; GENE; HEPATOCYTES	Interferon alpha (IFN alpha) is used for the treatment of hepatitis C infection and whilst efficacious it is associated with multiple adverse events including reduced leukocyte, erythrocyte, and platelet counts, fatigue, and depression. These events are most likely caused by systemic exposure to interferon. We therefore hypothesise that targeting the therapeutic directly to the intended site of action in the liver would reduce exposure in blood and peripheral tissue and hence improve the safety and tolerability of IFN alpha therapy. We genetically fused IFN to a domain antibody (dAb) specific to a hepatocyte restricted antigen, asialoglycoprotein receptor (ASGPR). Our results show that the murine IFN alpha 2 homolog (mIFN alpha 2) fused to an ASGPR specific dAb, termed DOM26h-196-61, could be expressed in mammalian tissue culture systems and retains the desirable biophysical properties and activity of both fusion partners when measured in vitro. Furthermore a clear increase in in vivo targeting of the liver by mIFN alpha 2-ASGPR dAb fusion protein, compared to that observed with either unfused mIFN alpha 2 or mIFN alpha 2 fused to an isotype control dAb V(H)D2 (which does not bind ASGPR) was demonstrated using microSPECT imaging. We suggest that these findings may be applicable in the development of a liver-targeted human IFN molecule with improved safety and patient compliance in comparison to the current standard of care, which could ultimately be used as a treatment for human hepatitis virus infections.	[Coulstock, Edward; Ovecka, Milan; Prince, Rob; Goodall, Laura; Mudd, Clare; Sepp, Armin; Davies, Marie; Dunlevy, Grainne; Walker, Adam] GlaxoSmithKline, Biopharm R&D, Innovat Biopharm Discovery Unit, Cambridge, England; [Sosabowski, Jane; Foster, Julie; Burnet, Jerome] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England	GlaxoSmithKline; University of London; Queen Mary University London	Walker, A (corresponding author), GlaxoSmithKline, Biopharm R&D, Innovat Biopharm Discovery Unit, Cambridge, England.	adam.z.walker@gsk.com		Sosabowski, Jane/0000-0001-7653-5923	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The authors have read the journal's policy and have the following conflicts: All authors (except JS, JF, and JB) were employees of GlaxoSmithKline at the time this work was carried out. JS, JF, and JB are researchers at Queen Mary University of London whose work on this project was funded by GlaxoSmithKline. All relevant patents have been declared, and there are no products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abe M, 2003, BIOCONJUGATE CHEM, V14, P997, DOI 10.1021/bc034081a; Deal KA, 1998, NUCL MED BIOL, V25, P379, DOI 10.1016/S0969-8051(97)00222-9; Dieperink E, 2003, PSYCHOSOMATICS, V44, P104, DOI 10.1176/appi.psy.44.2.104; DUNCAN R, 1986, BIOCHIM BIOPHYS ACTA, V880, P62, DOI 10.1016/0304-4165(86)90120-0; Dusheiko G, 1997, HEPATOLOGY, V26, pS112, DOI 10.1002/hep.510260720; Eto T, 1999, NAT MED, V5, P577, DOI 10.1038/8462; Fried MW, 2004, SEMIN LIVER DIS, V24, P47, DOI 10.1055/s-2004-832928; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gay RD, 2010, MABS-AUSTIN, V2, P625, DOI 10.4161/mabs.2.6.13493; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Holt LJ, 2008, PROTEIN ENG DES SEL, V21, P283, DOI 10.1093/protein/gzm067; Iorio R, 1997, PEDIATR INFECT DIS J, V16, P984, DOI 10.1097/00006454-199710000-00016; Iyer U, 2011, J PHARMACOL TOX MET, V64, P207, DOI 10.1016/j.vascn.2011.07.005; Jeong YI, 2005, INT J PHARMACEUT, V296, P151, DOI 10.1016/j.ijpharm.2005.02.027; Kabat EA, 1991, SEQUENCES PROTEINS I; Kallinteri P, 2001, J DRUG TARGET, V9, P155, DOI 10.3109/10611860108997925; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Pacifico F, 2003, MOL CELL ENDOCRINOL, V208, P51, DOI 10.1016/j.mce.2003.06.001; Pardridge WM, 2010, J DRUG TARGET, V18, P157, DOI 10.3109/10611860903548354; Park JH, 1998, BIOCHEM BIOPH RES CO, V244, P304, DOI 10.1006/bbrc.1998.8256; Peng DJ, 2007, CANCER GENE THER, V14, P66, DOI 10.1038/sj.cgt.7700985; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saunier B, 2003, J VIROL, V77, P546, DOI 10.1128/JVI.77.1.546-559.2003; Seow YYT, 2002, NEPHRON, V91, P431, DOI 10.1159/000064283; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; Trahtenherts A, 2009, HYBRIDOMA, V28, P225, DOI 10.1089/hyb.2009.0019; TREICHEL U, 1994, J GEN VIROL, V75, P3021, DOI 10.1099/0022-1317-75-11-3021; van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138; Walker A, 2010, PROTEIN ENG DES SEL, V23, P271, DOI 10.1093/protein/gzp091; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Yang DY, 2007, J DIGEST DIS, V8, P89, DOI 10.1111/j.1443-9573.2007.00291.x; Zhang XQ, 2005, J CONTROL RELEASE, V102, P749, DOI 10.1016/j.jconrel.2004.10.024; Zhang Y, 2007, J CONTROL RELEASE, V117, P281, DOI 10.1016/j.jconrel.2006.11.006	34	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57263	10.1371/journal.pone.0057263	http://dx.doi.org/10.1371/journal.pone.0057263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451195	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500082
J	Otranto, D; Dantas-Torres, F; de Caprariis, D; Di Paola, G; Tarallo, VD; Latrofa, MS; Lia, RP; Annoscia, G; Breitshwerdt, EB; Cantacessi, C; Capelli, G; Stanneck, D				Otranto, Domenico; Dantas-Torres, Filipe; de Caprariis, Donato; Di Paola, Giancarlo; Tarallo, Viviana D.; Latrofa, Maria S.; Lia, Riccardo P.; Annoscia, Giada; Breitshwerdt, Edward B.; Cantacessi, Cinzia; Capelli, Gioia; Stanneck, Dorothee			Prevention of Canine Leishmaniosis in a Hyper-Endemic Area Using a Combination of 10% Imidacloprid/4.5% Flumethrin	PLOS ONE			English	Article							VECTOR-BORNE DISEASES; IMPREGNATED DOG COLLARS; VISCERAL LEISHMANIASIS; PHLEBOTOMINE SANDFLIES; YOUNG-DOGS; TRANSMISSION; BRAZIL; PERMETHRIN; DIAGNOSIS; DYNAMICS	Background: Dogs are the main reservoir hosts of Leishmania infantum, the agent of human zoonotic visceral leishmaniosis. This study investigated the efficacy of a polymer matrix collar containing a combination of 10% imidacloprid and 4.5% flumethrin as a novel prophylactic measure to prevent L. infantum infections in young dogs from a hyper-endemic area of southern Italy, with a view towards enhancing current control strategies against both human and canine leishmaniosis. Methodology/Principal Findings: The study was carried out on 124 young dogs, of which 63 were collared (Group A) while 61 were left untreated (Group B), from March-April 2011 until March 2012. Blood and skin samples were collected at baseline (April 2011) and at the first, second, third and fourth follow-up time points (July, September 2011 and November 2011, and March 2012, respectively). Bone marrow and conjunctiva were sampled at baseline and at the fourth follow-up. Serological, cytological and molecular tests were performed to detect the presence of L. infantum in the different tissues collected. At the end of the trial, no dog from Group A proved positive for L. infantum at any follow-up, whereas 22 dogs from Group B were infected (incidence density rate = 45.1%); therefore, the combination of 10% imidacloprid and 4.5% flumethrin was 100% efficacious for the prevention of L. infantum infection in young dogs prior to their first exposure to the parasite in a hyper-endemic area for CanL. Conclusions: The use of collars containing 10% imidacloprid and 4.5% flumethrin conferred long-term protection against infection by L. infantum to dogs located in a hyper-endemic area, thus representing a reliable and sustainable strategy to decrease the frequency and spread of this disease among the canine population which will ultimately result in the reduction of associated risks to human health.	[Otranto, Domenico; Dantas-Torres, Filipe; de Caprariis, Donato; Di Paola, Giancarlo; Tarallo, Viviana D.; Latrofa, Maria S.; Lia, Riccardo P.; Annoscia, Giada; Cantacessi, Cinzia] Univ Bari, Dipartimento Med Vet, Valenzano, Italy; [Dantas-Torres, Filipe] Ctr Pesquisas Aggeu Magalhaes Fiocruz PE, Dept Imunol, Recife, PE, Brazil; [Breitshwerdt, Edward B.] N Carolina State Univ, Coll Vet Med, Intracellular Pathogens Res Lab, Raleigh, NC USA; [Cantacessi, Cinzia] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Cairns, Australia; [Capelli, Gioia] Ist Zooprofilatt Sperimentale Venezie, Parasitol Lab, Legnaro, Italy; [Stanneck, Dorothee] Bayer Anim Hlth GmbH, Leverkusen, Germany	Universita degli Studi di Bari Aldo Moro; Fundacao Oswaldo Cruz; University of North Carolina; North Carolina State University; James Cook University; IZS delle Venezie; Bayer AG	Otranto, D (corresponding author), Univ Bari, Dipartimento Med Vet, Valenzano, Italy.	domenico.otranto@uniba.it	Cantacessi, Cinzia/B-7356-2014; Dantas-Torres, Filipe/G-1617-2012; Otranto, Domenico/Y-3249-2019; Dantas-Torres, Filipe/AAC-5982-2020	Cantacessi, Cinzia/0000-0001-6863-2950; Dantas-Torres, Filipe/0000-0002-1496-6274; Lia, Riccardo Paolo/0000-0001-7239-1694; Latrofa, Maria Stefania/0000-0001-9061-437X; Otranto, Domenico/0000-0002-7518-476X; Breitschwerdt, Edward/0000-0002-3506-0279	Bayer Animal Health GmbH (Germany)	Bayer Animal Health GmbH (Germany)	This project was funded by Bayer Animal Health GmbH (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by Bayer Animal Health GmbH (Germany) and Dr. Dorothee Stanneck is an employee of Bayer Animal Health GmbH, Leverkusen, Germany. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x; Athanasiou LV, 2012, ACTA TROP, V122, P291, DOI 10.1016/j.actatropica.2012.02.003; Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Dantas-Torres F, 2006, VET PARASITOL, V140, P54, DOI 10.1016/j.vetpar.2006.03.008; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P531, DOI 10.1016/j.pt.2012.08.007; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Desjeux P, 2004, NAT REV MICROBIOL, V2, P692, DOI 10.1038/nrmicro981; Dogan N, 2006, J TROP PEDIATRICS, V52, P212, DOI 10.1093/tropej/fmi102; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; Manzillo VF, 2006, VET PARASITOL, V142, P142, DOI 10.1016/j.vetpar.2006.06.029; Maroli M., 1994, Parassitologia (Rome), V36, P251; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Maroli M, 2012, MED VET ENTOMOL, DOI [10.1111/j.1365-2915.2012.01034, DOI 10.1111/J.1365-2915.2012.01034]; Maroli M, 2008, TROP MED INT HEALTH, V13, P256, DOI [10.1111/j.1365-3156.2007.01998, 10.1111/j.1365-3156.2007.01998.x]; Menn B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-34; Moreira ED, 2004, VET PARASITOL, V122, P245, DOI 10.1016/j.vetpar.2004.05.019; NERY-GUIMARAES F., 1954, REV BRASIL MALARIOL E DOENCAS TROP, V6, P127; Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006; Otranto D, 2010, VET PARASITOL, V172, P323, DOI 10.1016/j.vetpar.2010.05.017; Otranto D, 2009, CLIN VACCINE IMMUNOL, V16, P337, DOI 10.1128/CVI.00268-08; Otranto D, 2007, VET PARASITOL, V144, P270, DOI 10.1016/j.vetpar.2006.09.012; Otranto D, 2010, J CLIN MICROBIOL, V48, P3316, DOI 10.1128/JCM.00379-10; Otranto D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S2; Paradies P, 2006, J VET MED B, V53, P295, DOI 10.1111/j.1439-0450.2006.00964.x; Petersen CA, 2009, VET CLIN N AM-SMALL, V39, P1065, DOI 10.1016/j.cvsm.2009.06.008; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Stanneck D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-73; Stanneck D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-66; Talmi-Frank D, 2006, CLIN VACCINE IMMUNOL, V13, P271, DOI 10.1128/CVI.13.2.271-276.2006; Tarallo VD, 2010, ACTA TROP, V116, P227, DOI 10.1016/j.actatropica.2010.08.013; Vlkova M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001344	35	43	43	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56374	10.1371/journal.pone.0056374	http://dx.doi.org/10.1371/journal.pone.0056374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451043	Green Published, gold, Green Accepted			2022-12-25	WOS:000316849500013
J	Sultana, R; Abdel-Fatah, T; Perry, C; Moseley, P; Albarakti, N; Mohan, V; Seedhouse, C; Chan, S; Madhusudan, S				Sultana, Rebeka; Abdel-Fatah, Tarek; Perry, Christina; Moseley, Paul; Albarakti, Nada; Mohan, Vivek; Seedhouse, Claire; Chan, Stephen; Madhusudan, Srinivasan			Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells	PLOS ONE			English	Article							DNA-REPAIR; GENETIC POLYMORPHISMS; DAMAGE; CHEMOTHERAPY; MECHANISMS; CISPLATIN	Introduction: Ataxia telangiectasia mutated and Rad3 Related (ATR) protein kinase is a key sensor of single-stranded DNA associated with stalled replication forks and repair intermediates generated during DNA repair. XRCC1 is a critical enzyme in single strand break repair and base excision repair. XRCC1-LIG3 complex is also an important contributor to the ligation step of the nucleotide excision repair response. Methods: In the current study, we investigated synthetic lethality in XRCC1 deficient and XRCC1 proficient Chinese Hamster ovary (CHO) and human ovarian cancer cells using ATR inhibitors (NU6027). In addition, we also investigated the ability of ATR inhibitors to potentiate cisplatin cytotoxicity in XRCC1 deficient and XRCC1 proficient CHO and human cancer cells. Clonogenic assays, alkaline COMET assays, gamma H2AX immunocytochemistry, FACS for cell cycle as well as FITC-annexin V flow cytometric analysis were performed. Results: ATR inhibition is synthetically lethal in XRCC1 deficient cells as evidenced by increased cytotoxicity, accumulation of double strand DNA breaks, G2/M cell cycle arrest and increased apoptosis. Compared to cisplatin alone, combination of cisplatin and ATR inhibitor results in enhanced cytotoxicity in XRCC1 deficient cells compared to XRCC1 proficient cells. Conclusions: Our data provides evidence that ATR inhibition is suitable for synthetic lethality application and cisplatin chemopotentiation in XRCC1 deficient ovarian cancer cells.	[Sultana, Rebeka; Perry, Christina; Albarakti, Nada; Mohan, Vivek; Madhusudan, Srinivasan] Univ Nottingham, Univ Nottingham Hosp, Mol Oncol Lab, Acad Unit Oncol,Sch Mol Med Sci, Nottingham NG7 2RD, England; [Abdel-Fatah, Tarek; Moseley, Paul; Chan, Stephen] Univ Nottingham Hosp, Dept Clin Oncol, Nottingham NG7 2UH, England; [Seedhouse, Claire] Univ Nottingham, Univ Nottingham Hosp, Sch Mol Med Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham; University of Nottingham	Madhusudan, S (corresponding author), Univ Nottingham, Univ Nottingham Hosp, Mol Oncol Lab, Acad Unit Oncol,Sch Mol Med Sci, Nottingham NG7 2RD, England.	srinivasan.madhusudan@nottingham.ac.uk	SEEDHOUSE, CLAIRE/B-3570-2009	Albarakati, Nada/0000-0001-5135-8684; Moseley, Paul/0000-0003-0795-9751; Madhusudan, Srinivasan/0000-0002-5354-5480; Seedhouse, Claire/0000-0003-2280-4045	Medical Research Council [MR/J008001/1] Funding Source: Medline; MRC [MR/J008001/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abdel-Fatah T, 2013, INT J CANCER, V132, P2778, DOI 10.1002/ijc.27980; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1992, NUCLEIC ACIDS RES, V20, P4575, DOI 10.1093/nar/20.17.4575; Caporali S, 2004, MOL PHARMACOL, V66, P478; Chen T, 2012, DRUG DISCOV TODAY, V17, P194, DOI 10.1016/j.drudis.2011.12.009; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Corso G, 2009, J GASTROINTEST SURG, V13, P2233, DOI 10.1007/s11605-009-0980-x; Fan JH, 2007, ENVIRON MOL MUTAGEN, V48, P491, DOI 10.1002/em.20312; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gossage L, 2007, MOL DIAGN THER, V11, P361, DOI 10.1007/BF03256260; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Kim K, 2008, GYNECOL ONCOL, V111, P509, DOI 10.1016/j.ygyno.2008.08.034; Ladiges WC, 2006, ONCOGENE, V25, P1612, DOI 10.1038/sj.onc.1209370; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Nam EA, 2011, BIOCHEM J, V436, P527, DOI 10.1042/BJ20102162; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Peasland A, 2011, BRIT J CANCER, V105, P372, DOI 10.1038/bjc.2011.243; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Serrano MA, 2012, ONCOGENE; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sirbu BM, 2012, PLOS ONE, V6, P1; Sultana R, 2012, INT J CANCER, V131, P2433, DOI 10.1002/ijc.27512; Sun XC, 2009, LUNG CANCER, V65, P230, DOI 10.1016/j.lungcan.2008.11.014; Svilar D, 2011, ANTIOXID REDOX SIGN, V14, P2491, DOI 10.1089/ars.2010.3466; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Zhang R, 2010, TOXICOL LETT, V192, P108, DOI 10.1016/j.toxlet.2009.10.012	35	58	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57098	10.1371/journal.pone.0057098	http://dx.doi.org/10.1371/journal.pone.0057098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451157	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500065
J	Yang, H; Cai, HW; Wan, L; Liu, S; Li, SF; Cheng, JQ; Lu, XF				Yang, Hao; Cai, Huawei; Wan, Lin; Liu, Shan; Li, Shengfu; Cheng, Jingqiu; Lu, Xiaofeng			Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells	PLOS ONE			English	Article							IN-VITRO; RADIONUCLIDE THERAPY; PROSTATE-CANCER; RECEPTOR; ANTAGONISTS; BINDING; DEATH	Tumor-homing peptides that recognize specific markers on tumor cells have shown potential as drug carriers for targeted cancer therapy. Bombesin receptors are frequently overexpressed or ectopically expressed in a wide range of human tumors. Bombesin and its analogues have been widely used as drug carriers for tumor imaging and tumor therapy. However, the cargos used in previous studies, including radioactive and chemotherapeutic agents, are usually small molecules. Mitochondrial-disrupting peptides depolarize the mitochondria and trigger apoptosis after entering tumor cells. We are interested in whether the bombesin analogue, Bn(6-14), which contains a bombesin receptor-binding motif, can specifically deliver the mitochondria-disrupting peptide, B28, to tumor cells. To this end, we created a chimeric peptide, B28Bn(6-14), by conjugating B28 to Bn(6-14) at its N-terminus. The cytotoxicity of B28Bn(6-14) in tumor cells was much stronger than unconjugated B28. The IC50 values of B28Bn(6-14) in tumor cells (1.7-3.5 mu M) were approximately 10 times lower than B28. However, conjugation of B28 to Bn(2-7), which lacks the bombesin receptor-binding motif, did not increase its cytotoxicity. In addition, the IC50 values of B28Bn(6-14) in tumor cells (1.7-3.5 mu M) was 3-10 times lower than in normal cells (10.8-16.8 mu M). We found that selective binding of B28Bn(6-14) to tumor cells is Bn(6-14)-dependent. Upon entering the tumor cell, B28Bn(6-14) accumulated in the mitochondria and triggered caspase-dependent apoptosis. Intratumoral and intraperitoneal administration of B28Bn(6-14) substantially suppressed the growth of DU145 tumor xenografts in mice. These results demonstrate that Bn(6-14) is able to deliver the mitochondria-disrupting peptide to tumor cells, and B28Bn(6-14) should be further developed as novel anti-cancer agent.	[Yang, Hao; Cai, Huawei; Wan, Lin; Liu, Shan; Li, Shengfu; Cheng, Jingqiu; Lu, Xiaofeng] Sichuan Univ, West China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610064, Peoples R China	Sichuan University	Lu, XF (corresponding author), Sichuan Univ, West China Hosp, Minist Hlth, Key Lab Transplant Engn & Immunol, Chengdu 610064, Peoples R China.	xiaofenglu@yahoo.com	Yang, Hao/ABV-4834-2022; Lu, Xiaofeng/ABD-9075-2021	Yang, Hao/0000-0003-2214-9474; Cai, Huawei/0000-0003-1341-8417	Natural Science Fund of China [81072566]; China Postdoctoral Science Foundation [201104645, 20100481392]	Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Natural Science Fund of China (81072566) and China Postdoctoral Science Foundation funded project (201104645, 20100481392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiraj K, 2011, J NUCL MED, V52, P1970, DOI 10.2967/jnumed.111.094375; Aluri S, 2009, ADV DRUG DELIVER REV, V61, P940, DOI 10.1016/j.addr.2009.07.002; Beer M, 2012, PROSTATE, V72, P318, DOI 10.1002/pros.21434; Bombardieri E, 2010, EUR J NUCL MED MOL I, V37, P1441, DOI 10.1007/s00259-010-1473-6; Cescato R, 2008, J NUCL MED, V49, P318, DOI 10.2967/jnumed.107.045054; Chanda N, 2010, P NATL ACAD SCI USA, V107, P8760, DOI 10.1073/pnas.1002143107; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Corti A, 2012, MED RES REV, V32, P1078, DOI 10.1002/med.20238; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dapp S, 2011, NUCL MED BIOL, V38, P997, DOI 10.1016/j.nucmedbio.2011.02.014; Do TN, 2003, ONCOGENE, V22, P1431, DOI 10.1038/sj.onc.1206258; Engel JB, 2005, CLIN CANCER RES, V11, P2408, DOI 10.1158/1078-0432.CCR-04-1670; GARGOSKY SE, 1987, BIOCHEM J, V247, P427, DOI 10.1042/bj2470427; Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harsman A, 2012, J BIOL CHEM, V287, P31437, DOI 10.1074/jbc.M112.392118; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Kapoor P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035187; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kwekkeboom DJ, 2011, ENDOCRIN METAB CLIN, V40, P173, DOI 10.1016/j.ecl.2010.12.003; Li Q, 2005, ANTIMICROB AGENTS CH, V49, P388, DOI 10.1128/AAC.49.1.388-397.2005; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; Modlin IM, 2010, ALIMENT PHARM THER, V31, P169, DOI 10.1111/j.1365-2036.2009.04174.x; Moody TW, 2006, J PHARMACOL EXP THER, V318, P1265, DOI 10.1124/jpet.106.104141; Rege K, 2007, CANCER RES, V67, P6368, DOI 10.1158/0008-5472.CAN-06-3658; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Safavy A, 2006, BIOCONJUGATE CHEM, V17, P565, DOI 10.1021/bc050224c; Sancho V, 2011, CURR DRUG DELIV, V8, P79, DOI 10.2174/156720111793663624; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Stangelberger A, 2005, CLIN CANCER RES, V11, P49; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; van Essen M, 2009, NAT REV ENDOCRINOL, V5, P382, DOI 10.1038/nrendo.2009.105; Wagh NK, 2012, BIOCONJUGATE CHEM, V23, P527, DOI 10.1021/bc200600w; Weber HC, 2009, CURR OPIN ENDOCRINOL, V16, P66, DOI 10.1097/MED.0b013e32831cf5aa; Yang H, 2007, PROTEIN EXPRES PURIF, V54, P309, DOI 10.1016/j.pep.2007.03.006; Yang H, 2010, J BIOL CHEM, V285, P25666, DOI 10.1074/jbc.M109.089417	41	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57358	10.1371/journal.pone.0057358	http://dx.doi.org/10.1371/journal.pone.0057358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451211	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500092
J	Chachadi, VB; Ali, MF; Cheng, PW				Chachadi, Vishwanath B.; Ali, Mohamed F.; Cheng, Pi-Wan			Prostatic Cell-Specific Regulation of the Synthesis of MUC1-Associated Sialyl Lewis a	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CANCER-CELLS; HUMAN COLON; ABERRANT EXPRESSION; ALTERED EXPRESSION; DNA METHYLATION; E-SELECTIN; ANTIGEN; MUC1; BETA-3GAL-T5	Sialyl Lewis antigens are selectin ligands involved in leukocyte trafficking and cancer metastasis. Biosynthesis of these selectin ligands occurs by the sequential actions of several glycosyltransferases in the Golgi apparatus following synthesis of the protein backbone in the endoplasmic reticulum. In this study, we examine how the synthesis of sialyl Lewis a (sLe(a)) is regulated in prostatic cells and identify a mucin that carries this glycotope. We treat human prostatic cells including one normal and three cancerous cells with histone deacetylase inhibitors, valproic acid, tricostatin A (TSA), and suberoylanilide hydroxamic acid (SAHA), and then monitor the expression of sLe(a). We have found that SAHA enhances the production of sLe(a) in normal prostatic RWPE-1 cells but not prostatic cancer cells. Employing siRNA technology and co-immunoprecipitation, we show that the sLe(a) is associated with MUC1, which is confirmed by confocal immunofluorescence microscopy and proximity ligation assay. The SAHA-induced production of sLe(a) in RWPE-1 cells is resulted from upregulation of B3GALT1 gene via enhancement of acetylated histone-3 and histone-4. Interestingly, PC3 and LNCaP C-81 cells do not produce detectable amounts of sLe(a) despite expressing high levels of B3GALT1. However, the MUC1-associated sLe(a) is generated in these cells after introduction of MUC1 cDNA. We conclude that the synthesis of sLe(a) is controlled by not only peptide backbone of the glycoprotein but also glycoprotein-specific glycosyltransferases involved in the synthesis of sLe(a). Further, the SAHA induction of this selectin ligand in normal prostatic cells may pose a potentially serious side effect of this drug recently approved by the US Food and Drug Administration.	[Chachadi, Vishwanath B.; Ali, Mohamed F.; Cheng, Pi-Wan] Vet Adm Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE USA; [Chachadi, Vishwanath B.; Ali, Mohamed F.; Cheng, Pi-Wan] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Cheng, PW (corresponding author), Vet Adm Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE USA.	pcheng@unmc.edu	Chachadi, Vishwanath/ABG-8002-2021	Chachadi, Vishwanath/0000-0002-4488-419X	Department of Veteran Affairs [1I1BX000985]; National Institutes of Health [2RO1HL48282];  [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048282] Funding Source: NIH RePORTER	Department of Veteran Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Department of Veteran Affairs 1I1BX000985; the National Institutes of Health 2RO1HL48282; and Nebraska LB506. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez-Lugo JA, 2012, J MOL MODEL, V18, P2301, DOI 10.1007/s00894-011-1240-z; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Beum PV, 1999, J BIOL CHEM, V274, P24641, DOI 10.1074/jbc.274.35.24641; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Burdick MD, 1997, J BIOL CHEM, V272, P24198, DOI 10.1074/jbc.272.39.24198; Butler LM, 2000, CANCER RES, V60, P5165; Caretti A, 2012, INT J BIOCHEM CELL B, V44, P84, DOI 10.1016/j.biocel.2011.09.010; Chachadi VB, 2011, INT J BIOCHEM CELL B, V43, P586, DOI 10.1016/j.biocel.2010.12.015; Chakraborty AK, 2006, GENE, V374, P166, DOI 10.1016/j.gene.2006.01.031; Santos MDL, 2007, MOL CANCER THER, V6, P1425, DOI 10.1158/1535-7163.MCT-06-0623; Demers M, 2009, BIOCHEM BIOPH RES CO, V387, P425, DOI 10.1016/j.bbrc.2009.07.015; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Fernandez-Rodriguez J, 2001, GLYCOCONJUGATE J, V18, P925, DOI 10.1023/A:1022208727512; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fukuda M, 1996, CANCER RES, V56, P2237; Giordanengo V, 2004, FASEB J, V18, P1961, DOI 10.1096/fj.04-2467fje; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi N, 2004, PATHOBIOLOGY, V71, P26, DOI 10.1159/000072959; Hey NA, 1996, GLYCOCONJUGATE J, V13, P769, DOI 10.1007/BF00702341; Holgersson J, 2006, GLYCOBIOLOGY, V16, P584, DOI 10.1093/glycob/cwj090; Ishihara K, 2004, BRIT J PHARMACOL, V142, P1020, DOI 10.1038/sj.bjp.0705869; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kannagi Reiji, 2007, Chang Gung Med J, V30, P189; Kannagi R, 2010, CANCER SCI, V101, P586, DOI 10.1111/j.1349-7006.2009.01455.x; Kawamura YI, 2008, GASTROENTEROLOGY, V135, P142, DOI 10.1053/j.gastro.2008.03.031; Kawarada Y, 2000, PATHOL RES PRACT, V196, P259, DOI 10.1016/S0344-0338(00)80075-8; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kim YJ, 1999, AM J PATHOL, V155, P461, DOI 10.1016/S0002-9440(10)65142-5; Kim YS, 2008, GASTROENTEROLOGY, V135, P305, DOI 10.1053/j.gastro.2008.06.013; Kishimoto T, 1996, INT J CANCER, V69, P290, DOI 10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Mare L, 2004, EUR J BIOCHEM, V271, P186, DOI 10.1046/j.1432-1033.2003.03919.x; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Matsui T, 2004, JPN J CLIN ONCOL, V34, P588, DOI 10.1093/jjco/hyh110; Mitchell S, 2002, NEOPLASIA, V4, P9, DOI 10.1038/sj.neo.7900194; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; NAKAYAMA T, 1995, CANCER, V75, P2051, DOI 10.1002/1097-0142(19950415)75:8<2051::AID-CNCR2820750804>3.0.CO;2-4; Oetke C, 2003, BIOCHEM BIOPH RES CO, V308, P892, DOI 10.1016/S0006-291X(03)01471-2; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Paganuzzi M, 2003, ONCOLOGY-BASEL, V65, P52, DOI 10.1159/000071205; Radhakrishnan P, 2007, BIOCHEM BIOPH RES CO, V359, P457, DOI 10.1016/j.bbrc.2007.05.165; Rajabi H, 2011, PROSTATE, V71, P1299, DOI 10.1002/pros.21344; Salvini R, 2001, J BIOL CHEM, V276, P3564, DOI 10.1074/jbc.M006662200; Sato M, 1997, ANTICANCER RES, V17, P3505; Serpa J, 2006, CANCER LETT, V242, P191, DOI 10.1016/j.canlet.2005.11.009; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Sumikura S, 2003, CANCER LETT, V200, P77, DOI 10.1016/S0304-3835(03)00388-4; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tomlinson J, 2000, INT J ONCOL, V16, P347; Ugorski M, 2002, ACTA BIOCHIM POL, V49, P303; Wang QY, 2003, J EXP CLIN CANC RES, V22, P431; Yusa A, 2010, CANCER RES, V70, P4064, DOI 10.1158/0008-5472.CAN-09-2383; Zhang K, 1997, TUMOR BIOL, V18, P175, DOI 10.1159/000218028	60	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57416	10.1371/journal.pone.0057416	http://dx.doi.org/10.1371/journal.pone.0057416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451223	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800105
J	Romero, MD; Holmgren-Holm, F; Grasa, MD; Esteve, M; Remesar, X; Fernandez-Lopez, JA; Alemany, M				del Mar Romero, Maria; Holmgren-Holm, Fredrik; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria			Modulation in Wistar Rats of Blood Corticosterone Compartmentation by Sex and a Cafeteria Diet	PLOS ONE			English	Article							CORTISOL-BINDING AFFINITY; WHITE ADIPOSE-TISSUE; INSULIN-RESISTANCE; PROTEINASE-INHIBITORS; SERPIN SUPERFAMILY; METABOLIC SYNDROME; ABDOMINAL OBESITY; IN-VIVO; GLOBULIN; GLUCOCORTICOIDS	In the metabolic syndrome, glucocorticoid activity is increased, but circulating levels show little change. Most of blood glucocorticoids are bound to corticosteroid-binding globulin (CBG), which liver expression and circulating levels are higher in females than in males. Since blood hormones are also bound to blood cells, and the size of this compartment is considerable for androgens and estrogens, we analyzed whether sex or eating a cafeteria diet altered the compartmentation of corticosterone in rat blood. The main corticosterone compartment in rat blood is that specifically bound to plasma proteins, with smaller compartments bound to blood cells or free. Cafeteria diet increased the expression of liver CBG gene, binding plasma capacity and the proportion of blood cell-bound corticosterone. There were marked sex differences in blood corticosterone compartmentation in rats, which were unrelated to testosterone. The use of a monoclonal antibody ELISA and a polyclonal Western blot for plasma CBG compared with both specific plasma binding of corticosterone and CBG gene expression suggested the existence of different forms of CBG, with varying affinities for corticosterone in males and females, since ELISA data showed higher plasma CBG for males, but binding and Western blot analyses (plus liver gene expression) and higher physiological effectiveness for females. Good cross-reactivity to the antigen for polyclonal CBG antibody suggests that in all cases we were measuring CBG. The different immunoreactivity and binding affinity may help explain the marked sex-related differences in plasma hormone binding as sex-linked different proportions of CBG forms.	[del Mar Romero, Maria; Holmgren-Holm, Fredrik; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [del Mar Romero, Maria; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Univ Barcelona, Inst Biomed, Barcelona, Spain; [del Mar Romero, Maria; del Mar Grasa, Maria; Esteve, Montserrat; Remesar, Xavier; Antonio Fernandez-Lopez, Jose; Alemany, Maria] Inst Hlth Carlos III, CIBER Obes & Nutr, Madrid, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Alemany, M (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	malemany@ub.edu	Alemany, Marià/H-5224-2011; Remesar, Xavier/L-4555-2019; del Mar Romero, Maria/K-9004-2017; Esteve, Montserrat/L-6272-2014; Remesar, Xavier/G-5703-2013; Esteve, Montserrat/AAR-4146-2021; López, José Antonio Fernández/C-5467-2017; Grasa Martínez, Maria del Mar/L-8031-2014	Alemany, Marià/0000-0002-9783-8293; Remesar, Xavier/0000-0002-9707-7287; del Mar Romero, Maria/0000-0001-6274-5743; Esteve, Montserrat/0000-0003-2128-7859; Remesar, Xavier/0000-0002-9707-7287; Esteve, Montserrat/0000-0003-2128-7859; López, José Antonio Fernández/0000-0002-2856-7223; Grasa Martínez, Maria del Mar/0000-0001-6362-0504	Plan Nacional de Investigacion en Biomedicina [SAF2009-11739]; Plan Nacional de Ciencia y Tecnologia de los Alimentos [AGL-2011-23635]; Fondo de Investigaciones Sanitarias of the Government of Spain [PI09/00505]; CIBER (Centro de Investigacion Biomedica en Red) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Spain	Plan Nacional de Investigacion en Biomedicina; Plan Nacional de Ciencia y Tecnologia de los Alimentos; Fondo de Investigaciones Sanitarias of the Government of Spain; CIBER (Centro de Investigacion Biomedica en Red) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Spain	This study was funded by grants SAF2009-11739 of the Plan Nacional de Investigacion en Biomedicina, AGL-2011-23635 from the Plan Nacional de Ciencia y Tecnologia de los Alimentos and PI09/00505 from the Fondo de Investigaciones Sanitarias of the Government of Spain. The salary of M.M. Romero was funded by CIBER (Centro de Investigacion Biomedica en Red) Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Spain. F. Holmgren-Holm was a visiting student with an Erasmus grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard Vincent, 2006, Metabolic Syndrome and Related Disorders, V4, P129, DOI 10.1089/met.2006.4.129; Alemany M, 2012, FRONTIERS ENDOCRINOL, V3; Alemany M, 2012, HORMONES, V11, P254; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burt MG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1426, DOI 10.1152/ajpendo.00524.2006; Cakir M, 2005, ENDOCR RES, V31, P213, DOI 10.1080/07435800500373199; CHADER GJ, 1968, J BIOL CHEM, V243, P928; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Cvoro A, 2011, J IMMUNOL, V186, P4354, DOI 10.4049/jimmunol.1002205; Davenport A.P., 1996, CURRENT DIRECTIONS R, P169, DOI DOI 10.1007/978-94-009-1768-2_11; Romero MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034381; Diederich S, 2002, J CLIN ENDOCR METAB, V87, P5695, DOI 10.1210/jc.2002-020970; Duclos M, 2005, OBES RES, V13, P1157, DOI 10.1038/oby.2005.137; Emptoz-Bonneton A, 2000, J CLIN ENDOCR METAB, V85, P361, DOI 10.1210/jc.85.1.361; Esteve M, 2012, OBESITY FACTS, V5, P118; Feldman D, 1979, AM J PHYSIOL, V287, pG493; Fernandez-Real JM, 2002, J CLIN ENDOCR METAB, V87, P4686, DOI 10.1210/jc.2001-011843; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; GALA RR, 1965, ENDOCRINOLOGY, V77, P841, DOI 10.1210/endo-77-5-841; Garrel DR, 1996, HORM RES, V45, P245, DOI 10.1159/000184796; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goldstein RE, 2002, AM J PHYSIOL-ENDOC M, V283, pE946, DOI 10.1152/ajpendo.00320.2002; Grasa MD, 2001, MOL CELL BIOCHEM, V228, P25, DOI 10.1023/A:1013304223967; Grasa MM, 2001, HORM METAB RES, V33, P407, DOI 10.1055/s-2001-16228; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; Hautanen A, 1997, J INTERN MED, V241, P451; Ibarrola I, 1996, BBA-BIOMEMBRANES, V1284, P41, DOI 10.1016/0005-2736(96)00110-1; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jirikowski GF, 2007, J CHEM NEUROANAT, V34, P22, DOI 10.1016/j.jchemneu.2007.03.007; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Komesaroff PA, 1999, J CLIN ENDOCR METAB, V84, P606, DOI 10.1210/jc.84.2.606; KUHN RW, 1988, ANN NY ACAD SCI, V538, P146; LEA OA, 1972, J STEROID BIOCHEMIST, V3, P409, DOI 10.1016/0022-4731(72)90087-8; Lewis JG, 2004, DIABETES OBES METAB, V6, P259, DOI 10.1111/j.1462-8902.2004.00343.x; Lewis JG, 2011, J STEROID BIOCHEM, V127, P289, DOI 10.1016/j.jsbmb.2011.08.006; MACADAMS MR, 1986, ANN INTERN MED, V104, P648, DOI 10.7326/0003-4819-104-5-648; Manco M, 2007, DIABETES CARE, V30, P1494, DOI 10.2337/dc06-1353; MAROTTA SF, 1975, HORM METAB RES, V7, P334, DOI 10.1055/s-0028-1093725; MATARADZE GD, 1992, J ENDOCRINOL, V132, P235, DOI 10.1677/joe.0.1320235; May RC, 1996, KIDNEY INT, V49, P679, DOI 10.1038/ki.1996.96; Natsui K, 2006, OSTEOPOROSIS INT, V17, P105, DOI 10.1007/s00198-005-1923-3; Ousova O, 2004, MOL ENDOCRINOL, V18, P1687, DOI 10.1210/me.2004-0005; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Perogamvros I, 2011, CLIN ENDOCRINOL, V74, P30, DOI 10.1111/j.1365-2265.2010.03897.x; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; Qian XX, 2011, ENDOCRINOLOGY, V152, P3738, DOI 10.1210/en.2011-1008; Reynolds RM, 2003, DIABETES OBES METAB, V5, P5, DOI 10.1046/j.1463-1326.2003.00221.x; RITZEN EM, 1971, ENDOCRINOLOGY, V89, P143; Romero MD, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-26; STRAIN GW, 1982, METABOLISM, V31, P209, DOI 10.1016/0026-0495(82)90054-3; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Stubbins RE, 2012, DIABETES OBES METAB, V14, P58, DOI 10.1111/j.1463-1326.2011.01488.x; VANBAELEN H, 1982, J BIOL CHEM, V257, P3397; VYTASEK R, 1982, ANAL BIOCHEM, V120, P243, DOI 10.1016/0003-2697(82)90342-6; Wang M, 2005, NUTR METAB, V2; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Wolf G, 2002, NUTR REV, V60, P148	59	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57342	10.1371/journal.pone.0057342	http://dx.doi.org/10.1371/journal.pone.0057342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451210	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800101
J	Monceau, V; Meziani, L; Strup-Perrot, C; Morel, E; Schmidt, M; Haagen, J; Escoubet, B; Dorr, W; Vozenin, MC				Monceau, Virginie; Meziani, Lydia; Strup-Perrot, Carine; Morel, Eric; Schmidt, Magret; Haagen, Julia; Escoubet, Brigitte; Doerr, Wolfgang; Vozenin, Marie-Catherine			Enhanced Sensitivity to Low Dose Irradiation of ApoE-/- Mice Mediated by Early Pro-Inflammatory Profile and Delayed Activation of the TGF beta 1 Cascade Involved in Fibrogenesis	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; INDUCED HEART-DISEASE; IONIZING-RADIATION; CARDIAC-FUNCTION; MORTALITY; RADIOTHERAPY; MECHANISMS; FIBROSIS; CANCER; CELLS	Aim: Investigating long-term cardiac effects of low doses of ionizing radiation is highly relevant in the context of interventional cardiology and radiotherapy. Epidemiological data report that low doses of irradiation to the heart can result in significant increase in the cardiovascular mortality by yet unknown mechanisms. In addition co-morbidity factor such as hypertension or/and atherosclerosis can enhance cardiac complications. Therefore, we explored the mechanisms that lead to long-term cardiac remodelling and investigated the interaction of radiation-induced damage to heart and cardiovascular systems with atherosclerosis, using wild-type and ApoE-deficient mice. Methods and Results: ApoE-/- and wild-type mice were locally irradiated to the heart at 0, 0.2 and 2 Gy (RX). Twenty, 40 and 60 weeks post-irradiation, echocardiography were performed and hearts were collected for cardiomyocyte isolation, histopathological analysis, study of inflammatory infiltration and fibrosis deposition. Common and strain-specific pathogenic pathways were found. Significant alteration of left ventricular function (eccentric hypertrophy) occurred in both strains of mice. Low dose irradiation (0.2 Gy) induced premature death in ApoE-/- mice (47% died at 20 weeks). Acute inflammatory infiltrate was observed in scarring areas with accumulation of M1-macrophages and secretion of IL-6. Increased expression of the fibrogenic factors (TGF-beta 1 and PAI-1) was measured earlier in cardiomyocytes isolated from ApoE-/- than in wt animals. Conclusion: The present study shows that cardiac exposure to low dose of ionizing radiation induce significant physiological, histopathological, cellular and molecular alterations in irradiated heart with mild functional impairment. Atherosclerotic predisposition precipitated cardiac damage induced by low doses with an early pro-inflammatory polarization of macrophages.	[Monceau, Virginie; Meziani, Lydia; Vozenin, Marie-Catherine] INSERM, U1030, Villejuif, France; [Monceau, Virginie; Meziani, Lydia; Vozenin, Marie-Catherine] Univ Paris 11, Le Kremlin Bicetre, France; [Monceau, Virginie; Meziani, Lydia; Vozenin, Marie-Catherine] Inst Gustave Roussy, Villejuif, France; [Monceau, Virginie; Strup-Perrot, Carine] LRTE SRBE DRPH, Inst Radioprtect & Surete Nucl, Fontenay Aux Roses, France; [Morel, Eric] INSERM, UMR S 769, Chatenay Malabry, France; [Schmidt, Magret; Haagen, Julia; Doerr, Wolfgang] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Radiotherapy & Radiat Oncol, Dresden, Germany; [Escoubet, Brigitte] Hop Bichat Claude Bernard, AP HP, Dept Physiol Explorat Fonct, F-75877 Paris, France; [Escoubet, Brigitte] Univ Paris 07, Paris, France; [Escoubet, Brigitte] INSERM, U872, Paris, France; [Doerr, Wolfgang] Med Univ, Dept Radiat Oncol, Vienna, Austria; [Doerr, Wolfgang] Med Univ, Christian Doppler Lab Med Radiat Res Radio Oncol, Vienna, Austria	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Monceau, V (corresponding author), INSERM, U1030, Villejuif, France.	virginie.monceau@igr.fr	Vozenin, Marie-Catherine/AAR-2268-2021; Doerr, Wolfgang/J-9344-2014	Vozenin, Marie-Catherine/0000-0002-2109-8073; Meziani, Lydia/0000-0002-1127-0183; Morel, Eric/0000-0001-6945-6442; Monceau, Virginie/0000-0002-1717-8935; Doerr, Wolfgang/0000-0003-1477-6849	CARDIORISK; European Commission (FP7); ANR [ANR-10-LABX-33]	CARDIORISK; European Commission (FP7)(European CommissionEuropean Commission Joint Research Centre); ANR(French National Research Agency (ANR))	This work was supported by CARDIORISK which is an Integrated Project funded by the European Commission (FP7-Fission-2007-3.1.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Olivia Bawa and Benoit Petit for excellent technical assistance in histology and IGR-SCEA for animal care. We thank Pr MJ McKay for critical reading of the MS and English edition. We thank the Department of LIPA for the use of ultrasonographic system (Aplio, Toshiba). Inserm U1030 is a member of the Laboratory of Excellence LERMIT supported by a grant from ANR (ANR-10-LABX-33).	Andratschke N, 2011, RADIOTHER ONCOL, V100, P160, DOI 10.1016/j.radonc.2010.08.010; Ashmore JP, 1998, AM J EPIDEMIOL, V148, P564, DOI 10.1093/oxfordjournals.aje.a009682; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Boerma M, 2005, CANCER RES, V65, P3100, DOI 10.1158/0008-5472.CAN-04-4333; Bouillon K, 2011, J AM COLL CARDIOL, V57, P445, DOI 10.1016/j.jacc.2010.08.638; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Cao TM, 2008, AM J HEMATOL, V83, P390, DOI 10.1002/ajh.21104; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; Fox JJ, 2013, NUCL ONCOLOGY, P763; Franken NAP, 1997, BRIT J RADIOL, V70, P1004, DOI 10.1259/bjr.70.838.9404203; Gabriels K, 2012, RADIOTHER ONCOL; Gervaz P, 2009, CURR MOL MED, V9, P273, DOI 10.2174/156652409787847164; Guldner L, 2006, RADIOTHER ONCOL, V81, P47, DOI 10.1016/j.radonc.2006.08.020; Haydont V, 2008, AM J PHYSIOL-CELL PH, V294, pC1332, DOI 10.1152/ajpcell.90626.2007; Hilbers FSM, 2012, RADIOTHER ONCOL, V102, P115, DOI 10.1016/j.radonc.2011.10.017; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Joiner MC, 2001, INT J RADIAT ONCOL, V49, P379, DOI 10.1016/S0360-3016(00)01471-1; KLONER RA, 1974, AM J PATHOL, V74, P399; Kreuzer M, 2006, RADIAT ENVIRON BIOPH, V45, P159, DOI 10.1007/s00411-006-0056-1; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Monceau V, 2010, CURR DRUG TARGETS, V11, P1395, DOI 10.2174/1389450111009011395; Nabeebaccus A, 2011, HEART FAIL REV, V16, P5, DOI 10.1007/s10741-010-9186-2; Pollick C, 1995, J Am Soc Echocardiogr, V8, P602, DOI 10.1016/S0894-7317(05)80373-6; Prech M, 2010, AM J CARDIOL, V105, P1240, DOI 10.1016/j.amjcard.2009.12.039; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Reinders JG, 1999, RADIOTHER ONCOL, V51, P35, DOI 10.1016/S0167-8140(99)00026-2; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SCHULTZHECTOR S, 1992, RADIAT RES, V129, P281, DOI 10.2307/3578027; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Zaman AKMT, 2009, EXP BIOL MED, V234, P246, DOI 10.3181/0811-RM-321	47	40	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57052	10.1371/journal.pone.0057052	http://dx.doi.org/10.1371/journal.pone.0057052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451141	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800067
J	Shi, K; Pandey, KK; Bera, S; Vora, AC; Grandgenett, DP; Aihara, H				Shi, Ke; Pandey, Krishan K.; Bera, Sibes; Vora, Ajaykumar C.; Grandgenett, Duane P.; Aihara, Hideki			A Possible Role for the Asymmetric C-Terminal Domain Dimer of Rous Sarcoma Virus Integrase in Viral DNA Binding	PLOS ONE			English	Article							HIV-1 INTEGRASE; RETROVIRAL INTEGRASE; CRYSTAL-STRUCTURE; TYPE-1 INTEGRASE; CATALYTIC CORE; PROTEIN; ORGANIZATION; MODEL; PHOSPHORYLATION; ARCHITECTURE	Integration of the retrovirus linear DNA genome into the host chromosome is an essential step in the viral replication cycle, and is catalyzed by the viral integrase (IN). Evidence suggests that IN functions as a dimer that cleaves a dinucleotide from the 3' DNA blunt ends while a dimer of dimers (tetramer) promotes concerted integration of the two processed ends into opposite strands of a target DNA. However, it remains unclear why a dimer rather than a monomer of IN is required for the insertion of each recessed DNA end. To help address this question, we have analyzed crystal structures of the Rous sarcoma virus (RSV) IN mutants complete with all three structural domains as well as its two-domain fragment in a new crystal form at an improved resolution. Combined with earlier structural studies, our results suggest that the RSV IN dimer consists of highly flexible N-terminal domains and a rigid entity formed by the catalytic and C-terminal domains stabilized by the well-conserved catalytic domain dimerization interaction. Biochemical and mutational analyses confirm earlier observations that the catalytic and the C-terminal domains of an RSV IN dimer efficiently integrates one viral DNA end into target DNA. We also show that the asymmetric dimeric interaction between the two C-terminal domains is important for viral DNA binding and subsequent catalysis, including concerted integration. We propose that the asymmetric C-terminal domain dimer serves as a viral DNA binding surface for RSV IN.	[Shi, Ke; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Pandey, Krishan K.; Bera, Sibes; Vora, Ajaykumar C.; Grandgenett, Duane P.] St Louis Univ, Hlth Sci Ctr, Inst Mol Virol, St Louis, MO 63103 USA	University of Minnesota System; University of Minnesota Twin Cities; Saint Louis University	Aihara, H (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	aihar001@umn.edu		Pandey, Krishan/0000-0002-3973-9844; , Ke/0000-0003-4175-3714	National Institutes of Health [AI087098, AI081629]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087098, R33AI087098, R21AI081629, R21AI100682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the National Institutes of Health (NIH) grants AI087098 (HA), AI081629 (DG), and Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballandras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023032; Bao KK, 2003, J BIOL CHEM, V278, P1323, DOI 10.1074/jbc.C200550200; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; BUSHMAN FD, 1994, J VIROL, V68, P2215, DOI 10.1128/JVI.68.4.2215-2223.1994; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Chiu R, 2003, J VIROL, V77, P6482, DOI 10.1128/JVI.77.11.6482-6492.2003; Craigie R, 2002, MOBILE DNA, P613; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Faure A, 2005, NUCLEIC ACIDS RES, V33, P977, DOI 10.1093/nar/gki241; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; HIPPENMEYER PJ, 1984, VIROLOGY, V137, P358, DOI 10.1016/0042-6822(84)90228-9; HORTON R, 1991, J VIROL, V65, P1141, DOI 10.1128/JVI.65.3.1141-1148.1991; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Katz RA, 1996, VIROLOGY, V217, P178, DOI 10.1006/viro.1996.0105; KATZMAN M, 1989, J VIROL, V63, P5319, DOI 10.1128/JVI.63.12.5319-5327.1989; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; MUMM SR, 1992, J VIROL, V66, P1995, DOI 10.1128/JVI.66.4.1995-1999.1992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; Peletskaya E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027751; PyMOL, PYMOL MOL GRAPHICS S; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Vora AC, 1997, J BIOL CHEM, V272, P23938, DOI 10.1074/jbc.272.38.23938; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Yao X, 2010, PROTEIN CELL, V1, P363, DOI 10.1007/s13238-010-0047-5; Zhou HB, 2001, J VIROL, V75, P1359, DOI 10.1128/JVI.75.3.1359-1370.2001	51	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56892	10.1371/journal.pone.0056892	http://dx.doi.org/10.1371/journal.pone.0056892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451105	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800045
J	Tveraa, T; Stien, A; Bardsen, BJ; Fauchald, P				Tveraa, Torkild; Stien, Audun; Bardsen, Bard-J.; Fauchald, Per			Population Densities, Vegetation Green-Up, and Plant Productivity: Impacts on Reproductive Success and Juvenile Body Mass in Reindeer	PLOS ONE			English	Article							LARGE HERBIVORES; CLIMATE-CHANGE; SVALBARD REINDEER; SPRING CONDITIONS; TROPHIC MISMATCH; LINKING CLIMATE; PHENOLOGY; NDVI; DYNAMICS; ALLOCATION	Global warming is expected to cause earlier springs and increased primary productivity in the Arctic. These changes may improve food availability for Arctic herbivores, but may also have negative effects by generating a mismatch between the surge of high quality food in the spring and the timing of reproduction. We analyzed a 10 year dataset of satellite derived measures of vegetation green-up, population densities, calf body masses and female reproductive success in 19 reindeer (Rangifer tarandus) populations in Northern Norway. An early onset of spring and high peak plant productivity had positive effects on calf autumn body masses and female reproductive success. In addition, body masses and reproductive success were both negatively related to population density. The quantity of food available, as determined by the onset of vegetation green-up and plant productivity over the summer were the main drivers of body mass growth and reproductive success. We found no evidence for an effect of the speed of spring green-up. Nor did we detect a negative mismatch between early springs and subsequent recruitment. Effects of global warming on plant productivity and onset of spring is likely to positively affect sub-Arctic reindeer.	[Tveraa, Torkild; Stien, Audun; Bardsen, Bard-J.; Fauchald, Per] NINA Norwegian Inst Nat Res, FRAM High North Res Ctr Climate & Environm, Tromso, Norway	Norwegian Institute Nature Research	Tveraa, T (corresponding author), NINA Norwegian Inst Nat Res, FRAM High North Res Ctr Climate & Environm, Tromso, Norway.	torkild.tveraa@nina.no	Bårdsen, Bård-Jørgen/B-6984-2015; Fauchald, Per/AAV-4242-2021	Bårdsen, Bård-Jørgen/0000-0001-6818-5249; Stien, Audun/0000-0001-8046-7337; Tveraa, Torkild/0000-0002-7501-3696	Norwegian Directorate of Nature Management	Norwegian Directorate of Nature Management	The work was financed by the Norwegian Directorate of Nature Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes R, 2002, ECOL LETT, V5, P445, DOI 10.1046/j.1461-0248.2002.00340.x; Aanes R, 2000, ECOGRAPHY, V23, P437, DOI 10.1034/j.1600-0587.2000.230406.x; Aanes R, 2003, CAN J ZOOL, V81, P103, DOI 10.1139/Z02-227; ACIA: Arctic Climate Impact Assessment, 2004, IMP WARM ARCT ARCT C; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; [Anonymous], 1999, NATL ATLAS NORWAY VE; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bardsen BJ, 2012, J ANIM ECOL, V81, P364, DOI 10.1111/j.1365-2656.2011.01913.x; Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; Beck PSA, 2007, INT J REMOTE SENS, V28, P4311, DOI 10.1080/01431160701241936; Beck PSA, 2006, REMOTE SENS ENVIRON, V100, P321, DOI 10.1016/j.rse.2005.10.021; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Busetto L, 2010, GLOBAL CHANGE BIOL, V16, P2504, DOI 10.1111/j.1365-2486.2010.02189.x; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Epstein HE, 2000, ECOL APPL, V10, P824, DOI 10.1890/1051-0761(2000)010[0824:ATNBMO]2.0.CO;2; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Forchhammer MC, 2002, POPUL ECOL, V44, P113, DOI 10.1007/s101440200013; Garel M, 2011, J MAMMAL, V92, P1112, DOI 10.1644/10-MAMM-A-056.1; Grotan V, 2009, OECOLOGIA, V161, P685, DOI 10.1007/s00442-009-1419-5; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Helle T, 2008, ECOGRAPHY, V31, P221, DOI 10.1111/j.0906-7590.2008.4912.x; Herfindal I, 2006, OECOLOGIA, V150, P213, DOI 10.1007/s00442-006-0519-8; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Ims RA, 2007, ECOSYSTEMS, V10, P607, DOI 10.1007/s10021-007-9060-9; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; NETELER M, 2002, OPEN SOURCE GIS GRAS; Paruelo JM, 1998, J BIOGEOGR, V25, P721, DOI 10.1046/j.1365-2699.1998.2540721.x; Pettorelli N, 2005, P ROY SOC B-BIOL SCI, V272, P2357, DOI 10.1098/rspb.2005.3218; Pettorelli N, 2005, BIOL LETT-UK, V1, P24, DOI 10.1098/rsbl.2004.0262; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2007, ECOLOGY, V88, P381, DOI 10.1890/06-0875; Pinheiro J, 2001, MIXED EFFECTS MODELS; Portier C, 1998, J ZOOL, V245, P271, DOI 10.1111/j.1469-7998.1998.tb00101.x; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 2008, P ROY SOC B-BIOL SCI, V275, P2005, DOI 10.1098/rspb.2008.0463; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reimers E., 1983, RANGIFER, V3, P3, DOI DOI 10.7557/2.3.1.463; Sother B. E., 1997, TRENDS ECOL EVOL, V12, P143; Tews J, 2007, ECOL MODEL, V207, P85, DOI 10.1016/j.ecolmodel.2007.04.011; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; Tveraa T, 2007, OIKOS, V116, P706, DOI [10.1111/j.2006.0030-1299.15257.x, 10.1111/j.0030-1299.2007.15257.x]; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	54	84	84	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56450	10.1371/journal.pone.0056450	http://dx.doi.org/10.1371/journal.pone.0056450			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451049	Green Published, gold			2022-12-25	WOS:000316658800012
J	Park, K; Nakagawa, Y; Kumagai, Y; Nagahara, M				Park, Kaechang; Nakagawa, Yoshinori; Kumagai, Yasuhiko; Nagahara, Mitsuhiro			Leukoaraiosis, a Common Brain Magnetic Resonance Imaging Finding, as a Predictor of Traffic Crashes	PLOS ONE			English	Article							CEREBRAL WHITE-MATTER; DIFFUSION TENSOR MRI; METABOLIC SYNDROME; HYPERINTENSITIES; DECLINE; LESIONS	Background: There are no reported studies on the relationship between traffic crashes and brain tissue changes in healthy drivers. The relationship between traffic crashes and leukoaraiosis, a common magnetic resonance imaging finding, was investigated in this study. Methods: A total of 3,930 automobile drivers (2,037 men and 1,893 women; age, 21-87 years) who underwent brain magnetic resonance imaging as part of total health check-ups and answered a road traffic questionnaire were examined to determine whether asymptomatic leukoaraiosis was associated with various types of traffic crashes. Multiple logistic regression analysis was performed to elucidate the relationship between leukoaraiosis and various types of traffic crashes. Results: Subcortical leukoaraiosis was diagnosed in 28.52% of all subjects, whereas periventricular leukoaraiosis was diagnosed in 9.57% of all subjects. Adjusted odds ratios for involvement in all types of traffic crashes were not significant for subjects with periventricular leukoaraiosis; however, they were significant for subjects with multiple and large multiple subcortical leukoaraiosis. Adjusted odds ratios for involvement in crashes at crossroads were 1.09 (95% confidence interval [CI], 0.60-2.00) for subjects with single subcortical leukoaraiosis, 3.35 (95% CI, 2.36-4.77) for subjects with multiple subcortical leukoaraiosis, and 2.45 (95% CI, 2.36-4.98) for subjects with large multiple subcortical leukoaraiosis. Periventricular leukoaraiosis was not significantly associated with crossroad crashes. Involvement in crashes of any type, parking lot crashes, and rear-end collisions showed no significant association with either subcortical or periventricular leukoaraiosis. Conclusions: Multiple subcortical leukoaraiosis, but not periventricular leukoaraiosis, is significantly associated with traffic crashes, in particular, crossroad crashes. This association is independent of sex, age, and driving exposure. To our knowledge, this is the first evidence describing the relationship between brain tissue changes and traffic crashes.	[Park, Kaechang] Kochi Univ Technol, Res Org Reg Alliance, Traff Med Lab, Kami, Kochi, Japan; [Nakagawa, Yoshinori] Kochi Univ Technol, Res Org Reg Alliance, Dept Management, Kami, Kochi, Japan; [Kumagai, Yasuhiko; Nagahara, Mitsuhiro] Kochi Univ Technol, Res Org Reg Alliance, Reg ITS Social Lab, Kami, Kochi, Japan	Kochi University Technology; Kochi University Technology; Kochi University Technology	Park, K (corresponding author), Kochi Univ Technol, Res Org Reg Alliance, Traff Med Lab, Kami, Kochi, Japan.	park.kaechang@kochi-tech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology in Japan [22656114]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant (No. 22656114) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, CATEGORICAL DATA ANA; [Anonymous], 2004, WORLD REP ROAD TRAFF; Bao S, 2009, ACCIDENT ANAL PREV, V41, P146, DOI 10.1016/j.aap.2008.10.007; Bokura H, 2008, STROKE, V39, P1607, DOI 10.1161/STROKEAHA.107.508630; Brodal P., 1998, CENTRAL NERVOUS SYST; Chabriat H, 1999, STROKE, V30, P2637, DOI 10.1161/01.STR.30.12.2637; de Groot JC, 2002, ANN NEUROL, V52, P335, DOI 10.1002/ana.10294; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Debette S, 2010, STROKE, V41, P600, DOI 10.1161/STROKEAHA.109.570044; Filley CM, 1998, NEUROLOGY, V50, P1535, DOI 10.1212/WNL.50.6.1535; Garde E, 2000, LANCET, V356, P628, DOI 10.1016/S0140-6736(00)02604-0; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Maltz M, 1999, HUM FACTORS, V41, P15, DOI 10.1518/001872099779577282; Moody DM, 2004, RADIOLOGY, V233, P883, DOI 10.1148/radiol.2333020981; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Park K, 2007, NEUROLOGY, V69, P974, DOI 10.1212/01.wnl.0000266562.54684.bf; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Sasaki M, 2008, NEURORADIOLOGY, V249, P624; Schmidt R, 2007, STROKE, V38, P2619, DOI 10.1161/STROKEAHA.107.489112; Shinohara Y, 2007, CEREBROVASC DIS, V24, P202, DOI 10.1159/000104478; van den Heuvel DMJ, 2006, J NEUROL NEUROSUR PS, V77, P149, DOI 10.1136/jnnp.2005.070193	21	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57255	10.1371/journal.pone.0057255	http://dx.doi.org/10.1371/journal.pone.0057255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437354	Green Published, gold			2022-12-25	WOS:000315184200232
J	Seltmann, KC; Penzes, Z; Yoder, MJ; Bertone, MA; Deans, AR				Seltmann, Katja C.; Penzes, Zsolt; Yoder, Matthew J.; Bertone, Matthew A.; Deans, Andrew R.			Utilizing Descriptive Statements from the Biodiversity Heritage Library to Expand the Hymenoptera Anatomy Ontology	PLOS ONE			English	Article								Hymenoptera, the insect order that includes sawflies, bees, wasps, and ants, exhibits an incredible diversity of phenotypes, with over 145,000 species described in a corpus of textual knowledge since Carolus Linnaeus. In the absence of specialized training, often spanning decades, however, these articles can be challenging to decipher. Much of the vocabulary is domain-specific (e.g., Hymenoptera biology), historically without a comprehensive glossary, and contains much homonymous and synonymous terminology. The Hymenoptera Anatomy Ontology was developed to surmount this challenge and to aid future communication related to hymenopteran anatomy, as well as provide support for domain experts so they may actively benefit from the anatomy ontology development. As part of HAO development, an active learning, dictionary-based, natural language recognition tool was implemented to facilitate Hymenoptera anatomy term discovery in literature. We present this tool, referred to as the 'Proofer', as part of an iterative approach to growing phenotype-relevant ontologies, regardless of domain. The process of ontology development results in a critical mass of terms that is applied as a filter to the source collection of articles in order to reveal term occurrence and biases in natural language species descriptions. Our results indicate that taxonomists use domain-specific terminology that follows taxonomic specialization, particularly at superfamily and family level groupings and that the developed Proofer tool is effective for term discovery, facilitating ontology construction.	[Seltmann, Katja C.] Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA; [Penzes, Zsolt] Univ Szeged, Dept Ecol, Szeged, Csongrad, Hungary; [Yoder, Matthew J.] Prairie Res Inst, Champaign, IL USA; [Bertone, Matthew A.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Deans, Andrew R.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	American Museum of Natural History (AMNH); Szeged University; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Seltmann, KC (corresponding author), Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA.	enicospilus@gmail.com	Pénzes, Zsolt/M-1395-2018; Seltmann, Katja/AAC-9120-2020; Deans, Andrew R./AAG-4166-2021	Pénzes, Zsolt/0000-0003-0447-5997; Seltmann, Katja/0000-0001-5354-6048; Deans, Andrew R./0000-0002-2119-4663; Bertone, Matt/0000-0001-7985-1913	NSF [BDI-0446224, EF-0337220, DEB-0328922, DBI-0850223];  [TAMOP-4.2/B-09/1/KONV-2010-0005];  [KTIA-OTKA CNK 80140];  [HURO/0901/205/2.2.2]; Div Of Biological Infrastructure [1321620] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ; ; ; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Hymenoptera Anatomy Ontology was initially funded in part by NSF grants BDI-0446224, EF-0337220, and DEB-0328922. Primary funding for this project was from NSF DBI-0850223 (http://www.nsf.gov/awardsearch/showAward?AWD_ID = 0850223). Additional support for Zsolt Penzes TAMOP-4.2/B-09/1/KONV-2010-0005, KTIA-OTKA CNK 80140, and HURO/0901/205/2.2.2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti Donat, 2009, BMC Res Notes, V2, P53, DOI 10.1186/1756-0500-2-53; Akella LM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-211; Bodenreider O., 2006, TEXT MINING BIOL BIO, P43; Catapano T, 2011, COMMUNICATION; Cui H, 2012, J AM SOC INF SCI TEC, V63, P738, DOI 10.1002/asi.22618; Dahdul WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010708; Day David, 1997, P 5 C APPL NAT LANG, P348, DOI [DOI 10.3115/974557.974608, 10.3115/974557.974608]; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Jensen LJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000374; Jurasinski G., 2012, COLLECTION FUNCTIONS; Kaufman L., 1990, FINDING GROUPS DATA, DOI [10.1002/9780470316801, DOI 10.1002/9780470316801]; Klingenberg C, 2012, GOLDENGATE XML MARKU; Leary PR, 2007, BIOINFORMATICS, V23, P1434, DOI 10.1093/bioinformatics/btm109; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Mullins PL, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.223.3572; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Development Core Team, 2010, LANG ENV STAT COMP; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sautter G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P391; Seltmann KC, 2012, J HYMENOPT RES, V27, P67, DOI 10.3897/JHR.27.2961; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Vogt L, 2010, CLADISTICS, V26, P301, DOI 10.1111/j.1096-0031.2009.00286.x; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	25	7	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55674	10.1371/journal.pone.0055674	http://dx.doi.org/10.1371/journal.pone.0055674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441153	gold, Green Submitted, Green Published			2022-12-25	WOS:000315159200011
J	Thriemer, K; Katuala, Y; Batoko, B; Alworonga, JP; Devlieger, H; Van Geet, C; Ngbonda, D; Jacobs, J				Thriemer, Kamala; Katuala, Yves; Batoko, Bibi; Alworonga, Jean-Pierre; Devlieger, Hugo; Van Geet, Christel; Ngbonda, Dauly; Jacobs, Jan			Antibiotic Prescribing in DR Congo: A Knowledge, Attitude and Practice Survey among Medical Doctors and Students	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; PERCEPTIONS; EXPECTATIONS; PHYSICIANS; BELIEFS	Objectives: Antibiotic resistance (ABR) particularly hits resource poor countries, and is fuelled by irrational antibiotic (AB) prescribing. We surveyed knowledge, attitudes and practices of AB prescribing among medical students and doctors in Kisangani, DR Congo. Methods: Self-administered questionnaires. Results: A total of 184 questionnaires were completed (response rate 94.4%). Knowledge about AB was low (mean score 4.9/8 points), as was the estimation of local resistance rates of S. Typhi and Klebsiella spp.(correct by 42.5% and 6.9% of respondents respectively). ABR was recognized as a problem though less in their own practice (67.4%) than nation- or worldwide (92.9% and 85.5%, p<.0001). Confidence in AB prescribing was high (88.6%) and students consulted more frequently colleagues than medical doctors when prescribing (25.4% versus 11.6%, p = 0.19). Sources of AB prescribing included pharmaceutical companies (73.9%), antibiotic guidelines (66.3%), university courses (63.6%), internet-sites (45.7%) and WHO guidelines (26.6%). Only 30.4% and 16.3% respondents perceived AB procured through the central procurement and local pharmacies as of good quality. Local AB guidelines and courses about AB prescribing are welcomed (73.4% and 98.8% respectively). Conclusions: This data shows the need for interventions that support rational AB prescribing.	[Thriemer, Kamala; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Katuala, Yves; Batoko, Bibi; Alworonga, Jean-Pierre; Ngbonda, Dauly] Univ Hosp Kisangani, Dept Pediat, Kisangani, DEM REP CONGO; [Devlieger, Hugo; Van Geet, Christel] Katholieke Univ Leuven Hosp, Dept Pediat, Louvain, Belgium	Institute of Tropical Medicine (ITM); Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Thriemer, K (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	kthriemer@itg.be	Jacobs, Jan/GRX-7316-2022	Thriemer, Kamala/0000-0001-7536-7497	Flemish Interuniversity Council [ZRDC2009EIN6]	Flemish Interuniversity Council	This study was sponsored by the Flemish Interuniversity Council Project ZRDC2009EIN6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda CMA, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P491, DOI 10.1007/978-0-387-89370-9_28; Britten N, 1997, BRIT MED J, V315, P1506, DOI 10.1136/bmj.315.7121.1506; Garcia Coralith, 2011, BMC Clin Pharmacol, V11, P18, DOI 10.1186/1472-6904-11-18; Gaudiano MC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-22; Giblin TB, 2004, ARCH INTERN MED, V164, P1662, DOI 10.1001/archinte.164.15.1662; Guerra CM, 2007, INFECT CONT HOSP EP, V28, P1411, DOI 10.1086/523278; Karras DJ, 2003, ANN EMERG MED, V42, P835, DOI 10.1016/S0196-0644(03)00602-4; Kinshasa Ud, 2009, ANN AFRICAINES MED; Lunguya Octavie, 2012, PLoS Negl Trop Dis, V6, pe1921, DOI 10.1371/journal.pntd.0001921; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; MULLER C, 1972, SCIENCE, V176, P488, DOI 10.1126/science.176.4034.488; Okeke IN, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P27, DOI 10.1007/978-0-387-89370-9_3; Olivier C, 2010, ANTIMICROBIAL RESISTANCE IN DEVELOPING COUNTRIES, P505, DOI 10.1007/978-0-387-89370-9_29; Pulcini C, 2011, CLIN MICROBIOL INFEC, V17, P80, DOI 10.1111/j.1469-0691.2010.03179.x; Srinivasan A, 2004, ARCH INTERN MED, V164, P1451, DOI 10.1001/archinte.164.13.1451; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015; Wester CW, 2002, ARCH INTERN MED, V162, P2210, DOI 10.1001/archinte.162.19.2210; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1	19	96	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55495	10.1371/journal.pone.0055495	http://dx.doi.org/10.1371/journal.pone.0055495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441152	Green Published, gold			2022-12-25	WOS:000315159200010
J	Ding, XM; Park, SI; McCauley, LK; Wang, CY				Ding, Xiangming; Park, Serk In; McCauley, Laurie K.; Wang, Cun-Yu			Signaling between Transforming Growth Factor beta (TGF-beta) and Transcription Factor SNAI2 Represses Expression of MicroRNA miR-203 to Promote Epithelial-Mesenchymal Transition and Tumor Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; E-CADHERIN; ZEB1; FAMILY; SLUG; CARCINOMA; INVASION; PHENOTYPE; MIGRATION; PROFILES	TGF-beta promotes tumor invasion and metastasis by inducing an epithelial-mesenchymal transition (EMT). Understanding the molecular and epigenetic mechanisms by which TGF-beta induces EMT may facilitate the development of new therapeutic strategies for metastasis. Here, we report that TGF-beta induced SNAI2 to promote EMT by repressing miR-203. Although miR-203 targeted SNAI2, SNAI2 induced by TGF-beta could directly bind to the miR-203 promoter to inhibit its transcription. SNAI2 and miR-203 formed a double negative feedback loop to inhibit each other's expression, thereby controlling EMT. Moreover, we found that miR-203 was significantly down-regulated in highly metastatic breast cancer cells. The restoration of miR-203 in highly metastatic breast cancer cells inhibited tumor cell invasion in vitro and lung metastatic colonization in vivo by repressing SNAI2. Taken together, our results suggest that the SNAI2 and miR-203 regulatory loop plays important roles in EMT and tumor metastasis.	[Ding, Xiangming; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Lab Mol Signaling, Div Oral Biol & Med, Los Angeles, CA 90095 USA; [Ding, Xiangming; Wang, Cun-Yu] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Ding, Xiangming; Wang, Cun-Yu] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Park, Serk In; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Park, Serk In; McCauley, Laurie K.] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cunywang@ucla.edu	Park, Serk In/D-2840-2011	Park, Serk In/0000-0001-8643-5096; ding, xiangming/0000-0003-1169-5998	National Institutes of Health from the NIDCR [R01 CA132134, R37 DE013848, R01 DE15964]; NATIONAL CANCER INSTITUTE [R01CA132134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE013848, R01DE015964] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA132134 and R37 DE013848 and R01 DE15964 from the NIDCR (to C.-Y.W.).	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Derksen PWB, 2006, CANCER CELL, V10, P437, DOI 10.1016/j.ccr.2006.09.013; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hajra KM, 2002, CANCER RES, V62, P1613; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Liu YN, 2013, ONCOGENE, V32, P296, DOI 10.1038/onc.2012.58; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Caro M, 2008, BRIT J CANCER, V98, P480, DOI 10.1038/sj.bjc.6604084; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Shalgi R, 2009, AGING-US, V1, P762, DOI 10.18632/aging.100085; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Takeshita N, 2012, INT J ONCOL, V41, P1653, DOI 10.3892/ijo.2012.1614; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wang C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-58; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Zhang Zhiqian, 2011, Genes Cancer, V2, P782, DOI 10.1177/1947601911429743	48	138	144	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10241	10253		10.1074/jbc.M112.443655	http://dx.doi.org/10.1074/jbc.M112.443655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447531	Green Published, hybrid			2022-12-25	WOS:000317565000006
J	Xu, YY; Wei, XY; Wang, M; Zhang, R; Fu, YB; Xing, MZ; Hua, QH; Xie, X				Xu, Yongyu; Wei, Xiaoyuan; Wang, Min; Zhang, Ru; Fu, Yanbin; Xing, Mingzhe; Hua, Qiuhong; Xie, Xin			Proliferation Rate of Somatic Cells Affects Reprogramming Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; SUBEROYLANILIDE HYDROXAMIC ACID; DEXAMETHASONE INHIBITS PROLIFERATION; SIGNALING PROMOTES PROLIFERATION; HISTONE DEACETYLASE INHIBITORS; HUMAN NEUROBLASTOMA-CELLS; C-MYC; SELF-RENEWAL; CANCER-CELLS; IN-VIVO	The discovery of induced pluripotent stem (iPS) cells provides not only new approaches for cell replacement therapy, but also new ways for drug screening. However, the undefined mechanism and relatively low efficiency of reprogramming have limited the application of iPS cells. In an attempt to further optimize the reprogramming condition, we unexpectedly observed that removing c-Myc from the Oct-4, Sox-2, Klf-4, and c-Myc (OSKM) combination greatly enhanced the generation of iPS cells. The iPS cells generated without c-Myc attained salient pluripotent characteristics and were capable of producing fullterm mice through tetraploid complementation. We observed that forced expression of c-Myc induced the expression of many genes involved in cell cycle control and a hyperproliferation state of the mouse embryonic fibroblasts during the early stage of reprogramming. This enhanced proliferation of mouse embryonic fibroblasts correlated negatively to the overall reprogramming efficiency. By applying small molecule inhibitors of cell proliferation at the early stage of reprogramming, we were able to improve the efficiency of iPS cell generation mediated by OSKM. Our data demonstrated that the proliferation rate of the somatic cell plays critical roles in reprogramming. Slowing down the proliferation of the original cells might be beneficial to the induction of iPS cells.	[Xu, Yongyu; Wei, Xiaoyuan; Zhang, Ru; Fu, Yanbin; Xing, Mingzhe; Hua, Qiuhong; Xie, Xin] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Lab Receptor Based Biomed, Shanghai 200092, Peoples R China; [Xu, Yongyu; Wei, Xiaoyuan; Wang, Min; Fu, Yanbin; Xing, Mingzhe; Xie, Xin] Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Stake Key Lab Drug Res, Shanghai 201203, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhang, R (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	ru.zhang@tongji.edu.cn; xxie@mail.shcnc.ac.cn			Chinese Academy of Sciences [XDA01040301]; Ministry of Science and Technology of China [2009CB940900, 2010CB944900, 2011CB965104, 2011DFB30010]; Shanghai Commission of Science and Technology [11DZ2292200, 12XD1402100]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by Chinese Academy of Sciences Grant XDA01040301, Ministry of Science and Technology of China Grants 2009CB940900, 2010CB944900, 2011CB965104, and 2011DFB30010, and Shanghai Commission of Science and Technology Grant 11DZ2292200 and 12XD1402100.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Bavaresco L, 2007, J NEURO-ONCOL, V84, P1, DOI 10.1007/s11060-007-9342-2; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Butler LM, 2000, CANCER RES, V60, P5165; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Chen JK, 2010, J BIOL CHEM, V285, P31066, DOI 10.1074/jbc.M110.139436; Chen MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028203; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hindley C, 2012, BIOCHEM J, V444, P375, DOI 10.1042/BJ20112040; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hurlin PJ, 2003, EMBO J, V22, P4584, DOI 10.1093/emboj/cdg442; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kaufmann L, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-15; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; KUNERTRADEK J, 1990, AGENTS ACTIONS, V29, P254, DOI 10.1007/BF01966455; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Liu HO, 2009, BRAIN RES, V1265, P1, DOI 10.1016/j.brainres.2009.01.050; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Luo JC, 2007, J PHARMACOL EXP THER, V320, P687, DOI 10.1124/jpet.106.113035; Lusher B, 2007, EMBO REP, V8, P1110, DOI 10.1038/sj.embor.7401121; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Malynn BA, 2000, GENE DEV, V14, P1390; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Medina V, 1997, CANCER RES, V57, P3697; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miller JP, 2007, CELL CYCLE, V6, P2932, DOI 10.4161/cc.6.23.5042; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Ota S, 2009, HUM MOL GENET, V18, P2609, DOI 10.1093/hmg/ddp195; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Pluck Anne, 2009, Methods Mol Biol, V561, P199, DOI 10.1007/978-1-60327-019-9_13; Richon VM, 2001, BLOOD CELL MOL DIS, V27, P260, DOI 10.1006/bcmd.2000.0376; ROCCHI P, 1992, ANTICANCER RES, V12, P917; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Schmidt K, 1999, ARCH PHARM, V332, P353, DOI 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO;2-X; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shang YC, 2007, ACTA PHARMACOL SIN, V28, P1761, DOI 10.1111/j.1745-7254.2007.00671.x; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wang Q, 2011, CELL RES, V21, P1424, DOI 10.1038/cr.2011.108; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; WELLER EM, 1993, CELL PROLIFERAT, V26, P45, DOI 10.1111/j.1365-2184.1993.tb00005.x; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; Yamamura S, 2012, INT J CANCER, V130, P20, DOI 10.1002/ijc.25961; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zaharevitz DW, 1999, CANCER RES, V59, P2566; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	83	42	45	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2013	288	14					9767	9778		10.1074/jbc.M112.403881	http://dx.doi.org/10.1074/jbc.M112.403881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	119RB	23439651	Green Published, hybrid			2022-12-25	WOS:000317114000018
J	Antti, H; Fahlgren, A; Nasstrom, E; Kouremenos, K; Sunden-Cullberg, J; Guo, YZ; Moritz, T; Wolf-Watz, H; Johansson, A; Fallman, M				Antti, Henrik; Fahlgren, Anna; Nasstrom, Elin; Kouremenos, Konstantinos; Sunden-Cullberg, Jonas; Guo, YongZhi; Moritz, Thomas; Wolf-Watz, Hans; Johansson, Anders; Fallman, Maria			Metabolic Profiling for Detection of Staphylococcus aureus Infection and Antibiotic Resistance	PLOS ONE			English	Article							SEVERE SEPSIS; SEPTIC SHOCK; FATTY-ACIDS; BACTEREMIA; MORTALITY; ELEVATION; DISEASE; GROWTH	Due to slow diagnostics, physicians must optimize antibiotic therapies based on clinical evaluation of patients without specific information on causative bacteria. We have investigated metabolomic analysis of blood for the detection of acute bacterial infection and early differentiation between ineffective and effective antibiotic treatment. A vital and timely therapeutic difficulty was thereby addressed: the ability to rapidly detect treatment failures because of antibiotic-resistant bacteria. Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) were used in vitro and for infecting mice, while natural MSSA infection was studied in humans. Samples of bacterial growth media, the blood of infected mice and of humans were analyzed with combined Gas Chromatography/Mass Spectrometry. Multivariate data analysis was used to reveal the metabolic profiles of infection and the responses to different antibiotic treatments. In vitro experiments resulted in the detection of 256 putative metabolites and mice infection experiments resulted in the detection of 474 putative metabolites. Importantly, ineffective and effective antibiotic treatments were differentiated already two hours after treatment start in both experimental systems. That is, the ineffective treatment of MRSA using cloxacillin and untreated controls produced one metabolic profile while all effective treatment combinations using cloxacillin or vancomycin for MSSA or MRSA produced another profile. For further evaluation of the concept, blood samples of humans admitted to intensive care with severe sepsis were analyzed. One hundred thirty-three putative metabolites differentiated severe MSSA sepsis (n = 6) from severe Escherichia coli sepsis (n = 10) and identified treatment responses over time. Combined analysis of human, in vitro, and mice samples identified 25 metabolites indicative of effective treatment of S. aureus sepsis. Taken together, this study provides a proof of concept of the utility of analyzing metabolite patterns in blood for early differentiation between ineffective and effective antibiotic treatment in acute S. aureus infections.	[Antti, Henrik; Nasstrom, Elin] Umea Univ, Dept Chem, Umea, Sweden; [Fahlgren, Anna] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, Umea, Sweden; [Johansson, Anders] Umea Univ, Dept Clin Microbiol, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden; [Sunden-Cullberg, Jonas] Karolinska Univ Hosp, Karolinska Inst, Ctr Infect Med, Dept Med F59, Stockholm, Sweden; [Guo, YongZhi] SLU, Fac Vet Med & Agr Sci, Div Reprod, Dept Clin Sci, Uppsala, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; [Wolf-Watz, Hans; Fallman, Maria] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden	Umea University; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University	Johansson, A (corresponding author), Umea Univ, Dept Clin Microbiol, Lab Mol Infect Med Sweden, Umea Ctr Microbial Res, Umea, Sweden.	anders.johansson@climi.umu.se; maria.fallman@molbiol.umu.se	Johansson, Anders/H-9362-2017; Johansson, Anders/D-2928-2012; Sundén-Cullberg, Jonas/AAW-5210-2020	Johansson, Anders/0000-0003-0548-5943; Johansson, Anders/0000-0003-0548-5943; Sundén-Cullberg, Jonas/0000-0002-8189-4960; Moritz, Thomas/0000-0002-4258-3190; Nasstrom, Elin/0000-0001-6499-3281; Kouremenos, Konstantinos/0000-0002-0625-2044	VINNOVA; Swedish Governmental Agency for Innovation Systems; Swedish Research Council [2010-4284, K2011-56X-11222-17-6]; Vasterbotten County Council Centrala ALF; Stockholm County Council ALF-medel	VINNOVA(Vinnova); Swedish Governmental Agency for Innovation Systems(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vasterbotten County Council Centrala ALF; Stockholm County Council ALF-medel(Stockholm County Council)	This work was funded by VINNOVA, the Swedish Governmental Agency for Innovation Systems (HA AJ); the the Swedish Research Council VR Dnr: 2010-4284 (HA MF) and K2011-56X-11222-17-6 (MF); Vasterbotten County Council Centrala ALF (AJ); and Stockholm County Council ALF-medel (JSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Antunes LCM, 2011, J BACTERIOL, V193, P4719, DOI 10.1128/JB.05132-11; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chan, 2012, ANTIMICROBIAL RESIST; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Hanberger H, 2011, INT J ANTIMICROB AG, V38, P331, DOI 10.1016/j.ijantimicag.2011.05.013; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Jensen AG, 2002, ARCH INTERN MED, V162, P25, DOI 10.1001/archinte.162.1.25; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; Kohler T, 2009, J BACTERIOL, V191, P4482, DOI 10.1128/JB.00221-09; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Mandell GL, 2010, MANDELL DOUGLAS BENN; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Sunden-Cullberg J, 2007, CRIT CARE MED, V35, P1536, DOI 10.1097/01.CCM.0000266536.14736.03; Thatcher JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3119tr3; Walker B, 2009, SCIENCE, V325, P1345, DOI 10.1126/science.1175325; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	27	27	27	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56971	10.1371/journal.pone.0056971	http://dx.doi.org/10.1371/journal.pone.0056971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451124	gold, Green Published			2022-12-25	WOS:000316849500048
J	Daniels, AH; Paller, DJ; Koruprolu, S; Palumbo, MA; Crisco, JJ				Daniels, Alan H.; Paller, David J.; Koruprolu, Sarath; Palumbo, Mark A.; Crisco, Joseph J.			Dynamic Biomechanical Examination of the Lumbar Spine with Implanted Total Spinal Segment Replacement (TSSR) Utilizing a Pendulum Testing System	PLOS ONE			English	Article							TOTAL DISC REPLACEMENT; INVESTIGATIONAL DEVICE EXEMPTION; CHARITE ARTIFICIAL DISC; PRODISC-L; DISPLACEMENT; ARTHRODESIS; KINEMATICS; COMPONENTS; STIFFNESS; BEHAVIOR	Background: Biomechanical investigations of spinal motion preserving implants help in the understanding of their in vivo behavior. In this study, we hypothesized that the lumbar spine with implanted total spinal segment replacement (TSSR) would exhibit decreased dynamic stiffness and more rapid energy absorption compared to native functional spinal units under simulated physiologic motion when tested with the pendulum system. Methods: Five unembalmed, frozen human lumbar functional spinal units were tested on the pendulum system with axial compressive loads of 181 N, 282 N, 385 N, and 488 N before and after Flexuspine total spinal segment replacement implantation. Testing in flexion, extension, and lateral bending began by rotating the pendulum to 5 degrees; resulting in unconstrained oscillatory motion. The number of rotations to equilibrium was recorded and bending stiffness (N-m/degrees) was calculated and compared for each testing mode. Results: The total spinal segment replacement reached equilibrium with significantly fewer cycles to equilibrium compared to the intact functional spinal unit at all loads in flexion (p<0.011), and at loads of 385 N and 488 N in lateral bending (p<0.020). Mean bending stiffness in flexion, extension, and lateral bending increased with increasing load for both the intact functional spinal unit and total spinal segment replacement constructs (p<0.001), with no significant differences in stiffness between the intact functional spinal unit and total spinal segment replacement in any of the test modes (p>0.18). Conclusions: Lumbar functional spinal units with implanted total spinal segment replacement were found to have similar dynamic bending stiffness, but absorbed energy at a more rapid rate than intact functional spinal units during cyclic loading with an unconstrained pendulum system. Although the effects on clinical performance of motion preserving devices is not fully known, these results provide further insight into the biomechanical behavior of this device under approximated physiologic loading conditions.	[Daniels, Alan H.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; Rhode Isl Hosp, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Daniels, AH (corresponding author), Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA.	alandanielsmd@gmail.com	Koruprolu, Sarath C/A-3825-2017	Koruprolu, Sarath C/0000-0003-4036-3212; Crisco, Joseph/0000-0002-8786-0905	RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	RIH Orthopaedic Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this study was provided by the RIH Orthopaedic Foundation. Flexuspine provided the implants for the investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WM, 2009, SPINE, V34, pE716, DOI 10.1097/BRS.0b013e3181ae23d1; Chung SK, 2009, SPINE, V34, P1281, DOI 10.1097/BRS.0b013e3181a4ec2d; Crisco JJ, 2007, J BIOMECH, V40, P2767, DOI 10.1016/j.jbiomech.2006.12.013; Cunningham BW, 2009, SPINE J, V9, P735, DOI 10.1016/j.spinee.2009.03.011; Cunningham BW, 2003, SPINE, V28, pS110, DOI 10.1097/01.BRS.0000092209.27573.90; Daniels AH, 2012, SPINE PHILA PA 1976; Davis R, 2012, 12 ANN M INT SOC ADV; Delamarter R, 2011, J BONE JOINT SURG AM, V93A, P705, DOI [10.2106/JBJS.I.00680, 10.2106/JBJS.1.00680]; Demetropoulos CK, 2010, SPINE, V35, P26, DOI 10.1097/BRS.0b013e3181c4eb9a; EDWARDS WT, 1987, J BIOMECH ENG-T ASME, V109, P35, DOI 10.1115/1.3138639; Ferguson SJ, 2003, EUR SPINE J, V12, pS97, DOI 10.1007/s00586-003-0621-0; Gardner-Morse MG, 2004, J BIOMECH, V37, P205, DOI 10.1016/j.jbiomech.2003.10.003; Goel VK, 2005, SPINE, V30, P2755, DOI 10.1097/01.brs.0000195897.17277.67; GOEL VK, 1995, SPINE, V20, P2354, DOI 10.1097/00007632-199511000-00017; GOEL VK, 1985, SPINE, V10, P543, DOI 10.1097/00007632-198507000-00008; GOEL VK, 1988, SPINE, V13, P294, DOI 10.1097/00007632-198803000-00012; GOEL VK, 1994, J BIOMECH ENG-T ASME, V116, P377, DOI 10.1115/1.2895787; Grassmann S, 1998, SPINE, V23, P1155, DOI 10.1097/00007632-199805150-00016; Guyer RD, 2009, SPINE J, V9, P374, DOI 10.1016/j.spinee.2008.08.007; Harrop JS, 2008, SPINE, V33, P1701, DOI 10.1097/BRS.0b013e31817bb956; Holm S, 2007, VET COMP ORTHOPAED, V20, P29; Izambert O, 2003, EUR SPINE J, V12, P562, DOI 10.1007/s00586-003-0569-0; Kosmopoulos V, 2009, EUR SPINE J, V18, P59, DOI 10.1007/s00586-008-0828-1; MILLER JAA, 1986, J BIOMECH, V19, P79, DOI 10.1016/0021-9290(86)90111-9; NACHEMSON A, 1979, SPINE, V4, P513, DOI 10.1097/00007632-197911000-00011; PANJABI MM, 1977, ORTHOP CLIN N AM, V8, P169; PANJABI MM, 1994, J BONE JOINT SURG AM, V76A, P413, DOI 10.2106/00004623-199403000-00012; Rawlinson JJ, 2007, J NEUROSURG-SPINE, V7, P165, DOI 10.3171/SPI-07/08/166; Rohlmann A, 2011, EUR SPINE J; Rohlmann A, 2009, EUR SPINE J, V18, P89, DOI 10.1007/s00586-008-0836-1; Rousseau Marc-Antoine, 2006, Spine J, V6, P258, DOI 10.1016/j.spinee.2005.07.004; Schmidt H, 2010, EUR SPINE J; Spenciner David, 2006, Spine J, V6, P248, DOI 10.1016/j.spinee.2005.08.020; Tang SJ, 2011, J ORTHOP SCI, V16, P221, DOI 10.1007/s00776-011-0037-3; White A.A., 1990, CLIN BIOMECH; Wilke HJ, 2001, SPINE, V26, P636, DOI 10.1097/00007632-200103150-00014; Yue J.J., 2008, MOTION PRESERVATION	37	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57412	10.1371/journal.pone.0057412	http://dx.doi.org/10.1371/journal.pone.0057412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451222	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500100
J	Feldmann, R; Geikowski, A; Weidner, C; Witzke, A; Kodelja, V; Schwarz, T; Gabriel, M; Erker, T; Sauer, S				Feldmann, Radmila; Geikowski, Anne; Weidner, Christopher; Witzke, Annabell; Kodelja, Vitam; Schwarz, Thomas; Gabriel, Mario; Erker, Thomas; Sauer, Sascha			Foam Cell Specific LXR alpha Ligand	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; ATHEROSCLEROSIS; MACROPHAGES; MICE	Objective: The liver X receptor alpha (LXR alpha) is a ligand-dependent nuclear receptor and the major regulator of reverse cholesterol transport in macrophages. This makes it an interesting target for mechanistic study and treatment of atherosclerosis. Methods and Results: We optimized a promising stilbenoid structure (STX4) in order to reach nanomolar effective concentrations in LXR alpha reporter-gene assays. STX4 displayed the unique property to activate LXR alpha effectively but not its subtype LXR beta. The potential of STX4 to increase transcriptional activity as an LXR alpha ligand was tested with gene expression analyses in THP1-derived human macrophages and oxLDL-loaded human foam cells. Only in foam cells but not in macrophage cells STX4 treatment showed athero-protective effects with similar potency as the synthetic LXR ligand T0901317 (T09). Surprisingly, combinatorial treatment with STX4 and T09 resulted in an additive effect on reporter-gene activation and target gene expression. In physiological tests the cellular content of total and esterified cholesterol was significantly reduced by STX4 without the undesirable increase in triglyceride levels as observed for T09. Conclusions: STX4 is a new LXR alpha-ligand to study transcriptional regulation of anti-atherogenic processes in cell or ex vivo models, and provides a promising lead structure for pharmaceutical development.	[Feldmann, Radmila; Geikowski, Anne; Weidner, Christopher; Witzke, Annabell; Kodelja, Vitam; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany; [Feldmann, Radmila] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Geikowski, Anne] Beuth Univ Appl Sci, Dept Life Sci & Technol, Berlin, Germany; [Schwarz, Thomas; Gabriel, Mario; Erker, Thomas] Univ Vienna, Dept Med Chem, Vienna, Austria	Max Planck Society; Free University of Berlin; University of Vienna	Sauer, S (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.	sauer@molgen.mpg.de		Schwarz, Thomas/0000-0002-1951-9676; Plauth, Annabell/0000-0002-4521-1368	BMBF [0315082]; NGFN [01 GS 0828]; European Union (FP7) [262055]; Max Planck Society; Hochschuljubilaumsstiftung of the City Vienna [H2158/2010]	BMBF(Federal Ministry of Education & Research (BMBF)); NGFN; European Union (FP7)(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Hochschuljubilaumsstiftung of the City Vienna	This work is supported by the BMBF (grant number 0315082), the NGFN (grant number 01 GS 0828), the European Union (FP7/2007-2013], under grant agreement no 262055 (ESGI)), and the Max Planck Society. The financial support from the Hochschuljubilaumsstiftung of the City Vienna (project number H2158/2010) is greatly appreciated for the synthetic part of the study (T.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Battke F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-121; Bischoff ED, 2010, J LIPID RES, V51, P900, DOI [10.1194/jlr.M900096-JLR200, 10.1194/jlr.M900096]; Chinetti-Gbaguidi G, 2009, BBA-MOL CELL BIOL L, V1791, P486, DOI 10.1016/j.bbalip.2009.01.009; Cuchel M, 2006, CIRCULATION, V113, P2548, DOI 10.1161/CIRCULATIONAHA.104.475715; Fievet C, 2009, BIOCHEM PHARMACOL, V77, P1316, DOI 10.1016/j.bcp.2008.11.026; Jakobsson T, 2012, TRENDS PHARMACOL SCI, V33, P394, DOI 10.1016/j.tips.2012.03.013; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Laffitte BA, 2001, MOL CELL BIOL, V21, P7558, DOI 10.1128/MCB.21.22.7558-7568.2001; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabas I, 2011, NAT MED, V17, P791, DOI 10.1038/nm0711-791; Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109; Zanotti I, 2008, J LIPID RES, V49, P954, DOI 10.1194/jlr.M700254-JLR200	17	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57311	10.1371/journal.pone.0057311	http://dx.doi.org/10.1371/journal.pone.0057311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451202	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000316849500087
J	Cashins, SD; Grogan, LF; McFadden, M; Hunter, D; Harlow, PS; Berger, L; Skerratt, LF				Cashins, Scott D.; Grogan, Laura F.; McFadden, Michael; Hunter, David; Harlow, Peter S.; Berger, Lee; Skerratt, Lee F.			Prior Infection Does Not Improve Survival against the Amphibian Disease Chytridiomycosis	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; IMMUNE DEFENSES; FROG; SKIN; RESISTANCE; DYNAMICS; DECLINES; CONSERVATION; VACCINATION	Many amphibians have declined globally due to introduction of the pathogenic fungus Batrachochytrium dendrobatidis (Bd). Hundreds of species, many in well-protected habitats, remain as small populations at risk of extinction. Currently the only proven conservation strategy is to maintain species in captivity to be reintroduced at a later date. However, methods to abate the disease in the wild are urgently needed so that reintroduced and wild animals can survive in the presence of Bd. Vaccination has been widely suggested as a potential strategy to improve survival. We used captive-bred offspring of critically endangered booroolong frogs (Litoria booroolongensis) to test if vaccination in the form of prior infection improves survival following re exposure. We infected frogs with a local Bd isolate, cleared infection after 30 days (d) using itraconazole just prior to the onset of clinical signs, and then re-exposed animals to Bd at 110 d. We found prior exposure had no effect on survival or infection intensities, clearly showing that real infections do not stimulate a protective adaptive immune response in this species. This result supports recent studies suggesting Bd may evade or suppress host immune functions. Our results suggest vaccination is unlikely to be useful in mitigating chytridiomycosis. However, survival of some individuals from all experimental groups indicates existence of protective innate immunity. Understanding and promoting this innate resistance holds potential for enabling species recovery.	[Cashins, Scott D.; Grogan, Laura F.; Berger, Lee; Skerratt, Lee F.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [McFadden, Michael; Harlow, Peter S.] Taronga Conservat Soc Australia, Herpetofauna Div, Mosman, NSW, Australia; [Hunter, David] New South Wales Off Environm & Heritage, Biodivers Conservat Sect, Queanbeyan, Australia	James Cook University; Office of Environment & Heritage - New South Wales	Cashins, SD (corresponding author), James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia.	scashins@gmail.com	Skerratt, Lee Francis/L-2797-2013; Grogan, Laura F/G-4047-2015	Grogan, Laura F/0000-0002-2553-7598; McFadden, Michael/0000-0001-6811-8505; Skerratt, Lee/0000-0003-3471-7512; Berger, Lee/0000-0001-9227-5439; Hunter, David/0000-0002-7330-7500	Australian Department of Sustainability, Environment, Water, Population and Communities (SEWPaC); Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease (AB-CRC); Australian Research Council (ARC) Linkage Grant [LP110200240]; Taronga Conservation Society (TCS); New South Wales Office of Environment and Heritage; Wilson HTM Foundation; SITA Australia's	Australian Department of Sustainability, Environment, Water, Population and Communities (SEWPaC)(Australian Government); Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease (AB-CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Research Council (ARC) Linkage Grant(Australian Research Council); Taronga Conservation Society (TCS); New South Wales Office of Environment and Heritage; Wilson HTM Foundation; SITA Australia's	This work was jointly funded by the Australian Department of Sustainability, Environment, Water, Population and Communities (SEWPaC), the Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease (AB-CRC), Australian Research Council (ARC) Linkage Grant LP110200240, Taronga Conservation Society (TCS), New South Wales Office of Environment and Heritage and Wilson HTM Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge SITA Australia's funding to amphibian conservation which helped enable this research.	Agnandji ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018559; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Berger Lee, 2009, Amphibian Biology, V8, P2986; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Buck JC, 2011, BIODIVERS CONSERV, V20, P3549, DOI 10.1007/s10531-011-0147-4; Cassone A, 2008, LANCET INFECT DIS, V8, P114, DOI 10.1016/S1473-3099(08)70016-1; Chai LYA, 2009, INFECT IMMUN, V77, P2184, DOI 10.1128/IAI.01455-08; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; Garland S, 2009, DIS AQUAT ORGAN, P1; Hero J-M, 2011, IUCN 2011 IUCN RED L; Hunter DA, 2010, DIS AQUAT ORGAN, V92, P209, DOI 10.3354/dao02118; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kurtz J, 2007, ANIM CONSERV, V10, P422, DOI 10.1111/j.1469-1795.2007.00149.x; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lindenmayer D, 2010, CONSERV BIOL, V24, P1459, DOI 10.1111/j.1523-1739.2010.01544.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longcore JR, 2007, J WILDLIFE MANAGE, V71, P435, DOI 10.2193/2006-345; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Nichols D.K., 2000, P GETT JUMP AMPH DIS, P51; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Robbins AH, 1998, J AM VET MED ASSOC, V213, P1407; Rocke TE, 2008, J WILDLIFE DIS, V44, P1; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rollins-Smith Louise A, 2009, Front Biosci (Schol Ed), V1, P68; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soorae PS, 2010, GLOBAL REINTRODUCTIO, pxii; Stice MJ, 2010, J WILDLIFE DIS, V46, P70, DOI 10.7589/0090-3558-46.1.70; Stockwell M. P., 2008, Australian Zoologist, V34, P379; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; VIGGERS KL, 1993, WILDLIFE RES, V20, P687, DOI 10.1071/WR9930687; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Waters H, 2011, NAT MED, V17, P1329, DOI 10.1038/nm1111-1329b; White A.W., 2006, Herpetofauna (Sydney), V36, P93; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	53	50	50	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56747	10.1371/journal.pone.0056747	http://dx.doi.org/10.1371/journal.pone.0056747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451076	gold, Green Accepted, Green Published			2022-12-25	WOS:000316658800031
J	Jia, LF; Wei, SB; Gong, K; Gan, YH; Yu, GY				Jia, Ling-fei; Wei, Su-bi; Gong, Kai; Gan, Ye-hua; Yu, Guang-yan			Prognostic Implications of MicoRNA miR-195 Expression in Human Tongue Squamous Cell Carcinoma	PLOS ONE			English	Article							CHROMOSOME 11Q13 AMPLIFICATION; SUPPRESSES TUMORIGENICITY; HEPATOCELLULAR-CARCINOMA; GENE AMPLIFICATION; PROMOTES APOPTOSIS; BCL-2 EXPRESSION; POOR-PROGNOSIS; CYCLIN D1; MICRORNA; CANCER	Background: miR-195 is aberrantly expressed in multiple types of disease. But little is known about the dysregulation of miR-195 in tongue squamous cell carcinoma (TSCC). In this study, we investigated the roles of miR-195 in the development and progression of TSCC. Methods: Using quantitative reverse transcription-polymerase chain reaction (qRT-PCR), we evaluated miR-195 expression in TSCC samples from 81 patients. Overall survival of these patients was examined using Kaplan-Meier curves with log-rank tests and the Cox proportional hazards model. The expression of two known miR-195 target genes, Cyclin D1 and Bcl-2, was also examined in the TSCC samples by immunohistochemistry. The effects of miR-195 overexpression on cell cycle progression and apoptosis and its effects on the expression of Cyclin D1 and Bcl-2 were examined in transfected TSCC cell lines (SCC-15 and Cal27) using fluorescence-activated cell sorting assays, luciferase reporter assays, and Western blots. Results: Reduced miR-195 expression was associated with tumor size and the clinical stage of TSCC tumors. Kaplan-Meier survival analysis indicated that the TSCC patients with reduced expression of miR-195 had poor overall survival and in multivariable analyses low levels of miR-195 emerged as an independent prognostic factor for this clinical outcome. Levels of miR-195 expression were inversely correlated with the expression of Cyclin D1 and Bcl-2. Overexpression of miR-195 inhibited cell cycle progression, promoted apoptosis, and reduced Cyclin D1 and Bcl-2 expression in two TSCC cell lines. Conclusions: miR-195 may have potential applications as a prognostic factor for TSCC patients.	[Jia, Ling-fei; Yu, Guang-yan] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Wei, Su-bi] Tsinghua Univ, Med Syst Biol Res Ctr, Beijing 100084, Peoples R China; [Gong, Kai] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China; [Gan, Ye-hua] Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Tsinghua University; Tsinghua University; Peking University	Gan, YH (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	kqyehuagan@bjmu.edu.cn; gyyu@263.net						Avissar M, 2009, CLIN CANCER RES, V15, P2850, DOI 10.1158/1078-0432.CCR-08-3131; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell RB, 2007, J ORAL MAXIL SURG, V65, P229, DOI 10.1016/j.joms.2005.11.094; Bova RJ, 1999, CLIN CANCER RES, V5, P2810; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Coutinho-Camillo CM, 2010, HISTOPATHOLOGY, V57, P304, DOI 10.1111/j.1365-2559.2010.03621.x; Davidson BJ, 1996, HEAD NECK-J SCI SPEC, V18, P512, DOI 10.1002/(SICI)1097-0347(199611/12)18:6<512::AID-HED5>3.3.CO;2-7; de Vicente JC, 2006, J ORAL PATHOL MED, V35, P140; Edge SB, 2010, AJCC CANC STAGING MA; ELNAGGAR AK, 1995, CYTOMETRY, V21, P47, DOI 10.1002/cyto.990210110; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; He JF, 2011, J BIOCHEM MOL TOXIC, V25, P404, DOI 10.1002/jbt.20396; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jiang L, 2010, INT J CANCER, V127, P505, DOI 10.1002/ijc.25320; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; LEONARD JH, 1991, INT J CANCER, V48, P511, DOI 10.1002/ijc.2910480406; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li LJ, 2003, J CELL SCI, V116, P3687, DOI 10.1242/jcs.00644; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; MARX J, 1994, SCIENCE, V263, P319, DOI 10.1126/science.8278804; MEREDITH SD, 1995, ARCH OTOLARYNGOL, V121, P790; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Popovic B, 2007, ANN NY ACAD SCI, V1095, P19, DOI 10.1196/annals.1397.003; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shaw RJ, 2009, BRIT J ORAL MAX SURG, V47, P356, DOI 10.1016/j.bjoms.2008.09.017; Soon PSH, 2009, CLIN CANCER RES, V15, P7684, DOI 10.1158/1078-0432.CCR-09-1587; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; WILLIAMS ME, 1993, ARCH OTOLARYNGOL, V119, P1238; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu YW, 2010, J NEUROSCI, V30, P8710, DOI 10.1523/JNEUROSCI.6323-09.2010; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yao L, 1999, ORAL ONCOL, V35, P56, DOI 10.1016/S1368-8375(98)00055-4; Yuen APW, 2002, HEAD NECK-J SCI SPEC, V24, P513, DOI 10.1002/hed.10094; Yuen PW, 1998, AM J SURG, V175, P242, DOI 10.1016/S0002-9610(97)00282-1	47	53	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56634	10.1371/journal.pone.0056634	http://dx.doi.org/10.1371/journal.pone.0056634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451060	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800021
J	Wu, CC; Lin, YH; Lu, YC; Chen, PJ; Yang, WS; Hsu, CJ; Chen, PL				Wu, Chen-Chi; Lin, Yin-Hung; Lu, Ying-Chang; Chen, Pei-Jer; Yang, Wei-Shiung; Hsu, Chuan-Jen; Chen, Pei-Lung			Application of Massively Parallel Sequencing to Genetic Diagnosis in Multiplex Families with Idiopathic Sensorineural Hearing Impairment	PLOS ONE			English	Article							MYOSIN-VIIA GENE; ENLARGED VESTIBULAR AQUEDUCT; CONNEXIN-26 GJB2 GENE; PALMOPLANTAR KERATODERMA; MUTATION SPECTRUM; DEAFNESS GENES; CHILDREN; VARIANTS; PERFORMANCE; ANNOTATION	Despite the clinical utility of genetic diagnosis to address idiopathic sensorineural hearing impairment (SNHI), the current strategy for screening mutations via Sanger sequencing suffers from the limitation that only a limited number of DNA fragments associated with common deafness mutations can be genotyped. Consequently, a definitive genetic diagnosis cannot be achieved in many families with discernible family history. To investigate the diagnostic utility of massively parallel sequencing (MPS), we applied the MPS technique to 12 multiplex families with idiopathic SNHI in which common deafness mutations had previously been ruled out. NimbleGen sequence capture array was designed to target all protein coding sequences (CDSs) and 100 bp of the flanking sequence of 80 common deafness genes. We performed MPS on the Illumina HiSeq2000, and applied BWA, SAMtools, Picard, GATK, Variant Tools, ANNOVAR, and IGV for bioinformatics analyses. Initial data filtering with allele frequencies (<5% in the 1000 Genomes Project and 5400 NHLBI exomes) and PolyPhen2/SIFT scores (>0.95) prioritized 5 indels (insertions/deletions) and 36 missense variants in the 12 multiplex families. After further validation by Sanger sequencing, segregation pattern, and evolutionary conservation of amino acid residues, we identified 4 variants in 4 different genes, which might lead to SNHI in 4 families compatible with autosomal dominant inheritance. These included GJB2 p.R75Q, MYO7A p.T381M, KCNQ4 p.S680F, and MYH9 p.E1256K. Among them, KCNQ4 p.S680F and MYH9 p.E1256K were novel. In conclusion, MPS allows genetic diagnosis in multiplex families with idiopathic SNHI by detecting mutations in relatively uncommon deafness genes.	[Wu, Chen-Chi; Lin, Yin-Hung; Lu, Ying-Chang; Hsu, Chuan-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Wu, Chen-Chi; Yang, Wei-Shiung; Chen, Pei-Lung] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Lin, Yin-Hung] Natl Taiwan Univ, Coll Med, Grad Inst Mol Med, Taipei 10764, Taiwan; [Chen, Pei-Jer; Yang, Wei-Shiung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chen, Pei-Jer; Yang, Wei-Shiung; Chen, Pei-Lung] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Yang, Wei-Shiung; Chen, Pei-Lung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chen, Pei-Lung] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Hsu, CJ (corresponding author), Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan.	cjhsu@ntu.edu.tw; paylong@ntu.edu.tw	Chen, Pei-Lung/A-3520-2010	Chen, Pei-Lung/0000-0002-5640-3074; YANG, WEI-SHIUNG/0000-0001-5087-373X; Chen, Pei-Jer/0000-0001-8316-3785; WU, CHEN-CHI/0000-0002-5047-2204	National Health Research Institute [NHRI-EX101-10147PI]; National Science Council of the Executive Yuan of the Republic of China [NSC 100-2314-B-002-031-MY3]; National Taiwan University [UN1UN101-013]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council of the Executive Yuan of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This study was supported by research grants from the National Health Research Institute (NHRI-EX101-10147PI), National Science Council of the Executive Yuan of the Republic of China (NSC 100-2314-B-002-031-MY3), and National Taiwan University (UN1UN101-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Brownstein Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-245; Brownstein Z, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r89; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; De Keulenaer S, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-17; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Even-Ram S, 2007, CELL ADHES MIGR, V1, P152, DOI 10.4161/cam.1.3.5089; Feldmann D, 2005, AM J MED GENET A, V137A, P225, DOI 10.1002/ajmg.a.30765; Hamasaki K, 1997, BIOCHEMISTRY-US, V36, P12323, DOI 10.1021/bi970962r; HARRIS H, 1968, ANN NY ACAD SCI, V151, P232, DOI 10.1111/j.1749-6632.1968.tb11893.x; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hwa HL, 2003, GENET MED, V5, P161, DOI 10.1097/01.GIM.0000066796.11916.94; Janecke AR, 2001, HUM GENET, V108, P269, DOI 10.1007/s004390100484; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalwani AK, 2000, AM J HUM GENET, V67, P1121, DOI 10.1016/S0002-9297(07)62942-5; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322; Morgan JE, 2010, HUM MUTAT, V31, P484, DOI 10.1002/humu.21216; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Nie LP, 2008, CURR OPIN OTOLARYNGO, V16, P441, DOI 10.1097/MOO.0b013e32830f4aa3; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; San Lucas FA, 2012, BIOINFORMATICS, V28, P421, DOI 10.1093/bioinformatics/btr667; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Su MC, 2009, INT J PEDIATR OTORHI, V73, P811, DOI 10.1016/j.ijporl.2009.02.009; Tang WX, 2012, GENET TEST MOL BIOMA, V16, P536, DOI 10.1089/gtmb.2011.0187; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Uyguner O, 2002, CLIN GENET, V62, P306, DOI 10.1034/j.1399-0004.2002.620409.x; Van Eyken E, 2007, OTOL NEUROTOL, V28, P970; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu CC, 2005, LARYNGOSCOPE, V115, P132, DOI 10.1097/01.mlg.0000150691.85387.3f; Wu CC, 2008, AUDIOL NEURO-OTOL, V13, P172, DOI 10.1159/000112425; Wu CC, 2008, ARCH PEDIAT ADOL MED, V162, P269, DOI 10.1001/archpediatrics.2007.59; Wu CC, 2011, LARYNGOSCOPE, V121, P1287, DOI 10.1002/lary.21751; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P311, DOI 10.1159/000284349; Wu CC, 2009, LARYNGOSCOPE, V119, P2411, DOI 10.1002/lary.20621; Yang JJ, 2010, HUM GENET, V128, P303, DOI 10.1007/s00439-010-0856-x	51	46	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57369	10.1371/journal.pone.0057369	http://dx.doi.org/10.1371/journal.pone.0057369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451214	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800103
J	Ye, RS; Xi, QY; Qi, Q; Cheng, X; Chen, T; Li, HY; Kallon, S; Shu, G; Wang, SB; Jiang, QY; Zhang, YL				Ye, Rui-Song; Xi, Qian-Yun; Qi, Qien; Cheng, Xiao; Chen, Ting; Li, Hongyi; Kallon, Sanpha; Shu, Gang; Wang, Song-Bo; Jiang, Qing-Yan; Zhang, Yong-Liang			Differentially Expressed miRNAs after GnRH Treatment and Their Potential Roles in FSH Regulation in Porcine Anterior Pituitary Cell	PLOS ONE			English	Article							GONADOTROPIN SUBUNIT; MICRORNA EXPRESSION; PULSE FREQUENCY; DOWN-REGULATION; LH-SECRETION; HORMONE; RECEPTOR; GROWTH; TRANSCRIPTION; STIMULATION	Hypothalamic gonadotropin-releasing hormone (GnRH) is a major regulator of follicle-stimulating hormone (FSH) secretion in gonadotrope cell in the anterior pituitary gland. microRNAs (miRNAs) are small RNA molecules that control gene expression by imperfect binding to the 3'-untranslated region (3'-UTR) of mRNA at the post-transcriptional level. It has been proven that miRNAs play an important role in hormone response and/or regulation. However, little is known about miRNAs in the regulation of FSH secretion. In this study, primary anterior pituitary cells were treated with 100 nM GnRH. The supernatant of pituitary cell was collected for FSH determination by enzyme-linked immunosorbent assay (ELISA) at 3 hours and 6 hours post GnRH treatment respectively. Results revealed that GnRH significantly promoted FSH secretion at 3 h and 6 h post-treatment by 1.40-fold and 1.80-fold, respectively. FSH beta mRNA at 6 h post GnRH treatment significantly increased by 1.60-fold. At 6 hours, cells were collected for miRNA expression profile analysis using MiRCURY LNA Array and quantitative PCR (qPCR). Consequently, 21 up-regulated and 10 down-regulated miRNAs were identified, and qPCR verification of 10 randomly selected miRNAs showed a strong correlation with microarray results. Chromosome location analysis indicated that 8 miRNAs were mapped to chromosome 12 and 4 miRNAs to chromosome X. Target and pathway analysis showed that some miRNAs may be associated with GnRH regulation pathways. In addition, In-depth analysis indicated that 10 up-regulated and 3 down-regulated miRNAs probably target FSHb mRNA 3'-UTR directly, including miR-361-3p, a highly conserved X-linked miRNA. Most importantly, functional experimental results showed that miR-361-3p was involved in FSH secretion regulation, and up-regulated miR-361-3p expression inhibited FSH secretion, while down-regulated miR-361-3p expression promoted FSH secretion in pig pituitary cell model. These differentially expressed miRNAs resolved in this study provide the first guide for post-transcriptional regulation of pituitary gonadotrope FSH secretion in pig, as well as in other mammals.	[Ye, Rui-Song; Xi, Qian-Yun; Qi, Qien; Cheng, Xiao; Chen, Ting; Li, Hongyi; Kallon, Sanpha; Shu, Gang; Wang, Song-Bo; Jiang, Qing-Yan; Zhang, Yong-Liang] South China Agr Univ, Coll Anim Sci, Guandong Prov Key Lab Agroanim Genom & Mol Breedi, Guangzhou, Guangdong, Peoples R China; [Li, Hongyi] Longyan Univ, Sch Life Sci, Longyan, Peoples R China	South China Agricultural University; Longyan University	Zhang, YL (corresponding author), South China Agr Univ, Coll Anim Sci, Guandong Prov Key Lab Agroanim Genom & Mol Breedi, Guangzhou, Guangdong, Peoples R China.	zhangyl@scau.edu.cn	Ye, Ruisong/ABH-3897-2020; Ye, Ruisong/AAL-8956-2020	Ye, Ruisong/0000-0002-7970-1015	National 973 Project of China [2011CB944200]; National Natural Science Foundation of China [31272529]	National 973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work were supported by National 973 Project of China (2011CB944200) and National Natural Science Foundation of China (31272529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa S, 2004, BIOCHEM BIOPH RES CO, V324, P946, DOI 10.1016/j.bbrc.2004.09.124; Aroua S, 2012, GEN COMP ENDOCR, V175, P82, DOI 10.1016/j.ygcen.2011.10.002; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; BARB CR, 1990, J REPROD FERTIL, V90, P213, DOI 10.1530/jrf.0.0900213; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cook T, 2000, Oncologist, V5, P162, DOI 10.1634/theoncologist.5-2-162; Curry E, 2009, MOL REPROD DEV, V76, DOI 10.1002/mrd.20980; Curry E, 2011, THERIOGENOLOGY; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Kaiser UB, 1997, ENDOCRINOLOGY, V138, P1224, DOI 10.1210/en.138.3.1224; Kakar SS, 1997, ANTI-CANCER DRUG, V8, P369, DOI 10.1097/00001813-199704000-00009; Keller A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-290; Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9; Lau Man-Tat, 2012, Front Endocrinol (Lausanne), V3, P47, DOI 10.3389/fendo.2012.00047; Lee HJ, 2006, P NATL ACAD SCI USA, V103, P15669, DOI 10.1073/pnas.0605781103; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024883; Li MZ, 2011, INT J BIOL SCI, V7, P1045, DOI 10.7150/ijbs.7.1045; Lin J, 2003, DOMEST ANIM ENDOCRIN, V24, P95, DOI 10.1016/S0739-7240(02)00209-6; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Lionetti M, 2009, BLOOD, V114, pE20, DOI 10.1182/blood-2009-08-237495; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Miles LEC, 2004, ENDOCRINOLOGY, V145, P194, DOI 10.1210/en.2003-0551; Naor Z, 2000, TRENDS ENDOCRIN MET, V11, P91, DOI 10.1016/S1043-2760(99)00232-5; Nemoto T, 2012, AM J PHYSIOL-ENDOC M, V302, pE781, DOI 10.1152/ajpendo.00616.2011; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ogura K, 2001, EUR J ENDOCRINOL, V144, P653, DOI 10.1530/eje.0.1440653; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roth C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038248; Schotte D, 2011, LEUKEMIA, V25, P1389, DOI 10.1038/leu.2011.105; Stanislaus D, 1998, MOL CELL ENDOCRINOL, V144, P1, DOI 10.1016/S0303-7207(98)00126-9; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Thompson I, 2012, END ABSTR, V28, pP257; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wu S, 2011, J NEUROSCI, V31, P184, DOI 10.1523/JNEUROSCI.2974-10.2011; Yao N, 2010, ENDOCRINE, V38, P158, DOI 10.1007/s12020-010-9345-1; Yuen T, 2009, MOL CELL ENDOCRINOL, V302, P12, DOI 10.1016/j.mce.2008.12.013; Zhang L, 2009, DEVELOPMENT, V136, P3043, DOI 10.1242/dev.039008; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x	49	45	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57156	10.1371/journal.pone.0057156	http://dx.doi.org/10.1371/journal.pone.0057156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451171	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800082
J	Wu, CW; Dong, YJ; Liang, QY; He, XQ; Ng, SSM; Chan, FKL; Sung, JJY; Yu, J				Wu, Chung-Wah; Dong, Yu-Juan; Liang, Qiao-Yi; He, Xin-Qi; Ng, Simon S. M.; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun			MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer	PLOS ONE			English	Article							MIR-17-92 CLUSTER; ATM; 5-FLUOROURACIL	Background: miR-18a is one of the most up-regulated miRNAs in colorectal cancers (CRC) based on miRNA profiling. In this study, we examined the functional significance of miR-18a in CRC. Methods: Expression of miR-18a was investigated in 45 CRC patients. Potential target genes of miR-18a were predicted by in silico search and confirmed by luciferase activity assay and Western blot. DNA damage was measured by comet assay. Gene function was measured by cell viability, colony formation and apoptosis assays. Results: The up-regulation of miR-18a was validated and confirmed in 45 primary CRC tumors compared with adjacent normal tissues (p<0.0001). Through in silico search, the 3'UTR of Ataxia telangiectasia mutated (ATM) contains a conserved miR-18a binding site. Expression of ATM was down-regulated in CRC tumors (p<0.0001) and inversely correlated with miR-18a expression (r = -0.4562, p<0.01). Over-expression of miR-18a in colon cancer cells significantly reduced the luciferase activity of the construct with wild-type ATM 39UTR but not that with mutant ATM 39UTR, inferring a direct interaction of miR-18a with ATM 39UTR. This was further confirmed by the down-regulation of ATM protein by miR-18a. As ATM is a key enzyme in DNA damage repair, we evaluated the effect of miR-18a on DNA double-strand breaks. Ectopic expression of miR-18a significantly inhibited the repair of DNA damage induced by etoposide (p<0.001), leading to accumulation of DNA damage, increase in cell apoptosis and poor clonogenic survival. Conclusion: miR-18a attenuates cellular repair of DNA double-strand breaks by directly suppressing ATM, a key enzyme in DNA damage repair.	[Wu, Chung-Wah; Liang, Qiao-Yi; He, Xin-Qi; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wu, Chung-Wah; Liang, Qiao-Yi; He, Xin-Qi; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, Chung-Wah; Liang, Qiao-Yi; Chan, Francis K. L.; Sung, Joseph J. Y.; Yu, Jun] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Shenzhen, Peoples R China; [Dong, Yu-Juan; Ng, Simon S. M.] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [He, Xin-Qi] Hebei Med Univ, Affiliated Hosp 1, Dept Surg, Shijiazhuang, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong; Hebei Medical University	Yu, J (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Chan, Francis K. L./F-4851-2010; Dong, Yujuan/AAS-3467-2021; Sung, Joseph J. Y./R-3203-2018; Ng, Simon S. M./M-1219-2018; Liang, Qiaoyi Jessie/G-9612-2019; Yu, Jun/D-8569-2015	Chan, Francis K. L./0000-0001-7388-2436; Sung, Joseph J. Y./0000-0003-3125-5199; Ng, Simon S. M./0000-0002-5389-9297; Liang, Qiaoyi Jessie/0000-0001-8496-3442; Yu, Jun/0000-0001-5008-2153	National Natural Science Foundation of China (NSFC) [81101488]; China 863 program [2012AA02A506]; Hong Kong ITF fund [ITS/276/11]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China 863 program(National High Technology Research and Development Program of China); Hong Kong ITF fund	This project was supported by a National Natural Science Foundation of China (NSFC) (Project code 81101488), a China 863 program (2012AA02A506) and Hong Kong ITF fund (ITS/276/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamsen BL, 2011, INT J ONCOL, V39, P673, DOI 10.3892/ijo.2011.1080; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bandres E, 2007, ORAL ONCOL, V43, P713, DOI 10.1016/j.oraloncology.2006.09.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BODER E, 1958, PEDIATRICS, V21, P526; Brennecke J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-228; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huehls AM, 2011, CANCER RES, V71, P4944, DOI 10.1158/0008-5472.CAN-11-0814; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kastan MB, 2000, COLD SPRING HARB SYM, V65, P521, DOI 10.1101/sqb.2000.65.521; Kim WJ, 2002, ONCOGENE, V21, P3864, DOI 10.1038/sj.onc.1205485; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Roossink F, 2012, INT J CANCER, V131, P2056, DOI 10.1002/ijc.27488; SONG BJ, 1987, MOL ENDOCRINOL, V1, P542, DOI 10.1210/mend-1-8-542; Tamakawa RA, 2010, CANCER RES, V70, P8684, DOI 10.1158/0008-5472.CAN-10-2227; Tao J, 2012, MOL MED REP, V5, P167, DOI 10.3892/mmr.2011.591; Wang CL, 2006, P NATL ACAD SCI USA, V103, P18680, DOI 10.1073/pnas.0609030103; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Wu CW, 2011, GASTROENTEROLOGY, V140, pS73	32	81	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57036	10.1371/journal.pone.0057036	http://dx.doi.org/10.1371/journal.pone.0057036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437304	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000069
J	He, B; Osterholm, AM; Ojala, JRM; Andersson, AC; Tryggvason, K				He, Bing; Osterholm, Anne-May; Ojala, Juha R. M.; Andersson, Ann-Charlotte; Tryggvason, Karl			A Remote Cis-Acting Variant at 3q Links Glomerular NCK1 to Diabetic Nephropathy	PLOS ONE			English	Article							KIDNEY DEVELOPMENT; CHROMOSOME 3Q; CELL BIOLOGY; ZEBRAFISH; PODOCYTE; NEPHRIN; DISEASE; GENES; LOCUS; RISK	We have previously reported genetic association of a single nucleotide polymorphism (SNP), rs1866813, at 3q locus with increased risk of diabetic nephropathy (DN). The SNP is located approximately 70 kb downstream of a cluster of four genes. This raises a question how the remote noncoding polymorphism affects the risk of DN. In this study, we tested a long-range regulatory potential of this variant by a series of experiments. In a luciferase assay, two alleles of the SNP showed differential effects on the luciferase activity in transfected cells in vitro. Using transgenic zebrafish, we further demonstrated in vivo that two alleles of the SNP differentially regulated GFP expression in zebrafish podocytes. Immunofluorescence staining and Western blotting verified that only Nck1 of the four nearby genes was predominantly expressed in mouse glomeruli as well as in podocytes. Furthermore, genotypes of the SNP rs1866813 were correlated with NCK1 expression in immortalized lymphocytes from diabetic patients. The risk allele was associated with increased NCK1 expression compared to the non-risk allele, consistent with the results of the reporter-based studies. Interestingly, differential expression of glomerular Nck1 between mouse strains carrying the nephropathy-prone 129/Sv allele and nephropathy-resistant C57BL/6 allele was also observed. Our results show that the DN-associated SNP rs1866813 is a remote cis-acting variant differentially regulating glomerular NCK1 expression. This finding implicates an important role for glomerular NCK1 in DN pathogenesis under hyperglycemia.	[He, Bing; Osterholm, Anne-May; Ojala, Juha R. M.; Andersson, Ann-Charlotte; Tryggvason, Karl] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden	Karolinska Institutet	Tryggvason, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, Stockholm, Sweden.	karl.tryggvason@ki.se		Ojala, Juha/0000-0003-2018-6124	Foundation of Knut and Alice Wallenberg; Foundation of Soderberg; Foundation of Hedlund; Swedish Medical Research Council; Swedish Foundation for Strategic Research	Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Soderberg; Foundation of Hedlund; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported in part by grants from Foundations of Knut and Alice Wallenberg (http://www.wallenberg.com), Soderberg (http://www.ragnarsoderbergsstiftelse.se) Hedlund (http://www.hedlundsstiftelse.se), the Swedish Medical Research Council (http://www.vr.se) and the Swedish Foundation for Strategic Research (http://www.stratresearch.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bowden DW, 2004, KIDNEY INT, V66, P1517, DOI 10.1111/j.1523-1755.2004.00915.x; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Carramolino L, 1997, GENE, V195, P151, DOI 10.1016/S0378-1119(97)00121-2; Conway BR, 2009, NEPHRON CLIN PRACT, V112, pC213, DOI 10.1159/000224787; Drummond IA, 2000, PEDIATR NEPHROL, V14, P428, DOI 10.1007/s004670050788; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; He B, 2009, AM J HUM GENET, V84, P5, DOI 10.1016/j.ajhg.2008.11.012; He B, 2011, J AM SOC NEPHROL, V22, P1019, DOI 10.1681/ASN.2010121291; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Ma LJ, 2003, KIDNEY INT, V64, P350, DOI 10.1046/j.1523-1755.2003.00058.x; Moczulski DK, 1998, DIABETES, V47, P1164, DOI 10.2337/diabetes.47.7.1164; Molitch ME, 2003, DIABETES CARE, V26, P2702, DOI 10.2337/diacare.26.9.2702; Mooyaart AL, 2011, DIABETOLOGIA, V54, P544, DOI 10.1007/s00125-010-1996-1; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Osterholm AM, 2007, KIDNEY INT, V71, P140, DOI 10.1038/sj.ki.5001933; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1717, DOI 10.1681/ASN.2012030252; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Vidal C, 2011, J MOL ENDOCRINOL, V47, P327, DOI 10.1530/JME-11-0067; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; White KE, 2006, DIABETIC MED, V23, P715, DOI 10.1111/j.1464-5491.2006.01790.x; Wolf G, 2007, NEPHRON PHYSIOL, V106, P26, DOI 10.1159/000101797	36	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56414	10.1371/journal.pone.0056414	http://dx.doi.org/10.1371/journal.pone.0056414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441190	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200047
J	Levin, E; Roll, U; Dolev, A; Yom-Tov, Y; Kronfeld-Shcor, N				Levin, Eran; Roll, Uri; Dolev, Amit; Yom-Tov, Yoram; Kronfeld-Shcor, Noga			Bats of a Gender Flock Together: Sexual Segregation in a Subtropical Bat	PLOS ONE			English	Article							HABITAT USE; THERMOREGULATION; HYPOTHESES; DIMORPHISM; SOCIALITY; SELECTION; SIZE	Competition has long been assumed to be a major driver in regulating ecological communities. Intra-specific competition is considered to be maximal as members of the same species use the same ecological niches in a similar way. Many species of animals exhibit great physiological, behavioral, and morphological differences between sexes (sexual dimorphism). Here we report an extreme geographical segregation between the sexes in the greater mouse-tailed bat (Rhinopoma microphyllum). To gain insight into the driving mechanisms of sexual segregation outside the mating season, we collected and integrated environmental, behavioral, physiological, and spatial information. We found that both sexes choose roosts with similar characteristics and the same food type, but use different habitats for different durations. Males forage around cliffs at higher and cooler elevations while females forage in lowlands around a river delta. We suggest that it is their different physiological and social needs, and not competition, that drives sexual segregation in this species.	[Levin, Eran; Roll, Uri; Yom-Tov, Yoram; Kronfeld-Shcor, Noga] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Dolev, Amit] INPA, Megido, Israel	Tel Aviv University	Levin, E (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	levineran1@gmail.com	Levin, Eran/GPF-5345-2022; Roll, Uri/AAE-7137-2019	Levin, Eran/0000-0002-9972-7028; Roll, Uri/0000-0002-5418-1164	Israel Science Foundation [232/08]; Adams Fellowship Program of the Israel Academy of Sciences and Humanities	Israel Science Foundation(Israel Science Foundation); Adams Fellowship Program of the Israel Academy of Sciences and Humanities	This research was supported by The Israel Science Foundation (grant No. 232/08). UR is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham John D., 2005, P280; Amichai E, 2012, MAMMALIAN BIOL; [Anonymous], 1999, WALKERS MAMMALS WORL; BEIER P, 1987, J MAMMAL, V68, P323, DOI 10.2307/1381471; Bowyer RT, 2004, J MAMMAL, V85, P1039, DOI 10.1644/BBL-002.1; BRADBURY JW, 1977, BEHAV ECOL SOCIOBIOL, V2, P1, DOI 10.1007/BF00299284; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Cryan PM, 2000, J MAMMAL, V81, P719, DOI 10.1644/1545-1542(2000)081<0719:EOEODO>2.3.CO;2; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Darwin C., 1859, ORIGIN SPECIES MEANS; DAYAN T, 1989, ECOLOGY, V70, P1526, DOI 10.2307/1938210; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Encarnacao JA, 2012, J ETHOL, V30, P271, DOI 10.1007/s10164-011-0323-8; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Gillam EH, 2007, CAN J ZOOL, V85, P795, DOI 10.1139/Z07-060; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillen J, 2011, ANN ZOOL FENN, V48, P180, DOI 10.5735/086.048.0306; Humphries MM, 2011, INTEGR COMP BIOL, V51, P419, DOI 10.1093/icb/icr059; Jenkins EV, 1998, ANIM BEHAV, V56, P909, DOI 10.1006/anbe.1998.0858; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kaciuba-Uscilko H, 2001, CURR OPIN CLIN NUTR, V4, P533, DOI 10.1097/00075197-200111000-00012; KALCOUNIS MC, 1995, CAN J ZOOL, V73, P89, DOI 10.1139/z95-011; Kazial KA, 2008, ETHOLOGY, V114, P469, DOI 10.1111/j.1439-0310.2008.01483.x; Komar O, 2005, AUK, V122, P938, DOI 10.1642/0004-8038(2005)122[0938:EOLSSA]2.0.CO;2; Kunz TH, 2003, BAT ECOLOGY, P3; Levin E, 2012, J COMP PHYSIOL B, P1; Levin Eran, 2012, P167; Levin E, 2008, ACTA CHIROPTEROL, V10, P207, DOI 10.3161/150811008X414791; Levin E, 2009, NATURWISSENSCHAFTEN, V96, P477, DOI 10.1007/s00114-008-0496-3; Main MB, 1996, J MAMMAL, V77, P449, DOI 10.2307/1382821; Martinez JJI, 2008, VIE MILIEU, V58, P233; Ruckstuhl KE, 2007, INTEGR COMP BIOL, V47, P245, DOI 10.1093/icb/icm030; Ruckstuhl KE, 2002, ANIM BEHAV, V64, P909, DOI 10.1006/anbe.2002.2015; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Safi K, 2007, BIOL CONSERV, V137, P28, DOI 10.1016/j.biocon.2007.01.011; Safi K, 2008, J MAMMAL, V89, P1342, DOI 10.1644/08-MAMM-S-058.1; Schlitter Duane A., 1996, Mammalian Species, V0, P1; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Terrien J, 2010, PHYSIOL BEHAV, V101, P469, DOI 10.1016/j.physbeh.2010.07.012; Wallace AR, 1889, DARWINISM; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	46	28	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e54987	10.1371/journal.pone.0054987	http://dx.doi.org/10.1371/journal.pone.0054987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441148	Green Published, gold			2022-12-25	WOS:000315159200006
J	Maruyama, T; Miyamoto, Y; Yamamoto, G; Yamada, A; Yoshimura, K; Suzawa, T; Takami, M; Akiyama, T; Hoshino, M; Iwasa, F; Ikumi, N; Tachikawa, T; Mishima, K; Baba, K; Kamijo, R				Maruyama, Toshifumi; Miyamoto, Yoichi; Yamamoto, Gou; Yamada, Atsushi; Yoshimura, Kentaro; Suzawa, Tetsuo; Takami, Masamichi; Akiyama, Tomohito; Hoshino, Marie; Iwasa, Fuminori; Ikumi, Noriharu; Tachikawa, Tetsuhiko; Mishima, Kenji; Baba, Kazuyoshi; Kamijo, Ryutaro			Downregulation of Carbonic Anhydrase IX Promotes Col10a1 Expression in Chondrocytes	PLOS ONE			English	Article							PROTEIN-KINASE-II; CADHERIN-MEDIATED ADHESION; HYPERTROPHIC DIFFERENTIATION; HYPOXIA; CELLS; GROWTH; SOX9; INHIBITION; CARTILAGE; HYPOXIA-INDUCIBLE-FACTOR-2-ALPHA	Carbonic anhydrase (CA) IX is a transmembrane isozyme of CAs that catalyzes reversible hydration of CO2. While it is known that CA IX is distributed in human embryonic chondrocytes, its role in chondrocyte differentiation has not been reported. In the present study, we found that Car9 mRNA and CA IX were expressed in proliferating but not hypertrophic chondrocytes. Next, we examined the role of CA IX in the expression of marker genes of chondrocyte differentiation in vitro. Introduction of Car9 siRNA to mouse primary chondrocytes obtained from costal cartilage induced the mRNA expressions of Col10a1, the gene for type X collagen alpha-1 chain, and Epas1, the gene for hypoxia-responsible factor-2 alpha (HIF-2 alpha), both of which are known to be characteristically expressed in hypertrophic chondrocytes. On the other hand, forced expression of CA IX had no effect of the proliferation of chondrocytes or the transcription of Col10a1 and Epas1, while the transcription of Col2a1 and Acan were up-regulated. Although HIF-2 alpha has been reported to be a potent activator of Col10a1 transcription, Epas1 siRNA did not suppress Car9 siRNA-induced increment in Col10a1 expression, indicating that down-regulation of CA IX induces the expression of Col10a1 in chondrocytes in a HIF-2 alpha-independent manner. On the other hand, cellular cAMP content was lowered by Car9 siRNA. Furthermore, the expression of Col10a1 mRNA after Car9 silencing was augmented by an inhibitor of protein kinase A, and suppressed by an inhibitor for phosphodiesterase as well as a brominated analog of cAMP. While these results suggest a possible involvement of cAMP-dependent pathway, at least in part, in induction of Col10a1 expression by down-regulation of Car9, more detailed study is required to clarify the role of CA IX in regulation of Col10a1 expression in chondrocytes.	[Maruyama, Toshifumi; Miyamoto, Yoichi; Yamada, Atsushi; Yoshimura, Kentaro; Suzawa, Tetsuo; Takami, Masamichi; Akiyama, Tomohito; Hoshino, Marie; Ikumi, Noriharu; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa, Tokyo, Japan; [Maruyama, Toshifumi; Akiyama, Tomohito; Hoshino, Marie; Iwasa, Fuminori; Baba, Kazuyoshi] Showa Univ, Sch Dent, Dept Prosthodont, Shinagawa, Tokyo, Japan; [Yamamoto, Gou; Tachikawa, Tetsuhiko; Mishima, Kenji] Showa Univ, Sch Dent, Dept Oral Diagnost Sci, Div Pathol, Shinagawa, Tokyo, Japan	Showa University; Showa University; Showa University	Miyamoto, Y (corresponding author), Showa Univ, Sch Dent, Dept Biochem, Shinagawa, Tokyo, Japan.	yoichim@dent.showa-u.jp	Baba, Kazuyoshi/AAY-2304-2021	Takami, Masamichi/0000-0002-4506-3975; Baba, Kazuyoshi/0000-0001-8025-2168	Japan Society for the Promotion of Science; Project to Establish Strategic Research Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24659830, 24592813, 23592718] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Project to Establish Strategic Research Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science, and the Project to Establish Strategic Research Center for Innovative Dentistry by Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alterio V, 2009, P NATL ACAD SCI USA, V106, P16233, DOI 10.1073/pnas.0908301106; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Araldi E, 2010, BONE, V47, P190, DOI 10.1016/j.bone.2010.04.606; Bursell L, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2308; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Chiche J, 2010, ADV ENZYME REGUL, V50, P20, DOI 10.1016/j.advenzreg.2009.10.005; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Chung UI, 2004, ENDOCR J, V51, P19, DOI 10.1507/endocrj.51.19; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; Hilvo M, 2004, J HISTOCHEM CYTOCHEM, V52, P1313, DOI 10.1369/jhc.3A6225.2004; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Liao SY, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-22; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Miyazawa T, 2002, ENDOCRINOLOGY, V143, P3604, DOI 10.1210/en.2002-220307; R Core Team, 2012, R LANG ENV STAT COMP; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Sato M, 2002, AM J RESP CELL MOL, V26, P127, DOI 10.1165/ajrcmb.26.1.4319; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Schipani E, 2001, GENE DEV, V15, P2865; Stewart AJ, 2006, J CELL PHYSIOL, V206, P435, DOI 10.1002/jcp.20481; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Thiry A, 2008, J MED CHEM, V51, P3051, DOI 10.1021/jm701526d; Tintut Y, 1999, J BIOL CHEM, V274, P28875, DOI 10.1074/jbc.274.41.28875; Wang XG, 2010, J CELL PHYSIOL, V225, P709, DOI 10.1002/jcp.22267; Wang YP, 2008, MOL CANCER THER, V7, P3867, DOI 10.1158/1535-7163.MCT-08-0603; Wykoff CC, 2000, CANCER RES, V60, P7075; Yoshimura K, 2011, J BIOL CHEM, V286, P14744, DOI 10.1074/jbc.M111.221259; Zavada J, 2000, BRIT J CANCER, V82, P1808, DOI 10.1054/bjoc.2000.1111	40	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56984	10.1371/journal.pone.0056984	http://dx.doi.org/10.1371/journal.pone.0056984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441228	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200085
J	van Beuge, MM; Prakash, J; Lacombe, M; Post, E; Reker-Smit, C; Beljaars, L; Poelstra, K				van Beuge, Marike Marjolijn; Prakash, Jai; Lacombe, Marie; Post, Eduard; Reker-Smit, Catharina; Beljaars, Leonie; Poelstra, Klaas			Enhanced Effectivity of an ALK5-Inhibitor after Cell-Specific Delivery to Hepatic Stellate Cells in Mice with Liver Injury	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; MANNOSE 6-PHOSPHATE; SELECTIVE DELIVERY; KINASE INHIBITOR; RAT; RECEPTOR; ACTIVATION; FIBROSIS; ALK5	Transforming growth factor-beta (TGF-beta) is a major pro-fibrotic cytokine, causing the overproduction of extracellular matrix molecules in many fibrotic diseases. Inhibition of its type-I receptor (ALK5) has been shown to effectively inhibit fibrosis in animal models. However, apart from its pro-fibrotic effects, TGF-beta also has a regulatory role in the immune system and influences tumorigenesis, which limits the use of inhibitors. We therefore explored the cell-specific delivery of an ALK5-inhibitor to hepatic stellate cells, a key cell in the development of liver fibrosis. We synthesized a conjugate of the ALK5-inhibitor LY-364947 coupled to mannose-6-phosphate human serum albumin (M6PHSA), which binds to the insulin-like growth factor II receptor on activated HSC. The effectivity of the conjugate was evaluated in primary HSC and in an acute liver injury model in mice. In vitro, the free drug and the conjugate significantly inhibited fibrotic markers in HSC. In hepatocytes, TGF-beta-dependent signaling was inhibited by free drug, but not by the conjugate, thus showing its cell-specificity. In vivo, the conjugate localized in desmin-positive cells in the liver and not in hepatocytes or immune cells. In the acute liver injury model in mice, the conjugate reduced fibrogenic markers and collagen deposition more effectively than free drug. We conclude that we can specifically deliver an ALK5-inhibitor to HSC using the M6PHSA carrier and that this targeted drug reduces fibrogenic parameters in vivo, without affecting other cell-types.	[van Beuge, Marike Marjolijn; Prakash, Jai; Post, Eduard; Reker-Smit, Catharina; Beljaars, Leonie; Poelstra, Klaas] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands; [Lacombe, Marie] Kreatech Diagnost, Amsterdam, Netherlands	University of Groningen	van Beuge, MM (corresponding author), Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, NL-9713 AV Groningen, Netherlands.	m.m.van.beuge@rug.nl	Prakash, Jai/C-8015-2014	Prakash, Jai/0000-0003-1050-650X; Post, Eduard/0000-0001-5885-0081; Beljaars, Leonie/0000-0003-3659-1896	European Framework program FP6 [LSHB-CT-2007-036644]	European Framework program FP6(European Commission)	This work was made possible by a grant from the European Framework program FP6 (LSHB-CT-2007-036644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton MJ, 2011, TOXICOL PATHOL, V39, P916, DOI 10.1177/0192623311416259; Arribillaga L, 2011, CYTOKINE, V53, P327, DOI 10.1016/j.cyto.2010.11.019; Beljaars L, 1999, HEPATOLOGY, V29, P1486, DOI 10.1002/hep.510290526; Beljaars L, 2001, LIVER, V21, P320, DOI 10.1034/j.1600-0676.2001.210504.x; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; de Gouville AC, 2006, DRUG NEWS PERSPECT, V19, P85, DOI 10.1358/dnp.2006.19.2.977444; DEBLESER PJ, 1995, HEPATOLOGY, V21, P1429, DOI 10.1016/0270-9139(95)90066-7; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dooley S, 2009, DIGEST DIS, V27, P93, DOI 10.1159/000218340; Fu K, 2008, ARTERIOSCL THROM VAS, V28, P665, DOI 10.1161/ATVBAHA.107.158030; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Greupink R, 2006, PHARM RES-DORDR, V23, P1827, DOI 10.1007/s11095-006-9025-2; Hageman J, 2005, CLIN CANCER RES, V11, P5956, DOI 10.1158/1078-0432.CCR-05-0427; Higashiyama H, 2007, EXP MOL PATHOL, V83, P39, DOI 10.1016/j.yexmp.2006.12.003; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Lahn M, 2005, EXPERT OPIN INV DRUG, V14, P629, DOI 10.1517/13543784.14.6.629; Laping NJ, 2007, CLIN CANCER RES, V13, P3087, DOI 10.1158/1078-0432.CCR-06-1811; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Ling L, 2011, CURR PHARM BIOTECHNO, V12, P2202; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Prakash J, 2008, PHARM RES-DORDR, V25, P2427, DOI 10.1007/s11095-007-9515-x; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Sedlaczek N, 2001, AM J PATHOL, V158, P1239, DOI 10.1016/S0002-9440(10)64074-6; Sherman M, 2010, DIGEST LIVER DIS, V42, pS215, DOI 10.1016/S1590-8658(10)60508-7; van Beuge MM, 2011, PHARM RES-DORDR, V28, P2045, DOI 10.1007/s11095-011-0430-9; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	30	22	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56442	10.1371/journal.pone.0056442	http://dx.doi.org/10.1371/journal.pone.0056442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441194	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200051
J	Curt, JR; de Navas, LF; Sanchez-Herrero, E				Curt, Jesus R.; de Navas, Luis F.; Sanchez-Herrero, Ernesto			Differential Activity of Drosophila Hox Genes Induces Myosin Expression and Can Maintain Compartment Boundaries	PLOS ONE			English	Article							ULTRABITHORAX PROTEINS; LINEAGE RESTRICTION; AFFINITY BOUNDARY; BITHORAX COMPLEX; NOTCH; MUTANTS; DORSAL; SEGMENTATION; MAINTENANCE; POLARITY	Compartments are units of cell lineage that subdivide territories with different developmental potential. In Drosophila, the wing and haltere discs are subdivided into anterior and posterior (A/P) compartments, which require the activity of Hedgehog, and into dorsal and ventral (D/V) compartments, needing Notch signaling. There is enrichment in actomyosin proteins at the compartment boundaries, suggesting a role for these proteins in their maintenance. Compartments also develop in the mouse hindbrain rhombomeres, which are characterized by the expression of different Hox genes, a group of genes specifying different structures along their main axis of bilaterians. We show here that the Drosophila Hox gene Ultrabithorax can maintain the A/P and D/V compartment boundaries when Hedgehog or Notch signaling is compromised, and that the interaction of cells with and without Ultrabithorax expression induces high levels of non-muscle myosin II. In the absence of Ultrabithorax there is occasional mixing of cells from different segments. We also show a similar role in cell segregation for the Abdominal-B Hox gene. Our results suggest that the juxtaposition of cells with different Hox gene expression leads to their sorting out, probably through the accumulation of non-muscle myosin II at the boundary of the different cell territories. The increase in myosin expression seems to be a general mechanism used by Hox genes or signaling pathways to maintain the segregation of different groups of cells.	[Sanchez-Herrero, Ernesto] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Sanchez-Herrero, E (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	esherrero@cbm.uam.es	Sánchez-Herrero, Ernesto/ABE-3595-2020	Rodriguez Curt, Jesus/0000-0002-5712-3031	Ministerio de Ciencia e Innovacion [2004-2OE172, BMC2005-04342, BFU2008-00632]; Consolider Program [CSD2007-0008]; Ramon Areces Foundation; CSIC-JAE fellowship from the Spanish Ministerio de Ciencia e Innovacion; FPU fellowship from the Spanish Ministerio de Ciencia e Innovacion	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider Program(Spanish Government); Ramon Areces Foundation; CSIC-JAE fellowship from the Spanish Ministerio de Ciencia e Innovacion; FPU fellowship from the Spanish Ministerio de Ciencia e Innovacion	The work was supported by grants from Ministerio de Ciencia e Innovacion (numbers 2004-2OE172, BMC2005-04342 and BFU2008-00632), the Consolider Program (CSD2007-0008) and an institutional grant from the Ramon Areces Foundation. J. R. is supported by a CSIC-JAE fellowship and L. de N. was supported by a FPU fellowship, both from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 2005, MOL CELL BIOL, V25, P3140, DOI 10.1128/MCB.25.8.3140-3150.2005; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; Becam I, 2008, DEV BIOL, V322, P190, DOI 10.1016/j.ydbio.2008.07.028; Blair SS, 2003, CURR BIOL, V13, pR548, DOI 10.1016/S0960-9822(03)00469-X; Blair SS, 1997, DEVELOPMENT, V124, P4053; BROWER DL, 1987, DEVELOPMENT, V101, P83; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Duncan D, 2010, DEV BIOL, V347, P82, DOI 10.1016/j.ydbio.2010.08.012; Estrada B, 2001, DEVELOPMENT, V128, P331; Filas BA, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/6/066007; Foronda D, 2009, INT J DEV BIOL, V53, P1409, DOI 10.1387/ijdb.072462df; FRASER S, 1990, NATURE, V344, P431, DOI 10.1038/344431a0; Gandille P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013946; GARCIABELLIDO A, 1976, DEV BIOL, V48, P400, DOI 10.1016/0012-1606(76)90101-9; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GARCIABELLIDO A, 1968, GENETICS, V59, P487; GARCIABELLIDO A, 1966, DEV BIOL, V14, P278, DOI 10.1016/0012-1606(66)90017-0; GARCIABELLIDO A, 1975, CIBA F SYMP, P161, DOI DOI 10.1002/9780470720110.CH8; Grenier JK, 2000, P NATL ACAD SCI USA, V97, P704, DOI 10.1073/pnas.97.2.704; Hejnol A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-65; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lebreton G, 2008, DEVELOPMENT, V135, P2301, DOI 10.1242/dev.017053; LEWIS EB, 1963, AM ZOOL, V3, P33; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Major RJ, 2006, DEV DYNAM, V235, P3051, DOI 10.1002/dvdy.20966; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 1999, MOL CELL, V4, P1073, DOI 10.1016/S1097-2765(00)80235-X; Monier B, 2005, DEVELOPMENT, V132, P5283, DOI 10.1242/dev.02091; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; MORATA G, 1976, ROUX ARCH DEV BIOL, V179, P125, DOI 10.1007/BF00848298; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Narita Y, 2009, CURR TOP DEV BIOL, V88, P139, DOI 10.1016/S0070-2153(09)88005-8; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; WHITE RAH, 1985, NATURE, V318, P563, DOI 10.1038/318563a0; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	47	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57159	10.1371/journal.pone.0057159	http://dx.doi.org/10.1371/journal.pone.0057159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451173	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500072
J	Ho, MC; Wilczek, C; Bonanno, JB; Xing, L; Seznec, J; Matsui, T; Carter, LG; Onikubo, T; Kumar, PR; Chan, MK; Brenowitz, M; Cheng, RH; Reimer, U; Almo, SC; Shechter, D				Ho, Meng-Chiao; Wilczek, Carola; Bonanno, Jeffrey B.; Xing, Li; Seznec, Janina; Matsui, Tsutomu; Carter, Lester G.; Onikubo, Takashi; Kumar, P. Rajesh; Chan, Man K.; Brenowitz, Michael; Cheng, R. Holland; Reimer, Ulf; Almo, Steven C.; Shechter, David			Structure of the Arginine Methyltransferase PRMT5-MEP50 Reveals a Mechanism for Substrate Specificity	PLOS ONE			English	Article							WD-REPEAT; SYMMETRIC DIMETHYLATION; CRYSTAL-STRUCTURE; DATA-ACQUISITION; HISTONE-BINDING; PRMT5; METHYLATION; NUCLEOPLASMIN; PROTEINS; SYSTEM	The arginine methyltransferase PRMT5-MEP50 is required for embryogenesis and is misregulated in many cancers. PRMT5 targets a wide variety of substrates, including histone proteins involved in specifying an epigenetic code. However, the mechanism by which PRMT5 utilizes MEP50 to discriminate substrates and to specifically methylate target arginines is unclear. To test a model in which MEP50 is critical for substrate recognition and orientation, we determined the crystal structure of Xenopus laevis PRMT5-MEP50 complexed with S-adenosylhomocysteine (SAH). PRMT5-MEP50 forms an unusual tetramer of heterodimers with substantial surface negative charge. MEP50 is required for PRMT5-catalyzed histone H2A and H4 methyltransferase activity and binds substrates independently. The PRMT5 catalytic site is oriented towards the cross-dimer paired MEP50. Histone peptide arrays and solution assays demonstrate that PRMT5-MEP50 activity is inhibited by substrate phosphorylation and enhanced by substrate acetylation. Electron microscopy and reconstruction showed substrate centered on MEP50. These data support a mechanism in which MEP50 binds substrate and stimulates PRMT5 activity modulated by substrate post-translational modifications.	[Ho, Meng-Chiao; Wilczek, Carola; Bonanno, Jeffrey B.; Onikubo, Takashi; Kumar, P. Rajesh; Chan, Man K.; Brenowitz, Michael; Almo, Steven C.; Shechter, David] Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA; [Almo, Steven C.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY USA; [Ho, Meng-Chiao] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Seznec, Janina; Reimer, Ulf] JPT Peptide Technol, Berlin, Germany; [Matsui, Tsutomu; Carter, Lester G.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Xing, Li; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Academia Sinica - Taiwan; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Davis	Ho, MC (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Biochem, Bronx, NY USA.	joeho@gate.sinica.edu.tw; david.shechter@einstein.yu.edu	Cheng, Holland/A-8973-2008; Carter, Lester/G-6561-2014; Ho, Meng-Chiao/H-2448-2015; Shechter, David/B-4660-2008	Ho, Meng-Chiao/0000-0002-5424-4524; Shechter, David/0000-0001-9388-6004; Reimer, Ulf/0000-0002-3375-6889; Matsui, Tsutomu/0000-0001-7101-5259; Kumar, P. Rajesh/0000-0002-0576-6967	Office of Biological and Environmental Research of the US Department of Energy; Office of Basic Energy Sciences of the US Department of Energy; National Center for Research Resources (NCRR) [P41RR012408]; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [P41GM103473]; DOE Office of Biological and Environmental Research; NIH, NCRR, Biomedical Technology Program [P41RR001209]; Academia Sinica, Taiwan; National Science Council, Taiwan [NSC101-2311-B-001-002]; NIH [GM093342, AI095382]; Albert Einstein Cancer Center [CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209, P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI095382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM093342, U54GM094662, P41GM103473] Funding Source: NIH RePORTER	Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, NCRR, Biomedical Technology Program; Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data for this study were measured at beamline X25 and X29A of the National Synchrotron Light Source. Financial support comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources (NCRR, P41RR012408) and the National Institute of General Medical Sciences (P41GM103473) of the National Institutes of Health (NIH). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the NIH, NCRR, Biomedical Technology Program (P41RR001209). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. This research was partially supported by grants from Academia Sinica, Taiwan, and from the National Science Council, Taiwan (NSC101-2311-B-001-002) to MHC, the NIH (GM093342 to SCA and AI095382 to RHC) and the Albert Einstein Cancer Center (CA013330). DS is a Scholar of the Alexander and Alexandrine Sinsheimer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Arnan C, 2005, ARCH BIOCHEM BIOPHYS, V437, P205, DOI 10.1016/j.abb.2005.03.011; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cote J, 1995, METH MOL G, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dutta S, 2001, MOL CELL, V8, P841, DOI 10.1016/S1097-2765(01)00354-9; Eckert D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Furuno K, 2006, BIOCHEM BIOPH RES CO, V345, P1051, DOI 10.1016/j.bbrc.2006.05.014; Guderian G, 2011, J BIOL CHEM, V286, P1976, DOI 10.1074/jbc.M110.148486; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanade SR, 2012, J BIOL CHEM, V287, P7313, DOI 10.1074/jbc.M111.331660; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 2006, INT TABLES CRYSTALLO, P353; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lacroix M, 2008, EMBO REP, V9, P452, DOI 10.1038/embor.2008.45; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Majumder S, 2010, J CELL BIOCHEM, V109, P553, DOI 10.1002/jcb.22432; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; Masch A, 2010, METHODS MOL BIOL, V669, P161, DOI 10.1007/978-1-60761-845-4_13; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Moscoso CG, 2011, P NATL ACAD SCI USA, V108, P6091, DOI 10.1073/pnas.1016113108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panse S, 2004, MOL DIVERS, V8, P291, DOI 10.1023/B:MODI.0000036240.39384.eb; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Ramos I, 2010, J BIOL CHEM, V285, P33771, DOI 10.1074/jbc.M110.150664; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Rouhana L, 2012, DEVELOPMENT, V139, P1083, DOI 10.1242/dev.076182; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; West AL, 2012, P NATL ACAD SCI USA, V109, P5633, DOI 10.1073/pnas.1120283109; Wilczek C, 2011, J BIOL CHEM, V286, P42221, DOI 10.1074/jbc.M111.303677; Wolf SS, 2009, CELL MOL LIFE SCI, V66, P2109, DOI 10.1007/s00018-009-0010-x; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6	71	92	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57008	10.1371/journal.pone.0057008	http://dx.doi.org/10.1371/journal.pone.0057008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451136	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500054
J	Neuhauser, L; Ivey, SL; Huang, D; Engelman, A; Tseng, W; Dahrouge, D; Gurung, S; Kealey, M				Neuhauser, Linda; Ivey, Susan L.; Huang, Debbie; Engelman, Alina; Tseng, Winston; Dahrouge, Donna; Gurung, Sidhanta; Kealey, Melissa			Availability and Readability of Emergency Preparedness Materials for Deaf and Hard-of-Hearing and Older Adult Populations: Issues and Assessments	PLOS ONE			English	Article							HEALTH LITERACY; COMMUNICATION; KATRINA; RISK	A major public health challenge is to communicate effectively with vulnerable populations about preparing for disasters and other health emergencies. People who are Deaf or Hard of Hearing (Deaf/HH) and older adults are particularly vulnerable during health emergencies and require communications that are accessible and understandable. Although health literacy studies indicate that the readability of health communication materials often exceeds people's literacy levels, we could find no research about the readability of emergency preparedness materials (EPM) intended for Deaf/HH and older adult populations. The objective of this study was to explore issues related to EPM for Deaf/HH and older adult populations, to assess the availability and readability of materials for these populations, and to recommend improvements. In two California counties, we interviewed staff at 14 community-based organizations (CBOs) serving Deaf/HH clients and 20 CBOs serving older adults selected from a stratified, random sample of 227 CBOs. We collected 40 EPM from 10 CBOs and 2 public health departments and 40 EPM from 14 local and national websites with EPM for the public. We used computerized assessments to test the U. S. grade reading levels of the 16 eligible CBO and health department EPM, and the 18 eligible website materials. Results showed that less than half of CBOs had EPM for their clients. All EPM intended for clients of Deaf/HH-serving CBOs tested above the recommended 4th grade reading level, and 91% of the materials intended for clients of older adult-serving CBOs scored above the recommended 6th grade level. EPM for these populations should be widely available through CBOs and public health departments, adhere to health literacy principles, and be accessible in alternative formats including American Sign Language. Developers should engage the intended users of EPM as co-designers and testers. This study adds to the limited literature about EPM for these populations.	[Neuhauser, Linda; Ivey, Susan L.; Huang, Debbie; Engelman, Alina; Tseng, Winston; Dahrouge, Donna; Gurung, Sidhanta; Kealey, Melissa] Univ Calif Berkeley, Sch Publ Hlth, Hlth Res Act Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Neuhauser, L (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Hlth Res Act Ctr, Berkeley, CA 94720 USA.	lindan@berkeley.edu			Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention [5P01TP000295, FOA RFA-TP-08-001]	Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention	This study was supported by a Preparedness and Emergency Response Research Center (PERRC) grant from the Centers for Disease Control and Prevention, under FOA RFA-TP-08-001, to the University of California at Berkeley (grant number 5P01TP000295). The CDC had helpful suggestions to enhance the authors' study design, but had no role in data collection, data analysis, decision to publish, or preparation of this manuscript. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the CDC.	Aguirre B.E., 1988, INT J MASS EMERGENCI, V6, P65; Aldrich N, 2008, CDCS DISASTER PLANNI; Altevogt BM, 2008, RES PRIORITIES EMERG; [Anonymous], 1999, REP COUNC SCI AFF; Baker DW, 2000, J GERONTOL B-PSYCHOL, V55, pS368, DOI 10.1093/geronb/55.6.S368; Barnett S, 2011, PREV CHRONIC DIS, V8; Beckman HT, 1997, J CLIN PSYCHOL, V53, P785, DOI 10.1002/(SICI)1097-4679(199712)53:8<785::AID-JCLP1>3.0.CO;2-F; Canadian Council on Learning, 2007, HLTH LIT CAN IN RES; CDC, 2008, PUBL HLTH PREP MOB S, P1; Centers for Disease Control and Prevention, 2006, PROM PREP PROT HLT 4; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; Deaf and Hard of Hearing Consumer Advocacy Network, 2004, EM PREP EM COMM ACC; Department of Homeland Security, 2008, NAT RESP FRAM; Doak CC, 1996, TEACHING PATIENTS LO; Doak L G, 1996, Oncol Nurs Forum, V23, P1305; Fothergill A, 1999, DISASTERS, V23, P156, DOI 10.1111/1467-7717.00111; Friedman DB, 2008, PREHOSP DISASTER MED, V23, P438, DOI 10.1017/S1049023X00006178; Glanz K., 2002, HLTH BEHAV HLTH ED T; Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123; Government Accountability Office, 2008, NAT DIS RESP FEMA SH; Green L. W., 2003, COMMUNITY BASED PART; Guidry J, 1997, J CANCER EDUC, P108; Hayunga M, 2006, WE CAN DO BETTER LES; Heppner C, 2006, M FED COMM COMM IND; James X, 2007, J HOMEL SECUR EMERG, V4; Kailes J.I., 2007, J DISABIL POLICY STU, V17, P230, DOI [10.1177/10442073070170040601, DOI 10.1177/10442073070170040601]; Kealey M, 2012, EMERGENCY PREPAREDNE; KIRSCH IS, 1993, ADULT LIT AM 1 LOOK; Klinenberg E., 2002, HEAT WAVE SOCIAL AUT; Kouznetsova S, 2010, WEB ACCESSIBILITY US; Kreps G, 2005, COMMUNITY PREPAREDNE, V3, P191; Kutner M., 2005, NATL ASSESSMENT ADUL; LaVigne M, 2003, WISC LAW REV, P843; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Marschark M, 2002, ED DEAF STUD RES PRA; Mensah GA, 2005, PREV CHRONIC DIS, V2; Merriam B.S., 2007, LEARNING ADULTHOOD C; Messias DKH, 2007, J HEALTH CARE POOR U, V18, P443, DOI 10.1353/hpu.2007.0041; Micro Power & LIght Co, 2005, READ CALC; Mohrmann CC, 2000, J CANCER EDUC, V15, P23; National Organization on Disability, 2005, EM PREP IN GUID SPEC; Neuhauser L, 2009, AM J PUBLIC HEALTH, V99, P2188, DOI 10.2105/AJPH.2008.155648; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Organization for Economic Co-Operation Development and Statistics Canada, 2000, LIT INF AG FIN REP I; Osborne H., 2005, HLTH LITERACY A Z PR; Paasche-Orlow MK, 2005, UNDERSTANDING HLTH L, P119; Perry R.W., 1986, MINORITY CITIZENS DI; Phillips B., 1993, INT J MASS EMERGENCI, V11, P99; Phillips B.D., 2007, NAT HAZARDS REV, V8, P61, DOI [10.1061/(ASCE)1527-6988(2007)8:3(61), DOI 10.1061/(ASCE)1527-6988(2007)8:3(61)]; Pollard RQ, 2009, REHABIL PSYCHOL, V54, P232, DOI 10.1037/a0015772; Pollard RQ, 1998, PSYCHOLOGICAL PERSPECTIVES ON DEAFNESS, VOL 2, P171; Pollard RQ, 2005, DEAF ROCHESTER NEWS, P10; Rudd R, 2000, HLTH LITERACY REV ME; Rudd RE, 2007, REV ADULT LEARNING L, V7; Rudd Rima E., 2007, HLTH LITERACY UPDATE; Satariano WA, 2006, EPIDEMIOLOGY AGING E; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Shi Leiyu, 2007, Organ Ethic, V4, P35; SHIN HB, 2003, LANGUAGE USE ENGLISH; Stebnicki J A, 1999, J Transcult Nurs, V10, P350, DOI 10.1177/104365969901000413; Swartzberg J, 2005, UNDERSTANDING HLTH L; Traxler C.B., 2000, J DEAF STUD DEAF EDU, V5, P337, DOI DOI 10.1093/DEAFED/5.4.337; U.S. Department of Health and Human Services, QUICK GUID HLTH LIT; [US Department of Health and Human Services Centers for Disease Control and Prevention (CDC)], SIMPL PUT; US Department of Health and Human Services Centers for Medicare and Medicaid Services, TOOLK MAK WRITT MAT; US Government, 2004, EX ORD IND DIS EM PR; Vanderford ML, 2007, J APPL COMMUN RES, V35, P9, DOI 10.1080/00909880601065649; Villaire M., 2007, HLTH LITERACY PRIMAR; Wallis D, 2004, J DEAF STUDIES DEAF, P9; WEISS BD, 2005, UNDERSTANDING HLTH L, P17; Wilbourn MP, 2007, INFANT BEHAV DEV, V30, P153, DOI 10.1016/j.infbeh.2006.08.006; Wilson FL, 2003, J CLIN NURS, V12, P275, DOI 10.1046/j.1365-2702.2003.00711.x; Wood VT, 2003, B AM METEOROLOGICAL, V84, P148; World Health Organization, 1998, HLTH PROM GLOSS; Zarcadoolas C, 2005, HEALTH PROMOT INT, V20, P195, DOI 10.1093/heapro/dah609	75	33	33	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55614	10.1371/journal.pone.0055614	http://dx.doi.org/10.1371/journal.pone.0055614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451029	Green Published, gold			2022-12-25	WOS:000316849500003
J	Ning, DG; Jiang, Y; Liu, ZY; Xu, QG				Ning, Degang; Jiang, Yan; Liu, Zhaoying; Xu, Qinggang			Characterization of a Chromosomal Type II Toxin-Antitoxin System mazEaFa in the Cyanobacterium Anabaena sp PCC 7120	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; PHOSPHORUS BIOAVAILABILITY; HETEROCYST DEVELOPMENT; PERSISTER CELLS; EXPRESSION; MODULE; GROWTH; GENE; MAZF	Cyanobacteria have evolved to survive stressful environmental changes by regulating growth, however, the underlying mechanism for this is obscure. The ability of chromosomal type II toxin-antitoxin (TA) systems to modulate growth or cell death has been documented in a variety of prokaryotes. A chromosomal mazEaFa locus of Anabaena sp. PCC 7120 has been predicted as a putative mazEF TA system. Here we demonstrate that mazEaFa form a bicistronic operon that is co-transcribed under normal growth conditions. Overproduction of MazFa induced Anabaena growth arrest which could be neutralized by co-expression of MazEa. MazFa also inhibited the growth of Escherichia coli cells, and this effect could be overcome by simultaneous or subsequent expression of MazEa via formation of the MazEa-MazFa complex in vivo, further confirming the nature of the mazEaFa locus as a type II TA system. Interestingly, like most TA systems, deletion of mazEaFa had no effect on the growth of Anabaena during the tested stresses. Our data suggest that mazEaFa, or together with other chromosomal type II TA systems, may promote cells to cope with particular stresses by inducing reversible growth arrest of Anabaena.	[Ning, Degang; Liu, Zhaoying] Jiangsu Univ, Dept Environm Sci, Sch Environm, Zhenjiang, Jiangsu, Peoples R China; [Jiang, Yan; Xu, Qinggang] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Ning, DG (corresponding author), Jiangsu Univ, Dept Environm Sci, Sch Environm, Zhenjiang, Jiangsu, Peoples R China.	306502@ujs.edu.cn		xu, qinggang/0000-0002-8659-7041	National Natural Science Foundation of China [30771176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by a grant from the National Natural Science Foundation of China (grant no. 30771176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2007, FEBS LETT, V581, P1727, DOI 10.1016/j.febslet.2007.03.051; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Munoz-Martin MA, 2011, ANAL BIOANAL CHEM, V400, P3573, DOI 10.1007/s00216-011-5017-0; [Anonymous], 1984, ANNU REV MICROBIOL, V69, P114; Asada K., 1994, Causes of photooxidative stress and amelioration of defense systems in plants., P77; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Boileau C, 2011, NEW PHYTOL, V191, P1108, DOI 10.1111/j.1469-8137.2011.03774.x; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; [常家宁 CHANG Jia-Ning], 2009, [微生物学通报, Microbiology], V36, P31; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; DEMARSAC NT, 1993, FEMS MICROBIOL LETT, V104, P119; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; Erental A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001281; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Florek P, 2008, FEMS MICROBIOL LETT, V278, P177, DOI 10.1111/j.1574-6968.2007.00984.x; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Makarova K.S., 2009, BIOL DIRECT, V4, DOI [10.1186/1745-6150-1184-1119, DOI 10.1186/1745-6150-1184-1119]; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Nieto C, 2007, J BACTERIOL, V189, P1266, DOI 10.1128/JB.01130-06; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; Ning DG, 2004, MICROBIOL-SGM, V150, P447, DOI 10.1099/mic.0.26747-0; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schopf J. W., 2002, ECOLOGY CYANOBACTERI, P12; Schreiter PPY, 2001, BIOSENS BIOELECTRON, V16, P811, DOI 10.1016/S0956-5663(01)00224-X; Schwarz R, 2005, MICROBIOL-SGM, V151, P2503, DOI 10.1099/mic.0.27883-0; Singletary LA, 2009, J BACTERIOL, V191, P7456, DOI 10.1128/JB.00963-09; Syed MA, 2011, J BACTERIOL, V193, P1122, DOI 10.1128/JB.01114-10; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhao LX, 2008, FEBS LETT, V582, P710, DOI 10.1016/j.febslet.2008.01.045	52	8	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56035	10.1371/journal.pone.0056035	http://dx.doi.org/10.1371/journal.pone.0056035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451033	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500006
J	Rentsch, CA; Biot, C; Gsponer, JR; Bachmann, A; Albert, ML; Breban, R				Rentsch, Cyrill A.; Biot, Claire; Gsponer, Joel R.; Bachmann, Alexander; Albert, Matthew L.; Breban, Romulus			BCG-Mediated Bladder Cancer Immunotherapy: Identifying Determinants of Treatment Response Using a Calibrated Mathematical Model	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; 27 MG; THERAPY	Intravesical Bacillus Calmette Guerin (BCG) immunotherapy is considered the standard of care for treatment of non-muscle invasive bladder cancer; however the treatment parameters were established empirically. In order to evaluate potential optimization of clinical parameters of BCG induction therapy, we constructed and queried a new mathematical model. Specifically, we assessed the impact of (1) duration between resection and the first instillation; (2) BCG dose; (3) indwelling time; and (4) treatment interval of induction therapy - using cure rate as the primary endpoint. Based on available clinical and in vitro experimental data, we constructed and parameterized a stochastic mathematical model describing the interactions between BCG, the immune system, the bladder mucosa and tumor cells. The primary endpoint of the model was the probability of tumor extinction following BCG induction therapy in patients with high risk for tumor recurrence. We theoretically demonstrate that extending the duration between the resection and the first BCG instillation negatively influences treatment outcome. Simulations of higher BCG doses and longer indwelling times both improved the probability of tumor extinction. A remarkable finding was that an inter-instillation interval two times longer than the seven-day interval used in the current standard of care would substantially improve treatment outcome. We provide insight into relevant clinical questions using a novel mathematical model of BCG immunotherapy. Our model predicts an altered regimen that may decrease side effects of treatment while improving response to therapy.	[Rentsch, Cyrill A.; Gsponer, Joel R.; Bachmann, Alexander] Univ Basel, Univ Basel Hosp, Dept Urol, Basel, Switzerland; [Rentsch, Cyrill A.; Biot, Claire; Gsponer, Joel R.; Albert, Matthew L.] Inst Pasteur, Unite Immunol Cellules Dendrit, Paris, France; [Biot, Claire] Ecole Natl Super Mines, Paris, France; [Biot, Claire; Albert, Matthew L.] Inst Natl Sante & Rech Med, U818, Paris, France; [Breban, Romulus] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France	University of Basel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Breban, R (corresponding author), Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France.	romulus.breban@pasteur.fr	Albert, Matthew L/C-9782-2009	Breban, Romulus/0000-0002-5821-8139; Rentsch, Cyrill/0000-0002-8085-6006	La Ligue Contre le Cancer; Association pour la Recherche sur le Cancer; Swiss National Foundation	La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by La Ligue Contre le Cancer and Association pour la Recherche sur le Cancer. CAR acknowledges support from the Swiss National Foundation. The opinions and statements in this article are those of the authors and do not represent the official policy, endorsement, or views of Institute Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal MS, 2007, UROLOGY, V70, P1075, DOI 10.1016/j.urology.2007.07.017; Andius P, 2005, BJU INT, V96, P1290, DOI 10.1111/j.1464-410X.2005.05817.x; Bassi P, 2000, EUR UROL, V37, P31, DOI 10.1159/000052380; Biot C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003586; Bisiaux A, 2009, J UROLOGY, V181, P1571, DOI 10.1016/j.juro.2008.11.124; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Breban R, 2012, ONCOIMMUNOLOGY, V1, P9, DOI 10.4161/onci.1.1.17884; Bunimovich-Mendrazitsky S, 2008, B MATH BIOL, V70, P2055, DOI 10.1007/s11538-008-9344-z; Bunimovich-Mendrazitsky S, 2007, B MATH BIOL, V69, P1847, DOI 10.1007/s11538-007-9195-z; Bunimovich-Mendrazitsky S, 2011, MATH BIOSCI ENG, V8, P529, DOI 10.3934/mbe.2011.8.529; Bunimovich-Mendrazitsky S, 2011, J THEOR BIOL, V277, P27, DOI 10.1016/j.jtbi.2011.02.008; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; de Boer EC, 2005, EUR UROL, V48, P333, DOI 10.1016/j.eururo.2005.05.004; Lamm DL, 2000, J UROLOGY, V163, P1124, DOI 10.1016/S0022-5347(05)67707-5; Losa A, 2000, J UROLOGY, V163, P68, DOI 10.1016/S0022-5347(05)67974-8; MACK D, 1995, BRIT J UROL, V75, P185, DOI 10.1111/j.1464-410X.1995.tb07308.x; Martinez-Pineiro JA, 2002, BJU INT, V89, P671, DOI 10.1046/j.1464-410X.2002.02722.x; MORALES A, 1976, J UROLOGY, V115, P377, DOI 10.1016/S0022-5347(17)59210-1; Ojea A, 2007, EUR UROL, V52, P1398, DOI 10.1016/j.eururo.2007.04.062; PAGANO F, 1991, J UROLOGY, V146, P32, DOI 10.1016/S0022-5347(17)37707-8; van der Meijden APM, 2003, EUR UROL, V44, P429, DOI 10.1016/S0302-2838(03)00357-9	22	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56327	10.1371/journal.pone.0056327	http://dx.doi.org/10.1371/journal.pone.0056327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451041	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500012
J	Bancos, I; Bida, JP; Tian, DF; Bundrick, M; John, K; Holte, MN; Her, YF; Evans, D; Saenz, DT; Poeschla, EM; Hook, D; Georg, G; Maher, LJ				Bancos, Irina; Bida, John Paul; Tian, Defeng; Bundrick, Mary; John, Kristen; Holte, Molly Nelson; Her, Yeng F.; Evans, Debra; Saenz, Dyana T.; Poeschla, Eric M.; Hook, Derek; Georg, Gunda; Maher, L. James			High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma	PLOS ONE			English	Article							SUCCINATE-DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; PROLYL HYDROXYLASE; CRYSTAL-STRUCTURE; PHEOCHROMOCYTOMA; MUTATIONS; GENE; ASSAY; SDHC; DISULFIRAM	Classical tumor suppressor genes block neoplasia by regulating cell growth and death. A remarkable puzzle is therefore presented by familial paraganglioma (PGL), a neuroendocrine cancer where the tumor suppressor genes encode subunits of succinate dehydrogenase (SDH), an enzyme of the tricarboxylic acid (TCA) cycle of central metabolism. Loss of SDH initiates PGL through mechanisms that remain unclear. Could this metabolic defect provide a novel opportunity for chemotherapy of PGL? We report the results of high throughput screening to identify compounds differentially toxic to SDH mutant cells using a powerful S. cerevisiae (yeast) model of PGL. Screening more than 200,000 compounds identifies 12 compounds that are differentially toxic to SDH-mutant yeast. Interestingly, two of the agents, dequalinium and tetraethylthiuram disulfide (disulfiram), are anti-malarials with the latter reported to be a glycolysis inhibitor. We show that four of the additional hits are potent inhibitors of yeast alcohol dehydrogenase. Because alcohol dehydrogenase regenerates NAD(+) in glycolytic cells that lack TCA cycle function, this result raises the possibility that lactate dehydrogenase, which plays the equivalent role in human cells, might be a target of interest for PGL therapy. We confirm that human cells deficient in SDH are differentially sensitive to a lactate dehydrogenase inhibitor.	[Bancos, Irina; Bida, John Paul; Bundrick, Mary; Holte, Molly Nelson; Her, Yeng F.; Evans, Debra; Maher, L. James] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Bida, John Paul; Her, Yeng F.; Evans, Debra] Mayo Clin, Coll Med, Mayo Grad Sch, Rochester, MN USA; [Tian, Defeng; John, Kristen; Hook, Derek; Georg, Gunda] Univ Minnesota Twin Cities, Coll Pharm, Inst Therapeut Discovery & Dev, Minneapolis, MN USA; [Saenz, Dyana T.; Poeschla, Eric M.] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Maher, LJ (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	maher@mayo.edu	Bancos, Irina/J-6560-2019	Georg, Gunda/0000-0002-8900-9460; Bancos, Irina/0000-0001-9332-2524	Mayo Foundation; Minnesota Partnership for Genomics and Biotechnology grant; Fraternal Order of Eagles grant; Ann and George M. Fisher Endowed Research Fund for Individualized Medicine grant; Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER	Mayo Foundation; Minnesota Partnership for Genomics and Biotechnology grant; Fraternal Order of Eagles grant; Ann and George M. Fisher Endowed Research Fund for Individualized Medicine grant; Mayo Graduate School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Mayo Foundation, by a Minnesota Partnership for Genomics and Biotechnology grant to GG and LJM, by a Fraternal Order of Eagles grant to LJM, and by an Ann and George M. Fisher Endowed Research Fund for Individualized Medicine grant to LJM. JPB, YH and DE were supported by Mayo Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baysal BE, 2004, J MED GENET, V41, P703, DOI 10.1136/jmg.2004.019224; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; Baysal BE, 2011, HUMAN MOL GEN; Bikhazi PH, 2000, LARYNGOSCOPE, V110, P1346, DOI 10.1097/00005537-200008000-00023; Bryant J, 2003, J NATL CANCER I, V95, P1196, DOI 10.1093/jnci/djg024; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; CARPER WR, 1987, CLIN CHEM, V33, P1906; CARRATLA R, 1950, Hospital (Rio J), V38, P277; Chrisoulidou A, 2007, ENDOCR-RELAT CANCER, V14, P569, DOI 10.1677/ERC-07-0074; Cottier V, 2006, ANTIMICROB AGENTS CH, V50, P565, DOI 10.1128/AAC.50.2.565-571.2006; Elder EE, 2003, EUR J SURG ONCOL, V29, P278, DOI 10.1053/ejso.2002.1413; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Favier J, 2010, BEST PRACT RES CL EN, V24, P957, DOI 10.1016/j.beem.2010.10.004; Garcia-Perez AI, 2011, LEUKEMIA RES, V35, P1395, DOI 10.1016/j.leukres.2011.03.012; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Goldstein RE, 1999, ANN SURG, V229, P755, DOI 10.1097/00000658-199906000-00001; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Gunde T, 2005, BIOTECHNIQUES, V39, P541, DOI 10.2144/000112011; Guterman L, 2011, CHEM ENG NEWS, V89, P19, DOI 10.1021/cen-v089n036.p019; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huth JR, 2007, CHEM RES TOXICOL, V20, P1752, DOI 10.1021/tx700319t; Inabnet WB, 2000, SURGERY, V128, P1007, DOI 10.1067/msy.2000.110846; Kaelin WG, 2009, CANCER CELL, V16, P180, DOI 10.1016/j.ccr.2009.08.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Langeland BT, 1996, ALCOHOL ALCOHOLISM, V31, P75; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; LESTER D, 1950, Q J STUD ALCOHOL, V11, P391; Li-Weber M., 2010, CANC LETT; Lloyd R, 2004, WHO CLASSIFICATION T; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; Maxwell PH, 2005, CANCER CELL, V8, P91, DOI 10.1016/j.ccr.2005.07.012; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Miest T, 2009, METHODS, V47, P298, DOI 10.1016/j.ymeth.2008.11.001; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Nieuwenhuijsen BW, 2003, J BIOMOL SCREEN, V8, P676, DOI 10.1177/1087057103258287; Plouin PF, 2012, HORM METAB RES, V44, P390, DOI 10.1055/s-0031-1299707; Potashman MH, 2009, J MED CHEM, V52, P1231, DOI 10.1021/jm8008597; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Toussaint M, 2006, NAT PROTOC, V1, P1922, DOI 10.1038/nprot.2006.304; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	56	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56827	10.1371/journal.pone.0056827	http://dx.doi.org/10.1371/journal.pone.0056827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451094	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800041
J	Chen, X; Liu, BG; Li, QH; Honorio, S; Liu, X; Liu, C; Multani, AS; Calhoun-Davis, T; Tang, DG				Chen, Xin; Liu, Bigang; Li, Qiuhui; Honorio, Sofia; Liu, Xin; Liu, Can; Multani, Asha S.; Calhoun-Davis, Tammy; Tang, Dean G.			Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-gamma Mice	PLOS ONE			English	Article							STEM-LIKE CELLS; INITIATING CELLS; STEM/PROGENITOR CELLS; ANDROGEN INDEPENDENCE; EXPRESSION PROFILES; PROGENITOR CELLS; SIDE POPULATION; IN-VIVO; METASTASIS; IDENTIFICATION	Reconstitution of tumor development in immunodeficient mice from disaggregated primary human tumor cells is always challenging. The main goal of the present study is to establish a reliable assay system that would allow us to reproducibly reconstitute human prostate tumor regeneration in mice using patient tumor-derived single cells. Using many of the 114 untreated primary human prostate cancer (HPCa) samples we have worked on, here we show that: 1) the subcutaneum represents the most sensitive site that allows the grafting of the implanted HPCa pieces; 2) primary HPCa cells by themselves fail to regenerate tumors in immunodeficient hosts; 3) when coinjected in Matrigel with rUGM (rat urogenital sinus mesenchyme), CAF (carcinoma-associated fibroblasts), or Hs5 (immortalized bone marrow derived stromal) cells, primary HPCa cells fail to initiate serially transplantable tumors in NOD/SCID mice; and 4) however, HPCa cells coinjected with the Hs5 cells into more immunodeficient NOD/SCID-IL2R gamma(-/-) (NSG) mice readily regenerate serially transplantable tumors. The HPCa/Hs5 reconstituted 'prostate' tumors present an overall epithelial morphology, are of the human origin, and contain cells positive for AR, CK8, and racemase. Cytogenetic analysis provides further evidence for the presence of karyotypically abnormal HPCa cells in the HPCa/Hs5 tumors. Of importance, HPCa/Hs5 xenograft tumors contain EpCAM(+) cells that are both clonogenic and tumorigenic. Surprisingly, all HPCa/Hs5 reconstituted tumors are undifferentiated, even for HPCa cells derived from Gleason 7 tumors. Our results indicate that primary HPCa cells coinjected with the immortalized Hs5 stromal cells generate undifferentiated tumors in NSG mice and we provide evidence that undifferentiated HPCa cells might be the cells that possessed tumorigenic potential and regenerated HPCa/Hs5 xenograft tumors.	[Chen, Xin; Liu, Bigang; Li, Qiuhui; Honorio, Sofia; Liu, Xin; Liu, Can; Calhoun-Davis, Tammy; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Chen, Xin; Liu, Can; Tang, Dean G.] Univ Texas Houston, Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX USA; [Li, Qiuhui] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Stomatol, Tongji Hosp, Wuhan 430074, Peoples R China; [Liu, Xin] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Multani, Asha S.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, RNA Interference & Noncoding RNAs & Mol Carcinoge, Ctr Canc Epigenet Stem Cell & Dev Biol, Houston, TX 77030 USA; [Tang, Dean G.] Tongji Univ, Sch Med, Res Ctr Translat Med, Canc Stem Cell Inst,East Hosp, Shanghai 200092, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tongji University	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Chen, Xin/0000-0002-0566-7678	NIH [R01-CA155693-01A]; Department of Defense [W81XWH-11-1-0331]; CPRIT [RP120380]; M.D. Anderson Cancer Center the Center for Cancer Epigenetics; Laura and John Arnold Foundation RNA Center pilot grant; Cockrell fellowship from Department of Molecular Carcinogenesis, M.D. Anderson Cancer Center;  [CCSG-5 P30 CA016672-34];  [ES007784]; NATIONAL CANCER INSTITUTE [R01CA155693, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); CPRIT; M.D. Anderson Cancer Center the Center for Cancer Epigenetics; Laura and John Arnold Foundation RNA Center pilot grant; Cockrell fellowship from Department of Molecular Carcinogenesis, M.D. Anderson Cancer Center; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from NIH (R01-CA155693-01A), Department of Defense (W81XWH-11-1-0331), CPRIT funding (RP120380), and the M.D. Anderson Cancer Center the Center for Cancer Epigenetics and Laura and John Arnold Foundation RNA Center pilot grant (to DGT) and by two Center Grants (CCSG-5 P30 CA016672-34 and ES007784). XC was supported by Cockrell fellowship from Department of Molecular Carcinogenesis, M.D. Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia B, 2008, INT J CANCER, V122, P1483, DOI 10.1002/ijc.23222; Cespedes M V, 2006, Clin Transl Oncol, V8, P318; CHUNG LWK, 1989, INT J CANCER, V43, P1179, DOI 10.1002/ijc.2910430636; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Colombel M, 2012, PROSTATE, V72, P713, DOI 10.1002/pros.21473; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Delk NA, 2012, AUTOPHAGY, V8, P650, DOI 10.4161/auto.19226; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Germann M, 2012, STEM CELLS, V30, P1076, DOI 10.1002/stem.1087; Goldstein AS, 2011, NAT PROTOC, V6, P656, DOI 10.1038/nprot.2011.317; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guzman-Ramirez N, 2009, PROSTATE, V69, P1683, DOI 10.1002/pros.21018; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Hayward SW, 2001, CANCER RES, V61, P8135; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Lacombe L, 1996, INT J CANCER, V69, P110, DOI 10.1002/(SICI)1097-0215(19960422)69:2<110::AID-IJC7>3.0.CO;2-3; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Li H, 2009, METHODS MOL BIOL, V568, P85, DOI 10.1007/978-1-59745-280-9_7; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Liu C, 2012, CANCER RES, V72, P3393, DOI 10.1158/0008-5472.CAN-11-3864; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031919; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nishida S, 2012, J UROLOGY, V188, P294, DOI 10.1016/j.juro.2012.02.2555; O'Connor JC, 2007, MOL CANCER RES, V5, P585, DOI 10.1158/1541-7786.MCR-06-0408; Olumi AF, 1999, CANCER RES, V59, P5002; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Penson DF, 2007, NIH PUBLICATION, V07-5512, P71; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Placencio VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012920; PRETLOW TG, 1991, CANCER RES, V51, P3814; Priolo C, 2010, AM J PATHOL, V176, P1901, DOI 10.2353/ajpath.2010.090873; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Schwab TS, 2000, PROSTATE, V44, P164; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silvers CR, 2010, PROSTATE, V70, P1379, DOI 10.1002/pros.21171; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tang DG, 2007, MOL CARCINOGEN, V46, P1, DOI 10.1002/mc.20255; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Toivanen R, 2011, STEM CELLS, V29, P1310, DOI 10.1002/stem.668; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042653; Wang YZ, 2005, PROSTATE, V64, P149, DOI 10.1002/pros.20225; Zhao HJ, 2010, AM J PATHOL, V177, P229, DOI 10.2353/ajpath.2010.090821; Zhou JJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-112	71	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56903	10.1371/journal.pone.0056903	http://dx.doi.org/10.1371/journal.pone.0056903			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451107	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800046
J	Chu, JJ; Zhang, HX; Huang, XQ; Lin, YJ; Shen, T; Chen, BD; Man, Y; Wang, S; Li, J				Chu, Jiaojiao; Zhang, Hangxiang; Huang, Xiuqing; Lin, Yajun; Shen, Tao; Chen, Beidong; Man, Yong; Wang, Shu; Li, Jian			Apelin Ameliorates TNF-alpha-Induced Reduction of Glycogen Synthesis in the Hepatocytes through G Protein-Coupled Receptor APJ	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; MIDDLE-AGED MEN; INSULIN-RESISTANCE; METABOLIC SYNDROME; PEPTIDE APELIN; EXPRESSION; LIGAND; OBESITY; MICE; ADIPOCYTES	Apelin, a novel adipokine, is the specific endogenous ligand of G protein-coupled receptor APJ. Consistent with its putative role as an adipokine, apelin has been linked to states of insulin resistance. However, the function of apelin in hepatic insulin resistance, a vital part of insulin resistance, and its underlying mechanisms still remains unclear. Here we define the impacts of apelin on TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes. Our studies indicate that apelin reversed TNF-alpha-induced reduction of glycogen synthesis in HepG2 cells, mouse primary hepatocytes and liver tissues of C57BL/6J mice by improving JNK-IRS1-AKT-GSK pathway. Moreover, Western blot revealed that APJ, but not apelin, expressed in the hepatocytes and liver tissues of mice. We found that F13A, a competitive antagonist for G protein- coupled receptor APJ, suppressed the effects of apelin on TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes, suggesting APJ is involved in the function of apelin. In conclusion, we show novel evidence suggesting that apelin ameliorates TNF-alpha-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ. Apelin appears as a beneficial adipokine with anti-insulin resistance properties, and thus as a promising therapeutic target in metabolic disorders.	[Chu, Jiaojiao; Zhang, Hangxiang; Huang, Xiuqing; Lin, Yajun; Shen, Tao; Chen, Beidong; Man, Yong; Wang, Shu; Li, Jian] Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China; [Chu, Jiaojiao; Zhang, Hangxiang; Huang, Xiuqing; Lin, Yajun; Shen, Tao; Chen, Beidong; Man, Yong; Wang, Shu; Li, Jian] Beijing Hosp, Minist Hlth, Beijing, Peoples R China; [Zhang, Hangxiang] Fourth Mil Med Univ, Xi Jing Hosp, Dept Gerontol, Xian 710032, Peoples R China; [Chu, Jiaojiao] Zhejiang Hosp, Hangzhou, Zhejiang, Peoples R China	Beijing Hospital; Air Force Military Medical University	Wang, S (corresponding author), Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.	ws3704@yahoo.com.cn; lijian@bjhmoh.cn		Shen, Tao/0000-0001-5856-0818	National Basic Research Program of China [2012CB517502]; National Natural Science Foundation of China [81070634, 81270887, 81270495]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China (2012CB517502) and National Natural Science Foundation of China (81070634, 81270887, 81270495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch-Damti A, 2005, ANTIOXID REDOX SIGN, V7, P1553, DOI 10.1089/ars.2005.7.1553; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Casciano DA, 2000, DRUG METAB REV, V32, P1, DOI 10.1081/DMR-100100561; Castan-Laurell I, 2011, ENDOCRINE, V40, P1, DOI 10.1007/s12020-011-9507-9; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; Devic E, 1999, MECH DEVELOP, V84, P199, DOI 10.1016/S0925-4773(99)00081-7; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Erdem G, 2008, EXP CLIN ENDOCR DIAB, V116, P289, DOI 10.1055/s-2007-1004564; Falcao-Pires I, 2010, EXPERT OPIN THER TAR, V14, P633, DOI 10.1517/14728221003752743; Foussal C, 2010, FEBS LETT, V584, P2363, DOI 10.1016/j.febslet.2010.04.025; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Glassford AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1590, DOI 10.1152/ajpendo.00490.2007; Goldstein BJ, 2002, AM J CARDIOL, V90, p3G; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hung WW, 2011, CARDIOVASC DRUG THER, V25, P3, DOI 10.1007/s10557-010-6274-4; Ingelsson E, 2006, HEART, V92, P1409, DOI 10.1136/hrt.2006.089011; Kadoglou NPE, 2010, METABOLISM, V59, P373, DOI 10.1016/j.metabol.2009.08.005; Katakam AK, 2005, J ENDOCRINOL, V187, P237, DOI 10.1677/joe.1.06411; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kleinz MJ, 2004, REGUL PEPTIDES, V118, P119, DOI 10.1016/j.regpep.2003.11.002; Kleinz MJ, 2005, PHARMACOL THERAPEUT, V107, P198, DOI 10.1016/j.pharmthera.2005.04.001; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Li L, 2006, EXP CLIN ENDOCR DIAB, V114, P544, DOI 10.1055/s-2006-948309; Li LF, 2010, FEBS LETT, V584, P995, DOI 10.1016/j.febslet.2010.01.044; Liang HF, 2008, ENDOCRINOLOGY, V149, P2943, DOI 10.1210/en.2007-0978; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Mlinar B, 2007, CLIN CHIM ACTA, V375, P20, DOI 10.1016/j.cca.2006.07.005; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Soriguer F, 2009, OBES SURG, V19, P1574, DOI 10.1007/s11695-009-9955-y; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Winzell MS, 2005, REGUL PEPTIDES, V131, P12, DOI 10.1016/j.regpep.2005.05.004; Xu SM, 2011, J DIABETES, V3, P225, DOI 10.1111/j.1753-0407.2011.00132.x; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zhang Yu, 2009, Diabetes Care, V32, pe150, DOI 10.2337/dc09-1146	41	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57231	10.1371/journal.pone.0057231	http://dx.doi.org/10.1371/journal.pone.0057231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437347	gold, Green Submitted, Green Published			2022-12-25	WOS:000315186000088
J	Fryer, RA; Graham, TJ; Smith, EM; Walker-Samuel, S; Morgan, GJ; Robinson, SP; Davies, FE				Fryer, Rosemary A.; Graham, Timothy J.; Smith, Emma M.; Walker-Samuel, Simon; Morgan, Gareth J.; Robinson, Simon P.; Davies, Faith E.			Characterization of a Novel Mouse Model of Multiple Myeloma and Its Use in Preclinical Therapeutic Assessment	PLOS ONE			English	Article							SCID MICE; CELLS; TRANSPLANTATION; PLASMACYTOMA; PATHOGENESIS; INHIBITION; STRATEGY; LEUKEMIA; CLONE; MYC	To aid preclinical development of novel therapeutics for myeloma, an in vivo model which recapitulates the human condition is required. An important feature of such a model is the interaction of myeloma cells with the bone marrow microenvironment, as this interaction modulates tumour activity and protects against drug-induced apoptosis. Therefore NOD/SCID gamma C-null mice were injected intra-tibially with luciferase-tagged myeloma cells. Disease progression was monitored by weekly bioluminescent imaging (BLI) and measurement of paraprotein levels. Results were compared with magnetic resonance imaging (MRI) and histology. Assessment of model suitability for preclinical drug testing was investigated using bortezomib, melphalan and two novel agents. Cells engrafted at week 3, with a significant increase in BLI radiance occurring between weeks 5 and 7. This was accompanied by an increase in paraprotein secretion, MRI-derived tumour volume and CD138 positive cells within the bone marrow. Treatment with known anti-myeloma agents or novel agents significantly attenuated the increase in all disease markers. In addition, intra-tibial implantation of primary patient plasma cells resulted in development of myeloma within bone marrow. In conclusion, using both myeloma cell lines and primary patient cells, we have developed a model which recapitulates human myeloma by ensuring the key interaction of tumour cells with the microenvironment.	[Fryer, Rosemary A.; Smith, Emma M.; Morgan, Gareth J.; Davies, Faith E.] Inst Canc Res, Haematooncol Res Unit, London SW3 6JB, England; [Graham, Timothy J.; Robinson, Simon P.] Canc Res UK, London, England; [Graham, Timothy J.; Robinson, Simon P.] Inst Canc Res, EPSRC Canc Imaging Ctr, London SW3 6JB, England; [Walker-Samuel, Simon] UCL, Ctr Adv Biomed Imaging, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; Institute of Cancer Research - UK; University of London; University College London	Davies, FE (corresponding author), Inst Canc Res, Haematooncol Res Unit, London SW3 6JB, England.	faith.davies@icr.ac.uk		Robinson, Simon/0000-0003-4101-7274; Davies, Faith/0000-0002-3971-2393; morgan, gareth/0000-0002-4271-6360	Cancer Research UK [C20826/A12103]; Myeloma UK and Kay Kendall Leukaemia Fund; Institute of Cancer Research; Cancer Research UK; Engineering and Physical Sciences Research Council Cancer Imaging Centre; Medical Research Council and Department of Health (England) [C1060/A10334]; National Health Service; MRC [G0701533] Funding Source: UKRI; Cancer Research UK [16464, 12103] Funding Source: researchfish; Medical Research Council [G0701533] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Myeloma UK and Kay Kendall Leukaemia Fund; Institute of Cancer Research; Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council Cancer Imaging Centre(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council and Department of Health (England)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from Cancer Research UK (FD is a Cancer Research UK Senior Fellow, grant number: C20826/A12103), Myeloma UK and Kay Kendall Leukaemia Fund. The authors acknowledge the support received for The Institute of Cancer Research, Cancer Research UK, and Engineering and Physical Sciences Research Council Cancer Imaging Centre, in association with the Medical Research Council and Department of Health (England), grant C1060/A10334, and National Health Service funding to the National Institute for Health Research Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boylan KLM, 2007, CANCER RES, V67, P4069, DOI 10.1158/0008-5472.CAN-06-3699; Calimeri T, 2011, LEUKEMIA, V25, P707, DOI 10.1038/leu.2010.300; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Edinger Matthias, 1999, Neoplasia (New York), V1, P303, DOI 10.1038/sj.neo.7900048; Gado K, 2001, HAEMATOLOGICA, V86, P227; Groen RW, 2010, BLOOD, V116; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lowenberg B, 2010, J CLIN ONCOL, V28, P4333, DOI 10.1200/JCO.2009.27.6295; Mitsiades CS, 2003, CANCER RES, V63, P6689; Miyakawa Y, 2004, BIOCHEM BIOPH RES CO, V313, P258, DOI 10.1016/j.bbrc.2003.11.120; Moore HE, 2009, MOL CANCER THER, V8, P762, DOI 10.1158/1535-7163.MCT-08-0735; Morito N, 2011, CANCER RES, V71, P339, DOI 10.1158/0008-5472.CAN-10-1057; Pattengale PK, 1997, AM J PATHOL, V151, P647; Podar K, 2007, BEST PRACT RES CL HA, V20, P597, DOI 10.1016/j.beha.2007.08.002; RADL J, 1979, J IMMUNOL, V122, P609; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; TONG AW, 1993, ANTICANCER RES, V13, P593; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yata K, 2004, LEUKEMIA, V18, P1891, DOI 10.1038/sj.leu.2403513	21	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57641	10.1371/journal.pone.0057641	http://dx.doi.org/10.1371/journal.pone.0057641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437401	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000114
J	He, YQ; Chen, J; Lu, XJ; Shi, YH				He, Yu-Qing; Chen, Jiong; Lu, Xin-Jiang; Shi, Yu-Hong			Characterization of P2X7R and Its Function in the Macrophages of ayu, Plecoglossus altivelis	PLOS ONE			English	Article							SCAVENGER RECEPTOR; APOPTOTIC CELLS; ATP; P2X(7); MYOSIN; LIPOPOLYSACCHARIDE; ZEBRAFISH; MECHANISM; MONOCYTES; BACTERIA	P2X purinoceptor 7 (P2X7R), an ATP-gated ion channel, plays an important role during the innate immune response in mammals. However, relatively little is known about the role of P2X7R in the fish immune system. Here, we cloned a cDNA sequence encoding ayu (Plecoglossus altivelis) P2X7R (aP2X7R). The predicted protein was composed of 574 amino acid residues with a P2X family signature, two transmembrane domains, and a long C-terminal. aP2X7R transcripts were mainly distributed in ayu immune tissues and significantly increased in all tested tissues and in macrophages after Listonella anguillarum infection. The aP2X7R protein was upregulated significantly in macrophages upon bacterial challenge. An antibody against the ectodomain of aP2X7R (aEPAb) and an antagonist (oATP) were used to block aP2X7R. aP2X7R siRNA was also used to knockdown the receptor expression in ayu macrophages. Cell death induced by ATP was significantly inhibited in ayu macrophages after aEPAb, oATP, or siRNA treatment. Moreover, aP2X7R ablation also resulted in suppression of phagocytic activity and ATP-induced bacterial killing in ayu macrophages. Our results indicated that aP2X7R was upregulated after infection and mediated cell death, phagocytosis, and bacterial killing of ayu macrophages.	[He, Yu-Qing; Chen, Jiong; Lu, Xin-Jiang; Shi, Yu-Hong] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University	Chen, J (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	jchen1975@163.com	He, Yuqing/GRR-5357-2022	He, Yuqing/0000-0002-7633-9188	Program for the National Natural Science Foundation of China [31201970]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201119291]; Research Fund for the Doctoral Program of Higher Education of China [20113305120001]; Discipline Project of Ningbo University [szx11069, xkc11004]; KC Wong Magna Fund in Ningbo University	Program for the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Zhejiang Provincial Education Department; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Discipline Project of Ningbo University; KC Wong Magna Fund in Ningbo University	The project was supported by the Program for the National Natural Science Foundation of China (31201970), the Scientific Research Fund of Zhejiang Provincial Education Department (Y201119291), the Research Fund for the Doctoral Program of Higher Education of China (20113305120001), the Discipline Project of Ningbo University (szx11069, xkc11004) and the KC Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; BRAUNNESJE R, 1981, J FISH DIS, V4, P141, DOI 10.1111/j.1365-2761.1981.tb01118.x; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chaves SP, 2009, MICROBES INFECT, V11, P842, DOI 10.1016/j.micinf.2009.05.001; Collo G, 1997, NEUROPHARMACOLOGY, V36, P1277, DOI 10.1016/S0028-3908(97)00140-8; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; Gu BJ, 2011, J IMMUNOL, V187, P2365, DOI 10.4049/jimmunol.1101178; Gu BJ, 2010, BLOOD, V115, P1621, DOI 10.1182/blood-2009-11-251744; Gu BJ, 2009, AM J PHYSIOL-CELL PH, V297, pC430, DOI 10.1152/ajpcell.00079.2009; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Kawano A, 2012, BIOCHEM BIOPH RES CO, V419, P374, DOI 10.1016/j.bbrc.2012.01.156; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Li Changhong, 2009, Weishengwu Xuebao, V49, P931; Lopez-Castejon G, 2007, MOL IMMUNOL, V44, P1286, DOI 10.1016/j.molimm.2006.05.015; Lu XJ, 2011, FISH SHELLFISH IMMUN, V31, P52, DOI 10.1016/j.fsi.2011.03.005; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; MURGIA M, 1993, J BIOL CHEM, V268, P8199; Nishimori E, 2000, INT J SYST EVOL MICR, V50, P83, DOI 10.1099/00207713-50-1-83; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Placido R, 2006, CELL IMMUNOL, V244, P10, DOI 10.1016/j.cellimm.2007.02.001; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Sambrook J., 1989, MOL CLONING LAB MANU; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Smith RA, 2001, VET IMMUNOL IMMUNOP, V78, P249, DOI 10.1016/S0165-2427(01)00245-8; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Watters JJ, 2001, DRUG DEVELOP RES, V53, P91, DOI 10.1002/ddr.1176; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Wiley JS, 2012, PURINERG SIGNAL, V8, P579, DOI 10.1007/s11302-012-9308-5	39	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57505	10.1371/journal.pone.0057505	http://dx.doi.org/10.1371/journal.pone.0057505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437395	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000108
J	Malda, J; de Grauw, JC; Benders, KEM; Kik, MJL; van de Lest, CHA; Creemers, LB; Dhert, WJA; van Weeren, PR				Malda, Jos; de Grauw, Janny C.; Benders, Kim E. M.; Kik, Marja J. L.; van de Lest, Chris H. A.; Creemers, Laura B.; Dhert, Wouter J. A.; van Weeren, P. Rene			Of Mice, Men and Elephants: The Relation between Articular Cartilage Thickness and Body Mass	PLOS ONE			English	Article							IN-VITRO; TOPOGRAPHICAL VARIATION; KNEE-JOINT; EQUINE; TISSUE; PROTEOGLYCAN; REGENERATION; ORGANIZATION; ALLOMETRY; STIFFNESS	Mammalian articular cartilage serves diverse functions, including shock absorption, force transmission and enabling low-friction joint motion. These challenging requirements are met by the tissue's thickness combined with its highly specific extracellular matrix, consisting of a glycosaminoglycan-interspersed collagen fiber network that provides a unique combination of resilience and high compressive and shear resistance. It is unknown how this critical tissue deals with the challenges posed by increases in body mass. For this study, osteochondral cores were harvested post-mortem from the central sites of both medial and lateral femoral condyles of 58 different mammalian species ranging from 25 g (mouse) to 4000 kg (African elephant). Joint size and cartilage thickness were measured and biochemical composition (glycosaminoclycan, collagen and DNA content) and collagen cross-links densities were analyzed. Here, we show that cartilage thickness at the femoral condyle in the mammalian species investigated varies between 90 mm and 3000 mm and bears a negative allometric relationship to body mass, unlike the isometric scaling of the skeleton. Cellular density (as determined by DNA content) decreases with increasing body mass, but gross biochemical composition is remarkably constant. This however need not affect life-long performance of the tissue in heavier mammals, due to relatively constant static compressive stresses, the zonal organization of the tissue and additional compensation by joint congruence, posture and activity pattern of larger mammals. These findings provide insight in the scaling of articular cartilage thickness with body weight, as well as in cartilage biochemical composition and cellularity across mammalian species. They underscore the need for the use of appropriate in vivo models in translational research aiming at human applications.	[Malda, Jos; Benders, Kim E. M.; Creemers, Laura B.; Dhert, Wouter J. A.] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Malda, Jos] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Malda, Jos; de Grauw, Janny C.; van de Lest, Chris H. A.; Dhert, Wouter J. A.; van Weeren, P. Rene] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Utrecht, Netherlands; [Kik, Marja J. L.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [van de Lest, Chris H. A.] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Queensland University of Technology (QUT); Utrecht University; Utrecht University; Utrecht University	Malda, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.malda@umcutrecht.nl	Malda, Jos/ABA-9685-2021; Creemers, Laura B/AAS-2424-2020	Dhert, Wouter/0000-0001-9150-6143; Malda, Jos/0000-0002-9241-7676; Creemers, Laura/0000-0002-1585-3052; van de Lest, Chris H.A./0000-0003-2143-2825	Dutch Arthritis Foundation; Alexandre Suerman Fellowship	Dutch Arthritis Foundation; Alexandre Suerman Fellowship	JM is supported by the Dutch Arthritis Foundation (www.reumafonds.nl). KB is supported by an Alexandre Suerman Fellowship (www.umcutrecht.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG SJ, 1995, OSTEOARTHR CARTILAGE, V3, P25, DOI 10.1016/S1063-4584(05)80035-4; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; Benninghoff A., 1925, CELL TISSUE RES, V2, P783, DOI [10.1007/bf00583443, DOI 10.1007/BF00583443, 10.1007/BF00583443]; Biewener AA, 2005, J EXP BIOL, V208, P1665, DOI 10.1242/jeb.01520; Brama PAJ, 2009, EQUINE VET J, V41, P557, DOI 10.2746/042516409X424162; Brama PAJ, 1999, AM J VET RES, V60, P341; Brama PAJ, 2000, EQUINE VET J, V32, P19, DOI 10.2746/042516400777612062; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Brommer H, 2005, EQUINE VET J, V37, P148, DOI 10.2746/0425164054223769; Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P600, DOI 10.2106/00004623-199704000-00021; Buckwalter JA, 1989, T ORTHOP RES SOC, V14, P155; Christiansen P, 2002, J MORPHOL, V251, P195, DOI 10.1002/jmor.1083; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Doube M, 2011, P BIOL SCI; Esquisatto MAM, 1997, ANN ANAT, V179, P433, DOI 10.1016/S0940-9602(97)80044-1; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142, DOI 10.1055/s-0038-1632990; Galilei Linceo G, 1683, DISCORZSI DEMOSTRAZI; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Han E, 2011, BIOPHYS J, V101, P916, DOI 10.1016/j.bpj.2011.07.006; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Holliday CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013120; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814; KEMPSON GE, 1970, BIOCHIM BIOPHYS ACTA, V215, P70, DOI 10.1016/0304-4165(70)90388-0; KIVIRANTA I, 1987, ARTHRITIS RHEUM, V30, P801, DOI 10.1002/art.1780300710; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Malda J, 2012, OSTEOARTHR CARTILAGE, V20, P1147, DOI 10.1016/j.joca.2012.06.005; Malda J, 2010, TISSUE ENG PT A, V16, P897, DOI 10.1089/ten.TEA.2009.0376; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; McGowan KB, 2002, OSTEOARTHR CARTILAGE, V10, P580, DOI 10.1053/joca.2002.0794; McIlwraith CW, 2011, CARTILAGE, V2, P317, DOI 10.1177/1947603511406531; McLure SWD, 2012, P I MECH ENG H, V226, P652, DOI 10.1177/0954411912447158; Rasanen T, 1996, J BIOMED MATER RES, V31, P519; REYNOLDS WW, 1977, HYDROBIOLOGIA, V56, P35, DOI 10.1007/BF00023283; Rogers BA, 2006, J BONE JOINT SURG BR, V88B, P1670, DOI 10.1302/0301-620X.88B12.18132; Schinagl RM, 1996, ANN BIOMED ENG, V24, P500, DOI 10.1007/BF02648112; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Schuurman W, 2009, AM J SPORT MED, V37, p97S, DOI 10.1177/0363546509350978; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; SIMON WH, 1970, ARTHRITIS RHEUM, V13, P244, DOI 10.1002/art.1780130305; Souza MV, 2010, EQUINE VET J, V42, P611, DOI 10.1111/j.2042-3306.2010.0089.x; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; STOCKWELL RA, 1971, J ANAT, V109, P411	44	81	82	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57683	10.1371/journal.pone.0057683	http://dx.doi.org/10.1371/journal.pone.0057683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437402	Green Published, gold			2022-12-25	WOS:000315186000115
J	O'Quin, KE; Yoshizawa, M; Doshi, P; Jeffery, WR				O'Quin, Kelly E.; Yoshizawa, Masato; Doshi, Pooja; Jeffery, William R.			Quantitative Genetic Analysis of Retinal Degeneration in the Blind Cavefish Astyanax mexicanus	PLOS ONE			English	Article							HOMEOBOX GENE; REGRESSIVE EVOLUTION; EYE DEGENERATION; AMACRINE CELLS; USHER-SYNDROME; OPSIN GENE; EXPRESSION; LENS; GANGLION; FISH	The retina is the light-sensitive tissue of the eye that facilitates vision. Mutations within genes affecting eye development and retinal function cause a host of degenerative visual diseases, including retinitis pigmentosa and anophthalmia/microphthalmia. The characin fish Astyanax mexicanus includes both eyed (surface fish) and eyeless (cavefish) morphs that initially develop eyes with normal retina; however, early in development, the eyes of cavefish degenerate. Since both surface and cave morphs are members of the same species, they serve as excellent evolutionary mutant models with which to identify genes causing retinal degeneration. In this study, we crossed the eyed and eyeless forms of A. mexicanus and quantified the thickness of individual retinal layers among 115 F-2 hybrid progeny. We used next generation sequencing (RAD-seq) and microsatellite mapping to construct a dense genetic map of the Astyanax genome, scan for quantitative trait loci (QTL) affecting retinal thickness, and identify candidate genes within these QTL regions. The map we constructed for Astyanax includes nearly 700 markers assembled into 25 linkage groups. Based on our scans with this map, we identified four QTL, one each associated with the thickness of the ganglion, inner nuclear, outer plexiform, and outer nuclear layers of the retina. For all but one QTL, cavefish alleles resulted in a clear reduction in the thickness of the affected layer. Comparative mapping of genetic markers within each QTL revealed that each QTL corresponds to an approximately 35 Mb region of the zebrafish genome. Within each region, we identified several candidate genes associated with the function of each affected retinal layer. Our study is the first to examine Astyanax retinal degeneration in the context of QTL mapping. The regions we identify serve as a starting point for future studies on the genetics of retinal degeneration and eye disease using the evolutionary mutant model Astyanax.	[O'Quin, Kelly E.; Yoshizawa, Masato; Doshi, Pooja; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	O'Quin, KE (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	koquin@umd.edu	Yoshizawa, Masato/AAE-9415-2022; Yoshizawa, Masato/D-6276-2013; Yoshizawa, Masato/AFD-8467-2022	Yoshizawa, Masato/0000-0001-8455-8252; Yoshizawa, Masato/0000-0001-9488-2283; Yoshizawa, Masato/0000-0001-8455-8252	Japan Society for the Promotion of Science; NSF [IBN-05384]; NIH [R01-EY014619]; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science to MY, and NSF (IBN-05384) and NIH (R01-EY014619) grants to WRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alunni A, 2007, J COMP NEUROL, V505, P221, DOI 10.1002/cne.21488; Behesti H, 2009, DEV BIOL, V333, P360, DOI 10.1016/j.ydbio.2009.06.026; Bem D, 2011, AM J HUM GENET, V88, P499, DOI 10.1016/j.ajhg.2011.03.012; Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Borowsky R, 2008, CURR BIOL, V18, pR23, DOI 10.1016/j.cub.2007.11.023; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2010, GENETIC MAP CONSTRUC; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Collery RF, 2010, ADV EXP MED BIOL, V664, P55, DOI 10.1007/978-1-4419-1399-9_7; de Melo J, 2005, DEVELOPMENT, V132, P311, DOI 10.1242/dev.01560; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Dowling JE, 2011, RETINA APPROACHABLE; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; Epting D, 2007, GENE EXPR PATTERNS, V7, P389, DOI 10.1016/j.modgep.2006.11.010; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Gallardo ME, 2004, AM J MED GENET A, V129A, P92, DOI 10.1002/ajmg.a.30126; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gordon A., 2011, FASTX TOOLKIT; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Grossman GH, 2009, INVEST OPHTH VIS SCI, V50, P3074, DOI 10.1167/iovs.08-3190; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P2706; Jeffery G, 1997, TRENDS NEUROSCI, V20, P165, DOI 10.1016/S0166-2236(96)10080-1; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; KIRBY RF, 1977, COPEIA, P578; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; LANGECKER TG, 1993, CELL TISSUE RES, V273, P183, DOI 10.1007/BF00304625; Lin-Jones J, 2007, INVEST OPHTH VIS SCI, V48, P1380, DOI 10.1167/iovs.06-0763; Liu XR, 1998, NAT GENET, V19, P117, DOI 10.1038/470; Manichaikul A, 2009, GENETICS, V181, P1077, DOI 10.1534/genetics.108.094565; MITCHELL RW, 1977, SPECIAL PUBLICATIONS, V12; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; O'Quin KE, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-251; Oetting WS, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9318; Porter FD, 1997, DEVELOPMENT, V124, P2935; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Scheer N, 2001, DEVELOPMENT, V128, P1099; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; Shen YC, 2004, DEV BIOL, V269, P237, DOI 10.1016/j.ydbio.2004.01.037; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Slavotinek AM, 2011, MOL GENET METAB, V104, P448, DOI 10.1016/j.ymgme.2011.09.029; Strickler AG, 2001, DEV GENES EVOL, V211, P138, DOI 10.1007/s004270000123; Strickler AG, 2007, DEV BIOL, V311, P512, DOI 10.1016/j.ydbio.2007.08.050; Strickler AG, 2009, INTEGR ZOOL, V4, P99, DOI 10.1111/j.1749-4877.2008.00139.x; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; WILKENS H, 1971, EVOLUTION, V25, P530, DOI 10.1111/j.1558-5646.1971.tb01913.x; WILKENS H, 1988, EVOL BIOL, V23, P271; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yamamoto Y, 2000, SCIENCE, V289, P631, DOI 10.1126/science.289.5479.631; YOKOYAMA S, 1995, MOL BIOL EVOL, V12, P527; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108	63	64	65	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57281	10.1371/journal.pone.0057281	http://dx.doi.org/10.1371/journal.pone.0057281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437360	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200236
J	Kim, H; Kim, MS; Wee, G; Lee, CI; Kim, H; Kim, JS				Kim, Hyojin; Kim, Myung-Sun; Wee, Gabbine; Lee, Choong-il; Kim, Hyongbum; Kim, Jin-Soo			Magnetic Separation and Antibiotics Selection Enable Enrichment of Cells with ZFN/TALEN-Induced Mutations	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; MAJOR HISTOCOMPATIBILITY COMPLEX; HYGROMYCIN-B PHOSPHOTRANSFERASE; CD4(+) T-CELLS; ESCHERICHIA-COLI; GENE CORRECTION; RESISTANCE; EXPRESSION; MOUSE; TRANSLOCATION	The ability to enrich cells with targeted mutations greatly facilitates the process of using engineered nucleases, including zinc-finger nucleases and transcription activator-like effector nucleases, to construct such cells. We previously used surrogate reporters to enrich cells containing nuclease-induced mutations via flow cytometry. This method is, however, limited by the availability of flow cytometers. Furthermore, sorted cells occasionally fail to form colonies after exposure to a strong laser and hydrostatic pressure. Here we describe two different types of novel reporters that enable mutant cell enrichment without the use of flow cytometers. We designed reporters that express H-2K(k), a surface antigen, and the hygromycin resistance protein (Hygro(R)), respectively, when insertions or deletions are generated at the target sequences by the activity of engineered nucleases. After cotransfection of these reporters and the engineered nuclease-encoding plasmids, H-2K(k)- and Hygro(R)-expressing cells were isolated using magnetic separation and hygromycin treatment, respectively. We found that mutant cells were drastically enriched in the isolated cells, suggesting that these two reporters enable efficient enrichment of mutants. We propose that these two reporters will greatly facilitate the use of engineered nucleases in a wider range of biomedical research.	[Kim, Hyojin; Wee, Gabbine; Lee, Choong-il; Kim, Jin-Soo] Seoul Natl Univ, Natl Creat Res Initiat Ctr Genome Engn, Seoul, South Korea; [Kim, Hyojin; Wee, Gabbine; Lee, Choong-il; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Kim, Myung-Sun; Kim, Hyongbum] Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hanyang University	Kim, H (corresponding author), Hanyang Univ, Coll Med, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea.	hkim1@hanyang.ac.kr; jskim01@snu.ac.kr	Kim, Hyongbum Henry/D-5804-2019; KIM, Jin-Soo/M-6918-2013	Kim, Hyongbum Henry/0000-0002-4693-738X; KIM, Jin-Soo/0000-0003-4847-1306	National Research Foundation of Korea [2012-0001225, 2012-0003376, 2012-0006735]	National Research Foundation of Korea(National Research Foundation of Korea)	J-SK and Hyongbum K. are supported in part by the National Research Foundation of Korea (J-SK, 2012-0001225; HK, 2012-0003376, 2012-0006735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; CABANAS MJ, 1978, EUR J BIOCHEM, V87, P21, DOI 10.1111/j.1432-1033.1978.tb12347.x; DAMJANOVICH S, 1984, MOL IMMUNOL, V21, P1151, DOI 10.1016/0161-5890(84)90003-8; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Gu Y, 2012, J VIROL METHODS, V182, P9, DOI 10.1016/j.jviromet.2012.02.007; Herrmann F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020913; HOOD L, 1983, ANNU REV IMMUNOL, V1, P529, DOI 10.1146/annurev.iy.01.040183.002525; Isalan M, 2012, NAT METHODS, V9, P32, DOI 10.1038/nmeth.1805; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; KUHSTOSS S, 1983, GENE, V26, P295, DOI 10.1016/0378-1119(83)90200-7; McMahon MA, 2012, NAT METHODS, V9, P28, DOI 10.1038/nmeth.1811; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porter CM, 2002, J IMMUNOL, V168, P4936, DOI 10.4049/jimmunol.168.10.4936; RAO RN, 1983, ANTIMICROB AGENTS CH, V24, P689, DOI 10.1128/AAC.24.5.689; SANTERRE RF, 1984, GENE, V30, P147, DOI 10.1016/0378-1119(84)90115-X; STEINMETZ M, 1983, SCIENCE, V222, P727, DOI 10.1126/science.6356354; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wei Q, 2001, POULTRY SCI, V80, P1671, DOI 10.1093/ps/80.12.1671; Willasch A, 2010, BONE MARROW TRANSPL, V45, P181, DOI 10.1038/bmt.2009.89; Zborowski M, 2011, ANAL CHEM, V83, P8050, DOI 10.1021/ac200550d; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	27	47	53	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56476	10.1371/journal.pone.0056476	http://dx.doi.org/10.1371/journal.pone.0056476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441197	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200054
J	Cho, YY; Kim, DJ; Lee, HS; Jeong, CH; Cho, EJ; Kim, MO; Byun, S; Lee, KY; Yao, K; Carper, A; Langfald, A; Bode, AM; Dong, ZG				Cho, Yong-Yeon; Kim, Dong Joon; Lee, Hye Suk; Jeong, Chul-Ho; Cho, Eun-Jin; Kim, Myong-Ok; Byun, Sanguine; Lee, Kun-Yeong; Yao, Ke; Carper, Andria; Langfald, Alyssa; Bode, Ann M.; Dong, Zigang			Autophagy and Cellular Senescence Mediated by Sox2 Suppress Malignancy of Cancer Cells	PLOS ONE			English	Article							INHIBITION; INDUCTION; GROWTH; DEATH; PTEN; PLURIPOTENCY; MECHANISMS; PHENOTYPE; APOPTOSIS; PATHWAY	Autophagy is a critical cellular process required for maintaining cellular homeostasis in health and disease states, but the molecular mechanisms and impact of autophagy on cancer is not fully understood. Here, we found that Sox2, a key transcription factor in the regulation of the "stemness'' of embryonic stem cells and induced-pluripotent stem cells, strongly induced autophagic phenomena, including intracellular vacuole formation and lysosomal activation in colon cancer cells. The activation occurred through Sox2-mediated ATG10 gene expression and resulted in the inhibition of cell proliferation and anchorage-independent colony growth ex vivo and tumor growth in vivo. Further, we found that Sox2-induced-autophagy enhanced cellular senescence by up-regulating tumor suppressors or senescence factors, including p16(INK4a), p21 and phosphorylated p53 (Ser15). Notably, knockdown of ATG10 in Sox2-expressing colon cancer cells restored cancer cell properties. Taken together, our results demonstrated that regulation of autophagy mediated by Sox2 is a mechanism-driven novel strategy to treat human colon cancers.	[Kim, Dong Joon; Jeong, Chul-Ho; Cho, Eun-Jin; Kim, Myong-Ok; Byun, Sanguine; Lee, Kun-Yeong; Yao, Ke; Carper, Andria; Langfald, Alyssa; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Cho, Yong-Yeon; Lee, Hye Suk] Catholic Univ Korea, Coll Pharm, Gyeonggi Do, South Korea	University of Minnesota System; Catholic University of Korea	Cho, YY (corresponding author), Catholic Univ Korea, Coll Pharm, Gyeonggi Do, South Korea.	yongyeon@catholic.ac.kr; zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; Byun, Sanguine/AAR-5451-2021	Byun, Sanguine/0000-0003-3903-5887; Cho, Yong-Yeon/0000-0003-1107-2651	Hormel Foundation; National Institutes of Health [CA111536, CA120388, CA077646, R37CA081064, ES016548]; Catholic University of Korea [M-2011-B0002-00025]; NATIONAL CANCER INSTITUTE [R37CA081064, R01CA120388, R01CA111536, R01CA077646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Catholic University of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by The Hormel Foundation and National Institutes of Health grants CA111536, CA120388, CA077646, R37CA081064 and ES016548, and by the Research Fund, M-2011-B0002-00025 of The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Choi HJ, 2006, GLYCOBIOLOGY, V16, P573, DOI 10.1093/glycob/cwj105; Colakoglu T, 2008, AM J SURG, V195, P719, DOI 10.1016/j.amjsurg.2007.05.061; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Ferbeyre G, 2000, GENE DEV, V14, P2015; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kanzawa T, 2003, CANCER RES, V63, P2103; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kuo TC, 2011, NAT CELL BIOL, V13, P1214, DOI 10.1038/ncb2332; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Oh S, 2011, CELL DEATH DIFFER, V18, P452, DOI 10.1038/cdd.2010.116; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sauer H, 2004, EXP CELL RES, V294, P313, DOI 10.1016/j.yexcr.2003.10.032; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schmelter M, 2006, FASEB J, V20, P1182, DOI 10.1096/fj.05-4723fje; SCHWEICHEL JU, 1973, TERATOLOGY, V7, P253, DOI 10.1002/tera.1420070306; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wacnik PW, 2005, PAIN, V115, P95, DOI 10.1016/j.pain.2005.02.024; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XL, 2005, J BIOL CHEM, V280, P19635, DOI 10.1074/jbc.M502262200; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4	49	27	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57172	10.1371/journal.pone.0057172	http://dx.doi.org/10.1371/journal.pone.0057172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451179	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500075
J	Gramlich, OW; Beck, S; Hohenstein-Blaul, NVU; Boehm, N; Ziegler, A; Vetter, JM; Pfeiffer, N; Grus, FH				Gramlich, Oliver W.; Beck, Sabine; Hohenstein-Blaul, Nadine von Thun Und; Boehm, Nils; Ziegler, Anika; Vetter, Jan M.; Pfeiffer, Norbert; Grus, Franz H.			Enhanced Insight into the Autoimmune Component of Glaucoma: IgG Autoantibody Accumulation and Pro-Inflammatory Conditions in Human Glaucomatous Retina	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; NORMAL-PRESSURE GLAUCOMA; NORMAL-TENSION GLAUCOMA; MYELIN BASIC-PROTEIN; MEMORY B-CELLS; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; AQUEOUS-HUMOR; SYSTEMIC INFLAMMATION	Background: There is accumulating evidence that autoimmune components, such as autoantibodies and autoantibody depositions, play a role in the pathogenesis of neurodegenerative diseases like Alzheimers disease or Multiple Sclerosis. Due to alterations of autoantibody patterns in sera and aqueous humor, an autoimmune component is also assumed in the pathogenesis of glaucoma, a common reason for irreversible blindness worldwide. So far there has been no convincing evidence that autoantibodies are accumulated in the retina of glaucoma patients and that the local immune homeostasis might be affected. Methods and Results: Six human glaucomatous donor eyes and nine samples from donors with no recorded ocular disease were included. Antibody microarrays were used to examine the patterns of pro-inflammatory proteins and complement proteins. Analysis of TNF-alpha and interleukin levels revealed a slight up-regulation exclusively in the glaucomatous group, while complement protein levels were not altered. IgG autoantibody accumulations and/or cellular components were determined by immunohistology (n = 4 per group). A significantly reduced number of retinal ganglion cells was found in the glaucomatous group (healthy: 104 +/- 7 nuclei/mm, glaucoma: 67 +/- 9 nuclei/mm; p = 0.0007). Cell loss was accompanied by strong retinal IgG autoantibody accumulations, which were at least twice as high as in healthy subjects (healthy: 5.0 +/- 0.5 IgG deposits/100 cells, glaucoma: 9.4 +/- 1.9 IgG deposits/100 cells; p = 0.004). CD27(+) cells and CD27(+)/IgG(+) plasma cells were observed in all glaucomatous subjects, but not in controls. Conclusion: This work provides serious evidence for the occurrence of IgG antibody deposition and plasma cells in human glaucomatous retina. Moreover, the results suggest that these IgG deposits occurred in a pro-inflammatory environment which seems to be maintained locally by immune-competent cells like microglia. Thereby, glaucoma features an immunological involvement comparable to other neurodegenerative diseases, but also shows a multifactorial pathomechanism, which diverges and might be linked to the specific nature of both eye and retina.	[Gramlich, Oliver W.; Beck, Sabine; Hohenstein-Blaul, Nadine von Thun Und; Boehm, Nils; Ziegler, Anika; Pfeiffer, Norbert; Grus, Franz H.] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Vetter, Jan M.] Univ Med Ctr Mainz, Dept Ophthalmol, Cornea Bank Rhineland Palatine, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	grus@eye-research.org	Pfeiffer, Norbert/AAO-7586-2020; Thun-Blaul, Nadine/B-6106-2018	Gramlich, Oliver W/0000-0001-6948-0522	Deutsche Forschungsgesellschaft (DFG) [Gr-1463/4-2]	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	This work was sponsored in parts by Deutsche Forschungsgesellschaft (DFG) Gr-1463/4-2. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, INDIAN J OPHTHALMOL, V57, P257, DOI 10.4103/0301-4738.53049; Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; BIGLER RD, 1988, J IMMUNOL, V141, P21; Chua J, 2012, MOL VIS, V18, P431; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; D'Andrea MR, 2005, MED HYPOTHESES, V64, P458, DOI 10.1016/j.mehy.2004.08.024; Daha NA, 2011, MOL IMMUNOL, V48, P1656, DOI 10.1016/j.molimm.2011.04.024; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Martin MD, 2007, FRONT BIOSCI-LANDMRK, V12, P2735, DOI 10.2741/2268; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; Duane TD, 2001, DUANES CLIN OPHTHALM; EGS, 2006, TERM GUID GLAUC; Emmerling MR, 2000, BBA-MOL BASIS DIS, V1502, P158, DOI 10.1016/S0925-4439(00)00042-9; Fecteau JF, 2009, IMMUNOLOGY, V128, pe353, DOI 10.1111/j.1365-2567.2008.02976.x; Gramlich OW, 2011, GRAEF ARCH CLIN EXP, V249, P1009, DOI 10.1007/s00417-011-1633-9; Grus FH, 2006, INVEST OPHTH VIS SCI, V47, P968, DOI 10.1167/iovs.05-0685; Grus FH, 2004, MOL VIS, V10, P132; Grus FH, 2003, INVEST OPHTH VIS SCI, V44, P2100; Grus FH, 2005, INVEST OPHTH VIS SCI, V46, P1285; Grus FH, 2008, J GLAUCOMA, V17, P79, DOI 10.1097/IJG.0b013e318156a592; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Ikeda Y, 2002, JPN J OPHTHALMOL, V46, P13, DOI 10.1016/S0021-5155(01)00455-5; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Janciauskiene S, 2011, EUR J OPHTHALMOL, V21, P104, DOI 10.5301/EJO.2010.2108; Joachim SC, 2005, GRAEF ARCH CLIN EXP, V243, P817, DOI 10.1007/s00417-004-1094-5; Joachim SC, 2003, EUR J OPHTHALMOL, V13, P752, DOI 10.1177/1120672103013009-1003; Joachim SC, 2004, INVEST OPHTH VIS SCI, V45, P879; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Joachim SC, 2007, MOL VIS, V13, P1573; Joachim SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040616; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kimura A, 2008, LUPUS, V17, P16, DOI 10.1177/0961203307085112; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kong GYX, 2009, J GLAUCOMA, V18, P93, DOI 10.1097/IJG.0b013e318181284f; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Kremmer S, 2001, CLIN EXP IMMUNOL, V125, P211, DOI 10.1046/j.1365-2249.2001.01578.x; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Laspas P, 2011, INVEST OPHTH VIS SCI, V52, P8835, DOI 10.1167/iovs.10-6889; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Maruyama I, 2000, INVEST OPHTH VIS SCI, V41, P1657; MAURER D, 1990, EUR J IMMUNOL, V20, P2679, DOI 10.1002/eji.1830201223; MAURER D, 1992, J IMMUNOL, V148, P3700; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor KC, 2003, J NEUROIMMUNOL, V136, P140, DOI 10.1016/S0165-5728(03)00002-X; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Osborne NN, 2010, NEUROCHEM RES, V35, P2027, DOI 10.1007/s11064-010-0273-5; Petrescu Simona, 2008, Oftalmologia, V52, P3; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ray K, 2009, J GENET, V88, P451, DOI 10.1007/s12041-009-0065-3; Reichelt J, 2008, CURR EYE RES, V33, P253, DOI 10.1080/02713680701871157; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Storch MK, 1998, ANN NEUROL, V43, P465, DOI 10.1002/ana.410430409; Streilein JW, 1999, PROG RETIN EYE RES, V18, P357, DOI 10.1016/S1350-9462(98)00022-6; Streilein JW, 2003, J LEUKOCYTE BIOL, V74, P179, DOI 10.1189/jlb.1102574; SUGITA K, 1992, J IMMUNOL, V149, P3208; SUTTER A, 1991, PATHOBIOLOGY, V59, P254; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Tezel G, 2000, ARCH OPHTHALMOL-CHIC, V118, P511, DOI 10.1001/archopht.118.4.511; Tezel G, 2003, INVEST OPHTH VIS SCI, V44, P3025, DOI 10.1167/iovs.02-1136; Tezel G, 1999, ARCH OPHTHALMOL-CHIC, V117, P917; Tezel G, 2011, EXP EYE RES, V93, P178, DOI 10.1016/j.exer.2010.07.009; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P5071, DOI 10.1167/iovs.10-5289; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P27, DOI 10.1097/00005072-199401000-00004; Veerhuis R, 2011, CURR ALZHEIMER RES, V8, P34, DOI 10.2174/156720511794604589; Vojdani A, 2003, J INTERN MED, V254, P363, DOI 10.1046/j.1365-2796.2003.01203.x; WARREN KG, 1994, ANN NEUROL, V35, P280, DOI 10.1002/ana.410350307; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wax MB, 1998, ARCH OPHTHALMOL-CHIC, V116, P993, DOI 10.1001/archopht.116.8.993; Wax MB, 1998, AM J OPHTHALMOL, V125, P145, DOI 10.1016/S0002-9394(99)80084-1; WAX MB, 1994, AM J OPHTHALMOL, V117, P561, DOI 10.1016/S0002-9394(14)70059-5; Wax MB, 2010, EXP EYE RES; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P1273; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104	87	84	85	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57557	10.1371/journal.pone.0057557	http://dx.doi.org/10.1371/journal.pone.0057557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451242	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500114
J	Grousl, T; Ivanov, P; Malcova, I; Pompach, P; Frydlova, I; Slaba, R; Senohrabkova, L; Novakova, L; Hasek, J				Grousl, Tomas; Ivanov, Pavel; Malcova, Ivana; Pompach, Petr; Frydlova, Ivana; Slaba, Renata; Senohrabkova, Lenka; Novakova, Lenka; Hasek, Jiri			Heat Shock-Induced Accumulation of Translation Elongation and Termination Factors Precedes Assembly of Stress Granules in S. cerevisiae	PLOS ONE			English	Article							CYTOPLASMIC PROCESSING BODIES; GUANINE-NUCLEOTIDE EXCHANGE; EUKARYOTIC MESSENGER-RNAS; SACCHAROMYCES-CEREVISIAE; P-BODIES; BUDDING YEAST; EIF2-ALPHA PHOSPHORYLATION; FISSION YEAST; POLYSOMES; BODY	In response to severe environmental stresses eukaryotic cells shut down translation and accumulate components of the translational machinery in stress granules (SGs). Since they contain mainly mRNA, translation initiation factors and 40S ribosomal subunits, they have been referred to as dominant accumulations of stalled translation preinitiation complexes. Here we present evidence that the robust heat shock-induced SGs of S. cerevisiae also contain translation elongation factors eEF3 (Yef3p) and eEF1B gamma 2 (Tef4p) as well as translation termination factors eRF1 (Sup45p) and eRF3 (Sup35p). Despite the presence of the yeast prion protein Sup35 in heat shock-induced SGs, we found out that its prion-like domain is not involved in the SGs assembly. Factors eEF3, eEF1B gamma 2 and eRF1 were accumulated and co-localized with Dcp2 foci even upon a milder heat shock at 42 degrees C independently of P-bodies scaffolding proteins. We also show that eEF3 accumulations at 42 degrees C determine sites of the genuine SGs assembly at 46 degrees C. We suggest that identification of translation elongation and termination factors in SGs might help to understand the mechanism of the eIF2 alpha factor phosphorylation-independent repression of translation and SGs assembly.	[Grousl, Tomas; Ivanov, Pavel; Malcova, Ivana; Pompach, Petr; Frydlova, Ivana; Slaba, Renata; Senohrabkova, Lenka; Novakova, Lenka; Hasek, Jiri] Inst Microbiol AS CR, Vvi, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Hasek, J (corresponding author), Inst Microbiol AS CR, Vvi, Prague, Czech Republic.	hasek@biomed.cas.cz	Malcova, Ivana/ABB-6413-2021; Ivanov, Pavel/AAZ-9197-2021; Malcova, Ivana/H-2439-2014; Hasek, Jiri/H-2427-2014; Pompach, Petr/J-6209-2014; Groušl, Tomáš/AAF-3655-2019; Ivanov, Pavel/F-3339-2016; Groušl, Tomáš/I-1727-2014; Senohrábková, Lenka/I-1668-2014; Lejskova, Renata/I-1669-2014	Malcova, Ivana/0000-0002-4385-3842; Ivanov, Pavel/0000-0002-7986-7760; Malcova, Ivana/0000-0002-4385-3842; Hasek, Jiri/0000-0001-6634-2386; Pompach, Petr/0000-0002-0606-0851; Groušl, Tomáš/0000-0002-6996-1323; Ivanov, Pavel/0000-0002-7986-7760; Groušl, Tomáš/0000-0002-6996-1323; Lejskova, Renata/0000-0002-5664-7837	Czech Science Foundation [204/09/1924, P305/12/0480, P305/10/P253, RVO61388971]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the grants of the Czech Science Foundation 204/09/1924, P305/12/0480 and P305/10/P253, and RVO61388971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Balagopal V, 2012, BIOCH BIOPHYS ACTA; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Brachmann CB, 1998, YEAST, V14, P115; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Campbell SG, 2005, J CELL BIOL, V170, P925, DOI 10.1083/jcb.200503162; Campbell SG, 2006, CELL CYCLE, V5, P678, DOI 10.4161/cc.5.7.2607; Chakraburtty K, 2001, RES MICROBIOL, V152, P391, DOI 10.1016/S0923-2508(01)01210-4; Cowart LA, 2010, BIOCHEM J, V431, P31, DOI 10.1042/BJ20100307; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Derkatch IL, 1996, GENETICS, V144, P1375; Dori D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000872; Dunand-Sauthier I, 2002, MOL BIOL CELL, V13, P1626, DOI 10.1091/mbc.01-06-0301; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hinnebusch AG, 2005, NAT STRUCT MOL BIOL, V12, P835, DOI 10.1038/nsmb1005-835; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kato K, 2011, YEAST, V28, P339, DOI 10.1002/yea.1842; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; MORTIMER RK, 1986, GENETICS, V113, P35; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Pisarev AV, 2010, MOL CELL, V37, P196, DOI 10.1016/j.molcel.2009.12.034; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J, 2001, MOL CLONING LAB MANU; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scarcelli JJ, 2008, GENETICS, V179, P1945, DOI 10.1534/genetics.108.091256; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Simpson CE, 2012, BIOCHEM SOC T, V40, P794, DOI 10.1042/BST20120078; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; TERAVANESYAN MD, 1994, GENETICS, V137, P671; Van Dyke N, 2009, NUCLEIC ACIDS RES, V37, P6116, DOI 10.1093/nar/gkp645; Zou TT, 2012, AM J PHYSIOL-CELL PH, V303, pC102, DOI 10.1152/ajpcell.00009.2012	56	41	41	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57083	10.1371/journal.pone.0057083	http://dx.doi.org/10.1371/journal.pone.0057083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451152	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500064
J	Jiang, X; Sun, LJ; Wang, BX; Yang, XJ; Shang, L; Zhang, YH				Jiang, Xun; Sun, Lijun; Wang, Baoxi; Yang, Xianjun; Shang, Lei; Zhang, Yuhai			Health-Related Quality of Life among Children with Recurrent Respiratory Tract Infections in Xi'an, China	PLOS ONE			English	Article							GENERIC CORE SCALES; FAMILY IMPACT MODULE; CHRONIC PAIN; SELF-REPORT; RELIABILITY; VALIDITY; PEDSQL(TM); AGREEMENT; PARENTS; VERSION	Objective: The aim of this study was to investigate the health-related quality of life (HRQOL) in 2-7-year-old children diagnosed with recurrent respiratory tract infections (RRTIs) and the impact of RRTIs on affected families. Methods: This was a cross-sectional case-control study evaluating 2-7-year-old children with RRTIs (n = 352), 2-7-year-old healthy children (n = 376), and associated caregivers (parents and/or grandparents). A Chinese version of the PedsQL (TM) 4.0 Generic Core Scale was used to assess childhood HRQOL, and a Chinese version of the Family Impact Module (FIM) was used to assess the impact of RRTIs on family members. HRQOL scores were compared between children with RRTIs and healthy children. In addition, a multiple step-wise regression with demographic variables of children and their caregivers, family economic status, and caregiver's HRQOL as independent variables determined factors that influenced HRQOL in children with RRTIs. Results: Children with RRTIs showed significantly lower physical, emotional, social, and school functioning scores than healthy children (p<0.05). Caregivers for children with RRTIs also scored significantly lower than caregivers for healthy children on physical, emotional, social, cognitive, and communication functioning (p<0.05). Caregivers for RRTIs affected children also reported significantly higher levels of worry. Multivariate analyses showed that children's age, children's relation with caregivers, the frequency of respiratory tract infections in the preceding year, caregiver's educational level, and caregiver's own HRQOL influenced HRQOL in children with RRTIs. Conclusions: The current data demonstrated that RRTIs were associated with lower HRQOL in both children and their caregivers and negatively influenced family functioning. In addition, caregivers' social characteristics also significantly affected HRQOL in children with RRTIs.	[Jiang, Xun; Wang, Baoxi] Fourth Mil Med Univ, Tangdu Hosp, Dept Pediat, Xian 710032, Shaanxi, Peoples R China; [Sun, Lijun; Yang, Xianjun; Shang, Lei; Zhang, Yuhai] Fourth Mil Med Univ, Dept Hlth Stat, Sch Publ Hlth, Xian 710032, Shaanxi, Peoples R China; [Sun, Lijun; Yang, Xianjun; Shang, Lei; Zhang, Yuhai] Fourth Mil Med Univ, Minist Educ, Sch Publ Hlth, Key Lab Hazard Assessment & Control Special Opera, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shang, L (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Sch Publ Hlth, Xian 710032, Shaanxi, Peoples R China.	shanglei@fmmu.edu.cn; zhyh@fmmu.edu.cn	Yang, Xian/GVU-9087-2022	Jiang, Xun/0000-0002-3344-4797	National Natural Science Funds [81273175]; Social Development Research Funds of Shaanxi Province [2011K12-31]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Social Development Research Funds of Shaanxi Province	This study was supported by National Natural Science Funds (No. 81273175) and Social Development Research Funds of Shaanxi Province (No. 2011K12-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bullinger M, 1995, EUR REV APPL PSYCHOL, V45, P245; Cazzola M, 2012, PULM PHARMACOL THER, V25, P62, DOI 10.1016/j.pupt.2011.11.002; Chang PC, 2005, PSYCHO-ONCOLOGY, V14, P125, DOI 10.1002/pon.828; Chen RQ, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-16; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; Eiser C, 2001, J DEV BEHAV PEDIATR, V22, P248, DOI 10.1097/00004703-200108000-00007; Esposito S, 2003, VACCINE, V21, P3162, DOI 10.1016/S0264-410X(03)00253-6; Gerson AC, 2010, PEDIATRICS, V125, pE349, DOI 10.1542/peds.2009-0085; Goldstein SL, 2008, AM J KIDNEY DIS, V51, P285, DOI 10.1053/j.ajkd.2007.09.021; Goldstein SL, 2006, PEDIATR NEPHROL, V21, P846, DOI 10.1007/s00467-006-0081-y; Hao YT, 2010, QUAL LIFE RES, V19, P1229, DOI 10.1007/s11136-010-9672-y; Huang IC, 2009, VALUE HEALTH, V12, P773, DOI 10.1111/j.1524-4733.2008.00487.x; Hunfeld JAM, 2001, J PEDIATR PSYCHOL, V26, P145, DOI 10.1093/jpepsy/26.3.145; Jokovic A, 2004, QUAL LIFE RES, V13, P1297, DOI 10.1023/B:QURE.0000037480.65972.eb; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; Korppi M, 1997, PEDIATR PULM, P144; [卢奕云 LU Yiyun], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P328; Mano KEJ, 2011, J PEDIATR PSYCHOL, V36, P517, DOI 10.1093/jpepsy/jsp099; Rajmil L, 2011, INT J NURS STUD, V48, P549, DOI 10.1016/j.ijnurstu.2010.09.004; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Sawyer MG, 2004, QUAL LIFE RES, V13, P1309, DOI 10.1023/B:QURE.0000037489.41344.b2; Shen X, 2008, PEDIATRICS, P259; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Williams S, 2000, J URBAN HEALTH, V77, P268, DOI 10.1007/BF02390538; Yackobovitch-Gavan M, 2009, NUTR RES, V29, P397, DOI 10.1016/j.nutres.2009.05.007	31	19	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56945	10.1371/journal.pone.0056945	http://dx.doi.org/10.1371/journal.pone.0056945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451114	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500045
J	Laokri, S; Drabo, MK; Weil, O; Kafando, B; Dembele, SM; Dujardin, B				Laokri, Samia; Drabo, Maxime Koine; Weil, Olivier; Kafando, Benoit; Dembele, Sary Mathurin; Dujardin, Bruno			Patients Are Paying Too Much for Tuberculosis: A Direct Cost-Burden Evaluation in Burkina Faso	PLOS ONE			English	Article							CASE-MANAGEMENT; 2 DISTRICTS; SERVICES; CARE; BARRIERS; ACCESS	Background: Paying for health care may exclude poor people. Burkina Faso adopted the DOTS strategy implementing "free care" for Tuberculosis (TB) diagnosis and treatment. This should increase universal health coverage and help to overcome social and economic barriers to health access. Methods: Straddling 2007 and 2008, in-depth interviews were conducted over a year among smear-positive pulmonary tuberculosis patients in six rural districts of Burkina Faso. Out-of-pocket expenses (direct costs) associated with TB were collected according to the different stages of their healthcare pathway. Results: Median direct cost associated with TB was US$ 101 (n = 229) (i.e. 2.8 months of household income). Respectively 72% of patients incurred direct costs during the pre-diagnosis stage (i.e. self-medication, travel, traditional healers' services), 95% during the diagnosis process (i.e. user fees, travel costs to various providers, extra sputum smears microscopy and chest radiology), 68% during the intensive treatment (i.e. medical and travel costs) and 50% during the continuation treatment (i.e. medical and travel costs). For the diagnosis stage, median direct costs already amounted to 35% of overall direct costs. Conclusions: The patient care pathway analysis in rural Burkina Faso showed substantial direct costs and healthcare system delay within a "free care" policy for TB diagnosis and treatment. Whether in terms of redefining the free TB package or rationalizing the care pathway, serious efforts must be undertaken to make "free" health care more affordable for the patients. Locally relevant for TB, this case-study in Burkina Faso has a real potential to document how health programs' weaknesses can be identified and solved.	[Laokri, Samia; Dujardin, Bruno] Univ Libre Brussels, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium; [Drabo, Maxime Koine] LNSP, Ouagadougou, Burkina Faso; [Weil, Olivier] HLSP Inst, London, England; [Kafando, Benoit] Bur Suivi Evaluat, Direct Regionale Sante DRS Plateau Cent, Ouagadougou, Burkina Faso; [Dembele, Sary Mathurin] Programme Natl Lutte AntiTB PNLAT, Ouagadougou, Burkina Faso	Universite Libre de Bruxelles	Laokri, S (corresponding author), Univ Libre Brussels, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium.	slaokri@ulb.ac.be	Laokri, Samia/AFT-2884-2022	Laokri, Samia/0000-0002-9814-5405	EUROPAID/COMMISSION EUROPEENNE [SANTE/2004/078-590]	EUROPAID/COMMISSION EUROPEENNE	Data was collected within the framework of a FORESA research-action project funded by PROJET SANTE/2004/078-590 EUROPAID/COMMISSION EUROPEENNE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANCET, V379, P1076, DOI DOI 10.1016/S0140-6736(12)60446-2; Auston Bonnie J, 2010, Find Brief, V13, P1; Aye R, 2011, TROP MED INT HEALTH, V16, P307, DOI 10.1111/j.1365-3156.2010.02710.x; Das P, 2012, LANCET, V379, P1089, DOI 10.1016/S0140-6736(12)60447-4; Dembele SM, 2006, INT J TUBERC LUNG D, V10, P436; Drabo KM, 2006, INT J TUBERC LUNG D, V10, P93; Gibson N, 1998, INT J TUBERC LUNG D, V2, P726; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Laokri S, 2011, TROP MED INT HEALTH, V16, P340; Laokri S, 2012, B WHO; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; Mauch V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-43; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mumba M, 2003, TROP MED INT HEALTH, V8, P544, DOI 10.1046/j.1365-3156.2003.01064.x; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Ravallion M, 2010, WORKING PAPER; Ridde V, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-409; Sanou A, 2004, INT J TUBERC LUNG D, V8, P1479; Ukwaja KN, 2012, INT J TUBERC LUNG DI; Umar NA, 2012, INT J TUBERC LUNG D, V16, P835, DOI 10.5588/ijtld.10.0774; Van Wyk SS, 2011, INT J TUBERC LUNG D, V15, P1069, DOI 10.5588/ijtld.10.0615; Xu K., 2005, DESIGNING HLTH FINAN	23	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56752	10.1371/journal.pone.0056752	http://dx.doi.org/10.1371/journal.pone.0056752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451079	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500026
J	Long, YQ; Kong, DL; Chen, ZX; Zeng, H				Long, Yingqian; Kong, Deliang; Chen, Zhengxia; Zeng, Hui			Variation of the Linkage of Root Function with Root Branch Order	PLOS ONE			English	Article							HYDRAULIC ARCHITECTURE; HAINAN ISLAND; ANATOMY; CARBON; WOOD; TRAITS; XYLEM; HETEROGENEITY; STRATEGIES; ALLOCATION	Mounting evidence has shown strong linkage of root function with root branch order. However, it is not known whether this linkage is consistent in different species. Here, root anatomic traits of the first five branch order were examined in five species differing in plant phylogeny and growth form in tropical and subtropical forests of south China. In Paramichelia baillonii, one tree species in Magnoliaceae, the intact cortex as well as mycorrhizal colonization existed even in the fifth-order root suggesting the preservation of absorption function in the higher-order roots. In contrast, dramatic decreases of cortex thickness and mycorrhizal colonization were observed from lower- to higher-order roots in three other tree species, Cunninghamia lanceolata, Acacia auriculiformis and Gordonia axillaries, which indicate the loss of absorption function. In a fern, Dicranopteris dichotoma, there were several cortex layers with prominently thickened cell wall and no mycorrhizal colonization in the third- and fourth-order roots, also demonstrating the loss of absorptive function in higher-order roots. Cluster analysis using these anatomic traits showed a different classification of root branch order in P. baillonii from other four species. As for the conduit diameter-density relationship in higher-order roots, the mechanism underpinning this relationship in P. baillonii was different from that in other species. In lower-order roots, different patterns of coefficient of variance for conduit diameter and density provided further evidence for the two types of linkage of root function with root branch order. These linkages corresponding to two types of ephemeral root modules have important implication in the prediction of terrestrial carbon cycling, although we caution that this study was pseudo-replicated. Future studies by sampling more species can test the generality of these two types of linkage.	[Long, Yingqian; Kong, Deliang; Chen, Zhengxia; Zeng, Hui] Peking Univ, Shenzhen Grad Sch, Key Lab Sci & Technol Urban Environm, Shenzhen, Peoples R China; [Kong, Deliang] Henan Univ, Sch Life Sci, Kaifeng, Peoples R China; [Zeng, Hui] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Zeng, Hui] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Beijing 100871, Peoples R China	Peking University; University Town of Shenzhen; Henan University; Peking University; Peking University	Kong, DL (corresponding author), Peking Univ, Shenzhen Grad Sch, Key Lab Sci & Technol Urban Environm, Shenzhen, Peoples R China.	deliangkong1999@126.com; zengh@pkusz.edu.cn			Innovative Research Group Project of National Natural Science Foundation of China [31021001]; Natural Science Foundation of China (NSFC grant) [31200344]	Innovative Research Group Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China (NSFC grant)(National Natural Science Foundation of China (NSFC))	This study was funded by Innovative Research Group Project of National Natural Science Foundation of China (31021001), and funded by Natural Science Foundation of China (NSFC grant 31200344). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas P., 2004, EVOLUTION PLANT PHYS, DOI DOI 10.1016/B978-012339552-8/50016-0; Baylis GTS, 1975, ENDOMYCORRHIZAS, V373, P389; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Christensen-Dalsgaard KK, 2007, J EXP BOT, V58, P4095, DOI 10.1093/jxb/erm268; Christensen-Dalsgaard KK, 2007, NEW PHYTOL, V176, P610, DOI 10.1111/j.1469-8137.2007.02227.x; Comas LH, 2004, FUNCT ECOL, V18, P388, DOI 10.1111/j.0269-8463.2004.00835.x; Drigo B, 2010, P NATL ACAD SCI USA, V107, P10938, DOI 10.1073/pnas.0912421107; Eissenstat DM, 1999, NEW PHYTOL, V141, P309, DOI 10.1046/j.1469-8137.1999.00342.x; Esau K., 1977, ANATOMY SEED PLANTS; Espeleta JF, 2009, ECOLOGY, V90, P1773, DOI 10.1890/08-0056.1; FALSTER DS, 2006, SMART STANDARDISED M; Fan ZX, 2009, IAWA J, V30, P1, DOI 10.1163/22941932-90000198; Fan ZX, 2012, J ECOLOGY; Farm K, 2002, S CHINA FOREST BIODI; Fellbaum CR, 2012, P NATL ACAD SCI USA, V109, P2666, DOI 10.1073/pnas.1118650109; Fitter Alastair H, 2004, New Phytol, V164, P15, DOI 10.1111/j.1469-8137.2004.01193.x; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Hacke UG, 2004, AM J BOT, V91, P386, DOI 10.3732/ajb.91.3.386; Hishi T, 2007, J FOREST RES-JPN, V12, P126, DOI 10.1007/s10310-006-0260-5; Hummel I, 2007, NEW PHYTOL, V173, P313, DOI 10.1111/j.1469-8137.2006.01912.x; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Keel SG, 2012, NEW PHYTOL, V194, P972, DOI 10.1111/j.1469-8137.2012.04120.x; Kong DL, 2010, PLANT SOIL, V336, P209, DOI 10.1007/s11104-010-0467-2; Lux A., 2004, ROOT RES, V13, P117, DOI [DOI 10.3117/ROOTRES.13.117, 10.3117/rootres.13.117]; Pittermann J, 2005, SCIENCE, V310, P1924, DOI 10.1126/science.1120479; Pittermann J, 2006, AM J BOT, V93, P1265, DOI 10.3732/ajb.93.9.1265; Pittermann J, 2011, NEW PHYTOL, V192, P449, DOI 10.1111/j.1469-8137.2011.03817.x; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Raven JA, 2001, J EXP BOT, V52, P381, DOI 10.1093/jexbot/52.suppl_1.381; Rewald B, 2011, PLANT CELL ENVIRON, V34, P33, DOI 10.1111/j.1365-3040.2010.02223.x; Robert EMR, 2009, FUNCT ECOL, V23, P649, DOI 10.1111/j.1365-2435.2009.01551.x; Rowe N, 2004, J PLANT GROWTH REGUL, V23, P108, DOI 10.1007/s00344-004-0044-0; Shen WJ, 2000, ACTA PHYTOECOLOGICA, V2; Sperry JS, 2008, PLANT CELL ENVIRON, V31, P632, DOI 10.1111/j.1365-3040.2007.01765.x; Sperry JS, 2006, AM J BOT, V93, P1490, DOI 10.3732/ajb.93.10.1490; St. John T. V., 1980, Acta Amazonica, V10, P527; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Sun Y, 2011, PLANT SOIL, V347, P351, DOI 10.1007/s11104-011-0854-3; Tyree M. T., 2002, SPR S WOOD; Valenzuela-Estrada LR, 2008, AM J BOT, V95, P1506, DOI 10.3732/ajb.0800092; Valenzuela-Estrada LR, 2009, J EXP BOT, V60, P1241, DOI 10.1093/jxb/ern367; Verdaguer D, 2002, AM J BOT, V89, P1189, DOI 10.3732/ajb.89.8.1189; Vogt K., 1991, TECHNIQUES APPROACHE, P477; Wahl S, 2000, NEW PHYTOL, V148, P459, DOI 10.1046/j.1469-8137.2000.00775.x; Wang JJ, 2012, ENVIRON SCI TECHNOL, V46, P769, DOI 10.1021/es2018708; Wei Xing, 2008, Zhiwu Shengtai Xuebao, V32, P1238, DOI 10.3773/j.issn.1005-264x.2008.06.004; Xia MX, 2010, NEW PHYTOL, V188, P1065, DOI 10.1111/j.1469-8137.2010.03423.x; Xiong YM, 2008, PLANT SOIL, V304, P179, DOI 10.1007/s11104-007-9536-6; Xu Yang, 2011, Chinese Journal of Plant Ecology, V35, P955, DOI 10.3724/SP.J.1258.2011.00955; Zhou Zhang, 2009, Shengtaixue Zazhi, V28, P1006	54	32	44	7	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57153	10.1371/journal.pone.0057153	http://dx.doi.org/10.1371/journal.pone.0057153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451168	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500070
J	Ranieri, D; Raffa, S; Parente, A; Del Monte, SR; Ziparo, V; Torrisi, MR				Ranieri, Danilo; Raffa, Salvatore; Parente, Andrea; Del Monte, Simone Rossi; Ziparo, Vincenzo; Torrisi, Maria Rosaria			High Adhesion of Tumor Cells to Mesothelial Monolayers Derived from Peritoneal Wash of Disseminated Gastrointestinal Cancers	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; IN-VITRO; COLORECTAL-CANCER; GASTRIC-CARCINOMA; OVARIAN-CARCINOMA; METASTASIS; GROWTH; EXPRESSION	The role of the mesothelial layer in the peritoneal spreading of cancer cells is only partially clarified. Here we attempted to better define the mesothelial contribution to the tumor cell adhesion using a direct adhesion test applied to human primary cultures of mesothelial cells (HPMCs) derived from the peritoneal washes of patients with gastric and colorectal cancers. Gastric and colon carcinoma cells were seeded on different mesothelial monolayers and quantitative fluorescence analysis was performed to analyze their growth and adhesive properties. The adhesion of the cancer cells was not affected by the origin of the HPMCs when derived from patients with different cancers or with benign disease. In contrast, the high levels of ICAM1 expression and ROS production, which characterize these senescent mesothelial cells, enhanced the tumor cell adhesion. These results suggest that the mesothelial adhesive properties are dependent on the cell senescence, while are not affected by the tumor environment. The use of peritoneal washes as a source to isolate HPMCs provides a practical and reliable tool for the in vitro analysis of the mesothelial conditions affecting the peritoneal carcinomatosis.	[Ranieri, Danilo; Raffa, Salvatore; Parente, Andrea; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Inst Pasteur Fdn Cenci Bolognetti, Dept Clin & Mol Med, Rome, Italy; [Del Monte, Simone Rossi; Ziparo, Vincenzo] Univ Roma La Sapienza, Dept Gen Surg, Rome, Italy; [Raffa, Salvatore; Ziparo, Vincenzo; Torrisi, Maria Rosaria] St Andrea Hosp, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Raffa, S (corresponding author), Univ Roma La Sapienza, Inst Pasteur Fdn Cenci Bolognetti, Dept Clin & Mol Med, Rome, Italy.	salvatore.raffa@uniroma1.it	RAFFA, SALVATORE/AAL-5514-2020; Raffa, Salvatore/AAW-7060-2020; Raffa, Salvatore/GPX-5723-2022	Raffa, Salvatore/0000-0001-9501-7638; Parente, Andrea/0000-0001-6820-9474	MIUR; AIRC - Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]	MIUR(Ministry of Education, Universities and Research (MIUR)); AIRC - Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from MIUR and from AIRC - Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhamesi NA, 2005, CLIN EXP METASTAS, V22, P449, DOI 10.1007/s10585-005-2893-8; Benevolo M, 1998, J CLIN ONCOL, V16, P3406, DOI 10.1200/JCO.1998.16.10.3406; Cabourne EJ, 2010, J SURG RES, V164, pE265, DOI 10.1016/j.jss.2010.09.041; Cardinali G, 2006, EXP MOL PATHOL, V81, P31, DOI 10.1016/j.yexmp.2005.10.001; Casey RC, 2003, CLIN EXP METASTAS, V20, P343, DOI 10.1023/A:1024009131191; Ceelen WP, 2009, LANCET ONCOL, V10, P72, DOI 10.1016/S1470-2045(08)70335-8; Del Monte SR, 2012, J SURG ONCOL, V106, P17, DOI 10.1002/jso.23052; Harada N, 2001, INT J CANCER, V91, P67, DOI 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D; Heyman L, 2008, TUMOR BIOL, V29, P231, DOI 10.1159/000152941; Ivarsson ML, 1998, SCAND J CLIN LAB INV, V58, P195, DOI 10.1080/00365519850186580; Jayne DG, 2002, BRIT J SURG, V89, P1545, DOI 10.1046/j.1365-2168.2002.02274.x; Jayne DG, 1999, CLIN EXP METASTAS, V17, P515, DOI 10.1023/A:1006606006878; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Kovacs D, 2009, J DERMATOL SCI, V54, P106, DOI 10.1016/j.jdermsci.2009.01.005; Ksiazek K, 2008, FREE RADICAL BIO MED, V45, P460, DOI 10.1016/j.freeradbiomed.2008.04.032; Ksiazek K, 2010, INT J CANCER, V127, P293, DOI 10.1002/ijc.25036; Ksiazek K, 2009, AM J PATHOL, V174, P1230, DOI 10.2353/ajpath.2009.080613; Nekarda H, 1999, BRIT J CANCER, V79, P611, DOI 10.1038/sj.bjc.6690096; Sadeghi B, 2000, CANCER-AM CANCER SOC, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Saito Y, 2010, CLIN EXP METASTAS, V27, P197, DOI 10.1007/s10585-010-9314-3; Sikkink CJJM, 2009, TRANSL RES, V153, P240, DOI 10.1016/j.trsl.2009.01.003; Sugarbaker PH, 2000, ONCOLOGY-BASEL, V58, P96, DOI 10.1159/000012086; Takatsuki H, 2004, CANCER RES, V64, P6065, DOI 10.1158/0008-5472.CAN-04-0321; van Grevenstein WMU, 2007, DIGEST DIS SCI, V52, P2775, DOI 10.1007/s10620-007-9778-4; Visco V, 2004, J CELL PHYSIOL, V200, P31, DOI 10.1002/jcp.10385; Yung S, 2006, PERITON DIALYSIS INT, V26, P162; Ziprin P, 2003, CELL COMMUN ADHES, V10, P141, DOI 10.1080/15419060390262561	27	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57659	10.1371/journal.pone.0057659	http://dx.doi.org/10.1371/journal.pone.0057659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451255	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500123
J	Begue, G; Douillard, A; Galbes, O; Rossano, B; Vernus, B; Candau, R; Py, G				Begue, Gwenaelle; Douillard, Aymeric; Galbes, Olivier; Rossano, Bernadette; Vernus, Barbara; Candau, Robin; Py, Guillaume			Early Activation of Rat Skeletal Muscle IL-6/STAT1/STAT3 Dependent Gene Expression in Resistance Exercise Linked to Hypertrophy	PLOS ONE			English	Article							SATELLITE CELL; MYOGENIC DIFFERENTIATION; MOLECULAR RESPONSES; ECCENTRIC EXERCISE; TRAPEZIUS MUSCLE; GROWTH-FACTOR; TNF-ALPHA; INTERLEUKIN-6; STAT3; HUMANS	Cytokine interleukin-6 (IL-6) is an essential regulator of satellite cell-mediated hypertrophic muscle growth through the transcription factor signal transducer and activator of transcription 3 (STAT3). The importance of this pathway linked to the modulation of myogenic regulatory factors expression in rat skeletal muscle undergoing hypertrophy following resistance exercise, has not been investigated. In this study, the phosphorylation and nuclear localization of STAT3, together with IL-6/STAT3-responsive gene expression, were measured after both a single bout of resistance exercise and 10 weeks of training. Flexor Digitorum Profundus muscle samples from Wistar rats were obtained 2 and 6 hours after a single bout of resistance exercise and 72 h after the last bout of either 2, 4, or 10 weeks of resistance training. We observed an increase in IL-6 and SOCS3 mRNAs concomitant with phosphorylation of STAT1 and STAT3 after 2 and 6 hours of a single bout of exercise (p<0.05). STAT3-dependent early responsive genes such as CyclinD1 and cMyc were also upregulated whereas MyoD and Myf5 mRNAs were downregulated (p<0.05). BrdU-positive satellite cells increased at 2 and 6 hours after exercise (p<0.05). Muscle fiber hypertrophy reached up to 100% after 10 weeks of training and the mRNA expression of Myf5, c-Myc and Cyclin-D1 decreased, whereas IL-6 mRNA remained upregulated. We conclude that the IL-6/STAT1/STAT3 signaling pathway and its responsive genes after a single bout of resistance exercise are an important event regulating the SC pool and behavior involved in muscle hypertrophy after ten weeks of training in rat skeletal muscle.	[Begue, Gwenaelle; Douillard, Aymeric; Galbes, Olivier; Rossano, Bernadette; Vernus, Barbara; Candau, Robin; Py, Guillaume] Univ Montpellier I, INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France	INRAE; Universite de Montpellier	Py, G (corresponding author), Univ Montpellier I, INRA, Dynam Musculaire & Metab UMR866, F-34060 Montpellier, France.	guillaume.py@univ-montp1.fr	Begue, Gwenaelle/X-8347-2019	Begue, Gwenaelle/0000-0002-0636-8303; candau, robin/0000-0002-5930-8750	World Anti-doping Agency	World Anti-doping Agency	This project was supported and funded by World Anti-doping Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY PJ, 1994, SPORTS MED, V17, P22, DOI 10.2165/00007256-199417010-00003; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Bickel CS, 2005, J APPL PHYSIOL, V98, P482, DOI 10.1152/japplphysiol.00895.2004; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Charifi N, 2003, MUSCLE NERVE, V28, P87, DOI 10.1002/mus.10394; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Costa A, 2007, EUR J APPL PHYSIOL, V101, P427, DOI 10.1007/s00421-007-0510-z; Dominov JA, 2001, DEV DYNAM, V220, P18, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1088>3.0.CO;2-#; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Haddad F, 2002, J APPL PHYSIOL, V93, P394, DOI 10.1152/japplphysiol.01153.2001; Hiscock N, 2004, FASEB J, V18, P992, DOI 10.1096/fj.03-1259fje; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Jenab S, 1996, ENDOCRINOLOGY, V137, P4738, DOI 10.1210/en.137.11.4738; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Matsui T, 2002, J BIOL CHEM, V277, P36167, DOI 10.1074/jbc.M203184200; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Parker PJ, 1999, J PEDIATR ORTHOP B, V8, P64; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Penkowa M, 2003, FASEB J, V17, DOI 10.1096/fj.03-0311fje; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Puntschart A, 1998, AM J PHYSIOL-CELL PH, V274, pC129, DOI 10.1152/ajpcell.1998.274.1.C129; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rennie MJ, 2004, ANNU REV PHYSIOL, V66, P799, DOI 10.1146/annurev.physiol.66.052102.134444; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Sakuma K, 1999, BBA-GEN SUBJECTS, V1428, P284, DOI 10.1016/S0304-4165(99)00086-0; SCHINDLER R, 1990, BLOOD, V75, P40; SCHULTZ E, 1989, MED SCI SPORT EXER, V21, pS181; Schultz E, 2006, DEV DYNAM, V235, P3230, DOI 10.1002/dvdy.20976; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; Steensberg A, 2006, BRAIN BEHAV IMMUN, V20, P585, DOI 10.1016/j.bbi.2006.03.002; Sun DQ, 2008, J CELL SCI, V121, P3815, DOI 10.1242/jcs.035493; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; TAMAKI T, 1992, MED SCI SPORT EXER, V24, P881; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; Trenerry MK, 2011, MUSCLE NERVE, V43, P385, DOI 10.1002/mus.21875; Vierck J, 2000, CELL BIOL INT, V24, P263, DOI 10.1006/cbir.2000.0499; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yang YP, 2009, CYTOKINE, V46, P137, DOI 10.1016/j.cyto.2008.12.015; Yoshida N, 1998, J CELL SCI, V111, P769	63	84	87	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57141	10.1371/journal.pone.0057141	http://dx.doi.org/10.1371/journal.pone.0057141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451164	Green Published, gold			2022-12-25	WOS:000316658800077
J	Kai, L; Dotsch, V; Kaldenhoff, R; Bernhard, F				Kai, Lei; Doetsch, Volker; Kaldenhoff, Ralf; Bernhard, Frank			Artificial Environments for the Co-Translational Stabilization of Cell-Free Expressed Proteins	PLOS ONE			English	Article							THERMAL-STABILITY; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; IN-VITRO; OSMOLYTES; ACCUMULATION; AGGREGATION; INHIBITION; TREHALOSE; ARGININE	An approach for designing individual expression environments that reduce or prevent protein aggregation and precipitation is described. Inefficient folding of difficult proteins in unfavorable translation environments can cause significant losses of overexpressed proteins as precipitates or inclusion bodies. A number of chemical chaperones including alcohols, polyols, polyions or polymers are known to have positive effects on protein stability. However, conventional expression approaches can use such stabilizing agents only post-translationally during protein extraction and purification. Proteins that already precipitate inside of the producer cells cannot be addressed. The open nature of cell-free protein expression systems offers the option to include single chemicals or cocktails of stabilizing compounds already into the expression environment. We report an approach for systematic screening of stabilizers in order to improve the solubility and quality of overexpressed proteins co-translationally. A comprehensive list of representative protein stabilizers from the major groups of naturally occurring chemical chaperones has been analyzed and their concentration ranges tolerated by cell-free expression systems have been determined. As a proof of concept, we have applied the method to improve the yield of proteins showing instability and partial precipitation during cell-free synthesis. Stabilizers that co-translationally improve the solubility and functional folding of human glucosamine 6-phosphate N-acetyltransferase have been identified and cumulative effects of stabilizers have been studied.	[Kai, Lei; Doetsch, Volker; Bernhard, Frank] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60054 Frankfurt, Germany; [Kai, Lei; Kaldenhoff, Ralf] Tech Univ Darmstadt, Inst Bot, Darmstadt, Germany	Goethe University Frankfurt; Technical University of Darmstadt	Bernhard, F (corresponding author), Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, Inst Biophys Chem, D-60054 Frankfurt, Germany.	fbern@bpc.uni-frankfurt.de	Kai, Lei/ABI-2652-2020	Kai, Lei/0000-0003-0879-7918; Dotsch, Volker/0000-0001-5720-212X; Bernhard, Frank/0000-0002-4860-1783	Collaborative Research Center of the German Research Foundation (DFG) [(SFB) 807]; European Drug Initiative on Channels and Transporters (EDICT) [HEALTH-F4-2007-201924]; European initiative on Structural Biology of Membrane Proteins (SBMP) [PITN-GA-2008-211800]	Collaborative Research Center of the German Research Foundation (DFG)(German Research Foundation (DFG)); European Drug Initiative on Channels and Transporters (EDICT); European initiative on Structural Biology of Membrane Proteins (SBMP)	This work was supported by the Collaborative Research Center (SFB) 807 of the German Research Foundation (DFG). The authors further thank the European Drug Initiative on Channels and Transporters (EDICT), contract number HEALTH-F4-2007-201924 and the European initiative on Structural Biology of Membrane Proteins (SBMP), contract number PITN-GA-2008-211800 for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Arora A, 2004, FEBS LETT, V564, P121, DOI 10.1016/S0014-5793(04)00326-6; ASAKURA T, 1978, J BIOL CHEM, V253, P6423; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Bolen DW, 2004, METHODS, V34, P312, DOI 10.1016/j.ymeth.2004.03.022; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Busche A, 2012, ACS CHEM BIOL, V7, P377, DOI 10.1021/cb200352q; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Chandrasekaran A, 2010, J PROTEOME RES, V9, P5677, DOI 10.1021/pr1003938; da Costa M. S., 1998, V61, P117; DAVID ET, 1983, J BIOL CHEM, V258, P7702; Endo Yaeta, 2004, Journal of Structural and Functional Genomics, V5, P45, DOI 10.1023/B:JSFG.0000029208.83739.49; Ge XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028707; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jamal S, 2009, FEBS J, V276, P6024, DOI 10.1111/j.1742-4658.2009.07317.x; Kai L, 2012, METHODS MOL BIOL, V800, P201, DOI 10.1007/978-1-61779-349-3_14; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Khnouf R, 2010, ANAL CHEM, V82, P7021, DOI 10.1021/ac1015479; Lamosa P, 1998, APPL ENVIRON MICROB, V64, P3591; Nakano H, 1996, J BIOTECHNOL, V46, P275, DOI 10.1016/0168-1656(96)00022-3; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Schwarz D, 2010, PROTEOMICS, V10, P1762, DOI 10.1002/pmic.200900485; Singh Somnath, 2003, AAPS PharmSciTech, V4, pE42; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Treetharnmathurot B, 2008, INT J PHARMACEUT, V1-2, P252; Tsumoto K, 2003, BIOCHEM BIOPH RES CO, V312, P1383, DOI 10.1016/j.bbrc.2003.11.055; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Welsh DT, 1999, FEMS MICROBIOL LETT, V174, P57, DOI 10.1016/S0378-1097(99)00122-6; Yang WC, 2012, BIOTECHNOL PROGR, V28, P413, DOI 10.1002/btpr.1509	32	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56637	10.1371/journal.pone.0056637	http://dx.doi.org/10.1371/journal.pone.0056637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451062	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800022
J	Li, Y; Xu, N; Cai, L; Gao, ZJ; Shen, L; Zhang, QM; Hou, WG; Zhong, HX; Wang, Q; Xiong, LZ				Li, Yan; Xu, Ning; Cai, Lei; Gao, Zijun; Shen, Lan; Zhang, Qiaomei; Hou, Wugang; Zhong, Haixing; Wang, Qiang; Xiong, Lize			NDRG2 Is a Novel p53-Associated Regulator of Apoptosis in C6-Originated Astrocytes Exposed to Oxygen-Glucose Deprivation	PLOS ONE			English	Article							DIFFERENTIATION-RELATED GENE; TARGET GENE; CELL-DEATH; P53; EXPRESSION; MYC; TRANSLOCATION; ACTIVATION; PROTEINS; BRAIN	N-myc downstream-regulated gene 2 (NDRG2) has been documented to be a pro-differentiative and anti-proliferative gene in cancer research. Our previous study found a significant NDRG2 up-regulation in reactive astrocytes of penumbra after transient focal cerebral ischemia, which was parallel to the enhancement of TUNEL-positive signals. However, it is still uncertain whether NDRG2 participates in cellular apoptosis induced by ischemia-reperfusion injury in brain. In this study, we investigated the role of NDRG2 in cellular apoptosis induced by oxygen-glucose deprivation (OGD) in IL-6-differentiated C6 glioma cells. The results showed that NDRG2 was up-regulated and translocated from the cytoplasm to the nucleus after OGD exposure. NDRG2 over-expression exhibited an anti-proliferative effect and increased the Bax/Bcl-2 ratio after OGD exposure, while NDRG2 silencing promoted the cellular proliferation and attenuated the up-regulation of Bax/Bcl-2 ratio. The pro-apoptotic effect of p53 was verified by the results in which p53 silencing greatly reduced the percentage of OGD-induced apoptotic cells. p53 silencing also reduced the OGD-induced NDRG2 up-regulation. However, over-expression of p53 did not further improve the NDRG2 up-regulation. In conclusion, NDRG2 is a p53-associated regulator of apoptosis in C6-originated astrocytes after OGD exposure. These findings bring insight to the roles of NDRG2 in ischemic-hypoxic injury and provide potential targets for future clinical therapies on stroke.	[Li, Yan; Xu, Ning; Gao, Zijun; Zhang, Qiaomei; Hou, Wugang; Zhong, Haixing; Wang, Qiang; Xiong, Lize] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Li, Yan] Shaanxi Prov Maternal & Child Hlth Hosp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China; [Cai, Lei] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Gastrointestinal Surg, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Shen, Lan] Fourth Mil Med Univ, Inst Mol Biol, Xian 710032, Shaanxi, Peoples R China; [Shen, Lan] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, Q (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China.	wangqiang@fmmu.edu.cn; lxiong@fmmu.edu.cn		Li, Yan/0000-0003-0096-0813; XIONG, Lize/0000-0002-9204-8129	Major Program of National Natural Science Foundation of China [30930091]; National Natural Science Foundation of China [81072888, 81071060, 81000563, 30900462]	Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major Program of National Natural Science Foundation of China (No. 30930091), and the National Natural Science Foundation of China (No. 81072888, No. 81071060, No. 81000563 and No. 30900462). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danilov CA, 2008, GLIA, V56, P801, DOI 10.1002/glia.20655; de Almodovar CR, 2004, J BIOL CHEM, V279, P4093, DOI 10.1074/jbc.M311243200; Deng YC, 2001, PROG BIOCHEM BIOPHYS, V28, P72; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Fang L, 2001, EMBO J, V20, P1931, DOI 10.1093/emboj/20.8.1931; Hwang J, 2011, J BIOL CHEM, V286, P12450, DOI 10.1074/jbc.M110.170803; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Levison SW, 2000, GLIA, V32, P328, DOI 10.1002/1098-1136(200012)32:3<328::AID-GLIA110>3.0.CO;2-7; Li Y, 2011, BRAIN RES, V1382, P252, DOI 10.1016/j.brainres.2011.01.023; Liu JY, 2010, EXP CELL RES, V316, P1985, DOI 10.1016/j.yexcr.2010.02.028; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Luo Y, 2009, ANN NEUROL, V65, P520, DOI 10.1002/ana.21592; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Ohki T, 2002, DEV BRAIN RES, V135, P55; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Patel JR, 2008, EXP NEUROL, V213, P93, DOI 10.1016/j.expneurol.2008.05.007; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shen L, 2008, NEUROREPORT, V19, P927, DOI 10.1097/WNR.0b013e32830163d0; Taga T, 2005, CLIN REV ALLERG IMMU, V28, P249, DOI 10.1385/CRIAI:28:3:249; Takahashi K, 2005, NEUROSCI LETT, V388, P157, DOI 10.1016/j.neulet.2005.06.055; Takano T, 2009, STROKE, V40, pS8, DOI 10.1161/STROKEAHA.108.533166; Wang LF, 2008, CELL PHYSIOL BIOCHEM, V21, P239, DOI 10.1159/000113765; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200	37	112	120	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57130	10.1371/journal.pone.0057130	http://dx.doi.org/10.1371/journal.pone.0057130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451161	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800076
J	Pasquali, M; Spanu, F; Scherm, B; Balmas, V; Hoffmann, L; Hammond-Kosack, KE; Beyer, M; Migheli, Q				Pasquali, Matias; Spanu, Francesca; Scherm, Barbara; Balmas, Virgilio; Hoffmann, Lucien; Hammond-Kosack, Kim E.; Beyer, Marco; Migheli, Quirico			FcStuA from Fusarium culmorum Controls Wheat Foot and Root Rot in a Toxin Dispensable Manner	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; TRANSCRIPTION FACTOR; MYCOTOXIN PRODUCTION; GENE-EXPRESSION; ENZYME SETS; CROWN ROT; PATHOGENICITY; GRAMINEARUM; REGULATORS; GROWTH	Fusarium culmorum is one of the most harmful pathogens of durum wheat and is the causal agent of foot and root rot (FRR) disease. F. culmorum produces the mycotoxin deoxynivalenol (DON) that is involved in the pathogenic process. The role of the gene FcStuA, a StuA ortholog protein with an APSES domain sharing 98.5% homology to the FgStuA protein (FGSG10129), was determined by functional characterisation of deletion mutants obtained from two F. culmorum wild-type strains, FcUk99 (a highly pathogenic DON producer) and Fc233B (unable to produce toxin and with a mild pathogenic behavior). The Delta FcStuA mutants originating from both strains showed common phenotypic characters including stunted vegetative growth, loss of hydrophobicity of the mycelium, altered pigmentation, decreased activity of polygalacturonic enzymes and catalases, altered and reduced conidiation, delayed conidial germination patterns and complete loss of pathogenicity towards wheat stem base/root tissue. Glycolytic process efficiency [measured as growth on glucose as sole carbon (C) source] was strongly impaired and growth was partially restored on glutamic acid. Growth on pectin-like sources ranked in between glucose and glutamic acid with the following order (the lowest to the highest growth): beechwood xylan, sugarbeet arabinan, polygalacturonic acid, citrus pectin, apple pectin, potato azogalactan. DON production in the mutants originating from FcUK99 strain was significantly decreased (-95%) in vitro. Moreover, both sets of mutants were unable to colonise non-cereal plant tissues, i.e. apple and tomato fruits and potato tubers. No differences between mutants, ectopic and wild-type strains were observed concerning the level of resistance towards four fungicides belonging to three classes, the demethylase inhibitors epoxiconazole and tebuconzole, the succinate dehydrogenase inhibitor isopyrazam and the cytochrome bc1 inhibitor trifloxystrobin. StuA, given its multiple functions in cell regulation and pathogenicity control, is proposed as a potential target for novel disease management strategies.	[Pasquali, Matias; Hoffmann, Lucien; Beyer, Marco] Ctr Rech Publ Gabriel Lippmann, Environm & Agrobiotechnol Dept, Belvaux, Luxembourg; [Spanu, Francesca; Scherm, Barbara; Balmas, Virgilio; Migheli, Quirico] Univ Sassari, Dipartimento Agr, Sez Patol Vegetale & Entomol, I-07100 Sassari, Italy; [Spanu, Francesca; Scherm, Barbara; Balmas, Virgilio; Migheli, Quirico] Univ Sassari, Unita Ric Ist Nazl Biostrutture & Biosistemi, I-07100 Sassari, Italy; [Hammond-Kosack, Kim E.] Rothamsted Res, Wheat Pathogen Plant Biol & Crop Sci Dept, Harpenden, Herts, England; [Migheli, Quirico] Univ Sassari, Ctr Interdisciplinare Sviluppo Ric Biotecnol & St, I-07100 Sassari, Italy	Luxembourg Institute of Science & Technology; University of Sassari; University of Sassari; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Sassari	Pasquali, M (corresponding author), Ctr Rech Publ Gabriel Lippmann, Environm & Agrobiotechnol Dept, Belvaux, Luxembourg.	pasquali@lippmann.lu	Beyer, Marco/S-9197-2019; Scherm, Barbara/J-8092-2015; Balmas, Virgilio/J-8194-2015; Beyer, Marco/T-1139-2019; Beyer, Marco/K-7198-2012; Migheli, Quirico/B-7203-2009; pasquali, matias/A-6362-2009; Migheli, Quirico/K-7065-2019	Scherm, Barbara/0000-0001-6122-7186; Balmas, Virgilio/0000-0003-3213-3089; Migheli, Quirico/0000-0002-2459-5833; pasquali, matias/0000-0002-9102-2066; Migheli, Quirico/0000-0002-2459-5833; Hammond-Kosack, kim/0000-0002-9699-485X; Beyer, Marco/0000-0002-9415-4718	Ministry of University and Research; Regione Autonoma della Sardegna (Legge Regionale); Qatar National Research Fund (National Priorities Research Program) [4 - 259 - 2 - 083]; Administration des Services Techniques de l'Agriculture du Luxembourg; PhD fellowship (XXIV cycle); AGRIS SARDEGNA - Agenzia per la Ricerca in Agricoltura; AM2c program of the National Research Fund of Luxembourg; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom through the Institute Strategic Programme [20:20 Wheat(R)]; BBSRC [BBS/E/C/00005192, BBS/E/C/00005203] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005192, BBS/E/C/00005203] Funding Source: researchfish	Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Autonoma della Sardegna (Legge Regionale); Qatar National Research Fund (National Priorities Research Program); Administration des Services Techniques de l'Agriculture du Luxembourg; PhD fellowship (XXIV cycle); AGRIS SARDEGNA - Agenzia per la Ricerca in Agricoltura; AM2c program of the National Research Fund of Luxembourg; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom through the Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Ministry of University and Research, by Regione Autonoma della Sardegna (Legge Regionale 7 agosto 2007, n. 7 "Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna'') and by Qatar National Research Fund (National Priorities Research Program Grant number 4 - 259 - 2 - 083) and by 'Administration des Services Techniques de l'Agriculture du Luxembourg'. FS acknowledges receipt of a PhD fellowship (XXIV cycle) sponsored by AGRIS SARDEGNA - Agenzia per la Ricerca in Agricoltura. MP acknowledges the AM2c program of the National Research Fund of Luxembourg. KHK is supported by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom through the Institute Strategic Programme Grant 20:20 Wheat (R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleandri MP, 2007, PLANT PATHOL, V56, P517, DOI 10.1111/j.1365-3059.2007.01574.x; Aleandri MP, 2008, PLANT PATHOL, V57, P1017, DOI 10.1111/j.1365-3059.2008.01859.x; Aramayo R, 1996, GENETICS, V144, P991; Baldwin TK, 2010, MOL PLANT MICROBE IN, V23, P566, DOI 10.1094/MPMI-23-5-0566; Balmas V, 2006, J AGR FOOD CHEM, V54, P480, DOI 10.1021/jf0523014; Beccari G, 2011, PLANT PATHOL, V60, P671, DOI 10.1111/j.1365-3059.2011.02425.x; Benoit I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-321; Borneman AR, 2002, MOL MICROBIOL, V44, P621, DOI 10.1046/j.1365-2958.2002.02906.x; Breakspear A, 2011, FUNGAL GENET BIOL, V48, P725, DOI 10.1016/j.fgb.2011.03.001; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cools HJ, 2013, MOL PLANT PATHOL, V14, P197, DOI 10.1111/mpp.12001; CORRELL JC, 1987, PHYTOPATHOLOGY, V77, P1640, DOI 10.1094/Phyto-77-1640; Cuzick A, 2008, NEW PHYTOL, V177, P990, DOI 10.1111/j.1469-8137.2007.02333.x; de Groot MJL, 2003, MICROBIOL-SGM, V149, P1183, DOI 10.1099/mic.0.25993-0; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dubos T, 2013, PESTIC BIOCHEM PHYS, V105, P28, DOI 10.1016/j.pestbp.2012.11.004; Dubos T, 2011, EUR J PLANT PATHOL, V130, P239, DOI 10.1007/s10658-011-9749-7; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; Acero FJF, 2011, INT J MOL SCI, V12, P795, DOI 10.3390/ijms12010795; Garcia-Pedrajas MD, 2010, MOL PLANT MICROBE IN, V23, P211, DOI 10.1094/MPMI-23-2-0211; Gardiner DM, 2009, MOL PLANT MICROBE IN, V22, P1588, DOI 10.1094/MPMI-22-12-1588; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; Giraud F, 2010, FOOD ADDIT CONTAM A, V27, P825, DOI 10.1080/19440040903567232; Ipcho SVS, 2010, EUKARYOT CELL, V9, P1100, DOI 10.1128/EC.00064-10; Iyer LM, 2002, GENOME BIOL, V3; Jaroszuk-Scisel J, 2011, MYCOLOGIA, V103, P929, DOI 10.3852/10-300; Jiao F, 2008, FEMS MICROBIOL LETT, V285, P212, DOI 10.1111/j.1574-6968.2008.01235.x; Kang Z, 2000, J PHYTOPATHOL, V148, P263, DOI 10.1046/j.1439-0434.2000.00489.x; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; LANGIN T, 1990, CURR GENET, V17, P313, DOI 10.1007/BF00314878; Lee BN, 2005, EUKARYOT CELL, V4, P545, DOI 10.1128/EC.4.3.545-555.2005; Lowe RGT, 2010, MOL PLANT MICROBE IN, V23, P1605, DOI 10.1094/MPMI-04-10-0092; Lysoe E, 2011, MOL PLANT MICROBE IN, V24, P54, DOI 10.1094/MPMI-03-10-0075; Maier FJ, 2006, MOL PLANT PATHOL, V7, P449, DOI 10.1111/j.1364-3703.2006.00351.x; MALALASEKERA RA, 1973, T BRIT MYCOL SOC, V60, P453, DOI 10.1016/S0007-1536(73)80030-0; MARASAS WFO, 1984, TOXIGENIC FUSARIUM S; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McKinney HH, 1923, J AGRIC RES, V26, P0195; MERSONDAVIES LA, 1992, J GEN MICROBIOL, V138, P461, DOI 10.1099/00221287-138-3-461; Migheli Q, 1996, MOL ECOL, V5, P641, DOI 10.1111/j.1365-294X.1996.tb00359.x; MILLER KY, 1992, GENE DEV, V6, P1770, DOI 10.1101/gad.6.9.1770; MILLER KY, 1991, MOL GEN GENET, V227, P285, DOI 10.1007/BF00259682; Mudge AM, 2006, PHYSIOL MOL PLANT P, V69, P73, DOI 10.1016/j.pmpp.2007.01.003; NIRENBERG HI, 1990, STUD MYCOL, P91; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Ohara T, 2004, EUKARYOT CELL, V3, P1412, DOI 10.1128/EC.3.6.1412-1422.2004; Pasquali M, 2010, INT J FOOD MICROBIOL, V137, P246, DOI 10.1016/j.ijfoodmicro.2009.11.009; Pasquali Matias, 2010, J Vis Exp, DOI 10.3791/1690; Ponts N, 2009, FEMS MICROBIOL LETT, V293, P255, DOI 10.1111/j.1574-6968.2009.01521.x; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Ramirez-Zavala B, 2008, FEMS YEAST RES, V8, P511, DOI 10.1111/j.1567-1364.2008.00370.x; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scherm B, 2013, MOL PLANT PATHOL, V14, P323, DOI 10.1111/mpp.12011; Scherm B, 2011, MOL PLANT PATHOL, V12, P759, DOI 10.1111/J.1364-3703.2011.00709.X; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Skov J, 2004, PHYSIOL MOL PLANT P, V64, P245, DOI 10.1016/j.pmpp.2004.09.005; Skovgaard K, 2003, MYCOLOGIA, V95, P630, DOI 10.2307/3761939; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Spanu F, 2012, MOL PLANT PATHOL, V13, P1149, DOI 10.1111/j.1364-3703.2012.00823.x; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; SZECSI A, 1990, J PHYTOPATHOL, V130, P188, DOI 10.1111/j.1439-0434.1990.tb01167.x; TAYLOR RJ, 1988, PHYTOPATHOLOGY, V78, P1101, DOI 10.1094/Phyto-78-1101; Teertstra WR, 2006, MICROBIOL-SGM, V152, P3607, DOI 10.1099/mic.0.29034-0; Tong XZ, 2007, MOL PLANT MICROBE IN, V20, P1102, DOI 10.1094/MPMI-20-9-1102; Urban M, 2003, MOL PLANT PATHOL, V4, P347, DOI 10.1046/J.1364-3703.2003.00183.X; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Wagacha JM, 2007, CROP PROT, V26, P877, DOI 10.1016/j.cropro.2006.09.003; WARD MP, 1995, MOL CELL BIOL, V15, P6854; Wu JG, 1997, MOL CELL BIOL, V17, P6191, DOI 10.1128/MCB.17.10.6191; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1	74	30	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57429	10.1371/journal.pone.0057429	http://dx.doi.org/10.1371/journal.pone.0057429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451228	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800107
J	Saini, S; Jagadish, N; Gupta, A; Bhatnagar, A; Suri, A				Saini, Shikha; Jagadish, Nirmala; Gupta, Anju; Bhatnagar, Amar; Suri, Anil			A Novel Cancer Testis Antigen, A-Kinase Anchor Protein 4 (AKAP4) Is a Potential Biomarker for Breast Cancer	PLOS ONE			English	Article							TUMOR-GROWTH; MAGE-A; EXPRESSION; IMMUNOTHERAPY; AUTOANTIBODIES; TARGET; PKA	Background: Breast cancer is the second leading cause of cancer related deaths in women worldwide. Reports about the early diagnosis of breast cancer are suggestive of an improved clinical outcome and overall survival rate in cancer patients. Therefore, cancer screening biomarker for early detection and diagnosis is urgently required for timely treatment and better cancer management. In this context, we investigated an association of cancer testis antigen, A-Kinase anchor protein 4 (AKAP4) with breast carcinoma. Methodology/Findings: We first compared the AKAP4 gene and protein expression in four breast cancer cells (MCF7, MDA-MB-231, SK-BR3 and BT474) and normal human mammary epithelial cells. In addition, 91 clinical specimens of breast cancer patients of various histotypes including ductal carcinoma in situ, infiltrating ductal carcinoma and infiltrating lobular carcinoma and 83 available matched adjacent non-cancerous tissues were examined for AKAP4 gene and protein expression by employing in situ RNA hybridization and immunohistochemistry respectively. Humoral response against AKAP4 was also investigated in breast cancer patients employing ELISA. Our in vitro studies in all breast cancer cells revealed AKAP4 gene and protein expression whereas, normal human mammary epithelial cells failed to show any expression. Using in situ RNA hybridization and immunohistochemistry, 85% (77/91) tissue specimens irrespective of histotypes, stages and grades of breast cancer clinical specimens revealed AKAP4 gene and protein expression. However, matched adjacent non-cancerous tissues failed to display any AKAP4 gene and protein expression. Furthermore, humoral response was observed in 79% (72/91) of total breast cancer patients. Interestingly, we observed that 94% (72/77) of breast cancer patients found positive for AKAP4 protein expression generated humoral response against AKAP4 protein. Conclusions: Collectively, our data suggests that AKAP4 may be used as serum based diagnostic test for an early detection and diagnosis of breast cancer and may be a potential target for immunotherapeutic use.	[Saini, Shikha; Jagadish, Nirmala; Suri, Anil] Natl Inst Immunol, Canc Microarray Genes & Prot Lab, New Delhi 110067, India; [Gupta, Anju] Vidyasagar Inst Mental Hlth & Neurosci, NMC Imaging & Diagnost Ctr, New Delhi, India; [Bhatnagar, Amar] Safdarjang Hosp, Dept Canc Surg, New Delhi, India; [Bhatnagar, Amar] Vardhman Mahavir Med Coll, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital	Suri, A (corresponding author), Natl Inst Immunol, Canc Microarray Genes & Prot Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	anil@nii.res.in	Suri, Anil/P-5128-2016; Jagadish, Nirmala/AAR-3046-2020; Saini, Shikha/ABC-7231-2020	Suri, Anil/0000-0001-5231-5555; Saini, Shikha/0000-0003-0557-1649; Jagadish, Nirmala/0000-0002-5812-9283	Indo-UK Cancer Research Program, Centre for Molecular Medicine, NII-core funding, Department of Biotechnology, Government of India	Indo-UK Cancer Research Program, Centre for Molecular Medicine, NII-core funding, Department of Biotechnology, Government of India	This work is supported by grants from Indo-UK Cancer Research Program, Centre for Molecular Medicine, NII-core funding, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2001, JPN J PHARMACOL, V87, P181, DOI 10.1254/jjp.87.181; Chapman C, 2007, ANN ONCOL, V18, P868, DOI 10.1093/annonc/mdm007; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chiriva-Internati M, 2008, BRIT J HAEMATOL, V140, P465, DOI 10.1111/j.1365-2141.2007.06940.x; Chiriva-Internati M, 2012, PROSTATE, V72, P12, DOI 10.1002/pros.21400; Garg M, 2008, CANCER RES, V68, P8240, DOI 10.1158/0008-5472.CAN-08-1708; Garg M, 2007, CLIN CANCER RES, V13, P1421, DOI 10.1158/1078-0432.CCR-06-2340; Garg M, 2009, J CLIN ENDOCR METAB, V94, P4613, DOI 10.1210/jc.2009-0703; Garg M, 2009, CANCER-AM CANCER SOC, V115, P2671, DOI 10.1002/cncr.24293; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Grigoriadis A, 2009, P NATL ACAD SCI USA, V106, P13493, DOI 10.1073/pnas.0906840106; Gu L, 2009, CLIN CANCER RES, V15, P7196, DOI 10.1158/1078-0432.CCR-09-0585; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Houssami N, 2009, ANN ONCOL, V20, P1505, DOI 10.1093/annonc/mdp037; Kanojia D, 2011, AM J PATHOL, V178, P1009, DOI 10.1016/j.ajpath.2010.11.047; Kanojia D, 2010, LEUKEMIA RES, V34, P858, DOI 10.1016/j.leukres.2010.01.017; Kanojia D, 2009, CANCER EPIDEM BIOMAR, V18, P630, DOI 10.1158/1055-9965.EPI-08-0629; Kruger S, 2007, PATHOL ONCOL RES, V13, P91; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Matkovic B, 2011, CROAT MED J, V52, P171, DOI 10.3325/cmj.2011.52.171; Miki K, 2002, DEV BIOL, V248, P331, DOI 10.1006/dbio.2002.0728; Miller WR, 2002, ANN NY ACAD SCI, V968, P37, DOI 10.1111/j.1749-6632.2002.tb04325.x; Mischo A, 2006, INT J CANCER, V118, P696, DOI 10.1002/ijc.21352; Mohapatra B, 1998, BIOCHEM BIOPH RES CO, V244, P540, DOI 10.1006/bbrc.1998.8079; Otte M, 2001, CANCER RES, V61, P6682; Radhi S, 2012, J CLIN ONCOL S, V30; Scudellari M, 2011, NAT MED, V17, P916, DOI 10.1038/nm0811-916; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Taplin S, 2008, J NATL CANCER I, V100, P876, DOI 10.1093/jnci/djn172; Tortora G, 2002, CLIN CANCER RES, V8, P303; Yu P, 2012, INT J GYNECOL CANCER, V22, P87, DOI 10.1097/IGC.0b013e3182370f2e; Zhong L, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2091	35	31	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57095	10.1371/journal.pone.0057095	http://dx.doi.org/10.1371/journal.pone.0057095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451156	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800073
J	Fujikawa, T; Miyata, SI; Iwanami, T				Fujikawa, Takashi; Miyata, Shin-Ichi; Iwanami, Toru			Convenient Detection of the Citrus Greening (Huanglongbing) Bacterium 'Candidatus Liberibacter asiaticus' by Direct PCR from the Midrib Extract	PLOS ONE			English	Article							SAO-PAULO STATE; DNA AMPLIFICATION; DISEASE; IDENTIFICATION; AMERICANUS; PATHOGEN; BRAZIL; CELLS; TREE	A phloem-limited bacterium, 'Candidatus Liberibacter asiaticus' (Las) is a major pathogen of citrus greening (huanglongbing), one of the most destructive citrus diseases worldwide. The rapid identification and culling of infected trees and budwoods in quarantine are the most important control measures. DNA amplification including conventional polymerase chain reaction (PCR) has commonly been used for rapid detection and identification. However, long and laborious procedures for DNA extraction have greatly reduced the applicability of this method. In this study, we found that the Las bacterial cells in the midribs of infected leaves were extracted rapidly and easily by pulverization and centrifugation with mini homogenization tubes. We also found that the Las bacterial cells in the midrib extract were suitable for highly sensitive direct PCR. The performance of direct PCR using this extraction method was not inferior to that of conventional PCR. Thus, the direct PCR method described herein is characterized by its simplicity, sensitivity, and robustness, and is applicable to quarantine testing.	[Fujikawa, Takashi; Miyata, Shin-Ichi; Iwanami, Toru] Natl Inst Fruit Tree Sci, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan	Iwanami, T (corresponding author), Natl Inst Fruit Tree Sci, Tsukuba, Ibaraki, Japan.	tiwsw37@affrc.go.jp	Fujikawa, Takashi/V-8150-2019	Fujikawa, Takashi/0000-0001-5659-0407	Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported in part by a Grant-in-Aid for Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry and Fisheries from the Ministry of Agriculture, Forestry and Fisheries of Japan. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Bove JM, 2006, J PLANT PATHOL, V88, P7; Committee on the strategic planning for the Florida citrus industry: addressing citrus greening disease (huanglongbing); National Research Council, 2010, STRATEGIC PLANNING F; Ding F, 2005, J PLANT PATHOL, V87, P207; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Fujikawa T, 2012, MOL CELL PROBE, V26, P194, DOI 10.1016/j.mcp.2012.06.001; Furuya N, 2010, J GEN PLANT PATHOL, V76, P122, DOI 10.1007/s10327-010-0223-8; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119, DOI 10.1099/00207713-50-6-2119; Garnier M, 1996, P 13 C INT ORG CITR, P388; Glockner FO, 1996, APPL ENVIRON MICROB, V65, P3721; Halbert SE., 2005, PROC 2 INT CITRUS CA, pH3; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Karner M, 1997, APPL ENVIRON MICROB, V63, P1208, DOI 10.1128/AEM.63.4.1208-1213.1997; Li WB, 2007, PLANT DIS, V91, P51, DOI 10.1094/PD-91-0051; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Roche Applied Science, 2002, DIG APPLICATION MANU; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Tomimura K, 2010, JARQ-JPN AGR RES Q, V44, P151, DOI 10.6090/jarq.44.151; Wang Z, 2006, PLANT PATHOL, V55, P630, DOI 10.1111/j.1365-3059.2006.01438.x; ZARDA B, 1991, J GEN MICROBIOL, V137, P2823, DOI 10.1099/00221287-137-12-2823	27	26	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57011	10.1371/journal.pone.0057011	http://dx.doi.org/10.1371/journal.pone.0057011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437295	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200198
J	Ito, TY; Lhagvasuren, B; Tsunekawa, A; Shinoda, M; Takatsuki, S; Buuveibaatar, B; Chimeddorj, B				Ito, Takehiko Y.; Lhagvasuren, Badamjav; Tsunekawa, Atsushi; Shinoda, Masato; Takatsuki, Seiki; Buuveibaatar, Bayarbaatar; Chimeddorj, Buyanaa			Fragmentation of the Habitat of Wild Ungulates by Anthropogenic Barriers in Mongolia	PLOS ONE			English	Article							GAZELLES PROCAPRA-GUTTUROSA; INTERANNUAL VARIATIONS; MIGRATION; UNDERPASSES; RAILROAD; SELECTION; SEARCH; EQUIDS	Habitat loss and habitat fragmentation caused by anthropogenic activities are the main factors that constrain long-distance movement of ungulates. Mongolian gazelles (Procapra gutturosa) and Asiatic wild asses (Equus hemionus) in Mongolia are facing habitat fragmentation and loss. To better understand how their movements respond to potential anthropogenic and natural barriers, we tracked 24 Mongolian gazelles and 12 wild asses near the Ulaanbaatar-Beijing Railroad and the fenced international border between Mongolia and China between 2002 and 2012. None of the tracked gazelles crossed the railroad, even though gazelles were captured on both sides of the tracks at the start of the study. Similarly, we did not observe cross-border movements between Mongolia and China for either species, even though some animals used areas adjacent to the border. The both species used close areas to the anthropogenic barriers more frequently during winter than summer. These results suggest strong impacts by the artificial barriers. The construction of new railroads and roads to permit mining and other resource development therefore creates the threat of further habitat fragmentation, because the planned routes will divide the remaining non-fragmented habitats of the ungulates into smaller pieces. To conserve long-distance movement of the ungulates in this area, it will be necessary to remove or mitigate the barrier effects of the existing and planned roads and railroads and to adopt a landscape-level approach to allow access by ungulates to wide ranges throughout their distribution.	[Ito, Takehiko Y.; Tsunekawa, Atsushi; Shinoda, Masato] Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan; [Lhagvasuren, Badamjav; Buuveibaatar, Bayarbaatar; Chimeddorj, Buyanaa] Mongolian Acad Sci, Inst Biol, Ulaanbaatar, Mongolia; [Lhagvasuren, Badamjav; Chimeddorj, Buyanaa] World Wide Fund Nat WWF Mongolia, Ulaanbaatar, Mongolia; [Takatsuki, Seiki] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan; [Buuveibaatar, Bayarbaatar] WCS, Mongolia Program, Ulaanbaatar, Mongolia	Tottori University; Mongolian Academy of Sciences; Azabu University	Ito, TY (corresponding author), Tottori Univ, Arid Land Res Ctr, Tottori 680, Japan.	ito@alrc.tottori-u.ac.jp	Bayarbaatar, Buuveibaatar/AAS-5963-2020; Shinoda, Masato/F-2830-2014; Buuveibaatar, Bayarbaatar/AAY-9092-2020; Tsunekawa, Atsushi/L-8526-2013; Ito, Takehiko Y/M-7221-2015	Tsunekawa, Atsushi/0000-0002-7690-0633; Ito, Takehiko Y/0000-0003-3203-9770; Bayarbaatar, Buuveibaatar/0000-0003-1803-0745	Japan Ministry of Education, Culture, Sports, Science, and Technology [14405039, 18255002, 20255001]; Ministry's 21st Century COE (Centers of Excellence) Program; Ministry's 21st Century Global COE program	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry's 21st Century COE (Centers of Excellence) Program; Ministry's 21st Century Global COE program	This research was supported by the Japan Ministry of Education, Culture, Sports, Science, and Technology's Grants-in-Aid for Scientific Research (B) 14405039, (A) 18255002, and (A) 20255001, and by the Ministry's 21st Century COE (Centers of Excellence) Program and Global COE program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Bolger DT, 2008, ECOL LETT, V11, P63; Collecte Localisation Satellites (CLS), 2007, ARG US MAN WORLDW TR; Dodd NL, 2011, WILDLIFE SOC B, V35, P270, DOI 10.1002/wsb.31; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Ito TY, 2006, J ZOOL, V269, P291, DOI 10.1111/j.1469-7998.2006.00077.x; Ito TY, 2013, J ARID ENVIRON, V91, P61, DOI 10.1016/j.jaridenv.2012.12.008; Ito TY, 2008, J WILDLIFE MANAGE, V72, P940, DOI 10.2193/2007-188; Ito TY, 2005, CONSERV BIOL, V19, P945, DOI 10.1111/j.1523-1739.2005.004364.x; Jiang Zhaowen, 1998, Mammal Study, V23, P63, DOI 10.3106/mammalstudy.23.63; Kaczensky P, 2008, J APPL ECOL, V45, P1762, DOI 10.1111/j.1365-2664.2008.01565.x; Kaczensky Petra, 2010, Wildlife Biology in Practice, V6, P108; Kaczensky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028057; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Leimgruber P, 2001, BIOL CONSERV, V102, P205, DOI 10.1016/S0006-3207(01)00041-6; Lhagvasuren B, 1997, ORYX, V31, P127, DOI 10.1046/j.1365-3008.1997.d01-6.x; Mallon D. P., 2008, IUCN 2012 IUCN RED L; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; McCollister MF, 2010, J WILDLIFE MANAGE, V74, P1722, DOI 10.2193/2009-535; Moehlman PD, 2008, IUCN 2012 IUCN RED L; Mueller T, 2008, OIKOS, V117, P654, DOI 10.1111/j.0030-1299.2008.16291.x; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Nandintsetseg B, 2011, INT J CLIMATOL, V31, P1143, DOI 10.1002/joc.2134; Okada Ayumi, 2012, Mongolian Journal of Biological Sciences, V10, P59; Olson K.A., 2009, MONGOLIAN J BIOL S, V7, P45; Olson KA, 2011, CONSERV LETT, V4, P304, DOI 10.1111/j.1755-263X.2011.00180.x; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Olson KA, 2009, ORYX, V43, P149, DOI 10.1017/S0030605307002293; Sawyer H, 2012, WILDLIFE SOC B, V36, P492, DOI 10.1002/wsb.166; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Singh NJ, 2011, ORYX, V45, P38, DOI 10.1017/S0030605310000839; Sorokin P.A., 2005, DOKL AKAD NAUK, V41, P1345, DOI [DOI 10.1134/S0012496606040120, 10.1134/S0012496606040120]; Sorokin PA, 2005, RUSS J GENET+, V41, P1101, DOI 10.1007/s11177-005-0206-6; Walzer Chris, 2006, Mongolian Journal of Biological Sciences, V4, P19; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Xia L, 2007, ORYX, V41, P352, DOI 10.1017/S0030605307000116; Yu F, 2004, INT J REMOTE SENS, V25, P327, DOI 10.1080/0143116031000084297; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5	39	62	66	9	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56995	10.1371/journal.pone.0056995	http://dx.doi.org/10.1371/journal.pone.0056995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437291	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200195
J	Pazoki, R; de Jong, JSSG; Marsman, RF; Bruinsma, N; Dekker, LRC; Wilde, AAM; Bezzina, CR; Tanck, MWT				Pazoki, Raha; de Jong, Jonas S. S. G.; Marsman, Roos F.; Bruinsma, Nienke; Dekker, Lukas R. C.; Wilde, Arthur A. M.; Bezzina, Connie R.; Tanck, Michael W. T.			SNPs Identified as Modulators of ECG Traits in the General Population Do Not Markedly Affect ECG Traits during Acute Myocardial Infarction nor Ventricular Fibrillation Risk in This Condition	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QT INTERVAL DURATION; COMMON GENETIC-VARIATION; SUDDEN CARDIAC DEATH; HEART-RATE; QRS DURATION; PR INTERVAL; VARIANTS; LOCI; REPOLARIZATION	Background: Ventricular fibrillation (VF) in the setting of acute ST elevation myocardial infarction (STEMI) is a leading cause of mortality. Although the risk of VF has a genetic component, the underlying genetic factors are largely unknown. Since heart rate and ECG intervals of conduction and repolarization during acute STEMI differ between patients who do and patients who do not develop VF, we investigated whether SNPs known to modulate these ECG indices in the general population also impact on the respective ECG indices during STEMI and on the risk of VF. Methods and Results: The study population consisted of participants of the Arrhythmia Genetics in the NEtherlandS (AGNES) study, which enrols patients with a first STEMI that develop VF (cases) and patients that do not develop VF (controls). SNPs known to impact on RR interval, PR interval, QRS duration or QTc interval in the general population were tested for effects on the respective STEMI ECG indices (stage 1). Only those showing a (suggestive) significant association were tested for association with VF (stage 2). On average, VF cases had a shorter RR and a longer QTc interval compared to non-VF controls. Eight SNPs showed a trend for association with the respective STEMI ECG indices. Of these, three were also suggestively associated with VF. Conclusions: RR interval and ECG indices of conduction and repolarization during acute STEMI differ between patients who develop VF and patients who do not. Although the effects of the SNPs on ECG indices during an acute STEMI seem to be similar in magnitude and direction as those found in the general population, the effects, at least in isolation, are too small to explain the differences in ECGs between cases and controls and to determine risk of VF.	[Pazoki, Raha; Tanck, Michael W. T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Pazoki, Raha; de Jong, Jonas S. S. G.; Marsman, Roos F.; Bruinsma, Nienke; Wilde, Arthur A. M.; Bezzina, Connie R.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Dekker, Lukas R. C.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Catharina Hospital	Bezzina, CR (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Dept Clin & Expt Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.r.bezzina@amc.uva.nl; m.w.tanck@amc.uva.nl		Tanck, Michael/0000-0001-9828-4459; Pazoki, Raha/0000-0002-5142-2348; Bezzina, Connie/0000-0002-0633-3514	Netherlands Heart Foundation [2001D019, 2003T302, 2007B202]; Leducq Foundation [05-CVD]; Netherlands Heart Institute (ICIN) [27]; Established Investigator of the Netherlands Heart Foundation [2005T024]	Netherlands Heart Foundation(Netherlands Heart Foundation); Leducq Foundation(Leducq Foundation); Netherlands Heart Institute (ICIN); Established Investigator of the Netherlands Heart Foundation	The authors are supported by research grants from the Netherlands Heart Foundation (grants 2001D019, 2003T302 and 2007B202), the Leducq Foundation (grant 05-CVD) and the Netherlands Heart Institute (ICIN project 27). CRB is an Established Investigator of the Netherlands Heart Foundation (grant 2005T024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Dekker LRC, 2006, CIRCULATION, V114, P1140, DOI 10.1161/CIRCULATIONAHA.105.606145; Eijgelsheim M, 2010, HUM MOL GENET, V19, P3885, DOI 10.1093/hmg/ddq303; HANSON B, 1989, AM J CARDIOL, V63, P606, DOI 10.1016/0002-9149(89)90907-7; HAVLIK RJ, 1980, J ELECTROCARDIOL, V13, P45, DOI 10.1016/S0022-0736(80)80008-2; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Kaikkonen KS, 2006, CIRCULATION, V114, P1462, DOI 10.1161/CIRCULATIONAHA.106.624593; Kolder ICRM, 2012, J MOL CELL CARDIOL, V52, P620, DOI 10.1016/j.yjmcc.2011.12.014; Lemmert ME, 2008, HEART RHYTHM, V5, P71, DOI 10.1016/j.hrthm.2007.09.011; Marroni F, 2009, CIRC-CARDIOVASC GENE, V2, P322, DOI 10.1161/CIRCGENETICS.108.833806; Myerburg R, 2007, BRAUNWALDS HEART DIS; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Nolte IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006138; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Postema PG, 2008, HEART RHYTHM, V5, P1015, DOI 10.1016/j.hrthm.2008.03.037; Russell MW, 1997, J ELECTROCARDIOL, V30, P64, DOI 10.1016/S0022-0736(98)80034-4; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; ZAREBA W, 1994, AM J CARDIOL, V74, P550, DOI 10.1016/0002-9149(94)90742-0	25	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57216	10.1371/journal.pone.0057216	http://dx.doi.org/10.1371/journal.pone.0057216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437344	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200228
J	Asai, H; Fujiwara, H; An, J; Ochi, T; Miyazaki, Y; Nagai, K; Okamoto, S; Mineno, J; Kuzushima, K; Shiku, H; Inoue, H; Yasukawa, M				Asai, Hiroaki; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Miyazaki, Yukihiro; Nagai, Kozo; Okamoto, Sachiko; Mineno, Junichi; Kuzushima, Kiyotaka; Shiku, Hiroshi; Inoue, Hirofumi; Yasukawa, Masaki			Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ANTITUMOR-ACTIVITY; ANTILEUKEMIA REACTIVITY; LUNG-CARCINOMA; WT1 PEPTIDE; LYMPHOCYTES; CHEMOKINE; MIGRATION; IMMUNOTHERAPY; KINASE	Background and Purpose: Although gene-modification of T cells to express tumor-related antigen-specific T-cell receptor (TCR) or chimeric antigen receptor (CAR) has clinically proved promise, there still remains room to improve the clinical efficacy of re-directed T-cell based antitumor adoptive therapy. In order to achieve more objective clinical responses using ex vivo-expanded tumor-responsive T cells, the infused T cells need to show adequate localized infiltration into the tumor. Methodology/Principal Findings: Human lung cancer cells variously express a tumor antigen, Wilms' Tumor gene product 1 (WT1), and an inflammatory chemokine, CCL2. However, CCR2, the relevant receptor for CCL2, is rarely expressed on activated T-lymphocytes. A HLA-A2402(+) human lung cancer cell line, LK79, which expresses high amounts of both CCL2 and WT1 mRNA, was employed as a target. Normal CD8(+) T cells were retrovirally gene-modified to express both CCR2 and HLA-A*2402-restricted and WT1235-243 nonapeptide-specific TCR as an effector. Anti-tumor functionality mediated by these effector cells against LK79 cells was assessed both in vitro and in vivo. Finally the impact of CCL2 on WT1 epitope-responsive TCR signaling mediated by the effector cells was studied. Introduced CCR2 was functionally validated using gene-modified Jurkat cells and human CD3(+) T cells both in vitro and in vivo. Double gene-modified CD3(+) T cells successfully demonstrated both CCL2-tropic tumor trafficking and cytocidal reactivity against LK79 cells in vitro and in vivo. CCL2 augmented the WT1 epitope-responsive TCR signaling shown by relevant luciferase production in double gene-modified Jurkat/MA cells to express luciferase and WT1-specific TCR, and CCL2 also dose-dependently augmented WT1 epitope-responsive IFN-gamma production and CD107a expression mediated by these double gene-modifiedCD3(+) T cells. Conclusion/Significance: Introduction of the CCL2/CCR2 axis successfully potentiated in vivo anti-lung cancer reactivity mediated by CD8(+) T cells double gene-modified to express WT1-specific TCR and CCR2 not only via CCL2-tropic tumor trafficking, but also CCL2-enhanced WT1-responsiveness.	[Asai, Hiroaki; Fujiwara, Hiroshi; An, Jun; Ochi, Toshiki; Miyazaki, Yukihiro; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Matsuyama, Ehime 790, Japan; [Fujiwara, Hiroshi; Yasukawa, Masaki] Ehime Univ, Proteomed Res Ctr, Dept Cell Growth & Tumor Regulat, Matsuyama, Ehime 790, Japan; [Ochi, Toshiki] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON, Canada; [Nagai, Kozo] Ehime Univ, Grad Sch Med, Dept Pediat, Matsuyama, Ehime 790, Japan; [Okamoto, Sachiko; Mineno, Junichi] Takara Bio Inc, Ctr Cell & Gene Therapy, Tokyo, Shiga, Japan; [Shiku, Hiroshi] Mie Univ, Grad Sch Med, Dept Canc Vaccine & Immunogene Therapy, Tsu, Mie, Japan; [Inoue, Hirofumi] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Matsuyama, Ehime 790, Japan	Ehime University; Ehime University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ehime University; Takara Bio Inc.; Mie University; Ehime University	Fujiwara, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Matsuyama, Ehime 790, Japan.	yunarief@m.ehime-u.ac.jp; yasukawa@m.ehime-u.ac.jp	Shiku, Hiroshi/U-7321-2019	Shiku, Hiroshi/0000-0002-0362-755X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare; Takara Bio, Inc.; Grants-in-Aid for Scientific Research [24390245] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takara Bio, Inc.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HF and MY, and a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare to MY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors except SO, JM and HS have declared that no competing interest exist. SO and JM are employee of Takara Bio, Inc.. HS is provided with research funding from Takara Bio, Inc.. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Berencsi K, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-33; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Calogero A, 2000, ANTICANCER RES, V20, P1793; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; Daurkin I, 2011, CANCER RES, V71, P6400, DOI 10.1158/0008-5472.CAN-11-1261; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Gomi S, 1999, J IMMUNOL, V163, P4994; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hayashi S, 2012, CANCER INVEST, V30, P165, DOI 10.3109/07357907.2011.633291; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ichinohasama R, 2010, CANCER SCI, V101, P1089, DOI 10.1111/j.1349-7006.2010.01522.x; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Izhak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028305; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Makita M, 2002, CLIN CANCER RES, V8, P2626; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Moon EK, 2011, CLIN CANCER RES, V17, P4719, DOI 10.1158/1078-0432.CCR-11-0351; Nagai K, 2012, BLOOD, V119, P368, DOI 10.1182/blood-2011-06-360354; NAKAO M, 1995, CANCER RES, V55, P4248; Niiya M, 2003, CANCER CHEMOTH PHARM, V52, P391, DOI 10.1007/s00280-003-0665-1; Ochi T, 2011, BLOOD, V118, P1495, DOI 10.1182/blood-2011-02-337089; Ochi T, 2009, BLOOD, V113, P66, DOI 10.1182/blood-2008-06-164889; Ohminami H, 2000, BLOOD, V95, P286; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Okamoto S, 2009, CANCER RES, V69, P9003, DOI 10.1158/0008-5472.CAN-09-1450; Park JR, 2007, MOL THER, V15, P825, DOI 10.1038/sj.mt.6300104; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Peng WY, 2010, CLIN CANCER RES, V16, P5458, DOI 10.1158/1078-0432.CCR-10-0712; Penido C, 2008, INT IMMUNOL, V20, P129, DOI 10.1093/intimm/dxm128; POCKAJ BA, 1994, CANCER, V73, P1731, DOI 10.1002/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Schaeuble K, 2011, J IMMUNOL, V187, P5645, DOI 10.4049/jimmunol.1101850; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Song LP, 2009, J CLIN INVEST, V119, P1524, DOI 10.1172/JCI37869; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; William WN, 2011, NAT REV CLIN ONCOL, V8, P611, DOI 10.1038/nrclinonc.2011.90; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhang TQ, 2006, EUR J IMMUNOL, V36, P457, DOI 10.1002/eji.200526208	48	34	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56820	10.1371/journal.pone.0056820	http://dx.doi.org/10.1371/journal.pone.0056820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441216	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200073
J	Dutta, A; Katarkar, A; Chaudhuri, K				Dutta, Avirup; Katarkar, Atul; Chaudhuri, Keya			In-Silico Structural and Functional Characterization of a V-cholerae O395 Hypothetical Protein Containing a PDZ1 and an Uncommon Protease Domain	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUBCELLULAR-LOCALIZATION; PATHOGENICITY ISLANDS; QUALITY-CONTROL; CRYSTAL-STRUCTURE; SERINE PROTEASES; CELLULAR STRESS; GAP PENALTIES; SWISS-MODEL; HTRA FAMILY	Vibrio cholerae, the causative agent of epidemic cholera, has been a constant source of concern for decades. It has constantly evolved itself in order to survive the changing environment. Acquisition of new genetic elements through genomic islands has played a major role in its evolutionary process. In this present study a hypothetical protein was identified which was present in one of the predicted genomic island regions of the large chromosome of V. cholerae O395 showing a strong homology with a conserved phage encoded protein. In-silico physicochemical analysis revealed that the hypothetical protein was a periplasmic protein. Homology modeling study indicated that the hypothetical protein was an unconventional and atypical serine protease belonging to HtrA protein family. The predicted 3D-model of the hypothetical protein revealed a catalytic centre serine utilizing a single catalytic residue for proteolysis. The predicted catalytic triad may help to deduce the active site for the recruitment of the substrate for proteolysis. The active site arrangements of this predicted serine protease homologue with atypical catalytic triad is expected to allow these proteases to work in different environments of the host.	[Dutta, Avirup] CSIR Indian Inst Chem Biol, Mol & Human Genet Div, CSIR SRF, Kolkata, W Bengal, India; [Katarkar, Atul] CSIR Indian Inst Chem Biol, Mol & Human Genet Div, ICMR SRF, Kolkata, W Bengal, India; [Chaudhuri, Keya] CSIR Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, W Bengal, India; [Chaudhuri, Keya] CSIR Indian Inst Chem Biol, Acad Affairs Div, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Chaudhuri, K (corresponding author), CSIR Indian Inst Chem Biol, Mol & Human Genet Div, Kolkata, W Bengal, India.	keya.chaudhuri@gmail.com		Dutta, Avirup/0000-0002-3595-6198	Council of Scientific and Industrial Research (CSIR), Govt. of India; CSIR; ICMR, Govt. of India	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR, Govt. of India(Indian Council of Medical Research (ICMR))	The study was funded by Council of Scientific and Industrial Research (CSIR), Govt. of India. AD and AK are recipients of fellowships from CSIR and ICMR, Govt. of India, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Bates PA, 2001, PROTEINS, P39; Chatterjee R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-150; CHOI KS, 1992, J BACTERIOL, V174, P6270, DOI 10.1128/JB.174.19.6270-6276.1992; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cortes G, 2002, INFECT IMMUN, V70, P4772, DOI 10.1128/IAI.70.9.4772-4776.2002; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HACKER J, 1999, PATHOGENICITY ISLAND, P1; Hansen G, 2012, CELL MOL LIFE SCI; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hewitt L, 2000, J MOL BIOL, V302, P887, DOI 10.1006/jmbi.2000.4105; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jones CH, 2001, INFECT IMMUN, V69, P5538, DOI 10.1128/IAI.69.9.5538-5545.2001; KAPER JB, 1984, NATURE, V308, P655, DOI 10.1038/308655a0; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Kim Y, 2002, J BIOL CHEM, V277, P2823, DOI 10.1074/jbc.M108888200; Kirk R, 2010, SENSORY MECHANISMS IN BACTERIA: MOLECULAR ASPECTS OF SIGNAL RECOGNITION, P231; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee J, 2010, PROTEINS, V78, P3428, DOI 10.1002/prot.22849; Lewis C, 2009, MICROBIOL-SGM, V155, P873, DOI 10.1099/mic.0.023754-0; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Mo E, 2006, MICROB PATHOGENESIS, V41, P174, DOI 10.1016/j.micpath.2006.07.004; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Shea YA, 2004, MICROBIOL-SGM, V150, P4053, DOI 10.1099/mic.0.27172-0; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; Pan L, 2007, EMBO J, V26, P4576, DOI 10.1038/sj.emboj.7601860; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Schrodinger L., 2020, PYMOL; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Wrase R, 2011, P NATL ACAD SCI USA, V108, P10490, DOI 10.1073/pnas.1101084108; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang WW, 2008, APPL ENVIRON MICROB, V74, P6254, DOI 10.1128/AEM.00109-08; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	78	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56725	10.1371/journal.pone.0056725	http://dx.doi.org/10.1371/journal.pone.0056725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441214	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200071
J	Kandeel, M; Kitade, Y				Kandeel, Mahmoud; Kitade, Yukio			Computational Analysis of siRNA Recognition by the Ago2 PAZ Domain and Identification of the Determinants of RNA-Induced Gene Silencing	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ARGONAUTE; STABILITY; PROTEINS; INSIGHTS; BINDING	RNA interference (RNAi) is a highly specialized process of protein-siRNA interaction that results in the regulation of gene expression and cleavage of target mRNA. The PAZ domain of the Argonaute proteins binds to the 3' end of siRNA, and during RNAi the attaching end of the siRNA switches between binding and release from its binding pocket. This biphasic interaction of the 3' end of siRNA with the PAZ domain is essential for RNAi activity; however, it remains unclear whether stronger or weaker binding with PAZ domain will facilitate or hinder the overall RNAi process. Here we report the correlation between the binding of modified siRNA 3' overhang analogues and their in vivo RNAi efficacy. We found that higher RNAi efficacy was associated with the parameters of lower Ki value, lower total intermolecular energy, lower free energy, higher hydrogen bonding, smaller total surface of interaction and fewer van der Waals interactions. Electrostatic interaction was a minor contributor to compounds recognition, underscoring the presence of phosphate groups in the modified analogues. Thus, compounds with lower binding affinity are associated with better gene silencing. Lower binding strength along with the smaller interaction surface, higher hydrogen bonding and fewer van der Waals interactions were among the markers for favorable RNAi activity. Within the measured parameters, the interaction surface, van der Waals interactions and inhibition constant showed a statistically significant correlation with measured RNAi efficacy. The considerations provided in this report will be helpful in the design of new compounds with better gene silencing ability.	[Kandeel, Mahmoud; Kitade, Yukio] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan; [Kitade, Yukio] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 50111, Japan; [Kandeel, Mahmoud] Kafrelshikh Univ, Fac Vet Med, Dept Pharmacol, Kafrelshikh, Egypt	Gifu University; Gifu University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Kitade, Y (corresponding author), Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan.	ykkitade@gifu-u.ac.jp	Kandeel, Mahmoud/G-3636-2016	Kandeel, Mahmoud/0000-0003-3668-5147	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science (JSPS) [24390025]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Research support from Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid for scientific Research (Grant no. 24390025) from the Japan Society for the Promotion of Science (JSPS) (URL: http://www.mext.go.jp/english/, http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparailly F, 2012, NATURE REV RHEUMATOL; Avino A, 2012, CHEM BIODIVERS, V9, P557, DOI 10.1002/cbdv.201100321; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Bouasker S, 2009, NATURE, V461, P743, DOI 10.1038/461743a; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Gong W, 2012, BIOORG MED CHEM LETT, V22, P6934, DOI 10.1016/j.bmcl.2012.09.009; Gu S, 2012, CURR BIOL, V22, P1536, DOI 10.1016/j.cub.2012.06.040; Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33; Jaronczyk K, 2005, BIOCHEM J, V387, P561, DOI 10.1042/BJ20041822; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Kuboe S, 2010, CHEM COMMUN, V46, P7367, DOI 10.1039/c0cc02450c; Li Y, 2011, CHEM BIOL DRUG DESIG; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; Rajasekaran R, 2012, J MOL MODELING; Sipa K, 2007, RNA, V13, P1301, DOI 10.1261/rna.538907; Somoza A, 2010, CHEM COMMUN, V46, P4270, DOI 10.1039/c003221b; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Taniho K, 2012, BIOORG MED CHEM LETT, V22, P2518, DOI 10.1016/j.bmcl.2012.01.132; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Ueno Y, 2005, J ORG CHEM, V70, P7925, DOI 10.1021/jo050635m; Ueno Y, 2008, BIOORG MED CHEM LETT, V18, P5194, DOI 10.1016/j.bmcl.2008.08.086; Ueno Yoshihito, 2009, Nucleic Acids Symp Ser (Oxf), P27, DOI 10.1093/nass/nrp014; Ueno Yoshihito, 2008, Nucleic Acids Symp Ser (Oxf), P503, DOI 10.1093/nass/nrn255; Ueno Y, 2009, BIOORGAN MED CHEM, V17, P1974, DOI 10.1016/j.bmc.2009.01.033; Wang J, 2012, TRANSL ANDROL UROL, V1, P33, DOI 10.3978/j.issn.2223-4683.2011.12.04; Wang L, 2013, BIOMATERIALS, V34, P262, DOI 10.1016/j.biomaterials.2012.09.037; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yoshikawa K, 2011, BIOCONJUGATE CHEM, V22, P42, DOI 10.1021/bc100301w; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zeng L, 2011, PROTEINS, V79, P2004, DOI 10.1002/prot.23003	37	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57140	10.1371/journal.pone.0057140	http://dx.doi.org/10.1371/journal.pone.0057140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441235	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200092
J	Snyder, JC; Rochelle, LK; Lyerly, HK; Caron, MG; Barak, LS				Snyder, Joshua C.; Rochelle, Lauren K.; Lyerly, H. Kim; Caron, Marc G.; Barak, Lawrence S.			Constitutive Internalization of the Leucine-rich G Protein-coupled Receptor-5 (LGR5) to the Trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; BETA-ARRESTIN; WNT/BETA-CATENIN; RETROGRADE TRANSPORT; PLASMA-MEMBRANE; HAIR FOLLICLE; WNT RECEPTORS; SELF-RENEWAL; IN-VITRO; PHOSPHORYLATION	LGR5 is a Wnt pathway associated G protein-coupled receptor (GPCR) that serves as a molecular determinant of stem cells in numerous tissues including the intestine, stomach, hair follicle, eye, and mammary gland. Despite its importance as a marker for this critical niche, little is known about LGR5 signaling nor the biochemical mechanisms and receptor determinants that regulate LGR5 membrane expression and intracellular trafficking. Most importantly, in cells LGR5 is predominantly intracellular, yet the mechanisms underlying this behavior have not been determined. In this work we elucidate a precise trafficking program for LGR5 and identify the motif at its C terminus that is responsible for the observed constitutive internalization. We show that this process is dependent upon dynamin GTPase activity and find that wild-type full-length LGR5 rapidly internalizes into EEA1- and Rab5-positive endosomes. However, LGR5 fails to rapidly recycle to the plasmid membrane through Rab4-positive vesicles, as is common for other GPCRs. Rather, internalized LGR5 transits through Rab7- and Rab9-positive vesicles, co-localizes in vesicles with Vps26, a retromer complex component that regulates retrograde trafficking to the trans-Golgi network (TGN) and reaches a steady-state distribution in the TGN within 2 h. Using mutagenesis, particularly of putative phosphorylation sites, we show that the amino acid pair, serine 861 and 864, is the principal C-tail determinant that mediates LGR5 constitutive internalization. The constitutive internalization of LGR5 to the TGN suggests the existence of novel biochemical roles for its Wnt pathway related, but ill defined signaling program.	[Snyder, Joshua C.; Rochelle, Lauren K.; Caron, Marc G.; Barak, Lawrence S.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287, Durham, NC 27710 USA.	marc.caron@dm.duke.edu; lawrence.barak@dm.duke.edu	Lyerly, Herbert Kim/AAX-4925-2020; Lyerly, Herbert K/B-6528-2014	Lyerly, Herbert Kim/0000-0002-0063-4770; Lyerly, Herbert K/0000-0002-0063-4770; Snyder, Joshua/0000-0002-9787-3371	Susan G. Komen Foundation [KG080627]; Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; National Institute of Drug Abuse [P30 5P30DA29925]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA029925] Funding Source: NIH RePORTER	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Duke Cancer Center Stewart Trust; Duke Cancer Center Cancer and the Environment; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Susan G. Komen Foundation Grant KG080627 (to J.C.S. and H. K. L.); Duke Cancer Center Stewart Trust and Duke Cancer Center Cancer and the Environment (to J.C.S., L. K. R., L. S. B., and M. C. G.); and National Institute of Drug Abuse Grant P30 5P30DA29925 (to L. S. B. and M.G.C.).	BARAK LS, 1994, J BIOL CHEM, V269, P2790; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Brzeszczynska J, 2012, INT J MOL MED, V29, P871, DOI 10.3892/ijmm.2012.904; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chang XB, 2008, J CELL SCI, V121, P2814, DOI 10.1242/jcs.028951; Chen CH, 2004, J BIOL CHEM, V279, P10020, DOI 10.1074/jbc.M310590200; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Chia PZC, 2011, J CELL SCI, V124, P2401, DOI 10.1242/jcs.083782; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; Escola JM, 2010, J BIOL CHEM, V285, P41772, DOI 10.1074/jbc.M110.153460; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Maestri-El Kouhen O, 2000, J BIOL CHEM, V275, P36659, DOI 10.1074/jbc.M006788200; Mallet WG, 1999, J CELL BIOL, V146, P345, DOI 10.1083/jcb.146.2.345; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; RIOS RM, 1994, J CELL BIOL, V125, P997, DOI 10.1083/jcb.125.5.997; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Snyder JC, 2009, AM J RESP CELL MOL, V40, P633, DOI 10.1165/rcmb.2008-0334OC; SOLDATI T, 1995, J BIOL CHEM, V270, P25541, DOI 10.1074/jbc.270.43.25541; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; von Zastrow M, 2012, NEURON, V76, P22, DOI 10.1016/j.neuron.2012.09.022; Wilbanks AM, 2002, BIOCHEMISTRY-US, V41, P11981, DOI 10.1021/bi020275m; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Windheim M, 2004, CURR TOP MICROBIOL, V273, P29; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	61	38	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10286	10297		10.1074/jbc.M112.447540	http://dx.doi.org/10.1074/jbc.M112.447540			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439653	hybrid, Green Published			2022-12-25	WOS:000317565000010
J	Fernandez, JM; Di Giusto, G; Kalstein, M; Melamud, L; Rivarola, V; Ford, P; Capurro, C				Fernandez, Juan M.; Di Giusto, Gisela; Kalstein, Maia; Melamud, Luciana; Rivarola, Valeria; Ford, Paula; Capurro, Claudia			Cell Volume Regulation in Cultured Human Retinal Muller Cells Is Associated with Changes in Transmembrane Potential	PLOS ONE			English	Article							OSMOTIC SWELLING CHARACTERISTICS; ACTIVATED CATION CHANNELS; GLIAL-CELLS; CHLORIDE CHANNELS; AMINO-ACIDS; POTASSIUM; ASTROCYTES; DECREASE; RELEASE; K+	Muller cells are mainly involved in controlling extracellular homeostasis in the retina, where intense neural activity alters ion concentrations and osmotic gradients, thus favoring cell swelling. This increase in cell volume is followed by a regulatory volume decrease response (RVD), which is known to be partially mediated by the activation of K+ and anion channels. However, the precise mechanisms underlying osmotic swelling and subsequent cell volume regulation in Muller cells have been evaluated by only a few studies. Although the activation of ion channels during the RVD response may alter transmembrane potential (V-m), no studies have actually addressed this issue in Muller cells. The aim of the present work is to evaluate RVD using a retinal Muller cell line (MIO-M1) under different extracellular ionic conditions, and to study a possible association between RVD and changes in V-m. Cell volume and V-m changes were evaluated using fluorescent probe techniques and a mathematical model. Results show that cell swelling and subsequent RVD were accompanied by V-m depolarization followed by repolarization. This response depended on the composition of extracellular media. Cells exposed to a hypoosmotic solution with reduced ionic strength underwent maximum RVD and had a larger repolarization. Both of these responses were reduced by K+ or Cl- channel blockers. In contrast, cells facing a hypoosmotic solution with the same ionic strength as the isoosmotic solution showed a lower RVD and a smaller repolarization and were not affected by blockers. Together, experimental and simulated data led us to propose that the efficiency of the RVD process in Muller glia depends not only on the activation of ion channels, but is also strongly modulated by concurrent changes in the membrane potential. The relationship between ionic fluxes, changes in ion permeabilities and ion concentrations -all leading to changes in V-m- define the success of RVD.	[Fernandez, Juan M.; Di Giusto, Gisela; Kalstein, Maia; Melamud, Luciana; Rivarola, Valeria; Ford, Paula; Capurro, Claudia] Univ Buenos Aires, Fac Med, Lab Biomembranas, Dept Fisiol & Biofis, Buenos Aires, DF, Argentina; [Melamud, Luciana] Univ Buenos Aires, Fac Med, Ctr Univ Neurol Dr JM Ramos Mejia, Consultorio Neuroinmunol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Capurro, C (corresponding author), Univ Buenos Aires, Fac Med, Lab Biomembranas, Dept Fisiol & Biofis, Buenos Aires, DF, Argentina.	capurro@retina.ar	Rivarola, Valeria/R-7128-2019	Rivarola, Valeria/0000-0002-8879-1198; Di Giusto, Gisela/0000-0002-7622-5172; Ford, Paula/0000-0002-3656-0806; Capurro, Claudia/0000-0003-3773-0202	Fondo Nacional para la Ciencia y la Tecnologia (FONCYT) [PICT 07-1060]; UBACYT Universidad de Buenos Aires (UBA) [MO 648/11]	Fondo Nacional para la Ciencia y la Tecnologia (FONCYT); UBACYT Universidad de Buenos Aires (UBA)	This work was supported by PICT 07-1060 Fondo Nacional para la Ciencia y la Tecnologia (FONCYT), http://www.agencia.gov.ar; UBACYT MO 648/11 Universidad de Buenos Aires (UBA), http://www.uba.rec.ar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLANYI K, 1990, GLIA, V3, P151, DOI 10.1002/glia.440030302; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; CHRISTENSEN O, 1992, J MEMBRANE BIOL, V129, P13; Di Giusto G, 2012, J CELL BIOCHEM, V113, P3721, DOI 10.1002/jcb.24246; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; EBERHARDT W, 1987, NEUROSCIENCE, V22, P687, DOI 10.1016/0306-4522(87)90365-4; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Ernest NJ, 2005, AM J PHYSIOL-CELL PH, V288, pC1451, DOI 10.1152/ajpcell.00503.2004; Ford P, 2005, BIOL CELL, V97, P687, DOI 10.1042/BC20040116; Franco R, 2001, PFLUG ARCH EUR J PHY, V442, P791; Galizia L, 2008, AM J PHYSIOL-RENAL, V294, pF582, DOI 10.1152/ajprenal.00427.2007; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hernandez JA, 1998, AM J PHYSIOL-CELL PH, V275, pC1067, DOI 10.1152/ajpcell.1998.275.4.C1067; Hirrlinger PG, 2008, J NEUROCHEM, V105, P1405, DOI 10.1111/j.1471-4159.2008.05243.x; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Ilyaskin A. V., 2011, Biophysics, V56, P516, DOI 10.1134/S0006350911030092; KIMELBERG HK, 1990, BRAIN RES, V529, P262, DOI 10.1016/0006-8993(90)90836-Z; KIMELBERG HK, 1988, GLIA, V1, P219, DOI 10.1002/glia.440010307; KIMELBERG HK, 1981, BIOCHIM BIOPHYS ACTA, V646, P179, DOI 10.1016/0005-2736(81)90285-6; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; Kuhrt H, 2008, INT J DEV NEUROSCI, V26, P745, DOI 10.1016/j.ijdevneu.2008.07.003; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; LEWIS R, 2011, J CELL PHYSL; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Olson JE, 1997, GLIA, V20, P254, DOI 10.1002/(SICI)1098-1136(199707)20:3<254::AID-GLIA9>3.0.CO;2-7; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, J NEUROIMMUNOL, V161, P145, DOI 10.1016/j.jneuroim.2005.01.003; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pannicke T, 2010, J NEUROSCI RES, V88, P2877, DOI 10.1002/jnr.22437; Parkerson KA, 2003, AM J PHYSIOL-CELL PH, V284, pC1460, DOI 10.1152/ajpcell.00603.2002; Pasantes-Morales H, 2002, NEUROCHEM RES, V27, P59, DOI 10.1023/A:1014850505400; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC172, DOI 10.1152/ajpcell.1994.266.1.C172; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC165, DOI 10.1152/ajpcell.1994.266.1.C165; Poignard C, 2011, EUR BIOPHYS J BIOPHY, V40, P235, DOI 10.1007/s00249-010-0641-8; VITARELLA D, 1994, J NEUROCHEM, V63, P1143; WANG K, 1992, AM J PHYSIOL, V263, pG566, DOI 10.1152/ajpgi.1992.263.4.G566; Welsh DG, 2000, J PHYSIOL-LONDON, V527, P139, DOI 10.1111/j.1469-7793.2000.t01-1-00139.x; Wurm A, 2006, GLIA, V54, P411, DOI 10.1002/glia.20391; Wurm A, 2009, MOL VIS, V15, P1858	43	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57268	10.1371/journal.pone.0057268	http://dx.doi.org/10.1371/journal.pone.0057268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451196	gold, Green Published			2022-12-25	WOS:000316849500083
J	Gueugneau, N; Bove, M; Avanzino, L; Jacquin, A; Pozzo, T; Papaxanthis, C				Gueugneau, Nicolas; Bove, Marco; Avanzino, Laura; Jacquin, Agnes; Pozzo, Thierry; Papaxanthis, Charalambos			Interhemispheric Inhibition during Mental Actions of Different Complexity	PLOS ONE			English	Article							IPSILATERAL MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; CORTICOSPINAL EXCITABILITY; FINGER MOVEMENTS; INTRACORTICAL INHIBITION; VOLUNTARY MOVEMENT; FUNCTIONAL-CHANGES; HAND MUSCLES; IMAGERY; MODULATION	Several investigations suggest that actual and mental actions trigger similar neural substrates. Yet, neurophysiological evidences on the nature of interhemispheric interactions during mental movements are still meagre. Here, we asked whether the content of mental images, investigated by task complexity, is finely represented in the inhibitory interactions between the two primary motor cortices (M1s). Subjects' left M1 was stimulated by means of transcranial magnetic stimulation (TMS) while they were performing actual or mental movements of increasing complexity with their right hand and exerting a maximum isometric force with their left thumb and index. Thus, we simultaneously assessed the corticospinal excitability in the right opponent pollicis muscle (OP) and the ipsilateral silent period (iSP) in the left OP during actual and mental movements. Corticospinal excitability in right OP increased during actual and mental movements, but task complexity-dependent changes were only observed during actual movements. Interhemispheric motor inhibition in the left OP was similarly modulated by task complexity in both mental and actual movements. Precisely, the duration and the area of the iSP increased with task complexity in both movement conditions. Our findings suggest that mental and actual movements share similar inhibitory neural circuits between the two homologous primary motor cortex areas.	[Gueugneau, Nicolas; Pozzo, Thierry; Papaxanthis, Charalambos] Univ Bourgogne, Unite Format & Rech Sci & Techn Activites Phys &, Dijon, France; [Gueugneau, Nicolas; Pozzo, Thierry; Papaxanthis, Charalambos] Inst Natl Sante & Rech Med INSERM, U1093, Dijon, France; [Bove, Marco; Avanzino, Laura] Univ Genoa, Dept Expt Med, Sect Human Physiol, Genoa, Italy; [Bove, Marco; Avanzino, Laura] Univ Genoa, Ctr Polifunz Sci Motorie, Genoa, Italy; [Pozzo, Thierry] Italian Inst Technol, Genoa, Italy; [Pozzo, Thierry] Inst Univ France IUF, Paris, France; [Jacquin, Agnes] Fac Med Dijon, Serv Neurol, Dijon, France	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; University of Genoa; University of Genoa; Istituto Italiano di Tecnologia - IIT; Institut Universitaire de France; Universite de Bourgogne	Papaxanthis, C (corresponding author), Univ Bourgogne, Unite Format & Rech Sci & Techn Activites Phys &, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr	JACQUIN, Agnès/AFN-9891-2022; Avanzino, Laura/K-6623-2016	AVANZINO, LAURA/0000-0001-6286-1509; Pozzo, Thierry/0000-0002-0585-7965				Abbruzzese G, 1999, NEUROSCI LETT, V263, P113, DOI 10.1016/S0304-3940(99)00120-2; Avanzino L, 2007, J PHYSIOL-LONDON, V583, P99, DOI 10.1113/jphysiol.2007.134510; Avanzino L, 2008, EUR J NEUROSCI, V27, P1285, DOI 10.1111/j.1460-9568.2008.06086.x; Avanzino L, 2009, NEUROSCI LETT, V466, P11, DOI 10.1016/j.neulet.2009.09.036; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; Debarnot U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026717; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety Jean, 1995, Behavioural Brain Research, V72, P127, DOI 10.1016/0166-4328(96)00141-6; Demougeot L, 2011, J NEUROSCI, V31, P10712, DOI 10.1523/JNEUROSCI.6032-10.2011; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fadiga L, 1999, NEUROPSYCHOLOGIA, V37, P147; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Giovannelli F, 2009, J PHYSIOL-LONDON, V587, P5393, DOI 10.1113/jphysiol.2009.175885; Gueugneau N, 2010, CHRONOBIOL INT, V27, P620, DOI 10.3109/07420521003664205; Gueugneau N, 2009, NEUROREHAB NEURAL RE, V23, P237, DOI 10.1177/1545968308321775; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; Hubers A, 2008, EUR J NEUROSCI, V28, P364, DOI 10.1111/j.1460-9568.2008.06335.x; Jackson PL, 2003, NEUROIMAGE, V20, P1171, DOI 10.1016/S1053-8119(03)00369-0; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Koch G, 2008, J NEUROSCI, V28, P5944, DOI 10.1523/JNEUROSCI.0957-08.2008; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Koch G, 2010, NEUROIMAGE, V51, P300, DOI 10.1016/j.neuroimage.2010.02.022; Kuhtz-Buschbeck JP, 2003, EUR J NEUROSCI, V18, P3375, DOI 10.1111/j.1460-9568.2003.03066.x; Kumru H, 2008, EXP BRAIN RES, V189, P373, DOI 10.1007/s00221-008-1433-6; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Lebon F, 2012, EUR J NEUROSCI, V35, P323, DOI 10.1111/j.1460-9568.2011.07938.x; Liang N, 2008, NEUROSCI LETT, V433, P135, DOI 10.1016/j.neulet.2007.12.058; Liang N, 2011, CLIN NEUROPHYSIOL, V122, P550, DOI 10.1016/j.clinph.2010.07.024; Liepert J, 2009, J NEURAL TRANSM, V116, P1613, DOI 10.1007/s00702-009-0287-9; Malouin F, 2004, NEUROREHAB NEURAL RE, V18, P66, DOI 10.1177/0888439004266304; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Morishita T, 2011, BRAIN RES, V1371, P65, DOI 10.1016/j.brainres.2010.11.049; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Papaxanthis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051191; Park WH, 2011, NEUROSCI LETT, V494, P255, DOI 10.1016/j.neulet.2011.03.027; Pelgrims B, 2011, HUM BRAIN MAPP, V32, P1471, DOI 10.1002/hbm.21121; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Porro CA, 1996, J NEUROSCI, V16, P7688; Porro CA, 2000, EUR J NEUROSCI, V12, P3059, DOI 10.1046/j.1460-9568.2000.00182.x; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reynolds C, 1999, NEUROLOGY, V53, P730, DOI 10.1212/WNL.53.4.730; Roosink M, 2010, BEHAV BRAIN RES, V213, P35, DOI 10.1016/j.bbr.2010.04.027; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Stinear CM, 2004, EXP BRAIN RES, V157, P351, DOI 10.1007/s00221-004-1851-z; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; Tia B, 2010, NEUROSCI LETT, V480, P138, DOI 10.1016/j.neulet.2010.06.026; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Trompetto C, 2004, EXP BRAIN RES, V158, P133, DOI 10.1007/s00221-004-1881-6; van den Berg FE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017742; Vargas CD, 2004, CEREB CORTEX, V14, P1200, DOI 10.1093/cercor/bhh080; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	72	17	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56973	10.1371/journal.pone.0056973	http://dx.doi.org/10.1371/journal.pone.0056973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451125	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500049
J	Lee, DW; Ramakrishnan, D; Valenta, J; Parney, IF; Bayless, KJ; Sitcheran, R				Lee, Dong Whan; Ramakrishnan, Dhivya; Valenta, John; Parney, Ian F.; Bayless, Kayla J.; Sitcheran, Raquel			The NF-kappa B RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; STEM-CELLS; PROLIFERATION; GROWTH; DIFFERENTIATION; TRANSCRIPTION; SUBCLASSES; PHENOTYPE; MIGRATION; SUBTYPES	High-grade gliomas, such as glioblastomas (GBMs), are very aggressive, invasive brain tumors with low patient survival rates. The recent identification of distinct glioma tumor subtypes offers the potential for understanding disease pathogenesis, responses to treatment and identification of molecular targets for personalized cancer therapies. However, the key alterations that drive tumorigenesis within each subtype are still poorly understood. Although aberrant NF-kappa B activity has been implicated in glioma, the roles of specific members of this protein family in tumorigenesis and pathogenesis have not been elucidated. In this study, we show that the NF-kappa B protein RelB is expressed in a particularly aggressive mesenchymal subtype of glioma, and loss of RelB significantly attenuated glioma cell survival, motility and invasion. We find that RelB promotes the expression of mesenchymal genes including YKL-40, a marker of the MES glioma subtype. Additionally, RelB regulates expression of Olig2, a regulator of cancer stem cell proliferation and a candidate marker for the cell of origin in glioma. Furthermore, loss of RelB in glioma cells significantly diminished tumor growth in orthotopic mouse xenografts. The relevance of our studies for human disease was confirmed by analysis of a human GBM genome database, which revealed that high RelB expression strongly correlates with rapid tumor progression and poor patient survival rates. Thus, our findings demonstrate that RelB is an oncogenic driver of mesenchymal glioma tumor growth and invasion, highlighting the therapeutic potential of inhibiting the noncanonical NF-kappa B (RelB-mediated) pathway to treat these deadly tumors.	[Lee, Dong Whan; Ramakrishnan, Dhivya; Valenta, John; Bayless, Kayla J.; Sitcheran, Raquel] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Parney, Ian F.] Mayo Clin, Ctr Canc, Dept Neurol Surg, Rochester, MN USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Mayo Clinic	Sitcheran, R (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA.	sitcheran@tamhsc.edu		Sitcheran, Raquel/0000-0001-8916-9707; Parney, Ian/0000-0002-9702-8047	National Cancer Institute of the National Institutes of Health [KO1-CA118274, 1P50CA108961-06I]; NATIONAL CANCER INSTITUTE [P50CA108961, K01CA118274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082554] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Cancer Institute of the National Institutes of Health under award numbers KO1-CA118274 (RS) and 1P50CA108961-06I (IFP). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bhat KP, 2008, FEBS LETT, V582, P3193, DOI 10.1016/j.febslet.2008.08.010; Bosma I, 2009, NEURO-ONCOLOGY, V11, P51, DOI 10.1215/15228517-2008-049; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbrainres.2004.10.010; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee DY, 2010, GENE DEV, V24, P2317, DOI 10.1101/gad.1957110; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Nutt CL, 2005, CLIN CANCER RES, V11, P2258, DOI 10.1158/1078-0432.CCR-04-1601; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Powolny-Budnicka I, 2011, IMMUNITY, V34, P364, DOI 10.1016/j.immuni.2011.02.019; Raychaudhuri B, 2007, J NEURO-ONCOL, V85, P39, DOI 10.1007/s11060-007-9390-7; Shih VFS, 2012, NAT IMMUNOL, V13, P1162, DOI 10.1038/ni.2446; Smith D, 2008, MOL CELL BIOCHEM, V307, P141, DOI 10.1007/s11010-007-9593-4; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Sun Y, 2011, NEURON, V69, P906, DOI 10.1016/j.neuron.2011.02.005; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Xu Y, 2009, CANCER RES, V69, P3267, DOI 10.1158/0008-5472.CAN-08-4635; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	41	44	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57489	10.1371/journal.pone.0057489	http://dx.doi.org/10.1371/journal.pone.0057489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451236	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500109
J	Sanchez-Carron, G; Garcia-Garcia, MI; Zapata-Perez, R; Takami, H; Garcia-Carmona, F; Sanchez-Ferrer, A				Sanchez-Carron, Guiomar; Inmaculada Garcia-Garcia, Maria; Zapata-Perez, Ruben; Takami, Hideto; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro			Biochemical and Mutational Analysis of a Novel Nicotinamidase from Oceanobacillus iheyensis HTE831	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; CRYSTAL-STRUCTURE; SALVAGE PATHWAY; NAD(+); PURIFICATION; MECHANISM; SEQUENCE; SIR2; METABOLISM	Nicotinamidases catalyze the hydrolysis of nicotinamide to nicotinic acid and ammonia, an important reaction in the NAD(+) salvage pathway. This paper reports a new nicotinamidase from the deep-sea extremely halotolerant and alkaliphilic Oceanobacillus iheyensis HTE831 (OiNIC). The enzyme was active towards nicotinamide and several analogues, including the prodrug pyrazinamide. The enzyme was more nicotinamidase (k(cat)/K-m = 43.5 mM(-1) s(-1)) than pyrazinamidase (k(cat)/K-m = 3.2 mM(-1) s(-1)). Mutational analysis was carried out on seven critical amino acids, confirming for the first time the importance of Cys133 and Phe68 residues for increasing pyrazinamidase activity 2.9- and 2.5-fold, respectively. In addition, the change in the fourth residue involved in the ion metal binding (Glu65) was detrimental to pyrazinamidase activity, decreasing it 6-fold. This residue was also involved in a new distinct structural motif DAHXXXDXXHPE described in this paper for Firmicutes nicotinamidases. Phylogenetic analysis revealed that OiNIC is the first nicotinamidase described for the order Bacillales.	[Sanchez-Carron, Guiomar; Inmaculada Garcia-Garcia, Maria; Zapata-Perez, Ruben; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Murcia, Spain; [Inmaculada Garcia-Garcia, Maria; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB, Murcia, Spain; [Takami, Hideto] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Microbial Genome Res Grp, Inst Biogeosci, Yokosuka, Kanagawa, Japan	University of Murcia; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum,Cam, Murcia, Spain.	alvaro@um.es	Garcia-Carmona, Francisco/K-6520-2017; GARCIA, MARIA/L-2643-2014; Takami, Hideto/D-4200-2012; Sánchez-Ferrer, Alvaro/M-1631-2014; Zapata-Perez, Ruben/AAA-9782-2020	Takami, Hideto/0000-0003-3433-7018; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Zapata-Perez, Ruben/0000-0003-4432-9652; Garcia-Carmona, Francisco/0000-0002-1318-7690	MINECO-FEDER [BIO2010-22225-C02-01]; Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca [04541/GERM/06]; Ministerio de Educacion; Fundacion Seneca	MINECO-FEDER(Spanish Government); Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca(Fundacion Seneca); Ministerio de Educacion; Fundacion Seneca(Fundacion Seneca)	This study was partially supported by Spanish grants from MINECO-FEDER (BIO2010-22225-C02-01) and from the Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, Fundacion Seneca (04541/GERM/06, Plan Regional de Ciencia y Tecnologia 2007-2010). GSC is supported by a predoctoral fellowship from Ministerio de Educacion and MIGG is a holder of a predoctoral fellowship associated with the above project from Fundacion Seneca. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Avalos JL, 2005, MOL CELL, V17, P855, DOI 10.1016/j.molcel.2005.02.022; Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Boshoff HIM, 1998, J BACTERIOL, V180, P5809, DOI 10.1128/JB.180.22.5809-5814.1998; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; French JB, 2010, BIOCHEMISTRY-US, V49, P8803, DOI 10.1021/bi1012436; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Gazanion E, 2011, MOL MICROBIOL, V82, P21, DOI 10.1111/j.1365-2958.2011.07799.x; Gazanion E, 2012, INT J PARASITOL, V42, P323, DOI 10.1016/j.ijpara.2012.02.007; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu G, 2007, ARCH BIOCHEM BIOPHYS, V461, P66, DOI 10.1016/j.abb.2007.01.037; JOSHI JG, 1962, J BIOL CHEM, V237, P929; Kawabata H, 2004, INFECT IMMUN, V72, P7147, DOI 10.1128/IAI.72.12.7147-7154.2004; Kim S, 2004, FEMS MICROBIOL LETT, V234, P289, DOI [10.1111/j.1574-6968.2004.tb09546.x, 10.1016/j.femsle.2004.03.038]; Kruger D, 2001, EUR J BIOCHEM, V268, P3831, DOI 10.1046/j.1432-1327.2001.02297.x; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lu J, 2001, FEMS MICROBIOL LETT, V205, P291, DOI 10.1111/j.1574-6968.2001.tb10963.x; Murphy DJ, 2004, ANAL BIOCHEM, V327, P61, DOI 10.1016/j.ab.2003.12.018; PARDEE AB, 1971, J BIOL CHEM, V246, P6792; Petrella S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015785; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Sambrook J., 1989, MOL CLONING LAB MANU; Sanchez-Carron G, 2011, APPL ENVIRON MICROB, V77, P2471, DOI 10.1128/AEM.02927-10; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanigawa Y, 1980, Methods Enzymol, V66, P132; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004; Wang GD, 2007, PLANT J, V49, P1020, DOI 10.1111/j.1365-313X.2006.03013.x; YAN C, 1987, J BIOL CHEM, V262, P9082; ZEREZ CR, 1990, BLOOD, V75, P1705; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x; Zhang JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039546	60	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56727	10.1371/journal.pone.0056727	http://dx.doi.org/10.1371/journal.pone.0056727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451075	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500024
J	Stirling, WC; Felin, T				Stirling, Wynn C.; Felin, Teppo			Game Theory, Conditional Preferences, and Social Influence	PLOS ONE			English	Article							FAIRNESS	Neoclassical noncooperative game theory is based on a simple, yet powerful synthesis of mathematical and logical concepts: unconditional and immutable preference orderings and individual rationality. Although this structure has proven useful for characterizing competitive multi-player behavior, its applicability to scenarios involving complex social relationships is problematic. In this paper we directly address this limitation by the introduction of a conditional preference structure that permits players to modulate their preference orderings as functions of the preferences of other players. Embedding this expanded preference structure in a formal and graphical framework provides a systematic approach for characterizing a complex society. The result is an influence network that allows conditional preferences to propagate through the community, resulting in an emergent social model which characterizes all of the social relationships that exist and which leads to solution concepts that account for both group and individual interests. The Ultimatum game is presented as an example of how social influence can be modeled with conditional preferences.	[Stirling, Wynn C.] Brigham Young Univ, Dept Elect & Comp Engn, Provo, UT 84602 USA; [Felin, Teppo] Brigham Young Univ, Marriott Sch, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Felin, T (corresponding author), Brigham Young Univ, Marriott Sch, Provo, UT 84602 USA.	teppo.felin@byu.edu		Felin, Teppo/0000-0003-2044-0145				Abbas AE, 2005, DECIS ANAL, V2, P195; Abel N.H., 1881, OEUVRES COMPLETES, V2, P36; Abell P, 2008, MANAG DECIS ECON, V29, P489, DOI 10.1002/mde.1413; [Anonymous], 1995, EVOLUTIONARY GAME TH; Armendt B, 1988, CAUSATION DECISION B, P3; Arrow K., 1963, SOCIAL CHOICE INDIVI; Arrow KJ, 1986, RATIONAL CHOICE; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bicchieri C, 2010, POLIT PHILOS ECON, V9, P297, DOI 10.1177/1470594X10369276; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Boutilier C, 2004, J ARTIF INTELL RES, V21, P135, DOI 10.1613/jair.1234; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 2004, ROUNDTABLE SER BEHAV, P1; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032890; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Durlauf SN, 1999, P NATL ACAD SCI USA, V96, P10582, DOI 10.1073/pnas.96.19.10582; Easley D, 2010, NETWORKS CROWDS MARK; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Friedman M, 1961, PRICE THEORY; Gaertner W., 2006, PRIMER SOCIAL CHOICE; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; Gibbard A, 1974, J ECON THEORY, V7, P617; Gintis Herbert, 2009, BOUNDS REASON GAME T; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Goyal S., 2007, CONNECTIONS; Harsanyi John C., 1977, RATIONAL BEHAV BARGA; Hausman D.M., 2012, PREFERENCE VALUE CHO; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Jaynes E.T., 2003, PROBABILITY THEORY L; Keeney RL, 1993, DECISIONS MULTIPLE O, DOI DOI 10.1017/CBO9781139174084; Margolis H, 1990, SELF INTEREST; Maynard-Smith J, 1982, EVOLUTION THEORY GAM; Palmer F., 1971, GRAMMAR; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; RABIN M, 1993, AM ECON REV, V83, P1281; Rawls J., 1971, THEORY JUSTICE; Shubik M, 1982, GAME THEORY SOCIAL S; Shubik M, 2001, ES14 YAL SCH MAN; Slatkin M, 1980, Science, V210, P633, DOI 10.1126/science.210.4470.633; Stirling W., 2012, THEORY CONDITIONAL G; Szolnoki A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078701; Szolnoki A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026104; Szolnoki A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38002; Vega-Redondo F., 2007, COMPLEX SOCIAL NETWO, P268; Wang T, 2003, J ECON THEORY, V108, P286, DOI 10.1016/S0022-0531(03)00028-0	49	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56751	10.1371/journal.pone.0056751	http://dx.doi.org/10.1371/journal.pone.0056751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115ZB	23451078	Green Published, gold			2022-12-25	WOS:000316849500025
J	Vila, B; Oms, O; Galobart, A; Bates, KT; Egerton, VM; Manning, PL				Vila, Bernat; Oms, Oriol; Galobart, Angel; Bates, Karl T.; Egerton, Victoria M.; Manning, Phillip L.			Dynamic Similarity in Titanosaur Sauropods: Ichnological Evidence from the Fumanya Dinosaur Tracksite (Southern Pyrenees)	PLOS ONE			English	Article							TRACKWAYS; GAUGE; MANUS; SPEEDS	The study of a small sauropod trackway from the Late Cretaceous Fumanya tracksite (southern Pyrenees, Catalonia) and further comparisons with larger trackways from the same locality suggest a causative relationship between gait, gauge, and body proportions of the respective titanosaur trackmakers. This analysis, conducted in the context of scaling predictions and using geometric similarity and dynamic similarity hypotheses, reveals similar Froude numbers and relative stride lengths for both small and large trackmakers from Fumanya. Evidence for geometric similarity in these trackways suggests that titanosaurs of different sizes moved in a dynamically similar way, probably using an amble gait. The wide gauge condition reported in trackways of small and large titanosaurs implies that they possessed similar body (trunk and limbs) proportions despite large differences in body size. These results strengthen the hypothesis that titanosaurs possessed a distinctive suite of anatomical characteristics that are well reflected in their tracks and trackways.	[Vila, Bernat] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain; [Vila, Bernat; Galobart, Angel] Sabadell, Inst Catala Paleontol Miquel Crusafont, Barcelona, Catalonia, Spain; [Oms, Oriol] Univ Autonoma Barcelona, Fac Ciencies, Dept Geol Estratig, E-08193 Barcelona, Catalonia, Spain; [Bates, Karl T.] Univ Liverpool, Inst Aging & Chron Dis, Dept Musculoskeletal Biol 2, Liverpool L69 3BX, Merseyside, England; [Egerton, Victoria M.; Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Manning, Phillip L.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA	University of Zaragoza; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona; University of Liverpool; University of Manchester; University of Pennsylvania	Vila, B (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	bernat.vila@unizar.es	Manning, Phillip/F-9966-2011; Oms, Oriol/AAZ-6312-2020; VILA, BERNAT/AAA-7367-2021; Galobart, Àngel À/H-5024-2011	Manning, Phillip/0000-0002-7161-6246; VILA, BERNAT/0000-0002-5935-1732; Galobart, Àngel À/0000-0003-1508-4561; Oms, Oriol/0000-0001-8355-847X; Egerton, Victoria/0000-0002-0739-6533	Ministerio de Ciencia e Innovacion [CGL 2008-06533-C03-02, CGL2011-30069-C02-01]; Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC))(Ministry of Science and Innovation, Spain (MICINN))	Funding is provided by CGL 2008-06533-C03-02 and CGL2011-30069-C02-01 project (Ministerio de Ciencia e Innovacion; http://www.idi.mineco.gob.es/portal/site/MICINN/). B. Vila acknowledges support from the Ministerio de Ciencia e Innovacion (Subprograma Juan de la Cierva (MICINN-JDC) 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; Bates KT, 2008, PALAEONTOLOGY, V51, P999, DOI 10.1111/j.1475-4983.2008.00789.x; Bates KT, 2008, J GEOL SOC LONDON, V165, P115, DOI 10.1144/0016-76492007-033; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Bravo A.M., 2005, REV ESPANOLA PALEONT, V10, P49; Carballido JL, 2012, PALAEONTOLOGY, V55, P567, DOI 10.1111/j.1475-4983.2012.01139.x; Carrano MT, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P229; Carrano MT, 1999, J ZOOL, V247, P29, DOI 10.1111/j.1469-7998.1999.tb00190.x; Christian Andreas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P63; Christian Andreas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P81; Christiansen Per, 1997, Gaia, V14, P45; Falkingham PL, 2012, J GEOL SOC LONDON, V169, P365, DOI 10.1144/0016-76492011-019; Farlow J.O., 1989, P371; Gonzalez-Riga BJ, 2010, AN ACAD BRAS CIENC, V83, P1; Le Loeuff J., 1997, Geogaceta, V21, P151; Lockley M, 2002, CRETACEOUS RES, V23, P363, DOI 10.1006/cres.2002.1005; Lockley M, 2002, CRETACEOUS RES, V23, P383, DOI 10.1006/cres.2002.1006; Lockley Martin G., 2001, New Mexico Geological Society Field Conference Guidebook, V52, P181; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; Marmi J, 2010, J VERTEBR PALEONTOL, V30, P970, DOI 10.1080/02724631003758011; Marmi J, 2009, CRETACEOUS RES, V30, P1307, DOI 10.1016/j.cretres.2009.07.008; MARTY D., 2008, GEOFOCUS, V21, P1; Marty Daniel, 2003, Ichnos, V10, P209, DOI 10.1080/10420940390256212; Mazzetta Gerardo V., 2004, Historical Biology, V16, P71, DOI 10.1080/08912960410001715132; Mazzetta GV, 2001, ACTA PALAEONTOL POL, V46, P235; Oms O, 2007, PALAEOGEOGR PALAEOCL, V255, P35, DOI 10.1016/j.palaeo.2007.02.039; Riera V, 2010, PALAEOGEOGR PALAEOCL, V288, P82, DOI 10.1016/j.palaeo.2010.01.037; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Romano M., 2007, Ichnos, V14, P257, DOI 10.1080/10420940601050014; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schulp Anne S., 1999, Ichnos, V6, P239; Schwarz Daniela, 2007, Historical Biology, V19, P225, DOI 10.1080/08912960601118651; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Thulborn RA., 1990, DINOSAUR TRACKS; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Vila B, 2005, LETHAIA, V38, P211, DOI 10.1080/00241160510013312; Vila B, 2008, ORYCTOS, V8, P150; Vila B, 2010, LETHAIA, V43, P197, DOI 10.1111/j.1502-3931.2009.00183.x; Wilhite DR, 2005, LIFE O PAST, P268; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; Wright JL, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P252	45	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57408	10.1371/journal.pone.0057408	http://dx.doi.org/10.1371/journal.pone.0057408			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451221	Green Published, gold			2022-12-25	WOS:000316849500099
J	Bentancor, LV; Bilen, MF; Mejias, MP; Fernandez-Brando, RJ; Panek, CA; Ramos, MV; Fernandez, GC; Isturiz, M; Ghiringhelli, PD; Palermo, MS				Bentancor, Leticia V.; Bilen, Marcos F.; Mejias, Maria P.; Fernandez-Brando, Romina J.; Panek, Cecilia A.; Ramos, Maria V.; Fernandez, Gabriela C.; Isturiz, Martin; Ghiringhelli, Pablo D.; Palermo, Marina S.			Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; HEMOLYTIC-UREMIC SYNDROME; IN-VIVO TRANSDUCTION; BACTERIOPHAGE-LAMBDA; PROTECTIVE IMMUNITY; GENE-EXPRESSION; PHAGE; DNA; TRANSCRIPTION; EPIDEMIOLOGY	Shiga toxins (Stx) are the main virulence factors in enterohemorrhagic Escherichia coli (EHEC) infections, causing diarrhea and hemolytic uremic syndrome (HUS). The genes encoding for Shiga toxin-2 (Stx2) are located in a bacteriophage. The toxin is formed by a single A subunit and five B subunits, each of which has its own promoter sequence. We have previously reported the expression of the B subunit within the eukaryotic environment, probably driven by their own promoter. The aim of this work was to evaluate the ability of the eukaryotic machinery to recognize stx2 sequences as eukaryotic-like promoters. Vero cells were transfected with a plasmid encoding Stx2 under its own promoter. The cytotoxic effect on these cells was similar to that observed upon incubation with purified Stx2. In addition, we showed that Stx2 expression in Stx2-insensitive BHK eukaryotic cells induced drastic morphological and cytoskeletal changes. In order to directly evaluate the capacity of the wild promoter sequences of the A and B subunits to drive protein expression in mammalian cells, GFP was cloned under eukaryotic-like putative promoter sequences. GFP expression was observed in 293T cells transfected with these constructions. These results show a novel and alternative way to synthesize Stx2 that could contribute to the global understanding of EHEC infections with immediate impact on the development of treatments or vaccines against HUS.	[Bentancor, Leticia V.; Mejias, Maria P.; Fernandez-Brando, Romina J.; Panek, Cecilia A.; Ramos, Maria V.; Fernandez, Gabriela C.; Isturiz, Martin; Palermo, Marina S.] Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, Div Immunol, Buenos Aires, DF, Argentina; [Bilen, Marcos F.; Ghiringhelli, Pablo D.] Univ Nacl Quilmes, Lab Ingn Genet & Biol Celular & Mol, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Bentancor, LV (corresponding author), Acad Nacl Med Buenos Aires, CONICET, Inst Med Expt IMEX, Div Immunol, Buenos Aires, DF, Argentina.	lbentan@unq.edu.ar	Ghiringhelli, Pablo D/N-8073-2017	Ghiringhelli, Pablo D/0000-0002-2003-0106	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 06/591]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by PICT 06/591 from the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (to MSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PDG, MSP, GCF, MVR and MFB are members of the Research Career of CONICET (Consejo Nacional de Ciencia y Tecnologia).	Acheson DWK, 1998, INFECT IMMUN, V66, P4496; Baumann M, 2010, MOL BIOTECHNOL, V45, P241, DOI 10.1007/s12033-010-9265-6; Bentancor LV, 2009, CLIN VACCINE IMMUNOL, V16, P712, DOI 10.1128/CVI.00328-08; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Clark JR, 2004, FEMS IMMUNOL MED MIC, V40, P21, DOI 10.1016/S0928-8244(03)00344-4; Cornick NA, 2006, APPL ENVIRON MICROB, V72, P5086, DOI 10.1128/AEM.00157-06; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Eguchi A, 2001, J BIOL CHEM, V276, P26204, DOI 10.1074/jbc.M010625200; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Gahan ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006062; Gamage SD, 2003, INFECT IMMUN, V71, P3107, DOI 10.1128/IAI.71.6.3107-3115.2003; GEIER MR, 1972, VIROLOGY, V47, P638, DOI 10.1016/0042-6822(72)90553-3; George AA, 2006, EMBO J, V25, P811, DOI 10.1038/sj.emboj.7600966; GOTTESMAN S, 1975, P NATL ACAD SCI USA, V72, P2188, DOI 10.1073/pnas.72.6.2188; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; KARMALI MA, 1985, J CLIN MICROBIOL, V22, P614, DOI 10.1128/JCM.22.4.614-619.1985; Lankes HA, 2007, J APPL MICROBIOL, V102, P1337, DOI 10.1111/j.1365-2672.2006.03182.x; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LITTLE JW, 1995, REGULATION GENE EXPR, P453; Lopez EL, 2000, INFECT DIS CLIN N AM, V14, P41, DOI 10.1016/S0891-5520(05)70217-8; MERRIL CR, 1971, NATURE, V233, P398, DOI 10.1038/233398a0; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Nakagawa I, 1999, MOL MICROBIOL, V33, P1190, DOI 10.1046/j.1365-2958.1999.01564.x; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; O'Loughlin EV, 2001, MICROBES INFECT, V3, P493, DOI 10.1016/S1286-4579(01)01405-8; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Paglia P, 1998, J LEUKOCYTE BIOL, P92; Petruzziello-Pellegrini TN, 2012, J CLIN INVEST, V122, P759, DOI 10.1172/JCI57313; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Ptashne M, 2004, GENETIC SWITCH PHAGE; Ptashne M, 1992, GENETIC SWITCH PHAGE; Rivas M, 2006, MEDICINA-BUENOS AIRE, V66, P27; Sapinoro R, 2008, VIROLOGY, V373, P274, DOI 10.1016/j.virol.2007.12.013; Schmidt H, 2001, RES MICROBIOL, V152, P687, DOI 10.1016/S0923-2508(01)01249-9; Shimada O, 1999, CELL STRUCT FUNCT, V24, P237, DOI 10.1247/csf.24.237; Shimada O, 1999, CELL STRUCT FUNCT, V24, P247, DOI 10.1247/csf.24.247; Slutsker L, 1997, ANN INTERN MED, V126, P505, DOI 10.7326/0003-4819-126-7-199704010-00002; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Takenouchi H, 2004, J CELL SCI, V117, P3911, DOI 10.1242/jcs.01246; Teel LD, 2002, INFECT IMMUN, V70, P4282, DOI 10.1128/IAI.70.8.4282-4291.2002; Thompson GS, 2000, BIOCHEMISTRY-US, V39, P13153, DOI 10.1021/bi001394+; Wagner PL, 2001, INFECT IMMUN, V69, P1934, DOI 10.1128/IAI.69.3.1934-1937.2001; Zanghi CN, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm146; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57128	10.1371/journal.pone.0057128	http://dx.doi.org/10.1371/journal.pone.0057128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451160	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800075
J	Kreitler, J; Papenfus, M; Byrd, K; Labiosa, W				Kreitler, Jason; Papenfus, Michael; Byrd, Kristin; Labiosa, William			Interacting Coastal Based Ecosystem Services: Recreation and Water Quality in Puget Sound, WA	PLOS ONE			English	Article							GEOGRAPHICAL INFORMATION-SYSTEMS; TRAVEL COST METHOD; ECONOMIC VALUATION; MODELING DEMAND; BEACH USE; BIODIVERSITY; BENEFITS; CONSERVATION; MANAGEMENT; STRATEGIES	Coastal recreation and water quality are major contributors to human well-being in coastal regions. They can also interact, creating opportunities for ecosystem based management, ecological restoration, and water quality improvement that can positively affect people and the environment. Yet the effect of environmental quality on human behavior is often poorly quantified, but commonly assumed in coastal ecosystem service studies. To clarify this effect we investigate a water quality dataset for evidence that environmental condition partially explains variation in recreational visitation, our indicator of human behavior. In Puget Sound, WA, we investigate variation in visitation in both visitation rate and fixed effects (FE) models. The visitation rate model relates the differences in annual recreational visitation among parks to environmental conditions, park characteristics, travel cost, and recreational demand. In our FE model we control for all time-invariant unobserved variables and compare monthly variation at the park level to determine how water quality affects visitation during the summer season. The results of our first model illustrate how visitation relates to various amenities and costs. In the FE analysis, monthly visitation was negatively related to water quality while controlling for monthly visitation trends. This indicates people are responding to changes in water quality, and an improvement would yield an increase in the value of recreation. Together, these results could help in prioritizing water quality improvements, could assist the creation of new parks or the modification of existing recreational infrastructure, and provide quantitative estimates for the expected benefits from potential changes in recreational visitation and water quality improvements. Our results also provide an example of how recreational visitation can be quantified and used in ecosystem service assessments.	[Kreitler, Jason] US Geol Survey, Western Geog Sci Ctr, Boise, ID USA; [Papenfus, Michael] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Byrd, Kristin] US Geol Survey, Western Geog Sci Ctr, Menlo Pk, CA 94025 USA; [Labiosa, William] US Geol Survey, Western Geog Sci Ctr, Seattle, WA USA	United States Department of the Interior; United States Geological Survey; Stanford University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Kreitler, J (corresponding author), US Geol Survey, Western Geog Sci Ctr, Boise, ID USA.	jkreitler@usgs.gov	Papenfus, Michael/GNM-9563-2022	Byrd, Kristin/0000-0002-5725-7486	Environmental Protection Agency [IA DW 14-95762701]; United States Geological Survey Geographical Analysis and Monitoring Program	Environmental Protection Agency(United States Environmental Protection Agency); United States Geological Survey Geographical Analysis and Monitoring Program	This project was supported by Environmental Protection Agency Interagency Agreement IA DW 14-95762701 and the United States Geological Survey Geographical Analysis and Monitoring Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; [Anonymous], 2006, MARINE COASTAL ECOSY; Arnberger A, 2007, J LEISURE RES, V39, P345, DOI 10.1080/00222216.2007.11950111; Assessment M.E., 2005, ECOSYSTEM HUMAN WELL; Baack B.D., 1972, THESIS U WASHINGTON; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Bateman IJ, 1999, REG STUD, V33, P191, DOI 10.1080/00343409950082391; Bateman IJ, 1996, J AGR ECON, V47, P191, DOI 10.1111/j.1477-9552.1996.tb00684.x; Beaumont NJ, 2007, MAR POLLUT BULL, V54, P253, DOI 10.1016/j.marpolbul.2006.12.003; Brainard J, 2001, FORESTRY, V74, P423, DOI 10.1093/forestry/74.5.423; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Busch J, 2009, COAST MANAGE, V37, P529, DOI 10.1080/08920750903044865; Byrd K, 2011, TOOLS EVALUATING REF; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan Kai Ma, 2010, F1000 Biol Rep, V2, P54, DOI 10.3410/B2-54; Clawson M., 1959, METHODS MEASURING DE; Coombes EG, 2009, COAST MANAGE, V37, P94, DOI 10.1080/08920750802527127; Coombes EG, 2010, GLOBAL ENVIRON CHANG, V20, P303, DOI 10.1016/j.gloenvcha.2009.12.004; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Deacon RT, 2000, J WATER RES PL-ASCE, V126, P374, DOI 10.1061/(ASCE)0733-9496(2000)126:6(374); Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; ENGLIN J, 1995, REV ECON STAT, V77, P104, DOI 10.2307/2109996; ESRI, 2008, ARCGIS DESKT 9 3; Farber S, 2006, BIOSCIENCE, V56, P121, DOI 10.1641/0006-3568(2006)056[0121:LEAEFE]2.0.CO;2; Gelfenbaum G, 2006, COASTAL HABITATS PUG; Given S, 2006, ENVIRON SCI TECHNOL, V40, P4851, DOI 10.1021/es060679s; Gossling S, 1999, ECOL ECON, V29, P303, DOI 10.1016/S0921-8009(99)00012-9; Guerry AD, 2011, THEORY PRACTICE ECOS; Haneman M, 2004, USING REVEALED PREFE; Hanley N, 2003, ENVIRON RESOUR ECON, V24, P273, DOI 10.1023/A:1022904706306; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Hicks CC, 2009, ECOL SOC, V14; Hilbe J., 2008, NEGATIVE BINOMIAL RE; Iceland C., 2008, IDENTIFYING IMPORTAN; KNETSCH JL, 1963, LAND ECON, V39, P387, DOI 10.2307/3144843; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Leggett CG, 2000, J ENVIRON ECON MANAG, V39, P121, DOI 10.1006/jeem.1999.1096; Leschine TM, 2007, 20077 PUG SOUND NEAR; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lew DK, 2005, COAST MANAGE, V33, P71, DOI 10.1080/08920750590883079; McLeod K., 2009, ECOSYSTEM BASED MANA; Mendelsohn R, 2009, ANNU REV ENV RESOUR, V34, P325, DOI [10.1146/annurev-environ-011509-135201, 10.1146/annurev.environ.011509-135201]; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Naidoo R, 2005, ENVIRON DEV ECON, V10, P159, DOI 10.1017/S1355770X0400186X; National Research Council, 2005, VAL EC SERV BETT ENV; Nelsen C., 2007, SHORE BEACH, V75, P32; Nelson Erik J, 2010, F1000 Biol Rep, V2, P53, DOI 10.3410/B2-53; Parsons GR, 2003, TRAVEL COST MODEL PR, P263; Pendleton L, 2001, MAR POLLUT BULL, V42, P1155, DOI 10.1016/S0025-326X(01)00131-X; Pendleton L, 2008, COAST MANAGE, V36, P165, DOI 10.1080/08920750701866352; PRISM Climate Group, 2010, PRISM; Puget Sound Partnership, 2009, STAT SOUND; Puget Sound Partnership, 2008, DRAFT 2020 ACT AG PU, P96; RANDALL A, 1994, LAND ECON, V70, P88, DOI 10.2307/3146443; StataCorp, 2019, STATA STAT SOFTWARE; Stinchfield, 2009, SOCIAL EC CONSIDERAT; Termansen M, 2004, ENVIRON PLANN A, V36, P1085, DOI 10.1068/a36164; U.S. Environmental Protection Agency, 2010, GUID PREP EC AN; Wilson MA, 1999, ECOL APPL, V9, P772, DOI 10.1890/1051-0761(1999)009[0772:EVOFES]2.0.CO;2; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	62	16	16	1	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56670	10.1371/journal.pone.0056670	http://dx.doi.org/10.1371/journal.pone.0056670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451067	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800025
J	Lombino, F; Biundo, F; Tamayev, R; Arancio, O; D'Adamio, L				Lombino, Franco; Biundo, Fabrizio; Tamayev, Robert; Arancio, Ottavio; D'Adamio, Luciano			An Intracellular Threonine of Amyloid-beta Precursor Protein Mediates Synaptic Plasticity Deficits and Memory Loss	PLOS ONE			English	Article							JNK-INTERACTING PROTEIN-1; C-TERMINAL FRAGMENTS; A-BETA; ALZHEIMERS-DISEASE; DANISH DEMENTIA; CYTOPLASMIC DOMAIN; MOUSE MODEL; PHOSPHORYLATION; APP; MICE	Mutations in Amyloid-beta Precursor Protein (APP) and BRI2/ITM2b genes cause Familial Alzheimer and Danish Dementias (FAD/FDD), respectively. APP processing by BACE1, which is inhibited by BRI2, yields sAPP beta and beta-CTF. beta-CTF is cleaved by gamma-secretase to produce A beta. A knock-in mouse model of FDD, called FDDKI, shows deficits in memory and synaptic plasticity, which can be attributed to sAPP beta/beta-CTF but not A beta. We have investigated further the pathogenic function of beta-CTF focusing on Thr(668) of beta-CTF because phosphorylation of Thr(668) is increased in AD cases. We created a knock-in mouse bearing a Thr(668)Ala mutation (APP(TA) mice) that prevents phosphorylation at this site. This mutation prevents the development of memory and synaptic plasticity deficits in FDDKI mice. These data are consistent with a role for the carboxyl-terminal APP domain in the pathogenesis of dementia and suggest that averting the noxious role of Thr(668) is a viable therapeutic strategy for human dementias.	[Lombino, Franco; Biundo, Fabrizio; Tamayev, Robert; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Dept Pathol & Cell Biol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University	D'Adamio, L (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	luciano.dadamio@einstein.yu.edu	Biundo, Fabrizio/ABH-7843-2020; biundo, fabrizio/A-4611-2019; arancio, ottavio/AAB-7959-2019; Biundo, Fabrizio/AAJ-1715-2021	D'Adamio, Luciano/0000-0002-2204-9441; Biundo, Fabrizio/0000-0003-2264-1872; arancio, ottavio/0000-0001-6335-164X; Lombino, Franco Luis/0000-0003-2326-6920; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer's Association [IIRG-09-129984, ZEN-11-201425]; Edward N. & Della L. Thome Memorial Foundation grant; National Institutes of Health (NIH) [R01AG033007, R01NS049442]; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033007, R01AG041531, R21AG041577] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Edward N. & Della L. Thome Memorial Foundation grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Cellular and Molecular Biology and Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Alzheimer's Association (IIRG-09-129984 and ZEN-11-201425 to L.D.), the Edward N. & Della L. Thome Memorial Foundation grant (to L.D.), the National Institutes of Health (NIH; R01AG033007 to L.D. and R01NS049442 to O.A.), the Training Program in Cellular and Molecular Biology and Genetics T32 GM007491 to R.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; D'Ambrosio C, 2006, MOL CELL PROTEOMICS, V5, P97, DOI 10.1074/mcp.M500226-MCP200; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; GARRINGER HJ, 2009, BRAIN STRUCT FUNCT; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Matrone C, 2012, AGING CELL, V11, P1084, DOI 10.1111/acel.12009; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, J ALZHEIMERS DIS, V27, P385, DOI 10.3233/JAD-2011-110785; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; Matsushima T, 2012, J BIOL CHEM, V287, P19715, DOI 10.1074/jbc.M111.334847; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Shin RW, 2007, ACTA NEUROPATHOL, V113, P627, DOI 10.1007/s00401-007-0211-z; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Tamayev R, 2012, MOL NEURODEGENER S1, V7, pL9; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-60; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vitale M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728178; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	41	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57120	10.1371/journal.pone.0057120	http://dx.doi.org/10.1371/journal.pone.0057120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451158	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800074
J	Moore, BT; Jordan, JM; Baugh, LR				Moore, Brad T.; Jordan, James M.; Baugh, L. Ryan			WormSizer: High-throughput Analysis of Nematode Size and Shape	PLOS ONE			English	Article							BIOLOGICAL-IMAGE-ANALYSIS; CAENORHABDITIS-ELEGANS; GROWTH; REPRODUCTION; LONGEVITY; DBL-1; DAF-2; GENE	The fundamental phenotypes of growth rate, size and morphology are the result of complex interactions between genotype and environment. We developed a high-throughput software application, WormSizer, which computes size and shape of nematodes from brightfield images. Existing methods for estimating volume either coarsely model the nematode as a cylinder or assume the worm shape or opacity is invariant. Our estimate is more robust to changes in morphology or optical density as it only assumes radial symmetry. This open source software is written as a plugin for the well-known image-processing framework Fiji/ImageJ. It may therefore be extended easily. We evaluated the technical performance of this framework, and we used it to analyze growth and shape of several canonical Caenorhabditis elegans mutants in a developmental time series. We confirm quantitatively that a Dumpy (Dpy) mutant is short and fat and that a Long (Lon) mutant is long and thin. We show that daf-2 insulin-like receptor mutants are larger than wild-type upon hatching but grow slow, and WormSizer can distinguish dauer larvae from normal larvae. We also show that a Small (Sma) mutant is actually smaller than wild-type at all stages of larval development. WormSizer works with Uncoordinated (Unc) and Roller (Rol) mutants as well, indicating that it can be used with mutants despite behavioral phenotypes. We used our complete data set to perform a power analysis, giving users a sense of how many images are needed to detect different effect sizes. Our analysis confirms and extends on existing phenotypic characterization of well-characterized mutants, demonstrating the utility and robustness of WormSizer.	[Moore, Brad T.] Duke Univ, PhD Program Computat Biol & Bioinformat, Durham, NC USA; [Jordan, James M.; Baugh, L. Ryan] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Baugh, L. Ryan] Duke Univ, Duke Ctr Syst Biol, Durham, NC USA	Duke University; Duke University; Duke University	Baugh, LR (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	ryan.baugh@duke.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Jordan, James/0000-0002-7620-462X; Moore, Bradley/0000-0003-4322-8841	National Science Foundation [IOS-1120206]; National Institutes of Health Training Grant [T32 GM071340]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071340] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Science Foundation (IOS-1120206) supported this work. Brad T. Moore is supported by National Institutes of Health Training Grant T32 GM071340 (P.I. Hartemink). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BIOSTATISTICAL ANAL; Arganda-Carreras I., 2008, SKELETONIZE3D; Baek J, 2002, J NEUROSCI METH, V00, P1; BYERLY L, 1975, REV SCI INSTRUM, V46, P517, DOI 10.1063/1.1134262; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Castle M., 2007, ROLLING BALL BACKGRO; Davis PJ, 1984, METHODS NUMERICAL IN, P51; Gems D, 1998, GENETICS, V150, P129; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Knight CG, 2002, EVOL DEV, V4, P16, DOI 10.1046/j.1525-142x.2002.01058.x; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Landini G, 2011, AUTOTHRESHOLD; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lewis JA, 1995, METHOD CELL BIOL, V48, P4; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; MADURO M, 1995, GENETICS, V141, P977; Morita K, 2002, EMBO J, V21, P1063, DOI 10.1093/emboj/21.5.1063; Peixoto CA, 1998, J PARASITOL, V84, P45, DOI 10.2307/3284528; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Rasband W, IMAGEJ; Ruaud AF, 2011, GENETICS, V187, P337, DOI 10.1534/genetics.110.123323; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Thacker C, 2006, CELL MOL LIFE SCI, V63, P1193, DOI 10.1007/s00018-006-6012-z; Wahlby C, 2012, NATURE METHODS	25	74	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57142	10.1371/journal.pone.0057142	http://dx.doi.org/10.1371/journal.pone.0057142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451165	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800078
J	Mertins, SD; Scudiero, DA; Hollingshead, MG; Divelbiss, RD; Alley, MC; Monks, A; Covell, DG; Hite, KM; Salomon, DS; Niederhuber, JE				Mertins, Susan D.; Scudiero, Dominic A.; Hollingshead, Melinda G.; Divelbiss, Raymond D., Jr.; Alley, Michael C.; Monks, Anne; Covell, David G.; Hite, Karen M.; Salomon, David S.; Niederhuber, John E.			A Small Molecule (Pluripotin) as a Tool for Studying Cancer Stem Cell Biology: Proof of Concept	PLOS ONE			English	Article							PROSPECTIVE IDENTIFICATION; GENE-EXPRESSION; TUMOR; DIFFERENTIATION; REVEALS; PATHWAY; GROWTH; MODEL; RSK	Background: Cancer stem cells (CSC) are thought to be responsible for tumor maintenance and heterogeneity. Bona fide CSC purified from tumor biopsies are limited in supply and this hampers study of CSC biology. Furthermore, purified stem-like CSC subpopulations from existing tumor lines are unstable in culture. Finding a means to overcome these technical challenges would be a useful goal. In a first effort towards this, we examined whether a chemical probe that promotes survival of murine embryonic stem cells without added exogenous factors can alter functional characteristics in extant tumor lines in a fashion consistent with a CSC phenotype. Methodology/Principal Findings: The seven tumor lines of the NCI60 colon subpanel were exposed to SC-1 (pluripotin), a dual kinase and GTPase inhibitor that promotes self-renewal, and then examined for tumorigenicity under limiting dilution conditions and clonogenic activity in soft agar. A statistically significant increase in tumor formation following SC-1 treatment was observed (p<0.04). Cloning efficiencies and expression of putative CSC surface antigens (CD133 and CD44) were also increased. SC-1 treatment led to sphere formation in some colon tumor lines. Finally, SC-1 inhibited in vitro kinase activity of RSK2, and another RSK2 inhibitor increased colony formation implicating a role for this kinase in eliciting a CSC phenotype. Conclusions/Significance: These findings validate a proof of concept study exposure of extant tumor lines to a small molecule may provide a tractable in vitro model for understanding CSC biology.	[Mertins, Susan D.; Alley, Michael C.; Covell, David G.] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA; [Scudiero, Dominic A.; Monks, Anne; Hite, Karen M.] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Hollingshead, Melinda G.; Divelbiss, Raymond D., Jr.] NCI, Biol Testing Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA; [Salomon, David S.] NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Niederhuber, John E.] NCI, Cell & Canc Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mertins, SD (corresponding author), NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA.	smertins@mail.nih.gov			Division for Cancer Diagnosis and Treatment; Center for Cancer Research at the National Cancer Institute; NCI Contract [HHSN261200800001E]	Division for Cancer Diagnosis and Treatment; Center for Cancer Research at the National Cancer Institute; NCI Contract	This study was supported by the Division for Cancer Diagnosis and Treatment and Center for Cancer Research at the National Cancer Institute and partially funded by NCI Contract HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alkatout I, 2008, BIOL CHEM, V389, P799, DOI 10.1515/BC.2008.094; ALLEY MC, 1991, CANCER RES, V51, P1247; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Borovski T, 2011, CANCER RES, V71, P634, DOI 10.1158/0008-5472.CAN-10-3220; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gamelin E, 1999, J UROLOGY, V162, P217, DOI 10.1097/00005392-199907000-00071; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Horiuchi KY, 2006, J BIOMOL SCREEN, V11, P48, DOI 10.1177/1087057105282097; Huang R, 2006, GENOMICS, V87, P315, DOI 10.1016/j.ygeno.2005.11.011; Huang RL, 2006, MOL CANCER THER, V5, P2417, DOI 10.1158/1535-7163.MCT-06-0239; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Hurt EM, 2010, STEM CELLS, V28, P390, DOI 10.1002/stem.271; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Kirkland SC, 2008, J BIOL CHEM, V283, P27612, DOI 10.1074/jbc.M802932200; Leder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014366; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nguyen TL, 2006, BIOORGAN MED CHEM, V14, P6097, DOI 10.1016/j.bmc.2006.05.001; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Plowman J, 1997, HUMAN TUMOR XENOGRAF; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rappa G, 2008, EXP CELL RES, V314, P2110, DOI 10.1016/j.yexcr.2008.03.008; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Smith JA, 2005, CANCER RES, V65, P1027; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; TASWELL C, 1981, J IMMUNOL, V126, P1614; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57099	10.1371/journal.pone.0057099	http://dx.doi.org/10.1371/journal.pone.0057099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437320	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000076
J	Warimwe, GM; Murungi, LM; Kamuyu, G; Nyangweso, GM; Wambua, J; Naranbhai, V; Fletcher, HA; Hill, AVS; Bejon, P; Osier, FHA; Marsh, K				Warimwe, George M.; Murungi, Linda M.; Kamuyu, Gathoni; Nyangweso, George M.; Wambua, Juliana; Naranbhai, Vivek; Fletcher, Helen A.; Hill, Adrian V. S.; Bejon, Philip; Osier, Faith H. A.; Marsh, Kevin			The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ACQUIRED-IMMUNITY; SURFACE-ANTIGENS; KILIFI DISTRICT; PROTECTION; ANTIBODIES; MORTALITY; RESPONSES	Background: Plasmodium falciparum malaria remains a major cause of illness and death in sub-Saharan Africa. Young children bear the brunt of the disease and though older children and adults suffer relatively fewer clinical attacks, they remain susceptible to asymptomatic P. falciparum infection. A better understanding of the host factors associated with immunity to clinical malaria and the ability to sustain asymptomatic P. falciparum infection will aid the development of improved strategies for disease prevention. Methods and Findings: Here we investigate whether full differential blood counts can predict susceptibility to clinical malaria among Kenyan children sampled at five annual cross-sectional surveys. We find that the ratio of monocytes to lymphocytes, measured in peripheral blood at the time of survey, directly correlates with risk of clinical malaria during follow-up. This association is evident among children with asymptomatic P. falciparum infection at the time the cell counts are measured (Hazard ratio (HR) = 2.7 (95% CI 1.42, 5.01, P = 0.002) but not in those without detectable parasitaemia (HR = 1.0 (95% CI 0.74, 1.42, P = 0.9). Conclusions: We propose that the monocyte to lymphocyte ratio, which is easily derived from routine full differential blood counts, reflects an individual's capacity to mount an effective immune response to P. falciparum infection.	[Warimwe, George M.; Fletcher, Helen A.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Murungi, Linda M.; Kamuyu, Gathoni; Nyangweso, George M.; Wambua, Juliana; Bejon, Philip; Osier, Faith H. A.; Marsh, Kevin] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Naranbhai, Vivek] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bejon, Philip; Marsh, Kevin] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	University of Oxford; Jenner Institute; Kenya Medical Research Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Warimwe, GM (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	george.warimwe@ndm.ox.ac.uk		Fletcher, Helen/0000-0002-0435-1006; Naranbhai, Vivek/0000-0003-4281-8882; Osier, Faith/0000-0001-7133-5375	Wellcome Trust grant [092741/Z/10/Z]; Medical Research Council [G1002624] Funding Source: researchfish; MRC [G1002624] Funding Source: UKRI	Wellcome Trust grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded through a Wellcome Trust grant (092741/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bull PC, 2002, J INFECT DIS, V185, P1688, DOI 10.1086/340420; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Dunachie SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012557; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Hanscheid T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-109; Kinyanjui SM, 2004, J INFECT DIS, V190, P1527, DOI 10.1086/424675; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; LINES J, 1992, PARASITOL TODAY, V8, P381, DOI 10.1016/0169-4758(92)90176-3; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mackintosh CL, 2008, INT J PARASITOL, V38, P1445, DOI 10.1016/j.ijpara.2008.03.009; Maina RN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S4; Manning L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048701; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; MARSH K, 1992, PARASITOLOGY, V104, pS53, DOI 10.1017/S0031182000075247; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Olliaro P, 2011, AM J TROP MED HYG, V85, P619, DOI 10.4269/ajtmh.2011.11-0154; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Rhee MSM, 2001, CLIN EXP IMMUNOL, V126, P503, DOI 10.1046/j.1365-2249.2001.01681.x; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Walther M, 2006, J IMMUNOL, V177, P5736, DOI 10.4049/jimmunol.177.8.5736; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660	28	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57320	10.1371/journal.pone.0057320	http://dx.doi.org/10.1371/journal.pone.0057320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437368	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000315184200243
J	Ellenbroek, JH; Tons, HA; de Graaf, N; Loomans, CJ; Engelse, MA; Vrolijk, H; Voshol, PJ; Rabelink, TJ; Carlotti, F; de Koning, EJ				Ellenbroek, Johanne H.; Tons, Hendrica A.; de Graaf, Natascha; Loomans, Cindy J.; Engelse, Marten A.; Vrolijk, Hans; Voshol, Peter J.; Rabelink, Ton J.; Carlotti, Francoise; de Koning, Eelco J.			Topologically Heterogeneous Beta Cell Adaptation in Response to High-Fat Diet in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; DIABETES-MELLITUS; ISLET FUNCTION; RAT ISLETS; PANCREAS; GROWTH; MASS; DORSAL; PROLIFERATION; LANGERHANS	Aims: Beta cells adapt to an increased insulin demand by enhancing insulin secretion via increased beta cell function and/or increased beta cell number. While morphological and functional heterogeneity between individual islets exists, it is unknown whether regional differences in beta cell adaptation occur. Therefore we investigated beta cell adaptation throughout the pancreas in a model of high-fat diet (HFD)-induced insulin resistance in mice. Methods: C57BL/6J mice were fed a HFD to induce insulin resistance, or control diet for 6 weeks. The pancreas was divided in a duodenal (DR), gastric (GR) and splenic (SR) region and taken for either histology or islet isolation. The capacity of untreated islets from the three regions to adapt in an extrapancreatic location was assessed by transplantation under the kidney capsule of streptozotocin-treated mice. Results: SR islets showed 70% increased beta cell proliferation after HFD, whereas no significant increase was found in DR and GR islets. Furthermore, isolated SR islets showed twofold enhanced glucose-induced insulin secretion after HFD, as compared with DR and GR islets. In contrast, transplantation of islets isolated from the three regions to an extrapancreatic location in diabetic mice led to a similar decrease in hyperglycemia and no difference in beta cell proliferation. Conclusions: HFD-induced insulin resistance leads to topologically heterogeneous beta cell adaptation and is most prominent in the splenic region of the pancreas. This topological heterogeneity in beta cell adaptation appears to result from extrinsic factors present in the islet microenvironment.	[Ellenbroek, Johanne H.; Tons, Hendrica A.; de Graaf, Natascha; Engelse, Marten A.; Rabelink, Ton J.; Carlotti, Francoise; de Koning, Eelco J.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Loomans, Cindy J.; de Koning, Eelco J.] Hubrecht Inst, Utrecht, Netherlands; [Vrolijk, Hans] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Voshol, Peter J.] Univ Cambridge, Inst Metab Sci, Cambridge, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	de Koning, EJ (corresponding author), Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.	e.dekoning@lumc.nl	Carlotti, Françoise/AAN-5018-2021; Carlotti, Françoise/H-1060-2014; Rabelink, Ton J./A-5316-2008; de Koning, Eelco JP/H-6030-2011	Carlotti, Françoise/0000-0001-7929-8468; Carlotti, Françoise/0000-0001-7929-8468; Rabelink, Ton J./0000-0001-6780-5186; de Koning, Eelco JP/0000-0002-1232-7022	Diabetes Cell Therapy Initiative consortium; Medical Research Council [G0600717B, G0600717, MC_UU_12012/5/B, MC_UU_12012/5] Funding Source: researchfish; MRC [G0600717, MC_UU_12012/5] Funding Source: UKRI	Diabetes Cell Therapy Initiative consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Diabetes Cell Therapy Initiative consortium including the Dutch Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2006, DIABETES, V55, pS98, DOI 10.2337/db06-S013; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Barreto SG, 2010, AM J PHYSIOL-GASTR L, V299, pG10, DOI 10.1152/ajpgi.00077.2010; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cano DA, 2007, GASTROENTEROLOGY, V132, P745, DOI 10.1053/j.gastro.2006.12.054; DEKONING EJP, 1993, DIABETOLOGIA, V36, P378, DOI 10.1007/BF00402271; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; Hornblad A, 2011, ISLETS, V3, P204, DOI 10.4161/isl.3.4.16417; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Inderbitzin D, 2006, MICROSURG, V26, P465, DOI 10.1002/micr.20271; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Lau J, 2012, DIABETOLOGIA, V55, P1390, DOI 10.1007/s00125-012-2476-6; Lindsay TH, 2006, NEUROSCIENCE, V137, P1417, DOI 10.1016/j.neuroscience.2005.10.055; MALAISSELAGAE F, 1983, EXPERIENTIA, V39, P1045, DOI 10.1007/BF01989796; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Ogilvie RF, 1933, J PATHOL BACTERIOL, V37, P473, DOI 10.1002/path.1700370314; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pissios P, 2007, DIABETES, V56, P311, DOI 10.2337/db06-0708; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596; TRIMBLE ER, 1981, AM J PHYSIOL, V240, pE422, DOI 10.1152/ajpendo.1981.240.4.E422; TRIMBLE ER, 1982, J CLIN INVEST, V69, P405, DOI 10.1172/JCI110464; WITTINGEN J, 1974, ANN SURG, V179, P412, DOI 10.1097/00000658-197404000-00005	29	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56922	10.1371/journal.pone.0056922	http://dx.doi.org/10.1371/journal.pone.0056922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441226	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200083
J	Zheng, HY; Zhou, MH; Hu, CL; Kuo, E; Peng, X; Hu, JJ; Kuo, L; Zhang, SYL				Zheng, Hongying; Zhou, Meng-Hua; Hu, Changlong; Kuo, Enoch; Peng, Xu; Hu, Junjie; Kuo, Lih; Zhang, Shenyuan L.			Differential Roles of the C and N Termini of Orai1 Protein in Interacting with Stromal Interaction Molecule 1 (STIM1) for Ca2(+) Release-activated Ca2+ (CRAC) Channel Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; PLASMA-MEMBRANE; T-LYMPHOCYTES; MECHANISTIC INSIGHTS; ION SELECTIVITY; SMOOTH-MUSCLE; I-CRAC; STORE; CELLS; DEPLETION	The entry of extracellular Ca2+, which is mediated by Ca2+ release-activated Ca2+ (CRAC) channels, is essential for T cell activation and the normal functioning of other immune cells. Although the molecular components of CRAC channels, the Orai1 pore-forming subunit and the STIM1-activating subunit have been recently identified, the gating mechanism by which Orai1 channels conduct Ca2+ entry upon Orai1-STIM1 interaction following Ca2+ store release remains elusive. Herein, we show that C-terminal truncations or point mutations prevented Orai1 from binding to STIM1 and subsequent channel opening. In contrast, an Orai1 mutant with an N-terminal truncation interacted with but failed to be activated by STIM1. Moreover, Orai1 channels with C-terminal disruption, but not N-terminal truncation, could be gated by fused functional domains of STIM1. Interestingly, the channel activities of Orai1 mutants carrying either an N-terminal or a C-terminal truncation were restored by a methionine mutation at the putative gating hinge, the conserved Gly-98 site in the first transmembrane segment (TM1) of Orai1. Collectively, these results support a stepwise gating mechanism of STIM1-operated Orai1 channels; the initial binding between STIM1 and the C terminus of Orai1 docks STIM1 onto the N terminus of Orai1 to initiate conformational changes of the pore-lining TM1 helix of Orai1, leading to the opening of the channel.	[Zheng, Hongying; Zhou, Meng-Hua; Kuo, Enoch; Peng, Xu; Kuo, Lih; Zhang, Shenyuan L.] Texas A&M Hlth Sci Ctr, Dept Med Physiol, Coll Med, Temple, TX 76504 USA; [Hu, Changlong] Fudan Univ, Sch Life Sci, Dept Physiol & Biophys, Shanghai 200433, Peoples R China; [Hu, Junjie] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Hu, Junjie] Nankai Univ, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China; [Kuo, Lih] Texas A&M Hlth Sci Ctr, Coll Med, Scott & White Mem Hosp, Dept Surg, Temple, TX 76504 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Fudan University; Nankai University; Nankai University; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Zhang, SYL (corresponding author), Texas A&M Hlth Sci Ctr, Dept Med Physiol, Coll Med, 702 Southwest HK Dodgen Loop, Temple, TX 76504 USA.	shenyuan.zhang@medicine.tamhsc.edu	Hu, Junjie/F-9713-2013; Hu, Changlong/AAQ-8348-2020	Hu, Changlong/0000-0002-8609-8947; Kuo, Lih/0000-0002-4912-6910	Texas A&M-Weizmann Program; Research Grants Program Grant [110598]; Scott & White Memorial Hospital; Kruse Family Centennial Chair Fund; National Basic Research Program of China (973 Program) [2010CB833702]; National Natural Science Foundation of China (NSFC) [31000515]	Texas A&M-Weizmann Program; Research Grants Program Grant; Scott & White Memorial Hospital; Kruse Family Centennial Chair Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the 2012 Texas A&M-Weizmann Program (to S. L. Z. and X. P.), the Research Grants Program Grant 110598, Scott & White Memorial Hospital (to S. L. Z.), the Kruse Family Centennial Chair Fund, Scott & White Memorial Hospital (to L. K.), the National Basic Research Program of China (973 Program; Grant 2010CB833702 to J. H.), and National Natural Science Foundation of China (NSFC) Grant 31000515 (to C. H.).	Beech DJ, 2012, PFLUG ARCH EUR J PHY, V463, P635, DOI 10.1007/s00424-012-1090-2; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Gemes G, 2011, J NEUROSCI, V31, P3536, DOI 10.1523/JNEUROSCI.5053-10.2011; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; Li J, 2011, BRIT J PHARMACOL, V164, P382, DOI 10.1111/j.1476-5381.2011.01368.x; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Li ZZ, 2011, CELL RES, V21, P305, DOI 10.1038/cr.2010.131; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mancarella S, 2013, FASEB J, V27, P893, DOI 10.1096/fj.12-215293; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	57	75	75	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11263	11272		10.1074/jbc.M113.450254	http://dx.doi.org/10.1074/jbc.M113.450254			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23447534	Green Published, hybrid			2022-12-25	WOS:000317915500029
J	Malasarn, D; Kropat, J; Hsieh, SI; Finazzi, G; Casero, D; Loo, JA; Pellegrini, M; Wollman, FA; Merchant, SS				Malasarn, Davin; Kropat, Janette; Hsieh, Scott I.; Finazzi, Giovanni; Casero, David; Loo, Joseph A.; Pellegrini, Matteo; Wollman, Francis-Andre; Merchant, Sabeeha S.			Zinc Deficiency Impacts CO2 Assimilation and Disrupts Copper Homeostasis in Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-CONCENTRATING MECHANISM; GENE-EXPRESSION; PLASMA-MEMBRANE; IRON; ANHYDRASE; TRANSPORTERS; PROTEIN; REGULATOR; ENCODES; DIOXIDE	Zinc is an essential nutrient because of its role in catalysis and in protein stabilization, but excess zinc is deleterious. We distinguished four nutritional zinc states in the alga Chlamydomonas reinhardtii: toxic, replete, deficient, and limited. Growth is inhibited in zinc-limited and zinc-toxic cells relative to zinc-replete cells, whereas zinc deficiency is visually asymptomatic but distinguished by the accumulation of transcripts encoding ZIP family transporters. To identify targets of zinc deficiency and mechanisms of zinc acclimation, we used RNA-seq to probe zinc nutrition-responsive changes in gene expression. We identified genes encoding zinc-handling components, including ZIP family transporters and candidate chaperones. Additionally, we noted an impact on two other regulatory pathways, the carbon-concentrating mechanism (CCM) and the nutritional copper regulon. Targets of transcription factor Ccm1 and various CAH genes are up-regulated in zinc deficiency, probably due to reduced carbonic anhydrase activity, validated by quantitative proteomics and immunoblot analysis of Cah1, Cah3, and Cah4. Chlamydomonas is therefore not able to grow photoautotrophically in zinc-limiting conditions, but supplementation with 1% CO2 restores growth to wild-type rates, suggesting that the inability to maintain CCM is a major consequence of zinc limitation. The Crr1 regulon responds to copper limitation and is turned on in zinc deficiency, and Crr1 is required for growth in zinc-limiting conditions. Zinc-deficient cells are functionally copper-deficient, although they hyperaccumulate copper up to 50-fold over normal levels. We suggest that zinc-deficient cells sequester copper in a biounavailable form, perhaps to prevent mismetallation of critical zinc sites.	[Malasarn, Davin; Kropat, Janette; Hsieh, Scott I.; Loo, Joseph A.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Casero, David; Loo, Joseph A.; Pellegrini, Matteo; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Finazzi, Giovanni; Wollman, Francis-Andre] Univ Paris 06, CNRS, Inst Biol Physicochim, F-75005 Paris, France; [Finazzi, Giovanni] Univ Grenoble 1, CNRS,Commissariat Energie Atom Grenoble,UMR 5168, Commissariat Energie Atom & Energies Alternat,Ins, Inst Natl Rech Agron,Lab Physiol Cellulaire & Veg, F-38054 Grenoble, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Merchant, SS (corresponding author), 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	merchant@chem.ucla.edu	Casero, David/E-7365-2010	Casero, David/0000-0002-7347-3330; Pellegrini, Matteo/0000-0001-9355-9564	National Institutes of Health [GM42143]; Office of Science (Biological and Environmental Research), United States Department of Energy [DE-FC02-02ER63421]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [F32GM083562, T32 GM07185]; Chateaubriand Fellowship for collaborative experiments; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042143, R37GM042143, F32GM083562, T32GM007185, R29GM042143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science (Biological and Environmental Research), United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chateaubriand Fellowship for collaborative experiments; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42143 (to S. M.) for work on the zinc-deficiency transcriptome. The proteomic analyses and expression of proteins for use as antigens were supported by the Institute of Genomics and Proteomics at UCLA (funded by the Office of Science (Biological and Environmental Research), United States Department of Energy, through Cooperative Agreement DE-FC02-02ER63421).r Supported in part by National Institutes of Health Ruth L. Kirschstein National Research Service Award F32GM083562 and a Chateaubriand Fellowship for collaborative experiments with G. F. and F. A. W.r Supported in part by National Institutes of Health Ruth L. Kirschstein National Research Service Award T32 GM07185 for the UCLA predoctoral Cellular and Molecular Biology Training Program.	Allen MD, 2007, EUKARYOT CELL, V6, P1841, DOI 10.1128/EC.00205-07; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bailleul B, 2010, PHOTOSYNTH RES, V106, P179, DOI 10.1007/s11120-010-9579-z; Ballestin R, 2011, ALCOHOL ALCOHOLISM, V46, P17, DOI 10.1093/alcalc/agq079; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Dainty SJ, 2008, EUKARYOT CELL, V7, P454, DOI 10.1128/EC.00408-07; DANCIS A, 1994, J BIOL CHEM, V269, P25660; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; DIEZ M, 1989, CANCER, V63, P726, DOI 10.1002/1097-0142(19890215)63:4<726::AID-CNCR2820630421>3.0.CO;2-P; Ehrensberger KM, 2011, TRENDS BIOCHEM SCI, V36, P524, DOI 10.1016/j.tibs.2011.07.002; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; Fang W, 2012, PLANT CELL, V24, P1876, DOI 10.1105/tpc.112.097949; Finazzi G, 1997, BIOCHEMISTRY-US, V36, P2867, DOI 10.1021/bi962717y; Fukuzawa H, 2001, P NATL ACAD SCI USA, V98, P5347, DOI 10.1073/pnas.081593498; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Hanikenne M, 2005, PLANT PHYSIOL, V137, P428, DOI 10.1104/pp.104.054189; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Harris EH., 2009, CHLAMYDOMONAS SOURCE, VSecond Edition; HOWE G, 1992, EMBO J, V11, P2789, DOI 10.1002/j.1460-2075.1992.tb05346.x; Hsieh SI, 2013, MOL CELL PROTEOMICS, V12, P65, DOI 10.1074/mcp.M112.021840; HUTNER S. H., 1950, PROC AMER PHIL SOC, V94, P152; Joliot P, 2002, P NATL ACAD SCI USA, V99, P10209, DOI 10.1073/pnas.102306999; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kim D, 2004, PLANT J, V39, P237, DOI 10.1111/j.1365-313X.2004.02126.x; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; Lane TW, 2000, PLANT PHYSIOL, V123, P345, DOI 10.1104/pp.123.1.345; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Merchant SS, 2012, ADV MICROB PHYSIOL, V60, P91, DOI 10.1016/B978-0-12-398264-3.00002-4; Mezzetti A, 1998, FREE RADICAL BIO MED, V25, P676, DOI 10.1016/S0891-5849(98)00109-9; Moroney JV, 2011, PHOTOSYNTH RES, V109, P133, DOI 10.1007/s11120-011-9635-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Page MD, 2009, PLANT CELL, V21, P928, DOI 10.1105/tpc.108.064907; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Quinn JM, 2000, J BIOL CHEM, V275, P6080, DOI 10.1074/jbc.275.9.6080; Roberts K, 2007, PHOTOSYNTH RES, V93, P79, DOI 10.1007/s11120-007-9172-2; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Ryu MS, 2008, J NUTR, V138, P2076, DOI 10.3945/jn.108.093575; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Sinetova MA, 2012, BBA-BIOENERGETICS, V1817, P1248, DOI 10.1016/j.bbabio.2012.02.014; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; TACHIKI A, 1992, BIOSCI BIOTECH BIOCH, V56, P794, DOI 10.1271/bbb.56.794; Toepel J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-579; Villarejo A, 2001, PLANTA, V213, P286, DOI 10.1007/s004250000508; Wang YJ, 2011, PHOTOSYNTH RES, V109, P115, DOI 10.1007/s11120-011-9643-3; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Yamano T, 2008, PLANT PHYSIOL, V147, P340, DOI 10.1104/pp.107.114652; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Yee D, 1996, LIMNOL OCEANOGR, V41, P573, DOI 10.4319/lo.1996.41.3.0573; Ynalvez RA, 2008, PHYSIOL PLANTARUM, V133, P15, DOI 10.1111/j.1399-3054.2007.01043.x; Zhang B, 2001, MOL CELL BIOL, V21, P4505, DOI 10.1128/MCB.21.14.4505-4514.2001; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	72	54	57	0	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10672	10683		10.1074/jbc.M113.455105	http://dx.doi.org/10.1074/jbc.M113.455105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439652	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000317565000045
J	Farina, F; Sancini, G; Battaglia, C; Tinaglia, V; Mantecca, P; Camatini, M; Palestini, P				Farina, Francesca; Sancini, Giulio; Battaglia, Cristina; Tinaglia, Valentina; Mantecca, Paride; Camatini, Marina; Palestini, Paola			Milano Summer Particulate Matter (PM10) Triggers Lung Inflammation and Extra Pulmonary Adverse Events in Mice	PLOS ONE			English	Article							AIR-POLLUTION; GENE-EXPRESSION; HEME OXYGENASE-1; CARDIOVASCULAR-DISEASE; ULTRAFINE PARTICLES; ENDOTHELIN SYSTEM; FINE PARTICLES; SHORT-TERM; IN-VIVO; TRANSLOCATION	Recent studies have suggested a link between particulate matter (PM) exposure and increased mortality and morbidity associated with pulmonary and cardiovascular diseases; accumulating evidences point to a new role for air pollution in CNS diseases. The purpose of our study is to investigate PM10sum effects on lungs and extra pulmonary tissues. Milano PM10sum has been intratracheally instilled into BALB/c mice. Broncho Alveolar Lavage fluid, lung parenchyma, heart and brain were screened for markers of inflammation (cell counts, cytokines, ET-1, HO-1, MPO, iNOS), cytotoxicity (LDH, ALP, Hsp70, Caspase8-p18, Caspase3-p17) for a putative pro-carcinogenic marker (Cyp1B1) and for TLR4 pathway activation. Brain was also investigated for CD68, TNF-alpha, GFAP. In blood, cell counts were performed while plasma was screened for endothelial activation (sP-selectin, ET-1) and for inflammation markers (TNF-alpha, MIP-2, IL-1 beta, MPO). Genes up-regulation (HMOX1, Cyp1B1, IL-1 beta, MIP-2, MPO) and miR-21 have been investigated in lungs and blood. Inflammation in the respiratory tract of PM10sum-treated mice has been confirmed in BALf and lung parenchyma by increased PMNs percentage, increased ET-1, MPO and cytokines levels. A systemic spreading of lung inflammation in PM10sum-treated mice has been related to the increased blood total cell count and neutrophils percentage, as well as to increased blood MPO. The blood-endothelium interface activation has been confirmed by significant increases of plasma ET-1 and sP-selectin. Furthermore PM10sum induced heart endothelial activation and PAHs metabolism, proved by increased ET-1 and Cyp1B1 levels. Moreover, PM10sum causes an increase in brain HO-1 and ET-1. These results state the translocation of inflammation mediators, ultrafine particles, LPS, metals associated to PM10sum, from lungs to bloodstream, thus triggering a systemic reaction, mainly involving heart and brain. Our results provided additional insight into the toxicity of PM10sum and could facilitate shedding light on mechanisms underlying the development of urban air pollution related diseases.	[Farina, Francesca; Sancini, Giulio; Palestini, Paola] Univ Milano Bicocca, Dept Hlth Sci, POLARIS Res Ctr, Monza, Italy; [Battaglia, Cristina; Tinaglia, Valentina] Univ Milan, PhD Sch Mol Med, Dept Med Biotechnol & Translat Med BIOMETRA, Segrate, Italy; [Mantecca, Paride; Camatini, Marina] Univ Milano Bicocca, Dept Environm Sci, POLARIS Res Ctr, Milan, Italy	University of Milano-Bicocca; University of Milan; University of Milano-Bicocca	Sancini, G (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, POLARIS Res Ctr, Monza, Italy.	giulio.sancini@unimib.it	Sancini, Giulio/I-5136-2012; Battaglia, Cristina/E-5166-2017; Palestini, PAOLA/AAD-9376-2019	Sancini, Giulio/0000-0003-2567-109X; Battaglia, Cristina/0000-0003-3025-9657; Palestini, PAOLA/0000-0002-1045-8838; Mantecca, Paride/0000-0002-6962-049X	CARIPLO Foundation; Scuola di Dottorato di Medicina Molecolare, Universita degli Studi di Milano	CARIPLO Foundation(Fondazione Cariplo); Scuola di Dottorato di Medicina Molecolare, Universita degli Studi di Milano	This research has received a financial support by the CARIPLO Foundation to the project TOSCA "Toxicity of particulate matter and marker of risk''. Francesca Farina obtained a grant for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors thank the researchers of the Atmospheric Chemistry group directed by Prof. E. Bolzacchini, operating in the POLARIS Research Center, Department of Environmental Science, University of Milano Bicocca, for their precious contribution in PM sampling and chemical characterization. Thanks to Prof. A. Pesci, Azienda Ospedaliera San Gerardo, Monza, for his precious contribution in microscope analyses. Valentina Tinaglia is recipient of PhD fellowship from Scuola di Dottorato di Medicina Molecolare, Universita degli Studi di Milano. We thank Maria Carla Proverbio (Universita degli Studi di Milano) for technical assistance with gene expression analysis.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Araujo JA, 2008, CIRC RES, V102, P589, DOI 10.1161/CIRCRESAHA.107.164970; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bessette EE, 2009, J BIOCHEM MOL TOXIC, V23, P222, DOI 10.1002/jbt.20283; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bourotte Christine Laure Marie, 2011, Rev. bras. meteorol., V26, P419, DOI 10.1590/S0102-77862011000300008; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Calderon-Garciduenas L, 2007, TOXICOL PATHOL, V35, P154, DOI 10.1080/01926230601059985; Camatini M, 2012, ENVIRON TOXICOL, V27, P63, DOI 10.1002/tox.20611; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Campen MJ, 2010, TOXICOL APPL PHARM, V242, P310, DOI 10.1016/j.taap.2009.10.021; Cao Q, 2007, TOXICOL LETT, V171, P126, DOI 10.1016/j.toxlet.2007.05.007; Case SR, 2011, EXP LUNG RES, V37, P500, DOI 10.3109/01902148.2011.596895; Chauhan V, 2005, CELL BIOL TOXICOL, V21, P191, DOI 10.1007/s10565-005-0162-x; Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016; Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9; DULARAY B, 1990, CLIN EXP IMMUNOL, V79, P195; Emmerechts J, 2010, J THROMB HAEMOST, V8, P2651, DOI 10.1111/j.1538-7836.2010.04081.x; Fagan KA, 2001, RESP RES, V2, P90, DOI 10.1186/rr44; Farina F, 2011, TOXICOL LETT, V202, P209, DOI 10.1016/j.toxlet.2011.01.031; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P665, DOI 10.1055/s-0029-1242720; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; Gilmour MI, 2007, INHAL TOXICOL, V19, P7, DOI 10.1080/08958370701490379; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Graff DW, 2009, ENVIRON HEALTH PERSP, V117, P1089, DOI 10.1289/ehp0900558; Graff DW, 2004, ENVIRON HEALTH PERSP, V112, P792, DOI 10.1289/ehp.112-1241994; Gualtieri M, 2009, TOXICOL LETT, V188, P52, DOI 10.1016/j.toxlet.2009.03.003; Gunnison A, 2005, INHAL TOXICOL, V17, P225, DOI 10.1080/08958370590912851; Guo L, 2012, J HAZARD MATER, V213, P28, DOI 10.1016/j.jhazmat.2012.01.034; Happo MS, 2010, INHAL TOXICOL, V22, P402, DOI 10.3109/08958370903527908; Hasegawa G, 2011, INHAL TOXICOL, V23, P897, DOI 10.3109/08958378.2011.625058; Henderson RF, 2005, EXP TOXICOL PATHOL, V57, P155, DOI 10.1016/j.etp.2005.05.004; JACQUIERSARLIN MR, 1994, EXPERIENTIA, V50, P1031, DOI 10.1007/BF01923458; Kang J, 2005, J HARD TISSUE BIOL, V14, P1; Kang Y James, 2002, Cardiovasc Toxicol, V2, P253, DOI 10.1385/CT:2:4:253; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kido T, 2011, AM J RESP CELL MOL, V44, P197, DOI 10.1165/rcmb.2009-0427OC; Kreyling WG, 2010, NAT BIOTECHNOL, V28, P1275, DOI 10.1038/nbt.1735; Langrish JP, 2009, HYPERTENSION, V54, P910, DOI 10.1161/HYPERTENSIONAHA.109.135947; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; Lund AK, 2009, ARTERIOSCL THROM VAS, V29, P511, DOI 10.1161/ATVBAHA.108.176107; MacNee W, 2003, EUR RESPIR J, V21, p47S, DOI 10.1183/09031936.03.00403203; Mantecca P, 2010, TOXICOL LETT, V198, P244, DOI 10.1016/j.toxlet.2010.07.002; Mantecca P, 2009, TOXICOL LETT, V189, P206, DOI 10.1016/j.toxlet.2009.05.023; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; MohanKumar SMJ, 2008, NEUROTOXICOLOGY, V29, P479, DOI 10.1016/j.neuro.2007.12.004; Naota M, 2009, TOXICOL PATHOL, V37, P456, DOI 10.1177/0192623309335059; Oberdorster G, 2002, ENVIRON HEALTH PERSP, V110, pA440, DOI 10.1289/ehp.110-a440; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Perrone MG, 2012, SCI TOTAL ENVIRON, V414, P343, DOI 10.1016/j.scitotenv.2011.11.026; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x; Reiter TA, 2005, FREE RADICAL BIO MED, V39, P1075, DOI 10.1016/j.freeradbiomed.2005.05.023; Samet JM, 2009, AM J RESP CRIT CARE, V179, P1034, DOI 10.1164/rccm.200807-1043OC; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Schicker B, 2009, EUR J APPL PHYSIOL, V105, P771, DOI 10.1007/s00421-008-0962-9; Schipper HM, 2004, ANN NY ACAD SCI, V1012, P84, DOI 10.1196/annals.1306.007; Schwarze PE, 2006, HUM EXP TOXICOL, V25, P559, DOI 10.1177/096032706072520; Shah KB, 2009, CLIN CHEM, V55, P59, DOI 10.1373/clinchem.2008.108159; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Stow LR, 2011, FASEB J, V25, P16, DOI 10.1096/fj.10-161612; Svensson PA, 2006, ATHEROSCLEROSIS, V185, P32, DOI 10.1016/j.atherosclerosis.2005.05.007; Thomson E, 2005, TOXICOL SCI, V88, P103, DOI 10.1093/toxsci/kfi272; Utell MJ, 2000, J AEROSOL MED, V13, P355, DOI 10.1089/jam.2000.13.355; van Eeden Stephan F, 2005, Proc Am Thorac Soc, V2, P61; Watterson TL, 2009, TOXICOL SCI, V112, P111, DOI 10.1093/toxsci/kfp186; WEINBERGER I, 1992, AM J CARDIOL, V70, P981, DOI 10.1016/0002-9149(92)90347-2; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; XU WB, 1995, THORAX, V50, P1136, DOI 10.1136/thx.50.11.1136	75	72	73	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56636	10.1371/journal.pone.0056636	http://dx.doi.org/10.1371/journal.pone.0056636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451061	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500019
J	Hegeman, MA; Hennus, MP; Cobelens, PM; Kavelaars, A; Jansen, NJG; Schultz, MJ; van Vught, AJ; Heijnen, CJ				Hegeman, Maria A.; Hennus, Marije P.; Cobelens, Pieter M.; Kavelaars, Annemieke; Jansen, Nicolaas J. G.; Schultz, Marcus J.; van Vught, Adrianus J.; Heijnen, Cobi J.			Dexamethasone Attenuates VEGF Expression and Inflammation but Not Barrier Dysfunction in a Murine Model of Ventilator-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; METHYLPREDNISOLONE INFUSION; ARDS; CORTICOSTEROIDS; RATS; PERMEABILITY; PULMONARY; GLUCOCORTICOIDS; ACTIVATION; INFLATION	Background: Ventilator-induced lung injury (VILI) is characterized by vascular leakage and inflammatory responses eventually leading to pulmonary dysfunction. Vascular endothelial growth factor (VEGF) has been proposed to be involved in the pathogenesis of VILI. This study examines the inhibitory effect of dexamethasone on VEGF expression, inflammation and alveolar-capillary barrier dysfunction in an established murine model of VILI. Methods: Healthy male C57Bl/6 mice were anesthetized, tracheotomized and mechanically ventilated for 5 hours with an inspiratory pressure of 10 cmH(2)O ("lower" tidal volumes of similar to 7.5 ml/kg; LVT) or 18 cmH(2)O ("higher" tidal volumes of similar to 15 ml/kg; HVT). Dexamethasone was intravenously administered at the initiation of HVT-ventilation. Non-ventilated mice served as controls. Study endpoints included VEGF and inflammatory mediator expression in lung tissue, neutrophil and protein levels in bronchoalveolar lavage fluid, PaO2 to FiO(2) ratios and lung wet to dry ratios. Results: Particularly HVT-ventilation led to alveolar-capillary barrier dysfunction as reflected by reduced PaO2 to FiO(2) ratios, elevated alveolar protein levels and increased lung wet to dry ratios. Moreover, VILI was associated with enhanced VEGF production, inflammatory mediator expression and neutrophil infiltration. Dexamethasone treatment inhibited VEGF and pro-inflammatory response in lungs of HVT-ventilated mice, without improving alveolar-capillary permeability, gas exchange and pulmonary edema formation. Conclusions: Dexamethasone treatment completely abolishes ventilator-induced VEGF expression and inflammation. However, dexamethasone does not protect against alveolar-capillary barrier dysfunction in an established murine model of VILI.	[Hegeman, Maria A.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Hegeman, Maria A.; Cobelens, Pieter M.; Kavelaars, Annemieke; Heijnen, Cobi J.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Hegeman, Maria A.; Hennus, Marije P.; Jansen, Nicolaas J. G.; van Vught, Adrianus J.] Univ Med Ctr Utrecht, Dept Pediat Intens Care, Utrecht, Netherlands; [Cobelens, Pieter M.] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Heijnen, CJ (corresponding author), Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands.	c.heijnen@umcutrecht.nl	Schultz, Marcus/AAB-6379-2021; Hennus, Marije/D-1643-2014	Schultz, Marcus/0000-0003-3969-7792; Hennus, Marije/0000-0003-1508-0456	Catharijne Foundation of the University Medical Center Utrecht, the Netherlands	Catharijne Foundation of the University Medical Center Utrecht, the Netherlands(Netherlands Government)	This research was financially supported by the Catharijne Foundation of the University Medical Center Utrecht, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Agarwal R, 2007, RESPIROLOGY, V12, P585, DOI 10.1111/j.1440-1843.2007.01060.x; Annane D, 2006, CRIT CARE MED, V34, P22, DOI 10.1097/01.CCM.0000194723.78632.62; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; BONE RC, 1987, CHEST, V92, P1032, DOI 10.1378/chest.92.6.1032; Brower RG, 2001, CHEST, V120, P1347, DOI 10.1378/chest.120.4.1347; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; Edelman JL, 2005, EXP EYE RES, V80, P249, DOI 10.1016/j.exer.2004.09.013; EGAN EA, 1982, J APPL PHYSIOL, V53, P121, DOI 10.1152/jappl.1982.53.1.121; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Fischer S, 2001, EUR J PHARMACOL, V411, P231, DOI 10.1016/S0014-2999(00)00915-8; Hegeman MA, 2011, BRIT J PHARMACOL, V163, P1048, DOI 10.1111/j.1476-5381.2011.01314.x; Hegeman MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015653; Hegeman MA, 2009, CRIT CARE, V13, DOI 10.1186/cc8168; HOOPER RG, 1990, CHEST, V97, P138, DOI 10.1378/chest.97.1.138; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; KAWANO T, 1987, J APPL PHYSIOL, V62, P27, DOI 10.1152/jappl.1987.62.1.27; Kuipers MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050559; Lahm T, 2007, SHOCK, V28, P4, DOI 10.1097/shk.0b013e31804d1998; Lamontagne F, 2010, J CRIT CARE, V25, P420, DOI 10.1016/j.jcrc.2009.08.009; Li LF, 2011, TRANSL RES, V157, P293, DOI 10.1016/j.trsl.2010.12.009; Luce JM, 2002, CRIT CARE CLIN, V18, P79, DOI 10.1016/S0749-0704(03)00066-6; Meduri GU, 2008, INTENS CARE MED, V34, P61, DOI 10.1007/s00134-007-0933-3; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; MEDURI GU, 1994, CHEST, V105, P1516, DOI 10.1378/chest.105.5.1516; Muller-Redetzky HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035832; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; Nin N, 2006, CRIT CARE MED, V34, P1093, DOI 10.1097/01.CCM.0000205663.92384.E7; Nin N, 2008, INTENS CARE MED, V34, P948, DOI 10.1007/s00134-007-0959-6; Nin N, 2009, SHOCK, V31, P429, DOI 10.1097/SHK.0b013e318188b720; Ohta N, 2001, CRIT CARE MED, V29, P1012, DOI 10.1097/00003246-200105000-00027; Papaioannou AI, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-128; PARKER JC, 1984, J APPL PHYSIOL, V57, P1809, DOI 10.1152/jappl.1984.57.6.1809; Ramsay PL, 1998, BIOCHEM PHARMACOL, V56, P259, DOI 10.1016/S0006-2952(98)00138-5; Seam N, 2012, CRIT CARE MED, V40, P495, DOI 10.1097/CCM.0b013e318232da5e; Slutsky AS, 1999, CHEST, V116, p9S, DOI 10.1378/chest.116.suppl_1.9S-a; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Uematsu S, 2012, CRIT CARE MED; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Wang K, 2008, BIOL PHARM BULL, V31, P1541, DOI 10.1248/bpb.31.1541; WEIGELT JA, 1985, ARCH SURG-CHICAGO, V120, P536; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57374	10.1371/journal.pone.0057374	http://dx.doi.org/10.1371/journal.pone.0057374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451215	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500094
J	Schaefer, JS; Montufar-Solis, D; Nakra, N; Vigneswaran, N; Klein, JR				Schaefer, Jeremy S.; Montufar-Solis, Dina; Nakra, Niyati; Vigneswaran, Nadarajah; Klein, John R.			Small Intestine Inflammation in Roquin-Mutant and Roquin-Deficient Mice	PLOS ONE			English	Article							T-CELL SUBSETS; BOWEL-DISEASE; IL-10-DEFICIENT MICE; IL-10(-/-) MICE; MESSENGER-RNA; SCID MICE; AUTOIMMUNITY; EXPRESSION; COLITIS; MANIFESTATIONS	Roquin, an E3 ubiquitin ligase that localizes to cytosolic RNA granules, is involved in regulating mRNA stability and translation. Mice that have a M199R mutation in the Roquin protein (referred to as sanroque or Roquin(san/san) mice) develop autoimmune pathologies, although the extent to which these occur in the intestinal mucosa has not been determined. Here, we demonstrate that Roquin(san/san) mice reproducibly develop intestinal inflammation in the small intestine but not the colon. Similarly, mice generated in our laboratory in which the Roquin gene was disrupted by insertion of a gene trap cassette (Roquin(gt/gt) mice) had small intestinal inflammation that mimicked that of Roquin(san/san) mice. MLN cells in Roquin(san/san) mice consisted of activated proliferating T cells, and had increased numbers of CD44(hi) CD62L(lo) KLRG1(+) short-lived effector cells. Proportionally more small intestinal intraepithelial lymphocytes in Roquin(san/san) mice expressed the ICOS T cell activation marker. Of particular interest, small intestinal lamina propria lymphocytes in Roquin(san/san) mice consisted of a high proportion of Gr-1(+) T cells that included IL-17A(+) cells and CD8(+) IFN-gamma(+) cells. Extensive cytokine dysregulation resulting in both over-expression and under-expression of chemotactic cytokines occurred in the ileum of Roquin(san/san) mice, the region most prone to the development of inflammation. These findings demonstrate that chronic inflammation ensues in the intestine following Roquin alteration either as a consequence of protein mutation or gene disruption, and they have implications for understanding how small intestinal inflammation is perpetuated in Crohn's disease (CD). Due to the paucity of animal models of CD-like pathophysiology in the small intestine, and because the primary gene/protein defects of the Roquin animal systems used here are well-defined, it will be possible to further elucidate the underlying genetic and molecular mechanisms that drive the disease process.	[Schaefer, Jeremy S.; Montufar-Solis, Dina; Nakra, Niyati; Vigneswaran, Nadarajah; Klein, John R.] Univ Texas Hlth Sci Ctr Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77225 USA		Klein, JR (corresponding author), Univ Texas Hlth Sci Ctr Sch Dent, Dept Diagnost & Biomed Sci, Houston, TX 77225 USA.	john.r.klein@uth.tmc.edu			United States National Institutes of Health [5R01DK035566]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035566] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding came from the United States National Institutes of Health (http://www.nih.gov/) (5R01DK035566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1917, INT IMMUNOL; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Basseri B, 2010, J CROHNS COLITIS, V4, P390, DOI 10.1016/j.crohns.2010.03.008; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Chang PP, 2012, J IMMUNOL, V189, P701, DOI 10.4049/jimmunol.1102432; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Claesson MH, 1996, CLIN EXP IMMUNOL, V104, P491, DOI 10.1046/j.1365-2249.1996.48757.x; Egan C.E., 2011, IMMUNOL CELL BIOL; Hale LP, 2005, INFLAMM BOWEL DIS, V11, P1060, DOI 10.1097/01.MIB.0000187582.90423.bc; Ji YR, 2012, J BIOL CHEM, V287, P42269, DOI 10.1074/jbc.M112.374835; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002; Manganelli C, 2009, EUR REV MED PHARMACO, V13, P11; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; Matsuzaki J, 2003, CELL IMMUNOL, V224, P98, DOI 10.1016/j.cellimm.2003.08.009; Montufar-Solis D, 2007, J LEUKOCYTE BIOL, V82, P1166, DOI 10.1189/jlb.0207108; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Srivastava AS, 2007, BIOCHEM BIOPH RES CO, V361, P953, DOI 10.1016/j.bbrc.2007.07.139; Veloso FT, 2011, WORLD J GASTROENTERO, V17, P2702, DOI 10.3748/wjg.v17.i22.2702; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vocanson M, 2010, J ALLERGY CLIN IMMUN, V126, P280, DOI 10.1016/j.jaci.2010.05.022; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	30	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56436	10.1371/journal.pone.0056436	http://dx.doi.org/10.1371/journal.pone.0056436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451046	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500014
J	Jamsai, D; O'Connor, AE; DeBoer, KD; Clark, BJ; Smith, SJ; Browne, CM; Bensley, JG; Merriman, JA; Yuen, WS; Koopman, P; Jones, KT; O'Bryan, MK				Jamsai, Duangporn; O'Connor, Anne E.; DeBoer, Kathleen D.; Clark, Brett J.; Smith, Stephanie J.; Browne, Catherine M.; Bensley, Jonathan G.; Merriman, Julie A.; Yuen, Wai Shan; Koopman, Peter; Jones, Keith T.; O'Bryan, Moira K.			Loss of GGN Leads to Pre-Implantation Embryonic Lethality and Compromised Male Meiotic DNA Double Strand Break Repair in the Mouse	PLOS ONE			English	Article							FANCONI-ANEMIA; TARGETED DISRUPTION; GENE LEADS; MICE; PATHWAY; FERTILITY; DEFICIENT; COMPLEX; BRCA1; CELLS	The integrity of male germ cell genome is critical for the correct progression of spermatogenesis, successful fertilization, and proper development of the offspring. Several DNA repair pathways exist in male germ cells. However, unlike somatic cells, key components of such pathways remain largely unidentified. Gametogenetin (GGN) is a testis-enriched protein that has been shown to bind to the DNA repair protein FANCL via yeast-two-hybrid assays. This finding and its testis-enriched expression pattern raise the possibility that GGN plays a role in DNA repair during spermatogenesis. Herein we demonstrated that the largest isoform GGN1 interacted with components of DNA repair machinery in the mouse testis. In addition to FANCL, GGN1 interacted with the critical component of the Fanconi Anemia (FA) pathway FANCD2 and a downstream component of the BRCA pathway, BRCC36. To define the physiological function of GGN, we generated a Ggn null mouse line. A complete loss of GGN resulted in embryonic lethality at the very earliest period of pre-implantation development, with no viable blastocysts observed. This finding was consistent with the observation that Ggn mRNA was also expressed in lower levels in the oocyte and pre-implantation embryos. Moreover, pachytene spermatocytes of the Ggn heterozygous knockout mice showed an increased incidence of unrepaired DNA double strand breaks (DSBs). Together, our results suggest that GGN plays a role in male meiotic DSB repair and is absolutely required for the survival of pre-implantation embryos.	[Jamsai, Duangporn; O'Connor, Anne E.; Smith, Stephanie J.; Bensley, Jonathan G.; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Jamsai, Duangporn; O'Connor, Anne E.; DeBoer, Kathleen D.; Clark, Brett J.; Smith, Stephanie J.; Browne, Catherine M.; Koopman, Peter; O'Bryan, Moira K.] Monash Univ, Australian Res Council Ctr Excellence Biotechnol, Clayton, Vic 3800, Australia; [Browne, Catherine M.; Koopman, Peter] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Merriman, Julie A.; Yuen, Wai Shan; Jones, Keith T.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia	Monash University; Monash University; University of Queensland; University of Newcastle	Jamsai, D (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	duangporn.jamsai@monash.edu	Jones, Keith/C-9821-2013; Koopman, Peter A/C-9416-2009; O'Connor, Anne/AAI-6479-2020; O'Bryan, Moira K/F-8256-2012; Jones, Keith/AAA-3479-2021	Jones, Keith/0000-0002-0294-0851; Koopman, Peter A/0000-0001-6939-0914; O'Connor, Anne/0000-0001-9334-4256; O'Bryan, Moira K/0000-0001-7298-4940; Jones, Keith/0000-0002-0294-0851; Bensley, Jonathan/0000-0003-2926-1856	NHMRC [143786]; ARC [CEO348239, DP110102288]; NHMRC Fellowships [384297, 384132]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the NHMRC (#143786) and the ARC (CEO348239,DP110102288). DJ and MKO'B are the recipient of the NHMRC Fellowships (#384297, #384132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Brown EJ, 2000, GENE DEV, V14, P397; Chen XW, 2006, CANCER RES, V66, P5039, DOI 10.1158/0008-5472.CAN-05-4194; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Cohen PE, 2006, ENDOCR REV, V27, P398, DOI 10.1210/er.2005-0017; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Jamsai D, 2011, INT J ANDROL, V34, P624, DOI 10.1111/j.1365-2605.2010.01127.x; Jamsai D, 2008, REPRODUCTION, V135, P751, DOI 10.1530/REP-07-0485; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Leduc F, 2008, SYST BIOL REPROD MED, V54, P3, DOI 10.1080/19396360701876823; Li X, 2007, PLOS GENET, V3, P1365, DOI 10.1371/journal.pgen.0030130; Lu BS, 2003, J BIOL CHEM, V278, P16289, DOI 10.1074/jbc.M211023200; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Mukherjee S, 2010, CURR OPIN UROL, V20, P525, DOI 10.1097/MOU.0b013e32833f1c21; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698; Reinholdt LG, 2009, CHROMOSOMA, V118, P723, DOI 10.1007/s00412-009-0230-8; Sanchez-Partida LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021597; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Tamburrino L, 2012, ASIAN J ANDROL, V14, P24, DOI 10.1038/aja.2011.59; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Whitney MA, 1996, BLOOD, V88, P49; WILLINGALETHEUNE J, 1989, J CELL SCI, V93, P651; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Yang Y, 2001, BLOOD, V98, P3435, DOI 10.1182/blood.V98.12.3435; Zhang J, 2005, FEBS LETT, V579, P559, DOI 10.1016/j.febslet.2004.10.112	38	12	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56955	10.1371/journal.pone.0056955	http://dx.doi.org/10.1371/journal.pone.0056955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451117	Green Published, gold			2022-12-25	WOS:000316658800052
J	Planson, AG; Guijarro, JI; Chaffotte, AF				Planson, Anne-Gaelle; Guijarro, J. Inaki; Chaffotte, Alain F.			New Insights for Native Production of MSP1(19), the Disulfide-Rich C-Terminal Fragment from Plasmodium falciparum Merozoite Surface Protein 1	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; MALARIA VACCINE; IDENTIFICATION; ANTIBODIES; PARASITE; IMMUNITY; COMPLEX	Malaria represents a major public health problem and an important cause of mortality and morbidity. The malaria parasites are becoming resistant to drugs used to treat the disease and still no efficient vaccine has been developed. One promising vaccine candidate is the merozoite surface protein 1 (MSP1), which has been extensively investigated as a vaccine target. The surface protein MSP1 plays an essential role in the erythrocyte invasion process and is an accessible target for the immune system. Antibodies to the carboxy-terminal region of the protein, named MSP1(19), can inhibit erythrocyte invasion and parasite growth. In order to develop an effective MSP1(19)- based vaccine against malaria, production of an antigen that is recognized by protective antibodies is mandatory. To this aim, we propose a method to produce the disulfide-rich MSP1(19) in its native conformation based on its in vitro oxidative refolding. The native conformation of the renatured MSP1(19) is carefully established by immunochemical reactivity experiments, circular dichroism and NMR. MSP1(19) can successfully be refolded in vitro as an isolated protein or as a fusion with the maltose binding protein. The possibility to properly fold MSP1(19) in vitro paves the way to new approaches for high titer production of native MSP1(19) using Escherichia coli as a host.	[Planson, Anne-Gaelle; Guijarro, J. Inaki; Chaffotte, Alain F.] Inst Pasteur, Unite RMN Biomol, Paris, France; [Guijarro, J. Inaki; Chaffotte, Alain F.] CNRS, UMR 3528, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Guijarro, JI (corresponding author), Inst Pasteur, Unite RMN Biomol, Paris, France.	inaki.guijarro@pasteur.fr; alain.chaffotte@pasteur.fr	Planson, Anne-Gaëlle/AAK-9595-2021; Guijarro, J. Inaki/E-6438-2019	Guijarro, J. Inaki/0000-0002-3826-5245; Planson, Anne-Gaelle/0000-0003-4343-3386	Institut Pasteur; CNRS; Pasteur-Weizmann program; Region Ile de France	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Pasteur-Weizmann program; Region Ile de France(Region Ile-de-France)	This work was supported by funds from the Institut Pasteur, the CNRS and the Pasteur-Weizmann program. The 600 MHz spectrometer was funded by the Region Ile de France and the Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bentley GA, 2006, CURR OPIN MICROBIOL, V9, P395, DOI 10.1016/j.mib.2006.06.002; Betton JM, 1998, J BIOL CHEM, V273, P8897, DOI 10.1074/jbc.273.15.8897; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; DALY TM, 1995, J IMMUNOL, V155, P236; Dluzewski AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003085; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Ellis RD, 2010, HUM VACCINES, V6, P627, DOI 10.4161/hv.6.8.11446; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; Holm I, 1997, MOL BIOCHEM PARASIT, V89, P313, DOI 10.1016/S0166-6851(97)00128-X; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; MILLER LH, 1993, MOL BIOCHEM PARASIT, V59, P1, DOI 10.1016/0166-6851(93)90002-F; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Perraut R, 2005, MICROBES INFECT, V7, P682, DOI 10.1016/j.micinf.2005.01.002; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; Planson AG, 2003, BIOCHEMISTRY-US, V42, P13202, DOI 10.1021/bi035321c; Reed ZH, 2009, VACCINE, V27, P1651, DOI 10.1016/j.vaccine.2008.10.093; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Thera MA, 2012, ANNU REV MED, V63, P345, DOI 10.1146/annurev-med-022411-192402; Vaughan AM, 2012, CURR OPIN IMMUNOL, V24, P324, DOI 10.1016/j.coi.2012.03.009; WHO, 2011, WORLD MALARIA REPORT 2011, P1	35	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57086	10.1371/journal.pone.0057086	http://dx.doi.org/10.1371/journal.pone.0057086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451153	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800070
J	Brochu, C; Cabrita, MA; Melanson, BD; Hamill, JD; Lau, R; Pratt, MAC; Mckay, BC				Brochu, Christian; Cabrita, Miguel A.; Melanson, Brian D.; Hamill, Jeffrey D.; Lau, Rosanna; Pratt, M. A. Christine; McKay, Bruce C.			NF-kappa B-Dependent Role for Cold-Inducible RNA Binding Protein in Regulating Interleukin 1 beta	PLOS ONE			English	Article							HIGHLY SELECTIVE INHIBITOR; GENE-EXPRESSION; DNA DAMAGE; TRANSCRIPTIONAL REGULATION; ACTIVATION; KINASE; CELLS; RICH; CIRP; IDENTIFICATION	The cold inducible RNA binding protein (CIRBP) responds to a wide array of cellular stresses, including short wavelength ultraviolet light (UVC), at the transcriptional and post-translational level. CIRBP can bind the 3'untranslated region of specific transcripts to stabilize them and facilitate their transport to ribosomes for translation. Here we used RNA interference and oligonucleotide microarrays to identify potential downstream targets of CIRBP induced in response to UVC. Twenty eight transcripts were statistically increased in response to UVC and these exhibited a typical UVC response. Only 5 of the 28 UVC-induced transcripts exhibited a CIRBP-dependent pattern of expression. Surprisingly, 3 of the 5 transcripts (IL1B, IL8 and TNFAIP6) encoded proteins important in inflammation with IL-1 beta apparently contributing to IL8 and TNFAIP6 expression in an autocrine fashion. UVC-induced IL1B expression could be inhibited by pharmacological inhibition of NF kappa B suggesting that CIRBP was affecting NF-kappa B signaling as opposed to IL1B mRNA stability directly. Bacterial lipopolysaccharide (LPS) was used as an activator of NF-kappa B to further study the potential link between CIRBP and NF kappa B. Transfection of siRNAs against CIRBP reduced the extent of the LPS-induced phosphorylation of I kappa B alpha, NF-kappa B DNA binding activity and IL-1 beta expression. The present work firmly establishes a novel link between CIRBP and NF-kappa B signaling in response to agents with diverse modes of action. These results have potential implications for disease states associated with inflammation.	[Brochu, Christian; Cabrita, Miguel A.; Melanson, Brian D.; Hamill, Jeffrey D.; McKay, Bruce C.] Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada; [Cabrita, Miguel A.; Melanson, Brian D.; Lau, Rosanna; Pratt, M. A. Christine; McKay, Bruce C.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Carleton University	Mckay, BC (corresponding author), Ottawa Hosp Res Inst, Canc Therapeut Program, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce C/I-4081-2013	McKay, Bruce C/0000-0002-7921-1331	Canadian Institutes of Health Research; Ottawa Regional Cancer Foundation; Cancer Research Society Fellowship; Ontario Graduate Scholarship in Science and Technology; National Cancer Institute of Canada; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Regional Cancer Foundation; Cancer Research Society Fellowship; Ontario Graduate Scholarship in Science and Technology; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by the Canadian Institutes of Health Research to B.C.M. and M.A.C.P. and funds from the Ottawa Regional Cancer Foundation. C.B. was a recipient of a Cancer Research Society Fellowship, B.D.M. held an Ontario Graduate Scholarship in Science and Technology and B.C.M. was supported with a Research Scientist Award from the National Cancer Institute of Canada supported with funds provided by the Canadian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Bashir MM, 2009, ARCH DERMATOL RES, V301, P87, DOI 10.1007/s00403-008-0893-7; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Cao SQ, 2006, CELL MOL BIOL LETT, V11, P526, DOI 10.2478/s11658-006-0042-2; CARRIER F, 1994, P NATL ACAD SCI USA, V91, P1554, DOI 10.1073/pnas.91.4.1554; Chang NB, 2010, INT J HYG ENVIR HEAL, V213, P359, DOI 10.1016/j.ijheh.2010.06.006; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Eskan MA, 2008, INFECT IMMUN, V76, P2080, DOI 10.1128/IAI.01428-07; FENTON MJ, 1987, J IMMUNOL, V138, P3972; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Guo X, 2010, MOL CARCINOGEN, V49, P130, DOI 10.1002/mc.20582; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Hong JK, 2007, METAB ENG, V9, P208, DOI 10.1016/j.ymben.2006.11.003; Huss JW, 2010, NUCLEIC ACIDS RES, V38, pD633, DOI 10.1093/nar/gkp760; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Katdare M, 2007, INT J ONCOL, V31, P1519; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Lau R, 2012, CELL CYCLE, V11, P4009, DOI 10.4161/cc.22223; LEE TH, 1993, J BIOL CHEM, V268, P6154; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Liu AJ, 2010, BRAIN RES, V1347, P104, DOI 10.1016/j.brainres.2010.05.029; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P142, DOI 10.3390/ijms13010142; Masuda T, 2012, P NATL ACAD SCI USA, V109, P10885, DOI 10.1073/pnas.1121524109; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Nishiyama H, 1997, GENE, V204, P115, DOI 10.1016/S0378-1119(97)00530-1; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; O'Hagan HM, 2004, EXP CELL RES, V297, P548, DOI 10.1016/j.yexcr.2004.03.051; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossi M, 2005, REPRODUCTION, V130, P721, DOI 10.1530/rep.1.00688; Ryan JC, 2005, NEUROSCIENCE, V136, P1121, DOI 10.1016/j.neuroscience.2005.08.047; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; SIBGHATULLAH, 1989, NUCLEIC ACIDS RES, V17, P4471, DOI 10.1093/nar/17.12.4471; Smith JM, 2007, NEOPLASIA, V9, P1057, DOI 10.1593/neo.07688; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; VANNOCKER S, 1993, PLANT MOL BIOL, V21, P695, DOI 10.1007/BF00014552; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang RQ, 2006, NUCLEIC ACIDS RES, V34, P1224, DOI 10.1093/nar/gkj519; Yang RQ, 2010, J BIOL CHEM, V285, P8887, DOI 10.1074/jbc.M109.013128; YOUNG PR, 1988, J CELL BIOL, V107, P447, DOI 10.1083/jcb.107.2.447	53	35	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57426	10.1371/journal.pone.0057426	http://dx.doi.org/10.1371/journal.pone.0057426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437386	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000102
J	Ferenci, T; Benyo, B; Kovacs, L; Fisk, L; Shaw, GM; Chase, JG				Ferenci, Tamas; Benyo, Balazs; Kovacs, Levente; Fisk, Liam; Shaw, Geoffrey M.; Chase, J. Geoffrey			Daily Evolution of Insulin Sensitivity Variability with Respect to Diagnosis in the Critically Ill	PLOS ONE			English	Article							MORTALITY; ASSOCIATION; THERAPY; IMPACT	Introduction: This study examines the likelihood and evolution of overall and hypoglycemia-inducing variability of insulin sensitivity in ICU patients based on diagnosis and day of stay. Materials and Methods: An analysis of model-based insulin sensitivity for n = 390 patients in a medical ICU (Christchurch, New Zealand). Two metrics are defined to measure the variability of a patient's insulin sensitivity relative to predictions of a stochastic model created from the same data for all patients over all days of stay. The first selectively captures large increases related to the risk of hypoglycemia. The second captures overall variability. Distributions of per-patient variability scores were evaluated over different ICU days of stay and for different diagnosis groups based on APACHE III: operative and non-operative cardiac, gastric, all other. Linear and generalized linear mixed effects models assess the statistical significance of differences between groups and over days. Results: Variability defined by the two metrics was not substantially different. Variability was highest on day 1, and decreased over time (p < 0.0001) in every diagnosis group. There were significant differences between some diagnosis groups: non-operative gastric patients were the least variable, while cardiac (operative and non-operative) patients exhibited the highest variability. Conclusions: This study characterizes the variability and evolution of insulin sensitivity in critically ill patients, and may help inform the clinical management of metabolic dysfunction in critical care.	[Ferenci, Tamas; Benyo, Balazs; Kovacs, Levente] Budapest Univ Technol & Econ, Fac Elect Engn & Informat, Dept Control Engn & Informat Technol, Budapest, Hungary; [Fisk, Liam; Chase, J. Geoffrey] Univ Canterbury, Dept Mech Engn, Ctr Bioengn, Christchurch 1, New Zealand; [Shaw, Geoffrey M.] Univ Otago, Christchurch Sch Med, Christchurch Hosp, Dept Intens Care, Christchurch, New Zealand	Budapest University of Technology & Economics; University of Canterbury; Christchurch Hospital New Zealand; University of Otago	Kovacs, L (corresponding author), Budapest Univ Technol & Econ, Fac Elect Engn & Informat, Dept Control Engn & Informat Technol, Budapest, Hungary.	lkovacs@iit.bme.hu	Kovacs, Levente/AAA-1781-2019; Benyó, Balázs/AAR-4275-2021; Ferenci, Tamás/H-4682-2012; Benyó, Balázs/H-6208-2012; Chase, James G/B-1584-2012; Kovacs, Levente/A-7539-2015	Kovacs, Levente/0000-0002-3188-0800; Benyó, Balázs/0000-0003-2770-9127; Ferenci, Tamás/0000-0001-6791-3080; Benyó, Balázs/0000-0003-2770-9127; Chase, James G/0000-0001-9989-4849; Kovacs, Levente/0000-0002-3188-0800	Hungarian National Scientific Research Foundation [CK80316, K82066]; New Hungary Development Plan [TAMOP-4.2.1/B-09/1/KMR-2010-0002]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	Hungarian National Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This research work was supported by the Hungarian National Scientific Research Foundation (http://www.otka.hu/), Grants No. CK80316 and K82066, and it is connected to the scientific program of the "Development of quality-oriented and harmonized R+D+I strategy and functional model at BME" project, supported by the New Hungary Development Plan (Project ID: TAMOP-4.2.1/B-09/1/KMR-2010-0002). Levente Kovacs is supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7921; Bates D, 2012, LME4 LINEAR MIXED EF; Brown, 2006, APPL MIXED MODELS ME; Chase JG, 2008, CRIT CARE, V12, DOI 10.1186/cc6868; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Fritzmaurice GM, 2004, APPL LONGITUDINAL AN; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hsu J., 1996, MULTIPLE COMP THEORY; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Langouche L, 2007, J CLIN ENDOCR METAB, V92, P3890, DOI 10.1210/jc.2007-0813; Lin J, 2008, COMPUT METH PROG BIO, V89, P141, DOI 10.1016/j.cmpb.2007.04.006; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Moghissi ES, 2009, DIABETES CARE, V32, P1119, DOI 10.2337/dc09-9029; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Pretty C, 2011, COMPUT METH PROG BIO, V102, P172, DOI 10.1016/j.cmpb.2010.08.004; R Core Team, 2012, R LANG ENV STAT COMP; Sarkar D., 2019, NLME LINEAR NONLINEA; Suhaimi Fatanah, 2010, J Diabetes Sci Technol, V4, P284	23	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57119	10.1371/journal.pone.0057119	http://dx.doi.org/10.1371/journal.pone.0057119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437328	Green Published, Green Accepted, gold			2022-12-25	WOS:000315186000077
J	Fry, EL; Manning, P; Allen, DGP; Hurst, A; Everwand, G; Rimmler, M; Power, SA				Fry, Ellen L.; Manning, Pete; Allen, David G. P.; Hurst, Alex; Everwand, Georg; Rimmler, Martin; Power, Sally A.			Plant Functional Group Composition Modifies the Effects of Precipitation Change on Grassland Ecosystem Function	PLOS ONE			English	Article							EXPERIMENTAL MANIPULATIONS; COMMUNITY DYNAMICS; SPECIES RICHNESS; SOIL; DIVERSITY; BIODIVERSITY; RESPONSES; TRAITS; DROUGHT; STABILITY	Temperate grassland ecosystems face a future of precipitation change, which can alter community composition and ecosystem functions through reduced soil moisture and waterlogging. There is evidence that functionally diverse plant communities contain a wider range of water use and resource capture strategies, resulting in greater resistance of ecosystem function to precipitation change. To investigate this interaction between composition and precipitation change we performed a field experiment for three years in successional grassland in southern England. This consisted of two treatments. The first, precipitation change, simulated end of century predictions, and consisted of a summer drought phase alongside winter rainfall addition. The second, functional group identity, divided the plant community into three groups based on their functional traits- broadly described as perennials, caespitose grasses and annuals- and removed these groups in a factorial design. Ecosystem functions related to C, N and water cycling were measured regularly. Effects of functional groupidentity were apparent, with the dominant trend being that process rates were higher under control conditions where a range of perennial species were present. E.g. litter decomposition rates were significantly higher in plots containing several perennial species, the group with the highest average leaf N content. Process rates were also very strongly affected by the precipitation change treatmentwhen perennial plant species were dominant, but not where the community contained a high abundance of annual species and caespitose grasses. This contrasting response could be attributable to differing rooting patterns (shallower structures under annual plants, and deeper roots under perennials) and faster nutrient uptake in annuals compared to perennials. Our results indicate that precipitation change will have a smaller effect on key process rates in grasslandscontaining a range of perennial and annual species, and that maintaining the presence of key functional groups should be a crucial consideration in future grassland management.	[Fry, Ellen L.; Manning, Pete; Allen, David G. P.; Hurst, Alex; Everwand, Georg; Rimmler, Martin; Power, Sally A.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England; [Fry, Ellen L.] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England; [Manning, Pete] Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Everwand, Georg] Univ Gottingen, D-37073 Gottingen, Germany; [Rimmler, Martin] Univ Bayreuth, Dept Ecol Modelling, Bayreuth, Germany; [Power, Sally A.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 1797, Australia	Imperial College London; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Gottingen; University of Bayreuth; Western Sydney University	Fry, EL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot, Berks, England.	ellen.l.fry@gmail.com	Power, Sally/I-2923-2012; Fry, Ellen/S-7483-2018; Manning, Peter/I-6523-2012	Power, Sally/0000-0002-2723-8671; Fry, Ellen/0000-0001-7513-2006; Manning, Peter/0000-0002-7940-2023	Grantham Institute for Climate Change at Imperial College; UK POPnet; Centre for Population Biology; UK Big Lottery Fund	Grantham Institute for Climate Change at Imperial College; UK POPnet; Centre for Population Biology; UK Big Lottery Fund	EF was supported by a PhD studentship funded by the Grantham Institute for Climate Change at Imperial College, URL http://www3.imperial.ac.uk/climatechange. The work was further supported by UK POPnet, Centre for Population Biology and the UK Big Lottery Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanderud ZT, 2011, ECOSYSTEMS, V14, P156, DOI 10.1007/s10021-010-9401-y; Allen SE, 1989, CHEM ANAL ECOLOGICAL, P46; [Anonymous], 2005, MILLENNIUM ECOSYSTEM; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Carey P.D., 2008, COUNTRYSIDE SURVEY U; Chimner RA, 2010, ECOHYDROLOGY, V3, P284, DOI 10.1002/eco.106; Chimner RA, 2005, BIOGEOCHEMISTRY, V73, P257, DOI 10.1007/s10533-004-1989-6; Cornelissen JHC, 1999, NEW PHYTOL, V143, P191, DOI 10.1046/j.1469-8137.1999.00430.x; Craine JM, 2011, OECOLOGIA, V165, P1109, DOI 10.1007/s00442-011-1938-8; Crawley M.J., 2007, J CHEM INF MODEL, DOI DOI 10.1002/9780470515075; Debinski DM, 2010, ECOLOGY, V91, P1672, DOI 10.1890/09-0567.1; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Edwards GR, 2000, J APPL ECOL, V37, P321, DOI 10.1046/j.1365-2664.2000.00495.x; Fay PA, 2011, BIOGEOSCIENCES DISCU, V8, P6859; Fortunel C, 2009, ECOLOGY, V90, P598, DOI 10.1890/08-0418.1; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP, 1985, POPULATION STRUCTURE, V3, P503, DOI DOI 10.1007/978-94-009-5500-4_21; Haddad NM, 2002, ECOL LETT, V5, P110, DOI 10.1046/j.1461-0248.2002.00293.x; Hector A, 2000, OIKOS, V90, P357, DOI 10.1034/j.1600-0706.2000.900217.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hooper D, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P329; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Lamb EG, 2011, PLANT SOIL, V338, P483, DOI 10.1007/s11104-010-0560-6; Laporte Michael F, 2002, BMC Ecol, V2, P10, DOI 10.1186/1472-6785-2-10; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lee M, 2010, PHILOS T R SOC B, V365, P2047, DOI 10.1098/rstb.2010.0028; LEPS J, 1982, VEGETATIO, V50, P53, DOI 10.1007/BF00120678; MACGILLIVRAY CW, 1995, FUNCT ECOL, V9, P640, DOI 10.2307/2390156; Markham JH, 2009, ECOL RES, V24, P93, DOI 10.1007/s11284-008-0485-1; McCulley RL, 2004, OECOLOGIA, V141, P620, DOI 10.1007/s00442-004-1687-z; Met Office, 2011, REGIONAL CLIMATE VAL; Minns A, 2001, OUTLOOK AGR, V30, P179, DOI 10.5367/000000001101293634; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mokany K, 2008, J VEG SCI, V19, P119, DOI 10.3170/2007-8-18340; Morecroft MD, 2004, FUNCT ECOL, V18, P648, DOI 10.1111/j.0269-8463.2004.00896.x; Murphy J.M, 2009, UK CLIMATE PROJECTIO; Murphy K., 2009, STATISTICAL POWER AN; Orwin KH, 2010, J ECOL, V98, P1074, DOI 10.1111/j.1365-2745.2010.01679.x; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Pang JY, 2011, CROP PASTURE SCI, V62, P992, DOI 10.1071/CP11229; R Development Core Team, 2009, R FDN STAT COMP; Roscher C, 2011, J ECOL, V99, P1460, DOI 10.1111/j.1365-2745.2011.01875.x; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; RYSER P, 1995, PLANT SOIL, V170, P251, DOI 10.1007/BF00010478; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Signarbieux C, 2011, ENVIRON EXP BOT, V71, P192, DOI 10.1016/j.envexpbot.2010.12.003; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Sternberg M, 1999, PLANT ECOL, V143, P29, DOI 10.1023/A:1009812024996; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; TILMAN D, 1991, ECOLOGY, V72, P685, DOI 10.2307/2937208; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Turner LR, 2012, GRASS FORAGE SCI, V67, P507, DOI 10.1111/j.1365-2494.2012.00866.x; USDA NRCS, 2010, THE PLANTS DATABASE; Van Peer L, 2004, FUNCT ECOL, V18, P769, DOI 10.1111/j.0269-8463.2004.00901.x; Volaire F, 1998, NEW PHYTOL, V140, P439, DOI [10.1046/j.1469-8137.1998.00288.x, 10.1111/j.1469-8137.1998.00288.x]; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Walter J, 2011, ENVIRON EXP BOT, V71, P34, DOI 10.1016/j.envexpbot.2010.10.020; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xu LK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002281; Yahdjian L, 2006, ECOLOGY, V87, P952, DOI 10.1890/0012-9658(2006)87[952:VSCPPR]2.0.CO;2; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643; Zhang L, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001504	72	57	59	4	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57027	10.1371/journal.pone.0057027	http://dx.doi.org/10.1371/journal.pone.0057027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437300	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200203
J	Horta, A; Nobrega, C; Amorim-Machado, P; Coutinho-Teixeira, V; Barreira-Silva, P; Boavida, S; Costa, P; Sarmento-Castro, R; Castro, AG; Correia-Neves, M				Horta, Ana; Nobrega, Claudia; Amorim-Machado, Pedro; Coutinho-Teixeira, Vitor; Barreira-Silva, Palmira; Boavida, Susana; Costa, Patricio; Sarmento-Castro, Rui; Castro, Antonio Gil; Correia-Neves, Margarida			Poor Immune Reconstitution in HIV-Infected Patients Associates with High Percentage of Regulatory CD4(+) T Cells	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD; COUNT RECOVERY; VIRAL LOAD; ACTIVATION; FOXP3; INDUCTION; DISEASE; REPOPULATION	CD4(+) regulatory T cells (Tregs) are essential for the maintenance of the immune system's equilibrium, by dampening the activation of potential auto-reactive T cells and avoiding excessive immune activation. To correctly perform their function, Tregs must be maintained at the right proportion with respect to effector T cells. Since this equilibrium is frequently disrupted in individuals infected with the human immunodeficiency virus (HIV), we hypothesize that its deregulation could hamper immune reconstitution in patients with poor CD4(+) T cell recovery under highly active antiretroviral therapy (HAART). We analysed Tregs percentages amongst CD4(+) T cells in 53 HIV-infected patients under HAART, with suppression of viral replication and distinct levels of immune reconstitution. As controls, 51 healthy individuals were also analysed. We observed that amongst the patients with Nadir values (the lowest CD4(+) T cell counts achieved) <200 cells/mu L, the individuals with high Tregs percentages (>= 10% of total CD4(+) T cells) had the worse CD4(+) T cell reconstitution. In accordance, the well-described direct correlation between the Nadir value and CD4(+) T cell reconstitution is clearly more evident in individuals with high Tregs proportions. Furthermore, we observed a strong negative correlation between Tregs percentages and CD4(+) T cell recovery among immunological non-responder HIV+ individuals. All together, this work shows that high Tregs frequency is an important factor associated with sub-optimal CD4(+) T cell recovery. This is particularly relevant for immunological non-responders with low Nadir values. Our results suggest that the Tregs proportion might be of clinical relevance to define cut-offs for HAART initiation.	[Horta, Ana; Nobrega, Claudia; Amorim-Machado, Pedro; Coutinho-Teixeira, Vitor; Barreira-Silva, Palmira; Costa, Patricio; Sarmento-Castro, Rui; Castro, Antonio Gil; Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Horta, Ana; Nobrega, Claudia; Amorim-Machado, Pedro; Coutinho-Teixeira, Vitor; Barreira-Silva, Palmira; Costa, Patricio; Sarmento-Castro, Rui; Castro, Antonio Gil; Correia-Neves, Margarida] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Horta, Ana; Boavida, Susana; Sarmento-Castro, Rui] Hosp Joaquim Urbano Unit, Ctr Hosp Porto, Infect Dis Serv, Oporto, Portugal	Universidade do Minho	Correia-Neves, M (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	mcorreianeves@ecsaude.uminho.pt	Correia-Neves, Margarida/C-9122-2009; Claudia, Nobrega/D-7537-2014; Barreira-Silva, Palmira/T-5360-2018; Costa, Patrício/A-3072-2013; Castro, Gil/T-7584-2018; Nóbrega, Cláudia/T-6430-2018; Correia-Neves, Margarida/AAH-4636-2020	Correia-Neves, Margarida/0000-0002-2202-5431; Claudia, Nobrega/0000-0002-0282-9619; Barreira-Silva, Palmira/0000-0002-8070-1856; Costa, Patrício/0000-0002-1201-9177; Castro, Gil/0000-0002-4684-4183; Nóbrega, Cláudia/0000-0002-0282-9619; Correia-Neves, Margarida/0000-0002-2202-5431; Horta, Ana/0000-0003-3342-9762	Portuguese Foundation for Science and Technology (FCT) [PIC/IC/83313/2007]; FCT [SFRH/BPD/65380/2009, SFRH/BD/73544/2010]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT; PIC/IC/83313/2007; http://www.fct.pt/apoios/projectos/consulta/vglobal_projecto.phtml.en?idProjecto = 83313&idElemConcurso = 1689). CN and PB-S received a fellowship from FCT (SFRH/BPD/65380/2009 and SFRH/BD/73544/2010, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fehervari Z, 2004, CURR OPIN IMMUNOL, V16, P203, DOI 10.1016/j.coi.2004.01.004; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Franco JM, 2002, BLOOD, V99, P3702, DOI 10.1182/blood.V99.10.3702; Gaardbo JC, 2008, CLIN EXP IMMUNOL, V154, P80, DOI 10.1111/j.1365-2249.2008.03725.x; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Guihot A, 2011, TRENDS IMMUNOL, V32, P131, DOI 10.1016/j.it.2010.12.002; Guihot A, 2010, AIDS, V24, P614, DOI 10.1097/QAD.0b013e32833556f3; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Jiao YM, 2009, IMMUNOLOGY, V128, pe366, DOI 10.1111/j.1365-2567.2008.02978.x; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kolte L, 2009, CLIN EXP IMMUNOL, V155, P44, DOI 10.1111/j.1365-2249.2008.03803.x; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Le Moing V, 2007, HIV MED, V8, P156, DOI 10.1111/j.1468-1293.2007.00446.x; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2011, J IMMUNOL, V187, P3511, DOI 10.4049/jimmunol.1003880; Mendez-Lagares G, 2012, J INFECT DIS, V205, P1501, DOI 10.1093/infdis/jis230; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Moreno-Fernandez ME, 2009, J VIROL, V83, P12925, DOI 10.1128/JVI.01352-09; Nasi M, 2005, IMMUNOGENETICS, V57, P628, DOI 10.1007/s00251-005-0031-z; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Rubio A, 2002, CLIN EXP IMMUNOL, V130, P121, DOI 10.1046/j.1365-2249.2002.01950.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365	54	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57336	10.1371/journal.pone.0057336	http://dx.doi.org/10.1371/journal.pone.0057336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437372	Green Published, gold			2022-12-25	WOS:000315184200246
J	La Riviere, M; Roumagnac, M; Garrabou, J; Bally, M				La Riviere, Marie; Roumagnac, Marie; Garrabou, Joaquim; Bally, Marc			Transient Shifts in Bacterial Communities Associated with the Temperate Gorgonian Paramuricea clavata in the Northwestern Mediterranean Sea	PLOS ONE			English	Article							CORAL POCILLOPORA-DAMICORNIS; MASS MORTALITY EVENTS; T-RFLP ANALYSIS; MICROBIAL COMMUNITIES; GENETIC DIVERSITY; LENGTH; SEAWATER; MUCUS; ASSEMBLAGES; POPULATIONS	Background: Bacterial communities that are associated with tropical reef-forming corals are being increasingly recognized for their role in host physiology and health. However, little is known about the microbial diversity of the communities associated with temperate gorgonian corals, even though these communities are key structural components of the ecosystem. In the Northwestern Mediterranean Sea, gorgonians undergo recurrent mass mortalities, but the potential relationship between these events and the structure of the associated bacterial communities remains unexplored. Because microbial assemblages may contribute to the overall health and disease resistance of their host, a detailed baseline of the associated bacterial diversity is required to better understand the functioning of the gorgonian holobiont. Methodology/Principal Findings: The bacterial diversity associated with the gorgonian Paramuricea clavata was determined using denaturing gradient gel electrophoresis, terminal-restriction fragment length polymorphism and the construction of clone libraries of the bacterial 16S ribosomal DNA. Three study sites were monitored for 4 years to assess the variability of communities associated with healthy colonies. Bacterial assemblages were highly dominated by one Hahellaceae-related ribotype and exhibited low diversity. While this pattern was mostly conserved through space and time, in summer 2007, a deep shift in microbiota structure toward increased bacterial diversity and the transient disappearance of Hahellaceae was observed. Conclusion/Significance: This is the first spatiotemporal study to investigate the bacterial diversity associated with a temperate shallow gorgonian. Our data revealed an established relationship between P. clavata and a specific bacterial group within the Oceanospirillales. These results suggest a potential symbiotic role of Hahellaceae in the host-microbe association, as recently suggested for tropical corals. However, a transient imbalance in bacterial associations can be tolerated by the holobiont without apparent symptoms of disease. The subsequent restoration of the Hahellaceae-dominated community is indicative of the specificity and resilience of the bacteria associated with the gorgonian host.	[La Riviere, Marie; Roumagnac, Marie; Garrabou, Joaquim; Bally, Marc] Univ Sud Toulon Var, Aix Marseille Univ, IRD, CNRS INSU,Mediterranean Inst Oceanog MIO UM 110, Marseille, France; [Garrabou, Joaquim] CSIC, ICM, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Bally, M (corresponding author), Univ Sud Toulon Var, Aix Marseille Univ, IRD, CNRS INSU,Mediterranean Inst Oceanog MIO UM 110, Marseille, France.	marc.bally@univ-amu.fr			French National Agency for Research (ANR); Total Foundation	French National Agency for Research (ANR)(French National Research Agency (ANR)); Total Foundation(Total SA)	This work was supported by the French National Agency for Research (ANR; http://www.agence-nationale-recherche.fr/en/) (MEDCHANGE ANR Project) and the Total Foundation (http://fondation.total.com/) (MAGIC3 Project; http://www.magic3-project.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2009, AQUAT BIOL, V4, P289, DOI 10.3354/ab00102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves N, 2010, ENV MICROBIOL REP, V2, P90, DOI 10.1111/j.1758-2229.2009.00101.x; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2005, ENVIRON MICROBIOL, V7, P1162, DOI 10.1111/j.1462-2920.2005.00793.x; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Bruck TB, 2007, MAR BIOTECHNOL, V9, P561, DOI 10.1007/s10126-007-9009-1; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; CHAO A, 1984, SCAND J STAT, V11, P265; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Crisci C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023814; Dahllof I, 2000, APPL ENVIRON MICROB, V66, P3376, DOI 10.1128/AEM.66.8.3376-3380.2000; de Castro AP, 2010, MICROB ECOL, V59, P658, DOI 10.1007/s00248-010-9646-1; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Fischer EM, 2009, CLIM DYNAM, V33, P917, DOI 10.1007/s00382-008-0473-8; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; Goffredi SK, 2007, APPL ENVIRON MICROB, V73, P2314, DOI 10.1128/AEM.01986-06; Gray MA, 2011, FEMS MICROBIOL ECOL, V76, P109, DOI 10.1111/j.1574-6941.2010.01033.x; Hall-Spencer JM, 2007, DIS AQUAT ORGAN, V76, P87, DOI 10.3354/dao076087; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Hennig C, 2012, FPC FLEXIBLE PROCEDU; Hewson I, 2012, CORAL REEFS, V31, P487, DOI 10.1007/s00338-011-0864-x; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Ji NN, 2004, J MICROBIOL METH, V57, P409, DOI 10.1016/j.mimet.2004.02.010; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lampert Y, 2008, FEMS MICROBIOL ECOL, V64, P187, DOI 10.1111/j.1574-6941.2008.00458.x; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; Martin Y, 2002, WATER RES, V36, P779, DOI 10.1016/S0043-1354(01)00251-2; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muyzer G., 2004, Molecular microbial ecology manual. Volumes 1 and 2, P743; Neulinger SC, 2008, APPL ENVIRON MICROB, V74, P7272, DOI 10.1128/AEM.01777-08; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Osborne CA, 2006, APPL ENVIRON MICROB, V72, P1270, DOI 10.1128/AEM.72.2.1270-1278.2006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodolfo-Metalpa R, 2005, ITAL J ZOOL, V72, P271, DOI 10.1080/11250000509356685; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schutte UME, 2008, APPL MICROBIOL BIOT, V80, P365, DOI 10.1007/s00253-008-1565-4; Shannon CE, 1949, MATH THEORY COMMUNIC, P125; Sharp KH, 2012, BIOL BULL-US, V223, P66, DOI 10.1086/BBLv223n1p66; SOUTHERN EM, 1979, ANAL BIOCHEM, V100, P319, DOI 10.1016/0003-2697(79)90235-5; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57	67	54	55	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57385	10.1371/journal.pone.0057385	http://dx.doi.org/10.1371/journal.pone.0057385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437379	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200251
J	Muller, KAL; Muller, I; Kramer, U; Kandolf, R; Gawaz, M; Bauer, A; Zuern, CS				Mueller, Karin A. L.; Mueller, Iris; Kramer, Ulrich; Kandolf, Reinhard; Gawaz, Meinrad; Bauer, Axel; Zuern, Christine S.			Prognostic Value of Contrast-enhanced Cardiac Magnetic Resonance Imaging in Patients with Newly Diagnosed Non-Ischemic Cardiomyopathy: Cohort Study	PLOS ONE			English	Article							LATE GADOLINIUM ENHANCEMENT; HEART-FAILURE; HYPERTROPHIC CARDIOMYOPATHY; POSTINFARCTION PATIENTS; DILATED CARDIOMYOPATHY; INTERNATIONAL SOCIETY; MYOCARDIAL-INFARCTION; DELAYED ENHANCEMENT; QRS DURATION; MORTALITY	Background: Owing to its variable course from asymptomatic cases to sudden death risk stratification is of paramount importance in newly diagnosed non-ischemic cardiomyopathy. We tested whether late gadolinium enhancement (LGE) assessed by cardiac magnetic resonance (CMR) imaging is a prognostic marker in consecutive patients with newly diagnosed non-ischemic cardiomyopathy. Methods: We enrolled 185 patients who presented for evaluation of newly diagnosed non-ischemic cardiomyopathy. Coronary artery disease was excluded by coronary angiography. Following risk markers were additionally assessed: NYHA functional class (>= II), brain natriuretic peptide (>100 ng/l), troponin I (Tnl, >= 0.03 mu g/l), left ventricular ejection fraction (LVEF, <= 40%), left ventricular enddiastolic diameter (>55 mm) and QRS duration (>98 ms). Endpoint of the study was the composite of all-cause mortality, heart transplantation, aborted sudden death, sustained ventricular tachycardia or hospitalization due to decompensated heart failure within three years of follow-up. Results: During median follow-up of 21 months, 54 patients (29.2%) reached the composite endpoint. Ninety-four of the 185 patients (50.8%) were judged LGE-positive. Prognosis of LGE-positive patients was significantly worse than that of LGE-negative patients (cumulative 3-year event rates of 67.4% in LGE-positive and 27.2% in LGE-negative patients, respectively; p = 0.021). However, in multivariable analysis, presence of LGE was not an independent predictor of outcome. Only LVEF <= 40% and Tnl >= 0.03 mu g/l were independent risk predictors of the composite endpoint yielding relative risks of 3.9 (95% CI 1.9-8.1; p<0.0001) and 2.2 (95% CI 1.2-4.0; p = 0.014), respectively. Conclusions: In consecutive patients presenting with newly diagnosed non-ischemic cardiomyopathy, LGE-positive patients had worse prognosis. However, only traditional risk parameters like left ventricular performance and cardiac biomarkers but not presence of LGE were independent risk predictors.	[Mueller, Karin A. L.; Mueller, Iris; Gawaz, Meinrad; Bauer, Axel; Zuern, Christine S.] Univ Tubingen, Med Klin 3, Tubingen, Germany; [Kramer, Ulrich] Univ Tubingen, Radiol Univ Klin, Tubingen, Germany; [Kandolf, Reinhard] Univ Tubingen, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Zuern, CS (corresponding author), Univ Tubingen, Med Klin 3, Tubingen, Germany.	christine.zuern@med.uni-tuebingen.de		Zuern, Christine/0000-0001-6625-284X; Bauer, Axel/0000-0001-9201-8555	Deutsche Forschungsgemeinschaft [Transregio-SFB-19]; Klinische Forschergruppe [KFO 274]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe	The study was supported by the Deutsche Forschungsgemeinschaft - Transregio-SFB-19 "Inflammatory Cardiomyopathy" and the Klinische Forschergruppe KFO 274 "Platelets-Molecular Mechanisms and Translational Implications". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Deutsche Forschungsgemeinschaft Transregio-SFB-19 "Inflammatory Cardiomyopathy" and the Klinische Forschergruppe KFO 274 "Platelets-Molecular Mechanisms and Translational Implications".	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Appelbaum E, 2012, CIRC-CARDIOVASC IMAG, V5, P78, DOI 10.1161/CIRCIMAGING.111.963819; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Bauer A, 2006, EUR HEART J, V27, P427, DOI 10.1093/eurheartj/ehi683; Bauer A, 2008, J AM COLL CARDIOL, V52, P1353, DOI 10.1016/j.jacc.2008.07.041; Bauer A, 2009, EUR HEART J, V30, P576, DOI 10.1093/eurheartj/ehn540; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; Bello D, 2005, J AM COLL CARDIOL, V45, P1104, DOI 10.1016/j.jacc.2004.12.057; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Camici PG, 2008, CIRCULATION, V117, P103, DOI 10.1161/CIRCULATIONAHA.107.702993; Camm AJ, 1996, EUR HEART J, V17, P354; Choi KA, 2001, CIRCULATION, V104, P1101, DOI 10.1161/hc3501.096798; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Geisler T, 2011, EUROPEAN J RADIOLOGY; Gruen S, 2012, J AM COLL CARDIOL, V59, P1604, DOI 10.1016/j.jacc.2012.01.007; Hsia HH, 2002, PACE, V25, P1114, DOI 10.1046/j.1460-9592.2002.01114.x; Ingkanisorn WP, 2004, J AM COLL CARDIOL, V43, P2253, DOI 10.1016/j.jacc.2004.02.046; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; KWONG RY, 2006, CIRCULATION, V113, P2733, DOI DOI 10.1161/CIRCULATIONHA.105.570648; Lehrke S, 2011, HEART, V97, P727, DOI 10.1136/hrt.2010.205542; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Michels VV, 2003, HEART, V89, P757, DOI 10.1136/heart.89.7.757; Miller WL, 2007, CLIN CARDIOL, V30, P245, DOI 10.1002/clc.20075; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; Ramani K, 1998, CIRCULATION, V98, P2687, DOI 10.1161/01.CIR.98.24.2687; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Wang NC, 2008, JAMA-J AM MED ASSOC, V299, P2656, DOI 10.1001/jama.299.22.2656; Wu KC, 2008, J AM COLL CARDIOL, V51, P2414, DOI 10.1016/j.jacc.2008.03.018; Yan AT, 2006, CIRCULATION, V114, P32, DOI 10.1161/CIRCULATIONAHA.106.613414	37	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57077	10.1371/journal.pone.0057077	http://dx.doi.org/10.1371/journal.pone.0057077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437315	gold, Green Submitted, Green Published			2022-12-25	WOS:000315184200211
J	Figueroa, M; Alderman, S; Garvin, DF; Pfender, WF				Figueroa, Melania; Alderman, Stephen; Garvin, David F.; Pfender, William F.			Infection of Brachypodium distachyon by Formae Speciales of Puccinia graminis: Early Infection Events and Host-Pathogen Incompatibility	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; NONHOST RESISTANCE; MODEL SYSTEM; STEM RUST; PERENNIAL RYEGRASS; DISEASE RESISTANCE; TALL FESCUE; GRASS; BARLEY; CEREAL	Puccinia graminis causes stem rust, a serious disease of cereals and forage grasses. Important formae speciales of P. graminis and their typical hosts are P. graminis f. sp. tritici (Pg-tr) in wheat and barley, P. graminis f. sp. lolii (Pg-lo) in perennial ryegrass and tall fescue, and P. graminis f. sp. phlei-pratensis (Pg-pp) in timothy grass. Brachypodium distachyon is an emerging genetic model to study fungal disease resistance in cereals and temperate grasses. We characterized the P. graminis-Brachypodium pathosystem to evaluate its potential for investigating incompatibility and non-host resistance to P. graminis. Inoculation of eight Brachypodium inbred lines with Pg-tr, Pg-lo or Pg-pp resulted in sporulating lesions later accompanied by necrosis. Histological analysis of early infection events in one Brachypodium inbred line (Bd1-1) indicated that Pg-lo and Pg-pp were markedly more efficient than Pg-tr at establishing a biotrophic interaction. Formation of appressoria was completed (60-70% of germinated spores) by 12 h post-inoculation (hpi) under dark and wet conditions, and after 4 h of subsequent light exposure fungal penetration structures (penetration peg, substomatal vesicle and primary infection hyphae) had developed. Brachypodium Bd1-1 exhibited pre-haustorial resistance to Pg-tr, i.e. infection usually stopped at appressorial formation. By 68 hpi, only 0.3% and 0.7% of the Pg-tr urediniospores developed haustoria and colonies, respectively. In contrast, development of advanced infection structures by Pg-lo and Pg-pp was significantly more common; however, Brachypodium displayed post-haustorial resistance to these isolates. By 68 hpi the percentage of urediniospores that only develop a haustorium mother cell or haustorium in Pg-lo and Pg-pp reached 8% and 5%, respectively. The formation of colonies reached 14% and 13%, respectively. We conclude that Brachypodium is an apt grass model to study the molecular and genetic components of incompatiblity and non-host resistance to P. graminis.	[Figueroa, Melania; Alderman, Stephen; Pfender, William F.] ARS, Forage Seed & Cereal Res Unit, USDA, Corvallis, OR USA; [Garvin, David F.] ARS, Plant Sci Res Unit, USDA, St Paul, MN USA; [Garvin, David F.] ARS, Dept Agron & Plant Genet, USDA, St Paul, MN USA; [Pfender, William F.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Oregon State University	Pfender, WF (corresponding author), ARS, Forage Seed & Cereal Res Unit, USDA, Corvallis, OR USA.	pfenderw@onid.orst.edu	Figueroa, Melania/R-7696-2017; Figueroa, Melania/AAI-8692-2021	Figueroa, Melania/0000-0003-2636-661X; Figueroa, Melania/0000-0003-2636-661X	USDA Agricultural Research Service [5358-22000-031-00D]	USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research was supported by basic operating funds of the USDA Agricultural Research Service, Project 5358-22000-031-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime MC, 2006, MYCOLOGIA, V98, P896, DOI 10.3852/mycologia.98.6.896; Anikster Y., 1984, CEREAL RUSTS, P124; [Anonymous], 1971, RUST CEREALS GRASSES; Ayliffe M, 2011, EUPHYTICA, V179, P33, DOI 10.1007/s10681-010-0280-2; Barbieri M, 2012, GENOME, V55, P152, DOI [10.1139/G2012-001, 10.1139/g2012-001]; Barbieri M, 2011, PLANT DIS, V95, P1339, DOI 10.1094/PDIS-11-10-0825; Barker RE, 2003, CROP SCI, V43, P75, DOI 10.2135/cropsci2003.0075; CUMMINS GB, 2004, ILLUSTRATED GENERA R; da Cunha L, 2006, MICROBES INFECT, V8, P1372, DOI 10.1016/j.micinf.2005.12.018; Drader T, 2010, GENOME, V53, P406, DOI [10.1139/G10-014, 10.1139/g10-014]; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Eriksson J., 1894, BER DEUT BOT GES, V12, P292; Fehser S, 2010, J PLANT PATHOL, V92, P709; Garvin D. F., 2011, Borlaug Global Rust Initiative (BGRI) 2011 Technical Workshop, 13-16 June, St Paul, Minnesota, USA. Oral Presentations, P89; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Harder D.E., 1984, CEREAL RUSTS, V1, P416; Heath MC, 2000, CURR OPIN PLANT BIOL, V3, P315, DOI 10.1016/S1369-5266(00)00087-X; HEATH MC, 1981, PHYTOPATHOLOGY, V71, P1121, DOI 10.1094/Phyto-71-1121; Heath MC, 1982, HOST DEFENSE MECH IN, P223; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Huo NX, 2011, THEOR APPL GENET, V123, P455, DOI 10.1007/s00122-011-1598-4; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Jafary H, 2008, GENETICS, V178, P2327, DOI 10.1534/genetics.107.077552; Jeuken M, 2002, THEOR APPL GENET, V105, P384, DOI 10.1007/s00122-002-0943-z; Kamoun S, 1999, TRENDS PLANT SCI, V4, P196, DOI 10.1016/S1360-1385(99)01404-1; LENNOX CL, 1989, PLANT PATHOL, V38, P547, DOI 10.1111/j.1365-3059.1989.tb01450.x; LENNOX CL, 1994, J PHYTOPATHOL, V140, P165, DOI 10.1111/j.1439-0434.1994.tb00188.x; Leonard KJ, 2005, MOL PLANT PATHOL, V6, P489, DOI 10.1111/J.1364-3703.2005.00299.X; Loehrer M, 2008, MOL PLANT MICROBE IN, V21, P1421, DOI 10.1094/MPMI-21-11-1421; Mellersh DG, 2003, MOL PLANT MICROBE IN, V16, P398, DOI 10.1094/MPMI.2003.16.5.398; Mur LAJ, 2011, NEW PHYTOL, V191, P334, DOI 10.1111/j.1469-8137.2011.03748.x; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Nurnberger T, 2005, MOL PLANT PATHOL, V6, P335, DOI 10.1111/j.1364-3703.2005.00279.x; Panstruga R, 2009, SCIENCE, V324, P748, DOI 10.1126/science.1171652; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; Peraldi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-100; Pfender W, 2009, PHYTOPATHOLOGY, V99, P1185, DOI 10.1094/PHYTO-99-10-1185; Pfender WF, 2001, PLANT DIS, V85, P993, DOI 10.1094/PDIS.2001.85.9.993; Pfender WF, 2001, PHYTOPATHOLOGY, V91, P111, DOI 10.1094/PHYTO.2001.91.1.111; Pretorius Z. A., 2000, Plant Disease, V84, P203, DOI 10.1094/PDIS.2000.84.2.203B; Roelfs A.P., 1992, RUST DIS WHEAT CONCE, P34; ROELFS AP, 1988, PHYTOPATHOLOGY, V78, P526, DOI 10.1094/Phyto-78-526; ROWELL JB, 1958, PHYTOPATHOLOGY, V48, P371; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Savile D, 1984, CEREAL RUSTS, VI, P89; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; SELLAM MA, 1976, PHYTOPATHOLOGY, V66, P667, DOI 10.1094/Phyto-66-667; Singh R.P., 2006, CAB REV, V1, P54, DOI [10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, 10.1079/PAVSNNR20061054]; SKIPP RA, 1974, CAN J BOT, V52, P1107, DOI 10.1139/b74-140; STAPLES RC, 2004, CEREAL RUSTS, V1, P250; URBAN Z., 1967, Encyclopedie mycologique, V34, P5; Vleeshouwers VGAA, 2000, PLANTA, V210, P853, DOI 10.1007/s004250050690; Vogel J, 2009, PLANT GENET GENOMICS, V7, P427, DOI 10.1007/978-0-387-77489-3_16; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; WATERHOUSE W. L., 1951, PROC LINN SOC N S WALES, V76, P57; WELTY RE, 1989, PLANT DIS, V73, P775, DOI 10.1094/PD-73-0775A; YIRGOU D, 1968, PHYTOPATHOLOGY, V58, P500; Zhang L, 2008, FUNCT INTEGR GENOMIC, V8, P187, DOI 10.1007/s10142-007-0069-0	60	41	42	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56857	10.1371/journal.pone.0056857	http://dx.doi.org/10.1371/journal.pone.0056857			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441218	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200075
J	Wang, XM; Li, J; Yan, MX; Liu, L; Jia, DS; Geng, Q; Lin, HC; He, XH; Li, JJ; Yao, M				Wang, Xiao-Min; Li, Jing; Yan, Ming-Xia; Liu, Lei; Jia, De-Shui; Geng, Qin; Lin, He-Chun; He, Xiang-Huo; Li, Jin-Jun; Yao, Ming			Integrative Analyses Identify Osteopontin, LAMB3 and ITGB1 as Critical Pro-Metastatic Genes for Lung Cancer	PLOS ONE			English	Article							CELL-MIGRATION; EXPRESSION; MODEL; ADHESION; GROWTH; TOOL	Objective: To explore the key regulatory genes associated with lung cancer in order to reduce its occurrence and progress through silencing these key genes. Methods: To identify the key regulatory genes involved in lung cancer, we performed a combination of gene array and bioinformatics analyses to compare gene transcription profiles in 3 monoclonal cell strains with high, medium or low metastatic abilities, which were separated from the SPC-A-1sci and SPC-A-1 cell lines by limiting dilution monoclone assay. We then analyzed those genes' biological activities by knocking down their expression in SPC-A-1sci cells using siRNA and lenti-viral shRNA vectors, followed by determinations of the invasion and migration capabilities of the resulting cell lines in vitro as well as their potential for inducing occurrence and metastasis of lung cancer in vivo. To examine the clinical relevance of these findings, we analyzed the expression levels of the identified genes in human lung cancer tissues (n = 135) and matched adjacent normal tissues by immunohistochemical (IHC) staining. Results: Three monoclonal cell strains characterized with high, medium or low metastatic abilities were successfully selected. Gene array and bioinformatics analyses implied that osteopontin, LAMB3 and ITGB1 were key genes involved in lung cancer. Knockdown of these genes suppressed human lung cancer cell invasion and metastasis in vitro and in vivo. Clinical sample analyses indicated that osteopontin, LAMB3 and ITGB1 protein expression levels were higher in lung cancer patients, compared to non-cancerous adjacent tissues, and correlated with lymphatic metastasis. Conclusions: We confirmed that osteopontin, LAMB3 and ITGB1 played important roles in the occurrence and metastasis of lung cancer, thus provided important clues to understanding the molecular mechanism of metastasis and contributing to the therapeutic treatment of lung cancer.	[Wang, Xiao-Min; Li, Jing; Yan, Ming-Xia; Liu, Lei; Jia, De-Shui; Geng, Qin; Lin, He-Chun; He, Xiang-Huo; Li, Jin-Jun; Yao, Ming] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yao, M (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Canc Inst,State Key Lab Oncogenes & Rela, Shanghai 200030, Peoples R China.	myao@shsci.org	He, Xianghuo/I-1497-2014; Jia, Deshui/U-9732-2019	He, Xianghuo/0000-0001-8872-668X; 	National Key Basic Research Program of China [2009CB521803]; "action plan to innovation'' of the Shanghai Science and Technology fund [10140902400]	National Key Basic Research Program of China(National Basic Research Program of China); "action plan to innovation'' of the Shanghai Science and Technology fund	This work was supported by grants from the National Key Basic Research Program of China (2009CB521803), and "action plan to innovation'' of the Shanghai Science and Technology fund (10140902400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Busch H, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.36; Calaluce R, 2004, NEOPLASIA, V6, P468, DOI 10.1593/neo.03499; Chung H, 2011, J BIOL CHEM, V286, P13438, DOI 10.1074/jbc.M110.166751; Courter D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009633; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; Cui R, 2007, LUNG CANCER, V57, P302, DOI 10.1016/j.lungcan.2007.03.019; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; Donati V, 2005, CLIN CANCER RES, V11, P6459, DOI 10.1158/1078-0432.CCR-05-0541; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; Griffin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023404; Hu Z, 2005, CLIN CANCER RES, V11, P4646, DOI 10.1158/1078-0432.CCR-04-2013; Ii M, 2011, INT J ONCOL, V39, P593, DOI 10.3892/ijo.2011.1048; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jia DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-364; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Luo JH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-428; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Mason CK, 2008, MOL CANCER THER, V7, P548, DOI 10.1158/1535-7163.MCT-07-2251; Mierke CT, 2008, EUR J CELL BIOL, V87, P669, DOI 10.1016/j.ejcb.2008.01.002; Nguyen DX, 2011, J PATHOL, V223, P195, DOI 10.1002/path.2801; Oikawa Y, 2011, EXP CELL RES, V317, P1119, DOI 10.1016/j.yexcr.2010.12.019; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Scheele S, 2007, J MOL MED, V85, P825, DOI 10.1007/s00109-007-0182-5; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Takahashi M, 2008, CLIN EXP METASTAS, V25, P517, DOI 10.1007/s10585-008-9163-5; Tarin D, 2012, CANCER MICROENVIRON, V5, P95, DOI 10.1007/s12307-012-0099-6; Tripathi M, 2008, J BIOL CHEM, V283, P30576, DOI 10.1074/jbc.M802312200; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wu SF, 1980, SCI CHINA, P913; Yi M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-30; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Young AL, 2011, EUR J DERMATOL, V21, P401, DOI 10.1684/ejd.2011.1360; Zhang R, 2011, PLOS ONE, V8	41	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55714	10.1371/journal.pone.0055714	http://dx.doi.org/10.1371/journal.pone.0055714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441154	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200012
J	Yang, XA; Vasudevan, P; Parekh, V; Penev, A; Cunningham, JM				Yang, Xinan; Vasudevan, Prabhakaran; Parekh, Vishwas; Penev, Aleks; Cunningham, John M.			Bridging Cancer Biology with the Clinic: Relative Expression of a GRHL2-Mediated Gene-Set Pair Predicts Breast Cancer Metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR; SIGNATURE; LUNG; PROGRESSION; PROGNOSIS; SURVIVAL; IDENTIFICATION; DISSEMINATION; CONTRIBUTES	Identification and characterization of crucial gene target(s) that will allow focused therapeutics development remains a challenge. We have interrogated the putative therapeutic targets associated with the transcription factor Grainy head-like 2 (GRHL2), a critical epithelial regulatory factor. We demonstrate the possibility to define the molecular functions of critical genes in terms of their personalized expression profiles, allowing appropriate functional conclusions to be derived. A novel methodology, relative expression analysis with gene-set pairs (RXA-GSP), is designed to explore the potential clinical utility of cancer-biology discovery. Observing that Grhl2-overexpression leads to increased metastatic potential in vitro, we established a model assuming Grhl2-induced or -inhibited genes confer poor or favorable prognosis respectively for cancer metastasis. Training on public gene expression profiles of 995 breast cancer patients, this method prioritized one gene-set pair (GRHL2, CDH2, FN1, CITED2, MKI67 versus CTNNB1 and CTNNA3) from all 2717 possible gene-set pairs (GSPs). The identified GSP significantly dichotomized 295 independent patients for metastasis-free survival (log-rank tested p = 0.002; severe empirical p = 0.035). It also showed evidence of clinical prognostication in another independent 388 patients collected from three studies (log-rank tested p = 3.3e-6). This GSP is independent of most traditional prognostic indicators, and is only significantly associated with the histological grade of breast cancer (p = 0.0017), a GRHL2-associated clinical character (p = 6.8e-6, Spearman correlation), suggesting that this GSP is reflective of GRHL2-mediated events. Furthermore, a literature review indicates the therapeutic potential of the identified genes. This research demonstrates a novel strategy to integrate both biological experiments and clinical gene expression profiles for extracting and elucidating the genomic impact of a novel factor, GRHL2, and its associated gene-sets on the breast cancer prognosis. Importantly, the RXA-GSP method helps to individualize breast cancer treatment. It also has the potential to contribute considerably to basic biological investigation, clinical tools, and potential therapeutic targets.	[Yang, Xinan; Vasudevan, Prabhakaran; Parekh, Vishwas; Penev, Aleks; Cunningham, John M.] Univ Chicago, Dept Pediat, Comer Childrens Hosp, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Yang, XA (corresponding author), Univ Chicago, Dept Pediat, Comer Childrens Hosp, Hematol Oncol Sect, Chicago, IL 60637 USA.	xyang2@uchicago.edu	Parekh, Vishwas/B-7162-2014	Parekh, Vishwas/0000-0003-3131-2958; Yang, Xinan Holly/0000-0001-8061-8692; Penev, Alex/0000-0002-6358-7780	Hecktman Senior Fellow Award; NATIONAL CANCER INSTITUTE [R21CA167305] Funding Source: NIH RePORTER	Hecktman Senior Fellow Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the financial support of the Hecktman Senior Fellow Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buness A, 2007, BIOINFORMATICS, V23, P2273, DOI 10.1093/bioinformatics/btm340; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; De Rienzo A, 2011, CLIN CANCER RES, V17, P310, DOI 10.1158/1078-0432.CCR-10-0806; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Eddy JA, 2010, TECHNOL CANCER RES T, V9, P149, DOI 10.1177/153303461000900204; Espinosa-Neira R, 2011, INT J BIOCHEM CELL B, V43, P1782, DOI 10.1016/j.biocel.2011.08.017; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Itoh S, 2012, J BIOCHEM, V151, P559, DOI 10.1093/jb/mvs042; Leth-Larsen R, 2012, MOL MED; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Ma Ji, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P784; Magis AT, 2011, BIOINFORMATICS, V27, P872, DOI 10.1093/bioinformatics/btr033; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Meehan M, 2007, GENE CHROMOSOME CANC, V46, P587, DOI 10.1002/gcc.20443; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MING T, 2011, CANCER RES, P30; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Moleirinho S, 2012, ONCOGENE; Morrogh M, 2012, BREAST CANCER RES TR, V132, P641, DOI 10.1007/s10549-011-1860-0; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pennacchio LA, 2003, J CLIN INVEST, V111, P1099, DOI 10.1172/JCI200317842; Pulaski B.A., 2001, CURR PROTOC IMMUNOL, V20; Ravnan MC, 2011, FORMULARY; Rennstam K, 2003, CANCER RES, V63, P8861; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Soikkeli J, 2010, AM J PATHOL, V177, P387, DOI 10.2353/ajpath.2010.090748; Thomassen M, 2007, CLIN CANCER RES, V13, P5355, DOI 10.1158/1078-0432.CCR-07-0249; van Agthoven T, 2009, BRIT J CANCER, V101, P1824, DOI 10.1038/sj.bjc.6605423; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Yamamoto S IM, 2012, BREAST CANC; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5	47	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56195	10.1371/journal.pone.0056195	http://dx.doi.org/10.1371/journal.pone.0056195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441166	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200023
J	Buzza, MS; Martin, EW; Driesbaugh, KH; Desilets, A; Leduc, R; Antalis, TM				Buzza, Marguerite S.; Martin, Erik W.; Driesbaugh, Kathryn H.; Desilets, Antoine; Leduc, Richard; Antalis, Toni M.			Prostasin Is Required for Matriptase Activation in Intestinal Epithelial Cells to Regulate Closure of the Paracellular Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE MATRIPTASE; AUTOSOMAL RECESSIVE ICHTHYOSIS; INFLAMMATORY-BOWEL-DISEASE; EPIDERMAL BARRIER FUNCTION; PROTEOLYTIC CASCADE; ZYMOGEN ACTIVATION; CELLULAR-LOCALIZATION; EXPRESSION; PERMEABILITY; INHIBITION	The type II transmembrane serine protease matriptase is a key regulator of epithelial barriers in skin and intestine. In skin, matriptase acts upstream of the glycosylphosphatidylinositol-anchored serine protease, prostasin, to activate the prostasin zymogen and initiate a proteolytic cascade that is required for stratum corneum barrier functionality. Here, we have investigated the relationship between prostasin and matriptase in intestinal epithelial barrier function. We find that similar to skin, matriptase and prostasin are components of a common intestinal epithelial barrier-forming pathway. Depletion of prostasin by siRNA silencing in Caco-2 intestinal epithelium inhibits barrier development similar to loss of matriptase, and the addition of recombinant prostasin to the basal side of polarized Caco-2 epithelium stimulates barrier forming changes similar to the addition of recombinant matriptase. However, in contrast to the proteolytic cascade in skin, prostasin functions upstream of matriptase to activate the endogenous matriptase zymogen. Prostasin is unable to proteolytically activate the matriptase zymogen directly but induces matriptase activation indirectly. Prostasin requires expression of endogenous matriptase to stimulate barrier formation since matriptase depletion by siRNA silencing abrogates prostasin barrier-forming activity. Active recombinant matriptase, however, does not require the expression of endogenous prostasin for barrier-forming activity. Together, these data show that matriptase and not prostasin is the primary effector protease of tight junction assembly in simple columnar epithelia and further highlight a spatial and tissue-specific aspect of cell surface proteolytic cascades.	[Buzza, Marguerite S.; Martin, Erik W.; Driesbaugh, Kathryn H.; Antalis, Toni M.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Buzza, Marguerite S.; Martin, Erik W.; Driesbaugh, Kathryn H.; Antalis, Toni M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Desilets, Antoine; Leduc, Richard] Univ Sherbrooke, Dept Pharmacol, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Sherbrooke	Antalis, TM (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St, Baltimore, MD 21201 USA.	tantalis@som.umaryland.edu		Desilets, Antoine/0000-0001-5081-5564; Martin, Erik/0000-0003-3979-2378	National Institutes of Health [CA098369, HL084387]; Department of Defense [PR110378]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R56CA098369, R01CA098369, P30CA134274] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084387, R01HL118390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants CA098369 and HL084387 (to T. M. A.), Department of Defense Grants PR110378 (to T. M. A.), and by the Canadian Institutes of Health Research (to R. L.).	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; CEREIJIDO M, 1981, AM J PHYSIOL, V240, pC96, DOI 10.1152/ajpcell.1981.240.3.C96; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Desilets A, 2008, J BIOL CHEM, V283, P10535, DOI 10.1074/jbc.M707012200; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; Henderson P, 2011, INFLAMM BOWEL DIS, V17, P382, DOI 10.1002/ibd.21379; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Inouye K, 2013, J BIOCHEM, V153, P51, DOI 10.1093/jb/mvs118; Kosa P, 2012, ONCOGENE, V31, P3679, DOI 10.1038/onc.2011.545; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Netzel-Arnett S, 2012, INFLAMM BOWEL DIS, V18, P1303, DOI 10.1002/ibd.21930; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Sanders SE, 1995, EPITHELIAL CELL BIOL, V4, P25; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shen L, 2009, DIGEST DIS, V27, P443, DOI 10.1159/000233282; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Steensgaard M, 2010, ACTA PHYSIOL, V200, P347, DOI 10.1111/j.1748-1716.2010.02170.x; Swystun VA, 2009, AM J PHYSIOL-GASTR L, V297, pG60, DOI 10.1152/ajpgi.00096.2009; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Vetrano S, 2011, P NATL ACAD SCI USA, V108, P19830, DOI 10.1073/pnas.1107140108; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	58	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10328	10337		10.1074/jbc.M112.443432	http://dx.doi.org/10.1074/jbc.M112.443432			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443662	Green Published, hybrid			2022-12-25	WOS:000317565000014
J	Rivera, MF; Lee, JY; Aneja, M; Goswami, V; Liu, LY; Velsko, IM; Chukkapalli, SS; Bhattacharyya, I; Chen, H; Lucas, AR; Kesavalu, LN				Rivera, Mercedes F.; Lee, Ju-Youn; Aneja, Monika; Goswami, Vishalkant; Liu, Liying; Velsko, Irina M.; Chukkapalli, Sasanka S.; Bhattacharyya, Indraneel; Chen, Hao; Lucas, Alexandra R.; Kesavalu, Lakshmyya N.			Polymicrobial Infection with Major Periodontal Pathogens Induced Periodontal Disease and Aortic Atherosclerosis in Hyperlipidemic ApoE(null) Mice	PLOS ONE			English	Article							ALVEOLAR BONE-RESORPTION; SITU HYBRIDIZATION FISH; CORONARY-HEART-DISEASE; FUSOBACTERIUM-NUCLEATUM; CARDIOVASCULAR-DISEASE; DIRECT VISUALIZATION; TREPONEMA-DENTICOLA; ORAL INFECTION; MESSENGER-RNA; RAT MODEL	Periodontal disease (PD) and atherosclerosis are both polymicrobial and multifactorial and although observational studies supported the association, the causative relationship between these two diseases is not yet established. Polymicrobial infection-induced periodontal disease is postulated to accelerate atherosclerotic plaque growth by enhancing atherosclerotic risk factors of orally infected Apolipoprotein E deficient (ApoE(null)) mice. At 16 weeks of infection, samples of blood, mandible, maxilla, aorta, heart, spleen, and liver were collected, analyzed for bacterial genomic DNA, immune response, inflammation, alveolar bone loss, serum inflammatory marker, atherosclerosis risk factors, and aortic atherosclerosis. PCR analysis of polymicrobial-infected (Porphyromonas gingivalis [P. gingivalis], Treponema denticola [T. denticola], and Tannerella forsythia [T. forsythia]) mice resulted in detection of bacterial genomic DNA in oral plaque samples indicating colonization of the oral cavity by all three species. Fluorescent in situ hybridization detected P. gingivalis and T. denticola within gingival tissues of infected mice and morphometric analysis showed an increase in palatal alveolar bone loss (p<0.0001) and intrabony defects suggesting development of periodontal disease in this model. Polymicrobial-infected mice also showed an increase in aortic plaque area (p<0.05) with macrophage accumulation, enhanced serum amyloid A, and increased serum cholesterol and triglycerides. A systemic infection was indicated by the detection of bacterial genomic DNA in the aorta and liver of infected mice and elevated levels of bacterial specific IgG antibodies (p<0.0001). This study was a unique effort to understand the effects of a polymicrobial infection with P. gingivalis, T. denticola and T. forsythia on periodontal disease and associated atherosclerosis in ApoE(null) mice.	[Rivera, Mercedes F.; Lee, Ju-Youn; Aneja, Monika; Goswami, Vishalkant; Velsko, Irina M.; Chukkapalli, Sasanka S.; Kesavalu, Lakshmyya N.] Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32610 USA; [Kesavalu, Lakshmyya N.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Liu, Liying; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, Gainesville, FL USA; [Liu, Liying; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Div Cardiovasc Med, Gainesville, FL USA; [Bhattacharyya, Indraneel] Univ Florida, Coll Dent, Dept Oral Diagnost Sci, Gainesville, FL USA; [Lee, Ju-Youn] Pusan Natl Univ, Sch Dent, Dept Periodontol, Yangsan, Gyeongsangnam D, South Korea	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pusan National University; Pusan National University Hospital	Kesavalu, LN (corresponding author), Univ Florida, Coll Dent, Dept Periodontol, Gainesville, FL 32610 USA.	Kesavalu@dental.ufl.edu	Bhattacharyya, Indraneel/U-7752-2019	LEE, JUYOUN/0000-0002-0772-033X; Bhattacharyya, Indraneel/0000-0002-0334-9051; Chen, Hao/0000-0003-0018-480X	NIH NIDCR [RO1 DE020820]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020820] Funding Source: NIH RePORTER	NIH NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was funded by NIH NIDCR RO1 DE020820 to Kesavalu Lakshmyya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz K, 2012, MOL MED; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bainbridge B, 2010, INFECT IMMUN, V78, P4560, DOI 10.1128/IAI.00703-10; Bartee MY, 2009, METHOD ENZYMOL, V460, P209, DOI 10.1016/S0076-6879(09)05210-0; Brodala N, 2005, ARTERIOSCL THROM VAS, V25, P1446, DOI 10.1161/01.ATV.0000167525.69400.9c; Dai E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010510; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Fiehn NE, 2005, J PERIODONTOL, V76, P731, DOI 10.1902/jop.2005.76.5.731; Figuero E, 2011, J PERIODONTOL, V82, P1469, DOI 10.1902/jop.2011.100719; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Iwai T, 2009, J PERIODONTAL RES, V44, P689, DOI 10.1111/j.1600-0765.2008.01165.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Kesavalu L, 2012, J DENT RES, V91, P255, DOI 10.1177/0022034511435101; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kolenbrander PE, 2011, INT J ORAL SCI, V3, P49, DOI 10.4248/IJOS11025; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3204, DOI 10.1128/IAI.57.10.3204-3209.1989; KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4584, DOI 10.1128/IAI.63.12.4584-4588.1995; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Kumon Y, 1999, J RHEUMATOL, V26, P785; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lalla E, 2003, ARTERIOSCL THROM VAS, V23, P1405, DOI 10.1161/01.ATV.0000082462.26258.FE; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Liu D, 2004, TRANSPLANTATION, V77, P1652, DOI 10.1097/01.TP.0000131173.52424.84; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Lockhart PB, 2012, CIRCULATION; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Manz W, 1999, METHOD ENZYMOL, V310, P79; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Miyamoto M, 2006, INFECT IMMUN, V74, P2462, DOI 10.1128/IAI.74.4.2462-2467.2006; Miyamoto T, 2006, INFECT IMMUN, V74, P1376, DOI 10.1128/IAI.74.2.1376-1380.2006; Mkonyi LE, 2012, AM J PATHOL, V181, P907, DOI 10.1016/j.ajpath.2012.05.027; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Mustapha IZ, 2007, J PERIODONTOL, V78, P2289, DOI 10.1902/jop.2007.070140; Nahid MA, 2011, INFECT IMMUN, V79, P1597, DOI 10.1128/IAI.01062-10; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nonnenmacher C, 2007, J PERIODONTOL, V78, P1724, DOI 10.1902/jop.2007.060345; Okuda K, 2001, J CLIN MICROBIOL, V39, P1114, DOI 10.1128/JCM.39.3.1114-1117.2001; OTT K, 1982, DEUT ZAHNAERZTL Z, V37, P634; Paquette DW, 2007, PERIODONTOL 2000, V44, P113, DOI 10.1111/j.1600-0757.2006.00196.x; Rudney JD, 2005, J DENT RES, V84, P1165, DOI 10.1177/154405910508401214; Saadi-Thiers K, 2012, J PERIODONTOL; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Verma RK, 2010, ORAL DIS, V16, P686, DOI 10.1111/j.1601-0825.2010.01678.x; Verma RK, 2010, INTERDISCIP PERSPECT, V2010, DOI DOI 10.1155/2010/605125; Yamazaki M, 2007, AM J PHYSIOL-HEART C, V292, pH539, DOI 10.1152/ajpheart.00640.2006; Zelkha SA, 2010, PERIODONTOL 2000, V54, P207, DOI 10.1111/j.1600-0757.2010.00358.x	55	59	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57178	10.1371/journal.pone.0057178	http://dx.doi.org/10.1371/journal.pone.0057178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451182	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500076
J	van Steenbeek, FG; Van den Bossche, L; Grinwis, GCM; Kummeling, A; van Gils, IHM; Koerkamp, MJAG; van Leenen, D; Holstege, FCP; Penning, LC; Rothuizen, J; Leegwater, PAJ; Spee, B				van Steenbeek, Frank G.; Van den Bossche, Lindsay; Grinwis, Guy C. M.; Kummeling, Anne; van Gils, Ingrid H. M.; Koerkamp, Marian J. A. Groot; van Leenen, Dik; Holstege, Frank C. P.; Penning, Louis C.; Rothuizen, Jan; Leegwater, Peter A. J.; Spee, Bart			Aberrant Gene Expression in Dogs with Portosystemic Shunts	PLOS ONE			English	Article							IRISH WOLFHOUNDS; DUCTUS-ARTERIOSUS; OXYGEN-SATURATION; LIVER-DISEASE; CATS; DIAGNOSIS; ANATOMY; BIRTH; INHERITANCE; PREDICTION	Congenital portosystemic shunts are developmental anomalies of the splanchnic vascular system that cause portal blood to bypass the liver. Large-breed dogs are predisposed for intrahepatic portosystemic shunts (IHPSS) and small-breed dogs for extrahepatic portosystemic shunts (EHPSS). While the phenotype resulting from portal bypass of the liver of the two types of shunt is identical, the genotype and molecular pathways involved are probably different. The aim of this study was to gain insight into the pathways involved in the different types of portosystemic shunting. Microarray analysis of mRNA expression in liver tissue from dogs with EHPSS and IHPSS revealed that the expression of 26 genes was altered in either IHPSS or EHPSS samples compared with that in liver samples from control dogs. Quantitative real-time PCR of these genes in 14 IHPSS, 17 EHPSS, and 8 control liver samples revealed a significant differential expression of ACBP, CCBL1, GPC3, HAMP, PALLD, VCAM1, and WEE1. Immunohistochemistry and Western blotting confirmed an increased expression of VCAM1 in IHPSS but its absence in EHPSS, an increased WEE1 expression in IHPSS but not in EHPSS, and a decreased expression of CCBL1 in both shunt types. Regarding their physiologic functions, these findings may indicate a causative role for VCAM1 in IHPSS and WEE1 for IHPSS. CCBL1 could be an interesting candidate to study not yet elucidated aspects in the pathophysiology of hepatic encephalopathy.	[van Steenbeek, Frank G.; Van den Bossche, Lindsay; Kummeling, Anne; van Gils, Ingrid H. M.; Penning, Louis C.; Rothuizen, Jan; Leegwater, Peter A. J.; Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; van Leenen, Dik; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	van Steenbeek, FG (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	f.g.vansteenbeek@uu.nl	Holstege, Frank/AAM-9944-2021; Kummeling, Anne/GNW-3198-2022; van Steenbeek, F.G./AFL-0046-2022; Penning, Louis/AAC-7524-2019; Fiumefreddo, Andrea/T-2977-2019	van Steenbeek, F.G./0000-0001-5460-6540; Leegwater, Peter/0000-0002-4100-015X; Grinwis, Guy/0000-0002-1583-9648; Groot Koerkamp, Marian JA/0000-0002-0867-0821	European Commission [LUPA-GA-201370]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was partly funded by the European Commission (LUPA-GA-201370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Caretti E, 2008, J CELL BIOCHEM, V103, P556, DOI 10.1002/jcb.21426; Coceani F, 2012, SEMIN PERINATOL, V36, P92, DOI 10.1053/j.semperi.2011.09.018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; Hong KS, 2011, EXPT MOL MED; Hunt GB, 2004, AUST VET J, V82, P746, DOI 10.1111/j.1751-0813.2004.tb13233.x; Ijzer J, 2010, VET J, V184, P308, DOI 10.1016/j.tvjl.2009.02.016; Kamlin COF, 2006, J PEDIATR-US, V148, P585, DOI 10.1016/j.jpeds.2005.12.050; Lamb CR, 1998, VET REC, V142, P55, DOI 10.1136/vr.142.3.55; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Mariani G, 2007, J PEDIATR-US, V150, P418, DOI 10.1016/j.jpeds.2006.12.015; MARTIN RA, 1993, VET CLIN N AM-SMALL, V23, P609, DOI 10.1016/S0195-5616(93)50309-1; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Meyer H P, 1991, Tijdschr Diergeneeskd, V116 Suppl 1, p80S; MEYER HP, 1995, VET REC, V136, P13, DOI 10.1136/vr.136.1.13; PAYNE JT, 1990, SEMIN VET MED SURG, V5, P76; PERRY S, 1995, FEBS LETT, V360, P277, DOI 10.1016/0014-5793(95)00123-Q; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabi Y, 2006, J PEDIATR-US, V148, P590, DOI 10.1016/j.jpeds.2005.12.047; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; ROTHUIZEN J, 1982, RES VET SCI, V33, P22, DOI 10.1016/S0034-5288(18)32353-1; Schotanus BA, 2009, LIVER INT, V29, P1241, DOI 10.1111/j.1478-3231.2009.02024.x; Spee Bart, 2007, Comp Hepatol, V6, P8, DOI 10.1186/1476-5926-6-8; STARLING MB, 1974, PROSTAGLANDINS, V8, P187, DOI 10.1016/0090-6980(74)90042-2; Stringer MD, 2008, CLIN ANAT, V21, P147, DOI 10.1002/ca.20574; TISDALL PLC, 1994, AUST VET J, V71, P174, DOI 10.1111/j.1751-0813.1994.tb03382.x; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; Tobias KM, 2003, J AM ANIM HOSP ASSOC, V39, P385, DOI 10.5326/0390385; Treiber G, 2005, DIGEST DIS, V23, P6, DOI 10.1159/000084720; Ubbink GJ, 1998, AM J VET RES, V59, P1553; Uchino T, 1999, J PEDIATR-US, V135, P254, DOI 10.1016/S0022-3476(99)70031-4; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Steenbeek FG, 2009, J VET INTERN MED, V23, P950, DOI 10.1111/j.1939-1676.2009.0319.x; van Steenbeek FG, 2012, MAMM GENOME, V23, P76, DOI 10.1007/s00335-011-9364-0; van Straten G, 2005, J VET INTERN MED, V19, P321, DOI 10.1892/0891-6640(2005)19[321:ICEPSI]2.0.CO;2; VANDENINGH TSGAM, 1995, VET QUART, V17, P70, DOI 10.1080/01652176.1995.9694536; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VULGAMOTT JC, 1985, VET CLIN N AM-SMALL, V15, P229, DOI 10.1016/S0195-5616(85)50013-3; Winkler JT, 2003, J AM ANIM HOSP ASSOC, V39, P169, DOI 10.5326/0390169; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yokoyama Y, 2007, J HEPATO-BILIARY-PAN, V14, P159, DOI 10.1007/s00534-006-1125-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57662	10.1371/journal.pone.0057662	http://dx.doi.org/10.1371/journal.pone.0057662			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451256	Green Published, gold			2022-12-25	WOS:000316849500124
J	Venkatakrishnan, S; Mackey, D; Meier, I				Venkatakrishnan, Sowmya; Mackey, David; Meier, Iris			Functional Investigation of the Plant-Specific Long Coiled-Coil Proteins PAMP-INDUCED COILED-COIL (PICC) and PICC-LIKE (PICL) in Arabidopsis thaliana	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTOR; TAIL-ANCHORED PROTEINS; ABSCISIC-ACID; DEFENSE RESPONSES; SECRETORY PATHWAY; GENE-EXPRESSION; IN-VITRO; MEMBRANE; RESISTANCE; SYSTEM	We have identified and characterized two Arabidopsis long coiled-coil proteins PAMP-INDUCED COILED-COIL (PICC) and PICC-LIKE (PICL). PICC (147 kDa) and PICL (87 kDa) are paralogs that consist predominantly of a long coiled-coil domain (expanded in PICC), with a predicted transmembrane domain at the immediate C-terminus. Orthologs of PICC and PICL were found exclusively in vascular plants. PICC and PICL GFP fusion proteins are anchored to the cytoplasmic surface of the endoplasmic reticulum (ER) membrane by a C-terminal transmembrane domain and a short tail domain, via a tail-anchoring mechanism. T-DNA-insertion mutants of PICC and PICL as well as the double mutant show an increased sensitivity to the plant abiotic stress hormone abscisic acid (ABA) in a post-germination growth response. PICC, but not PICL gene expression is induced by the bacterial pathogen-associated molecular pattern (PAMP) flg22. T-DNA insertion alleles of PICC, but not PICL, show increased susceptibility to the non-virulent strain P. syringae pv. tomato DC3000 hrcC, but not to the virulent strain P. syringae pv. tomato DC3000. This suggests that PICC mutants are compromised in PAMP-triggered immunity (PTI). The data presented here provide first evidence for the involvement of a plant long coiled-coil protein in a plant defense response.	[Venkatakrishnan, Sowmya; Mackey, David; Meier, Iris] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Mackey, David] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Meier, I (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12Th Ave, Columbus, OH 43210 USA.	meier.56@osu.edu			National Science Foundation [NSF-MCB-0641271]	National Science Foundation(National Science Foundation (NSF))	This work has been funded by a grant from the National Science Foundation (NSF-MCB-0641271; http://www.nsf.gov/div/index.jsp?div=MCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2011, PLANT CELL REP, V30, P137, DOI 10.1007/s00299-010-0925-6; Afzal AJ, 2011, PLANT CELL, V23, P3798, DOI 10.1105/tpc.111.088708; Agusti J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-127; Aung K, 2011, PLANT CELL, V23, P4446, DOI 10.1105/tpc.111.090142; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Boutrot F, 2010, P NATL ACAD SCI USA, V107, P14502, DOI 10.1073/pnas.1003347107; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Candela H, 1999, DEV BIOL, V205, P205, DOI 10.1006/dbio.1998.9111; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gay PA, 2000, CAN J BOT, V78, P1144, DOI 10.1139/cjb-78-9-1144; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Grunwald I, 2003, PHYSIOL PLANTARUM, V119, P192, DOI 10.1034/j.1399-3054.2003.00202.x; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hugouvieux V, 1998, MOL PLANT MICROBE IN, V11, P537, DOI 10.1094/MPMI.1998.11.6.537; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Iyer K., 2005, SCI STKE SIGNAL TRAN, V2005, pl3; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jeong SY, 2003, NUCLEIC ACIDS RES, V31, P5175, DOI 10.1093/nar/gkg693; Jessberger R, 2002, NAT REV MOL CELL BIO, V3, P767, DOI 10.1038/nrm930; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kim Min Gab, 2008, V415, P443, DOI 10.1007/978-1-59745-570-1_26; Kodama Y, 2010, P NATL ACAD SCI USA, V107, P19591, DOI 10.1073/pnas.1007836107; Kriechbaumer V, 2009, TRAFFIC, V10, P1753, DOI 10.1111/j.1600-0854.2009.00991.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee YRJ, 2004, PLANT PHYSIOL, V136, P3877, DOI 10.1104/pp.104.052621; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Liu CM, 2002, PLANT J, V29, P405, DOI 10.1046/j.1365-313x.2002.01224.x; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; MATSUI M, 1995, P NATL ACAD SCI USA, V92, P4239, DOI 10.1073/pnas.92.10.4239; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Oikawa K, 2008, PLANT PHYSIOL, V148, P829, DOI 10.1104/pp.108.123075; Passarinho PA, 2001, PLANTA, V212, P556, DOI 10.1007/s004250000464; Pedrazzini E, 2009, J PLANT BIOL, V52, P88, DOI 10.1007/s12374-009-9014-1; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Rose A, 2004, PLANT PHYSIOL, V134, P927, DOI 10.1104/pp.103.035626; Runions J, 2006, J EXP BOT, V57, P43, DOI 10.1093/jxb/eri289; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SAMAC DA, 1991, PLANT CELL, V3, P1063, DOI 10.1105/tpc.3.10.1063; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Sparkes I, 2010, PLANT CELL, V22, P1333, DOI 10.1105/tpc.110.074385; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takemoto D, 2003, PLANT J, V33, P775, DOI 10.1046/j.1365-313X.2003.01673.x; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Underwood W, 2008, J EXP BOT, V59, P3501, DOI 10.1093/jxb/ern205; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang PW, 2011, PLANT J, V66, P613, DOI 10.1111/j.1365-313X.2011.04522.x; Watanabe K, 2009, PLANT CELL, V21, P2688, DOI 10.1105/tpc.108.060525; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xu XM, 2007, CURR BIOL, V17, P1157, DOI 10.1016/j.cub.2007.05.076; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhao Q, 2006, PLANT PHYSIOL, V140, P869, DOI 10.1104/pp.105.075499; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	91	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57283	10.1371/journal.pone.0057283	http://dx.doi.org/10.1371/journal.pone.0057283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451199	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500084
J	Wedde, M; Wahlisch, S; Wolff, T; Schweiger, B				Wedde, Marianne; Waehlisch, Stephanie; Wolff, Thorsten; Schweiger, Brunhilde			Predominance of HA-222D/G Polymorphism in Influenza A(H1N1)pdm09 Viruses Associated with Fatal and Severe Outcomes Recently Circulating in Germany	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; RECEPTOR-BINDING; IMMUNE-RESPONSE; SEVERE DISEASE; HEMAGGLUTININ; SUBSTITUTION; ORIGIN; D222G; ERYTHROCYTES	Influenza A(H1N1)pdm09 viruses cause sporadically very severe disease including fatal clinical outcomes associated with pneumonia, viremia and myocarditis. A mutation characterized by the substitution of aspartic acid (wild-type) to glycine at position 222 within the haemagglutinin gene (HA-D222G) was recorded during the 2009 H1N1 pandemic in Germany and other countries with significant frequency in fatal and severe cases. Additionally, A(H1N1)pdm09 viruses exhibiting the polymorphism HA-222D/G/N were detected both in the respiratory tract and in blood. Specimens from mild, fatal and severe cases were collected to study the heterogeneity of HA-222 in A(H1N1)pdm09 viruses circulating in Germany between 2009 and 2011. In order to enable rapid and large scale analysis we designed a pyrosequencing (PSQ) assay. In 2009/2010, the 222D wild-type of A(H1N1)pdm09 viruses predominated in fatal and severe outcomes. Moreover, co-circulating virus mutants exhibiting a D222G or D222E substitution (8/6%) as well as HA-222 quasispecies were identified (10%). Both the 222D/G and the 222D/G/N/V/Y polymorphisms were confirmed by TA cloning. PSQ analyses of viruses associated with mild outcomes revealed mainly the wild-type 222D and no D222G change in both seasons. However, an increase of variants with 222D/G polymorphism (60%) was characteristic for A(H1N1)pdm09 viruses causing fatal and severe cases in the season 2010/2011. Pure 222G viruses were not observed. Our results support the hypothesis that the D222G change may result from adaptation of viral receptor specificity to the lower respiratory tract. This could explain why transmission of the 222G variant is less frequent among humans. Thus, amino acid changes at HA position 222 may be the result of viral intra-host evolution leading to the generation of variants with an altered viral tropism.	[Wedde, Marianne; Waehlisch, Stephanie; Wolff, Thorsten; Schweiger, Brunhilde] Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany	Robert Koch Institute	Wedde, M (corresponding author), Robert Koch Inst, Natl Reference Ctr Influenza, Berlin, Germany.	WeddeM@rki.de						Baldanti F, 2011, CLIN MICROBIOL INFEC, V17, P1166, DOI 10.1111/j.1469-0691.2010.03403.x; Baldanti F, 2011, EURO SURVEILL, V16; Belser JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025091; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Bratincsak A, 2010, J AM COLL CARDIOL, V55, P928, DOI 10.1016/j.jacc.2010.01.004; Buda S, 2011, INFLUENZA WOCHENBERI; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; CORNACOFF JB, 1983, J CLIN INVEST, V71, P236, DOI 10.1172/JCI110764; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ellis J, 2011, EURO SURVEILL, V16, P19760; European Centre for Disease Prevention and Control, 2009, PAND INFL A H1N1 VIR; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Hua Yang, 2010, CHINA TECHNOLOGY REV, P1, DOI DOI 10.1371/CURRENTS.RRN1152; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Khouzam RN, 2011, HEART LUNG, V40, P566, DOI 10.1016/j.hrtlng.2011.01.004; Kilander A, 2010, EUROSURVEILLANCE, V4, P15; Kilander A, 2010, EURO SURVEILL, V15; Levine M, 2011, J CLIN MICROBIOL, V49, P1307, DOI 10.1128/JCM.02424-10; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; MILLER RR, 2010, EURO SURVEILL, V15; Morera D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-89; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; POWERS JH, 1995, INFECT IMMUN, V63, P1329, DOI 10.1128/IAI.63.4.1329-1335.1995; Puzelli S., 2010, EURO SURVEILL, V15, P19696; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Weinheimer V.K., 2012, J INFECT DI IN PRESS; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P21; World Health Organization, 2009, CLIN MAN HUM INF PAN	39	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57059	10.1371/journal.pone.0057059	http://dx.doi.org/10.1371/journal.pone.0057059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451145	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500058
J	Xie, F; Fu, H; Hou, JF; Jiao, K; Costigan, M; Chen, J				Xie, Fang; Fu, Han; Hou, Jun-Feng; Jiao, Kai; Costigan, Michael; Chen, Jun			High Energy Diets-Induced Metabolic and Prediabetic Painful Polyneuropathy in Rats	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ZUCKER DIABETIC FATTY; KININ B-1 RECEPTOR; BB-WISTAR-RAT; NEUROPATHIC PAIN; INSULIN-RESISTANCE; SENSORY NEUROPATHY; NEUROLOGICAL COMPLICATIONS; PHARMACOLOGICAL MANAGEMENT; PERIPHERAL NEUROPATHY	To establish the role of the metabolic state in the pathogenesis of polyneuropathy, an age- and sex-matched, longitudinal study in rats fed high-fat and high-sucrose diets (HFSD) or high-fat, high-sucrose and high-salt diets (HFSSD) relative to controls was performed. Time courses of body weight, systolic blood pressure, fasting plasma glucose (FPG), insulin, free fatty acids (FFA), homeostasis model assessment-insulin resistance index (HOMA-IR), thermal and mechanical sensitivity and motor coordination were measured in parallel. Finally, large and small myelinated fibers (LMF, SMF) as well as unmyelinated fibers (UMF) in the sciatic nerves and ascending fibers in the spinal dorsal column were quantitatively assessed under electron microscopy. The results showed that early metabolic syndrome (hyperinsulinemia, dyslipidemia, and hypertension) and prediabetic conditions (impaired fasting glucose) could be induced by high energy diet, and these animals later developed painful polyneuropathy characterized by myelin breakdown and LMF loss in both peripheral and central nervous system. In contrast SMF and UMF in the sciatic nerves were changed little, in the same animals. Therefore the phenomenon that high energy diets induce bilateral mechanical, but not thermal, pain hypersensitivity is reflected by severe damage to LMF, but mild damage to SMF and UMF. Moreover, dietary sodium (high-salt) deteriorates the neuropathic pathological process induced by high energy diets, but paradoxically high salt consumption, may reduce, at least temporarily, chronic pain perception in these animals.	[Xie, Fang; Fu, Han; Hou, Jun-Feng; Chen, Jun] Fourth Mil Med Univ, Tangdu Hosp, Inst Biomed Sci Pain, Xian 710032, Peoples R China; [Xie, Fang; Fu, Han; Hou, Jun-Feng; Chen, Jun] Fourth Mil Med Univ, Tangdu Hosp, Inst Funct Brain Disorders, Xian 710032, Peoples R China; [Xie, Fang; Fu, Han; Chen, Jun] PLA, Key Lab Brain Stress & Behav, Xian, Peoples R China; [Hou, Jun-Feng; Jiao, Kai] Fourth Mil Med Univ, Tangdu Hosp, Dept Endocrinol, Xian 710032, Peoples R China; [Costigan, Michael] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Harvard University; Boston Children's Hospital	Chen, J (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Inst Biomed Sci Pain, Xian 710032, Peoples R China.	junchen@fmmu.edu.cn	Chen, Jun/R-8412-2017	Chen, Jun/0000-0003-2637-8442	MOST [2011CB504100, 2013BAI04B04]; NSFC [81171049]; NIH [R01NS074430]; Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074430] Funding Source: NIH RePORTER	MOST; NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Adelson Medical Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the MOST (2011CB504100 and 2013BAI04B04) and the NSFC (81171049) to J.C. M.C. thanks the NIH (R01NS074430) and the Adelson Medical Research Foundation for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; BENARROCH IS, 1979, ACTA DIABETOL LAT, V16, P211, DOI 10.1007/BF02629114; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bokura H, 2008, STROKE, V39, P1607, DOI 10.1161/STROKEAHA.107.508630; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Brussee V, 2008, DIABETES, V57, P1664, DOI 10.2337/db07-1737; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Chen J, 1999, PAIN, V83, P67, DOI 10.1016/S0304-3959(99)00075-5; Chen YS, 2005, DIABETES, V54, P3112, DOI 10.2337/diabetes.54.11.3112; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dias JP, 2007, BRIT J PHARMACOL, V152, P280, DOI 10.1038/sj.bjp.0707388; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Dworkin RH, 2010, MAYO CLIN PROC, V85, pS3, DOI 10.4065/mcp.2009.0649; Dyck PJ, 2011, DIABETES-METAB RES, V27, P620, DOI 10.1002/dmrr.1226; Estrella JS, 2008, MICROVASC RES, V75, P403, DOI 10.1016/j.mvr.2007.12.002; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Ghione S, 1996, HYPERTENSION, V28, P494, DOI 10.1161/01.HYP.28.3.494; Greenwood CE, 2005, NEUROBIOL AGING, V26, pS42, DOI 10.1016/j.neurobiolaging.2005.08.017; Gregory JA, 2012, ACTA NEUROPATHOL, V124, P561, DOI 10.1007/s00401-012-1012-6; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hennes MMI, 1997, DIABETES, V46, P57, DOI 10.2337/diabetes.46.1.57; HILDEBRAND J, 1968, ARCH NEUROL-CHICAGO, V18, P633, DOI 10.1001/archneur.1968.00470360055005; Hughes RAC, 2004, BRAIN, V127, P1723, DOI 10.1093/brain/awh192; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Ismael MA, 2008, EUR J PHARMACOL, V589, P66, DOI 10.1016/j.ejphar.2008.05.006; Kalichman MW, 1998, ACTA NEUROPATHOL, V95, P47, DOI 10.1007/s004010050764; Kamiya H, 2006, DIABETOLOGIA, V49, P2763, DOI 10.1007/s00125-006-0379-0; Kamiya H, 2005, DIABETES-METAB RES, V21, P448, DOI 10.1002/dmrr.541; Katsumata T, 2010, NEUROL RES, V32, P743, DOI 10.1179/016164109X12608733393755; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Lennertz RC, 2011, J NEUROPHYSIOL, V106, P905, DOI 10.1152/jn.01123.2010; Lin YH, 2012, DIABETES TECHNOL THE, V14, P430, DOI 10.1089/dia.2011.0244; Long AN, 2011, J CLIN HYPERTENS, V13, P244, DOI 10.1111/j.1751-7176.2011.00434.x; Lungu C, 2007, NEUROPEPTIDES, V41, P375, DOI 10.1016/j.npep.2007.09.005; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MENEELY GR, 1961, MED CLIN N AM, V45, P271, DOI 10.1016/S0025-7125(16)33891-3; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Mimran A, 2008, NEPHROL DIAL TRANSPL, V23, P2138, DOI 10.1093/ndt/gfn160; Mizisin AP, 2007, ACTA NEUROPATHOL, V113, P431, DOI 10.1007/s00401-006-0163-8; Mizisin AP, 1998, ACTA NEUROPATHOL, V95, P171, DOI 10.1007/s004010050783; Mizisin AP, 2002, J NEUROPATH EXP NEUR, V61, P872, DOI 10.1093/jnen/61.10.872; Mohseni S, 1998, ACTA NEUROPATHOL, V96, P151, DOI 10.1007/s004010050875; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nowicki M, 2012, J NEUROSCI RES, V90, P122, DOI 10.1002/jnr.22728; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Obrosova IG, 2007, DIABETES, V56, P2598, DOI 10.2337/db06-1176; Oltman CL, 2005, AM J PHYSIOL-ENDOC M, V289, pE113, DOI 10.1152/ajpendo.00594.2004; Papanas N, 2011, NAT REV ENDOCRINOL, V7, P682, DOI 10.1038/nrendo.2011.113; Paton JFR, 2009, NEUROSCI BIOBEHAV R, V33, P89, DOI 10.1016/j.neubiorev.2008.05.020; Peltier A, 2009, MUSCLE NERVE, V39, P529, DOI 10.1002/mus.21210; Perry RC, 1999, DIABETES CARE, V22, P883, DOI 10.2337/diacare.22.6.883; Piercy V, 1999, J DIABETES COMPLICAT, V13, P163, DOI 10.1016/S1056-8727(99)00034-3; Romanovsky D, 2008, NEUROSCI LETT, V445, P220, DOI 10.1016/j.neulet.2008.08.087; Sandoval DA, 2009, NAT REV DRUG DISCOV, V8, P386, DOI 10.1038/nrd2874; Segura B, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-64; SHARMA AK, 1974, J NEUROL SCI, V23, P1, DOI 10.1016/0022-510X(74)90136-1; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; SIMA AAF, 1983, METABOLISM, V32, P136, DOI 10.1016/S0026-0495(83)80027-4; SIMA AAF, 1980, ACTA NEUROPATHOL, V51, P223, DOI 10.1007/BF00687389; Singleton J Rob, 2007, Curr Diab Rep, V7, P420, DOI 10.1007/s11892-007-0070-y; Singleton J Robinson, 2005, Curr Treat Options Neurol, V7, P33, DOI 10.1007/s11940-005-0004-4; Singleton JR, 2006, NAT CLIN PRACT NEURO, V2, P276, DOI 10.1038/ncpneuro0172; Singleton JR, 2001, DIABETES CARE, V24, P1448, DOI 10.2337/diacare.24.8.1448; Singleton JR, 2001, MUSCLE NERVE, V24, P1225, DOI 10.1002/mus.1136; Smith AG, 2008, J NEUROL SCI, V273, P25, DOI 10.1016/j.jns.2008.06.005; Smith AG, 2008, NEUROLOGIST, V14, P23, DOI 10.1097/NRL.0b013e31815a3956; Smith AG, 2012, J PERIPHER NERV SYST, V17, P15, DOI 10.1111/j.1529-8027.2012.00390.x; Sugimoto K, 2008, DIABETES-METAB RES, V24, P642, DOI 10.1002/dmrr.903; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; Szilvassy Z, 2012, METABOLISM, V61, P776, DOI 10.1016/j.metabol.2011.10.010; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Tracy JA, 2008, PHYS MED REH CLIN N, V19, P1, DOI 10.1016/j.pmr.2007.10.010; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Uzu T, 2012, AM J HYPERTENS, V25, P1170, DOI 10.1038/ajh.2012.102; Vincent AM, 2009, DIABETES, V58, P2376, DOI 10.2337/db09-0047; Vinik Aaron I, 2012, Front Endocrinol (Lausanne), V3, P71, DOI 10.3389/fendo.2012.00071; Walker D, 2001, J PERIPHER NERV SYST, V6, P219, DOI 10.1046/j.1529-8027.2001.01023.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Watcho P, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/268547; YAGIHASHI S, 1990, AM J PATHOL, V136, P1365; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796; Zilliox L, 2011, NEUROLOGY, V76, P1099, DOI 10.1212/WNL.0b013e3182120147	97	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57427	10.1371/journal.pone.0057427	http://dx.doi.org/10.1371/journal.pone.0057427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451227	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500103
J	Jack, APM; Bussemer, S; Hahn, M; Punzeler, S; Snyder, M; Wells, M; Csankovszki, G; Solovei, I; Schotta, G; Hake, SB				Jack, Antonia P. M.; Bussemer, Silva; Hahn, Matthias; Puenzeler, Sebastian; Snyder, Martha; Wells, Michael; Csankovszki, Gyorgyi; Solovei, Irina; Schotta, Gunnar; Hake, Sandra B.			H3K56me3 Is a Novel, Conserved Heterochromatic Mark That Largely but Not Completely Overlaps with H3K9me3 in Both Regulation and Localization	PLOS ONE			English	Article							H3 LYSINE-56 ACETYLATION; DNA-DAMAGE RESPONSE; HISTONE H3; CAENORHABDITIS-ELEGANS; GENOME INTEGRITY; X-CHROMOSOMES; HUMAN-CELLS; CHROMATIN; METHYLTRANSFERASES; TRIMETHYLATION	Histone lysine (K) methylation has been shown to play a fundamental role in modulating chromatin architecture and regulation of gene expression. Here we report on the identification of histone H3K56, located at the pivotal, nucleosome DNA entry/exit point, as a novel methylation site that is evolutionary conserved. We identify trimethylation of H3K56 (H3K56me3) as a modification that is present during all cell cycle phases, with the exception of S-phase, where it is underrepresented on chromatin. H3K56me3 is a novel heterochromatin mark, since it is enriched at pericentromeres but not telomeres and is thereby similar, but not identical, to the localization of H3K9me3 and H4K20me3. Possibly due to H3 sequence similarities, Suv39h enzymes, responsible for trimethylation of H3K9, also affect methylation of H3K56. Similarly, we demonstrate that trimethylation of H3K56 is removed by members of the JMJD2 family of demethylases that also target H3K9me3. Furthermore, we identify and characterize mouse mJmjd2E and its human homolog hKDM4L as novel, functionally active enzymes that catalyze the removal of two methyl groups from trimethylated H3K9 and K56. H3K56me3 is also found in C. elegans, where it co-localizes with H3K9me3 in most, but not all, tissues. Taken together, our findings raise interesting questions regarding how methylation of H3K9 and H3K56 is regulated in different organisms and their functional roles in heterochromatin formation and/or maintenance.	[Jack, Antonia P. M.; Bussemer, Silva; Hahn, Matthias; Puenzeler, Sebastian; Schotta, Gunnar; Hake, Sandra B.] Univ Munich, Dept Mol Biol, Adolf Butenandt Inst, CIPSM, Munich, Germany; [Snyder, Martha; Wells, Michael; Csankovszki, Gyorgyi] Univ Michigan, Dept MCDB, Ann Arbor, MI 48109 USA; [Solovei, Irina] Univ Munich, Dept Biol 2, LMU Biozentrum, Planegg Martinsried, Germany	University of Munich; University of Michigan System; University of Michigan; University of Munich	Hake, SB (corresponding author), Univ Munich, Dept Mol Biol, Adolf Butenandt Inst, CIPSM, Munich, Germany.	sandra.hake@med.uni-muenchen.de	Wells, Michael/GOP-0974-2022; Solovei, Irina/K-1191-2014	Wells, Michael/0000-0002-4278-1824; Schotta, Gunnar/0000-0003-4940-6135; Csankovszki, Gyorgyi/0000-0001-5918-034X; Solovei, Irina/0000-0002-6813-7279	DFG [HA 5437/3-1, SO1054/1, SFB TR5]; CIPSM; National Institutes of Health (NIH) [R01 GM079533]; BioImaging Network Munich; BMBF (EpiSys);  [SPP1356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079533] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); CIPSM; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioImaging Network Munich; BMBF (EpiSys)(Federal Ministry of Education & Research (BMBF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the DFG (HA 5437/3-1 and SFB TR5), as well as CIPSM to S.B.H. and from the National Institutes of Health (NIH) R01 GM079533 to G.C. I.S. was supported by DFG (SO1054/1) and BioImaging Network Munich and G.S. by SFB TR5, SPP1356 and BMBF (EpiSys). A.P.M.J. and S.P. are members of the IMPRS/LS program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010851; Bessler JB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000830; Bonisch C, 2012, NUCL ACIDS RES; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chadwick BP, 2007, CHROMOSOMA, V116, P147, DOI 10.1007/s00412-006-0085-1; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Gu BN, 2012, CELL CYCLE, V11, P79, DOI 10.4161/cc.11.1.18402; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guoping S, 2010, CHROMOSOMA, V119, P73, DOI 10.1007/s00412-009-0235-3; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Hou HF, 2010, CURR OPIN STRUC BIOL, V20, P739, DOI 10.1016/j.sbi.2010.09.006; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tian XQ, 2007, ACTA BIOCH BIOPH SIN, V39, P81, DOI 10.1111/j.1745-7270.2007.00272.x; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Trievel RC, 2004, CRIT REV EUKAR GENE, V14, P147, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.10; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Wells MB, 2012, MOL CELL BIOL, V32, P1710, DOI 10.1128/MCB.06546-11; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wiedemann SM, 2010, J CELL BIOL, V190, P777, DOI 10.1083/jcb.201002043; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yu Y, 2012, MOL CELL; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620	53	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e51765	10.1371/journal.pone.0051765	http://dx.doi.org/10.1371/journal.pone.0051765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451023	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800001
J	Taher, C; de Boniface, J; Mohammad, AA; Religa, P; Hartman, J; Yaiw, KC; Frisell, J; Rahbar, A; Soderberg-Naucler, C				Taher, Chato; de Boniface, Jana; Mohammad, Abdul-Aleem; Religa, Piotr; Hartman, Johan; Yaiw, Koon-Chu; Frisell, Jan; Rahbar, Afsar; Soderberg-Naucler, Cecilia			High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; IE2 PROTEINS; IE86 PROTEIN; INFECTION; TRANSFORMATION; LOCALIZATION; INHIBITION; ACTIVATION; CARCINOMA; KINASE	Background: Breast cancer is a leading cause of death among women worldwide. Increasing evidence implies that human cytomegalovirus (HCMV) infection is associated with several malignancies. We aimed to examine whether HCMV is present in breast cancer and sentinel lymph node (SLN) metastases. Materials and Methods: Formalin-fixed paraffin-embedded tissue specimens from breast cancer and paired sentinel lymph node (SLN) samples were obtained from patients with (n = 35) and without SLN metastasis (n = 38). HCMV immediate early (IE) and late (LA) proteins were detected using a sensitive immunohistochemistry (IHC) technique and HCMV DNA by real-time PCR. Results: HCMV IE and LA proteins were abundantly expressed in 100% of breast cancer specimens. In SLN specimens, 94% of samples with metastases (n = 34) were positive for HCMV IE and LA proteins, mostly confined to neoplastic cells while some inflammatory cells were HCMV positive in 60% of lymph nodes without metastases (n = 35). The presence of HCMV DNA was confirmed in 12/12 (100%) of breast cancer and 10/11 (91%) SLN specimens from the metastatic group, but was not detected in 5/5 HCMV-negative, SLN-negative specimens. There was no statistically significant association between HCMV infection grades and progesterone receptor, estrogen receptor alpha and Elston grade status. Conclusions: The role of HCMV in the pathogenesis of breast cancer is unclear. As HCMV proteins were mainly confined to neoplastic cells in primary breast cancer and SLN samples, our observations raise the question whether HCMV contributes to the tumorigenesis of breast cancer and its metastases.	[Taher, Chato; Mohammad, Abdul-Aleem; Religa, Piotr; Yaiw, Koon-Chu; Rahbar, Afsar; Soderberg-Naucler, Cecilia] Karolinska Univ Hosp, Dept Med, Stockholm, Sweden; [de Boniface, Jana; Frisell, Jan] Karolinska Univ Hosp, Dept Breast & Endocrine Surg, Stockholm, Sweden; [Hartman, Johan] Karolinska Univ Hosp, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Soderberg-Naucler, C (corresponding author), Karolinska Univ Hosp, Dept Med, Stockholm, Sweden.	Cecilia.Naucler@ki.se	de Boniface, Jana/ABH-4020-2020; Yaiw, Koon-Chu/AAJ-9682-2020; Hartman, Johan/N-1406-2015	de Boniface, Jana/0000-0001-9518-0902; Yaiw, Koon-Chu/0000-0001-5329-1815; Hartman, Johan/0000-0002-6500-8527; Rahbar, Afsar/0000-0003-1158-2512; Religa, Piotr/0000-0002-3884-2954	RATOS; Ragnar Soderbergs Research Foundation; Swedish Research Council; Swedish Children Cancer Research Foundation; Swedish Cancer Foundation; Swedish Society for Medical Research (SLS); Percy Falks foundation; The Royal Swedish Academy of Sciences (KVA); Goljes Memory Foundation; Magnus Bergvalls Foundation; Tore Nilsons Foundation; Kurdistan Regional Government/Iraq; Roche	RATOS; Ragnar Soderbergs Research Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children Cancer Research Foundation; Swedish Cancer Foundation; Swedish Society for Medical Research (SLS); Percy Falks foundation; The Royal Swedish Academy of Sciences (KVA); Goljes Memory Foundation; Magnus Bergvalls Foundation; Tore Nilsons Foundation; Kurdistan Regional Government/Iraq; Roche(Roche Holding)	This work was supported by RATOS, the Ragnar Soderbergs Research Foundation, the Swedish Research Council, the Swedish Children Cancer Research Foundation, the Swedish Cancer Foundation, Swedish Society for Medical Research (SLS), Percy Falks foundation, The Royal Swedish Academy of Sciences (KVA), Goljes Memory Foundation, Magnus Bergvalls Foundation, Tore Nilsons Foundation, and CT was supported by a scholarship from Kurdistan Regional Government/Iraq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: CSN has received speakers fees and travel grants from Roche to present the groups data on molecular mechanisms of CMV infection at scientific meeting and at one SAB meeting for Roche and also earlier held an independent investigational grant from Roche to perform a clinical trial on anti-CMV treatment in glioblastoma patients. All this was more than 3 years ago. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Altundag K, 2006, BRIT J CANCER, V94, P338, DOI 10.1038/sj.bjc.6602944; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Andersson Y, 2010, J CLIN ONCOL, V28, P2868, DOI 10.1200/JCO.2009.24.5001; Asanuma H, 1996, MICROBIOL IMMUNOL, V40, P201, DOI 10.1111/j.1348-0421.1996.tb03335.x; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bergkvist L, 2008, ANN SURG, V247, P150, DOI 10.1097/SLA.0b013e318153ff40; BOLDOGH I, 1990, SCIENCE, V247, P561, DOI 10.1126/science.1689075; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; BRITT WJ, 1996, FIELDS VIROLOGY; Cinati J, 2004, TRENDS MOL MED, V10, P19, DOI 10.1016/j.molmed.2003.11.002; Cinatl J, 2004, FEMS MICROBIOL REV, V28, P59, DOI 10.1016/j.femsre.2003.07.005; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cox B, 2010, BRIT J CANCER, V102, P1665, DOI 10.1038/sj.bjc.6605675; DALTON LW, 1994, CANCER, V73, P2765, DOI 10.1002/1097-0142(19940601)73:11<2765::AID-CNCR2820731119>3.0.CO;2-K; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; GEDER L, 1977, CANCER TREAT REP, V61, P139; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Harkins Lualhati E, 2010, Herpesviridae, V1, P8, DOI 10.1186/2042-4280-1-8; Ismail-Khan R, 2010, CANCER CONTROL, V17, P173, DOI 10.1177/107327481001700305; Joshi D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008180; Kalejta RF, 2008, MICROBIOL MOL BIOL R, V72, P249, DOI 10.1128/MMBR.00040-07; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Melana SM, 2010, J VIROL METHODS, V163, P157, DOI 10.1016/j.jviromet.2009.09.015; Melnick M, 2012, EXP MOL PATHOL, V92, P118, DOI 10.1016/j.yexmp.2011.10.011; Michaelis M, 2009, MED MICROBIOL IMMUN, V198, P79, DOI 10.1007/s00430-009-0107-8; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; NELSON JA, 1982, J VIROL, V43, P83, DOI 10.1128/JVI.43.1.83-91.1982; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Powers C, 2008, CURR TOP MICROBIOL, V325, P333; Price RL, 2012, CANCER RES, V72, P5669, DOI 10.1158/0008-5472.CAN-12-2425; Rahbar Afsar, 2012, Herpesviridae, V3, P3, DOI 10.1186/2042-4280-3-3; Richardson A, 1997, MED HYPOTHESES, V48, P491, DOI 10.1016/S0306-9877(97)90118-3; Shen YQ, 1997, P NATL ACAD SCI USA, V94, P3341, DOI 10.1073/pnas.94.7.3341; Sissons JGP, 2002, J INFECTION, V44, P73, DOI 10.1053/jinf.2001.0948; Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x; Song YJ, 2005, J VIROL, V79, P2597, DOI 10.1128/JVI.79.4.2597-2603.2005; Soroceanu L, 2011, VIRUS RES, V157, P193, DOI 10.1016/j.virusres.2010.10.026; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Speir E, 1995, SCAND J INFECT DIS, P78; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Straat K, 2009, JNCI-J NATL CANCER I, V101, P488, DOI 10.1093/jnci/djp031; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsai JH, 2007, J CANCER RES CLIN, V133, P13, DOI 10.1007/s00432-006-0141-5; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	51	95	98	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56795	10.1371/journal.pone.0056795	http://dx.doi.org/10.1371/journal.pone.0056795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451089	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800038
J	Arias-Goeta, C; Mousson, L; Rougeon, F; Failloux, AB				Arias-Goeta, Camilo; Mousson, Laurence; Rougeon, Francois; Failloux, Anna-Bella			Dissemination and Transmission of the E1-226V Variant of Chikungunya Virus in Aedes albopictus Are Controlled at the Midgut Barrier Level	PLOS ONE			English	Article							MOSQUITO; VECTORS; ARBOVIRUSES; INFECTION; EMERGENCE; CULICIDAE; EPIDEMIC; OUTBREAK; PATTERNS; DIPTERA	Emergence of arboviruses could result from their ability to exploit new environments, for example a new host. This ability is facilitated by the high mutation rate occurring during viral genome replication. The last emergence of chikungunya in the Indian Ocean region corroborates this statement since a single viral mutation at the position 226 on the E1 glycoprotein (E1-A226V) was associated with enhanced transmission by the mosquito Aedes albopictus in regions where the major mosquito vector, Aedes aegypti, is absent. We used direct competition assays in vivo to dissect out the mechanisms underlying the selection of E1-226V by Ae. albopictus. When the original variant E1-226A and the newly emerged E1-226V were provided in the same blood-meal at equal titers to both species of mosquitoes, we found that the proportion of both variants was drastically different in the two mosquito species. Following ingestion of the infectious blood-meal, the E1-226V variant was preferentially selected in Ae. albopictus, whereas the E1-226A variant was sometimes favored in Ae. aegypti. Interestingly, when the two variants were introduced into the mosquitoes by intrathoracic inoculations, E1-226V was no longer favored for dissemination and transmission in Ae. albopictus, showing that the midgut barrier plays a key role in E1-226V selection. This study sheds light on the role of the midgut barrier in the selection of novel arbovirus emerging variants. We also bring new insight into how the pre-existing variant E1-226V was selected among other viral variants including E1-226A. Indeed the E1-226V variant present at low levels in natural viral populations could rapidly emerge after being selected in Ae. albopictus at the midgut barrier level.	[Arias-Goeta, Camilo; Mousson, Laurence; Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France; [Arias-Goeta, Camilo] Univ Paris 06, Cellule Pasteur, Paris, France; [Rougeon, Francois] Inst Pasteur, CNRS, URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Failloux, AB (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.	anna-bella.failloux@pasteur.fr			Institut Pasteur (ACIP) [A-10-2009]; European Commission Framework Program Seven Award "InfraVec'' [228421]; French Ministry of Superior Education and Research	Institut Pasteur (ACIP); European Commission Framework Program Seven Award "InfraVec''; French Ministry of Superior Education and Research	This work was funded by the Institut Pasteur (ACIP grant A-10-2009) and the European Commission Framework Program Seven Award "InfraVec'' (no228421). CAG was supported by the French Ministry of Superior Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; JUPP PG, 1990, J AM MOSQUITO CONTR, V6, P415; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; Sang RC, 2008, AM J TROP MED HYG, V78, P77; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Smith DR, 2008, VIROLOGY, V372, P176, DOI 10.1016/j.virol.2007.10.011; Tsetsarkin KA, 2009, THESIS U TEXAS MED B; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168	27	57	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57548	10.1371/journal.pone.0057548	http://dx.doi.org/10.1371/journal.pone.0057548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437397	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000110
J	Biffi, S; Dal Monego, S; Dullin, C; Garrovo, C; Bosnjak, B; Licha, K; Welker, P; Epstein, MM; Alves, F				Biffi, Stefania; Dal Monego, Simeone; Dullin, Christian; Garrovo, Chiara; Bosnjak, Berislav; Licha, Kai; Welker, Pia; Epstein, Michelle M.; Alves, Frauke			Dendritic Polyglycerolsulfate Near Infrared Fluorescent (NIRF) Dye Conjugate for Non-Invasively Monitoring of Inflammation in an Allergic Asthma Mouse Model	PLOS ONE			English	Article							L-SELECTIN; PULMONARY INFLAMMATION; AIRWAY INFLAMMATION; MICE; SULFATES; INHIBITORS; VOLUME	Background: Non-invasive in vivo imaging strategies are of high demand for longitudinal monitoring of inflammation during disease progression. In this study we present an imaging approach using near infrared fluorescence (NIRF) imaging in combination with a polyanionic macromolecular conjugate as a dedicated probe, known to target L- and P-selectin and C3/C5 complement factors. Methodology/Principal Findings: We investigated the suitability of dendritic polyglycerol sulfates (dPGS), conjugated with a hydrophilic version of the indocyanine green label with 6 sulfonate groups (6S-ICG) to monitor sites of inflammation using an experimental mouse model of allergic asthma. Accumulation of the NIRF-conjugated dPGS (dPGS-NIRF) in the inflamed lungs was analyzed in and ex vivo in comparison with the free NIRF dye using optical imaging. Commercially available smart probes activated by matrix metalloproteinase's (MMP) and cathepsins were used as a comparative control. The fluorescence intensity ratio between lung areas of asthmatic and healthy mice was four times higher for the dPGS in comparison to the free dye in vivo at four hrs post intravenous administration. No significant difference in fluorescence intensity between healthy and asthmatic mice was observed 24 hrs post injection for dPGS-NIRF. At this time point ex-vivo scans of asthmatic mice confirmed that the fluorescence within the lungs was reduced to approximately 30% of the intensity observed at 4 hrs post injection. Conclusions/Significance: Compared with smart-probes resulting in a high fluorescence level at 24 hrs post injection optical imaging with dPGS-NIRF conjugates is characterized by fast uptake of the probe at inflammatory sites and represents a novel approach to monitor lung inflammation as demonstrated in mice with allergic asthma.	[Biffi, Stefania; Garrovo, Chiara] Cluster Biomed CBM Scrl, Opt Imaging Lab, Trieste, Italy; [Biffi, Stefania; Garrovo, Chiara] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Dal Monego, Simeone] Cluster Biomed CBM Scrl, Bioinformat, Trieste, Italy; [Dullin, Christian] Univ Med Ctr Gottingen, Dept Diagnost Radiol, Gottingen, Germany; [Bosnjak, Berislav; Epstein, Michelle M.] Med Univ Vienna, Div Immunol Allergy & Infect Dis, Dept Dermatol, Vienna, Austria; [Licha, Kai; Welker, Pia] Mivenion GmbH, Berlin, Germany; [Alves, Frauke] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany	IRCCS Burlo Garofolo; University of Gottingen; Medical University of Vienna; University of Gottingen	Biffi, S (corresponding author), Cluster Biomed CBM Scrl, Opt Imaging Lab, Trieste, Italy.	stefania.biffi@cbm.fvg.it	Biffi, Stefania/C-6652-2015; Bošnjak, Berislav/H-7370-2019	Biffi, Stefania/0000-0003-2257-2053; Bošnjak, Berislav/0000-0003-3374-7488; Dullin, Christian/0000-0003-4297-8077; Garrovo, Chiara/0000-0003-1432-0147; Epstein, Michelle/0000-0002-4755-0224	European Commission through an FP7- IAPP Marie Curie Action [GA 230739]	European Commission through an FP7- IAPP Marie Curie Action	The funders (European Commission through an FP7- IAPP Marie Curie Action - (GA 230739)) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis C, 2011, BLOOD, V118, P4231, DOI 10.1182/blood-2011-01-333617; Banerjee ER, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-19; Biffi S, 2008, MOL IMAGING, V7, P272, DOI 10.2310/7290.2008.00028; Clapper ML, 2011, NEOPLASIA, V13, P685, DOI 10.1593/neo.11400; Cortez-Retamozo V, 2008, J CLIN INVEST, V118, P4058, DOI 10.1172/JCI36335; Dernedde J, 2010, P NATL ACAD SCI USA, V107, P19679, DOI 10.1073/pnas.1003103107; Dullin C, 2009, MOL IMAGING, V8, P2, DOI 10.2310/7290.2009.00001; Epstein MM, 2004, INT ARCH ALLERGY IMM, V133, P84, DOI 10.1159/000076131; GOOTZ TD, 1988, ANTIMICROB AGENTS CH, V32, P159, DOI 10.1128/AAC.32.2.159; Hafezi-Moghadam A, 2001, J EXP MED, V193, P863, DOI 10.1084/jem.193.7.863; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Hammer O, 2001, PAST PALEONTOLOGICAL, P22; Hutteman M, 2011, ANN SURG ONCOL, V18, P1006, DOI 10.1245/s10434-010-1426-0; Jannasch K., 2009, DRUG DISCOV TODAY, V6, P129, DOI DOI 10.1016/J.DDMOD.2009.12.003; Keramidaris E, 2001, J ALLERGY CLIN IMMUN, V107, P734, DOI 10.1067/mai.2001.114050; Licha K, 2011, BIOCONJUGATE CHEM, V22, P2453, DOI 10.1021/bc2002727; Ma GB, 2007, APPL OPTICS, V46, P1650, DOI 10.1364/AO.46.001650; Montet X, 2007, RADIOLOGY, V242, P751, DOI 10.1148/radiol.2423052065; Napp J, 2011, PEDIATR RADIOL, V41, P161, DOI 10.1007/s00247-010-1907-0; Ntziachristos Vasilis, 2009, Proc Am Thorac Soc, V6, P416, DOI 10.1513/pats.200901-003AW; Reichert S, 2011, SMALL, V7, P820, DOI 10.1002/smll.201002220; Royce SG, 2010, J ASTHMA ALLERGY, V3, P9; Tang MLK, 2001, PULM PHARMACOL THER, V14, P203, DOI 10.1006/pupt.2001.0293; Turk H, 2004, BIOCONJUGATE CHEM, V15, P162, DOI 10.1021/bc034044j; Ushiki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011114; Weinhart M, 2011, BIOMACROMOLECULES, V12, P2502, DOI 10.1021/bm200250f	26	34	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57150	10.1371/journal.pone.0057150	http://dx.doi.org/10.1371/journal.pone.0057150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437332	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000079
J	Knaepen, L; Rayen, I; Charlier, TD; Fillet, M; Houbart, V; van Kleef, M; Steinbusch, HW; Patijn, J; Tibboel, D; Joosten, EA; Pawluski, JL				Knaepen, Liesbeth; Rayen, Ine; Charlier, Thierry D.; Fillet, Marianne; Houbart, Virginie; van Kleef, Maarten; Steinbusch, Harry W.; Patijn, Jacob; Tibboel, Dick; Joosten, Elbert A.; Pawluski, Jodi L.			Developmental Fluoxetine Exposure Normalizes the Long-Term Effects of Maternal Stress on Post-Operative Pain in Sprague-Dawley Rat Offspring	PLOS ONE			English	Article							DEPRESSION-LIKE BEHAVIOR; PITUITARY-ADRENAL AXIS; MONTHS CORRECTED AGE; GLUCOCORTICOID-RECEPTOR; MEDICATION EXPOSURE; PLACENTAL-TRANSFER; BINDING GLOBULIN; CORTISOL-LEVELS; SPINAL-CORD; ANTIDEPRESSANTS	Early life events can significantly alter the development of the nociceptive circuit. In fact, clinical work has shown that maternal adversity, in the form of depression, and concomitant selective serotonin reuptake inhibitor (SSRI) treatment influence nociception in infants. The combined effects of maternal adversity and SSRI exposure on offspring nociception may be due to their effects on the developing hypothalamic-pituitary-adrenal (HPA) system. Therefore, the present study investigated long-term effects of maternal adversity and/or SSRI medication use on nociception of adult Sprague-Dawley rat offspring, taking into account involvement of the HPA system. Dams were subject to stress during gestation and were treated with fluoxetine (26/5 mg/kg/day) prior to parturition and throughout lactation. Four groups of adult male offspring were used: 1. Control+Vehicle, 2. Control+Fluoxetine, 3. Prenatal Stress+Vehicle, 4. Prenatal Stress+Fluoxetine. Results show that post-operative pain, measured as hypersensitivity to mechanical stimuli after hind paw incision, was decreased in adult offspring subject to prenatal stress alone and increased in offspring developmentally exposed to fluoxetine alone. Moreover, post-operative pain was normalized in prenatally stressed offspring exposed to fluoxetine. This was paralleled by a decrease in corticosteroid binding globulin (CBG) levels in prenatally stressed offspring and a normalization of serum CBG levels in prenatally stressed offspring developmentally exposed to fluoxetine. Thus, developmental fluoxetine exposure normalizes the long-term effects of maternal adversity on post-operative pain in offspring and these effects may be due, in part, to the involvement of the HPA system.	[Knaepen, Liesbeth; van Kleef, Maarten; Patijn, Jacob; Joosten, Elbert A.] Maastricht Univ, Med Ctr, Dept Anesthesiol Pain Management, Univ Pain Ctr Maastricht, Maastricht, Netherlands; [Rayen, Ine; Steinbusch, Harry W.; Pawluski, Jodi L.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Charlier, Thierry D.; Tibboel, Dick; Pawluski, Jodi L.] Univ Liege, GIGA Neurosci, Liege, Belgium; [Fillet, Marianne; Houbart, Virginie] Univ Liege, Dept Pharm, CIRM, Lab Analyt Pharmaceut Chem, Liege, Belgium; Erasmus MC Sophia, Rotterdam, Netherlands; Erasmus MC Sophia, Dept Pediat Surg, Rotterdam, Netherlands	Maastricht University; Maastricht University; University of Liege; University of Liege; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pawluski, JL (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	j.pawluski@ulg.ac.be	Charlier, Thierry/J-4668-2015; Pawluski, Jodi L/K-5801-2015; Steinbusch, Heinrich/L-6950-2017	Pawluski, Jodi L/0000-0002-8240-8178; Fillet, Marianne/0000-0002-1453-6282	Fonds de la Recherche Scientifique-FNRS, Belgium; Pain Knowledge Centers of Maastricht and Rotterdam	Fonds de la Recherche Scientifique-FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); Pain Knowledge Centers of Maastricht and Rotterdam	This research was funded by a Charge de recherche and Apirant grants from Fonds de la Recherche Scientifique-FNRS, Belgium (to JLP and VH) and by the Pain Knowledge Centers of Maastricht and Rotterdam (to LK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2007, NEUROSCI RES, V59, P145, DOI 10.1016/j.neures.2007.06.1465; Andrews MH, 2004, STRESS, V7, P15, DOI 10.1080/10253890310001650277; BARDEN N, 1995, TRENDS NEUROSCI, V18, P6, DOI 10.1016/0166-2236(95)93942-Q; Benedetti M, 2012, EUR J PAIN, V16, P803, DOI 10.1002/j.1532-2149.2011.00066.x; Berguer R, 1998, SURG ENDOSC-ULTRAS, V12, P236, DOI 10.1007/s004649900642; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; Brummelte S, 2011, DEV PSYCHOBIOL, V53, P184, DOI 10.1002/dev.20511; Butkevich I, 2011, PHYSIOL BEHAV, V102, P137, DOI 10.1016/j.physbeh.2010.10.023; Butkevich IP, 2007, EUR J PAIN, V11, P888, DOI 10.1016/j.ejpain.2007.02.001; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; CINTRA A, 1993, BRAIN RES, V632, P334, DOI 10.1016/0006-8993(93)91172-O; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FUXE K, 1985, NEUROSCI LETT, V60, P1, DOI 10.1016/0304-3940(85)90372-6; Goodin BR, 2012, BIOL PSYCHOL; Green MK, 2011, NEUROSCIENCE, V192, P438, DOI 10.1016/j.neuroscience.2011.06.041; Green PG, 2011, PAIN, V152, P2549, DOI 10.1016/j.pain.2011.07.021; Grunau RE, 2010, CLIN J PAIN, V26, P698, DOI 10.1097/AJP.0b013e3181e5bb00; Hamalainen MM, 2009, J PAIN, V10, P637, DOI 10.1016/j.jpain.2009.01.003; HAMMOND GL, 1983, CLIN CHIM ACTA, V132, P101, DOI 10.1016/0009-8981(83)90237-1; Helgeland H, 2010, J PSYCHOSOM RES, V68, P359, DOI 10.1016/j.jpsychores.2009.10.010; Houbart V, 2012, ELECTROPHORESIS, V33, P3370, DOI 10.1002/elps.201200168; Knaepen L, 2013, DEV NEUROBIOL, V73, P85, DOI 10.1002/dneu.22047; Kotani N, 2001, ANESTHESIOLOGY, V95, P349, DOI 10.1097/00000542-200108000-00015; Laplante P, 2002, DEV BRAIN RES, V139, P199, DOI 10.1016/S0165-3806(02)00550-3; Lee LJ, 2009, NEUROTOX RES, V15, P212, DOI 10.1007/s12640-009-9022-4; Leung BMY, 2009, J AM DIET ASSOC, V109, P1566, DOI 10.1016/j.jada.2009.06.368; Lisboa SFS, 2007, PHARMACOLOGY, V80, P49, DOI 10.1159/000103097; McLean SA, 2005, ARTHRITIS RHEUM-US, V52, P3660, DOI 10.1002/art.21372; Moloney RD, 2012, NEUROSCI LETT, V512, P99, DOI 10.1016/j.neulet.2012.01.066; Motamed S, 1998, ANESTHESIOLOGY, V88, P1211, DOI 10.1097/00000542-199805000-00011; O'Connor TG, 2012, DEV PSYCHOBIOL; O'Mahony SM, 2006, NEUROIMMUNOMODULAT, V13, P82, DOI 10.1159/000096090; Oberlander TF, 2005, PEDIATRICS, V115, P411, DOI 10.1542/peds.2004-0420; Oberlander TF, 2002, PEDIATR RES, V51, P443, DOI 10.1203/00006450-200204000-00008; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Panchaud A, 2011, CLIN PHARMACOL THER, V89, P830, DOI 10.1038/clpt.2011.23; Pawluski JL, 2012, NEUROSCIENCE, V220, P131, DOI 10.1016/j.neuroscience.2012.06.034; Pawluski JL, 2012, PSYCHONEUROENDOCRINO, V37, P1019, DOI 10.1016/j.psyneuen.2011.11.011; Pawluski JL, 2012, BEHAV BRAIN RES, V228, P159, DOI 10.1016/j.bbr.2011.11.043; Pawluski JL, 2009, PHYSIOL BEHAV, V96, P108, DOI 10.1016/j.physbeh.2008.09.004; POHLAND RC, 1989, TOXICOL APPL PHARM, V98, P198, DOI 10.1016/0041-008X(89)90225-1; Powers BE, 2006, TOXICOL SCI, V89, P415, DOI 10.1093/toxsci/kfj051; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Smith JW, 2004, PSYCHONEUROENDOCRINO, V29, P227, DOI 10.1016/S0306-4530(03)00025-8; Tsang SW, 2011, EUR J PAIN; Van den Hove DLA, 2005, DEV NEUROSCI-BASEL, V27, P313, DOI 10.1159/000086711; Ververs T, 2006, EUR J CLIN PHARMACOL, V62, P863, DOI 10.1007/s00228-006-0177-0; Wang SX, 2005, J NEUROSCI, V25, P488, DOI 10.1523/JNEUROSCI.4127-04.2005; WARD IL, 1984, ENDOCRINOLOGY, V114, P1635, DOI 10.1210/endo-114-5-1635; Wolff N, 2010, J PEDIATR PSYCHOL, V35, P306, DOI 10.1093/jpepsy/jsp058	55	42	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57608	10.1371/journal.pone.0057608	http://dx.doi.org/10.1371/journal.pone.0057608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437400	gold, Green Published, Green Submitted			2022-12-25	WOS:000315186000113
J	Lee, ST; Wong, PF; He, H; Hooper, JD; Mustafa, MR				Lee, Sui-Ting; Wong, Pooi-Fong; He, Hui; Hooper, John David; Mustafa, Mohd Rais			Alpha-Tomatine Attenuation of In Vivo Growth of Subcutaneous and Orthotopic Xenograft Tumors of Human Prostate Carcinoma PC-3 Cells Is Accompanied by Inactivation of Nuclear Factor-Kappa B Signaling	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; ACTIVATION; INHIBITION; EXPRESSION; INVASION; SURVIVAL; AGENTS; LIVER	Background: Nuclear factor-kappa B (NF-kappa B) plays a role in prostate cancer and agents that suppress its activation may inhibit development or progression of this malignancy. Alpha (alpha)-tomatine is the major saponin present in tomato ( Lycopersicon esculentum) and we have previously reported that it suppresses tumor necrosis factor-alpha (TNF-alpha)-induced nuclear translocation of nuclear factor-kappa B (NF-k beta) in androgen-independent prostate cancer PC-3 cells and also potently induces apoptosis of these cells. However, the precise mechanism by which alpha-tomatine suppresses NF-kappa B nuclear translocation is yet to be elucidated and the anti-tumor activity of this agent in vivo has not been examined. Methodology/Principal Findings: In the present study we show that suppression of NF-kappa B activation by alpha-tomatine occurs through inhibition of I kappa B alpha (I kappa B alpha) kinase activity, leading to sequential suppression of IkBa phosphorylation, I kappa B alpha degradation, NF-kappa B/p65 phosphorylation, and NF-kappa B p50/p65 nuclear translocation. Consistent with its ability to induce apoptosis, alpha-tomatine reduced TNF-alpha induced activation of the pro-survival mediator Akt and its inhibition of NF-kappa B activation was accompanied by significant reduction in the expression of NF-kappa B-dependent anti-apoptotic (c-IAP1, c-IAP2, Bcl-2, Bcl-xL, XIAP and survivin) proteins. We also evaluated the antitumor activity of alpha-tomatine against PC-3 cell tumors grown subcutaneously and orthotopically in mice. Our data indicate that intraperitoneal administration of alpha-tomatine significantly attenuates the growth of PC-3 cell tumors grown at both sites. Analysis of tumor material indicates that the tumor suppressing effects of alpha-tomatine were accompanied by increased apoptosis and lower proliferation of tumor cells as well as reduced nuclear translocation of the p50 and p65 components of NF-kappa B. Conclusion/Significance: Our study provides first evidence for in vivo antitumor efficacy of alpha-tomatine against the human androgen-independent prostate cancer. The potential usefulness of alpha-tomatine in prostate cancer prevention and therapy requires further investigation.	[Lee, Sui-Ting; Wong, Pooi-Fong; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [He, Hui; Hooper, John David] Mater Med Res Inst, Brisbane, Qld, Australia	Universiti Malaya; Mater Research	Mustafa, MR (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	rais@um.edu.my	WONG, POOI-FONG PF/B-5234-2010; Mustafa, Mohamed R/B-1647-2009; Hooper, John/C-1481-2016	WONG, POOI-FONG PF/0000-0002-6705-2521; Mustafa, Mohamed R/0000-0002-7864-5189; Hooper, John/0000-0003-1054-8486	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) [E000002-20001]; University Malaya Research Grant (UMRG) [RG161/09HTM]	Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG); University Malaya Research Grant (UMRG)	This work was funded by Malaysian Ministry of Higher Education (MOHE) High Impact Research Grant (HIRG) E000002-20001 and University Malaya Research Grant (UMRG) RG161/09HTM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal Bharat B., 2004, Indian Journal of Experimental Biology, V42, P341; Akimoto T, 2001, INT J RADIAT ONCOL, V50, P195, DOI 10.1016/S0360-3016(00)01560-1; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bracarda S, 2005, CRIT REV ONCOL HEMAT, V56, P379, DOI 10.1016/j.critrevonc.2005.03.010; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Dagher R, 2004, CLIN CANCER RES, V10, P8147, DOI 10.1158/1078-0432.CCR-04-1402; Das KC, 1997, J BIOL CHEM, V272, P14914, DOI 10.1074/jbc.272.23.14914; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Estrada AC, 2010, MOL PHARMACOL, V77, P378, DOI 10.1124/mol.109.060475; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Friedman M, 2005, J AGR FOOD CHEM, V53, P6162, DOI 10.1021/jf050620p; Friedman M, 2007, MOL NUTR FOOD RES, V51, P1485, DOI 10.1002/mnfr.200700176; Friedman M, 2009, J AGR FOOD CHEM, V57, P5727, DOI 10.1021/jf900364j; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; Gasparian AV, 2002, J CELL SCI, V115, P141; Gill C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-39; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Husain K, 2011, MOL CANCER THER, V10, P2363, DOI 10.1158/1535-7163.MCT-11-0424; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Khan N, 2010, ENDOCR-RELAT CANCER, V17, pR39, DOI 10.1677/ERC-09-0262; Komatsu K, 1997, CANCER LETT, V112, P135, DOI 10.1016/S0304-3835(96)04555-7; Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593; Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319; Lee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018915; Li YW, 2005, CANCER RES, V65, P6934, DOI 10.1158/0008-5472.CAN-04-4604; Luk SU, 2011, INT J CANCER, V128, P2182, DOI 10.1002/ijc.25546; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; Morrow WJW, 2004, VACCINE, V22, P2380, DOI 10.1016/j.vaccine.2004.03.022; Nobili S, 2009, PHARMACOL RES, V59, P365, DOI 10.1016/j.phrs.2009.01.017; Ozes ON, 1999, NATURE, V401, P82; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Plymate SR, 2003, ONCOGENE, V22, P1024, DOI 10.1038/sj.onc.1206210; Sakurai H, 1999, J BIOL CHEM, V274, P10641, DOI 10.1074/jbc.274.15.10641; Sandur SK, 2009, INT J RADIAT ONCOL, V75, P534, DOI 10.1016/j.ijrobp.2009.06.034; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sethi G, 2009, TRENDS PHARMACOL SCI, V30, P313, DOI 10.1016/j.tips.2009.03.004; Shieh JM, 2011, CELL BIOCHEM BIOPHYS, V60, P297, DOI 10.1007/s12013-011-9152-1; Shih YW, 2009, FOOD CHEM TOXICOL, V47, P1985, DOI 10.1016/j.fct.2009.05.011; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Suh JH, 2002, PROSTATE, V52, P183, DOI 10.1002/pros.10082; Sweeney C, 2004, CLIN CANCER RES, V10, P5501, DOI 10.1158/1078-0432.CCR-0571-03; Tamatani M, 1999, J BIOL CHEM, V274, P8531, DOI 10.1074/jbc.274.13.8531; Tang YX, 2011, NEOPLASIA, V13, P108, DOI 10.1593/neo.101092; Uetsuka H, 2003, EXP CELL RES, V289, P27, DOI 10.1016/S0014-4827(03)00223-4; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yemelyanov A, 2006, ONCOGENE, V25, P387, DOI 10.1038/sj.onc.1209066; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zhu L, 2001, FEBS LETT, V508, P369, DOI 10.1016/S0014-5793(01)03084-8; Zoberi I, 2002, CANCER LETT, V175, P165, DOI 10.1016/S0304-3835(01)00719-4	57	126	129	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57708	10.1371/journal.pone.0057708	http://dx.doi.org/10.1371/journal.pone.0057708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437404	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000315186000117
J	Godel, M; Ostendorf, BN; Baumer, J; Weber, K; Huber, TB				Goedel, Markus; Ostendorf, Benjamin N.; Baumer, Jessica; Weber, Katrin; Huber, Tobias B.			A Novel Domain Regulating Degradation of the Glomerular Slit Diaphragm Protein Podocin in Cell Culture Systems	PLOS ONE			English	Article							NEPHROTIC SYNDROME; NEPHRIN; NPHS2; EXPRESSION; MUTATIONS; MICRODOMAINS; ENDOCYTOSIS; PODOCYTES; PLATFORM; PATHWAY	Mutations in the gene NPHS2 are the most common cause of hereditary steroid-resistant nephrotic syndrome. Its gene product, the stomatin family member protein podocin represents a core component of the slit diaphragm, a unique structure that bridges the space between adjacent podocyte foot processes in the kidney glomerulus. Dislocation and misexpression of slit diaphragm components have been described in the pathogenesis of acquired and hereditary nephrotic syndrome. However, little is known about mechanisms regulating cellular trafficking and turnover of podocin. Here, we discover a three amino acids-comprising motif regulating intracellular localization of podocin in cell culture systems. Mutations of this motif led to markedly reduced degradation of podocin. These findings give novel insight into the molecular biology of the slit diaphragm protein podocin, enabling future research to establish the biological relevance of podocin turnover and localization.	[Goedel, Markus; Ostendorf, Benjamin N.; Baumer, Jessica; Weber, Katrin; Huber, Tobias B.] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Huber, TB (corresponding author), Univ Hosp Freiburg, Div Renal, Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de	Ostendorf, Benjamin Nils/AAA-2109-2022	Ostendorf, Benjamin Nils/0000-0003-4492-9252; Huber, Tobias B./0000-0001-7175-5062	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft; Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Gesellschaft fur Nephrologie	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Deutsche Gesellschaft fur Nephrologie	This study was supported by Else Kroner-Fresenius-Stiftung (http://www.ekfs.de/, TBH), Deutsche Forschungsgemeinschaft (http://www.dfg.de/,TBH), the Excellence Initiative of the German Federal and State Governments EXC 294 (http://www.bioss.uni-freiburg.de/, TBH) and Deutsche Gesellschaft fur Nephrologie (http://dgfn.eu/, MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Caridi G, 2010, PEDIATR NEPHROL, V25, P241, DOI 10.1007/s00467-008-1051-3; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hartleben B, 2008, J BIOL CHEM, V283, P23033, DOI 10.1074/jbc.M803143200; Hosoyamada M, 2005, J PHARMACOL SCI, V97, P234, DOI 10.1254/jphs.FP0040802; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kawachi H, 2003, J AM SOC NEPHROL, V14, P46, DOI 10.1097/01.ASN.0000037401.02391.76; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; McCarthy HJ, 2011, NEPHRON EXP NEPHROL, V118, pE1, DOI 10.1159/000320878; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Nickel C, 2002, J CLIN INVEST, V109, P481, DOI 10.1172/JC1200212867; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Quack I, 2011, J BIOL CHEM, V286, P12959, DOI 10.1074/jbc.M110.204024; Relle M, 2011, MODERN PATHOL, V24, P1101, DOI 10.1038/modpathol.2011.58; Roselli S, 2004, TRAFFIC, V5, P37, DOI 10.1046/j.1600-0854.2003.00148.x; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Tossidou I, 2010, J BIOL CHEM, V285, P25285, DOI 10.1074/jbc.M109.087239; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Waters AM, 2012, J AM SOC NEPHROL, V23, P27, DOI 10.1681/ASN.2011010027	36	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57078	10.1371/journal.pone.0057078	http://dx.doi.org/10.1371/journal.pone.0057078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437316	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200212
J	Leach, G; Adidharma, W; Yan, L				Leach, Greg; Adidharma, Widya; Yan, Lily			Depression-Like Responses Induced by Daytime Light Deficiency in the Diurnal Grass Rat (Arvicanthis niloticus)	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; SEASONAL AFFECTIVE-DISORDER; ANXIETY-LIKE BEHAVIORS; FAT SAND RAT; BRIGHT LIGHT; TRYPTOPHAN DEPLETION; RETINAL PROJECTION; SHORT DAYLIGHT; MODEL; MOOD	Seasonal Affective Disorder (SAD) is one of the most common mood disorders with depressive symptoms recurring in winter when there is less sunlight. The fact that light is the most salient factor entraining circadian rhythms leads to the phase-shifting hypothesis, which suggests that the depressive episodes of SAD are caused by misalignments between the circadian rhythms and the habitual sleep times. However, how changes in environmental lighting conditions lead to the fluctuations in mood is largely unknown. The objective of this study is to develop an animal model for some of the features/symptoms of SAD using the diurnal grass rats Arvichantis niloticus and to explore the neural mechanisms underlying the light associated mood changes. Animals were housed in either a 12:12 hr bright light:dark (1000lux, BLD) or dim light: dark (50lux, DLD) condition. The depression-like behaviors were assessed by sweet-taste Saccharin solution preference (SSP) and forced swimming test (FST). Animals in the DLD group showed higher levels of depression-like behaviors compared to those in BLD. The anxiety-like behaviors were assessed in open field and light/dark box test, however no significant differences were observed between the two groups. The involvement of the circadian system on depression-like behaviors was investigated as well. Analysis of locomotor activity revealed no major differences in daily rhythms that could possibly contribute to the depression-like behaviors. To explore the neural substrates associated with the depression-like behaviors, the brain tissues from these animals were analyzed using immunocytochemistry. Attenuated indices of 5-HT signaling were observed in DLD compared to the BLD group. The results lay the groundwork for establishing a novel animal model and a novel experimental paradigm for SAD. The results also provide insights into the neural mechanisms underlying light-dependent mood changes.	[Leach, Greg; Adidharma, Widya; Yan, Lily] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Yan, Lily] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Yan, L (corresponding author), Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA.	yanl@msu.edu	Yan, Lily/AAU-2005-2021	Yan, Lily/0000-0002-6261-2542	National Institute of Mental Health [R03MH093760]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH093760] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by grant number R03MH093760 from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; Adidharma W, 2012, NEUROSCIENCE, V220, P201, DOI 10.1016/j.neuroscience.2012.06.020; Ashkenazy T, 2009, BEHAV BRAIN RES, V201, P343, DOI 10.1016/j.bbr.2009.03.005; Ashkenazy T, 2009, INT J NEUROPSYCHOPH, V12, P83, DOI 10.1017/S1461145708009115; Ashkenazy-Frolinger T, 2010, J NEUROSCI METH, V186, P165, DOI 10.1016/j.jneumeth.2009.11.013; Bennett MR, 2011, PROG NEUROBIOL, V93, P468, DOI 10.1016/j.pneurobio.2011.01.006; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Einat H, 2006, BEHAV BRAIN RES, V173, P153, DOI 10.1016/j.bbr.2006.06.006; Fite KV, 1999, J COMP NEUROL, V414, P469, DOI 10.1002/(SICI)1096-9861(19991129)414:4<469::AID-CNE4>3.0.CO;2-P; Fite KV, 2001, BRAIN RES, V895, P139, DOI 10.1016/S0006-8993(01)02061-3; Flaisher-Grinberg S, 2011, BEHAV PHARMACOL, V22, P23, DOI 10.1097/FBP.0b013e3283425012; Fonken LK, 2012, J BIOL RHYTHM, V27, P319, DOI 10.1177/0748730412448324; Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004; Hale MW, 2011, PSYCHOPHARMACOLOGY, V213, P243, DOI 10.1007/s00213-010-2089-z; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hebert M, 1998, CHRONOBIOL INT, V15, P59; Janusonis S, 2001, J COMP NEUROL, V440, P31, DOI 10.1002/cne.1368; Kawano H, 1996, NEUROSCI LETT, V212, P143, DOI 10.1016/0304-3940(96)12795-6; Krivisky K, 2012, J NEURAL TRANSM, V119, P1241, DOI 10.1007/s00702-012-0783-1; Krivisky K, 2011, NEUROPSYCHOBIOLOGY, V63, P191, DOI 10.1159/000321805; Kronfeld-Schor N, 2012, NEUROPHARMACOLOGY, V62, P101, DOI 10.1016/j.neuropharm.2011.08.020; Lam RW, 1996, ARCH GEN PSYCHIAT, V53, P41; Lam RW, 2006, AM J PSYCHIAT, V163, P805, DOI 10.1176/appi.ajp.163.5.805; Leach G, 2013, NEUROSCIENCE; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Levitan Robert D, 2007, Dialogues Clin Neurosci, V9, P315; Lewy Alfred J, 2007, Dialogues Clin Neurosci, V9, P291; Lewy AJ, 2009, CURR PSYCHIAT REP, V11, P459, DOI 10.1007/s11920-009-0070-5; Michelsen KA, 2007, BRAIN RES REV, V55, P329, DOI 10.1016/j.brainresrev.2007.01.002; Neumeister A, 1997, ARCH GEN PSYCHIAT, V54, P133; Neumeister A, 2001, INT J NEUROPSYCHOPH, V4, P409, DOI 10.1017/S1461145701002644; Nixon JP, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-28; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Peyron C, 1998, J NEUROSCI, V18, P9996; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prendergast BJ, 2005, PSYCHONEUROENDOCRINO, V30, P438, DOI 10.1016/j.psyneuen.2004.08.008; Puig MV, 2011, MOL NEUROBIOL, V44, P449, DOI 10.1007/s12035-011-8214-0; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Ruhrmann S, 1998, PSYCHOL MED, V28, P923, DOI 10.1017/S0033291798006813; SHEN H, 1994, BRAIN RES, V635, P159, DOI 10.1016/0006-8993(94)91435-4; Smale L, 2003, J BIOL RHYTHM, V18, P356, DOI 10.1177/0748730403256651; Stephenson KM, 2012, SLEEP MED REV, V16, P445, DOI 10.1016/j.smrv.2011.09.002; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; Turner PL, 2010, SLEEP MED REV, V14, P269, DOI 10.1016/j.smrv.2009.11.002; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WIRZJUSTICE A, 1992, INT CLIN PSYCHOPHARM, V7, P109, DOI 10.1097/00004850-199211000-00008; Workman JL, 2011, NEUROSCI BIOBEHAV R, V35, P669, DOI 10.1016/j.neubiorev.2010.08.005; Yan L, 2011, NEUROSCIENCE, V183, P99, DOI 10.1016/j.neuroscience.2011.03.041; Yan L, 2010, J BIOL RHYTHM, V25, P19, DOI 10.1177/0748730409352054	50	55	59	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57115	10.1371/journal.pone.0057115	http://dx.doi.org/10.1371/journal.pone.0057115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437327	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200220
J	Milstein, JA; Elnabawi, A; Vinish, M; Swanson, T; Enos, JK; Bailey, AM; Kolb, B; Frost, DO				Milstein, Jean A.; Elnabawi, Ahmed; Vinish, Monika; Swanson, Thomas; Enos, Jennifer K.; Bailey, Aileen M.; Kolb, Bryan; Frost, Douglas O.			Olanzapine Treatment of Adolescent Rats Causes Enduring Specific Memory Impairments and Alters Cortical Development and Function	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; AMPHETAMINE-INDUCED CHANGES; PRENATAL COCAINE EXPOSURE; DOPAMINE-RECEPTORS; ATYPICAL ANTIPSYCHOTICS; BASOLATERAL AMYGDALA; PROJECTION NEURONS; NUCLEUS-ACCUMBENS; PYRAMIDAL NEURONS	Antipsychotic drugs are increasingly used in children and adolescents to treat a variety of psychiatric disorders. However, little is known about the long-term effects of early life antipsychotic drug treatment. Most antipsychotic drugs are potent antagonists or partial agonists of dopamine D2 receptors; atypical antipsychotic drugs also antagonize type 2A serotonin receptors. Dopamine and serotonin regulate many neurodevelopmental processes. Thus, early life antipsychotic drug treatment can, potentially, perturb these processes, causing long- term behavioral- and neurobiological impairments. Here, we treated adolescent, male rats with olanzapine on post-natal days 28-49. As adults, they exhibited impaired working memory, but normal spatial memory, as compared to vehicle-treated control rats. They also showed a deficit in extinction of fear conditioning. Measures of motor activity and skill, habituation to an open field, and affect were normal. In the orbital- and medial prefrontal cortices, parietal cortex, nucleus accumbens core and dentate gyrus, adolescent olanzapine treatment altered the developmental dynamics and mature values of dendritic spine density in a region-specific manner. Measures of motor activity and skill, habituation to an open field, and affect were normal. In the orbital- and medial prefrontal cortices, D1 binding was reduced and binding of GABA(A) receptors with open Cl- channels was increased. In medial prefrontal cortex, D2 binding was also increased. The persistence of these changes underscores the importance of improved understanding of the enduring sequelae of pediatric APD treatment as a basis for weighing the benefits and risks of adolescent antipsychotic drug therapy, especially prophylactic treatment in high risk, asymptomatic patients. The long- term changes in neurotransmitter receptor binding and neural circuitry induced by adolescent APD treatment may also cause enduring changes in behavioral- and neurobiological responses to other therapeutic- or illicit psychotropic drugs.	[Milstein, Jean A.; Vinish, Monika; Swanson, Thomas; Enos, Jennifer K.; Frost, Douglas O.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Elnabawi, Ahmed] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Bailey, Aileen M.] St Marys Coll Maryland, Dept Psychol, St Marys, MD USA; [Kolb, Bryan] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Frost, Douglas O.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Frost, Douglas O.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Lethbridge; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Frost, DO (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.	dfrost@umaryland.edu	Burne, Thomas/C-5656-2009	Burne, Thomas/0000-0003-3502-9789	NIMH grant [MH07083]; CIHR grant; Eli Lilly Co.; NINDS training grant [T32 NS007375]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER	NIMH grant; CIHR grant(Canadian Institutes of Health Research (CIHR)); Eli Lilly Co.(Eli Lilly); NINDS training grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by: NIMH grant MH07083 to DOF (http://www.nih.gov/); a CIHR grant to BK (http://www.cihr-irsc.gc.ca); olanzapine from Eli Lilly & Co. and NIMH. JM was partially supported by NINDS training grant T32 NS007375 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 2011, PHARMACOEPIDEM DR S, V20, P177, DOI 10.1002/pds.2082; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Andersen SL, 2004, NEUROPSYCHOPHARMACOL, V29, P1988, DOI 10.1038/sj.npp.1300528; Andersen SL, 2008, EUR J NEUROSCI, V27, P2962, DOI 10.1111/j.1460-9568.2008.06254.x; Arnsten AFT, 2011, BIOL PSYCHIAT, V69, pE89, DOI 10.1016/j.biopsych.2011.01.027; Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P485; BARON JC, 1989, PSYCHOPHARMACOLOGY, V99, P463, DOI 10.1007/BF00589893; BARTOLINI L, 1992, PHARMACOL BIOCHEM BE, V43, P1161, DOI 10.1016/0091-3057(92)90497-4; Beduin AS, 2010, PSYCHOPHARMACOL BULL, V43, P45; Benes FM, 2000, CEREB CORTEX, V10, P1014, DOI 10.1093/cercor/10.10.1014; Bourgeois JP, 1996, EUR J NEUROSCI, V8, P942, DOI 10.1111/j.1460-9568.1996.tb01581.x; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Brenhouse HC, 2010, NEUROSCIENCE, V169, P628, DOI 10.1016/j.neuroscience.2010.05.063; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; Chen LG, 2011, TOXICOL APPL PHARM, V250, P221, DOI 10.1016/j.taap.2010.11.010; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; Cheng-Shannon J, 2004, J CHILD ADOL PSYCHOP, V14, P372, DOI 10.1089/1044546042389037; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; El-Nabawi A, 2000, TOXICOL APPL PHARM, V169, P84, DOI 10.1006/taap.2000.9042; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; FOOTE SL, 1987, CURR TOP DEV BIOL, V21, P391; Frankfurt M, 2009, DEV NEUROSCI-BASEL, V31, P71, DOI 10.1159/000207495; Frost DO, 2000, BRAIN RES REV, V34, P103, DOI 10.1016/S0165-0173(00)00042-4; Frost DO, 2010, SYNAPSE, V64, P191, DOI 10.1002/syn.20715; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Giedd JN, 2009, J AM ACAD CHILD PSY, V48, P465, DOI 10.1097/CHI.0b013e31819f2715; Ginovart N, 2009, NEUROPSYCHOPHARMACOL, V34, P662, DOI 10.1038/npp.2008.116; Halliwell C, 2009, DEV NEUROREHABIL, V12, P269, DOI 10.3109/17518420903087715; Hartley CA, 2010, NEUROPSYCHOPHARMACOL, V35, P136, DOI 10.1038/npp.2009.121; Heijtz RD, 2003, EUR J NEUROSCI, V18, P3394, DOI 10.1046/j.1460-9568.2003.03067.x; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; Jones LB, 2000, J NEUROSCI, V20, P4606, DOI 10.1523/JNEUROSCI.20-12-04606.2000; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; KASPER EM, 1994, J COMP NEUROL, V339, P495, DOI 10.1002/cne.903390404; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; KOESTER SE, 1992, J NEUROSCI, V12, P1382; KOLB B, 1994, CEREB CORTEX, V4, P664, DOI 10.1093/cercor/4.6.664; KOLB B, 1981, J COMP PHYSIOL PSYCH, V95, P863, DOI 10.1037/h0077849; Kolb B, 2008, ABSTRACT VIEWER ITIN; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; LEYSEN JE, 1988, J PHARMACOL EXP THER, V247, P661; Li YL, 2003, NEUROPSYCHOPHARMACOL, V28, P1082, DOI 10.1038/sj.npp.1300115; Llorente-Berzal A., 2011, NEUROPHARMACOLOGY; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McCracken JT, 2008, J CHILD ADOL PSYCHOP, V18, P501, DOI 10.1089/cap.2007.135; McKnight RF, 2010, EUR EAT DISORD REV, V18, P10, DOI 10.1002/erv.988; Meyer U, 2010, SCHIZOPHRENIA BULL, V36, P607, DOI 10.1093/schbul/sbn131; Moran-Gates T, 2006, SYNAPSE, V59, P92, DOI 10.1002/syn.20220; Moran-Gates T, 2007, EUR NEUROPSYCHOPHARM, V17, P448, DOI 10.1016/j.euroneuro.2006.10.004; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; MORGAN MA, 1995, BEHAV NEUROSCI, V109, P681, DOI 10.1037/0735-7044.109.4.681; Morrow BA, 2005, SYNAPSE, V56, P1, DOI 10.1002/syn.20121; Morrow BA, 2007, SYNAPSE, V61, P862, DOI 10.1002/syn.20430; Muhammad A, 2012, SYNAPSE, V66, P950, DOI 10.1002/syn.21589; Mukda S, 2009, DEV NEUROSCI-BASEL, V31, P193, DOI 10.1159/000193395; Mychasiuk R, 2012, BRAIN RES IN PRESS; Nader K, 1999, BEHAV NEUROSCI, V113, P152, DOI 10.1037/0735-7044.113.1.152; Oberlander TF, 2009, CLIN PHARMACOL THER, V86, P672, DOI 10.1038/clpt.2009.201; Pappadopulos E, 2003, J AM ACAD CHILD PSY, V42, P145, DOI 10.1097/00004583-200302000-00008; Pappadopulos E, 2011, J CHILD ADOL PSYCHOP, V21, P505, DOI 10.1089/cap.2010.0128; Perez-Costas E, 2008, J NEURAL TRANSM, V115, P745, DOI 10.1007/s00702-007-0004-5; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Piontkewitz Y, 2011, SCHIZOPHRENIA BULL, V37, P1257, DOI 10.1093/schbul/sbq040; Piontkewitz Y, 2012, NEUROPHARMACOLOGY, V62, P1273, DOI 10.1016/j.neuropharm.2011.04.019; Piontkewitz Y, 2009, BIOL PSYCHIAT, V66, P1038, DOI 10.1016/j.biopsych.2009.07.005; PRIBRAM KH, 1961, EXP NEUROL, V3, P432, DOI 10.1016/0014-4886(61)90021-8; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Redmond L, 2008, NEUROSIGNALS, V16, P194, DOI 10.1159/000111563; Remington G, 2010, SCHIZOPHRENIA BULL, V36, P900, DOI 10.1093/schbul/sbq083; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Robinson TE, 1997, J NEUROSCI, V17, P8491; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001; Samaha AN, 2007, J NEUROSCI, V27, P2979, DOI 10.1523/JNEUROSCI.5416-06.2007; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sikich L, 2008, J CLIN PSYCHIAT, V69, P21; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Simpson KL, 2011, P NATL ACAD SCI USA, V108, P18465, DOI 10.1073/pnas.1109353108; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Stanwood GD, 2005, J COMP NEUROL, V487, P270, DOI 10.1002/cne.20548; Stanwood GD, 2001, CEREB CORTEX, V11, P430, DOI 10.1093/cercor/11.5.430; Stanwood GD, 2001, NEUROSCIENCE, V106, P5, DOI 10.1016/S0306-4522(01)00256-1; Strawn JR, 2008, EXPERT OPIN PHARMACO, V9, P467, DOI [10.1517/14656566.9.3.467, 10.1517/14656566.9.3.467 ]; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; Suzuki M, 2001, SYNAPSE, V41, P285, DOI 10.1002/syn.1085; Tarazi FI, 2001, J PHARMACOL EXP THER, V297, P711; Terry AV, 2008, NEUROSCIENCE, V156, P1005, DOI 10.1016/j.neuroscience.2008.08.030; Thomas T, 2011, PEDIATR CLIN N AM, V58, pxii; Thomas T, 2011, PEDIATR CLIN N AM, V58, P173, DOI 10.1016/j.pcl.2010.10.001; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Tseng KY, 2005, CEREB CORTEX, V15, P49, DOI 10.1093/cercor/bhh107; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vasconcelos SMM, 2003, BEHAV PROCESS, V63, P45, DOI 10.1016/S0376-6357(03)00028-7; Vinish M, 2012, INT J NEURO IN PRESS; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Weller EB, 2009, CURR PSYCHIAT REP, V11, P95, DOI 10.1007/s11920-009-0015-z; WHISHAW IQ, 1990, BEHAV BRAIN RES, V41, P49, DOI 10.1016/0166-4328(90)90053-H; WHISHAW IQ, 1991, BEHAV BRAIN RES, V42, P77, DOI 10.1016/S0166-4328(05)80042-7; Yadav PN, 2011, NEUROPSYCHOPHARMACOL, V36, P638, DOI 10.1038/npp.2010.195; Zilles K., 1985, CORTEX RAT STEREOTAX; Zuddas A, 2011, EUR NEUROPSYCHOPHARM	115	40	40	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57308	10.1371/journal.pone.0057308	http://dx.doi.org/10.1371/journal.pone.0057308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437365	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200240
J	Min, Y; Jin, XG; Ge, Y; Chang, J				Min, Yong; Jin, Xiaogang; Ge, Ying; Chang, Jie			The Role of Community Mixing Styles in Shaping Epidemic Behaviors in Weighted Networks	PLOS ONE			English	Article							TRANSPORTATION NETWORK; COMPLEX NETWORKS; DYNAMICS; DISEASE	The dynamics of infectious diseases that are spread through direct contact have been proven to depend on the strength of community structure or modularity within the underlying network. It has been recently shown that weighted networks with similar modularity values may exhibit different mixing styles regarding the number of connections among communities and their respective weights. However, the effect of mixing style on epidemic behavior was still unclear. In this paper, we simulate the spread of disease within networks with different mixing styles: a dense-weak style (i.e., many edges among the communities with small weights) and a sparse-strong style (i.e., a few edges among the communities with large weights). Simulation results show that, with the same modularity: 1) the mixing style significantly influences the epidemic size, speed, pattern and immunization strategy; 2) the increase of the number of communities amplifies the effect of the mixing style; 3) when the mixing style changes from sparse-strong to dense-weak, there is a 'saturation point', after which the epidemic size and pattern become stable. We also provide a mean-field solution of the epidemic threshold and size on weighted community networks with arbitrary external and internal degree distribution. The solution explains the effect of the second moment of the degree distribution, and a symmetric effect of internal and external connections (incl. degree distribution and weight). Our study has both potential significance for designing more accurate metrics for the community structure and exploring diffusion dynamics on metapopulation networks.	[Min, Yong] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Min, Yong; Ge, Ying; Chang, Jie] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Xiaogang] Zhejiang Univ, Coll Comp Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University; Zhejiang University	Chang, J (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	jchang@zju.edu.cn			China Postdoctoral Science Foundation [2012M510202]; National Science Foundation of China [30970281, 31170305, 60873033]; Natural Science Foundation of Zhejiang Province, China [R1090569, LZ12F02003, LY12F02018]; State Key Laboratory of Software Development Environment Open Fund [SKLSDE-2012KF-05]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); State Key Laboratory of Software Development Environment Open Fund	Funding provided by China Postdoctoral Science Foundation (2012M510202), National Science Foundation of China (30970281, 31170305, and 60873033), and Natural Science Foundation of Zhejiang Province, China (R1090569, LZ12F02003, and LY12F02018), and the State Key Laboratory of Software Development Environment Open Fund (SKLSDE-2012KF-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Chen JC, 2012, PHYSICA A, V391, P1848, DOI 10.1016/j.physa.2011.10.011; Chu X, 2009, J STAT MECH-THEORY E, V7; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kiss IZ, 2008, J R SOC INTERFACE, V5, P791, DOI 10.1098/rsif.2007.1272; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Liu ZH, 2005, EUROPHYS LETT, V72, P315, DOI 10.1209/epl/i2004-10550-5; Masuda N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093009; May R., 2007, THEORETICAL ECOLOGY, V3rd; Min Y, 2011, ARXIV11101724; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-11; Vazquez A, 2007, J THEOR BIOL, V245, P125, DOI 10.1016/j.jtbi.2006.09.018; Vespignani A, 2008, EUR PHYS J B, V64, P349, DOI 10.1140/epjb/e2008-00302-y; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160	34	15	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57100	10.1371/journal.pone.0057100	http://dx.doi.org/10.1371/journal.pone.0057100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437321	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200214
J	Sato, A; Yamada, N; Ogawa, Y; Ikegami, M				Sato, Atsuyasu; Yamada, Norishige; Ogawa, Yuya; Ikegami, Machiko			CCAAT/Enhancer-Binding Protein-alpha Suppresses Lung Tumor Development in Mice through the p38 alpha MAP Kinase Pathway	PLOS ONE			English	Article							FREQUENT DOWN-REGULATION; C/EBP-ALPHA; CELL-PROLIFERATION; CANCER; TUMORIGENESIS; INHIBITION; REVEALS; LESIONS; GROWTH; LIVER	The transcription factor CCAAT/enhancer-binding protein alpha (C/EBP alpha) is a basic leucine zipper transcription factor and is expressed in alveolar type II cells, alveolar macrophages and Clara cells in the lung. Although decrease or absence of C/EBP alpha expression in human non-small cell lung cancer suggests a possible role of C/EBP alpha as a lung tumor suppressor, there is no direct proof for this hypothesis. In this study, we investigated, for the first time, the role of C/EBP alpha in lung tumors in vivo using transgenic mice with lung epithelial specific conditional deletion of Cebpa (Cebp alpha(Delta/Delta) mice) and a urethane-induced lung tumor model. C/EBP alpha expression in the lung was dispensable, and its deletion was not oncogenic under unstressed conditions. However, at 28 wk after urethane injection, the number and size of tumors and the tumor burden were significantly higher in Cebp alpha(Delta/Delta) mice than in littermate control mice. Urethane-injected Cebp alpha(Delta/Delta) mice showed highly proliferative adenomas and adenocarcinomas in the lung, and survival time after urethane-injection was significantly shorter than that in control mice. In control mice, C/ EBP alpha was strongly induced in the tumor tissues at 28 weeks after urethane-injection, but became weakened or absent as tumors progressed after long-term observation for over 1 year. Using intraperitoneal injection of p38 inhibitor (SB203580), we demonstrated that the induction of C/EBP alpha is strongly regulated by the p38 MAP kinase in murine alveolar epithelial cells. A high correlation was demonstrated between the expression of C/EBP alpha and p38 alpha MAP kinase in tumor cells, suggesting that C/EBP alpha silencing in tumor cells is caused by down-regulation of p38 alpha MAP kinase. In conclusion, the role of C/EBP alpha as a lung tumor suppressor was demonstrated for the first time in the present study, and the extinguished C/EBP alpha expression through p38 alpha inactivation leads tumor promotion and progression.	[Sato, Atsuyasu; Ikegami, Machiko] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA; [Yamada, Norishige; Ogawa, Yuya] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Ikegami, M (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45221 USA.	machiko.ikegami@cchmc.org	Sato, Atsuyasu/H-9690-2016	Sato, Atsuyasu/0000-0001-8068-9984				Basseres DS, 2012, LUNG CANCER, V77, P31, DOI 10.1016/j.lungcan.2012.01.011; Biesalski HK, 1998, CA-CANCER J CLIN, V48, P167, DOI 10.3322/canjclin.48.3.167; Cheriyan J, 2011, CIRCULATION, V123, P515, DOI 10.1161/CIRCULATIONAHA.110.971986; Cisowski J, 2011, AM J PATHOL, V179, P513, DOI 10.1016/j.ajpath.2011.03.025; Costa DB, 2007, LUNG CANCER, V56, P97, DOI 10.1016/j.lungcan.2006.11.023; Costa DB, 2006, LUNG CANCER, V53, P253, DOI 10.1016/j.lungcan.2006.04.011; Dhawan P, 2009, J BIOL CHEM, V284, P3086, DOI 10.1074/jbc.M803602200; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Forkert PG, 2010, DRUG METAB REV, V42, P355, DOI 10.3109/03602531003611915; Geest CR, 2009, STEM CELLS, V27, P2271, DOI 10.1002/stem.152; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Halmos B, 2002, CANCER RES, V62, P528; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0; Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060; Khanna-Gupta A, 2008, BLOOD CELL MOL DIS, V41, P77, DOI 10.1016/j.bcmd.2008.02.011; Lomas DA, 2012, J CLIN PHARMACOL, V52, P416, DOI 10.1177/0091270010397050; Loomis KD, 2007, CANCER RES, V67, P6768, DOI 10.1158/0008-5472.CAN-07-0139; Lopez RG, 2009, NAT CELL BIOL, V11, P1181, DOI 10.1038/ncb1960; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Nord M, 2000, ANN NY ACAD SCI, V923, P154; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Oikonomopoulou K, 2010, BIOL CHEM, V391, P299, DOI 10.1515/BC.2010.038; Qiao LP, 2006, J BIOL CHEM, V281, P24390, DOI 10.1074/jbc.M603038200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Sato A, 2012, AM J RESP CELL MOL B; Sato A, 2012, AM J RESP CELL MOL, V47, P454, DOI 10.1165/rcmb.2011-0239OC; Schuster MB, 2006, BBA-REV CANCER, V1766, P88, DOI 10.1016/j.bbcan.2006.02.003; Shim M, 2005, CANCER RES, V65, P861; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Xu Y, 2009, AM J PHYSIOL-LUNG C, V297, pL286, DOI 10.1152/ajplung.00094.2009	49	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57013	10.1371/journal.pone.0057013	http://dx.doi.org/10.1371/journal.pone.0057013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437297	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200200
J	Bodur, C; Kutuk, O; Karsli-Uzunbas, G; Isimjan, TT; Harrison, P; Basaga, H				Bodur, Cagri; Kutuk, Ozgur; Karsli-Uzunbas, Gizem; Isimjan, Tayirjan T.; Harrison, Paul; Basaga, Huveyda			Pramanicin Analog Induces Apoptosis in Human Colon Cancer Cells: Critical Roles for Bcl-2, Bim, and p38 MAPK Signaling	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTOR; DEPENDENT APOPTOSIS; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; ANTIFUNGAL AGENT; GENE-EXPRESSION; FAMILY PROTEINS; BREAST-CANCER	Pramanicin (PMC) is an antifungal agent that was previously demonstrated to exhibit antiangiogenic and anticancer properties in a few in vitro studies. We initially screened a number of PMC analogs for their cytotoxic effects on HCT116 human colon cancer cells. PMC-A, the analog with the most potent antiproliferative effect was chosen to further interrogate the underlying mechanism of action. PMC-A led to apoptosis through activation of caspase-9 and -3. The apoptotic nature of cell death was confirmed by abrogation of cell death with pretreatment with specific caspase inhibitors. Stress-related MAPKs JNK and p38 were both activated concomittantly with the intrinsic apoptotic pathway. Moreover, pharmacological inhibition of p38 proved to attenuate the cell death induction while pretreatment with JNK inhibitor did not exhibit a protective effect. Resistance of Bax -/- cells and the protective nature of caspase-9 inhibition indicate that mitochondria play a central role in PMC-A induced apoptosis. Early post-exposure elevation of cellular Bim and Bax was followed by a marginal Bcl-2 depletion and Bid cleavage. Further analysis revealed that Bcl-2 downregulation occurs at the mRNA level and is critical to mediate PMC-A induced apoptosis, as ectopic Bcl-2 expression substantially spared the cells from death. Conversely, forced expression of Bim proved to significantly increase cell death. In addition, analyses of p53-/- cells demonstrated that Bcl-2/Bim/Bax modulation and MAPK activations take place independently of p53 expression. Taken together, p53-independent transcriptional Bcl-2 downregulation and p38 signaling appear to be the key modulatory events in PMC-A induced apoptosis.	[Bodur, Cagri; Karsli-Uzunbas, Gizem; Basaga, Huveyda] Sabanci Univ, Biol Sci & Bioengn Program, Istanbul, Turkey; [Kutuk, Ozgur] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Isimjan, Tayirjan T.; Harrison, Paul] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada	Sabanci University; Harvard University; Dana-Farber Cancer Institute; McMaster University	Basaga, H (corresponding author), Sabanci Univ, Biol Sci & Bioengn Program, Istanbul, Turkey.	huveyda@sabanciuniv.edu	KUTUK, OZGUR/AAH-1671-2019; Harrison, Paul/Q-9417-2019	KUTUK, OZGUR/0000-0001-9854-7220; 	Sabanci University faculty research funds	Sabanci University faculty research funds(Sabanci University)	The funding for the work was provided by Sabanci University faculty research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SF, 2012, EUR J IMMUNOL, V42, P1327, DOI 10.1002/eji.201142226; Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Bentires-Alj M, 2001, ONCOGENE, V20, P2805, DOI 10.1038/sj.onc.1204343; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; Bodur C, 2012, CURR MED CHEM, V19, P1804, DOI 10.2174/092986712800099839; Bodur C, 2012, J CELL PHYSIOL, V227, P3556, DOI 10.1002/jcp.24057; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chintharlapalli S, 2005, J BIOL CHEM, V280, P24903, DOI 10.1074/jbc.M500107200; Christoffers J, 2003, EUR J ORG CHEM, V2003, P425; delasAlas MM, 1997, J NATL CANCER I, V89, P1537, DOI 10.1093/jnci/89.20.1537; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Erster S, 2005, BIOCHEM BIOPH RES CO, V331, P843, DOI 10.1016/j.bbrc.2005.03.187; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; GREEN DR, 1994, IMMUNOL REV, V142, P321, DOI 10.1111/j.1600-065X.1994.tb00895.x; Grimm T, 2005, BLOOD, V105, P3263, DOI 10.1182/blood-2004-07-2752; Hara S, 2008, INT HEART J, V49, P329, DOI 10.1536/ihj.49.329; Harrison PHM, 2000, J CHEM SOC PERK T 1, P4390, DOI 10.1039/b006007k; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; Heist RS, 2010, J THORAC ONCOL, V5, P1637, DOI 10.1097/JTO.0b013e3181e8f4dc; Igata E, 1999, GENE, V238, P407, DOI 10.1016/S0378-1119(99)00348-0; Kannan K, 2001, ONCOGENE, V20, P2225, DOI 10.1038/sj.onc.1204319; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kutuk O, 2005, APOPTOSIS, V10, P597, DOI 10.1007/s10495-005-1894-z; Kwan CY, 2003, J PHARMACOL SCI, V92, P203; Kwan CY, 2003, VASC PHARMACOL, V40, P35, DOI 10.1016/S1537-1891(02)00314-2; Kwan CY, 2001, JPN J PHARMACOL, V85, P234, DOI 10.1254/jjp.85.234; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li QX, 2006, HISTOL HISTOPATHOL, V21, P533, DOI 10.14670/HH-21.533; Li ZL, 2003, J HISTOCHEM CYTOCHEM, V51, P1601, DOI 10.1177/002215540305101204; Lim EJ, 2007, EXP MOL MED, V39, P239, DOI 10.1038/emm.2007.27; MIYASHITA T, 1995, CELL, V80, P293; Moulder SL, 2008, CLIN CANCER RES, V14, P7909, DOI 10.1158/1078-0432.CCR-08-1104; NAGASAKA T, 1995, CHEM PHARM BULL, V43, P1081; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nesbit CE, 1998, BLOOD, V92, P1003; Nunez G, 1998, ONCOGENE, V17, P3237, DOI 10.1038/sj.onc.1202581; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Paik PK, 2010, CANCER CHEMOTH PHARM, V66, P1079, DOI 10.1007/s00280-010-1265-5; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Sheikh MS, 1998, CANCER RES, V58, P1593; Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; Tuli R, 2002, ANN NY ACAD SCI, V961, P172, DOI 10.1111/j.1749-6632.2002.tb03077.x; Vitale I, 2008, CELL CYCLE, V7, P1956, DOI 10.4161/cc.7.13.6073; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Weecharangsan W, 2009, MOL PHARMACEUT, V6, P1848, DOI 10.1021/mp900150g; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI 10.1016/S1470-2045(10)70261-8; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang T, 2009, MOL CANCER RES, V7, P1408, DOI 10.1158/1541-7786.MCR-08-0533	69	17	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56369	10.1371/journal.pone.0056369	http://dx.doi.org/10.1371/journal.pone.0056369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441183	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200040
J	Goh, KS; Sheu, HS; Hua, TE; Kang, MH; Li, CW				Goh, King-Siang; Sheu, Hwo-Shuenn; Hua, Tzu-En; Kang, Mei-Hua; Li, Chia-Wei			Uric Acid Spherulites in the Reflector Layer of Firefly Light Organ	PLOS ONE			English	Article							MONOSODIUM URATE; EVOLUTION; SOLUBILITY; DEGRADATION; PEROXISOMES; LAMPYRIDAE; PHYSIOLOGY; DIHYDRATE; CRYSTALS	Background: In firefly light organs, reflector layer is a specialized tissue which is believed to play a key role for increasing the bioluminescence intensity through reflection. However, the nature of this unique tissue remains elusive. In this report, we investigated the role, fine structure and nature of the reflector layer in the light organ of adult Luciola cerata. Principal Findings: Our results indicated that the reflector layer is capable of reflecting bioluminescence, and contains abundant uric acid. Electron microscopy (EM) demonstrated that the cytosol of the reflector layer's cells is filled with densely packed spherical granules, which should be the uric acid granules. These granules are highly regular in size (similar to 700 nm in diameter), and exhibit a radial internal structure. X-ray diffraction (XRD) analyses revealed that an intense single peak pattern with a d-spacing value of 0.320 nm is specifically detected in the light organ, and is highly similar to the diffraction peak pattern and d-spacing value of needle-formed crystals of monosodium urate monohydrate. However, the molar ratio evaluation of uric acid to various cations (K+, Na+, Ca2+ and Mg2+) in the light organ deduced that only a few uric acid molecules were in the form of urate salts. Thus, non-salt uric acid should be the source of the diffraction signal detected in the light organ. Conclusions: In the light organ, the intense single peak diffraction signal might come from a unique needle-like uric acid form, which is different from other known structures of non-salt uric acid form. The finding of a radial structure in the granules of reflector layer implies that the spherical uric acid granules might be formed by the radial arrangement of needle-formed packing matter.	[Goh, King-Siang; Kang, Mei-Hua; Li, Chia-Wei] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Dept Life Sci, Hsinchu, Taiwan; [Hua, Tzu-En] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu, Taiwan; [Sheu, Hwo-Shuenn] Natl Synchrotron Radiat Res Ctr, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Synchrotron Radiation Research Center	Li, CW (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Dept Life Sci, Hsinchu, Taiwan.	cwli@life.nthu.edu.tw			National Science Council (Taiwan, R.O.C) [NSC97-2311-B-007-001-MY3]	National Science Council (Taiwan, R.O.C)(Ministry of Science and Technology, Taiwan)	Funding was provided by NSC97-2311-B-007-001-MY3 from the National Science Council (Taiwan, R.O.C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; BUCK JB, 1948, ANN NY ACAD SCI, V49, P397, DOI 10.1111/j.1749-6632.1948.tb30944.x; Casotti G, 2004, J EXP ZOOL PART A, V301A, P579, DOI 10.1002/jez.a.85; Coleman NRB, 2001, MICROPOR MESOPOR MAT, V44, P73, DOI 10.1016/S1387-1811(01)00170-6; Drees LR, 1996, CATENA, V27, P287, DOI 10.1016/0341-8162(96)00022-7; FOLK RL, 1969, SCIENCE, V166, P1516, DOI 10.1126/science.166.3912.1516; Ghiradella H, 2004, INTEGR COMP BIOL, V44, P203, DOI 10.1093/icb/44.3.203; Goh KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029576; Granasy L, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.011605; HAYASHI S, 1989, J BIOL CHEM, V264, P3211; Hayashi S, 2000, CELL BIOCHEM BIOPHYS, V32, P123, DOI 10.1385/CBB:32:1-3:123; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Imrie CT, 2004, J MATER CHEM, V14, P2486, DOI 10.1039/b404319g; IWATA H, 1989, J UROLOGY, V142, P1095, DOI 10.1016/S0022-5347(17)39003-1; KLOHN M, 1986, UROL RES, V14, P315; Koksharova TV, 2002, RUSS J COORD CHEM+, V28, P505, DOI 10.1023/A:1016257429532; Lambert CC, 1998, J EXP ZOOL, V282, P323, DOI 10.1002/(SICI)1097-010X(19981015)282:3<323::AID-JEZ5>3.3.CO;2-7; Lewis SM, 2008, ANNU REV ENTOMOL, V53, P293, DOI 10.1146/annurev.ento.53.103106.093346; LONSDALE K, 1971, SCIENCE, V172, P958, DOI 10.1126/science.172.3986.958; Lund EJ, 1911, J EXP ZOOL, V11, P415, DOI 10.1002/jez.1400110405; Magill JH, 2001, J MATER SCI, V36, P3143, DOI 10.1023/A:1017974016928; MANDEL NS, 1980, ARTHRITIS RHEUM, V23, P772, DOI 10.1002/art.1780230610; MCNABB RA, 1980, COMP BIOCHEM PHYS A, V67, P27, DOI 10.1016/0300-9629(80)90405-3; MINNICH JE, 1972, COMP BIOCHEM PHYSIOL, V41, P551, DOI 10.1016/0300-9629(72)90012-6; Ninomiya Y, 2006, J INSECT PHYSIOL, V52, P638, DOI 10.1016/j.jinsphys.2006.03.002; Perrin CM, 2012, CRYSTENGCOMM, V14, P1709, DOI 10.1039/c2ce05985a; Perrin CM, 2011, CRYSTENGCOMM, V13, P1111, DOI 10.1039/c0ce00737d; PETERSON MK, 1968, BIOL BULL, V135, P335, DOI 10.2307/1539786; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Rao QL, 2005, APPL SURF SCI, V240, P28, DOI 10.1016/j.apsusc.2004.07.059; Sabina EP, 2008, J PHARM PHARM SCI, V11, P46; Sheu HS, 2004, INT J BIOL MACROMOL, V34, P325, DOI 10.1016/j.ijbiomac.2004.09.004; TAMURA T, 1990, Cytologia (Tokyo), V55, P519, DOI 10.1508/cytologia.55.519; TOJO S, 1972, J INSECT PHYSIOL, V18, P403, DOI 10.1016/0022-1910(72)90073-X; Ugarova NN, 2002, LUMINESCENCE, V17, P321, DOI 10.1002/bio.688; WILCOX WR, 1972, MED BIOL ENG, V10, P522, DOI 10.1007/BF02474201; WRIGHT PA, 1995, J EXP BIOL, V198, P273; Wu CH, 2010, COLEOPTS BULL, V64, P235, DOI 10.1649/0010-065X-64.3.235.9; Zellelow AZ, 2010, CRYST GROWTH DES, V10, P418, DOI 10.1021/cg9010218	40	8	8	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56406	10.1371/journal.pone.0056406	http://dx.doi.org/10.1371/journal.pone.0056406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441187	gold, Green Submitted, Green Published			2022-12-25	WOS:000315159200044
J	Chung, YL				Chung, Yih-Lin			Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen	FASEB JOURNAL			English	Article						tumor suppressor; promyelocytic leukemia protein; synthetic lethality	PROMYELOCYTIC LEUKEMIA PROTEIN; ALPHA-INDUCED APOPTOSIS; PML NUCLEAR-BODIES; HEPATOCELLULAR-CARCINOMA; CLASS-I; SYNTHETIC LETHALITY; SUPPRESSOR PML; TARGETS; INCREASE; PATHWAYS	Hepatitis B virus (HBV) is implicated in liver cancer. The aim of this study was to find out whether HBV or its components [HBV surface antigen (HBsAg), HBV core protein (HBc), and HBV X protein (HBx)] could interfere with the host DNA damage response and repair pathway. The full HBV genome or individual HBV open-reading frame (ORF) was introduced into HepG2 cells to examine the effect on host genomic stability, DNA repair efficacy in response to double-strand DNA damage, and DNA damage-induced cell death. Responses to apoptosis induction in the HBV ORF-transfected HepG2 cells were also compared with those in HBV-positive and HBV-negative human hepatocellular carcinoma (HCC) cells. In the absence of HBV replication, accumulation of HBsAg in liver cells without other HBV proteins enhanced DNA repair protein and tumor suppressor promyelocytic leukemia (PML) degradation, which resulted in resistance to apoptosis induction and deficient double-strand DNA repair. However, HBsAg-positive cells exhibited increased cell death with exposure to the poly(ADP-ribose) polymerase inhibitor that blocks single-strand DNA repair. These results indicate that suppression of PML by HBsAg disrupts cellular mechanisms that respond to double-strand DNA damage for DNA repair or apoptosis induction, which may facilitate hepatocarcinogenesis and open up a synthetic lethality strategy for HBsAg-positive HCC treatment.-Chung, Y.-L. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.	Koo Fdn Sun Yat Sen Canc Ctr, Dept Radiat Oncol, Taipei 112, Taiwan		Chung, YL (corresponding author), Koo Fdn Sun Yat Sen Canc Ctr, Dept Radiat Oncol, 125 Lih Der Rd, Taipei 112, Taiwan.	ylchung@kfsyscc.org			National Science Council in Taiwan [97-2320-B-368-001-MY2, 100-2320-B-368-001-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council in Taiwan (grants 97-2320-B-368-001-MY2 and 100-2320-B-368-001-MY3 to Y.C.).	Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Basu B, 2012, CURR OPIN ONCOL, V24, P316, DOI 10.1097/CCO.0b013e32835280c6; Boichuk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025814; Borden KLB, 2009, FRONT BIOSCI-LANDMRK, V14, P497, DOI 10.2741/3258; Chalmers AJ, 2010, SEMIN RADIAT ONCOL, V20, P274, DOI 10.1016/j.semradonc.2010.06.001; Chan JYH, 1998, EUR J CANCER, V34, P1015, DOI 10.1016/S0959-8049(97)10138-1; Chen YY, 2006, CELL MOL IMMUNOL, V3, P373; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; Chou YC, 2005, J VIROL, V79, P1813, DOI 10.1128/JVI.79.3.1813-1823.2005; Chung YL, 2009, MOL CANCER RES, V7, P1672, DOI 10.1158/1541-7786.MCR-09-0112; Crowder C, 2005, BLOOD, V105, P1280, DOI 10.1182/blood-2004-04-1614; Damia G, 2007, EUR J CANCER, V43, P1791, DOI 10.1016/j.ejca.2007.05.003; de The H, 2012, J CELL BIOL, V198, P11, DOI 10.1083/jcb.201112044; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; Du J, 2009, CELL DEATH DIFFER, V16, P219, DOI 10.1038/cdd.2008.144; Geng X, 2012, P NATL ACAD SCI USA, V109, P18465, DOI 10.1073/pnas.1204652109; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Ibarra RA, 2012, ACTA ONCOL, V51, P575, DOI 10.3109/0284186X.2011.652736; Iglehart JD, 2009, NEW ENGL J MED, V361, P189, DOI 10.1056/NEJMe0903044; Jalal S, 2011, CLIN CANCER RES, V17, P6973, DOI 10.1158/1078-0432.CCR-11-0761; Kasparek TR, 2011, SEMIN CELL DEV BIOL, V22, P886, DOI 10.1016/j.semcdb.2011.10.007; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Kuribayashi K, 2011, CELL CYCLE, V10, P2380, DOI 10.4161/cc.10.14.16588; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Liu YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036914; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Na B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026240; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Tavalai N, 2009, VIRUSES-BASEL, V1, P1240, DOI 10.3390/v1031240; Tsai HW, 2011, CANCER-AM CANCER SOC, V117, P2951, DOI 10.1002/cncr.25837; Tsai WL, 2010, ONCOGENE, V29, P2309, DOI 10.1038/onc.2010.36; Tseng TC, 2012, GASTROENTEROLOGY, V142, P1140, DOI 10.1053/j.gastro.2012.02.007; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; Varadaraj A, 2007, J PATHOL, V211, P471, DOI 10.1002/path.2126; Xia M, 2007, TISSUE ANTIGENS, V70, P272, DOI 10.1111/j.1399-0039.2007.00892.x; Yeung PL, 2012, J CELL BIOCHEM, V113, P1787, DOI 10.1002/jcb.24050; Yoo YG, 2004, J BIOL CHEM, V279, P36242, DOI 10.1074/jbc.M401290200; Yoon GS, 2001, J KOREAN MED SCI, V16, P433, DOI 10.3346/jkms.2001.16.4.433; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445	51	18	18	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2316	2327		10.1096/fj.12-226639	http://dx.doi.org/10.1096/fj.12-226639			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23444429				2022-12-25	WOS:000319667600021
J	Popat, H; Richmond, S; Zhurov, AI; Rosin, PL; Marshall, D				Popat, Hashmat; Richmond, Stephen; Zhurov, Alexei I.; Rosin, Paul L.; Marshall, David			A Geometric Morphometric Approach to the Analysis of Lip Shape during Speech: Development of a Clinical Outcome Measure	PLOS ONE			English	Article							FACIAL EXPRESSIONS; REPRODUCIBILITY; MOVEMENT; GROWTH; MOTION	Objective assessments of lip movement can be beneficial in many disciplines including visual speech recognition, for surgical outcome assessment in patients with cleft lip and for the rehabilitation of patients with facial nerve impairments. The aim of this study was to develop an outcome measure for lip shape during speech using statistical shape analysis techniques. Lip movements during speech were captured from a sample of adult subjects considered as average using a three-dimensional motion capture system. Geometric Morphometrics was employed to extract three-dimensional coordinate data for lip shape during four spoken words decomposed into seven visemes (which included the resting lip shape). Canonical variate analysis was carried out in an attempt to statistically discriminate the seven visemes. The results showed that the second canonical variate discriminated the resting lip shape from articulation of the utterances and accounted for 17.2% of the total variance of the model. The first canonical variate was significant in discriminating between the utterances and accounted for 72.8% of the total variance of the model. The outcome measure was created using the 95% confidence intervals of the canonical variate scores for each subject plotted as ellipses for each viseme. The method and outcome model is proposed as reference to compare lip movement during speech in similar population groups.	[Popat, Hashmat; Richmond, Stephen; Zhurov, Alexei I.] Cardiff Univ, Sch Dent, Cardiff CF10 3AX, S Glam, Wales; [Rosin, Paul L.; Marshall, David] Cardiff Univ, Cardiff Sch Comp Sci & Informat, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Popat, H (corresponding author), Cardiff Univ, Sch Dent, Cardiff CF10 3AX, S Glam, Wales.	popath@cardiff.ac.uk	Zhurov, Alexei I/P-4410-2014; Richmond, Steve/K-6696-2012	Zhurov, Alexei I/0000-0002-5594-0740; Richmond, Steve/0000-0001-5449-5318; Rosin, Paul/0000-0002-4965-3884	Cardiff University	Cardiff University	The study was funded by Cardiff University as a Ph.D. project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens H, 1958, BIOMETRIKA TABLES ST; Aleksic PS, 2009, ESSENTIAL GUIDE TO VIDEO PROCESSING, 2ND EDITION, P689, DOI 10.1016/B978-0-12-374456-2.00024-4; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; Dawes KS, 2005, MED ENG PHYS, V27, P523, DOI 10.1016/j.medengphy.2004.11.007; Duffy J. R., 2020, MOTOR SPEECH DISORDE, V4th; Fidell L., 2007, USING MULTIVARIATE S, P607; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gupta S, 2010, INT J COMPUT VISION, V90, P331, DOI 10.1007/s11263-010-0360-8; HANS MG, 1994, AM J ORTHOD DENTOFAC, V105, P598, DOI 10.1016/S0889-5406(94)70145-8; Hennessy RJ, 2001, EUR J ORTHODONT, V23, P275, DOI 10.1093/ejo/23.3.275; HOUSE JW, 1983, LARYNGOSCOPE, V93, P1056; Johnston DJ, 2003, CLEFT PALATE-CRAN J, V40, P291, DOI 10.1597/1545-1569(2003)040<0291:AFER>2.0.CO;2; Kau CH, 2005, J ORTHOD, V32, P282, DOI 10.1179/146531205225021285; Mishima K, 2006, COMPUT MED IMAG GRAP, V30, P53, DOI 10.1016/j.compmedimag.2005.11.002; Neely JG, 2010, OTOL NEUROTOL, V31, P1488, DOI 10.1097/MAO.0b013e3181edb6b8; PEARSON D, 1981, IEEE T COMMUN, V29, P1986, DOI 10.1109/TCOM.1981.1094934; Popat H, 2012, ORTHOD CRANIOFAC RES, V15, P92, DOI 10.1111/j.1601-6343.2011.01539.x; Popat H, 2009, COMPUT MED IMAG GRAP, V33, P377, DOI 10.1016/j.compmedimag.2009.03.003; Popat H, 2010, OTOLARYNG HEAD NECK, V142, P867, DOI 10.1016/j.otohns.2010.03.003; Qifeng Z, 2000, USE VARIABLE FRAME R, P1783; Roach Peter., 2004, J INT PHON ASSOC, V34, P239, DOI [DOI 10.1017/S0025100304001768, 10.1017/S0025100304001768]; Savran A, 2008, LECT NOTES COMPUT SC, V5372, P47, DOI 10.1007/978-3-540-89991-4_6; Sawyer AR, 2009, OTOLARYNG HEAD NECK, V140, P76, DOI 10.1016/j.otohns.2008.09.007; Sell D, 1999, INT J LANG COMM DIS, V34, P17; Sidorov K. A., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2401, DOI 10.1109/CVPR.2011.5995632; Sjogreen L, 2011, J ORAL REHABIL, V38, P410, DOI 10.1111/j.1365-2842.2010.02168.x; Toma AM, 2009, ORTHOD CRANIOFAC RES, V12, P33, DOI 10.1111/j.1601-6343.2008.01435.x; WOOD DA, 1994, AM J OTOL, V15, P61	29	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57368	10.1371/journal.pone.0057368	http://dx.doi.org/10.1371/journal.pone.0057368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451213	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500093
J	Yang, J; Yang, ZX; Lv, HJ; Lou, Y; Wang, J; Wu, NP				Yang, Jin; Yang, Zongxing; Lv, Hangjun; Lou, Yi; Wang, Juan; Wu, Nanping			Bridging HIV-1 Cellular Latency and Clinical Long-Term Non-Progressor: An Interactomic View	PLOS ONE			English	Article							LOW-LEVEL VIREMIA; GENE-EXPRESSION; TRANSCRIPTIONAL PROFILES; BIOLOGICAL NETWORKS; T-CELLS; INFECTION; REACTIVATION; IDENTIFICATION; PROTEINS	Development of an effective HIV management is enticed by the fact that long-term non-progressors (LTNP) restrict viral replication spontaneously, but is hindered by HIV-1 latency. Given that the most overlapping characteristics found between HIV-1 LTNP and latency, detailed analysis of the difference would disclose the essentials of latency. In this study, microarray data from our previous study was combined with HIV-1 latency and LTNP data obtained from NCBI GEO database. Principal variance component analysis and hierarchical clustering verified the removal of batch effect across platform. The analysis revealed a total of 456 differential expressed genes with >2-fold change and B-statistic >0. Bayesian inference was used to reconstitute the transcriptional network of HIV-1 latency or LTNP, respectively. Gene regulation was reprogrammed under different disease condition. By network interference, KPNA2 and ATP5G3 were identified as the hubs in latency network which mediate nuclear export and RNA processing. These data offer comparative insights into HIV-1 latency, which will facilitate the understanding of the genetic basis of HIV-1 latency in vivo and serve as a clue for future treatment dealing with key targets in HIV-1 latency.	[Yang, Jin; Yang, Zongxing; Wang, Juan; Wu, Nanping] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Inst In, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Jin; Lv, Hangjun] Blood Ctr Zhejiang Prov, Dept Med, Hangzhou, Zhejiang, Peoples R China; [Lou, Yi] Hangzhou Normal Univ, Dept Med, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Normal University	Wu, NP (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Inst In, Hangzhou 310003, Zhejiang, Peoples R China.	flwnp@yahoo.com.cn	yu, yu/AAL-5178-2020	, Jin Yang/0000-0001-8018-4556	National Natural Science Foundation of China [87024787, 81273313]; National Key Projects of China [2012ZX10001-003-004]; Zhejiang medical development project [2012KYA060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Projects of China; Zhejiang medical development project	This work was supported by the National Natural Science Foundation of China (Grant No. 87024787, No. 81273313), National Key Projects of China (Grant No. 2012ZX10001-003-004), Zhejiang medical development project (Grant No. 2012KYA060); http://isisn.nsfc.gov.cn/egrantweb/; http://www.zjmed.org.cn/20120504/2012050400001.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Caly L, 2012, ANTIVIR RES, V95, P202, DOI 10.1016/j.antiviral.2012.06.008; Cheng G, 2011, BIOMED PHARMACOTHER, V65, P230, DOI 10.1016/j.biopha.2011.02.012; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Dahl V, 2010, ANTIVIR RES, V85, P286, DOI 10.1016/j.antiviral.2009.09.016; Diboun I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-252; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Fackler OT, 2006, CURR OPIN MICROBIOL, V9, P409, DOI 10.1016/j.mib.2006.06.010; Fujimura K, 2010, BBA-MOL CELL RES, V1803, P865, DOI 10.1016/j.bbamcr.2010.03.020; Gandhi RT, 2010, J INFECT DIS, V201, P293, DOI 10.1086/649569; Hakre S, 2012, FEMS MICROBIOL REV, V36, P706, DOI 10.1111/j.1574-6976.2012.00335.x; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan V, 2004, J VIROL, V78, P9458, DOI 10.1128/JVI.78.17.9458-9473.2004; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Ooi BNS, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-13; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Pentchev K, 2010, BIOINFORMATICS, V26, P2796, DOI 10.1093/bioinformatics/btq522; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rotger M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000781; Salgado M, 2011, VIROLOGY, V411, P103, DOI 10.1016/j.virol.2010.12.037; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Schaub MC, 2007, J BIOL CHEM, V282, P13617, DOI 10.1074/jbc.M700774200; Shen A, 2005, IMMUNOLOGY, V116, P276, DOI 10.1111/j.1365-2567.2005.02222.x; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Silva JM, 2009, CELL, V137, P1047, DOI 10.1016/j.cell.2009.04.013; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tyler AL, 2009, BIOESSAYS, V31, P220, DOI 10.1002/bies.200800022; Veloso S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-63; Vigneault F, 2011, J VIROL, V85, P3015, DOI 10.1128/JVI.01846-10; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Wu JQ, 2008, VIROLOGY, V380, P124, DOI 10.1016/j.virol.2008.06.039; Wu JQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-18; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	53	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55791	10.1371/journal.pone.0055791	http://dx.doi.org/10.1371/journal.pone.0055791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451031	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500005
J	Zhang, Y; Jiang, N; Zarnitsyna, VI; Klopocki, AG; McEver, RP; Zhu, C				Zhang, Yan; Jiang, Ning; Zarnitsyna, Veronika I.; Klopocki, Arkadiusz G.; McEver, Rodger P.; Zhu, Cheng			P-Selectin Glycoprotein Ligand-1 Forms Dimeric Interactions with E-Selectin but Monomeric Interactions with L-Selectin on Cell Surfaces	PLOS ONE			English	Article							CLATHRIN-COATED PITS; LEUKOCYTE ADHESION; 2-DIMENSIONAL KINETICS; BINDING-KINETICS; RECEPTOR; INTEGRIN; TRANSMEMBRANE; DIMERIZATION; BONDS; IDENTIFICATION	Interactions of selectins with cell surface glycoconjugates mediate the first step of the adhesion and signaling cascade that recruits circulating leukocytes to sites of infection or injury. P-selectin dimerizes on the surface of endothelial cells and forms dimeric bonds with P-selectin glycoprotein ligand-1 (PSGL-1), a homodimeric sialomucin on leukocytes. It is not known whether leukocyte L-selectin or endothelial cell E-selectin are monomeric or oligomeric. Here we used the micropipette technique to analyze two-dimensional binding of monomeric or dimeric L- and E-selectin with monomeric or dimeric PSGL-1. Adhesion frequency analysis demonstrated that E-selectin on human aortic endothelial cells supported dimeric interactions with dimeric PSGL-1 and monomeric interactions with monomeric PSGL-1. In contrast, L- selectin on human neutrophils supported monomeric interactions with dimeric or monomeric PSGL-1. Our work provides a new method to analyze oligomeric cross-junctional molecular binding at the interface of two interacting cells.	[Zhang, Yan; Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Jiang, Ning; Zarnitsyna, Veronika I.; Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Klopocki, Arkadiusz G.; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Jiang, Ning/M-5448-2017	Jiang, Ning/0000-0003-1103-5922; Zhu, Cheng/0000-0002-1718-565X; Zarnitsyna, Veronika/0000-0003-3096-3695; Zhang, Yan/0000-0001-5791-4389	National Institutes of Health grant [AI077343, HL034363]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034363, R01HL034363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077343, R56AI077343] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI077343 and HL034363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkalow FJ, 2000, BLOOD, V96, P3070; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Dwir O, 2002, J BIOL CHEM, V277, P21130, DOI 10.1074/jbc.M201999200; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; ERBE DV, 1992, J CELL BIOL, V119, P215, DOI 10.1083/jcb.119.1.215; Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Kinoshita K, 2010, BIOPHYS J, V98, P1467, DOI 10.1016/j.bpj.2009.12.4316; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; Laplantine E, 2002, BIOL CELL, V94, P375, DOI 10.1016/S0248-4900(02)00009-6; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li RH, 2001, P NATL ACAD SCI USA, V98, P12462, DOI 10.1073/pnas.221463098; Li X, 1998, J EXP MED, V188, P1385, DOI 10.1084/jem.188.7.1385; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2005, LEUKOCYTE TRAFFICKING: MOLECULAR MECHANISMS, THERAPEUTIC TARGETS, AND METHODS, P219; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; McEver RP, 2001, THROMB HAEMOSTASIS, V86, P746; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Myou S, 2002, IMMUNOLOGY, V107, P77, DOI 10.1046/j.1365-2567.2002.01486.x; Newton JP, 1999, BIOCHEM BIOPH RES CO, V261, P283, DOI 10.1006/bbrc.1999.1018; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Powell MS, 2006, J IMMUNOL, V176, P7489, DOI 10.4049/jimmunol.176.12.7489; Ramachandran V, 1999, P NATL ACAD SCI USA, V96, P13771, DOI 10.1073/pnas.96.24.13771; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Rose SL, 2007, ANN BIOMED ENG, V35, P1382, DOI 10.1007/s10439-007-9311-0; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Sarangapani KK, 2011, J BIOL CHEM, V286, P9567, DOI 10.1074/jbc.M110.196485; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Setiadi H, 2003, J CELL BIOL, V163, P1385, DOI 10.1083/jcb.200307178; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Setiadi H, 2008, BLOOD, V111, P1989, DOI 10.1182/blood-2007-09-113423; Shao B, 2012, J BIOL CHEM IN PRESS; Sigalov AB, 2008, ADV EXP MED BIOL, V640, P121, DOI 10.1007/978-0-387-09789-3_12; Srinivasan S, 2011, BBA-BIOMEMBRANES, V1808, P1709, DOI 10.1016/j.bbamem.2011.02.006; Sulchek TA, 2005, P NATL ACAD SCI USA, V102, P16638, DOI 10.1073/pnas.0505208102; Sulchek T, 2006, BIOPHYS J, V90, P4686, DOI 10.1529/biophysj.105.080291; Troyanovsky RB, 2007, MOL BIOL CELL, V18, P4343, DOI 10.1091/mbc.E07-01-0084; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; VONANDRIAN UH, 1995, CELL, V82, P989, DOI 10.1016/0092-8674(95)90278-3; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Xia LJ, 2004, BLOOD, V104, P3091, DOI 10.1182/blood-2004-02-0650; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Zarnitsyna VI, 2011, JOVE-J VIS EXP, DOI 10.3791/3519; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200	65	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57202	10.1371/journal.pone.0057202	http://dx.doi.org/10.1371/journal.pone.0057202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451187	Green Published, gold			2022-12-25	WOS:000316849500078
J	Al Dhaheri, Y; Eid, A; AbuQamar, S; Attoub, S; Khasawneh, M; Aiche, G; Hisaindee, S; Iratni, R				Al Dhaheri, Yusra; Eid, Ali; AbuQamar, Synan; Attoub, Samir; Khasawneh, Mohammad; Aiche, Ghenima; Hisaindee, Soleiman; Iratni, Rabah			Mitotic Arrest and Apoptosis in Breast Cancer Cells Induced by Origanum majorana Extract: Upregulation of TNF-alpha and Downregulation of Survivin and Mutant p53	PLOS ONE			English	Article							VOLATILE OIL; INHIBITION; PHYTOCHEMICALS; EXPRESSION; TOXICITY; PROTEINS; RECEPTOR	Background: In the present study, we investigated the effect of Origanum majorana ethanolic extract on the survival of the highly proliferative and invasive triple-negative p53 mutant breast cancer cell line MDA-MB-231. Results: We found that O. majorana extract (OME) was able to inhibit the viability of the MDA-MB-231 cells in a time- and concentration-dependent manner. The effect of OME on cellular viability was further confirmed by the inhibition of colony growth. We showed, depending on the concentration used, that OME elicited different effects on the MDA-MB 231 cells. Concentrations of 150 and 300 mu g/mL induced an accumulation of apoptotic-resistant population of cells arrested in mitotis and overexpressing the cyclin-dependent kinase inhibitor, p21 and the inhibitor of apoptosis, survivin. On the other hand, higher concentrations of OME (450 and 600 mu g/mL) triggered a massive apoptosis through the extrinsic pathway, including the activation of tumor necrosis factor-alpha (TNF-alpha), caspase 8, caspase 3, and cleavage of PARP, downregulation of survivin as well as depletion of the mutant p53 in MDA-MB-231 cells. Furthermore, OME induced an upregulation of gamma-H2AX, a marker of double strand DNA breaks and an overall histone H3 and H4 hyperacetylation. Conclusion: Our findings provide strong evidence that O. majorana may be a promising chemopreventive and therapeutic candidate against cancer especially for highly invasive triple negative p53 mutant breast cancer; thus validating its complementary and alternative medicinal use.	[Al Dhaheri, Yusra; Eid, Ali; AbuQamar, Synan; Iratni, Rabah] United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates; [Attoub, Samir] United Arab Emirates Univ, Dept Pharmacol & Therapeut, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Khasawneh, Mohammad; Hisaindee, Soleiman] United Arab Emirates Univ, Dept Chem, Coll Sci, UAE Univ, Al Ain, U Arab Emirates; [Aiche, Ghenima] Univ Mouloud Mammeri, Dept Biochem & Microbiol, Fac Sci Biol & Agron, Tizi Ouzou, Algeria	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; Universite Mouloud Mammeri de Tizi Ouzou	Iratni, R (corresponding author), United Arab Emirates Univ, Dept Biol, Coll Sci, Al Ain, U Arab Emirates.	R_iratni@uaeu.ac.ae	Attoub, Samir/N-6852-2018; Eid, Ali Hussein/ABD-6291-2021; Hisaindee, Soleiman/AAK-4862-2020; AbuQamar, Synan/AAV-1229-2021	Eid, Ali Hussein/0000-0003-3004-5675; Hisaindee, Soleiman/0000-0003-0084-8362; AbuQamar, Synan/0000-0002-2129-7689	Faculty of Science interdisciplinary research grant UAE University; Emirates Foundation research grant [2009-80]	Faculty of Science interdisciplinary research grant UAE University; Emirates Foundation research grant	This work was supported by the Faculty of Science interdisciplinary research grant UAE University and by the Emirates Foundation research grant (2009-80) to R. Iratni. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LS, 2010, CANCER RES, V70, P3594, DOI 10.1158/0008-5472.CAN-09-3565; Al-Harbi NO, 2011, J MED PLANTS RES, V5, P5479; American Cancer Society, 2012, CANC FACTS FIG; Attoub S, 2011, EUR J PHARMACOL, V651, P18, DOI 10.1016/j.ejphar.2010.10.063; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Cai Y, 2007, CANCER BIOL THER, V6, P1794, DOI 10.4161/cbt.6.11.4860; Chandele A, 2004, NEOPLASIA, V6, P29, DOI 10.1016/S1476-5586(04)80051-4; Choi HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024312; Cragg GM, 2000, EXPERT OPIN INV DRUG, V9, P2783, DOI 10.1517/13543784.9.12.2783; El-Ashmawy I.M., 2007, ALEX J PHARM SCI, V21, P29; El-Ashmawy IM, 2007, BASIC CLIN PHARMACOL, V101, P320, DOI 10.1111/j.1742-7835.2007.00125.x; El-Ashmawy IM, 2005, BASIC CLIN PHARMACOL, V97, P238, DOI 10.1111/j.1742-7843.2005.pto_136.x; Fojo T, 2002, DRUG RESIST UPDATE, V5, P209, DOI 10.1016/S1368-7646(02)00119-X; Gu YH, 2006, ONCOL REP, V15, P417; Gupta S, 2003, INT J ONCOL, V22, P15; Han J, 2012, ONCOL REP, V27, P517, DOI 10.3892/or.2011.1511; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Kaczirek K, 2004, J CLIN ENDOCR METAB, V89, P2397, DOI 10.1210/jc.2003-031314; Konopleva M, 1999, ADV EXP MED BIOL, V457, P217; Kuno T., 2012, Journal of Biophysical Chemistry, V3, P156, DOI 10.4236/jbpc.2012.32018; Lee HS, 2008, J NUTR BIOCHEM, V19, P313, DOI 10.1016/j.jnutbio.2007.05.008; Leeja L, 2007, J ENVIRON BIOL, V28, P145; Lin LT, 2002, PHYTOTHER RES, V16, P440, DOI 10.1002/ptr.937; Ljungman M, 2010, ENVIRON MOL MUTAGEN, V51, P879, DOI 10.1002/em.20597; Maurer M, 2009, ANN NY ACAD SCI, V1171, P250, DOI 10.1111/j.1749-6632.2009.04717.x; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miron TL, 2011, J CHROMATOGR A, V1218, P4918, DOI 10.1016/j.chroma.2010.11.055; Nawab A., 2011, Molecular and Cellular Pharmacology, V3, P21; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Rajendran P, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-4; Reed JC, 2001, TRENDS MOL MED, V7, P314, DOI 10.1016/S1471-4914(01)02026-3; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Selivanova G, 2001, Curr Opin Investig Drugs, V2, P1136; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Tamm I, 1998, CANCER RES, V58, P5315; Teiten MH, 2010, GENES NUTR, V5, P61, DOI 10.1007/s12263-009-0152-3; Tsimogiannis D, 2006, INT J FOOD SCI TECH, V41, P39, DOI 10.1111/j.1365-2621.2006.01259.x; Vagi E, 2005, J AGR FOOD CHEM, V53, P17, DOI 10.1021/jf048777p; Vogel C, 2007, CANCER RES, V67, P339, DOI 10.1158/0008-5472.CAN-06-2548; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XT, 2011, J MED CHEM, V54, P809, DOI 10.1021/jm101199t; Watson WH, 2000, ANNU REV NUTR, V20, P485, DOI 10.1146/annurev.nutr.20.1.485; Yazdanparast R, 2008, VASC PHARMACOL, V48, P32, DOI 10.1016/j.vph.2007.11.003; Zhu H, 2007, MOL CANCER THER, V6, P484, DOI 10.1158/1535-7163.MCT-06-0584; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	46	30	30	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56649	10.1371/journal.pone.0056649	http://dx.doi.org/10.1371/journal.pone.0056649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451065	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800024
J	Meyer, J; Gorbach, AM; Liu, WM; Medic, N; Young, M; Nelson, C; Arceo, S; Desai, A; Metcalfe, DD; Komarow, HD				Meyer, Joseph; Gorbach, Alexander M.; Liu, Wei-Min; Medic, Nevenka; Young, Michael; Nelson, Celeste; Arceo, Sarah; Desai, Avanti; Metcalfe, Dean D.; Komarow, Hirsh D.			Mast Cell Dependent Vascular Changes Associated with an Acute Response to Cold Immersion in Primary Contact Urticaria	PLOS ONE			English	Article							ALLERGIC INFLAMMATION; CHOLINERGIC URTICARIA; HISTAMINE; ANAPHYLAXIS; BASOPHILS; TRYPTASE; RELEASE; MICROCIRCULATION; PATHOPHYSIOLOGY; DEGRANULATION	Background: While a number of the consequences of mast cell degranulation within tissues have been documented including tissue-specific changes such as bronchospasm and the subsequent cellular infiltrate, there is little known about the immediate effects of mast cell degranulation on the associated vasculature, critical to understanding the evolution of mast cell dependent inflammation. Objective: To characterize the microcirculatory events that follow mast cell degranulation. Methodology/Principal Findings: Perturbations in dermal blood flow, temperature and skin color were analyzed using laser-speckle contrast imaging, infrared and polarized-light colorimetry following cold-hand immersion (CHI) challenge in patients with cold-induced urticaria compared to the response in healthy controls. Evidence for mast cell degranulation was established by documentation of serum histamine levels and the localized release of tryptase in post-challenge urticarial biopsies. Laser-speckle contrast imaging quantified the attenuated response to cold challenge in patients on cetirizine. We found that the histamine-associated vascular response accompanying mast cell degranulation is rapid and extensive. At the tissue level, it is characterized by a uniform pattern of increased blood flow, thermal warming, vasodilation, and recruitment of collateral circulation. These vascular responses are modified by the administration of an antihistamine. Conclusions/Significance: Monitoring the hemodynamic responses within tissues that are associated with mast cell degranulation provides additional insight into the evolution of the acute inflammatory response and offers a unique approach to assess the effectiveness of treatment intervention.	[Meyer, Joseph; Gorbach, Alexander M.; Liu, Wei-Min] Natl Inst Biomed Imaging & Bioengn, Infrared Imaging & Thermometry Unit, NIH, Bethesda, MD USA; [Medic, Nevenka; Nelson, Celeste; Arceo, Sarah; Desai, Avanti; Metcalfe, Dean D.; Komarow, Hirsh D.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Young, Michael] NCI, Clin Res Directorate, CMRP, SAIC Frederick, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Komarow, HD (corresponding author), NIAID, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	komarowh@niaid.nih.gov		Liu, Wei-Min/0000-0002-3617-1739	Division of Intramural Research, NIAID, NIH; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000078] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Division of Intramural Research, NIAID, NIH. Support by M.Y. for this project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; COWEN T, 1979, BRIT J DERMATOL, V100, P635, DOI 10.1111/j.1365-2133.1979.tb08066.x; Cuss FM, 1999, CLIN EXP ALLERGY, V29, P54; Foster B, 2002, J ALLERGY CLIN IMMUN, V109, P287, DOI 10.1067/mai.2002.121454; Fromy B, 2010, J INVEST DERMATOL, V130, P849, DOI 10.1038/jid.2009.279; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gentinetta T, 2011, J ALLERGY CLIN IMMUN, V128, P1227, DOI 10.1016/j.jaci.2011.07.021; GRANDEL KE, 1985, NEW ENGL J MED, V313, P405, DOI 10.1056/NEJM198508153130702; Haas N, 1998, ARCH DERMATOL, V134, P41, DOI 10.1001/archderm.134.1.41; JUHLIN L, 1961, JAMA-J AM MED ASSOC, V177, P371, DOI 10.1001/jama.1961.73040320001004; KAPLAN AP, 1981, NEW ENGL J MED, V305, P1074, DOI 10.1056/NEJM198110293051808; KAPLAN AP, 1975, J ALLERGY CLIN IMMUN, V55, P394, DOI 10.1016/0091-6749(75)90078-0; Kingwell BA, 2003, DIABETES CARE, V26, P899, DOI 10.2337/diacare.26.3.899; KleinJan A, 2000, J ALLERGY CLIN IMMUN, V106, P677, DOI 10.1067/mai.2000.109621; LAWLOR F, 1989, CLIN EXP DERMATOL, V14, P416, DOI 10.1111/j.1365-2230.1989.tb02601.x; Leutenegger M, 2011, BIOMED OPT EXPRESS, V2, P1470, DOI 10.1364/BOE.2.001470; Lin RY, 2000, J ALLERGY CLIN IMMUN, V106, P65, DOI 10.1067/mai.2000.107600; MCCLEAN SP, 1989, J ALLERGY CLIN IMMUN, V83, P738, DOI 10.1016/0091-6749(89)90008-0; Merla A, 2002, IEEE ENG MED BIOL, V21, P73, DOI 10.1109/MEMB.2002.1175141; MINER PB, 1991, J INVEST DERMATOL, V96, pS40, DOI 10.1111/1523-1747.ep12469015; MURPHY GF, 1987, J ALLERGY CLIN IMMUN, V80, P603, DOI 10.1016/0091-6749(87)90015-7; Nhan BR, 2009, PHYSIOL MEAS, V30, pN23, DOI 10.1088/0967-3334/30/4/N01; O'Doherty J, 2007, SKIN RES TECHNOL, V13, P472, DOI 10.1111/j.1600-0846.2007.00253.x; O'Mahony L, 2011, J ALLERGY CLIN IMMUN, V128, P1153, DOI 10.1016/j.jaci.2011.06.051; Pearlman DS, 1999, J ALLERGY CLIN IMMUN, V104, pS132, DOI 10.1016/S0091-6749(99)70308-8; Pellaton C, 2002, AM HEART J, V144, P269, DOI 10.1067/mhj.2002.123842; Cruz GAS, 2009, APPL RADIAT ISOTOPES, V67, pS54, DOI 10.1016/j.apradiso.2009.03.093; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; SHEFFER AL, 1985, J ALLERGY CLIN IMMUN, V75, P479, DOI 10.1016/S0091-6749(85)80021-X; SOTER NA, 1976, NEW ENGL J MED, V294, P687, DOI 10.1056/NEJM197603252941302; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Taylor S, 2006, J AM ACAD DERMATOL, V54, pS282, DOI 10.1016/j.jaad.2005.12.041; Wanderer AA, 2004, IMMUNOL ALLERGY CLIN, V24, P259, DOI 10.1016/j.iac.2004.01.001	33	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56773	10.1371/journal.pone.0056773	http://dx.doi.org/10.1371/journal.pone.0056773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451084	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800036
J	Shakibaei, M; Mobasheri, A; Lueders, C; Busch, F; Shayan, P; Goel, A				Shakibaei, Mehdi; Mobasheri, Ali; Lueders, Cora; Busch, Franziska; Shayan, Paviz; Goel, Ajay			Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-kappa B and Src Protein Kinase Signaling Pathways	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; COLON-CANCER; ADJUVANT THERAPY; TUMOR-CELLS; APOPTOSIS; RESISTANCE; INFLAMMATION; SUPPRESSION; METASTASIS; ACTIVATION	Objective: Development of treatment resistance and adverse toxicity associated with classical chemotherapeutic agents highlights the need for safer and effective therapeutic approaches. Herein, we examined the effectiveness of a combination treatment regimen of 5-fluorouracil (5-FU) and curcumin in colorectal cancer (CRC) cells. Methods: Wild type HCT116 cells and HCT116+ch3 cells (complemented with chromosome 3) were treated with curcumin and 5-FU in a time- and dose-dependent manner and evaluated by cell proliferation assays, DAPI staining, transmission electron microscopy, cell cycle analysis and immunoblotting for key signaling proteins. Results: The individual IC50 of curcumin and 5-FU were approximately 20 mu M and 5 mu M in HCT116 cells and 5 mu M and 1 mu M in HCT116+ch3 cells, respectively (p<0.05). Pretreatment with curcumin significantly reduced survival in both cells; HCT116+ch3 cells were considerably more sensitive to treatment with curcumin and/or 5-FU than wild-type HCT116 cells. The IC50 values for combination treatment were approximately 5 mu M and 1 mu M in HCT116 and 5 mu M and 0.1 mu M in HCT116+ch3, respectively (p<0.05). Curcumin induced apoptosis in both cells by inducing mitochondrial degeneration and cytochrome c release. Cell cycle analysis revealed that the anti-proliferative effect of curcumin and/or 5-FU was preceded by accumulation of CRC cells in the S cell cycle phase and induction of apoptosis. Curcumin potentiated 5-FU-induced expression or cleavage of pro-apoptotic proteins (caspase-8, -9, -3, PARP and Bax), and down-regulated anti-apoptotic (Bcl-xL) and proliferative (cyclin D1) proteins. Although 5-FU activated NF-kappa B/PI-3K/Src pathway in CRC cells, this was down-regulated by curcumin treatment through inhibition of I kappa B alpha kinase activation and I kappa B alpha phosphorylation. Conclusions: Combining curcumin with conventional chemotherapeutic agents such as 5-FU could provide more effective treatment strategies against chemoresistant colon cancer cells. The mechanisms involved may be mediated via NF-kappa B/PI-3K/Src pathways and NF-kappa B regulated gene products.	[Shakibaei, Mehdi; Busch, Franziska] Univ Munich, Inst Anat, Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Div Vet Med, Loughborough, England; [Lueders, Cora] German Heart Inst, Lab Tissue Engn, Dept Thorac & Cardiovasc Surg, Berlin, Germany; [Shayan, Paviz] Invest Inst Mol Biol Syst Transfer, Tehran, Iran; [Goel, Ajay] Baylor Univ, Med Ctr, Gastrointestinal Canc Res Lab, Div Gastroenterol,Baylor Res Inst, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA	University of Munich; University of Nottingham; German Heart Center Berlin; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Goel, Ajay/0000-0003-1396-6341				Aebi S, 1997, CLIN CANCER RES, V3, P1763; Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Benson AB, 2006, ONCOLOGIST, V11, P973, DOI 10.1634/theoncologist.11-9-973; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bharti AC, 2002, ANN NY ACAD SCI, V973, P392, DOI 10.1111/j.1749-6632.2002.tb04671.x; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; Chauhan DP, 2002, CURR PHARM DESIGN, V8, P1695, DOI 10.2174/1381612023394016; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Drummond JT, 1996, J BIOL CHEM, V271, P19645, DOI 10.1074/jbc.271.33.19645; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; George JA, 2005, CANCER RES, V65, P10381, DOI 10.1158/0008-5472.CAN-05-1822; Griffiths GJ, 2004, J BIOL CHEM, V279, P46113, DOI 10.1074/jbc.M408550200; Gupta SC, 2010, CANCER METAST REV, V29, P405, DOI 10.1007/s10555-010-9235-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; KOI M, 1994, CANCER RES, V54, P4308; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Lujambio A, 2009, CELL CYCLE, V8, P377, DOI 10.4161/cc.8.3.7526; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Ng SSW, 2001, CLIN CANCER RES, V7, P3269; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Verma SP, 1998, ENVIRON HEALTH PERSP, V106, P807, DOI 10.2307/3434124; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193	57	156	161	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57218	10.1371/journal.pone.0057218	http://dx.doi.org/10.1371/journal.pone.0057218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451189	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800092
J	Helbig, A; Kaasen, A; Malt, UF; Haugen, G				Helbig, Anne; Kaasen, Anne; Malt, Ulrik Fredrik; Haugen, Guttorm			Does Antenatal Maternal Psychological Distress Affect Placental Circulation in the Third Trimester?	PLOS ONE			English	Article							VEIN BLOOD-FLOW; GENERAL HEALTH QUESTIONNAIRE; UMBILICAL VEIN; UTERINE ARTERY; EVENT SCALE; VENOUS FLOW; PREGNANCY; STRESS; GROWTH; ANXIETY	Introduction: Some types of antenatal maternal psychological distress may be associated with reduced fetal growth and birthweight. A stress-mediated reduction in placental blood flow has been suggested as a mechanism. Previous studies have examined this using ultrasound-derived arterial resistance measures in the uterine (UtA) and umbilical (UA) arteries, with mixed conclusions. However, a reduction in placental volume blood flow may occur before changes in arterial resistance measures are seen. Fetoplacental volume blood flow can be quantified non-invasively in the umbilical vein (UV). Our objective was to study whether specific types of maternal psychological distress affect the placental circulation, using volume blood flow quantification in addition to arterial resistance measures. Methods: This was a prospective observational study of 104 non-smoking pregnant women (gestational age 30 weeks) with uncomplicated obstetric histories. Psychological distress was measured by General Health Questionnaire-28 (subscales anxiety and depression) and Impact of Event Scale-22 (subscales intrusion, avoidance and arousal). UtA and UA resistance measures and UV volume blood flow normalized for fetal abdominal circumference, were obtained by Doppler ultrasound. Results: IES intrusion scores above the mean were associated with a reduction in normalized UV volume blood flow (corresponding to -0.61 SD; P = 0.003). Adjusting for UA resistance increased the strength of this association (difference -0.66 SD; P<0.001). Other distress types were not associated with UV volume blood flow. Maternal distress was not associated with arterial resistance measures, despite adjustment for confounders. Conclusions: Intrusive thoughts and emotional distress regarding the fetus were associated with reduced fetoplacental volume blood flow in third trimester. Uterine and umbilical artery resistance measures were not associated with maternal distress. Our findings support a decrease in fetoplacental blood flow as a possible pathway between maternal distress and reduced fetal growth.	[Helbig, Anne; Kaasen, Anne] Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway; [Helbig, Anne; Haugen, Guttorm] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Kaasen, Anne] Oslo & Akershus Univ Coll Appl Sci, Dept Hlth Nutr & Management, Oslo, Norway; [Malt, Ulrik Fredrik] Oslo Univ Hosp, Dept Neuropsychiat & Psychosomat Med, Oslo, Norway; [Malt, Ulrik Fredrik; Haugen, Guttorm] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway	University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet); University of Oslo; University of Oslo	Helbig, A (corresponding author), Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway.	helbig@frisurf.no	Kaasen, Anne/ABE-1562-2020	Kaasen, Anne/0000-0001-9291-0105; Malt, Ulrik/0000-0002-9881-2511	Norwegian Resource Centre for Women's Health; Norwegian Women's Public Health Association	Norwegian Resource Centre for Women's Health; Norwegian Women's Public Health Association	This study was financially supported by the Norwegian Resource Centre for Women's Health(http://www.oslo-universitetssykehus.no/omoss/avdelinger/kvinnehelse/Sider/enhet.aspx) and the Norwegian Women's Public Health Association (http://www.sanitetskvinnene.no/filestore/N.K.S.Hovedbrosjyre_Engelsk_Korr3.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2005, PRENATAL DIAG, V25, P99, DOI 10.1002/pd.1091; Acharya G, 2004, AM J PHYSIOL-HEART C, V286, pH1266, DOI 10.1152/ajpheart.00523.2003; Barbera A, 1999, AM J OBSTET GYNECOL, V181, P174, DOI 10.1016/S0002-9378(99)70456-4; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Di Naro E, 2002, ACTA OBSTET GYN SCAN, V81, P527, DOI 10.1034/j.1600-0412.2002.810609.x; DiPietro JA, 2012, J ADOLESCENT HEALTH, V51, pS3, DOI 10.1016/j.jadohealth.2012.04.008; Dunkel Schetter C., 2011, HDB HLTH PSYCHOL, P431; Ebbing C, 2011, ULTRASOUND OBST GYN, V38, P303, DOI 10.1002/uog.9046; Eid J, 2009, NORD J PSYCHIAT, V63, P426, DOI 10.1080/08039480903118190; GILL R W, 1979, Ultrasound in Medicine and Biology, V5, P223, DOI 10.1016/0301-5629(79)90014-0; GILL RW, 1984, ULTRASOUND MED BIOL, V10, P349, DOI 10.1016/0301-5629(84)90169-8; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; HARRINGTON KF, 1991, EUR J OBSTET GYN R B, V42, pS14; Harville EW, 2008, ULTRASOUND OBST GYN, V32, P23, DOI 10.1002/uog.5344; Helbig A, 2011, BJOG-INT J OBSTET GY, V118, P1653, DOI 10.1111/j.1471-0528.2011.03155.x; Henrichs J, 2010, PSYCHOL MED, V40, P633, DOI 10.1017/S0033291709990894; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Huizink AC, 2004, EARLY HUM DEV, V79, P81, DOI 10.1016/j.earlhumdev.2004.04.014; Kaasen A, 2010, BJOG-INT J OBSTET GY, V117, P1127, DOI 10.1111/j.1471-0528.2010.02622.x; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Kiserud T, 1998, ULTRASOUND OBST GYN, V11, P419, DOI 10.1046/j.1469-0705.1998.11060419.x; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Lees C, 1999, ULTRASOUND OBST GYN, V14, P250, DOI 10.1046/j.1469-0705.1999.14040250.x; Littleton HL, 2010, J PSYCHOSOM OBST GYN, V31, P219, DOI 10.3109/0167482X.2010.518776; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Ohman SG, 2004, ACTA OBSTET GYN SCAN, V83, P634; Rigano S, 2001, AM J OBSTET GYNECOL, V185, P834, DOI 10.1067/mob.2001.117356; Rizzo G, 2008, ULTRASOUND OBST GYN, V32, P155, DOI 10.1002/uog.5389; Roesch SC, 2004, ANXIETY STRESS COPIN, V17, P87, DOI 10.1080/1061580031000123667; Salvesen KA, 1997, ULTRASOUND OBST GYN, V9, P80, DOI 10.1046/j.1469-0705.1997.09020080.x; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; Sjostrom K, 1997, EUR J OBSTET GYN R B, V74, P149, DOI 10.1016/S0301-2115(97)00100-0; Skari H, 2002, BJOG-INT J OBSTET GY, V109, P1154, DOI 10.1111/j.1471-0528.2002.00468.x; Statham H, 1997, BIRTH-ISS PERINAT C, V24, P223, DOI 10.1111/j.1523-536X.1997.tb00595.x; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; TRUDINGER BJ, 1985, BRIT J OBSTET GYNAEC, V92, P23, DOI 10.1111/j.1471-0528.1985.tb01044.x; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Vythilingum B, 2010, ARCH WOMEN MENT HLTH, V13, P359, DOI 10.1007/s00737-010-0144-8; Weiss Daniel S., 1997, P399; Willmott SA, 2004, SOC PSYCH PSYCH EPID, V39, P613, DOI 10.1007/s00127-004-0801-1	42	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57071	10.1371/journal.pone.0057071	http://dx.doi.org/10.1371/journal.pone.0057071			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23437312	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200209
J	Ustinova, EE; Shurin, GV; Gutkin, DW; Shurin, MR				Ustinova, Elena E.; Shurin, Galina V.; Gutkin, Dmitriy W.; Shurin, Michael R.			The Role of TLR4 in the Paclitaxel Effects on Neuronal Growth In Vitro	PLOS ONE			English	Article							DENDRITIC CELL-FUNCTION; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-4; SUPPORTING CELLS; NONCYTOTOXIC CONCENTRATIONS; MURINE MACROPHAGES; SENSORY NEURONS; TAXOL; INHIBITION; CULTURES	Paclitaxel (Pac) is an antitumor agent that is widely used for treatment of solid cancers. While being effective as a chemotherapeutic agent, Pac in high doses is neurotoxic, specifically targeting sensory innervations. In view of these toxic effects associated with conventional chemotherapy, decreasing the dose of Pac has been recently suggested as an alternative approach, which might limit neurotoxicity and immunosuppression. However, it remains unclear if low doses of Pac retain its neurotoxic properties or might exhibit unusual effects on neuronal cells. The goal of this study was to analyze the concentration-dependent effect of Pac on isolated and cultured DRG neuronal cells from wild-type and TLR4 knockout mice. Three different morphological parameters were analyzed: the number of neurons which developed neurites, the number of neurites per cell and the total length of neurites per cell. Our data demonstrate that low concentrations of Pac (0.1 nM and 0.5 nM) do not influence the neuronal growth in cultures in both wild type and TLR4 knockout mice. Higher concentrations of Pac (1-100 nM) had a significant effect on DRG neurons from wild type mice, affecting the number of neurons which developed neurites, number of neurites per cell, and the length of neurites. In DRG from TLR4 knockout mice high concentrations of Pac showed a similar effect on the number of neurons which developed neurites and the length of neurites. At the same time, the number of neurites per cell, indicating the process of growth cone initiation, was not affected by high concentrations of Pac. Thus, our data showed that Pac in high concentrations has a significant damaging effect on axonal growth and that this effect is partially mediated through TLR4 pathways. Low doses of Pac are devoid of neuronal toxicity and thus can be safely used in a chemomodulation mode.	[Ustinova, Elena E.; Shurin, Galina V.; Gutkin, Dmitriy W.; Shurin, Michael R.] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ustinova, EE (corresponding author), Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15260 USA.	eustinova@hotmail.com		Shurin, Michael/0000-0002-6570-7395	NIH NCI [RO1 CA154369]; NATIONAL CANCER INSTITUTE [R01CA154369] Funding Source: NIH RePORTER	NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported in part by NIH NCI RO1 CA154369 (to M.R. Shurin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barajon I, 2009, J HISTOCHEM CYTOCHEM, V57, P1013, DOI 10.1369/jhc.2009.953539; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; CAVALETTI G, 1995, EXP NEUROL, V133, P64, DOI 10.1006/exnr.1995.1008; CHUANG LT, 1994, CANCER RES, V54, P1286; Crown J, 2000, LANCET, V355, P1176, DOI 10.1016/S0140-6736(00)02074-2; Crume KP, 2007, EXP BIOL MED, V232, P607; Goldspiel BR, 1997, PHARMACOTHERAPY, V17, pS110; Hagiwara Hiroki, 2004, Breast Cancer, V11, P82, DOI 10.1007/BF02968008; Hua Z, 2007, CLIN CANCER RES, V13, P5455, DOI 10.1158/1078-0432.CCR-07-0517; Jimenez-Andrade JM, 2006, NEUROSCI LETT, V405, P62, DOI 10.1016/j.neulet.2006.06.043; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; John J, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-14; Kaneno R, 2011, CELL ONCOL, V34, P97, DOI 10.1007/s13402-010-0005-5; Kaneno R, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-58; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; KIRIKAE F, 1995, INFECT IMMUN, V63, P486, DOI 10.1128/IAI.63.2.486-497.1995; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Lee JJ, 2006, J CLIN ONCOL, V24, P1633, DOI 10.1200/JCO.2005.04.0543; LETOURNEAU PC, 1984, J CELL BIOL, V98, P1355, DOI 10.1083/jcb.98.4.1355; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Marupudi NI, 2007, EXPERT OPIN DRUG SAF, V6, P609, DOI 10.1517/14740338.6.5.609; MASUROVSKY EB, 1983, NEUROSCIENCE, V10, P491, DOI 10.1016/0306-4522(83)90148-3; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mekhail Tarek M, 2002, Expert Opin Pharmacother, V3, P755; Michels T, 2012, J IMMUNOTOX IN PRESS; Naiditch H, 2011, IMMUNOL RES, V50, P276, DOI 10.1007/s12026-011-8213-2; Nowicki M, 2010, J NEUROSCI RES, V88, P403, DOI 10.1002/jnr.22205; Park SB, 2011, MUSCLE NERVE, V43, P367, DOI 10.1002/mus.21874; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Pfannenstiel LW, 2010, CELL IMMUNOL, V263, P79, DOI 10.1016/j.cellimm.2010.03.001; Risinger AL, 2009, CANCER TREAT REV, V35, P255, DOI 10.1016/j.ctrv.2008.11.001; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Scuteri A, 2006, ANTICANCER RES, V26, P1065; Sevko A, 2012, J IMMUNOTOX IN PRESS; Shurin GV, 2012, CANCER IMMUNOL IMMUN, V61, P223, DOI 10.1007/s00262-011-1138-8; Shurin GV, 2009, J IMMUNOL, V183, P137, DOI 10.4049/jimmunol.0900734; Shurin M, 2012, CURRENT MED IN PRESS; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tichomirowa MA, 2008, INT J CANCER, V123, P1956, DOI 10.1002/ijc.23737; van Noort JM, 2009, PROG BRAIN RES, V175, P139, DOI 10.1016/S0079-6123(09)17509-X; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Wang J, 2002, BRIT J HAEMATOL, V118, P638, DOI 10.1046/j.1365-2141.2002.03645.x; Wozniak KM, 2011, CANCER RES, V71, P3952, DOI 10.1158/0008-5472.CAN-10-4184; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Zimmer SM, 2008, J BIOL CHEM, V283, P27916, DOI 10.1074/jbc.M802826200	47	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56886	10.1371/journal.pone.0056886	http://dx.doi.org/10.1371/journal.pone.0056886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441224	Green Published, gold, Green Accepted			2022-12-25	WOS:000315159200081
J	Xiao, HJ; Wu, SH; Chen, C; Xue, FS				Xiao, HaiJun; Wu, ShaoHui; Chen, Chao; Xue, FangSen			Optimal Low Temperature and Chilling Period for Both Summer and Winter Diapause Development in Pieris melete: Based on a Similar Mechanism	PLOS ONE			English	Article							LARVAL DIAPAUSE; LEPIDOPTERA PIERIDAE; EMBRYONIC DIAPAUSE; INSECT DIAPAUSE; EMERGENCE TIME; DELIA-ANTIQUA; ONION MAGGOT; TERMINATION; HYMENOPTERA; PHOTOPERIOD	The cabbage butterfly, Pieris melete hibernates and aestivates as a diapausing pupa. We present evidence that the optimum of low temperature and optimal chilling periods for both summer and winter diapause development are based on a similar mechanism. Summer or winter diapausing pupae were exposed to different low temperatures of 1, 5, 10 or 15 degrees C for different chilling periods (ranging from 30 to 120 d) or chilling treatments started at different stages of diapause, and were then transferred to 20 degrees C, LD12.5:11.5 to terminate diapause. Chilling temperature and duration had a significant effect on the development of aestivating and hibernating pupae. The durations of diapause for both aestivating and hibernating pupae were significantly shorter when they were exposed to low temperatures of 1, 5 or 10 degrees C for 50 or 60 days, suggesting that the optimum chilling temperatures for diapause development were between 1 and 10 degrees C and the required optimal chilling period was about 50-60 days. Eighty days of chilling was efficient for the completion of both summer and winter diapause. When chilling periods were >= 90 days, the durations of summer and winter diapause were significantly lengthened; however, the adult emergence was more synchronous. The adaptive significance of a similar mechanism on summer and winter diapause development is discussed.	[Xiao, HaiJun; Chen, Chao; Xue, FangSen] Jiangxi Agr Univ, Inst Entomol, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Peoples R China; [Xiao, HaiJun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wu, ShaoHui] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA	Jiangxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Virginia Polytechnic Institute & State University	Xiao, HJ (corresponding author), Jiangxi Agr Univ, Inst Entomol, Key Lab Crop Physiol Ecol & Genet Breeding, Nanchang, Peoples R China.	hjxiao@yahoo.com.cn; xue_fangsen@hotmail.com	Wu, Shaohui/AAH-2795-2019; Xiao, Haijun/HGE-3088-2022; XIAO, Haijun/AAJ-5321-2021	Xiao, Haijun/0000-0002-0832-0493; XIAO, Haijun/0000-0002-0832-0493	National Natural Science Foundation of China [30900916]; New Teachers' Fund of doctoral program; Ministry of Education of China [20093603120002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund of doctoral program; Ministry of Education of China(Ministry of Education, China)	This work was supported by a grant from National Natural Science Foundation of China (30900916) and New Teachers' Fund of doctoral program sponsored by Ministry of Education of China (20093603120002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO Y, 1993, PHYSIOL ENTOMOL, V18, P1, DOI 10.1111/j.1365-3032.1993.tb00442.x; Bosch J, 2003, ENVIRON ENTOMOL, V32, P711, DOI 10.1603/0046-225X-32.4.711; Bosch J, 2004, APIDOLOGIE, V35, P469, DOI 10.1051/apido:2004035; Broufas GD, 2006, ENVIRON ENTOMOL, V35, P1216, DOI 10.1603/0046-225X(2006)35[1216:EOCEAP]2.0.CO;2; Damos PT, 2010, PHYSIOL ENTOMOL, V35, P64, DOI 10.1111/j.1365-3032.2009.00715.x; DANKS HV, 1987, BIOL SURVEY CANADA M, V1; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Ding L, 2003, J INSECT PHYSIOL, V49, P1153, DOI 10.1016/j.jinsphys.2003.08.012; Eizaguirre M, 2008, J INSECT PHYSIOL, V54, P1057, DOI 10.1016/j.jinsphys.2008.04.011; Fisher JR, 1997, ENVIRON ENTOMOL, V26, P906, DOI 10.1093/ee/26.4.906; Higaki M, 2005, J INSECT PHYSIOL, V51, P1352, DOI 10.1016/j.jinsphys.2005.08.006; HODEK I, 1988, ENTOMOL EXP APPL, V49, P153, DOI 10.1007/BF00188248; Hodek I, 2002, EUR J ENTOMOL, V99, P163, DOI 10.14411/eje.2002.024; Ishikawa Y, 2000, J INSECT PHYSIOL, V46, P161, DOI 10.1016/S0022-1910(99)00112-2; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2000, J INSECT PHYSIOL, V46, P417, DOI 10.1016/S0022-1910(99)00124-9; Larios GLB, 2007, APPL ENTOMOL ZOOL, V42, P587, DOI 10.1303/aez.2007.587; Nomura M, 2000, J INSECT PHYSIOL, V46, P373, DOI 10.1016/S0022-1910(99)00120-1; Quesada-Moraga E, 2000, PHYSIOL ENTOMOL, V25, P191, DOI 10.1046/j.1365-3032.2000.00185.x; Shimoda M, 1997, APPL ENTOMOL ZOOL, V32, P617, DOI 10.1303/aez.32.617; Tachibana SI, 2004, ZOOL SCI, V21, P197, DOI 10.2108/zsj.21.197; Takeda M, 2006, APPL ENTOMOL ZOOL, V41, P429, DOI 10.1303/aez.2006.429; TAUBER MJ, 1986, SEASONAL ADAPTIONS I; Trudel R, 2002, AGR FOREST ENTOMOL, V4, P301, DOI 10.1046/j.1461-9563.2002.00155.x; WIPKING W, 1995, OECOLOGIA, V102, P202, DOI 10.1007/BF00333252; Xiao HJ, 2012, B ENTOMOL RES, V102, P267, DOI 10.1017/S0007485311000587; Xiao HJ, 2006, EUR J ENTOMOL, V103, P537, DOI 10.14411/eje.2006.071; Xiao HJ, 2009, J INSECT PHYSIOL, V55, P488, DOI 10.1016/j.jinsphys.2008.12.012; Xiao HJ, 2008, EUR J ENTOMOL, V105, P607, DOI 10.14411/eje.2008.081; Xiao HJ, 2008, J INSECT PHYSIOL, V54, P755, DOI 10.1016/j.jinsphys.2008.01.009; Xue FS, 1997, J INSECT PHYSIOL, V43, P701, DOI 10.1016/S0022-1910(97)00053-X; Zhu DH, 2009, ENTOMOL EXP APPL, V133, P1, DOI 10.1111/j.1570-7458.2009.00901.x	32	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56404	10.1371/journal.pone.0056404	http://dx.doi.org/10.1371/journal.pone.0056404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441185	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200042
J	Jiang, YL; Lin, AHY; Xia, Y; Lee, S; Paudel, O; Sun, H; Yang, XR; Ran, PX; Sham, JSK				Jiang, Yong-Liang; Lin, Amanda H. Y.; Xia, Yang; Lee, Suengwon; Paudel, Omkar; Sun, Hui; Yang, Xiao-Ru; Ran, Pixin; Sham, James S. K.			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Activates Global and Heterogeneous Local Ca2+ Signals from NAADP- and Ryanodine Receptor-gated Ca2+ Stores in Pulmonary Arterial Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE; INOSITOL TRISPHOSPHATE; MOBILIZES CALCIUM; 2-PORE CHANNELS; RELEASE CHANNEL; CHRONIC HYPOXIA; SENSITIVE CA2+; TRIGGER ZONE; LYSOSOMES; SPARKS	Nicotinic acid adenine dinucleotide phosphate (NAADP) is the most potent Ca2+-mobilizing messenger that releases Ca2+ from endolysosomal organelles. Recent studies showed that NAADP-induced Ca2+ release is mediated by the two-pore channels (TPCs) TPC1 and TPC2. However, the expression of TPCs and the NAADP-induced local Ca2+ signals have not been examined in vascular smooth muscle. Here, we found that both TPC1 and TPC2 are expressed in rat pulmonary arterial smooth muscle cells (PASMCs), with TPC1 being the major subtype. Application of membrane-permeant NAADP acetoxymethyl ester to PASMCs elicited a biphasic increase in global [Ca2+](i), which was independent of extracellular Ca2+ and blocked by the NAADP antagonist Ned-19 or the vacuolar H+-ATPase inhibitor bafilomycin A1, indicating Ca2+ release from acidic endolysosomal Ca2+ stores. The Ca2+ response was unaffected by xestospongin C but was partially blocked by ryanodine or thapsigargin. NAADP triggered heterogeneous local Ca2+ signals, including a diffuse increase in cytosolic [Ca2+], Ca2+ sparks, Ca2+ bursts, and regenerative Ca2+ release. The diffuse Ca2+ increase and Ca(2+)bursts were ryanodine-insensitive, presumably arising from different endolysosomal sources. Ca2+ sparks and regenerative Ca2+ release were inhibited by ryanodine, consistent with cross-activation of loosely coupled ryanodine receptors. Moreover, Ca2+ release stimulated by endothelin-1 was inhibited by Ned-19, ryanodine, or xestospongin C, suggesting that NAADP-mediated Ca2+ signals interact with both ryanodine and inositol 1,4,5-trisphosphate receptors during agonist stimulation. Our results show that NAADP mediates complex global and local Ca2+ signals. Depending on the physiological stimuli, these diverse Ca2+ signals may serve to regulate different cellular functions in PASMCs.	[Jiang, Yong-Liang; Lin, Amanda H. Y.; Xia, Yang; Lee, Suengwon; Paudel, Omkar; Sun, Hui; Yang, Xiao-Ru; Sham, James S. K.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21224 USA; [Jiang, Yong-Liang; Ran, Pixin] Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China	Johns Hopkins University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Ran, PX (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China.	pxran@gzhmc.edu.cn; jsks@jhmi.edu	Lin, Amanda/C-6964-2014	Xia, Yang/0000-0003-2487-2244; Sham, James/0000-0002-3571-8712	National Institutes of Health [R01 HL071835, R01 HL075134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071835, R01HL075134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL071835 and R01 HL075134 (to J. S. K. S.).	Aarhus R, 1996, J BIOL CHEM, V271, P8513, DOI 10.1074/jbc.271.15.8513; Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boittin FX, 2002, CIRC RES, V91, P1168, DOI 10.1161/01.RES.0000047507.22487.85; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Collins TP, 2011, CELL CALCIUM, V50, P449, DOI 10.1016/j.ceca.2011.07.007; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Esposito B, 2011, BLOOD, V117, P4968, DOI 10.1182/blood-2010-02-266338; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Kinnear NP, 2008, CELL CALCIUM, V44, P190, DOI 10.1016/j.ceca.2007.11.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Lipp P, 2002, J PHYSIOL-LONDON, V542, P383, DOI 10.1113/jphysiol.2001.013382; Lipp P, 1996, J PHYSIOL-LONDON, V492, P31, DOI 10.1113/jphysiol.1996.sp021286; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Lopez Sanjurjo C. I., 2013, J CELL SCI IN PRESS; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Narayanan D, 2012, AM J PHYSIOL-HEART C, V302, pH2190, DOI 10.1152/ajpheart.01146.2011; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Remillard CV, 2002, AM J PHYSIOL-LUNG C, V283, pL433, DOI 10.1152/ajplung.00468.2001; Rosen D, 2009, J BIOL CHEM, V284, P34930, DOI 10.1074/jbc.M109.016519; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Rybalchenko V, 2012, J BIOL CHEM, V287, P20407, DOI 10.1074/jbc.M112.359612; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; SHAM JSK, 1995, P NATL ACAD SCI USA, V92, P121, DOI 10.1073/pnas.92.1.121; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Thai TL, 2009, AM J PHYSIOL-RENAL, V297, pF510, DOI 10.1152/ajprenal.00116.2009; TINKER A, 1992, J GEN PHYSIOL, V100, P479, DOI 10.1085/jgp.100.3.479; Umesh A, 2006, J BIOL CHEM, V281, P34312, DOI 10.1074/jbc.M606765200; Umesh A, 2011, J VASC RES, V48, P525, DOI 10.1159/000329593; Wang SQ, 2004, P NATL ACAD SCI USA, V101, P3979, DOI 10.1073/pnas.0306157101; Yamaguchi S, 2011, J BIOL CHEM, V286, P22934, DOI 10.1074/jbc.M110.210930; YANAI K, 1992, N-S ARCH PHARMACOL, V346, P51, DOI 10.1007/BF00167570; Yang XR, 2005, AM J PHYSIOL-LUNG C, V289, pL338, DOI 10.1152/ajplung.00328.2004; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yusufi ANK, 2002, EXP BIOL MED, V227, P36, DOI 10.1177/153537020222700107; Yusufi ANK, 2001, BIOCHEM J, V353, P531, DOI 10.1042/0264-6021:3530531; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang F, 2010, AM J PHYSIOL-CELL PH, V298, pC1209, DOI 10.1152/ajpcell.00533.2009; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zhang WM, 2004, J CARDIOVASC PHARM, V44, pS121, DOI 10.1097/01.fjc.0000166226.03712.4f; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	62	25	26	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10381	10394		10.1074/jbc.M112.423053	http://dx.doi.org/10.1074/jbc.M112.423053			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443655	Green Published, hybrid			2022-12-25	WOS:000317565000019
J	Zmrzljak, UP; Korencic, A; Kosir, R; Golicnik, M; Sassone-Corsi, P; Rozman, D				Zmrzljak, Ursula Prosenc; Korencic, Anja; Kosir, Rok; Golicnik, Marko; Sassone-Corsi, Paolo; Rozman, Damjana			Inducible cAMP Early Repressor Regulates the Period 1 Gene of the Hepatic and Adrenal Clocks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN TRANSCRIPTION; ICER; CREM; EXPRESSION; MOUSE; BRAIN; TIME; GLUCOCORTICOIDS; CRYPTOCHROME; MECHANISMS	Light, restricted feeding, and hormonal inputs may operate as time givers (zeitgebers) for the circadian clock within peripheral organs through the activation of tissue-specific signaling cascades. cAMP signaling through CREM (cAMP-responsive element modulator) and its variant ICER (inducible cAMP early repressor) is linked to the circadian regulation of pineal melatonin synthesis, although little is known about its influence in other organs. We performed experiments in the absence of light and feeding-time cues to test which core clock genes are controlled by CREM/ICER in the liver and adrenal gland. In vivo, Crem loss-of-function mutation resulted in fine-tuning of all measured adrenal clock genes (Per1/2/3, Cry1/2, Bmal1, and Rev-erb alpha), whereas only Per1 and Cry1 were affected in the liver. Icer expression was circadian in the adrenal gland, with peak gene expression at zeitgeber 12 and the highest protein levels at zeitgeber similar to 20. The expression of both Icer and Per1 genes responded to cAMP stimuli in an immediate-early fashion. In immortal cells, forskolin induced expression of Per1 after 2 h, and de novo protein synthesis led to Per1 attenuation. We show that the de novo synthesized protein responsible for Per1 attenuation is ICER. Indeed, Per1 expression is up-regulated in cells ectopically expressing antisense Icer, and mobility shift experiments identified ICER binding to cAMP-responsive elements of the Per1 promoter. We propose that ICER acts as a noise filter for different signals that could affect transcription in the adrenal gland. Because ICER is an immediate-early repressor, the circadian nature of adrenal Icer expression could serve a role in a time-dependent gating mechanism.	[Zmrzljak, Ursula Prosenc; Korencic, Anja; Kosir, Rok; Golicnik, Marko; Rozman, Damjana] Univ Ljubljana, Ctr Funct Genom & Biochips, Inst Biochem, Fac Med, SI-1000 Ljubljana, Slovenia; [Zmrzljak, Ursula Prosenc] Inst Oncol, Dept Lab Diagnost, SI-1000 Ljubljana, Slovenia; [Kosir, Rok] DiaGenomi Ltd, Ljubljana 1000, Slovenia; [Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92606 USA	University of Ljubljana; Institute of Oncology - Slovenia; University of California System; University of California Irvine	Rozman, D (corresponding author), Univ Ljubljana, Ctr Funct Genom & Biochips, Inst Biochem, Fac Med, Zaloska 4, SI-1000 Ljubljana, Slovenia.	damjana.rozman@mf.uni-lj.si	Kosir, Rok/AAT-2901-2020	Kosir, Rok/0000-0002-1197-9627; Prosenc Zmrzljak, Ursula/0000-0002-9034-790X; Rozman, Damjana/0000-0002-6501-2163	Slovenian Research Agency [P1-0104]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Program Grant P1-0104.	Barabitskaja O, 2006, J LEUKOCYTE BIOL, V79, P378, DOI 10.1189/jlb.0505255; Borlikova G, 2009, MOL NEUROBIOL, V40, P73, DOI 10.1007/s12035-009-8072-1; Bur IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015316; Bureau C, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-430, 10.3201/eid1508.080772]; Christ E, 2010, NEUROSCIENCE, V171, P398, DOI 10.1016/j.neuroscience.2010.09.009; Fink M, 2008, ACTA CHIM SLOV, V55, P85; Folco EJ, 1997, BIOCHEM J, V328, P37; Foulkes NS, 1997, BIOL CELL, V89, P487, DOI 10.1016/S0248-4900(98)80004-X; Ho AK, 2007, ENDOCRINOLOGY, V148, P743, DOI 10.1210/en.2006-1154; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kell CA, 2004, J COMP NEUROL, V478, P379, DOI 10.1002/cne.20290; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Korencic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046835; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kovach SJ, 2006, J CELL PHYSIOL, V206, P411, DOI 10.1002/jcp.20474; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Maronde E, 1999, J NEUROSCI, V19, P3326; MELLSTROM B, 1993, NEURON, V10, P655, DOI 10.1016/0896-6273(93)90167-P; Memin E, 2011, EXP CELL RES, V317, P2490, DOI 10.1016/j.yexcr.2011.07.001; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; OKAMURA H, 2007, COLD SPRING HARB SYM, V72, P551; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pfeffer M, 2000, J PINEAL RES, V29, P24, DOI 10.1034/j.1600-079X.2000.290104.x; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schwartz WJ, 2005, NEUROSCI LETT, V385, P87, DOI 10.1016/j.neulet.2005.05.018; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Spencer CM, 2005, J NEUROSCI RES, V82, P273, DOI 10.1002/jnr.20617; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zmrzljak UP, 2012, CHEM RES TOXICOL, V25, P811, DOI 10.1021/tx200538r; Zwermann O, 2007, HORM METAB RES, V39, P560, DOI 10.1055/s-2007-985141	42	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10318	10327		10.1074/jbc.M112.445692	http://dx.doi.org/10.1074/jbc.M112.445692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443664	Green Published, hybrid			2022-12-25	WOS:000317565000013
J	Dong, Y; Stephens, C; Walpole, C; Swedberg, JE; Boyle, GM; Parsons, PG; McGuckin, MA; Harris, JM; Clements, JA				Dong, Ying; Stephens, Carson; Walpole, Carina; Swedberg, Joakim E.; Boyle, Glen M.; Parsons, Peter G.; McGuckin, Michael A.; Harris, Jonathan M.; Clements, Judith A.			Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; PLASMINOGEN ACTIVATION SYSTEM; HUMAN TISSUE KALLIKREINS; EXTRACELLULAR-MATRIX; DRUG-RESISTANCE; SERINE-PROTEASE; CARCINOMA CELLS; EXPRESSION; TUMOR; KLK4	High tumor kallikrein-related-peptidase 4 (KLK4) levels are associated with a poor outcome for women with serous epithelial ovarian cancer (EOC), for which peritoneal dissemination and chemoresistance are key events. To determine the role of KLK4 in these events, we examined KLK4-transfected SKOV-3 and endogenous KLK4 expressing OVCA432 cells in 3-dimensional (3D) suspension culture to mimic the ascites microenvironment. KLK4-SKOV-3 cells formed multicellular aggregates (MCAs) as seen in ascites, as did SKOV-3 cells treated with active KLK4. MCA formation was reduced by treatment with a KLK4 blocking antibody or the selective active site KLK4 sunflower trypsin inhibitor (SFTI-FCQR). KLK4-MCAs formed larger cancer cell foci in mesothelial cell monolayers than those formed by vector and native SKOV-3 cells, suggesting KLK4-MCAs are highly invasive in the peritoneal microenvironment. A high level of KLK4 is expressed by ascitic EOC cells compared to matched primary tumor cells, further supporting its role in the ascitic microenvironment. Interestingly, KLK4 transfected SKOV-3 cells expressed high levels of the KLK4 substrate, urokinase plasminogen activator (uPA), particularly in 3D-suspension, and high levels of both KLK4 and uPA were observed in patient cells taken from ascites. Importantly, the KLK4-MCAs were paclitaxel resistant which was reversed by SFTI-FCQR and to a lesser degree by the general serine protease inhibitor, Aprotinin, suggesting that in addition to uPA, other as yet unidentified substrates of KLK4 must be involved. Nonetheless, these data suggest that KLK4 inhibition, in conjunction with paclitaxel, may improve the outcome for women with serous epithelial ovarian cancer and high KLK4 levels in their tumors.	[Dong, Ying; Stephens, Carson; Walpole, Carina; Swedberg, Joakim E.; Harris, Jonathan M.; Clements, Judith A.] Queensland Univ Technol, Canc Program, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Dong, Ying; Stephens, Carson; Walpole, Carina; Swedberg, Joakim E.; Harris, Jonathan M.; Clements, Judith A.] Queensland Univ Technol, Fac Sci & Technol, Kelvin Grove, Qld, Australia; [Boyle, Glen M.; Parsons, Peter G.] Queensland Inst Med Res, Div Canc & Cell Biol, Drug Discovery Grp, Herston, Qld 4006, Australia; [McGuckin, Michael A.] Mater Med Res Inst, Immun Infect & Inflammat Program, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Mater Research	Clements, JA (corresponding author), Queensland Univ Technol, Canc Program, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.	j.clements@qut.edu.au	Parsons, Peter G/H-8163-2015; Boyle, Glen/G-1347-2013; McGuckin, Michael/G-2310-2010; Parsons, Peter/J-4683-2013; swedberg, Joakim/K-1501-2014	Parsons, Peter G/0000-0002-0473-3346; Boyle, Glen/0000-0002-1385-529X; McGuckin, Michael/0000-0002-8375-2675; Parsons, Peter/0000-0002-0473-3346; swedberg, Joakim/0000-0003-4243-8660; Harris, Jonathan/0000-0003-4209-2380; Walpole, Carina/0000-0002-9599-3396; Clements, Judith/0000-0001-6026-1964	National Health and Medical Research Council (NHMRC) of Australia [242220, 390123, 550523]; Cancer Council of Queensland; Queensland University of Technology; Science and Technology Facilities Council [ST/L001314/1, ST/I005765/1] Funding Source: researchfish; UK Space Agency [ST/J004812/1, ST/G003874/1] Funding Source: researchfish; STFC [ST/I005765/1, ST/L001314/1] Funding Source: UKRI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland); Queensland University of Technology; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The project is supported by National Health and Medical Research Council (NHMRC) of Australia grants 242220, 390123, and 550523; the Cancer Council of Queensland and Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, BRIT J CANCER, V92, P1475, DOI 10.1038/sj.bjc.6602495; Barbolina MV, 2009, CANCER TREAT RES, V149, P319, DOI 10.1007/978-0-387-98094-2_15; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Beaufort N, 2006, BIOL CHEM, V387, P217, DOI 10.1515/BC.2006.029; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2004, MOL CANCER RES, V2, P257; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; Chen H, 2009, BRIT J CANCER, V101, P432, DOI 10.1038/sj.bjc.6605185; Clements JA, 2004, CRIT REV CL LAB SCI, V41, P265, DOI 10.1080/10408360490471931; Cristea Mihaela, 2010, Ther Adv Med Oncol, V2, P175, DOI 10.1177/1758834010361333; Davidowitz RA, 2012, JOVE-J VIS EXP, DOI 10.3791/3888; Davidson B, 2005, AM J CLIN PATHOL, V123, P360, DOI 10.1309/PTBB5BPCKX8K9V69; Davidson B, 2003, GYNECOL ONCOL, V90, P248, DOI 10.1016/S0090-8258(03)00321-4; Davidson B, 2000, J PATHOL, V192, P460; Davidson B, 2010, HISTOL HISTOPATHOL, V25, P1591, DOI 10.14670/HH-25.1591; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Dong Y, 2003, CLIN CANCER RES, V9, P1710; Dong Y, 2001, CLIN CANCER RES, V7, P2363; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Dorn J, 2011, ANN ONCOL, V22, P877, DOI 10.1093/annonc/mdq462; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Frankel A, 1997, CANCER RES, V57, P2388; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Goodman MT, 2003, CANCER, V97, P2648, DOI 10.1002/cncr.11347; Huang L, 2010, J CANCER RES CLIN, V136, P447, DOI 10.1007/s00432-009-0675-4; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Kobayashi H, 2004, INT J CANCER, V110, P134, DOI 10.1002/ijc.20082; Kuhn W, 1999, BRIT J CANCER, V79, P1746, DOI 10.1038/sj.bjc.6690278; Kuk C, 2009, MOL CELL PROTEOMICS, V8, P661, DOI 10.1074/mcp.M800313-MCP200; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Lu Y, 2008, BIOL CHEM, V389, P695, DOI 10.1515/BC.2008.080; Magdolen V, 2003, RECENT RESULTS CANC, V162, P43; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Obiezu CV, 2006, BIOL CHEM, V387, P749, DOI 10.1515/BC.2006.094; Obiezu CV, 2001, CLIN CANCER RES, V7, P2380; Oikonomopoulou K, 2010, BIOL CHEM, V391, P381, DOI 10.1515/BC.2010.045; Pepin D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026075; Puls LE, 1996, GYNECOL ONCOL, V61, P109, DOI 10.1006/gyno.1996.0106; Ramsay AJ, 2008, J BIOL CHEM, V283, P12293, DOI 10.1074/jbc.M709493200; Rauh-Adelmann C, 2000, MOL CARCINOGEN, V28, P236, DOI 10.1002/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H; Ryu O, 2002, EUR J ORAL SCI, V110, P358, DOI 10.1034/j.1600-0722.2002.21349.x; SAKATA K, 1991, BRIT J CANCER, V64, P809, DOI 10.1038/bjc.1991.405; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Shih LM, 2007, GYNECOL ONCOL, V105, P501, DOI 10.1016/j.ygyno.2007.01.018; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Sun XY, 2001, CARCINOGENESIS, V22, P1775, DOI 10.1093/carcin/22.11.1775; Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; Witz CA, 2001, J SOC GYNECOL INVEST, V8, P299, DOI 10.1016/S1071-5576(01)00122-8; Xi ZJ, 2004, GYNECOL ONCOL, V94, P80, DOI 10.1016/j.ygyno.2004.03.044; Yamakoshi Y, 2011, EUR J ORAL SCI, V119, P234, DOI 10.1111/j.1600-0722.2011.00863.x; Yousef GM, 2003, CANCER RES, V63, P2223	60	45	49	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57056	10.1371/journal.pone.0057056	http://dx.doi.org/10.1371/journal.pone.0057056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451143	Green Published, gold			2022-12-25	WOS:000316849500056
J	Jacob, NK; Cooley, JV; Yee, TN; Jacob, J; Alder, H; Wickramasinghe, P; Maclean, KH; Chakravarti, A				Jacob, Naduparambil Korah; Cooley, James V.; Yee, Tamara N.; Jacob, Jidhin; Alder, Hansjuerg; Wickramasinghe, Priyankara; Maclean, Kirsteen H.; Chakravarti, Arnab			Identification of Sensitive Serum microRNA Biomarkers for Radiation Biodosimetry	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; MIR-150; CANCER; CELLS; POPULATION; MECHANISM; PROTEINS; VESICLES; MARKER	Exposure to ionizing radiation through environmental, occupational or a nuclear reactor accident such as the recent Fukushima Daiichi incident often results in major consequences to human health. The injury caused by radiation can manifest as acute radiation syndromes within weeks in organs with proliferating cells such as hematopoietic and gastrointestinal systems. Cancers, fibrosis and degenerative diseases are also reported in organs with differentiated cells, months or years later. Studies conducted on atom bomb survivors, nuclear reactor workers and animal models have shown a direct correlation of these effects with the absorbed dose. Physical dosimeters and the available radio-responsive biologics in body fluids, whose responses are rather indirect, have limitations to accurately evaluate the extent of post exposure damage. We have used an amplification-free, hybridization based quantitative assay utilizing the nCounter multiplex platform developed by nanoString Technologies to compare the levels of over 600 miRNAs in serum from mice irradiated at a range of 1 to 12 Gy at 24 and 48 hr time points. Development of a novel normalization strategy using multiple spike-in oligonucleotides allowed accurate measurement of radiation dose and time dependent changes in serum miRNAs. The response of several evolutionarily conserved miRNAs abundant in serum, were found to be robust and sensitive in the dose range relevant for medical triage and in patients who receive total body radiation as preparative regimen for bone marrow transplantation. Notably, miRNA-150, abundant in lymphocytes, exhibited a dose and time dependent decrease in serum, which we propose as a sensitive marker indicative of lymphocyte depletion and bone marrow damage. Our study has identified several markers useful for evaluation of an individual's response by minimally invasive methods, relevant to triage in case of a radiation accident and evaluation of toxicity and response during and after therapeutic radiation.	[Jacob, Naduparambil Korah; Cooley, James V.; Yee, Tamara N.; Jacob, Jidhin; Chakravarti, Arnab] Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, Columbus, OH 43210 USA; [Alder, Hansjuerg] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Wickramasinghe, Priyankara] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Maclean, Kirsteen H.] NanoString Technol, Seattle, WA USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; The Wistar Institute	Jacob, NK (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, Columbus, OH 43210 USA.	Naduparambil.Jacob@osumc.edu			Ohio State University Comprehensive Cancer Center Research funds; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Ohio State University Comprehensive Cancer Center Research funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Ohio State University Comprehensive Cancer Center Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2012, CELL REP, V2, P1048, DOI 10.1016/j.celrep.2012.09.014; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barcellos-Hoff MH, 1998, RADIAT RES, V150, pS109, DOI 10.2307/3579813; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blakely WF, 2010, HEALTH PHYS, V99, pS184, DOI 10.1097/HP.0b013e3181f26895; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Chng WJ, 2004, CLIN DIAGN LAB IMMUN, V11, P168, DOI 10.1128/CDLI.11.1.168-173.2004; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goans RE, 1997, HEALTH PHYS, V72, P513, DOI 10.1097/00004032-199704000-00001; Hall EJ, 2012, RADIOBIOLOGY RADIOLO, P193; HANSON WR, 1984, RADIAT RES, V100, P290, DOI 10.2307/3576350; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Li CW, 2012, CLIN BIOCHEM, V45, P727, DOI 10.1016/j.clinbiochem.2012.04.013; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Macnaughton WK, 2000, ALIMENT PHARM THER, V14, P523; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Scholl V, 2012, LEUKEMIA RES, V36, P119, DOI 10.1016/j.leukres.2011.08.023; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Singh VK, 2010, EXP HEMATOL, V38, P61, DOI 10.1016/j.exphem.2009.10.008; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Teichler S, 2011, BLOOD, V118, P1899, DOI 10.1182/blood-2010-09-306258; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF ION RAD, VII; UNSCEAR, 2000, SOURC EFF ION RAD UN, VI; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Venugopal SK, 2010, AM J PHYSIOL-GASTR L, V298, pG101, DOI 10.1152/ajpgi.00220.2009; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiland M, 2012, RNA BIOL, V9, P850, DOI 10.4161/rna.20378; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhu Y, 2010, INT J CLIN EXP MED, V3, P211	47	91	102	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57603	10.1371/journal.pone.0057603	http://dx.doi.org/10.1371/journal.pone.0057603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451251	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500120
J	Byers, JE; McDowell, WG; Dodd, SR; Haynie, RS; Pintor, LM; Wilde, SB				Byers, James E.; McDowell, William G.; Dodd, Shelley R.; Haynie, Rebecca S.; Pintor, Lauren M.; Wilde, Susan B.			Climate and pH Predict the Potential Range of the Invasive Apple Snail (Pomacea insularum) in the Southeastern United States	PLOS ONE			English	Article							VACUOLAR MYELINOPATHY; SPECIES DISTRIBUTION; AQUATIC PLANTS; WATER; IMPACTS; PROJECTIONS; DYNAMICS; MODELS; RISK; AREA	Predicting the potential range of invasive species is essential for risk assessment, monitoring, and management, and it can also inform us about a species' overall potential invasiveness. However, modeling the distribution of invasive species that have not reached their equilibrium distribution can be problematic for many predictive approaches. We apply the modeling approach of maximum entropy (MaxEnt) that is effective with incomplete, presence-only datasets to predict the distribution of the invasive island apple snail, Pomacea insularum. This freshwater snail is native to South America and has been spreading in the USA over the last decade from its initial introductions in Texas and Florida. It has now been documented throughout eight southeastern states. The snail's extensive consumption of aquatic vegetation and ability to accumulate and transmit algal toxins through the food web heighten concerns about its spread. Our model shows that under current climate conditions the snail should remain mostly confined to the coastal plain of the southeastern USA where it is limited by minimum temperature in the coldest month and precipitation in the warmest quarter. Furthermore, low pH waters (pH<5.5) are detrimental to the snail's survival and persistence. Of particular note are low-pH blackwater swamps, especially Okefenokee Swamp in southern Georgia (with a pH below 4 in many areas), which are predicted to preclude the snail's establishment even though many of these areas are well matched climatically. Our results elucidate the factors that affect the regional distribution of P. insularum, while simultaneously presenting a spatial basis for the prediction of its future spread. Furthermore, the model for this species exemplifies that combining climatic and habitat variables is a powerful way to model distributions of invasive species.	[Byers, James E.; McDowell, William G.; Pintor, Lauren M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Dodd, Shelley R.; Haynie, Rebecca S.; Wilde, Susan B.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Pintor, Lauren M.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University	Byers, JE (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jebyers@uga.edu	Byers, James/AFJ-8413-2022; McDowell, William/AAC-7707-2019	Byers, James/0000-0001-9240-0287; McDowell, William/0000-0003-0937-9435; Wilde, Susan/0000-0002-5388-9582	State Wildlife Grant Program	State Wildlife Grant Program	Funding came from the State Wildlife Grant Program to Georgia Department of Natural Resources to JEB and SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P, 2010, J MOLLUS STUD, V76, P138, DOI 10.1093/mollus/eyp050; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barnes MA, 2008, J N AM BENTHOL SOC, V27, P738, DOI 10.1899/08-013.1; Beniash E, 2010, MAR ECOL PROG SER, V419, P95, DOI 10.3354/meps08841; Benson AJ, 2010, POMACEA INSULARUM; Berry JP, 2010, TOXICON, V55, P930, DOI 10.1016/j.toxicon.2009.07.035; Blank L., 2012, HYDROBIOLOGIA, V685, P121; Bossenbroek JM, 2001, ECOL APPL, V11, P1778, DOI 10.2307/3061095; Bradley BA, 2006, ECOL APPL, V16, P1132, DOI 10.1890/1051-0761(2006)016[1132:CTLDOA]2.0.CO;2; Burlakova LE, 2010, BIOL INVASIONS, V12, P927, DOI 10.1007/s10530-009-9513-5; Burlakova LE, 2009, RESTOR ECOL, V17, P433, DOI 10.1111/j.1526-100X.2008.00429.x; Byers JE, 2002, CONSERV BIOL, V16, P630, DOI 10.1046/j.1523-1739.2002.01057.x; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Cattau CE, 2010, BIOL CONSERV, V143, P513, DOI 10.1016/j.biocon.2009.11.022; Conner SL, 2008, J MOLLUS STUD, V74, P355, DOI 10.1093/mollus/eyn024; Cowie R. H., 2002, Molluscs as crop pests, P145, DOI 10.1079/9780851993201.0145; Darby Philip C., 2007, Florida Field Naturalist, V35, P79; de Rivera CE, 2011, DIVERS DISTRIB, V17, P1198, DOI 10.1111/j.1472-4642.2011.00790.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Estebenet A.L., 1992, Malacological Review, V25, P1; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Glass NH, 2009, AQUAT ECOL, V43, P1085, DOI 10.1007/s10452-008-9226-3; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Howells RG, 2007, GLOBAL ADV ECOLOGY M, P73; Howells RG., 2001, TEXAS PARKS WILDLIFE, V188; HUNTER RD, 1990, CAN J ZOOL, V68, P1578, DOI 10.1139/z90-233; Jarnevich CS, 2006, DIVERS DISTRIB, V12, P511, DOI 10.1111/j.1366-9516.2006.00278.x; Jarnevich CS, 2009, BIOL INVASIONS, V11, P1373, DOI 10.1007/s10530-008-9345-8; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Karatayev AY, 2009, HYDROBIOLOGIA, V619, P181, DOI 10.1007/s10750-008-9639-y; KEAWJAM R S, 1986, Malacological Review, V19, P61; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lv S, 2011, FRESHWATER BIOL, V56, P717, DOI 10.1111/j.1365-2427.2011.02579.x; Milanovich JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012189; Morisette JT, 2006, FRONT ECOL ENVIRON, V4, P11, DOI 10.1890/1540-9295(2006)004[0012:ATHSMF]2.0.CO;2; Naylor R, 1996, AMBIO, V25, P443; OKLAND J, 1992, ENVIRON POLLUT, V78, P127, DOI 10.1016/0269-7491(92)90020-B; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Perera G., 1996, APPLE SNAILS AQUARIU; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qian SS, 2001, ENVIRON SCI TECHNOL, V35, P941, DOI 10.1021/es0013069; RAMAKRISHNAN V, 2007, SALINITY PH TEMPERAT; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Robertson S, 2012, THESIS U GEORGIA ATH; Rosalino LM, 2010, VIE MILIEU, V60, P39; Roura-Pascual N, 2006, ECOL APPL, V16, P1832, DOI 10.1890/1051-0761(2006)016[1832:NDAFPF]2.0.CO;2; Stohlgren TJ, 2006, RISK ANAL, V26, P163, DOI 10.1111/j.1539-6924.2006.00707.x; STORET, 1995, STORAGE RETRIEVAL US; Thomas NJ, 1998, VET PATHOL, V35, P479, DOI 10.1177/030098589803500602; Turner Richard L., 1996, Florida Scientist, V59, P34; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wilde SB, 2005, ENVIRON TOXICOL, V20, P348, DOI 10.1002/tox.20111	57	58	63	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56812	10.1371/journal.pone.0056812	http://dx.doi.org/10.1371/journal.pone.0056812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451090	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800039
J	Huynh, D; Akcora, D; Malaterre, J; Chan, CK; Dai, XM; Bertoncello, I; Stanley, ER; Ramsay, RG				Duy Huynh; Akcora, Dilara; Malaterre, Jordane; Chan, Chee Kai; Dai, Xu-Ming; Bertoncello, Ivan; Stanley, E. Richard; Ramsay, Robert G.			CSF-1 Receptor-Dependent Colon Development, Homeostasis and Inflammatory Stress Response	PLOS ONE			English	Article							STIMULATING FACTOR-I; EPITHELIAL-CELL TYPES; MOUSE SMALL INTESTINE; MACROPHAGE PROGENITOR CELLS; STEM-CELLS; C-MYB; DIFFERENTIAL SUSCEPTIBILITY; CLONOGENIC GROWTH; FACTOR-1 RECEPTOR; GENE-EXPRESSION	The colony stimulating factor-1 (CSF-1) receptor (CSF-1R) directly regulates the development of Paneth cells (PC) and influences proliferation and cell fate in the small intestine (SI). In the present study, we have examined the role of CSF-1 and the CSF-1R in the large intestine, which lacks PC, in the steady state and in response to acute inflammation induced by dextran sulfate sodium (DSS). As previously shown in mouse, immunohistochemical (IHC) analysis of CSF-1R expression showed that the receptor is baso-laterally expressed on epithelial cells of human colonic crypts, indicating that this expression pattern is shared between species. Colons from Csf1r null and Csf1(op/op) mice were isolated and sectioned for IHC identification of enterocytes, enteroendocrine cells, goblet cells and proliferating cells. Both Csf1r(-/-) and Csf1(op/op) mice were found to have colon defects in enterocytes and enteroendocrine cell fate, with excessive goblet cell staining and reduced cell proliferation. In addition, the gene expression profiles of the cell cycle genes, cyclinD1, c-myc, c-fos, and c-myb were suppressed in Csf1r(-/-) colonic crypt, compared with those of WT mice and the expression of the stem cell marker gene Lgr5 was markedly reduced. However, analysis of the proliferative responses of immortalized mouse colon epithelial cells (lines; Immorto-5 and YAMC) indicated that CSF-1R is not a major regulator of colonocyte proliferation and that its effects on proliferation are indirect. In an examination of the acute inflammatory response, Csf1r(+/-) male mice were protected from the adverse affects of DSS-induced colitis compared with WT mice, while Csf1r(+/-) female mice were significantly less protected. These data indicate that CSF-1R signaling plays an important role in colon homeostasis and stem cell gene expression but that the receptor exacerbates the response to inflammatory challenge in male mice.	[Duy Huynh; Akcora, Dilara; Malaterre, Jordane; Ramsay, Robert G.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Duy Huynh; Chan, Chee Kai] La Trobe Univ, Dept Genet, Melbourne, Vic, Australia; [Akcora, Dilara; Ramsay, Robert G.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Malaterre, Jordane; Ramsay, Robert G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Dai, Xu-Ming; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Bertoncello, Ivan] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; La Trobe University; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Yeshiva University; University of Melbourne	Ramsay, RG (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.	rob.ramsay@petermac.org	Stanley, Evan R/J-9154-2013; Chan, Chee Kai/C-1504-2011; Ramsay, Robert G/C-3291-2015; Bertoncello, Ivan/B-9235-2008	Stanley, Evan R/0000-0002-2910-2065; Chan, Chee Kai/0000-0002-2436-3282; Ramsay, Robert G/0000-0001-5003-0433; Dai, Xuming/0000-0003-3092-9323; AKCORA YILDIZ, Dilara/0000-0003-2586-4385	National Health and Medical Research Council of Australia Program [487922]; Cancer Council of Victoria project grant [400217]; National Institutes of Health grant [CA32551]; Albert Einstein College of Medicine Cancer Center grant [5P30-CA13330]; American Society of Hematology Fellow Scholar Award; Leukaemia and Lymphoma Society Special Fellow Award; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA032551] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Victoria project grant(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Cancer Center grant; American Society of Hematology Fellow Scholar Award; Leukaemia and Lymphoma Society Special Fellow Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Health and Medical Research Council of Australia Program # 487922, the Cancer Council of Victoria project grant #400217 (R.R.), National Institutes of Health grant CA32551 (E.R.S), the Albert Einstein College of Medicine Cancer Center grant 5P30-CA13330, an American Society of Hematology Fellow Scholar Award (X-M. D.) and a Leukaemia and Lymphoma Society Special Fellow Award (X-M.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2006, GUT, V55, P1104, DOI 10.1136/gut.2005.081745; ALEXANDER RJ, 1995, DIGEST DIS SCI, V40, P485, DOI 10.1007/BF02064355; ALTMANN GG, 1983, AM J ANAT, V167, P95, DOI 10.1002/aja.1001670109; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BEDARD M, 1993, AM J RESP CELL MOL, V9, P455, DOI 10.1165/ajrcmb/9.4.455; BEGG SK, 1993, J EXP MED, V177, P237, DOI 10.1084/jem.177.1.237; BERTONCELLO I, 1986, J IMMUNOL, V136, P3219; BERTONCELLO I, 1981, EXP HEMATOL, V9, P604; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BRADLEY TR, 1979, BLOOD, V54, P1446; Calatayud S, 2002, CYTOKINE, V20, P163, DOI 10.1006/cyto.2002.1999; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Cheasley D, 2011, STEM CELLS; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P481, DOI 10.1002/aja.1001410404; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Ginhoux F, 2006, NAT IMMUNOL, V7, P265, DOI 10.1038/ni1307; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Harnish DC, 2004, AM J PHYSIOL-GASTR L, V286, pG118, DOI 10.1152/ajpgi.00024.2003; Hocker M, 1998, ANN NY ACAD SCI, V859, P160, DOI 10.1111/j.1749-6632.1998.tb11120.x; HORIGUCHI J, 1988, BIOCHEM BIOPH RES CO, V157, P395, DOI 10.1016/S0006-291X(88)80060-3; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; MARKS SC, 1976, J HERED, V67, P11, DOI 10.1093/oxfordjournals.jhered.a108657; Marshall D, 2007, INFLAMM BOWEL DIS, V13, P219, DOI 10.1002/ibd.20055; Martin GR, 2006, EXP BIOL MED, V231, P130; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; ORLOFSKY A, 1987, EMBO J, V6, P2947, DOI 10.1002/j.1460-2075.1987.tb02599.x; Pollard JW, 1997, MOL REPROD DEV, V46, P54, DOI 10.1002/(SICI)1098-2795(199701)46:1&lt;54::AID-MRD9&gt;3.0.CO;2-Q; Pollard JW., 1996, ADV D BIOCH, V4, P153; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Ramsay RG, 2004, MOL CANCER RES, V2, P354; Ramsay RG, 2004, J INTERF CYTOK RES, V24, P416, DOI 10.1089/1079990041535638; Romberg-Camps M, 2010, INFLAMM BOWEL DIS, V16, P1397, DOI 10.1002/ibd.21189; Rosenthal MA, 1996, CELL GROWTH DIFFER, V7, P961; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Roussel MF, 1997, MOL REPROD DEV, V46, P11, DOI 10.1002/(SICI)1098-2795(199701)46:1<11::AID-MRD3>3.0.CO;2-U; ROUSSEL MF, 1994, J CELL SCI, P105; Saleiro D, 2012, INT J CANCER, V131, P2553, DOI 10.1002/ijc.27578; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sapi E, 1999, P SOC EXP BIOL MED, V220, P1, DOI 10.1046/j.1525-1373.1999.d01-1.x; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Staley EM, 2009, INFLAMM BOWEL DIS, V15, P684, DOI 10.1002/ibd.20824; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; Whitehead RH, 1999, GASTROENTEROLOGY, V117, P858, DOI 10.1016/S0016-5085(99)70344-6; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WIKTORJEDRZEJCZAK W, 1992, EXP HEMATOL, V20, P1004; Yazbeck R, 2008, FRONT BIOSCI-LANDMRK, V13, P6850, DOI 10.2741/3193; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	64	30	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56951	10.1371/journal.pone.0056951	http://dx.doi.org/10.1371/journal.pone.0056951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451116	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800051
J	Cui, M; Bai, X; Li, TF; Chen, FZ; Dong, Q; Zhao, YX; Liu, XY				Cui, Mei; Bai, Xue; Li, Tianfu; Chen, Fangzhe; Dong, Qiang; Zhao, Yanxin; Liu, Xueyuan			Decreased Extracellular Adenosine Levels Lead to Loss of Hypoxia-Induced Neuroprotection after Repeated Episodes of Exposure to Hypoxia	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INDUCIBLE FACTOR-I; A(2A) RECEPTOR ANTAGONIST; SHORT-TERM PROGNOSIS; ISCHEMIC TOLERANCE; ECTO-5'-NUCLEOTIDASE CD73; FOCAL ISCHEMIA; TARGET GENES; ATP RELEASE; ERYTHROPOIETIN	Achieving a prolonged neuroprotective state following transient ischemic attacks (TIAs) is likely to effectively reduce the brain damage and neurological dysfunction associated with recurrent stroke. HPC is a phenomenon in which advanced exposure to mild hypoxia reduces the stroke volume produced by a subsequent TIA. However, this neuroprotection is not long-lasting, with the effects reaching a peak after 3 days. Therefore, in this study, we investigated the use of multiple episodes of hypoxic exposure at different time intervals to induce longer-term protection in a mouse stroke model. C57BL/6 mice were subjected to different hypoxic preconditioning protocols: a single episode of HPC or five identical episodes at intervals of 3 days (E3d HPC) or 6 days (E6d HPC). Three days after the last hypoxic exposure, temporary middle cerebral artery occlusion (MCAO) was induced. The effects of these HPC protocols on hypoxia-inducible factor (HIF) regulated gene mRNA expression were measured by quantitative PCR. Changes in extracellular adenosine concentrations, known to exert neuroprotective effects, were also measured using in vivo microdialysis and high pressure liquid chromatography (HPLC). Neuroprotection was provided by E6d HPC but not E3d HPC. HIF-regulated target gene expression increased significantly following all HPC protocols. However, E3d HPC significantly decreased extracellular adenosine and reduced cerebral blood flow in the ischemic region with upregulated expression of the adenosine transporter, equilibrative nucleoside transporter 1 (ENT1). An ENT1 inhibitor, propentofylline increased the cerebral blood flow and re-established neuroprotection in E3d HPC. Adenosine receptor specific antagonists showed that adenosine mainly through A1 receptor mediates HPC induced neuroprotection. Our data indicate that cooperation of HIF-regulated genes and extracellular adenosine is necessary for HPC-induced neuroprotection.	[Bai, Xue; Zhao, Yanxin; Liu, Xueyuan] Shanghai Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China; [Cui, Mei; Chen, Fangzhe; Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Li, Tianfu] Capital Med Univ, Beijing Sanbo Brain Hosp, Epilepsy Ctr, Beijing, Peoples R China	Tongji University; Fudan University; Capital Medical University	Zhao, YX (corresponding author), Shanghai Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, Shanghai, Peoples R China.	zhao_yanxin@126.com; Liuxy@tongji.edu.cn			National Natural Science Foundation of China [81000487, 81171023]; Shanghai Rising-Star Program [11QA1400900]; Shanghai Pujiang Program [12PJ1407200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by National Natural Science Foundation of China 81000487 (to M.C) 81171023 (to Y.Z) and Shanghai Rising-Star Program (11QA1400900) and Shanghai Pujiang Program (12PJ1407200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.0.CO;2-8; Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Correia M, 2006, STROKE, V37, P50, DOI 10.1161/01.STR.0000195209.26543.8f; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Feoktistov I, 2004, HYPERTENSION, V44, P649, DOI 10.1161/01.HYP.0000144800.21037.a5; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gui L, 2009, BRAIN RES, V1297, P185, DOI 10.1016/j.brainres.2009.08.050; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Hoyte LC, 2006, BRAIN RES, V1121, P231, DOI 10.1016/j.brainres.2006.08.107; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Jones NM, 2008, PEDIATR RES, V63, P620, DOI 10.1203/PDR.0b013e31816d9117; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Jones PA, 1998, BRAIN RES, V800, P328, DOI 10.1016/S0006-8993(98)00540-X; Khorasani MZ, 2006, BRAIN RES, V1084, P61, DOI 10.1016/j.brainres.2006.01.106; Kim HH, 2008, J CEREBR BLOOD F MET, V28, P1285, DOI 10.1038/jcbfm.2008.24; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; KITAKAZE M, 1994, CIRCULATION, V89, P1237, DOI 10.1161/01.CIR.89.3.1237; Knutsen HK, 1996, BIOL REPROD, V55, P5, DOI 10.1095/biolreprod55.1.5; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kolar F, 2007, AM J PHYSIOL-HEART C, V292, pH224, DOI 10.1152/ajpheart.00689.2006; Leisewitz AV, 2011, BIOCHEM BIOPH RES CO, V404, P370, DOI 10.1016/j.bbrc.2010.11.125; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; Li Yun-Xia, 2008, Neurosci Bull, V24, P89, DOI 10.1007/s12264-008-0089-3; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Lovatt D, 2012, P NATL ACAD SCI USA, V109, P6265, DOI 10.1073/pnas.1120997109; Melani A, 2003, BRAIN RES, V959, P243, DOI 10.1016/S0006-8993(02)03753-8; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Oberdorster G, 1972, PFLUGERS ARCH S332, V332, pR359; Olsson T, 2004, EUR J NEUROSCI, V20, P1197, DOI 10.1111/j.1460-9568.2004.03564.x; PARKINSON FE, 1994, GEN PHARMACOL, V25, P1053, DOI 10.1016/0306-3623(94)90119-8; Parkinson FE, 2000, J NEUROCHEM, V75, P795, DOI 10.1046/j.1471-4159.2000.0750795.x; Parkinson FE, 2005, NEUROL RES, V27, P153, DOI 10.1179/016164105X21878; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Prass K, 2002, J CEREBR BLOOD F MET, V22, P520, DOI 10.1097/00004647-200205000-00003; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sebastiao AM, 2001, J NEUROSCI, V21, P8564, DOI 10.1523/JNEUROSCI.21-21-08564.2001; Sharp Frank R, 2004, NeuroRx, V1, P26, DOI 10.1602/neurorx.1.1.26; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Stagliano NE, 1999, J CEREBR BLOOD F MET, V19, P757, DOI 10.1097/00004647-199907000-00005; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; Wick A, 2002, J NEUROSCI, V22, P6401; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Zhang DL, 2011, J NEUROCHEM, V118, P4, DOI 10.1111/j.1471-4159.2011.07242.x; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230	63	33	34	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57065	10.1371/journal.pone.0057065	http://dx.doi.org/10.1371/journal.pone.0057065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437309	gold, Green Submitted, Green Published			2022-12-25	WOS:000315186000071
J	Li, YM; Lip, G; Chong, V; Yuan, JH; Ding, ZX				Li, Yumei; Lip, Gerald; Chong, Vincent; Yuan, Jianhua; Ding, Zhongxiang			Idiopathic Orbital Inflammation Syndrome with Retro-Orbital Involvement: A Retrospective Study of Eight Patients	PLOS ONE			English	Article							TOLOSA-HUNT-SYNDROME; PSEUDOTUMOR; EXTENSION	Background: The aim of this retrospective study was to document the clinical findings and radiological features of idiopathic orbital inflammation syndrome with retro-orbital involvement. Methods: We searched for ophthalmological patients who received orbital imaging at Zhejiang Provincial People's Hospital between October 2003 and April 2010. Seventy-three patients were diagnosed with idiopathic orbital inflammation syndrome based on clinicoradiological features, with pathological confirmation of nonspecific inflammatory conditions in 47 patients. Eight patients (11%) had MRI or CT evidence of retro-orbital involvement. All 8 patients were diagnosed with idiopathic orbital inflammation syndrome after biopsy of the orbital lesion. MR images were obtained for all 8 patients; 3 patients also had a contrast-enhanced CT scan. Results: Seven out of 8 patients with retro-orbital involvement also had orbital apex lesions. Of the 65 patients without retro-orbital involvement, 19 had orbital apex lesions. The difference in the number of patients with orbital apex lesions between the two populations was significant (Fisher exact test P = .002). In all 8 patients with retro-orbital involvement, the inflammation spread through the superior orbital fissure. The retro-orbital lesions were isointense to grey matter on T1-weighted images, hypointense on T2-weighted images, and displayed uniform contrast enhancement; on contrast-enhanced CT scans, they were hyperdense relative to the contralateral mirror area and had radiological contours that were similar to those seen on MR images. The diffuse inflammation with marked sclerosis and hyalinization that we observed in the patients with retro-orbital involvement is consistent with the diagnosis of the sclerosing subtype of idiopathic orbital inflammation syndrome. All 8 patients also complained of mild to moderate periorbital pain (headache). Conclusions: In patients with idiopathic orbital inflammation syndrome, it is important to perform MRI and CT scans to identify possible retro-orbital involvement. Retro-orbital involvement is more frequent when the lesion is present in the orbital apex.	[Li, Yumei; Yuan, Jianhua; Ding, Zhongxiang] Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Lip, Gerald; Chong, Vincent; Ding, Zhongxiang] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Dept Diagnost Imaging, Singapore 117595, Singapore	Zhejiang Provincial People's Hospital; National University of Singapore	Ding, ZX (corresponding author), Zhejiang Prov Peoples Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China.	hangzhoudzx73@126.com						Bag AK, 2010, AM J ROENTGENOL, V 195, pS37, DOI 10.2214/AJR.09.7200; Birch-Hirschfeld A., 1905, BER DTSCH OPHTHALMOL, V32, P127; Charkoudian LD, 2012, OCUL IMMUNOL INFLAMM, V20, P91, DOI 10.3109/09273948.2011.646382; Chua JLL, 2008, ANN ACAD MED SINGAP, V37, P964; CLIFTON AG, 1992, CLIN RADIOL, V45, P23, DOI 10.1016/S0009-9260(05)81462-X; Ding ZX, 2011, CLIN RADIOL, V66, P886, DOI 10.1016/j.crad.2011.03.018; Goh PS, 2008, EUR J RADIOL, V66, P387, DOI 10.1016/j.ejrad.2008.03.031; HARDMAN JA, 1995, NEURORADIOLOGY, V37, P475; Kapur R, 2009, AM J NEURORADIOL, V30, P64, DOI 10.3174/ajnr.A1315; Kline LB, 2001, J NEUROL NEUROSUR PS, V71, P577, DOI 10.1136/jnnp.71.5.577; Lee EJ, 2005, KOREAN J RADIOL, V6, P82, DOI 10.3348/kjr.2005.6.2.82; McKinney AM, 2006, AM J NEURORADIOL, V27, P2217; Pemberton JD, 2012, OPHTHAL PLAST RECONS, V28, P79, DOI 10.1097/IOP.0b013e318238ecf7; Som PM, 2003, HEAD NECK IMAGING, P329; Weber AL, 1999, RADIOL CLIN N AM, V37, P151, DOI 10.1016/S0033-8389(05)70084-1; YOUSEM DM, 1990, AM J ROENTGENOL, V154, P167, DOI 10.2214/ajr.154.1.2104703	16	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57126	10.1371/journal.pone.0057126	http://dx.doi.org/10.1371/journal.pone.0057126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437329	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000078
J	Lobelle, D; Kenyon, EJ; Cook, KJ; Bull, JC				Lobelle, Delphine; Kenyon, Emma J.; Cook, Kevan J.; Bull, James C.			Local Competition and Metapopulation Processes Drive Long-Term Seagrass-Epiphyte Population Dynamics	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; COLONIZATION-EXTINCTION DYNAMICS; POSIDONIA-OCEANICA; COMMUNITY STRUCTURE; WESTERN AUSTRALIA; ALGAL EPIPHYTES; WASTING DISEASE; COCKBURN SOUND; BIOMASS; ASSEMBLAGES	It is well known that ecological processes such as population regulation and natural enemy interactions potentially occur over a range of spatial scales, and there is a substantial body of literature developing theoretical understanding of the interplay between these processes. However, there are comparatively few studies quantifying the long-term effects of spatial scaling in natural ecosystems. A key challenge is that trophic complexity in real-world biological communities quickly obscures the signal from a focal process. Seagrass meadows provide an excellent opportunity in this respect: in many instances, seagrasses effectively form extensive natural monocultures, in which hypotheses about endogenous dynamics can be formulated and tested. We present amongst the longest unbroken, spatially explict time series of seagrass abundance published to date. Data include annual measures of shoot density, total above-ground abundance, and associated epiphyte cover from five Zostera marina meadows distributed around the Isles of Scilly, UK, from 1996 to 2011. We explore empirical patterns at the local and metapopulation scale using standard time series analysis and develop a simple population dynamic model, testing the hypothesis that both local and metapopulation scale feedback processes are important. We find little evidence of an interaction between scales in seagrass dynamics but that both scales contribute approximately equally to observed local epiphyte abundance. By quantifying the long-term dynamics of seagrass-epiphyte interactions we show how measures of density and extent are both important in establishing baseline information relevant to predicting responses to environmental change and developing management plans. We hope that this study complements existing mechanistic studies of physiology, genetics and productivity in seagrass, whilst highlighting the potential of seagrass as a model ecosystem. More generally, this study provides a rare opportunity to test some of the predictions of ecological theory in a natural ecosystem of global conservation and economic value.	[Lobelle, Delphine; Bull, James C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Kenyon, Emma J.] Univ Birmingham, Coll Med & Dent Sci, Birmingham, AL USA; [Cook, Kevan J.] Nat England, Truro, England	University of Warwick	Bull, JC (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	jimbull@gmail.com		Lobelle, Delphine/0000-0003-1517-4815; Bull, James/0000-0002-4373-6830				Alcoverro T, 1997, AQUAT BOT, V56, P93, DOI 10.1016/S0304-3770(96)01098-4; Amarasekare P, 1998, AM NAT, V152, P298, DOI 10.1086/286169; Bonsall MB, 2005, P ROY SOC B-BIOL SCI, V272, P1465, DOI 10.1098/rspb.2005.3111; Bonsall MB, 2004, J ANIM ECOL, V73, P1043, DOI 10.1111/j.0021-8790.2004.00874.x; Borowitzka M, 1989, BIOL SEAGRASSES, P458; BOROWITZKA MA, 1990, MAR ECOL PROG SER, V64, P281, DOI 10.3354/meps064281; Borowitzka MA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P441; BORUM J, 1985, MAR BIOL, V87, P211, DOI 10.1007/BF00539431; Bowden DA, 2001, J EXP MAR BIOL ECOL, V259, P133, DOI 10.1016/S0022-0981(01)00236-2; Bull JC, 2006, J ANIM ECOL, V75, P899, DOI 10.1111/j.1365-2656.2006.01107.x; Bull JC, 2012, OECOLOGIA, V169, P135, DOI 10.1007/s00442-011-2187-6; BULTHUIS DA, 1983, AQUAT BOT, V16, P137, DOI 10.1016/0304-3770(83)90089-X; BURDICK DM, 1993, MAR ECOL PROG SER, V94, P83, DOI 10.3354/meps094083; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAMBRIDGE ML, 1986, AQUAT BOT, V24, P269, DOI 10.1016/0304-3770(86)90062-8; Cardoso PG, 2004, J EXP MAR BIOL ECOL, V302, P233, DOI 10.1016/j.jembe.2003.10.014; Caruso A, 2010, OIKOS, V119, P1947, DOI 10.1111/j.1600-0706.2010.18713.x; COLEMAN VL, 1994, J EXP MAR BIOL ECOL, V179, P29, DOI 10.1016/0022-0981(94)90015-9; Cook K.J., 2002, ISLES SCILLY ZOSTERA; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; CULLINANE J, 1985, CRYPTOGAMIE ALGOL, V6, P239; Cunha AH, 2009, ESTUAR COAST SHELF S, V84, P584, DOI 10.1016/j.ecss.2009.07.030; Cunha AH, 2005, ESTUAR COAST SHELF S, V64, P636, DOI 10.1016/j.ecss.2005.03.018; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; Deegan LA, 2002, AQUAT CONSERV, V12, P193, DOI 10.1002/aqc.490; DENNISON WC, 1987, AQUAT BOT, V27, P15, DOI 10.1016/0304-3770(87)90083-0; Duarte CM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P271; DUARTE CM, 1987, CAN J FISH AQUAT SCI, V44, P1759, DOI 10.1139/f87-215; Duarte CM, 1999, AQUAT BOT, V65, P159, DOI 10.1016/S0304-3770(99)00038-8; Duarte CM, 2002, ENVIRON CONSERV, V29, P192, DOI 10.1017/S0376892902000127; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Fourqurean JW, 2010, MAR ECOL PROG SER, V419, P223, DOI 10.3354/meps08853; Frankovich TA, 1997, MAR ECOL PROG SER, V159, P37, DOI 10.3354/meps159037; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Hanski I., 1999, METAPOPULATION ECOLO; HARLIN M M, 1975, Aquatic Botany, V1, P125, DOI 10.1016/0304-3770(75)90017-0; HEIJS FML, 1985, AQUAT BOT, V21, P295, DOI 10.1016/0304-3770(85)90074-9; HEIJS FML, 1984, AQUAT BOT, V20, P195, DOI 10.1016/0304-3770(84)90087-1; Jackson EL, 2011, 087 NAT ENGL; Johansson V, 2012, ECOLOGY, V93, P235, DOI 10.1890/11-0760.1; Johnson MP, 2005, AQUAT BOT, V82, P12, DOI 10.1016/j.aquabot.2005.02.003; Kendrick GA, 2005, MAR ECOL PROG SER, V290, P291, DOI 10.3354/meps290291; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Lavery PS, 2002, MAR ECOL PROG SER, V236, P99, DOI 10.3354/meps236099; Lepoint G, 1999, HYDROBIOLOGIA, V394, P63, DOI 10.1023/A:1003557303904; LETHBRIDGE RC, 1988, AQUAT BOT, V31, P153, DOI 10.1016/0304-3770(88)90045-9; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; MacArthur R.H., 1972, pvii; Marba N, 1996, MAR ECOL PROG SER, V137, P203, DOI 10.3354/meps137203; McGlinn DJ, 2012, ECOLOGY, V93, P294, DOI 10.1890/11-0229.1; McLaughlin JF, 1992, THEOR POPUL BIOL, V41, P337; MONCREIFF CA, 1992, MAR ECOL PROG SER, V87, P161, DOI 10.3354/meps087161; Moore KA, 1997, J EXP MAR BIOL ECOL, V215, P115, DOI 10.1016/S0022-0981(96)02774-8; OLESEN B, 1994, J ECOL, V82, P379, DOI 10.2307/2261305; OLESEN B, 1994, MAR ECOL PROG SER, V109, P283, DOI 10.3354/meps109283; ORTH RJ, 1984, AQUAT BOT, V18, P43, DOI 10.1016/0304-3770(84)90080-9; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Peck SL, 2012, ECOL MODEL, V246, P99, DOI 10.1016/j.ecolmodel.2012.07.016; Piazzi L, 2000, CRYPTOGAMIE ALGOL, V21, P291, DOI 10.1016/S0181-1568(00)00116-1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plus M, 2001, J EXP MAR BIOL ECOL, V259, P63, DOI 10.1016/S0022-0981(01)00223-4; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Reusch TBH, 1999, MOL ECOL, V8, P317, DOI 10.1046/j.1365-294X.1999.00531.x; Reyes J, 1998, BOT MAR, V41, P543, DOI 10.1515/botm.1998.41.1-6.543; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; Roberge JM, 2011, J APPL ECOL, V48, P650, DOI 10.1111/j.1365-2664.2011.01963.x; Romero J, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P227; Royama T., 1992, ANAL POPULATION ECOL; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Ruiz JM, 2001, MAR ECOL PROG SER, V215, P107, DOI 10.3354/meps215107; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; SAND-JENSEN K, 1977, Aquatic Botany, V3, P55, DOI 10.1016/0304-3770(77)90004-3; Saunders JE, 2003, MAR ECOL PROG SER, V249, P107, DOI 10.3354/meps249107; SILBERSTEIN K, 1986, AQUAT BOT, V24, P355, DOI 10.1016/0304-3770(86)90102-6; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Stankelis RM, 2003, ESTUARIES, V26, P186, DOI 10.1007/BF02695961; Sutcliffe OL, 1997, OECOLOGIA, V109, P235, DOI 10.1007/s004420050078; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Thomsen MS, 2012, PLOS ONE, V7, P21, DOI 10.1371/journal.pone.0028595; Townsend C., 2008, ESSENTIALS ECOLOGY, P281; van der Heide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042060; Vanderklift MA, 2000, MAR ECOL PROG SER, V192, P127, DOI 10.3354/meps192127; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wear DJ, 1999, MAR ECOL PROG SER, V179, P201, DOI 10.3354/meps179201; Winkler M, 2009, ANN BOT-LONDON, V104, P995, DOI 10.1093/aob/mcp188; Yamamuro M, 1999, CORAL REEFS, V18, P263, DOI 10.1007/s003380050191; Zimmerman RC, 1987, STROKE MICROCIRCULAT, P303; Zipperle AM, 2011, ANN BOT-LONDON, V107, P127, DOI 10.1093/aob/mcq214; Zipperle AM, 2010, AQUAT BOT, V93, P202, DOI 10.1016/j.aquabot.2010.05.002	92	15	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57072	10.1371/journal.pone.0057072	http://dx.doi.org/10.1371/journal.pone.0057072			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437313	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000315186000073
J	Gierszewski, S; Bleckmann, H; Schluessel, V				Gierszewski, Stefanie; Bleckmann, Horst; Schluessel, Vera			Cognitive Abilities in Malawi Cichlids (Pseudotropheus sp.): Matching-to-Sample and Image/Mirror-Image Discriminations	PLOS ONE			English	Article							VISUAL-PATTERN-RECOGNITION; MENTAL ROTATION; CONDITIONAL DISCRIMINATION; MIRROR IMAGES; ORIENTATION; PERFORMANCE; PERCEPTION; EVOLUTION; STIMULI; PIGEONS	The ability to recognize and distinguish between visual stimuli is fundamental for everyday survival of many species. While diverse aspects of cognition, including complex visual discrimination tasks were previously successfully assessed in fish, it remains unknown if fish can learn a matching-to-sample concept using geometrical shapes and discriminate between images and their mirror-image counterparts. For this purpose a total of nine Malawi cichlids (Pseudotropheus sp.) were trained in two matching-to-sample (MTS) and three two-choice discrimination tasks using geometrical, two-dimensional visual stimuli. Two out of the three discrimination experiments focused on the ability to discriminate between images and their mirror-images, the last was a general discrimination test. All fish showed quick associative learning but were unable to perform successfully in a simultaneous MTS procedure within a period of 40 sessions. Three out of eight fish learned to distinguish between an image and its mirror-image when reflected vertically; however none of the fish mastered the task when the stimulus was reflected horizontally. These results suggest a better discrimination ability of vertical compared to horizontal mirror-images, an observation that is widespread in literature on mirror-image discrimination in animals. All fish performed well in the general visual discrimination task, thereby supporting previous results obtained for this species.	[Gierszewski, Stefanie; Bleckmann, Horst; Schluessel, Vera] Univ Bonn, Inst Zool, Bonn, Nordrhein Westf, Germany	University of Bonn	Schluessel, V (corresponding author), Univ Bonn, Inst Zool, Bonn, Nordrhein Westf, Germany.	v.schluessel@uni-bonn.de	Gierszewski, Stefanie/AAE-8869-2020; Gierszewski, Stefanie/I-5925-2015	Gierszewski, Stefanie/0000-0002-0043-5077				APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Arthur D, 2001, ANIM COGN, V4, P125, DOI DOI 10.1007/S100710100111; Beale I.L., 2020, PSYCHOL LEFT RIGHT; BEHREND ER, 1961, AM J PSYCHOL, V74, P542, DOI 10.2307/1419664; BERRYMAN R, 1963, J EXP ANAL BEHAV, V6, P101, DOI 10.1901/jeab.1963.6-101; BLOUGH DS, 1959, J EXP ANAL BEHAV, V2, P151, DOI 10.1901/jeab.1959.2-151; BORNSTEIN MH, 1978, COGNITION, V6, P89, DOI 10.1016/0010-0277(78)90017-3; BOWMAN R, 1969, Q J EXP PSYCHOL, V21, P69, DOI 10.1080/14640746908400198; BRADSHAW J, 1976, Q J EXP PSYCHOL, V28, P221, DOI 10.1080/14640747608400553; BROWN JV, 1983, Q J EXP PSYCHOL-B, V35, P119, DOI 10.1080/14640748308400898; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Burmann B, 2005, BRAIN BEHAV EVOLUT, V65, P168, DOI 10.1159/000083626; CARTER DE, 1975, SCIENCE, V187, P662, DOI 10.1126/science.1114318; Colwill RM, 2005, BEHAV PROCESS, V70, P19, DOI 10.1016/j.beproc.2005.03.001; CORBALLIS MC, 1984, J EXP PSYCHOL HUMAN, V10, P318, DOI 10.1037/0096-1523.10.2.318; DAMATO MR, 1985, ANIM LEARN BEHAV, V13, P375, DOI 10.3758/BF03208013; DAMATO MR, 1985, J EXP PSYCHOL ANIM B, V11, P35, DOI 10.1037/0097-7403.11.1.35; Day LB, 2003, J COMP PSYCHOL, V117, P440, DOI 10.1037/0735-7036.117.4.440; DELIUS JD, 1995, J COMP PSYCHOL, V109, P278, DOI 10.1037/0735-7036.109.3.278; Demski L.S., 1983, P317; DUCKER G, 1979, Z TIERPSYCHOL, V51, P269; Ducker G, 1984, ZOOL BEITR, V28, P187; Dyer AG, 2012, J EXP BIOL, V215, P387, DOI 10.1242/jeb.038190; Engelmann WE, 2005, ZOOTIERHALTUNG TIERE, V3; ETTLINGER G, 1962, NATURE, V194, P1101, DOI 10.1038/1941101c0; FARTHING GW, 1974, J EXP ANAL BEHAV, V21, P199, DOI 10.1901/jeab.1974.21-199; FOSTER TM, 1995, J EXP ANAL BEHAV, V64, P19, DOI 10.1901/jeab.1995.64-19; Frech B, 2012, J COMP PHYSIOL A, V198, P53, DOI 10.1007/s00359-011-0685-y; Gellermann LW, 1933, PEDAGOG SEMIN J GEN, V42, P206; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; GOLDMAN M, 1979, J EXP ANAL BEHAV, V31, P259, DOI 10.1901/jeab.1979.31-259; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; HEPPER PG, 1988, PERCEPTION, V17, P549, DOI 10.1068/p170549; HERMAN LM, 1974, J EXP ANAL BEHAV, V21, P17; HERT E, 1989, ANIM BEHAV, V37, P726, DOI 10.1016/0003-3472(89)90058-4; Herter K, 1953, FISCHDRESSUREN IHRE; HOLLARD VD, 1982, SCIENCE, V218, P804, DOI 10.1126/science.7134976; HOPKINS WD, 1993, J EXP PSYCHOL GEN, V122, P61, DOI 10.1037/0096-3445.122.1.61; Huber R, 1997, BRAIN BEHAV EVOLUT, V50, P167, DOI 10.1159/000113330; IVERSEN IH, 1993, J EXP ANAL BEHAV, V59, P471, DOI 10.1901/jeab.1993.59-471; Iversen IH, 1997, J EXP ANAL BEHAV, V68, P27, DOI 10.1901/jeab.1997.68-27; IVERSEN IH, 1986, J EXP ANAL BEHAV, V45, P297, DOI 10.1901/jeab.1986.45-297; Jenkin SEM, 2010, LEARN BEHAV, V38, P418, DOI 10.3758/LB.38.4.418; KASTAK D, 1994, ANIM LEARN BEHAV, V22, P427, DOI 10.3758/BF03209162; Keenleyside MHA, 1991, CHICHLID FISHES BEHA; Kirk SA, 1936, J COMP PSYCHOL, V21, P145, DOI 10.1037/h0057154; KONORSKI J., 1959, BULL ACAD POLONAISE SCI SER SCI BIOL, V7, P115; KORNELUK YG, 1995, BEHAVIOUR, V132, P87, DOI 10.1163/156853995X00306; Kotrschal K, 1998, REV FISH BIOL FISHER, V8, P373, DOI 10.1023/A:1008839605380; Lashley KS, 1938, J GEN PSYCHOL, V18, P123, DOI 10.1080/00221309.1938.9709894; Leal M, 2012, BIOL LETTERS, V8, P28, DOI 10.1098/rsbl.2011.0480; LOHMANN A, 1988, J COMP PSYCHOL, V102, P3, DOI 10.1037/0735-7036.102.1.3; Mackay H.A., 1991, EXPT ANAL BEHAV, V6, P301; MACKINTOSH J., 1963, ANIMAL BEHAVIOUR, V11, P135, DOI 10.1016/0003-3472(63)90021-6; MARK RF, 1969, ANIM BEHAV, V17, P155, DOI 10.1016/0003-3472(69)90124-9; MARK RF, 1966, EXP NEUROL, V16, P215, DOI 10.1016/0014-4886(66)90100-2; Mauck B, 1997, J EXP BIOL, V200, P1309; Nissen HW, 1937, J COMP PSYCHOL, V23, P165, DOI 10.1037/h0062381; PACK AA, 1991, ANIM LEARN BEHAV, V19, P37, DOI 10.3758/BF03197858; Phillmore LS, 2008, BEHAV PROCESS, V77, P285, DOI 10.1016/j.beproc.2007.11.004; Plowright CMS, 1997, ANIM BEHAV, V53, P1295, DOI 10.1006/anbe.1996.0363; Preacher KJ, 2001, CALCULATION CHI SQUA; Range F, 2008, ACTA ETHOL, V11, P34, DOI 10.1007/s10211-008-0039-0; RIOPELLE AJ, 1964, PERCEPT MOTOR SKILL, V19, P383, DOI 10.2466/pms.1964.19.2.383; RUDEL RG, 1963, J COMP PHYSIOL PSYCH, V56, P892, DOI 10.1037/h0046592; SANFORD CG, 1986, PSYCHOL REC, V36, P439, DOI 10.1007/BF03394964; SCHALLER A., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P370, DOI 10.1007/BF00340839; Schluessel V, 2012, ANIM COGN, V15, P525, DOI 10.1007/s10071-012-0480-3; SCHUCK JR, 1960, J COMP PHYSIOL PSYCH, V53, P251, DOI 10.1037/h0044769; Schuster S, 2002, J EXP BIOL, V205, P549; Schwarz S, 2011, ANIM COGN, V14, P861, DOI 10.1007/s10071-011-0419-0; Shettleworth S.J., 2009, COGNITION EVOLUTION; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; Shumway CA, 2008, BRAIN BEHAV EVOLUT, V72, P123, DOI 10.1159/000151472; Shumway CA, 2010, CURR ZOOL, V56, P144, DOI 10.1093/czoolo/56.1.144; SIDMAN M, 1982, J EXP ANAL BEHAV, V37, P5, DOI 10.1901/jeab.1982.37-5; Siebeck UE, 2009, J EXP BIOL, V212, P2112, DOI 10.1242/jeb.028936; Smirnova AA, 2000, J EXP ANAL BEHAV, V73, P163, DOI 10.1901/jeab.2000.73-163; Smith NB, 1928, J EDUC PSYCHOL, V19, P560, DOI 10.1037/h0069779; Sovrano VA, 2008, ANIM COGN, V11, P161, DOI 10.1007/s10071-007-0100-9; Sovrano VA, 2009, PERCEPTION, V38, P579, DOI 10.1068/p6121; SUTHERLA.NS, 1969, Q J EXP PSYCHOL, V21, P330, DOI 10.1080/14640746908400228; SUTHERLAND NS, 1957, NATURE, V179, P11, DOI 10.1038/179011a0; SUTHERLAND NS, 1964, BRIT MED BULL, V20, P54, DOI 10.1093/oxfordjournals.bmb.a070283; SUTHERLAND NS, 1969, J COMP PHYSIOL PSYCH, V67, P160, DOI 10.1037/h0026798; SUTHERLAND NS, 1960, BRIT J PSYCHOL, V51, P9, DOI 10.1111/j.2044-8295.1960.tb00719.x; SUTHERLAND NS, 1958, J COMP PHYSIOL PSYCH, V51, P452, DOI 10.1037/h0048231; TODRIN DC, 1983, PERCEPT PSYCHOPHYS, V34, P397, DOI 10.3758/BF03203053; Tomina Y, 2012, BEHAV BRAIN RES, V229, P91, DOI 10.1016/j.bbr.2011.12.044; Vermaercke B, 2012, CURR BIOL, V22, P50, DOI 10.1016/j.cub.2011.11.041; WARREN JM, 1969, J COMP PHYSIOL PSYCH, V69, P9, DOI 10.1037/h0027954; WRIGHT AA, 1988, ANIM LEARN BEHAV, V16, P436, DOI 10.3758/BF03209384; WRIGHT AA, 2001, AVIAN VISUAL COGNITI; Wyzisk K, 2007, VISUAL NEUROSCI, V24, P291, DOI 10.1017/S095252380707023X; ZERBOLIO DJ, 1983, ANIM LEARN BEHAV, V11, P341, DOI 10.3758/BF03199786	95	32	32	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57363	10.1371/journal.pone.0057363	http://dx.doi.org/10.1371/journal.pone.0057363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437376	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200248
J	Raman, K; Trivedi, NN; Raymond, WW; Ganesan, R; Kirchhofer, D; Verghese, GM; Craik, CS; Schneider, EL; Nimishakavi, S; Caughey, GH				Raman, Kavita; Trivedi, Neil N.; Raymond, Wilfred W.; Ganesan, Rajkumar; Kirchhofer, Daniel; Verghese, George M.; Craik, Charles S.; Schneider, Eric L.; Nimishakavi, Shilpa; Caughey, George H.			Mutational Tail Loss Is an Evolutionary Mechanism for Liberating Marapsins and Other Type I Serine Proteases from Transmembrane Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIRWAY EPITHELIAL-CELLS; MAST-CELL; SUBSTRATE-SPECIFICITY; PRIMATE EVOLUTION; CATHEPSINS L; PROSTASIN; TRYPTASES; PEPTIDASES; CHYMASE; EXPRESSION	Human and mouse marapsins (Prss27) are serine proteases preferentially expressed by stratified squamous epithelia. However, mouse marapsin contains a transmembrane anchor absent from the human enzyme. To gain insights into physical forms, activities, inhibition, and roles in epithelial differentiation, we traced tail loss in human marapsin to a nonsense mutation in an ancestral ape, compared substrate preferences of mouse and human marapsins with those of the epithelial peptidase prostasin, designed a selective substrate and inhibitor, and generated Prss27-null mice. Phylogenetic analysis predicts that most marapsins are transmembrane proteins. However, nonsense mutations caused membrane anchor loss in three clades: human/bonobo/chimpanzee, guinea pig/degu/tuco-tuco/mole rat, and cattle/yak. Most marapsin-related proteases, including prostasins, are type I transmembrane proteins, but the closest relatives (prosemins) are not. Soluble mouse and human marapsins are tryptic with subsite preferences distinct from those of prostasin, lack general proteinase activity, and unlike prostasins resist antiproteases, including leupeptin, aprotinin, serpins, and alpha(2)-macroglobulin, suggesting the presence of non-canonical active sites. Prss27-null mice develop normally in barrier conditions and are fertile without overt epithelial defects, indicating that marapsin does not play critical, non-redundant roles in development, reproduction, or epithelial differentiation. In conclusion, marapsins are conserved, inhibitor-resistant, tryptic peptidases. Although marapsins are type I transmembrane proteins in their typical form, they mutated independently into anchorless forms in several mammalian clades, including one involving humans. Similar pathways appear to have been traversed by prosemins and tryptases, suggesting that mutational tail loss is an important means of evolving new functions of tryptic serine proteases from transmembrane ancestors.	[Raman, Kavita; Raymond, Wilfred W.; Nimishakavi, Shilpa; Caughey, George H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Trivedi, Neil N.; Caughey, George H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Craik, Charles S.; Schneider, Eric L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Ganesan, Rajkumar; Kirchhofer, Daniel] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Verghese, George M.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Caughey, George H.] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; University of Virginia; Northern California Institute for Research & Education; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Caughey, GH (corresponding author), Vet Affairs Med Ctr, 111D,4150 Clement St, San Francisco, CA 94121 USA.	george.caughey@ucsf.edu	Ganesan, Rajkumar/B-1093-2008	Ganesan, Rajkumar/0000-0002-3431-9664; Schneider, Eric/0000-0001-7274-7961	National Institutes of Health [P01 HL024136]; Northern California Institute for Research and Education; United States Department of Defense [PC111318]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northern California Institute for Research and Education; United States Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL024136 (to K. R, W. W. R., S. N., and G. H. C.). This work was also supported by the Northern California Institute for Research and Education (to N. N. T. and G. H. C.) and United States Department of Defense Grant PC111318 (to C. S. C.).	Adachi W, 2006, INVEST OPHTH VIS SCI, V47, P3801, DOI 10.1167/iovs.06-0216; Bhagwandin VJ, 2003, J BIOL CHEM, V278, P3363, DOI 10.1074/jbc.M209353200; Caughey GH, 2008, J BIOL CHEM, V283, P13943, DOI 10.1074/jbc.M710502200; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Chen LM, 2001, J BIOL CHEM, V276, P21434, DOI 10.1074/jbc.M011423200; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Le QT, 2011, J IMMUNOL, V187, P1912, DOI 10.4049/jimmunol.1001806; Le QT, 2011, J IMMUNOL, V186, P7136, DOI 10.4049/jimmunol.1001804; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li W, 2009, J BIOL CHEM, V284, P218, DOI 10.1074/jbc.M806267200; Netzel-Arnett S, 2003, CANCER METAST REV, V22, P237, DOI 10.1023/A:1023003616848; Nimishakavi S, 2012, AM J PHYSIOL-LUNG C, V303, pL97, DOI 10.1152/ajplung.00303.2011; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; Raymond WW, 2009, J IMMUNOL, V182, P5770, DOI 10.4049/jimmunol.0900127; Raymond WW, 2006, J BIOL CHEM, V281, P1489, DOI 10.1074/jbc.M511154200; Raymond WW, 2005, ARCH BIOCHEM BIOPHYS, V435, P311, DOI 10.1016/j.abb.2004.12.025; Raymond WW, 2003, J BIOL CHEM, V278, P34517, DOI 10.1074/jbc.M304087200; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Reimer JM, 2010, IMMUNOGENETICS, V62, P369, DOI 10.1007/s00251-010-0443-2; Spraggon G, 2009, PROTEIN SCI, V18, P1081, DOI 10.1002/pro.118; Trivedi NN, 2008, J ALLERGY CLIN IMMUN, V121, P1262, DOI 10.1016/j.jaci.2008.01.019; Trivedi NN, 2007, J IMMUNOL, V179, P6072, DOI 10.4049/jimmunol.179.9.6072; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Verghese GM, 2004, AM J RESP CELL MOL, V30, P519, DOI 10.1165/rcmb.2003-0251OC; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Wong GW, 2005, BIOCHEM BIOPH RES CO, V336, P579, DOI 10.1016/j.bbrc.2005.08.137; Wong GW, 2004, J BIOL CHEM, V279, P2438, DOI 10.1074/jbc.M308209200; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Wong UW, 1999, J BIOL CHEM, V274, P30784, DOI 10.1074/jbc.274.43.30784; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	41	4	4	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10588	10598		10.1074/jbc.M112.449033	http://dx.doi.org/10.1074/jbc.M112.449033			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447538	Green Published, hybrid			2022-12-25	WOS:000317565000038
J	Ren, WY; Sun, YM; Cheema, S; Du, KY				Ren, Wenying; Sun, Yingmin; Cheema, Sarwat; Du, Keyong			Interaction of Constitutive Photomorphogenesis 1 Protein with Protein-Tyrosine Phosphatase 1B Suppresses Protein-Tyrosine Phosphatase 1B Activity and Enhances Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE COP1; REGULATES C-JUN; TUMOR-SUPPRESSOR; DOWN-REGULATION; MICE LACKING; KINASE-B; PTP1B; TRB3; TRANSDUCTION; ACTIVATION	Recent studies reveal that COP1 suppresses the expression of gluconeogenetic genes and prohibits hepatic glucose production. To get more insight into COP1 in hepatic cells, we examined the impact of COP1 on insulin-responsive genes and insulin signaling. We found that COP1 increased the responsiveness of insulin-modulated genes to insulin in that it promoted the expression of insulin-induced genes and inhibited that of insulin-suppressed genes and that COP1 enhanced insulin signaling as it promoted phosphorylation of Akt and ERK as well as tyrosine phosphorylation of IR beta induced by insulin. To delineate the mechanism under which COP1 modulates insulin signaling, we examined the possibility that COP1 modulates the activity of PTP1B, the major insulin receptor tyrosine phosphatase. The results indicated that COP1 physically interacted with PTP1B and suppressed PTP1B phosphatase activity as well as the association of PTP1B with IR beta. We suggest that COP1 is a positive regulator of hepatic insulin signaling.	[Ren, Wenying; Sun, Yingmin; Cheema, Sarwat; Du, Keyong] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Tufts Medical Center	Du, KY (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, 800 Washington St, Boston, MA 02111 USA.	kdu@tuftsmedicalcenter.org			National Institutes of Health [RO1 DK084319, R56 DK084319]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084319, R56DK084319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK084319 and R56 DK084319 (to K. D.). This work was also supported by The American Diabetes Association Career Development Award (to K. D.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Baert JL, 2010, ONCOGENE, V29, P1810, DOI 10.1038/onc.2009.471; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; Baumann CA, 2001, BIOESSAYS, V23, P215, DOI 10.1002/1521-1878(200103)23:3<215::AID-BIES1031>3.0.CO;2-S; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Darnay BG, 1997, J LEUKOCYTE BIOL, V61, P559, DOI 10.1002/jlb.61.5.559; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Ding JX, 2008, EXP CELL RES, V314, P1566, DOI 10.1016/j.yexcr.2008.01.026; Du KY, 2009, MOL ENDOCRINOL, V23, P475, DOI 10.1210/me.2008-0284; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; FAURE R, 1992, J BIOL CHEM, V267, P11215; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kato S, 2008, J BIOL CHEM, V283, P35464, DOI 10.1074/jbc.M801011200; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Liang FB, 2005, J BIOL CHEM, V280, P24857, DOI 10.1074/jbc.M502780200; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stuible M, 2010, TRENDS CELL BIOL, V20, P672, DOI 10.1016/j.tcb.2010.08.013; Subramanian C, 2004, P NATL ACAD SCI USA, V101, P6798, DOI 10.1073/pnas.0307964101; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; White MF, 1998, MOL CELL BIOCHEM, V182, P3, DOI 10.1023/A:1006806722619; Wing SS, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S6; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang ZY, 2003, EXPERT OPIN INV DRUG, V12, P223, DOI 10.1517/eoid.12.2.223.21411	59	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10902	10913		10.1074/jbc.M112.369371	http://dx.doi.org/10.1074/jbc.M112.369371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439647	hybrid, Green Published			2022-12-25	WOS:000317565000067
J	Cervadoro, A; Giverso, C; Pande, R; Sarangi, S; Preziosi, L; Wosik, J; Brazdeikis, A; Decuzzi, P				Cervadoro, Antonio; Giverso, Chiara; Pande, Rohit; Sarangi, Subhasis; Preziosi, Luigi; Wosik, Jarek; Brazdeikis, Audrius; Decuzzi, Paolo			Design Maps for the Hyperthermic Treatment of Tumors with Superparamagnetic Nanoparticles	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; RADIOFREQUENCY ABLATION; DRUG-DELIVERY; HEAT-TRANSFER; TEMPERATURE; THERAPY; CYTOSKELETON; NANOCUBES; MELANOMA; TISSUE	A plethora of magnetic nanoparticles has been developed and investigated under different alternating magnetic fields (AMF) for the hyperthermic treatment of malignant tissues. Yet, clinical applications of magnetic hyperthermia are sporadic, mostly due to the low energy conversion efficiency of the metallic nanoparticles and the high tissue concentrations required. Here, we study the hyperthermic performance of commercially available formulations of superparamagnetic iron oxide nanoparticles (SPIOs), with core diameter of 5, 7 and 14 nm, in terms of absolute temperature increase Delta T and specific absorption rate (SAR). These nanoparticles are operated under a broad range of AMF conditions, with frequency f varying between 0.2 and 30 MHz; field strength H ranging from 4 to 10 kA m(-1); and concentration c(MNP) varying from 0.02 to 3.5 mg ml(-1). At high frequency field (similar to 30 MHz), non specific heating dominates and Delta T correlates with the electrical conductivity of the medium. At low frequency field (<1 MHz), non specific heating is negligible and the relaxation of the SPIO within the AMF is the sole energy source. We show that the Delta T of the medium grows linearly with c(MNP), whereas the SAR(MNP) of the magnetic nanoparticles is independent of c(MNP) and varies linearly with f and H-2. Using a computational model for heat transport in a biological tissue, the minimum requirements for local hyperthermia (T-tissue >42 degrees C) and thermal ablation (T-tissue >50 degrees C) are derived in terms of c(MNP), operating AMF conditions and blood perfusion. The resulting maps can be used to rationally design hyperthermic treatments and identifying the proper route of administration - systemic versus intratumor injection - depending on the magnetic and biodistribution properties of the nanoparticles.	[Cervadoro, Antonio; Decuzzi, Paolo] Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX 77030 USA; [Cervadoro, Antonio] Politecn Torino, Dept Mech, Turin, Italy; [Giverso, Chiara; Preziosi, Luigi] Politecn Torino, Dept Math Sci, Turin, Italy; [Pande, Rohit; Wosik, Jarek] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA; [Pande, Rohit; Sarangi, Subhasis; Wosik, Jarek; Brazdeikis, Audrius] Univ Houston, Texas Ctr Superconduct, Houston, TX USA; [Brazdeikis, Audrius] Univ Houston, Dept Phys, Houston, TX USA; [Decuzzi, Paolo] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	The Methodist Hospital System; The Methodist Hospital - Houston; Polytechnic University of Turin; Polytechnic University of Turin; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; Magna Graecia University of Catanzaro	Decuzzi, P (corresponding author), Methodist Hosp, Res Inst, Dept Translat Imaging, 6535 Fannin, Houston, TX 77030 USA.	pdecuzzi@tmhs.org	Decuzzi, Paolo/F-1899-2016; Brazdeikis, Audrius/H-3837-2015; Preziosi, Luigi/AAF-4875-2020	Decuzzi, Paolo/0000-0001-6050-4188; Brazdeikis, Audrius/0000-0001-9536-1586; CERVADORO, ANTONIO/0000-0003-3087-2363	Cancer Prevention Research Institute of Texas [CPRIT RP110262]; National Institutes of Health (United States of America) [U54CA143837, U54CA151668]; NATIONAL CANCER INSTITUTE [U54CA143837, U54CA151668] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; National Institutes of Health (United States of America)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Cancer Prevention Research Institute of Texas through the grant CPRIT RP110262. (CPRIT: www.cprit.state.tx.us/). PD also aknowledges partial support through grants from the National Institutes of Health (United States of America) U54CA143837 and U54CA151668 (www.cancer.gov). AC acknowledges travel support from the Scuola Interpolitecnica di Dottorato - SCUDO. (http://dottorato.polito.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Cancer Prevention Research Institute of Texas through the grant CPRIT RP110262. This work was also partially supported through grants from the National Institutes of Health (USA) (NIH) U54CA143837 and U54CA151668. AC acknowledges travel support from the Scuola Interpolitecnica di Dottorato - SCUDO.	Arciero CA, 2008, SEMIN ONCOL, V35, P147, DOI 10.1053/j.seminoncol.2007.12.004; ARKIN H, 1994, IEEE T BIO-MED ENG, V41, P97, DOI 10.1109/10.284920; ATKINSON WJ, 1984, IEEE T BIO-MED ENG, V31, P70, DOI 10.1109/TBME.1984.325372; Bae KH, 2012, ACS NANO, V6, P5266, DOI 10.1021/nn301046w; Bekovic M, 2010, IEEE T MAGN, V46, P4; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Chertok B, 2008, BIOMATERIALS, V29, P487, DOI 10.1016/j.biomaterials.2007.08.050; Cherukuri P, 2010, ADV DRUG DELIVER REV, V62, P339, DOI 10.1016/j.addr.2009.11.006; Coleman A, 2009, EXPERT REV ANTICANC, V9, P1599, DOI 10.1586/ERA.09.126; Coss RA, 1996, INT J HYPERTHER, V12, P173, DOI 10.3109/02656739609022507; Crayton SH, 2012, BIOMATERIALS, V33, P1509, DOI 10.1016/j.biomaterials.2011.10.077; Curley SA, 2003, ANN SURG ONCOL, V10, P338, DOI 10.1245/ASO.2003.07.017; Dennis CL, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/13/134020; Dennis CL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/39/395103; dos Santos I, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-21; Elsherbini AAM, 2011, MAGN RESON IMAGING, V29, P272, DOI 10.1016/j.mri.2010.08.010; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Gannon CJ, 2007, CANCER-AM CANCER SOC, V110, P2654, DOI 10.1002/cncr.23155; Garcia MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035489; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; Gobin AM, 2010, SMALL, V6, P745, DOI 10.1002/smll.200901557; Godin B, 2012, ADV FUNCT MATER, V22, P4225, DOI 10.1002/adfm.201200869; Guardia P, 2012, ACS NANO, V6, P3080, DOI 10.1021/nn2048137; Heidsieck A, 2012, MOL PHARM; Hergt R, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/38/385214; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hildebrandt B, 2007, Cancer Treat Res, V134, P171; Huang SH, 1999, J CELL BIOCHEM, V75, P327, DOI 10.1002/(SICI)1097-4644(19991101)75:2<327::AID-JCB14>3.3.CO;2-7; Huber DL, 2005, SMALL, V1, P482, DOI 10.1002/smll.200500006; Jia DW, 2010, EXPERT REV MED DEVIC, V7, P407, DOI [10.1586/erd.10.13, 10.1586/ERD.10.13]; Kallumadil M, 2009, J MAGN MAGN MATER, V321, P1509, DOI 10.1016/j.jmmm.2009.02.075; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Kumar CSSR, 2011, ADV DRUG DELIVER REV, V63, P789, DOI 10.1016/j.addr.2011.03.008; Laurent S, 2011, ADV COLLOID INTERFAC; Laurent S, 2010, FUTURE MED CHEM, V2, P427, DOI 10.4155/FMC.09.164; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; Levy M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/39/395103; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li YF, 2011, SMALL, V7, P2965, DOI 10.1002/smll.201101059; Li ZX, 2010, MAT SCI ENG C-MATER, V30, P990, DOI 10.1016/j.msec.2010.04.016; Lobo SM, 2004, RADIOLOGY, V230, P175, DOI 10.1148/radiol.2301021512; Lu W, 2011, CANCER RES, V71, P6116, DOI 10.1158/0008-5472.CAN-10-4557; MAJDA JA, 1994, EXP CELL RES, V210, P46, DOI 10.1006/excr.1994.1007; Manthe RL, 2010, MOL PHARMACEUT, V7, P1880, DOI 10.1021/mp1001944; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Pennes HH, 1998, J APPL PHYSIOL, V85, P5, DOI 10.1152/jappl.1998.85.1.5; Purushotham S, 2010, J APPL PHYS, V107, DOI 10.1063/1.3432757; Rao Wei, 2010, Critical Reviews in Biomedical Engineering, V38, P101, DOI 10.1615/CritRevBiomedEng.v38.i1.80; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Schutt DJ, 2008, MED PHYS, V35, P3462, DOI 10.1118/1.2948388; Shenoi MM, 2009, IEEE ENG MED BIO, P1979, DOI 10.1109/IEMBS.2009.5333447; Stafford RJ, 2011, INT J HYPERTHER, V27, P782, DOI 10.3109/02656736.2011.614671; Stern JM, 2008, J UROLOGY, V179, P748, DOI 10.1016/j.juro.2007.09.018; Suzuki M, 2003, MELANOMA RES, V13, P129, DOI 10.1097/00008390-200304000-00004; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; van der Zee J, 2002, ANN ONCOL, V13, P1173, DOI 10.1093/annonc/mdf280; von Maltzahn G, 2009, CANCER RES, V69, P3892, DOI 10.1158/0008-5472.CAN-08-4242; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5	60	73	74	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57332	10.1371/journal.pone.0057332	http://dx.doi.org/10.1371/journal.pone.0057332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451208	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500091
J	Liu, YY; Evans, JP; McCabe, MF; de Jeu, RAM; van Dijk, AIJM; Dolman, AJ; Saizen, I				Liu, Yi Y.; Evans, Jason P.; McCabe, Matthew F.; de Jeu, Richard A. M.; van Dijk, Albert I. J. M.; Dolman, Albertus J.; Saizen, Izuru			Changing Climate and Overgrazing Are Decimating Mongolian Steppes	PLOS ONE			English	Article							POLARIZATION DIFFERENCE INDEX; VEGETATION OPTICAL DEPTH; MICROWAVE EMISSION; WATER-CONTENT; PRECIPITATION; GRASSLAND; DATABASE; SOILS; MODEL	Satellite observations identify the Mongolian steppes as a hotspot of global biomass reduction, the extent of which is comparable with tropical rainforest deforestation. To conserve or restore these grasslands, the relative contributions of climate and human activities to degradation need to be understood. Here we use a recently developed 21-year (1988-2008) record of satellite based vegetation optical depth (VOD, a proxy for vegetation water content and aboveground biomass), to show that nearly all steppe grasslands in Mongolia experienced significant decreases in VOD. Approximately 60% of the VOD declines can be directly explained by variations in rainfall and surface temperature. After removing these climate induced influences, a significant decreasing trend still persists in the VOD residuals across regions of Mongolia. Correlations in spatial patterns and temporal trends suggest that a marked increase in goat density with associated grazing pressures and wild fires are the most likely non-climatic factors behind grassland degradation.	[Liu, Yi Y.; McCabe, Matthew F.] Univ New S Wales, Sch Civil & Environm Engn, Water Res Ctr, Sydney, NSW, Australia; [Liu, Yi Y.; Evans, Jason P.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [Liu, Yi Y.; de Jeu, Richard A. M.; Dolman, Albertus J.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Dept Earth Sci, Amsterdam, Netherlands; [Liu, Yi Y.; van Dijk, Albert I. J. M.] CSIRO Land & Water, Black Mt Labs, Canberra, ACT, Australia; [McCabe, Matthew F.] King Abdullah Univ Sci & Technol, Water Desalinat & Reuse Ctr, Thuwal, Saudi Arabia; [van Dijk, Albert I. J. M.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Saizen, Izuru] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan	University of New South Wales Sydney; University of New South Wales Sydney; Vrije Universiteit Amsterdam; Commonwealth Scientific & Industrial Research Organisation (CSIRO); King Abdullah University of Science & Technology; Australian National University; Kyoto University	Liu, YY (corresponding author), Univ New S Wales, Sch Civil & Environm Engn, Water Res Ctr, Sydney, NSW, Australia.	yiliu001@gmail.com	de Jeu, Richard/AAE-6922-2019; McCabe, Matthew F/G-5194-2011; Liu, Yi/H-9226-2013; Evans, Jason P./F-3716-2011; Van Dijk, Albert/B-3106-2011; Liu, Yi/M-7169-2015	McCabe, Matthew F/0000-0002-1279-5272; Evans, Jason P./0000-0003-1776-3429; Van Dijk, Albert/0000-0002-6508-7480; Liu, Yi/0000-0001-9059-8269; Dolman, A.J./0000-0003-0099-0457	University of New South Wales International Postgraduate Award; CSIRO Water for a Healthy Country Flagship Program scholarship; Research Institute for Humanity and Nature [D-04]	University of New South Wales International Postgraduate Award; CSIRO Water for a Healthy Country Flagship Program scholarship; Research Institute for Humanity and Nature	Funding for this research was through a University of New South Wales International Postgraduate Award and CSIRO Water for a Healthy Country Flagship Program scholarship. The data used in Figure 3b were supported through the Research Institute for Humanity and Nature (project number D-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MONG STAT ENV 2002; Badarch M., 2009, MONGOLIANS 4 NATL RE; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Ceccato P, 2002, REMOTE SENS ENVIRON, V82, P198, DOI [10.1016/S0034-4257(02)00036-6, 10.1016/S0034-4257(02)00037-8]; Chu T., 2012, EARTH SCI RES, V1, P1, DOI [10.5539/esr.v1n2p279, DOI 10.5539/ESR.V1N2P279]; ERDENESAIKHAN N, 1999, INT FOREST FIRE NEWS, V21, P71; Evans J, 2004, J ARID ENVIRON, V57, P535, DOI 10.1016/S0140-1963(03)00121-6; Farukh M.A., 2009, J NAT DISASTER SCI, V31, P23, DOI [10.2328/jnds.31.23, DOI 10.2328/JNDS.31.23]; Guo R, 2006, J ENVIRON SCI, V18, P1024, DOI 10.1016/S1001-0742(06)60033-8; Hirsch R. M., 2002, STAT METHODS WATER R; Holmes TRH, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010257; Hu ZM, 2007, SCI CHINA SER D, V50, P754, DOI 10.1007/s11430-007-0010-3; Indree T, 2007, INT FOREST FIRE NEWS, V36, P67; JACKSON TJ, 1991, REMOTE SENS ENVIRON, V36, P203, DOI 10.1016/0034-4257(91)90057-D; Karnieli A, 2006, INT J REMOTE SENS, V27, P2017, DOI 10.1080/01431160500121727; KERR YH, 1990, IEEE T GEOSCI REMOTE, V28, P384, DOI 10.1109/36.54364; Kirdyashev K. P., 1979, Radio Engineering and Electronic Physics, V24, P37; Liu YY, 2013, GLOBAL ECOL BIOGEOGR, V22, P692, DOI 10.1111/geb.12024; Liu YY, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048684; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Matsuura K., 2009, TERRESTRIAL AIR TEMP; Meesters AGCA, 2005, IEEE GEOSCI REMOTE S, V2, P121, DOI 10.1109/LGRS.2005.843983; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nyamjav B, 2008, 1 INT CENTR AS WILDL; Owe M, 2001, IEEE T GEOSCI REMOTE, V39, P1643, DOI 10.1109/36.942542; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Rudolf B., 2005, P 2 WORKSH INT PREC, P231; Sato T, 2007, J HYDROL, V333, P144, DOI 10.1016/j.jhydrol.2006.07.023; WANG JR, 1980, IEEE T GEOSCI REMOTE, V18, P288, DOI 10.1109/TGRS.1980.350304; Xu ZZ, 2005, PLANT SOIL, V269, P131, DOI 10.1007/s11104-004-0397-y	31	80	86	6	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57599	10.1371/journal.pone.0057599	http://dx.doi.org/10.1371/journal.pone.0057599			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451249	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500119
J	Queiroz, DMM; Rocha, AMC; Melo, FF; Rocha, GA; Teixeira, KN; Carvalho, SD; Bittencourt, PFS; Castro, LPF; Crabtree, JE				Magalhaes Queiroz, Dulciene Maria; Camargos Rocha, Andreia Maria; Melo, Fabricio Freire; Rocha, Gifone Aguiar; Teixeira, Kadima Nayara; Carvalho, Simone Diniz; Souto Bittencourt, Paulo Fernando; Fonseca Castro, Lucia Porto; Crabtree, Jean E.			Increased Gastric IL-1 beta Concentration and Iron Deficiency Parameters in H. pylori Infected Children	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HELICOBACTER-PYLORI; IMMUNE-RESPONSE; ACID-SECRETION; PARIETAL-CELLS; INTERLEUKIN-1-BETA; HEPCIDIN; ANEMIA; RISK; ERADICATION	Association between H. pylori infection, iron deficiency and iron deficiency anaemia has been described, but the mechanisms involved have not been established. We hypothesized that in H. pylori infected children increased gastric concentrations of IL-1 beta and/or TNF-alpha, both potent inhibitors of gastric acid secretion that is essential for iron absorption, are predictors for low blood concentrations of ferritin and haemoglobin, markers of early depletion of iron stores and anaemia, respectively. We evaluated 125 children undergoing endoscopy to clarify the origin of gastrointestinal symptoms. Gastric specimens were obtained for H. pylori status and cytokine evaluation and blood samples for determination of iron deficiency/iron deficiency anaemia parameters and IL1 cluster and TNFA polymorphisms that are associated with increased cytokine secretions. Higher IL-1 beta and TNF-alpha gastric concentrations were observed in H. pylori-positive (n = 47) than in -negative (n = 78) children. Multiple linear regression models revealed gastric IL-1 beta, but not TNF-alpha, as a significant predictor of low ferritin and haemoglobin concentrations; results were reproduced in young children in whom IL1RN polymorphic genotypes associated with higher gastric IL-1 beta expression and lower blood ferritin and haemoglobin concentrations. In conclusion, high gastric levels of IL-1 beta can be the link between H. pylori infection and iron deficiency/iron deficiency anaemia in childhood.	[Magalhaes Queiroz, Dulciene Maria; Camargos Rocha, Andreia Maria; Melo, Fabricio Freire; Rocha, Gifone Aguiar; Teixeira, Kadima Nayara] Univ Fed Minas Gerais, Fac Med, Lab Res Bacteriol, Belo Horizonte, MG, Brazil; [Carvalho, Simone Diniz; Souto Bittencourt, Paulo Fernando] Univ Fed Minas Gerais, Univ Hosp, Endoscopy Serv, Belo Horizonte, MG, Brazil; [Fonseca Castro, Lucia Porto] Univ Fed Minas Gerais, Fac Med, Dept Pathol, Belo Horizonte, MG, Brazil; [Crabtree, Jean E.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Leeds	Queiroz, DMM (corresponding author), Univ Fed Minas Gerais, Fac Med, Lab Res Bacteriol, Belo Horizonte, MG, Brazil.	dqueiroz@medicina.ufmg.br	Rocha, Gifone A/N-6913-2018; Queiroz, Dulciene/AAU-9386-2020; de Melo, Fabrício/AAN-5517-2020	Rocha, Gifone A/0000-0002-1858-3166; Queiroz, Dulciene/0000-0003-1334-9423; de Melo, Fabrício/0000-0002-5680-2753	Sixth Framework Programme of the European Union, Project CONTENT [INCO-DEV-3-032136]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil); Instituto de Biomedicina do Semi-Arido (INCT-IBISAB/Brazil)	Sixth Framework Programme of the European Union, Project CONTENT; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto de Biomedicina do Semi-Arido (INCT-IBISAB/Brazil)	The study was supported by the Sixth Framework Programme of the European Union, Project CONTENT (INCO-DEV-3-032136); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq/Brazil); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Brazil) and Instituto de Biomedicina do Semi-Arido (INCT-IBISAB/Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale B, 2003, GUT, V52, P496, DOI 10.1136/gut.52.4.496; Baggett HC, 2006, PEDIATRICS, V117, pE396, DOI 10.1542/peds.2005-1129; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Cardinali LDC, 2003, J CLIN MICROBIOL, V41, P3334, DOI 10.1128/JCM.41.7.3334-3335.2003; Choe YH, 2000, ACTA PAEDIATR, V89, P154, DOI 10.1080/080352500750028753; Correa P, 2008, DIGEST LIVER DIS, V40, P490, DOI 10.1016/j.dld.2008.02.035; CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; de Melo FF, 2012, MICROBES INFECT, V14, P341, DOI 10.1016/j.micinf.2011.11.008; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FOX JG, 1991, INFECT IMMUN, V59, P1875, DOI 10.1128/IAI.59.6.1875-1880.1991; Harford WV, 2000, GUT, V47, P467, DOI 10.1136/gut.47.4.467; Hurtado EK, 1999, AM J CLIN NUTR, V69, P115; IDJRADINATA P, 1993, LANCET, V341, P1, DOI 10.1016/0140-6736(93)92477-B; Inamura J, 2005, HEPATOL RES, V33, P198, DOI 10.1016/j.hepres.2005.08.005; Kurekci AE, 2005, J TROP PEDIATRICS, V51, P166, DOI 10.1093/tropej/fmi015; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; MANSFIELD JC, 1994, GASTROENTEROLOGY, V106, P637, DOI 10.1016/0016-5085(94)90696-3; Marignani M, 1997, SCAND J GASTROENTERO, V32, P617, DOI 10.3109/00365529709025109; Queiroz DMM, 2004, GASTROENTEROLOGY, V127, P73, DOI 10.1053/j.gastro.2004.03.069; Rocha GA, 2005, INT J CANCER, V115, P678, DOI 10.1002/ijc.20935; Schwarz P, 2012, GUT, V61, P193, DOI 10.1136/gut.2011.241208; Soares TF, 2005, SCAND J IMMUNOL, V62, P63, DOI 10.1111/j.1365-3083.2005.01638.x; SOBALA GM, 1991, GUT, V32, P1415, DOI 10.1136/gut.32.11.1415; Takashima M, 2001, GUT, V48, P765, DOI 10.1136/gut.48.6.765; Vannella L, 2008, ALIMENT PHARM THER, V28, P422, DOI 10.1111/j.1365-2036.2008.03741.x; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Windle HJ, 2007, PEDIATRICS, V119, pE754, DOI 10.1542/peds.2006-2196; World Health Organization, 2001, IR DEF AN ASS PREV C; Yip R, 1997, JAMA-J AM MED ASSOC, V277, P1135, DOI 10.1001/jama.277.14.1135; Yokota S, 2008, CLIN INFECT DIS, V46, pE31, DOI 10.1086/526784; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57420	10.1371/journal.pone.0057420	http://dx.doi.org/10.1371/journal.pone.0057420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451225	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500102
J	Rebelo, MD; Figueiredo, ED; Mariante, RM; Nobrega, A; de Barros, CM; Allodi, S				Rebelo, Mauro de Freitas; Figueiredo, Eliane de Souza; Mariante, Rafael M.; Nobrega, Alberto; de Barros, Cintia Monteiro; Allodi, Silvana			New Insights from the Oyster Crassostrea rhizophorae on Bivalve Circulating Hemocytes	PLOS ONE			English	Article							MYTILUS-GALLOPROVINCIALIS; MONOCLONAL-ANTIBODIES; MERCENARIA-MERCENARIA; HEMOLYMPH CELLS; MORPHOLOGY; VIRGINICA; ADULT; CLAM; PROLIFERATION; PHAGOCYTOSIS	Hemocytes are the first line of defense of the immune system in invertebrates, but despite their important role and enormous potential for the study of gene-environment relationships, research has been impeded by a lack of consensus on their classification. Here we used flow cytometry combined with histological procedures, histochemical reactions and transmission electron microscopy to characterize the hemocytes from the oyster Crassostrea rhizophorae. Transmission electron microscopy revealed remarkable morphological characteristics, such as the presence of membranous cisternae in all mature cells, regardless of size and granulation. Some granular cells contained many cytoplasmic granules that communicated with each other through a network of channels, a feature never previously described for hemocytes. The positive reactions for esterase and acid phosphatase also indicated the presence of mature cells of all sizes and granule contents. Flow cytometry revealed a clear separation in complexity between agranular and granular populations, which could not be differentiated by size, with cells ranging from 2.5 to 25 mu m. Based on this evidence we suggest that, at least in C. rhizophorae, the different subpopulations of hemocytes may in reality be different stages of one type of cell, which accumulates granules and loses complexity (with no reduction in size) as it degranulates in the event of an environmental challenge.	[Rebelo, Mauro de Freitas; Figueiredo, Eliane de Souza; Mariante, Rafael M.; Allodi, Silvana] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Nobrega, Alberto] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil; [de Barros, Cintia Monteiro] Univ Fed Rio de Janeiro, Nucleo Pesquisa & Desenvolvimento Socioambiental, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Allodi, S (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil.	sallodi@biof.ufrj.br	Mariante, Rafael/AAM-6010-2021; Mariante, Rafael/A-2971-2015; S, Allodi/AAR-7968-2020; Nobrega, Alberto/U-1161-2019; de Barros, Cintia Monteiro/AAP-8834-2021; Allodi, Silvana/G-1781-2012	Mariante, Rafael/0000-0001-8024-9612; Mariante, Rafael/0000-0001-8024-9612; Allodi, Silvana/0000-0002-3053-3866; Nobrega, Alberto/0000-0002-9840-0103	Conselho Nacional de Desenvolvimento Cientifico e Tenologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio/Universidade Federal do Rio de Janeiro, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tenologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio/Universidade Federal do Rio de Janeiro, Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tenologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria Jose Bonifacio/Universidade Federal do Rio de Janeiro, Brazil. M.F.R., A.N. and S.A. are CNPq research fellows. R.M.M. holds a post-doctoral fellowship from PAPDRJ (FAPERJ/CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladaileh S, 2007, J INVERTEBR PATHOL, V96, P48, DOI 10.1016/j.jip.2007.02.011; Allam B, 2002, FISH SHELLFISH IMMUN, V13, P141, DOI 10.1006/fsim.2001.0389; Ashton-Alcox KA, 1998, TISSUE CELL, V30, P195, DOI 10.1016/S0040-8166(98)80068-2; Beaven AE, 1999, BIOL BULL-US, V196, P26, DOI 10.2307/1543163; CAJARAVILLE MP, 1995, CELL STRUCT FUNCT, V20, P355, DOI 10.1247/csf.20.355; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; da Silva PGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039267; Cheng T. C., 1996, HEMOCYTES FORMS FUNC, P299; Cima F, 2000, FISH SHELLFISH IMMUN, V10, P677, DOI 10.1006/fsim.2000.0282; de Barros CM, 2007, J BIOL CHEM, V282, P1615, DOI 10.1074/jbc.M604056200; Donaghy L, 2010, FISH SHELLFISH IMMUN, V28, P87, DOI 10.1016/j.fsi.2009.10.006; Dyrynda EA, 1997, CELL TISSUE RES, V289, P527, DOI 10.1007/s004410050898; Fawcett DW, 1981, GOLGI APPARATUS, P369; Fawcett DW, 1981, CELL, P641; FOLEY DA, 1974, BIOL BULL, V146, P343, DOI 10.2307/1540410; FOLEY DA, 1975, J INVERTEBR PATHOL, V25, P189, DOI 10.1016/0022-2011(75)90068-3; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gonzalez M, 2007, DEV COMP IMMUNOL, V31, P332, DOI 10.1016/j.dci.2006.07.006; Hegaret H, 2003, J EXP MAR BIOL ECOL, V293, P237, DOI 10.1016/S0022-0981(03)00236-3; Hine PM, 1999, FISH SHELLFISH IMMUN, V9, P367, DOI 10.1006/fsim.1998.0205; Kelley ML, 2001, ONCOGENE, V20, P748, DOI 10.1038/sj.onc.1204144; Lambert C, 2007, AQUACULTURE, V270, P276, DOI 10.1016/j.aquaculture.2007.03.016; Marigomez I, 2002, MICROSC RES TECHNIQ, V56, P358, DOI 10.1002/jemt.10040; Ottaviani E, 1998, ITAL J ZOOL, V65, P349, DOI 10.1080/11250009809386772; Pearse A.G.E., 1968, HISTOCHEMISTRY THEOR, V3rd, P1518; RODRICK GE, 1984, HELGOLANDER MEERESUN, V37, P167, DOI 10.1007/BF01989301; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Sun JF, 2006, J SHELLFISH RES, V25, P55, DOI 10.2983/0730-8000(2006)25[55:MSAFCO]2.0.CO;2; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P249, DOI 10.1016/S1050-4648(02)00164-X; Xue Q, 2001, DEV COMP IMMUNOL, V25, P187, DOI 10.1016/S0145-305X(00)00058-6; Zhang P, 2011, VET PARASITOL, V182, P287, DOI 10.1016/j.vetpar.2011.05.053; Zhang Y, 2009, DEV NEUROBIOL, V69, P415, DOI 10.1002/dneu.20717; Zhang ZF, 2006, FISH SHELLFISH IMMUN, V21, P159, DOI 10.1016/j.fsi.2005.11.003	34	73	75	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57384	10.1371/journal.pone.0057384	http://dx.doi.org/10.1371/journal.pone.0057384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451217	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500096
J	Kohl, C; Riccio, O; Grosse, J; Zanoletti, O; Fournier, C; Schmidt, MV; Sandi, C				Kohl, Christine; Riccio, Orbicia; Grosse, Jocelyn; Zanoletti, Olivia; Fournier, Celine; Schmidt, Mathias V.; Sandi, Carmen			Hippocampal Neuroligin-2 Overexpression Leads to Reduced Aggression and Inhibited Novelty Reactivity in Rats	PLOS ONE			English	Article							CELL-ADHESION MOLECULES; BORDERLINE PERSONALITY; SYNAPTIC-TRANSMISSION; RISK-FACTORS; AUTISM; MICE; SCHIZOPHRENIA; NEUROBIOLOGY; NEUREXINS; MATURATION	Disturbances of the excitation/inhibition (E/I) balance in the brain were recently suggested as potential factors underlying disorders like autism and schizophrenia resulting in associated behavioral alterations including changes in social and emotional behavior as well as abnormal aggression. Neuronal cell adhesion molecules (nCAMs) and mutations in these genes were found to be strongly implicated in the pathophysiology of these disorders. Neuroligin2 (nlgn2) is a postsynaptic cell adhesion molecule, which is predominantly expressed at inhibitory synapses and required for synapse specification and stabilization. Changes in the expression of nlgn2 were shown to result in alterations of social behavior as well as altered inhibitory synaptic transmission, hence modifying the E/I balance. In our study, we focused on the role of nlgn2 in the dorsal hippocampus in the regulation of emotional and social behaviors. To this purpose, we injected an AAV construct overexpressing nlgn2 in the hippocampus of rats and investigated the effects on behavior and on markers for the E/I ratio. We could show an increase in GAD65, a GABA-synthesizing protein in neuronal terminals, and furthermore, reduced exploration of novel stimuli and less offensive behavior. Our data suggest nlgn2 in the hippocampus to be strongly implicated in maintaining the E/I balance in the brain and thereby modulating social and emotional behavior.	[Kohl, Christine; Riccio, Orbicia; Grosse, Jocelyn; Zanoletti, Olivia; Fournier, Celine; Sandi, Carmen] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lab Behav Genet, Lausanne, Switzerland; [Kohl, Christine; Schmidt, Mathias V.] Max Planck Inst Psychiat, Munich, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Max Planck Society	Schmidt, MV (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	mschmidt@mpipsykl.mpg.de; carmen.sandi@epfl.ch		Schmidt, Mathias/0000-0002-3788-2268; Sandi, Carmen/0000-0001-7713-8321	European Union integrated project MEMSTICK [FP7-HEALTH-F2M-2007-201600]; Swiss National Science Foundation [310000-120791, 31003AB-135710]; Sinergia [CRSIK3-122691]; NCCR; Swiss Network for International Studies (SNIS); EPFL	European Union integrated project MEMSTICK; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sinergia; NCCR(Swiss National Science Foundation (SNSF)); Swiss Network for International Studies (SNIS); EPFL	This work was supported by grants from the European Union integrated project MEMSTICK (FP7-HEALTH-F2M-2007-201600; MemStick), the Swiss National Science Foundation (310000-120791 and 31003AB-135710; Sinergia CRSIK3-122691; and the NCCR "The synaptic basis of mental diseases" and the Swiss Network for International Studies (SNIS) as well as intramural funding from the EPFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann N, 2010, NEUROCHEM RES, V35, P1875, DOI 10.1007/s11064-010-0298-9; Belichenko PV, 2009, J COMP NEUROL, V512, P453, DOI 10.1002/cne.21895; Belligni EF, 2012, EUR J MED GENET, V55, P222, DOI 10.1016/j.ejmg.2012.01.016; Bisaz R, 2009, NEUROBIOL LEARN MEM, V91, P333, DOI 10.1016/j.nlm.2008.11.003; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bottos A, 2011, CELL MOL LIFE SCI, V68, P2655, DOI 10.1007/s00018-011-0664-z; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comai S, 2012, J CLIN PSYCHOPHARM, V32, P83, DOI 10.1097/JCP.0b013e31823f8770; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; CRUSIO WE, 1989, J NEUROGENET, V5, P87, DOI 10.3109/01677068909167267; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dell'Osso B, 2010, NEUROPSYCHOBIOLOGY, V61, P169, DOI 10.1159/000297734; Ekinci O, 2012, NORD J PSYCHIAT, P1; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Ey E, 2011, AUTISM RES, V4, P5, DOI 10.1002/aur.175; Fantin M, 2012, REGULATION IN PRESS; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; File SE, 1998, BEHAV NEUROSCI, V112, P1423, DOI 10.1037/0735-7044.112.6.1423; Fu ZY, 2009, MOL CELL NEUROSCI, V42, P45, DOI 10.1016/j.mcn.2009.05.004; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Gregg TR, 2001, PROG NEURO-PSYCHOPH, V25, P91, DOI 10.1016/S0278-5846(00)00150-0; GUILLOT PV, 1994, BRAIN RES, V660, P167, DOI 10.1016/0006-8993(94)90852-4; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hasan KM, 2012, J CHILD NEUROL; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jackson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035557; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lewis MD, 2006, ANN NY ACAD SCI, V1094, P164, DOI 10.1196/annals.1376.017; Lise MF, 2006, CELL MOL LIFE SCI, V63, P1833, DOI 10.1007/s00018-006-6061-3; Maskey M, 2012, J AUTISM DEV DISORD; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Moses SN, 2002, BRAIN RES BULL, V58, P517, DOI 10.1016/S0361-9230(02)00820-1; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Paz RD, 2008, EUR NEUROPSYCHOPHARM, V18, P773, DOI 10.1016/j.euroneuro.2008.06.005; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Rossi R, 2012, PSYCHIAT RES-NEUROIM, V203, P132, DOI 10.1016/j.pscychresns.2011.12.004; Sala M, 2011, J AFFECT DISORDERS, V131, P417, DOI 10.1016/j.jad.2010.11.036; Sandi C, 2011, EUR NEUROPSYCHOPHARM, V21, pS211, DOI 10.1016/S0924-977X(11)70303-0; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Sun C, 2011, HUM MOL GENET, P1; Sustkova-Fiserova M, 2009, NEUROENDOCRINOL LETT, V30, P79; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008; Zhang C, 2009, J NEUROSCI, V29, P10843, DOI 10.1523/JNEUROSCI.1248-09.2009	61	43	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56871	10.1371/journal.pone.0056871	http://dx.doi.org/10.1371/journal.pone.0056871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451101	gold, Green Published			2022-12-25	WOS:000316658800044
J	Moustakas, A; Kunin, WE; Cameron, TC; Sankaran, M				Moustakas, Aristides; Kunin, William E.; Cameron, Tom C.; Sankaran, Mahesh			Facilitation or Competition? Tree Effects on Grass Biomass across a Precipitation Gradient	PLOS ONE			English	Article							SOUTHERN AFRICAN SAVANNA; POSITIVE INTERACTIONS; PLANT-COMMUNITIES; UNDERSTOREY VEGETATION; CENTRAL CALIFORNIA; TEMPERATE SAVANNA; HYDRAULIC LIFT; WOODY COVER; ENVIRONMENTS; FIRE	Savanna ecosystems are dominated by two distinct plant life forms, grasses and trees, but the interactions between them are poorly understood. Here, we quantified the effects of isolated savanna trees on grass biomass as a function of distance from the base of the tree and tree height, across a precipitation gradient in the Kruger National Park, South Africa. Our results suggest that mean annual precipitation (MAP) mediates the nature of tree-grass interactions in these ecosystems, with the impact of trees on grass biomass shifting qualitatively between 550 and 737 mm MAP. Tree effects on grass biomass were facilitative in drier sites (MAP <= 550 mm), with higher grass biomass observed beneath tree canopies than outside. In contrast, at the wettest site (MAP = 737 mm), grass biomass did not differ significantly beneath and outside tree canopies. Within this overall precipitation-driven pattern, tree height had positive effect on sub-canopy grass biomass at some sites, but these effects were weak and not consistent across the rainfall gradient. For a more synthetic understanding of tree-grass interactions in savannas, future studies should focus on isolating the different mechanisms by which trees influence grass biomass, both positively and negatively, and elucidate how their relative strengths change over broad environmental gradients.	[Moustakas, Aristides; Kunin, William E.; Cameron, Tom C.; Sankaran, Mahesh] Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England; [Moustakas, Aristides] Univ London, Sch Biol & Chem Sci, London, England; [Cameron, Tom C.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Sankaran, Mahesh] TIFR, Natl Ctr Biol Sci, Bangalore, Karnataka, India	University of Leeds; University of London; Umea University; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Moustakas, A (corresponding author), Univ Leeds, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds, W Yorkshire, England.	arismoustakas@gmail.com	Moustakas, Aristides/ABE-2662-2020; Cameron, Tom/H-9555-2012	Cameron, Tom/0000-0002-5875-1494; Moustakas, Aristides (Aris)/0000-0002-6334-747X	NERC Research Grant [NE-E017436-1]; University of Leeds; Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Government of India; Natural Environment Research Council [NE/E017436/1] Funding Source: researchfish; NERC [NE/E017436/1] Funding Source: UKRI	NERC Research Grant; University of Leeds; Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Government of India; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a NERC Research Grant to MS, WEK, and AM (NE-E017436-1). TCC was funded by the University of Leeds. MS would also like to acknowledge support provided by the Ramalingaswami Re-entry Fellowship, Department of Biotechnology, Government of India. AM thanks the School of Biological and Chemical Sciences, Queen Mary University of London and the Head of School, Matthew Evans for covering the publications fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier N, 2008, ECOLOGY, V89, P1521, DOI 10.1890/07-0365.1; BELSKY AJ, 1993, J APPL ECOL, V30, P143, DOI 10.2307/2404278; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bransby D. I., 1977, Proceedings of the Grassland Society of Southern Africa, V12, P115; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bullock JM, 2009, J ECOL, V97, P646, DOI 10.1111/j.1365-2745.2009.01502.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BURROWS WH, 1990, J BIOGEOGR, V17, P503, DOI 10.2307/2845383; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Callaway RM, 2005, ECOLOGY, V86, P1856, DOI 10.1890/04-0784; CALLAWAY RM, 1993, ECOLOGY, V74, P1567, DOI 10.2307/1940084; CALLAWAY RM, 1991, ECOLOGY, V72, P1484, DOI 10.2307/1941122; Dickie IA, 2005, ECOL LETT, V8, P1191, DOI 10.1111/j.1461-0248.2005.00822.x; Dohn J, 2013, J ECOL, V101, P202, DOI 10.1111/1365-2745.12010; du Toit J.T., 2003, KRUGER EXPERIENCE EC; Durr PA, 2002, AGROFOREST SYST, V54, P99, DOI 10.1023/A:1015070203455; Freckleton RP, 2009, J ECOL, V97, P379, DOI 10.1111/j.1365-2745.2009.01497.x; Frost PGH, 1986, BIOL INT SPEC ISSUE, V10, P1; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Grouzis M, 1997, J ARID ENVIRON, V35, P285, DOI 10.1006/jare.1995.0138; HARMON ME, 1989, ECOLOGY, V70, P48, DOI 10.2307/1938411; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hoffmann WA, 2005, OECOLOGIA, V145, P307, DOI 10.1007/s00442-005-0129-x; Kikvidze Z, 2006, J VEG SCI, V17, P77, DOI 10.1111/j.1654-1103.2006.tb02425.x; KNOOP WT, 1985, J ECOL, V73, P235, DOI 10.2307/2259780; Ludwig F, 2004, ECOL LETT, V7, P623, DOI 10.1111/j.1461-0248.2004.00615.x; Ludwig F, 2004, PLANT ECOL, V170, P93, DOI 10.1023/B:VEGE.0000019023.29636.92; Ludwig F, 2003, OECOLOGIA, V134, P293, DOI 10.1007/s00442-002-1119-x; Ludwig F, 2001, J VEG SCI, V12, P579, DOI 10.2307/3237009; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; MILCHUNAS DG, 1989, VEGETATIO, V80, P11, DOI 10.1007/BF00049137; Mlambo D, 2005, FOREST ECOL MANAG, V212, P394, DOI 10.1016/j.foreco.2005.03.022; MORDELET P, 1995, J VEG SCI, V6, P223, DOI 10.2307/3236217; Moustakas A., 2010, FRONT BIOGEOGR, V2, P47, DOI DOI 10.21425/F5FBG12335; Pinheiro JC, 2004, MIXED EFFECTS MODES; R Development Core Team, 2012, R LANG ENV STAT COMP; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Riginos C, 2009, J ECOL, V97, P1337, DOI 10.1111/j.1365-2745.2009.01563.x; Riginos C, 2009, ECOLOGY, V90, P335, DOI 10.1890/08-0462.1; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Schade JD, 2003, J VEG SCI, V14, P743, DOI 10.1658/1100-9233(2003)014[0743:TIOPCO]2.0.CO;2; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; STUARTHILL GC, 1989, J APPL ECOL, V26, P285, DOI 10.2307/2403668; Tirado R, 2005, OIKOS, V111, P437, DOI 10.1111/j.1600-0706.2005.14094.x; Treydte AC, 2008, J VEG SCI, V19, P663, DOI 10.3170/2008-8-18435; Treydte AC, 2007, PERSPECT PLANT ECOL, V8, P197, DOI 10.1016/j.ppees.2007.03.001; Treydte AC, 2010, J ARID ENVIRON, V74, P1597, DOI 10.1016/j.jaridenv.2010.07.003; Trollope W. S. W., 1986, Journal of the Grassland Society of Southern Africa, V3, P148; WALKER BH, 1986, S AFR J BOT, V52, P397, DOI 10.1016/S0254-6299(16)31502-2; Walter H., 1971, ECOLOGY TROPICAL SUB; Weltzin JF, 1997, OECOLOGIA, V112, P156, DOI 10.1007/s004420050295; WELTZIN JF, 1990, J VEG SCI, V1, P325, DOI 10.2307/3235707; Weltzin JF, 2000, ECOLOGY, V81, P1902, DOI 10.1890/0012-9658(2000)081[1902:IOPRFS]2.0.CO;2; Xu C, 2011, J ARID ENVIRON, V75, P953, DOI 10.1016/j.jaridenv.2011.04.037; Xu C, 2012, PLANT ECOL, V213, P225, DOI 10.1007/s11258-011-0018-9	65	48	48	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57025	10.1371/journal.pone.0057025	http://dx.doi.org/10.1371/journal.pone.0057025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451137	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000316658800063
J	Tamamiya, Y; Hiraki, K				Tamamiya, Yoshiyuki; Hiraki, Kazuo			Individual Differences in the Recognition of Facial Expressions: An Event-Related Potentials Study	PLOS ONE			English	Article							FUSIFORM FACE AREA; EMOTIONAL EXPRESSION; SOCIAL COGNITION; N170; PERCEPTION; INVERSION; DEFICITS; LATERALIZATION; DISCRIMINATION; REPETITION	Previous studies have shown that early posterior components of event-related potentials (ERPs) are modulated by facial expressions. The goal of the current study was to investigate individual differences in the recognition of facial expressions by examining the relationship between ERP components and the discrimination of facial expressions. Pictures of 3 facial expressions (angry, happy, and neutral) were presented to 36 young adults during ERP recording. Participants were asked to respond with a button press as soon as they recognized the expression depicted. A multiple regression analysis, where ERP components were set as predictor variables, assessed hits and reaction times in response to the facial expressions as dependent variables. The N170 amplitudes significantly predicted for accuracy of angry and happy expressions, and the N170 latencies were predictive for accuracy of neutral expressions. The P2 amplitudes significantly predicted reaction time. The P2 latencies significantly predicted reaction times only for neutral faces. These results suggest that individual differences in the recognition of facial expressions emerge from early components in visual processing.	[Tamamiya, Yoshiyuki; Hiraki, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan	University of Tokyo	Tamamiya, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	tamamiya@ardbeg.c.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan Research [22240026]; "Pedagogical Machine: Developmental cognitive science approach to create teaching/teachable machines" the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [21118001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; "Pedagogical Machine: Developmental cognitive science approach to create teaching/teachable machines" the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Hiraki is supported by a Research Project Grant-in-aid for Scientific Research (A) (22240026) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and "Pedagogical Machine: Developmental cognitive science approach to create teaching/teachable machines" the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency. Mr. Tamamiya has no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association, 2010, PUBL MAN AM PSYCH AS; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Batty M, 2011, J EXP CHILD PSYCHOL, V109, P430, DOI 10.1016/j.jecp.2011.02.001; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Caharel S, 2006, INT J PSYCHOPHYSIOL, V62, P141, DOI 10.1016/j.ijpsycho.2006.03.002; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; Clark US, 2008, NEUROPSYCHOLOGIA, V46, P2300, DOI 10.1016/j.neuropsychologia.2008.03.014; Galli G, 2006, BRAIN RES, V1119, P190, DOI 10.1016/j.brainres.2006.08.076; Gordon EM, 2012, HUM BRAIN MAPP, V33, P1536, DOI 10.1002/hbm.21306; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Hargrave R, 2002, J NEUROPSYCH CLIN N, V14, P64, DOI 10.1176/jnp.14.1.64; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Herrmann MJ, 2004, AM J PSYCHIAT, V161, P915, DOI 10.1176/appi.ajp.161.5.915; Herzmann G, 2010, J COGNITIVE NEUROSCI, V22, P571, DOI 10.1162/jocn.2009.21249; Ibanez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037306; Ibanez A, 2012, PSYCHIAT RES, V195, P18, DOI 10.1016/j.psychres.2011.07.027; Ibanez A, 2011, SOC NEUROSCI-UK, V6, P464, DOI 10.1080/17470919.2011.620769; Ibanez A, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-8; Isaacowitz DM, 2007, PSYCHOL AGING, V22, P147, DOI 10.1037/0882-7974.22.1.147; Itier RJ, 2004, NEUROIMAGE, V21, P1518, DOI 10.1016/j.neuroimage.2003.12.016; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; James MS, 2001, J PSYCHOPHYSIOL, V15, P275, DOI 10.1027//0269-8803.15.4.275; Kahler CW, 2012, PERS INDIV DIFFER, V52, P444, DOI 10.1016/j.paid.2011.11.009; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Latinus M, 2005, J COGNITIVE NEUROSCI, V17, P1316, DOI 10.1162/0898929055002490; Latinus M, 2006, BRAIN RES, V1123, P179, DOI 10.1016/j.brainres.2006.09.031; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Petroni A, 2011, NEUROSCI LETT, V505, P41, DOI 10.1016/j.neulet.2011.09.062; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; Sagiv N, 2001, J COGNITIVE NEUROSCI, V13, P937, DOI 10.1162/089892901753165854; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schefter M, 2012, NEUROPSYCHOLOGY DEV, P37; Tanaka JW, 2001, PSYCHOL SCI, V12, P43, DOI 10.1111/1467-9280.00308; Taylor SF, 2012, BIOL PSYCHIAT, V71, P136, DOI 10.1016/j.biopsych.2011.09.007; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wilhelm O, 2010, J PERS SOC PSYCHOL, V99, P530, DOI 10.1037/a0019972	51	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57325	10.1371/journal.pone.0057325	http://dx.doi.org/10.1371/journal.pone.0057325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451205	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800099
J	Bhatia, S; Pilquil, C; Roth-Albin, I; Draper, JS				Bhatia, Sonam; Pilquil, Carlos; Roth-Albin, Ivana; Draper, Jonathan S.			Demarcation of Stable Subpopulations within the Pluripotent hESC Compartment	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MOUSE EPIBLAST; ES CELLS; EXTRAEMBRYONIC LINEAGES; MAINTAIN PLURIPOTENCY; NANOG EXPRESSION; PROGENITOR CELLS; GENE-EXPRESSION; SELF-RENEWAL; IN-VITRO	Heterogeneity is a feature of stem cell populations, resulting from innate cellular hierarchies that govern differentiation capability. How heterogeneity impacts human pluripotent stem cell populations is directly relevant to their efficacious use in regenerative medicine applications. The control of pluripotency is asserted by a core transcription factor network, of which Oct4 is a necessary member. In mouse embryonic stem cells (ESCs), the zinc finger transcription factor Rex1 (Zfp42) closely tracks the undifferentiated state and is capable of segregating Oct4 positive mESCs into metastable populations expressing or lacking Rex1 that are inter-convertible. However, little is currently understood about the extent or function of heterogeneous populations in the human pluripotent compartment. Human ESCs express REX1 transcripts but the distribution and properties of REX1 expressing cells have yet to be described. To address these questions, we used gene targeting in human ESCs to insert the fluorescent protein Venus and an antibiotic selection marker under the control of the endogenous REX1 transcription regulatory elements, generating a sensitive, selectable reporter of pluripotency. REX1 is co-expressed in OCT4 and TRA-1-60 positive hESCs and rapidly lost upon differentiation. Importantly, REX1 expression reveals significant heterogeneity within seemingly homogenous populations of OCT4 and TRA-1-60 hESCs. REX1 expression is extinguished before OCT4 during differentiation, but, in contrast to the mouse, loss of REX1 expression demarcates a stable, OCT4 positive lineage-primed state in pluripotent hESCs that does not revert back to REX1 positivity under normal conditions. We show that loss of REX1 expression correlates with altered patterns of DNA methylation at the REX1 locus, implying that epigenetic mechanisms may interfere with the metastable phenotype commonly found in murine pluripotency.	[Bhatia, Sonam; Pilquil, Carlos; Roth-Albin, Ivana; Draper, Jonathan S.] McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada; [Draper, Jonathan S.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Bhatia, Sonam; Draper, Jonathan S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Draper, JS (corresponding author), McMaster Univ, Michael G DeGroote Sch Med, McMaster Stem Cell & Canc Res Inst, Hamilton, ON, Canada.	draperj@mcmaster.ca		Bhatia, Sonam/0000-0002-0124-2621; Draper, Jonathan/0000-0002-3241-7009	CIHR; SCN; MEDI GL2 OCRIT; Canada Research Chair in Human Stem Cell Lineage Commitment	CIHR(Canadian Institutes of Health Research (CIHR)); SCN; MEDI GL2 OCRIT; Canada Research Chair in Human Stem Cell Lineage Commitment	This work was supported in part by funding to JSD from CIHR, SCN and a MEDI GL2 OCRIT. JSD is also supported by a Canada Research Chair in Human Stem Cell Lineage Commitment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Calder A, 2012, STEM CELLS DEV; CERDAN C, 2007, CURR PROTOC STEM CEL, pCH1; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cherry A, 2010, CELL STEM CELL, V7, P641, DOI 10.1016/j.stem.2010.11.020; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Deuve JL, 2010, ANN REV CELL DEV BIO; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Do Kim J, 2011, HUM MOL GENET, V20, P1353, DOI 10.1093/hmg/ddr017; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Egozi D, 2007, FASEB J, V21, P2807, DOI 10.1096/fj.06-7758com; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Garcia-Tunon I, 2011, STEM CELL RES, V7, P1, DOI 10.1016/j.scr.2011.02.005; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Migeon BR, 2011, HUM GENET, V130, P281, DOI 10.1007/s00439-011-1016-7; Migeon BR, 2003, NAT GENET, V33, P337, DOI 10.1038/ng0303-337a; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Najm FJ, 2011, CELL STEM CELL, V8, P318, DOI 10.1016/j.stem.2011.01.016; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pelton TA, 2002, J CELL SCI, V115, P329; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Rezende NC, 2011, DEV BIOL, V356, P370, DOI 10.1016/j.ydbio.2011.05.664; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Stewart MH, 2010, NAT METHODS, V7, P917, DOI 10.1038/nmeth.1519; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomoda K, 2012, CELL STEM CELL, V11, P91, DOI 10.1016/j.stem.2012.05.019; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027	70	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57276	10.1371/journal.pone.0057276	http://dx.doi.org/10.1371/journal.pone.0057276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437358	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000093
J	Micaroni, M; Stanley, AC; Khromykh, T; Venturato, J; Wong, CXF; Lim, JP; Marsh, BJ; Storrie, B; Gleeson, PA; Stow, JL				Micaroni, Massimo; Stanley, Amanda C.; Khromykh, Tatiana; Venturato, Juliana; Wong, Colin X. F.; Lim, Jet P.; Marsh, Brad J.; Storrie, Brian; Gleeson, Paul A.; Stow, Jennifer L.			Rab6a/a ' Are Important Golgi Regulators of Pro-Inflammatory TNF Secretion in Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; COILED-COIL PROTEINS; ACTIVATED MACROPHAGES; RETROGRADE TRANSPORT; CYTOKINE SECRETION; NETWORK GOLGIN; BINDING-SITES; RAB PROTEINS; GRIP DOMAINS; MEMBRANE	Lipopolysaccharide (LPS)-activated macrophages secrete pro-inflammatory cytokines, including tumor necrosis factor (TNF) to elicit innate immune responses. Secretion of these cytokines is also a major contributing factor in chronic inflammatory disease. In previous studies we have begun to elucidate the pathways and molecules that mediate the intracellular trafficking and secretion of TNF. Rab6a and Rab6a' (collectively Rab6) are trans-Golgi-localized GTPases known for roles in maintaining Golgi structure and Golgi-associated trafficking. We found that induction of TNF secretion by LPS promoted the selective increase of Rab6 expression. Depletion of Rab6 (via siRNA and shRNA) resulted in reorganization of the Golgi ribbon into more compact structures that at the resolution of electron microcopy consisted of elongated Golgi stacks that likely arose from fusion of smaller Golgi elements. Concomitantly, the delivery of TNF to the cell surface and subsequent release into the media was reduced. Dominant negative mutants of Rab6 had similar effects in disrupting TNF secretion. In live cells, Rab6-GFP were localized on trans-Golgi network (TGN)-derived tubular carriers demarked by the golgin p230. Rab6 depletion and inactive mutants altered carrier egress and partially reduced p230 membrane association. Our results show that Rab6 acts on TNF trafficking at the level of TGN exit in tubular carriers and our findings suggest Rab6 may stabilize p230 on the tubules to facilitate TNF transport. Both Rab6 isoforms are needed in macrophages for Golgi stack organization and for the efficient post-Golgi transport of TNF. This work provides new insights into Rab6 function and into the role of the Golgi complex in cytokine secretion in inflammatory macrophages.	[Micaroni, Massimo; Stanley, Amanda C.; Khromykh, Tatiana; Venturato, Juliana; Wong, Colin X. F.; Marsh, Brad J.; Stow, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Lim, Jet P.; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Lim, Jet P.; Gleeson, Paul A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Storrie, Brian] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA	University of Queensland; University of Melbourne; University of Melbourne; University of Arkansas System; University of Arkansas Medical Sciences	Stow, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	j.stow@imb.uq.edu.au	Khromykh, Tatiana/D-3952-2017; Stow, Jennifer L/I-4723-2013	Khromykh, Tatiana/0000-0001-6629-6885; Stow, Jennifer L/0000-0002-5409-9101; Gleeson, Paul/0000-0002-5336-6503; Micaroni, Massimo/0000-0001-6405-0451	National Health and Medical Research Council (NHMRC, Australia) [569535, 631621]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS081930] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding to support this work was provided by National Health and Medical Research Council (NHMRC, Australia) grants to BJM and BS (#569535) and to JLS and PAG (#631621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; Beutler BA, 1999, J RHEUMATOL, V26, P16; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Di Paola S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037352; Echard A, 2000, MOL BIOL CELL, V11, P3819, DOI 10.1091/mbc.11.11.3819; Fernandes H, 2009, BIOCHEM SOC T, V37, P1037, DOI 10.1042/BST0371037; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Grigoriev I, 2011, CURR BIOL, V21, P967, DOI 10.1016/j.cub.2011.04.030; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Houghton FJ, 2009, CELL, V138, P787, DOI 10.1016/j.cell.2009.05.048; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jackson C L, 2000, Subcell Biochem, V34, P233; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Kakinuma T, 2004, EXP CELL RES, V298, P388, DOI 10.1016/j.yexcr.2004.04.047; Kay JG, 2006, J BIOL CHEM, V281, P11949, DOI 10.1074/jbc.M600857200; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Kjer-Nielsen L, 1999, J CELL SCI, V112, P1645; Klumperman J., 2011, COLD SPRING HARB PER, V3; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Liu SJ, 2012, CELL MOL LIFE SCI, V69, P4093, DOI 10.1007/s00018-012-1021-6; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Low PC, 2010, J CELL BIOL, V190, P1053, DOI 10.1083/jcb.201001028; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Man ZQ, 2011, J BIOL CHEM, V286, P11569, DOI 10.1074/jbc.M110.201442; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; MARTINEZ O, 1994, J CELL BIOL, V127, P1575, DOI 10.1083/jcb.127.6.1575; Micaroni M, 2010, TRAFFIC, V11, P1315, DOI 10.1111/j.1600-0854.2010.01096.x; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Murray RZ, 2005, SCIENCE, V310, P1492, DOI 10.1126/science.1120225; Opdam FJM, 2000, J CELL SCI, V113, P2725; Pagan JK, 2003, CURR BIOL, V13, P156, DOI 10.1016/S0960-9822(03)00006-X; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pusapati GV, 2012, J BIOL CHEM, V287, P42129, DOI 10.1074/jbc.M112.414565; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rossi A, 2012, TRAFFIC, V13, P43, DOI 10.1111/j.1600-0854.2011.01299.x; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x; Stow JL, 2006, NAT REV IMMUNOL, V6, P919, DOI 10.1038/nri1980; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8, DOI 10.1002/jlb.60.1.8; Vitriol EA, 2007, P NATL ACAD SCI USA, V104, P6702, DOI 10.1073/pnas.0701801104; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358; Young J, 2010, J MOL BIOL, V397, P69, DOI 10.1016/j.jmb.2010.01.009; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	71	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57034	10.1371/journal.pone.0057034	http://dx.doi.org/10.1371/journal.pone.0057034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437303	Green Published, gold			2022-12-25	WOS:000315186000068
J	Soares, HP; Ni, Y; Kisfalvi, K; Sinnett-Smith, J; Rozengurt, E				Soares, Heloisa P.; Ni, Yang; Kisfalvi, Krisztina; Sinnett-Smith, James; Rozengurt, Enrique			Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; COMPETITIVE MAMMALIAN TARGET; INSULIN-RECEPTOR; TUMOR-SUPPRESSOR; GROWTH-FACTOR; PATHWAY ACTIVATION; SIGNALING SYSTEMS; DIABETIC-PATIENTS; KINASE; RISK	The mTOR pathway is aberrantly stimulated in many cancer cells, including pancreatic ductal adenocarcinoma (PDAC), and thus it is a potential target for therapy. However, the mTORC1/S6K axis also mediates negative feedback loops that attenuate signaling via insulin/IGF receptor and other tyrosine kinase receptors. Suppression of these feed-back loops unleashes over-activation of upstream pathways that potentially counterbalance the antiproliferative effects of mTOR inhibitors. Here, we demonstrate that treatment of PANC-1 or MiaPaCa-2 pancreatic cancer cells with either rapamycin or active-site mTOR inhibitors suppressed S6K and S6 phosphorylation induced by insulin and the GPCR agonist neurotensin. Rapamycin caused a striking increase in Akt phosphorylation at Ser(473) while the active-site inhibitors of mTOR (KU63794 and PP242) completely abrogated Akt phosphorylation at this site. Conversely, active-site inhibitors of mTOR cause a marked increase in ERK activation whereas rapamycin did not have any stimulatory effect on ERK activation. The results imply that first and second generation of mTOR inhibitors promote over-activation of different pro-oncogenic pathways in PDAC cells, suggesting that suppression of feed-back loops should be a major consideration in the use of these inhibitors for PDAC therapy. In contrast, metformin abolished mTORC1 activation without over-stimulating Akt phosphorylation on Ser(473) and prevented mitogen-stimulated ERK activation in PDAC cells. Metformin induced a more pronounced inhibition of proliferation than either KU63794 or rapamycin while, the active-site mTOR inhibitor was more effective than rapamycin. Thus, the effects of metformin on Akt and ERK activation are strikingly different from allosteric or active-site mTOR inhibitors in PDAC cells, though all these agents potently inhibited the mTORC1/S6K axis.	[Soares, Heloisa P.; Ni, Yang; Kisfalvi, Krisztina; Sinnett-Smith, James; Rozengurt, Enrique] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Div Digest Dis, Los Angeles, CA 90095 USA; [Soares, Heloisa P.; Ni, Yang; Kisfalvi, Krisztina; Sinnett-Smith, James; Rozengurt, Enrique] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Soares, Heloisa P.] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Ni, Yang] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan, Shandong, Peoples R China	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Shandong University	Rozengurt, E (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, CURE Digest Dis Res Ctr,Div Digest Dis, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu			National Institutes of Health [P30DK41301, P01CA163200, R01DK55003]; Department of Veterans Affair Grant [1I01BX001473]; Ronald S. Hirshberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P01CA163200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055003, P30DK041301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affair Grant; Ronald S. Hirshberg Chair of Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health Grants P30DK41301, P01CA163200 and R01DK55003, Department of Veterans Affair Grant 1I01BX001473 and funds from the endowed Ronald S. Hirshberg Chair of Pancreatic Cancer Research all to ER. (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Asano T, 2005, CANCER RES, V65, P9164, DOI 10.1158/0008-5472.CAN-05-0779; Asano T, 2005, BIOCHEM BIOPH RES CO, V331, P295, DOI 10.1016/j.bbrc.2005.03.166; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chong CR, 2009, ONCOLOGIST, V14, P1178, DOI 10.1634/theoncologist.2009-0286; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Dong XQ, 2010, GASTROENTEROLOGY, V139, P464, DOI 10.1053/j.gastro.2010.04.042; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Feng ZH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001057; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Guha S, 2003, CANCER RES, V63, P2379; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Kisfalvi K, 2005, J CELL PHYSIOL, V202, P880, DOI 10.1002/jcp.20187; Kisfalvi K, 2007, ENDOCRINOLOGY, V148, P3246, DOI 10.1210/en.2006-1711; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Kolb S, 2007, CANCER RES, V67, P4679, DOI 10.1158/0008-5472.CAN-06-3308; Kornmann M, 1998, CANCER RES, V58, P4250; Kwon J, 2009, CANCER RES, V69, P1350, DOI 10.1158/0008-5472.CAN-08-1328; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-20; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pham NA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-43; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Ryder NM, 2001, J CELL PHYSIOL, V186, P53, DOI 10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sinnett-Smith J, 2012, BIOCH BIOPH IN PRESS; Stoeltzing O, 2003, AM J PATHOL, V163, P1001, DOI 10.1016/S0002-9440(10)63460-8; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Ying HQ, 2011, CANCER DISCOV, V1, P158, DOI 10.1158/2159-8290.CD-11-0031; Young SH, 2010, BIOCHEM BIOPH RES CO, V401, P154, DOI 10.1016/j.bbrc.2010.09.036; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	73	107	109	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57289	10.1371/journal.pone.0057289	http://dx.doi.org/10.1371/journal.pone.0057289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437362	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000095
J	Hirnstein, M; Westerhausen, R; Hugdahl, K				Hirnstein, Marco; Westerhausen, Rene; Hugdahl, Kenneth			The Right Planum Temporale Is Involved in Stimulus-Driven, Auditory Attention - Evidence from Transcranial Magnetic Stimulation	PLOS ONE			English	Article							DICHOTIC-LISTENING TASK; HEMISPHERIC-ASYMMETRY; SELECTIVE ATTENTION; CORPUS-CALLOSUM; CONSONANT-VOWEL; FMRI; CORTEX; BRAIN; PERCEPTION; MODULATION	It is well known that the planum temporale (PT) area in the posterior temporal lobe carries out spectro-temporal analysis of auditory stimuli, which is crucial for speech, for example. There are suggestions that the PT is also involved in auditory attention, specifically in the discrimination and selection of stimuli from the left and right ear. However, direct evidence is missing so far. To examine the role of the PT in auditory attention we asked fourteen participants to complete the Bergen Dichotic Listening Test. In this test two different consonant-vowel syllables (e.g., "ba" and "da") are presented simultaneously, one to each ear, and participants are asked to verbally report the syllable they heard best or most clearly. Thus attentional selection of a syllable is stimulus-driven. Each participant completed the test three times: after their left and right PT (located with anatomical brain scans) had been stimulated with repetitive transcranial magnetic stimulation (rTMS), which transiently interferes with normal brain functioning in the stimulated sites, and after sham stimulation, where participants were led to believe they had been stimulated but no rTMS was applied (control). After sham stimulation the typical right ear advantage emerged, that is, participants reported relatively more right than left ear syllables, reflecting a left-hemispheric dominance for language. rTMS over the right but not left PT significantly reduced the right ear advantage. This was the result of participants reporting more left and fewer right ear syllables after right PT stimulation, suggesting there was a leftward shift in stimulus selection. Taken together, our findings point to a new function of the PT in addition to auditory perception: particularly the right PT is involved in stimulus selection and (stimulus-driven), auditory attention.	[Hirnstein, Marco; Westerhausen, Rene; Hugdahl, Kenneth] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Westerhausen, Rene; Hugdahl, Kenneth] Haukeland Hosp, Div Psychiat, N-5021 Bergen, Norway; [Hugdahl, Kenneth] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Hirnstein, M (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	marco.hirnstein@psybp.uib.no	Hirnstein, Marco/A-4642-2015; Hirnstein, Marco/D-2450-2013; Westerhausen, René/D-2441-2013	Hirnstein, Marco/0000-0002-6291-0929; Westerhausen, René/0000-0001-7107-2712; Hugdahl, Kenneth/0000-0002-0008-4326	European Research Council (ERC) [249516]	European Research Council (ERC)(European Research Council (ERC))	This work was supported by the Advanced Grant VOICE 249516 from the European Research Council (ERC) to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho K, 2012, BRAIN RES, V1442, P47, DOI 10.1016/j.brainres.2012.01.007; [Anonymous], 1968, CORTEX, DOI [10.1016/S0010-9452(68)80009-7, DOI 10.1016/S0010-9452(68)80009-7]; Awiszus F., TMS MOTOR THRESHOLD; Beaton AA, 1997, BRAIN LANG, V60, P255, DOI 10.1006/brln.1997.1825; BIRKETT P, 1977, NEUROPSYCHOLOGIA, V15, P693, DOI 10.1016/0028-3932(77)90075-6; BROADBENT DE, 1954, J EXP PSYCHOL, V47, P191, DOI 10.1037/h0054182; BROADBENT DE, 1952, J EXP PSYCHOL, V44, P51, DOI 10.1037/h0056491; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cowey A, 2005, PHILOS T R SOC B, V360, P1185, DOI 10.1098/rstb.2005.1658; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Ellison A, 2004, BRAIN, V127, P2307, DOI 10.1093/brain/awh244; Frith CD, 1996, NEUROIMAGE, V4, P210, DOI 10.1006/nimg.1996.0072; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Hall DA, 2000, HUM BRAIN MAPP, V10, P107, DOI 10.1002/1097-0193(200007)10:3<107::AID-HBM20>3.0.CO;2-8; Hashimoto R, 2000, NEUROIMAGE, V12, P147, DOI 10.1006/nimg.2000.0603; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hirnstein M, 2011, NEUROPSYCHOLOGIA, V49, P29, DOI 10.1016/j.neuropsychologia.2010.10.028; Hugdahl K, 1999, NEUROPSYCHOLOGIA, V37, P431, DOI 10.1016/S0028-3932(98)00101-8; Hugdahl K, 1997, ARCH NEUROL-CHICAGO, V54, P1494, DOI 10.1001/archneur.1997.00550240046011; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2013, SEX DIFFERE IN PRESS; Hugdahl Kenneth, 1995, P123; Jacobs S, 2012, NEUROPSYCHOLOGIA, V50, P1029, DOI 10.1016/j.neuropsychologia.2012.03.018; Jancke L, 2003, COGNITIVE BRAIN RES, V16, P257, DOI 10.1016/S0926-6410(02)00281-1; Jancke L, 2001, BRAIN LANG, V78, P349, DOI 10.1006/brln.2000.2476; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Kompus K, 2012, BRAIN LANG, V121, P240, DOI 10.1016/j.bandl.2012.03.004; Komssi S, 2006, BRAIN RES REV, V52, P183, DOI 10.1016/j.brainresrev.2006.01.008; LEE GP, 1994, EPILEPSY RES, V19, P153, DOI 10.1016/0920-1211(94)90025-6; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MAZZUCCHI A, 1985, EPILEPSIA, V26, P379, DOI 10.1111/j.1528-1157.1985.tb05668.x; MAZZUCCHI A, 1978, CORTEX, V14, P381, DOI 10.1016/S0010-9452(78)80064-1; MILNER B, 1968, SCIENCE, V161, P184, DOI 10.1126/science.161.3837.184; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLeary DS, 1996, BRAIN LANG, V53, P20, DOI 10.1006/brln.1996.0034; Pollmann S, 2004, NEUROPSYCHOLOGY, V18, P710, DOI 10.1037/0894-4105.18.4.710; Pollmann S, 2002, NEUROPSYCHOLOGY, V16, P56, DOI 10.1037//0894-4105.16.1.56; Pollmann S, 2010, 2 HALVES BRAIN INFOR, P441; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Rimol LM, 2006, NEUROPSYCHOLOGIA, V44, P191, DOI 10.1016/j.neuropsychologia.2005.05.006; Rimol LM, 2005, NEUROIMAGE, V26, P1059, DOI 10.1016/j.neuroimage.2005.03.028; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sequeira SD, 2006, NEUROPSYCHOLOGIA, V44, P622, DOI 10.1016/j.neuropsychologia.2005.06.014; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Silvanto J, 2008, TRENDS COGN SCI, V12, P447, DOI 10.1016/j.tics.2008.09.004; Specht K, 2003, NEUROIMAGE, V20, P1944, DOI 10.1016/j.neuroimage.2003.07.034; STUDDERTKENNEDY M, 1970, J ACOUST SOC AM, V48, P579, DOI 10.1121/1.1912174; Thomsen T, 2004, NEUROIMAGE, V21, P211, DOI 10.1016/j.neuroimage.2003.08.039; Tzourio N, 1997, NEUROIMAGE, V5, P63, DOI 10.1006/nimg.1996.0252; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Walsh V, 2003, BRADFORD BOOKS, P1; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Westerhausen R, 2009, CEREB CORTEX, V19, P1322, DOI 10.1093/cercor/bhn173; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Zatorre RJ, 1999, NEUROIMAGE, V10, P544, DOI 10.1006/nimg.1999.0491	63	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57316	10.1371/journal.pone.0057316	http://dx.doi.org/10.1371/journal.pone.0057316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437367	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200242
J	Long, Y; Li, Q; Zhou, BL; Song, GL; Li, T; Cui, ZB				Long, Yong; Li, Qing; Zhou, Bolan; Song, Guili; Li, Tao; Cui, Zongbin			De Novo Assembly of Mud Loach (Misgurnus anguillicaudatus) Skin Transcriptome to Identify Putative Genes Involved in Immunity and Epidermal Mucus Secretion	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; FISH SKIN; JAPANESE EEL; PARASIN-I; EXPRESSION; POLYSACCHARIDE; POLYPEPTIDE; ANNOTATION; MECHANISMS; COMPONENTS	Fish skin serves as the first line of defense against a wide variety of chemical, physical and biological stressors. Secretion of mucus is among the most prominent characteristics of fish skin and numerous innate immune factors have been identified in the epidermal mucus. However, molecular mechanisms underlying the mucus secretion and immune activities of fish skin remain largely unclear due to the lack of genomic and transcriptomic data for most economically important fish species. In this study, we characterized the skin transcriptome of mud loach using Illumia paired-end sequencing. A total of 40364 unigenes were assembled from 86.6 million (3.07 gigabases) filtered reads. The mean length, N50 size and maximum length of assembled transcripts were 387, 611 and 8670 bp, respectively. A total of 17336 (43.76%) unigenes were annotated by blast searches against the NCBI non-redundant protein database. Gene ontology mapping assigned a total of 108513 GO terms to 15369 (38.08%) unigenes. KEGG orthology mapping annotated 9337 (23.23%) unigenes. Among the identified KO categories, immune system is the largest category that contains various components of multiple immune pathways such as chemokine signaling, leukocyte transendothelial migration and T cell receptor signaling, suggesting the complexity of immune mechanisms in fish skin. As for mucin biosynthesis, 37 unigenes were mapped to 7 enzymes of the mucin type O-glycan biosynthesis pathway and 8 members of the polypeptide N-acetylgalactosaminyltransferase family were identified. Additionally, 38 unigenes were mapped to 23 factors of the SNARE interactions in vesicular transport pathway, indicating that the activity of this pathway is required for the processes of epidermal mucus storage and release. Moreover, 1754 simple sequence repeats (SSRs) were detected in 1564 unigenes and dinucleotide repeats represented the most abundant type. These findings have laid the foundation for further understanding the secretary processes and immune functions of loach skin mucus.	[Long, Yong; Li, Qing; Zhou, Bolan; Song, Guili; Li, Tao; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China; [Zhou, Bolan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, ZB (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Hubei, Peoples R China.	zbcui@ihb.ac.cn			Knowledge Innovation Program of the Chinese 590 Academy of Sciences [Y25E05-1-501]; National Natural Science 591 Foundation of China [31101892]	Knowledge Innovation Program of the Chinese 590 Academy of Sciences; National Natural Science 591 Foundation of China	This study was supported by the Knowledge Innovation Program of the Chinese 590 Academy of Sciences (#Y25E05-1-501 to YL) and the National Natural Science 591 Foundation of China (#31101892 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; ALHASSAN JM, 1983, LANCET, V1, P1043; Aranishi F, 1999, FISH SHELLFISH IMMUN, V9, P61, DOI 10.1006/fsim.1998.0160; Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; BROWN GA, 1970, Z ZELLFORSCH MIK ANA, V103, P149, DOI 10.1007/BF00337309; Buchmann K, 1999, FOLIA PARASIT, V46, P1; Bureau of Fisheries MoA, 2011, CHIN FISH STAT YB; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; care Ccoa, 2005, GUID CAR US FISH RES; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Cole AM, 1997, J BIOL CHEM, V272, P12008, DOI 10.1074/jbc.272.18.12008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coppe A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-635; Dong XZ, 2002, PROTEIN EXPRES PURIF, V26, P235, DOI 10.1016/S1046-5928(02)00514-4; Easy RH, 2010, J FISH BIOL, V77, P1616, DOI 10.1111/j.1095-8649.2010.02796.x; Ellis AE, 2001, DEV COMP IMMUNOL, V25, P827, DOI 10.1016/S0145-305X(01)00038-6; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328; Goda Y, 1997, P NATL ACAD SCI USA, V94, P769, DOI 10.1073/pnas.94.3.769; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; HARRIS JE, 1975, CELL TISSUE RES, V157, P553; HAWKES JW, 1974, CELL TISSUE RES, V149, P147, DOI 10.1007/BF00222270; Hsiao CD, 2003, DEV DYNAM, V228, P745, DOI 10.1002/dvdy.10411; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kasai K, 2010, FEBS J, V277, P453, DOI 10.1111/j.1742-4658.2009.07497.x; Koo YS, 2008, PEPTIDES, V29, P1102, DOI 10.1016/j.peptides.2008.02.019; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Marel Maria van der, 2012, Fish Shellfish Immunol, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Nam YK, 2011, FISH SHELLFISH IMMUN, V31, P1251, DOI 10.1016/j.fsi.2011.09.007; Palaksha KJ, 2008, FISH SHELLFISH IMMUN, V24, P479, DOI 10.1016/j.fsi.2008.01.005; Park CB, 1997, FEBS LETT, V411, P173, DOI 10.1016/S0014-5793(97)00684-4; Park IY, 1998, FEBS LETT, V437, P258, DOI 10.1016/S0014-5793(98)01238-1; Pereiro P, 2012, PLOS ONE, V7; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Qin CG, 2008, INT IMMUNOPHARMACOL, V8, P607, DOI 10.1016/j.intimp.2007.12.015; Raj VS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-92; Rakers S, 2010, EXP DERMATOL, V19, P313, DOI 10.1111/j.1600-0625.2009.01059.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SHAI Y, 1988, FEBS LETT, V242, P161, DOI 10.1016/0014-5793(88)81007-X; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; Subramanian S, 2007, COMP BIOCHEM PHYS B, V148, P256, DOI 10.1016/j.cbpb.2007.06.003; Subramanian S, 2009, MAR BIOTECHNOL, V11, P748, DOI 10.1007/s10126-009-9189-y; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tasumi S, 2004, DEV COMP IMMUNOL, V28, P325, DOI 10.1016/j.dci.2003.08.006; Tasumi S, 2002, J BIOL CHEM, V277, P27305, DOI 10.1074/jbc.M202648200; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tsutsui S, 2011, J BIOCHEM, V150, P501, DOI 10.1093/jb/mvr085; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wilson JM, 2009, J AM ASSOC LAB ANIM, V48, P785; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xia JH, 2011, DNA RES, V18, P513, DOI 10.1093/dnares/dsr036; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You LJ, 2011, J AGR FOOD CHEM, V59, P7948, DOI 10.1021/jf2016368; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang CX, 2006, TOXICOL APPL PHARM, V210, P236, DOI 10.1016/j.taap.2005.04.019; Zhang CX, 2005, J ETHNOPHARMACOL, V99, P385, DOI 10.1016/j.jep.2005.02.033	75	49	52	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56998	10.1371/journal.pone.0056998	http://dx.doi.org/10.1371/journal.pone.0056998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437293	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200197
J	Sharma, A; Krause, A; Xu, YQ; Sung, BI; Wu, W; Worgall, S				Sharma, Anurag; Krause, Anja; Xu, Yaqin; Sung, Biin; Wu, Wendy; Worgall, Stefan			Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa	PLOS ONE			English	Article							MEMBRANE PROTEIN-F; HETEROLOGOUS IMMUNOTYPE STRAINS; CHRONIC PULMONARY INFECTION; DENDRITIC CELLS; GENE-THERAPY; T-CELLS; VECTORS; LUNG; ANTIBODIES; RESPONSES	Adenovirus (Ad) vector-based vaccines displaying pathogen-derived epitopes on Ad capsid proteins can elicit antipathogen immunity. This approach seems to be particularly efficient with epitopes incorporated into the Ad fiber protein. Here, we explore epitope insertion into various sites of the Ad fiber to elicit epitope-specific immunity. Ad vectors expressing the 14-mer Pseudomonas aeruginosa immune-dominant outer membrane protein F (OprF) epitope 8 (Epi8) in five distinct sites of the Ad5 fiber, loops CD (AdZ.F(CD)Epi8), DE (AdZ.F(DE)Epi8), FG (AdZ.F(FG)Epi8), HI (AdZ.F(HI)Epi8) and C terminus (AdZ.F(CT)Epi8), or the hexon HVR5 loop (AdZ.HxEpi8) were compared in their capacity to elicit anti-P. aeruginosa immunity to AdOprF, an Ad expressing the entire OprF protein. Intramuscular immunization of BALB/c mice with AdZ.F(FG)Epi8 or AdZ.F(HI)Epi8 elicited higher anti-OprF humoral and cellular CD4 and CD8 responses as well as enhanced protection against respiratory infection with P. aeruginosa compared to immunization with AdZ.F(CD)Epi8, AdZ.F(DE)Epi8, AdZ.F(CT)Epi8 or AdZ.HxEpi8. Importantly, repeat administration of the fiber- and hexon-modified Ad vectors boosted the OprF-specific humoral immune response in contrast to immunization with AdOprF. Strikingly, following three doses of AdZ.F(FG)Epi8 or AdZ.F(HI)Epi8 anti-OprF immunity surpassed that induced by AdOprF. Furthermore, in the presence of anti-Ad5 immunity, immunization with AdZ.F(FG)Epi8 or AdZ.F(HI)Epi8, but not with AdOprF, induced protective immunity against P. aeruginosa. This suggests that incorporation of epitopes into distinct sites of the Ad fiber is a promising vaccine strategy.	[Sharma, Anurag; Krause, Anja; Sung, Biin; Wu, Wendy; Worgall, Stefan] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [Xu, Yaqin; Worgall, Stefan] Weill Cornell Med Coll, Dept Pediat, New York, NY USA	Cornell University; Cornell University	Worgall, S (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY USA.	stw2006@med.cornell.edu	SHARMA, ANURAG/GQA-9578-2022	SHARMA, ANURAG/0000-0002-5769-8185	National Heart, Lung, and Blood Institute (NHLBI) [U01 AI069032, RO1 AI72238]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072238, U01AI069032] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Heart, Lung, and Blood Institute (NHLBI) U01 AI069032 and RO1 AI72238 to Stefan Worgall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Motal U, 2006, J VIROL, V80, P6943, DOI 10.1128/JVI.00310-06; Ahi YS, 2011, CURR GENE THER, V11, P307; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; CROMPTON J, 1994, J GEN VIROL, V75, P133, DOI 10.1099/0022-1317-75-1-133; Doring G, 2008, VACCINE, V26, P1011, DOI 10.1016/j.vaccine.2007.12.007; DUNKLEY ML, 1994, IMMUNOLOGY, V83, P362; GILLELAND HE, 1988, INFECT IMMUN, V56, P1017, DOI 10.1128/IAI.56.5.1017-1022.1988; GILLELAND LB, 1995, INFECT IMMUN, V63, P2347, DOI 10.1128/IAI.63.6.2347-2351.1995; Hackett NR, 2000, CURR OPIN MOL THER, V2, P376; Hashimoto M, 2005, INFECT IMMUN, V73, P6885, DOI 10.1128/IAI.73.10.6885-6891.2005; HERSH J, 1995, GENE THER, V2, P124; Hicks MJ, 2011, MOL THER, V19, P612, DOI 10.1038/mt.2010.280; HUGHES EE, 1992, INFECT IMMUN, V60, P3497, DOI 10.1128/IAI.60.9.3497-3503.1992; Kikuchi T, 2001, HUM GENE THER, V12, P1251, DOI 10.1089/104303401750270913; Koizumi N, 2003, J VIROL, V77, P13062, DOI 10.1128/JVI.77.24.13062-13072.2003; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Krause A, 2011, VACCINE, V29, P2131, DOI 10.1016/j.vaccine.2010.12.087; Lanzi A, 2011, VACCINE, V29, P1463, DOI 10.1016/j.vaccine.2010.12.025; Lasaro MO, 2009, MOL THER, V17, P1333, DOI 10.1038/mt.2009.130; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; MUTHARIA LM, 1982, J INFECT DIS, V146, P770, DOI 10.1093/infdis/146.6.770; MUTHARIA LM, 1983, INFECT IMMUN, V42, P1027, DOI 10.1128/IAI.42.3.1027-1033.1983; PORWOLL JM, 1983, INFECT IMMUN, V40, P670, DOI 10.1128/IAI.40.2.670-674.1983; Price BM, 2001, INFECT IMMUN, V69, P3510, DOI 10.1128/IAI.69.5.3510-3515.2001; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Sharma A, 2011, HUM VACCINES, V7, P999, DOI 10.4161/hv.7.10.16369; Sharma A, 2009, CURR DRUG THER, V4, P117, DOI 10.2174/157488509788185123; Sharma A, 2009, VIRUS RES, V143, P184, DOI 10.1016/j.virusres.2009.02.010; Sharma A, 2009, VIROLOGY, V386, P44, DOI 10.1016/j.virol.2009.01.008; Song W, 1997, J EXP MED, V186, P1247, DOI 10.1084/jem.186.8.1247; Sorichter S, 2009, VACCINE, V27, P2755, DOI 10.1016/j.vaccine.2009.03.010; STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017; Stone D, 2006, CURR OPIN MOL THER, V8, P423; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Worgall S, 2005, J CLIN INVEST, V115, P1281, DOI 10.1172/JCI200523135; Worgall S, 2001, INFECT IMMUN, V69, P4521, DOI 10.1128/IAI.69.7.4521-4527.2001; Worgall S, 2007, J VIROL, V81, P13801, DOI 10.1128/JVI.01246-07; XIA D, 1994, STRUCTURE, V2, P1259, DOI 10.1016/S0969-2126(94)00126-X; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; Zaiss AK, 2009, J CELL BIOCHEM, V108, P778, DOI 10.1002/jcb.22328; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	43	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56996	10.1371/journal.pone.0056996	http://dx.doi.org/10.1371/journal.pone.0056996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437292	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200196
J	Agaisse, H; Derre, I				Agaisse, Herve; Derre, Isabelle			A C-trachomatis Cloning Vector and the Generation of C-trachomatis Strains Expressing Fluorescent Proteins under the Control of a C-trachomatis Promoter	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; INCLUSION MEMBRANE-PROTEINS; CHLAMYDIA-TRACHOMATIS; COXIELLA-BURNETII; TRANSPOSON MUTAGENESIS; RICKETTSIA-PROWAZEKII; GENE-TRANSFER; IN-VITRO; Q-FEVER; FUSION	Here we describe a versatile cloning vector for conducting genetic experiments in C. trachomatis. We successfully expressed various fluorescent proteins (i.e. GFP, mCherry and CFP) from C. trachomatis regulatory elements (i.e. the promoter and terminator of the incDEFG operon) and showed that the transformed strains produced wild type amounts of infectious particles and recapitulated major features of the C. trachomatis developmental cycle. C. trachomatis strains expressing fluorescent proteins are valuable tools for studying the C. trachomatis developmental cycle. For instance, we show the feasibility of investigating the dynamics of inclusion fusion and interaction with host proteins and organelles by time-lapse video microscopy.	[Agaisse, Herve; Derre, Isabelle] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University	Derre, I (corresponding author), Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT 06520 USA.	isabelle.derre@yale.edu			National Institutes of Health grant [R21 AI088312]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088312] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R21 AI088312 to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-86; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008965; Bannantine JP, 1998, INFECT IMMUN, V66, P6017, DOI 10.1128/IAI.66.12.6017-6021.1998; Beare PA, 2012, APPL ENVIRON MICROB, V78, P4580, DOI 10.1128/AEM.00881-12; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00097; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Binet R, 2009, P NATL ACAD SCI USA, V106, P292, DOI 10.1073/pnas.0806768106; CAMPBELL S, 1989, J GEN MICROBIOL, V135, P1153; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Dautry-Varsat A, 2005, CELL MICROBIOL, V7, P1714, DOI 10.1111/j.1462-5822.2005.00627.x; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; DeMars R, 2008, J BACTERIOL, V190, P1605, DOI 10.1128/JB.01592-07; DeMars R, 2007, J BACTERIOL, V189, P991, DOI 10.1128/JB.00845-06; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Elwell CA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000021; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; FRIIS RR, 1972, J BACTERIOL, V110, P706, DOI 10.1128/JB.110.2.706-721.1972; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Kari L, 2011, P NATL ACAD SCI USA, V108, P7189, DOI 10.1073/pnas.1102229108; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Renesto P, 2002, MICROB PATHOGENESIS, V33, P17, DOI 10.1006/mpat.2002.0508; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore-Carlson MA, 1999, MOL MICROBIOL, V33, P753, DOI 10.1046/j.1365-2958.1999.01523.x; Skilton RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007723; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Suchland RJ, 2000, INFECT IMMUN, V68, P360, DOI 10.1128/IAI.68.1.360-367.2000; TAM JE, 1994, CAN J MICROBIOL, V40, P583, DOI 10.1139/m94-093; Van Ooij C, 1998, INFECT IMMUN, V66, P5364, DOI 10.1128/IAI.66.11.5364-5371.1998; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258	53	74	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57090	10.1371/journal.pone.0057090	http://dx.doi.org/10.1371/journal.pone.0057090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441233	gold, Green Submitted, Green Published			2022-12-25	WOS:000315159200090
J	Schoen, CJ; Burmeister, M; Lesperance, MM				Schoen, Cynthia J.; Burmeister, Margit; Lesperance, Marci M.			Diaphanous homolog 3 (Diap3) Overexpression Causes Progressive Hearing Loss and Inner Hair Cell Defects in a Transgenic Mouse Model of Human Deafness	PLOS ONE			English	Article							DENDRITIC SPINE PLASTICITY; AUDITORY-NERVE; MECHANICAL TRANSDUCTION; MICE; CYTOSKELETON; ACTIN; MICROTUBULES; IMPAIRMENT; NEUROPATHY; DROSOPHILA	We previously demonstrated that a mutation in the 5' untranslated region of Diaphanous homolog 3 (DIAPH3) results in 2 to 3-fold overexpression of the gene, leading to a form of delayed onset, progressive human deafness known as AUNA1 (auditory neuropathy, nonsyndromic, autosomal dominant, 1). To investigate the mechanism of deafness, we generated two lines of transgenic mice overexpressing Diap3, the murine ortholog of DIAPH3, on an FVB/NJ background. Line 771 exhibits a relatively mild 20 dB hearing loss at 12 kHz at 4 and 8 weeks of age, progressing to 40 dB and 60 dB losses at 16 and 24 weeks, respectively, at 12 and 24 kHz. Line 924 shows no hearing loss at 4 or 8 weeks, but manifests 35 and 50 dB threshold shifts at 16 and 24 weeks, respectively, at both 12 and 24 kHz. Notably, mice from the two transgenic lines retain distortion product otoacoustic emissions, indicative of normal cochlear outer hair cell (OHC) function despite elevation of auditory thresholds. Scanning electron microscopy of the organ of Corti demonstrates striking anomalies of the inner hair cell (IHC) stereocilia, while OHCs are essentially intact. Over time, IHCs of both lines develop elongated stereocilia that appear fused with neighboring stereocilia, in parallel to the time course of hearing loss in each line. Furthermore, we observe significant reduction in the number of IHC ribbon synapses over 24 weeks in both lines, although this reduction does not correlate temporally with onset and progression of hearing loss or stereociliary anomalies. In summary, overexpression of wild-type Diap3 in two lines of transgenic mice results in hearing loss that recapitulates human AUNA1 deafness. These findings suggest an essential role of Diap3 in regulating assembly and/or maintenance of actin filaments in IHC stereocilia, as well as a potential role at the IHC ribbon synapse.	[Schoen, Cynthia J.] Univ Michigan Hlth Syst, Neurosci Program, Ann Arbor, MI USA; [Schoen, Cynthia J.; Burmeister, Margit] Univ Michigan Hlth Syst, Mol & Behav Neurosci Inst, Ann Arbor, MI USA; [Burmeister, Margit] Univ Michigan Hlth Syst, Dept Human Genet, Ann Arbor, MI USA; [Burmeister, Margit] Univ Michigan Hlth Syst, Dept Psychiat, Ann Arbor, MI USA; [Lesperance, Marci M.] Univ Michigan Hlth Syst, Div Pediat Otolaryngol, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lesperance, MM (corresponding author), Univ Michigan Hlth Syst, Div Pediat Otolaryngol, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA.	lesperan@umich.edu	Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434	National Institutes of Health [R01 DC007380, F31 DC011428, T32 DC000011, P30 DC005188]; University of Michigan Office of the Vice President for Research; University of Michigan Nathan Shock Aging Rodent Core; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS076401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007380, T32DC000011, F31DC011428, P30DC005188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Office of the Vice President for Research(University of Michigan System); University of Michigan Nathan Shock Aging Rodent Core; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health Grants R01 DC007380 (to MML), F31 DC011428 (to CJS), T32 DC000011 (supported CJS), and P30 DC005188 (in support of the University of Michigan Auditory Physiology and Histology-Pathology Cores), the University of Michigan Office of the Vice President for Research, and the University of Michigan Nathan Shock Aging Rodent Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Beyer LA, 2000, J NEUROCYTOL, V29, P227, DOI 10.1023/A:1026515619443; Brzostowski Joseph A., 2009, Communicative & Integrative Biology, V2, P337; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; COSTALUPES JA, 1984, J NEUROPHYSIOL, V51, P1326, DOI 10.1152/jn.1984.51.6.1326; Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013; DeWard AD, 2010, BBA-MOL CELL RES, V1803, P226, DOI 10.1016/j.bbamcr.2009.11.006; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Hoogenraad CC, 2010, NEUROSCIENTIST, V16, P650, DOI 10.1177/1073858410386357; JAEGER RG, 1994, HEARING RES, V77, P207, DOI 10.1016/0378-5955(94)90268-2; Johnson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036074; Karolyi IJ, 2007, MAMM GENOME, V18, P596, DOI 10.1007/s00335-007-9038-0; Kim TB, 2004, J MED GENET, V41, P872, DOI 10.1136/jmg.2004.020628; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Muller M, 2005, NEUROREPORT, V16, P1183; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OSBORNE MP, 1991, SCANNING MICROSCOPY, V5, P555; Peng J, 2007, CANCER RES, V67, P7565, DOI 10.1158/0008-5472.CAN-07-1467; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Ruel J, 2008, AM J HUM GENET, V83, P278, DOI 10.1016/j.ajhg.2008.07.008; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schoen CJ, 2010, P NATL ACAD SCI USA, V107, P13396, DOI 10.1073/pnas.1003027107; Self T, 1998, DEVELOPMENT, V125, P557; Stamataki S, 2006, HEARING RES, V221, P104, DOI 10.1016/j.heares.2006.07.014; Starr A, 2004, JARO-J ASSOC RES OTO, V5, P411, DOI 10.1007/s10162-004-5014-5; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Thumkeo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025465; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019; Zilberstein Y, 2012, J NEUROSCI, V32, P405, DOI 10.1523/JNEUROSCI.4678-11.2012	41	26	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56520	10.1371/journal.pone.0056520	http://dx.doi.org/10.1371/journal.pone.0056520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441200	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200057
J	Starke, IC; Zentek, J; Vahjen, W				Starke, Ingo C.; Zentek, Juergen; Vahjen, Wilfried			Ex Vivo - Growth Response of Porcine Small Intestinal Bacterial Communities to Pharmacological Doses of Dietary Zinc Oxide	PLOS ONE			English	Article							PIGS	Piglets were fed diets containing 57 (low) or 2425 (high) mg zinc from analytical grade zinc oxide (ZnO) .kg(-1) feed. Digesta samples from the stomach and jejuna of 32, 39, 46 and 53 d old animals (n = 6 per group) were incubated in media containing 80, 40, 20 and 0 mu g.mL(-1) soluble zinc from ZnO. Turbidity was recorded for 16 h and growth parameters were calculated. Additionally, DNA extracts of selected samples were analyzed via qPCR for different bacterial groups. Samples from animals fed the low dietary zinc concentration always showed highest rate of growth and lowest lag times in media without added zinc. However, media supplemented with zinc displayed highest growth rates and lowest lag time in the high dietary zinc group. Specific growth rates and lag time showed significant differences on day 32 and 39 of age, but rarely on days 46 and 53 of age. Bacterial growth in digesta samples from the high dietary zinc group was less influenced by zinc and recovered growth more rapidly than in the low dietary zinc group. Specific growth rates and bacterial cell numbers from qPCR results showed that lactobacilli were most susceptible to zinc, while bifidobacteria, enterobacteria and enterococci exhibited increased growth rates in samples of animals from the high dietary zinc treatment. No treatment related differences were observed for clostridial cluster IV and the Bacteroides-Prevotella-Porphyromonas cluster. The diversity of enterobacteria after incubation was always higher in the high dietary zinc treatment or in medium supplemented with 80 mu g.mL(-1) soluble ZnO. This study has shown that a pharmacological dosage of ZnO leads to a reduced ex vivo-bacterial growth rate of bacteria from the stomach and jejunum of weaned piglets. In view of the rapid bacterial adaptation to dietary zinc, the administration of ZnO in feeds for weaned piglets might only be beneficial in a short period after weaning.	[Starke, Ingo C.; Zentek, Juergen; Vahjen, Wilfried] Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany	Free University of Berlin	Starke, IC (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Anim Nutr, Berlin, Germany.	starke@zedat.fu-berlin.de			Deutsche Forschungsgemeinschaft (DFG) through Collaborative Research Group (SFB) 852/Project A1	Deutsche Forschungsgemeinschaft (DFG) through Collaborative Research Group (SFB) 852/Project A1	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) through grant of the Collaborative Research Group (SFB) 852/Project A1, "Nutrition and intestinal microbiota - host interactions in the pig". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardinal F, 2006, J SWINE HEALTH PROD, V14, P10; DINTZIS FR, 1995, J ANIM SCI, V73, P1138; HILL GM, 1983, J ANIM SCI, V57, P130, DOI 10.2527/jas1983.571130x; Hojberg O, 2005, APPL ENVIRON MICROB, V71, P2267, DOI 10.1128/AEM.71.5.2267-2277.2005; Janczyk P, 2007, FEMS MICROBIOL ECOL, V61, P132, DOI 10.1111/j.1574-6941.2007.00317.x; Katouli M, 1999, J APPL MICROBIOL, V87, P564, DOI 10.1046/j.1365-2672.1999.00853.x; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Liedtke J, 2012, VET MICROBIOL, V160, P251, DOI 10.1016/j.vetmic.2012.05.013; Martin L., 2012, 12 INT S DIG PHYS PI; Mertens J, 2006, ENVIRON MICROBIOL, V8, P2170, DOI 10.1111/j.1462-2920.2006.01100.x; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; Perumbakkam S, 2011, FEMS MICROBIOL ECOL, V76, P156, DOI 10.1111/j.1574-6941.2011.01042.x; Pettigrew JE, 2006, ANIM BIOTECHNOL, V17, P207, DOI 10.1080/10495390600956946; Pieper R, 2008, MICROB ECOL, V56, P474, DOI 10.1007/s00248-008-9366-y; Starke IC, 2012, P 12 INT S DIG PHYS, P39; Su Y, 2008, FEMS MICROBIOL ECOL, V66, P546, DOI 10.1111/j.1574-6941.2008.00529.x; Vahjen W, 2007, Curr Issues Intest Microbiol, V8, P1; Vahjen W, 2011, J ANIM SCI, V89, P2430, DOI 10.2527/jas.2010-3270; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09	20	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56405	10.1371/journal.pone.0056405	http://dx.doi.org/10.1371/journal.pone.0056405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441186	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200043
J	Yang, JY; Cho, SW; An, JH; Jung, JY; Kim, SW; Kim, SY; Kim, JE; Shin, CS				Yang, Jae-Yeon; Cho, Sun Wook; An, Jee Hyun; Jung, Ju Yeon; Kim, Sang Wan; Kim, Seong Yeon; Kim, Jung Eun; Shin, Chan Soo			Osteoblast-Targeted Overexpression of TAZ Increases Bone Mass In Vivo	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR TAZ; STEM-CELL DIFFERENTIATION; ACTIVATED RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; PROTEIN; OSF2/CBFA1; EXPRESSION; FAMILY; BETA; MICE	Osteoblasts are derived from mesenchymal progenitors. Differentiation to osteoblasts and adipocytes is reciprocally regulated. Transcriptional coactivator with a PDZ-binding motif (TAZ) is a transcriptional coactivator that induces differentiation of mesenchymal cells into osteoblasts while blocking differentiation into adipocytes. To investigate the role of TAZ on bone metabolism in vivo, we generated transgenic mice that overexpress TAZ under the control of the procollagen type 1 promoter (Col1-TAZ). Whole body bone mineral density (BMD) of 6- to 19-week-old Col-TAZ mice was 4% to 7% higher than that of their wild-type (WT) littermates, whereas no difference was noticed in Col.1-TAZ female mice. Microcomputed tomography analyses of proximal tibiae at 16 weeks of age demonstrated a significant increase in trabecular bone volume (26.7%) and trabecular number (26.6%) with a reciprocal decrease in trabecular spacing (14.2%) in Col1-TAZ mice compared with their WT littermates. In addition, dynamic histomorphometric analysis of the lumbar spine revealed increased mineral apposition rate (42.8%) and the serum P1NP level was also significantly increased (53%) in Col.1-TAZ mice. When primary calvaria cells were cultured in osteogenic medium, alkaline phosphatase (ALP) activity was significantly increased and adipogenesis was significantly suppressed in Col1-TAZ mice compared with their WT littermates. Quantitative real-time polymerase chain reaction analyses showed that expression of collagen type 1, bone sialoprotein, osteocalcin, ALP, osterix, and Runx2 was significantly increased in calvaria cells from Col1-TAZ mice compared to their WT littermates. In vitro, TAZ enhanced Runx2-mediated transcriptional activity while suppressing the peroxisome proliferator-activated receptor gamma signaling pathway. TAZ also enhanced transcriptional activity from 3TP-Lux, which reflects transforming growth factor-beta (TGF-beta)-mediated signaling. In addition, TAZ enhanced TGF-beta-dependent nuclear translocation of Smad2/3 and Smad4. Taken together, these results suggest that TAZ positively regulates bone formation in vivo, which seems to be mediated by enhancing both Runx2 and TGF-beta signaling.	[Yang, Jae-Yeon; Cho, Sun Wook; An, Jee Hyun; Jung, Ju Yeon; Kim, Sang Wan; Kim, Seong Yeon; Shin, Chan Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Jung Eun] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Taegu, South Korea	Seoul National University (SNU); Kyungpook National University	Shin, CS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	csshin@snu.ac.kr	Kim, Sang Wan/J-5399-2012	Kim, Sang Wan/0000-0001-9561-9110	Ministry of Education, Science and Technology of Korea [2009-0077579]	Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the Ministry of Education, Science and Technology of Korea (grant # 2009-0077579, http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boban I, 2006, BONE, V39, P1302, DOI 10.1016/j.bone.2006.06.025; Byun MR, 2012, FEBS LETT, V586, P1086, DOI 10.1016/j.febslet.2012.03.008; Cho SW, 2011, J BONE MINER RES, V26, P1939, DOI 10.1002/jbmr.366; Ciavarella S, 2009, STEM CELLS DEV, V18, P1211, DOI 10.1089/scd.2008.0340; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Jang EJ, 2012, BRIT J PHARMACOL, V165, P1584, DOI 10.1111/j.1476-5381.2011.01664.x; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Jung H, 2009, BIOCHEM PHARMACOL, V78, P1323, DOI 10.1016/j.bcp.2009.07.001; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim SW, 2005, BIOCHEM BIOPH RES CO, V327, P811, DOI 10.1016/j.bbrc.2004.12.076; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; TAPSCOTT SJ, 1991, J CLIN INVEST, V87, P1133, DOI 10.1172/JCI115109; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhang X, 2006, CALCIFIED TISSUE INT, V79, P169, DOI 10.1007/s00223-006-0083-6; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	40	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56585	10.1371/journal.pone.0056585	http://dx.doi.org/10.1371/journal.pone.0056585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441207	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200064
J	Zou, QH; Li, RQ; Wang, YJ; Liu, SL				Zou, Qing-Hua; Li, Ren-Qing; Wang, Ye-Jun; Liu, Shu-Lin			Identification of Genes to Differentiate Closely Related Salmonella Lineages	PLOS ONE			English	Article							GENOMIC CLEAVAGE MAP; PATHOGENICITY ISLANDS; ENTERICA; PARATYPHI; TYPHI; EVOLUTION; SEQUENCE; CONVERGENCE; DIVERGENCE; PHYLOGENY	Background: Salmonella are important human and animal pathogens. Though highly related, the Salmonella lineages may be strictly adapted to different hosts or cause different diseases, from mild local illness like gastroenteritis to fatal systemic infections like typhoid. Therefore, rapid and accurate identification of Salmonella is essential for timely and correct diagnosis of Salmonella infections. The current identification methods such as 16S rRNA sequencing and multilocus sequence typing are expensive and time consuming. Additionally, these methods often do not have sufficient distinguishing resolution among the Salmonella lineages. Methodologies/Principal Findings: We compared 27 completely sequenced Salmonella genomes to identify possible genomic features that could be used for differentiation of individual lineages. We concatenated 2372 core genes in each of the 27 genomes and constructed a neighbor-joining tree. On the tree, strains of each serotype were clustered tightly together and different serotypes were unambiguously separated with clear genetic distances, demonstrating systematic genomic divergence among the Salmonella lineages. We made detailed comparisons among the 27 genomes and identified distinct sets of genomic differences, including nucleotide variations and genomic islands (GIs), among the Salmonella lineages. Two core genes STM4261 and entF together could unambiguously distinguish all Salmonella lineages compared in this study. Additionally, strains of a lineage have a common set of GIs and closely related lineages have similar sets of GIs. Conclusions: Salmonella lineages have accumulated distinct sets of mutations and laterally acquired DNA (e.g., GIs) in evolution. Two genes entF and STM4261 have diverged sufficiently among the Salmonella lineages to be used for their differentiation. Further investigation of the distinct sets of mutations and GIs will lead to novel insights into genomic evolution of Salmonella and greatly facilitate the elucidation of pathogeneses of Salmonella infections.	[Zou, Qing-Hua; Liu, Shu-Lin] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China; [Li, Ren-Qing] Beijing Ctr Dis Control & Prevent, Inst Immunol, Beijing, Peoples R China; [Wang, Ye-Jun; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Labs Biomed Pharmaceut China, Harbin, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	Peking University; Harbin Medical University; University of Calgary	Liu, SL (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Microbiol, Beijing 100871, Peoples R China.	slliu@ucalgary.ca			National Natural Science Foundation of China [31100134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a project of National Natural Science Foundation of China (31100134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; BARROW PA, 1994, INFECT IMMUN, V62, P4602, DOI 10.1128/IAI.62.10.4602-4610.1994; Chen C, FOODBORNE PATHOG DIS, V9, P325; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Feng Y, 2012, OMICS, MICROBIAL MODELING AND TECHNOLOGIES FOR FOODBORNE PATHOGENS, P43; Feng Y, 2012, J BACTERIOL, V194, P744, DOI 10.1128/JB.06507-11; Feng Y, 2011, SALMONELLA: FROM GENOME TO FUNCTION, P49; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; KAUFFMANN F., 1957, ACTA PATHOL ET MICROBIOL SCAND, V41, P242; Kothapalli S, 2005, J BACTERIOL, V187, P2638, DOI 10.1128/JB.187.8.2638-2650.2005; Lienau EK, N ENGL J MED, V364, P981; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Liu GR, 2003, J BACTERIOL, V185, P2131, DOI 10.1128/JB.185.7.2131-2142.2003; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu GR, 2006, NEAR COMPLETE CONSER, P97; Liu Shu-Lin, 2007, V394, P39, DOI 10.1007/978-1-59745-512-1_3; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; LIU SL, 1992, J BACTERIOL, V174, P1662, DOI 10.1128/jb.174.5.1662-1672.1992; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; LIU SL, 1993, MOL MICROBIOL, V10, P655, DOI 10.1111/j.1365-2958.1993.tb00937.x; LIU SL, 1995, J BACTERIOL, V177, P5099, DOI 10.1128/jb.177.17.5099-5107.1995; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Ochman H, 1996, INFECT IMMUN, V64, P5410, DOI 10.1128/IAI.64.12.5410-5412.1996; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OCHMAN H, 1995, CURR OPIN GENET DEV, V5, P734, DOI 10.1016/0959-437X(95)80005-P; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; STACKEBRANDT E, 1984, MICROBIOL SCI, V1, P117; Tang L, 2012, ANTON LEEUW INT J G, V101, P67, DOI 10.1007/s10482-011-9680-0; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005	44	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55988	10.1371/journal.pone.0055988	http://dx.doi.org/10.1371/journal.pone.0055988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441160	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200017
J	Romanow, A; Haselhorst, T; Stummeyer, K; Claus, H; Bethe, A; Muenhoff, M; Vogel, U; von Itzstein, M; Gerardy-Schahn, R				Romanow, Angela; Haselhorst, Thomas; Stummeyer, Katharina; Claus, Heike; Bethe, Andrea; Muehlenhoff, Martina; Vogel, Ulrich; von Itzstein, Mark; Gerardy-Schahn, Rita			Biochemical and Biophysical Characterization of the Sialyl-/Hexosyltransferase Synthesizing the Meningococcal Serogroup W135 Heteropolysaccharide Capsule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; NEISSERIA-MENINGITIDIS; PASTEURELLA-MULTOCIDA; POLYSIALIC ACID; BACTERIAL SIALYLTRANSFERASES; STRUCTURAL DETERMINATION; POLYSACCHARIDE ANTIGENS; MOLECULAR RECOGNITION; CATALYTIC MECHANISM; SUBSTRATE-BINDING	Neisseria meningitidis (Nm) is a leading cause of bacterial meningitis and sepsis. Crucial virulence determinants of pathogenic Nm strains are the polysaccharide capsules that support invasion by hindering complement attack. In NmW-135 and NmY the capsules are built from the repeating units (-> 6)-alpha-D-Gal-(1 -> 4)-alpha-Neu5Ac-(2 ->)(n) and (-> 6)-alpha-D-Glc-(1 -> 4)-alpha-Neu5Ac-(2 ->)(n), respectively. These unusual heteropolymers represent unique examples of a conjugation between sialic acid and hexosyl-sugars in a polymer chain. Moreover, despite the various catalytic strategies needed for sialic acid and hexose transfer, single enzymes (SiaD(W-135/Y)) have been identified to form these heteropolymers. Here we used SiaD(W-135) as a model system to delineate structure-function relationships. In size exclusion chromatography active SiaD(W-135) migrated as a monomer. Fold recognition programs suggested two separate glycosyltransferase domains, both containing a GT-B-fold. Based on conserved motifs predicted folds could be classified as a hexosyl- and sialyltransferase. To analyze enzyme properties and interplay of the two identified glycosyltransferase domains, saturation transfer difference NMR and mutational studies were carried out. Simultaneous and independent binding of UDP-Gal and CMP-Sia was seen in the absence of an acceptor as well as when the catalytic cycle was allowed to proceed. Enzyme variants with only one functionality were generated by site-directed mutagenesis and shown to complement each other in trans when combined in an in vitro test system. Together the data strongly suggests that SiaD(W-135) has evolved by fusion of two independent ancestral genes encoding sialyl- and galactosyltransferase activity.	[Romanow, Angela; Stummeyer, Katharina; Bethe, Andrea; Muehlenhoff, Martina; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Haselhorst, Thomas; von Itzstein, Mark] Griffith Univ, Inst Glyc, Nathan, Qld 4222, Australia; [Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	Hannover Medical School; Griffith University; University of Wurzburg	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de	Haselhorst, Thomas/A-5066-2015; von Itzstein, Mark/E-4823-2010	Haselhorst, Thomas/0000-0002-3373-8680; 	LOM; Australian Research Council	LOM; Australian Research Council(Australian Research Council)	The work was supported by LOM (impact oriented funding) funds to the Institute for Cellular Chemistry and the Australian Research Council through a Federation Fellowship (to M. v. I.).	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Biet T, 2001, ANGEW CHEM INT EDIT, V40, P4189, DOI 10.1002/1521-3773(20011119)40:22<4189::AID-ANIE4189>3.0.CO;2-A; Bohm R, 2010, CHEMBIOCHEM, V11, P170, DOI 10.1002/cbic.200900659; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chiu CPC, 2004, NAT STRUCT MOL BIOL, V11, P163, DOI 10.1038/nsmb720; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Claus H, 1997, MOL GEN GENET, V257, P28, DOI 10.1007/s004380050620; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Damerow S, 2010, J BIOL CHEM, V285, P878, DOI 10.1074/jbc.M109.067223; Decosas J, 2002, LANCET INFECT DIS, V2, P763, DOI 10.1016/S1473-3099(02)00455-3; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; HAGOPIAN A, 1968, ARCH BIOCHEM BIOPHYS, V128, P387, DOI 10.1016/0003-9861(68)90045-3; Hao JJ, 2005, BIOCHEM BIOPH RES CO, V338, P1507, DOI 10.1016/j.bbrc.2005.10.113; Kakuta Y, 2008, GLYCOBIOLOGY, V18, P66, DOI 10.1093/glycob/cwm119; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kean EL, 2004, BBA-GEN SUBJECTS, V1673, P56, DOI 10.1016/j.bbagen.2004.04.006; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DU, 2008, BMB REP, V41, P48; May JF, 2012, BIOCHEMISTRY-US, V51, P1148, DOI 10.1021/bi201820p; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McGowen MM, 2001, GLYCOBIOLOGY, V11, P613, DOI 10.1093/glycob/11.8.613; MIN H, 1986, ANAL BIOCHEM, V155, P275, DOI 10.1016/0003-2697(86)90437-9; Ni LS, 2007, BIOCHEMISTRY-US, V46, P6288, DOI 10.1021/bi700346w; Ni LS, 2006, BIOCHEMISTRY-US, V45, P2139, DOI 10.1021/bi0524013; Pollard A J, 2001, J Paediatr Child Health, V37, pS20, DOI 10.1046/j.1440-1754.2001.00679.x; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; Ram S, 2003, J BIOL CHEM, V278, P50853, DOI 10.1074/jbc.M308364200; Raymond NJ, 1997, J INFECT DIS, V176, P1277, DOI 10.1086/514123; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Saksouk N, 2005, BIOCHEM J, V389, P63, DOI 10.1042/BJ20050217; Schwarzer D, 2007, J BIOL CHEM, V282, P2821, DOI 10.1074/jbc.M609543200; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Tzeng YL, 2000, MICROBES INFECT, V2, P687, DOI 10.1016/S1286-4579(00)00356-7; Vogel U, 1998, J CLIN MICROBIOL, V36, P2465, DOI 10.1128/JCM.36.9.2465-2470.1998; WEISGERBER C, 1990, J BIOL CHEM, V265, P1578; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Yamamoto T, 2008, BIOCHEM BIOPH RES CO, V365, P340, DOI 10.1016/j.bbrc.2007.10.201	47	21	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					11718	11730		10.1074/jbc.M113.452276	http://dx.doi.org/10.1074/jbc.M113.452276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23439648	Green Published, hybrid			2022-12-25	WOS:000318157600009
J	Unciti-Broceta, JD; Maceira, J; Morales, S; Garcia-Perez, A; Munoz-Torres, ME; Garcia-Salcedo, JA				Unciti-Broceta, Juan D.; Maceira, Jose; Morales, Sonia; Garcia-Perez, Angelica; Munoz-Torres, Manuel E.; Garcia-Salcedo, Jose A.			Nicotinamide Inhibits the Lysosomal Cathepsin b-like Protease and Kills African Trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL CEREBRAL-ISCHEMIA; REPLICATIVE LIFE-SPAN; IN-VITRO; CYSTEINE PROTEASE; HUMAN-CELLS; BRUCEI; RATS; DEGRADATION; EXTENDS; CYCLE	Nicotinamide, a soluble compound of the vitamin B-3 group, has antimicrobial activity against several microorganisms ranging from viruses to parasite protozoans. However, the mode of action of this antimicrobial activity is unknown. Here, we investigate the trypanocidal activity of nicotinamide on Trypanosoma brucei, the causative agent of African trypanosomiasis. Incubation of trypanosomes with nicotinamide causes deleterious defects in endocytic traffic, disruption of the lysosome, failure of cytokinesis, and, ultimately, cell death. At the same concentrations there was no effect on a cultured mammalian cell line. The effects on endocytosis and vesicle traffic were visible within 3 h and can be attributed to inhibition of lysosomal cathepsin b-like protease activity. The inhibitory effect of nicotinamide was confirmed by a direct activity assay of recombinant cathepsin b-like protein. Taken together, these data demonstrate that inhibition of the lysosomal protease cathepsin b-like blocks endocytosis, causing cell death. In addition, these results demonstrate for the first time the inhibitory effect of nicotinamide on a protease.	[Unciti-Broceta, Juan D.; Maceira, Jose; Morales, Sonia; Garcia-Perez, Angelica; Garcia-Salcedo, Jose A.] Inst Invest Biosanitaria Granada IBIG, Unidad Enfermedades Infecciosas, Granada 18012, Spain; [Munoz-Torres, Manuel E.] Inst Invest Biosanitaria Granada IBIG, Unidad Metab Oseo, Granada 18012, Spain; [Unciti-Broceta, Juan D.; Maceira, Jose; Morales, Sonia; Garcia-Perez, Angelica; Garcia-Salcedo, Jose A.] Inst Parasitol & Biomed Lopez Neyra IPBLN CSIC, Armilla 18016, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Garcia-Salcedo, JA (corresponding author), Inst Parasitol & Biomed Lopez Neyra IPBLN CSIC, Granada 18100, Spain.	jagarciasalcedo@ipb.csic.es	Torres, Manuel Muñoz/O-2330-2016; Garcia-Salcedo, Jose A/AAA-9434-2019; Morales-Santana, Sonia/ABG-8889-2020	Torres, Manuel Muñoz/0000-0002-9645-3260; Garcia-Salcedo, Jose A/0000-0003-3399-1835; Morales-Santana, Sonia/0000-0001-8403-2496; Unciti-Broceta, Juan Diego/0000-0002-4068-5943	Plan Nacional de Investigacion (Ministerio de Economia y Competitividad, Spain) [SAF2011-30528]; European Union [FP7-HEALTH-2007-B-2.3.4-1.223048]	Plan Nacional de Investigacion (Ministerio de Economia y Competitividad, Spain); European Union(European Commission)	This work was supported by Plan Nacional de Investigacion (Ministerio de Economia y Competitividad, Spain) Grant SAF2011-30528 (to J. A. G. S.) and European Union Grant FP7-HEALTH-2007-B-2.3.4-1.223048, NANOTRYP (to J. A. G. S.).	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; [Anonymous], 1986, WHO TECH REP SER, VXIV, p[211, I]; Caffrey CR, 2001, MOL BIOCHEM PARASIT, V118, P61, DOI 10.1016/S0166-6851(01)00368-1; COPPENS I, 1993, MOL BIOCHEM PARASIT, V58, P223, DOI 10.1016/0166-6851(93)90044-X; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gazanion E, 2011, PARASITOL INT, V60, P19, DOI 10.1016/j.parint.2010.09.005; Gould MK, 2008, ANAL BIOCHEM, V382, P87, DOI 10.1016/j.ab.2008.07.036; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; JACKSON TM, 1995, J NUTR, V125, P1455; KALLMANN B, 1992, LIFE SCI, V51, P671, DOI 10.1016/0024-3205(92)90240-P; Kang HT, 2006, AGING CELL, V5, P423, DOI 10.1111/j.1474-9726.2006.00234.x; Kelley RJ, 1999, MOL BIOCHEM PARASIT, V98, P17, DOI 10.1016/S0166-6851(98)00155-8; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Landeira D, 2007, J CELL BIOL, V176, P133, DOI 10.1083/jcb.200607174; Lim CS, 2006, MECH AGEING DEV, V127, P511, DOI 10.1016/j.mad.2006.02.001; LIU G, 1982, J BACTERIOL, V152, P1111; Mackey ZB, 2004, J BIOL CHEM, V279, P48426, DOI 10.1074/jbc.M402470200; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mendoza-Palomares C, 2008, EUKARYOT CELL, V7, P684, DOI 10.1128/EC.00405-07; Mokudai T, 2000, STROKE, V31, P1679, DOI 10.1161/01.STR.31.7.1679; MURRAY MF, 1995, BIOCHEM BIOPH RES CO, V210, P954, DOI 10.1006/bbrc.1995.1749; Murray MF, 2003, CLIN INFECT DIS, V36, P453, DOI 10.1086/367544; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Prusty D, 2008, FEMS MICROBIOL LETT, V282, P266, DOI 10.1111/j.1574-6968.2008.01135.x; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Sakai Y, 2002, CELL TRANSPLANT, V11, P435; Scory S, 1999, EXP PARASITOL, V91, P327, DOI 10.1006/expr.1998.4381; Scory Stefan, 2007, Kinetoplastid Biol Dis, V6, P2, DOI 10.1186/1475-9292-6-2; Sereno D, 2005, ANTIMICROB AGENTS CH, V49, P808, DOI 10.1128/AAC.49.2.808-812.2005; Soares MBP, 2012, ACTA TROP, V122, P224, DOI 10.1016/j.actatropica.2012.01.001; Spitznagel D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012282; Sun AY, 1998, ACTA PHARMACOL SIN, V19, P104; Vaca P, 2003, TRANSPL P, V35, P2021, DOI 10.1016/S0041-1345(03)00735-8; Vermelrio A.B., 2007, CURR ENZYME INHIB, V3, P19; Wurtele H, 2010, NAT MED, V16, P774, DOI 10.1038/nm.2175	39	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10548	10557		10.1074/jbc.M112.449207	http://dx.doi.org/10.1074/jbc.M112.449207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443665	Green Published, hybrid			2022-12-25	WOS:000317565000034
J	Kilarski, WW; Guc, E; Teo, JCM; Oliver, SR; Lund, AW; Swartz, MA				Kilarski, Witold W.; Guec, Esra; Teo, Jeremy C. M.; Oliver, S. Ryan; Lund, Amanda W.; Swartz, Melody A.			Intravital Immunofluorescence for Visualizing the Microcirculatory and Immune Microenvironments in the Mouse Ear Dermis	PLOS ONE			English	Article							IN-VIVO; FLUORESCENCE MICROSCOPY; LEUKOCYTE MIGRATION; LYMPHATIC VESSELS; CELLS; TUMORS; TRAFFICKING; COLLAGEN; MICE; ADHESION	Visualizing the dynamic behaviors of immune cells in living tissue has dramatically increased our understanding of how cells interact with their surroundings, contributing important insights into mechanisms of leukocyte trafficking, tumor cell invasion, and T cell education by dendritic cells, among others. Despite substantial advances with various intravital imaging techniques including two-photon microscopy and the generation of multitudes of reporter mice, there is a growing need to assess cell interactions in the context of specific extracellular matrix composition and microvascular functions, and as well, simpler and more widely accessible methods are needed to image cell behaviors in the context of living tissue physiology. Here we present an antibody-based method for intravital imaging of cell interactions with the blood, lymphatic, and the extracellular matrix compartments of the living dermis while simultaneously assessing capillary permeability and lymphatic drainage function. Using the exposed dorsal ear of the anesthetized mouse and a fluorescence stereomicroscope, such events can be imaged in the context of specific extracellular matrix proteins, or matrix-bound chemokine stores. We developed and optimized the method to minimize tissue damage to the ear, rapidly immunostain for multiple extracellular or cell surface receptors of interest, minimize immunotoxicity with pre-blocking Fc gamma receptors and phototoxicity with extracellular antioxidants, and highlight the major dermal tissue structures with basement membrane markers. We demonstrate differential migration behaviors of bone marrow-derived dendritic cells, blood-circulating leukocytes, and dermal dendritic cells, with the latter entering sparse CCL21-positive areas of pre-collecting lymphatic vessels. This new method allows simultaneous imaging of cells and tissue structures, microvascular function, and extracellular microenvironment in multiple skin locations for 12 hours or more, with the flexibility of immunolabeling in addition to genetic-based fluorescent reporters.	[Kilarski, Witold W.; Guec, Esra; Teo, Jeremy C. M.; Oliver, S. Ryan; Lund, Amanda W.; Swartz, Melody A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Teo, Jeremy C. M.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Lausanne, Switzerland; [Teo, Jeremy C. M.] Khalifa Univ Sci Technol & Res, Abu Dhabi, U Arab Emirates	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Khalifa University of Science & Technology	Kilarski, WW (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland.	witold.kilarski@epfl.ch; melody.swartz@epfl.ch	Kilarski, Witold W./G-8673-2012; Teo, Jeremy CM/D-7590-2015; Kilarski, Witold/AAA-1843-2019; Teo, Jeremy C.M./J-6440-2019	Kilarski, Witold W./0000-0003-0734-4749; Teo, Jeremy CM/0000-0001-6869-3833; Teo, Jeremy C.M./0000-0001-6869-3833; Lund, Amanda/0000-0001-7389-9983	European Research Commission (DC-Lymph) [206653-2]; European Framework Project 7 (AngioScaff); Swiss National Science Foundation [31-135756]; U.S. National Institutes of Health (NIH)/NIH Heart, Lung, and Blood Institute (NHLBI) [RO1 HL096539]; Robert Wenner Award (Swiss Cancer League); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096539] Funding Source: NIH RePORTER	European Research Commission (DC-Lymph); European Framework Project 7 (AngioScaff); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. National Institutes of Health (NIH)/NIH Heart, Lung, and Blood Institute (NHLBI); Robert Wenner Award (Swiss Cancer League); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the European Research Commission (DC-Lymph, 206653-2), the European Framework Project 7 (AngioScaff), the Swiss National Science Foundation (31-135756), and the U.S. National Institutes of Health (NIH)/NIH Heart, Lung, and Blood Institute (NHLBI) (RO1 HL096539). Additionally, funds from the Robert Wenner Award (Swiss Cancer League) allowed the purchase the Leica stereomicroscope used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Brown E, 2010, COLD SPRING HARB PRO, P5452; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Eichten A, 2005, CURR PROTOC CYTOM, V12; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Haessler U, 2011, P NATL ACAD SCI USA, P3; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hubner MP, 2012, J IMMUNOL, V188, P559, DOI 10.4049/jimmunol.1100335; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Jenne CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025109; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Kilarski WW, 2009, NAT MED, V15, P657, DOI 10.1038/nm.1985; Kimpton WG, 2009, ENCY LIFE SCI; Kuijpers TW, 2001, ENCY LIFE SCI, P1; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li JL, 2012, NAT PROTOC, V7, P221, DOI 10.1038/nprot.2011.438; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinez-Corral I, 2012, P NATL ACAD SCI US; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Roos A., 2005, ENCY LIFE SCI, P1; Saetzler RK, 1997, J HISTOCHEM CYTOCHEM, V45, P505, DOI 10.1177/002215549704500403; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spangrude GJ, 2001, CURRENT PROTOCOLS IM; Steinbauer M, 2003, CLIN EXP METASTAS, V20, P135, DOI 10.1023/A:1022618909921; Steinbauer M, 2000, LANGENBECK ARCH SURG, V385, P290, DOI 10.1007/s004239900108; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Truman LA, 2012, AM J PATHOL, V180, P1715, DOI 10.1016/j.ajpath.2011.12.026; Vigl B, 2011, BLOOD, P1; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Zhi L, 2011, J IMMUNOL, V187, P2244, DOI 10.4049/jimmunol.1100670	45	52	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57135	10.1371/journal.pone.0057135	http://dx.doi.org/10.1371/journal.pone.0057135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451163	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500068
J	Seo, JW; Cho, SC; Park, SJ; Lee, EJ; Lee, JH; Han, SS; Pyo, BS; Park, DH; Kim, BH				Seo, Joung-Wook; Cho, Soon-Chang; Park, Sang-Joon; Lee, Eun-Ji; Lee, Jong-Hwa; Han, Sang-Seop; Pyo, Byeong Sik; Park, Dae-Hun; Kim, Bong-Hee			1 '-Acetoxychavicol Acetate Isolated from Alpinia galanga Ameliorates Ovalbumin-Induced Asthma in Mice	PLOS ONE			English	Article							ALLERGIC-ASTHMA; CYTOKINE PRODUCTION; CELLS; DISEASES; HYPERREACTIVITY; INFLAMMATION; EOSINOPHILIA; RELEASE; ALPHA; GAMMA	The World Health Organization reports that 235 million people are currently affected by asthma. This disease is associated with an imbalance of Th1 and Th2 cells, which results in the upregulation of cytokines that promote chronic inflammation of the respiratory system. The inflammatory response causes airway obstruction and can ultimately result in death. In this study we evaluated the effect of 1'-acetoxychavicol acetate (ACA) isolated from Alpinia galanga rhizomes in a mouse model of ovalbumin (OVA)-induced asthma. To generate the mouse model, BALB/c mice were sensitized by intraperitoneal injection of OVA and then challenged with OVA inhalation for 5 days. Mice in the vehicle control group were sensitized with OVA but not challenged with OVA. Treatment groups received dexamethasone, 25 mg/kg/day ACA, or 50 mg/kg/day ACA for 5 days. Asthma-related inflammation was assessed by bronchoalveolar lavage fluid cell counts and histopathological and immunohistochemical analysis of lung tissues. Our results showed that ACA reduced the infiltration of white blood cells (especially eosinophils) and the level of IgE in the lungs of mice challenged with OVA and suppressed histopathological changes such as airway remodeling, goblet-cell hyperplasia, eosinophil infiltration, and glycoprotein secretion. In addition, ACA inhibited expression of the Th2 cytokines interleukin (IL)-4 and IL-13, and Th1 cytokines IL-12 alpha and interferon-gamma. Because asthmatic reactions are mediated by diverse immune and inflammatory pathways, ACA shows promise as an antiasthmatic drug candidate.	[Seo, Joung-Wook; Lee, Jong-Hwa] Korea Inst Toxicol, Taejon, South Korea; [Seo, Joung-Wook; Kim, Bong-Hee] Chungnam Natl Univ, Coll Pharm, Taejon, South Korea; [Cho, Soon-Chang] Youngdong Univ, Ctr Senior Ind, Yeongdong, South Korea; [Park, Sang-Joon] Kyungpook Natl Univ, Coll Vet Med, Taegu, South Korea; [Lee, Eun-Ji] Chungnam Natl Univ, Coll Vet Med, Taejon, South Korea; [Han, Sang-Seop] Konyang Univ, Taejon, South Korea; [Pyo, Byeong Sik; Park, Dae-Hun] Dongshin Univ, Naju, South Korea	Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Chungnam National University; Kyungpook National University; Chungnam National University; Konyang University; Dongshin University	Park, DH (corresponding author), Dongshin Univ, Naju, South Korea.	dhj1221@paran.com; bhkimnh@cnu.ac.kr		Lee, Jong-Hwa/0000-0002-5131-0514	National Research Foundation of Korea [2009-0073116]; Business for Cooperative RD [C0018727]	National Research Foundation of Korea(National Research Foundation of Korea); Business for Cooperative RD	This work was supported by a grant (Code No. 2009-0073116) from National Research Foundation of Korea and a grant (Code No. C0018727) from Business for Cooperative R&D between Industry, Academy, and Research Institute funded Korea Small and Medium Business Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2005, BIOORGAN MED CHEM, V13, P3289, DOI 10.1016/j.bmc.2005.02.022; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V101, pS427, DOI 10.1016/S0091-6749(98)70154-X; Bosnjak B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-114; Brightling CE, 2002, J ALLERGY CLIN IMMUN, V110, P899, DOI 10.1067/mai.2002.129698; Carson F. L., 2009, HISTOTECHNOLOGY SELF, V3th, P137; CEMBRZYNSKANOWAK M, 1993, AM REV RESPIR DIS, V147, P291, DOI 10.1164/ajrccm/147.2.291; Commins SP, 2010, J ALLERGY CLIN IMMUN, V125, pS53, DOI 10.1016/j.jaci.2009.07.008; CORRIGAN CJ, 1991, INT ARCH ALLER A IMM, V94, P270, DOI 10.1159/000235380; DING JY, 1989, J STEROID BIOCHEM, V33, P1139, DOI 10.1016/0022-4731(89)90421-4; Ferreira MAR, 2004, RESPIROLOGY, V9, P16, DOI 10.1111/j.1440-1843.2003.00516.x; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; KAM JC, 1993, J IMMUNOL, V151, P3460; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Magnan AO, 2000, AM J RESP CRIT CARE, V161, P1790, DOI 10.1164/ajrccm.161.6.9906130; Mamessier E, 2006, EUR J DERMATOL, V16, P103; Matsuda H, 2003, BIOORG MED CHEM LETT, V13, P3197, DOI 10.1016/S0960-894X(03)00710-8; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Min HJ, 2009, INT IMMUNOPHARMACOL, V9, P448, DOI 10.1016/j.intimp.2009.01.008; Miteva L, 2008, HUM IMMUNOL, V69, P562, DOI 10.1016/j.humimm.2008.07.008; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; National asthma education and prevention program, 2002, J ALLERGY CLIN IMM S, V110, pS141; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Warrier PK, 1993, INDIAN MED PLANTS, V1-5; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; World Health Organization, 2011, ASTHMA; ZHENG GQ, 1993, J AGR FOOD CHEM, V41, P153, DOI 10.1021/jf00026a001; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	31	45	49	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56447	10.1371/journal.pone.0056447	http://dx.doi.org/10.1371/journal.pone.0056447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451048	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500016
J	Wall, NA; Chue, CD; Edwards, NC; Pankhurst, T; Harper, L; Steeds, RP; Lauder, S; Townend, JN; Moss, P; Ferro, CJ				Wall, Nadezhda A.; Chue, Colin D.; Edwards, Nicola C.; Pankhurst, Tanya; Harper, Lorraine; Steeds, Richard P.; Lauder, Sarah; Townend, Jonathan N.; Moss, Paul; Ferro, Charles J.			Cytomegalovirus Seropositivity Is Associated with Increased Arterial Stiffness in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							HELICOBACTER-PYLORI; ENDOTHELIAL DYSFUNCTION; HEART-TRANSPLANTATION; CHLAMYDIA-PNEUMONIAE; AORTIC STIFFNESS; CONTROLLED-TRIAL; RISK-FACTOR; YOUNG MEN; INFECTION; ATHEROSCLEROSIS	Background: Patients with chronic kidney disease have an increased cardiovascular risk that is not fully explained by traditional risk factors but appears to be related to increased arterial stiffness. Cytomegalovirus (CMV) infection is associated with increased cardiovascular risk although the mechanisms for this are unknown. We examined whether CMV seropositivity was associated with increased arterial stiffness in patients with chronic kidney disease. Methodology and Principal Findings: In 215 non-diabetic patients with chronic kidney disease, CMV seropositivity was determined using an anti-CMV IgG ELISA. Pulse wave velocity was measured and aortic distensibility assessed in the ascending, proximal descending and distal descending thoracic aorta. Patients seropositive for CMV had a higher pulse wave velocity and lower aortic distensibility at all 3 levels. These differences (except for ascending aortic distensibility) persisted in a subcohort matched for age, gender and renal function, and when the whole cohort was divided into quartiles of age. In multivariable analyses, CMV seropositivity was an independent determinant of pulse wave velocity and proximal and distal descending aortic distensibility. Conclusions: In patients with chronic kidney disease, CMV seropositivity is associated with increased arterial stiffness and decreased distensibility of the proximal descending and distal aorta. These findings suggest that further research is required to examine CMV as a possible cause of arterial disease and increased cardiovascular risk in patients with CKD and may be relevant more widely for CMV seropositive patients with normal renal function.	[Wall, Nadezhda A.; Pankhurst, Tanya; Harper, Lorraine; Ferro, Charles J.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England; [Wall, Nadezhda A.; Harper, Lorraine; Ferro, Charles J.] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England; [Chue, Colin D.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Chue, Colin D.; Edwards, Nicola C.; Steeds, Richard P.; Townend, Jonathan N.] Queen Elizabeth Hosp, Dept Cardiol, Birmingham B15 2TH, W Midlands, England; [Lauder, Sarah; Moss, Paul] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Ferro, CJ (corresponding author), Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England.	charles.ferro@uhb.nhs.uk	Moss, Paul/D-1728-2009; Ferro, Charles J./O-8912-2016; ferro, charles/L-7250-2019	Moss, Paul/0000-0002-6895-1967; Ferro, Charles J./0000-0003-0577-7081; ferro, charles/0000-0003-0577-7081; Steeds, Richard/0000-0001-5687-2535; Townend, Jonathan/0000-0002-5881-5806; harper, lorraine/0000-0003-1343-9234	Department of Renal Medicine; Department of Haematology; British Heart Foundation [FS/11/17/28700] Funding Source: researchfish; National Institute for Health Research [ACF-2010-09-008, PDF-2012-05-205] Funding Source: researchfish	Department of Renal Medicine; Department of Haematology; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work has received no external funding and was supported by internal departmental funds from Departments of Renal Medicine and Haematology to prime future grant applications. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SP, 1998, J INFECT DIS, V177, P209, DOI 10.1086/517355; BLAND JM, 1994, BRIT MED J, V309, P1128, DOI 10.1136/bmj.309.6962.1128; Blum A, 1998, AM J CARDIOL, V81, P866, DOI 10.1016/S0002-9149(98)00019-8; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Caposio P, 2011, VIRUS RES, V157, P204, DOI 10.1016/j.virusres.2010.09.011; Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Doyle A, 2008, NEPHRON CLIN PRACT, V109, pC1, DOI 10.1159/000130170; Edwards NC, 2006, QJM-INT J MED, V99, P723, DOI 10.1093/qjmed/hcl101; Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066; Espinola-Klein C, 2000, STROKE, V31, P2127, DOI 10.1161/01.STR.31.9.2127; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Grahame-Clarke C, 2003, CIRCULATION, V108, P678, DOI 10.1161/01.CIR.0000084505.54603.C7; Groenink M, 1998, AM J CARDIOL, V82, P203, DOI 10.1016/S0002-9149(98)00315-4; Haarala A, 2012, CLIN EXP IMMUNOL, V167, P309, DOI 10.1111/j.1365-2249.2011.04513.x; Haider AW, 2002, J AM COLL CARDIOL, V40, P1408, DOI 10.1016/S0735-1097(02)02272-6; Hertoghs KML, 2010, J CLIN INVEST, V120, P4077, DOI 10.1172/JCI42758; Joly L, 2009, EUR J NUCL MED MOL I, V36, P979, DOI 10.1007/s00259-008-1047-z; Khairy P, 2003, CIRCULATION, V107, P1966, DOI 10.1161/01.CIR.0000064895.89033.97; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MERIGAN TC, 1992, NEW ENGL J MED, V326, P1182, DOI 10.1056/NEJM199204303261803; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Oshima T, 2005, J AM COLL CARDIOL, V45, P1219, DOI 10.1016/j.jacc.2005.01.019; Parrinello CM, 2012, J INFECT DIS; Persoons MCJ, 1997, CARDIOVASC RES, V36, P282, DOI 10.1016/S0008-6363(97)00189-2; Potena L, 2006, TRANSPLANTATION, V82, P398, DOI 10.1097/01.tp.0000229039.87735.76; Simmonds J, 2008, CIRCULATION, V117, P2657, DOI 10.1161/CIRCULATIONAHA.107.718874; Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Stassen FR, 2008, PHARMACOL REP, V60, P85; Steptoe A, 2008, HEART, V94, P1075, DOI 10.1136/hrt.2008.143305; Yi L, 2008, ACTA VIROL, V52, P99; Yi L, 2008, J FORMOS MED ASSOC, V107, P774, DOI 10.1016/S0929-6646(08)60190-4	37	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e55686	10.1371/journal.pone.0055686	http://dx.doi.org/10.1371/journal.pone.0055686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451030	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500004
J	Zhang, SH; Tian, HZ; Wu, J; Zhao, SM; Li, CT				Zhang, Suhua; Tian, Huaizhou; Wu, Jun; Zhao, Shumin; Li, Chengtao			A New Multiplex Assay of 17 Autosomal STRs and Amelogenin for Forensic Application	PLOS ONE			English	Article							TANDEM REPEAT LOCI; LINKAGE DISEQUILIBRIUM; DNA; GENOME	This paper describes a newly devised autosomal short tandem repeat (STR) multiplex polymerase chain reaction (PCR) systems for 17 autosomal loci (D1S1656, D2S441, D3S1358, D3S3045, D6S477, D7S3048, D8S1132, D10S1435, D10S1248, D11S2368, D13S325, D14S608, D15S659, D17S1290, D18S535, D19S253 and D22-GATA198B05) and Amelogenin. Primers for the loci were designed and optimized so that all of the amplicons were distributed from 50 base pairs (bp) to less than 500 bp within a five-dye chemistry design with the fifth dye reserved for the sizing standard. Strategies were developed to overcome challenges that encountered in creating the final assay. The limits of the multiplex were tested, resulting in the successful amplification of genomic DNA range from 0.25-4 ng with 30 PCR cycles. A total of 681 individuals from the Chinese Han population were studied and forensic genetic data were present. No significant deviations from Hardy-Weinberg equilibrium were observed. A total of 180 alleles were detected for the 17 autosomal STRs. The cumulative mean exclusion chance in duos (CMECD) was 0.999967, and cumulative mean exclusion chance in trios (CMECT) was 0.99999995. We conclude that the present 17plex autosomal STRs assay provides an additional powerful tool for forensic applications.	[Zhang, Suhua; Zhao, Shumin; Li, Chengtao] Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai, Peoples R China; [Tian, Huaizhou; Wu, Jun] PEOPLESPOTINC Res & Dev, Beijing, Peoples R China	Institute of Forensic Science Ministry of Justice PRC	Li, CT (corresponding author), Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai, Peoples R China.	lichengtaohla@163.com		Zhang, Suhua/0000-0002-3984-9728; Li, Chengtao/0000-0001-6852-9144	National Natural Science Foundation of People's Republic of China [30901701, 81172908]; National Key Technology Research & Development Program of the Ministry of Science and Technology of People's Republic of China [2012BAK16B01]	National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research & Development Program of the Ministry of Science and Technology of People's Republic of China	This study was supported by grants from the National Natural Science Foundation of People's Republic of China (No.30901701, 81172908, http://www.nsfc.gov.cn/Portal0/default166.htm) and the National Key Technology Research & Development Program of the Ministry of Science and Technology of People's Republic of China (2012BAK16B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Chakraborty R, 1999, ELECTROPHORESIS, V20, P1682; Hill CR, 2009, J FORENSIC SCI, V54, P1008, DOI 10.1111/j.1556-4029.2009.01110.x; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Opel KL, 2007, J FORENSIC SCI, V52, P1263, DOI 10.1111/j.1556-4029.2007.00584.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Service SK, 2001, HUM MOL GENET, V10, P545, DOI 10.1093/hmg/10.5.545; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wenk RE, 2003, TRANSFUSION, V43, P979, DOI 10.1046/j.1537-2995.2003.00439.x	12	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57471	10.1371/journal.pone.0057471	http://dx.doi.org/10.1371/journal.pone.0057471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451235	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500108
J	Walter, V; Yin, XY; Wilkerson, MD; Cabanski, CR; Zhao, N; Du, Y; Ang, MK; Hayward, MC; Salazar, AH; Hoadley, KA; Fritchie, K; Sailey, CG; Weissler, MC; Shockley, WW; Zanation, AM; Hackman, T; Thorne, LB; Funkhouser, WD; Muldrew, KL; Olshan, AF; Randell, SH; Wright, FA; Shores, CG; Hayes, DN				Walter, Vonn; Yin, Xiaoying; Wilkerson, Matthew D.; Cabanski, Christopher R.; Zhao, Ni; Du, Ying; Ang, Mei Kim; Hayward, Michele C.; Salazar, Ashley H.; Hoadley, Katherine A.; Fritchie, Karen; Sailey, Charles G.; Weissler, Mark C.; Shockley, William W.; Zanation, Adam M.; Hackman, Trevor; Thorne, Leigh B.; Funkhouser, William D.; Muldrew, Kenneth L.; Olshan, Andrew F.; Randell, Scott H.; Wright, Fred A.; Shores, Carol G.; Hayes, D. Neil			Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; CYCLIN D1 AMPLIFICATION; HUMAN-PAPILLOMAVIRUS; EXPRESSION; MICROARRAYS; SURVIVAL; TUMORS; LUNG; ABERRATIONS	Head and neck squamous cell carcinoma (HNSCC) is a frequently fatal heterogeneous disease. Beyond the role of human papilloma virus (HPV), no validated molecular characterization of the disease has been established. Using an integrated genomic analysis and validation methodology we confirm four molecular classes of HNSCC (basal, mesenchymal, atypical, and classical) consistent with signatures established for squamous carcinoma of the lung, including deregulation of the KEAP1/NFE2L2 oxidative stress pathway, differential utilization of the lineage markers SOX2 and TP63, and preference for the oncogenes PIK3CA and EGFR. For potential clinical use the signatures are complimentary to classification by HPV infection status as well as the putative high risk marker CCND1 copy number gain. A molecular etiology for the subtypes is suggested by statistically significant chromosomal gains and losses and differential cell of origin expression patterns. Model systems representative of each of the four subtypes are also presented.	[Walter, Vonn; Yin, Xiaoying; Wilkerson, Matthew D.; Cabanski, Christopher R.; Zhao, Ni; Du, Ying; Ang, Mei Kim; Hayward, Michele C.; Salazar, Ashley H.; Hoadley, Katherine A.; Wright, Fred A.; Hayes, D. Neil] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yin, Xiaoying; Weissler, Mark C.; Shockley, William W.; Zanation, Adam M.; Hackman, Trevor; Shores, Carol G.; Hayes, D. Neil] Univ N Carolina, Dept Otolaryngol, Chapel Hill, NC USA; [Cabanski, Christopher R.] Washington Univ, Genome Inst, St Louis, MO USA; [Zhao, Ni; Wright, Fred A.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Ang, Mei Kim] Natl Canc Ctr Singapore, Dept Med Oncol, Singapore, Singapore; [Fritchie, Karen] Mayo Clin, Dept Pathol, Rochester, MN USA; [Sailey, Charles G.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Thorne, Leigh B.; Funkhouser, William D.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Muldrew, Kenneth L.] Univ Toledo, Dept Pathol, Toledo, OH 43606 USA; [Olshan, Andrew F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Randell, Scott H.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC USA; [Hayes, D. Neil] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; National Cancer Centre Singapore (NCCS); Mayo Clinic; University of Arkansas System; University of Arkansas Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Toledo; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hayes, DN (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	hayes@med.unc.edu	Walter, Vonn/AAI-3450-2021; , Pathology Services Core/CEZ-2246-2022; Zhao, Ni/P-9086-2014	Walter, Vonn/0000-0001-6114-6714; Zhao, Ni/0000-0002-7762-3949; Hoadley, Katherine/0000-0002-1216-477X; Hayes, D. Neil/0000-0001-6203-7771	UNC Lineberger Comprehensive Cancer Center [K12-RR-023248]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, R01ES014843] Funding Source: NIH RePORTER	UNC Lineberger Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Clinical/Translational Award from the UNC Lineberger Comprehensive Cancer Center; http://unclineberger.org/research/research/research/developmental-research-awards K12-RR-023248; http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ang KK, 2002, CANCER RES, V62, P7350; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Chen Chao, 2010, Cancers (Basel), V2, P1528, DOI 10.3390/cancers2031528; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Edge SB, 2009, AJCC CANC STAGING MA, V7; Fujii M, 2001, CANCER LETT, V172, P187, DOI 10.1016/S0304-3835(01)00651-6; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Martin A, 2010, NAT CELL BIOL, V12, P924, DOI 10.1038/ncb1010-924; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Mehanna H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4690; Namazie A, 2002, LARYNGOSCOPE, V112, P472, DOI 10.1097/00005537-200203000-00013; Okami K, 1999, ONCOGENE, V18, P3541, DOI 10.1038/sj.onc.1202837; Patmore HS, 2005, ANN SURG ONCOL, V12, P831, DOI 10.1245/ASO.2005.09.017; Pedrero JMG, 2005, INT J CANCER, V114, P242, DOI 10.1002/ijc.20711; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh B, 2001, CANCER RES, V61, P4506; Slebos RJC, 2006, CLIN CANCER RES, V12, P701, DOI 10.1158/1078-0432.CCR-05-2017; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Therneau TM, 2012, PACKAGE SURVIVAL S R; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Walter V, 2011, BIOINFORMATICS, V27, P678, DOI 10.1093/bioinformatics/btq717; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	50	200	200	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56823	10.1371/journal.pone.0056823	http://dx.doi.org/10.1371/journal.pone.0056823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451093	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800040
J	Zhang, J; Wang, JH; Geng, DY; Li, YX; Song, DL; Gu, YX				Zhang, Jun; Wang, Jianhong; Geng, Daoying; Li, Yuxin; Song, Donglei; Gu, Yuxiang			Whole-Brain CT Perfusion and CT Angiography Assessment of Moyamoya Disease before and after Surgical Revascularization: Preliminary Study with 256-Slice CT	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; INITIAL-EXPERIENCE; IMAGING TECHNIQUES; STENOSIS	Background/Aims: The 256-slice CT enables the entire brain to be scanned in a single examination. We evaluated the application of 256-slice whole-brain CT perfusion (CTP) in determining graft patency as well as investigating cerebral hemodynamic changes in Moyamoya disease before and after surgical revascularization. Methods: Thirty-nine cases of Moyamoya disease were evaluated before and after surgical revascularization with 256-slice CT. Whole-brain perfusion images and dynamic 3D CT angiographic images generated from perfusion source data were obtained in all patients. Cerebral blood flow (CBF), cerebral blood volume (CBV), time to peak (TTP) and mean transit time (MTT) of one hemisphere in the region of middle cerebral artery (MCA) distribution and contralateral mirroring areas were measured. Relative CTP values (rCBF, rCBV, rTTP, rMTT) were also obtained. Differences in pre- and post-operation perfusion CT values were assessed with paired t test or matched-pairs signed-ranks test. Results: Preoperative CBF, MTT and TTP of potential surgical side were significantly different from those of contralateral side (P<0.01 for all). All graft patencies were displayed using the 3D-CTA images. Postoperative CBF, rCBF and rCBV values of surgical side in the region of MCA were significantly higher than those before operation (P<0.01 for all). Postoperative MTT, TTP, rMTT and rTTP values of the surgical side in the region of MCA were significantly lower than those before operation (P<0.05 for all). Conclusion: The 256-slice whole-brain CTP can be used to evaluate cerebral hemodynamic changes in Moyamoya disease before and after surgery and the 3D-CTA is useful for assessing the abnormalities of intracranial arteries and graft patencies.	[Zhang, Jun; Geng, Daoying; Li, Yuxin] Fudan Univ, Dept Radiol, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Jianhong] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Song, Donglei; Gu, Yuxiang] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Geng, DY (corresponding author), Fudan Univ, Dept Radiol, Huashan Hosp, Shanghai 200433, Peoples R China.	fdhsgdy@163.com	gu, yu/GSD-4507-2022; li, Yu/HCI-9086-2022; Cao, Xin/AAX-8367-2021; wang, jian/GVS-0711-2022; Li, yu/HHZ-5236-2022; Li, yuxin/GSD-1668-2022; li, yu/HGL-9518-2022	zhang, jun/0000-0003-1849-9199	Science and Technical committee of Shanghai Municipality [12ZR1441600, 12XD1401500]	Science and Technical committee of Shanghai Municipality	This work was supported by the grant from Science and Technical committee of Shanghai Municipality (12ZR1441600, 12XD1401500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Eastwood JD, 2002, RADIOLOGY, V222, P227, DOI 10.1148/radiol.2221010471; Funama Y, 2011, J COMPUT ASSIST TOMO, V35, P480, DOI 10.1097/RCT.0b013e31821fee94; Kang KH, 2008, AM J NEURORADIOL, V29, P1487, DOI 10.3174/ajnr.A1129; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Murayama K, 2009, RADIOLOGY, V250, P202, DOI 10.1148/radiol.2501071809; Nguyen-Huynh MN, 2008, STROKE, V39, P1184, DOI 10.1161/STROKEAHA.107.502906; Rim NJ, 2008, AM J NEURORADIOL, V29, P1658, DOI 10.3174/ajnr.A1229; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Scott RM, 2004, J NEUROSURG, V100, P142, DOI 10.3171/ped.2004.100.2.0142; So Y, 2005, STROKE, V36, P1485, DOI 10.1161/01.STR.0000170709.95185.b1; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Togao O, 2006, AM J NEURORADIOL, V27, P391; Turk AS, 2007, NEURORADIOLOGY, V49, P955, DOI 10.1007/s00234-007-0276-3; Waaijer A, 2007, AM J NEURORADIOL, V28, P927; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wintermark M, 2001, AM J NEURORADIOL, V22, P905	17	39	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57595	10.1371/journal.pone.0057595	http://dx.doi.org/10.1371/journal.pone.0057595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451248	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800112
J	Eckman, DM; Stacey, RB; Rowe, R; D'Agostino, R; Kock, ND; Sane, DC; Torti, FM; Yeboah, J; Workman, S; Lane, KS; Hundley, WG				Eckman, Delrae M.; Stacey, R. Brandon; Rowe, Robert; D'Agostino, Ralph, Jr.; Kock, Nancy D.; Sane, David C.; Torti, Frank M.; Yeboah, Joseph; Workman, Susan; Lane, Kimberly S.; Hundley, W. Gregory			Weekly Doxorubicin Increases Coronary Arteriolar Wall and Adventitial Thickness	PLOS ONE			English	Article							ANTHRACYCLINE CARDIOTOXICITY; CANCER-THERAPY; BREAST-CANCER; DISEASE; RISK; CARDIOMYOCYTES; PROLIFERATION; MORTALITY; STRESS; DAMAGE	Background: Doxorubicin (DOX) is associated with premature cardiovascular events including myocardial infarction. This study was performed to determine if the weekly administration of DOX influenced coronary arteriolar medial and/or adventitial wall thickening. Methods: Thirty-two male Sprague-Dawley rats aged 25.16 +/- 2.4 weeks were randomly divided into three groups and received weekly intraperitoneal injections of normal saline (saline, n=7), or low (1.5 mg/kg to 1.75 mg/kg, n=14) or high (2.5 mg/kg, n = 11) doses of DOX. The animals were treated for 2-12 weeks, and euthanized at pre-specified intervals (2, 4, 7, or 10+ weeks) to obtain histopathologic assessments of coronary arteriolar lumen diameter, medial wall thickness, adventitial wall thickness, and total wall thickness (medial thickness + adventitial thickness). Results: Lumen diameter was similar across all groups (saline: 315 +/- 34 mu m, low DOX: 286 +/- 24 mu m, high DOX: 242 +/- 27 mu m; p=0.22). In comparison to animals receiving weekly saline, animals receiving weekly injections of 2.5 mg/kg of DOX experienced an increase in medial (23 +/- 2 mu m vs. 13 +/- 3 mu m; p=0.005), and total wall thickness (51 +/- 4 mu m vs. 36 +/- 5 mu m; p=0.022), respectively. These increases, as well as adventitial thickening became more prominent after normalizing for lumen diameter (p<0.05 to p<0.001) and after adjusting for age, weight, and total cumulative DOX dose (p=0.02 to p=0.01). Animals receiving low dose DOX trended toward increases in adventitial and total wall thickness after normalization to lumen diameter and accounting for age, weight, and total cumulative DOX dose (p=0.06 and 0.09, respectively). Conclusion: In conclusion, these data demonstrate that weekly treatment of rats with higher doses of DOX increases coronary arteriolar medial, adventitial, and total wall thickness. Future studies are warranted to determine if DOX related coronary arteriolar effects are reversible or preventable, exacerbate the known cardiomyopathic effects of DOX, influence altered resting or stress-induced myocardial perfusion, or contribute to the occurrence of myocardial infarction.	[Eckman, Delrae M.; Rowe, Robert] Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, Winston Salem, NC 27103 USA; [Stacey, R. Brandon; Yeboah, Joseph; Workman, Susan; Lane, Kimberly S.; Hundley, W. Gregory] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC 27103 USA; [D'Agostino, Ralph, Jr.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Kock, Nancy D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA; [Sane, David C.] Virginia Tech, Caril Sch Med, Div Cardiol, Dept Internal Med, Roanoke, VA USA; [Torti, Frank M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Hundley, W. Gregory] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hundley, WG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Cardiol Sect, Winston Salem, NC 27103 USA.	ghundley@wakehealth.edu	Dagostino, Ralph/C-4060-2017	Dagostino, Ralph/0000-0002-3550-8395	National Institute of Health [R21CA109224, R33CA12196]; Susan G. Komen Foundation [BCTR0707769]; NATIONAL CANCER INSTITUTE [R21CA109224] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research supported in part by National Institute of Health (http://www.nih.gov) grants R21CA109224, R33CA12196, and a grant (BCTR0707769) from the Susan G. Komen Foundation (http://ww5.komen.org). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Aleman BMP, 2003, J CLIN ONCOL, V21, P3431, DOI 10.1200/JCO.2003.07.131; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bar-Joseph H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023492; BARKER SGE, 1993, ARTERIOSCLER THROMB, V13, P70, DOI 10.1161/01.ATV.13.1.70; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Chaosuwannakit N, 2010, J CLIN ONCOL, V28, P166, DOI 10.1200/JCO.2009.23.8527; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Dalla Pozza R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-53; Du XL, 2008, AM J CLIN ONCOL-CANC, V31, P105, DOI 10.1097/COC.0b013e318142c865; FERRANS VJ, 1978, CANCER TREAT REP, V62, P955; Floyd JD, 2005, J CLIN ONCOL, V23, P7685, DOI 10.1200/JCO.2005.08.789; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Heon S, 2003, AM J PHYSIOL-HEART C, V285, pH499, DOI 10.1152/ajpheart.00047.2003; Jensen BV, 2006, SEMIN ONCOL, V33, pS15, DOI 10.1053/j.seminoncol.2006.04.022; Kotamraju S, 2004, METHOD ENZYMOL, V378, P362; Kuhnl A, 2005, J ENDOVASC THER, V12, P171, DOI 10.1583/1384R.1; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Lightfoot JC, 2010, CIRC-CARDIOVASC IMAG, V3, P550, DOI 10.1161/CIRCIMAGING.109.918540; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; MEHRA MR, 1995, J HEART LUNG TRANSPL, V14, P632; Moser EC, 2006, BLOOD, V107, P2912, DOI 10.1182/blood-2005-08-3392; Murata T, 2001, LIFE SCI, V69, P2685, DOI 10.1016/S0024-3205(01)01352-2; Silber JH, 2004, J CLIN ONCOL, V22, P820, DOI 10.1200/JCO.2004.06.022; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Timolati F, 2006, J MOL CELL CARDIOL, V41, P845, DOI 10.1016/j.yjmcc.2006.08.002; Ueno H, 2000, HYPERTENSION, V36, P89, DOI 10.1161/01.HYP.36.1.89; Wolf MB, 2006, BBA-GEN SUBJECTS, V1760, P267, DOI 10.1016/j.bbagen.2005.10.012; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Zhao YY, 2010, CANCER RES, V70, P9287, DOI 10.1158/0008-5472.CAN-10-2664	31	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57554	10.1371/journal.pone.0057554	http://dx.doi.org/10.1371/journal.pone.0057554			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437398	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000111
J	Del Bello, B; Toscano, M; Moretti, D; Maellaro, E				Del Bello, Barbara; Toscano, Marzia; Moretti, Daniele; Maellaro, Emilia			Cisplatin-Induced Apoptosis Inhibits Autophagy, Which Acts as a Pro-Survival Mechanism in Human Melanoma Cells	PLOS ONE			English	Article							MEDIATED CLEAVAGE; TARGETING AUTOPHAGY; CALPAIN SYSTEM; CANCER-THERAPY; IN-VITRO; DEATH; PATHWAY; METASTASIS; EXPRESSION; PROTEINS	The interplay between a non-lethal autophagic response and apoptotic cell death is still a matter of debate in cancer cell biology. In the present study performed on human melanoma cells, we investigate the role of basal or stimulated autophagy in cisplatin-induced cytotoxicity, as well as the contribution of cisplatin-induced activation of caspases 3/7 and conventional calpains. The results show that, while down-regulating Beclin-1, Atg14 and LC3-II, cisplatin treatment inhibits the basal autophagic response, impairing a physiological pro-survival response. Consistently, exogenously stimulated autophagy, obtained with trehalose or calpains inhibitors (MDL-28170 and calpeptin), protects from cisplatin-induced apoptosis, and such a protection is reverted by inhibiting autophagy with 3-methyladenine or ATG5 silencing. In addition, during trehalose-stimulated autophagy, the cisplatin-induced activation of calpains is abrogated, suggesting the existence of a feedback loop between the autophagic process and calpains. On the whole, our results demonstrate that in human melanoma cells autophagy may function as a beneficial stress response, hindered by cisplatin-induced death mechanisms. In a therapeutic perspective, these findings suggest that the efficacy of cisplatin-based polychemotherapies for melanoma could be potentiated by inhibitors of autophagy.	[Del Bello, Barbara; Toscano, Marzia; Moretti, Daniele; Maellaro, Emilia] Univ Siena, Ist Toscano Tumori, Dept Pathophysiol Expt Med & Publ Hlth, I-53100 Siena, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena	Maellaro, E (corresponding author), Univ Siena, Ist Toscano Tumori, Dept Pathophysiol Expt Med & Publ Hlth, Via Laterina 8, I-53100 Siena, Italy.	emilia.maellaro@unisi.it			Istituto Toscano Tumori (ITT), Italy	Istituto Toscano Tumori (ITT), Italy	This work has received financial support from Istituto Toscano Tumori (ITT), Italy (www.ittumori.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JL, 2011, CLIN CANCER RES, V17, P2216, DOI 10.1158/1078-0432.CCR-10-3003; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Del Bello B, 2007, ONCOGENE, V26, P2717, DOI 10.1038/sj.onc.1210079; Del Bello B, 2004, EXP CELL RES, V293, P302, DOI 10.1016/j.yexcr.2003.10.024; Demarchi F, 2007, CELL CYCLE, V6, P136; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Han CR, 2011, TOHOKU J EXP MED, V223, P243, DOI 10.1620/tjem.223.243; Harhaji-Trajkovic L, 2009, AMPK MEDIATED AUTOPH; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Lazova R, 2010, J CUTAN PATHOL, V37, P256, DOI 10.1111/j.1600-0560.2009.01359.x; Lazova R, 2009, EXP DERMATOL, V18, P934, DOI 10.1111/j.1600-0625.2009.00933.x; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Madden DT, 2007, AUTOPHAGY, V3, P519; Mallya SK, 1998, BIOCHEM BIOPH RES CO, V248, P293, DOI 10.1006/bbrc.1998.8952; Marino ML, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.67; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moretti D, 2009, CARCINOGENESIS, V30, P960, DOI 10.1093/carcin/bgp098; Norman JM, 2010, AUTOPHAGY, V6, P1042, DOI 10.4161/auto.6.8.13337; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SUPINO R, 1992, MELANOMA RES, V2, P377, DOI 10.1097/00008390-199212000-00012; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Wangpaichitr M, 2008, EUR J PHARMACOL, V591, P124, DOI 10.1016/j.ejphar.2008.06.028; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Xia HG, 2010, AUTOPHAGY, V6, P61, DOI 10.4161/auto.6.1.10326; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yang ZS, 2010, CANCER SCI, V101, P494, DOI 10.1111/j.1349-7006.2009.01412.x; Yoo BH, 2010, J BIOL CHEM, V285, P5438, DOI 10.1074/jbc.M109.046789; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang JY, 2009, J ALZHEIMERS DIS, V16, P39, DOI 10.3233/JAD-2009-0908	46	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57236	10.1371/journal.pone.0057236	http://dx.doi.org/10.1371/journal.pone.0057236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437349	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200229
J	Claesen, J; Clement, L; Shkedy, Z; Foulquie-Moreno, MR; Burzykowski, T				Claesen, Jurgen; Clement, Lieven; Shkedy, Ziv; Foulquie-Moreno, Maria R.; Burzykowski, Tomasz			Simultaneous Mapping of Multiple Gene Loci with Pooled Segregants	PLOS ONE			English	Article							SEQUENCING DATA; IDENTIFICATION; TRAIT	The analysis of polygenic, phenotypic characteristics such as quantitative traits or inheritable diseases remains an important challenge. It requires reliable scoring of many genetic markers covering the entire genome. The advent of high-throughput sequencing technologies provides a new way to evaluate large numbers of single nucleotide polymorphisms (SNPs) as genetic markers. Combining the technologies with pooling of segregants, as performed in bulked segregant analysis (BSA), should, in principle, allow the simultaneous mapping of multiple genetic loci present throughout the genome. The gene mapping process, applied here, consists of three steps: First, a controlled crossing of parents with and without a trait. Second, selection based on phenotypic screening of the offspring, followed by the mapping of short offspring sequences against the parental reference. The final step aims at detecting genetic markers such as SNPs, insertions and deletions with next generation sequencing (NGS). Markers in close proximity of genomic loci that are associated to the trait have a higher probability to be inherited together. Hence, these markers are very useful for discovering the loci and the genetic mechanism underlying the characteristic of interest. Within this context, NGS produces binomial counts along the genome, i.e., the number of sequenced reads that matches with the SNP of the parental reference strain, which is a proxy for the number of individuals in the offspring that share the SNP with the parent. Genomic loci associated with the trait can thus be discovered by analyzing trends in the counts along the genome. We exploit the link between smoothing splines and generalized mixed models for estimating the underlying structure present in the SNP scatterplots.	[Claesen, Jurgen; Clement, Lieven; Shkedy, Ziv; Burzykowski, Tomasz] Hasselt Univ, I BioStat, Diepenbeek, Belgium; [Clement, Lieven] KULeuven, I BioStat, Louvain, Belgium; [Clement, Lieven] Univ Ghent, Dept Appl Math & Comp Sci, B-9000 Ghent, Belgium; [Foulquie-Moreno, Maria R.] Katholieke Univ Leuven, Inst Bot & Microbiol, Mol Cell Biol Lab, Louvain, Belgium; [Foulquie-Moreno, Maria R.] VIB, Dept Mol Microbiol, Louvain, Belgium	Hasselt University; KU Leuven; Ghent University; KU Leuven; Flanders Institute for Biotechnology (VIB)	Claesen, J (corresponding author), Hasselt Univ, I BioStat, Diepenbeek, Belgium.	jurgen.claesen@uhasselt.be	Shkedy, Ziv/AAQ-3096-2020; Burzykowski, Tomasz/T-2222-2018	Shkedy, Ziv/0000-0002-6306-0823; Burzykowski, Tomasz/0000-0003-3378-975X; clement, lieven/0000-0002-9050-4370; CLAESEN, Jurgen/0000-0001-7615-5322	Bijzonder Onderzoeksfonds Universiteit Hasselt [BOF09NI006]	Bijzonder Onderzoeksfonds Universiteit Hasselt	JC gratefully acknowledges financial support from Bijzonder Onderzoeksfonds Universiteit Hasselt (grant BOF09NI006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634; Bravo HC, 2010, BIOMETRICS, V66, P665, DOI 10.1111/j.1541-0420.2009.01353.x; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Rougemont J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-431; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Swindell S R, 1997, Methods Mol Biol, V70, P75, DOI 10.1385/0-89603-358-9:75; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Thevelein JM, 2003, EP1397513, Patent No. 1397513	11	7	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55133	10.1371/journal.pone.0055133	http://dx.doi.org/10.1371/journal.pone.0055133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441149	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200007
J	Pan, XH; Zhang, XL; Sun, HL; Zhang, JJ; Yan, MM; Zhang, HB				Pan, Xiaohong; Zhang, Xiuli; Sun, Hongliu; Zhang, Jinjin; Yan, Miaomiao; Zhang, Huaibin			Autophagy Inhibition Promotes 5-Fluorouraci-Induced Apoptosis by Stimulating ROS Formation in Human Non-Small Cell Lung Cancer A549 Cells	PLOS ONE			English	Article							DOWN-REGULATION; DEATH; 5-FU; MECHANISMS; EXPRESSION; INDUCTION; PROTEIN	Chemotherapy is an important option for the treatment of various cancers including lung cancer. However, tumor resistance towards cytotoxic chemotherapy has become more common. It has been reported that autophagy is one of the processes contributing to this resistance. In the present study, we found that the anti-cancer drug 5-fluorouraci(5-FU) could induce autophagy in A549 cells. 5-FU treatment could lead to the conversion of LC3 I/II, the up-regulation of Beclin-1, the down-regulation of p62 and the formation of acidic vesicular organelles (AVOs) in A549 cells. Pre-treatment of cancer cells with 3-MA or siAtg7 could enhance 5-FU-induced apoptosis through the activation of caspases, and the caspase inhibitor z-VAD-fmk rescued the cell viability reduction. Furthermore, the inhibition of autophagy also stimulated ROS formation and scavenging of ROS by antioxidant NAC inhibited caspase-3 activity, prevented the release of cyt-c from mitochondria and eventually rescued cancer cells from 5-FU-mediated apoptosis. These results suggest that 5-FU-elicited autophagic response plays a protective role against cell apoptosis and the inhibition of autophagy could sensitize them to 5-FU-induced caspase-dependent apoptosis through the stimulation of ROS formation.	[Pan, Xiaohong; Zhang, Xiuli; Sun, Hongliu; Yan, Miaomiao; Zhang, Huaibin] Binzhou Med Univ, Dept Pharmaceut Sci, Yantai, Shandong, Peoples R China; [Zhang, Jinjin] Binzhou Med Univ, Med Res Ctr, Yantai, Shandong, Peoples R China	Binzhou Medical University; Binzhou Medical University	Pan, XH (corresponding author), Binzhou Med Univ, Dept Pharmaceut Sci, Yantai, Shandong, Peoples R China.	panxh_2008@126.com	zhang, jin/GXV-9154-2022		Project of Shandong Province Higher Educational Science and Technology Program [J10LC66]; National Natural Science Foundation of China [81102828, 81273037, 81202516]	Project of Shandong Province Higher Educational Science and Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by A Project of Shandong Province Higher Educational Science and Technology Program (J10LC66) and the National Natural Science Foundation of China (Grant Nos. 81102828, 81273037, 81202516). The authors also wanted to show appreciation to the Natural Science Foundation of Shandong province of China (No. ZR2011HM011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellot GL, 2012, MITOCHONDRION; Chen CY, 2006, CHINESE J PHYSIOL, V49, P31; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Galluzzi L, 2008, CURR MOL MED, V8, P78; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Jiang H, 2009, METHOD ENZYMOL, V453, P273, DOI 10.1016/S0076-6879(08)04013-5; Kaminskyy V, 2011, AUTOPHAGY, V7, P83, DOI 10.4161/auto.7.1.13893; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li X, 2011, TOXICOL APPL PHARM, V251, P146, DOI 10.1016/j.taap.2010.12.007; Lin HI, 2005, CANCER LETT, V230, P248, DOI 10.1016/j.canlet.2004.12.044; Ling YH, 2011, CLIN CANCER RES, V17, P5353, DOI 10.1158/1078-0432.CCR-10-1948; Liu DL, 2011, MED ONCOL, V28, P105, DOI 10.1007/s12032-009-9397-3; Liu J, 2012, J PHARM PHARMACOL, V64, P146, DOI 10.1111/j.2042-7158.2011.01371.x; Macchioni L, 2011, J BIOENERG BIOMEMBR, V43, P507, DOI 10.1007/s10863-011-9375-2; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Miyake M, 2012, ONCOL LETT, V3, P1195, DOI 10.3892/ol.2012.662; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nicolau-Galmes F, 2011, APOPTOSIS, V16, P1253, DOI 10.1007/s10495-011-0640-y; Nordman IC, 2006, ANZ J SURG, V76, P373, DOI 10.1111/j.1445-2197.2006.03726.x; Noro R, 2010, CANCER SCI, V101, P1424, DOI 10.1111/j.1349-7006.2010.01559.x; Nyhan MJ, 2012, BRIT J CANCER, V106, P711, DOI 10.1038/bjc.2011.604; Pan XH, 2008, BIOORGAN MED CHEM, V16, P9093, DOI 10.1016/j.bmc.2008.09.046; Qin L, 2008, BIOCHEM BIOPH RES CO, V371, P531, DOI 10.1016/j.bbrc.2008.04.117; Saleem A, 2012, PROSTATE, V72, P1374, DOI 10.1002/pros.22487; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Sharma N, 2012, CANCER LETT, V326, P143, DOI 10.1016/j.canlet.2012.07.029; Wang CZ, 2009, ANTICANCER RES, V29, P2927; Xi GM, 2011, CANCER LETT, V307, P141, DOI 10.1016/j.canlet.2011.03.026; Xiong HY, 2010, CANCER LETT, V288, P68, DOI 10.1016/j.canlet.2009.06.039; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yi H, 2012, KOREAN J PHYSIOL PHA, V16, P11, DOI 10.4196/kjpp.2012.16.1.11; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Zhang T, 2012, AUTOPHAGY, V8, P559, DOI 10.4161/auto.18867	38	83	88	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56679	10.1371/journal.pone.0056679	http://dx.doi.org/10.1371/journal.pone.0056679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441212	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200069
J	Petruno, SK; Clark, RE; Reinagel, P				Petruno, Sarah K.; Clark, Robert E.; Reinagel, Pamela			Evidence That Primary Visual Cortex Is Required for Image, Orientation, and Motion Discrimination by Rats	PLOS ONE			English	Article							STRIATE CORTEX; RESPONSE PROPERTIES; RESIDUAL VISION; AREA MT; FUNCTIONAL SPECIALIZATION; CONTOUR DISCRIMINATION; SUPERIOR COLLICULUS; RECEPTIVE-FIELDS; AFFERENT BASIS; LESIONS	The pigmented Long-Evans rat has proven to be an excellent subject for studying visually guided behavior including quantitative visual psychophysics. This observation, together with its experimental accessibility and its close homology to the mouse, has made it an attractive model system in which to dissect the thalamic and cortical circuits underlying visual perception. Given that visually guided behavior in the absence of primary visual cortex has been described in the literature, however, it is an empirical question whether specific visual behaviors will depend on primary visual cortex in the rat. Here we tested the effects of cortical lesions on performance of two-alternative forced-choice visual discriminations by Long-Evans rats. We present data from one highly informative subject that learned several visual tasks and then received a bilateral lesion ablating >90% of primary visual cortex. After the lesion, this subject had a profound and persistent deficit in complex image discrimination, orientation discrimination, and full-field optic flow motion discrimination, compared with both pre-lesion performance and sham-lesion controls. Performance was intact, however, on another visual two-alternative forced-choice task that required approaching a salient visual target. A second highly informative subject learned several visual tasks prior to receiving a lesion ablating >90% of medial extrastriate cortex. This subject showed no impairment on any of the four task categories. Taken together, our data provide evidence that these image, orientation, and motion discrimination tasks require primary visual cortex in the Long-Evans rat, whereas approaching a salient visual target does not.	[Petruno, Sarah K.; Reinagel, Pamela] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Clark, Robert E.] Univ Calif San Diego, Vet Affairs Med Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Reinagel, P (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	preinagel@ucsd.edu	Reinagel, Pamela/ABI-7659-2020	Reinagel, Pamela/0000-0002-6338-2611	National Eye Institute [R01 5R01EY016856]; J.S. McDonnell Foundation Scholar Award; Kavli Institute for Mind and Brain at UCSD - Innovative Research Grant; VA Merit Review [NSF IOS1120395]; NSF Temporal Dynamics of Learning Center at UCSD; NATIONAL EYE INSTITUTE [R01EY016856] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); J.S. McDonnell Foundation Scholar Award; Kavli Institute for Mind and Brain at UCSD - Innovative Research Grant; VA Merit Review(US Department of Veterans Affairs); NSF Temporal Dynamics of Learning Center at UCSD; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding provided by National Eye Institute R01 5R01EY016856 (www.nei.nih.gov/; Reinagel, PI), a J.S. McDonnell Foundation Scholar Award (www.jsmf.org/; Reinagel, PI), a Kavli Institute for Mind and Brain at UCSD - Innovative Research Grant (kibm.ucsd.edu/; Reinagel, PI), a VA Merit Review (http://www.sandiego.va.gov/; Clark, PI), NSF IOS1120395 (nsf.gov; Clark; Squire, PI), and the NSF Temporal Dynamics of Learning Center at UCSD (tdlc.ucsd.edu/; Clark, Subproject Leader). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander I, 2009, EXP BRAIN RES, V192, P407, DOI 10.1007/s00221-008-1508-4; Andermann ML, 2011, NEURON, V72, P1025, DOI 10.1016/j.neuron.2011.11.013; Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; BARBUR JL, 1993, BRAIN, V116, P1293, DOI 10.1093/brain/116.6.1293; BLAND BH, 1969, J COMP PHYSIOL PSYCH, V69, P345, DOI 10.1037/h0028160; BLAND BH, 1970, PHYSIOL BEHAV, V5, P211, DOI 10.1016/0031-9384(70)90067-3; BLYTHE IM, 1987, BRAIN, V110, P887, DOI 10.1093/brain/110.4.887; BLYTHE IM, 1986, NATURE, V320, P619, DOI 10.1038/320619a0; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; BRAUN JJ, 1970, BRAIN RES, V20, P283, DOI 10.1016/0006-8993(70)90295-7; BRIDGEMAN B, 1982, VISION RES, V22, P1199, DOI 10.1016/0042-6989(82)90085-2; Brigman JL, 2005, BEHAV NEUROSCI, V119, P839, DOI 10.1037/0735-7044.119.3.839; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Campion J, 1983, BEHAV BRAIN SCI, P6; Ch'ng YH, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00020; Clark RE, 2011, NEURON, V70, P132, DOI 10.1016/j.neuron.2011.03.007; COOGAN TA, 1993, J NEUROSCI, V13, P3749; COWEY A, 1971, BRAIN RES, V30, P241, DOI 10.1016/0006-8993(71)90076-X; Cowey A, 2010, CURR BIOL, V20, pR702, DOI 10.1016/j.cub.2010.07.014; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; DEAN P, 1981, EXP BRAIN RES, V43, P145; DEAN P, 1978, BRAIN RES, V156, P17, DOI 10.1016/0006-8993(78)90076-8; ESPINOZA SG, 1983, BRAIN RES, V272, P137, DOI 10.1016/0006-8993(83)90370-0; GOLDSTEIN LH, 1987, BEHAV BRAIN RES, V24, P181, DOI 10.1016/0166-4328(87)90056-8; GROSS CG, 1991, NEUROPSYCHOLOGIA, V29, P497, DOI 10.1016/0028-3932(91)90007-U; Hubel DH., 2005, BRAIN VISUAL PERCEPT; Huberman AD, 2011, TRENDS NEUROSCI, V34, P464, DOI 10.1016/j.tins.2011.07.002; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Koch C, 2012, NATURE, V483, P397, DOI 10.1038/483397a; Lashley KS, 1931, J COMP NEUROL, V53, P419, DOI 10.1002/cne.900530304; Lashley KS, 1934, J COMP PSYCHOL, V17, P355, DOI 10.1037/h0073094; Lashley KS, 1939, J COMP NEUROL, V70, P45, DOI 10.1002/cne.900700104; LAVOND DG, 1980, PHYSIOL PSYCHOL, V8, P1; Lavond DG, 1970, PHYSL PSYCHOL, V6, P471; LEWELLYN D, 1969, J COMP PHYSIOL PSYCH, V69, P25, DOI 10.1037/h0027927; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P238, DOI 10.1016/0010-0285(83)90010-5; Marshel JH, 2011, NEURON, V72, P1040, DOI 10.1016/j.neuron.2011.12.004; Meier P, 2011, J VIS, V11, P22; MESTRE DR, 1992, NEUROPSYCHOLOGIA, V30, P783, DOI 10.1016/0028-3932(92)90082-W; Millner AD, 1995, VISUAL BRAIN ACTION; MIZE RR, 1971, PHYSIOL BEHAV, V6, P241; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; OAKLEY DA, 1981, BEHAV BRAIN RES, V3, P55, DOI 10.1016/0166-4328(81)90028-0; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perenin MT, 1996, NEUROREPORT, V7, P793, DOI 10.1097/00001756-199602290-00027; PERENIN MT, 1991, NEUROREPORT, V2, P397, DOI 10.1097/00001756-199107000-00011; PERENIN MT, 1975, NEUROPSYCHOLOGIA, V13, P1, DOI 10.1016/0028-3932(75)90041-X; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Ptito A, 2007, NEUROSCIENTIST, V13, P506, DOI 10.1177/1073858407300598; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Rees G, 2008, BRAIN, V131, P1414, DOI 10.1093/brain/awn089; Reinagel P, 2012, 12060311 ARXIV; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; Rumberger A, 2001, NEUROSCIENCE, V102, P35, DOI 10.1016/S0306-4522(00)00475-9; SANDERS MD, 1974, LANCET, V1, P707; Schmid MC, 2010, NATURE, V466, P373, DOI 10.1038/nature09179; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; SOLOMON SJ, 1981, EXP BRAIN RES, V44, P259; Tafazoli S, 2012, J NEUROSCI, V32, P21, DOI 10.1523/JNEUROSCI.3932-11.2012; THOMPSON R, 1969, J COMP PHYSIOL PSYCH, V69, P1, DOI 10.1037/h0028219; THOMPSON VE, 1970, J COMP PHYSIOL PSYCH, V72, P444, DOI 10.1037/h0029733; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Wang QX, 2007, J COMP NEUROL, V502, P339, DOI 10.1002/cne.21286; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; WEISKRANTZ L, 1987, BRAIN, V110, P77, DOI 10.1093/brain/110.1.77; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Whishaw IQ, 2004, BEHAV BRAIN RES, V155, P177, DOI 10.1016/j.bbr.2004.04.013; ZIHL J, 1980, BEHAV BRAIN RES, V1, P287; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	76	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56543	10.1371/journal.pone.0056543	http://dx.doi.org/10.1371/journal.pone.0056543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441202	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200059
J	Vacaru, AM; van den Dikkenberg, J; Ternes, P; Holthuis, JCM				Vacaru, Ana M.; van den Dikkenberg, Joep; Ternes, Philipp; Holthuis, Joost C. M.			Ceramide Phosphoethanolamine Biosynthesis in Drosophila Is Mediated by a Unique Ethanolamine Phosphotransferase in the Golgi Lumen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RAT-LIVER; SPHINGOMYELIN SYNTHASES; STRUCTURAL ELUCIDATION; AQUATIC ANIMALS; SEA ANEMONE; MEMBRANE; CELLS; PHOSPHOLIPIDS; PROTEIN	Sphingomyelin (SM) is a vital component of mammalian membranes, providing mechanical stability and a structural framework for plasma membrane organization. Its production involves the transfer of phosphocholine from phosphatidylcholine onto ceramide, a reaction catalyzed by SM synthase in the Golgi lumen. Drosophila lacks SM and instead synthesizes the SM analogue ceramide phosphoethanolamine (CPE) as the principal membrane sphingolipid. The corresponding CPE synthase shares mechanistic features with enzymes mediating phospholipid biosynthesis via the Kennedy pathway. Using a functional cloning strategy, we here identified a CDP-ethanolamine: ceramide ethanolamine phosphotransferase as the enzyme responsible for CPE production in Drosophila. CPE synthase constitutes a new branch within the CDP-alcohol phosphotransferase superfamily with homologues in Arthropoda (insects, spiders, mites, scorpions), Cnidaria (Hydra, sea anemones), and Mollusca (oysters) but not in most other animal phyla. The enzyme resides in the Golgi complex with its active site facing the lumen, contrary to the membrane topology of other CDP-alcohol phosphotransferases. Our findings open up an important new avenue to address the biological role of CPE, an enigmatic membrane constituent of a wide variety of invertebrate and marine organisms.	[Vacaru, Ana M.; van den Dikkenberg, Joep; Ternes, Philipp; Holthuis, Joost C. M.] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; [Vacaru, Ana M.; van den Dikkenberg, Joep; Ternes, Philipp; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Vacaru, Ana M.] Ichan Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA; [Vacaru, Ana M.] Ichan Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Ternes, Philipp] Metanomics GmbH, D-10589 Berlin, Germany; [Holthuis, Joost C. M.] Univ Osnabruck, Mol Cell Biol Div, D-49076 Osnabruck, Germany	Utrecht University; Utrecht University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University Osnabruck	Ternes, P (corresponding author), Metanomics GmbH, Tegeler Weg 33, D-10589 Berlin, Germany.	philipp.ternes@arcor.de; holthuis@uos.de	Holthuis, Joost/AAL-9157-2020; Vacaru, Ana/AAR-7370-2021	Holthuis, Joost/0000-0001-8912-1586; Ternes, Philipp/0000-0003-0886-5474; Vacaru, Ana Maria/0000-0001-7976-8992	European Union Framework V Program (the Flippase Project); Marie Curie Intra-European Fellowship; European Molecular Biology Organization (EMBO) Long-Term Fellowship; Dutch Organization of Sciences (NWO-CW); Utrecht University High Potential Program	European Union Framework V Program (the Flippase Project); Marie Curie Intra-European Fellowship(European Commission); European Molecular Biology Organization (EMBO) Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Dutch Organization of Sciences (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Utrecht University High Potential Program	Supported by the European Union Framework V Program (the Flippase Project).; Supported by a Marie Curie Intra-European Fellowship and an European Molecular Biology Organization (EMBO) Long-Term Fellowship. To whom correspondence may be addressed: Metanomics GmbH, Tegeler Weg 33, 10589 Berlin, Germany. Tel.: 49-30-34807-177; Fax: 49-30-34807-300; E-mail: philipp.ternes@arcor.de.; Supported by grants from the Dutch Organization of Sciences (NWO-CW) and the Utrecht University High Potential Program. To whom correspondence may be addressed: Molecular Cell Biology Division, University of Osnabruck, Barbarastrasse 13, 49076 Osnabruck, Germany. Tel.: 49-541969-7140; Fax: 49-541969-2884; E-mail: holthuis@uos.de.	Abeytunga DTU, 2004, J LIPID RES, V45, P1221, DOI 10.1194/jlr.M300392-JLR200; Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Barenholz Y., 1982, PHOSPHOLIPIDS, V4, P129; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; CRONE HD, 1963, BIOCHEM J, V89, P11, DOI 10.1042/bj0890011; Guan XL, 2013, DEV CELL, V24, P98, DOI 10.1016/j.devcel.2012.11.012; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Henneberry AL, 2002, MOL BIOL CELL, V13, P3148, DOI 10.1091/mbc.01-11-0540; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; HORI T, 1968, BIOCHIM BIOPHYS ACTA, V152, P211; HORI T, 1967, J BIOCHEM-TOKYO, V62, P67, DOI 10.1093/oxfordjournals.jbchem.a128637; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kariotoglou DM, 2003, COMP BIOCHEM PHYS B, V136, P27, DOI 10.1016/S1096-4959(03)00168-4; KARLANDER SG, 1972, BIOCHIM BIOPHYS ACTA, V270, P117, DOI 10.1016/0005-2760(72)90185-3; KITTREDGE JS, 1962, BIOCHEMISTRY-US, V1, P624, DOI 10.1021/bi00910a013; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Le Grand F, 2011, COMP BIOCHEM PHYS A, V159, P383, DOI 10.1016/j.cbpa.2011.04.006; LUUKKONEN A, 1973, BIOCHIM BIOPHYS ACTA, V326, P256, DOI 10.1016/0005-2760(73)90251-8; MALGAT M, 1987, J LIPID RES, V28, P138; MALGAT M, 1986, J LIPID RES, V27, P251; MAURICE A, 1989, BIOCHIMIE, V71, P373, DOI 10.1016/0300-9084(89)90009-6; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Connor J. D, 1970, Biochim. biophys. Acta, V202, P195, DOI 10.1016/0005-2760(70)90234-1; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; SIMON G, 1967, LIPIDS, V2, P55, DOI 10.1007/BF02532001; Tafesse FG, 2007, J BIOL CHEM, V282, P17537, DOI 10.1074/jbc.M702423200; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Terova B, 2005, BIOPHYS J, V88, P2661, DOI 10.1529/biophysj.104.058149; Trooskens G, 2005, BIOINFORMATICS, V21, P3801, DOI 10.1093/bioinformatics/bti590; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; YANG TK, 1974, LIPIDS, V9, P1009, DOI 10.1007/BF02533827	48	42	43	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11520	11530		10.1074/jbc.M113.460972	http://dx.doi.org/10.1074/jbc.M113.460972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449981	Green Published, hybrid			2022-12-25	WOS:000317915500058
J	Souza-Fonseca-Guimaraes, F; Parlato, M; de Oliveira, RB; Golenbock, D; Fitzgerald, K; Shalova, IN; Biswas, SK; Cavaillon, JM; Adib-Conquy, M				Souza-Fonseca-Guimaraes, Fernando; Parlato, Marianna; de Oliveira, Rosane B.; Golenbock, Douglas; Fitzgerald, Katherine; Shalova, Irina N.; Biswas, Subhra K.; Cavaillon, Jean-Marc; Adib-Conquy, Minou			Interferon-gamma and Granulocyte/Monocyte Colony-stimulating Factor Production by Natural Killer Cells Involves Different Signaling Pathways and the Adaptor Stimulator of Interferon Genes (STING)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING ADAPTER; TOLL-LIKE RECEPTORS; NK CELLS; RANTES PRODUCTION; INNATE IMMUNITY; CUTTING EDGE; IFN-BETA; T-CELLS; KAPPA-B; PROTEIN	Natural killer (NK) cells are important for innate immunity in particular through the production of IFN-gamma and GM-CSF. Both cytokines are important in restoration of immune function of tolerized leukocytes under inflammatory events. The expression of TLRs in NK cells has been widely studied by analyzing the mRNA of these receptors, rarely seeking their protein expression. We previously showed that murine spleen NK cells express TLR9 intracellularly and respond to CpG oligodeoxynucleotide (CpG-ODN) by producing IFN-gamma and GM-CSF. However, to get such production the presence of accessory cytokines (such as IL-15 and IL-18) was required, whereas CpG-ODN or accessory cytokines alone did not induce IFN-gamma or GM-CSF. We show here that TLR9 overlaps with the Golgi apparatus in NK cells. Furthermore, CpG-ODN stimulation in the presence of accessory cytokines induces the phosphorylation of c-Jun, STAT3, and I kappa B alpha. IFN-gamma and GM-CSF production requires NF-kappa B and STAT3 activation as well as Erk-dependent mechanisms for IFN-gamma and p38 signaling for GM-CSF. Using knock-out-mice, we show that UNC93b1 and IL-12 (produced by NK cells themselves) are also necessary for IFN-gamma and GM-CSF production. IFN-gamma production was found to be MyD88- and TLR9-dependent, whereas GM-CSF was TLR9-independent but dependent on STING (stimulator of interferon genes), a cytosolic adaptor recently described for DNA sensing. Our study thereby allows us to gain insight into the mechanisms of synergy between accessory cytokines and CpG-ODN in NK cells. It also identifies a new and alternative signaling pathway for CpG-ODN in murine NK cells.	[Souza-Fonseca-Guimaraes, Fernando; Parlato, Marianna; Cavaillon, Jean-Marc; Adib-Conquy, Minou] Inst Pasteur, Unite Cytokines & Inflammat, Dept Infect & Epidemiol, F-75015 Paris, France; [de Oliveira, Rosane B.; Golenbock, Douglas; Fitzgerald, Katherine] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Dept Med, Worcester, MA 01605 USA; [Shalova, Irina N.; Biswas, Subhra K.] ASTAR, Singapore Immunol Network, Singapore 13848, Singapore	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Massachusetts System; University of Massachusetts Worcester; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Adib-Conquy, M (corresponding author), Inst Pasteur, Unite Cytokines & Inflammat, Dept Infect & Epidemiol, 28 Rue Docteur Roux, F-75015 Paris, France.	minou.adib-conquy@pasteur.fr	Guimarães, Fernando/AAQ-2535-2021; Fitzgerald, Katherine/ABE-6317-2020; Parlato, Marianna/H-9467-2017	Guimarães, Fernando/0000-0002-2718-8993; Fitzgerald, Kate/0000-0003-3175-609X; Souza-Fonseca-Guimaraes, Fernando/0000-0002-2037-8946	Pasteur fellowship (Pasteur University International PhD Program); Pasteur-Weizmann fellowship; European Molecular Biology Organization short term fellowship; EGIDE (Merlion program)	Pasteur fellowship (Pasteur University International PhD Program); Pasteur-Weizmann fellowship; European Molecular Biology Organization short term fellowship; EGIDE (Merlion program)	Supported by a Pasteur fellowship (Pasteur University International PhD Program), a Pasteur-Weizmann fellowship, an European Molecular Biology Organization short term fellowship, and a travel grant by EGIDE (Merlion program). Present address: Immunology in Cancer and Infection Laboratory, Queensland Institute of Medical Research, 300 Herston Rd., 4006 Brisbane, Queensland, Australia.	Beuneu H, 2011, J IMMUNOL, V187, P2084, DOI 10.4049/jimmunol.1004210; Boudreau JE, 2011, CANCER RES, V71, P2497, DOI 10.1158/0008-5472.CAN-10-3025; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; CAR BD, 1994, J EXP MED, V179, P1437, DOI 10.1084/jem.179.5.1437; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Couture LA, 2012, J BIOL CHEM, V287, P24641, DOI 10.1074/jbc.M112.360925; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; Engel A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3150pe45; Fitting C, 2004, J INFECT DIS, V189, P1295, DOI 10.1086/382657; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Hagele H, 2009, AM J PATHOL, V175, P1896, DOI 10.2353/ajpath.2009.090182; Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Kapetanovic R, 2011, AM J PHYSIOL-CELL PH, V300, pC850, DOI 10.1152/ajpcell.00187.2010; Kashuba VI, 2002, GENE, V283, P209, DOI 10.1016/S0378-1119(01)00856-3; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Koppe U, 2012, J IMMUNOL, V188, P811, DOI 10.4049/jimmunol.1004143; Landrigan A, 2011, J IMMUNOL, V187, P3033, DOI 10.4049/jimmunol.1003414; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Martinez J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000811; Ogbomo H, 2007, FEBS LETT, V581, P1317, DOI 10.1016/j.febslet.2007.02.045; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Sawaki J, 2007, INT IMMUNOL, V19, P311, DOI 10.1093/intimm/dxl148; Souza-Fonseca-Guimaraes F, 2012, J IMMUNOL, V188, P5850, DOI 10.4049/jimmunol.1103616; Souza-Fonseca-Guimaraes F, 2012, MOL MED, V18, P270, DOI 10.2119/molmed.2011.00201; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668	36	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10715	10721		10.1074/jbc.M112.435602	http://dx.doi.org/10.1074/jbc.M112.435602			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443666	Green Published, hybrid			2022-12-25	WOS:000317565000049
J	Itzhaki, O; Greenberg, E; Shalmon, B; Kubi, A; Treves, AJ; Shapira-Frommer, R; Avivi, C; Ortenberg, R; Ben-Ami, E; Schachter, J; Besser, MJ; Markel, G				Itzhaki, Orit; Greenberg, Eyal; Shalmon, Bruria; Kubi, Adva; Treves, Avraham J.; Shapira-Frommer, Ronnie; Avivi, Camilla; Ortenberg, Rona; Ben-Ami, Eytan; Schachter, Jacob; Besser, Michal J.; Markel, Gal			Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma	PLOS ONE			English	Article							SCHIFF-POSITIVE PATTERNS; TUMOR-CELL PLASTICITY; CANCER STEM-CELLS; VE-CADHERIN; EMBRYONIC VASCULOGENESIS; PROGNOSTIC-SIGNIFICANCE; MALIGNANT-MELANOMA; EXPRESSION; DIFFERENTIATION; IMMUNOTHERAPY	Vasculogenic mimicry (VM) describes functional vascular channels composed only of tumor cells and its presence predicts poor prognosis in melanoma patients. Inhibition of this alternative vascularization pathway might be of clinical importance, especially as several anti-angiogenic therapies targeting endothelial cells are largely ineffective in melanoma. We show the presence of VM structures histologically in a series of human melanoma lesions and demonstrate that cell cultures derived from these lesions form tubes in 3D cultures ex vivo. We tested the ability of nicotinamide, the amide form of vitamin B3 (niacin), which acts as an epigenetic gene regulator through unique cellular pathways, to modify VM. Nicotinamide effectively inhibited the formation of VM structures and destroyed already formed ones, in a dose-dependent manner. Remarkably, VM formation capacity remained suppressed even one month after the complete withdrawal of Nicotimamid. The inhibitory effect of nicotinamide on VM formation could be at least partially explained by a nicotinamide-driven downregulation of vascular endothelial cadherin (VE-Cadherin), which is known to have a central role in VM. Further major changes in the expression profile of hundreds of genes, most of them clustered in biologically-relevant clusters, were observed. In addition, nicotinamide significantly inhibited melanoma cell proliferation, but had an opposite effect on their invasion capacity. Cell cycle analysis indicated moderate changes in apoptotic indices. Therefore, nicotinamide could be further used to unravel new biological mechanisms that drive VM and tumor progression. Targeting VM, especially in combination with anti-angiogenic strategies, is expected to be synergistic and might yield substantial anti neoplastic effects in a variety of malignancies.	[Itzhaki, Orit; Greenberg, Eyal; Kubi, Adva; Shapira-Frommer, Ronnie; Ortenberg, Rona; Ben-Ami, Eytan; Schachter, Jacob; Besser, Michal J.; Markel, Gal] Chaim Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel; [Greenberg, Eyal; Ortenberg, Rona; Besser, Michal J.; Markel, Gal] Tel Aviv Univ, Sackler Fac Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Treves, Avraham J.] Chaim Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Shalmon, Bruria; Avivi, Camilla] Chaim Sheba Med Ctr, Dept Pathol, Ramat Gan, Israel; [Markel, Gal] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Besser, MJ (corresponding author), Chaim Sheba Med Ctr, Ella Inst Melanoma, Ramat Gan, Israel.	michal.besser@sheba.health.gov.il; markel@post.tau.ac.il			Recanty foundation for medical research	Recanty foundation for medical research	This study was supported by a grant from the Recanty foundation for medical research (GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arganda-Carreras I, 2010, MICROSC RES TECH; Ascierto PA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-38; Audrito V, 2011, CANCER RES, V71, P4473, DOI 10.1158/0008-5472.CAN-10-4452; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Besser MJ, 2009, J IMMUNOTHER, V32, P415, DOI 10.1097/CJI.0b013e31819c8bda; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; CHAPLIN DJ, 1990, JNCI-J NATL CANCER I, V82, P672, DOI 10.1093/jnci/82.8.672; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cong RH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-124; Emmett MS, 2011, AM J CANCER RES, V1, P852; Fan YZ, 2010, WORLD J GASTRO SURG, V2, P117, DOI 10.4240/wjgs.v2.i4.117; Farina HG, 2006, ONCOL REP, V16, P885; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Folberg R, 2004, APMIS, V112, P508, DOI 10.1111/j.1600-0463.2004.apm11207-0810.x; Gensler HL, 1999, NUTR CANCER, V34, P36, DOI 10.1207/S15327914NC340105; Girouard SD, 2011, LAB INVEST, V91, P647, DOI 10.1038/labinvest.2011.50; Gloster HM, 1996, DERMATOL SURG, V22, P217, DOI 10.1111/j.1524-4725.1996.tb00312.x; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018936; Guzman G, 2007, ARCH PATHOL LAB MED, V131, P1776; Hardy KM, 2010, CANCER RES, V70, P10340, DOI 10.1158/0008-5472.CAN-10-0705; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Hendrix MJC, 2001, P NATL ACAD SCI USA, V98, P8018, DOI 10.1073/pnas.131209798; Hess AR, 2007, DEV DYNAM, V236, P3283, DOI 10.1002/dvdy.21190; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; Hess AR, 2001, CANCER RES, V61, P3250; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; HORSMAN MR, 1989, RADIAT RES, V118, P139, DOI 10.2307/3577429; Hoskin PJ, 2010, J CLIN ONCOL, V28, P4912, DOI 10.1200/JCO.2010.28.4950; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Iwata K, 2003, BIOSCI BIOTECH BIOCH, V67, P1132, DOI 10.1271/bbb.67.1132; JACOBSON EL, 1993, J INTERN MED, V233, P59, DOI 10.1111/j.1365-2796.1993.tb00649.x; Josko J, 2000, Med Sci Monit, V6, P1047; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Kim WJ, 2011, J UROLOGY, V185, P2366, DOI 10.1016/j.juro.2011.02.017; Kirkwood JM, 2008, J CLIN ONCOL, V26, P3445, DOI 10.1200/JCO.2007.14.6423; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Monzani E, 2008, STEM CELL REV, V4, P51, DOI 10.1007/s12015-008-9009-1; Namazi MR, 2003, FASEB J, V17, P1377, DOI 10.1096/fj.03-0002hyp; Orgaz JL, 2009, ONCOGENE, V28, P4147, DOI 10.1038/onc.2009.284; Paulis YWJ, 2010, BBA-REV CANCER, V1806, P18, DOI 10.1016/j.bbcan.2010.01.001; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Qu B, 2010, MED HYPOTHESES, V74, P360, DOI 10.1016/j.mehy.2009.08.020; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rosenberg SA, 2011, NAT REV CLIN ONCOL, V8, P577, DOI 10.1038/nrclinonc.2011.116; Rybak SM, 2003, CANCER RES, V63, P2812; Seftor EA, 2006, J CELL MOL MED, V10, P174, DOI 10.1111/j.1582-4934.2006.tb00299.x; Seftor REB, 2001, CANCER RES, V61, P6322; Shirakawa K, 2002, INT J CANCER, V99, P821, DOI 10.1002/ijc.10423; Sood AK, 2002, CANCER BIOL THER, V1, P661, DOI 10.4161/cbt.316; Strizzi L, 2011, LAB INVEST, V91, P819, DOI 10.1038/labinvest.2011.63; Sun BC, 2006, ONCOL REP, V16, P693; Surjana D, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/157591; Thies A, 2001, J PATHOL, V195, P537, DOI 10.1002/path.988; Vaca P, 2003, TRANSPL P, V35, P2021, DOI 10.1016/S0041-1345(03)00735-8; van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/0008-5472.CAN-05-2468; van der Schaft DWJ, 2004, JNCI-J NATL CANCER I, V96, P1473, DOI 10.1093/jnci/djh267; Vartanian A, 2011, MELANOMA RES, V21, P91, DOI 10.1097/CMR.0b013e328343a237; Vartanian AA, 2009, CAN J UROL, V16, P4726; VINDELOV LL, 1983, CYTOMETRY, V3, P328, DOI 10.1002/cyto.990030504; Warso MA, 2001, CLIN CANCER RES, V7, P473; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Yiasemides E, 2009, CARCINOGENESIS, V30, P101, DOI 10.1093/carcin/bgn248; Zhang SW, 2007, CANCER LETT, V254, P157, DOI 10.1016/j.canlet.2006.12.036	71	51	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57160	10.1371/journal.pone.0057160	http://dx.doi.org/10.1371/journal.pone.0057160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451174	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500073
J	He, Y; Zeng, Q; Li, XH; Liu, BH; Wang, PY				He, Yuan; Zeng, Qiang; Li, Xiaohui; Liu, Baohua; Wang, Peiyu			The Association between Subclinical Atherosclerosis and Uterine Fibroids	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PREMENOPAUSAL WOMEN; BREAST-CANCER; BODY-SIZE; PLASMA HOMOCYSTEINE; RISK-FACTORS; BLACK-WOMEN; LEIOMYOMA; HYPERTENSION; ETIOLOGY	Objective(s): To explore the atherogenic hypothesis of uterine fibroids among Chinese women. Methods: In a case-control study, 335 patients confirmed by ultrasound or hysterectomy surgery and 539 controls were enrolled between October 1, 2009 and April 1, 2012. Unconditional logistic regressions were used to calculate the odds ratios (ORs) for the associations of subclinical atherogenic and cardiovascular risk parameters with uterine fibroids in the overall case group and hysterectomy-confirmed case group, respectively. Results: Higher level of ankle-brachial index (ABI) was independently associated with increased odds of uterine fibroids. The odds of UF among women in the highest tertile of ABI were 1.88 times higher (95%CI: 1.17, 3.02, P-trend = 0.008) compared to those in the lowest tertile. The serum concentration of homocysteine was inversely related to fibroids (middle vs. low: OR 0.56, 95%CI: 0.36, 0.85; high vs. low: OR 0.50, 95% CI: 0.32, 0.79; P-trend = 0.002). In the hysterectomy-confirmed group, an inverse association was suggested between high-density lipoprotein cholesterol (HDL-C) and fibroids (OR 0.46, 95% CI: 0.25, 0.84, P-trend = 0.014). Moreover, the effect of homocysteine concentration was not observed in this group. Conclusion(s): These findings suggest that women with uterine fibroids might have an increased risk of subclinical atherosclerosis.	[He, Yuan; Zeng, Qiang; Li, Xiaohui] Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China; [He, Yuan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100871, Peoples R China; [Liu, Baohua; Wang, Peiyu] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Social Med & Hlth Educ, Beijing 100871, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University; Peking University	Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Int Med Ctr, Beijing, Peoples R China.	zq301@126.com; wpeiyu@bjmu.edu.cn			state science and technology support program [2012BAI37B04]; Institutional Review Board of the PLA General Hospital	state science and technology support program; Institutional Review Board of the PLA General Hospital	This study was supported by the state science and technology support program [grant number: 2012BAI37B04]. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the Institutional Review Board of the PLA General Hospital for supporting the study.	Agrawal Alok, 2010, Cardiovascular & Hematological Disorders - Drug Targets, V10, P235; Al-Awadi F, 2008, ANTICANCER RES, V28, P2541; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Borgfeldt C, 2000, ACTA OBSTET GYN SCAN, V79, P202, DOI 10.1034/j.1600-0412.2000.079003202.x; Boynton-Jarrett R, 2005, AM J EPIDEMIOL, V161, P628, DOI 10.1093/aje/kwi072; Buttram V C Jr, 1986, Prog Clin Biol Res, V225, P275; Chou YC, 2007, BREAST CANCER RES TR, V101, P199, DOI 10.1007/s10549-006-9278-9; Danese C, 2006, Clin Ter, V157, P9; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; DORGAN JF, 1995, CANCER EPIDEM BIOMAR, V4, P381; Downes E, 2010, EUR J OBSTET GYN R B, V152, P96, DOI 10.1016/j.ejogrb.2010.05.012; Faerstein E, 2001, AM J EPIDEMIOL, V153, P11, DOI 10.1093/aje/153.1.11; Faerstein E, 2001, AM J EPIDEMIOL, V153, P1, DOI 10.1093/aje/153.1.1; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; GARFAGNINI A, 1995, EUR HEART J, V16, P465, DOI 10.1093/oxfordjournals.eurheartj.a060937; Hamed SA, 2005, J PHARMACOL SCI, V98, P340, DOI 10.1254/jphs.CRJ05003X; Hasimu B, 2006, HYPERTENS RES, V29, P23, DOI 10.1291/hypres.29.23; Held C, 2008, VASC MED, V13, P245, DOI 10.1177/1358863X08092102; HOCUTT JE, 1979, DEL MED J, V51, P697; Hofmann MA, 2001, J CLIN INVEST, V107, P675, DOI 10.1172/JCI10588; Isobe A, 2008, HUM REPROD, V23, P440, DOI 10.1093/humrep/dem247; Kaminski B T, 1994, Ceska Gynekol, V59, P247; Laughlin SK, 2010, SEMIN REPROD MED, V28, P203, DOI 10.1055/s-0030-1251477; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Luoto R, 2001, J REPROD MED, V46, P359; Marshall LM, 1998, EPIDEMIOLOGY, V9, P511, DOI 10.1097/00001648-199809000-00007; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; MOSS NS, 1975, AM J PATHOL, V78, P175; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Parazzini F, 2004, EUR J EPIDEMIOL, V19, P249, DOI 10.1023/B:EJEP.0000020448.43323.2a; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; RATECH H, 1982, DIAGN GYNECOL OBSTET, V4, P21; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Sadlonova J, 2008, INT J GYNECOL OBSTET, V102, P50, DOI 10.1016/j.ijgo.2008.01.022; Schwartz SM, 2000, ENVIRON HEALTH PERSP, V108, P821, DOI 10.2307/3454313; Silver Marc A, 2005, J Clin Hypertens (Greenwich), V7, P664, DOI 10.1111/j.1524-6175.2005.04384.x; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Takeda T, 2008, GYNECOL OBSTET INVES, V66, P14, DOI 10.1159/000114250; Templeman C, 2009, FERTIL STERIL, V92, P1436, DOI 10.1016/j.fertnstert.2008.08.074; Terry KL, 2007, EPIDEMIOLOGY, V18, P758, DOI 10.1097/EDE.0b013e3181567eed; van Popele NM, 2006, J HYPERTENS, V24, P2371, DOI 10.1097/01.hjh.0000251896.62873.c4; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Williams VSL, 2006, J WOMENS HEALTH, V15, P818, DOI 10.1089/jwh.2006.15.818; Wise LA, 2005, EPIDEMIOLOGY, V16, P346, DOI 10.1097/01.ede.0000158742.11877.99; Zeigler-Johnson CM, 1998, STROKE, V29, P759, DOI 10.1161/01.STR.29.4.759; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373; Zhu BT, 2003, INT J ONCOL, V22, P499	50	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57089	10.1371/journal.pone.0057089	http://dx.doi.org/10.1371/journal.pone.0057089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451155	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800072
J	Lau, JTF; Wang, ZX; Kim, JH; Lau, M; Lai, CHY; Mo, PKH				Lau, Joseph T. F.; Wang, Zixin; Kim, Jean H.; Lau, Mason; Lai, Coco H. Y.; Mo, Phoenix K. H.			Acceptability of HPV Vaccines and Associations with Perceptions Related to HPV and HPV Vaccines Among Men Who Have Sex with Men in Hong Kong	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; SEXUALLY-TRANSMITTED-DISEASES; SOCIAL MARKETING CAMPAIGN; UNITED-STATES; GENITAL WARTS; BISEXUAL MEN; PLANNED BEHAVIOR; RISK BEHAVIORS; INFECTION; HIV	HPV vaccines are available to men but there are few studies investigating the acceptability of HPV vaccines among men who have sex with men (MSM), a high risk group. We assessed the intention to take up HPV vaccines among MSM in Hong Kong and the associated factors related to cognitions on HPV and HPV vaccines, basing on the Health Belief Model (n = 542). The acceptability of HPV vaccines was 20% (unconditional on efficacies and price), 29.2% (conditional on efficacies and market price), 51.7% (conditional on efficacies and discounted price) and 79.1% (conditional on efficacies and free price). Adjusting for background variables, composite scores of perceived susceptibility, perceived severity, perceived barriers and cue to actions were significantly associated with acceptability of HPV vaccines conditional on specific efficacies and the market price. Acceptability of HPV vaccines was highly price sensitive. Future studies need to use conditional measures. Implementation and translational researches are warranted.	[Lau, Joseph T. F.; Wang, Zixin; Kim, Jean H.; Lau, Mason; Lai, Coco H. Y.; Mo, Phoenix K. H.] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022; Mo, Phoenix K.H./K-2853-2013	Mo, Phoenix K.H./0000-0001-9822-5424; /0000-0002-5799-5913	Merck Sharp &Dohme (Asia) Ltd. [IISP 37671]	Merck Sharp &Dohme (Asia) Ltd.(Merck & Company)	This study was funded by the Merck Sharp &Dohme (Asia) Ltd. (Ref: IISP 37671), http://www.hkexporter.net/medicine/merck-sharp.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Merck Sharp & Dohme (Asia) Ltd. (MSD ref: IISP 37671). The authors declare that none of the authors served as paid employees, consultants or board members of above mentioned company. No patent has been applied in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2012, HPV CANC; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Auvert B, 2010, JAIDS-J ACQ IMM DEF, V53, P111, DOI 10.1097/QAI.0b013e3181b327e7; Blas MM, 2007, SEX TRANSM INFECT, V83, P567, DOI 10.1136/sti.2007.027276; Bushley AW, 2005, PREV MED, V41, P98, DOI 10.1016/j.ypmed.2004.10.019; Center for Disease Control and Prevention, 2012, HPV VACC; Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Department of Health The Government of Hong Kong Special Adminstrative Region, 2011, FAC PRISM HIV PREV R; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; EASTWOOD CM, 1985, J ADV NURS, V10, P245, DOI 10.1111/j.1365-2648.1985.tb00519.x; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; European Medicines Agency, 2012, GARD EPAR PROD INF; Ford CA, 2004, PERSPECT SEX REPRO H, V36, P258, DOI 10.1363/3625804; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Gilbert P, 2011, AM J MENS HEALTH, V5, P297, DOI 10.1177/1557988310372802; Gilbert PA, 2011, J LOW GENIT TRACT DI, V15, P83, DOI 10.1097/LGT.0b013e3181f1a960; Giordano TP, 2013, AIDS BEHAV, V17, P104, DOI 10.1007/s10461-012-0295-x; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Gu J, 2011, PUBLIC HEALTH, V125, P275, DOI 10.1016/j.puhe.2011.01.010; H. Lee Mofitt Cancer Center and Research Institute, STUD GARD MID MAL MA; Hinman AR, 2005, HEALTH AFFAIR, V24, P701, DOI 10.1377/hlthaff.24.3.701; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Jin F, 2007, SEX TRANSM DIS, V34, P488, DOI 10.1097/01.olq.0000245960.52668.e5; Juraskova I, 2012, INT J BEHAV MED, V19, P518, DOI 10.1007/s12529-011-9182-5; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Kreuter A, 2010, BRIT J DERMATOL, V162, P1269, DOI 10.1111/j.1365-2133.2010.09712.x; Lau JTF, 2008, AIDS CARE, V20, P820, DOI 10.1080/09540120701694048; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2004, SEX TRANSM DIS, V31, P568, DOI 10.1097/01.olq.0000137905.94154.0a; Lau JTF, 2002, ARCH SEX BEHAV, V31, P367, DOI 10.1023/A:1016280411280; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Lee N. R., 2011, SOCIAL MARKETING INF; Lee SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031072; Lin CQ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-272; Logie CH, 2012, SOC SCI MED, V74, P1261, DOI 10.1016/j.socscimed.2012.01.008; Mehta P, 2011, J COMMUNITY MED HTLH, V1; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; National Institute of Allergy and Infectious Diseases (NIAID), EV EFF QUADR HUM PAP; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Pedrana A, 2012, SEX TRANSM DIS, V39, P651, DOI 10.1097/OLQ.0b013e318255df06; Poulos C, 2011, SOC SCI MED, V73, P226, DOI 10.1016/j.socscimed.2011.05.029; Rees R, 2004, HIV HLTH PROMOTION M; Reiter PL, 2010, SEX TRANSM DIS, V37, P197, DOI 10.1097/OLQ.0b013e3181bf542c; Rispel LC, 2011, J PUBLIC HEALTH POL, V32, pS137, DOI 10.1057/jphp.2011.29; Sanchez DM, 2012, INT J STD AIDS, V23, P41, DOI 10.1258/ijsa.2011.011163; Scarinci IC, 2012, HEALTH PROMOT PRACT, V13, P29, DOI 10.1177/1524839910366416; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Stupiansky NW, 2012, CURR OPIN INFECT DIS, V25, P86, DOI 10.1097/QCO.0b013e32834ed5be; Suarez-Almazor ME, 2011, OSTEOPOROSIS INT, V22, pS461, DOI 10.1007/s00198-011-1699-6; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; The Society of Physicians of Hong Kong, 2012, YOUTH HPV PREV PROGR; Thompson C, 1997, INT J STD AIDS, V8, P412; Wheldon CW, 2011, VACCINE, V29, P8060, DOI 10.1016/j.vaccine.2011.08.045; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yang H., 2010, SEXUALLY TRANSMITTED	62	27	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57204	10.1371/journal.pone.0057204	http://dx.doi.org/10.1371/journal.pone.0057204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451188	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800091
J	Lu, LL; Tian, SK; Liao, HB; Zhang, J; Yang, XE; Labavitch, JM; Chen, WR				Lu, Lingli; Tian, Shengke; Liao, Haibing; Zhang, Jie; Yang, Xiaoe; Labavitch, John M.; Chen, Wenrong			Analysis of Metal Element Distributions in Rice (Oryza sativa L.) Seeds and Relocation during Germination Based on X-Ray Fluorescence Imaging of Zn, Fe, K, Ca, and Mn	PLOS ONE			English	Article							PHYTIC ACID; BROWN RICE; ZINC; LOCALIZATION; SPECIATION; GRAIN; IRON; SEQUESTRATION; TRANSLOCATION; HOMEOSTASIS	Knowledge of mineral localization within rice grains is important for understanding the role of different elements in seed development, as well as for facilitating biofortification of seed micronutrients in order to enhance seeds' values in human diets. In this study, the concentrations of minerals in whole rice grains, hulls, brown rice, bran and polished rice were quantified by inductively coupled plasma mass spectroscopy. The in vivo mineral distribution patterns in rice grains and shifts in those distribution patterns during progressive stages of germination were analyzed by synchrotron X-ray microfluorescence. The results showed that half of the total Zn, two thirds of the total Fe, and most of the total K, Ca and Mn were removed by the milling process if the hull and bran were thoroughly polished. Concentrations of all elements were high in the embryo regions even though the local distributions within the embryo varied between elements. Mobilization of the minerals from specific seed locations during germination was also element-specific. High mobilization of K and Ca from grains to growing roots and leaf primordia was observed; the flux of Zn to these expanding tissues was somewhat less than that of K and Ca; the mobilization of Mn or Fe was relatively low, at least during the first few days of germination.	[Lu, Lingli; Tian, Shengke; Liao, Haibing; Zhang, Jie; Yang, Xiaoe] Zhejiang Univ, Coll Environm & Resources Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Liao, Haibing; Chen, Wenrong] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Tian, Shengke; Labavitch, John M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Zhejiang University; Zhejiang Normal University; University of California System; University of California Davis	Chen, WR (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	cwr@zjnu.cn	Tian, Shengke/G-8307-2016; Zhang, Jie/E-4768-2013	Tian, Shengke/0000-0001-8242-3581; Zhang, Jie/0000-0002-8344-5907	Normal project from the National Natural Science Foundation of China [30900921, 31000935]; Fundamental Research Funds for the Central Universities [2012FZA6008]	Normal project from the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by Normal project from the National Natural Science Foundation of China (30900921, 31000935), and the Fundamental Research Funds for the Central Universities (2012FZA6008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, WHO TECHN REP SER; Arora S, 2010, FOOD CHEM, V119, P779, DOI 10.1016/j.foodchem.2009.07.035; Bam R. K., 2006, Asian Journal of Plant Sciences, V5, P948; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; Cakmak I, 2000, NEW PHYTOL, V146, P185, DOI 10.1046/j.1469-8137.2000.00630.x; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2009, J TRACE ELEM MED BIO, V23, P281, DOI 10.1016/j.jtemb.2009.05.002; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gibson RS, 2006, P NUTR SOC, V65, P51, DOI 10.1079/PNS2005474; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Iwai T, 2012, PLANT PHYSIOL, V160, P2007, DOI 10.1104/pp.112.206573; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kranner I, 2011, ENVIRON EXP BOT, V72, P93, DOI 10.1016/j.envexpbot.2010.05.005; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Lamberts L, 2007, FOOD CHEM, V100, P1496, DOI 10.1016/j.foodchem.2005.11.042; Lombi E, 2009, NEW PHYTOL, V184, P193, DOI 10.1111/j.1469-8137.2009.02912.x; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Meharg AA, 2008, ENVIRON SCI TECHNOL, V42, P1051, DOI 10.1021/es702212p; Nakano K, 2006, BUNSEKI KAGAKU, V55, P427, DOI 10.2116/bunsekikagaku.55.427; Omary MB, 2012, CEREAL CHEM, V89, P1, DOI 10.1094/CCHEM-01-11-0008; Ozturk L, 2006, PHYSIOL PLANTARUM, V128, P144, DOI 10.1111/j.1399-3054.2006.00737.x; Patil SB, 2011, J FOOD SCI TECH MYS, V48, P661, DOI 10.1007/s13197-011-0232-4; Punshon T, 2009, ANN BOT-LONDON, V103, P665, DOI 10.1093/aob/mcn264; Sun GX, 2010, ENVIRON SCI TECHNOL, V44, P6706, DOI 10.1021/es101843x; Takahashi M, 2009, PLANT SOIL, V325, P39, DOI 10.1007/s11104-009-0045-7; Thomine S, 2003, PLANT J, V34, P685, DOI 10.1046/j.1365-313X.2003.01760.x; Tian SK, 2009, NEW PHYTOL, V182, P116, DOI 10.1111/j.1469-8137.2008.02740.x; Tian SK, 2011, PLANT PHYSIOL, V157, P1914, DOI 10.1104/pp.111.183947; Tian SK, 2010, ENVIRON SCI TECHNOL, V44, P5920, DOI 10.1021/es903921t; Walker EL, 2011, CURR OPIN PLANT BIOL, V14, P318, DOI 10.1016/j.pbi.2011.03.025; Wang KM, 2011, J CEREAL SCI, V54, P116, DOI 10.1016/j.jcs.2011.03.002; Wei YY, 2012, J AGR FOOD CHEM, V60, P1871, DOI 10.1021/jf205025b; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; Welch RM, 1999, FIELD CROP RES, V60, P1, DOI 10.1016/S0378-4290(98)00129-4; West M, 2007, J ANAL ATOM SPECTROM, V22, P1304, DOI 10.1039/b712079f; WHO, 2006, MICR DEF IR DEF AN; Zhang Y, 2012, PLANT J, V72, P400, DOI 10.1111/j.1365-313X.2012.05088.x; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x	41	83	84	4	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57360	10.1371/journal.pone.0057360	http://dx.doi.org/10.1371/journal.pone.0057360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451212	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800102
J	Reuss, DE; Mucha, J; Hagenlocher, C; Ehemann, V; Kluwe, L; Mautner, V; von Deimling, A				Reuss, David E.; Mucha, Jana; Hagenlocher, Christian; Ehemann, Volker; Kluwe, Lan; Mautner, Victor; von Deimling, Andreas			Sensitivity of Malignant Peripheral Nerve Sheath Tumor Cells to TRAIL Is Augmented by Loss of NF1 through Modulation of MYC/MAD and Is Potentiated by Curcumin through Induction of ROS	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; DRUG-INDUCED APOPTOSIS; OXYGEN SPECIES ROS; CANCER-CELLS; KAPPA-B; DEATH RECEPTOR-4; COLON CELLS; IN-VIVO; C-MYC; RAS	Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often associated with the tumor syndrome neurofibromatosis type 1 (NF1). We investigated the effects of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) on NF1 associated MPNST and determinants of TRAIL sensitivity. MPNST cell lines with complete neurofibromin deficiency were sensitive to apoptotic cell death induced by TRAIL whereas MPNST cells with retained neurofibromin expression or normal human Schwann cells were resistant. Increased sensitivity to TRAIL was associated with overexpression of death receptors, especially DR5. Re-expression of the GAP related domain of neurofibromin (NF1-GRD) suppressed DR5 expression and decreased sensitivity to TRAIL. We show that death receptor expression and TRAIL sensitivity critically depend on c-MYC and that c-MYC amounts are increased by MEK/ERK and PI3K/AKT signalling pathways which are suppressed by neurofibromin. Furthermore PI3K/AKT signalling strongly suppresses the MYC-antagonist MAD1 which significantly contributes to TRAIL sensitivity. Re-expression of the NF1-GRD decreased c-MYC and increased MAD1 amounts suggesting that neurofibromin influences TRAIL sensitivity at least in part by modulating the MYC/MAX/MAD network. The phytochemical curcumin further increased the sensitivity of neurofibromin deficient MPNST cells to TRAIL. This was presumably mediated by ROS, as it correlated with increased ROS production, was blocked by N-acetylcysteine and mimicked by exogenous ROS.	[Reuss, David E.; Mucha, Jana; Hagenlocher, Christian; von Deimling, Andreas] CCU Neuropathol German Canc Res Ctr DKFZ, Heidelberg, Germany; [Reuss, David E.; von Deimling, Andreas] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany; [Kluwe, Lan; Mautner, Victor] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Ehemann, Volker] Heidelberg Univ, Inst Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	von Deimling, A (corresponding author), CCU Neuropathol German Canc Res Ctr DKFZ, Heidelberg, Germany.	andreas.vondeimling@med.uni-heidelberg.de	von Deimling, Andreas/F-7774-2013	von Deimling, Andreas/0000-0002-5863-540X	Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases [01GM0841]	Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) program rare diseases (grant 01GM0841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony B, 2008, INDIAN J PHARM SCI, V70, P445, DOI 10.4103/0250-474X.44591; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Bisht S, 2010, MOL CANCER THER, V9, P2255, DOI 10.1158/1535-7163.MCT-10-0172; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bottillo I, 2009, J PATHOL, V217, P693, DOI 10.1002/path.2494; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Carroll SL, 2005, J NEUROPATH EXP NEUR, V64, P1; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Dubska L, 2005, FEBS LETT, V579, P4149, DOI 10.1016/j.febslet.2005.06.047; Ehemann V, 2003, CANCER LETT, V194, P125, DOI 10.1016/S0304-3835(03)00054-5; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Hagel C, 2007, J NEURO-ONCOL, V82, P187, DOI 10.1007/s11060-006-9266-2; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hoogwater FJH, 2010, GASTROENTEROLOGY, V138, P2357, DOI 10.1053/j.gastro.2010.02.046; Jacquemin G, 2010, CELL MOL LIFE SCI, V67, P3115, DOI 10.1007/s00018-010-0407-6; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER; Kang YH, 2008, J CELL PHYSIOL, V217, P23, DOI 10.1002/jcp.21470; Kim KH, 2000, CLIN CANCER RES, V6, P335; Mellier G, 2012, FREE RADICAL RES, V46, P996, DOI 10.3109/10715762.2012.690514; Mitsiades N, 2001, CANCER RES, V61, P2704; Nesterov A, 2004, CANCER RES, V64, P3922, DOI 10.1158/0008-5472.CAN-03-2219; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Opel D, 2011, CLIN CANC RES; Opel D, 2008, CANCER RES, V68, P6271, DOI 10.1158/0008-5472.CAN-07-6769; Perry A, 2001, AM J PATHOL, V159, P57, DOI 10.1016/S0002-9440(10)61673-2; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Prasad S, 2011, CANCER RES, V71, P538, DOI 10.1158/0008-5472.CAN-10-3121; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sheikh MS, 2004, CELL CYCLE, V3, P920; Siegelin MD, 2009, NEURO-ONCOLOGY, V11, P122, DOI 10.1215/15228517-2008-085; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Subramaniam D, 2008, CANCER RES, V68, P1962, DOI 10.1158/0008-5472.CAN-07-6011; Sussman RT, 2007, CANCER BIOL THER, V6, P1490, DOI 10.4161/cbt.6.9.4905; Thayyullathil F, 2008, FREE RADICAL BIO MED, V45, P1403, DOI 10.1016/j.freeradbiomed.2008.08.014; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Upadhyaya M, 2008, HUM MUTAT, V29, P74, DOI [10.1002/humu.20601, 10.1002/humu.20793]; Upadhyaya M, 2004, HUM MUTAT, V23, P134, DOI 10.1002/humu.10305; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Webb J, 1963, ENZYMES METABOL INH, P487; ZHANG K, 1992, SCIENCE, V257, P671, DOI 10.1126/science.1496380; Zhu JD, 2008, P NATL ACAD SCI USA, V105, P6584, DOI 10.1073/pnas.0802785105	49	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57152	10.1371/journal.pone.0057152	http://dx.doi.org/10.1371/journal.pone.0057152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437333	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000080
J	Francis, MP				Francis, Malcolm P.			Temporal and Spatial Patterns of Habitat Use by Juveniles of a Small Coastal Shark (Mustelus lenticulatus) in an Estuarine Nursery	PLOS ONE			English	Article							TERM MOVEMENT PATTERNS; SMOOTH DOGFISH; SITE FIDELITY; TOMALES BAY; REEF SHARKS; CONSERVATION; AREAS; ABUNDANCE; INDEXES; GROWTH	Juvenile rig (Mustelus lenticulatus) were internally tagged with acoustic transmitters and tracked with acoustic receivers deployed throughout two arms of Porirua Harbour, a small (7 km(2)) estuary in New Zealand. Ten rig were tracked for up to four months during summer-autumn to determine their spatial and temporal use of the habitat. The overall goal was to estimate the size of Marine Protected Areas required to protect rig nursery areas from direct human impacts. Rig showed clear site preferences, but those preferences varied among rig and over time. They spent most of their time in large basins and on shallow sand and mud flats around the margins, and avoided deep channels. Habitat range increased during autumn for many of the rig. Only one shark spent time in both harbour arms, indicating that there was little movement between the two. Rig home ranges were 2-7 km(2), suggesting that an effective MPA would need to cover the entire Porirua Harbour. They moved to outer harbour sites following some high river flow rates, and most left the harbour permanently during or soon after a river spike, suggesting that they were avoiding low salinity water. Rig showed strong diel movements during summer, although the diel pattern weakened in autumn. Persistent use of the same day and night sites indicates that diel movements are directed rather than random. Further research is required to determine the sizes of rig home ranges in larger harbours where nursery habitat is more extensive. Marine Protected Areas do not control land-based impacts such as accelerated sedimentation and heavy metal pollution, so integration of marine and terrestrial management tools across a range of government agencies is essential to fully protect nursery areas.	Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Francis, MP (corresponding author), Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand.	malcolm.francis@niwa.co.nz			New Zealand Ministry of Business, Innovation and Employment [C01X0502]	New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This study was funded by the New Zealand Ministry of Business, Innovation and Employment under research contract C01X0502. (http://www.msi.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Barnett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015464; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Blaschke P., 2010, PORIRUA HARBOUR ITS; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Briggs I, 1980, UPPER WAITEMATA HARB; Bush A, 2003, ENVIRON BIOL FISH, V67, P1, DOI 10.1023/A:1024438706814; Campos BR, 2009, ENVIRON BIOL FISH, V85, P3, DOI 10.1007/s10641-009-9462-y; CASTERLIN ME, 1979, B MAR SCI, V29, P440; Chapman DD, 2005, MAR TECHNOL SOC J, V39, P42, DOI 10.4031/002533205787521640; Discovery Marine, 2009, POR HARB SURV REP SU; Edren SMC, 2005, ENVIRON BIOL FISH, V72, P267, DOI 10.1007/s10641-004-2583-4; Espinoza M, 2011, J EXP MAR BIOL ECOL, V401, P63, DOI 10.1016/j.jembe.2011.03.001; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Forch EC, 1983, THESIS VICTORIA U NZ; Francis M, 2012, NZ AQUAT ENV BIODIV; FRANCIS MP, 1980, NEW ZEAL J MAR FRESH, V14, P303, DOI 10.1080/00288330.1980.9515873; FRANCIS MP, 1992, AUST J MAR FRESH RES, V43, P1157; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Getzlaff C, 2012, THESIS MASSEY U PALM; Gibb J.G., 2009, PATTERNS RATES SEDIM; Gotelli N.J., 1996, NULL MODELS ECOLOGY, DOI DOI 10.1098/rspb.2014.0675; Gotelli NJ, 2012, ECOSIM 7 72; Healy WB, 1980, DSIR INF SER; Hendry RT, 2004, ASSESSMENT SPATIAL E; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; Heupel MR, 2005, MAR TECHNOL SOC J, V39, P10, DOI 10.4031/002533205787521749; Heupel MR, 2004, ENVIRON BIOL FISH, V71, P135, DOI 10.1023/B:EBFI.0000045710.18997.f7; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Heupel MR, 2003, J FISH BIOL, V63, P1357, DOI 10.1046/j.1095-8649.2003.00250.x; Hurst RJ, 2000, ATLAS JUVENILE ADULT; Jones E, NZ AQUAT EN IN PRESS; JONES JB, 1985, NEW ZEAL J MAR FRESH, V19, P477, DOI 10.1080/00288330.1985.9516112; KING KJ, 1984, NEW ZEAL J MAR FRESH, V18, P21, DOI 10.1080/00288330.1984.9516025; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Knip DM, 2011, MAR FRESHWATER RES, V62, P658, DOI 10.1071/MF10136; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; LINTON LR, 1981, J ANIM ECOL, V50, P283, DOI 10.2307/4045; Lucifora LO, 2005, MAR ECOL PROG SER, V289, P237, DOI 10.3354/meps289237; Lucifora LO, 2006, MAR ECOL PROG SER, V315, P259, DOI 10.3354/meps315259; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Ministry of Fisheries, 2008, NZ NAT PLAN ACT CONS; Ministry of Fisheries Science Group, 2011, REP MIDY FISH UNPUB; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Rechisky EL, 2003, ENVIRON BIOL FISH, V68, P113, DOI 10.1023/B:EBFI.0000003820.62411.cb; RICKLEFS RE, 1980, ECOLOGY, V61, P1019, DOI 10.2307/1936817; Rountree RA, 1996, FISH B-NOAA, V94, P522; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2002, CAN J FISH AQUAT SCI, V59, P23, DOI 10.1139/F01-191; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Sokal R. R., 1981, BIOMETRY; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581	59	18	18	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57021	10.1371/journal.pone.0057021	http://dx.doi.org/10.1371/journal.pone.0057021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437298	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200201
J	Starosta, S; Gunturkun, O; Stuttgen, MC				Starosta, Sarah; Guentuerkuen, Onur; Stuettgen, Maik C.			Stimulus-Response-Outcome Coding in the Pigeon Nidopallium Caudolaterale	PLOS ONE			English	Article							AVIAN PREFRONTAL CORTEX; NEOSTRIATUM CAUDOLATERALE; DOPAMINE; LESIONS; REPRESENTATION; MICRODRIVE; STRIATUM; REVERSAL; AFFERENT; DEFICITS	A prerequisite for adaptive goal-directed behavior is that animals constantly evaluate action outcomes and relate them to both their antecedent behavior and to stimuli predictive of reward or non-reward. Here, we investigate whether single neurons in the avian nidopallium caudolaterale (NCL), a multimodal associative forebrain structure and a presumed analogue of mammalian prefrontal cortex, represent information useful for goal-directed behavior. We subjected pigeons to a go-nogo task, in which responding to one visual stimulus (S+) was partially reinforced, responding to another stimulus (S-) was punished, and responding to test stimuli from the same physical dimension (spatial frequency) was inconsequential. The birds responded most intensely to S+, and their response rates decreased monotonically as stimuli became progressively dissimilar to S+; thereby, response rates provided a behavioral index of reward expectancy. We found that many NCL neurons' responses were modulated in the stimulus discrimination phase, the outcome phase, or both. A substantial fraction of neurons increased firing for cues predicting non-reward or decreased firing for cues predicting reward. Interestingly, the same neurons also responded when reward was expected but not delivered, and could thus provide a negative reward prediction error or, alternatively, signal negative value. In addition, many cells showed motor-related response modulation. In summary, NCL neurons represent information about the reward value of specific stimuli, instrumental actions as well as action outcomes, and therefore provide signals useful for adaptive behavior in dynamically changing environments.	[Starosta, Sarah; Guentuerkuen, Onur; Stuettgen, Maik C.] Ruhr Univ Bochum, Fac Psychol, Dept Biopsychol, Bochum, Germany	Ruhr University Bochum	Stuttgen, MC (corresponding author), Ruhr Univ Bochum, Fac Psychol, Dept Biopsychol, Bochum, Germany.	maik.stuettgen@rub.de	Stüttgen, Maik C./K-1494-2019	Stüttgen, Maik C./0000-0002-7031-262X; Gunturkun, Onur/0000-0003-4173-5233	German Research Foundation (DFG) [STU 544/1-1, SFB 874]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by grants from the German Research Foundation (DFG) to MCS (STU 544/1-1) and OG (SFB 874). The website of the DFG is http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Bast T, 2002, J COMP NEUROL, V446, P58, DOI 10.1002/cne.10187; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Bilkey DK, 2003, METHODS, V30, P152, DOI 10.1016/S1046-2023(03)00076-8; Bilkey DK, 1999, J NEUROSCI METH, V92, P87, DOI 10.1016/S0165-0270(99)00102-8; BLOUGH DS, 1975, J EXP PSYCHOL-ANIM B, V104, P3, DOI 10.1037/0097-7403.1.1.3; BLOUGH DS, 1967, SCIENCE, V158, P940, DOI 10.1126/science.158.3803.940; BROWN PL, 1968, J EXP ANAL BEHAV, V11, P1, DOI 10.1901/jeab.1968.11-1; Browning R, 2011, EUR J NEUROSCI, V33, P726, DOI 10.1111/j.1460-9568.2010.07540.x; Diekamp B, 2002, J NEUROSCI, V22, P9573; Diekamp B, 2002, J NEUROSCI, V22; DIVAC I, 1985, BRAIN RES, V332, P365, DOI 10.1016/0006-8993(85)90606-7; Durstewitz D, 1999, PROG NEUROBIOL, V59, P161, DOI 10.1016/S0301-0082(98)00100-2; EPSTEIN R, 1984, NATURE, V308, P61, DOI 10.1038/308061a0; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GOODALE MA, 1983, BRAIN BEHAV EVOLUT, V22, P22, DOI 10.1159/000121504; Grabenhorst F, 2011, TRENDS COGN SCI, V15, P56, DOI 10.1016/j.tics.2010.12.004; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Gunturkun O, 2012, PSYCHOL RES-PSYCH FO, V76, P212, DOI 10.1007/s00426-011-0377-9; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; Gunturkun O, 1997, J BRAIN RES, V38, P133; GUTTMAN N, 1956, J EXP PSYCHOL, V51, P79, DOI 10.1037/h0046219; Hartmann B, 1998, BEHAV BRAIN RES, V96, P125, DOI 10.1016/S0166-4328(98)00006-0; Hentschke H, 2011, EUR J NEUROSCI; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hill DN, 2011, J NEUROSCI, V31, P8699, DOI 10.1523/JNEUROSCI.0971-11.2011; HONIG WK, 1962, J EXP PSYCHOL, V64, P239, DOI 10.1037/h0048290; JENKINS HM, 1973, J EXP ANAL BEHAV, V20, P163, DOI 10.1901/jeab.1973.20-163; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kalt T, 1999, BRAIN RES, V839, P263, DOI 10.1016/S0006-8993(99)01727-8; Karakuyu D, 2007, EUR J NEUROSCI, V26, P2293, DOI 10.1111/j.1460-9568.2007.05840.x; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Kennerley SW, 2009, EUR J NEUROSCI, V29, P2061, DOI 10.1111/j.1460-9568.2009.06743.x; Kirsch JA, 2009, BEHAV BRAIN RES, V198, P214, DOI 10.1016/j.bbr.2008.11.010; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; Lissek S, 2005, BEHAV NEUROSCI, V119, P797, DOI 10.1037/0735-7044.119.3.797; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Mazur JE, 2006, J EXP ANAL BEHAV, V85, P275, DOI 10.1901/jeab.2006.65-05; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; Milmine M, 2008, BEHAV NEUROSCI, V122, P199, DOI 10.1037/0735-7044.122.1.199; MOGENSEN J, 1982, BRAIN BEHAV EVOLUT, V21, P60, DOI 10.1159/000121617; Morrison SE, 2009, J NEUROSCI, V29, P11471, DOI 10.1523/JNEUROSCI.1815-09.2009; Rose J, 2005, PLOS BIOL, V3, P1139, DOI 10.1371/journal.pbio.0030190; Rose J, 2008, J NEUROSCI METH, V175, P104, DOI 10.1016/j.jneumeth.2008.08.006; Scarf D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014589; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Stuttgen MC, 2008, NAT NEUROSCI, V11, P1091, DOI 10.1038/nn.2162; Stuttgen MC, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00125; Stuttgen MC, 2011, J EXP ANAL BEHAV, V96, P155, DOI 10.1901/jeab.2011.96-155; Sul JH, 2010, NEURON, V66, P449, DOI 10.1016/j.neuron.2010.03.033; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Wallis JD, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00124	55	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57407	10.1371/journal.pone.0057407	http://dx.doi.org/10.1371/journal.pone.0057407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437383	Green Published, gold			2022-12-25	WOS:000315184200253
J	Tsurumoto, T; Saiki, K; Okamoto, K; Imamura, T; Maeda, J; Manabe, Y; Wakebe, T				Tsurumoto, Toshiyuki; Saiki, Kazunobu; Okamoto, Keishi; Imamura, Takeshi; Maeda, Junichiro; Manabe, Yoshitaka; Wakebe, Tetsuaki			Periarticular Osteophytes as an Appendicular Joint Stress Marker (JSM): Analysis in a Contemporary Japanese Skeletal Collection	PLOS ONE			English	Article							CALCIFYING NANOPARTICLES; OSTEOARTHRITIS; KNEE; ASSOCIATION; POPULATION; AGE; PREVALENCE; DISEASE; PATTERN; GOTLAND	Objective: The aim of this study was to investigate the possibility that periarticular osteophytes plays a role as a appendicular joint stress marker (JSM) which reflects the biomechanical stresses on individuals and populations. Methods: A total of 366 contemporary Japanese skeletons (231 males, 135 females) were examined closely to evaluate the periarticular osteophytes of six major joints, the shoulder, elbow, wrist, hip, knee, and ankle and osteophyte scores (OS) were determined using an original grading system. These scores were aggregated and analyzed statistically from some viewpoints. Results: All of the OS for the respective joints were correlated logarithmically with the age-at-death of the individuals. For 70 individuals, in whom both sides of all six joints were evaluated without missing values, the age-standardized OS were calculated. A right side dominancy was recognized in the joints of the upper extremities, shoulder and wrist joints, and the bilateral correlations were large in the three joints on the lower extremity. For the shoulder joint and the hip joint, it was inferred by some distinctions that systemic factors were relatively large. All of these six joints could be assorted by the extent of systemic and local factors on osteophytes formation. Moreover, when the age-standardized OS of all the joints was summed up, some individuals had significantly high total scores, and others had significantly low total scores; namely, all of the individuals varied greatly in their systemic predisposition for osteophytes formation. Conclusions: This study demonstrated the significance of periarticular osteophytes; the evaluating system for OS could be used to detect differences among joints and individuals. Periarticular osteophytes could be applied as an appendicular joint stress marker (JSM); by applying OS evaluating system for skeletal populations, intra-skeletal and inter-skeletal variations in biomechanical stresses throughout the lives could be clarified.	[Tsurumoto, Toshiyuki; Saiki, Kazunobu; Okamoto, Keishi; Wakebe, Tetsuaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Macroscop Anat, Nagasaki 852, Japan; [Imamura, Takeshi; Maeda, Junichiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Nagasaki 852, Japan; [Manabe, Yoshitaka] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Anat & Dent Anthropol, Nagasaki 852, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Tsurumoto, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Macroscop Anat, Nagasaki 852, Japan.	tsurumot@nagasaki-u.ac.jp		Tsurumoto, Toshiyuki/0000-0001-6069-6490	Grants-in-Aid for Scientific Research [25251042, 22370087] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Anderson AS, 2010, BEST PRACT RES CL RH, V24, P15, DOI 10.1016/j.berh.2009.08.006; Braga L, 2009, OSTEOARTHR CARTILAGE, V17, P1554, DOI 10.1016/j.joca.2009.07.011; Bratos-Perez MA, 2008, EUR HEART J, V29, P371, DOI 10.1093/eurheartj/ehm592; Brickley M, 1998, BONE, V22, P279, DOI 10.1016/S8756-3282(97)00272-X; BRIDGES PS, 1991, AM J PHYS ANTHROPOL, V85, P379, DOI 10.1002/ajpa.1330850403; BUCKLANDWRIGHT JC, 1991, ANN RHEUM DIS, V50, P627, DOI 10.1136/ard.50.9.627; Candemir B, 2010, J HEART VALVE DIS, V19, P745; Cooper C, 1996, J RHEUMATOL, V23, P1938; Currey J.D., 2002, BONES STRUCTURE MECH; Dai J, 2010, J HUM GENET, V55, P77, DOI 10.1038/jhg.2009.137; Debono L, 2004, JOINT BONE SPINE, V71, P397, DOI 10.1016/j.jbspin.2003.11.005; Esposito A, 2006, SKELETAL RADIOL, V35, P847, DOI 10.1007/s00256-006-0134-0; Fischer A, 1932, ACTA RHEUMATOL, V4, P24; Guo YA, 2012, INT J NANOMED, V7, P1679, DOI 10.2147/IJN.S29786; HAWKEY DE, 1995, INT J OSTEOARCHAEOL, V5, P324, DOI 10.1002/oa.1390050403; Heine J, 1926, VIRCHOWS ARCH A, V260, P521, DOI 10.1007/BF01889359; HERNBORG J, 1973, ACTA ORTHOP SCAND, V44, P69, DOI 10.3109/17453677308988675; Inoue K, 2001, RHEUMATOLOGY, V40, P70, DOI 10.1093/rheumatology/40.1.70; Irlenbusch U, 2006, OSTEOARTHR CARTILAGE, V14, P423, DOI 10.1016/j.joca.2005.11.016; Jelic TM, 2008, INT J NANOMED, V3, P385; Jurmain R. D., 1991, INT J OSTEOARCHAEOL, V1, P247, DOI DOI 10.1002/OA.1390010319; JURMAIN RD, 1995, ANN RHEUM DIS, V54, P443, DOI 10.1136/ard.54.6.443; JURMAIN RD, 1977, AM J PHYS ANTHROPOL, V46, P353, DOI 10.1002/ajpa.1330460214; JURMAIN RD, 1980, AM J PHYS ANTHROPOL, V53, P143, DOI 10.1002/ajpa.1330530119; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Klaus HD, 2009, AM J PHYS ANTHROPOL, V139, P204, DOI 10.1002/ajpa.20973; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; Messent EA, 2007, OSTEOARTHR CARTILAGE, V15, P179, DOI 10.1016/j.joca.2006.06.020; Meulenbelt I, 2012, OSTEOARTHR CARTILAGE, V20, P218, DOI 10.1016/j.joca.2012.01.007; Molnar P, 2006, AM J PHYS ANTHROPOL, V129, P12, DOI 10.1002/ajpa.20234; Molnar P, 2011, INT J OSTEOARCHAEOL, V21, P283, DOI 10.1002/oa.1131; Neame R, 2004, ARTHRITIS RHEUM-US, V50, P1487, DOI 10.1002/art.20162; Petersson IF, 1996, ANN RHEUM DIS, V55, P659, DOI 10.1136/ard.55.9.659; Petersson IF, 2002, BEST PRACT RES CL RH, V16, P741, DOI 10.1053/berh.2002.0266; RALPHS JR, 1994, J ANAT, V184, P503; Rogers J, 1997, ANN RHEUM DIS, V56, P85, DOI 10.1136/ard.56.2.85; Rogers J, 2004, ARTHRITIS RHEUM-US, V50, P452, DOI 10.1002/art.20136; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; Timms AE, 2002, RHEUMATOLOGY, V41, P725, DOI 10.1093/rheumatology/41.7.725; Tsurumoto T, 2006, J PROTEOME RES, V5, P1276, DOI 10.1021/pr050450w; van der Kraan PM, 2007, OSTEOARTHR CARTILAGE, V15, P237, DOI 10.1016/j.joca.2006.11.006; VANSAASE JLCM, 1989, ANN RHEUM DIS, V48, P271, DOI 10.1136/ard.48.4.271; Waldron HA, 1997, ANN RHEUM DIS, V56, P116, DOI 10.1136/ard.56.2.116; WALDRON HA, 1991, ANN RHEUM DIS, V50, P301, DOI 10.1136/ard.50.5.301; Waldron HA, 1986, BR J IND MED, V46, P420; Watkins R, 2012, INT J OSTEOARCHAEOL, V22, P22, DOI 10.1002/oa.1178; Weiss E, 2007, INT J OSTEOARCHAEOL, V17, P437, DOI 10.1002/oa.889; Weiss E, 2003, AM J PHYS ANTHROPOL, V121, P230, DOI 10.1002/ajpa.10226; Zhou ZS, 2008, UROLOGY, V71, P1091, DOI 10.1016/j.urology.2008.02.041	50	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57049	10.1371/journal.pone.0057049	http://dx.doi.org/10.1371/journal.pone.0057049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437307	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200206
J	Akefeldt, SO; Maisse, C; Belot, A; Mazzorana, M; Salvatore, G; Bissay, N; Jurdic, P; Arico, M; Rabourdin-Combe, C; Henter, JI; Delprat, C				Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Arico, Maurizio; Rabourdin-Combe, Chantal; Henter, Jan-Inge; Delprat, Christine			Chemoresistance of Human Monocyte-Derived Dendritic Cells Is Regulated by IL-17A	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 HOMOLOG; T-CELLS; EXPRESSION; FAMILY; BFL-1; INTERLEUKIN-17; CYTOKINES; GENE	Dendritic cells initiate adaptive immune responses, leading either to control cancer by effector T cells or to exacerbate cancer by regulatory T cells that inhibit IFN-gamma-mediated Th1-type response. Dendritic cells can also induce Th17-type immunity, mediated by IL-17A. However, the controversial role of this cytokine in cancer requires further investigations. We generated dendritic cells from peripheral blood monocytes to investigate lifespan, phenotype and chemoresistance of dendritic cells, treated with IL-17A with or without IFN-gamma. Studying the expression of Bcl-2 family members, we demonstrated that dendritic cells constitutively express one pro-survival Bcl-2 member: MCL1. Immature dendritic cells were CD40(low)HLADR(low) CD1a(+) MCL1(+), did not express CD14, CD68 or BCL2A1, and displayed a short 2-day lifespan. IL-17A-treated DC exhibited a semi-mature (CD40(high)HLADR(low)) pre-M2 (CCL22(+) CD206(+) CD163(+) IL1RN(+) IL-10(-) CXCL10(-) IL-12(-)) mixed (CD1a(+) CD14+ CD68(+)) macrophage-dendritic cell phenotype. They efficiently exerted mannose receptor-mediated endocytosis and did not produce superoxide anions, in the absence of TLR engagement. Interestingly, IL-17A promoted a long-term survival of dendritic cells, beyond 12 days, that correlated to BCL2A1 induction, a pro-survival Bcl-2 family member. BCL2A1 transcription was activated by NF-kappa B, downstream of IL-17A transduction. Thus, immature dendritic cells only express MCL1, whereas IL-17A-treated dendritic cells concomitantly expressed two pro-survival Bcl-2 family members: MCL1 and BCL2A1. These latter developed chemoresistance to 11 of the 17 chemotherapy agents tested. However, high doses of either vinblastine or cytarabine decreased MCL1 expression and induced dendritic cell death. When IL-17A is produced in vivo, administration of anti-IL-17A biotherapy may impair dendritic cell survival by targeting BCL2A1 expression. Consequently, depending on the effector or regulatory role of dendritic cells, blocking IL-17A, may be either dangerous or beneficial for cancer outcomes, thus contributing to the apparent controversy around the role of IL-17A in cancer.	[Akefeldt, Selma Olsson; Henter, Jan-Inge] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Salvatore, Giulia; Bissay, Nathalie; Delprat, Christine] CNRS, UMR5239, Lab Biol Mol Cellule, Lyon, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Delprat, Christine] Ecole Normale Super Lyon, F-69364 Lyon, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Rabourdin-Combe, Chantal; Delprat, Christine] Univ Lyon, Lyon, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Rabourdin-Combe, Chantal; Delprat, Christine] Univ Lyon 1, F-69622 Villeurbanne, France; [Akefeldt, Selma Olsson; Maisse, Carine; Belot, Alexandre; Mazzorana, Marlene; Salvatore, Giulia; Bissay, Nathalie; Jurdic, Pierre; Rabourdin-Combe, Chantal; Delprat, Christine] UMS3444 US8, Lyon, France; [Belot, Alexandre] Hop Femme Mere Enfant, Hosp Civils Lyon, Bron, France; [Mazzorana, Marlene; Jurdic, Pierre] CNRS, UMR5242, Inst Genom Fonct Lyon, Lyon, France; [Salvatore, Giulia] Univ Florence, Florence, Italy; [Salvatore, Giulia; Arico, Maurizio] Azienda Osped Univ Meyer Children Hosp, Dept Pediat Hematol Oncol, Florence, Italy; [Rabourdin-Combe, Chantal] INSERM, U851, F-69008 Lyon, France; [Delprat, Christine] Inst Univ France, Paris, France	Karolinska Institutet; Karolinska University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Florence; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France	Delprat, C (corresponding author), CNRS, UMR5239, Lab Biol Mol Cellule, Lyon, France.	cdelprat@free.fr	Belot, Alexandre/C-7378-2013; Arico, Maurizio/S-3039-2019	Belot, Alexandre/0000-0003-4902-5332; Arico, Maurizio/0000-0002-1908-6671; Salvatore, Giulia/0000-0003-3573-9254; MAZZORANA, Marlene/0000-0002-3956-4319; Henter, Jan-Inge/0000-0002-0629-2126; Maisse, Carine/0000-0003-2848-1638	CNRS; INSERM; Universite de Lyon; Institut Universitaire de France; Fondation Innovations en Infectiologie; Fondation de France [2008002100]; Agence Nationale de la Recherche [08-MIEN-001-02]; (USA) Histiocytosis Association of America; Ministero Sanita; Progetto di Ricerca Finalizzata; Regione Toscana; Progetto di Ricerca Malattie Rare; Associazione Italiana Ricerca Istiocitosi (AIRI); Swedish Children's Cancer Foundation; Swedish Research Council; Marta och Gunnar V Philipson's Foundation; Cancer and Allergy Foundation of Sweden; Karolinska Institutet (KID project); Stockholm County Council (ALF project)	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Lyon; Institut Universitaire de France; Fondation Innovations en Infectiologie; Fondation de France(Fondation de France); Agence Nationale de la Recherche(French National Research Agency (ANR)); (USA) Histiocytosis Association of America; Ministero Sanita; Progetto di Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Regione Toscana(Regione Toscana); Progetto di Ricerca Malattie Rare; Associazione Italiana Ricerca Istiocitosi (AIRI); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marta och Gunnar V Philipson's Foundation; Cancer and Allergy Foundation of Sweden; Karolinska Institutet (KID project); Stockholm County Council (ALF project)(Stockholm County Council)	This work was supported by grants from (F) CNRS, INSERM, Universite de Lyon, Institut Universitaire de France, Fondation Innovations en Infectiologie, Fondation de France 2008002100, Agence Nationale de la Recherche 08-MIEN-001-02; (USA) Histiocytosis Association of America 2008; (I) Ministero Sanita, Progetto di Ricerca Finalizzata 2008: "Getting deeper in histiocytosis", Regione Toscana, Progetto di Ricerca Malattie Rare 2008, Associazione Italiana Ricerca Istiocitosi (AIRI); (S) the Swedish Children's Cancer Foundation, the Swedish Research Council, Marta och Gunnar V Philipson's Foundation, the Cancer and Allergy Foundation of Sweden, Karolinska Institutet (KID project) and the Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; BINASCHI M, 1990, INT J CANCER, V45, P347, DOI 10.1002/ijc.2910450223; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brien G, 2007, ONCOGENE, V26, P5828, DOI 10.1038/sj.onc.1210363; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chang SH, 2011, CELL SIGNAL, V23, P1069, DOI 10.1016/j.cellsig.2010.11.022; Chao D, 1999, BRIT J CANCER, V81, P1280, DOI 10.1038/sj.bjc.6694366; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Chuang PI, 2002, BLOOD, V99, P3350, DOI 10.1182/blood.V99.9.3350; Coury F, 2008, NAT MED, V14, P81, DOI 10.1038/nm1694; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; D'Souza BN, 2004, J VIROL, V78, P1800, DOI 10.1128/JVI.78.4.1800-1816.2004; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Feuerhake F, 2005, BLOOD, V106, P1392, DOI 10.1182/blood-2004-12-4901; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; Gaffen Sarah L, 2009, Curr Rheumatol Rep, V11, P365; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Johnson SA, 2000, CLIN PHARMACOKINET, V39, P5, DOI 10.2165/00003088-200039010-00002; Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201; Karsan A, 1996, BLOOD, V87, P3089, DOI 10.1182/blood.V87.8.3089.bloodjournal8783089; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; Kriehuber E, 2005, BLOOD, V106, P175, DOI 10.1182/blood-2004-08-3072; Lu TY, 2011, J CLIN INVEST, V121, P4015, DOI 10.1172/JCI45862; Macaire H, 2012, J BIOL CHEM, V287, P21357, DOI 10.1074/jbc.M112.340992; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Olsson A, 2007, BRIT J CANCER, V97, P769, DOI 10.1038/sj.bjc.6603951; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rivollier A, 2004, BLOOD, V104, P4029, DOI 10.1182/blood-2004-01-0041; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Tanikawa T, 2012, CANCER RES, V72, P420, DOI 10.1158/0008-5472.CAN-10-4627; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Wang CY, 1999, MOL CELL BIOL, V19, P5923; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Yang HL, 2010, J BIOL CHEM, V285, P32242, DOI 10.1074/jbc.M110.160820	40	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56865	10.1371/journal.pone.0056865	http://dx.doi.org/10.1371/journal.pone.0056865			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441221	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200078
J	da Silva, M; Santos, DVV; Costa, KM				da Silva Filho, Manoel; Vasconcelos Santos, Daniel Valle; Costa, Kaue Machado			A New Low Cost Wide-Field Illumination Method for Photooxidation of Intracellular Fluorescent Markers	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; CORRELATED LIGHT; BRAIN-SLICES; PHOTOCONVERSION; DII; NEURONS; MONKEY; EOSIN	Analyzing cell morphology is crucial in the fields of cell biology and neuroscience. One of the main methods for evaluating cell morphology is by using intracellular fluorescent markers, including various commercially available dyes and genetically encoded fluorescent proteins. These markers can be used as free radical sources in photooxidation reactions, which in the presence of diaminobenzidine (DAB) forms an opaque and electron-dense precipitate that remains localized within the cellular and organelle membranes. This method confers many methodological advantages for the investigator, including absence of photo-bleaching, high visual contrast and the possibility of correlating optical imaging with electron microscopy. However, current photooxidation techniques require the continuous use of fluorescent or confocal microscopes, which wastes valuable mercury lamp lifetime and limits the conversion process to a few cells at a time. We developed a low cost optical apparatus for performing photooxidation reactions and propose a new procedure that solves these methodological restrictions. Our "photooxidizer" consists of a high power light emitting diode (LED) associated with a custom aluminum and acrylic case and a microchip-controlled current source. We demonstrate the efficacy of our method by converting intracellular DiI in samples of developing rat neocortex and post-mortem human retina. DiI crystals were inserted in the tissue and allowed to diffuse for 20 days. The samples were then processed with the new photooxidation technique and analyzed under optical microscopy. The results show that our protocols can unveil the fine morphology of neurons in detail. Cellular structures such as axons, dendrites and spine-like appendages were well defined. In addition to its low cost, simplicity and reliability, our method precludes the use of microscope lamps for photooxidation and allows the processing of many labeled cells simultaneously in relatively large tissue samples with high efficacy.	[da Silva Filho, Manoel; Vasconcelos Santos, Daniel Valle; Costa, Kaue Machado] Fed Univ Para, Inst Biol Sci, BR-66059 Belem, Para, Brazil	Universidade Federal do Para	da Silva, M (corresponding author), Fed Univ Para, Inst Biol Sci, BR-66059 Belem, Para, Brazil.	manoel@ufpa.br	Costa, Kauê M/H-5574-2012; da Silva Filho, Manoel/C-6684-2013	Costa, Kauê M/0000-0002-5562-6495; 	National Counsel of Technological and Scientific Development (CNPQ) [470827/2009-2]; Coordination for the Improvement of Higher Education Personnel (CAPES)	National Counsel of Technological and Scientific Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by the National Counsel of Technological and Scientific Development (CNPQ; grant number 470827/2009-2). DVVS received a graduate student fellowship from the Coordination for the Improvement of Higher Education Personnel (CAPES). MSF is a CNPQ research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTIVOGLIO M, 1990, NEUROSCI LETT, V113, P127, DOI 10.1016/0304-3940(90)90291-G; BUHL EH, 1989, NEUROSCIENCE, V28, P3, DOI 10.1016/0306-4522(89)90227-3; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; Dantuma NP, 1998, J HISTOCHEM CYTOCHEM, V46, P1085, DOI 10.1177/002215549804600913; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Dos Santos SN, 2005, VISUAL NEUROSCI, V22, P405, DOI 10.1017/S0952523805224033; Ghosh KK, 1999, J COMP NEUROL, V413, P417, DOI 10.1002/(SICI)1096-9861(19991025)413:3<417::AID-CNE5>3.0.CO;2-H; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Lubke J, 1993, MICROSC RES TECHNIQ, V1, P2; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Meisslitzer-Ruppitsch C, 2009, J MICROSC-OXFORD, V235, P322, DOI 10.1111/j.1365-2818.2009.03220.x; Mezey SE, 2003, NEUROSCI RES, V47, P299, DOI 10.1016/S0168-0102(03)00219-0; PAPADOPOULOS GC, 1993, J NEUROSCI METH, V46, P251, DOI 10.1016/0165-0270(93)90074-2; Prusky G, 1999, BRAIN RES PROTOC, V3, P313, DOI 10.1016/S1385-299X(98)00055-5; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; Santos DVV, 2012, BRAZ J MED BIOL RES, V45, P1221, DOI 10.1590/S0100-879X2012007500137; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Singleton CD, 1996, J NEUROSCI METH, V64, P47, DOI 10.1016/0165-0270(95)00097-6; VONBARTHELD CS, 1990, J HISTOCHEM CYTOCHEM, V38, P725, DOI 10.1177/38.5.2185313	19	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56512	10.1371/journal.pone.0056512	http://dx.doi.org/10.1371/journal.pone.0056512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441199	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200056
J	Frey, S; Goldstone, RL				Frey, Seth; Goldstone, Robert L.			Cyclic Game Dynamics Driven by Iterated Reasoning	PLOS ONE			English	Article							STRATEGIC THINKING; COORDINATION; BIODIVERSITY; ATTRACTION; PROMOTES; MODEL; COST	Recent theories from complexity science argue that complex dynamics are ubiquitous in social and economic systems. These claims emerge from the analysis of individually simple agents whose collective behavior is surprisingly complicated. However, economists have argued that iterated reasoning-what you think I think you think-will suppress complex dynamics by stabilizing or accelerating convergence to Nash equilibrium. We report stable and efficient periodic behavior in human groups playing the Mod Game, a multi-player game similar to Rock-Paper-Scissors. The game rewards subjects for thinking exactly one step ahead of others in their group. Groups that play this game exhibit cycles that are inconsistent with any fixed-point solution concept. These cycles are driven by a "hopping'' behavior that is consistent with other accounts of iterated reasoning: agents are constrained to about two steps of iterated reasoning and learn an additional one-half step with each session. If higher-order reasoning can be complicit in complex emergent dynamics, then cyclic and chaotic patterns may be endogenous features of real-world social and economic systems.	[Frey, Seth; Goldstone, Robert L.] Indiana Univ, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Frey, S (corresponding author), Indiana Univ, Bloomington, IN 47405 USA.	sethfrey@indiana.edu	Frey, Seth/AAF-8499-2021	Frey, Seth/0000-0002-5298-5089	National Science Foundation IGERT training grant in the Dynamics of Brain-Body-Environment Systems at Indiana University [0903495]; National Science Foundation REESE grant [0910218]; Department of Education IES grant [R305A1100060]	National Science Foundation IGERT training grant in the Dynamics of Brain-Body-Environment Systems at Indiana University; National Science Foundation REESE grant; Department of Education IES grant	This research was supported in part by National Science Foundation IGERT training grant 0903495 in the Dynamics of Brain-Body-Environment Systems at Indiana University, National Science Foundation REESE grant 0910218, and Department of Education IES grant R305A1100060. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2001, BEHAV ECOL SOCIOBIOL, V49, P176, DOI 10.1007/s002650000265; Bednar J, 2012, GAME ECON BEHAV, V74, P12, DOI 10.1016/j.geb.2011.06.009; BLOOMFIELD R, 1994, J ECON BEHAV ORGAN, V25, P411, DOI 10.1016/0167-2681(94)90108-2; Bottazzi G, 2007, J EVOL ECON, V17, P241, DOI 10.1007/s00191-006-0040-6; BROWN JN, 1990, ECONOMETRICA, V58, P1065, DOI 10.2307/2938300; Camerer C. F., 2002, COGNITIVE HIERACHY T, P1; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Camerer CF, 2002, J ECON THEORY, V104, P137, DOI 10.1006/jeth.2002.2927; Camerer CF, 2003, BEHAV GAME THEORY EX, p[270, 322]; Cason TN, 2005, J ECON DYN CONTROL, V29, P801, DOI 10.1016/j.jedc.2003.07.007; Cason TN, 2012, CYCLES INSTABILITY R; Costa-Gomes MA, 2009, J EUR ECON ASSOC, V7, P365, DOI 10.1162/JEEA.2009.7.2-3.365; Crawford VP, 2007, AM ECON REV, V97, P1731, DOI 10.1257/aer.97.5.1731; Crawford VP, 2007, ECONOMETRICA, V75, P1721, DOI 10.1111/j.1468-0262.2007.00810.x; Duffy J, 1997, ECON J, V107, P1684, DOI 10.1111/1468-0297.00250; Duffy J, 2005, GAME ECON BEHAV, V51, P31, DOI 10.1016/j.geb.2004.04.007; Eckert A, 2004, ANN REGIONAL SCI, V38, P25, DOI 10.1007/s00168-003-0144-y; Edgeworth F, 1925, ROYAL EC SOC, V2, P118; Frey S, 2011, 2011 P COGN SCI SOC; FUDENBERG D, 1993, GAME ECON BEHAV, V5, P320, DOI 10.1006/game.1993.1021; Galla T, 2011, ARXIV11094250; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Ho TH, 2011, DYNAMIC LEVEL K MODE; Hoffman M, 2012, EXPT TEST NASH EQUIL; Hommes CH, 2012, GAME ECON BEHAV, V74, P434, DOI 10.1016/j.geb.2011.05.014; JORDAN JS, 1993, GAME ECON BEHAV, V5, P368, DOI 10.1006/game.1993.1022; Kantz H., 2003, NONLINEAR TIME SERIE; Kawagoe T, 2012, J ECON BEHAV ORGAN, V82, P548, DOI 10.1016/j.jebo.2012.03.010; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; KLEINBERG R., 2011, S INN COMP SCI ICS; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; Nagel R, 1995, AM ECON REV, V85, P1313; Noel MD, 2007, REV ECON STAT, V89, P324, DOI 10.1162/rest.89.2.324; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; RAPOPORT A, 1992, J EXP PSYCHOL GEN, V121, P352, DOI 10.1037/0096-3445.121.3.352; Reichenbach T, 2008, J THEOR BIOL, V254, P368, DOI 10.1016/j.jtbi.2008.05.014; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Rubinstein A, 1993, NAIVE STRATEGIES ZER; Sato Y, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.015206; Sato Y, 2005, PHYSICA D, V210, P21, DOI 10.1016/j.physd.2005.06.031; Selten R, 1998, EUR ECON REV, V42, P413, DOI 10.1016/S0014-2921(97)00148-7; Selten Reinhard., 1991, GAME EQUILIBRIUM MOD, P98; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shapley L. S., 1964, ADV GAME THEORY; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; SMITH VL, 1993, ECON INQ, V31, P245, DOI 10.1111/j.1465-7295.1993.tb00881.x; Stahl DO, 2000, GAME ECON BEHAV, V32, P105, DOI 10.1006/game.1999.0754; Sumpter D, 2010, COLLECTIVE ANIMAL BE, P149; Tang FF, 2001, J ECON BEHAV ORGAN, V44, P221, DOI 10.1016/S0167-2681(00)00155-4; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Wilensky U., NETLOGO; Wilensky U, HUBNET; Winkler AA, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.060901; Zhang X, 2005, PRICE CYCLES ONLINE	59	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56416	10.1371/journal.pone.0056416	http://dx.doi.org/10.1371/journal.pone.0056416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092YP	23441191	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200048
J	Bartus, K; Pigott, B; Garthwaite, J				Bartus, Katalin; Pigott, Beatrice; Garthwaite, John			Cellular Targets of Nitric Oxide in the Hippocampus	PLOS ONE			English	Article							SOLUBLE GUANYLYL CYCLASE; LONG-TERM POTENTIATION; CYCLIC-GMP; SPECIES-DIFFERENCES; GABAERGIC SYNAPSES; RAT-BRAIN; CGMP; RECEPTOR; LOCALIZATION; NO	In the hippocampus, as in many other CNS areas, nitric oxide (NO) participates in synaptic plasticity, manifested as changes in pre- and/or postsynaptic function. While it is known that these changes are brought about by cGMP following activation of guanylyl cyclase-coupled NO receptors attempts to locate cGMP by immunocytochemistry in hippocampal slices in response to NO have failed to detect the cGMP elevation where expected, i.e. in the pyramidal neurones. Instead, astrocytes, unidentified varicose fibres and GABA-ergic nerve terminals are reported to be the prominent NO targets, raising the possibility that NO acts indirectly via other cells. We have re-investigated the distribution of cGMP generated in response to endogenous and exogenous NO in hippocampal slices using immunohistochemistry and new conditions designed to optimise cGMP accumulation and, hence, its detectability. The conditions included use of tissue from the developing rat hippocampus, a potent inhibitor of phosphodiesterase-2, and an allosteric enhancer of the NO-receptive guanylyl cyclase. Under these conditions, cGMP was formed in response to endogenous NO and was found in a population of pyramidal cell somata in area CA3 and subiculum as well as in structures described previously. The additional presence of exogenous NO resulted in hippocampal cGMP reaching the highest level recorded for brain tissue (1700 pmol/mg protein) and in cGMP immunolabelling throughout the pyramidal cell layer. Populations of axons and interneurones were also stained. According with these results, immunohistochemistry for the common NO receptor beta 1-subunit indicated widespread expression. A similar staining pattern for the alpha 1-subunit with an antibody used previously in the hippocampus and elsewhere, however, proved to be artefactual. The results indicate that the targets of NO in the hippocampus are more varied and extensive than previous evidence had suggested and, in particular, that the pyramidal neurones participating in NO-dependent synaptic plasticity are direct NO targets.	[Bartus, Katalin; Pigott, Beatrice; Garthwaite, John] UCL, Wolfson Inst Biomed Res, London, England	University of London; University College London	Garthwaite, J (corresponding author), UCL, Wolfson Inst Biomed Res, London, England.	john.garthwaite@ucl.ac.uk			Wellcome Trust [081512/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Funded by The Wellcome Trust (grant number 081512/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; Arancio O, 2001, J NEUROSCI, V21, P143, DOI 10.1523/JNEUROSCI.21-01-00143.2001; Bellamy TC, 2001, MOL PHARMACOL, V59, P54, DOI 10.1124/mol.59.1.54; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; BOULTON CL, 1994, EUR J NEUROSCI, V6, P1528, DOI 10.1111/j.1460-9568.1994.tb00543.x; Burette A, 2002, J NEUROSCI, V22, P8961; Cserep C, 2011, CEREB CORTEX, V21, P2065, DOI 10.1093/cercor/bhq281; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; deVente J, 1996, J CHEM NEUROANAT, V10, P241, DOI 10.1016/0891-0618(95)00144-1; Ding JD, 2004, J COMP NEUROL, V472, P437, DOI 10.1002/cne.20054; EAST SJ, 1991, NEUROSCI LETT, V123, P17, DOI 10.1016/0304-3940(91)90147-L; Feil Robert, 2008, V184, P529; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Friebe A, 2009, NITRIC OXIDE-BIOL CH, V21, P149, DOI 10.1016/j.niox.2009.07.004; Fukutani T, 2009, ARCH HISTOL CYTOL, V72, P117, DOI 10.1679/aohc.72.117; GARTHWAITE G, 1989, J NEUROSCI METH, V29, P33, DOI 10.1016/0165-0270(89)90106-4; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gibb BJ, 2001, EUR J NEUROSCI, V13, P539, DOI 10.1046/j.1460-9568.2001.01421.x; Hall CN, 2006, J PHYSIOL-LONDON, V577, P549, DOI 10.1113/jphysiol.2006.118380; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Huang RH, 2007, EXP BIOL MED, V232, P118; Iino S, 2008, NEUROSCIENCE, V152, P437, DOI 10.1016/j.neuroscience.2007.12.044; Lin DTS, 2010, SYNAPSE, V64, P460, DOI 10.1002/syn.20750; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Lu YF, 1999, J NEUROSCI, V19, P10250; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Makara JK, 2007, J NEUROSCI, V27, P10211, DOI 10.1523/JNEUROSCI.2104-07.2007; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Mo E, 2004, J BIOL CHEM, V279, P26149, DOI 10.1074/jbc.M400916200; Mullershausen F, 2001, J CELL BIOL, V155, P271, DOI 10.1083/jcb.200107001; Neitz A, 2011, EUR J NEUROSCI, V33, P1611, DOI 10.1111/j.1460-9568.2011.07654.x; Pifarre P, 2007, J COMP NEUROL, V500, P942, DOI 10.1002/cne.21241; Roy B, 2008, J BIOL CHEM, V283, P18841, DOI 10.1074/jbc.M801712200; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Szabadits E, 2007, J NEUROSCI, V27, P8101, DOI 10.1523/JNEUROSCI.1912-07.2007; Szabadits E, 2011, J NEUROSCI, V31, P5893, DOI 10.1523/JNEUROSCI.5938-10.2011; Tanaka J, 1997, GLIA, V19, P286; Taqatqeh F, 2009, J NEUROSCI, V29, P9344, DOI 10.1523/JNEUROSCI.1902-09.2009; van Langen J, 2012, EUR J PHARMACOL, V696, P111, DOI 10.1016/j.ejphar.2012.09.016; van Staveren WCG, 2005, BRAIN RES, V1036, P77, DOI 10.1016/j.brainres.2004.12.040; van Staveren WCG, 2004, EUR J NEUROSCI, V19, P2155, DOI 10.1111/j.0953-816X.2004.03327.x; van Staveren WCG, 2003, J COMP NEUROL, V467, P566, DOI 10.1002/cne.10955; van Staveren WCG, 2001, BRAIN RES, V888, P275, DOI 10.1016/S0006-8993(00)03081-X; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Wilson GW, 2010, EUR J NEUROSCI, V31, P1935, DOI 10.1111/j.1460-9568.2010.07226.x; Wood KC, 2011, J BIOL CHEM, V286, P43172, DOI 10.1074/jbc.M111.289777	54	25	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57292	10.1371/journal.pone.0057292	http://dx.doi.org/10.1371/journal.pone.0057292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451200	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500085
J	Elliott, JA; Abdulhadi, NN; Al-Maniri, AA; Al-Shafaee, MA; Wahlstrom, R				Elliott, James A.; Abdulhadi, Nadia Noor; Al-Maniri, Abdullah A.; Al-Shafaee, Mohammed A.; Wahlstrom, Rolf			Diabetes Self-Management and Education of People Living with Diabetes: A Survey in Primary Health Care in Muscat Oman	PLOS ONE			English	Article							DISEASE; PREVALENCE; KNOWLEDGE; MELLITUS; ILLNESS	Background: Although the prevalence of type 2 diabetes in Oman is high and rising, information on how people were self-managing their disease has been lacking. The objective of this study was therefore to assess diabetes self-management and education (DSME) among people living with type 2 diabetes in Oman. Methods: A questionnaire survey was conducted in public primary health care centres in Muscat. Diabetes self-management and education was assessed by asking how patients recognized and responded to hypo- and hyperglycaemia, and if they had developed strategies to maintain stable blood glucose levels. Patients' demographic information, self-treatment behaviours, awareness of potential long-term complications, and attitudes concerning diabetes management were also recorded. Associations between these factors and diabetes self-management and education were analysed. Results: In total, 309 patients were surveyed. A quarter (26%, n = 83) were unaware how to recognize hypoglycaemia or respond to it (26%, n = 81). Around half (49%, n = 151), could not recognize hyperglycaemia and more than half could not respond to it (60%, n = 184). Twelve percent (n = 37) of the patients did not have any strategies to stabilize their blood glucose levels. Patients with formal education generally had more diabetes self-management and education than those without (p<0.001), as had patients with longer durations of diabetes (p<0.01). Self-monitoring of blood glucose was practiced by 38% (n = 117) of the patients, and insulin was used by 22% (n = 67), of which about one third independently adjusted dosages. Patients were most often aware of complications concerning loss of vision, renal failure and cardiac problems. Many patients desired further health education. Conclusions: Many patients displayed dangerous diabetes self-management and education knowledge gaps. The findings suggest a need for improving knowledge transfer to people living with diabetes in the Omani clinical setting.	[Elliott, James A.; Abdulhadi, Nadia Noor; Wahlstrom, Rolf] Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden; [Abdulhadi, Nadia Noor] Minist Hlth, Dept Hlth Affairs, Muscat, Oman; [Al-Maniri, Abdullah A.; Al-Shafaee, Mohammed A.] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Family Med & Publ Hlth, Muscat, Oman; [Wahlstrom, Rolf] Uppsala Univ, Dept Publ Hlth & Caring Sci Family Med & Clin Epi, Uppsala, Sweden	Karolinska Institutet; Sultan Qaboos University; Uppsala University	Abdulhadi, NN (corresponding author), Karolinska Inst, Div Global Hlth, Dept Publ Hlth Sci, Stockholm, Sweden.	nadia.abdulhadi@ki.se		Elliott, James/0000-0001-7150-6074; Al Shafaee, Mohammed/0000-0002-4816-1706	Ministry of Health, Oman; Karolinska Institutet, Sweden; Sultan Qaboos University in Oman	Ministry of Health, Oman; Karolinska Institutet, Sweden(Karolinska Institutet); Sultan Qaboos University in Oman	Funding provided by Ministry of Health, Oman; Karolinska Institutet, Sweden (www.ki.se) and Sultan Qaboos University in Oman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhadi N., 2006, BMC Family Practice, V7; Al Shafaee MA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-249; Al-Lawati JA, 2002, DIABETIC MED, V19, P954, DOI 10.1046/j.1464-5491.2002.00818.x; Al-Lawati Jawad A, 2008, Prev Chronic Dis, V5, pA99; Al-Moosa Siba, 2006, Popul Health Metr, V4, P5, DOI 10.1186/1478-7954-4-5; Al-Shafaee Mohammed Ali, 2008, Metabolic Syndrome and Related Disorders, V6, P275, DOI 10.1089/met.2008.0019; Al-Shahib W, 2003, INT J FOOD SCI NUTR, V54, P247, DOI [10.1080/09637480120091982, 10.1080/096374803766666120]; Assal J P, 1995, Pharmacoeconomics, V8 Suppl 1, P68; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Fitzner K, 2008, POPUL HEALTH MANAG, V11, P329, DOI 10.1089/pop.2008.0012; Funnell Martha M, 2004, Crit Care Nurs Q, V27, P201; Funnell MM, 2002, AM J PREV MED, V22, P3, DOI 10.1016/S0749-3797(02)00431-2; Ganguly S S, 2009, East Mediterr Health J, V15, P209; Hjelm K, 2003, INT J NURS STUD, V40, P627, DOI 10.1016/S0020-7489(03)00020-8; Holmstrom IM, 2005, J ADV NURS, V49, P146, DOI 10.1111/j.1365-2648.2004.03274.x; Insight Guides, 2009, OMAN UAE; Kendall DM, 2001, AM J MANAG CARE, V7, pS327; Krosnick JA, 2010, HANDBOOK OF SURVEY RESEARCH, 2ND EDITION, P263; Lawrence P, 2001, J Transcult Nurs, V12, P228, DOI 10.1177/104365960101200307; Marrero David G, 2007, Clin Cornerstone, V8, P33; Ministry of Health Sultanate of Oman, 2003, DIAB MELL MAN GUID P; Ministry of Health Sultanate of Oman, 2008, WORLD HLTH SURV; Ministry of Information Sultanate of Oman, 2002, TRAD MOD; National Diabetes Information Clearinghouse, 2011, NAT DIAB STAT 2011; National Diabetes Information Clearinghouse, 2008, HYP; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Otero LM, 2008, REV LAT-AM ENFERM, V16, P231, DOI 10.1590/S0104-11692008000200010; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Rothman RL, 2005, DIABETES EDUCATOR, V31, P215, DOI 10.1177/0145721705275002; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sidorov J, 2002, DIABETES CARE, V25, P684, DOI 10.2337/diacare.25.4.684; Thompson DM, 1999, CAN MED ASSOC J, V161, P959; Travaline JM, 2005, J AM OSTEOPATH ASSOC, V105, P13; United Nations Development Program, 2010, 40 YEAR TRENDS AN SH; Urbanski P, 2008, J AM DIET ASSOC, V108, pS6, DOI 10.1016/j.jada.2008.01.019; Veg A, 2006, J ADV NURS, V56, P44, DOI 10.1111/j.1365-2648.2006.03978.x; Weiss BD, 2009, HLTH LIT PATIENT SAF, P1; Westphal SA, 2010, ENDOCR PRACT, V16, P506, DOI 10.4158/EP09344.RA; White J.R., 2003, CLIN DIABETES, V21, P14; WHO, 2010, COUNTR COOP STRAT WH	40	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57400	10.1371/journal.pone.0057400	http://dx.doi.org/10.1371/journal.pone.0057400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451219	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800104
J	Ku, ZQ; Ye, XH; Huang, XL; Cai, YC; Liu, QW; Li, Y; Su, ZG; Huang, Z				Ku, Zhiqiang; Ye, Xiaohua; Huang, Xulin; Cai, Yicun; Liu, Qingwei; Li, Yan; Su, Zhiguo; Huang, Zhong			Neutralizing Antibodies Induced by Recombinant Virus-Like Particles of Enterovirus 71 Genotype C4 Inhibit Infection at Pre- and Post-attachment Steps	PLOS ONE			English	Article							MOUTH-DISEASE; VP1 PROTEIN; MICE; HAND; IMMUNIZATION; VACCINE; LETHAL; IDENTIFICATION; CHALLENGE; OUTBREAK	Background: Enterovirus 71 (EV71) is a major causative agent of hand, foot and mouth disease, which has been prevalent in Asia-Pacific regions, causing significant morbidity and mortality in young children. Antibodies elicited by experimental EV71 vaccines could neutralize infection in vitro and passively protect animal models from lethal challenge, indicating that neutralizing antibodies play an essential role in protection. However, how neutralizing antibodies inhibit infection in vitro remains unclear. Methods/Findings: In the present study, we explored the mechanisms of neutralization by antibodies against EV71 virus-like particles (VLPs). Recombinant VLPs of EV71 genotype C4 were produced in insect cells using baculovirus vectors. Immunization with the VLPs elicited a high-titer, EV71-specific antibody response in mice. Anti-VLP mouse sera potently neutralized EV71 infection in vitro. The neutralizing antibodies in the anti-VLP mouse sera were found to target mainly an extremely conserved epitope (FGEHKQEKDLEYGAC) located at the GH loop of the VP1 protein. The neutralizing anti-VLP antisera were able to inhibit virus binding to target cells efficiently. In addition, post-attachment treatment of virus-bound cells with the anti-VLP antisera also neutralized virus infection, although the antibody concentration required was higher than that of the pre-attachment treatment. Conclusions: Collectively, our findings represent a valuable addition to the understanding of mechanisms of EV71 neutralization and have strong implications for EV71 vaccine development.	[Ku, Zhiqiang; Ye, Xiaohua; Huang, Xulin; Cai, Yicun; Liu, Qingwei; Huang, Zhong] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Yan; Su, Zhiguo] Chinese Acad Sci, Natl Key Lab Biochem Engn, Inst Proc Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Institute of Process Engineering, CAS	Huang, Z (corresponding author), Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	huangzhong@ips.ac.cn	Ku, Zhiqiang/D-9283-2018; Ye, Xiaohua/U-6501-2017	Ku, Zhiqiang/0000-0001-8347-0013; Ye, Xiaohua/0000-0002-2300-4739; Huang, Zhong/0000-0002-2161-1359	Chinese Academy of Sciences "100 Talents" program [KSCX2-YW-BR-2]; Open Funding Project of the National Key Laboratory of Biochemical Engineering [2010KF-07]	Chinese Academy of Sciences "100 Talents" program(Chinese Academy of Sciences); Open Funding Project of the National Key Laboratory of Biochemical Engineering	This work was supported by a grant (#KSCX2-YW-BR-2) from the Chinese Academy of Sciences "100 Talents" program and a grant (#2010KF-07) from the Open Funding Project of the National Key Laboratory of Biochemical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen HF, 2006, VACCINE, V24, P2944, DOI 10.1016/j.vaccine.2005.12.047; Chen HL, 2008, VACCINE, V26, P2882, DOI 10.1016/j.vaccine.2008.03.041; Chung CY, 2010, VACCINE, V28, P6951, DOI 10.1016/j.vaccine.2010.08.052; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Feng Yan-fang, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P535; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Ku Z, 2012, J VIROL METHODS; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Liu QW, 2012, VACCINE, V30, P6642, DOI 10.1016/j.vaccine.2012.08.071; Liu QW, 2011, J VIROL METHODS, V173, P115, DOI 10.1016/j.jviromet.2011.01.016; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Plevka P, 2012, SCIENCE, V336, P1274, DOI 10.1126/science.1218713; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ryu WS, 2010, EMERG INFECT DIS, V16, P1764, DOI 10.3201/eid1611.100104; Tran Chau Bich Nguyen, 2011, PLoS One, V6, pe21116, DOI 10.1371/journal.pone.0021116; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	27	59	66	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57601	10.1371/journal.pone.0057601	http://dx.doi.org/10.1371/journal.pone.0057601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451250	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800113
J	Lau, E; Fisher, MC; Steudler, PA; Cavanaugh, CM				Lau, Evan; Fisher, Meredith C.; Steudler, Paul A.; Cavanaugh, Colleen M.			The Methanol Dehydrogenase Gene, mxaF, as a Functional and Phylogenetic Marker for Proteobacterial Methanotrophs in Natural Environments	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; SP NOV.; ACIDOPHILIC BACTERIUM; ATMOSPHERIC METHANE; ANAEROBIC OXIDATION; MUSSELS; BIOGEOGRAPHY; CONGRUENCE; METABOLISM; MYTILIDAE	The mxaF gene, coding for the large (a) subunit of methanol dehydrogenase, is highly conserved among distantly related methylotrophic species in the Alpha-, Beta- and Gammaproteobacteria. It is ubiquitous in methanotrophs, in contrast to other methanotroph-specific genes such as the pmoA and mmoX genes, which are absent in some methanotrophic proteobacterial genera. This study examined the potential for using the mxaF gene as a functional and phylogenetic marker for methanotrophs. mxaF and 16S rRNA gene phylogenies were constructed based on over 100 database sequences of known proteobacterial methanotrophs and other methylotrophs to assess their evolutionary histories. Topology tests revealed that mxaF and 16S rDNA genes of methanotrophs do not show congruent evolutionary histories, with incongruencies in methanotrophic taxa in the Methylococcaceae, Methylocystaceae, and Beijerinckiacea. However, known methanotrophs generally formed coherent clades based on mxaF gene sequences, allowing for phylogenetic discrimination of major taxa. This feature highlights the mxaF gene's usefulness as a biomarker in studying the molecular diversity of proteobacterial methanotrophs in nature. To verify this, PCR-directed assays targeting this gene were used to detect novel methanotrophs from diverse environments including soil, peatland, hydrothermal vent mussel tissues, and methanotroph isolates. The placement of the majority of environmental mxaF gene sequences in distinct methanotroph-specific clades (Methylocystaceae and Methylococcaceae) detected in this study supports the use of mxaF as a biomarker for methanotrophic proteobacteria.	[Lau, Evan] W Liberty Univ, Dept Nat Sci & Math, W Liberty, WV USA; [Lau, Evan; Fisher, Meredith C.; Cavanaugh, Colleen M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Steudler, Paul A.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	Harvard University; Marine Biological Laboratory - Woods Hole	Lau, E (corresponding author), W Liberty Univ, Dept Nat Sci & Math, W Liberty, WV USA.	evanlau28@gmail.com		Lau, Evan/0000-0002-7434-4362	U.S. National Science Foundation Ecosystems Studies program [DEB9708092, DEB0089738]	U.S. National Science Foundation Ecosystems Studies program	This work was supported in part by grants from the U.S. National Science Foundation Ecosystems Studies program (awards # DEB9708092 and DEB0089738). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anthony C, 2004, ARCH BIOCHEM BIOPHYS, V428, P2, DOI 10.1016/j.abb.2004.03.038; Anthony C, 2000, Subcell Biochem, V35, P73; Auman AJ, 2000, APPL ENVIRON MICROB, V66, P5259, DOI 10.1128/AEM.66.12.5259-5266.2000; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Berestovskaya JJ, 2012, INT J SYST EVOL MICR, V62, P638, DOI 10.1099/ijs.0.007005-0; Buckley TR, 2002, SYST BIOL, V51, P4, DOI 10.1080/106351502753475844; Chen Y, 2010, J BACTERIOL, V192, P3840, DOI 10.1128/JB.00506-10; Chistoserdova L, 2011, ENVIRON MICROBIOL, V13, P2603, DOI 10.1111/j.1462-2920.2011.02464.x; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; DeChaine EG, 2006, ENVIRON MICROBIOL, V8, P1902, DOI 10.1111/j.1462-2920.2005.01113.x; Dedysh SN, 2005, J BACTERIOL, V187, P3884, DOI 10.1128/JB.187.11.3884-3888.2005; Dedysh SN, 2002, INT J SYST EVOL MICR, V52, P251, DOI 10.1099/00207713-52-1-251; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; Dlugokencky EJ, 2011, PHILOS T R SOC A, V369, P2058, DOI 10.1098/rsta.2010.0341; Dunfield PF, 2007, NATURE, V450, P879, DOI 10.1038/nature06411; Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; Ettwig KF, 2010, NATURE, V464, P543, DOI 10.1038/nature08883; Fuse H, 1998, BIOSCI BIOTECH BIOCH, V62, P1925, DOI 10.1271/bbb.62.1925; Gulledge J, 2004, FEMS MICROBIOL ECOL, V49, P389, DOI 10.1016/j.femsec.2004.04.013; Gulledge J, 2001, APPL ENVIRON MICROB, V67, P4726, DOI 10.1128/AEM.67.10.4726-4733.2001; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Heyer J, 2002, MICROBIOL-SGM, V148, P2831, DOI 10.1099/00221287-148-9-2831; Hipp AL, 2004, SYST BIOL, V53, P81, DOI 10.1080/10635150490264752; Hou SB, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-26; Kalyuzhnaya MG, 2008, J BACTERIOL, V190, P3817, DOI 10.1128/JB.00180-08; Keitel T, 2000, J MOL BIOL, V297, P961, DOI 10.1006/jmbi.2000.3603; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Lau E, 2007, FEMS MICROBIOL ECOL, V60, P490, DOI 10.1111/j.1574-6941.2007.00308.x; Lidstrom ME, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P618, DOI 10.1007/0-387-30742-7_20; LIDSTROM ME, 1994, FEMS MICROBIOL LETT, V117, P103, DOI 10.1111/j.1574-6968.1994.tb06749.x; Luesken FA, 2012, ENVIRON MICROBIOL, V14, P1024, DOI 10.1111/j.1462-2920.2011.02682.x; MARIN LE, 1990, BIOGEOCHEMISTRY, V11, P63; McDonald IR, 2008, APPL ENVIRON MICROB, V74, P1305, DOI 10.1128/AEM.02233-07; McDonald IR, 1997, APPL ENVIRON MICROB, V63, P3218, DOI 10.1128/AEM.63.8.3218-3224.1997; MCDONALD IR, 1995, APPL ENVIRON MICROB, V61, P116, DOI 10.1128/AEM.61.1.116-121.1995; Nauhaus K, 2007, ENVIRON MICROBIOL, V9, P187, DOI 10.1111/j.1462-2920.2006.01127.x; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; Op den Camp HJM, 2009, ENV MICROBIOL REP, V1, P293, DOI 10.1111/j.1758-2229.2009.00022.x; Petersen J. E., 2009, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Schmidt S, 2010, MICROBIOL-SGM, V156, P2575, DOI 10.1099/mic.0.038570-0; Stewart FJ, 2005, TRENDS MICROBIOL, V13, P439, DOI 10.1016/j.tim.2005.07.007; Struck TH, 2006, SYST BIOL, V55, P1, DOI 10.1080/10635150500354910; Suzuki R, 2009, J GEN APPL MICROBIOL, V55, P101, DOI 10.2323/jgam.55.101; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Vorob'ev AV, 2009, INT J SYST EVOL MICR, V59, P2538, DOI 10.1099/ijs.0.010074-0; Vorobev AV, 2011, INT J SYST EVOL MICR, V61, P2456, DOI 10.1099/ijs.0.028118-0; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Whittenbury R, 1970, J GEN MICROBIOL, V59, P2771; Wick LY, 1998, ENVIRON SCI TECHNOL, V32, P1319, DOI 10.1021/es970544+; Won YJ, 2003, APPL ENVIRON MICROB, V69, P6785, DOI 10.1128/AEM.69.11.6785-6792.2003; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2; Wu ML, 2011, BIOCHEM SOC T, V39, P243, DOI 10.1042/BST0390243; Zhang M, 2003, MICROBIOL-SGM, V149, P1033, DOI 10.1099/mic.0.26105-0	59	33	33	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56993	10.1371/journal.pone.0056993	http://dx.doi.org/10.1371/journal.pone.0056993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451130	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800060
J	Zhang, B; McDaniel, SS; Rensing, NR				Zhang, Bo; McDaniel, Sharon S.; Rensing, Nicholas R.			Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex	PLOS ONE			English	Article							MAMMALIAN TARGET; ANTIEPILEPTIC DRUGS; REFRACTORY EPILEPSY; INFANTILE SPASMS; NATURAL-HISTORY; METABOLISM; ASTROCYTES; THERAPY	Epilepsy is a common neurological disorder and cause of significant morbidity and mortality. Although antiseizure medication is the first-line treatment for epilepsy, currently available medications are ineffective in a significant percentage of patients and have not clearly been demonstrated to have disease-specific effects for epilepsy. While seizures are usually intractable to medication in tuberous sclerosis complex (TSC), a common genetic cause of epilepsy, vigabatrin appears to have unique efficacy for epilepsy in TSC. While vigabatrin increases gamma-aminobutyric acid (GABA) levels, the precise mechanism of action of vigabatrin in TSC is not known. In this study, we investigated the effects of vigabatrin on epilepsy in a knock-out mouse model of TSC and tested the novel hypothesis that vigabatrin inhibits the mammalian target of rapamycin (mTOR) pathway, a key signaling pathway that is dysregulated in TSC. We found that vigabatrin caused a modest increase in brain GABA levels and inhibited seizures in the mouse model of TSC. Furthermore, vigabatrin partially inhibited mTOR pathway activity and glial proliferation in the knock-out mice in vivo, as well as reduced mTOR pathway activation in cultured astrocytes from both knock-out and control mice. This study identifies a potential novel mechanism of action of an antiseizure medication involving the mTOR pathway, which may account for the unique efficacy of this drug for a genetic epilepsy.	[Rensing, Nicholas R.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Rensing, NR (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wong_m@wustl.edu			National Institutes of Health [R01 NS056872, P20 NS080199, NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105, R01NS056872, P20NS080199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (R01 NS056872 and P20 NS080199 to M.W.; NIH Neuroscience Blueprint Core Grant NS057105 to Washington University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Menachem E, 2011, ACTA NEUROL SCAND, V124, P5, DOI 10.1111/j.1600-0404.2011.01596.x; Bombardieri R, 2010, EUR J PAEDIATR NEURO, V14, P146, DOI 10.1016/j.ejpn.2009.03.003; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo P, 2001, BRAIN DEV-JPN, V23, P649, DOI 10.1016/S0387-7604(01)00290-X; Elger CE, 2008, EPILEPSY BEHAV, V12, P501, DOI 10.1016/j.yebeh.2008.01.003; Erbayat-Altay E, 2007, EPILEPSIA, V48, P1470, DOI 10.1111/j.1528-1167.2007.01110.x; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; French JA, 2007, EPILEPSIA, V48, P3, DOI 10.1111/j.1528-1167.2007.00992.x; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Hancock E, 1999, J CHILD NEUROL, V14, P71, DOI 10.1177/088307389901400201; HERTZ E, 1986, NEUROPHARMACOLOGY, V25, P533, DOI 10.1016/0028-3908(86)90180-2; HERTZ L, 1980, CAN J PHYSIOL PHARM, V58, P217, DOI 10.1139/y80-036; Holmes GL, 2007, EPILEPSIA, V48, P617, DOI 10.1111/j.1528-1167.2007.01035.x; Jozwiak S, 2011, EUR J PAEDIATR NEURO, V15, P424, DOI 10.1016/j.ejpn.2011.03.010; JUNG MJ, 1977, J NEUROCHEM, V29, P797, DOI 10.1111/j.1471-4159.1977.tb10721.x; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Overstreet LS, 2001, J NEUROPHYSIOL, V86, P596, DOI 10.1152/jn.2001.86.2.596; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; SCHULZ DW, 1981, BRAIN RES, V209, P177, DOI 10.1016/0006-8993(81)91179-3; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Willmore LJ, 2009, EPILEPSIA, V50, P163, DOI 10.1111/j.1528-1167.2008.01988.x; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; Wu YM, 2001, J NEUROSCI, V21, P2630, DOI 10.1523/JNEUROSCI.21-08-02630.2001; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2007, NEUROBIOL DIS, V28, P184, DOI 10.1016/j.nbd.2007.07.015; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5; Zhang B, 2012, EPILEPSIA, V53, P506, DOI 10.1111/j.1528-1167.2011.03384.x	35	75	77	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57445	10.1371/journal.pone.0057445	http://dx.doi.org/10.1371/journal.pone.0057445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437388	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200256
J	D'Armiento, JM; Goldklang, MP; Hardigan, AA; Geraghty, P; Roth, MD; Connett, JE; Wise, RA; Sciurba, FC; Scharf, SM; Thankachen, J; Islam, M; Ghio, AJ; Foronjy, RF				D'Armiento, Jeanine M.; Goldklang, Monica P.; Hardigan, Andrew A.; Geraghty, Patrick; Roth, Michael D.; Connett, John E.; Wise, Robert A.; Sciurba, Frank C.; Scharf, Steven M.; Thankachen, Jincy; Islam, Monirul; Ghio, Andrew J.; Foronjy, Robert F.			Increased Matrix Metalloproteinase (MMPs) Levels Do Not Predict Disease Severity or Progression in Emphysema	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SMOKE-INDUCED EMPHYSEMA; ADULT-ONSET EMPHYSEMA; CIGARETTE-SMOKE; ALVEOLAR MACROPHAGES; LUNG-FUNCTION; MATRIX-METALLOPROTEINASE-9; EXPRESSION; COPD; MICE	Rationale: Though matrix metalloproteinases (MMPs) are critical in the pathogenesis of COPD, their utility as a disease biomarker remains uncertain. This study aimed to determine whether bronchoalveolar lavage (BALF) or plasma MMP measurements correlated with disease severity or functional decline in emphysema. Methods: Enzyme-linked immunosorbent assay and luminex assays measured MMP-1, -9, -12 and tissue inhibitor of matrix metalloproteinase-1 in the BALF and plasma of non-smokers, smokers with normal lung function and moderate-to-severe emphysema subjects. In the cohort of 101 emphysema subjects correlative analyses were done to determine if MMP or TIMP-1 levels were associated with key disease parameters or change in lung function over an 18-month time period. Main Results: Compared to non-smoking controls, MMP and TIMP-1 BALF levels were significantly elevated in the emphysema cohort. Though MMP-1 was elevated in both the normal smoker and emphysema groups, collagenase activity was only increased in the emphysema subjects. In contrast to BALF, plasma MMP-9 and TIMP-1 levels were actually decreased in the emphysema cohort compared to the control groups. Both in the BALF and plasma, MMP and TIMP-1 measurements in the emphysema subjects did not correlate with important disease parameters and were not predictive of subsequent functional decline. Conclusions: MMPs are altered in the BALF and plasma of emphysema; however, the changes in MMPs correlate poorly with parameters of disease intensity or progression. Though MMPs are pivotal in the pathogenesis of COPD, these findings suggest that measuring MMPs will have limited utility as a prognostic marker in this disease.	[D'Armiento, Jeanine M.; Goldklang, Monica P.; Thankachen, Jincy; Islam, Monirul] Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Hardigan, Andrew A.; Geraghty, Patrick; Foronjy, Robert F.] St Lukes Roosevelt Hlth Sci Ctr, Div Pulm & Crit Care Med, New York, NY 10032 USA; [Roth, Michael D.] Univ Calif Los Angeles, Div Pulm & Crit Care Med, Los Angeles, CA USA; [Connett, John E.] Univ Minnesota, Dept Biostat CCBR, St Paul, MN USA; [Wise, Robert A.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Baltimore, MD USA; [Sciurba, Frank C.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Scharf, Steven M.] Univ Maryland, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Ghio, Andrew J.] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; University of California System; University of California Los Angeles; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; United States Environmental Protection Agency	Foronjy, RF (corresponding author), St Lukes Roosevelt Hlth Sci Ctr, Div Pulm & Crit Care Med, New York, NY 10032 USA.	rforonjy@chpnet.org	Sciurba, Frank/AAZ-9339-2021	sciurba, frank/0000-0001-7468-2225; Geraghty, Patrick/0000-0003-1647-5505; Wise, Robert/0000-0002-8353-2349; Goldklang, Monica/0000-0002-7019-3130	National Institutes of Health [HL086936-04, 5R01HL098528-04]; Flight Attendant Medical Research Institute [074047]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086936, R01HL098528, T32HL007343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL086936-04, 5R01HL098528-04) and the Flight Attendant Medical Research Institute (Clinical Innovator Award 074047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Atkinson JJ, 2011, AM J RESP CRIT CARE, V183, P876, DOI 10.1164/rccm.201005-0718OC; BIETH J, 1974, BIOCHEM MED METAB B, V11, P350, DOI 10.1016/0006-2944(74)90134-3; Boedeker KL, 2004, RADIOLOGY, V232, P295, DOI 10.1148/radiol.2321030383; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; Croxton TL, 2003, AM J RESP CRIT CARE, V167, P1142, DOI 10.1164/rccm.200207-756WS; D'Armiento JM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-113; FEINSTEIN G, 1973, BIOCHEM BIOPH RES CO, V50, P1020, DOI 10.1016/0006-291X(73)91508-8; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; Foronjy RF, 2003, AM J PHYSIOL-LUNG C, V284, pL727, DOI 10.1152/ajplung.00349.2002; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Haq I, 2011, THORAX, V66, P970, DOI 10.1136/thx.2011.159087; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Huang YL, 2008, J TOXICOL ENV HEAL A, V71, P1490, DOI 10.1080/15287390802350030; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Ilumets Helen, 2007, Int J Chron Obstruct Pulmon Dis, V2, P369; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Ito I, 2005, AM J RESP CRIT CARE, V172, P1378, DOI 10.1164/rccm.200506-953OC; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Lee SY, 2010, RESPIRATION, V80, P133, DOI 10.1159/000284926; MANDL I, 1953, J CLIN INVEST, V32, P1323, DOI 10.1172/JCI102861; MOORE S, 1948, FED PROC, V7, P174; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Navratilova Z, 2012, RESPIROLOGY; Ohnishi K, 1998, LAB INVEST, V78, P1077; Rajendrasozhan S, 2010, AM J PHYSIOL-LUNG C, V298, pL197, DOI 10.1152/ajplung.00265.2009; Roth MD, 2006, CHEST, V130, P1334, DOI 10.1378/chest.130.5.1334; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Shiomi T, 2001, EXP LUNG RES; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789; Zucker S, 2004, ADV CLIN CHEM, V38, P37, DOI 10.1016/S0065-2423(04)38002-9	37	41	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56352	10.1371/journal.pone.0056352	http://dx.doi.org/10.1371/journal.pone.0056352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441181	Green Published, Green Accepted, gold			2022-12-25	WOS:000315159200038
J	Hairston, WD; Letowski, TR; McDowell, K				Hairston, W. David; Letowski, Tomasz R.; McDowell, Kaleb			Task-Related Suppression of the Brainstem Frequency following Response	PLOS ONE			English	Article							AUDITORY SELECTIVE ATTENTION; EVOKED-POTENTIALS; INFERIOR COLLICULUS; MUSICAL EXPERIENCE; VISUAL-CORTEX; SPEECH; MODULATION; PITCH; STIMULI; DEACTIVATION	Recent evidence has shown top-down modulation of the brainstem frequency following response (FFR), generally in the form of signal enhancement from concurrent stimuli or from switching between attention-demanding task stimuli. However, it is also possible that the opposite may be true - the addition of a task, instead of a resting, passive state may suppress the FFR. Here we examined the influence of a subsequent task, and the relevance of the task modality, on signal clarity within the FFR. Participants performed visual and auditory discrimination tasks in the presence of an irrelevant background sound, as well as a baseline consisting of the same background stimuli in the absence of a task. FFR pitch strength and amplitude of the primary frequency response were assessed within non-task stimulus periods in order to examine influences due solely to general cognitive state, independent of stimulus-driven effects. Results show decreased signal clarity with the addition of a task, especially within the auditory modality. We additionally found consistent relationships between the extent of this suppressive effect and perceptual measures such as response time and proclivity towards one sensory modality. Together these results suggest that the current focus of attention can have a global, top-down effect on the quality of encoding early in the auditory pathway.	[Hairston, W. David; Letowski, Tomasz R.; McDowell, Kaleb] USA, Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL)	Hairston, WD (corresponding author), USA, Res Lab, Human Res & Engn Directorate, Aberdeen Proving Ground, MD USA.	William.d.hairston4.civ@mail.mil		Hairston, W. David/0000-0003-4432-8430				Ahveninen J, 2011, P NATL ACAD SCI USA, V108, P4182, DOI 10.1073/pnas.1016134108; Akhoun I, 2008, CLIN NEUROPHYSIOL, V119, P922, DOI 10.1016/j.clinph.2007.12.010; Alain C, 2008, CURR OPIN OTOLARYNGO, V16, P485, DOI 10.1097/MOO.0b013e32830e2096; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Bidelman GM, 2009, J NEUROSCI, V29, P13165, DOI 10.1523/JNEUROSCI.3900-09.2009; Burkard RF., 2007, AUDITORY EVOKED POTE; Chandrasekaran B, 2010, PSYCHOPHYSIOLOGY, V47, P236, DOI 10.1111/j.1469-8986.2009.00928.x; CONNOLLY JF, 1989, PSYCHOPHYSIOLOGY, V26, P292, DOI 10.1111/j.1469-8986.1989.tb01920.x; de Boer J, 2008, J NEUROSCI, V28, P4929, DOI 10.1523/JNEUROSCI.0902-08.2008; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Diederich A, 2009, PROG BRAIN RES, V174, P119, DOI 10.1016/S0079-6123(09)01311-9; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Fujiwara N, 1998, COGNITIVE BRAIN RES, V7, P99, DOI 10.1016/S0926-6410(98)00014-7; GALBRAITH GC, 1995, INT J PSYCHOPHYSIOL, V19, P203, DOI 10.1016/0167-8760(95)00008-G; Galbraith GC, 1998, NEUROREPORT, V9, P1889, DOI 10.1097/00001756-199806010-00041; Galbraith GC, 2003, NEUROREPORT, V14, P735, DOI 10.1097/00001756-200304150-00015; Galbraith GC, 2000, NEUROSCI LETT, V292, P123, DOI 10.1016/S0304-3940(00)01436-1; GIARD MH, 1994, BRAIN RES, V633, P353, DOI 10.1016/0006-8993(94)91561-X; Gondan M, 2011, J EXP PSYCHOL HUMAN, V37, P1887, DOI 10.1037/a0025635; GREGORY SD, 1989, ELECTROEN CLIN NEURO, V73, P557, DOI 10.1016/0013-4694(89)90266-6; HACKLEY SA, 1990, PSYCHOPHYSIOLOGY, V27, P195, DOI 10.1111/j.1469-8986.1990.tb00370.x; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; Hairston WD, 2006, NEUROREPORT, V17, P791, DOI 10.1097/01.wnr.0000220141.29413.b4; Hairston WD, 2009, COMPUT METH PROG BIO, V93, P104, DOI 10.1016/j.cmpb.2008.08.003; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HILLYARD SA, 1973, SCIENCE, V182, P177, DOI 10.1126/science.182.4108.177; HIRSCHHORN TN, 1990, PSYCHOPHYSIOLOGY, V27, P495, DOI 10.1111/j.1469-8986.1990.tb01964.x; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; HOORMANN J, 1994, NEUROREPORT, V5, P1609, DOI 10.1097/00001756-199408150-00017; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; Johnson JA, 2006, NEUROIMAGE, V31, P1673, DOI 10.1016/j.neuroimage.2006.02.026; Kaiser J, 2005, NEUROREPORT, V16, P207, DOI 10.1097/00001756-200502280-00001; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kraus N, 2009, ANN NY ACAD SCI, V1169, P543, DOI 10.1111/j.1749-6632.2009.04549.x; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Krishnan A, 2002, HEARING RES, V166, P192, DOI 10.1016/S0378-5955(02)00327-1; Laurienti PJ, 2004, EXP BRAIN RES, V158, P405, DOI 10.1007/s00221-004-1913-2; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LUKAS JH, 1981, INT J NEUROSCI, V12, P137, DOI 10.3109/00207458108985796; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; Musacchia G, 2006, EXP BRAIN RES, V168, P1, DOI 10.1007/s00221-005-0071-5; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; Okamoto H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-1; PAPANICOLAOU AC, 1984, INT J NEUROSCI, V24, P107, DOI 10.3109/00207458409089800; Posner M. I., 2011, NEUROIMAGE; Saldana E, 1996, J COMP NEUROL, V371, P15, DOI 10.1002/(SICI)1096-9861(19960715)371:1<15::AID-CNE2>3.0.CO;2-O; Santangelo V, 2010, NEUROIMAGE, V49, P2717, DOI 10.1016/j.neuroimage.2009.10.061; Senkowski D, 2008, TRENDS NEUROSCI, V31, P401, DOI 10.1016/j.tins.2008.05.002; Shomstein S, 2004, J NEUROSCI, V24, P10702, DOI 10.1523/JNEUROSCI.2939-04.2004; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Skoe E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013645; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Strait DL, 2009, EUR J NEUROSCI, V29, P661, DOI 10.1111/j.1460-9568.2009.06617.x; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872	60	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e55215	10.1371/journal.pone.0055215	http://dx.doi.org/10.1371/journal.pone.0055215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441150	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200008
J	Sonnemann, I; Hempel, S; Beutel, M; Hanauer, N; Reidinger, S; Wurst, S				Sonnemann, Ilja; Hempel, Stefan; Beutel, Maria; Hanauer, Nicola; Reidinger, Stefan; Wurst, Susanne			The Root Herbivore History of the Soil Affects the Productivity of a Grassland Plant Community and Determines Plant Response to New Root Herbivore Attack	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SPECIES-SPECIFIC RESPONSES; POPULATION-DYNAMICS; TRIFOLIUM-REPENS; AGRIOTES SPP.; COLONIZATION; INDICATORS; SUSTAINABILITY; IDENTIFICATION; RHIZOSPHERE	Insect root herbivores can alter plant community structure by affecting the competitive ability of single plants. However, their effects can be modified by the soil environment. Root herbivory itself may induce changes in the soil biota community, and it has recently been shown that these changes can affect plant growth in a subsequent season or plant generation. However, so far it is not known whether these root herbivore history effects (i) are detectable at the plant community level and/or (ii) also determine plant species and plant community responses to new root herbivore attack. The present greenhouse study determined root herbivore history effects of click beetle larvae (Elateridae, Coleoptera, genus Agriotes) in a model grassland plant community consisting of six common species (Achillea millefolium, Plantago lanceolata, Taraxacum officinale, Holcus lanatus, Poa pratensis, Trifolium repens). Root herbivore history effects were generated in a first phase of the experiment by growing the plant community in soil with or without Agriotes larvae, and investigated in a second phase by growing it again in the soils that were either Agriotes trained or not. The root herbivore history of the soil affected plant community productivity (but not composition), with communities growing in root herbivore trained soil producing more biomass than those growing in untrained soil. Additionally, it influenced the response of certain plant species to new root herbivore attack. Effects may partly be explained by herbivore-induced shifts in the community of arbuscular mycorrhizal fungi. The root herbivore history of the soil proved to be a stronger driver of plant growth on the community level than an actual root herbivore attack which did not affect plant community parameters. History effects have to be taken into account when predicting the impact of root herbivores on grasslands.	[Sonnemann, Ilja; Hempel, Stefan; Beutel, Maria; Hanauer, Nicola; Wurst, Susanne] Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany; [Reidinger, Stefan] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Free University of Berlin; University of York - UK	Sonnemann, I (corresponding author), Free Univ Berlin, Dahlem Ctr Plant Sci, Berlin, Germany.	i.sonnemann@fu-berlin.de			Deutsche Forschungsgemeinschaft [1374, DFG-WU 603/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work has been funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (DFG-WU 603/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett RD, 1999, ECOL LETT, V2, P357; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Borstler B, 2006, BIOL FERT SOILS, V42, P286, DOI 10.1007/s00374-005-0026-9; Brown V.K., 1990, Advances in Ecological Research, V20, P1, DOI 10.1016/S0065-2504(08)60052-5; Currie AF, 2006, SOIL BIOL BIOCHEM, V38, P1994, DOI 10.1016/j.soilbio.2005.11.015; Currie AF, 2011, APPL SOIL ECOL, V47, P77, DOI 10.1016/j.apsoil.2010.12.002; Dawson LA, 2002, SOIL BIOL BIOCHEM, V34, P609, DOI 10.1016/S0038-0717(01)00217-6; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Dosdall LM, 2004, AGRON J, V96, P1306, DOI 10.2134/agronj2004.1306; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Araujo ASF, 2012, AGRON SUSTAIN DEV, V32, P215, DOI 10.1007/s13593-011-0026-0; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fitzjohn RG, 2007, MOL ECOL NOTES, V7, P583, DOI 10.1111/j.1471-8286.2007.01744.x; Gange AC, 2002, ECOL RES, V17, P217, DOI 10.1046/j.1440-1703.2002.00481.x; Gange AC, 2001, NEW PHYTOL, V150, P611, DOI 10.1046/j.1469-8137.2001.00137.x; GANGE AC, 1994, ENTOMOL EXP APPL, V70, P115, DOI 10.1007/BF02380519; Hemerik L, 2003, J INSECT BEHAV, V16, P647, DOI 10.1023/B:JOIR.0000007701.04296.45; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jedlicka P, 2007, BIOLOGIA, V62, P103, DOI 10.2478/s11756-007-0017-4; KALB DW, 1994, PLANT DIS, V78, P491, DOI 10.1094/PD-78-0491; Klausnitzer B, 1994, LARVEN KAEFER MITTEL; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kosola KR, 1999, OECOLOGIA, V118, P69, DOI 10.1007/s004420050704; Kostenko O, 2012, ECOL LETT, V15, P813, DOI 10.1111/j.1461-0248.2012.01801.x; Martin SL, 2012, SOIL BIOL BIOCHEM, V49, P167, DOI 10.1016/j.soilbio.2012.02.036; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Parker WE, 1997, ANN APPL BIOL, V130, P409, DOI 10.1111/j.1744-7348.1997.tb07671.x; R Core Team, 2016, R FDN STAT COMP; Rodriguez-Echeverria S, 2009, BASIC APPL ECOL, V10, P131, DOI 10.1016/j.baae.2008.01.004; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sonnemann I, 2012, BASIC APPL ECOL, V13, P579, DOI 10.1016/j.baae.2012.09.010; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Treonis AM, 2005, APPL SOIL ECOL, V28, P203, DOI 10.1016/j.apsoil.2004.08.004; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Watt MS, 2008, FOREST ECOL MANAG, V256, P180, DOI 10.1016/j.foreco.2008.04.024; Watt MS, 2005, FOREST ECOL MANAG, V216, P51, DOI 10.1016/j.foreco.2005.05.064; Wurst S, 2008, J CHEM ECOL, V34, P1360, DOI 10.1007/s10886-008-9537-9; Wurst S, 2007, BASIC APPL ECOL, V8, P491, DOI 10.1016/j.baae.2006.09.015; Yeates GW, 1998, NEMATOLOGICA, V44, P81, DOI 10.1163/005225998X00082; Zaller JG, 2011, EUR J SOIL BIOL, V47, P175, DOI 10.1016/j.ejsobi.2011.03.001; Zuur Alain F., 2009, P1	44	10	10	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56524	10.1371/journal.pone.0056524	http://dx.doi.org/10.1371/journal.pone.0056524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441201	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200058
J	Kats, A; Bage, T; Georgsson, P; Jonsson, J; Quezada, HC; Gustafsson, A; Jansson, L; Lindberg, C; Nasstrom, K; Yucel-Lindberg, T				Kats, Anna; Bage, Tove; Georgsson, Pierre; Jonsson, Jorgen; Quezada, Hernan Concha; Gustafsson, Anders; Jansson, Leif; Lindberg, Claes; Nasstrom, Karin; Yucel-Lindberg, Tulay			Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E-2 synthesis in vitro and ameliorates experimental periodontitis in vivo	FASEB JOURNAL			English	Article						cyclooxygenase-2; gingival fibroblasts; interleukin-1 beta; PGE(2); mPGES-1 inhibitor; anti-inflammatory	COLLAGEN-INDUCED ARTHRITIS; GINGIVAL CREVICULAR FLUID; ALVEOLAR BONE LOSS; RHEUMATOID-ARTHRITIS; IDENTIFICATION; EXPRESSION; CYCLOOXYGENASE-2; DISEASE; CELECOXIB; MPGES-1	The potent inflammatory mediator prostaglandin E-2 (PGE(2)) is implicated in the pathogenesis of several chronic inflammatory conditions, including periodontitis. The inducible enzyme microsomal prostaglandin E synthase-1 (mPGES-1), catalyzing the terminal step of PGE(2) biosynthesis, is an attractive target for selective PGE(2) inhibition. To identify mPGES-1 inhibitors, we investigated the effect of aminothiazoles on inflammation-induced PGE(2) synthesis in vitro, using human gingival fibroblasts stimulated with the cytokine IL-1 beta and a cell-free mPGES-1 activity assay, as well as on inflammation-induced bone resorption in vivo, using ligature-induced experimental periodontitis in SpragueDawley rats. Aminothiazoles 4-([4-(2-naphthyl)-1,3-thiazol-2-yl]amino)phenol (TH-848) and 4-(3-fluoro-4-methoxyphenyl)-N-(4-phenoxyphenyl)-1,3-thiazol-2-amine (TH-644) reduced IL-1 beta-induced PGE(2) production in fibroblasts (IC50 1.1 and 1.5 mu M, respectively) as well as recombinant mPGES-1 activity, without affecting activity or expression of the upstream enzyme cyclooxygenase-2. In ligature-induced experimental periodontitis, alveolar bone loss, assessed by X-ray imaging, was reduced by 46% by local treatment with TH-848, compared to vehicle, without any systemic effects on PGE(2), 6-keto PGF(1 alpha), LTB4 or cytokine levels. In summary, these results demonstrate that the aminothiazoles represent novel mPGES-1 inhibitors for inhibition of PGE(2) production and reduction of bone resorption in experimental periodontitis, and may be used as potential anti-inflammatory drugs for treatment of chronic inflammatory diseases, including periodontitis.-Kats, A., Bage, T., Georgsson, P., Jonsson, J., Quezada, H. C., Gustafsson, A., Jansson, L., Lindberg, C., Nasstrom, K., Yucel-Lindberg, T. Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E-2 synthesis in vitro and ameliorates experimental periodontitis in vivo.	[Kats, Anna; Bage, Tove; Georgsson, Pierre; Jonsson, Jorgen; Gustafsson, Anders; Yucel-Lindberg, Tulay] Karolinska Inst, Div Periodontol, Dept Dent Med, S-14104 Huddinge, Sweden; [Kats, Anna; Bage, Tove; Georgsson, Pierre; Yucel-Lindberg, Tulay] Karolinska Inst, Div Pediat Dent, S-14104 Huddinge, Sweden; [Nasstrom, Karin] Karolinska Inst, Ctr Infect Med, S-14104 Huddinge, Sweden; [Quezada, Hernan Concha] Karolinska Inst, Div Image & Funct Odontol & Oral Pathol, S-14104 Huddinge, Sweden; [Jansson, Leif] Stockholm Cty Council, Dept Periodontol Skanstull, Stockholm, Sweden; [Lindberg, Claes] MedicinTeknik AB, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm County Council	Yucel-Lindberg, T (corresponding author), Karolinska Inst, Div Periodontol, Dept Dent Med, Box 4064, S-14104 Huddinge, Sweden.	tulay.lindberg@ki.se		Yucel-Lindberg, Tulay/0000-0003-0129-8809	Swedish Patent Revenue Fund; Swedish Research Council [73XD-15005]; Swedish Dental Society; Karolinska Institutet	Swedish Patent Revenue Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Dental Society; Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swedish Patent Revenue Fund (T.Y.-L.); the Swedish Research Council, project number 73XD-15005 (T.Y.-L.); the Swedish Dental Society (A.K.); and Karolinska Institutet (A.K., T.Y.-L.). The authors thank Ms. Ann-Britt Lundberg and Professor Dowen Birkhed (Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden) for disc diffusion tests; Ms. Haleh Davanian and Ms. Kaja Eriksson (Department of Dental Medicine, Karolinska Institutet) for assistance with laboratory work; and Dr. Rachael Sugars (Department of Dental Medicine, Karolinska Institutet) for editing the English language.	Akaogi Jun, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P383; Anderson GD, 2009, INFLAMM RES, V58, P109, DOI 10.1007/s00011-009-8149-3; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Bage T, 2007, BBA-MOL CELL RES, V1773, P1589, DOI 10.1016/j.bbamcr.2007.07.008; Bage T, 2011, AM J PATHOL, V178, P1676, DOI 10.1016/j.ajpath.2010.12.048; Bage T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-241; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Blinkhorn A, 2009, BRIT DENT J, V207, P117, DOI 10.1038/sj.bdj.2009.669; Bruno A, 2010, BIOCHEM PHARMACOL, V79, P974, DOI 10.1016/j.bcp.2009.11.011; Cannon CP, 2012, SCIENCE, V336, P1386, DOI 10.1126/science.1224398; Capone ML, 2007, PROSTAG OTH LIPID M, V82, P85, DOI 10.1016/j.prostaglandins.2006.05.019; Cavanaugh PF, 1998, J PERIODONTAL RES, V33, P75; Chang HH, 2012, INVEST NEW DRUG, V30, P1865, DOI 10.1007/s10637-011-9748-8; Chang HH, 2011, FUTURE MED CHEM, V3, P1909, DOI [10.4155/FMC.11.136, 10.4155/fmc.11.136]; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Cheng WC, 2010, J PERIODONTAL RES, V45, P788, DOI 10.1111/j.1600-0765.2010.01301.x; Cho YS, 2010, PHARMACOLOGY, V86, P65, DOI 10.1159/000315488; Di Paola R, 2006, J DENT RES, V85, P156, DOI 10.1177/154405910608500208; El-Rayes BF, 2004, MOL CANCER THER, V3, P1421; Friesen RW, 2008, J MED CHEM, V51, P4059, DOI 10.1021/jm800197b; Giroux A, 2009, BIOORG MED CHEM LETT, V19, P5837, DOI 10.1016/j.bmcl.2009.08.085; Gudis K, 2005, LAB INVEST, V85, P225, DOI 10.1038/labinvest.3700200; Guimaraes MR, 2011, J PERIODONTAL RES, V46, P269, DOI 10.1111/j.1600-0765.2010.01342.x; Guimaraes MR, 2012, INNATE IMMUN-LONDON, V18, P155, DOI 10.1177/1753425910392935; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jegerschold C, 2008, P NATL ACAD SCI USA, V105, P11110, DOI 10.1073/pnas.0802894105; Kinney JS, 2007, ANN NY ACAD SCI, V1098, P230, DOI 10.1196/annals.1384.028; Koeberle A, 2009, CURR MED CHEM, V16, P4274, DOI 10.2174/092986709789578178; Koeberle A, 2008, J PHARMACOL EXP THER, V326, P975, DOI 10.1124/jpet.108.139444; Koeberle A, 2009, MOL CANCER THER, V8, P2348, DOI 10.1158/1535-7163.MCT-09-0290; Luan Q, 2008, J DENT RES, V87, P148, DOI 10.1177/154405910808700208; Mancini JA, 2001, J BIOL CHEM, V276, P4469, DOI 10.1074/jbc.M006865200; Mbalaviele G, 2010, BIOCHEM PHARMACOL, V79, P1445, DOI 10.1016/j.bcp.2010.01.003; Moldovan CM, 2011, EUR J MED CHEM, V46, P526, DOI 10.1016/j.ejmech.2010.11.032; Moon Y, 2005, J PHARMACOL EXP THER, V315, P788, DOI 10.1124/jpet.105.084434; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Mustafa M, 2005, J CLIN PERIODONTOL, V32, P6, DOI 10.1111/j.1600-051X.2004.00622.x; Ng SC, 2010, CURR OPIN GASTROEN, V26, P611, DOI 10.1097/MOG.0b013e32833e91eb; NISHIKAKU F, 1993, IMMUNOPHARMACOLOGY, V25, P65, DOI 10.1016/0162-3109(93)90031-K; NISHIKAKU F, 1994, INT J IMMUNOPHARMACO, V16, P91, DOI 10.1016/0192-0561(94)90064-7; OFFENBACHER S, 1993, J PERIODONTOL, V64, P432, DOI 10.1902/jop.1993.64.5s.432; Ohno H, 2008, EUR J IMMUNOL, V38, P283, DOI 10.1002/eji.200737199; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Pawelzik SC, 2010, J BIOL CHEM, V285, P29254, DOI 10.1074/jbc.M110.114454; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Preshaw PM, 2002, J CLIN PERIODONTOL, V29, P15, DOI 10.1034/j.1600-051x.2002.290103.x; Ricart M, 2010, AQUAT TOXICOL, V100, P346, DOI 10.1016/j.aquatox.2010.08.010; Rosenstock M, 1999, BBA-MOL CELL BIOL L, V1440, P127, DOI 10.1016/S1388-1981(99)00105-5; Saleh S, 2011, LETT APPL MICROBIOL, V52, P87, DOI 10.1111/j.1472-765X.2010.02976.x; Salvi GE, 2005, CURR PHARM DESIGN, V11, P1757, DOI 10.2174/1381612053764878; Sanghi Sandhya, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P85; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tonetti MS, 2011, J CLIN PERIODONTOL, V38, P114, DOI 10.1111/j.1600-051X.2010.01675.x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tseng CH, 2012, MOL DIVERS, V16, P215, DOI 10.1007/s11030-011-9347-9; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Wang M, 2008, J INTERN MED, V263, P500, DOI 10.1111/j.1365-2796.2008.01938.x; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Yen CA, 2008, J PERIODONTOL, V79, P104, DOI [10.1902/jop.2008.070271, 10.1902/jop.2008.070271 ]; Yucel-Lindberg T, 2004, INFLAMMATION, V28, P89, DOI 10.1023/B:IFLA.0000033024.13748.c1; Yucel-Lindberg T, 2006, CELL SIGNAL, V18, P2131, DOI 10.1016/j.cellsig.2006.04.003	67	23	24	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2013	27	6					2328	2341		10.1096/fj.12-214445	http://dx.doi.org/10.1096/fj.12-214445			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23447581	hybrid, Green Published			2022-12-25	WOS:000319667600022
J	Fortier, AM; Asselin, E; Cadrin, M				Fortier, Anne-Marie; Asselin, Eric; Cadrin, Monique			Keratin 8 and 18 Loss in Epithelial Cancer Cells Increases Collective Cell Migration and Cisplatin Sensitivity through Claudin1 Up-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TIGHT JUNCTION PROTEIN; X-LINKED INHIBITOR; CARCINOMA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; MESENCHYMAL TRANSITION; AKT ISOFORMS; INDUCED APOPTOSIS; DOWN-REGULATION; ACTIVATION	Keratins 8 and 18 (K8/18) are simple epithelial cell-specific intermediate filament proteins. Keratins are essential for tissue integrity and are involved in intracellular signaling pathways that regulate cell response to injuries, cell growth, and death. K8/18 expression is maintained during tumorigenesis; hence, they are used as a diagnostic marker in tumor pathology. In recent years, studies have provided evidence that keratins should be considered not only as markers but also as regulators of cancer cell signaling. The loss of K8/18 expression during epithelial-mesenchymal transition (EMT) is associated with metastasis and chemoresistance. In the present study, we investigated whether K8/18 expression plays an active role in EMT. We show that K8/18 stable knockdown using shRNA increased collective migration and invasiveness of epithelial cancer cells without modulating EMT markers. K8/18-depleted cells showed PI3K/Akt/NF-kappa B hyperactivation and increased MMP2 and MMP9 expression. K8/18 deletion also increased cisplatin-induced apoptosis. Increased Fas receptor membrane targeting suggests that apoptosis is enhanced via the extrinsic pathway. Interestingly, we identified the tight junction protein claudin1 as a regulator of these processes. This is the first indication that modulation of K8/18 expression can influence the phenotype of epithelial cancer cells at a transcriptional level and supports the hypothesis that keratins play an active role in cancer progression.	[Fortier, Anne-Marie; Asselin, Eric; Cadrin, Monique] Univ Quebec Trois Rivieres, Mol Oncol & Endocrinol Res Grp, Dept Med Biol, Trois Rivieres, PQ G9A 5H7, Canada	University of Quebec; University of Quebec Trois Rivieres	Asselin, E (corresponding author), Univ Quebec Trois Rivieres, Mol Oncol & Endocrinol Res Grp, Dept Med Biol, CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	eric.asselin@uqtr.ca; monique.cadrin@uqtr.ca		Fortier, Anne-Marie/0000-0002-0428-3066	Natural Sciences and Engineering Research Council of Canada; Canadian Institute of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by a research grant from the Natural Sciences and Engineering Research Council of Canada (to M.C.).; Holds research grants from the Canadian Institute of Health Research and Natural Sciences and Engineering Research Council of Canada and is Chairholder of the Canada Research Chair in molecular gyneco-oncology. To whom correspondence may be addressed: Molecular Oncology and Endocrinology Research Group, Dept. of Medical Biology, University of Quebec at Trois-Rivieres, C.P. 500, Trois-Rivieres, Quebec G9A 5H7, Canada. Tel.: 819-376-5011; Fax: 819-376-5057; E-mail: eric.asselin@uqtr.ca.; Holds a research grant from the Natural Sciences and Engineering Research Council of Canada. To whom correspondence may be addressed: Molecular Oncology and Endocrinology Research Group, Dept. of Medical Biology, University of Quebec at Trois-Rivieres, C.P. 500, Trois-Rivieres, Quebec G9A 5H7, Canada. Tel.: 819-376-5011; Fax: 819-376-5057; E-mail: monique.cadrin@uqtr.ca.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Amantana A, 2004, MOL CANCER THER, V3, P699; Asselin E, 2001, CANCER RES, V61, P1862; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Beeman N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.14; Buhler H, 2005, MOL CANCER RES, V3, P365, DOI 10.1158/1541-7786.MCR-04-0117; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chaudhry P, 2012, MOL CELL BIOL, V32, P826, DOI 10.1128/MCB.06321-11; CHOU CF, 1993, J BIOL CHEM, V268, P4465; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; De Santis G, 2009, ONCOGENE, V28, P1206, DOI 10.1038/onc.2008.470; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; dos Reis PP, 2008, CANCER-AM CANCER SOC, V113, P3169, DOI 10.1002/cncr.23934; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fortier Anne-Marie, 2011, Biomol Concepts, V2, P1, DOI 10.1515/bmc.2011.003; Fortier AM, 2010, FEBS LETT, V584, P984, DOI 10.1016/j.febslet.2010.01.045; French AD, 2009, INT J MED SCI, V6, P93; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Gaggioli C, 2008, CELL ADHES MIGR, V2, P45, DOI 10.4161/cam.2.1.5705; Gagnon V, 2008, APOPTOSIS, V13, P259, DOI 10.1007/s10495-007-0165-6; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Gilbert S, 2004, MOL CELL BIOL, V24, P7072, DOI 10.1128/MCB.24.16.7072-7081.2004; Girouard J, 2013, GYNECOL ONCOL, V128, P335, DOI 10.1016/j.ygyno.2012.11.016; Gregory M, 2001, ENDOCRINOLOGY, V142, P854, DOI 10.1210/en.142.2.854; Han YP, 2001, J CELL SCI, V114, P131; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inada H, 2001, J CELL BIOL, V155, P415, DOI 10.1083/jcb.200103078; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanaji N, 2011, ONCOL REP, V26, P763, DOI 10.3892/or.2011.1357; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, NAT STRUCT MOL BIOL, V14, P982, DOI 10.1038/nsmb1301; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Leotlela PD, 2007, ONCOGENE, V26, P3846, DOI 10.1038/sj.onc.1210155; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Lin ML, 2010, MOL CARCINOGEN, V49, P783, DOI 10.1002/mc.20652; Long HA, 2006, J CELL SCI, V119, P5147, DOI 10.1242/jcs.03304; Macpherson IR, 2007, ONCOGENE, V26, P5214, DOI 10.1038/sj.onc.1210334; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Paccione RJ, 2008, MOL CANCER THER, V7, P2894, DOI 10.1158/1535-7163.MCT-08-0450; Park BK, 2001, CANCER RES, V61, P7647; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Santi SA, 2010, AM J PHYSIOL-CELL PH, V298, pC580, DOI 10.1152/ajpcell.00375.2009; Schaller G, 1996, CLIN CANCER RES, V2, P1879; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Singh AB, 2010, J ONCOL, V2010, DOI 10.1155/2010/541957; Sjo A, 2010, J MEMBRANE BIOL, V236, P181, DOI 10.1007/s00232-010-9289-7; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Sullivan BT, 2010, INT J GYNECOL CANCER, V20, P1474, DOI 10.1111/IGC.0b013e3181fc3a03; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Van Themsche C, 2007, J BIOL CHEM, V282, P4794, DOI 10.1074/jbc.M608497200; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang Y, 2008, CANCER LETT, V265, P188, DOI 10.1016/j.canlet.2008.02.015; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	81	137	148	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11555	11571		10.1074/jbc.M112.428920	http://dx.doi.org/10.1074/jbc.M112.428920			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449973	Green Published, hybrid			2022-12-25	WOS:000317915500061
J	Fukuzawa, T; Fukazawa, M; Ueda, O; Shimada, H; Kito, A; Kakefuda, M; Kawase, Y; Wada, NA; Goto, C; Fukushima, N; Jishage, K; Honda, K; King, GL; Kawabe, Y				Fukuzawa, Taku; Fukazawa, Masanori; Ueda, Otoya; Shimada, Hideaki; Kito, Aki; Kakefuda, Mami; Kawase, Yosuke; Wada, Naoko A.; Goto, Chisato; Fukushima, Naoshi; Jishage, Kou-ichi; Honda, Kiyofumi; King, George L.; Kawabe, Yoshiki			SGLT5 Reabsorbs Fructose in the Kidney but Its Deficiency Paradoxically Exacerbates Hepatic Steatosis Induced by Fructose	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TRANSPORTER; METABOLIC SYNDROME; RAT-KIDNEY; GLUT2; EXPRESSION; DISEASE; CONSUMPTION; INTESTINE; MANNOSE	Although excessive fructose intake is epidemiologically linked with dyslipidemia, obesity, and diabetes, the mechanisms regulating plasma fructose are not well known. Cells transfected with sodium/glucose cotransporter 5 (SGLT5), which is expressed exclusively in the kidney, transport fructose in vitro; however, the physiological role of this transporter in fructose metabolism remains unclear. To determine whether SGLT5 functions as a fructose transporter in vivo, we established a line of mice lacking the gene encoding SGLT5. Sodium-dependent fructose uptake disappeared in renal brush border membrane vesicles from SGLT5-deficient mice, and the increased urinary fructose in SGLT5-deficient mice indicated that SGLT5 was the major fructose reabsorption transporter in the kidney. From this, we hypothesized that urinary fructose excretion induced by SGLT5 deficiency would ameliorate fructose-induced hepatic steatosis. To test this hypothesis we compared SGLT5-deficient mice with wild-type mice under conditions of long-term fructose consumption. Paradoxically, however, fructose-induced hepatic steatosis was exacerbated in the SGLT5-deficient mice, and the massive urinary fructose excretion was accompanied by reduced levels of plasma triglycerides and epididymal fat but fasting hyperinsulinemia compared with fructose-fed wild-type mice. There was no difference in food consumption, water intake, or plasma fructose between the two types of mice. No compensatory effect by other transporters reportedly involved in fructose uptake in the liver and kidney were indicated at the mRNA level. These surprising findings indicated a previously unrecognized link through SGLT5 between renal fructose reabsorption and hepatic lipid metabolism.	[Fukuzawa, Taku; Fukazawa, Masanori; Ueda, Otoya; Shimada, Hideaki; Kito, Aki; Wada, Naoko A.; Fukushima, Naoshi; Jishage, Kou-ichi; Honda, Kiyofumi; Kawabe, Yoshiki] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan; [Kakefuda, Mami; Kawase, Yosuke; Goto, Chisato] Chugai Res Inst Med Sci Inc, Shizuoka, Japan; [King, George L.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA	Chugai Pharmaceutical Co., Ltd.; Roche Holding; Chugai Pharmaceutical Co., Ltd.; Chugai Research Institute for Medical Science, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Fukazawa, M (corresponding author), Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan.	fukazawamsn@chugai-pharm.co.jp		Kawabe, Yoshiki/0000-0002-6465-7146	Chugai Pharmaceutical Co., Ltd.; Sanofi Aventis	Chugai Pharmaceutical Co., Ltd.; Sanofi Aventis(Sanofi-Aventis)	No sources of funding outside Chugai Pharmaceutical Co., Ltd. supported this work, and there are no current external funding sources for this study.; T. Fukuzawa, M. Fukazawa, O. Ueda, H. Shimada, A. Kito, N.A. Wada, N. Fukushima, K. Jishage, K. Honda, and Y. Kawabe are employees of Chugai Pharmaceutical Co., Ltd. M. Kakefuda, Y. Kawase, and C. Goto are employees of Chugai Research Institute for Medical Science, Inc. These employments do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. George L. King has received a grant from Sanofi Aventis for research unrelated to the current study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Angrand P O, 1999, Nucleic Acids Res, V27, pe16, DOI 10.1093/nar/27.17.e16; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Basciano Heather, 2005, Nutr Metab (Lond), V2, P5, DOI 10.1186/1743-7075-2-5; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; BURANT CF, 1992, J BIOL CHEM, V267, P14523; CHEESEMAN CI, 1993, GASTROENTEROLOGY, V105, P1050, DOI 10.1016/0016-5085(93)90948-C; DAVIDSON NO, 1992, AM J PHYSIOL, V262, pC795, DOI 10.1152/ajpcell.1992.262.3.C795; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004; Grempler R, 2012, FEBS LETT, V586, P248, DOI 10.1016/j.febslet.2011.12.027; Horiba N, 2003, FEBS LETT, V546, P276, DOI 10.1016/S0014-5793(03)00600-8; Jishage K, 2002, P NATL ACAD SCI USA, V99, P8903, DOI 10.1073/pnas.122254599; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kadowaki T, 2012, DIABETES, V61, pA22; Kawasaki T, 2004, METABOLISM, V53, P583, DOI 10.1016/j.metabol.2003.12.007; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; Kemp M, 2004, BRIT J ANAESTH, V93, P63, DOI 10.1093/bja/aeh148; Leicht S, 2006, HSGLT5 SLC5A10 IS SO, P1512; Leturque A, 2005, J PHYSIOL BIOCHEM, V61, P529, DOI 10.1007/BF03168378; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mayes Peter A., 1993, American Journal of Clinical Nutrition, V58, p754S, DOI 10.1093/ajcn/58.5.754S; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Ohi A, 2011, AM J PHYSIOL-RENAL, V301, pF1105, DOI 10.1152/ajprenal.00663.2010; Pitkanen E, 1996, CLIN CHIM ACTA, V251, P91, DOI 10.1016/0009-8981(96)06284-5; Ren LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030816; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Stanhope KL, 2010, ANN NY ACAD SCI, V1190, P15, DOI 10.1111/j.1749-6632.2009.05266.x; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Sugawara-Yokoo M, 1999, KIDNEY INT, V56, P1022, DOI 10.1046/j.1523-1755.1999.00635.x; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tazawa S, 2005, LIFE SCI, V76, P1039, DOI 10.1016/j.lfs.2004.10.016; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; THORENS B, 1990, AM J PHYSIOL, V259, pC286; Wei YR, 2004, AM J PHYSIOL-ENDOC M, V287, pE926, DOI 10.1152/ajpendo.00185.2004; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Xia MF, 2011, CLIN EXP PHARMACOL P, V38, P373, DOI 10.1111/j.1440-1681.2011.05519.x	40	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56681	10.1371/journal.pone.0056681	http://dx.doi.org/10.1371/journal.pone.0056681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451068	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500022
J	Shen, MJ; Ding, XP; Li, TJ; Chen, GY; Zhou, X				Shen, Mengjie; Ding, Xianping; Li, Tianjun; Chen, Gangyi; Zhou, Xiao			Sequence Variation Analysis of HPV-18 Isolates in Southwest China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; RETINOBLASTOMA GENE-PRODUCT; CERVICAL-CANCER PATIENTS; TRANSFORMATION FUNCTIONS; CRYSTAL-STRUCTURE; E2; PROTEIN; E6; VARIANTS; E7	Intratypic variations of HPV-18 are known to differ in the persistence of the infection, frequency of carcinogenesis and the progression of precursor lesions to advanced cervical cancer. This study was designed to analyze sequence variations of HPV-18 isolates in order to discover novel HPV-18 variants and to evaluate the variations among infected women in southwest China. Cervical biopsies from 56 HPV-18-positive women with cervical neoplasia were assayed by PCR amplification and sequencing of all eight genes (E1, E2, E4, E5, E6, E7, L1, L2) of the HPV-18 genome. The most frequently observed variation was a C to G transversion at nucleotide 287 of E6, which was found in 48.2% of samples. Analysis of E7 revealed only one specimen as having sequence variations. In addition, we have identified several novel variations: A551C in E6, G6906A in L1, and C4915T and C5147A in L2. The mutations in E6 and L2 are silent, while the E7 mutation results in a single amino acid change. This study complements and expands on previous descriptions of HPV-18 variants. The sequence variation data presented here provides a foundation for future research on HPV-induced oncogenesis and may prove valuable for developing diagnostic probes and in the design of HPV vaccines for targeted populations.	[Shen, Mengjie; Ding, Xianping; Li, Tianjun; Chen, Gangyi; Zhou, Xiao] Sichuan Univ, Bioresource Res & Utilizat Joint Key Lab Sichuan, Inst Med Genet, Coll Life Sci, Chengdu 610064, Peoples R China; [Shen, Mengjie; Ding, Xianping; Li, Tianjun; Chen, Gangyi] Sichuan Univ, Inst Med Genet, Coll Life Sci, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Ding, XP (corresponding author), Sichuan Univ, Bioresource Res & Utilizat Joint Key Lab Sichuan, Inst Med Genet, Coll Life Sci, Chengdu 610064, Peoples R China.	xianping2011@yeah.net			Science and Technology Department of Sichuan Province, China	Science and Technology Department of Sichuan Province, China	This work was supported by funds from the Science and Technology Department of Sichuan Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Amador-Molina A, 2012, J GEN VIROL; ANDROPHY EJ, 1987, NATURE, V325, P70, DOI 10.1038/325070a0; Angulo M, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-33; [Anonymous], 2011, MON EV CARC RISKS B, V100; Arias-Pulido H, 2005, VIROLOGY, V338, P22, DOI 10.1016/j.virol.2005.04.022; Arroyo SL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-258; Bellanger S, 2011, AM J CANCER RES, V1, P373; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Blachon S, 2003, BIOCHIMIE, V85, P813, DOI 10.1016/j.biochi.2003.09.008; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Cai HB, 2010, EJSO-EUR J SURG ONC, V36, P160, DOI 10.1016/j.ejso.2009.07.186; Chang CH, 2005, J CLIN VIROL, V32, P33, DOI 10.1016/j.jcv.2004.06.011; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cooper CS, 1998, VIROLOGY, V241, P312, DOI 10.1006/viro.1997.8941; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Demeret C, 1998, VIROLOGY, V242, P378, DOI 10.1006/viro.1997.9023; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Fragoso-Ontiveros V, 2012, VIROLOGY, V432, P81, DOI 10.1016/j.virol.2012.05.029; Frati E, 2011, INFECT GENET EVOL, V11, P2119, DOI 10.1016/j.meegid.2011.06.014; Garcia-Vallve S, 2005, TRENDS MICROBIOL, V13, P514, DOI 10.1016/j.tim.2005.09.003; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Harris SF, 1999, SCIENCE, V284, P1673, DOI 10.1126/science.284.5420.1673; Liu SQ, 2010, BIOCHIMIE, V92, P901, DOI 10.1016/j.biochi.2010.02.028; Londesborough P, 1996, INT J CANCER, V69, P364; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Paavonen J, 2007, INT J INFECT DIS, V11, pS3, DOI 10.1016/S1201-9712(07)60015-0; Pande S, 2008, J CLIN MICROBIOL, V46, P1060, DOI 10.1128/JCM.02202-07; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Rhond CK, 2009, J PNAS, V106, P20458; Rose BR, 1997, GYNECOL ONCOL, V66, P282, DOI 10.1006/gyno.1997.4740; Sathish N, 2005, CANCER LETT, V229, P93, DOI 10.1016/j.canlet.2005.04.026; Stephen AL, 2000, INT J CANCER, V86, P695, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;695::AID-IJC15&gt;3.0.CO;2-C; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; Todorovic B, 2011, J VIROL, V85, P10048, DOI 10.1128/JVI.00643-11; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; WALKER J, 1989, OBSTET GYNECOL, V74, P781; Wang Y, 2004, J BIOL CHEM, V279, P6976, DOI 10.1074/jbc.M311376200; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wu MH, 2007, INT J BIOCHEM CELL B, V39, P413, DOI 10.1016/j.biocel.2006.09.008; Wu YP, 2006, J GEN VIROL, V87, P1181, DOI 10.1099/vir.0.81649-0; Yatsudo M, 1988, VIROLOGY, V166, P594; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605; Yumin W, 2012, AFRICAN J MICROBIOLO, V6, P1048; Zehbe I, 1998, CANCER RES, V58, P829	52	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56614	10.1371/journal.pone.0056614	http://dx.doi.org/10.1371/journal.pone.0056614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451059	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500018
J	Ozeki, K; Tanida, S; Morimoto, C; Inoue, Y; Mizoshita, T; Tsukamoto, H; Shimura, T; Kataoka, H; Kamiya, T; Nishiwaki, E; Ishiguro, H; Higashiyama, S; Joh, T				Ozeki, Keiji; Tanida, Satoshi; Morimoto, Chie; Inoue, Yoshimasa; Mizoshita, Tsutomu; Tsukamoto, Hironobu; Shimura, Takaya; Kataoka, Hiromi; Kamiya, Takeshi; Nishiwaki, Eiji; Ishiguro, Hiroshi; Higashiyama, Shigeki; Joh, Takashi			Telmisartan Inhibits Cell Proliferation by Blocking Nuclear Translocation of ProHB-EGF C-Terminal Fragment in Colon Cancer Cells	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; ACTIVATED-RECEPTOR-GAMMA; II TYPE-1 RECEPTOR; GROWTH-FACTOR; HB-EGF; GASTRIC-CANCER; THERAPY; CHEMOTHERAPY; MECHANISM; CETUXIMAB	Background & Aims: Current treatment target toward advanced colorectal cancers is mainly focused on the epidermal growth factor receptor (EGFR) signaling, but its additive effects with chemotherapy are still limited. A disintegrin and metalloproteinase (ADAM) cleaves the proheparin-binding epidermal growth factor like growth factor (proHB-EGF). And soluble HB-EGF activates EGFR. In parallel, the carboxy-terminal fragment of proHB-EGF (HB-EGF-CTF) translocates into the inner nuclear membrane, and subsequently exerts on the regulation of cell proliferation by binding nuclear promyelocytic leukemia zinc finger (PLZF) protein, a transcriptional repressor, thereby causing its nuclear export. We hypothesized that the inhibition of HB-EGF-CTF nuclear translocation may be a new strategy in preventing cell proliferation. Methods: 12-O-tetradecanoylphorbor-13-acetate (TPA) was treated to activate ADAM. Nine-thousand chemical compounds were screened for their efficacies in blocking the binding of HB-EGF-CTF to promyelocytic leukemia zinc finger (PLZF) with Alphascreen system. The obtained candidates were then used to block the binding of HB-EGF-CTF to PLZF in colon cancer cells, HT29 and HCT116. Cell proliferation was investigated with a growth curve assay. The intracellular localization, and association between HB-EGF-CTF and PLZF, was assessed with immunofluorescent staining, and immunoprecipitation and Western blotting, respectively. The effects of obtained candidates on EGFR phosphorylation and on nuclear translocation of HB-EGF-CTF and export of PLZF during the angiotensin II type1 receptor (AT1R) knockdown were also investigated. Results: Telmisartan and candesartan were found to be potential candidates. Telmisartan inhibited TPA-induced cell proliferation stronger than candesartan. Telmisartan, but not candesartan blocked the nuclear translocation of HB-EGF-CTF, and binding of HB-EGF-CTF to PLZF, during TPA stimulation. Both telmisartan and candesartan did not inhibit TPA-induced EGFR phosphorylation, and telmisartan, but not candesartan, inhibited TPA-induced nuclear translocation of HB-EGF-CTF after knockdown of AT1R. Conclusions: The inhibition of HB-EGF-CTF nuclear translocation with telmisartan may be a novel strategy in preventing cell proliferation.	[Ozeki, Keiji; Tanida, Satoshi; Mizoshita, Tsutomu; Tsukamoto, Hironobu; Shimura, Takaya; Kataoka, Hiromi; Kamiya, Takeshi; Joh, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan; [Morimoto, Chie] Matsuyama Shinonome Jr Coll, Nutr Course, Dept Life Sci, Matsuyama, Ehime, Japan; [Inoue, Yoshimasa; Nishiwaki, Eiji] Carna Biosci Incorp, Kobe, Hyogo, Japan; [Ishiguro, Hiroshi] Gifu Univ Med Sci, Sch Hlth Sci, Dept Med Technol, Seki, Gifu, Japan; [Higashiyama, Shigeki] Ehime Univ, Proteomed Res Ctr, Dept Cell Growth & Tumor Regulat, Toon, Ehime, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Toon, Ehime, Japan	Nagoya City University; Ehime University; Ehime University	Tanida, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi, Japan.	stanida@med.nagoya-cu.ac.jp; shigeki@m.ehime-u.ac.jp	Tanida, Satoshi/AAA-1805-2021	Shimura, Takaya/0000-0002-6048-0021	Japan Society for the Promotion of Science (JSPS) [KAKENHI 22590704]; Grants-in-Aid for Scientific Research [23790802] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in Aid for scientific research C (KAKENHI 22590704) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Funao K, 2008, ONCOL REP, V20, P295, DOI 10.3892/or_00000006; GOISHI K, 1995, MOL BIOL CELL, V6, P967, DOI 10.1091/mbc.6.8.967; HASHIMOTO K, 1994, J BIOL CHEM, V269, P20060; Hieda M, 2008, J CELL BIOL, V180, P763, DOI 10.1083/jcb.200710022; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Imayama I, 2006, CARDIOVASC RES, V72, P184, DOI 10.1016/j.cardiores.2006.07.014; Isobe A, 2008, HUM REPROD, V23, P440, DOI 10.1093/humrep/dem247; Kinney EL, 2008, J CELL PHYSIOL, V216, P621, DOI 10.1002/jcp.21437; Kopp R, 2003, RECENT RESULTS CANC, V162, P115; Nanba D, 2003, J CELL BIOL, V163, P489, DOI 10.1083/jcb.200303017; Saika K, 2011, JPN J CLIN ONCOL, V41, P1153, DOI 10.1093/jjco/hyr130; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Shimada T, 2002, GUT, V50, P658, DOI 10.1136/gut.50.5.658; Shimura T, 2008, CLIN CANCER RES, V14, P3956, DOI 10.1158/1078-0432.CCR-07-4794; Shimura T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-205; Tanida S, 2004, GASTROENTEROLOGY, V127, P559, DOI 10.1053/j.gastro.2004.05.017; Tanida S, 2010, DIGESTION, V82, P145, DOI 10.1159/000310903; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wang F, 2007, ONCOGENE, V26, P2006, DOI 10.1038/sj.onc.1209999; Wienen W, 2000, CARDIOVASC DRUG REV, V18, P127; Yoshida M, 2012, J CANC RES CLIN ONCO; Yoshida T, 2006, DIABETOLOGIA, V49, P3094, DOI 10.1007/s00125-006-0437-7; Yotsumoto F, 2008, BIOCHEM BIOPH RES CO, V365, P555, DOI 10.1016/j.bbrc.2007.11.015	27	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56770	10.1371/journal.pone.0056770	http://dx.doi.org/10.1371/journal.pone.0056770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451083	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800035
J	Pan, XH; Zhu, YY; Wang, Q; Zheng, H; Chen, X; Su, J; Peng, ZH; Yu, RB; Wang, N				Pan, Xiaohong; Zhu, Yingying; Wang, Qing; Zheng, Hui; Chen, Xin; Su, Jing; Peng, Zhihang; Yu, Rongbin; Wang, Ning			Prevalence of HIV, Syphilis, HCV and Their High Risk Behaviors among Migrant Workers in Eastern China	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; TO-URBAN MIGRATION; RURAL MIGRANTS; SEX WORKERS; INFECTION; POPULATION; SHANGHAI; ACCEPTANCE; RESIDENTS; ATTITUDES	Objective: The goal of this study was to understand the knowledge about AIDS, identify the correlates and determine the prevalence of HIV infection, syphilis, HCV among migrant workers in Zhejiang, China. Methods: A cross-sectional study using face-to-face anonymous questionnaire interviews was conducted and blood samples were collected for HIV, syphilis and Hepatitis C infection screening. Results: 17,377 (92.8%) of 18,730 migrant workers approached were interviewed. Among 17,377 participants, the HIV/AIDS knowledge rate was 66.2%. A total of 12,694 (73%) of the participants reported having ever had sexual intercourse, with 30.1% of single participants reporting having had sexual intercourse. Among those respondents with sexual experiences, 7.5% admitted they had two or more sexual partners and 4.9% reported having had sex with casual (unpaid) partners in the previous 12 months, whilst 3.7% had paid for sex. More than half of those who had paid for sex (59.4%) had not used a condom every time in their sexual acts with the sex workers. Multiple logistic regression analysis indicated that high risk sexual behavior (defined as sex with a casual or commercial sex partner without using a condom consistently) was associated with being divorced or widowed (P<0.05 for single); male gender; shorter duration of stay in Zhejiang; working in factory, market or domestic service (P<0.05 for odd job); having a province of origin inside Zhejiang; and drug use. The prevalence of HIV and HCV infections were 0.02% (95% CI: 0.01%-0.06%) and 0.40% (95% CI: 0.31%-0.51%), respectively. The prevalence of syphilis among those who were sexually active was 0.55% (95% CI: 0.43%-0.70%). Risk factors for syphilis included shorter duration of stay in Zhejiang, ethnic minority status, being divorced or widowed and having had multiple sex partners. Conclusions: Much greater efforts are needed to promote safer sex, and programs for the control of syphilis need to be tailored for migrant workers in China.	[Zhu, Yingying; Wang, Qing; Zheng, Hui; Chen, Xin; Su, Jing; Peng, Zhihang; Yu, Rongbin] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Pan, Xiaohong] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Zhejiang Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Peng, ZH (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	zhihangpeng@yahoo.com.cn			National Natural Science Foundation of China [81001288]; Natural Science Foundation Key Project of Jiangsu Province, China [BK2010079]; National S & T Major Project Foundation of China [2012ZX10001-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Key Project of Jiangsu Province, China; National S & T Major Project Foundation of China	This work was supported in part by National Natural Science Foundation of China (81001288), Natural Science Foundation Key Project of Jiangsu Province, China (BK2010079) and "National S & T Major Project Foundation of China" (2012ZX10001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; Arneborn M, 2007, EURO SURVEILL, V12; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Burns FM, 2009, AIDS, V23, P262, DOI 10.1097/QAD.0b013e32831c546b; *CDCP, 2009, HIV AIDS SURV REP 20; *CHIN STAT COUNC A, 2007, JOINT ASS HIV AIDS P; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cui Q, 2011, INFECT GENET EVOL, V11, P1682, DOI 10.1016/j.meegid.2011.06.016; Duan C., 2008, POPULATION RES, V32, P30; Duan S, 2010, SCI DECISION MAKING, V10, P47; Gunn RA, 2005, SEX TRANSM DIS, V32, P328, DOI 10.1097/01.olq.0000154562.51908.c6; Hahm H, 2008, J YOUTH ADOLESCENCE, V37, P74, DOI 10.1007/s10964-007-9234-y; Hargreaves S, 2008, LANCET INFECT DIS, V8, P470, DOI 10.1016/S1473-3099(08)70169-5; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; He N, 2005, SEX TRANSM DIS, V32, P286, DOI 10.1097/01.olq.0000152219.58592.9b; He N, 2009, AIDS EDUC PREV, V21, P570, DOI 10.1521/aeap.2009.21.6.570; Hesketh T, 2006, SEX TRANSM INFECT, V82, P11, DOI 10.1136/sti.2004.014043; Hesketh T, 2005, SEX TRANSM INFECT, V81, P108, DOI 10.1136/sti.2004.009704; Hong Y, 2009, AIDS CARE, V21, P212, DOI 10.1080/09540120801932165; Hu Z, 2006, PUBLIC HEALTH, V120, P339, DOI 10.1016/j.puhe.2005.10.016; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Liu YJ, 2012, EUR J CONTRACEP REPR, V17, P219, DOI 10.3109/13625187.2012.662544; Locke TF, 2008, HEALTH PSYCHOL, V27, P337, DOI 10.1037/0278-6133.27.3.337; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; *MIN HLTH CHIN, 2011, EST HIV AIDS EP CHIN; Ministry of Health China Joint United Nations Programme on HIV/AIDS World Health Organization, 2009, EST HIV AIDS EP CHIN; Ministry of Health in China UNAIDS WHO, 2005, 2005 UPD HIV AIDS EP; Nansheng Bai, 2002, SHEHUIXUE YANJIU, V3, P64; National Center for AIDS/STD Control and Prevention of China CDC, 2009, NAT HIV SURV SURV RE; Nguyen HV, 2012, ARCH SEX BEHAV, V41, P1231, DOI 10.1007/s10508-012-9904-z; Qiu PY, 2011, J AFFECT DISORDERS, V134, P198, DOI 10.1016/j.jad.2011.05.043; Quigley M, 1997, AIDS, V11, P237, DOI 10.1097/00002030-199702000-00015; Riaz M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-368; Srithanaviboonchai K, 2002, AIDS, V16, P929, DOI 10.1097/00002030-200204120-00015; USAID, 2008, HIV AIDS HLTH PROFIL; Vaidya NK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-310; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Wang B, 2007, SEX TRANSM DIS, V34, P1, DOI 10.1097/01.olq.0000222668.95038.03; Wang B, 2007, AIDS PATIENT CARE ST, V21, P57, DOI 10.1089/apc.2006.0031; Wong DFK, 2008, INT J SOC PSYCHIATR, V54, P131, DOI 10.1177/0020764007083877; Xia DY, 2011, CHIN J AIDS STD, V17, P430; Xu F, 2010, ZHEJIANG PREV MED, V22, P8; Zhang ZQ., 2007, STAT RES, V24, P9; Zhejiang Provincial Government, 2012, POP STAT 2010; Zhuang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031986	47	23	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57258	10.1371/journal.pone.0057258	http://dx.doi.org/10.1371/journal.pone.0057258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451193	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800095
J	Li, SY; Liu, QQ; Wang, YJ; Gu, Y; Liu, D; Wang, CM; Ding, GH; Chen, JP; Liu, J; Gu, XS				Li, Shiying; Liu, Qianqian; Wang, Yongjun; Gu, Yun; Liu, Dong; Wang, Chunming; Ding, Guohui; Chen, Jianping; Liu, Jie; Gu, Xiaosong			Differential Gene Expression Profiling and Biological Process Analysis in Proximal Nerve Segments after Sciatic Nerve Transection	PLOS ONE			English	Article							OLFACTORY RECEPTOR; AXON REGENERATION; SCHWANN-CELLS; MULTIGENE FAMILY; ODORANT RECEPTOR; INJURY; RAT; MYELINATION; DEMYELINATION; RECOGNITION	After traumatic injury, peripheral nerves can spontaneously regenerate through highly sophisticated and dynamic processes that are regulated by multiple cellular elements and molecular factors. Despite evidence of morphological changes and of expression changes of a few regulatory genes, global knowledge of gene expression changes and related biological processes during peripheral nerve injury and regeneration is still lacking. Here we aimed to profile global mRNA expression changes in proximal nerve segments of adult rats after sciatic nerve transection. According to DNA microarray analysis, the huge number of genes was differentially expressed at different time points (0.5 h-14 d) post nerve transection, exhibiting multiple distinct temporal expression patterns. The expression changes of several genes were further validated by quantitative real-time RT-PCR analysis. The gene ontology enrichment analysis was performed to decipher the biological processes involving the differentially expressed genes. Collectively, our results highlighted the dynamic change of the important biological processes and the time-dependent expression of key regulatory genes after peripheral nerve injury. Interestingly, we, for the first time, reported the presence of olfactory receptors in sciatic nerves. Hopefully, this study may provide a useful platform for deeply studying peripheral nerve injury and regeneration from a molecular-level perspective.	[Li, Shiying; Liu, Qianqian; Wang, Yongjun; Gu, Yun; Liu, Dong; Liu, Jie; Gu, Xiaosong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China; [Wang, Chunming; Chen, Jianping] Nantong Univ, Sch Comp Sci & Technol, Nantong, Peoples R China; [Ding, Guohui] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Nantong University; Nantong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gu, XS (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	nervegu@ntu.edu.cn	liu, qian/HDM-2936-2022; Liu, Dong/O-1271-2013	Liu, Dong/0000-0002-2764-6544	Hi-Tech Research and Development Program of China (863 Program) [2012AA020502]; State Key Program of National Natural Science of China [81130080]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the Hi-Tech Research and Development Program of China (863 Program, grant no. 2012AA020502), the State Key Program of National Natural Science of China (grant no. 81130080) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Barrette B, 2008, J NEUROSCI, V28, P9363, DOI 10.1523/JNEUROSCI.1447-08.2008; Belanger E, 2011, BIOMED OPT EXPRESS, V2, P2698, DOI 10.1364/BOE.2.002698; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buser AM, 2009, EUR J NEUROSCI, V29, P2276, DOI 10.1111/j.1460-9568.2009.06785.x; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Donnerer J, 2003, PHARMACOLOGY, V67, P169, DOI 10.1159/000068405; DRUTEL G, 1995, RECEPTOR CHANNEL, V3, P33; Goto T, 2001, MOL HUM REPROD, V7, P553, DOI 10.1093/molehr/7.6.553; Grinspan JB, 1996, J NEUROSCI, V16, P6107; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kerr BJ, 2001, NEUROREPORT, V12, P3331, DOI 10.1097/00001756-200110290-00037; Koenig HL, 2000, REV REPROD, V5, P189; Kosins AM, 2012, ANN PLAS SURG, V68, P290, DOI 10.1097/SAP.0b013e31823dce7e; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Moalem G, 1999, FASEB J, V13, P1207, DOI 10.1096/fasebj.13.10.1207; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nef S, 1997, P NATL ACAD SCI USA, V94, P4766, DOI 10.1073/pnas.94.9.4766; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; ROBERSON MD, 1995, MOL BRAIN RES, V28, P231, DOI 10.1016/0169-328X(94)00211-V; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Schmidhammer R, 2007, ACTA NEUROCHIR SUPPL, V100, P161; Sheth S, 2011, MODERN PATHOL, V24, P343, DOI 10.1038/modpathol.2010.203; Sheu JY, 2000, EXP NEUROL, V166, P392, DOI 10.1006/exnr.2000.7508; Thomas MB, 1996, GENE, V178, P1, DOI 10.1016/0378-1119(96)00311-3; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Wang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048669, 10.1371/journal.pone.0030635, 10.1371/journal.pone.0047302]; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zhou SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044768; Zochodne DW, 2000, MUSCLE NERVE, pS33	41	81	81	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57000	10.1371/journal.pone.0057000	http://dx.doi.org/10.1371/journal.pone.0057000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437294	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000066
J	Miao, Y; Sun, YB; Wang, WJ; Du, BJ; Xiao, SE; Hu, YJ; Hu, ZQ				Miao, Yong; Sun, Yabin; Wang, Wenjun; Du, Benjun; Xiao, Shun-e; Hu, Yijue; Hu, Zhiqi			6-Gingerol Inhibits Hair Shaft Growth in Cultured Human Hair Follicles and Modulates Hair Growth in Mice	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; IN-VITRO; APOPTOSIS; BCL-2; PROLIFERATION; MITOCHONDRIA; PROTEINS; ALOPECIA; SURVIVAL; EXTRACT	Ginger (Zingiber officinale) has been traditionally used to check hair loss and stimulate hair growth in East Asia. Several companies produce shampoo containing an extract of ginger claimed to have anti-hair loss and hair growth promotion properties. However, there is no scientific evidence to back up these claims. This study was undertaken to measure 6-gingerol, the main active component of ginger, on hair shaft elongation in vitro and hair growth in vivo, and to investigate its effect on human dermal papilla cells (DPCs) in vivo and in vitro. 6-Gingerol suppressed hair growth in hair follicles in culture and the proliferation of cultured DPCs. The growth inhibition of DPCs by 6-gingerol in vitro may reflect a decrease in the Bcl-2/Bax ratio. Similar results were obtained in vivo. The results of this study showed that 6-gingerol does not have the ability to promote hair growth, on the contrary, can suppress human hair growth via its inhibitory and pro-apoptotic effects on DPCs in vitro, and can cause prolongation of telogen phase in vivo. Thus, 6-gingerol rather than being a hair growth stimulating drug, it is a potential hair growth suppressive drug; i.e. for hair removal.	[Miao, Yong; Du, Benjun; Xiao, Shun-e; Hu, Yijue; Hu, Zhiqi] So Med Univ, Nanfang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Guangdong, Peoples R China; [Sun, Yabin] So Med Univ, Nanfang Hosp, GCP Off, Guangzhou, Guangdong, Peoples R China; [Wang, Wenjun] So Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Hu, ZQ (corresponding author), So Med Univ, Nanfang Hosp, Dept Plast & Aesthet Surg, Guangzhou, Guangdong, Peoples R China.	doctorhzq@hotmail.com	Hu, Zhi/AAD-1479-2020		Natural Science Foundation of China [31170949]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant No. 31170949). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; Baliga MS, 2011, CRIT REV FOOD SCI, V51, P499, DOI 10.1080/10408391003698669; Blume-Peytavi U, 2011, BRIT J DERMATOL, V165, P19, DOI 10.1111/j.1365-2133.2011.10632.x; Botchkareva NV, 2006, J INVEST DERMATOL, V126, P258, DOI 10.1038/sj.jid.5700007; Cash TF, 1999, BRIT J DERMATOL, V141, P398; Datta K, 2009, J ETHNOPHARMACOL, V124, P450, DOI 10.1016/j.jep.2009.05.023; Han JH, 2004, J DERMATOL SCI, V34, P91, DOI 10.1016/j.jdermsci.2004.01.002; Kawano M, 2009, J NAT MED-TOKYO, V63, P335, DOI 10.1007/s11418-009-0324-x; Kim SC, 2010, EUR J DERMATOL, V20, P42, DOI 10.1684/ejd.2010.0807; Kwon OS, 2007, PHYTOMEDICINE, V14, P551, DOI 10.1016/j.phymed.2006.09.009; Lee C, 2011, FOOD CHEM TOXICOL, V49, P1261, DOI 10.1016/j.fct.2011.03.005; Lindner G, 1997, AM J PATHOL, V151, P1601; Luanpitpong S, 2011, APOPTOSIS, V16, P769, DOI 10.1007/s10495-011-0609-x; Magerl M, 2002, EXP DERMATOL, V11, P381, DOI 10.1034/j.1600-0625.2002.110414.x; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller-Rover S, 1999, J INVEST DERM SYMP P, V4, P272, DOI 10.1038/sj.jidsp.5640228; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nigam N, 2010, CANCER CHEMOTH PHARM, V65, P687, DOI 10.1007/s00280-009-1074-x; Park HJ, 2011, J ETHNOPHARMACOL, V135, P369, DOI 10.1016/j.jep.2011.03.028; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Philpott MP, 1990, CELL SCI, V97, P471; Price VH, 1999, NEW ENGL J MED, V341, P964, DOI 10.1056/NEJM199909233411307; Schmidt S, 2001, BRIT J DERMATOL, V144, P1038, DOI 10.1046/j.1365-2133.2001.04195.x; Shukla Y, 2007, MOL NUTR FOOD RES, V51, P1492, DOI 10.1002/mnfr.200700197; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Zoumaras J, 2008, BURNS, V34, P254, DOI 10.1016/j.burns.2007.03.018	28	16	16	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57226	10.1371/journal.pone.0057226	http://dx.doi.org/10.1371/journal.pone.0057226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437345	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000086
J	Zhang, T; Liu, JC; Zhang, J; Thekkethottiyil, EB; Macatee, TL; Ismat, FA; Wang, F; Stoller, JZ				Zhang, Tao; Liu, Junchen; Zhang, Jue; Thekkethottiyil, Eldhose B.; Macatee, Timothy L.; Ismat, Fraz A.; Wang, Fen; Stoller, Jason Z.			Jun Is Required in Isl1-Expressing Progenitor Cells for Cardiovascular Development	PLOS ONE			English	Article							CARDIAC NEURAL CREST; CONGENITAL HEART-DISEASE; FACTOR C-JUN; TISSUE-SPECIFIC EXPRESSION; OUTFLOW TRACT; MOUSE DEVELOPMENT; LINEAGE DEVELOPMENT; LIVER-REGENERATION; VENTRICULAR SEPTUM; REPORTER MOUSE	Jun is a highly conserved member of the multimeric activator protein 1 transcription factor complex and plays an important role in human cancer where it is known to be critical for proliferation, cell cycle regulation, differentiation, and cell death. All of these biological functions are also crucial for embryonic development. Although all Jun null mouse embryos die at mid-gestation with persistent truncus arteriosus, a severe cardiac outflow tract defect also seen in human congenital heart disease, the developmental mechanisms are poorly understood. Here we show that murine Jun is expressed in a restricted pattern in several cell populations important for cardiovascular development, including the second heart field, pharyngeal endoderm, outflow tract and atrioventricular endocardial cushions and post-migratory neural crest derivatives. Several genes, including Isl1, molecularly mark the second heart field. Isl1 lineages include myocardium, smooth muscle, neural crest, endocardium, and endothelium. We demonstrate that conditional knockout mouse embryos lacking Jun in Isl1-expressing progenitors display ventricular septal defects, double outlet right ventricle, semilunar valve hyperplasia and aortic arch artery patterning defects. In contrast, we show that conditional deletion of Jun in Tie2-expressing endothelial and endocardial precursors does not result in aortic arch artery patterning defects or embryonic death, but does result in ventricular septal defects and a low incidence of semilunar valve defects, atrioventricular valve defects and double outlet right ventricle. Our results demonstrate that Jun is required in Isl1-expressing progenitors and, to a lesser extent, in endothelial cells and endothelial-derived endocardium for cardiovascular development but is dispensable in both cell types for embryonic survival. These data provide a cellular framework for understanding the role of Jun in the pathogenesis of congenital heart disease.	[Zhang, Tao; Thekkethottiyil, Eldhose B.; Stoller, Jason Z.] Univ Penn, Childrens Hosp Philadelphia, Div Neonatol, Dept Pediat,Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Junchen; Wang, Fen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX USA; [Zhang, Jue] Morgridge Inst Res, Madison, WI USA; [Macatee, Timothy L.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ismat, Fraz A.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Cardiol,Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Pennsylvania; University of Pennsylvania; Childrens Hospital of Philadelphia	Stoller, JZ (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Div Neonatol, Dept Pediat,Perelman Sch Med, Philadelphia, PA 19104 USA.	stoller@email.chop.edu	Ismat, Fraz Ahmed/AAG-7470-2019; Stoller, Jason/AAA-2535-2020	Stoller, Jason/0000-0002-8475-690X; Liu, Junchen/0000-0003-2765-9780; Ismat, Fraz/0000-0002-2172-146X	National Institutes of Health (NIH); American Heart Association (AHA); Cancer Prevention and Research Institute of Texas (CPRIT); AHA [2010130, 11BGIA7370043]; NIH [R01-2R01CA096824, K08-HL086633]; CPRIT [RP110555]; NATIONAL CANCER INSTITUTE [P50CA140388, R01CA096824] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL086633] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Cancer Prevention and Research Institute of Texas (CPRIT); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH, www.nih.gov), American Heart Association (AHA, www.heart.org) and the Cancer Prevention and Research Institute of Texas (CPRIT, www.cprit.state.tx.us). JZ was supported by the AHA (2010130). FW was supported by the NIH (R01-2R01CA096824) and the CPRIT (RP110555). JZS was supported by the NIH (K08-HL086633) and AHA (11BGIA7370043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Anderson RH, 2010, CARDIOL YOUNG, V20, P92, DOI 10.1017/S1047951110001137; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Behrens A, 2003, DEVELOPMENT, V130, P103, DOI 10.1242/dev.00186; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Brown CB, 2001, DEVELOPMENT, V128, P3071; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; CARRASCO D, 1995, ONCOGENE, V10, P1069; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; DeLaughter DM, 2011, BIRTH DEFECTS RES A, V91, P511, DOI 10.1002/bdra.20809; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; FOLETTA VC, 1994, ONCOGENE, V9, P3305; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Ishii Y, 2009, CELL TISSUE RES, V335, P67, DOI 10.1007/s00441-008-0663-z; Jiang XB, 2000, DEVELOPMENT, V127, P1607; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Katabami M, 2005, J BIOL CHEM, V280, P16728, DOI 10.1074/jbc.M413892200; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Liao J, 2004, HUM MOL GENET, V13, P1577, DOI 10.1093/hmg/ddh176; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Meixner A, 2010, CELL DEATH DIFFER, V17, P1409, DOI 10.1038/cdd.2010.22; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Parisot P, 2011, BIRTH DEFECTS RES A, V91, P477, DOI 10.1002/bdra.20803; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; Scambler PJ, 2010, PEDIATR CARDIOL, V31, P378, DOI 10.1007/s00246-009-9613-0; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Sclafani AM, 2006, GENESIS, V44, P336, DOI 10.1002/dvg.20220; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shimomura H, 2000, DIABETES, V49, P1597, DOI 10.2337/diabetes.49.9.1597; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Smith TK, 2007, SEMIN CELL DEV BIOL, V18, P84, DOI 10.1016/j.semcdb.2006.12.013; Snarr BS, 2008, DEV DYNAM, V237, P2804, DOI 10.1002/dvdy.21725; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; SZABO E, 1991, CELL GROWTH DIFFER, V2, P475; Thepot D, 2000, DEVELOPMENT, V127, P143; THIENE G, 1980, BRIT HEART J, V43, P605; Tian Y, 2012, CIRC RES, V110, P1023, DOI 10.1161/CIRCRESAHA.111.243899; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; Webb S, 2003, J ANAT, V202, P327, DOI 10.1046/j.1469-7580.2003.00168.x; WILKINSON DG, 1989, DEVELOPMENT, V106, P465; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wu BR, 2011, CIRC RES, V109, P183, DOI 10.1161/CIRCRESAHA.111.245035; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011; Zenz R, 2003, DEV CELL, V4, P879, DOI 10.1016/S1534-5807(03)00161-8; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zhang J, 2008, DEVELOPMENT, V135, P3611, DOI 10.1242/dev.025361; Zhang J, 2010, CIRC RES, V107, P1209, DOI 10.1161/CIRCRESAHA.110.225318; Zhang Z, 2006, DEVELOPMENT, V133, P3587, DOI 10.1242/dev.02539	89	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57032	10.1371/journal.pone.0057032	http://dx.doi.org/10.1371/journal.pone.0057032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437302	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000067
J	Mineau, P; Whiteside, M				Mineau, Pierre; Whiteside, Melanie			Pesticide Acute Toxicity Is a Better Correlate of US Grassland Bird Declines than Agricultural Intensification	PLOS ONE			English	Article							INSECTICIDE USE	Common agricultural birds are in decline, both in Europe and in North America. Evidence from Europe suggests that agricultural intensification and, for some species, the indirect effects of pesticides mediated through a loss of insect food resource is in part responsible. On a state-by-state basis for the conterminous Unites States (U.S.), we looked at several agronomic variables to predict the number of grassland species increasing or declining according to breeding bird surveys conducted between 1980 and 2003. Best predictors of species declines were the lethal risk from insecticide use modeled from pesticide impact studies, followed by the loss of cropped pasture. Loss of permanent pasture or simple measures of agricultural intensification such as the proportion of land under crop or the proportion of farmland treated with herbicides did not explain bird declines as well. Because the proportion of farmland treated with insecticides, and more particularly the lethal risk to birds from the use of current insecticides feature so prominently in the best models, this suggests that, in the U.S. at least, pesticide toxicity to birds should be considered as an important factor in grassland bird declines.	[Mineau, Pierre; Whiteside, Melanie] Environm Canada, Natl Wildlife Res Ctr, Sci & Technol Branch, Ottawa, ON K1A 0H3, Canada; [Whiteside, Melanie] Hlth Canada, Pest Management Regulatory Agcy, Ottawa, ON K1A 0L2, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Health Canada	Mineau, P (corresponding author), Environm Canada, Natl Wildlife Res Ctr, Sci & Technol Branch, Carleton Univ Campus, Ottawa, ON K1A 0H3, Canada.	pierre.mineau@ec.gc.ca			Environment Canada	Environment Canada(CGIAR)	The work was funded by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, EFSA J, VXXXVI, P1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CAMPBELL LH, 1997, 227 JOINT NAT CONS C; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dunn E, 2000, 216 CAN WILDL SERV E; Evans KL, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00231.x; Fox AD, 2004, J APPL ECOL, V41, P427, DOI 10.1111/j.0021-8901.2004.00917.x; Fuller RJ, 2000, ECOLOGY AND CONSERVATION OF LOWLAND FARMLAND BIRDS, P5; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Heath SA, 2008, THESIS G MASON U FAI; McLaughlin A, 1995, AGR ECOSYST ENVIRON, V55, P201, DOI 10.1016/0167-8809(95)00609-V; Mineau P, 2005, ECOSCIENCE, V12, P267, DOI 10.2980/i1195-6860-12-2-267.1; Mineau P, 2002, ENVIRON TOXICOL CHEM, V21, P1497, DOI 10.1897/1551-5028(2002)021&lt;1497:ETPOBM&gt;2.0.CO;2; Mineau P, 2001, REV ENVIRON CONTAM T, V170, P13; Mineau P, 1999, J RAPTOR RES, V33, P1; Mineau P., 2004, WILLIAM MARY ENV LAW, V28, P313; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; Mineau Pierre, 2005, U S Forest Service General Technical Report PSW, V191, P1065; Murphy MT, 2003, AUK, V120, P20, DOI 10.1642/0004-8038(2003)120[0020:APTWTE]2.0.CO;2; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Pain DJ, 1997, FARMING BIRDS EUROPE; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; RODENHOUSE NL, 1993, USDA ROCKY, V229, P280; Sauer J.R., 2000, N AM BREEDING BIRD S	25	125	129	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57457	10.1371/journal.pone.0057457	http://dx.doi.org/10.1371/journal.pone.0057457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437392	Green Published, gold			2022-12-25	WOS:000315184200257
J	Bailey, DP; Boddy, LM; Savory, LA; Denton, SJ; Kerr, CJ				Bailey, Daniel P.; Boddy, Lynne M.; Savory, Louise A.; Denton, Sarah J.; Kerr, Catherine J.			Choice of Activity-Intensity Classification Thresholds Impacts upon Accelerometer-Assessed Physical Activity-Health Relationships in Children	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; REFERENCE CURVES; INDEPENDENT ASSOCIATIONS; CARDIOMETABOLIC RISK; METABOLIC SYNDROME; RT3 ACCELEROMETER; ADOLESCENTS; YOUTH; ADIPOSITY	Background: It is unknown whether using different published thresholds (PTs) for classifying physical activity (PA) impacts upon activity-health relationships. This study explored whether relationships between PA (sedentary [SED], light PA [LPA], moderate PA [MPA], moderate-to-vigorous PA, vigorous PA [VPA]) and health markers differed in children when classified using three different PTs. Methods: 104 children (63 girls) aged 10-14 years wore an RT3 triaxial accelerometer for seven days and measures of adiposity and cardiometabolic risk markers were taken. Results: Significant associations (p<.05) in boys were found between LPA and body mass index z-score and waist circumference z-score for the Rowlands et al PT only (beta=.459 and. 401, respectively) and body fat% (BF%) for the Chu et al PT only (beta=.322) and in girls with BF% for the Rowlands et al PT only (beta=.303) and systolic BP and blood glucose for the Vanhelst et al PT only (beta=-2.298 and -2.283, respectively). MPA was significantly (p<05) associated with BF%, diastolic BP, and cardiorespiratory fitness (CRF) for the Chu et al PT only in girls (beta=-.436, -.529, and .446, respectively). SED was significantly (p<.05) associated with triglycerides (beta=.492) for the Rowlands et al PT only in boys and VPA with CRF (p<.05) for the Rowlands et al and Vanhelst et al PTs only in girls (beta=.416 and .352, respectively). Conclusions: The choice of PT impacted upon activity-health relationships. A consensus on appropriate accelerometer thresholds for quantifying PA intensity and sedentary behaviour is needed in order to make accurate evidence-based recommendations for health promotion.	[Bailey, Daniel P.; Savory, Louise A.; Denton, Sarah J.; Kerr, Catherine J.] Univ Bedfordshire, ISPAR, Bedford, England; [Boddy, Lynne M.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool L3 5UX, Merseyside, England	University of Bedfordshire; Liverpool John Moores University	Bailey, DP (corresponding author), Univ Bedfordshire, ISPAR, Bedford, England.	daniel.bailey@beds.ac.uk	Bailey, Daniel/HDL-7697-2022	Boddy, Lynne/0000-0002-7477-4389; Charman, Sarah/0000-0002-3029-7672; Bailey, Daniel/0000-0003-3772-630X	Bedford Charity [166/308]	Bedford Charity	This work was funded by the Bedford Charity (grant number 166/308; http://www.bedfordcharity.org.uk). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires L, 2010, J PHYS ACT HEALTH, V7, P54, DOI 10.1123/jpah.7.1.54; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Bailey DP, 2012, EUR J PEDIATR, V171, P1317, DOI 10.1007/s00431-012-1719-3; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Camhi SM, 2010, INT J PEDIATR OBES, V5, P122, DOI 10.3109/17477160903111763; Chaput JP, 2012, PEDIATR OBES, V7, P251, DOI 10.1111/j.2047-6310.2011.00028.x; Chu EYW, 2007, MED SCI SPORT EXER, V39, P2085, DOI 10.1249/mss.0b013e318148436c; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; *DEP HLTH, 2008, HLTH SURV ENGL 2008; Department of Health, 2011, START ACT STAY ACT R; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Ekelund U, 2009, AM J CLIN NUTR, V89, P90, DOI 10.3945/ajcn.2008.26649; Ferreira I, 2005, ARCH INTERN MED, V165, P42, DOI 10.1001/archinte.165.1.42; Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gaya AR, 2009, ANN HUM BIOL, V36, P379, DOI 10.1080/03014460902817976; Gutin B, 2005, AM J CLIN NUTR, V81, P746, DOI 10.1093/ajcn/81.4.746; Hussey J, 2007, BRIT J SPORT MED, V41, P311, DOI 10.1136/bjsm.2006.032045; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Krekoukia M, 2007, METABOLISM, V56, P206, DOI 10.1016/j.metabol.2006.09.014; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Mattocks C, 2008, J PHYS ACT HEALTH, V5, pS98, DOI 10.1123/jpah.5.s1.s98; Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b; McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; Parikh P, 2009, AM J HEALTH PROMOT, V23, P279, DOI 10.4278/ajhp.071221140; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Rowlands AV, 2008, PREV MED, V46, P317, DOI 10.1016/j.ypmed.2007.11.004; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Rowlands AV, 2004, MED SCI SPORT EXER, V36, P518, DOI 10.1249/01.MSS.0000117158.14542.E7; Shemesh T, 2006, CLIN CHIM ACTA, V367, P69, DOI 10.1016/j.cca.2005.11.014; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Stone MR, 2009, J SPORT SCI MED, V8, P136; Vahlkvist S, 2009, ALLERGY, V64, P1649, DOI 10.1111/j.1398-9995.2009.02081.x; Vanhelst J, 2010, J SPORT SCI, V28, P381, DOI 10.1080/02640410903508821	38	9	9	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57101	10.1371/journal.pone.0057101	http://dx.doi.org/10.1371/journal.pone.0057101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441234	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200091
J	Hu, YS; Xu, HP; Li, ZH; Zheng, XJ; Jia, XZ; Nie, QH; Zhang, XQ				Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan			Comparison of the Genome-Wide DNA Methylation Profiles between Fast-Growing and Slow-Growing Broilers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; CARCASS TRAITS; CPG ISLANDS; CHROMATIN-STRUCTURE; SIGNALING PATHWAY; BODY-COMPOSITION; F-2 INTERCROSS; GROWTH-FACTORS; CHICKEN; GENE	Introduction: Growth traits are important in poultry production, however, little is known for its regulatory mechanism at epigenetic level. Therefore, in this study, we aim to compare DNA methylation profiles between fast-and slow-growing broilers in order to identify candidate genes for chicken growth. Methylated DNA immunoprecipitation-sequencing (MeDIP-seq) was used to investigate the genome-wide DNA methylation pattern in high and low tails of Recessive White Rock (WRRh; WRRl) and that of Xinhua Chickens (XHh; XHl) at 7 weeks of age. The results showed that the average methylation density was the lowest in CGIs followed by promoters. Within the gene body, the methylation density of introns was higher than that of UTRs and exons. Moreover, different methylation levels were observed in different repeat types with the highest in LINE/CR1. Methylated CGIs were prominently distributed in the intergenic regions and were enriched in the size ranging 200-300 bp. In total 13,294 methylated genes were found in four samples, including 4,085 differentially methylated genes of WRRh Vs. WRRl, 5,599 of XHh Vs. XHl, 4,204 of WRRh Vs. XHh, as well as 7,301 of WRRl Vs. XHl. Moreover, 132 differentially methylated genes related to growth and metabolism were observed in both inner contrasts (WRRh Vs. WRRl and XHh Vs. XHl), whereas 129 differentially methylated genes related to growth and metabolism were found in both across-breed contrasts (WRRh Vs. XHh and WRRl Vs. XHl). Further analysis showed that overall 75 genes exhibited altered DNA methylation in all four contrasts, which included some well-known growth factors of IGF1R, FGF12, FGF14, FGF18, FGFR2, and FGFR3. In addition, we validate the MeDIP-seq results by bisulfite sequencing in some regions. Conclusions: This study revealed the global DNA methylation pattern of chicken muscle, and identified candidate genes that potentially regulate muscle development at 7 weeks of age at methylation level.	[Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan] S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China; [Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Guangzhou, Guangdong, Peoples R China; [Hu, Yongsheng; Xu, Haiping; Li, Zhenhui; Zheng, Xuejuan; Jia, Xinzheng; Nie, Qinghua; Zhang, Xiquan] Minist Agr, Key Lab Chicken Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Nie, QH (corresponding author), S China Agr Univ, Coll Anim Sci, Dept Anim Genet Breeding & Reprod, Guangzhou, Guangdong, Peoples R China.	nqinghua@scau.edu.cn	Jia, Xinzheng/W-7312-2019; xu, haiping/GSJ-1374-2022; li, zh/HII-5698-2022; jia, xinzheng/K-7220-2017	Jia, Xinzheng/0000-0001-5699-8285; jia, xinzheng/0000-0001-5699-8285	National Natural Scientific Foundation of China [31172200, 31000544]; National Broiler Industry Technology System [CARS-42-G05]; National High Technology Research and Development Program (863) of China [2011AA100301, 2010AA10A102]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Broiler Industry Technology System; National High Technology Research and Development Program (863) of China(National High Technology Research and Development Program of China)	This research was supported by grants from the National Natural Scientific Foundation of China (31172200; 31000544), the National Broiler Industry Technology System (CARS-42-G05) and the National High Technology Research and Development Program (863) of China (2011AA100301; 2010AA10A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Ankra-Badu GA, 2010, ANIM GENET, V41, P400, DOI 10.1111/j.1365-2052.2009.02017.x; Arbabi S, 2002, CRIT CARE MED, V30, pS74, DOI 10.1097/00003246-200201001-00010; Balda MS, 1998, J CELL SCI, V111, P541; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen KF, 2012, ANIM BIOTECHNOL, V23, P43, DOI 10.1080/10495398.2011.630897; Conerly M, 2010, DIS MODEL MECH, V3, P290, DOI 10.1242/dmm.004812; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Cormier S, 2005, GENE EXPR PATTERNS, V5, P569, DOI 10.1016/j.modgep.2004.10.008; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deeb N, 2002, J HERED, V93, P107, DOI 10.1093/jhered/93.2.107; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029173; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lei MM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-70; Li QH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019428; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Nadaf J, 2009, PHYSIOL GENOMICS, V38, P241, DOI 10.1152/physiolgenomics.90384.2008; Ohuchi H, 2000, MECH DEVELOP, V95, P55, DOI 10.1016/S0925-4773(00)00331-2; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Sasaki H., 1993, Experientia Supplementum (Basel), V64, P469; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Sati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031621; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SCANES CG, 1984, POULTRY SCI, V63, P2062, DOI 10.3382/ps.0632062; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Uemoto Y, 2009, POULTRY SCI, V88, P477, DOI 10.3382/ps.2008-00296; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; Zhang H, 2011, J ANIM BREED GENET, V128, P366, DOI 10.1111/j.1439-0388.2011.00927.x; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou H, 2006, POULTRY SCI, V85, P1700, DOI 10.1093/ps/85.10.1700	56	62	68	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56411	10.1371/journal.pone.0056411	http://dx.doi.org/10.1371/journal.pone.0056411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441189	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200046
J	Scholz, I; Lange, SJ; Hein, S; Hess, WR; Backofen, R				Scholz, Ingeborg; Lange, Sita J.; Hein, Stephanie; Hess, Wolfgang R.; Backofen, Rolf			CRISPR-Cas Systems in the Cyanobacterium Synechocystis sp PCC6803 Exhibit Distinct Processing Pathways Involving at Least Two Cas6 and a Cmr2 Protein	PLOS ONE			English	Article							SECONDARY STRUCTURES; ANTIVIRAL DEFENSE; IMMUNE-SYSTEMS; RNA CLEAVAGE; BACTERIA; ARCHAEA; COMPLEX; RECOGNITION; PROKARYOTES; GENES	The CRISPR-Cas (Clustered Regularly Interspaced Short Palindrome Repeats - CRISPR associated proteins) system provides adaptive immunity in archaea and bacteria. A hallmark of CRISPR-Cas is the involvement of short crRNAs that guide associated proteins in the destruction of invading DNA or RNA. We present three fundamentally distinct processing pathways in the cyanobacterium Synechocystis sp. PCC6803 for a subtype I-D (CRISPR1), and two type III systems (CRISPR2 and CRISPR3), which are located together on the plasmid pSYSA. Using high-throughput transcriptome analyses and assays of transcript accumulation we found all CRISPR loci to be highly expressed, but the individual crRNAs had profoundly varying abundances despite single transcription start sites for each array. In a computational analysis, CRISPR3 spacers with stable secondary structures displayed a greater ratio of degradation products. These structures might interfere with the loading of the crRNAs into RNP complexes, explaining the varying abundancies. The maturation of CRISPR1 and CRISPR2 transcripts depends on at least two different Cas6 proteins. Mutation of gene sll7090, encoding a Cmr2 protein led to the disappearance of all CRISPR3-derived crRNAs, providing in vivo evidence for a function of Cmr2 in the maturation, regulation of expression, Cmr complex formation or stabilization of CRISPR3 transcripts. Finally, we optimized CRISPR repeat structure prediction and the results indicate that the spacer context can influence individual repeat structures.	[Scholz, Ingeborg; Hein, Stephanie; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Genet & Expt Bioinformat Grp, D-79106 Freiburg, Germany; [Lange, Sita J.; Backofen, Rolf] Univ Freiburg, Bioinformat Grp, Dept Comp Sci, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Hess, WR (corresponding author), Univ Freiburg, Fac Biol, Genet & Expt Bioinformat Grp, Hugstetter Str 55, D-79106 Freiburg, Germany.	wolfgang.hess@biologie.uni-freiburg.de	Backofen, Rolf/AAC-1569-2021	Saunders, Sita/0000-0002-2243-5422; Backofen, Rolf/0000-0001-8231-3323; Hess, Wolfgang/0000-0002-5340-3423	German Research Foundation (DFG) program FOR1680 "Unravelling the Prokaryotic Immune System'' [HE 2544/8-1, BA 2168/5-1]; Microsoft Corporation	German Research Foundation (DFG) program FOR1680 "Unravelling the Prokaryotic Immune System''(German Research Foundation (DFG)); Microsoft Corporation(Microsoft)	Support by the German Research Foundation (DFG) program FOR1680 "Unravelling the Prokaryotic Immune System'' (grants HE 2544/8-1 and BA 2168/5-1) to WRH and RB is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The utilised software FASTQC and FASTX are unpublished and have been developed by the Bioinformatics Group at the Babraham Institute in Cambridge, UK, and the Computational Biology Service Unit from Cornell University in Ithaca, New York, USA, which is partially funded by Microsoft Corporation, respectively. We would also like to thank Elena Conti and Christian Benda for helpful dicussion on possible Cmr2 functions, and Daniel Maticzka, Steve Hoffmann, and Christian Otto for sharing their expertise in the mapping of large-scale sequencing reads.	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-43; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Brodt A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-65; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cocozaki AI, 2012, STRUCTURE, V20, P545, DOI 10.1016/j.str.2012.01.018; Danika T, 2012, DNA RES, V19, P435, DOI 10.1093/dnares/dss024; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Djordjevic M, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-24; Garrett RA, 2011, BIOCHEM SOC T, V39, P51, DOI 10.1042/BST0390051; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Haurwitz RE, 2012, EMBO J; Hein S, 2013, RNA BIOL IN PRESS; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Juranek S, 2012, RNA, V18, P783, DOI 10.1261/rna.031468.111; Kaneko T, 2003, DNA RES, V10, P221, DOI 10.1093/dnares/10.5.221; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lange SJ, 2012, NUCLEIC ACIDS RES, V40, P5215, DOI 10.1093/nar/gks181; Lawrence CM, 2011, STRUCTURE, V19, P142, DOI 10.1016/j.str.2011.01.003; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Przybilski R, 2011, RNA BIOL, V8, P517, DOI 10.4161/rna.8.3.15190; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Shah SA, 2011, RES MICROBIOL, V162, P27, DOI 10.1016/j.resmic.2010.09.001; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	57	91	95	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56470	10.1371/journal.pone.0056470	http://dx.doi.org/10.1371/journal.pone.0056470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441196	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200053
J	Sun, SY; Kjelleberg, S; McDougald, D				Sun, Shuyang; Kjelleberg, Staffan; McDougald, Diane			Relative Contributions of Vibrio Polysaccharide and Quorum Sensing to the Resistance of Vibrio cholerae to Predation by Heterotrophic Protists	PLOS ONE			English	Article							O1 EL-TOR; SECRETION SYSTEM; GRAZING RESISTANCE; COLONY MORPHOLOGY; BIOFILM FORMATION; BACTERIA; VIRULENCE; SURVIVAL; IDENTIFICATION; COLONIZATION	Protozoan grazing is a major mortality factor faced by bacteria in the environment. Vibrio cholerae, the causative agent of the disease cholera, is a natural inhabitant of aquatic ecosystems, and its survival depends on its ability to respond to stresses, such as predation by heterotrophic protists. Previous results show that grazing pressure induces biofilm formation and enhances a smooth to rugose morphotypic shift, due to increased expression of Vibrio polysaccharide (VPS). In addition to negatively controlling vps genes, the global quorum sensing (QS) regulator, HapR, plays a role in grazing resistance as the DhapR strain is efficiently consumed while the wild type (WT) is not. Here, the relative and combined contributions of VPS and QS to grazing resistance were investigated by exposing VPS and HapR mutants and double mutants in VPS and HapR encoding genes at different phases of biofilm development to amoeboid and flagellate grazers. Data show that the WT biofilms were grazing resistant, the VPS mutants were less resistant than the WT strain, but more resistant than the QS mutant strain, and that QS contributes to grazing resistance mainly in mature biofilms. In addition, grazing effects on biofilms of mixed WT and QS mutant strains were investigated. The competitive fitness of each strain in mixed biofilms was determined by CFU and microscopy. Data show that protozoa selectively grazed the QS mutant in mixed biofilms, resulting in changes in the composition of the mixed community. A small proportion of QS mutant cells which comprised 4% of the mixed biofilm biovolume were embedded in grazing resistant WT microcolonies and shielded from predation, indicating the existence of associational protection in mixed biofilms.	[Sun, Shuyang; Kjelleberg, Staffan; McDougald, Diane] Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Kjelleberg, Staffan] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [McDougald, Diane] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [McDougald, Diane] Nanyang Technol Univ, Adv Environm Biotechnol Ctr, Nanyang Environm & Water Inst, Singapore 639798, Singapore	University of New South Wales Sydney; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	McDougald, D (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	D.McDougald@unsw.edu.au	McDougald, Diane/AAF-4799-2020; McDougald, Diane/B-5564-2009; Kjelleberg, Staffan/AAB-4641-2020; SUN, SHUYANG/E-6671-2016; Kjelleberg, Staffan/C-9229-2015	McDougald, Diane/0000-0001-5827-8441; McDougald, Diane/0000-0001-5827-8441; Kjelleberg, Staffan/0000-0003-4271-6413; SUN, SHUYANG/0000-0001-6013-0614; Kjelleberg, Staffan/0000-0003-4271-6413	Australian Research Council [DP1096481]; Centre for Marine Bio-Innovation; University of New South Wales, Sydney	Australian Research Council(Australian Research Council); Centre for Marine Bio-Innovation; University of New South Wales, Sydney	This project was supported by the Australian Research Council grant DP1096481 and the Centre for Marine Bio-Innovation, the University of New South Wales, Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2007, P NATL ACAD SCI USA, V104, P17801, DOI 10.1073/pnas.0705599104; ALEXEYEV MF, 1995, GENE, V160, P59, DOI 10.1016/0378-1119(95)00141-R; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Boenigk J, 2000, J EUKARYOT MICROBIOL, V47, P350, DOI 10.1111/j.1550-7408.2000.tb00060.x; BROWN RC, 1975, NATURE, V254, P434, DOI 10.1038/254434a0; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Erken M, 2011, FEMS MICROBIOL ECOL, V76, P504, DOI 10.1111/j.1574-6941.2011.01067.x; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; Grossart HP, 2010, ENV MICROBIOL REP, V2, P706, DOI 10.1111/j.1758-2229.2010.00179.x; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Huq A, 1996, APPL ENVIRON MICROB, V62, P2508, DOI 10.1128/AEM.62.7.2508-2512.1996; Huws SA, 2005, J APPL MICROBIOL, V98, P238, DOI 10.1111/j.1365-2672.2004.02449.x; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Jousset A, 2009, ISME J, V3, P666, DOI 10.1038/ismej.2009.26; KING CH, 1988, APPL ENVIRON MICROB, V54, P3023, DOI 10.1128/AEM.54.12.3023-3033.1988; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Macek M, 1997, AQUAT MICROB ECOL, V13, P257, DOI 10.3354/ame013257; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Matz C, 2004, ENVIRON MICROBIOL, V6, P218, DOI 10.1111/j.1462-2920.2004.00556.x; Matz C, 2008, ISME J, V2, P843, DOI 10.1038/ismej.2008.47; Matz C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002744; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; Mueller RS, 2007, J BACTERIOL, V189, P5348, DOI 10.1128/JB.01867-06; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Parry JD, 2007, LETT APPL MICROBIOL, V45, P364, DOI 10.1111/j.1472-765X.2007.02213.x; Pruzzo C, 2006, OCEANS AND HEALTH: PATHOGENS IN THE MARINE ENVIRONMENT, P217; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; RICE EW, 1992, LANCET, V340, P740, DOI 10.1016/0140-6736(92)92289-R; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; VAATANEN P, 1976, W A DENOTTBECK F SCI, V1, P1; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; Weitere M, 2005, ENVIRON MICROBIOL, V7, P1593, DOI 10.1111/j.1462-2920.2005.00851.x; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Worden AZ, 2006, ENVIRON MICROBIOL, V8, P21, DOI 10.1111/j.1462-2920.2005.00863.x; Worner U, 2000, MICROB ECOL, V40, P209; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	56	25	28	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56338	10.1371/journal.pone.0056338	http://dx.doi.org/10.1371/journal.pone.0056338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441178	Green Published, gold			2022-12-25	WOS:000315159200035
J	Ghodke, I; Muniyappa, K				Ghodke, Indrajeet; Muniyappa, K.			Processing of DNA Double-stranded Breaks and Intermediates of Recombination and Repair by Saccharomyces cerevisiae Mre11 and Its Stimulation by Rad50, Xrs2, and Sae2 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEASE ACTIVITY; END-RESECTION; MRE11/RAD50/XRS2 COMPLEX; MEIOTIC RECOMBINATION; TELOMERE MAINTENANCE; FUNCTIONAL-ANALYSIS; REPLICATION FORKS; PATHWAY CHOICE; HAIRPIN DNA; CELL-CYCLE	Saccharomyces cerevisiae RAD50, MRE11, and XRS2 genes are essential for telomere length maintenance, cell cycle checkpoint signaling, meiotic recombination, and DNA double-stranded break (DSB) repair via nonhomologous end joining and homologous recombination. The DSB repair pathways that draw upon Mre11-Rad50-Xrs2 subunits are complex, so their mechanistic features remain poorly understood. Moreover, the molecular basis of DSB end resection in yeast mre11-nuclease deficient mutants and Mre11 nuclease-independent activation of ATM in mammals remains unknown and adds a new dimension to many unanswered questions about the mechanism of DSB repair. Here, we demonstrate that S. cerevisiae Mre11 (ScMre11) exhibits higher binding affinity for single-over double-stranded DNA and intermediates of recombination and repair and catalyzes robust unwinding of substrates possessing a 3' single-stranded DNA overhang but not of 5' overhangs or blunt-ended DNA fragments. Additional evidence disclosed that ScMre11 nuclease activity is dispensable for its DNA binding and unwinding activity, thus uncovering the molecular basis underlying DSB end processing in mre11 nuclease deficient mutants. Significantly, Rad50, Xrs2, and Sae2 potentiate the DNA unwinding activity of Mre11, thus underscoring functional interaction among the components of DSB end repair machinery. Our results also show that ScMre11 by itself binds to DSB ends, then promotes end bridging of duplex DNA, and directly interacts with Sae2. We discuss the implications of these results in the context of an alternative mechanism for DSB end processing and the generation of single-stranded DNA for DNA repair and homologous recombination.	[Ghodke, Indrajeet; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Muniyappa, K (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	kmbc@biochem.iisc.ernet.in			Council of Scientific and Industrial Research, New Delhi; J. C. Bose National Fellowship from the Department of Science and Technology, Government of India, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose National Fellowship from the Department of Science and Technology, Government of India, New Delhi	This work was supported by a grant from the Council of Scientific and Industrial Research, New Delhi, and by a J. C. Bose National Fellowship from the Department of Science and Technology, Government of India, New Delhi (to K. M.).	Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Barlow JH, 2008, MOL CELL, V30, P73, DOI 10.1016/j.molcel.2008.01.016; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bonetti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014142; Borde V, 2009, INT J BIOCHEM CELL B, V41, P1249, DOI 10.1016/j.biocel.2008.12.013; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bressan DA, 1998, GENETICS, V150, P591; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Declais AC, 2008, CURR OPIN STRUC BIOL, V18, P86, DOI 10.1016/j.sbi.2007.11.001; Dong F, 2001, NUCLEIC ACIDS RES, V29, P3248, DOI 10.1093/nar/29.15.3248; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Foster SS, 2011, MOL CELL BIOL, V31, P4379, DOI 10.1128/MCB.05854-11; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Ghosal G, 2005, NUCLEIC ACIDS RES, V33, P4692, DOI 10.1093/nar/gki777; Ghosal G, 2007, J MOL BIOL, V372, P864, DOI 10.1016/j.jmb.2007.07.013; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; JOHZUKA K, 1995, GENETICS, V139, P1521; KADYK LC, 1992, GENETICS, V132, P387; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Khanduja JS, 2012, J BIOL CHEM, V287, P1345, DOI 10.1074/jbc.M111.304741; Kim HS, 2008, GENETICS, V178, P711, DOI 10.1534/genetics.107.081331; Kironmai KM, 1997, GENES CELLS, V2, P443; Krogh BO, 2005, GENETICS, V171, P1561, DOI 10.1534/genetics.105.049478; Lammens K, 2011, CELL, V145, P54, DOI 10.1016/j.cell.2011.02.038; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Lim HS, 2011, GENE DEV, V25, P1091, DOI 10.1101/gad.2037811; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lydeard JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000973; Majka J, 2012, J BIOL CHEM, V287, P2328, DOI 10.1074/jbc.M111.307041; Malmqvist M, 1997, CURR OPIN CHEM BIOL, V1, P378, DOI 10.1016/S1367-5931(97)80077-4; McKee AHZ, 1997, GENETICS, V146, P797; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mockel C, 2012, NUCLEIC ACIDS RES, V40, P914, DOI 10.1093/nar/gkr749; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Rattray AJ, 2001, GENETICS, V158, P109; Raynard S, 2008, GENE DEV, V22, P2903, DOI 10.1101/gad.1742408; Robison JG, 2005, J BIOL CHEM, V280, P12927, DOI 10.1074/jbc.M414391200; Sambrook J., 2002, MOL CLONING LAB MANU; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Trenz K, 2006, EMBO J, V25, P1764, DOI 10.1038/sj.emboj.7601045; Tripathi P, 2006, J MOL BIOL, V364, P599, DOI 10.1016/j.jmb.2006.08.096; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Wyman C, 2011, DNA REPAIR, V10, P1066, DOI 10.1016/j.dnarep.2011.07.008; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	89	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11273	11286		10.1074/jbc.M112.439315	http://dx.doi.org/10.1074/jbc.M112.439315			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443654	Green Published, hybrid			2022-12-25	WOS:000317915500030
J	Xu, CL; Ren, GW; Cao, G; Chen, Q; Shou, PS; Zheng, CX; Du, LM; Han, XY; Jiang, MH; Yang, Q; Lin, LY; Wang, G; Yu, PF; Zhang, X; Cao, W; Brewer, G; Wang, Y; Shi, YF				Xu, Chunliang; Ren, Guangwen; Cao, Gang; Chen, Qing; Shou, Peishun; Zheng, Chunxing; Du, Liming; Han, Xiaoyan; Jiang, Menghui; Yang, Qian; Lin, Liangyu; Wang, Guan; Yu, Pengfei; Zhang, Xin; Cao, Wei; Brewer, Gary; Wang, Ying; Shi, Yufang			miR-155 Regulates Immune Modulatory Properties of Mesenchymal Stem Cells by Targeting TAK1-binding Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED IMMUNOSUPPRESSION; DENDRITIC CELLS; TISSUE; DIFFERENTIATION; MICRORNA-155; MECHANISMS; EXPRESSION; PATHWAY; MARROW	MSCs possess potent immunosuppressive capacity. We have reported that mouse MSCs inhibit T cell proliferation and function via nitric oxide. This immune regulatory capacity of MSCs is induced by the inflammatory cytokines IFN gamma together with either TNF alpha or IL-1 beta. This effect of inflammatory cytokines on MSCs is extraordinary; logarithmic increases in the expression of iNOS and chemokines are often observed. To investigate the molecular mechanisms underlying this robust effect of cytokines, we examined the expression of microRNAs in MSCs before and after cytokine treatment. We found that miR-155 is most significantly up-regulated. Furthermore, our results showed that miR-155 inhibits the immunosuppressive capacity of MSCs by reducing iNOS expression. We further demonstrated that miR-155 targets TAK1-binding protein 2 (TAB2) to regulate iNOS expression. Additionally, knockdown of TAB2 reduced iNOS expression. In summary, our study demonstrated that miR-155 inhibits the immunosuppressive capacity of MSCs by reducing iNOS expression by targeting TAB2. Our data revealed a novel role of miR-155 in regulating the immune modulatory activities of MSCs.	[Xu, Chunliang; Ren, Guangwen; Cao, Gang; Chen, Qing; Shou, Peishun; Zheng, Chunxing; Du, Liming; Han, Xiaoyan; Jiang, Menghui; Yang, Qian; Lin, Liangyu; Wang, Guan; Yu, Pengfei; Zhang, Xin; Cao, Wei; Brewer, Gary; Wang, Ying; Shi, Yufang] Shanghai Jiao Tong Univ, Key Lab Stem Cell Biol, Shanghai Inst Biol Sci, Inst Hlth Sci,Chinese Acad Sci,Sch Med, Shanghai 200025, Peoples R China; [Ren, Guangwen; Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Ren, Guangwen; Shi, Yufang] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ 08901 USA; [Brewer, Gary] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, Y (corresponding author), Chinese Acad Sci, Key Lab Stem Cell Biol, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China.	yingwang@sibs.ac.cn; yufangshi@sibs.ac.cn	han, xiao/HDN-9782-2022; Shou, Peishun/J-7985-2014; Shi, Yufang/AAE-4431-2020; Du, Liming/M-8227-2019; Yu, Pengfei/AHC-3497-2022; Xu, Chunliang/R-7065-2018	Shou, Peishun/0000-0001-7685-7471; Shi, Yufang/0000-0001-8964-319X; Yu, Pengfei/0000-0002-3894-5697; Du, Liming/0000-0002-0527-3556; Chen, Qing/0000-0002-2088-0370; wang, ying/0000-0002-2571-9367	Ministry of Science and Technology of China [2010CB945600, 2011DFA30630]; Scientific Innovation Project of the Chinese Academy of Science [XDA 01040107, XDA 01040110]; National Science and Technology Project of China [31010103908, 81273316]; Shanghai Municipal Key Projects of Basic Research [12JC1409200]; Shanghai Municipal Natural Science Foundation [12ZR1452600]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2012KIP202]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Scientific Innovation Project of the Chinese Academy of Science; National Science and Technology Project of China; Shanghai Municipal Key Projects of Basic Research; Shanghai Municipal Natural Science Foundation; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the Ministry of Science and Technology of China (2010CB945600 and 2011DFA30630), Scientific Innovation Project of the Chinese Academy of Science (XDA 01040107 and XDA 01040110), the National Science and Technology Project of China (31010103908 and 81273316), Shanghai Municipal Key Projects of Basic Research (12JC1409200), Shanghai Municipal Natural Science Foundation (12ZR1452600), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, and the Chinese Academy of Sciences (2012KIP202).	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim YJ, 2009, STEM CELLS, V27, P3093, DOI 10.1002/stem.235; Lakshmipathy U, 2008, STEM CELLS, V26, P356, DOI 10.1634/stemcells.2007-0625; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ren G., 2001, J IMMUNOL, V184, P2321; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Xu GW, 2007, CELL RES, V17, P240, DOI 10.1038/cr.2007.4; Zhou HB, 2010, BLOOD, V116, P5885, DOI 10.1182/blood-2010-04-280156	25	68	79	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11074	11079		10.1074/jbc.M112.414862	http://dx.doi.org/10.1074/jbc.M112.414862			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23449975	Green Published, hybrid			2022-12-25	WOS:000317915500013
J	Blair, C; Arcos, VHJ; de la Cruz, FRM; Murphy, RW				Blair, Christopher; Jimenez Arcos, Victor H.; Mendez de la Cruz, Fausto R.; Murphy, Robert W.			Landscape Genetics of Leaf-Toed Geckos in the Tropical Dry Forest of Northern Mexico	PLOS ONE			English	Article							POPULATION-STRUCTURE; CONSERVATION PRIORITIES; MULTIPLE-REGRESSION; DISTANCE MATRICES; SPATIAL-ANALYSIS; MANTEL TEST; FLOW; CONNECTIVITY; DISPERSAL; BARRIERS	Habitat fragmentation due to both natural and anthropogenic forces continues to threaten the evolution and maintenance of biological diversity. This is of particular concern in tropical regions that are experiencing elevated rates of habitat loss. Although less well-studied than tropical rain forests, tropical dry forests (TDF) contain an enormous diversity of species and continue to be threatened by anthropogenic activities including grazing and agriculture. However, little is known about the processes that shape genetic connectivity in species inhabiting TDF ecosystems. We adopt a landscape genetic approach to understanding functional connectivity for leaf-toed geckos (Phyllodactylus tuberculosus) at multiple sites near the northernmost limit of this ecosystem at Alamos, Sonora, Mexico. Traditional analyses of population genetics are combined with multivariate GIS-based landscape analyses to test hypotheses on the potential drivers of spatial genetic variation. Moderate levels of within-population diversity and substantial levels of population differentiation are revealed by F-ST and D-est. Analyses using STRUCTURE suggest the occurrence of from 2 to 9 genetic clusters depending on the model used. Landscape genetic analysis suggests that forest cover, stream connectivity, undisturbed habitat, slope, and minimum temperature of the coldest period explain more genetic variation than do simple Euclidean distances. Additional landscape genetic studies throughout TDF habitat are required to understand species-specific responses to landscape and climate change and to identify common drivers. We urge researchers interested in using multivariate distance methods to test for, and report, significant correlations among predictor matrices that can impact results, particularly when adopting least-cost path approaches. Further investigation into the use of information theoretic approaches for model selection is also warranted.	[Blair, Christopher; Murphy, Robert W.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Blair, Christopher; Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Jimenez Arcos, Victor H.; Mendez de la Cruz, Fausto R.] Univ Nacl Autonoma Mexico, Inst Biol, Lab Herpetol, Mexico City 04510, DF, Mexico; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China	University of Toronto; Royal Ontario Museum; Universidad Nacional Autonoma de Mexico; Chinese Academy of Sciences; Kunming Institute of Zoology	Blair, C (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	Christopher.Blair@utoronto.ca	Mendez, Fausto R./O-3512-2018; Mendez, Fausto/HGD-1205-2022; Jiménez-Arcos, Victor H/GPX-4805-2022	Mendez, Fausto R./0000-0002-5084-1276; Murphy, Robert/0000-0001-8555-2338	Natural Sciences and Engineering Research Council of Canada [3148]; Theodore Roosevelt Memorial Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Theodore Roosevelt Memorial Fund	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant 3148) and the Theodore Roosevelt Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D, 2012, LME4 LINEAR MIXED EF; Becerra JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003436; Becerra JX, 2005, P NATL ACAD SCI USA, V102, P10919, DOI 10.1073/pnas.0409127102; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Blair C, 2012, CONSERV GENET RESOUR, V4, P807, DOI 10.1007/s12686-012-9649-y; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bowne DR, 2004, LANDSCAPE ECOL, V19, P1, DOI 10.1023/B:LAND.0000018357.45262.b9; Braunisch V, 2010, MOL ECOL, V19, P3664, DOI 10.1111/j.1365-294X.2010.04703.x; Burgos A, 2004, AGR ECOSYST ENVIRON, V104, P475, DOI 10.1016/j.agee.2004.01.038; Cascante A, 2002, CONSERV BIOL, V16, P137, DOI 10.1046/j.1523-1739.2002.00317.x; Ceballos G, 1995, CONSERV BIOL, V9, P1349, DOI 10.1046/j.1523-1739.1995.09061349.x; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clarke RT, 2002, J AGRIC BIOL ENVIR S, V7, P361, DOI 10.1198/108571102320; Clobert J, 2001, DISPERSAL, P452; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dixon JR, 1964, NEW MEXICO STATE U S, V64-1, P1; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Etherington TR, 2011, METHODS ECOL EVOL, V2, P52, DOI 10.1111/j.2041-210X.2010.00048.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 1998, ECOL MODEL, V105, P273, DOI 10.1016/S0304-3800(97)00163-4; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2002, INTRO CONSERVATION G; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Garcia A, 2006, BIOL CONSERV, V130, P25, DOI 10.1016/j.biocon.2005.11.030; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goslee S, 2008, DISSIMILARITY BASED; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Halekoh U., 2012, PBKRTEST PARAMETRIC; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Hirao AS, 2008, HEREDITY, V100, P424, DOI 10.1038/hdy.2008.1; Hirao AS, 2004, HEREDITY, V93, P290, DOI 10.1038/sj.hdy.6800503; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Sigala-Rodriguez JJ, 2009, REV MEX BIODIVERS, V80, P231; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kutner M. H., 2004, APPL LINEAR REGRESSI; Kuznetsova A., 2012, MIXMOD ANAL MIXED MO; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Leclerc E, 2008, MOL ECOL, V17, P1702, DOI 10.1111/j.1365-294X.2008.03710.x; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Michels E, 2001, MOL ECOL, V10, P1929, DOI 10.1046/j.1365-294X.2001.01340.x; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Miller MP, 1997, TOOLS POPULATION GEN; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Neel MC, 2008, BIOL CONSERV, V141, P938, DOI 10.1016/j.biocon.2007.12.031; Perez-Espona S, 2008, MOL ECOL, V17, P981, DOI 10.1111/j.1365-294X.2007.03629.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2022, R LANG ENV STAT COMP; Raeymaekers JAM, 2008, EVOL APPL, V1, P475, DOI 10.1111/j.1752-4571.2008.00019.x; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Robichaux R. H., 2000, TROPICAL DECIDUOUS F; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Shah V.B.., 2008, PROC 7 PYTHON SCI C, V7, P62; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2008, MOL ECOL, V17, P4642, DOI 10.1111/j.1365-294X.2008.03952.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Spear SF, 2010, BIOL CONSERV, V143, P778, DOI 10.1016/j.biocon.2009.12.021; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Vignieri SN, 2005, MOL ECOL, V14, P1925, DOI 10.1111/j.1365-294X.2005.02568.x; VilSS, 2003, P ROY SOC LOND B BIO, V270, P91, DOI [DOI 10.1098/RSPB.2002.2184, 10.1098/rspb.2002.2184]; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wilson L.D., 2010, CONSERVATION MESOAME; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Wofford JEB, 2005, ECOL APPL, V15, P628, DOI 10.1890/04-0095; Wright S, 1943, GENETICS, V28, P139	117	23	25	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57433	10.1371/journal.pone.0057433	http://dx.doi.org/10.1371/journal.pone.0057433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451230	Green Published, gold			2022-12-25	WOS:000316849500105
J	Mu, YN; Lian, FM; Teng, YB; Ao, JQ; Jiang, YL; He, YX; Chen, YX; Zhou, CZ; Chen, XH				Mu, Yinnan; Lian, Fu-Ming; Teng, Yan-Bin; Ao, Jingqun; Jiang, Yong-Liang; He, Yong-Xing; Chen, Yuxing; Zhou, Cong-Zhao; Chen, Xinhua			The N-Terminal beta-Sheet of Peroxiredoxin 4 in the Large Yellow Croaker Pseudosciaena crocea Is Involved in Its Biological Functions	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; KAPPA-B; SACCHAROMYCES-CEREVISIAE; 2-CYS PEROXIREDOXINS; HYDROGEN-PEROXIDE; OXIDATIVE DAMAGE; THIOREDOXIN; REDUCTASE; PROTEIN; IV	Peroxiredoxins (Prxs) are thiol-specific antioxidant proteins that exhibit peroxidase and peroxynitrite reductase activities involved in the reduction of reactive oxygen species. The peroxiredoxin Prx4 from the large yellow croaker Pseudosciaena crocea is a typical 2-Cys Prx with an N-terminal signal peptide. We solved the crystal structure of Prx4 at 1.90 angstrom and revealed an N-terminal antiparallel beta-sheet that contributes to the dimer interface. Deletion of this beta-sheet decreased the in vitro peroxidase activity to about 50% of the wild-type. In vivo assays further demonstrated that removal of this beta-sheet led to some impairment in the ability of Prx4 to negatively regulate nuclear factor-kappa B (NF-kappa B) activity and to perform its role in anti-bacterial immunity. These results provide new insights into the structure and function relationship of a peroxiredoxin from bony fish.	[Mu, Yinnan; Ao, Jingqun; Chen, Xinhua] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian, Peoples R China; [Lian, Fu-Ming; Teng, Yan-Bin; Jiang, Yong-Liang; He, Yong-Xing; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Lian, Fu-Ming; Teng, Yan-Bin; Jiang, Yong-Liang; He, Yong-Xing; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	State Oceanic Administration; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	zcz@ustc.edu.cn; Chenxinh@tom.com	Zhou, Cong-Zhao/E-9174-2011; Chen, Yuxing/P-4156-2014	Zhou, Cong-Zhao/0000-0002-6881-7151; Lian, Fu-Ming/0000-0001-7999-6565; Jiang, YongLiang/0000-0001-5441-4936; Chen, Yuxing/0000-0002-7560-1922	National Natural Science Foundation of China [31125027, 30870490, 31001131]; National Basic Research Program of China [2012CB114402, 2006CB910202]; Nation '863' Project of China [2012AA092202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Nation '863' Project of China	This work was supported by the National Natural Science Foundation of China (31125027, 30870490 and 31001131), the National Basic Research Program of China (2012CB114402 and 2006CB910202), and the Nation '863' Project of China (2012AA092202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Cao ZB, 2011, J BIOL CHEM, V286, P42257, DOI 10.1074/jbc.M111.298810; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; DeLano W.L., PYMOL MOL GRAPHICS S; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii J, 2002, REDOX REP, V7, P123, DOI 10.1179/135100002125000352; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Haridas V, 1998, J IMMUNOL, V161, P1; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Jin DY, 1997, J BIOL CHEM, V272, P30952, DOI 10.1074/jbc.272.49.30952; Joensson Thomas J., 2007, V44, P115; Karplus P. Andrew, 2007, V44, P41; Kim H, 2000, J BIOL CHEM, V275, P18266, DOI 10.1074/jbc.275.24.18266; Kim JA, 2005, ANAL BIOCHEM, V338, P216, DOI 10.1016/j.ab.2004.12.008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 2010, J BIOCHEM, V147, P109, DOI 10.1093/jb/mvp154; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsonage D, 2005, BIOCHEMISTRY-US, V44, P10583, DOI 10.1021/bi050448i; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Pineyro MD, 2005, J STRUCT BIOL, V150, P11, DOI 10.1016/j.jsb.2004.12.005; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wong CM, 2000, ANTIOXID REDOX SIGN, V2, P507, DOI 10.1089/15230860050192288; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yu SH, 2010, J PROTEOME RES, V9, P1424, DOI 10.1021/pr900961x; Zhang Y, 2008, ACTA CRYSTALLOGR F, V64, P323, DOI 10.1107/S1744309108004612; Zhang ZY, 2009, BBA-PROTEINS PROTEOM, V1794, P124, DOI 10.1016/j.bbapap.2008.09.011	41	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57061	10.1371/journal.pone.0057061	http://dx.doi.org/10.1371/journal.pone.0057061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451146	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500059
J	Sugahara, M; Takehira, M; Yutani, K				Sugahara, Michihiro; Takehira, Michiyo; Yutani, Katsuhide			Effect of Heavy Atoms on the Thermal Stability of alpha-Amylase from Aspergillus oryzae	PLOS ONE			English	Article							CHEMICAL CROSS-LINKING; CONFORMATIONAL STABILITY; PROTEIN CRYSTALLIZATION; TRYPTOPHAN SYNTHASE; AUTOMATED-SYSTEM; DATABASE-SYSTEM; STABILIZATION; BINDING; OPTIMIZATION; SEQUENCE	Currently, there are no versatile and established methods for improving stability of proteins. In an entirely different approach from conventional techniques such as mutagenesis, we attempted to enhance enzyme stability of alpha-amylase from Aspergillus oryzae using a heavy-atom derivatization technique. We evaluated changes in stability using differential scanning calorimetry (DSC). Candidate heavy atoms were identified using the Heavy-Atom Database System HATODAS, a Web-based tool designed to assist in heavy-atom derivatization of proteins for X-ray crystallography. The denaturation temperature of alpha-amylase derivatized with gadolinium (Gd) or samarium (Sm) ions increased by 6.2 or 5.7 degrees C, respectively, compared to that of the native protein (60.6 degrees C). The binding of six Gd ions was confirmed by X-ray crystallography of the enzyme at 1.5 angstrom resolution. DSC and dynamic light-scattering data revealed a correlation between stability and the aggregation state upon addition of Gd ions. These results show that HATODAS search is an effective tool for selecting heavy atoms for stabilization of this protein.	[Sugahara, Michihiro; Takehira, Michiyo; Yutani, Katsuhide] RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan	RIKEN	Sugahara, M (corresponding author), RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan.	msuga@spring8.or.jp			Hyogo Science and Technology Association [22S022]; Japan Society for the Promotion of Science (KAKENHI) [22770116]	Hyogo Science and Technology Association; Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a '2010 Incentive Research Grant' from Hyogo Science and Technology Association (No. 22S022) and by a 'Grant in Aid for Scientific Research' from Japan Society for the Promotion of Science (KAKENHI No. 22770116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABORI S, 1954, J BIOCHEM-TOKYO, V41, P577, DOI 10.1093/oxfordjournals.jbchem.a126475; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blundell T. L., 1976, PROTEIN CRYSTALLOGRA, P183; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; CHANG CT, 1995, BIOCHEM MOL BIOL INT, V36, P185; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; DONOVAN JW, 1975, J BIOL CHEM, V250, P6022; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Funahashi J, 2001, PROTEIN ENG, V14, P127, DOI 10.1093/protein/14.2.127; Jeyakanthan J., 2009, J BIOPHYS, V2009; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; KUROKI R, 1992, P NATL ACAD SCI USA, V89, P6803, DOI 10.1073/pnas.89.15.6803; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; MATSUURA Y, 1979, J BIOCHEM-TOKYO, V86, P1773, DOI 10.1093/oxfordjournals.jbchem.a132699; MATSUURA Y, 1980, J BIOCHEM-TOKYO, V87, P1555, DOI 10.1093/oxfordjournals.jbchem.a132896; Ogasahara K, 2003, J BIOL CHEM, V278, P8922, DOI 10.1074/jbc.M210893200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1988, J BIOL CHEM, V263, P11820; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; PETERS K, 1977, ANNU REV BIOCHEM, V46, P523, DOI 10.1146/annurev.bi.46.070177.002515; Richardson TH, 2002, J BIOL CHEM, V277, P26501, DOI 10.1074/jbc.M203183200; SCHELLMAN JA, 1976, BIOPOLYMERS, V15, P999, DOI 10.1002/bip.1976.360150513; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; Sugahara M, 2005, ACTA CRYSTALLOGR D, V61, P1302, DOI 10.1107/S0907444905019670; Sugahara M, 2008, ACTA CRYSTALLOGR D, V64, P686, DOI 10.1107/S0907444908009980; Sugahara M, 2011, CRYST GROWTH DES, V11, P110, DOI 10.1021/cg100987g; Sugahara M, 2010, J APPL CRYSTALLOGR, V43, P940, DOI 10.1107/S0021889810018595; Sugahara M, 2009, J APPL CRYSTALLOGR, V42, P540, DOI 10.1107/S0021889809012370; SWIFT HJ, 1991, ACTA CRYSTALLOGR B, V47, P535, DOI 10.1107/S0108768191001970; Takano K, 1997, BIOCHEMISTRY-US, V36, P688, DOI 10.1021/bi9621829; Tripathi P, 2008, BIOPHYS CHEM, V137, P95, DOI 10.1016/j.bpc.2008.07.007; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Veprintsev DB, 1999, PROTEINS, V37, P65, DOI 10.1002/(SICI)1097-0134(19991001)37:1<65::AID-PROT7>3.0.CO;2-2; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vujicic-Zagar A, 2006, ACTA CRYSTALLOGR F, V62, P716, DOI 10.1107/S1744309106024729; Wold F, 1972, Methods Enzymol, V25, P623, DOI 10.1016/S0076-6879(72)25061-3; WONG SS, 1992, ENZYME MICROB TECH, V14, P866, DOI 10.1016/0141-0229(92)90049-T; Xiao ZZ, 2006, ANAL BIOCHEM, V351, P146, DOI 10.1016/j.ab.2006.01.036; Xue YL, 2009, J BIOCHEM, V146, P193, DOI 10.1093/jb/mvp055; YUTANI K, 1987, P NATL ACAD SCI USA, V84, P4441, DOI 10.1073/pnas.84.13.4441	47	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57432	10.1371/journal.pone.0057432	http://dx.doi.org/10.1371/journal.pone.0057432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451229	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500104
J	Wang, K; Jiang, Y; Zheng, WY; Liu, ZY; Li, H; Lou, JZ; Gu, MD; Wang, XJ				Wang, Kai; Jiang, Yu; Zheng, Weiyan; Liu, Zhiyong; Li, Hui; Lou, Jianzhou; Gu, Meidi; Wang, Xiaojian			Silencing of Human Phosphatidylethanolamine-Binding Protein 4 Enhances Rituximab-Induced Death and Chemosensitization in B-Cell Lymphoma	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; TRAIL-INDUCED APOPTOSIS; DRUG-INDUCED APOPTOSIS; KINASE INHIBITOR PROTEIN; ALPHA-INDUCED APOPTOSIS; BREAST-CANCER CELLS; SIGNALING PATHWAY; DEXAMETHASONE REGIMEN; ELDERLY-PATIENTS; DOWN-REGULATION	Rituximab is the first line drug to treat non Hodgkin's lymphoma (B-NHL) alone or in combination with chemotherapy. However, 30-40% of B-NHL patients are unresponsive to rituximab or resistant after therapy. Human phosphatidylethanolamine-binding protein 4 (hPEBP4) is a novel member of PEBP family and functions as an anti-apoptotic molecule. In this study, we found hPEBP4 to be expressed in up to 90% of B-cell lymphoma patients, but in only 16.7% of normal lymph nodes. Interestingly, hPEBP4 overexpression inhibited rituximab-mediated complement dependent cytotoxicity (R-CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC) in B-NHL cells while downregulation of hPEBP4 augmented the therapeutic efficacy of rituximab both in vitro and in vivo. Furthermore, hPEBP4 silencing sensitized the primary B-acute lymphocytic leukemia (B-ALL) cells to R-CDC. During rituximab-mediated complement dependent cytotoxicity, hPEBP4 was recruited to the cell membrane in a PE-binding domain dependent manner and inhibited R-CDC induced calcium flux and reactive oxygen species (ROS) generation. These events contributed to the decrease of cell death induced by R-CDC in B-cell lymphomas. Meanwhile, hPEBP4 knockdown potentiated the chemosensitization of the rituximab in B-cell lymphoma cells by regulating the expression of Bcl-xl, Cycline E, p21(waf/cip1) and p53 and the activation of caspase-3 and caspase-9. Considering that hPEBP4 conferred cellular resistance to rituximab treatment and was preferentially expressed in lymphoma tissue, it could be a potential valuable target for adjuvant therapy for B-cell lymphoma.	[Wang, Kai] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Yu; Liu, Zhiyong; Li, Hui; Lou, Jianzhou; Gu, Meidi; Wang, Xiaojian] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Weiyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Wang, XJ (corresponding author), Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China.	wangxiaojian@cad.zju.edu.cn	Liu, Zhiyong/CAF-2366-2022	Liu, Zhiyong/0000-0001-6473-348X	Zhejiang major science and technology special project [2009C13018]; National Natural Science Foundation of China [81072437, 81272353]; SRF for ROCS, SEM; Fundamental Research Funds for the Central Universities	Zhejiang major science and technology special project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SRF for ROCS, SEM(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Zhejiang major science and technology special project (2009C13018), The National Natural Science Foundation of China (81072437, 81272353), The Project-sponsored by SRF for ROCS, SEM and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Bellosillo B, 2001, BLOOD, V98, P2771, DOI 10.1182/blood.V98.9.2771; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Beum PV, 2011, EUR J IMMUNOL, V41, P2436, DOI 10.1002/eji.201041204; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Du ZY, 2009, J BIOL CHEM, V284, P27808, DOI 10.1074/jbc.M109.028324; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hauptrock B, 2008, BIOL-TARGETS THER, V2, P619; Jacquemin G, 2012, HAEMATOL-HEMATOL J, V97, P38, DOI 10.3324/haematol.2011.046466; Jak M, 2011, LEUKEMIA, V25, P968, DOI 10.1038/leu.2011.39; Janas E, 2005, CLIN EXP IMMUNOL, V139, P439, DOI 10.1111/j.1365-2249.2005.02720.x; Jazirehi AR, 2011, METHODS MOL BIOL, V731, P407, DOI 10.1007/978-1-61779-080-5_33; Jazirehi AR, 2004, CANCER RES, V64, P7117, DOI 10.1158/0008-5472.CAN-03-3500; Jazirehi AR, 2003, MOL CANCER THER, V2, P1183; Jazirehi AR, 2005, CANCER RES, V65, P264; Li BH, 2008, CANCER RES, V68, P2400, DOI 10.1158/0008-5472.CAN-07-6663; Li BH, 2009, BLOOD, V114, P5007, DOI 10.1182/blood-2009-06-225474; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Li P, 2006, INT J MOL MED, V18, P505; Liu HY, 2012, TUMOR BIOL, V33, P267, DOI 10.1007/s13277-011-0279-x; Molina A, 2008, ANNU REV MED, V59, P237, DOI 10.1146/annurev.med.59.060906.220345; Niitsu N, 2007, CANCER SCI, V98, P109, DOI 10.1111/j.1349-7006.2006.00349.x; Niitsu N, 2006, CANCER SCI, V97, P933, DOI 10.1111/j.1349-7006.2006.00249.x; Nijmeijer BA, 2010, BLOOD, V116, P5930, DOI 10.1182/blood-2010-01-262006; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Qiu JM, 2010, J BIOL CHEM, V285, P12241, DOI 10.1074/jbc.M110.111898; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Shimizu R, 2010, LEUKEMIA, V24, P1760, DOI 10.1038/leu.2010.157; Stolz C, 2009, LEUKEMIA LYMPHOMA, V50, P873, DOI 10.1080/10428190902878471; Suzuki E, 2007, ONCOGENE, V26, P6184, DOI 10.1038/sj.onc.1210448; Turturro F, 2007, CLIN CANCER RES, V13, P3724, DOI 10.1158/1078-0432.CCR-07-0244; Unruh TL, 2005, IMMUNOLOGY, V116, P223, DOI 10.1111/j.1365-2567.2005.02213.x; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vega MI, 2005, ONCOGENE, V24, P8114, DOI 10.1038/sj.onc.1208954; Walshe CA, 2008, J BIOL CHEM, V283, P16971, DOI 10.1074/jbc.M708459200; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; You T, 2011, CELL MOL IMMUNOL, V8, P157, DOI 10.1038/cmi.2010.35; Yu GP, 2011, TUMOR BIOL, V32, P1257, DOI 10.1007/s13277-011-0230-1; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312	45	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56829	10.1371/journal.pone.0056829	http://dx.doi.org/10.1371/journal.pone.0056829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451095	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500033
J	Yamada, T; Urano-Tashiro, Y; Tanaka, S; Akiyama, H; Tashiro, F				Yamada, Takeyuki; Urano-Tashiro, Yumiko; Tanaka, Saori; Akiyama, Hirotada; Tashiro, Fumio			Involvement of Crosstalk between Oct4 and Meis1a in Neural Cell Fate Decision	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; PLURIPOTENT STEM-CELLS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTOR; SELF-RENEWAL; SEGMENTAL EXPRESSION; PBX; COMPLEXES; NEUROGENESIS; GLIOGENESIS	Oct4 plays a critical role both in maintaining pluripotency and the cell fate decision of embryonic stem (ES) cells. Nonetheless, in the determination of the neuroectoderm (NE) from ES cells, the detailed regulation mechanism of the Oct4 gene expression is poorly understood. Here, we report that crosstalk between Oct4 and Meis1a, a Pbx-related homeobox protein, is required for neural differentiation of mouse P19 embryonic carcinoma (EC) cells induced by retinoic acid (RA). During neural differentiation, Oct4 expression was transiently enhanced during 6-12 h of RA addition and subsequently disappeared within 48 h. Coinciding with up-regulation of Oct4 expression, the induction of Meis1a expression was initiated and reached a plateau at 48 h, suggesting that transiently induced Oct4 activates Meis1a expression and the up-regulated Meis1a then suppresses Oct4 expression. Chromatin immunoprecipitation (ChIP) and luciferase reporter analysis showed that Oct4 enhanced Meis1a expression via direct binding to the Meis1 promoter accompanying histone H3 acetylation and appearance of 5-hydoxymethylcytosine (5hmC), while Meis1a suppressed Oct4 expression via direct association with the Oct4 promoter together with histone deacetylase 1 (HDAC1). Furthermore, ectopic Meis1a expression promoted neural differentiation via formation of large neurospheres that expressed Nestin, GLAST, BLBP and Sox1 as neural stem cell (NSC)/neural progenitor markers, whereas its down-regulation generated small neurospheres and repressed neural differentiation. Thus, these results imply that crosstalk between Oct4 and Meis1a on mutual gene expressions is essential for the determination of NE from EC cells.	[Yamada, Takeyuki; Urano-Tashiro, Yumiko; Tanaka, Saori; Akiyama, Hirotada; Tashiro, Fumio] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 278, Japan	Tokyo University of Science	Tashiro, F (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Noda, Chiba 278, Japan.	ftashir@rs.noda.tus.ac.jp	TASHIRO, Yumiko/AAV-2054-2020	Tashiro, Yumiko/0000-0002-8328-2634	MEXT (Ministry of Education, Cultures, Science and Technology of Japan) [S1001020]; Grants-in-Aid for Scientific Research [23701104, 23501271] Funding Source: KAKEN	MEXT (Ministry of Education, Cultures, Science and Technology of Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FT acknowledges support from the 'Academic Frontier' for Private Universities: Matching Fund Subsidy from MEXT (Ministry of Education, Cultures, Science and Technology of Japan), 2010-2014 (S1001020) (URL: http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; Barnea E, 2000, J BIOL CHEM, V275, P6608, DOI 10.1074/jbc.275.9.6608; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Elizalde C, 2011, STEM CELLS, V29, P141, DOI 10.1002/stem.562; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Ferretti E, 2000, DEVELOPMENT, V127, P155; Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Huang H, 2005, J BIOL CHEM, V280, P10119, DOI 10.1074/jbc.M413963200; Jezierski A, 2012, J NEUROSCI RES, V90, P2362, DOI 10.1002/jnr.23118; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Saleh M, 2000, MOL CELL BIOL, V20, P8623, DOI 10.1128/MCB.20.22.8623-8633.2000; Salzberg A, 1999, MECH DEVELOP, V80, P3, DOI 10.1016/S0925-4773(98)00187-7; SCHOLER HR, 1990, EMBO J, V9, P2185, DOI 10.1002/j.1460-2075.1990.tb07388.x; SCHOORLEMMER J, 1994, MOL CELL BIOL, V14, P1122, DOI 10.1128/MCB.14.2.1122; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shibata T, 1997, J NEUROSCI, V17, P9212; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Snow GE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-383; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang K, 2002, BIOCHEM BIOPH RES CO, V293, P167, DOI 10.1016/S0006-291X(02)00215-2; Teramoto S, 2005, ONCOL REP, V14, P1231; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; TOMOOKA Y, 1993, P NATL ACAD SCI USA, V90, P9683, DOI 10.1073/pnas.90.20.9683; Tucker ES, 2010, DEVELOPMENT, V137, P2471, DOI 10.1242/dev.049718; Urano Y, 2006, J BIOL CHEM, V281, P7498, DOI 10.1074/jbc.M510881200; Urano-Tashiro Y, 2010, J NEUROSCI RES, V88, P2787, DOI 10.1002/jnr.22455; Waskiewicz AJ, 2001, DEVELOPMENT, V128, P4139	52	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56997	10.1371/journal.pone.0056997	http://dx.doi.org/10.1371/journal.pone.0056997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451132	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500051
J	Yin, H; Gao, M; Leoni, L; Han, HF; Zhang, X; Fu, ZR				Yin, Hao; Gao, Ming; Leoni, Lara; Han, Huifang; Zhang, Xing; Fu, Zhiren			The Therapeutic Role of Monocyte Chemoattractant Protein-1 in a Renal Tissue Engineering Strategy for Diabetic Patients	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ISLET TRANSPLANTATION; IN-VITRO; ELECTROSPUN SCAFFOLD; GLYCEMIC CONTROL; MICE; INFLAMMATION; REGENERATION; NEPHROPATHY; NANOFIBERS	In this study we aim to boost the functional output of the intra-kidney islet transplantation for diabetic patients using a tissue engineered polymeric scaffold. This highly porous electrospun scaffold featured randomly distributed fibers composed of polycaprolactone (PCL) and poliglecaprone (PGC). It successfully sustained murine islets in vitro for up to 4 weeks without detected cytotoxicity. The in vivo study showed that the islet population proliferated by 89% within 12 weeks when they were delivered by the scaffold but only 18% if freely injected. Correspondingly, the islet population delivered by the scaffold unleashed a greater capability to produce insulin that in turn further drove down the blood glucose within 12 weeks after the surgery. Islets delivered by the scaffold most effectively prevented diabetic deterioration of kidney as evidenced by the lack of a kidney or glomerular enlargement and physiological levels of creatinine, urea nitrogen and albumin through week 12 after the surgery. Unlike traditional wisdom in diabetic research, the mechanistic study suggested that monocytes chemoattractant protein-1 (MCP-1) was responsible for the improved preservation of renal functions. This study revealed a therapeutic role of MCP-1 in rescuing kidneys in diabetic patients, which can be integrated into a tissue engineered scaffold to simultaneously preserved renal functions and islet transplantation efficacy. Also, this study affords a simple yet effective solution to improve the clinical output of islet transplantation.	[Yin, Hao; Fu, Zhiren] Shanghai Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Surg, Shanghai, Peoples R China; [Yin, Hao; Gao, Ming; Han, Huifang] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Leoni, Lara] Univ Chicago, Integrated Small Anim Imaging Res Ctr, Chicago, IL 60637 USA; [Gao, Ming] Shanghai Chongming Hosp, Dept Surg, Shanghai, Chongming Count, Peoples R China; [Zhang, Xing] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Naval Medical University; University of Chicago; University of Chicago; Harvard University	Fu, ZR (corresponding author), Shanghai Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Surg, Shanghai, Peoples R China.	zhirenfu.sh@gmail.com	han, han/HDL-7807-2022		China's Natural Science Foundation [30772056]	China's Natural Science Foundation	The authors acknowledge the financial support from China's Natural Science Foundation (grant number 30772056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann B, 2003, DIABETES CARE, V26, P2421, DOI 10.2337/diacare.26.8.2421; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655; Chen YZ, 2011, ARCH BIOCHEM BIOPHYS, V507, P241, DOI 10.1016/j.abb.2010.12.020; Cho H, 2012, ACTA BIOMATER, V8, P154, DOI 10.1016/j.actbio.2011.08.029; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Deb DK, 2010, KIDNEY INT, V77, P1000, DOI 10.1038/ki.2010.22; Grossman EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008749; Guo ZG, 1997, TRANSPLANTATION, V63, P711, DOI 10.1097/00007890-199703150-00017; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Jaeger C, 1997, DIABETES, V46, P1907, DOI 10.2337/diabetes.46.11.1907; Kong JA, 2010, AM J PATHOL, V177, P622, DOI 10.2353/ajpath.2010.091292; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Ohtsuki K, 2001, CIRCULATION, V104, P203, DOI 10.1161/01.CIR.104.2.203; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Thomas V, 2007, BIOMED MATER, V2, P224, DOI 10.1088/1748-6041/2/4/004; Thomas V, 2009, BIOTECHNOL BIOENG, V104, P1025, DOI 10.1002/bit.22467; Tian YF, 2011, SOFT MATTER, V7, P6005, DOI 10.1039/c1sm05504f; Yin DP, 2006, DIABETES, V55, P3256, DOI 10.2337/db05-1275; Zhang X, 2011, J BIOMED MATER RES A, V97A, P145, DOI 10.1002/jbm.a.33040; Zhang X, 2010, BIOMATERIALS, V31, P4376, DOI 10.1016/j.biomaterials.2010.02.017; Zhang X, 2010, J MATER SCI-MATER M, V21, P541, DOI 10.1007/s10856-009-3922-y; Zhang X, 2009, J BIOMED MATER RES B, V89B, P135, DOI 10.1002/jbm.b.31196	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57635	10.1371/journal.pone.0057635	http://dx.doi.org/10.1371/journal.pone.0057635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451253	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500122
J	Dangardt, F; Chen, Y; Berggren, K; Osika, W; Friberg, P				Dangardt, Frida; Chen, Yun; Berggren, Krister; Osika, Walter; Friberg, Peter			Increased Rate of Arterial Stiffening with Obesity in Adolescents: A Five-Year Follow-Up Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; PULSE-WAVE VELOCITY; BODY-MASS INDEX; CAROTID-ARTERY; WALL THICKNESS; YOUNG FINNS; ALL-CAUSE; CHILDREN; CHILDHOOD; STIFFNESS	Background: We prospectively and longitudinally determined the effects of childhood obesity on arterial stiffening and vascular wall changes. Changes in arterial stiffness measured as pulse wave velocity (PWV) and vascular morphology of the radial (RA) and dorsal pedal arteries (DPA) were examined in obese adolescents compared to lean subjects in a 5-year follow-up study. Methodology/Principal Findings: A total of 28 obese subjects and 14 lean controls participated in both baseline (14 years old) and follow-up studies. PWV was measured by tonometer (SphygmoCor (R)) and recorded at RA and carotid artery, respectively. Intima thickness (IT), intima-media thickness (IMT) and RA and DPA diameters were measured using high-resolution ultrasound (Vevo 770 (TM)). Over the course of 5 years, PWV increased by 25% in the obese subjects as compared to 3% in the controls (p = 0.01). Diastolic blood pressure (DBP) increased by 23% in the obese subjects as opposed to 6% in controls (p = 0.009). BMI increased similarly in both groups, as did the IT and IMT. The change in PWV was strongly associated to the baseline BMI z -score (r = 0.51, p<0.001), as was the change in DBP (r = 0.50, p = 0.001). Conclusions/Significance: During the transition from early to late adolescence, there was a general increase in arterial stiffness, which was aggravated by childhood obesity. The increase in arterial stiffness and DBP after 5 years was closely correlated to the baseline BMI z -score, indicating that childhood obesity has an adverse impact on vascular adaptation.	[Dangardt, Frida; Chen, Yun; Berggren, Krister; Osika, Walter; Friberg, Peter] Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Dangardt, F (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden.	frida.dangardt@gu.se	Dangardt, Frida/AHC-9294-2022; Osika, Walter/AAH-7966-2020; Dangardt, Frida/V-9640-2019; Stefanadis, Christodoulos/ABH-2232-2020	Osika, Walter/0000-0002-1583-7319; Chen, Yun/0000-0002-3746-594X; Dangardt, Frida/0000-0003-4632-3916; Stefanadis, Christodoulos/0000-0001-5974-6454	Swedish Council for Medical Research (Vetenskapsr (A) over tilde (sic)det); Heart and Lung Foundation; Public Health committee of the Western Region of Sweden; Sahlgrenska University Hospital/Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden	Swedish Council for Medical Research (Vetenskapsr (A) over tilde (sic)det); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Public Health committee of the Western Region of Sweden; Sahlgrenska University Hospital/Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden	This study was supported by the Swedish Council for Medical Research (Vetenskapsr (A) over tilde (sic)det), Heart and Lung Foundation, Public Health committee of the Western Region of Sweden and Sahlgrenska University Hospital/Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatola H, 2010, HYPERTENSION, V55, P806, DOI 10.1161/HYPERTENSIONAHA.109.145102; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dangardt F, 2008, CLIN PHYSIOL FUNCT I, V28, P287, DOI 10.1111/j.1475-097X.2008.00806.x; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; De Angelis L, 2004, HYPERTENSION, V44, P67, DOI 10.1161/01.HYP.0000130482.81883.fd; Donald AE, 2010, EUR HEART J, V31, P1502, DOI 10.1093/eurheartj/ehq062; FOLKOW B, 1990, HYPERTENSION, V16, P89, DOI 10.1161/01.HYP.16.1.89; Friberg P, 2004, EUR HEART J, V25, P987, DOI 10.1016/j.ehj.2004.03.018; Kapiotis S, 2006, ARTERIOSCL THROM VAS, V26, P2541, DOI 10.1161/01.ATV.0000245795.08139.70; Karlberg J, 2001, ACTA PAEDIATR, V90, P1427, DOI 10.1080/08035250152708851; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; MESSERLI FH, 1981, ARCH INTERN MED, V141, P81, DOI 10.1001/archinte.141.1.81; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Osika W, 2007, ARTERIOSCL THROM VAS, V27, P671, DOI 10.1161/01.ATV.0000256468.95403.6f; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Sakuragi S, 2009, HYPERTENSION, V53, P611, DOI 10.1161/HYPERTENSIONAHA.108.123364; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; WENDELHAG I, 1991, CLIN PHYSIOL, V11, P565, DOI 10.1111/j.1475-097X.1991.tb00676.x; Whincup PH, 2005, CIRCULATION, V112, P1789, DOI 10.1161/CIRCULATIONAHA.104.532663	23	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57454	10.1371/journal.pone.0057454	http://dx.doi.org/10.1371/journal.pone.0057454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451232	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800109
J	Garcia-Cortes, LA; Legarra, A; Chevalet, C; Toro, MA				Garcia-Cortes, Luis Alberto; Legarra, Andres; Chevalet, Claude; Toro, Miguel Angel			Variance and Covariance of Actual Relationships between Relatives at One Locus	PLOS ONE			English	Article							COEFFICIENTS	The relationship between pairs of individuals is an important topic in many areas of population and quantitative genetics. It is usually measured as the proportion of thegenome identical by descent shared by the pair and it can be inferred from pedigree information. But there is a variance in actual relationships as a consequence of Mendelian sampling, whose general formula has not been developed. The goal of this work is to develop this general formula for the one-locus situation,. We provide simple expressions for the variances and covariances of all actual relationships in an arbitrary complex pedigree. The proposed method relies on the use of the nine identity coefficients and the generalized relationship coefficients; formulas have been checked by computer simulation. Finally two examples for a short pedigree of dogs and a long pedigree of sheep are given.	[Garcia-Cortes, Luis Alberto] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Legarra, Andres] INRA, UR SAGA 631, F-31326 Castanet Tolosan, France; [Chevalet, Claude] INRA, UMR LGC 444, F-31326 Castanet Tolosan, France; [Toro, Miguel Angel] Univ Politecn Madrid, Dept Anim Prod, Madrid, Spain	INRAE; INRAE; Universidad Politecnica de Madrid	Legarra, A (corresponding author), INRA, UR SAGA 631, F-31326 Castanet Tolosan, France.	andres.legarra@toulouse.inra.fr	Toro, Miguel Angel Angel/H-9370-2015; Legarra, Andres/AAW-2371-2021; Toro, Miguel Angel/AAA-1309-2019; garcia, luis/C-5971-2008; Legarra, Andres/G-9451-2012	Toro, Miguel Angel Angel/0000-0001-7460-2483; Legarra, Andres/0000-0001-8893-7620; Toro, Miguel Angel/0000-0001-7460-2483; garcia, luis/0000-0003-1116-7271; Legarra, Andres/0000-0001-8893-7620	Ministerio de Ciencia e Innovacion (Spain) [CGL2009-1327-C02-02]; ANR project Rules Tools (France); action X-Gen of the SelGen metaprogram (INRA, France); platform bioinformatics Toulouse Midi-Pyrenees	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ANR project Rules Tools (France)(French National Research Agency (ANR)); action X-Gen of the SelGen metaprogram (INRA, France); platform bioinformatics Toulouse Midi-Pyrenees	This work has been partially supported by project CGL2009-1327-C02-02 of the Ministerio de Ciencia e Innovacion (Spain), ANR project Rules & Tools (France) and action X-Gen of the SelGen metaprogram (INRA, France). Project partially supported by the platform bioinformatics Toulouse Midi-Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Boichard D., 2002, Proceedings of the 7th World Congress on Genetics Applied to Livestock Production, Montpellier, France, August, 2002. Session 28, P1; Colleau JJ, 2011, J ANIM BREED GENET, V128, P163, DOI 10.1111/j.1439-0388.2010.00899.x; Gillois M, 1964, THESIS FACULTE SCI P; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; HARRIS DL, 1964, GENETICS, V50, P1319; Hill WG, 2011, GENET RES, V93, P47, DOI 10.1017/S0016672310000480; Hill WG, 2007, THEOR POPUL BIOL, V72, P179, DOI 10.1016/j.tpb.2006.05.006; KARIGL G, 1981, ANN HUM GENET, V45, P299, DOI 10.1111/j.1469-1809.1981.tb00341.x; Laverack E, 1872, SETTER; Lynch M., 1998, GENETICS ANAL QUANTI; MacCluer JW, 1986, ZOO BIOL, V5, P149; PEREZENCISO M, 1992, THEOR APPL GENET, V84, P173, DOI 10.1007/BF00223997; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980	14	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57003	10.1371/journal.pone.0057003	http://dx.doi.org/10.1371/journal.pone.0057003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451134	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800062
J	Salmon, B; Bardet, C; Khaddam, M; Naji, J; Coyac, BR; Baroukh, B; Letourneur, F; Lesieur, J; Decup, F; Le Denmat, D; Nicoletti, A; Poliard, A; Rowe, PS; Huet, E; Vital, SO; Linglart, A; Mckee, MD; Chaussain, C				Salmon, Benjamin; Bardet, Claire; Khaddam, Mayssam; Naji, Jiar; Coyac, Benjamin R.; Baroukh, Brigitte; Letourneur, Franck; Lesieur, Julie; Decup, Franck; Le Denmat, Dominique; Nicoletti, Antonino; Poliard, Anne; Rowe, Peter S.; Huet, Eric; Vital, Sibylle Opsahl; Linglart, Agnes; McKee, Marc D.; Chaussain, Catherine			MEPE-Derived ASARM Peptide Inhibits Odontogenic Differentiation of Dental Pulp Stem Cells and Impairs Mineralization in Tooth Models of X-Linked Hypophosphatemia	PLOS ONE			English	Article							D-RESISTANT RICKETS; EXFOLIATED DECIDUOUS TEETH; VITAMIN-D; PHEX GENE; MOTIF PEPTIDE; IN-VIVO; BONE; PHOSPHATE; PROTEINS; COLLAGEN	Mutations in PHEX (phosphate-regulating gene with homologies to endopeptidases on the X-chromosome) cause X-linked familial hypophosphatemic rickets (XLH), a disorder having severe bone and tooth dentin mineralization defects. The absence of functional PHEX leads to abnormal accumulation of ASARM (acidic serine- and aspartate-rich motif) peptide - a substrate for PHEX and a strong inhibitor of mineralization - derived from MEPE (matrix extracellular phosphoglycoprotein) and other matrix proteins. MEPE-derived ASARM peptide accumulates in tooth dentin of XLH patients where it may impair dentinogenesis. Here, we investigated the effects of ASARM peptides in vitro and in vivo on odontoblast differentiation and matrix mineralization. Dental pulp stem cells from human exfoliated deciduous teeth (SHEDs) were seeded into a 3D collagen scaffold, and induced towards odontogenic differentiation. Cultures were treated with synthetic ASARM peptides (phosphorylated and nonphosphorylated) derived from the human MEPE sequence. Phosphorylated ASARM peptide inhibited SHED differentiation in vitro, with no mineralized nodule formation, decreased odontoblast marker expression, and upregulated MEPE expression. Phosphorylated ASARM peptide implanted in a rat molar pulp injury model impaired reparative dentin formation and mineralization, with increased MEPE immunohistochemical staining. In conclusion, using complementary models to study tooth dentin defects observed in XLH, we demonstrate that the MEPE-derived ASARM peptide inhibits both odontogenic differentiation and matrix mineralization, while increasing MEPE expression. These results contribute to a partial mechanistic explanation of XLH pathogenesis: direct inhibition of mineralization by ASARM peptide leads to the mineralization defects in XLH teeth. This process appears to be positively reinforced by the increased MEPE expression induced by ASARM. The MEPE-ASARM system can therefore be considered as a potential therapeutic target.	[Salmon, Benjamin; Bardet, Claire; Khaddam, Mayssam; Naji, Jiar; Coyac, Benjamin R.; Baroukh, Brigitte; Lesieur, Julie; Decup, Franck; Le Denmat, Dominique; Poliard, Anne; Vital, Sibylle Opsahl; Chaussain, Catherine] Univ Paris Descartes PRES Sorbonne Paris Cite, UFR Odontol, EA 2496, Montrouge, France; [Salmon, Benjamin; Coyac, Benjamin R.; Vital, Sibylle Opsahl; Chaussain, Catherine] Hop Univ Paris Nord Val Seine, AP HP, Odontol Dept Bretonneau Louis Mourier, Paris, France; [Salmon, Benjamin; Vital, Sibylle Opsahl; Linglart, Agnes; Chaussain, Catherine] AP HP, Ctr Reference Malad Rares Metab Phosphore & Calci, Le Kremlin Bicetre, France; [Letourneur, Franck] Univ Paris Descartes PRES Sorbonne Paris Cite, Inst Cochin, Paris, France; [Rowe, Peter S.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA; [Decup, Franck] AP HP Odontol, Dept Charles Foix, Ivry, France; [Huet, Eric] Univ Paris Est, Lab CRRET, CNRS, Creteil, France; [Linglart, Agnes] Bicetre Paris Sud Hosp, APHP Endocrinol & Diabetol Children, Le Kremlin Bicetre, France; [Linglart, Agnes] Univ Paris 11, Le Kremlin Bicetre, France; [Coyac, Benjamin R.; McKee, Marc D.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Coyac, Benjamin R.; McKee, Marc D.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Nicoletti, Antonino] INSERM, UMRS698, Paris, France; [Nicoletti, Antonino] Denis Diderot Univ, UMRS698, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Kansas; University of Kansas Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; McGill University; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chaussain, C (corresponding author), Univ Paris Descartes PRES Sorbonne Paris Cite, UFR Odontol, EA 2496, Montrouge, France.	catherine.chaussain@parisdescartes.fr	SALMON, Benjamin/X-4286-2019; HUET, Eric/R-3178-2018; McKee, Marc D/E-2187-2011; Linglart, Agnès/A-8047-2016; Coyac, Benjamin R./M-3743-2013; Nicoletti, Antonino/A-9460-2015; Vital, Sibylle/AAK-3479-2021; Coyac, Benny R./AAA-4775-2021	SALMON, Benjamin/0000-0001-8739-2753; HUET, Eric/0000-0002-5541-5954; McKee, Marc D/0000-0001-8349-965X; Linglart, Agnès/0000-0003-3455-002X; Coyac, Benjamin R./0000-0003-0105-6703; Nicoletti, Antonino/0000-0002-2623-0897; Vital, Sibylle/0000-0001-6352-2525; Coyac, Benny R./0000-0003-0105-6703; Bardet, Claire/0000-0002-0874-4843; Chaussain, Catherine/0000-0002-3463-3936; Lesieur, Julie/0000-0002-5981-3458	University Paris Descartes; Fondation pour la Recherche Medicale; Fondation de l'Avenir [EA2496]; National Institutes of Health grant [5RO-1-AR51598-01]; Societe Francaise des Tissus Mineralises; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051598] Funding Source: NIH RePORTER	University Paris Descartes; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fondation de l'Avenir; National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Societe Francaise des Tissus Mineralises; Alexion Pharmaceuticals; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from University Paris Descartes, Fondation pour la Recherche Medicale, Fondation de l'Avenir to EA2496, and by the National Institutes of Health grant (5RO-1-AR51598-01 to PSR). MDM is a member of the Fonds de Recherche Quebec-Sante (FRQ-S) Reseau de Recherche en Sante Buccodentaire et Osseuse, the FRQ-S Groupe de Recherche Axe sur la Structure des Proteines, and the Jamson T.N. Wong Laboratories in Calcified Tissue Research of the McGill Centre for Bone and Periodontal Research. The Ph.D. program of BS was supported by the Fondation pour la Recherche Medicale and by the Societe Francaise des Tissus Mineralises. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MDM has received research contracts and consulting honoraria from Enobia Pharma (now Alexion Pharmaceuticals). The other authors state no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Argiro L, 2001, GENOMICS, V74, P342, DOI 10.1006/geno.2001.6553; Arnold WH, 2007, ANN ANAT, V189, P183, DOI 10.1016/j.aanat.2006.09.008; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Baroukh B, 2000, BONE, V27, P627, DOI 10.1016/S8756-3282(00)00372-0; Barragan-Adjemian C, 2006, CALCIFIED TISSUE INT, V79, P340, DOI 10.1007/s00223-006-0107-2; Barros NM, 2012, J BONE MINER RES; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Bitar M, 2008, BIOMACROMOLECULES, V9, P129, DOI 10.1021/bm701112w; Boskey AL, 2010, CALCIFIED TISSUE INT, V86, P42, DOI 10.1007/s00223-009-9313-z; Boukpessi T, 2006, CALCIFIED TISSUE INT, V79, P294, DOI 10.1007/s00223-006-0182-4; Boukpessi T, 2010, AM J PATHOL, V177, P803, DOI 10.2353/ajpath.2010.091231; Bresler D, 2004, J ENDOCRINOL, V183, pR1, DOI 10.1677/joe.1.05989; Carpenter TO, 2011, J BONE MINER RES, V26, P1381, DOI 10.1002/jbmr.340; Chaussain C, 2009, EUR CELLS MATER, V18, P84, DOI 10.22203/eCM.v018a08; Chaussain-Miller C, 2007, ORAL DIS, V13, P482, DOI 10.1111/j.1601-0825.2006.01326.x; Chaussain-Miller C, 2003, J PEDIATR-US, V142, P324, DOI 10.1067/mpd.2003.119; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; COULOMB B, 1984, BRIT J DERMATOL, V111, P83, DOI 10.1111/j.1365-2133.1984.tb15585.x; David V, 2011, AM J PHYSIOL-RENAL, V300, pF783, DOI 10.1152/ajprenal.00304.2010; David V, 2009, ENDOCRINOLOGY, V150, P4012, DOI 10.1210/en.2009-0216; Econs MJ, 1998, J CLIN ENDOCR METAB, V83, P3459, DOI 10.1210/jc.83.10.3459; Estes BT, 2011, METHODS MOL BIOL, V702, P201, DOI 10.1007/978-1-61737-960-4_15; Filisetti D, 1999, EUR J HUM GENET, V7, P615, DOI 10.1038/sj.ejhg.5200341; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; Gaucher C, 2009, CELLS TISSUES ORGANS, V189, P219, DOI 10.1159/000151382; Gaucher C, 2009, HUM GENET, V125, P401, DOI 10.1007/s00439-009-0631-z; Gorski JP, 2011, FRONT BIOSCI-LANDMRK, V16, P2598, DOI 10.2741/3875; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; Kerkis I, 2012, TISSUE ENG PART B-RE, V18, P129, DOI [10.1089/ten.teb.2011.0327, 10.1089/ten.TEB.2011.0327]; Liu H, 2005, ARCH ORAL BIOL, V50, P923, DOI 10.1016/j.albchoralbio.2005.03.003; Liu SG, 2007, J ENDOCRINOL, V192, P261, DOI 10.1677/joe.1.07059; Lorenz-Depiereux B, 2004, MAMM GENOME, V15, P151, DOI 10.1007/s00335-003-2310-z; Martin A, 2008, ENDOCRINOLOGY, V149, P1757, DOI 10.1210/en.2007-1205; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Mishima H, 1998, EUR J ORAL SCI, V106, P392, DOI 10.1111/j.1600-0722.1998.tb02204.x; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Murayama T, 2000, ORAL SURG ORAL MED O, V90, P310, DOI 10.1067/moe.2000.107522; Ortinau S, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-70; Pedraza CE, 2010, TISSUE ENG PT A, V16, P781, DOI [10.1089/ten.tea.2009.0351, 10.1089/ten.TEA.2009.0351]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Quarles LD, 2003, AM J PHYSIOL-ENDOC M, V285, pE1, DOI 10.1152/ajpendo.00016.2003; Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430; ROCHE PC, 1992, ENDOCRINOLOGY, V131, P268, DOI 10.1210/en.131.1.268; Rowe PSN, 2012, CELL BIOCHEM FUNCT, V30, P355, DOI 10.1002/cbf.2841; Rowe PSN, 2012, CRIT REV EUKAR GENE, V22, P61, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.50; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Rowe PSN, 2004, CRIT REV ORAL BIOL M, V15, P264, DOI 10.1177/154411130401500503; Rowe PSN, 2004, BONE, V34, P303, DOI 10.1016/j.bone.2003.10.005; Rowe PSN, 1997, HUM MOL GENET, V6, P539, DOI 10.1093/hmg/6.4.539; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; Sakai V T, 2011, Adv Dent Res, V23, P325, DOI 10.1177/0022034511405325; Seow W. Kim, 1995, Pediatric Dentistry, V17, P346; SEOW WK, 1984, AUST DENT J, V29, P371, DOI 10.1111/j.1834-7819.1984.tb05304.x; Six N, 2007, J DENT RES, V86, P780, DOI 10.1177/154405910708600818; Staines KA, 2012, BONE, V51, P418, DOI 10.1016/j.bone.2012.06.022; Suzumura Shinya, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. 22nd International Conference on Artificial Neural Networks, P1, DOI 10.1007/978-3-642-33266-1_1; Szpalski C, 2011, TISSUE ENG B; Vital SO, 2012, BONE, V50, P989, DOI 10.1016/j.bone.2012.01.010; Wang HG, 2010, BIOCHEM BIOPH RES CO, V398, P406, DOI 10.1016/j.bbrc.2010.06.085; Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034	66	47	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56749	10.1371/journal.pone.0056749	http://dx.doi.org/10.1371/journal.pone.0056749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451077	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800032
J	Targher, G; Valbusa, F; Bonapace, S; Bertolini, L; Zenari, L; Rodella, S; Zoppini, G; Mantovani, W; Barbieri, E; Byrne, CD				Targher, Giovanni; Valbusa, Filippo; Bonapace, Stefano; Bertolini, Lorenzo; Zenari, Luciano; Rodella, Stefano; Zoppini, Giacomo; Mantovani, William; Barbieri, Enrico; Byrne, Christopher D.			Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; GAMMA-GLUTAMYL-TRANSFERASE; C-REACTIVE PROTEIN; MYOCARDIAL STEATOSIS; PERICARDIAL FAT; HEART-FAILURE; RISK-FACTORS; PREVALENCE; PREDICTOR; ENZYMES	Background: The relationship between non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) in type 2 diabetes is currently unknown. We examined the relationship between NAFLD and risk of incident AF in people with type 2 diabetes. Methods and Results: We prospectively followed for 10 years a random sample of 400 patients with type 2 diabetes, who were free from AF at baseline. A standard 12-lead electrocardiogram was undertaken annually and a diagnosis of incident AF was confirmed in affected participants by a single cardiologist. At baseline, NAFLD was defined by ultrasonographic detection of hepatic steatosis in the absence of other liver diseases. During the 10 years of follow-up, there were 42 (10.5%) incident AF cases. NAFLD was associated with an increased risk of incident AF (odds ratio [OR] 4.49, 95% CI 1.6-12.9, p<0.005). Adjustments for age, sex, hypertension and electrocardiographic features (left ventricular hypertrophy and PR interval) did not attenuate the association between NAFLD and incident AF (adjusted-OR 6.38, 95% CI 1.7-24.2, p = 0.005). Further adjustment for variables that were included in the 10-year Framingham Heart Study-derived AF risk score did not appreciably weaken this association. Other independent predictors of AF were older age, longer PR interval and left ventricular hypertrophy. Conclusions: Our results indicate that ultrasound-diagnosed NAFLD is strongly associated with an increased incidence of AF in patients with type 2 diabetes even after adjustment for important clinical risk factors for AF.	[Targher, Giovanni; Zoppini, Giacomo] Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, I-37100 Verona, Italy; [Targher, Giovanni; Zoppini, Giacomo] Azienda Osped Univ Integrata Verona, Verona, Italy; [Valbusa, Filippo] Sacro Cuore Hosp Negrar, Div Gen Med, Verona, Italy; [Bonapace, Stefano; Barbieri, Enrico] Sacro Cuore Hosp Negrar, Div Cardiol, Verona, Italy; [Bertolini, Lorenzo; Zenari, Luciano] Sacro Cuore Hosp Negrar, Diabet Unit, Verona, Italy; [Rodella, Stefano] Sacro Cuore Hosp Negrar, Div Radiol, Verona, Italy; [Mantovani, William] Univ Verona, Dept Publ Hlth & Community Med, Sect Hyg & Prevent Environm & Occupat Med, I-37100 Verona, Italy; [Mantovani, William] Publ Hlth Trust, Dept Prevent, Trento, Italy; [Byrne, Christopher D.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Byrne, Christopher D.] Southampton Univ Hosp, Southampton Natl Inst Hlth Res Biomed Res Ctr, Southampton, Hants, England	University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Southampton; University of Southampton	Targher, G (corresponding author), Univ Verona, Dept Med, Div Endocrinol Diabet & Metab, I-37100 Verona, Italy.	giovanni.targher@univr.it	zoppini, giacomo/AAA-9000-2022; Targher, Giovanni/AAB-9008-2019	zoppini, giacomo/0000-0003-1085-554X; Targher, Giovanni/0000-0002-4325-3900; Bonapace, Stefano/0000-0001-9122-2642; Valbusa, Filippo/0000-0001-7527-6974; Byrne, Christopher D/0000-0001-6322-7753				[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Conen D, 2010, EUR HEART J, V31, P1730, DOI 10.1093/eurheartj/ehq146; Darbar D, 2002, PACE, V25, P1447, DOI 10.1046/j.1460-9592.2002.01447.x; Dhingra R, 2010, ARTERIOSCL THROM VAS, V30, P1855, DOI 10.1161/ATVBAHA.110.207340; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; Goland S, 2006, J CLIN GASTROENTEROL, V40, P949, DOI 10.1097/01.mcg.0000225668.53673.e6; Hallsworth K, 2013, J HEPATOL, V58, P757, DOI 10.1016/j.jhep.2012.11.015; Jabre P, 2011, CIRCULATION, V123, P1587, DOI 10.1161/CIRCULATIONAHA.110.986661; Lin YK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0293-1; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Makar GA, 2008, PHARMACOEPIDEM DR S, V17, P43, DOI 10.1002/pds.1514; Mehta SR, 2008, WORLD J GASTROENTERO, V14, P3476, DOI 10.3748/wjg.14.3476; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Ng ACT, 2010, CIRCULATION, V122, P2538, DOI 10.1161/CIRCULATIONAHA.110.955542; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Psaty BM, 1997, CIRCULATION, V96, P2455; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rosenberg MA, 2012, EUR HEART J, V33, P904, DOI 10.1093/eurheartj/ehr378; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Sinner MF, 2013, AM J CARDIOL, V111, P219, DOI 10.1016/j.amjcard.2012.09.021; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Targher G, 2009, SEMIN THROMB HEMOST, V35, P277, DOI 10.1055/s-0029-1222606; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Vanezis AP, 2008, J ELECTROCARDIOL, V41, P404, DOI 10.1016/j.jelectrocard.2008.02.013; Wannamethee SG, 2012, ARTERIOSCL THROM VAS, V32, P830, DOI 10.1161/ATVBAHA.111.240457	36	108	115	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57183	10.1371/journal.pone.0057183	http://dx.doi.org/10.1371/journal.pone.0057183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451184	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000316658800089
J	Chojnicka, I; Gajos, K; Strawa, K; Broda, G; Fudalej, S; Fudalej, M; Stawinski, P; Pawlak, A; Krajewski, P; Wojnar, M; Ploski, R				Chojnicka, Izabela; Gajos, Krzysztof; Strawa, Katarzyna; Broda, Grazyna; Fudalej, Sylwia; Fudalej, Marcin; Stawinski, Piotr; Pawlak, Aleksandra; Krajewski, Pawel; Wojnar, Marcin; Ploski, Rafal			Possible Association between Suicide Committed under Influence of Ethanol and a Variant in the AUTS2 Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSLOCATION BREAKPOINT; EXECUTIVE FUNCTION; ALCOHOL; AUTISM; DISORDER; IDENTIFICATION	Background: rs6943555 in AUTS2 has been shown to modulate ethanol consumption. We hypothesized that rs6943555 might be associated with completed suicide. Methods: We genotyped rs6943555 in 625 completed suicides and 3861 controls using real-time TaqMan Allelic Discrimination Assay. All individuals were Polish Caucasians. Results: We detected an association between suicide and rs6943555 A allele (OR = 1.17, P = 0.018 for allelic comparison, OR = 1.24, P = 0.013 for dominant, and OR = 1.18, P = 0.020 for co-dominant model of inheritance). The association remained significant after adjusting for age and gender (co-dominant: P = 0.002 and dominant model: P = 0.001). After stratifying suicides according to blood ethanol concentration (BAC <= 20 mg/dl and BAC > 20 mg/dl) the association remained significant only for cases who committed suicide under influence of alcohol (co-dominant: OR = 1.37, P = 0.004 and dominant model: OR = 1.45, P = 0.006). To validate this finding we genotyped another cohort of 132 cases. We reproduced the association between rs6943555 A allele and suicide under influence of ethanol (allelic comparison: OR = 1.55, P = 0.023; co-dominant : OR = 1.54, P = 0.031; dominant model: OR = 1.84, P = 0.015). Analyzing pooled suicides with BAC > 20 mg/dl (N = 300) we found the association of rs6943555 A allele not only vs. controls (allelic OR = 1.41, P = 0.00029) but also vs. cases with BAC <= 20 mg/dl (N = 449, allelic OR = 1.33, P = 0.019). Conclusions: In our study rs6943555 A allele is associated with suicide committed after drinking ethanol shortly before death. The rs6943555 A allele may be linked to adverse emotional reaction to ethanol, which could explain the association with lower consumption in general population as well as the predisposition to suicide under influence of ethanol.	[Chojnicka, Izabela; Gajos, Krzysztof; Strawa, Katarzyna; Stawinski, Piotr; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Fudalej, Sylwia; Wojnar, Marcin] Med Univ Warsaw, Dept Psychiat, Warsaw, Poland; [Fudalej, Marcin; Pawlak, Aleksandra; Krajewski, Pawel] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Broda, Grazyna] Inst Cardiol, Dept Cardiovasc Dis Epidemiol Prevent & Hlth Prom, Warsaw, Poland; [Wojnar, Marcin] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw; Institute of Cardiology - Poland; University of Michigan System; University of Michigan	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Wojnar, Marcin/N-7111-2018; Fudalej, Sylwia/X-1511-2018	Wojnar, Marcin/0000-0001-5138-9050; Fudalej, Sylwia/0000-0003-3610-7312; Ploski, Rafal/0000-0001-6286-5526; krajewski, Pawel/0000-0001-8352-4077; Chojnicka, Izabela/0000-0001-8723-6873	Medical University of Warsaw Grant [1WY/WB1/10]; Fogarty International Center/NIAAA Grant [5 D43 TW007569]; FOGARTY INTERNATIONAL CENTER [D43TW007569] Funding Source: NIH RePORTER	Medical University of Warsaw Grant; Fogarty International Center/NIAAA Grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research was supported by the Medical University of Warsaw Grant 1WY/WB1/10 and by the Fogarty International Center/NIAAA Grant 5 D43 TW007569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2011, INT J CIRCUMPOL HEAL, V70, P473, DOI 10.3402/ijch.v70i5.17847; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Bolling-Sternevald E, 2002, SCAND J GASTROENTERO, V37, P1395, DOI 10.1080/003655202762671260; Branas CC, 2011, SUBST USE MISUSE, V46, P1592, DOI 10.3109/10826084.2011.604371; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; BRODA G, 2005, POL POPUL REV, V27, P29; Burton CZ, 2011, J NEUROPSYCH CLIN N, V23, P173, DOI 10.1176/appi.neuropsych.23.2.173; Butler AW, 2010, AM J MED GENET B, V153B, P1465, DOI 10.1002/ajmg.b.31127; Christ SE, 2010, NEUROPSYCHOLOGY, V24, P590, DOI 10.1037/a0019176; Courtet P, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.6; de la Barra F, 1986, Rev Chil Pediatr, V57, P549; Duberstein PR, 2004, PSYCHOL MED, V34, P1331, DOI 10.1017/S0033291704002600; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Embregts P, 2009, J INTELL DISABIL RES, V53, P922, DOI 10.1111/j.1365-2788.2009.01204.x; Gibbs LM, 2009, INT J GERIATR PSYCH, V24, P1396, DOI 10.1002/gps.2276; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Hansen SK, 2004, DIABETOLOGIA, V47, P1079, DOI 10.1007/s00125-004-1418-3; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Huang XL, 2010, AM J MED GENET A, V152A, P2112, DOI 10.1002/ajmg.a.33497; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kim S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-413; Kohli MA, 2010, ARCH GEN PSYCHIAT, V67, P348, DOI 10.1001/archgenpsychiatry.2009.201; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitchell DGV, 2011, BEHAV BRAIN RES, V217, P215, DOI 10.1016/j.bbr.2010.10.030; Orui Masatsugu, 2011, Environmental Health and Preventive Medicine, V16, P384, DOI 10.1007/s12199-011-0209-y; Parnowski T, 1977, Psychiatr Pol, V11, P417; Pedersen NL, 2010, EUR PSYCHIAT, V25, P264, DOI 10.1016/j.eurpsy.2009.12.008; Pellicano E, 2010, DEV PSYCHOL, V46, P530, DOI 10.1037/a0018287; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Pollock LR, 1998, SUICIDE LIFE-THREAT, V28, P375; Porteri C, 2012, MED HLTH CARE PHILOS; Raja Michele, 2011, Clin Pract Epidemiol Ment Health, V7, P97, DOI 10.2174/1745017901107010097; Rywik S, 2005, POL POPUL REV, V27, P37; Schosser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020690; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Stickley A, 2011, J STUD ALCOHOL DRUGS, V72, P341, DOI 10.15288/jsad.2011.72.341; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Szanto K, 2012, AM J GERIAT PSYCHIAT, V20, P257, DOI 10.1097/JGP.0b013e31820eea0c; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Tsai SJ, 2011, PROG NEURO-PSYCHOPH, V35, P809, DOI 10.1016/j.pnpbp.2010.10.014; Voracek M, 2007, WIEN KLIN WOCHENSCHR, V119, P463, DOI 10.1007/s00508-007-0823-2; Westheide J, 2008, EUR ARCH PSY CLIN N, V258, P414, DOI 10.1007/s00406-008-0811-1; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Zhang YL, 2012, J STUD ALCOHOL DRUGS, V73, P15, DOI 10.15288/jsad.2012.73.15	48	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57199	10.1371/journal.pone.0057199	http://dx.doi.org/10.1371/journal.pone.0057199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437340	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200226
J	Soderholm, J; Waldenstrom, J; Askarieh, G; Pilli, M; Bochud, PY; Negro, F; Pawlotsky, JM; Zeuzem, S; Ferrari, C; Norkrans, G; Wejstal, R; Westin, J; Neumann, AU; Haagmans, BL; Lindh, M; Missale, G; Hellstrand, K; Lagging, M				Soderholm, Jonas; Waldenstrom, Jesper; Askarieh, Galia; Pilli, Massimo; Bochud, Pierre-Yves; Negro, Francesco; Pawlotsky, Jean-Michel; Zeuzem, Stefan; Ferrari, Carlo; Norkrans, Gunnar; Wejstal, Rune; Westin, Johan; Neumann, Avidan U.; Haagmans, Bart L.; Lindh, Magnus; Missale, Gabriele; Hellstrand, Kristoffer; Lagging, Martin			Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection	PLOS ONE			English	Article							INTERFERON-GAMMA; INDUCIBLE PROTEIN-10; RIBAVIRIN THERAPY; ANTIVIRAL THERAPY; GENETIC-VARIATION; VIRAL CLEARANCE; HCV INFECTION; ASSOCIATION; PREDICTS; IL28B	Background: Interferon and ribavirin therapy for chronic hepatitis C virus (HCV) infection yields sustained virological response (SVR) rates of 50-80%. Several factors such as non-1 genotype, beneficial IL28B genetic variants, low baseline IP-10, and the functionality of HCV-specific T cells predict SVR. With the pending introduction of new therapies for HCV entailing very rapid clearance of plasma HCV RNA, the importance of baseline biomarkers likely will increase in order to tailor therapy. CD26 (DPPIV) truncates the chemokine IP-10 into a shorter antagonistic form, and this truncation of IP-10 has been suggested to influence treatment outcome in patients with chronic HCV infection patients. In addition, previous reports have shown CD26 to be a co-stimulator for T cells. The aim of the present study was to assess the utility of CD26 as a biomarker for treatment outcome in chronic hepatitis C and to define its association with HCV-specific T cells. Methods: Baseline plasma from 153 genotype 1 and 58 genotype 2/3 infected patients enrolled in an international multicenter phase III trial (DITTO-HCV) and 36 genotype 1 infected patients participating in a Swedish trial (TTG1) were evaluated regarding baseline soluble CD26 (sCD26) and the functionality of HCV-specific CD8(+) T cells. Results: Genotype 1 infected patients achieving SVR in the DITTO (P = 0.002) and the TTG1 (P = 0.02) studies had lower pretreatment sCD26 concentrations compared with non-SVR patients. Sixty-five percent of patients with sCD26 concentrations below 600 ng/mL achieved SVR compared with 39% of the patients with sCD26 exceeding 600 ng/mL (P = 0.01). Patients with sCD26 concentrations below 600 ng/mL had significantly higher frequencies of HCV-specific CD8(+) T cells (P = 0.02). Conclusions: Low baseline systemic concentrations of sCD26 predict favorable treatment outcome in chronic HCV infection and may be associated with higher blood counts of HCV-specific CD8(+) T cells.	[Soderholm, Jonas; Waldenstrom, Jesper; Askarieh, Galia; Norkrans, Gunnar; Wejstal, Rune; Westin, Johan; Lindh, Magnus; Hellstrand, Kristoffer; Lagging, Martin] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Pilli, Massimo; Ferrari, Carlo; Missale, Gabriele] Azienda Osped Parma, Parma, Italy; [Bochud, Pierre-Yves] Univ Lausanne Hosp, Dept Med, Infect Dis Serv, Lausanne, Switzerland; [Bochud, Pierre-Yves] Univ Lausanne, Lausanne, Switzerland; [Negro, Francesco] Univ Hosp Geneva, Geneva, Switzerland; [Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, F-94010 Creteil, France; [Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Zeuzem, Stefan] JW Goethe Univ Hosp, Dept Med 1, Frankfurt, Germany; [Neumann, Avidan U.] Bar Ilan Univ, Ramat Gan, Israel; [Haagmans, Bart L.] Erasmus MC, Dept Virol, Rotterdam, Netherlands	University of Gothenburg; University of Parma; University Hospital of Parma; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Bar Ilan University; Erasmus University Rotterdam; Erasmus MC	Soderholm, J (corresponding author), Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden.	jonas.soderholm@gmail.com	Zeuzem, Stefan/AAE-7435-2019; Pawlotsky, Jean-Michel/R-8159-2018; Negro, Francesco/E-2183-2012; Missale, Gabriele/J-6083-2016; Lagging, Martin/D-7734-2015; Haagmans, Bart/E-9791-2015; Söderholm, Jonas/U-2091-2019; Bochud, Pierre-Yves/ABE-5979-2020; Ferrari, Carlo/D-5663-2017	Missale, Gabriele/0000-0001-6691-8701; Lagging, Martin/0000-0002-7995-3626; Haagmans, Bart/0000-0001-6221-2015; Söderholm, Jonas/0000-0002-7810-3005; Ferrari, Carlo/0000-0002-5461-6842; Hellstrand, Kristoffer/0000-0002-6617-5976; Bochud, Pierre-Yves/0000-0002-2208-4757; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Ferrari, Carlo/0000-0002-7843-4963	Wilhelm and Martina Lundgren's Scientific Foundation; Swedish Society of Medicine; Swedish Medical Research Council; Cancerfonden; Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; ALF (Avtal om Lakarutbildning och Forskning) Funds at the Sahlgrenska University Hospital; FIRB grant from the Italian Ministry of the University and Research [RBAP10RPXK]	Wilhelm and Martina Lundgren's Scientific Foundation; Swedish Society of Medicine; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Cancerfonden(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation; Swedish Society of Microbiology; ALF (Avtal om Lakarutbildning och Forskning) Funds at the Sahlgrenska University Hospital; FIRB grant from the Italian Ministry of the University and Research(Ministry of Education, Universities and Research (MIUR))	JS and J. Waldenstrom were supported by the Wilhelm and Martina Lundgren's Scientific Foundation. The Swedish Society of Medicine, The Swedish Medical Research Council, Cancerfonden, The Torsten and Ragnar Soderberg Foundation, The Swedish Society of Microbiology, and ALF (Avtal om Lakarutbildning och Forskning) Funds at the Sahlgrenska University Hospital supported this study, as did a FIRB grant from the Italian Ministry of the University and Research, Protocol RBAP10RPXK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge S, 2011, BIOL CHEM, V392, P153, DOI 10.1515/BC.2011.008; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bochud PY, 2011, J HEPATOL; Butera D, 2005, BLOOD, V106, P1175, DOI 10.1182/blood-2005-01-0126; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Denney H, 2009, BIOCHEM BIOPH RES CO, V382, P341, DOI 10.1016/j.bbrc.2009.02.164; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; eBioscience, HUM SCD26 PLAT ELISA; Firneisz G, 2001, SCAND J GASTROENTERO, V36, P877, DOI 10.1080/003655201750313423; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; GREINER M, 1995, J IMMUNOL METHODS, V185, P145, DOI 10.1016/0022-1759(95)00078-O; GREINER M, 1995, J IMMUNOL METHODS, V185, P123, DOI 10.1016/0022-1759(95)00121-P; Hyland R.H., 2012, 46 ANN M EUR ASS STU; Ishii T, 2001, P NATL ACAD SCI USA, V98, P12138, DOI 10.1073/pnas.211439098; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lindh M, 2005, J CLIN VIROL, V34, P108, DOI 10.1016/j.jcv.2005.02.002; Lindh M, 2011, J VIRAL HEPATITIS, V18, pE325, DOI 10.1111/j.1365-2893.2010.01425.x; Munir S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-296; Ohnuma K, 2001, J IMMUNOL, V167, P6745, DOI 10.4049/jimmunol.167.12.6745; Pilli M, 2007, GASTROENTEROLOGY, V133, P1132, DOI 10.1053/j.gastro.2007.06.059; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Romagnani P, 2001, BLOOD, V97, P601, DOI 10.1182/blood.V97.3.601; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Systems RD, HUM CXCL10 IP 10 IMM; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P4586, DOI 10.1073/pnas.90.10.4586; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Wedemeyer H, 2002, J IMMUNOL, V169, P3447, DOI 10.4049/jimmunol.169.6.3447; Yusim Karina, 2005, Appl Bioinformatics, V4, P217, DOI 10.2165/00822942-200504040-00002; Zeuzem S, 2005, J HEPATOL, V43, P250, DOI 10.1016/j.jhep.2005.05.016; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	39	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e56991	10.1371/journal.pone.0056991	http://dx.doi.org/10.1371/journal.pone.0056991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437290	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200194
J	Hanley, MB; Lomas, W; Mittar, D; Maino, V; Park, E				Hanley, Mary Beth; Lomas, Woodrow; Mittar, Dev; Maino, Vernon; Park, Emily			Detection of Low Abundance RNA Molecules in Individual Cells by Flow Cytometry	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; IN-SITU HYBRIDIZATION; TRANSCRIPTS; PROBES; LEUKEMIA; CANCER; FISH; PCR; SEQ	A variety of RNA analysis technologies are available for the detection of RNA transcripts from bulk cell populations. However, the techniques for RNA detection from individual cells have been limited. Here we adapt a novel in situ signal amplification method (the RNAScope (R) detection platform) for the analysis of intracellular RNAs in individual cells by flow cytometry. Using novel target-specific probes that were designed to suppress background signals, we demonstrate the specific detection of HIV gag RNAs in HIV-infected cellular samples, in addition to bcr and abl mRNAs in the K562 cell line. This method was capable of distinguishing cells expressing low abundance RNA transcripts and correlated well with quantitative imaging analysis. Furthermore, multiple distinct RNA targets were simultaneously detected with a high specificity without interference. Overall, the sensitivity and specificity of this method will be useful for the analysis of functionally important RNA species from individual cells, even at very low copy numbers.	[Hanley, Mary Beth; Lomas, Woodrow; Mittar, Dev; Maino, Vernon; Park, Emily] BD Biosci, Res & Dev, San Jose, CA USA		Park, E (corresponding author), BD Biosci, Res & Dev, San Jose, CA USA.	emily_park@bd.com						Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Crouch J, 1997, CYTOMETRY, V29, P50, DOI 10.1002/(SICI)1097-0320(19970901)29:1<50::AID-CYTO5>3.3.CO;2-R; De Spiegelaere Ward, 2012, Methods Mol Biol, V853, P29, DOI 10.1007/978-1-61779-567-1_4; Di Carlo Dino, 2012, Methods Mol Biol, V853, P1, DOI 10.1007/978-1-61779-567-1_1; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Freeman WM, 2000, BIOTECHNIQUES, V29, P1042, DOI 10.2144/00295rv01; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gourronc FA, 2010, EXP DERMATOL, V19, P279, DOI 10.1111/j.1600-0625.2009.00916.x; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Herzenberg LA, 2002, CLIN CHEM, V48, P1819; Iacobucci I, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.6; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Luo Y, 2010, MULTIPLEX DETECTION; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, METHOD ENZYMOL, V472, P365, DOI 10.1016/S0076-6879(10)72004-8; Robertson KL, 2010, RNA, V16, P1679, DOI 10.1261/rna.2016410; Robertson KL, 2009, ANAL BIOCHEM, V390, P109, DOI 10.1016/j.ab.2009.04.026; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Symmans WF, 2003, CANCER, V97, P2960, DOI 10.1002/cncr.11435; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	32	39	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e57002	10.1371/journal.pone.0057002	http://dx.doi.org/10.1371/journal.pone.0057002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441230	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200087
J	Yost, SE; Pastorino, S; Rozenzhak, S; Smith, EN; Chao, YS; Jiang, PF; Kesari, S; Frazer, KA; Harismendy, O				Yost, Shawn E.; Pastorino, Sandra; Rozenzhak, Sophie; Smith, Erin N.; Chao, Ying S.; Jiang, Pengfei; Kesari, Santosh; Frazer, Kelly A.; Harismendy, Olivier			High-Resolution Mutational Profiling Suggests the Genetic Validity of Glioblastoma Patient-Derived Pre-Clinical Models	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; TYROSINE KINASE GENES; CELL-LINES; STEM-CELLS; IN-VIVO; AMPLIFICATION; IDH1; EGFR; SUBPOPULATIONS; HETEROGENEITY	Recent advances in the ability to efficiently characterize tumor genomes is enabling targeted drug development, which requires rigorous biomarker-based patient selection to increase effectiveness. Consequently, representative DNA biomarkers become equally important in pre-clinical studies. However, it is still unclear how well these markers are maintained between the primary tumor and the patient-derived tumor models. Here, we report the comprehensive identification of somatic coding mutations and copy number aberrations in four glioblastoma (GBM) primary tumors and their matched pre-clinical models: serum-free neurospheres, adherent cell cultures, and mouse xenografts. We developed innovative methods to improve the data quality and allow a strict comparison of matched tumor samples. Our analysis identifies known GBM mutations altering PTEN and TP53 genes, and new actionable mutations such as the loss of PIK3R1, and reveals clear patient-to-patient differences. In contrast, for each patient, we do not observe any significant remodeling of the mutational profile between primary to model tumors and the few discrepancies can be attributed to stochastic errors or differences in sample purity. Similarly, we observe similar to 96% primary-to-model concordance in copy number calls in the high-cellularity samples. In contrast to previous reports based on gene expression profiles, we do not observe significant differences at the DNA level between in vitro compared to in vivo models. This study suggests, at a remarkable resolution, the genome-wide conservation of a patient's tumor genetics in various pre-clinical models, and therefore supports their use for the development and testing of personalized targeted therapies.	[Yost, Shawn E.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Yost, Shawn E.; Rozenzhak, Sophie; Smith, Erin N.; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Dept Pediat, Div Genome Informat Sci, La Jolla, CA 92093 USA; [Yost, Shawn E.; Rozenzhak, Sophie; Smith, Erin N.; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Rady Childrens Hosp, La Jolla, CA 92093 USA; [Pastorino, Sandra; Chao, Ying S.; Jiang, Pengfei; Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Pastorino, Sandra; Chao, Ying S.; Jiang, Pengfei; Kesari, Santosh] Univ Calif San Diego, Translat Neurooncol Labs, La Jolla, CA 92093 USA; [Kesari, Santosh; Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Frazer, Kelly A.; Harismendy, Olivier] Univ Calif San Diego, Clin & Translat Res Inst, La Jolla, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kesari, S (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	skesari@ucsd.edu; oharismendy@ucsd.edu	Jiang, Pengfei/M-1759-2013; Harismendy, Olivier/AAM-2072-2021; Kesari, Santosh/E-8461-2013	Jiang, Pengfei/0000-0003-1912-8824; Harismendy, Olivier/0000-0002-8098-9888; Frazer, Kelly/0000-0002-6060-8902; Yost, Shawn/0000-0001-6653-1056	Center for Translational Science Award from the National Center for Research Resources [UL1RR031980, UL1TR000100]; National Cancer Institute [1R21CA152613-01, 1R21CA155615-01A1, CA69375]; National Institutes of Health [3P30CA023100-25S8, K08CA124804]; National Brain Tumor Foundation; James S. McDonnell Foundation; California Institute for Regenerative Medicine [CL1-00502, RT1-01108, TR1-01250]; NATIONAL CANCER INSTITUTE [P30CA023100, R21CA152613, R01CA069375, K08CA124804, R21CA155615] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980] Funding Source: NIH RePORTER	Center for Translational Science Award from the National Center for Research Resources; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Foundation; James S. McDonnell Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Center for Translational Science Award (UL1RR031980 and UL1TR000100) from the National Center for Research Resources, three grants (1R21CA152613-01, 1R21CA155615-01A1, CA69375) from the National Cancer Institute. This work was also supported in part by grants from National Institutes of Health (3P30CA023100-25S8 and K08CA124804), National Brain Tumor Foundation, and James S. McDonnell Foundation to SK. Dr. Laurent's contribution was supported by California Institute for Regenerative Medicine grants CL1-00502, RT1-01108, and TR1-01250 to Jeanne F. Loring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ding L, 2012, NATURE; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Fraley C, 2007, MCLUST VERSION 3 R N; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hodgson JG, 2009, NEURO-ONCOLOGY, V11, P477, DOI 10.1215/15228517-2008-113; Jeuken JWM, 2000, J NEUROSURG, V92, P652, DOI 10.3171/jns.2000.92.4.0652; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Koboldt DC, 2012, GENOME RES; Krzywinski MI, 2009, GENOME RES; Lathia JD, 2011, CELL STEM CELL, V8, P482, DOI 10.1016/j.stem.2011.04.013; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leuraud P, BR J CANC, V89, P2327; Little SE, 2012, CANCER RES, V72, P1614, DOI 10.1158/0008-5472.CAN-11-4069; Masramon L, 2006, J CELL SCI, V119, P1477, DOI 10.1242/jcs.02871; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pastor DM, 2010, INT J CLIN EXP MED, V3, P69; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Shah SP, 2012, NATURE; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	48	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56185	10.1371/journal.pone.0056185	http://dx.doi.org/10.1371/journal.pone.0056185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441165	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200022
J	Suginta, W; Chumjan, W; Mahendran, KR; Schulte, A; Winterhalter, M				Suginta, Wipa; Chumjan, Watcharin; Mahendran, Kozhinjampara R.; Schulte, Albert; Winterhalter, Mathias			Chitoporin from Vibrio harveyi, a Channel with Exceptional Sugar Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLACK LIPID-MEMBRANES; ESCHERICHIA-COLI; OUTER-MEMBRANE; CHITIN UTILIZATION; CURRENT NOISE; PSEUDOMONAS-AERUGINOSA; UTILIZATION PATHWAY; KLEBSIELLA-OXYTOCA; MARINE BACTERIUM; SINGLE-CHANNEL	Chitoporin (VhChiP) is a sugar-specific channel responsible for the transport of chitooligosaccharides through the outer membrane of the marine bacterium Vibrio harveyi. Single channel reconstitution into black lipid membrane allowed single chitosugar binding events in the channel to be resolved. VhChiP has an exceptionally high substrate affinity, with a binding constant of K = 5.0 x 10(6) M-1 for its best substrate (chitohexaose). The on-rates of chitosugars depend on applied voltages, as well as the side of the sugar addition, clearly indicating the inherent asymmetry of the VhChiP lumen. The binding affinity of VhChiP for chitohexaose is 1-5 orders of magnitude larger than that of other known sugar-specific porins for their preferred substrates. Thus, VhChiP is the most potent sugar-specific channel reported to date, with its high efficiency presumably reflecting the need for the bacterium to take up chitin-containing nutrients promptly under turbulent aquatic conditions to exploit them efficiently as its sole source of energy.	[Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Chem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa; Chumjan, Watcharin; Schulte, Albert] Suranaree Univ Technol, Biochem Electrochem Res Unit, Sch Biochem, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Mahendran, Kozhinjampara R.; Winterhalter, Mathias] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany	Suranaree University of Technology; Suranaree University of Technology; Jacobs University	Suginta, W (corresponding author), Suranaree Univ Technol, 111 Univ Ave, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		Winterhalter, Mathias/0000-0002-1604-3318	Alexander von Humboldt Fellowship for Experienced Researchers from the Alexander von Humboldt Foundation (Bonn, Germany); CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand) [60/2550]; Deutsche Forschungsgemeinschaft (DFG) [WI 2278/18-1]	Alexander von Humboldt Fellowship for Experienced Researchers from the Alexander von Humboldt Foundation (Bonn, Germany)(Alexander von Humboldt Foundation); CHE-PhD-SW Scholarship from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Humboldt Fellow supported by an Alexander von Humboldt Fellowship for Experienced Researchers from the Alexander von Humboldt Foundation (Bonn, Germany). To whom correspondence should be addressed: Suranaree University of Technology, 111 University Ave., Nakhon Ratchasima 30000, Thailand. Fax: 66-44-226-187; E-mail: wipa@sut.ac.th.; Supported by CHE-PhD-SW Scholarship Contract 60/2550 from the Commission of Higher Education, Ministry of University Affairs (Bangkok, Thailand).; Supported by Deutsche Forschungsgemeinschaft (DFG) Grant WI 2278/18-1.	Actis LA, 2011, FISH DISEASES AND DISORDERS, VOL 3: VIRAL, BACTERIAL AND FUNGAL INFECTIONS, 2ND EDITION, P570, DOI 10.1079/9781845935542.0570; Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BENZ R, 1987, J GEN PHYSIOL, V89, P275, DOI 10.1085/jgp.89.2.275; BENZ R, 1986, J BACTERIOL, V165, P978, DOI 10.1128/jb.165.3.978-986.1986; Berkane E, 2005, J Nanobiotechnology, V3, P3, DOI 10.1186/1477-3155-3-3; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Hjerde E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-616; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Jung BO, 2008, MACROMOL RES, V16, P1, DOI 10.1007/BF03218953; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Klebba PE, 2002, RES MICROBIOL, V153, P417, DOI 10.1016/S0923-2508(02)01340-2; Kullman L, 2002, BIOPHYS J, V82, P803, DOI 10.1016/S0006-3495(02)75442-8; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Liuxy P. C., 1996, LETT APPL MICROBIOL, V22, P413; LUGTENBERG B, 1983, BIOCHIM BIOPHYS ACTA, V737, P51, DOI 10.1016/0304-4157(83)90014-X; Mahendran KR, 2009, EUR BIOPHYS J BIOPHY, V38, P1141, DOI 10.1007/s00249-009-0495-0; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; Orlik F, 2003, BIOPHYS J, V85, P876, DOI 10.1016/S0006-3495(03)74527-5; Pajatsch M, 1999, J BIOL CHEM, V274, P25159, DOI 10.1074/jbc.274.35.25159; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; SARAVOLAC EG, 1991, J BACTERIOL, V173, P4970, DOI 10.1128/jb.173.16.4970-4976.1991; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Suginta W, 2000, J APPL MICROBIOL, V89, P76, DOI 10.1046/j.1365-2672.2000.01076.x; Suginta W, 2007, ENZYME MICROB TECH, V41, P212, DOI 10.1016/j.enzmictec.2007.01.006; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Van Gelder P, 2000, BIOPHYS CHEM, V85, P153, DOI 10.1016/S0301-4622(99)00153-2; Van Gelder P, 2002, J BACTERIOL, V184, P2994, DOI 10.1128/JB.184.11.2994-2999.2002; Van Gelder P, 2001, PROTEIN ENG, V14, P943, DOI 10.1093/protein/14.11.943; Winterhalter M, 2000, CURR OPIN COLLOID IN, V5, P250, DOI 10.1016/S1359-0294(00)00063-7; WYLIE JL, 1993, J BIOENERG BIOMEMBR, V25, P547, DOI 10.1007/BF01108411; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200	40	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11038	11046		10.1074/jbc.M113.454108	http://dx.doi.org/10.1074/jbc.M113.454108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23447539	hybrid, Green Published			2022-12-25	WOS:000317915500010
J	Novoselova, TV; Rose, RS; Marks, HM; Sullivan, JA				Novoselova, Tatiana Vladislavovna; Rose, Ruth-Sarah; Marks, Helen Margaret; Sullivan, James Andrew			SUMOylation Regulates the Homologous to E6-AP Carboxyl Terminus (HECT) Ubiquitin Ligase Rsp5p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST METAL TRANSPORTER; PROSTATE-CANCER CELLS; RNA-POLYMERASE-II; SUMO MODIFICATION; PROTEIN LIGASE; PLASMA-MEMBRANE; IN-VITRO; SACCHAROMYCES-CEREVISIAE; ANDROGEN RECEPTOR; CHANNEL K2P1	The post-translational modifiers ubiquitin and small ubiquitin-related modifier (SUMO) regulate numerous critical signaling pathways and are key to controlling the cellular fate of proteins in eukaryotes. The attachment of ubiquitin and SUMO involves distinct, but related, machinery. However, it is now apparent that many substrates can be modified by both ubiquitin and SUMO and that some regulatory interaction takes place between the respective attachment machinery. Here, we demonstrate that the Saccharomyces cerevisiae ubiquitin ligase Rsp5p, a member of the highly conserved Nedd4 family of ubiquitin ligases, is SUMOylated in vivo. We further show that Rsp5p SUMOylation is mediated by the SUMO ligases Siz1p and Siz2p, members of the conserved family of PIAS SUMO ligases that are, in turn, substrates for Rsp5p-mediated ubiquitylation. Our experiments show that SUMOylated Rsp5p has reduced ubiquitin ligase activity, and similarly, ubiquitylated Siz1p demonstrates reduced SUMO ligase activity leading to respective changes in both ubiquitin-mediated sorting of the manganese transporter Smf1p and polySUMO chain formation. This reciprocal regulation of these highly conserved ligases represents an exciting and previously unidentified system of cross talk between the ubiquitin and SUMO systems.	[Novoselova, Tatiana Vladislavovna; Rose, Ruth-Sarah; Marks, Helen Margaret; Sullivan, James Andrew] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Sullivan, JA (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.a.sullivan@qmul.ac.uk	Rose, Ruth/AAW-3844-2020	Rose, Ruth/0000-0001-6406-137X; Sullivan, James/0000-0003-1457-2950	Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/G004412/1] Funding Source: researchfish; BBSRC [BB/G004412/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council.	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Erdeniz N, 2000, MOL CELL BIOL, V20, P224, DOI 10.1128/MCB.20.1.224-232.2000; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hang LE, 2011, NAT STRUCT MOL BIOL, V18, P920, DOI 10.1038/nsmb.2100; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Leon S, 2008, MOL BIOL CELL, V19, P2379, DOI 10.1091/mbc.E08-01-0068; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu XF, 1999, J BIOL CHEM, V274, P4863, DOI 10.1074/jbc.274.8.4863; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Plant LD, 2010, P NATL ACAD SCI USA, V107, P10743, DOI 10.1073/pnas.1004712107; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Tang ZS, 2005, J BIOL CHEM, V280, P38153, DOI 10.1074/jbc.M508168200; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Werner Andreas, 2009, V497, P187, DOI 10.1007/978-1-59745-566-4_12; Wible BA, 2002, J BIOL CHEM, V277, P17852, DOI 10.1074/jbc.M201689200; Wible BA, 1998, J BIOL CHEM, V273, P11745, DOI 10.1074/jbc.273.19.11745; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	60	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10308	10317		10.1074/jbc.M112.424234	http://dx.doi.org/10.1074/jbc.M112.424234			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23443663	Green Published, hybrid			2022-12-25	WOS:000317565000012
J	Pal, PB; Sinha, K; Sil, PC				Pal, Pabitra Bikash; Sinha, Krishnendu; Sil, Parames C.			Mangiferin, a Natural Xanthone, Protects Murine Liver in Pb(II) Induced Hepatic Damage and Cell Death via MAP Kinase, NF-kappa B and Mitochondria Dependent Pathways	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; CAJANUS-INDICUS L; 43 KD PROTEIN; PHYLLANTHUS-NIRURI; ARJUNOLIC ACID; LEAD-EXPOSURE; INDUCED CYTOTOXICITY; ACTIVATOR PROTEIN-1; L. EXTRACT; IN-VITRO	One of the most well-known naturally occurring environmental heavy metals, lead (Pb) has been reported to cause liver injury and cellular apoptosis by disturbing the prooxidant-antioxidant balance via oxidative stress. Several studies, on the other hand, reported that mangiferin, a naturally occurring xanthone, has been used for a broad range of therapeutic purposes. In the present study, we, therefore, investigated the molecular mechanisms of the protective action of mangiferin against lead-induced hepatic pathophysiology. Lead [Pb(II)] in the form of Pb(NO3)(2) (at a dose of 5 mg/kg body weight, 6 days, orally) induced oxidative stress, hepatic dysfunction and cell death in murine liver. Post treatment of mangiferin at a dose of 100 mg/kg body weight (6 days, orally), on the other hand, diminished the formation of reactive oxygen species (ROS) and reduced the levels of serum marker enzymes [alanine aminotranferase (ALT) and alkaline phosphatase (ALP)]. Mangiferin also reduced Pb(II) induced alterations in antioxidant machineries, restored the mitochondrial membrane potential as well as mutual regulation of Bcl-2/Bax. Furthermore, mangiferin inhibited Pb(II)-induced activation of mitogen-activated protein kinases (MAPKs) (phospho-ERK 1/2, phosphor-JNK phospho- p38), nuclear translocation of NF-kappa B and apoptotic cell death as was evidenced by DNA fragmentation, FACS analysis and histological assessment. In vitro studies using hepatocytes as the working model also showed the protective effect of mangiferin in Pb(II) induced cytotoxicity. All these beneficial effects of mangiferin contributes to the considerable reduction of apoptotic hepatic cell death induced by Pb(II). Overall results demonstrate that mangiferin exhibit both antioxidative and antiapoptotic properties and protects the organ in Pb(II) induced hepatic dysfunction.	[Pal, Pabitra Bikash; Sinha, Krishnendu; Sil, Parames C.] Bose Inst, Div Mol Med, Kolkata, India	Department of Science & Technology (India); Bose Institute	Sil, PC (corresponding author), Bose Inst, Div Mol Med, P-1-12,CIT Scheme 7 M, Kolkata, India.	parames_95@yahoo.co.in		Sinha, Krishnendu/0000-0001-9590-3875				Aderibigbe AO, 1999, PHYTOTHER RES, V13, P504, DOI 10.1002/(SICI)1099-1573(199909)13:6&lt;504::AID-PTR533&gt;3.0.CO;2-9; Agency for Toxic Substances and Disease Registry (ATSDR), 1992, CAS STUD ENV MED LEA; Ahamed M, 2007, CLIN CHIM ACTA, V383, P57, DOI 10.1016/j.cca.2007.04.024; Aiyelaagbe O.O., 2009, OYO STATE PLANT SCI, V2, P11; Anila L, 2002, J ETHNOPHARMACOL, V79, P81, DOI 10.1016/S0378-8741(01)00361-0; ARITOMI M, 1969, TETRAHEDRON LETT, P941; ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF LEAD; Bairy Indira, 2002, Indian J Pathol Microbiol, V45, P307; Bhattacharjee Rajesh, 2006, Biomedical Research (Aligarh), V17, P75; Bhattacharjee R, 2007, FOOD CHEM TOXICOL, V45, P817, DOI 10.1016/j.fct.2006.10.029; Bhattacharjee R, 2007, TOXICOL MECH METHOD, V17, P41, DOI 10.1080/15376510600970034; Bhattacharjee R, 2006, PHYTOTHER RES, V20, P595, DOI 10.1002/ptr.1933; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Centers for Disease Control and Prevention, 1991, PREV LEAD POIS YOUNG; Chandrasekaran VRM, 2009, SHOCK, V32, P89, DOI 10.1097/SHK.0b013e31818ede6f; Chatterjee Mary, 2006, Pathophysiology, V13, P95, DOI 10.1016/j.pathophys.2006.02.003; Chatterjee M, 2006, INDIAN J BIOCHEM BIO, V43, P299; Chatterjee M, 2007, INDIAN J CLIN BIOCHE, V22, P109, DOI 10.1007/BF02912892; CHRISTIE NT, 1984, BIOL TRACE ELEM RES, V6, P139, DOI 10.1007/BF02916931; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; Das J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012602; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; Farghali H, 2000, PHARMACOL RES, V41, P231, DOI 10.1006/phrs.1999.0575; Garcia D, 2003, PHYTOTHER RES, V17, P1203, DOI 10.1002/ptr.1343; Ghosh A, 2009, CHEM-BIOL INTERACT, V177, P96, DOI 10.1016/j.cbi.2008.09.006; Ghosh A, 2008, BIOL PHARM BULL, V31, P1651, DOI 10.1248/bpb.31.1651; Ghosh A, 2007, J BIOCHEM MOL BIOL, V40, P1039; Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010; Ghosh J, 2010, FOOD CHEM, V123, P1062, DOI 10.1016/j.foodchem.2010.05.062; Ghosh M, 2012, FREE RADICAL RES, V46, P116, DOI 10.3109/10715762.2011.644240; GOYER RA, 1993, ENVIRON HEALTH PERSP, V100, P177, DOI 10.2307/3431524; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guha S, 1996, CHEMOTHERAPY, V42, P443, DOI 10.1159/000239478; Gurer H., 2000, FREE RADIC BIOL MED, V299, P27; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Keeble JA, 2007, CELL RES, V17, P976, DOI 10.1038/cr.2007.101; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; LEBEL CP, 1990, NEUROCHEM INT, V17, P435, DOI 10.1016/0197-0186(90)90025-O; Leiro J, 2004, INT IMMUNOPHARMACOL, V4, P763, DOI 10.1016/j.intimp.2004.03.002; Madesh M, 1997, INDIAN J BIOCHEM BIO, V34, P535; Makare N, 2001, J ETHNOPHARMACOL, V78, P133, DOI 10.1016/S0378-8741(01)00326-9; Manna P, 2011, EVID-BASED COMPL ALT, DOI [10.1155/2010/neq065, DOI 10.1155/2010/NEQ065]; Manna P, 2008, REDOX REP, V13, P67, DOI 10.1179/135100008X259169; Manna P, 2007, J BIOCHEM MOL BIOL, V40, P382; Manna Prasenjit, 2006, BMC Complement Altern Med, V6, P33, DOI 10.1186/1472-6882-6-33; Manna P, 2010, FREE RADICAL BIO MED, V48, P1465, DOI 10.1016/j.freeradbiomed.2010.02.025; Manna P, 2009, TOXICOLOGY, V257, P53, DOI 10.1016/j.tox.2008.12.008; MARCOCCI L, 1994, BIOCHEM BIOPH RES CO, V201, P748, DOI 10.1006/bbrc.1994.1764; Martinez G, 2000, PHYTOTHER RES, V14, P424, DOI 10.1002/1099-1573(200009)14:6&lt;424::AID-PTR643&gt;3.0.CO;2-8; Mingatto FE, 2002, J PHARMACOL EXP THER, V303, P601, DOI 10.1124/jpet.102.038620; Mishra B, 2006, RADIAT PHYS CHEM, V75, P70, DOI 10.1016/j.radphyschem.2005.05.015; Muruganandan S, 2002, TOXICOLOGY, V176, P165, DOI 10.1016/S0300-483X(02)00069-0; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Pagliara P, 2003, COMP HEPATOL, V2, P1; Pal Pabitra Bikash, 2012, Pathophysiology, V19, P101, DOI 10.1016/j.pathophys.2012.02.001; Patil Arun J., 2006, Journal of Basic and Clinical Physiology and Pharmacology, V17, P213; Patra RC, 2001, TOXICOLOGY, V162, P81, DOI 10.1016/S0300-483X(01)00345-6; Ramesh GT, 1999, TOXICOL APPL PHARM, V155, P280, DOI 10.1006/taap.1999.8624; Ramesh GT, 2001, TOXICOL LETT, V123, P195, DOI 10.1016/S0378-4274(01)00395-2; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Sairam K, 2003, J ETHNOPHARMACOL, V84, P11, DOI 10.1016/S0378-8741(02)00250-7; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Sanchez GM, 2000, PHARMACOL RES, V42, P565, DOI 10.1006/phrs.2000.0727; Sarkar K, 2005, HEPATOL RES, V33, P39, DOI 10.1016/j.hepres.2005.06.007; Sarkar K, 2007, TOXICOL MECH METHOD, V17, P305, DOI 10.1080/15376510601031919; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Sarkar Kasturi, 2011, Pathophysiology, V18, P295, DOI 10.1016/j.pathophys.2011.05.001; Sarkar K, 2006, PROTEIN J, V25, P411, DOI 10.1007/s10930-006-9030-7; Sarkar MK, 2010, TOXICOL IN VITRO, V24, P1711, DOI 10.1016/j.tiv.2010.05.014; Sarkar Mrinal K, 2007, Pathophysiology, V14, P113, DOI 10.1016/j.pathophys.2007.08.001; Sarkar MK, 2009, FOOD CHEM, V114, P1405, DOI 10.1016/j.foodchem.2008.11.022; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Sharma V., 2011, TOXICOL INT, V17, P12; Sharma V., 2011, INT J PHARM SCI REV, V7, P116; Sinha M, 2008, J BIOCHEM MOL TOXIC, V22, P15, DOI 10.1002/jbt.20209; Sinha M, 2007, ARCH TOXICOL, V81, P397, DOI 10.1007/s00204-007-0176-7; UCHIDA K, 1993, J BIOL CHEM, V268, P6388; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001; Yedjou Clement G, 2007, Int J Environ Res Public Health, V4, P132, DOI 10.3390/ijerph2007040007; Yoshimi N, 2001, CANCER LETT, V163, P163, DOI 10.1016/S0304-3835(00)00678-9	85	69	74	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56894	10.1371/journal.pone.0056894	http://dx.doi.org/10.1371/journal.pone.0056894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451106	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500041
J	Wood, JR; Wilmshurst, JM; Rawlence, NJ; Bonner, KI; Worthy, TH; Kinsella, JM; Cooper, A				Wood, Jamie R.; Wilmshurst, Janet M.; Rawlence, Nicolas J.; Bonner, Karen I.; Worthy, Trevor H.; Kinsella, John M.; Cooper, Alan			A Megafauna's Microfauna: Gastrointestinal Parasites of New Zealand's Extinct Moa (Aves: Dinornithiformes)	PLOS ONE			English	Article							ANCIENT DNA; PALEOPARASITOLOGICAL ANALYSIS; GROUND SLOTH; N-G; COPROLITES; DIET; PLANT; NEMATODA; MIOCENE; REMAINS	We perform the first multidisciplinary study of parasites from an extinct megafaunal clade using coprolites from the New Zealand moa (Aves: Dinornithiformes). Ancient DNA and microscopic analyses of 84 coprolites deposited by four moa species (South Island giant moa, Dinornis robustus; little bush moa, Anomalopteryx didiformis; heavy-footed moa, Pachyornis elephantopus; and upland moa, Megalapteryx didinus) reveal an array of gastrointestinal parasites including coccidians (Cryptosporidium and members of the suborder Eimeriorina), nematodes (Heterakoidea, Trichostrongylidae, Trichinellidae) and a trematode (Echinostomida). Parasite eggs were most prevalent and diverse in coprolites from lowland sites, where multiple sympatric moa species occurred and host density was therefore probably higher. Morphological and phylogenetic evidence supports a possible vicariant Gondwanan origin for some of the moa parasites. The discovery of apparently host-specific parasite taxa suggests paleoparasitological studies of megafauna coprolites may provide useful case-studies of coextinction.	[Wood, Jamie R.; Wilmshurst, Janet M.; Bonner, Karen I.] Landcare Res, Canterbury, New Zealand; [Rawlence, Nicolas J.; Cooper, Alan] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Worthy, Trevor H.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Kinsella, John M.] HelmWest Lab, Missoula, MT USA	Landcare Research - New Zealand; University of Adelaide; University of New South Wales Sydney	Wood, JR (corresponding author), Landcare Res, Canterbury, New Zealand.	woodj@landcareresearch.co.nz	Cooper, Alan/E-8171-2012; Wood, Jamie/A-9393-2008; Wilmshurst, Janet M/C-2209-2009; Worthy, Trevor/B-3781-2012; Wilmshurst, Janet/O-8611-2019; Wood, Jamie/AAU-5530-2021	Cooper, Alan/0000-0002-7738-7851; Wood, Jamie/0000-0001-8008-6083; Wilmshurst, Janet M/0000-0002-4474-8569; Worthy, Trevor/0000-0001-7047-4680; Wilmshurst, Janet/0000-0002-4474-8569; 	Royal Society of New Zealand Marsden Fund [08-LCR-012]	Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was funded by the Royal Society of New Zealand Marsden Fund (08-LCR-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeret O, 1999, HOLOCENE, V9, P175, DOI 10.1191/095968399666631581; Allentoft ME, 2012, ANN ANAT, V194, P36, DOI 10.1016/j.aanat.2011.04.002; Araujo A, 2003, MEM I OSWALDO CRUZ, V98, P5, DOI 10.1590/S0074-02762003000900003; ARAUJO AJG, 1982, J PARASITOL, V68, P511, DOI 10.2307/3280974; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Barton DP, 2005, KEYS TREMATODA, V2; Bouchet F, 2003, MEM I OSWALDO CRUZ, V98, P47, DOI 10.1590/S0074-02762003000900009; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; BUSH AO, 1994, INT J PARASITOL, V24, P1333, DOI 10.1016/0020-7519(94)90199-6; Clayton DH, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P310; Cooper A, 2000, SCIENCE, V289, P1139; Craig Thomas M., 1996, P115; DAVIS O K, 1984, Carnegie Museum of Natural History Special Publication, P267; Dickison MJ, 2007, THESIS DUKE U US; Dunn Robert R., 2009, P167; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; FERREIRA LF, 1993, J PARASITOL, V79, P440, DOI 10.2307/3283583; Fleming C.A., 1975, BIOGEOGRAPHY ECOLOGY, V27, P1; Fugassa MH, 2007, J PARASITOL, V93, P421, DOI 10.1645/GE-989R.1; Fugassa MH, 2006, J PARASITOL, V92, P1110, DOI 10.1645/GE-876R1.1; Gibbs G., 2006, GHOSTS GONDWANA HIST; Gill B.J., 2010, CHECKLIST BIRDS NZ N, V4th edition; Gordo FP, 2002, VET PARASITOL, V107, P137; Holmstad PR, 2005, OIKOS, V111, P377, DOI 10.1111/j.0030-1299.2005.13640.x; Fugassa MH, 2010, J ARCHAEOL SCI, V37, P880, DOI 10.1016/j.jas.2009.11.018; Horrocks M, 2004, EMU, V104, P149, DOI 10.1071/MU03019; Horrocks M, 2008, REV PALAEOBOT PALYNO, V149, P229, DOI 10.1016/j.revpalbo.2007.12.009; INGLIS WG, 1990, SYST PARASITOL, V15, P75, DOI 10.1007/BF00009919; INGLIS WG, 1991, SYST PARASITOL, V20, P89, DOI 10.1007/BF00007385; Iniguez AM, 2003, MEM I OSWALDO CRUZ, V98, P67, DOI 10.1590/S0074-02762003000900013; James HF, 1997, BIOL J LINN SOC, V62, P279, DOI 10.1111/j.1095-8312.1997.tb01627.x; Jones MEH, 2009, P ROY SOC B-BIOL SCI, V276, P1385, DOI 10.1098/rspb.2008.1785; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Kropf M, 2007, QUATERNARY RES, V67, P143, DOI 10.1016/j.yqres.2006.10.002; Le Bailly M, 2003, J PARASITOL, V89, P1073, DOI 10.1645/GE-3202RN; Loreille O, 2001, INT J PARASITOL, V31, P1101, DOI 10.1016/S0020-7519(01)00214-4; Marshall BA, 2011, MOLLUSCAN RES, V31, P47; McKenna P., 2010, WEBMED CENTRAL PARAS, V1, pWMC00705; Mitchell D, 2005, MUTAT RES-FUND MOL M, V571, P265, DOI 10.1016/j.mrfmmm.2004.06.060; Moore P.D., 1991, BLACKWELL SCI PUBLI; Morley NJ, 2008, AQUAT SCI, V70, P107, DOI 10.1007/s00027-007-7052-7; Poinar G, 2006, PARASITOLOGY, V133, P245, DOI 10.1017/S0031182006000138; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Reinhard KJ, 1998, MUMMIES DIS ANCIENT, P377; Ryan U, 2010, EXP PARASITOL, V124, P113, DOI 10.1016/j.exppara.2009.02.002; Sardella NH, 2009, J PARASITOL, V95, P646, DOI 10.1645/GE-1809.1; SCHMIDT GD, 1992, J PARASITOL, V78, P811, DOI 10.2307/3283310; Sianto L, 2005, J PARASITOL, V91, P972, DOI 10.1645/GE-3445RN.1; Waters JM, 2006, SYST BIOL, V55, P351, DOI 10.1080/10635150600681659; WATVE MG, 1995, P NATL ACAD SCI USA, V92, P8945, DOI 10.1073/pnas.92.19.8945; Williams PJ, 2005, NATION, V281, P13; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Wood JR, 2011, NEW ZEAL J GEOL GEOP, V54, P431, DOI 10.1080/00288306.2011.590212; Wood JR, 2012, CONSERV BIOL, V26, P1091, DOI 10.1111/j.1523-1739.2012.01931.x; Wood JR, 2012, NEW ZEAL J ECOL, V36, P164; Wood JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040025; Wood JR, 2008, QUATERNARY SCI REV, V27, P2593, DOI 10.1016/j.quascirev.2008.09.019; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; Worthy TH, 2010, J VERTEBR PALEONTOL, V30, P479, DOI 10.1080/02724631003618033; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578	60	56	56	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57315	10.1371/journal.pone.0057315	http://dx.doi.org/10.1371/journal.pone.0057315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451203	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500088
J	Emery, VJ; Tsutsui, ND				Emery, Virginia J.; Tsutsui, Neil D.			Recognition in a Social Symbiosis: Chemical Phenotypes and Nestmate Recognition Behaviors of Neotropical Parabiotic Ants	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; INTERSPECIFIC RECOGNITION; HYMENOPTERA-FORMICIDAE; ARGENTINE ANT; DISCRIMINATION; PARASITISM; COMPONENT; MIMICRY; GARDENS; ODORS	Social organisms rank among the most abundant and ecologically dominant species on Earth, in part due to exclusive recognition systems that allow cooperators to be distinguished from exploiters. Exploiters, such as social parasites, manipulate their hosts' recognition systems, whereas cooperators are expected to minimize interference with their partner's recognition abilities. Despite our wealth of knowledge about recognition in single-species social nests, less is known of the recognition systems in multi-species nests, particularly involving cooperators. One uncommon type of nesting symbiosis, called parabiosis, involves two species of ants sharing a nest and foraging trails in ostensible cooperation. Here, we investigated recognition cues (cuticular hydrocarbons) and recognition behaviors in the parabiotic mixed-species ant nests of Camponotus femoratus and Crematogaster levior in North-Eastern Amazonia. We found two sympatric, cryptic Cr. levior chemotypes in the population, with one type in each parabiotic colony. Although they share a nest, very few hydrocarbons were shared between Ca. femoratus and either Cr. levior chemotype. The Ca. femoratus hydrocarbons were also unusually long-chained branched alkenes and dienes, compounds not commonly found amongst ants. Despite minimal overlap in hydrocarbon profile, there was evidence of potential interspecific nestmate recognition =Cr. levior ants were more aggressive toward Ca. femoratus non-nestmates than Ca. femoratus nestmates. In contrast to the prediction that sharing a nest could weaken conspecific recognition, each parabiotic species also maintains its own aggressive recognition behaviors to exclude conspecific non-nestmates. This suggests that, despite cohabitation, parabiotic ants maintain their own species-specific colony odors and recognition mechanisms. It is possible that such social symbioses are enabled by the two species each using their own separate recognition cues, and that interspecific nestmate recognition may enable this multi-species cooperative nesting.	[Emery, Virginia J.; Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Emery, VJ (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	vj.emery@berkeley.edu	Emery, Vincent/G-8928-2013	Emery, Vincent/0000-0001-5893-9756	American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Society for Integrative and Comparative Biology Fellowship for Graduate Student Travel; Margaret C. Walker Fund for Teaching and Research in Systematic Entomology; Johannes Joos Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)	American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Society for Integrative and Comparative Biology Fellowship for Graduate Student Travel; Margaret C. Walker Fund for Teaching and Research in Systematic Entomology; Johannes Joos Fund; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by the American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award, the Society for Integrative and Comparative Biology Fellowship for Graduate Student Travel, the Margaret C. Walker Fund for Teaching and Research in Systematic Entomology, the Johannes Joos Fund, and a Post-Graduate Fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) to VJE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding URLs: http://www.aaas.org/, http://www.sicb.org/, http://www.nserc-crsng.gc.ca/.	Achenbach A, 2010, BEHAV ECOL, V21, P948, DOI 10.1093/beheco/arq008; BAGNERES AG, 1991, J CHEM ECOL, V17, P1641, DOI 10.1007/BF00984695; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; Blumstein DT, 2004, P ROY SOC B-BIOL SCI, V271, P1851, DOI 10.1098/rspb.2004.2808; Bos N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00083; Bos N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019435; Brandt M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-71; BREED MD, 1983, ANIM BEHAV, V31, P86, DOI 10.1016/S0003-3472(83)80176-6; BREED MD, 1985, P NATL ACAD SCI USA, V82, P3058, DOI 10.1073/pnas.82.9.3058; BUCKLE GR, 1981, ANIM BEHAV, V29, P802, DOI 10.1016/S0003-3472(81)80014-0; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; CARLIN NF, 1983, SCIENCE, V222, P1027, DOI 10.1126/science.222.4627.1027; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; ERRARD C, 1992, ANIM BEHAV, V43, P787, DOI 10.1016/S0003-3472(05)80201-5; Errard C, 2008, INSECT SOC, V55, P115, DOI 10.1007/s00040-008-0979-4; Errard C, 2006, BEHAV ECOL SOCIOBIOL, V59, P353, DOI 10.1007/s00265-005-0058-z; Errard C, 2003, INSECT SOC, V50, P268, DOI 10.1007/s00040-003-0677-1; Errard C, 1997, INSECT SOC, V44, P189, DOI 10.1007/s000400050040; ESPELIE KE, 1988, BIOCHEM SYST ECOL, V16, P505, DOI 10.1016/0305-1978(88)90053-1; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Huang MH, 2008, ECOL ENTOMOL, V33, P589, DOI 10.1111/j.1365-2311.2008.01005.x; Johnson BR, 2011, BEHAV ECOL SOCIOBIOL, V65, P935, DOI 10.1007/s00265-010-1094-x; Katritzky AR, 2000, ANAL CHEM, V72, P101, DOI 10.1021/ac990800w; Lambardi D, 2007, BEHAV ECOL SOCIOBIOL, V61, P843, DOI 10.1007/s00265-006-0313-y; Lenoir A, 1997, BIOCHEM SYST ECOL, V25, P379, DOI 10.1016/S0305-1978(97)00025-2; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Liang D, 2000, NATURWISSENSCHAFTEN, V87, P412, DOI 10.1007/s001140050752; Liebert AE, 2004, ANN ZOOL FENN, V41, P747; Longino J. T., 2007, TAXONOMIC REV GENUS; Longino John T., 2003, Zootaxa, V151, P1; Magrath RD, 2009, BEHAV ECOL, V20, P745, DOI 10.1093/beheco/arp055; Mann William M., 1912, Psyche Boston, V19, DOI 10.1155/1912/68363; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Menzel F, 2010, J ANIM ECOL, V79, P71, DOI 10.1111/j.1365-2656.2009.01628.x; Menzel F, 2009, INSECT SOC, V56, P251, DOI 10.1007/s00040-009-0018-0; Menzel F, 2011, EVOLUTION, V66, P869; Menzel F, 2008, ANIM BEHAV, V75, P837, DOI 10.1016/j.anbehav.2007.07.005; Menzel F, 2010, ECOL ENTOMOL, V35, P711, DOI 10.1111/j.1365-2311.2010.01231.x; Menzel F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-16; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; Orivel J, 2011, MYRMECOL NEWS, V14, P73; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Sledge MF, 2001, P ROY SOC B-BIOL SCI, V268, P2253, DOI 10.1098/rspb.2001.1799; Sturgis SJ, 2012, MYRMECOL NEWS, V16, P101; SWAIN RB, 1980, INSECT SOC, V27, P377, DOI 10.1007/BF02223730; Team RCD, 2012, R LANG ENV STAT COMP; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; van Wilgenburg E, 2012, BIOL LETTERS, V8, P17, DOI 10.1098/rsbl.2011.0643; VANDERMEER RK, 1982, SCIENCE, V218, P806, DOI 10.1126/science.218.4574.806; Vantaux A, 2007, INSECT SOC, V54, P95, DOI 10.1007/s00040-007-0914-0; VIENNE C, 1995, INSECT SOC, V42, P267, DOI 10.1007/BF01240421; von Beeren C, 2012, J CHEM ECOL, V38, P262, DOI 10.1007/s10886-012-0083-0; Weber NA, 1943, ECOLOGY, V24, P400, DOI 10.2307/1930541; Weddle CB, 2012, J EVOLUTION BIOL, V25, P2112, DOI 10.1111/j.1420-9101.2012.02593.x; Wheeler WM, 1921, ECOLOGY, V2, P89, DOI 10.2307/1928921; Yeo K, 2006, INSECT SOC, V53, P435, DOI 10.1007/s00040-005-0890-9; Youngsteadt E, 2008, P NATL ACAD SCI USA, V105, P4571, DOI 10.1073/pnas.0708643105	60	14	14	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56492	10.1371/journal.pone.0056492	http://dx.doi.org/10.1371/journal.pone.0056492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451053	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800016
J	Pastar, I; Nusbaum, AG; Gil, J; Patel, SB; Chen, J; Valdes, J; Stojadinovic, O; Plano, LR; Tomic-Canic, M; Davis, SC				Pastar, Irena; Nusbaum, Aron G.; Gil, Joel; Patel, Shailee B.; Chen, Juan; Valdes, Jose; Stojadinovic, Olivera; Plano, Lisa R.; Tomic-Canic, Marjana; Davis, Stephen C.			Interactions of Methicillin Resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in Polymicrobial Wound Infection	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; SOFT-TISSUE INFECTIONS; IN-VIVO; BACTERIAL DIVERSITY; PRESSURE ULCERS; MOUSE MODEL; VIRULENCE; BIOFILMS; SKIN; COLONIZATION	Understanding the pathology resulting from Staphylococcus aureus and Pseudomonas aeruginosa polymicrobial wound infections is of great importance due to their ubiquitous nature, increasing prevalence, growing resistance to antimicrobial agents, and ability to delay healing. Methicillin-resistant S. aureus USA300 is the leading cause of community-associated bacterial infections resulting in increased morbidity and mortality. We utilized a well-established porcine partial thickness wound healing model to study the synergistic effects of USA300 and P. aeruginosa on wound healing. Wound re-epithelialization was significantly delayed by mixed-species biofilms through suppression of keratinocyte growth factor 1. Pseudomonas showed an inhibitory effect on USA300 growth in vitro while both species co-existed in cutaneous wounds in vivo. Polymicrobial wound infection in the presence of P. aeruginosa resulted in induced expression of USA300 virulence factors Panton-Valentine leukocidin and alpha-hemolysin. These results provide evidence for the interaction of bacterial species within mixed-species biofilms in vivo and for the first time, the contribution of virulence factors to the severity of polymicrobial wound infections.	[Pastar, Irena; Nusbaum, Aron G.; Gil, Joel; Patel, Shailee B.; Valdes, Jose; Stojadinovic, Olivera; Plano, Lisa R.; Tomic-Canic, Marjana; Davis, Stephen C.] Univ Miami, Miller Sch Med, Wound Healing & Regenerat Med Res Program, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Chen, Juan; Plano, Lisa R.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Plano, Lisa R.] Univ Miami, Miller Sch Med, Dept Immunol & Microbiol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Davis, SC (corresponding author), Univ Miami, Miller Sch Med, Wound Healing & Regenerat Med Res Program, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA.	sdavis@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198				Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Biswas L, 2009, APPL ENVIRON MICROB, V75, P6910, DOI 10.1128/AEM.01211-09; Black CE, 2010, SURG CLIN N AM, V90, P1147, DOI 10.1016/j.suc.2010.08.009; Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Co EM, 2011, MIL MED, V176, P89; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Davis SC, 2001, DERMATOL SURG, V27, P783, DOI 10.1046/j.1524-4725.2001.00322.x; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; Diep BA, 2004, J CLIN MICROBIOL, V42, P2080, DOI 10.1128/JCM.42.5.2080-2084.2004; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Ebright JR, 2005, NURS CLIN N AM, V40, P207, DOI 10.1016/j.cnur.2004.09.003; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Fadeev S. B., 2009, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P114; Fazli M, 2011, WOUND REPAIR REGEN, V19, P387, DOI 10.1111/j.1524-475X.2011.00681.x; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Frank DN, 2009, WOUND REPAIR REGEN, V17, P163, DOI 10.1111/j.1524-475X.2009.00472.x; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gomez R, 2009, J AM COLL SURGEONS, V208, P348, DOI 10.1016/j.jamcollsurg.2008.11.012; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Gurjala AN, 2011, WOUND REPAIR REGEN, V19, P400, DOI 10.1111/j.1524-475X.2011.00690.x; Heggers John P., 1992, Journal of Burn Care and Rehabilitation, V13, P512, DOI 10.1097/00004630-199209000-00003; Hongo I, 2009, J INFECT DIS, V200, P715, DOI 10.1086/605332; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Keen EF, 2010, BURNS, V36, P461, DOI 10.1016/j.burns.2009.10.012; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lipinska U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022864; Loughman JA, 2009, J INFECT DIS, V199, P294, DOI 10.1086/595982; Madsen SM, 1996, APMIS, V104, P895, DOI 10.1111/j.1699-0463.1996.tb04955.x; Malic S, 2009, MICROBIOL-SGM, V155, P2603, DOI 10.1099/mic.0.028712-0; Martin JM, 2010, J INVEST DERMATOL, V130, P38, DOI 10.1038/jid.2009.221; Mitchell G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-33; Nakagami G, 2011, WOUND REPAIR REGEN, V19, P214, DOI 10.1111/j.1524-475X.2010.00653.x; Nusbaum AG, 2012, J SURG RES, V176, P701, DOI 10.1016/j.jss.2011.11.1040; O'Hara FP, 2012, MICROB DRUG RESIST; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Pastar Irena, 2008, Surg Technol Int, V17, P105; Pechter PM, 2012, WOUND REPAIR REGEN, V20, P236, DOI 10.1111/j.1524-475X.2012.00768.x; PFALLER MA, 1989, DIAGN MICR INFEC DIS, V12, P1, DOI 10.1016/0732-8893(89)90035-7; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Roghmann MC, 2001, J HOSP INFECT, V47, P98, DOI 10.1053/jhin.2000.0903; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Schaber JA, 2004, J MED MICROBIOL, V53, P841, DOI 10.1099/jmm.0.45617-0; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Schierle CF, 2009, WOUND REPAIR REGEN, V17, P354, DOI 10.1111/j.1524-475X.2009.00489.x; Seth AK, 2012, J AM COLL SURG; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; Soong G, 2012, J INFECT DIS, V205, P1571, DOI 10.1093/infdis/jis244; Storey DG, 1998, INFECT IMMUN, V66, P2521, DOI 10.1128/IAI.66.6.2521-2528.1998; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Wolcott RD, 2008, JAMA-J AM MED ASSOC, V299, P2682, DOI 10.1001/jama.299.22.2682; Yang L, 2011, FEMS IMMUNOL MED MIC, V62, P339, DOI 10.1111/j.1574-695X.2011.00820.x; Zhao G, 2012, WOUND REPAIR REGEN, V20, P342, DOI 10.1111/j.1524-475X.2012.00793.x; Zhao G, 2010, WOUND REPAIR REGEN, V18, P467, DOI 10.1111/j.1524-475X.2010.00608.x	72	205	217	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56846	10.1371/journal.pone.0056846	http://dx.doi.org/10.1371/journal.pone.0056846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451098	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800043
J	Rostila, M; Saarela, J; Kawachi, I				Rostila, Mikael; Saarela, Jan; Kawachi, Ichiro			Fatal Stroke after the Death of a Sibling: A Nationwide Follow-Up Study from Sweden	PLOS ONE			English	Article							ISCHEMIC-STROKE; RISK-FACTORS; MORTALITY; BEREAVEMENT; STRESS; PARENTS; CHILD; MEN	Background: Although less studied than other types of familial losses, the loss of a sibling could be a potential trigger of stroke as it represents a stressful life event. We studied the association between loss of a sibling and fatal stroke up to 18 years since bereavement. Methodology/Principal Findings: We conducted a follow-up study between 1981 and 2002, based on register data covering the total population of Swedes aged 40-69 years (n = 1,617,010). An increased risk of fatal stroke (1.31 CI: 1.05, 1.62) was found among women who had experienced the loss of a sibling. No increase in the overall mortality risk was found in men (1.11 CI: 0.92, 1.33). An elevated risk in the short term (during the second and third half-year after the death) was found among both men and women, whereas longer-term elevation in risk was found primarily for women. Both external (1.47 CI: 1.00, 2.17) and not external (1.26 CI: 1.00, 1.60) causes of sibling death showed associations among women. In men, an association was found only if the sibling also died from stroke (1.78 CI: 1.00, 3.17). However, among women, we found an increased risk of stroke mortality if the sibling died from causes other than stroke (1.30 CI: 1.04, 1.62). Conclusions/Significance: The findings suggest an increased risk of dying from stroke mortality after the death of a sibling, and that bereavement affects particularly women. It is important for health care workers to follow bereaved siblings and recognize potential changes of stress-levels and health related behaviours that could lead to risk of stroke.	[Rostila, Mikael] Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden; [Saarela, Jan] Abo Akad Univ, Vaasa, Finland; [Saarela, Jan] Univ Helsinki, Vaasa, Finland; [Saarela, Jan] Abo Akad Univ, Helsinki, Finland; [Saarela, Jan] Univ Helsinki, Helsinki, Finland; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Karolinska Institutet; Stockholm University; Abo Akademi University; University of Helsinki; Abo Akademi University; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health	Rostila, M (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equ Studies, S-10691 Stockholm, Sweden.	mikael.rostila@chess.su.se			Swedish Council for Working Life and Social Research [2009-0547]; Swedish Research Council [421-2011-1649]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Council for Working Life and Social Research (grant number 2009-0547) and the Swedish Research Council (grant number 421-2011-1649). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALK D, 1983, J YOUTH ADOLESCENCE, V12, P137, DOI 10.1007/BF02088310; BOWLING A, 1987, SOC SCI MED, V24, P117, DOI 10.1016/0277-9536(87)90244-9; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Engstrom G, 2004, CEREBROVASC DIS, V18, P318, DOI 10.1159/000080770; Guiraud V, 2010, STROKE, V41, P2669, DOI 10.1161/STROKEAHA.110.597443; HARMSEN P, 1990, STROKE, V21, P223, DOI 10.1161/01.STR.21.2.223; Hendrickson Karrie Cummings, 2009, Palliat Support Care, V7, P109, DOI 10.1017/S1478951509000133; Hogan N., 1996, CONTINUING BONDS NEW, P235; Kammersgaard LP, 2006, CEREBROVASC DIS, V21, P187, DOI 10.1159/000090531; Kasiman K, 2012, CIRC-CARDIOVASC GENE, V5, P226, DOI 10.1161/CIRCGENETICS.111.962241; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Li J, 2003, NEUROEPIDEMIOLOGY, V22, P211, DOI 10.1159/000069898; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Milberg A, 2008, J PAIN SYMPTOM MANAG, V35, P58, DOI 10.1016/j.jpainsymman.2007.02.039; Movahed MR, 2007, CARDIOVASC REVASCULA, V8, P289, DOI 10.1016/j.carrev.2007.02.001; Nakamura K, 2012, CEREBROVASC DIS, V33, P480, DOI 10.1159/000336764; Oki I, 2006, CEREBROVASC DIS, V22, P409, DOI 10.1159/000094860; REED MD, 1991, SUICIDE LIFE-THREAT, V21, P385; Robinson L, 1997, DEATH STUD, V21, P477; Rostila M., 2007, HLTH INEQUALITIES WE, P157; Rostila M, 2012, AM J EPIDEMIOL, V176, P338, DOI 10.1093/aje/kws163; Rostila M, 2011, J MARRIAGE FAM, V73, P236, DOI 10.1111/j.1741-3737.2010.00801.x; SEGAL NL, 1995, PERS INDIV DIFFER, V18, P511, DOI 10.1016/0191-8869(94)00174-Q; STROEBE MS, 1994, J COMMUNITY APPL SOC, V4, P47, DOI 10.1002/casp.2450040110; Truelsen T, 2003, STROKE, V34, P856, DOI 10.1161/01.STR.0000062345.80774.40; Tsutsumi A, 2009, ARCH INTERN MED, V169, P56, DOI 10.1001/archinternmed.2008.503; Umberson D, 1996, AM SOCIOL REV, V61, P837, DOI 10.2307/2096456; Valdimarsdottir U, 2003, SCAND J PUBLIC HEALT, V31, P31, DOI 10.1080/14034940210165109; Wittstein Ilan S, 2007, Cleve Clin J Med, V74 Suppl 1, pS17; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	32	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56994	10.1371/journal.pone.0056994	http://dx.doi.org/10.1371/journal.pone.0056994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	113IC	23451131	Green Published, gold			2022-12-25	WOS:000316658800061
J	Weber, S; Fernandez-Cachon, ML; Nascimento, JM; Knauer, S; Offermann, B; Murphy, RF; Boerries, M; Busch, H				Weber, Sebastian; Fernandez-Cachon, Maria L.; Nascimento, Juliana M.; Knauer, Steffen; Offermann, Barbara; Murphy, Robert F.; Boerries, Melanie; Busch, Hauke			Label-Free Detection of Neuronal Differentiation in Cell Populations Using High-Throughput Live-Cell Imaging of PC12 Cells	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; ERK; FATE; SEQUENCES; CULTURE; MODELS	Detection of neuronal cell differentiation is essential to study cell fate decisions under various stimuli and/or environmental conditions. Many tools exist that quantify differentiation by neurite length measurements of single cells. However, quantification of differentiation in whole cell populations remains elusive so far. Because such populations can consist of both proliferating and differentiating cells, the task to assess the overall differentiation status is not trivial and requires a high-throughput, fully automated approach to analyze sufficient data for a statistically significant discrimination to determine cell differentiation. We address the problem of detecting differentiation in a mixed population of proliferating and differentiating cells over time by supervised classification. Using nerve growth factor induced differentiation of PC12 cells, we monitor the changes in cell morphology over 6 days by phase-contrast live-cell imaging. For general applicability, the classification procedure starts out with many features to identify those that maximize discrimination of differentiated and undifferentiated cells and to eliminate features sensitive to systematic measurement artifacts. The resulting image analysis determines the optimal post treatment day for training and achieves a near perfect classification of differentiation, which we confirmed in technically and biologically independent as well as differently designed experiments. Our approach allows to monitor neuronal cell populations repeatedly over days without any interference. It requires only an initial calibration and training step and is thereafter capable to discriminate further experiments. In conclusion, this enables long-term, large-scale studies of cell populations with minimized costs and efforts for detecting effects of external manipulation of neuronal cell differentiation.	[Weber, Sebastian; Fernandez-Cachon, Maria L.; Nascimento, Juliana M.; Knauer, Steffen; Murphy, Robert F.; Boerries, Melanie; Busch, Hauke] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Weber, Sebastian; Fernandez-Cachon, Maria L.; Nascimento, Juliana M.; Knauer, Steffen; Offermann, Barbara; Murphy, Robert F.; Boerries, Melanie; Busch, Hauke] Univ Freiburg, Ctr Biol Syst Anal, D-79106 Freiburg, Germany; [Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	University of Freiburg; University of Freiburg; Carnegie Mellon University; Carnegie Mellon University	Boerries, M (corresponding author), Univ Freiburg, Freiburg Inst Adv Studies FRIAS, Hugstetter Str 55, D-79106 Freiburg, Germany.	melanie.boerries@frias.uni-freiburg.de; hauke.busch@frias.uni-freiburg.de	Boerries, Melanie/AAM-2602-2021; Nascimento, Juliana M/B-8764-2009; Busch, Hauke/R-6452-2016	Nascimento, Juliana M/0000-0003-3126-4984; Busch, Hauke/0000-0003-4763-4521	Excellence Initiative of the German Federal and State Governments (FRIAS LIFENET); German Federal Ministry of Education and Research (Gerontosys I) [0315896A]; Alexander von Humboldt Research Foundation	Excellence Initiative of the German Federal and State Governments (FRIAS LIFENET); German Federal Ministry of Education and Research (Gerontosys I); Alexander von Humboldt Research Foundation(Alexander von Humboldt Foundation)	This study was supported by the Excellence Initiative of the German Federal and State Governments (FRIAS LIFENET to HB, MB, MF, JN, RFM) and by the German Federal Ministry of Education and Research (Gerontosys I, 0315896A, to SW and MB). RFM was supported by a Research Award from the Alexander von Humboldt Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi O, 2006, IEEE T BIO-MED ENG, V53, P1109, DOI 10.1109/TBME.2006.873565; ANSCOMBE FJ, 1948, BIOMETRIKA, V35, P246, DOI 10.1093/biomet/35.3-4.246; Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06; BREUSCH TS, 1978, AUST ECON PAP, V17, P334, DOI 10.1111/j.1467-8454.1978.tb00635.x; Chen JY, 2012, MOL CELL, V45, P196, DOI 10.1016/j.molcel.2011.11.023; Chung JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009011; Dehmelt L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-100; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Fanti Z, 2011, DEV NEUROBIOL, V71; Frimat JP, 2010, LAB CHIP, V10, P701, DOI 10.1039/b922193j; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUPTA M, 1987, BRAIN RES BULL, V18, P555, DOI 10.1016/0361-9230(87)90119-5; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Keenan TM, 2006, J NEUROSCI METH, V151, P232, DOI 10.1016/j.jneumeth.2005.07.010; Kobayashi D, 2009, MOL CELL PROTEOMICS, V8, P2350, DOI 10.1074/mcp.M900179-MCP200; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Narro ML, 2007, BRAIN RES, V1138, P57, DOI 10.1016/j.brainres.2006.10.094; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Radio NM, 2008, TOXICOL SCI, V105, P106, DOI 10.1093/toxsci/kfn114; Ramm P, 2003, J BIOMOL SCREEN, V8, P7, DOI 10.1177/1087057102239779; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wei N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-449; Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x; Wu CH, 2010, NEUROINFORMATICS, V8, P83, DOI 10.1007/s12021-010-9067-9; Yeyeodu Susan T, 2010, Curr Chem Genomics, V4, P74, DOI 10.2174/1875397301004010074	33	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56690	10.1371/journal.pone.0056690	http://dx.doi.org/10.1371/journal.pone.0056690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451069	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800026
J	Zhang, Y; Han, YL; Dong, L; Yu, HF; Cheng, L; Zhao, XX; Ding, MJ				Zhang, Yan; Han, Yuling; Dong, Liang; Yu, Huafeng; Cheng, Lu; Zhao, Xiuxia; Ding, Mingjie			Genetic Variation of ITGB3 Is Associated with Asthma in Chinese Han Children	PLOS ONE			English	Article							ALLERGIES; EXPOSURE	Previous studies have demonstrated that integrins are involved in the aetiology of asthma. Several single-nucleotide polymorphisms (SNPs) in the integrin beta 3 (ITGB3) gene are significantly associated with asthma in Western populations. Given the important roles of environmental exposures in the development of asthma, we evaluated the associations between six SNPs in ITGB3 and asthma in Chinese Han children. A total of 321 unrelated Chinese children with asthma and 315 healthy children were recruited for the study. SNP genotyping was performed by high-resolution melting analysis (HRM). The selected SNPs were well genotyped by HRM, and SNP rs3809865 in the 3' untranslated region (3'UTR) of ITGB3 was found to be strongly associated with asthma (adjusted p = 0.004). The minor allele of rs3809865 showed a protective effect against asthma (OR: 0.59; 95% CI: 0.43-0.8). The seed regions of two miRNAs (hsa-mir-124 and hsa-mir-506) were predicted to bind to the sequence containing rs3809865 by TargetScan and PITA. Luciferase reporter assays demonstrated that the T allele of rs3809865 was more efficiently targeted by hsa-mir-124 than was the A allele, which suggested that rs3809865 could affect the binding of hsa-mir-124 to ITGB3. Furthermore, the transfection of A549 cells with hsa-mir-124 resulted in the downregulation of ITGB3 expression. Our results revealed that rs3809865 was significantly associated with asthma due to its effect on the binding of hsa-mir-124 to ITGB3.	[Zhang, Yan; Han, Yuling; Yu, Huafeng; Cheng, Lu; Zhao, Xiuxia; Ding, Mingjie] Shandong Univ, QiLu Childrens Hosp, Dept Resp Med, Jinan 250100, Shandong, Peoples R China; [Han, Yuling; Dong, Liang] Shandong Univ, Dept Resp Med, QiLu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Han, YL (corresponding author), Shandong Univ, QiLu Childrens Hosp, Dept Resp Med, Jinan 250100, Shandong, Peoples R China.	evelyn.han@163.com; ding.mj@126.com		Dong, Liang/0000-0001-7707-9982	project of tackle key problems in science and technology of Shandong province [2006GG2202030]	project of tackle key problems in science and technology of Shandong province	This work was supported by the project of tackle key problems in science and technology of Shandong province (No. 2006GG2202030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Custovic A, 2012, EXPERT REV RESP MED, V6, P301, DOI [10.1586/ERS.12.24, 10.1586/ers.12.24]; Heederik D, 2012, J ALLERGY CLIN IMMUN, V130, P44, DOI 10.1016/j.jaci.2012.01.067; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032060; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Rogers Angela J, 2009, Am J Respir Crit Care Med, V179, P1084, DOI 10.1164/rccm.200812-1860OC; Shi F, 2012, MOL CELL BIOCHEM, V361, P111, DOI 10.1007/s11010-011-1095-8; Simpson A, 2005, CURR ALLERGY ASTHM R, V5, P212, DOI 10.1007/s11882-005-0040-x; Subspecialty Group of Respiratory Diseases Society of Pediatrics, 2008, Zhonghua Er Ke Za Zhi, V46, P745; Thompson EE, 2007, J ALLERGY CLIN IMMUN, V119, P1423, DOI 10.1016/j.jaci.2007.03.029; Torres-Borrego J, 2012, ALLERGOL IMMUNOPATH, V40, P244, DOI 10.1016/j.aller.2011.12.006; Weiss LA, 2005, AM J RESP CRIT CARE, V172, P67, DOI 10.1164/rccm.200411-1555OC	12	39	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56914	10.1371/journal.pone.0056914	http://dx.doi.org/10.1371/journal.pone.0056914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451109	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800047
J	Friedman, SR; West, BS; Pouget, ER; Hall, HI; Cantrell, J; Tempalski, B; Chatterjee, S; Hu, XH; Cooper, HLF; Galea, S; Jarlais, DCD				Friedman, Samuel R.; West, Brooke S.; Pouget, Enrique R.; Hall, H. Irene; Cantrell, Jennifer; Tempalski, Barbara; Chatterjee, Sudip; Hu, Xiaohong; Cooper, Hannah L. F.; Galea, Sandro; Des Jarlais, Don C.			Metropolitan Social Environments and Pre-HAART/HAART Era Changes in Mortality Rates (per 10,000 Adult Residents) among Injection Drug Users Living with AIDS	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INCOME INEQUALITY; TREATMENT COVERAGE; HIV PREVALENCE; UNITED-STATES; US; AREAS; INCARCERATION; HEALTH; IMPACT	Background: Among the largest US metropolitan areas, trends in mortality rates for injection drug users (IDUs) with AIDS vary substantially. Ecosocial, risk environment and dialectical theories suggest many metropolitan areas characteristics that might drive this variation. We assess metropolitan area characteristics associated with decline in mortality rates among IDUs living with AIDS (per 10,000 adult MSA residents) after highly active antiretroviral therapy (HAART) was developed. Methods: This is an ecological cohort study of 86 large US metropolitan areas from 1993-2006. The proportional rate of decline in mortality among IDUs diagnosed with AIDS (as a proportion of adult residents) from 1993-1995 to 2004-2006 was the outcome of interest. This rate of decline was modeled as a function of MSA-level variables suggested by ecosocial, risk environment and dialectical theories. In multiple regression analyses, we used 1993-1995 mortality rates to (partially) control for pre-HAART epidemic history and study how other independent variables affected the outcomes. Results: In multivariable models, pre-HAART to HAART era increases in 'hard drug' arrest rates and higher pre-HAART income inequality were associated with lower relative declines in mortality rates. Pre-HAART per capita health expenditure and drug abuse treatment rates, and pre- to HAART-era increases in HIV counseling and testing rates, were weakly associated with greater decline in AIDS mortality. Conclusions: Mortality among IDUs living with AIDS might be decreased by reducing metropolitan income inequality, increasing public health expenditures, and perhaps increasing drug abuse treatment and HIV testing services. Given prior evidence that drug-related arrest rates are associated with higher HIV prevalence rates among IDUs and do not seem to decrease IDU population prevalence, changes in laws and policing practices to reduce such arrests while still protecting public order should be considered.	[Friedman, Samuel R.; West, Brooke S.; Pouget, Enrique R.; Tempalski, Barbara; Des Jarlais, Don C.] Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY USA; [Hall, H. Irene; Hu, Xiaohong] Ctr Dis Control, Atlanta, GA 30333 USA; [Cantrell, Jennifer] Legacy Fdn, Washington, DC USA; [Cooper, Hannah L. F.] Emory Univ, Dept Behav Sci & Hlth Educ, Atlanta, GA 30322 USA; [Galea, Sandro] Columbia Univ, Dept Epidemiol, New York, NY USA; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10003 USA	National Development & Research Institutes, Inc; Centers for Disease Control & Prevention - USA; Emory University; Columbia University; Harvard University; Beth Israel Deaconess Medical Center	Friedman, SR (corresponding author), Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY USA.	friedman@ndri.org	Pouget, Enrique Rodriguez/AAJ-5786-2020; Galea, Sandro/GLR-6066-2022	Pouget, Enrique Rodriguez/0000-0002-5907-1909; Galea, Sandro/0000-0002-7534-0945; West, Brooke S./0000-0003-0496-5769; Friedman, Sam/0000-0003-2083-1226; Tempalski, Barbara/0000-0002-6128-2510	National Institute of Drug Abuse [R01 DA013336, R01 DA 003574, 5T32 DA007233]; Public Health Solutions; National Development and Research Institutes; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013336, T32DA007233, R01DA003574] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Public Health Solutions; National Development and Research Institutes; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Drug Abuse grants # R01 DA013336 (Community Vulnerability and Responses to Drug-User-Related HIV/AIDS), R01 DA 003574 (Risk Factors for AIDS among Intravenous Drug Users), and 5T32 DA007233 (Behavioral Sciences Training in Drug Abuse Research program sponsored by Public Health Solutions and National Development and Research Institutes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2002, INT J DRUG POLICY, DOI [DOI 10.1016/S0955-3959(02)00075-0, DOI 10.1016/S0955-3959]; Backlund E, 2007, INT J EPIDEMIOL, V36, P590, DOI 10.1093/ije/dym012; Beal D. J., 2005, SAS CODE SELECT BEST; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Bluthenthal R N, 1997, Med Anthropol, V18, P61, DOI 10.1080/01459740.1997.9966150; Bluthenthal RN, 1999, J DRUG ISSUES, V29, P1; Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Brown B. S., 1993, HDB RISK AIDS INJECT; Bureau of Labor Statistics, 2009, LOC AR UN STAT; [Bureau UC US Census Bureau], 1990, HOUS HOUS EC STAT DI; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Cooper H, 2005, SOC SCI MED, V61, P673, DOI 10.1016/j.socscimed.2004.12.030; Cooper H, 2005, ANN EPIDEMIOL, V15, P326, DOI 10.1016/j.annepidem.2004.10.008; Cooper HLF, 2007, AM J PUBLIC HEALTH, V97, P344, DOI 10.2105/AJPH.2005.074542; Cooper HLF, 2009, J URBAN HEALTH, V86, P929, DOI 10.1007/s11524-009-9399-7; Cooper HLF, 2008, J URBAN HEALTH, V85, P826, DOI 10.1007/s11524-008-9304-9; Cooper RS, 2001, PUBLIC HEALTH REP, V116, P464, DOI 10.1016/S0033-3549(04)50074-2; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Federal Bureau of Investigation, 2009, CRIM US; Friedman S, 2008, GEOGRAPHY DRUG ADDIC; Friedman SR, 2011, DIALECT ANTHROPOL, V35, P453, DOI 10.1007/s10624-011-9257-3; Friedman SR, 2011, DIALECT ANTHROPOL, V35, P403, DOI 10.1007/s10624-011-9222-1; Friedman SR, 2007, INT J DRUG POLICY, V18, P475, DOI 10.1016/j.drugpo.2006.10.004; Friedman SR, 2011, AM J PUBLIC HEALTH, V101, P344, DOI 10.2105/AJPH.2010.191759; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2004, J URBAN HEALTH, V81, P377, DOI 10.1093/jurban/jth125; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Friedman SR, 2001, 2000 GLOB RES NETW M, P147; Galea S, 2005, J EPIDEMIOL COMMUN H, V59, P822, DOI 10.1136/jech.2005.033084; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Harper S, 2005, ESTIMATES GINI COEFF; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Kerr T, 2005, AIDS CARE, V17, P539, DOI 10.1080/09540120412331319778; Khan MR, 2008, ANN EPIDEMIOL, V18, P403, DOI 10.1016/j.annepidem.2007.12.003; Kondo N, 2009, BMJ, V10; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krusi A, 2010, INT J DRUG POLICY, V21, P4, DOI 10.1016/j.drugpo.2009.08.003; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Link BG, 2005, POLICY CHALLENGES MO, P71; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Lynch J, 2004, MILBANK Q, V82, P5, DOI 10.1111/j.0887-378X.2004.00302.x; Marmot M., 2004, STATUS SYNDROME SOCI; Marmot M., 2005, PUBLIC HEALTH; Meditz AL, 2011, J INFECT DIS, V203, P442, DOI 10.1093/infdis/jiq085; Milloy MJ, 2011, J INFECT DIS, V203, P1215, DOI 10.1093/infdis/jir032; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; Nandi A, 2006, SOC SCI MED, V63, P662, DOI 10.1016/j.socscimed.2006.02.001; Office of Management and Budget, 2000, FED REG, V65, P8228; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Roberts ET, 2010, DRUG ALCOHOL DEPEN, V106, P142, DOI 10.1016/j.drugalcdep.2009.08.007; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; Rubin MS, 2010, AM J PUBLIC HEALTH, V100, P1053, DOI 10.2105/AJPH.2009.170241; SAS, 2002, SAS 9 2; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Small W, 2007, INT J DRUG POLICY, V18, P27, DOI 10.1016/j.drugpo.2006.11.019; Small W, 2009, AIDS CARE, V21, P708, DOI 10.1080/09540120802511869; Song RG, 2011, PUBLIC HEALTH REP, V126, P70, DOI 10.1177/00333549111260S312; Springer KW, 1999, SUBST USE MISUSE, V34, P1917, DOI 10.3109/10826089909039432; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Substance Abuse and Mental Health Services Administration, 1998, NAT HOUS SURV DRUG A; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 1992, TREATMENT EPISODE DA; Syme S, 2005, EPIDEMIOL PERSPECT I, V2; Tempalski B, 2009, J URBAN HEALTH, V86, P132, DOI 10.1007/s11524-008-9328-1; Tempalski B, 2009, INT J DRUG POLICY, V20, P4, DOI 10.1016/j.drugpo.2008.02.002; Tempalski B, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-23; Thomas JC, 2005, J INFECT DIS, V191, pS55, DOI 10.1086/425278; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; United States Census Bureau, 2002, CENS GOV; *US BUR CENS, 1990, POP EST; US Census Bureau, 1992, CENS GOV; US Census Bureau, 2000, POP EST; [US Census Bureau Bureau UC], 2000, HOUS HOUS EC STAT DI; Wilkinson R, 1999, SOCIAL DETERMINANTS, pp256; Wood E, 2004, CAN MED ASSOC J, V170, P1551, DOI 10.1503/cmaj.1031928	79	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57201	10.1371/journal.pone.0057201	http://dx.doi.org/10.1371/journal.pone.0057201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437341	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000084
J	Urbizu, A; Toma, C; Poca, MA; Sahuquillo, J; Cuenca-Leon, E; Cormand, B; Macaya, A				Urbizu, Aintzane; Toma, Claudio; Poca, Maria A.; Sahuquillo, Juan; Cuenca-Leon, Ester; Cormand, Bru; Macaya, Alfons			Chiari Malformation Type I: A Case-Control Association Study of 58 Developmental Genes	PLOS ONE			English	Article							POSTERIOR CRANIAL FOSSA; NEURAL-TUBE DEFECTS; RETINOIC ACID; LINKAGE DISEQUILIBRIUM; TYROSINE KINASE; AXIAL SKELETON; GROWTH-FACTOR; VASCULOGENESIS; ANGIOGENESIS; EXPRESSION	Chiari malformation type I (CMI) is a disorder characterized by hindbrain overcrowding into an underdeveloped posterior cranial fossa (PCF), often causing progressive neurological symptoms. The etiology of CMI remains unclear and is most likely multifactorial. A putative genetic contribution to CMI is suggested by familial aggregation and twin studies. Experimental models and human morphometric studies have suggested an underlying paraxial mesoderm insufficiency. We performed a case-control association study of 303 tag single nucleotide polymorphisms (SNP) across 58 candidate genes involved in early paraxial mesoderm development in a sample of 415 CMI patients and 524 sex-matched controls. A subgroup of patients diagnosed with classical, small-PCF CMI by means of MRI-based PCF morphometry (n = 186), underwent additional analysis. The genes selected are involved in signalling gradients occurring during segmental patterning of the occipital somites (FGF8, Wnt, and retinoic acid pathways and from bone morphogenetic proteins or BMP, Notch, Cdx and Hox pathways) or in placental angiogenesis, sclerotome development or CMI-associated syndromes. Single-marker analysis identified nominal associations with 18 SNPs in 14 genes (CDX1, FLT1, RARG, NKD2, MSGN1, RBPJ1, FGFR1, RDH10, NOG, RARA, LFNG, KDR, ALDH1A2, BMPR1A) considering the whole CMI sample. None of these overcame corrections for multiple comparisons, in contrast with four SNPs in CDX1, FLT1 and ALDH1A2 in the classical CMI group. Multiple marker analysis identified a risk haplotype for classical CMI in ALDH1A2 and CDX1. Furthermore, we analyzed the possible contributions of the most significantly associated SNPs to different PCF morphometric traits. These findings suggest that common variants in genes involved in somitogenesis and fetal vascular development may confer susceptibility to CMI.	[Urbizu, Aintzane; Cuenca-Leon, Ester; Macaya, Alfons] Univ Autonoma Barcelona, Vall dHebron Res Inst, Pediat Neurol Res Grp, E-08193 Barcelona, Spain; [Poca, Maria A.; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Unit, Dept Neurosurg, E-08193 Barcelona, Spain; [Poca, Maria A.; Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Res Unit, E-08193 Barcelona, Spain; [Toma, Claudio; Cormand, Bru] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Toma, Claudio; Cormand, Bru] Biomed Network Res Ctr Rare Dis, Barcelona, Spain; [Cormand, Bru] Univ Barcelona, Inst Biomed, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona	Macaya, A (corresponding author), Univ Autonoma Barcelona, Vall dHebron Res Inst, Pediat Neurol Res Grp, E-08193 Barcelona, Spain.	amacaya@vhebron.net	Toma, Claudio/L-7853-2014; Urbizu, Aintzane/A-8208-2018; Sahuquillo, Juan/B-3577-2008; Cormand, Bru/H-5338-2015; Poca, Maria A./B-8475-2008	Toma, Claudio/0000-0003-3901-7507; Urbizu, Aintzane/0000-0001-8458-1209; Sahuquillo, Juan/0000-0003-0713-5875; Cormand, Bru/0000-0001-5318-4382; Poca, Maria A./0000-0002-3831-0536; Macaya Ruiz, Alfons/0000-0001-7998-4185	Instituto de Salud Carlos III, Spain [PI061606]; Fundacio La Marato TV3, Spain [062710]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Spain [2009SGR -0078]; AGAUR (Spain); European Union (Marie Curie) [PIEF-GA-2009-254930]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Fundacio La Marato TV3, Spain; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); AGAUR (Spain)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Union (Marie Curie)(European Commission)	Work supported by Instituto de Salud Carlos III, Spain, grant PI061606; Fundacio La Marato TV3, Spain, grant 062710; and Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Spain, grant 2009SGR -0078. A.U. is the recipient of a scholarship from AGAUR (Spain). C.T. was supported by the European Union (Marie Curie, PIEF-GA-2009-254930). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Aulehla A, 2009, COLD SPRING HARB PER, V2; Aydin S, 2005, SURG NEUROL, V64, P237, DOI 10.1016/j.surneu.2005.02.021; BARKOVICH AJ, 1986, AM J NEURORADIOL, V7, P795; Barnes MR, 2006, BRIEF BIOINFORM, V7, P211, DOI 10.1093/bib/bbl021; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BARRY A, 1957, J NEUROSURG, V14, P285, DOI 10.3171/jns.1957.14.3.0285; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Boyles AL, 2006, AM J MED GENET A, V140A, P2776, DOI 10.1002/ajmg.a.31546; Boyles AL, 2005, AM J MED GENET C, V135C, P9, DOI 10.1002/ajmg.c.30048; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; CHIARI H, 1987, PEDIATR NEUROSCI, V13, P3, DOI 10.1159/000120293; Demir R, 2004, PLACENTA, V25, P560, DOI 10.1016/j.placenta.2003.11.011; Demir R, 2007, ACTA HISTOCHEM, V109, P257, DOI 10.1016/j.acthis.2007.02.008; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Freeman AF, 1993, GENEREVIEWS; Fujisawa H, 2002, J NEUROSURG, V97, P396, DOI 10.3171/jns.2002.97.2.0396; Fujita K, 2009, AM J NEURORADIOL, V30, P629, DOI 10.3174/ajnr.A1380; GARDNER WJ, 1950, J NEUROSURG, V7, P199, DOI 10.3171/jns.1950.7.3.0199; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Greene NDE, 2009, HUM MOL GENET, V18, pR113, DOI 10.1093/hmg/ddp347; Greenlee JDW, 2002, PEDIATRICS, V110, P1212, DOI 10.1542/peds.110.6.1212; Gu CC, 2008, ADV GENET, V60, P407, DOI 10.1016/S0065-2660(07)00415-4; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Kageyama R, 2009, MOL CELLS, V27, P497, DOI 10.1007/s10059-009-0068-1; KANE WJ, 1977, CLIN ORTHOP RELAT R, P43; Karagoz F, 2002, ACTA NEUROCHIR, V144, P165, DOI 10.1007/s007010200020; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; MARINPADILLA M, 1981, J NEUROL SCI, V50, P29, DOI 10.1016/0022-510X(81)90040-X; MARINPADILLA M, 1991, CAN J NEUROL SCI, V18, P153, DOI 10.1017/S0317167100031632; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; MARTINOT A, 1993, INTENS CARE MED, V19, P73, DOI 10.1007/BF01708364; MCLONE DG, 1989, PEDIATR NEUROSCI, V15, P1, DOI 10.1159/000120432; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Milhorat TH, 2010, ACTA NEUROCHIR, V152, P1117, DOI 10.1007/s00701-010-0636-3; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Miura S, 2006, DEVELOPMENT, V133, P3767, DOI 10.1242/dev.02552; Monsoro-Burq AH, 2005, INT J DEV BIOL, V49, P301, DOI 10.1387/ijdb.041953am; Morris Z, 2009, BMJ-BRIT MED J, V339, pb3016, DOI [10.1136/bmj.b3016, DOI 10.1136/BMJ.B3016]; Mueller JC, 2004, BRIEF BIOINFORM, V5, P355, DOI 10.1093/bib/5.4.355; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Noudel R, 2009, J NEUROSURG, V111, P1046, DOI 10.3171/2009.2.JNS08284; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SCHADY W, 1987, J NEUROL SCI, V82, P193, DOI 10.1016/0022-510X(87)90018-9; Schanker BD, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.6.FOCUS11104; Schimmenti LA, 1999, HUM MUTAT, V14, P369, DOI 10.1002/(SICI)1098-1004(199911)14:5<369::AID-HUMU2>3.0.CO;2-E; SHAPIRO R, 1976, AM J ROENTGENOL, V126, P1063, DOI 10.2214/ajr.126.5.1063; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Speer M C, 2000, Neurosurg Focus, V8, pE12; Speer Marcy C, 2003, J Genet Couns, V12, P297, DOI 10.1023/A:1023948921381; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STOVNER LJ, 1993, NEURORADIOLOGY, V35, P113, DOI 10.1007/BF00593966; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tubbs RS, 2011, J NEUROSURG-PEDIATR, V7, P248, DOI 10.3171/2010.12.PEDS10379; Tubbs RS, 2004, PEDIATR NEUROL, V30, P278, DOI 10.1016/j.pediatrneurol.2003.09.013; Urbizu A, 2012, J NEUROIMAG IN PRESS; VEGA A, 1990, J NEUROL SCI, V99, P137, DOI 10.1016/0022-510X(90)90150-L; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; William DA, 2007, DEV BIOL, V305, P172, DOI 10.1016/j.ydbio.2007.02.007; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Wojcik C, 2010, AM J MED GENET A, V152A, P479, DOI 10.1002/ajmg.a.33303; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290	73	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57241	10.1371/journal.pone.0057241	http://dx.doi.org/10.1371/journal.pone.0057241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437350	gold, Green Published			2022-12-25	WOS:000315186000090
J	Cheng, XB; Jiang, HQ; Li, WZ; Lv, HL; Gong, ZF; Liu, L				Cheng, Xuebo; Jiang, Huoqing; Li, Weizhe; Lv, Hailong; Gong, Zhefeng; Liu, Li			Ten-a Affects Fusion of Central Complex Primordia in Drosophila	PLOS ONE			English	Article							INTRACELLULAR DOMAIN; LOCOMOTOR-ACTIVITY; GLIAL-CELLS; BRAIN; BODY; ORGANIZATION; ARCHITECTURE; ORIENTATION; TENEURINS; PROTEINS	The central complex of Drosophila melanogaster plays important functions in various behaviors, such as visual and olfactory memory, visual orientation, sleep, and movement control. However little is known about the genes regulating the development of the central complex. Here we report that a mutant gene affecting central complex morphology, cbd (central brain defect), was mapped to ten-a, a type II trans-membrane protein coding gene. Down-regulation of ten-a in pan-neural cells contributed to abnormal morphology of central complex. Over-expression of ten-a by C767-Gal4 was able to partially restore the abnormal central complex morphology in the cbd mutant. Tracking the development of FB primordia revealed that C767-Gal4 labeled interhemispheric junction that separated fan-shaped body precursors at larval stage withdrew to allow the fusion of the precursors. While the C767-Gal4 labeled structure did not withdraw properly and detached from FB primordia, the two fan-shaped body precursors failed to fuse in the cbd mutant. We propose that the withdrawal of C767-Gal4 labeled structure is related to the formation of the fan-shaped body. Our result revealed the function of ten-a in central brain development, and possible cellular mechanism underlying Drosophila fan-shaped body formation.	[Cheng, Xuebo; Jiang, Huoqing; Li, Weizhe; Lv, Hailong; Gong, Zhefeng; Liu, Li] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Cheng, Xuebo] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gong, Zhefeng] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Li] Chinese Acad Sci, Key Lab Mental Hlth, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; Chinese Academy of Sciences	Gong, ZF (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	zfgong@gmail.com; liuli@sun5.ibp.ac.cn		Lv, Hailong/0000-0002-3714-9859	'973 Program' [2009CB918702, 2012CB825504]; National Natural Sciences Foundation of China [31030037, 30921064, 31070944]; External Cooperation Program of the Chinese Academy of Sciences [GJHZ1005]	'973 Program'(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the '973 Program' (2009CB918702, 2012CB825504), the National Natural Sciences Foundation of China (31030037, 30921064 and 31070944), and the External Cooperation Program of the Chinese Academy of Sciences (GJHZ1005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagutti C, 2003, J CELL SCI, V116, P2957, DOI 10.1242/jcs.00603; BAUMGARTNER S, 1993, MECH DEVELOP, V40, P165, DOI 10.1016/0925-4773(93)90074-8; Boyan GS, 2011, TRENDS NEUROSCI, V34, P247, DOI 10.1016/j.tins.2011.02.002; Callaerts P, 2003, DEV BIOL, V259, P464; Carhan A, 2005, GENES BRAIN BEHAV, V4, P449, DOI 10.1111/j.1601-183X.2004.00117.x; Chand D, 2012, NEUROSCIENCE, V219, P255, DOI 10.1016/j.neuroscience.2012.05.069; Chen WT, 2008, DEV NEUROBIOL, V68, P1029, DOI 10.1002/dneu.20644; Engle EC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001784; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Goossens T, 2011, DEVELOPMENT, V138, P1595, DOI 10.1242/dev.052787; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hanesch U, 1987, THESIS U WUERZBURG G; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hitier R, 2000, MECH DEVELOP, V99, P93, DOI 10.1016/S0925-4773(00)00483-4; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9; Kenzelmann D, 2007, CELL MOL LIFE SCI, V64, P1452, DOI 10.1007/s00018-007-7108-9; Kurumaji A, 2001, AM J MED GENET, V105, P99; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Li WZ, 2009, CELL TISSUE RES, V336, P509, DOI 10.1007/s00441-009-0781-2; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Lovejoy DA, 2006, GEN COMP ENDOCR, V148, P299, DOI 10.1016/j.ygcen.2006.01.012; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Minet AD, 2000, GENE, V257, P87, DOI 10.1016/S0378-1119(00)00388-7; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nunes SM, 2005, EXP CELL RES, V305, P122, DOI 10.1016/j.yexcr.2004.12.020; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Qian XJ, 2004, GEN COMP ENDOCR, V137, P205, DOI 10.1016/j.ygcen.2004.02.007; Raabe T, 2004, P NATL ACAD SCI USA, V101, P14276, DOI 10.1073/pnas.0405887101; Silies M, 2011, CURR OPIN NEUROBIOL, V21, P11, DOI 10.1016/j.conb.2010.08.011; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Wang LQ, 2005, MOL BRAIN RES, V133, P253, DOI 10.1016/j.molbrainres.2004.10.019; Xiong Y, 2010, FLY, V4, P194, DOI 10.4161/fly.12668; Yamamoto M, 2006, CURR BIOL, V16, P1678, DOI 10.1016/j.cub.2006.06.061; Young JM, 2010, J COMP NEUROL, V518, P1525, DOI 10.1002/cne.22285	41	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57129	10.1371/journal.pone.0057129	http://dx.doi.org/10.1371/journal.pone.0057129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437330	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200221
J	Erfmeier, A; Hantsch, L; Bruelheide, H				Erfmeier, Alexandra; Hantsch, Lydia; Bruelheide, Helge			The Role of Propagule Pressure, Genetic Diversity and Microsite Availability for Senecio vernalis Invasion	PLOS ONE			English	Article							SPECIES-DIVERSITY; ECOLOGICAL RESISTANCE; GENOTYPIC DIVERSITY; DENSITY-DEPENDENCE; PLANT COMMUNITY; LIFE-HISTORY; SEED DENSITY; BIODIVERSITY; FACILITATION; ECOSYSTEM	Genetic diversity is supposed to support the colonization success of expanding species, in particular in situations where microsite availability is constrained. Addressing the role of genetic diversity in plant invasion experimentally requires its manipulation independent of propagule pressure. To assess the relative importance of these components for the invasion of Senecio vernalis, we created propagule mixtures of four levels of genotype diversity by combining seeds across remote populations, across proximate populations, within single populations and within seed families. In a first container experiment with constant Festuca rupicola density as matrix, genotype diversity was crossed with three levels of seed density. In a second experiment, we tested for effects of establishment limitation and genotype diversity by manipulating Festuca densities. Increasing genetic diversity had no effects on abundance and biomass of S. vernalis but positively affected the proportion of large individuals to small individuals. Mixtures composed from proximate populations had a significantly higher proportion of large individuals than mixtures composed from within seed families only. High propagule pressure increased emergence and establishment of S. vernalis but had no effect on individual growth performance. Establishment was favoured in containers with Festuca, but performance of surviving seedlings was higher in open soil treatments. For S. vernalis invasion, we found a shift in driving factors from density dependence to effects of genetic diversity across life stages. While initial abundance was mostly linked to the amount of seed input, genetic diversity, in contrast, affected later stages of colonization probably via sampling effects and seemed to contribute to filtering the genotypes that finally grew up. In consequence, when disentangling the mechanistic relationships of genetic diversity, seed density and microsite limitation in colonization of invasive plants, a clear differentiation between initial emergence and subsequent survival to juvenile and adult stages is required.	[Erfmeier, Alexandra; Hantsch, Lydia; Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany; [Erfmeier, Alexandra; Bruelheide, Helge] German Inst Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg	Erfmeier, A (corresponding author), Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, D-06108 Halle, Saale, Germany.	alexandra.erfmeier@botanik.uni-halle.de	Erfmeier, Alexandra/C-3381-2013; Erfmeier, Alexandra/L-1986-2016; Bruelheide, Helge/G-3907-2013	Bruelheide, Helge/0000-0003-3135-0356; Erfmeier, Alexandra/0000-0002-1002-9216				Baeten L, 2009, J ECOL, V97, P109, DOI 10.1111/j.1365-2745.2008.01455.x; BERGELSON J, 1993, ECOLOGY, V74, P999, DOI 10.2307/1940470; Brown RL, 2003, OIKOS, V102, P15, DOI 10.1034/j.1600-0706.2003.12191.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Clark CJ, 2007, AM NAT, V170, P128, DOI 10.1086/518565; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Comes HP, 1999, EVOLUTION, V53, P36, DOI [10.2307/2640918, 10.1111/j.1558-5646.1999.tb05331.x]; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Crawford KM, 2010, MOL ECOL, V19, P1253, DOI 10.1111/j.1365-294X.2010.04550.x; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drake JM, 2006, BIOL INVASIONS, V8, P843, DOI 10.1007/s10530-005-4205-2; Duncan RP, 2009, ECOLOGY, V90, P2129, DOI 10.1890/08-1436.1; Erfmeier A, 2011, INT J PLANT SCI, V172, P795, DOI 10.1086/660194; Erfmeier A, 2011, BIOL INVASIONS, V13, P1599, DOI 10.1007/s10530-010-9917-2; Filin I, 2008, AM NAT, V172, P233, DOI 10.1086/589459; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Garcia-Serrano H, 2008, BOTANY, V86, P63, DOI 10.1139/B07-117; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; HARPER JL, 1961, EVOLUTION, V15, P209, DOI 10.2307/2406081; Hegi G, 1928, ILLUSTRIERTE FLORA M, V2; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Howard TG, 2001, ECOLOGY, V82, P979, DOI 10.1890/0012-9658(2001)082[0979:CRHFGG]2.0.CO;2; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Jager EJ, 2002, ROTHMALER EXKURSIONS, V2; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lachmuth S, 2010, MOL ECOL, V19, P3952, DOI 10.1111/j.1365-294X.2010.04797.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Leger EA, 2010, PLANT ECOL, V208, P333, DOI 10.1007/s11258-009-9710-4; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lortie CJ, 2008, OIKOS, V117, P1511, DOI 10.1111/j.0030-1299.2008.16664.x; Lortie CJ, 2002, J ECOL, V90, P435, DOI 10.1046/j.1365-2745.2002.00686.x; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; MEUSEL H, 1992, VERGLEICHENDE CHOROL; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Peterson-Smith J, 2010, J TORREY BOT SOC, V137, P287, DOI 10.3159/09-RA-070R1.1; Ramula S, 2009, OIKOS, V118, P1164, DOI 10.1111/j.1600-0706.2009.17595.x; Saccone P, 2010, NEW PHYTOL, V187, P831, DOI 10.1111/j.1469-8137.2010.03289.x; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Sanders NJ, 2010, MOL ECOL, V19, P1079, DOI 10.1111/j.1365-294X.2010.04551.x; *SAS I INC, 2002, SAS WIND SAS 9 2 TS; Schiffers K, 2006, J ECOL, V94, P336, DOI 10.1111/j.1365-2745.2006.01097.x; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Thomsen MA, 2006, ECOL LETT, V9, P160, DOI 10.1111/j.1461-0248.2005.00857.x; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; Vellend M, 2006, ECOLOGY, V87, P304, DOI 10.1890/05-0173; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Vellend M, 2010, OECOLOGIA, V162, P371, DOI 10.1007/s00442-009-1480-0; Vellend M, 2009, WEED SCI, V57, P410, DOI 10.1614/WS-09-004.1; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Wang XY, 2012, MOL ECOL, V21, P2542, DOI 10.1111/j.1365-294X.2012.05531.x; Warren RJ, 2012, OIKOS, V121, P874, DOI 10.1111/j.1600-0706.2011.20174.x; Weltzin JF, 2003, OIKOS, V103, P505, DOI 10.1034/j.1600-0706.2003.12389.x; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitlock R, 2007, J ECOL, V95, P895, DOI 10.1111/j.1365-2745.2007.01275.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0	69	16	17	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57029	10.1371/journal.pone.0057029	http://dx.doi.org/10.1371/journal.pone.0057029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437301	Green Submitted, gold, Green Published			2022-12-25	WOS:000315184200204
J	Martinez-Haro, M; Taggart, MA; Lefranc, H; Martin-Doimeadios, RC; Green, AJ; Mateo, R				Martinez-Haro, Monica; Taggart, Mark A.; Lefranc, Hugues; Martin-Doimeadios, Rosa C.; Green, Andy J.; Mateo, Rafael			Monitoring of Pb Exposure in Waterfowl Ten Years after a Mine Spill through the Use of Noninvasive Sampling	PLOS ONE			English	Article							MASSIVE SULFIDE DEPOSITS; STORKS CICONIA-CICONIA; IBERIAN PYRITE BELT; LEAD-EXPOSURE; HEAVY-METALS; SEDIMENT INGESTION; TAILING ACCIDENT; OXIDATIVE STRESS; GUADIAMAR RIVER; TRACE-ELEMENTS	Lead exposure in waterfowl was studied using noninvasive fecal sampling in the Guadalquivir Marshes in Spain, an area affected by the 1998 Aznalcollar mine disaster. Feces of greylag geese (Anser anser, n = 191) and purple gallinule (Porphyrio porphyrio, n = 91) were collected from three different impacted sites (Entremuros, Caracoles and Cerro de los Ansares) during the winters of 2004 to 2008. Lead and aluminium (an indicator of sediment ingestion) and Pb isotope signatures (to discriminate between sources of Pb exposure) were analyzed in freeze-dried, acid digested samples. The concentrations of fecal porphyrins and biliverdin were determined as noninvasive biomarkers to study Pb exposure effects. Results showed a decrease in Pb exposure over time in wintering greylag geese. In contrast, for purple gallinule resident in the Entremuros a clear trend was not evident. For both species, sediment ingestion appeared to be the main source of exposure to Pb. In the Entremuros, some samples from purple gallinule were detected with higher Pb levels than expected for simple soil ingestion, and these had Pb isotopic profiles compatible with mining sludge or Pb shot. Whilst fecal Pb isotopic profiles were effective in differentiating between samples from sites with different levels and sources of pollution, the combined use of element ratios (such as Pb/Al) and other non-traditional stable isotope signatures may also prove worthwhile. Overall, the fecal Pb levels detected were below those described in feces for waterfowl from other uncontaminated areas(<10 mu g/g d.w.). Despite this, for both species fecal Pb levels were positively correlated with porphyrin excretion, and for purple gallinule, with the coproporphyrin III/I ratio, suggesting some subtle effects on heme synthesis in birds. Ten years after the mine spill, Pb contamination in birds by this pollution source was still detectable and subtlethal effects may persist.	[Martinez-Haro, Monica; Taggart, Mark A.; Mateo, Rafael] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain; [Martinez-Haro, Monica; Lefranc, Hugues; Green, Andy J.] Estn Biol Donana EBD CSIC, Dept Wetland Ecol, Seville, Spain; [Taggart, Mark A.] Univ Highlands & Isl, ERI, Thurso, Scotland; [Martin-Doimeadios, Rosa C.] Univ Castilla La Mancha, Fac Environm Sci & Biochem, Dept Analyt Chem & Food Technol, Toledo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UHI Millennium Institute; Universidad de Castilla-La Mancha	Martinez-Haro, M (corresponding author), Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain.	monica.martinezharo@gmail.com	Green, Andy J/A-5189-2008; Martín-Doimeadios, Rosa C. Rodriguez/L-3354-2014; Martinez-Haro, Mónica/B-8363-2015; Mateo, Rafael/A-3117-2011; Mateo, Rafael/AAU-1480-2020	Green, Andy J/0000-0002-1268-4951; Martín-Doimeadios, Rosa C. Rodriguez/0000-0001-6922-6460; Martinez-Haro, Mónica/0000-0002-4326-5805; Mateo, Rafael/0000-0003-1307-9152; Mateo, Rafael/0000-0003-1307-9152; Taggart, Mark/0000-0002-0649-8490	Consejeria, de Medio Ambiente, Junta de Andalucia; MICINN [CGL2007-62797]; Portuguese Foundation for Science and Technology (FCT); European Social Fund; POPH programme;  [SFRH/BPD/73890/2010]	Consejeria, de Medio Ambiente, Junta de Andalucia(Junta de Andalucia); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); POPH programme; 	M. Martinez-Haro was supported by a project funded by the Consejeria, de Medio Ambiente, Junta de Andalucia, under a CSIC contract. This study was also funded by MICINN (under CGL2007-62797). Currently, M. Martinez-Haro is supported by a postdoctoral grant (Ref: SFRH/BPD/73890/2010) funded by the Portuguese Foundation for Science and Technology (FCT) the European Social Fund and POPH programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2012, J ANIM ECOL, V81, P1113, DOI 10.1111/j.1365-2656.2012.01972.x; Almodovar GR, 1998, MINER DEPOSITA, V33, P111; AMAT JA, 1991, ARDEA, V79, P271; Amat JA, 2008, WATERBIRDS, V31, P133, DOI 10.1675/1524-4695(2008)31[133:GIASCO]2.0.CO;2; Badosa A, 2010, HYDROBIOLOGIA, V654, P67, DOI 10.1007/s10750-010-0370-0; Baos R, 2006, ENVIRON TOXICOL CHEM, V25, P2794, DOI 10.1897/05-570R.1; Baos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034716; Benito V, 1999, SCI TOTAL ENVIRON, V242, P309, DOI 10.1016/S0048-9697(99)00398-8; Beyer WN, 1999, SCI TOTAL ENVIRON, V231, P235; Beyer WN, 2000, ECOTOXICOLOGY, V9, P207, DOI 10.1023/A:1008998821913; BEYER WN, 1994, J WILDLIFE MANAGE, V58, P375, DOI 10.2307/3809405; Beyer WN, 1998, ENVIRON TOXICOL CHEM, V17, P2298, DOI [10.1897/1551-5028(1998)017&lt;2298:ROLETS&gt;2.3.CO;2, 10.1002/etc.5620171121]; Beyer WN, 1997, ECOTOXICOLOGY, V6, P181; Beyer WN, 1998, J ENVIRON QUAL, V27, P1533, DOI 10.2134/jeq1998.00472425002700060033x; BURTON BA, 1979, J WILDLIFE MANAGE, V43, P728, DOI 10.2307/3808751; Cabrera F, 1999, SCI TOTAL ENVIRON, V242, P117, DOI 10.1016/S0048-9697(99)00379-4; Carlisle MC, 2004, LEAD POISONING SPANI; Casini S, 2003, ECOTOXICOLOGY, V12, P297, DOI 10.1023/A:1022519214505; Chanton JP, 2008, ENVIRON SCI TECHNOL, V42, P655, DOI 10.1021/es0870855; Galan E, 2002, SCI TOTAL ENVIRON, V286, P167, DOI 10.1016/S0048-9697(01)00974-3; Gomez G, 2004, ARCH ENVIRON CON TOX, V47, P521, DOI 10.1007/s00244-004-0189-z; Goyer R.A., 2001, CASARETT DOULLS TOXI, P811; Grimalt JO, 1999, SCI TOTAL ENVIRON, V242, P3, DOI 10.1016/S0048-9697(99)00372-1; Hahn S, 2008, FRESHWATER BIOL, V53, P181, DOI 10.1111/j.1365-2427.2007.01881.x; Hansel CM, 2001, ENVIRON SCI TECHNOL, V35, P3863, DOI 10.1021/es0105459; Hernandez LM, 1999, SCI TOTAL ENVIRON, V242, P293, DOI 10.1016/S0048-9697(99)00397-6; Karasov W.H., 1990, Studies in Avian Biology, P391; Leistel JM, 1998, MINER DEPOSITA, V33, P2; Lopez-Pamo E, 1999, SCI TOTAL ENVIRON, V242, P57, DOI 10.1016/S0048-9697(99)00376-9; Madejon P, 2006, CHEMOSPHERE, V64, P742, DOI 10.1016/j.chemosphere.2005.11.032; Marquez-Ferrando R, 2009, ARCH ENVIRON CON TOX, V56, P276, DOI 10.1007/s00244-008-9189-3; Martinez-Haro M, 2010, ENVIRON POLLUT, V158, P2485, DOI 10.1016/j.envpol.2010.03.018; Martinez-Haro M, 2011, ENVIRON SCI TECHNOL, V45, P6153, DOI 10.1021/es2009242; Martinez-Haro M, 2011, ENVIRON RES, V111, P530, DOI 10.1016/j.envres.2011.02.012; Mateo R, 2007, ECOTOX ENVIRON SAFE, V66, P119, DOI 10.1016/j.ecoenv.2005.12.010; Mateo R, 2006, ENVIRON TOXICOL CHEM, V25, P203, DOI 10.1897/04-460R.1; Mateo R, 2004, J CHROMATOGR B, V810, P305, DOI 10.1016/j.jchromb.2004.08.019; Mateo R, 2003, J TOXICOL ENV HEAL A, V66, P1371, DOI 10.1080/15287390306390; Mateo R, 1998, ARCH ENVIRON CON TOX, V35, P342, DOI 10.1007/s002449900385; Mateo R, 2000, ECOTOXICOLOGY ENV RE, V3, P76; Mayhew Peter W., 1993, Wildfowl, V44, P174; Meharg AA, 2002, SCI TOTAL ENVIRON, V300, P81, DOI 10.1016/S0048-9697(02)00283-8; Meharg AA, 1999, ENVIRON POLLUT, V105, P387, DOI 10.1016/S0269-7491(99)00033-0; Pain DJ, 1998, SCI TOTAL ENVIRON, V222, P45, DOI 10.1016/S0048-9697(98)00290-3; Prat N, 1999, SCI TOTAL ENVIRON, V242, P231, DOI 10.1016/S0048-9697(99)00393-9; Quarterman J, 1986, TRACE ELEMENTS HUMAN, P281; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Rodriguez R., 1975, Doiiana Acta vert, V2, P201; Sakai T, 2000, IND HEALTH, V38, P127, DOI 10.2486/indhealth.38.127; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; Simon M, 2008, SCI TOTAL ENVIRON, V407, P23, DOI 10.1016/j.scitotenv.2008.07.040; Simon M, 2009, WATER AIR SOIL POLL, V198, P77, DOI 10.1007/s11270-008-9827-4; Sola C, 2004, SCI TOTAL ENVIRON, V333, P109, DOI 10.1016/j.scitotenv.2004.05.011; Svanberg F, 2006, SCI TOTAL ENVIRON, V370, P416, DOI 10.1016/j.scitotenv.2006.07.006; Taggart MA, 2009, ENVIRON POLLUT, V157, P946, DOI 10.1016/j.envpol.2008.10.020; Taggart MA, 2006, ENVIRON RES, V100, P349, DOI 10.1016/j.envres.2005.07.009; Taggart MA, 2004, SCI TOTAL ENVIRON, V323, P137, DOI 10.1016/j.scitotenv.2003.10.008	57	16	16	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57295	10.1371/journal.pone.0057295	http://dx.doi.org/10.1371/journal.pone.0057295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437364	Green Published, Green Submitted, gold			2022-12-25	WOS:000315184200239
J	Mattii, L; Ippolito, C; Segnani, C; Battolla, B; Colucci, R; Dolfi, A; Bassotti, G; Blandizzi, C; Bernardini, N				Mattii, Letizia; Ippolito, Chiara; Segnani, Cristina; Battolla, Barbara; Colucci, Rocchina; Dolfi, Amelio; Bassotti, Gabrio; Blandizzi, Corrado; Bernardini, Nunzia			Altered Expression Pattern of Molecular Factors Involved in Colonic Smooth Muscle Functions: An Immunohistochemical Study in Patients with Diverticular Disease	PLOS ONE			English	Article							INTERSTITIAL-CELLS; NITRIC-OXIDE; CONNEXIN PHOSPHORYLATION; ULCERATIVE-COLITIS; GAP-JUNCTION; RHO-GTPASES; MOTILITY; ACTIN; CAJAL; ABNORMALITIES	Background: The pathogenesis of diverticular disease (DD) is thought to result from complex interactions among dietary habits, genetic factors and coexistence of other bowel abnormalities. These conditions lead to alterations in colonic pressure and motility, facilitating the formation of diverticula. Although electrophysiological studies on smooth muscle cells (SMCs) have investigated colonic motor dysfunctions, scarce attention has been paid to their molecular abnormalities, and data on SMCs in DD are lacking. Accordingly, the main purpose of this study was to evaluate the expression patterns of molecular factors involved in the contractile functions of SMCs in the tunica muscularis of colonic specimens from patients with DD. Methods and Findings: By means of immunohistochemistry and image analysis, we examined the expression of Cx26 and Cx43, which are prominent components of gap junctions in human colonic SMCs, as well as pS368-Cx43, PKCps, RhoA and alpha SMA, all known to regulate the functions of gap junctions and the contractile activity of SMCs. The immunohistochemical analysis revealed significant abnormalities in DD samples, concerning both the expression and distribution patterns of most of the investigated molecular factors. Conclusion: This study demonstrates, for the first time, that an altered pattern of factors involved in SMC contractility is present at level of the tunica muscularis of DD patients. Moreover, considering that our analysis was conducted on colonic tissues not directly affected by diverticular lesions or inflammatory reactions, it is conceivable that these molecular alterations may precede and predispose to the formation of diverticula, rather than being mere consequences of the disease.	[Mattii, Letizia; Ippolito, Chiara; Segnani, Cristina; Battolla, Barbara; Dolfi, Amelio; Bernardini, Nunzia] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embriol, Pisa, Italy; [Colucci, Rocchina; Blandizzi, Corrado] Univ Pisa, Dept Clin & Expt Med, Pharmacol Unit, Pisa, Italy; [Bassotti, Gabrio] Univ Perugia, Dept Clin & Expt Med, Unit Gastroenterol & Hepatol, I-06100 Perugia, Italy	University of Pisa; University of Pisa; University of Perugia	Mattii, L (corresponding author), Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embriol, Pisa, Italy.	letizia.mattii@med.unipi.it	Blandizzi, Corrado/AAB-8736-2019; mattii, letizia/K-3023-2019; Bernardini, Nunzia/AAC-4602-2021; Mattii, Letizia/AAZ-4735-2021; MATTII, LETIZIA/B-6123-2018	MATTII, LETIZIA/0000-0001-6835-7987; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; BERNARDINI, NUNZIA/0000-0001-9061-9402; BLANDIZZI, CORRADO/0000-0001-9927-5386; Ippolito, Chiara/0000-0001-8671-313X	Interdepartmental Centre for research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa	Interdepartmental Centre for research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa	This work is partially supported by the Interdepartmental Centre for research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen V, 2006, J HISTOCHEM CYTOCHEM, V54, P795, DOI 10.1369/jhc.5A6839.2006; Aronica E, 2001, ACTA NEUROPATHOL, V101, P449; Bassotti G, 2005, CLIN GASTROENTEROL H, V3, P248, DOI 10.1016/S1542-3565(04)00614-7; Bassotti G, 2005, J CLIN PATHOL, V58, P973, DOI 10.1136/jcp.2005.026112; Bassotti G, 2011, TECH COLOPROCTOL, V15, P371, DOI 10.1007/s10151-011-0721-5; Bassotti G, 1999, AM J GASTROENTEROL, V94, P1760; BASSOTTI G, 1995, INT J COLORECTAL DIS, V10, P173, DOI 10.1007/BF00298543; Bassotti G, 2003, WORLD J GASTROENTERO, V9, P2140; Bassotti G, 2001, DIS COLON RECTUM, V44, P1814, DOI 10.1007/BF02234460; Bassotti G, 2012, DIGEST DIS, V30, P24, DOI 10.1159/000335702; Bernardini N, 2012, J CELL MOL MED, V16, P318, DOI 10.1111/j.1582-4934.2011.01298.x; Bivi N, 2011, J CELL BIOCHEM, V112, P2920, DOI 10.1002/jcb.23208; Derangeon M, 2008, J BIOL CHEM, V283, P30754, DOI 10.1074/jbc.M801556200; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Fornai M, 2007, BRIT J PHARMACOL, V151, P1246, DOI 10.1038/sj.bjp.0707339; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2006, HISTOCHEM CELL BIOL, V126, P537, DOI 10.1007/s00418-006-0190-5; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jee H, 2001, DIGEST DIS SCI, V56, P1323; Kanczuga-Koda L, 2004, FOLIA HISTOCHEM CYTO, V42, P203; Kanczuga-Koda L, 2010, IN VIVO, V24, P101; Knowles CH, 2004, GUT, V53, P1583, DOI 10.1136/gut.2003.037275; Knowles CH, 2009, ACTA NEUROPATHOL, V118, P271, DOI 10.1007/s00401-009-0527-y; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Liu L, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2011.01685.x; Liu L, 2002, J PHARMACOL EXP THER, V302, P627, DOI 10.1124/jpet.102.034702; Liu L, 2011, NEUROGASTROENT MOTIL, V23, pe179; Matrana Marc R, 2009, Clin Colon Rectal Surg, V22, P141, DOI 10.1055/s-0029-1236157; Mattii L, 2005, LEUKEMIA RES, V29, P1285, DOI 10.1016/j.leukres.2005.04.011; Mattii L, 2004, J CELL BIOCHEM, V93, P1231, DOI 10.1002/jcb.20248; Mattii L, 2011, LEUKEMIA RES, V35, P265, DOI 10.1016/j.leukres.2010.05.027; Ohama T, 2008, J GASTROENTEROL, V43, P858, DOI 10.1007/s00535-008-2241-2; Olbina G, 2003, MOL CANCER RES, V1, P690; Rattan S, 2010, GASTROENTEROLOGY, V138, P13, DOI 10.1053/j.gastro.2009.11.016; Richards RJ, 2002, DIGEST DIS SCI, V47, P1903, DOI 10.1023/A:1019624101225; Salem L, 2004, J AM COLL SURGEONS, V199, P904, DOI 10.1016/j.jamcollsurg.2004.07.029; Sanders KM, 2006, J PHYSIOL-LONDON, V576, P721, DOI 10.1113/jphysiol.2006.115279; Sarna SK., 2010, COLONIC MOTILITY BEN, DOI 10.4199/C00020ED1V01Y201011ISP011; Straub AC, 2010, J VASC RES, V47, P277, DOI 10.1159/000265562; Takahashi A, 2005, J GASTROENTEROL, V40, P1043, DOI 10.1007/s00535-005-1688-7; ter Beek WP, 2008, INFLAMM BOWEL DIS, V14, P612, DOI 10.1002/ibd.20364; Tomita R, 2000, HEPATO-GASTROENTEROL, V47, P692; Wedel T, 2006, NEUROGASTROENT MOTIL, V18, P526, DOI 10.1111/j.1365-2982.2006.00781.x; Wedel T, 2010, NEUROGASTROENT MOTIL, V22, P407, DOI 10.1111/j.1365-2982.2009.01445.x	49	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57023	10.1371/journal.pone.0057023	http://dx.doi.org/10.1371/journal.pone.0057023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437299	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200202
J	Hackett, TD; Korine, C; Holderied, MW				Hackett, Talya D.; Korine, Carmi; Holderied, Marc W.			The Importance of Acacia Trees for Insectivorous Bats and Arthropods in the Arava Desert	PLOS ONE			English	Article							LARGE MAMMALIAN HERBIVORES; MKOMAZI-GAME-RESERVE; HABITAT USE; RHINOLOPHUS-HIPPOSIDEROS; NEGEV DESERT; FORAGING BEHAVIOR; ACTIVITY PATTERNS; FEEDING-HABITS; ECHOLOCATION; CHIROPTERA	Anthropogenic habitat modification often has a profound negative impact on the flora and fauna of an ecosystem. In parts of the Middle East, ephemeral rivers (wadis) are characterised by stands of acacia trees. Green, flourishing assemblages of these trees are in decline in several countries, most likely due to human-induced water stress and habitat changes. We examined the importance of healthy acacia stands for bats and their arthropod prey in comparison to other natural and artificial habitats available in the Arava desert of Israel. We assessed bat activity and species richness through acoustic monitoring for entire nights and concurrently collected arthropods using light and pit traps. Dense green stands of acacia trees were the most important natural desert habitat for insectivorous bats. Irrigated gardens and parks in villages and fields of date palms had high arthropod levels but only village sites rivalled acacia trees in bat activity level. We confirmed up to 13 bat species around a single patch of acacia trees; one of the richest sites in any natural desert habitat in Israel. Some bat species utilised artificial sites; others were found almost exclusively in natural habitats. Two rare species (Barbastella leucomelas and Nycteris the baica) were identified solely around acacia trees. We provide strong evidence that acacia trees are of unique importance to the community of insectivorous desert-dwelling bats, and that the health of the trees is crucial to their value as a foraging resource. Consequently, conservation efforts for acacia habitats, and in particular for the green more densely packed stands of trees, need to increase to protect this vital habitat for an entire community of protected bats.	[Hackett, Talya D.; Holderied, Marc W.] Univ Bristol, Dept Biol Sci, Bristol, Avon, England; [Korine, Carmi] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Swiss Inst Dryland Environm & Energy Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Korine, Carmi] Tamar Reg Council, Dead Sea & Arava Sci Ctr, Neveh Zohar, Israel	University of Bristol; Ben Gurion University	Holderied, MW (corresponding author), Univ Bristol, Dept Biol Sci, Bristol, Avon, England.	Marc.Holderied@bristol.ac.uk	Holderied, Marc/M-9382-2013	Holderied, Marc/0000-0002-1573-7908; Hackett, Talya/0000-0001-7727-8842	Israeli Ministry of Science and Technology; Explorers Club Exploration Fund; European Commission Dryland Research Specific Support Action Plan; BBSRC [BB/F002386/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F002386/1] Funding Source: researchfish	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); Explorers Club Exploration Fund; European Commission Dryland Research Specific Support Action Plan; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Israeli Ministry of Science and Technology (to C.K.): US $13333; The Explorers Club Exploration Fund (to T.D.H.): US $750; European Commission Dryland Research Specific Support Action Plan (to T.D.H.): 9,000 pound. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM MD, 1994, J WILDLIFE MANAGE, V58, P462, DOI 10.2307/3809317; Adams AM, 2012, METHODS ECOLOGY EVOL; ANTHONY ELP, 1981, OECOLOGIA, V51, P151, DOI 10.1007/BF00540593; ARLETTAZ R, 1995, J MAMMAL, V76, P873, DOI 10.2307/1382757; Ashkenazi S, 1995, ACACIA TREES NEGEV I; Barclay RMR, 1999, J MAMMAL, V80, P290, DOI 10.2307/1383229; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; Benda Petr, 2008, Acta Societatis Zoologicae Bohemicae, V72, P1; Bohm SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017857; Bontadina F, 2002, J ZOOL, V258, P281, DOI 10.1017/S0952836902001401; Bruins HJ, 2012, LAND DEGRAD DEV, V23, P365, DOI 10.1002/ldr.2149; Ciechanowski M, 2007, CAN J ZOOL, V85, P1249, DOI 10.1139/Z07-090; Dietz C, 2004, ILLUSTRATED IDENTIFI; Dolev A., 2004, RED BOOK VERTEBRATES; Downs CT, 2003, J CHEM ECOL, V29, P845, DOI 10.1023/A:1022975531372; ERNST WHO, 1989, OIKOS, V54, P294, DOI 10.2307/3565288; Feldman R, 2000, ACTA CHIROPTEROL, V2, P15; FENTON MB, 1983, J ZOOL, V200, P347; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; FENTON MB, 1977, BIOTROPICA, V9, P73, DOI 10.2307/2387662; Fenton MB, 1999, ISR J ZOOL, V45, P501; Gharaibeh Burhan M., 1995, Mammalian Species, V514, P1; Ginat H., 2011, J DEAD SEA ARAV RES, V1, P1; Goldreich Yair, 2001, Israel Journal of Earth Sciences, V50, P53, DOI 10.1560/1V61-FPGF-Y5VK-ADAG; Gray PA, 1999, NYCTERIS THEBAICA, P1; HAUSER TP, 1994, OIKOS, V70, P421, DOI 10.2307/3545781; Hayes John P., 2009, P112; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Holderied M, 2011, J COMP PHYSIOL A, V197, P425, DOI 10.1007/s00359-010-0608-3; HOROVITZ A, 1983, ISRAEL J BOT, V32, P75; IUCN, 2019, IUCN RED LIST THREAT; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kruger O, 1998, ECOGRAPHY, V21, P261, DOI 10.1111/j.1600-0587.1998.tb00563.x; Kruger O, 1998, AFR J ECOL, V36, P213, DOI 10.1046/j.1365-2028.1998.00130.x; Kruger O, 2000, ACTA OECOL, V21, P21, DOI 10.1016/S1146-609X(00)00112-0; KUNZ TH, 1973, J MAMMAL, V54, P14, DOI 10.2307/1378869; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Lovich JE, 1999, ENVIRON MANAGE, V24, P309, DOI 10.1007/s002679900235; Martins Dino J., 2004, International Journal of Tropical Insect Science, V24, P105, DOI 10.1079/IJT200411; Mendelssohn H., 1999, FAUNA PALAESTINA MAM; Meyer CFJ, 2004, J TROP ECOL, V20, P397, DOI 10.1017/S0266467404001373; MILLER MF, 1995, AFR J ECOL, V33, P194, DOI 10.1111/j.1365-2028.1995.tb00797.x; Milne DJ, 2005, J MAMMAL, V86, P909, DOI 10.1644/1545-1542(2005)86[909:TPOBIT]2.0.CO;2; Monadjem A, 2008, ACTA CHIROPTEROL, V10, P339, DOI 10.3161/150811008X414917; Munzbergova Z, 2002, J VEG SCI, V13, P227, DOI 10.1658/1100-9233(2002)013[0227:ATAKSI]2.0.CO;2; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; O'Donnell CFJ, 2000, NEW ZEAL J ZOOL, V27, P207, DOI 10.1080/03014223.2000.9518228; Or K, 2003, AFR J ECOL, V41, P257, DOI 10.1046/j.1365-2028.2003.00451.x; Palmer TM, 2003, ECOLOGY, V84, P2843, DOI 10.1890/02-0528; Polak T, 2011, J ZOOL, V285, P21, DOI 10.1111/j.1469-7998.2011.00808.x; Razgour O, 2011, OECOLOGIA, V167, P493, DOI 10.1007/s00442-011-1995-z; Rebelo H, 2007, AFR J ECOL, V45, P228, DOI 10.1111/j.1365-2028.2006.00721.x; Riskin DK, 2001, PIPISTRELLUS BODENHE, P1; Rohner C, 1999, CONSERV BIOL, V13, P1162, DOI 10.1046/j.1523-1739.1999.97300.x; Russ JM, 2002, BIOL CONSERV, V108, P49, DOI 10.1016/S0006-3207(02)00089-7; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; RYDELL J, 1991, HOLARCTIC ECOL, V14, P203; Schlitter Duane A., 1996, Mammalian Species, V0, P1; SCHNITZLER H-U, 1971, Zeitschrift fuer Vergleichende Physiologie, V73, P209, DOI 10.1007/BF00304133; Shalmon B., 1993, FIELD GUIDE LAND MAM; Sher AA, 2010, J ARID ENVIRON, V74, P338, DOI 10.1016/j.jaridenv.2009.09.007; Shrestha MK, 2003, PLANT ECOL, V168, P297, DOI 10.1023/A:1024431124954; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Spitzenberger F, 2006, ZOOL SCR, V35, P187, DOI 10.1111/j.1463-6409.2006.00224.x; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Stone G, 1996, P ROY SOC B-BIOL SCI, V263, P1389, DOI 10.1098/rspb.1996.0203; Stone GN, 1998, ECOLOGY, V79, P2808, DOI 10.1890/0012-9658(1998)079[2808:POPDFI]2.0.CO;2; VAUGHAN TA, 1986, J MAMMAL, V67, P91, DOI 10.2307/1381005; Ward D, 1997, BIODIVERS CONSERV, V6, P877, DOI 10.1023/B:BIOC.0000010408.90955.48; Webala PW, 2001, AFRICAN J ECOLOGY, V42, P171; WELTZIN JF, 1990, J VEG SCI, V1, P325, DOI 10.2307/3235707; Whitaker JO, 2002, MAMM BIOL, V67, P378, DOI 10.1078/1616-5047-00053; WHITAKER JO, 1994, Z SAUGETIERKD, V59, P74; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944; Yom-Tov Yoram, 1998, Diversity and Distributions, V4, P63, DOI 10.1046/j.1472-4642.1998.00012.x; YOMTOV Y, 1993, J ZOOL, V230, P347; Young M, 2005, METH ECOL, P116, DOI 10.1002/9780470750513.ch6; Young TP, 1997, OECOLOGIA, V109, P98, DOI 10.1007/s004420050063; Zahn A, 2008, MAMM BIOL, V73, P222, DOI 10.1016/j.mambio.2007.02.005	82	27	27	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e52999	10.1371/journal.pone.0052999	http://dx.doi.org/10.1371/journal.pone.0052999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441145	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200003
J	Knight, EJ; Min, HK; Hwang, SC; Marsh, MP; Paek, S; Kim, I; Felmlee, JP; Abulseoud, OA; Bennet, KE; Frye, MA; Lee, KH				Knight, Emily J.; Min, Hoon-Ki; Hwang, Sun-Chul; Marsh, Michael P.; Paek, Seungleal; Kim, Inyong; Felmlee, Joel P.; Abulseoud, Osama A.; Bennet, Kevin E.; Frye, Mark A.; Lee, Kendall H.			Nucleus Accumbens Deep Brain Stimulation Results in Insula and Prefrontal Activation: A Large Animal fMRI Study	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; GLUCOSE METABOLIC-RATES; CEREBRAL-BLOOD-FLOW; CAPSULAR STIMULATION; SYMPTOM PROVOCATION; FUNCTIONAL MRI; BASAL GANGLIA; NEGATIVE BOLD; LONG-TERM; DEPRESSION	Background: Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) has previously been investigated clinically for the treatment of several psychiatric conditions, including obsessive-compulsive disorder and treatment resistant depression. However, the mechanism underlying the therapeutic benefit of DBS, including the brain areas that are activated, remains largely unknown. Here, we utilized 3.0 T functional Magnetic Resonance Imaging (fMRI) changes in Blood Oxygenation Level-Dependent (BOLD) signal to test the hypothesis that NAc/internal capsule DBS results in global neural network activation in a large animal (porcine) model Methods: Animals (n = 10) were implanted in the NAc/internal capsule with DBS electrodes and received stimulation (1, 3, and 5 V, 130 Hz, and pulse widths of 100 and 500 mu sec). BOLD signal changes were evaluated using a gradient echo-echo planar imaging (GRE-EPI) sequence in 3.0 T MRI. We used a normalized functional activation map for group analysis and applied general linear modeling across subjects (FDR<0.001). The anatomical location of the implanted DBS lead was confirmed with a CT scan Results: We observed stimulation-evoked activation in the ipsilateral prefrontal cortex, insula, cingulate and bilateral parahippocampal region along with decrease in BOLD signal in the ipsilateral dorsal region of the thalamus. Furthermore, as the stimulation voltage increased from 3 V to 5 V, the region of BOLD signal modulation increased in insula, thalamus, and parahippocampal cortex and decreased in the cingulate and prefrontal cortex. We also demonstrated that right and left NAc/internal capsule stimulation modulates identical areas ipsilateral to the side of the stimulation Conclusions: Our results suggest that NAc/internal capsule DBS results in modulation of psychiatrically important brain areas notably the prefrontal cortex, cingulate, and insular cortex, which may underlie the therapeutic effect of NAc DBS in psychiatric disorders. Finally, our fMRI setup in the large animal may be a useful platform for translational studies investigating the global neuromodulatory effects of DBS	[Knight, Emily J.; Min, Hoon-Ki; Hwang, Sun-Chul; Marsh, Michael P.; Paek, Seungleal; Kim, Inyong; Lee, Kendall H.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Hwang, Sun-Chul] Soonchunhyang Univ, Busheon Hosp, Dept Neurosurg, Puchon, South Korea; [Felmlee, Joel P.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Abulseoud, Osama A.; Frye, Mark A.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Bennet, Kevin E.] Mayo Clin, Div Engn, Rochester, MN USA; [Lee, Kendall H.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Soonchunhyang University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Lee, KH (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA.	lee.kendall@mayo.edu	Min, Hoon-Ki/A-6025-2018	Min, Hoon-Ki/0000-0002-1084-2469; Knight, Emily/0000-0002-6971-1148	National Institutes of Health [K08 NS 52232, R01 NS 70872]; Oxley Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070872, K08NS052232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oxley Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (K08 NS 52232 and R01 NS 70872 awards to KHL) and the Oxley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson JL, 2005, BIOL PSYCHIAT, V57, P510, DOI 10.1016/j.biopsych.2004.11.042; Angenstein F, 2010, NEUROIMAGE, V50, P1364, DOI 10.1016/j.neuroimage.2010.01.070; Angenstein F, 2009, J NEUROSCI, V29, P2428, DOI 10.1523/JNEUROSCI.5015-08.2009; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Babiloni C, 2009, INT REV NEUROBIOL, V86, P67, DOI 10.1016/S0074-7742(09)86005-4; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; BENKELFAT C, 1990, ARCH GEN PSYCHIAT, V47, P840; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Brooks JO, 2009, AM J GERIAT PSYCHIAT, V17, P1022, DOI 10.1097/JGP.0b013e3181ad4d47; CALDWELL AE, 1967, DIS NERV SYST, V28, P816; Carmichael DW, 2007, NEUROIMAGE, V37, P508, DOI 10.1016/j.neuroimage.2007.04.058; Craig AD, 2011, BRAIN, V134, DOI 10.1093/brain/awq308; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2011, BRAIN J NEUROLOGY, V134, pe165; Craig AD, 2011, BRAIN, V133, P2528; Denys D, 2010, ARCH GEN PSYCHIAT, V67, P1061, DOI 10.1001/archgenpsychiatry.2010.122; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Franzini A, 2010, NEUROL SCI, V31, P353, DOI 10.1007/s10072-009-0214-8; Georgi JC, 2004, MAGNET RESON MED, V51, P380, DOI 10.1002/mrm.10699; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Greenberg BD, 2010, NEUROPSYCHOPHARMACOL, V35, P317, DOI 10.1038/npp.2009.128; Grubert C, 2011, WORLD J BIOL PSYCHIA, V12, P516, DOI 10.3109/15622975.2011.583940; Hardman CD, 2002, J COMP NEUROL, V445, P238, DOI 10.1002/cne.10165; Heimer L, 2003, AM J PSYCHIAT, V160, P1726, DOI 10.1176/appi.ajp.160.10.1726; Henderson MB, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.4.FOCUS10105; Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006; Jech R, 2001, MOVEMENT DISORD, V16, P1126, DOI 10.1002/mds.1217; Jin T, 2008, NEUROIMAGE, V43, P1, DOI 10.1016/j.neuroimage.2008.06.029; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Knapp CM, 2009, PHARMACOL BIOCHEM BE, V92, P474, DOI 10.1016/j.pbb.2009.01.017; Kopell BH, 2008, NEUROSCI BIOBEHAV R, V32, P408, DOI 10.1016/j.neubiorev.2007.07.004; Kuhn J, 2009, BMJ CASE REPORTS, V2009; Kuhn J, 2007, J NEUROL, V254, P963, DOI 10.1007/s00415-006-0404-8; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lippitz BE, 1999, NEUROSURGERY, V44, P452, DOI 10.1097/00006123-199903000-00005; Liu HY, 2008, ADDICT BIOL, V13, P40, DOI 10.1111/j.1369-1600.2007.00088.x; Lujan JL, 2011, HUMAN BRAIN MAPPING; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Min HHSC, 2012, NEUROIMAGE IN PRESS; Miocinovic S, 2007, J NEUROSCI METH, V162, P32, DOI 10.1016/j.jneumeth.2006.12.007; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Moro E, 2002, NEUROLOGY, V59, P706, DOI 10.1212/WNL.59.5.706; Mundt A, 2009, EUR J NEUROSCI, V29, P2401, DOI 10.1111/j.1460-9568.2009.06777.x; Neuner Irene, 2009, Biol Psychiatry, V65, pe5, DOI 10.1016/j.biopsych.2008.09.030; Nuttin BJ, 2003, NEUROSURGERY, V52, P1263, DOI 10.1227/01.NEU.0000064565.49299.9A; Rauch SL, 2006, J NEUROSURG, V104, P558, DOI 10.3171/jns.2006.104.4.558; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Servello D, 2010, NEUROMODULATION, V13, P187, DOI 10.1111/j.1525-1403.2009.00253.x; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shon YM, 2010, NEUROSCI LETT, V475, P136, DOI 10.1016/j.neulet.2010.03.060; Teneback CC, 1999, J NEUROPSYCH CLIN N, V11, P426; van Eijsden P, 2009, NEUROIMAGE, V45, P1047, DOI 10.1016/j.neuroimage.2008.08.026; Van Gompel JJ, 2011, EPILEPSIA, V52, pE49, DOI 10.1111/j.1528-1167.2011.03096.x; Van Laere K, 2006, J NUCL MED, V47, P740; Vassoler FM, 2008, J NEUROSCI, V28, P8735, DOI 10.1523/JNEUROSCI.5277-07.2008; Wakeman DR, 2006, REGEN MED, V1, P405, DOI 10.2217/17460751.1.4.405; Zabek M, 2008, NEUROL NEUROCHIR POL, V42, P554	71	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56640	10.1371/journal.pone.0056640	http://dx.doi.org/10.1371/journal.pone.0056640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441210	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200067
J	Liu, YQ; Sanchez-Tillo, E; Lu, XQ; Huang, L; Clem, B; Telang, S; Jenson, AB; Cuatrecasas, M; Chesney, J; Postigo, A; Dean, DC				Liu, Yongqing; Sanchez-Tillo, Ester; Lu, Xiaoqin; Huang, Li; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Cuatrecasas, Miriam; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.			Sequential Inductions of the ZEB1 Transcription Factor Caused by Mutation of Rb and Then Ras Proteins Are Required for Tumor Initiation and Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RETINOBLASTOMA GENE; CELL-CYCLE; SIGNALING PATHWAY; DOWN-REGULATION; FEEDBACK LOOP; CANCER-CELLS; G(1) CONTROL; IN-VIVO; K-RAS	Rb1 restricts cell cycle progression, and it imposes cell contact inhibition to suppress tumor outgrowth. It also triggers oncogene-induced senescence to block Ras mutation. Loss of the Rb1 pathway, which is a hallmark of cancer cells, then provides a permissive environment for Ras mutation, and Ras is sufficient for invasive tumor formation in Rb1 family mutant mouse embryo fibroblasts (MEFs). These results demonstrate that sequential mutation of the Rb1 and Ras pathways comprises a tumor initiation axis. Both Rb1 and Ras regulate expression of the transcription factor ZEB1, thereby linking tumor initiation to the subsequent invasion and metastasis, which is induced by ZEB1. ZEB1 acts in a negative feedback loop to block expression of miR-200, which is thought to facilitate tumor invasion and metastasis. However, ZEB1 also represses cyclin-dependent kinase (cdk) inhibitors to control the cell cycle; its mutation in MEFs leads to induction of these inhibitors and premature senescence. Here, we provide evidence for two sequential inductions of ZEB1 during Ras transformation of MEFs. Rb1 constitutively represses cdk inhibitors, and induction of ZEB1 when the Rb1 pathway is lost is required to maintain this repression, allowing for the classic immortalization and loss of cell contact inhibition seen when the Rb1 pathway is lost. In vivo, we show that this induction of ZEB1 is required for Ras-initiated tumor formation. ZEB1 is then further induced by Ras, beyond the level seen with Rb1 mutation, and this Ras superinduction is required to reach a threshold of ZEB1 sufficient for repression of miR-200 and tumor invasion.	[Liu, Yongqing; Clem, Brian; Telang, Sucheta; Jenson, Alfred B.; Chesney, Jason; Postigo, Antonio; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Mol Targets Program, James Graham Brown Canc Ctr, Louisville, KY 40202 USA; [Liu, Yongqing; Lu, Xiaoqin; Huang, Li; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA; [Liu, Yongqing; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Birth Defects Ctr, Louisville, KY 40202 USA; [Sanchez-Tillo, Ester; Postigo, Antonio] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Grp Transcript Regulat Gene Express, CIBERehd, Barcelona 08036, Spain; [Postigo, Antonio] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona 08010, Spain; [Cuatrecasas, Miriam] Univ Barcelona, Dept Pathol, Ctr Diagnost Biomed CDB Hosp Clin, E-08036 Barcelona, Spain; [Cuatrecasas, Miriam] Univ Barcelona, Tumor Bank Biobank, IDIBAPS, Hosp Clin, E-08036 Barcelona, Spain; [Huang, Li] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	University of Louisville; University of Louisville; University of Louisville; University of Louisville; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ICREA; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Zhejiang University	Postigo, A (corresponding author), IDIBAPS, Grp Transcript Regulat Gene Express, Villarroel 170, Barcelona 08036, Spain.	idib412@clinic.ub.es; dcdean01@louisville.edu	Cuatrecasas, Miriam/C-9156-2019	Cuatrecasas, Miriam/0000-0003-3063-0110; Postigo, Antonio/0000-0003-4605-2634	National Institutes of Health [EY019113, EY018603, EY015636]; National Institutes of Health through the NIGMS [P20GM103453]; Olga Torres Foundation (FOT); Spanish Association Against Cancer (AECC); Avon Breast Cancer Campaign (AVON-SAU); Ministry of Economy and Competitiveness (MEC) [MICINN-BFU2010-15163]; NATIONAL CANCER INSTITUTE [R01CA149438] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY015636, R01EY018603, R21EY019113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103453, P30GM106396] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Olga Torres Foundation (FOT); Spanish Association Against Cancer (AECC); Avon Breast Cancer Campaign (AVON-SAU); Ministry of Economy and Competitiveness (MEC); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grants EY019113 and EY018603 (to D.C.D.), National Institutes of Health Institutional Development Award P20GM103453 through the NIGMS (to Y.L.), and National Institutes of Health Core Grant EY015636 (to A.P.). This work was also supported by the Olga Torres Foundation (FOT), Spanish Association Against Cancer (AECC), Avon Breast Cancer Campaign (AVON-SAU), and Ministry of Economy and Competitiveness (MEC)/MICINN-BFU2010-15163 (to A.P.).	Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chassot AA, 2008, CELL CYCLE, V7, P2038, DOI 10.4161/cc.7.13.6233; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; El-Naggar S, 2009, MOL CELL BIOL, V29, P5710, DOI 10.1128/MCB.00197-09; Foijer F, 2005, CANCER CELL, V8, P455, DOI 10.1016/j.ccr.2005.10.021; Foijer F, 2007, CANCER RES, V67, P9244, DOI 10.1158/0008-5472.CAN-07-1650; Geryk-Hall M, 2009, CURR ONCOL REP, V11, P446, DOI 10.1007/s11912-009-0061-z; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ho VM, 2009, ONCOGENE, V28, P1393, DOI 10.1038/onc.2008.491; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Li W, 2009, P NATL ACAD SCI USA, V106, P486, DOI 10.1073/pnas.0804177106; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mora J, 2012, PEDIATR BLOOD CANCER, V58, P532, DOI 10.1002/pbc.23348; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen AD, 2012, J SURG ONCOL, V105, P830, DOI 10.1002/jso.23012; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yoo JY, 1999, MODERN PATHOL, V12, P775; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X	42	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2013	288	16					11572	11580		10.1074/jbc.M112.434951	http://dx.doi.org/10.1074/jbc.M112.434951			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	130KW	23443660	hybrid, Green Published			2022-12-25	WOS:000317915500062
J	Asai, T; Morrison, SL				Asai, Tsuneaki; Morrison, Sherie L.			The SRC Family Tyrosine Kinase HCK and the ETS Family Transcription Factors SPIB and EHF Regulate Transcytosis across a Human Follicle-associated Epithelium Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATCH M-CELLS; SECRETORY IGA; IN-VITRO; GM-CSF; HUMAN ENTEROCYTES; CACO-2 CELLS; DIFFERENTIATION; TRANSPORT; EXPRESSION; RECEPTOR	A critical step in the induction of adaptive mucosal immunity is antigen transcytosis, in which luminal antigens are transported to organized lymphoid tissues across the follicle-associated epithelium (FAE) of Peyer's patches. However, virtually nothing is known about intracellular signaling proteins and transcription factors that regulate apical-to-basolateral transcytosis. The FAE can transcytose a variety of luminal contents, including inert particles, in the absence of specific opsonins. Furthermore, it expresses receptors for secretory immunoglobulin A(SIgA), the main antibody in mucosal secretions, and uses them to efficiently transcytose SIgA-opsonized particles present in the lumen. Using a human FAE model, we show that the tyrosine kinase HCK regulates apical-to-basolateral transcytosis of non-opsonized and SIgA-opsonized particles. We also show that, in cultured intestinal epithelial cells, ectopic expression of the transcription factor SPIB or EHF is sufficient to activate HCK-dependent apical-to-basolateral transcytosis of these particles. Our results provide the first molecular insights into the intracellular regulation of antigen sampling at mucosal surfaces.	[Asai, Tsuneaki; Morrison, Sherie L.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Asai, T (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 615 Charles Young Dr, Los Angeles, CA 90095 USA.	tsuneaki.asai@ucla.edu			National Institutes of Health [R21AI092386]; California HIV/AIDS Research Program [ID10-LA-012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI092386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AI092386. This work was also supported by California HIV/AIDS Research Program Grant ID10-LA-012 (to S. L. M.).	Baumann J, 2010, IMMUNOL LETT, V131, P59, DOI 10.1016/j.imlet.2010.03.005; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Blanco LP, 2006, INFECT IMMUN, V74, P6957, DOI 10.1128/IAI.00905-06; Brandtzaeg P, 2010, IMMUNOL INVEST, V39, P303, DOI 10.3109/08820131003680369; BROWN D, 1990, J PHYSIOL-LONDON, V427, P81, DOI 10.1113/jphysiol.1990.sp018162; Carreno S, 2002, J BIOL CHEM, V277, P21007, DOI 10.1074/jbc.M201212200; CHANTRET I, 1994, J CELL SCI, V107, P213; Corthesy B, 2009, IMMUNOPHARM IMMUNOT, V31, P174, DOI 10.1080/08923970802438441; Crottet P, 1998, J IMMUNOL, V161, P5445; de Lau W, 2012, MOL CELL BIOL, V32, P3639, DOI 10.1128/MCB.00434-12; des Rieux A, 2007, EUR J PHARM SCI, V30, P380, DOI 10.1016/j.ejps.2006.12.006; Ferruzza S, 2012, TOXICOL IN VITRO, V26, P1252, DOI 10.1016/j.tiv.2012.01.008; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Gullberg E, 2000, BIOCHEM BIOPH RES CO, V279, P808, DOI 10.1006/bbrc.2000.4038; Harper LV, 2003, MOL CELL PROBE, V17, P261, DOI 10.1016/S0890-8508(03)00063-X; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Innes NPT, 1999, ARCH ORAL BIOL, V44, P519, DOI 10.1016/S0003-9969(99)00027-8; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; Kerneis S, 2000, MICROBES INFECT, V2, P1119, DOI 10.1016/S1286-4579(00)01266-1; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kesisoglou F, 2010, MOL PHARMACEUT, V7, P619, DOI 10.1021/mp9001377; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Kunisawa J, 2012, ADV DRUG DELIVER REV, V64, P523, DOI 10.1016/j.addr.2011.07.003; Le Ferrec E, 2001, ATLA-ALTERN LAB ANIM, V29, P649, DOI 10.1177/026119290102900604; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; LINNEKIN D, 1994, BLOOD, V84, P94, DOI 10.1182/blood.V84.1.94.bloodjournal84194; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Mantis NJ, 2004, J IMMUNOL, V172, P6838, DOI 10.4049/jimmunol.172.11.6838; Mantis NJ, 2002, J IMMUNOL, V169, P1844, DOI 10.4049/jimmunol.169.4.1844; Morel E, 2005, AM J PATHOL, V167, P1033, DOI 10.1016/S0002-9440(10)61192-3; Munera J, 2011, STEM CELLS, V29, P430, DOI 10.1002/stem.599; Murthy AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016847; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Oikawa T, 2003, GENE, V303, P11, DOI 10.1016/S0378-1119(02)01156-3; Pagel JM, 2007, CANCER RES, V67, P5921, DOI 10.1158/0008-5472.CAN-07-0080; PORTA C, 1992, EXP PHYSIOL, V77, P929, DOI 10.1113/expphysiol.1992.sp003662; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz O., 2013, TRENDS IMMU IN PRESS; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Sui LL, 2004, BIOCHEM BIOPH RES CO, V319, P920, DOI 10.1016/j.bbrc.2004.05.065; Takatsu H, 2006, BIOCHEM BIOPH RES CO, V348, P183, DOI 10.1016/j.bbrc.2006.07.047; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Tyrer P, 2006, INFECT IMMUN, V74, P625, DOI 10.1128/IAI.74.1.625-631.2006; van Spriel AB, 2002, J IMMUNOL, V169, P3831, DOI 10.4049/jimmunol.169.7.3831; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Zucco F, 2005, ATLA-ALTERN LAB ANIM, V33, P603, DOI 10.1177/026119290503300618	55	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10395	10405		10.1074/jbc.M112.437475	http://dx.doi.org/10.1074/jbc.M112.437475			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23439650	Green Published, hybrid			2022-12-25	WOS:000317565000020
J	Hollegaard, B; Byars, SG; Lykke, J; Boomsma, JJ				Hollegaard, Birgitte; Byars, Sean G.; Lykke, Jacob; Boomsma, Jacobus J.			Parent-Offspring Conflict and the Persistence of Pregnancy-Induced Hypertension in Modern Humans	PLOS ONE			English	Article							WEIGHT PERCENTILE CURVES; FETAL-GROWTH; IMPRINTING CENTER; GESTATIONAL-AGE; BLOOD-PRESSURE; PREECLAMPSIA; MORTALITY; OUTCOMES; GENES; COMPLICATIONS	Preeclampsia is a major cause of perinatal mortality and disease affecting 5-10% of all pregnancies worldwide, but its etiology remains poorly understood despite considerable research effort. Parent-offspring conflict theory suggests that such hypertensive disorders of pregnancy may have evolved through the ability of fetal genes to increase maternal blood pressure as this enhances general nutrient supply. However, such mechanisms for inducing hypertension in pregnancy would need to incur sufficient offspring health benefits to compensate for the obvious risks for maternal and fetal health towards the end of pregnancy in order to explain why these disorders have not been removed by natural selection in our hunter-gatherer ancestors. We analyzed >750,000 live births in the Danish National Patient Registry and all registered medical diagnoses for up to 30 years after birth. We show that offspring exposed to pregnancy-induced hypertension (PIH) in trimester 1 had significantly reduced overall later-life disease risks, but increased risks when PIH exposure started or developed as preeclampsia in later trimesters. Similar patterns were found for first-year mortality. These results suggest that early PIH leading to improved postpartum survival and health represents a balanced compromise between the reproductive interests of parents and offspring, whereas later onset of PIH may reflect an unbalanced parent-offspring conflict at the detriment of maternal and offspring health.	[Hollegaard, Birgitte; Byars, Sean G.; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark; [Lykke, Jacob] Roskilde Hosp, Dept Obstet & Gynaecol, Roskilde, Denmark	University of Copenhagen	Boomsma, JJ (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	JJBoomsma@bio.ku.dk	Boomsma, Jacobus J/M-2785-2014	Boomsma, Jacobus J/0000-0002-3598-1609; Byars, Sean/0000-0002-3797-8112; Lykke, Jacob Alexander/0000-0002-3698-9792	Danish National Research Foundation; Marie Curie International Incoming Fellowship [FP7-PEOPLE-2010-IIF-276565]	Danish National Research Foundation(Danmarks Grundforskningsfond); Marie Curie International Incoming Fellowship(European Commission)	The Centre for Social Evolution is funded by the Danish National Research Foundation. S. G. Byars was also supported by a Marie Curie International Incoming Fellowship FP7-PEOPLE-2010-IIF-276565. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2006, CYTOGENET GENOME RES, V113, P262, DOI 10.1159/000090841; Almog B, 2011, PLACENTA, V32, P58, DOI 10.1016/j.placenta.2010.10.008; Ananth CV, 2010, EPIDEMIOLOGY, V21, P118, DOI 10.1097/EDE.0b013e3181c297af; Badcock C, 2008, NATURE, V454, P1054, DOI 10.1038/4541054a; Bakker R, 2011, AM J EPIDEMIOL, V174, P797, DOI 10.1093/aje/kwr151; Buchbinder A, 2002, AM J OBSTET GYNECOL, V186, P66, DOI 10.1067/mob.2002.120080; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Byars SG, 2010, P NATL ACAD SCI USA, V107, P1787, DOI 10.1073/pnas.0906199106; Chen XK, 2007, BJOG-INT J OBSTET GY, V114, P24, DOI 10.1111/j.1471-0528.2006.01177.x; Cruz MO, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.033; Gluckman PD, 2009, PRINCIPLES EVOLUTION, P124; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hager R, 2003, NATURE, V421, P533, DOI 10.1038/nature01239; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; Haig D., 2008, EVOLUTION HLTH DIS, P65; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Hibbard JU, 1999, CHESLEYS HYPERTENSIV, pxiv; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Kliman HJ, 2012, REPROD SCI, V19, P16, DOI 10.1177/1933719111424445; Kolliker M, 2001, ANIM BEHAV, V62, P395, DOI 10.1006/anbe.2001.1792; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lykke JA, 2010, PAEDIATR PERINAT EP, V24, P323, DOI 10.1111/j.1365-3016.2010.01120.x; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; NAEYE RL, 1981, AM J OBSTET GYNECOL, V141, P780, DOI 10.1016/0002-9378(81)90704-3; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Oudejans CBM, 2004, MOL HUM REPROD, V10, P589, DOI 10.1093/molehr/gah080; Rabinovitz S, 2012, P NATL ACAD SCI USA, V109, P7403, DOI 10.1073/pnas.1116661109; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Robillard PY, 2002, AM J REPROD IMMUNOL, V47, P104, DOI 10.1034/j.1600-0897.2002.1o043.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; SYMONDS EM, 1980, J ROY SOC MED, V73, P871, DOI 10.1177/014107688007301210; Thompson JMD, 2007, BJOG-INT J OBSTET GY, V114, P715, DOI 10.1111/j.1471-0528.2007.01327.x; TRIVERS RL, 1974, AM ZOOL, V14, P249; Turner JA, 2010, INT J WOMENS HEALTH, V2, P327, DOI 10.2147/IJWH.S8550; von Dadelszen P, 2005, OBSTET GYNECOL, V106, P335, DOI 10.1097/01.AOG.0000171121.31564.14; Wagner LK, 2004, AM FAM PHYSICIAN, V70, P2317; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Wu CS, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.046; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Xia Y, 2009, CLIN IMMUNOL, V133, P1, DOI 10.1016/j.clim.2009.05.004; Yuan HT, 2005, CURR TOP DEV BIOL, V71, P297, DOI 10.1016/S0070-2153(05)71009-7	47	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56821	10.1371/journal.pone.0056821	http://dx.doi.org/10.1371/journal.pone.0056821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451092	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500032
J	Kadohama, N; Goh, T; Ohnishi, M; Fukaki, H; Mimura, T; Suzuki, Y				Kadohama, Noriaki; Goh, Tatsuaki; Ohnishi, Miwa; Fukaki, Hidehiro; Mimura, Tetsuro; Suzuki, Yoshihiro			Sudden Collapse of Vacuoles in Saintpaulia sp Palisade Cells Induced by a Rapid Temperature Decrease	PLOS ONE			English	Article							CYTOPLASMIC PH REGULATION; CHLOROPHYLL FLUORESCENCE; COLD-ACCLIMATION; PHOTOSYSTEM-II; HEAT-STRESS; LEAF-SPOT; IN-VIVO; PHOTOSYNTHETIC ACTIVITY; REGULATORY NETWORKS; CULTURED-CELLS	It is well known that saintpaulia leaf is damaged by the rapid temperature decrease when cold water is irrigated onto the leaf surface. We investigated this temperature sensitivity and the mechanisms of leaf damage in saintpaulia (Saintpaulia sp. cv. 'Iceberg') and other Gesneriaceae plants. Saintpaulia leaves were damaged and discolored when subjected to a rapid decrease in temperature, but not when the temperature was decreased gradually. Sensitivity to rapid temperature decrease increased within 10 to 20 min during pre-incubation at higher temperature. Injury was restricted to the palisade mesophyll cells, where there was an obvious change in the color of the chloroplasts. During a rapid temperature decrease, chlorophyll fluorescence monitored by a pulse amplitude modulated fluorometer diminished and did not recover even after rewarming to the initial temperature. Isolated chloroplasts were not directly affected by the rapid temperature decrease. Intracellular pH was monitored with a pH-dependent fluorescent dye. In palisade mesophyll cells damaged by rapid temperature decrease, the cytosolic pH decreased and the vacuolar membrane collapsed soon after a temperature decrease. In isolated chloroplasts, chlorophyll fluorescence declined when the pH of the medium was lowered. These results suggest that a rapid temperature decrease directly or indirectly affects the vacuolar membrane, resulting in a pH change in the cytosol that subsequently affects the chloroplasts in palisade mesophyll cells. We further confirmed that the same physiological damage occurs in other Gesneriaceae plants. These results strongly suggested that the vacuoles of palisade mesophyll cells collapsed during the initial phase of leaf injury.	[Kadohama, Noriaki; Goh, Tatsuaki; Ohnishi, Miwa; Fukaki, Hidehiro; Mimura, Tetsuro] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 657, Japan; [Suzuki, Yoshihiro] Kanagawa Univ, Grad Sch Sci, Dept Biol Sci, Hiratsuka, Kanagawa, Japan; [Ohnishi, Miwa; Fukaki, Hidehiro; Mimura, Tetsuro] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan	Kobe University; Kanagawa University; Japan Science & Technology Agency (JST)	Mimura, T (corresponding author), Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 657, Japan.	mimura@kobe-u.ac.jp	Goh, Tatsuaki/H-4538-2011		Japanese Ministry of Education, Culture, Sports, Science and Technology [22120006]; CREST of JST (Japan Science and Technology Agency)	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST of JST (Japan Science and Technology Agency)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (22120006) by the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm) and CREST of JST (Japan Science and Technology Agency) (http://www.jst.go.jp/kisoken/crest/en/index.html) to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Taweel K, 2007, PLANT PHYSIOL, V145, P258, DOI 10.1104/pp.107.101733; ANSARI AQ, 1959, AM J BOT, V46, P713, DOI 10.1002/j.1537-2197.1959.tb07076.x; Baatvik S. T., 1993, Fragmenta Floristica et Geobotanica, P97; Barbagallo RP, 2003, PLANT PHYSIOL, V132, P485, DOI 10.1104/pp.102.018093; BODNER M, 1987, ANGEW BOT, V61, P225; Bohn M, 2007, J PLANT PHYSIOL, V164, P146, DOI 10.1016/j.jplph.2005.12.008; BROWN MS, 1974, PLANT PHYSIOL, V53, P709, DOI 10.1104/pp.53.5.709; Burtt B.L, 1998, DIVERSITY TAXONOMY T, P1; CRIDDLE RS, 1994, PLANT CELL ENVIRON, V17, P233, DOI 10.1111/j.1365-3040.1994.tb00289.x; DANIELL JW, 1969, PLANT PHYSIOL, V44, P1684, DOI 10.1104/pp.44.12.1684; Danon A, 2012, ADV PHOTOSYNTH RESP, V34, P319, DOI 10.1007/978-94-007-1579-0_15; ELLIOTT FH, 1946, P AM SOC HORTIC SCI, V47, P511; Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339; ESPIE GS, 1981, PLANTA, V153, P210, DOI 10.1007/BF00383889; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fujikawa S, 1999, J PLANT RES, V112, P237, DOI 10.1007/PL00013880; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Good R., 1974, GEOGRAPHY FLOWERING; Grennan AK, 2007, PHOTOSYNTH RES, V94, P375, DOI 10.1007/s11120-007-9169-x; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; HAVAUX M, 1991, PLANTA, V186, P88, DOI 10.1007/BF00201502; HEBER U, 1994, PLANT CELL PHYSIOL, V35, P479; JOHANSSON DR, 1978, BIOL CONSERV, V14, P45, DOI 10.1016/0006-3207(78)90005-8; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; KATSUHARA M, 1989, PLANT PHYSIOL, V90, P1102, DOI 10.1104/pp.90.3.1102; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kawamura Y, 2008, PLANT CELL ENVIRON, V31, P288, DOI 10.1111/j.1365-3040.2007.01762.x; Kim C, 2012, PLANT CELL, V24, P3026, DOI 10.1105/tpc.112.100479; Kitao M, 2000, PHYSIOL PLANTARUM, V109, P284, DOI 10.1034/j.1399-3054.2000.100309.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kratsch HA, 2000, PLANT CELL ENVIRON, V23, P337, DOI 10.1046/j.1365-3040.2000.00560.x; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kudoh H, 2002, PLANTA, V215, P541, DOI 10.1007/s00425-002-0790-9; LARCHER W, 1989, PLANT PHYSIOL, V89, P740, DOI 10.1104/pp.89.3.740; LILLEY RM, 1975, NEW PHYTOL, V75, P1, DOI 10.1111/j.1469-8137.1975.tb01365.x; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; MADISON M, 1977, Selbyana, V2, P1; MAEKAWA S, 1987, J JPN SOC HORTIC SCI, V55, P484, DOI 10.2503/jjshs.55.484; MELLOR RS, 1964, PLANTA, V61, P56, DOI 10.1007/BF01895390; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; MIYADAI K, 1990, PLANT PHYSIOL, V92, P1215, DOI 10.1104/pp.92.4.1215; Obara K, 2001, PLANT PHYSIOL, V125, P615, DOI 10.1104/pp.125.2.615; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Poesch GH, 1942, P AM SOC HORTIC SCI, V47, P381; ROBERTS JKM, 1984, P NATL ACAD SCI-BIOL, V81, P3379, DOI 10.1073/pnas.81.11.3379; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savchenko G, 2000, PLANTA, V211, P246, DOI 10.1007/s004250000280; SMILLIE RM, 1983, PLANT PHYSIOL, V72, P1043, DOI 10.1104/pp.72.4.1043; Smith JF, 1997, ANN MO BOT GARD, V84, P50, DOI 10.2307/2399953; Stael S, 2012, J EXP BOT, V63, P1525, DOI 10.1093/jxb/err394; Suzuki Y, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P2517; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YL, 2007, PLANT PHYSIOL, V143, P629, DOI 10.1104/pp.106.090712; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; WITHERS LA, 1979, PLANT PHYSIOL, V64, P675, DOI 10.1104/pp.64.5.675; Xu CC, 1999, PHYSIOL PLANTARUM, V107, P447, DOI 10.1034/j.1399-3054.1999.100411.x; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SJ, 2001, SCI HORTIC-AMSTERDAM, V88, P59, DOI 10.1016/S0304-4238(00)00235-1; Yang XH, 2007, PLANTA, V225, P719, DOI 10.1007/s00425-006-0380-3; Yasuda Y, 1997, ACTA HISTOCHEM CYTOC, V30, P303, DOI 10.1267/ahc.30.303; YOSHIDA S, 1994, PLANT PHYSIOL, V104, P1131, DOI 10.1104/pp.104.4.1131; YOSHIDA S, 1995, PLANT CELL PHYSIOL, V36, P1075, DOI 10.1093/oxfordjournals.pcp.a078850; Yun JaeGill, 2001, Korean Journal of Horticultural Science & Technology, V19, P153; Yun JG, 1998, SCI HORTIC-AMSTERDAM, V72, P157, DOI 10.1016/S0304-4238(97)00068-X; Yun JG, 1997, PLANT SCI, V127, P25, DOI 10.1016/S0168-9452(97)00112-X; Yun JG, 1996, J PLANT RES, V109, P339, DOI 10.1007/BF02344482	74	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57259	10.1371/journal.pone.0057259	http://dx.doi.org/10.1371/journal.pone.0057259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451194	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500081
J	Ramadoss, NS; Zhou, X; Keiler, KC				Ramadoss, Nitya S.; Zhou, Xin; Keiler, Kenneth C.			tmRNA Is Essential in Shigella flexneri	PLOS ONE			English	Article							NONSTOP MESSENGER-RNAS; PEPTIDYL-TRANSFER-RNA; ESCHERICHIA-COLI; RIBOSOME-RESCUE; STALLED RIBOSOMES; TRANS-TRANSLATION; QUALITY-CONTROL; TAGGING SYSTEM; PROTEIN; SSRA	Nonstop mRNAs pose a challenge for bacteria, because translation cannot terminate efficiently without a stop codon. The trans-translation pathway resolves nonstop translation complexes by removing the nonstop mRNA, the incomplete protein, and the stalled ribosome. P1 co-transduction experiments demonstrated that tmRNA, a key component of the trans-translation pathway, is essential for viability in Shigella flexneri. tmRNA was previously shown to be dispensable in the closely related species Escherichia coli, because E. coli contains a backup system for trans-translation mediated by the alternative release factor ArfA. Genome sequence analysis showed that S. flexneri does not have a gene encoding ArfA. E. coli ArfA could suppress the requirement for tmRNA in S. flexneri, indicating that tmRNA is essential in S. flexneri because there is no functional backup system. These data suggest that resolution of nonstop translation complexes is required for most bacteria.	[Ramadoss, Nitya S.; Zhou, Xin; Keiler, Kenneth C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Keiler, KC (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	kkeiler@psu.edu		Keiler, Kenneth/0000-0001-8753-335X	NIH grant [GM68720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068720] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM68720. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ausubel FM, 1994, CURRENT PROTOCOLS MO; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Novoa PG, 2004, NUCLEIC ACIDS RES, V32, pD104, DOI 10.1093/nar/gkh102; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Dulebohn DP, 2006, J BIOL CHEM, V281, P28536, DOI 10.1074/jbc.M605137200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Huang CH, 2000, EMBO J, V19, P1098, DOI 10.1093/emboj/19.5.1098; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Ito K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028413; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, J BIOL CHEM, V271, P2589, DOI 10.1074/jbc.271.5.2589; Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2007, CURR OPIN MICROBIOL, V10, P169, DOI 10.1016/j.mib.2007.03.014; Keiler KC, 2011, BIOCHIMIE, V93, P1993, DOI 10.1016/j.biochi.2011.05.029; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; OH BK, 1991, MOL GEN GENET, V229, P52, DOI 10.1007/BF00264212; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Sambrook J, 1989, MOL CLONING LAB MANU, V1-3; Schaub RE, 2012, J BIOL CHEM, V287, P29765, DOI 10.1074/jbc.M112.374074; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; WU TT, 1966, GENETICS, V54, P405; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803	39	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57537	10.1371/journal.pone.0057537	http://dx.doi.org/10.1371/journal.pone.0057537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451240	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500112
J	Corsinotti, A; Kapopoulou, A; Gubelmann, C; Imbeault, M; de Sio, FRS; Rowe, HM; Mouscaz, Y; Deplancke, B; Trono, D				Corsinotti, Andrea; Kapopoulou, Adamandia; Gubelmann, Carine; Imbeault, Michael; de Sio, Francesca R. Santoni; Rowe, Helen M.; Mouscaz, Yoann; Deplancke, Bart; Trono, Didier			Global and Stage Specific Patterns of Kruppel-Associated-Box Zinc Finger Protein Gene Expression in Murine Early Embryonic Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR TIF1-BETA; GROUND-STATE PLURIPOTENCY; STEM-CELLS; REPRESSION DOMAIN; LEUKEMIA-VIRUS; X-CHROMOSOME; SELF-RENEWAL; HUMAN GENOME; SSX GENES; DIFFERENTIATION	Highly coordinated transcription networks orchestrate the self-renewal of pluripotent stem cell and the earliest steps of mammalian development. KRAB-containing zinc finger proteins represent the largest group of transcription factors encoded by the genomes of higher vertebrates including mice and humans. Together with their putatively universal cofactor KAP1, they have been implicated in events as diverse as the silencing of endogenous retroelements, the maintenance of imprinting and the pluripotent self-renewal of embryonic stem cells, although the genomic targets and specific functions of individual members of this gene family remain largely undefined. Here, we first generated a list of Ensembl-annotated KRAB-containing genes encoding the mouse and human genomes. We then defined the transcription levels of these genes in murine early embryonic cells. We found that the majority of KRAB-ZFP genes are expressed in mouse pluripotent stem cells and other early progenitors. However, we also identified distinctively cell- or stage-specific patterns of expression, some of which are pluripotency-restricted. Finally, we determined that individual KRAB-ZFP genes exhibit highly distinctive modes of expression, even when grouped in genomic clusters, and that these cannot be correlated with the presence of prototypic repressive or activating chromatin marks. These results pave the way to delineating the role of specific KRAB-ZFPs in early embryogenesis.	[Corsinotti, Andrea; Kapopoulou, Adamandia; Gubelmann, Carine; Imbeault, Michael; de Sio, Francesca R. Santoni; Rowe, Helen M.; Mouscaz, Yoann; Deplancke, Bart; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Corsinotti, Andrea; Kapopoulou, Adamandia; Gubelmann, Carine; Imbeault, Michael; de Sio, Francesca R. Santoni; Rowe, Helen M.; Mouscaz, Yoann; Deplancke, Bart; Trono, Didier] Ecole Polytech Fed Lausanne, Frontiers Genet Program, Lausanne, Switzerland; [Kapopoulou, Adamandia; Mouscaz, Yoann] Swiss Inst Bioinformat, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland.	didier.trono@epfl.ch	de Sio, Francesca Santoni/AAF-3432-2020; Rowe, Helen/AAQ-7138-2021	Rowe, Helen/0000-0001-5881-0290; Imbeault, Michael/0000-0002-0073-0922; MOUSCAZ, Yoann/0000-0001-7352-3740; Deplancke, Bart/0000-0001-9935-843X; Santoni de Sio, Francesca Romana/0000-0002-6522-0499	European Research Council [268721]; Swiss National Science Foundation Programme National de Recherche 63 subside [406340_128157]	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation Programme National de Recherche 63 subside	Grants: European Research Council contract number 268721, Swiss National Science Foundation Programme National de Recherche 63 subside 406340_128157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Birtle Z, 2006, BIOINFORMATICS, V22, P2841, DOI 10.1093/bioinformatics/btl498; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cammas F, 2002, J CELL SCI, V115, P3439; Cammas F, 2000, GENE, V253, P231, DOI 10.1016/S0378-1119(00)00263-8; Cammas F, 2007, DIFFERENTIATION, V75, P627, DOI 10.1111/j.1432-0436.2007.00166.x; Chen YT, 2003, GENOMICS, V82, P628, DOI 10.1016/S0888-7543(03)00183-6; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; de Sio FRS, 2012, BLOOD, V119, P4675, DOI 10.1182/blood-2011-12-401117; deLeeuw B, 1996, CYTOGENET CELL GENET, V73, P179, DOI 10.1159/000134334; Ding G, 2009, NUCLEIC ACIDS RES, V37, pD267, DOI 10.1093/nar/gkn782; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Gubelmann C, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar040; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iyengar S, 2011, MOL CELL BIOL, V31, P1833, DOI 10.1128/MCB.01331-10; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Lim FL, 1998, ONCOGENE, V17, P2013, DOI 10.1038/sj.onc.1202122; Lin ZY, 2011, STEM CELLS, V29, P1963, DOI 10.1002/stem.752; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nowick K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021553; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Peng HZ, 2009, J BIOL CHEM, V284, P35670, DOI 10.1074/jbc.M109.032086; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Rowe HM, 2012, GENOME RES; Santoni de Sio FR, 2012, FASEB J; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shannon M, 2003, GENOME RES, V13, P1097, DOI 10.1101/gr.963903; Shannon M, 1996, GENOMICS, V33, P112, DOI 10.1006/geno.1996.0166; Shannon M, 1998, DNA SEQUENCE, V8, P303, DOI 10.3109/10425179809034075; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Tadepally HD, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-176; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; Thomas JH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-51; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	73	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56721	10.1371/journal.pone.0056721	http://dx.doi.org/10.1371/journal.pone.0056721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451074	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800030
J	Strigens, A; Schipprack, W; Reif, JC; Melchinger, AE				Strigens, Alexander; Schipprack, Wolfgang; Reif, Jochen C.; Melchinger, Albrecht E.			Unlocking the Genetic Diversity of Maize Landraces with Doubled Haploids Opens New Avenues for Breeding	PLOS ONE			English	Article							CORE COLLECTION; EARLY GROWTH; FLINT; LINES; POPULATIONS; HYBRIDS; PERFORMANCE; HISTORY; YIELD; INDIVIDUALS	Landraces are valuable genetic resources for broadening the genetic base of elite germplasm in maize. Extensive exploitation of landraces has been hampered by their genetic heterogeneity and heavy genetic load. These limitations may be overcome by the in-vivo doubled haploid (DH) technique. A set of 132 DH lines derived from three European landraces and 106 elite flint (EF) lines were genotyped for 56,110 single nucleotide polymorphism (SNP) markers and evaluated in field trials at five locations in Germany in 2010 for several agronomic traits. In addition, the landraces were compared with synthetic populations produced by intermating DH lines derived from the respective landrace. Our objectives were to (1) evaluate the phenotypic and molecular diversity captured within DH lines derived from European landraces, (2) assess the breeding potential (usefulness) of DH lines derived from landraces to broaden the genetic base of the EF germplasm, and (3) compare the performance of each landrace with the synthetic population produced from the respective DH lines. Large genotypic variances among DH lines derived from landraces allowed the identification of DH lines with grain yields comparable to those of EF lines. Selected DH lines may thus be introgressed into elite germplasm without impairing its yield level. Large genetic distances of the DH lines to the EF lines demonstrated the potential of DH lines derived from landraces to broaden the genetic base of the EF germplasm. The comparison of landraces with their respective synthetic population showed no yield improvement and no reduction of phenotypic diversity. Owing to the low population structure and rapid decrease of linkage disequilibrium within populations of DH lines derived from landraces, these would be an ideal tool for association mapping. Altogether, the DH technology opens new opportunities for characterizing and utilizing the genetic diversity present in gene bank accessions of maize.	[Strigens, Alexander; Schipprack, Wolfgang; Melchinger, Albrecht E.] Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, Stuttgart, Germany; [Reif, Jochen C.] Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany	University Hohenheim; University Hohenheim	Melchinger, AE (corresponding author), Univ Hohenheim, Inst Plant Breeding Seed Sci & Populat Genet, Stuttgart, Germany.	melchinger@uni-hohenheim.de		Strigens, Alexander/0000-0001-8809-1899; Melchinger, Albrecht E./0000-0002-8346-7786; Reif, Jochen/0000-0002-6742-265X	German Research Foundation (DFG) [RE2254/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was and financed by the German Research Foundation (DFG, RE2254/3-1, http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barriere Y, 2006, MAYDICA, V51, P435; Betran FJ, 2003, FIELD CROP RES, V83, P51, DOI 10.1016/S0378-4290(03)00061-3; Butler D., 2007, ANAL MIXED MODELS S; CHARLESWORTH D, 1992, EVOLUTION, V46, P703, DOI [10.2307/2409639, 10.1111/j.1558-5646.1992.tb02077.x]; CIMMYT International Maize and Wheat Improvement Center, 2005, LAB PROT CIMMYT APPL, VThird; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; CROSSA J, 1987, CROP SCI, V27, P187, DOI 10.2135/cropsci1987.0011183X002700020008x; Duvick DN, 2005, MAYDICA, V50, P193; Eder J, 2002, THEOR APPL GENET, V104, P703, DOI 10.1007/s00122-001-0773-4; EDMEADES GO, 1993, CROP SCI, V33, P1029, DOI 10.2135/cropsci1993.0011183X003300050031x; Eschholz TW, 2010, GENET RESOUR CROP EV, V57, P71, DOI 10.1007/s10722-009-9452-0; Eschholz TW, 2008, GENET RESOUR CROP EV, V55, P971, DOI 10.1007/s10722-007-9304-8; Falconer D. S, 1996, INTRO QUANTITATIVE G; Ferro RA, 2007, GENET RESOUR CROP EV, V54, P295, DOI 10.1007/s10722-005-4500-x; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Frascaroli E, 2012, THEORETICAL IN PRESS; GALLAIS A, 1990, GENETICS, V124, P199; Gallais A, 1990, THEORIE SELECTION AM; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gouesnard B, 2005, MAYDICA, V50, P225; Gouesnard B, 1997, AGRONOMIE, V17, P491, DOI 10.1051/agro:19970906; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; LASHERMES P, 1988, THEOR APPL GENET, V76, P570, DOI 10.1007/BF00260910; Lauer S, 2012, CROP SCI, V52, P1033, DOI [10.2135/cropsci2011.05.0274, 10.2135/cropsci2011.12.0668]; Lucchin M, 2003, GENET RESOUR CROP EV, V50, P315, DOI 10.1023/A:1023578207258; Malvar RA, 2007, CROP PROT, V26, P775, DOI 10.1016/j.cropro.2006.07.004; Malvar RA, 2004, J ECON ENTOMOL, V97, P628, DOI 10.1603/0022-0493-97.2.628; Martin M, 2012, CROP SCI, V52, P32, DOI 10.2135/cropsci2011.04.0214; MELCHINGER AE, 1985, MAYDICA, V30, P395; Melchinger AE, 2003, THEOR APPL GENET, V106, P332, DOI 10.1007/s00122-002-1000-7; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Messmer MM, 1992, THEOR APPL GENET, V83, P1003, DOI 10.1007/BF00232964; Montes JM, 2011, FIELD CROP RES, V121, P268, DOI 10.1016/j.fcr.2010.12.017; MURIGNEUX A, 1993, THEOR APPL GENET, V87, P278, DOI 10.1007/BF00223777; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; PATTERSON HD, 1976, BIOMETRIKA, V63, P83, DOI 10.1093/biomet/63.1.83; Peter R, 2009, FIELD CROP RES, V110, P157, DOI 10.1016/j.fcr.2008.07.015; Peter R, 2009, CROP SCI, V49, P169, DOI 10.2135/cropsci2007.10.0538; Prigge V, 2012, EUPHYTICA, V185, P453, DOI 10.1007/s10681-012-0626-z; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebourg C, 2003, THEOR APPL GENET, V106, P895, DOI 10.1007/s00122-002-1140-9; Reif JC, 2005, THEOR APPL GENET, V111, P838, DOI 10.1007/s00122-005-0004-5; Revilla P, 2006, EUPHYTICA, V152, P275, DOI 10.1007/s10681-006-9214-4; Rodriguez VM, 2010, GENET RESOUR CROP EV, V57, P329, DOI 10.1007/s10722-009-9529-9; Rober FK, 2005, MAYDICA, V50, P275; Schneider DN, 2011, MAYDICA, V56, P33; Schnell F, 1983, PROBLEME ELTERNWAHL; Schnell FW, 1959, DREISSIG JAHRE ZUCHT, P140; Strigens A, 2012, PLANT CELL IN PRESS; Strigens A, 2012, CROP SCI, V52, P1084, DOI 10.2135/cropsci2011.08.0426; Tenaillon MI, 2011, CR BIOL, V334, P221, DOI 10.1016/j.crvi.2010.12.015; Troyer AF, 2009, CROP SCI, V49, P1969, DOI 10.2135/cropsci2009.04.0170; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Wilde K, 2010, PLANT BREEDING, V129, P181, DOI 10.1111/j.1439-0523.2009.01677.x; Wright S., 1978, EVOLUTION GENETICS P, V4; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	59	46	48	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57234	10.1371/journal.pone.0057234	http://dx.doi.org/10.1371/journal.pone.0057234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451190	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800093
J	Suzuki, I; Tsuboi, Y; Shinoda, M; Shibuta, K; Honda, K; Katagiri, A; Kiyomoto, M; Sessle, BJ; Matsuura, S; Ohara, K; Urata, K; Iwata, K				Suzuki, Ikuko; Tsuboi, Yoshiyuki; Shinoda, Masamichi; Shibuta, Kazuo; Honda, Kuniya; Katagiri, Ayano; Kiyomoto, Masaaki; Sessle, Barry J.; Matsuura, Shingo; Ohara, Kinuyo; Urata, Kentaro; Iwata, Koichi			Involvement of ERK Phosphorylation of Trigeminal Spinal Subnucleus Caudalis Neurons in Thermal Hypersensitivity in Rats with Infraorbital Nerve Injury	PLOS ONE			English	Article							INFERIOR ALVEOLAR NERVE; EXPERIMENTAL PERIPHERAL NEUROPATHY; PRIMARY AFFERENT NEURONS; SIGNAL-REGULATED KINASE; LONG-TERM POTENTIATION; DORSAL-HORN NEURONS; FIBER-EVOKED POTENTIALS; ROOT GANGLION NEURONS; SCIATIC-NERVE; MAP KINASE	To evaluate the involvement of the mitogen-activated protein kinase (MAPK) cascade in orofacial neuropathic pain mechanisms, this study assessed nocifensive behavior evoked by mechanical or thermal stimulation of the whisker pad skin, phosphorylation of extracellular signal-regulated kinase (ERK) in trigeminal spinal subnucleus caudalis (Vc) neurons, and Vc neuronal responses to mechanical or thermal stimulation of the whisker pad skin in rats with the chronic constriction nerve injury of the infraorbital nerve (ION-CCI). The mechanical and thermal nocifensive behavior was significantly enhanced on the side ipsilateral to the ION-CCI compared to the contralateral whisker pad or sham rats. ION-CCI rats had an increased number of phosphorylated ERK immunoreactive (pERK-IR) cells which also manifested NeuN-IR but not GFAP-IR and Iba1-IR, and were significantly more in ION-CCI rats compared with sham rats following noxious but not non-noxious mechanical stimulation. After intrathecal administration of the MEK1 inhibitor PD98059 in ION-CCI rats, the number of pERK-IR cells after noxious stimulation and the enhanced thermal nocifensive behavior but not the mechanical nocifensive behavior were significantly reduced in ION-CCI rats. The enhanced background activities, afterdischarges and responses of wide dynamic range neurons to noxious mechanical and thermal stimulation in ION-CCI rats were significantly depressed following i.t. administration of PD98059, whereas responses to non-noxious mechanical and thermal stimulation were not altered. The present findings suggest that pERK-IR neurons in the Vc play a pivotal role in the development of thermal hypersensitivity in the face following trigeminal nerve injury.	[Suzuki, Ikuko; Tsuboi, Yoshiyuki; Shinoda, Masamichi; Shibuta, Kazuo; Honda, Kuniya; Katagiri, Ayano; Kiyomoto, Masaaki; Iwata, Koichi] Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 101, Japan; [Honda, Kuniya] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Chiyoda Ku, Tokyo 101, Japan; [Sessle, Barry J.] Univ Toronto, Fac Dent, Dept Oral Physiol, Toronto, ON, Canada; [Matsuura, Shingo; Ohara, Kinuyo] Nihon Univ, Sch Dent, Dept Endodont, Chiyoda Ku, Tokyo 101, Japan; [Urata, Kentaro] Nihon Univ, Sch Dent, Dept Prosthodont, Chiyoda Ku, Tokyo 101, Japan; [Iwata, Koichi] Nihon Univ, Sch Dent, Div Funct Morphol, Dent Res Ctr, Tokyo 101, Japan; [Iwata, Koichi] Nihon Univ, Grad Sch Med Sci, Div Appl Syst Neurosci, Adv Med Res Ctr, Tokyo, Japan	Nihon University; Nihon University; University of Toronto; Nihon University; Nihon University; Nihon University; Nihon University	Iwata, K (corresponding author), Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 101, Japan.	iwata-k@dent.nihon-u.ac.jp	Sessle, Barry/AAD-7771-2022		Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology [22792021]; Japan-Canada (CIHR) Joint Health Research Program; National Institutes of Health grant [DE015420]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015420] Funding Source: NIH RePORTER	Nihon University School of Dentistry; Dental Research Center, Nihon University School of Dentistry; Nihon University; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Canada (CIHR) Joint Health Research Program(Canadian Institutes of Health Research (CIHR)); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported in part by Research grants from Sato and Uemura Funds from Nihon University School of Dentistry, and Grant from Dental Research Center, Nihon University School of Dentistry; Nihon University multidisciplinary research grant and Individual Research Grant; a Grant from the Ministry of Education, Culture, Sports, Science and Technology to promote multi-disciplinary research Projects (KAKENHI (Grant-in-Aid for Young Scientist (B)) # 22792021 to MS); grants from the Ministry of Education, Culture, Sports, Science, Technology to promote multidisciplinary research projects "Brain Mechanisms for Cognition, Memory and Behavior" and "Translational Research Network on Orofacial Neurological Disorders" at Nihon University, and Japan-Canada (CIHR) Joint Health Research Program, and National Institutes of Health grant DE015420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aita M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-8; Allchorne AJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-36; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CARLTON SM, 1991, NEUROSCI LETT, V131, P88, DOI 10.1016/0304-3940(91)90343-R; Dai Y, 2002, J NEUROSCI, V22, P7737; Fields RD, 1997, J NEUROSCI, V17, P7252; Fields RD, 1998, J NEUROBIOL, V37, P158, DOI 10.1002/(SICI)1097-4695(199810)37:1<158::AID-NEU12>3.0.CO;2-A; Forssell H, 2007, NEUROLOGY, V69, P1451, DOI 10.1212/01.wnl.0000277274.83301.c0; Fukui T, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-18; GAUTRON M, 1990, NEUROSCI LETT, V111, P28, DOI 10.1016/0304-3940(90)90339-B; GUILBAUD G, 1990, J NEUROPHYSIOL, V64, P1537, DOI 10.1152/jn.1990.64.5.1537; Honda K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-59; Imamura Y, 1997, EXP BRAIN RES, V116, P97, DOI 10.1007/PL00005748; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Iwata K, 2001, J NEUROPHYSIOL, V86, P2868, DOI 10.1152/jn.2001.86.6.2868; Jaaskelainen SK, 2004, J OROFAC PAIN, V18, P355; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; KAJANDER KC, 1992, J NEUROPHYSIOL, V68, P734, DOI 10.1152/jn.1992.68.3.734; Kitagawa J, 2006, EUR J NEUROSCI, V24, P1976, DOI 10.1111/j.1460-9568.2006.05065.x; Kobayashi A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-12; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; LAIRD JMA, 1993, J NEUROPHYSIOL, V69, P2072, DOI 10.1152/jn.1993.69.6.2072; LISNEY SJW, 1987, BRAIN RES, V415, P122, DOI 10.1016/0006-8993(87)90275-7; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; MOLANDER C, 1992, NEUROSCIENCE, V50, P223, DOI 10.1016/0306-4522(92)90394-H; Nakagawa K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-9; Nakajima A, 2011, J DENT RES, V90, P777, DOI 10.1177/0022034511401406; NOGUCHI K, 1994, J NEUROSCI RES, V37, P596, DOI 10.1002/jnr.490370506; NOGUCHI K, 1995, J NEUROSCI, V15, P7633; Noma N, 2008, J COMP NEUROL, V507, P1428, DOI 10.1002/cne.21620; Nomura H, 2002, PAIN, V95, P225, DOI 10.1016/S0304-3959(01)00403-1; PALECEK J, 1992, J NEUROPHYSIOL, V68, P1951, DOI 10.1152/jn.1992.68.6.1951; PALECEK J, 1992, J NEUROPHYSIOL, V67, P1562, DOI 10.1152/jn.1992.67.6.1562; Peng GD, 2009, J BIOL CHEM, V284, P30138, DOI 10.1074/jbc.M109.036756; Robinson PP, 2004, J OROFAC PAIN, V18, P287; Saito K, 2008, J NEUROPHYSIOL, V99, P2251, DOI 10.1152/jn.00794.2007; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Shibuta K, 2012, BRAIN RES, V1451, P74, DOI 10.1016/j.brainres.2012.02.023; Shimizu K, 2006, BRAIN RES, V1072, P99, DOI 10.1016/j.brainres.2005.12.040; SHIR Y, 1990, NEUROSCI LETT, V115, P62, DOI 10.1016/0304-3940(90)90518-E; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; Suzuki I, 2008, NEUROSCI LETT, V442, P39, DOI 10.1016/j.neulet.2008.07.003; Svendsen F, 1998, NEUROREPORT, V9, P1185, DOI 10.1097/00001756-199804200-00041; Takeda M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-5; Tal M, 1996, PAIN, V64, P511, DOI 10.1016/0304-3959(95)00175-1; Truelove E, 2004, J OROFAC PAIN, V18, P374; Tsuboi Y, 2004, PAIN, V111, P323, DOI 10.1016/j.pain.2004.07.014; Vickers ER, 1998, ORAL SURG ORAL MED O, V85, P24, DOI 10.1016/S1079-2104(98)90393-6; Vikman KS, 2005, NEUROSCIENCE, V135, P969, DOI 10.1016/j.neuroscience.2005.06.059; VOS BP, 1994, J NEUROSCI, V14, P2708; Woolf CJ, 2001, ANESTHESIOLOGY, V95, P241, DOI 10.1097/00000542-200107000-00034; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Xu M, 2008, J PAIN, V9, P1036, DOI 10.1016/j.jpain.2008.06.006; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022	60	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57278	10.1371/journal.pone.0057278	http://dx.doi.org/10.1371/journal.pone.0057278			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451198	gold, Green Published, Green Submitted			2022-12-25	WOS:000316658800097
J	Takata, Y; Shu, XO; Gao, YT; Li, HL; Zhang, XL; Gao, J; Cai, H; Yang, G; Xiang, YB; Zheng, W				Takata, Yumie; Shu, Xiao-Ou; Gao, Yu-Tang; Li, Honglan; Zhang, Xianglan; Gao, Jing; Cai, Hui; Yang, Gong; Xiang, Yong-Bing; Zheng, Wei			Red Meat and Poultry Intakes and Risk of Total and Cause-Specific Mortality: Results from Cohort Studies of Chinese Adults in Shanghai	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LUNG-CANCER; CONSUMPTION; STROKE; MEN; REPRODUCIBILITY; TESTOSTERONE; ASSOCIATIONS; VALIDITY	Most previous studies of meat intake and total or cause-specific mortality were conducted in North America, whereas studies in other areas have been limited and reported inconsistent results. This study investigated the association of red meat or poultry intake with risk of total and cause-specific mortality, including cancer and cardiovascular disease (CVD), in two large population-based prospective cohort studies of 134,290 Chinese adult women and men in Shanghai. Meat intakes were assessed through validated food frequency questionnaires administered in person at baseline. Vital status and dates and causes of deaths were ascertained through annual linkage to the Shanghai Vital Statistics Registry and Shanghai Cancer Registry databases and home visits every 2-3 years. Cox regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of death associated with quintiles of meat intake. During 803,265 person-years of follow up for women and 334,281 person-years of follow up for men, a total of 4,210 deaths in women and 2,733 deaths in men accrued. The median intakes of red meat were 43 g/day among women and 54 g/day among men, and pork constituted at least 95% of total meat intake for both women and men. Red meat intake was associated with increased total mortality among men, but not among women; the HR (95% CI) comparing the highest with the lowest quintiles were 1.18 (1.02-1.35) and 0.92 (0.82-1.03), respectively. This sex difference was statistically significant (P = 0.01). Red meat intake was associated with increased risk of ischemic heart disease mortality (HR = 1.41, 95% CI = 1.05-1.89) and with decreased risk of hemorrhagic stroke mortality (HR = 0.62, 95% CI = 0.45-0.87). There were suggestive inverse associations of poultry intake with risk of total and all-CVD mortality among men, but not among women. Further investigations are needed to elucidate the sex-specific associations between red meat intake and mortality.	[Takata, Yumie; Shu, Xiao-Ou; Zhang, Xianglan; Cai, Hui; Yang, Gong; Zheng, Wei] Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Gao, Yu-Tang; Li, Honglan; Gao, Jing; Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Vanderbilt University; Shanghai Jiao Tong University	Shu, XO (corresponding author), Vanderbilt Univ, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA.	xiao-ou.shu@vanderbilt.edu	Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; zhang, weihua/GXV-1334-2022; Zheng, Wei/O-3351-2013; Gao, Yu/HGE-1937-2022	Zheng, Wei/0000-0003-1226-070X; 	National Cancer Institute [R37CA070867, R01 CA082729]; National Heart, Lung, and Blood Institute [R0 1HL095931]; NATIONAL CANCER INSTITUTE [R01CA082729, R37CA070867] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095931] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Cancer Institute grants (R37CA070867, PI: WZ; R01 CA082729, PI: XOS) and the National Heart, Lung, and Blood Institute (R0 1HL095931, PI: XZ). The funders had no role in study design, data	Bernstein AM, 2010, CIRCULATION, V122, P876, DOI 10.1161/CIRCULATIONAHA.109.915165; Cai H, 2007, BRIT J NUTR, V98, P1006, DOI 10.1017/S0007114507750900; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Choi JS, 2007, ATHEROSCLEROSIS, V192, P445, DOI 10.1016/j.atherosclerosis.2007.03.006; Silva EOD, 2009, ARCH INTERN MED, V169, P1538, DOI 10.1001/archinternmed.2009.278; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Du SF, 2000, J NUTR, V130, P193, DOI 10.1093/jn/130.2.193; Fang Jing, 2006, J Immigr Minor Health, V8, P387, DOI 10.1007/s10903-006-9009-7; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; He K, 2003, BRIT MED J, V327, P777, DOI 10.1136/bmj.327.7418.777; Hyde Z, 2012, CANCER EPIDEM BIOMAR, V21, P1319, DOI 10.1158/1055-9965.EPI-12-0129; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Iso H, 2001, CIRCULATION, V103, P856, DOI 10.1161/01.CIR.103.6.856; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Mirvish SS, 2002, J NUTR, V132, p3526S, DOI 10.1093/jn/132.11.3526S; Nagao M, 2012, EUR J CLIN NUTR, V66, P687, DOI 10.1038/ejcn.2012.6; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; REED DM, 1990, AM J EPIDEMIOL, V131, P579, DOI 10.1093/oxfordjournals.aje.a115542; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Skog KI, 1998, FOOD CHEM TOXICOL, V36, P879, DOI 10.1016/S0278-6915(98)00061-1; Sugimura T, 1990, Princess Takamatsu Symp, V21, P279; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Villegas R, 2007, BRIT J NUTR, V97, P993, DOI 10.1017/S0007114507669189; Warlow CP, 1998, LANCET S3, V352, pSIII1, DOI DOI 10.1016/S0140-6736(98)90086-1; World Health Organization, 1977, INT CLASS DIS 9 VERS; Yang WS, 2012, ANN ONCOL, V23, P3163, DOI 10.1093/annonc/mds207; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	35	62	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56963	10.1371/journal.pone.0056963	http://dx.doi.org/10.1371/journal.pone.0056963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451121	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800054
J	Wei, WJ; Wang, YL; Li, DS; Wang, Y; Wang, XF; Zhu, YX; Yang, YJ; Wang, ZY; Ma, YY; Wu, Y; Jin, L; Ji, QH; Wang, JC				Wei, Wen-Jun; Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Wang, Xiao-Feng; Zhu, Yong-Xue; Yang, Ya-jun; Wang, Zhuo-Ying; Ma, Yan-yun; Wu, Yi; Jin, Li; Ji, Qing-Hai; Wang, Jiu-Cun			Association between the rs2910164 Polymorphism in Pre-Mir-146a Sequence and Thyroid Carcinogenesis	PLOS ONE			English	Article							HASHIMOTOS-THYROIDITIS; COMMON VARIANTS; RISK-FACTORS; CANCER-RISK; CARCINOMA; NODULES; MICRORNAS; TSH; CONFIRMATION; LINKAGE	Background: Rs2910164, a Single nucleotide polymorphism (SNP) located in the precursor microRNA sequence of miR-146a, is the only MicroRNA sequence SNP studied in papillary thyroid cancer (PTC). Association studies had been performed in US and UK-Northern European populations, but results were inconsistence. This study evaluated the association between rs2910164 and the risk of PTC as well as benign thyroid tumor (BN), and examined the clinicopathological characteristics of PTC and BN for different genotypes. Methods: This case-control study genotyped rs2910164 in 753 PTCs, 484 BNs and 760 controls in a Chinese Han population. Clinicopathological and genetic data were collected and compared. Multivariate logistic regression was performed to calculate adjusted odds ratios (ORs). Results: There were no differences in rs2910164 genotype distributions between the three groups. PTC cases with three genotypes (CC, CG, GG) had similar clinicopathological characteristics except the existence of "para-cancer" BN (PTC/BN, P = 0.006). PTC/BN patients were older (P = 0.009), and had smaller cancer lesions (P<0.001), lower serum thyrotropin levels (1.82 +/- 1.42 vs. 2.21 +/- 1.74, P = 0.04), and lower rates of level VI lymph node metastasis (20.8% vs. 52.7%, P < 0.001) and lateral neck lymph node metastasis (11.5% vs. 23.0%, P = 0.011) compared with PTC only. Then we supposed a possible progression from BN to PTC which may involve rs2910164 in and performed a multivariate logistic regression analysis of PTC/BN and BN cases to determine risk factors of this progression. Results showed that the rs2910164 GG homozygote (OR = 2.25, 95% CI 1.22-4.14, P = 0.01) was the only risk factor in this study. Conclusion: Rs2910164 was not associated with increased risk of PTC and BN in Chinese patients, but may play a latent role in the transformation from BN to PTC.	[Wei, Wen-Jun; Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Wang, Zhuo-Ying; Wu, Yi; Ji, Qing-Hai] Fudan Univ, Dept Head & Neck Surg, Canc Hosp, Shanghai 200433, Peoples R China; [Wei, Wen-Jun; Wang, Yu-Long; Li, Duan-Shu; Wang, Yu; Zhu, Yong-Xue; Wang, Zhuo-Ying; Wu, Yi; Ji, Qing-Hai] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Xiao-Feng; Yang, Ya-jun; Ma, Yan-yun; Jin, Li; Wang, Jiu-Cun] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Ji, QH (corresponding author), Fudan Univ, Dept Head & Neck Surg, Canc Hosp, Shanghai 200433, Peoples R China.	jiqinghai@shca.org.cn; jcwang@fudan.edu.cn	Wang, Jiucun/J-8744-2012; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019; Wang, Yu-Long/AEF-9362-2022; MA, YAN/HHN-2912-2022	Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; Wang, Yu-Long/0000-0002-3830-7257; Wei, Wen-Jun/0000-0003-1963-2609	National Science Foundation of China [81001204, 30872958, 30971594]; Ministry of Health [201002007]; Ministry of Science and Technology [2011BAI09B00]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Science Foundation of China (81001204 to Y.-L. Wang, 30872958 to Q.-H. Ji and 30971594 to J.-C. Wang), the grants from the Ministry of Health (201002007 to L. Jin) and the Ministry of Science and Technology (2011BAI09B00 to L. Jin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil C, 2010, THYROID, V20, P601, DOI 10.1089/thy.2009.0450; Arora N, 2008, WORLD J SURG, V32, P1237, DOI 10.1007/s00268-008-9484-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bevan S, 2001, J CLIN ENDOCR METAB, V86, P3701, DOI 10.1210/jc.86.8.3701; Boelaert K, 2006, J CLIN ENDOCR METAB, V91, P4295, DOI 10.1210/jc.2006-0527; Botrugno I, 2011, AM SURGEON, V77, P1553; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; de la Chapelle A, 2011, J CLIN ENDOCR METAB, V96, P3326, DOI 10.1210/jc.2011-1004; Fiore E, 2011, ENDOCR-RELAT CANCER, V18, P429, DOI [10.1530/ERC-11-0028, 10.1530/ERC-11-002]; Fiore E, 2012, J CLIN ENDOCR METAB, V97, P1134, DOI 10.1210/jc.2011-2735; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Haymart MR, 2008, J CLIN ENDOCR METAB, V93, P809, DOI 10.1210/jc.2007-2215; He HL, 2009, CANCER RES, V69, P625, DOI 10.1158/0008-5472.CAN-08-1071; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kim ES, 2010, THYROID, V20, P885, DOI 10.1089/thy.2009.0384; Kim KW, 2011, HEAD NECK-J SCI SPEC, V33, P691, DOI 10.1002/hed.21518; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Leone V, 2011, J CLIN ENDOCR METAB, V96, pE1388, DOI 10.1210/jc.2011-0345; Lesueur F, 1999, J CLIN ENDOCR METAB, V84, P2157, DOI 10.1210/jc.84.6.2157; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Trocchi P, 2012, LANGENBECK ARCH SURG, V397, P421, DOI 10.1007/s00423-011-0897-1; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wang YL, 2008, EJSO-EUR J SURG ONC, V34, P77, DOI 10.1016/j.ejso.2007.08.012; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Zhang L, 2012, J CLIN ENDOCR METAB, V97, P1250, DOI 10.1210/jc.2011-1546	30	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56638	10.1371/journal.pone.0056638	http://dx.doi.org/10.1371/journal.pone.0056638			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451063	Green Published, Green Submitted, gold			2022-12-25	WOS:000316658800023
J	Cheng, KD; Drebot, M; McCrea, J; Peterson, L; Lee, D; McCorrister, S; Nickel, R; Gerbasi, A; Sloan, A; Janella, D; Van Domselaar, G; Beniac, D; Booth, T; Chui, LD; Tabor, H; Westmacott, G; Gilmour, M; Wang, GH				Cheng, Keding; Drebot, Mike; McCrea, Joanne; Peterson, Lorea; Lee, David; McCorrister, Stuart; Nickel, Richard; Gerbasi, Alyssia; Sloan, Angela; Janella, Debra; Van Domselaar, Gary; Beniac, Daniel; Booth, Tim; Chui, Linda; Tabor, Helen; Westmacott, Garrett; Gilmour, Matthew; Wang, Gehua			MS-H: A Novel Proteomic Approach to Isolate and Type the E. coli H Antigen Using Membrane Filtration and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)	PLOS ONE			English	Article							ESCHERICHIA-COLI; IDENTIFICATION; RESTRICTION; SPECIFICITY; SENSITIVITY; TIME	Serotyping is the long-standing gold standard method to determine E. coli H antigens; however, this method requires a panel of H-antigen specific antibodies and often culture-based induction of the H-antigen flagellar motility. In this study, a rapid and accurate method to isolate and identify the Escherichia coli (E. coli) H flagellar antigen was developed using membrane filtration and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Flagella were isolated from pure culture, digested with trypsin, and then subjected to LC-MS/MS using one of two systems (Agilent-nano-LC-QSTAR XL or Proxeon-nano-LC-LTQ-Orbitrap XL). The resulting peptide sequence data were searched against a custom E. coli flagella/H antigen database. This approach was evaluated using flagella isolated from reference E. coli strains representing all 53 known H antigen types and 41 clinical E. coli strains. The resulting LC-MS/MS classifications of H antigen types (MS-H) were concordant with the known H serogroup for all 53 reference types, and of 41 clinical isolates tested, 38 (92.7%) were concordant with the known H serogroup. MS-H clearly also identified two clinical isolates (4.9%) that were untypeable by serotyping. Notably, successful detection and classification of flagellar antigens with MS-H did not generally require induction of motility, establishing this proteomic approach as more rapid and cost-effective than traditional methods, while providing equitable specificity for typing E. coli H antigens.	[Cheng, Keding; Drebot, Mike; McCrea, Joanne; Peterson, Lorea; Lee, David; McCorrister, Stuart; Nickel, Richard; Gerbasi, Alyssia; Sloan, Angela; Janella, Debra; Van Domselaar, Gary; Beniac, Daniel; Booth, Tim; Tabor, Helen; Westmacott, Garrett; Gilmour, Matthew; Wang, Gehua] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Cheng, Keding] Univ Manitoba, Fac Med, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Chui, Linda] Alberta Prov Lab Publ Hlth, Calgary, AB, Canada	Public Health Agency of Canada; University of Manitoba	Cheng, KD (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.	Keding.Cheng@phac-aspc.gc.ca; Gehua.Wang@phac-aspc.gc.ca			Public Agency of Canada	Public Agency of Canada	The project was supported by the yearly budget of Public Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aygan A., 2007, INT J AGRIC BIOL, V9, P193; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Beutin L, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-4; DEPAMPHI.ML, 1971, J BACTERIOL, V105, P376, DOI 10.1128/JB.105.1.376-383.1971; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Ewing W.H., 1986, EDWARDS EWINGS IDENT; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Galkin VE, 2008, SCIENCE, V320, P382, DOI 10.1126/science.1155307; Goldman E, 2009, PRACTICAL HDB MICROB, P217; Graham Ciaren, 2011, Bioeng Bugs, V2, P17, DOI 10.4161/bbug.2.1.14413; GROSS RJ, 1985, VIRULENCE ESCHERICHI, V13, P345; Karger A, 2011, APPL ENVIRON MICROB, V77, P896, DOI 10.1128/AEM.01686-10; KAUFFMANN F, 1947, J IMMUNOL, V57, P71; Kim MS, 2010, J AM SOC MASS SPECTR, V21, P1606, DOI 10.1016/j.jasms.2010.04.011; Koskinen MT, 2009, J DAIRY SCI, V92, P952, DOI 10.3168/jds.2008-1549; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; POWER ME, 1994, J BACTERIOL, V176, P3303, DOI 10.1128/jb.176.11.3303-3313.1994; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Ratiner YA, 2010, ARCH MICROBIOL, V192, P267, DOI 10.1007/s00203-010-0556-x; Saah AJ, 1997, ANN INTERN MED, V126, P91, DOI 10.7326/0003-4819-126-1-199701010-00026; Sauer S, 2010, NAT REV MICROBIOL, V8, P74, DOI 10.1038/nrmicro2243; Taylor GK, 2005, RAPID COMMUN MASS SP, V19, P3420, DOI 10.1002/rcm.2225; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; The International Conference on Harmonization (ICH), 2005, HARM TRIP GUID VAL A, V2, P1; Twine SM, 2008, FEBS J, V275, P4428, DOI 10.1111/j.1742-4658.2008.06589.x; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57339	10.1371/journal.pone.0057339	http://dx.doi.org/10.1371/journal.pone.0057339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437374	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000098
J	Persak, H; Pitzschke, A				Persak, Helene; Pitzschke, Andrea			Tight Interconnection and Multi-Level Control of Arabidopsis MYB44 in MAPK Cascade Signalling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; CONSERVED DOCKING SITE; TRANSCRIPTION FACTOR; ABSCISIC-ACID; GENE-EXPRESSION; INNATE IMMUNITY; SEED-GERMINATION; STRESS TOLERANCE; FLORAL ORGANS; THALIANA	Abiotic stress poses a huge, ever-increasing problem to plants and agriculture. The dissection of signalling pathways mediating stress tolerance is a prerequisite to develop more resistant plant species. Mitogen-activated protein kinase (MAPK) cascades are universal signalling modules. In Arabidopsis, the MAPK MPK3 and its upstream regulator MAPK kinase MKK4 initiate the adaptation response to numerous abiotic and biotic stresses. Yet, molecular steps directly linked with MKK4 - MPK3 activation are largely unknown. Starting with a yeast-two-hybrid screen for interacting partners of MKK4, we identified a transcription factor, MYB44. MYB44 is controlled at multiple levels by and strongly inter-connected with MAPK signalling. As we had shown earlier, stress-induced expression of the MYB44 gene is regulated by a MPK3-targeted bZIP transcription factor VIP1. At the protein level, MYB44 interacts with MPK3 in vivo. MYB44 is phosphorylated by MPK3 in vitro at a single residue, Ser145. Although replacement of Ser145 by a non-phosphorylatable (S145A) or phosphomimetic (S145D) residue did not alter MYB44 subcellular localisation, dimerization behaviour nor DNA-binding characteristics, abiotic stress tolerance tests in stable transgenic Arabidopsis plants clearly related S145 phosphorylation to MYB44 function: Compared to Arabidopsis wild type plants, MYB44 overexpressing lines exhibit an enhanced tolerance to osmotic stress and are slightly more sensitive to abscisic acid. Interestingly, overexpression of the S145A variant revealed that impaired phosphorylation does not render the MYB44 protein non-functional. Instead, S145A lines are highly sensitive to abiotic stress, and thereby remarkably similar to mpk3-deficient plants. Its in vivo interaction with the nuclear sub-pools of both MPK3 and MKK4 renders MYB44 the first plant transcription factor to have a second function as putative MAPK cascade scaffolding protein.	[Persak, Helene; Pitzschke, Andrea] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Persak, H (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	Helene.Persak@boku.ac.at; Andrea.Pitzschke@boku.ac.at		Pitzschke, Andrea/0000-0002-3451-1429	Austrian Science Foundation, FWF [P21851]; Austrian Science Fund (FWF) [P 21851] Funding Source: researchfish	Austrian Science Foundation, FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project was funded by the Austrian Science Foundation, FWF (P21851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; [Anonymous], 2002, TRENDS PLANT SCI, V7, P301; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Assmann SM, 2003, TRENDS PLANT SCI, V8, P151, DOI 10.1016/S1360-1385(03)00052-9; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bethke G, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0810206106; Bhat RA, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-12; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Christmann A, 2006, PLANT BIOLOGY, V8, P314, DOI 10.1055/s-2006-924120; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Djamei A, 2007, SCIENCE, V318, P453, DOI 10.1126/science.1148110; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ernst HA, 2004, EMBO REP, V5, P297, DOI 10.1038/sj.embor.7400093; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Galletti R, 2011, PLANT PHYSIOL, V157, P804, DOI 10.1104/pp.111.174003; GROTEWOLD E, 1994, CELL, V76, P543, DOI 10.1016/0092-8674(94)90117-1; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hilder TL, 2007, METHOD ENZYMOL, V428, P297, DOI 10.1016/S0076-6879(07)28017-6; Hong JY, 2011, PHYTOCHEMISTRY, V72, P27, DOI 10.1016/j.phytochem.2010.10.005; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; HOWE KM, 1991, NUCLEIC ACIDS RES, V19, P3913, DOI 10.1093/nar/19.14.3913; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kim SH, 2011, BIOCHEM BIOPH RES CO, V412, P150, DOI 10.1016/j.bbrc.2011.07.064; Kirchler T, 2010, EUR J CELL BIOL, V89, P175, DOI 10.1016/j.ejcb.2009.11.023; Kirik V, 1998, PLANT MOL BIOL, V37, P819, DOI 10.1023/A:1006011002499; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Lampard GR, 2009, PLANT CELL, V21, P3506, DOI 10.1105/tpc.109.070110; Liu RX, 2011, MOL PLANT MICROBE IN, V24, P377, DOI 10.1094/MPMI-07-10-0170; Lu C, 2002, P NATL ACAD SCI USA, V99, P15812, DOI 10.1073/pnas.242607499; Lu BB, 2011, J BIOSCIENCES, V36, P123, DOI 10.1007/s12038-011-9016-2; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Morse AM, 2009, NEW PHYTOL, V183, P1001, DOI 10.1111/j.1469-8137.2009.02900.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Pajonk S, 2008, J BIOL CHEM, V283, P26974, DOI 10.1074/jbc.M805236200; Pitzschke A, 2012, MAKE YOUR BEST MYB T, P481; Pitzschke A, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-14; Pitzschke A, 2009, P NATL ACAD SCI USA, V106, P18414, DOI 10.1073/pnas.0905599106; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Pitzschke A, 2009, PLANT PHYSIOL, V149, P606, DOI 10.1104/pp.108.131557; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Seo JS, 2012, MOL BREEDING, V29, P601, DOI 10.1007/s11032-011-9576-8; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Spoel SH, 2010, NEW PHYTOL, V186, P333, DOI 10.1111/j.1469-8137.2009.03125.x; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; van Bentem SD, 2008, J PROTEOME RES, V7, P2458, DOI 10.1021/pr8000173; Verslues PE, 2006, J EXP BOT, V57, P201, DOI 10.1093/jxb/erj026; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Williams CE, 1997, J BIOL CHEM, V272, P563, DOI 10.1074/jbc.272.1.563; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Nguyen XC, 2012, BIOCHEM BIOPH RES CO, V423, P703, DOI 10.1016/j.bbrc.2012.06.019; Yang SH, 2010, METHODS MOL BIOL, V661, P343, DOI 10.1007/978-1-60761-795-2_21; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543	71	65	70	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57547	10.1371/journal.pone.0057547	http://dx.doi.org/10.1371/journal.pone.0057547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437396	Green Submitted, Green Published, gold			2022-12-25	WOS:000315186000109
J	Biddle, A; Gammon, L; Fazil, B; Mackenzie, IC				Biddle, Adrian; Gammon, Luke; Fazil, Bilal; Mackenzie, Ian C.			CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							HUMAN COLORECTAL-CANCER; BREAST-CANCER; PROSPECTIVE IDENTIFICATION; PANCREATIC-CANCER; MELANOMA-CELLS; NECK-CANCER; CARCINOMA; HEAD; METASTASIS; GROWTH	CD44 is commonly used as a cell surface marker of cancer stem-like cells in epithelial tumours, and we have previously demonstrated the existence of two different CD44(high) cancer stem-like cell populations in squamous cell carcinoma, one having undergone epithelial-to-mesenchymal transition and the other maintaining an epithelial phenotype. Alternative splicing of CD44 variant exons generates a great many isoforms, and it is not known which isoforms are expressed on the surface of the two different cancer stem-like cell phenotypes. Here, we demonstrate that cancer stem-like cells with an epithelial phenotype predominantly express isoforms containing the variant exons, whereas the cancer stem-like cells that have undergone an epithelial-to-mesenchymal transition down-regulate these variant isoforms and up-regulate expression of the standard CD44 isoform that contains no variant exons. In addition, we find that enzymatic treatments used to dissociate cells from tissue culture or fresh tumour specimens cause destruction of variant CD44 isoforms at the cell surface whereas expression of the standard CD44 isoform is preserved. This results in enrichment within the CD44(high) population of cancer stem-like cells that have undergone an epithelial-to-mesenchymal transition and depletion from the CD44(high) population of cancer stem-like cells that maintain an epithelial phenotype, and therefore greatly effects the characteristics of any cancer stem-like cell population isolated based on expression of CD44. As well as effecting the CD44(high) population, enzymatic treatment also reduces the percentage of the total epithelial cancer cell population staining CD44-positive, with potential implications for studies that aim to use CD44-positive staining as a prognostic indicator. Analyses of the properties of cancer stem-like cells are largely dependent on the ability to accurately identify and assay these populations. It is therefore critical that consideration be given to use of multiple cancer stem-like cell markers and suitable procedures for cell isolation in order that the correct populations are assayed.	[Biddle, Adrian; Gammon, Luke; Fazil, Bilal; Mackenzie, Ian C.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Gammon, Luke] Univ Bergen, Haukeland Univ Hosp, Gade Inst, Bergen, Norway	University of London; Queen Mary University London; University of Bergen; Haukeland University Hospital	Biddle, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	a.biddle@qmul.ac.uk	Mackenzie, Ian C/B-9653-2013	Mackenzie, Ian C/0000-0003-1373-062X; Biddle, Adrian/0000-0003-4371-9720	The National Centre for the Replacement, Refinement and Reduction of Animals in Research; Barts and the London Charity; National Centre for the Replacement [NC/K500495/1, G0900799/1] Funding Source: researchfish	The National Centre for the Replacement, Refinement and Reduction of Animals in Research; Barts and the London Charity; National Centre for the Replacement	This study was funded by the The National Centre for the Replacement, Refinement and Reduction of Animals in Research, Barts and the London Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ANSTEE DJ, 1991, IMMUNOLOGY, V74, P197; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cao C, 2012, MOL CANCER RES, V10, P892, DOI 10.1158/1541-7786.MCR-12-0169; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; FRIEDRICHS K, 1995, CANCER RES, V55, P5424; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; HeroldMende C, 1996, J PATHOL, V179, P66, DOI 10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Mackenzie IC, 2004, J ORAL PATHOL MED, V33, P71, DOI 10.1111/j.1600-0714.2004.00157.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Proby CM, 2000, EXP DERMATOL, V9, P104, DOI 10.1034/j.1600-0625.2000.009002104.x; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2003, CANCER RES, V63, P5821; Skvortsova I, 2010, RADIOTHER ONCOL, V96, P108, DOI 10.1016/j.radonc.2010.04.017; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Wang SJ, 2006, ARCH OTOLARYNGOL, V132, P771, DOI 10.1001/archotol.132.7.771; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	41	55	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57314	10.1371/journal.pone.0057314	http://dx.doi.org/10.1371/journal.pone.0057314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437366	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200241
J	Zhang, Y; Guo, XA; Wu, AH				Zhang, Yang; Guo, Xianan; Wu, Anhua			Association between a Novel Mutation in SLC20A2 and Familial Idiopathic Basal Ganglia Calcification	PLOS ONE			English	Article							APE LEUKEMIA-VIRUS; PHOSPHATE COTRANSPORTER; FAHR-DISEASE; IDENTIFICATION; BRAIN; LOCUS; PIT-1	Familial idiopathic basal ganglia calcification (FIBGC) is a rare, autosomal dominant disorder involving bilateral calcification of the basal ganglia. To identify gene mutations related to a Chinese FIBGC lineage, we evaluated available individuals in the family using CT scans. DNA was extracted from the peripheral blood of available family members, and both exonic and flanking intronic sequences of the SLC20A2 gene were amplified by PCR and then sequenced. Non-denaturing polyacrylamide gel electrophoresis (PAGE) was used to confirm the presence of mutations. Allele imbalances of the SLC20A2 gene or relative quantity of SLC20A2 transcripts were evaluated using qRT-PCR. A novel heterozygous single base-pair deletion (c.510delA) within the SLC20A2 gene was identified. This deletion mutation was found to co-segregate with basal ganglia calcification in all of the affected family members but was not detected in unaffected individuals or in 167 unrelated Han Chinese controls. The mutation will cause a frameshift, producing a truncated SLC20A2 protein with a premature termination codon, most likely leading to the complete loss of function of the SLC20A2 protein. This mutation may also lead to a reduction in SLC20A2 mRNA expression by approximately 30% in cells from affected individuals. In conclusion, we identified a novel mutation in SLC20A2 that is linked to FIBGC. In addition to the loss of function at the protein level, decreasing the expression of SLC20A2 mRNA may be another mechanism that can regulate SLC20A2 function in IBGC individuals. We propose that the regional expression pattern of SLC20A1 and SLC20A2 might explain the unique calcification pattern observed in FIBGC patients.	[Zhang, Yang; Guo, Xianan; Wu, Anhua] China Med Univ, Coll Basic Med Sci, Minist Educ, Res Ctr Med Genom,Key Lab Med Cell Biol, Shenyang, Peoples R China; [Wu, Anhua] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang, Peoples R China	China Medical University; China Medical University	Wu, AH (corresponding author), China Med Univ, Coll Basic Med Sci, Minist Educ, Res Ctr Med Genom,Key Lab Med Cell Biol, Shenyang, Peoples R China.	wuanhua@yahoo.com			National Natural Science Foundation of China [81071283]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was mainly supported by the National Natural Science Foundation of China (81071283). The funder's website: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barker PB, 1999, MAGNET RESON MED, V41, P400, DOI 10.1002/(SICI)1522-2594(199902)41:2<400::AID-MRM26>3.0.CO;2-E; Bottger P, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-21; Casanova MF, 2003, PSYCHIAT RES, V121, P59, DOI 10.1016/S0165-1781(03)00202-6; Dai XH, 2010, AM J MED GENET B, V153B, P1305, DOI 10.1002/ajmg.b.31102; Geschwind DH, 1999, AM J HUM GENET, V65, P764, DOI 10.1086/302558; Gonzalez M, 2009, CURR VASC PHARMACOL, V7, P506, DOI 10.2174/157016109789043946; Lagrue E, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-91; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manyam BV, 2005, PARKINSONISM RELAT D, V11, P73, DOI 10.1016/j.parkreldis.2004.12.001; Manyam BV, 2001, MOVEMENT DISORD, V16, P258, DOI 10.1002/mds.1049; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; Oliveira JRM, 2004, NEUROLOGY, V63, P2165, DOI 10.1212/01.WNL.0000145601.88274.88; Tsuchiya Y, 2011, INTERNAL MED, V50, P2351, DOI 10.2169/internalmedicine.50.5747; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; Villa-Bellosta R, 2010, PFLUG ARCH EUR J PHY, V459, P499, DOI 10.1007/s00424-009-0746-z; Volpato CB, 2009, J MOL NEUROSCI, V39, P346, DOI 10.1007/s12031-009-9287-3; Waleria-Aleixo A, 2000, DIAGN MICR INFEC DIS, V36, P225, DOI 10.1016/S0732-8893(00)00112-7; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Werner A, 1998, J EXP BIOL, V201, P3135	21	43	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57060	10.1371/journal.pone.0057060	http://dx.doi.org/10.1371/journal.pone.0057060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437308	Green Published, gold, Green Submitted			2022-12-25	WOS:000315184200207
J	Thomas, CE; Gaffney-Stomberg, E; Sun, BH; O'Brien, KO; Kerstetter, JE; Insogna, KL				Thomas, Carrie E.; Gaffney-Stomberg, Erin; Sun, Ben-Hua; O'Brien, Kimberly O.; Kerstetter, Jane E.; Insogna, Karl L.			Increasing dietary protein acutely augments intestinal iron transporter expression and significantly increases iron absorption in rats	FASEB JOURNAL			English	Article						DMT1; microarray; Dcytb; IRE	NONHEME IRON; HEPCIDIN; FOOD; DEFICIENCY; NRAMP2; MICE	Iron (Fe) deficiency is endemic worldwide. Little data are available regarding acute effects of dietary protein on intestinal Fe absorption. The current study evaluated the short-term effects of increasing dietary protein on Fe absorption and expression of genes involved in Fe homeostasis. Sprague Dawley rats (24, female) were randomly assigned to custom-formulated isocaloric diets containing 40, 20 (control), or 5% protein (as percentage of total kilocalories) for 7 d. Whole-body Fe balance studies demonstrated that Fe retention was greater in the 40% group than in the 5% group (30.8 vs. 7.3%; P<0.01). In a separate study utilizing stable iron isotopes, the 40% group absorbed 30% of ingested Fe, while the 20% group absorbed 18% (P=0.005). Whole-genome profiling revealed that increasing dietary protein from 5 to 40% increased duodenal transcript expression of divalent metal transporter 1 (DMT1) 3.2-fold, duodenal cytochrome b (Dcytb) 1.8-fold, and transferrin receptor (TfR) 1.8-fold. Consistent with these findings, DMT1 transcript expression was 4-fold higher in RNA prepared from duodenal mucosa in the 40% group compared to the 20% group (P<0.001). These data suggest that increasing dietary protein increases intestinal Fe absorption in part by up-regulating DMT1, Dcytb, and TfR.-Thomas, C. E., Gaffney-Stomberg, E., Sun, B.-H., O'Brien, K. O., Kerstetter, J. E., Insogna, K. L. Increasing dietary protein acutely augments intestinal iron transporter expression and significantly increases iron absorption in rats.	[Thomas, Carrie E.] Univ Connecticut, Dept Nutr Sci, Storrs, CT 06269 USA; [Kerstetter, Jane E.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT 06269 USA; [Gaffney-Stomberg, Erin] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Oncol, Bronx, NY 10467 USA; [Sun, Ben-Hua; Insogna, Karl L.] Yale Univ, Dept Internal Med Endocrinol, New Haven, CT USA; [O'Brien, Kimberly O.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of Connecticut; University of Connecticut; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yale University; Cornell University	Thomas, CE (corresponding author), Univ Connecticut, Dept Allied Hlth Sci, 358 Mansfield Rd,Unit 1101, Storrs, CT 06269 USA.	carrie.cucchi@yale.edu	Gaffney-Stomberg, Erin/Y-1016-2018; Gaffney-Stomberg, Erin/AAT-8826-2020	Gaffney-Stomberg, Erin/0000-0002-0241-2282; Gaffney-Stomberg, Erin/0000-0002-0241-2282; Insogna, Karl/0000-0001-6973-5679	Yale Bone Center; University of Connecticut	Yale Bone Center; University of Connecticut	C.T., E.G.-S., K.O., J.K., and K.I., designed the research; C.T. and E.G.-S. conducted the research; E.G.-S. conducted the microarray screen; C.T., E.G.-S., and K.I. analyzed the data; C.T. and K.I. wrote the paper; and J.K. and K.I. had responsibility for the final content. All authors read and approved the final manuscript. The authors thank Gang-Qing Yao for assistance with the isoform-specific qPCR analysis, Tera Kent for assistance with the mass spectrometry analyses, and Heidi Vogeli and Stacey Brown for technical assistance with the oral gavage studies. This project was funded by the Yale Bone Center and by a Hatch grant from the University of Connecticut. The authors report no conflicts of interest.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Ammann P, 2000, J BONE MINER RES, V15, P683, DOI 10.1359/jbmr.2000.15.4.683; Argyri K, 2007, J AGR FOOD CHEM, V55, P10221, DOI 10.1021/jf0727387; Argyri K, 2009, J AGR FOOD CHEM, V57, P1538, DOI 10.1021/jf802877n; BALLOT D, 1987, BRIT J NUTR, V57, P331, DOI 10.1079/BJN19870041; BJORNRASMUSSEN E, 1974, NUTR METAB, V16, P94; Bouhallab S, 2002, J AGR FOOD CHEM, V50, P7127, DOI 10.1021/jf025554v; Chaud MV, 2002, J AGR FOOD CHEM, V50, P871, DOI 10.1021/jf0111312; COOK JD, 1976, AM J CLIN NUTR, V29, P859, DOI 10.1093/ajcn/29.8.859; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Gaffney-Stomberg E., ENDOCRINOLOGY, V151, P1071; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HURRELL RF, 1989, AM J CLIN NUTR, V49, P546, DOI 10.1093/ajcn/49.3.546; KAPSOKEFALOU M, 1991, J FOOD SCI, V56, P352, DOI 10.1111/j.1365-2621.1991.tb05278.x; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P571, DOI 10.1007/s00424-003-1141-9; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; National Research Council, 1995, NUTR REQ LAB AN; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Peres JM, 1999, J NUTR BIOCHEM, V10, P215, DOI 10.1016/S0955-2863(98)00101-6; Probst RJ, 2006, J AM ASSOC LAB ANIM, V45, P49; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Young MF, 2009, AM J CLIN NUTR, V89, P533, DOI 10.3945/ajcn.2008.26589	27	8	8	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JUN	2013	27	6					2476	2483		10.1096/fj.12-221945	http://dx.doi.org/10.1096/fj.12-221945			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	154II	23447582				2022-12-25	WOS:000319667600035
J	Chen, XL; Anel, JA; Su, ZB; de la Torre, L; Kelder, H; van Peet, J; Ma, YM				Chen, Xuelong; Anel, Juan A.; Su, Zhongbo; de la Torre, Laura; Kelder, Hennie; van Peet, Jacob; Ma, Yaoming			The Deep Atmospheric Boundary Layer and Its Significance to the Stratosphere and Troposphere Exchange over the Tibetan Plateau	PLOS ONE			English	Article							GLOBAL WATER CYCLE; LAGRANGIAN ANALYSIS; ASIAN MONSOON; SURFACE OZONE; EVOLUTION; TRANSPORT; SUMMER; CHINA; AIR; CONVECTION	In this study the depth of the atmospheric boundary layer (ABL) over the Tibetan Plateau was measured during a regional radiosonde observation campaign in 2008 and found to be deeper than indicated by previously measurements. Results indicate that during fair weather conditions on winter days, the top of the mixed layers can be up to 5 km above the ground (9.4 km above sea level). Measurements also show that the depth of the ABL is quite distinct for three different periods (winter, monsoon-onset, and monsoon seasons). Turbulence at the top of a deep mixing layer can rise up to the upper troposphere. As a consequence, as confirmed by trajectory analysis, interaction occurs between deep ABLs and the low tropopause during winter over the Tibetan Plateau.	[Chen, Xuelong; Ma, Yaoming] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China; [Chen, Xuelong; Su, Zhongbo] Univ Twente, Fac Geoinformat Sci & Earth Observat, NL-7500 AE Enschede, Netherlands; [Anel, Juan A.] Univ Oxford, Smith Sch Enterprise & Environm, Oxford, England; [Anel, Juan A.; de la Torre, Laura] Univ Vigo, Fac Sci, EPhysLab, Orense, Spain; [Kelder, Hennie] Eindhoven Univ, Eindhoven, Netherlands; [van Peet, Jacob] Royal Netherlands Meteorol Inst KNMI, Utricht, Netherlands	Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; University of Twente; University of Oxford; Universidade de Vigo; Eindhoven University of Technology; Royal Netherlands Meteorological Institute	Ma, YM (corresponding author), Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Tibetan Environm Changes & Land Surface P, Beijing, Peoples R China.	ymma@itpcas.ac.cn	de la Torre, Laura/Y-3723-2019; Chen, Xuelong/AAF-6616-2019; Chen, Xuelong/C-2748-2014; , Juan Antonio Añel Cabanelas/N-1866-2019; Su, Z. (Bob)/D-4383-2009	de la Torre, Laura/0000-0001-5305-6946; Chen, Xuelong/0000-0003-3892-5298; Chen, Xuelong/0000-0003-3892-5298; , Juan Antonio Añel Cabanelas/0000-0003-2448-4647; van Peet, J.C.A./0000-0002-8979-5000; Su, Zhongbo/0000-0003-2096-1733	Chinese National Key Programme for Developing Basic Sciences [2010CB951701]; Chinese National Natural Science Foundation [40825015, 40810059006]; KNAW; European Regional Development Fund	Chinese National Key Programme for Developing Basic Sciences; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); KNAW; European Regional Development Fund(European Commission)	This research was funded by the Chinese National Key Programme for Developing Basic Sciences (2010CB951701), and the Chinese National Natural Science Foundation (40825015 and 40810059006). Xuelong Chen acknowledges the support of KNAW. The authors thank all the participants from China and Japan for their work during the JICA Tibetan Plateau meteorological observations. Laura de la Torre was partially supported by the European Regional Development Fund. The funders played no part in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. No additional external funding was received for this study.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Anel JC, 2012, SCI WORLD J, V2012, P1; Anel JA, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009697; Ao CO, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017598; Bergman JW, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016992; Betts AK, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000158; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; Callies J, 2000, ESA BULL-EUR SPACE, P28; Chen B, 2012, ATMOS CHEM PHYS, V12, P5827, DOI 10.5194/acp-12-5827-2012; [陈闯 Chen Chuang], 2012, [高原气象, Plateau Meteorology], V31, P295; Chen XL, 2011, ATMOS CHEM PHYS, V11, P5113, DOI 10.5194/acp-11-5113-2011; Cooper OR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005783; Cuesta J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009417; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Fan SJ, 2011, ATMOS CHEM PHYS, V11, P6297, DOI 10.5194/acp-11-6297-2011; Fu R, 2006, P NATL ACAD SCI USA, V103, P5664, DOI 10.1073/pnas.0601584103; Gamo M, 1996, BOUND-LAY METEOROL, V79, P265, DOI 10.1007/BF00119441; GAO YX, 1981, B AM METEOROL SOC, V62, P31, DOI 10.1175/1520-0477(1981)062<0031:SAORRO>2.0.CO;2; Griffiths M, 2000, Q J ROY METEOR SOC, V126, P125, DOI 10.1002/qj.49712656207; Hennemuth B, 2006, BOUND-LAY METEOROL, V120, P181, DOI [10.1007/s10546-005-9035-3, 10.1007/S10546-005-9035-3]; Holzworth G.C., 1964, MON WEATHER REV, V92, P235, DOI [DOI 10.1175/1520-0493(1964)092<0235:EOMMMD>2.3.CO;2, 10.1175/1520-0493(1964)092%3C0235:eommmd%3E2.3.co;2, DOI 10.1175/1520-0493(1964)0922.3.CO;2]; Hu XM, 2012, ATMOS ENVIRON, V46, P354, DOI 10.1016/j.atmosenv.2011.09.054; JOHNSON WB, 1981, ATMOS ENVIRON, V15, P1309, DOI 10.1016/0004-6981(81)90325-5; Ladstatter-Weissenmayer A, 2004, ATMOS CHEM PHYS, V4, P903, DOI 10.5194/acp-4-903-2004; Langford AO, 1998, J GEOPHYS RES-ATMOS, V103, P31265, DOI 10.1029/98JD02596; [李茂善 LI Maoshan], 2006, [高原气象, Plateau Meteorology], V25, P807; Li Y, 2007, ARCT ANTARCT ALP RES, V39, P708, DOI 10.1657/1523-0430(07-504)[LI]2.0.CO;2; Lin JT, 2008, ATMOS ENVIRON, V42, P8470, DOI 10.1016/j.atmosenv.2008.08.012; Ma Y, 2009, HYDROL EARTH SYST SC, V13, P1103, DOI 10.5194/hess-13-1103-2009; Ma YM, 2002, HYDROL PROCESS, V16, P2963, DOI 10.1002/hyp.1079; Randel WJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007904; Rao ST, 2003, PURE APPL GEOPHYS, V160, P21, DOI 10.1007/s00024-003-8764-9; Rodgers C. D, 2000, INVERSE METHODS ATMO; Santanello JA, 2005, J APPL METEOROL, V44, P917, DOI 10.1175/JAM2240.1; Seibert P, 2000, ATMOS ENVIRON, V34, P1001, DOI 10.1016/S1352-2310(99)00349-0; Seidel DJ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018143; Skerlak B, 2012, GLOBAL ERA INTERIM C, P1249; Sprenger M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002587; STENSRUD DJ, 1993, J ATMOS SCI, V50, P2284, DOI 10.1175/1520-0469(1993)050<2284:ERLATI>2.0.CO;2; Stohl A, 2005, J HYDROMETEOROL, V6, P961, DOI 10.1175/JHM470.1; Stohl A, 2004, J HYDROMETEOROL, V5, P656, DOI 10.1175/1525-7541(2004)005<0656:ALAOTA>2.0.CO;2; Stull R.B., 1988, ATMOSPHERIC OCEANOGR, DOI 10.1007/978-94-009-3027-8; Sun FL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029484; TAO SY, 1981, B AM METEOROL SOC, V62, P23, DOI 10.1175/1520-0477(1981)062<0023:OEOTIO>2.0.CO;2; von Engeln A, 2006, ATMOSPHERE AND CLIMATE: STUDIES BY OCCULTATION METHODS, P265; Wang T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006527; WMO, 1957, WMO B, V6, P134; Xu GR, 2009, TORRENTIAL RAIN DISA, V28, P112; Xu XD, 2002, SCI CHINA SER D, V45, P577, DOI 10.1360/02yd9060; Xu XD, 2008, B AM METEOROL SOC, V89, P1492, DOI 10.1175/2008BAMS2557.1; YANAI M, 1994, MON WEATHER REV, V122, P305, DOI 10.1175/1520-0493(1994)122<0305:MOHATB>2.0.CO;2; YANAI MH, 1992, J METEOROL SOC JPN, V70, P319, DOI 10.2151/jmsj1965.70.1B_319; Yang K, 2004, J METEOROL SOC JPN, V82, P1777, DOI 10.2151/jmsj.82.1777; Yang X, 1999, J GEOPHYS RES-ATMOS, V104, P30341, DOI 10.1029/1999JD900810; Zhang GZ, 2003, ADV ATMOS SCI, V20, P349, DOI 10.1007/BF02690793; Zhang J, 1999, J APPL METEOROL, V38, P1674, DOI 10.1175/1520-0450(1999)038<1674:TROVMI>2.0.CO;2; Zhang Q, 2011, SCI CHINA EARTH SCI, V54, P1586, DOI 10.1007/s11430-011-4207-0; Zhou X., 2006, J METEOROL RES-PRC, V20, P129; Zuo HC, 2005, PROG NAT SCI-MATER, V15, P239	59	42	48	7	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56909	10.1371/journal.pone.0056909	http://dx.doi.org/10.1371/journal.pone.0056909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451108	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500042
J	Dalquen, DA; Altenhoff, AM; Gonnet, GH; Dessimoz, C				Dalquen, Daniel A.; Altenhoff, Adrian M.; Gonnet, Gaston H.; Dessimoz, Christophe			The Impact of Gene Duplication, Insertion, Deletion, Lateral Gene Transfer and Sequencing Error on Orthology Inference: A Simulation Study	PLOS ONE			English	Article							EUKARYOTIC GENOMES; PROTEIN FAMILIES; EVOLUTION; IDENTIFICATION; PERFORMANCE; FRAMEWORK; PARALOGS	The identification of orthologous genes, a prerequisite for numerous analyses in comparative and functional genomics, is commonly performed computationally from protein sequences. Several previous studies have compared the accuracy of orthology inference methods, but simulated data has not typically been considered in cross-method assessment studies. Yet, while dependent on model assumptions, simulation-based benchmarking offers unique advantages: contrary to empirical data, all aspects of simulated data are known with certainty. Furthermore, the flexibility of simulation makes it possible to investigate performance factors in isolation of one another. Here, we use simulated data to dissect the performance of six methods for orthology inference available as standalone software packages (Inparanoid, OMA, OrthoInspector, OrthoMCL, QuartetS, SPIMAP) as well as two generic approaches (bidirectional best hit and reciprocal smallest distance). We investigate the impact of various evolutionary forces (gene duplication, insertion, deletion, and lateral gene transfer) and technological artefacts (ambiguous sequences) on orthology inference. We show that while gene duplication/loss and insertion/deletion are well handled by most methods (albeit for different trade-offs of precision and recall), lateral gene transfer disrupts all methods. As for ambiguous sequences, which might result from poor sequencing, assembly, or genome annotation, we show that they affect alignment score-based orthology methods more strongly than their distance-based counterparts.	[Dalquen, Daniel A.; Altenhoff, Adrian M.; Gonnet, Gaston H.; Dessimoz, Christophe] Eldgenoss Tech Hsch Zurich, Dept Comp Sci, Zurich, Switzerland; [Dalquen, Daniel A.; Altenhoff, Adrian M.; Gonnet, Gaston H.; Dessimoz, Christophe] Swiss Inst Bioinformat, Zurich, Switzerland; [Dessimoz, Christophe] European Bioinformat Inst, Cambridge, England	Swiss Institute of Bioinformatics; European Molecular Biology Laboratory (EMBL)	Dalquen, DA (corresponding author), Eldgenoss Tech Hsch Zurich, Dept Comp Sci, Zurich, Switzerland.	ddalquen@ethz.ch; dessimoz@ebi.ac.uk	Altenhoff, Adrian Michael/P-5024-2019; Dessimoz, Christophe/D-3678-2011	Altenhoff, Adrian Michael/0000-0001-7492-1273; Dessimoz, Christophe/0000-0002-2170-853X	Eldgenossische Technische Hochschule Independent Investigators' Research Award; Swiss National Science Foundation [136461]	Eldgenossische Technische Hochschule Independent Investigators' Research Award; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Part of the work was funded by an Eldgenossische Technische Hochschule Independent Investigators' Research Award to GHG and CD, and by a Swiss National Science Foundation advanced researcher fellowship (#136461) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Altenhoff AM, 2012, METHODS MOL BIOL, V855, P259, DOI 10.1007/978-1-61779-582-4_9; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altenhoff AM, 2012, GRAPH BASED AL UNPUB; BENNER SA, 1993, J MOL BIOL, V229, P1065, DOI 10.1006/jmbi.1993.1105; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Dalquen DA, 2012, MOL BIOL EVOL, V29, P1115, DOI 10.1093/molbev/msr268; Dessimoz C, 2012, OMA STANDALONE CLIEN; Dessimoz C, 2006, NUCLEIC ACIDS RES, V34, P3309, DOI 10.1093/nar/gkl433; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Linard B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-11; Milinkovitch MC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r16; Ohno S., 1970, EVOLUTION GENE DUPLI; Rasmussen MD, 2011, MOL BIOL EVOL, V28, P273, DOI 10.1093/molbev/msq189; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Sennblad B, 2009, SYST BIOL, V58, P411, DOI 10.1093/sysbio/syp046; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yu CG, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr308; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	32	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56925	10.1371/journal.pone.0056925	http://dx.doi.org/10.1371/journal.pone.0056925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451112	Green Submitted, Green Published, gold			2022-12-25	WOS:000316849500044
J	Lee, YR; Yu, DS; Liang, YC; Huang, KF; Chou, SJ; Chen, TC; Lee, CC; Chen, CL; Chiou, SH; Huang, HS				Lee, Yu-Ru; Yu, Dah-Shyong; Liang, Ya-Chun; Huang, Kuo-Feng; Chou, Shih-Jie; Chen, Tsung-Chih; Lee, Chia-Chung; Chen, Chun-Liang; Chiou, Shih-Hwa; Huang, Hsu-Shan			New Approaches of PARP-1 Inhibitors in Human Lung Cancer Cells and Cancer Stem-Like Cells by Some Selected Anthraquinone-Derived Small Molecules	PLOS ONE			English	Article							HUMAN TELOMERASE INHIBITION; POLY(ADP-RIBOSE) POLYMERASE-1 PARP-1; RAPID COLORIMETRIC ASSAY; ANTICANCER DRUG SCREEN; ADP-RIBOSE POLYMERASE; CYTOTOXICITY; DERIVATIVES; ROLES; ADENOCARCINOMA; IDENTIFICATION	Poly (ADP-ribose) polymerase-1 (PARP-1) and telomerase, as well as DNA damage response pathways are targets for anticancer drug development, and specific inhibitors are currently under clinical investigation. The purpose of this work is to evaluate anticancer activities of anthraquinone-derived tricyclic and tetracyclic small molecules and their structure-activity relationships with PARP-1 inhibition in non-small cell lung cancer (NSCLC) and NSCLC-overexpressing Oct4 and Nanog clone, which show high-expression of PARP-1 and more resistance to anticancer drug. We applied our library selected compounds to NCI's 60 human cancer cell-lines (NCI-60) in order to generate systematic profiling data. Based on our analysis, it is hypothesized that these drugs might be, directly and indirectly, target components to induce mitochondrial permeability transition and the release of pro-apoptotic factors as potential anti-NSCLC or PARP inhibitor candidates. Altogether, the most active NSC747854 showed its cytotoxicity and dose-dependent PARP inhibitory manner, thus it emerges as a promising structure for anti-cancer therapy with no significant negative influence on normal cells. Our studies present evidence that telomere maintenance should be taken into consideration in efforts not only to overcome drug resistance, but also to optimize the use of telomere-based therapeutics. These findings will be of great value to facilitate structure-based design of selective PARP inhibitors, in general, and telomerase inhibitors, in particular. Together, the data presented here expand our insight into the PARP inhibitors and support the resource-demanding lead optimization of structurally related small molecules for human cancer therapy.	[Lee, Yu-Ru; Chen, Tsung-Chih; Lee, Chia-Chung; Chen, Chun-Liang; Huang, Hsu-Shan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yu, Dah-Shyong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Liang, Ya-Chun; Huang, Hsu-Shan] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Yu, Dah-Shyong] Triserv Gen Hosp, Urooncol Lab, Div Urol, Dept Surg, Taipei, Taiwan; [Huang, Hsu-Shan] Triserv Gen Hosp, Dept Pharm Practice, Taipei, Taiwan; [Huang, Kuo-Feng; Chou, Shih-Jie] Chi Mei Med Ctr, Tainan, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; Chi Mei Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chiou, SH (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.	shchiou@vghtpe.gov.tw; huanghs@ndmctsgh.edu.tw	Park, Chankyu/C-1936-2011	CHEN, Tsung-Chih/0000-0001-8256-6240; Huang, Hsu-Shan/0000-0001-8162-5608	National Science Council [NSC99-2113-M-016-001, NSC100-2113-M-016-001, NSC 97-3111-B-075-001-MY3, CMNDMC10101]; NIH-NCI	National Science Council(Ministry of Science and Technology, Taiwan); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present study was supported by National Science Council Grants NSC99-2113-M-016-001, NSC100-2113-M-016-001 and NSC 97-3111-B-075-001-MY3 respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present study was supported by National Science Council Grants NSC100-2113-M-016-001, NSC97-3111-B-075-001-MY3 and CMNDMC10101, respectively. We are grateful to NIH-NCI for their support and also wish to thank the stem cell project of Taipei Veterans General Hospital, Taipei, Taiwan.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Bradshaw TD, 2005, CANCER RES, V65, P3911, DOI 10.1158/0008-5472.CAN-04-4141; Castiel A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-412; Cepeda V, 2006, RECENT PAT ANTI-CANC, V1, P39, DOI 10.2174/157489206775246430; Chang YL, 2011, INT J BIOCHEM CELL B, V43, P1720, DOI 10.1016/j.biocel.2011.08.006; Chen CL, 2013, EUR J MED CHEM, V60, P29, DOI 10.1016/j.ejmech.2012.11.032; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cheng MH, 2012, ANTI-CANCER DRUG, V23, P191, DOI 10.1097/CAD.0b013e32834cd277; Chevanne M, 2010, J CELL PHYSIOL, V222, P401, DOI 10.1002/jcp.21964; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clark GR, 2003, J AM CHEM SOC, V125, P4066, DOI 10.1021/ja0297988; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Ferraris D, 2003, BIOORGAN MED CHEM, V11, P3695, DOI 10.1016/S0968-0896(03)00333-X; Gartner EM, 2010, CANCER J, V16, P83, DOI 10.1097/PPO.0b013e3181d78223; Guyen B, 2004, ORG BIOMOL CHEM, V2, P981, DOI 10.1039/b316055f; Haider SM, 2003, J MOL BIOL, V326, P117, DOI 10.1016/S0022-2836(02)01354-2; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Huang HS, 2006, CHEM PHARM BULL, V54, P458, DOI 10.1248/cpb.54.458; Huang HS, 2005, BIOORGAN MED CHEM, V13, P1435, DOI 10.1016/j.bmc.2004.12.036; Huang HS, 2004, BIOORGAN MED CHEM, V12, P6163, DOI 10.1016/j.bmc.2004.09.001; Huang HS, 2008, BIOORGAN MED CHEM, V16, P6976, DOI 10.1016/j.bmc.2008.05.072; Huang HS, 2007, CHEM PHARM BULL, V55, P284, DOI 10.1248/cpb.55.284; Huang HS, 2010, ANTI-CANCER DRUG, V21, P169, DOI 10.1097/CAD.0b013e3283324d0a; Huang HS, 2009, BIOORGAN MED CHEM, V17, P7418, DOI 10.1016/j.bmc.2009.09.033; Iwasaki H, 2006, CANCER CHEMOTH PHARM, V58, P451, DOI 10.1007/s00280-005-0183-4; Iwasaki H, 2010, CANCER CHEMOTH PHARM, V65, P719, DOI 10.1007/s00280-009-1077-7; Jagtap P, 2002, CRIT CARE MED, V30, P1071, DOI 10.1097/00003246-200205000-00019; Jones C, 2008, BRIT J RADIOL, V81, pS2, DOI 10.1259/bjr/30872348; Kanjanabuch T, 2007, KIDNEY INT, V71, P1232, DOI 10.1038/sj.ki.5002248; Kaye SB, 2012, J CLIN ONCOL, V30, P372, DOI 10.1200/JCO.2011.36.9215; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kruse V, 2011, ACTA CLIN BELG, V66, P2, DOI 10.1179/ACB.66.1.2062507; Lee CC, 2012, EUR J MED CHEM, V47, P323, DOI 10.1016/j.ejmech.2011.10.059; Lin SG, 2003, ARCH BIOCHEM BIOPHYS, V418, P99, DOI 10.1016/j.abb.2003.08.004; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Mattson MP, 2001, J NEUROSCI RES, V63, P1; Mertins SD, 2004, MOL CANCER THER, V3, P849; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Monks A, 1997, ANTI-CANCER DRUG DES, V12, P533; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munoz-Gamez JA, 2005, BIOCHEM J, V386, P119, DOI 10.1042/BJ20040776; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Nguyen TL, 2006, BIOORGAN MED CHEM, V14, P6097, DOI 10.1016/j.bmc.2006.05.001; Nukuzuma S, 2012, J MED VIROL; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Patel AG, 2012, CLIN CANCER RES, V18, P1655, DOI 10.1158/1078-0432.CCR-11-2890; Perry PJ, 1998, J MED CHEM, V41, P3253, DOI 10.1021/jm9801105; Perry PJ, 1998, J MED CHEM, V41, P4873, DOI 10.1021/jm981067o; POHLE W, 1990, BIOPHYS CHEM, V35, P213, DOI 10.1016/0301-4622(90)80010-5; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Samper E, 2001, J CELL BIOL, V154, P49, DOI 10.1083/jcb.200103049; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SIKIC BI, 1991, J NATL CANCER I, V83, P738, DOI 10.1093/jnci/83.11.738; Smith V, 2009, J CHEMOTHERAPY, V21, P542, DOI 10.1179/joc.2009.21.5.542; Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375	62	67	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56284	10.1371/journal.pone.0056284	http://dx.doi.org/10.1371/journal.pone.0056284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451039	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849500010
J	Matthaei, M; Budt, M; Wolff, T				Matthaei, Markus; Budt, Matthias; Wolff, Thorsten			Highly Pathogenic H5N1 Influenza A Virus Strains Provoke Heterogeneous IFN-alpha/beta Responses That Distinctively Affect Viral Propagation in Human Cells	PLOS ONE			English	Article							LOWER RESPIRATORY-TRACT; I INTERFERON INDUCTION; SINGLE-AMINO-ACID; NF-KAPPA-B; AVIAN-INFLUENZA; NS1 PROTEIN; RIG-I; TRANSCRIPTION FACTORS; RECEPTOR SPECIFICITY; ANTIVIRAL RESPONSES	The fatal transmissions of highly pathogenic avian influenza A viruses (IAV) of the H5N1 subtype to humans and high titer replication in the respiratory tract indicate that these pathogens can overcome the bird-to-human species barrier. While type I interferons (IFN-alpha/beta) are well described to contribute to the species barrier of many zoonotic viruses, current data to the role of these antiviral cytokines during human H5N1 IAV infections is limited and contradictory. We hypothesized an important role for the IFN system in limiting productive infection of avian H5N1 strains in human cells. Hence, we examined IFN-alpha/beta gene activation by different avian and human H5N1 isolates, if the IFN-alpha/beta response restricts H5N1 growth and whether the different strains were equally capable to regulate the IFN-alpha/beta system via their IFN-antagonistic NS1 proteins. Two human H5N1 isolates and a seasonal H3N2 strain propagated efficiently in human respiratory cells and induced little IFN-beta, whereas three purely avian H5N1 strains were attenuated for replication and provoked higher IFN secretion. Replication of avian viruses was significantly enhanced on interferon-deficient cells, and exogenous IFN potently limited the growth of all strains in human cells. Moreover, IFN-alpha/beta activation by all strains depended on retinoic acid-inducible gene I excluding principal differences in receptor activation between the different viruses. Interestingly, all H5N1 NS1 proteins suppressed IFN-alpha/beta induction comparably well to the NS1 of seasonal IAV. Thus, our study shows that H5N1 strains are heterogeneous in their capacity to activate human cells in an NS1-independent manner. Our findings also suggest that H5N1 viruses need to acquire adaptive changes to circumvent strong IFN-alpha/beta activation in human host cells. Since no single amino acid polymorphism could be associated with a respective high- or low induction phenotype we propose that the necessary adaptations to overcome the human IFN-alpha/beta barrier involve mutations in multiple H5N1 genes.	[Matthaei, Markus; Budt, Matthias; Wolff, Thorsten] Robert Koch Inst, Div Influenza Resp Viruses, Berlin, Germany	Robert Koch Institute	Wolff, T (corresponding author), Robert Koch Inst, Div Influenza Resp Viruses, Berlin, Germany.	wolfft@rki.de	Budt, Matthias/E-7735-2018; Matthaei, Markus/G-1230-2010	Budt, Matthias/0000-0001-5960-515X	German Research Council [Wo 554/3-2]; FLURESEARCHNET; German Federal Ministry of Research and Education (BMBF) [01 KI 1006 C]	German Research Council(German Research Foundation (DFG)); FLURESEARCHNET; German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants to TW of the German Research Council (www.dfg.de) (Wo 554/3-2) and FLURESEARCHNET, which is funded by the German Federal Ministry of Research and Education (BMBF grant 01 KI 1006 C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Bussey KA, 2010, J VIROL, V84, P4395, DOI 10.1128/JVI.02642-09; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Conenello GM, 2011, J VIROL, V85, P652, DOI 10.1128/JVI.01987-10; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Deng R, 2008, J PATHOL, V216, P328, DOI 10.1002/path.2417; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Didcock L, 1999, J VIROL, V73, P3125, DOI 10.1128/JVI.73.4.3125-3133.1999; Dudek SE, 2011, BIOL CHEM; Forbes NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031839; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gao RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013315; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Haasbach E, 2011, J INTERF CYTOK RES, V31, P515, DOI 10.1089/jir.2010.0071; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hayman A, 2007, J VIROL, V81, P2318, DOI 10.1128/JVI.01856-06; Hayman A, 2006, VIROLOGY, V347, P52, DOI 10.1016/j.virol.2005.11.024; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hui KPY, 2011, J INFECT DIS, V204, P1866, DOI 10.1093/infdis/jir665; Imai H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001106; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kalthoff D, 2010, VET MICROBIOL, V140, P237, DOI 10.1016/j.vetmic.2009.08.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Le QM, 2010, J GEN VIROL, V91, P2485, DOI 10.1099/vir.0.021659-0; Lee MH, 2011, J GEN VIROL; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Lycett SJ, 2009, J VIROL, V83, P9901, DOI 10.1128/JVI.00608-09; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Regan JF, 2006, J VIROL, V80, P252, DOI 10.1128/JVI.80.1.252-261.2006; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Sirinonthanawech N, 2011, J MED VIROL, V83, P1418, DOI 10.1002/jmv.22146; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Terrier O, 2012, VIROLOGY, V432, P204, DOI 10.1016/j.virol.2012.05.019; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Unterstab G, 2005, P NATL ACAD SCI USA, V102, P13640, DOI 10.1073/pnas.0502883102; Valmas C, 2011, J VIROL, V85, P4309, DOI 10.1128/JVI.02575-10; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weinheimer VK, 2012, J INFECT DIS; Wolff T, 2008, BIOL CHEM, V389, P1299, DOI 10.1515/BC.2008.146; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027	100	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56659	10.1371/journal.pone.0056659	http://dx.doi.org/10.1371/journal.pone.0056659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451066	Green Published, gold			2022-12-25	WOS:000316849500021
J	Yang, YF; Cao, ZH; Tian, L; Garvey, WT; Cheng, GJ				Yang, Youfeng; Cao, Zehong; Tian, Ling; Garvey, W. Timothy; Cheng, Guangjie			VPO1 Mediates ApoE Oxidation and Impairs the Clearance of Plasma Lipids	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; VASCULAR PEROXIDASE 1; APOLIPOPROTEIN-E; DEFICIENT MICE; CHOLESTEROL EFFLUX; TNF-ALPHA; ATHEROSCLEROSIS; MYELOPEROXIDASE; BINDING; HYPOCHLORITE	Objective: ApoE is an abundant component of chylomicron, VLDL, IDL, and HDL. It binds to multiple types of lipids and is implicated in cholesterol and triglyceride homeostasis. Oxidation of ApoE plays a crucial role in the genesis of atherosclerosis. It is proposed that heme-containing peroxidases (hPx) are major mediators of lipoprotein oxidization. Vascular peroxidase 1 (VPO1) is a recently-discovered hPx, which is expressed in cardiovascular system, lung, liver etc. and secreted into plasma. Its plasma concentration is three orders of magnitude of that of myeloperoxidase. If VPO1 mediates ApoE oxidation and affects the lipid metabolism remains to be elucidated. Methods: Recombinant ApoE and VPO1 were expressed and purified from stably-expressing cell lines deriving from HEK293 cells. ApoE oxidation was carried out by VPO1 in the presence of H2O2 and chloride. ApoE oxidation was verified by a variety of approaches including immunoblot and amino acid analyses. To evaluate the functional changes in VPO1-oxidized ApoE, lipid emulsion particle binding assays were employed. Results: Oxidized ApoE binds weaker to lipid emulsion particles, which mimic the large lipid complexes in vivo. In lipid efflux assay, oxidized ApoE showed reduced capability in efflux of lipids from foam cells. Mice administrated with oxidized ApoE via blood exhibited weaker clearance ability of plasma lipids. Conclusions: Our data suggest that VPO1 is a new mediator regulating lipid homeostasis, implying a role in genesis and development of atherosclerosis.	[Yang, Youfeng; Cao, Zehong; Cheng, Guangjie] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA; [Tian, Ling; Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA; [Garvey, W. Timothy] Birmingham VA Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Cheng, GJ (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA.	gjcheng@uab.edu		Cheng, Guangjie/0000-0002-9368-379X	National Heart, Blood, and Lung Institute; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01 HL086836, R21AI101642]; National Institutes of Health [DK-083562, DK-038764]; Merit Review program of the Department of Veterans Affairs; UAB Diabetes Research and Training Center [P60-DK079626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626, R01DK083562] Funding Source: NIH RePORTER	National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review program of the Department of Veterans Affairs(US Department of Veterans Affairs); UAB Diabetes Research and Training Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Blood, and Lung Institute, and National Institute of Allergy and Infectious Diseases, National Institutes of Health under Award Number R01 HL086836 and R21AI101642 (to GC). WTG was supported by the National Institutes of Health (Award Number DK-083562 and DK-038764), the Merit Review program of the Department of Veterans Affairs, and the UAB Diabetes Research and Training Center (P60-DK079626). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABAEV VR, 1990, ATHEROSCLEROSIS, V85, P239, DOI 10.1016/0021-9150(90)90116-Z; Bai YP, 2011, FREE RADICAL BIO MED, V51, P1492, DOI 10.1016/j.freeradbiomed.2011.07.004; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chantepie S, 2009, ARCH BIOCHEM BIOPHYS, V487, P28, DOI 10.1016/j.abb.2009.05.005; Cheng GJ, 2011, FREE RADICAL BIO MED, V51, P1445, DOI 10.1016/j.freeradbiomed.2011.07.002; Cheng GJ, 2008, FREE RADICAL BIO MED, V45, P1682, DOI 10.1016/j.freeradbiomed.2008.09.009; Choy PC, 2004, BIOCHEM CELL BIOL, V82, P212, DOI 10.1139/o03-085; Cox RA., 1990, CLIN METHODS HIST PH, V3rd, P153; Dornelles FN, 2009, J PHARMACOL EXP THER, V330, P756, DOI 10.1124/jpet.109.155762; Frey RS, 2002, CIRC RES, V90, P1012, DOI 10.1161/01.RES.0000017631.28815.8E; Gaudreault N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035816; Guzik TJ, 2000, CIRC RES, V86, pE85, DOI 10.1161/01.RES.86.9.e85; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Hasty AH, 1999, J LIPID RES, V40, P1529; Hasty AH, 1999, CIRCULATION, V99, P2571, DOI 10.1161/01.CIR.99.19.2571; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; HAZELL LJ, 1993, BIOCHEM J, V290, P165, DOI 10.1042/bj2900165; Itabe H, 2011, J LIPIDS, V2011, DOI 10.1155/2011/418313; Jerlich A, 2000, EUR J BIOCHEM, V267, P4137, DOI 10.1046/j.1432-1327.2000.01449.x; Jolivalt C, 1996, NEUROSCI LETT, V210, P61, DOI 10.1016/0304-3940(96)12661-6; Jolivalt C, 2000, FREE RADICAL BIO MED, V28, P129, DOI 10.1016/S0891-5849(99)00232-4; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kalayoglu MV, 1999, J INFECT DIS, V180, P780, DOI 10.1086/314931; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Li H, 2012, FREE RADICAL BIO MED, V53, P1954, DOI 10.1016/j.freeradbiomed.2012.08.597; Li H, 2012, INFECT IMMUN, V80, P2528, DOI 10.1128/IAI.06337-11; Lin CY, 1999, J LIPID RES, V40, P1618; LUC G, 1991, AM J CLIN NUTR, V53, pS206, DOI 10.1093/ajcn/53.1.206S; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Malle E, 2006, ARCH BIOCHEM BIOPHYS, V445, P245, DOI 10.1016/j.abb.2005.08.008; Marsche G, 2002, J BIOL CHEM, V277, P32172, DOI 10.1074/jbc.M200503200; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; OBRIEN KD, 1994, AM J PATHOL, V144, P538; Panzenboeck U, 1997, J BIOL CHEM, V272, P29711, DOI 10.1074/jbc.272.47.29711; Park JG, 2011, BMB REP, V44, P497, DOI 10.5483/BMBRep.2011.44.8.497; Pennathur Subramaniam, 2007, Curr Diab Rep, V7, P257, DOI 10.1007/s11892-007-0041-3; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sharp JS, 2007, BIOPHYS J, V92, P1682, DOI 10.1529/biophysj.106.099093; Shi RZ, 2011, CARDIOVASC RES, V91, P27, DOI 10.1093/cvr/cvr042; SHIMANO H, 1995, J CLIN INVEST, V95, P469, DOI 10.1172/JCI117687; SING CF, 1985, AM J HUM GENET, V37, P268; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Smith JD, 1996, J BIOL CHEM, V271, P30647, DOI 10.1074/jbc.271.48.30647; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Szasz T, 2007, EXP BIOL MED, V232, P27; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; Tian L, 2009, ATHEROSCLEROSIS, V202, P152, DOI 10.1016/j.atherosclerosis.2008.04.011; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57571	10.1371/journal.pone.0057571	http://dx.doi.org/10.1371/journal.pone.0057571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451244	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500115
J	Wu, AL; Feng, B; Chen, MZ; Kolumam, G; Zavala-Solorio, J; Wyatt, SK; Gandham, VD; Carano, RAD; Sonoda, J				Wu, Ai-Luen; Feng, Bo; Chen, Mark Z.; Kolumam, Ganesh; Zavala-Solorio, Jose; Wyatt, Shelby K.; Gandham, Vineela D.; Carano, Richard A. D.; Sonoda, Junichiro			Antibody-Mediated Activation of FGFR1 Induces FGF23 Production and Hypophosphatemia	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; VITAMIN-D; MORPHOMETRIC-ANALYSIS; PHOSPHATE; BONE; EXPRESSION; MUTATIONS; RECEPTOR; MINERALIZATION; PROTEIN	The phosphaturic hormone Fibroblast Growth Factor 23 (FGF23) controls phosphate homeostasis by regulating renal expression of sodium-dependent phosphate co-transporters and cytochrome P450 enzymes involved in vitamin D catabolism. Multiple FGF Receptors (FGFRs) can act as receptors for FGF23 when bound by the co-receptor Klotho expressed in the renal tubular epithelium. FGFRs also regulate skeletal FGF23 secretion; ectopic FGFR activation is implicated in genetic conditions associated with FGF23 overproduction and hypophosphatemia. The identity of FGFRs that mediate the activity of FGF23 or that regulate skeletal FGF23 secretion remains ill defined. Here we report that pharmacological activation of FGFR1 with monoclonal anti-FGFR1 antibodies (R1MAb) in adult mice is sufficient to cause an elevation in serum FGF23 and mild hypophosphatemia. In cultured rat calvariae osteoblasts, R1MAb induces FGF23 mRNA expression and FGF23 protein secretion into the culture medium. In a cultured kidney epithelial cell line, R1MAb acts as a functional FGF23 mimetic and activates the FGF23 program. siRNA-mediated Fgfr1 knockdown induced the opposite effects. Taken together, our work reveals the central role of FGFR1 in the regulation of FGF23 production and signal transduction, and has implications in the pathogenesis of FGF23-related hypophosphatemic disorders.	[Wu, Ai-Luen; Feng, Bo; Chen, Mark Z.; Sonoda, Junichiro] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kolumam, Ganesh; Zavala-Solorio, Jose; Wyatt, Shelby K.; Gandham, Vineela D.; Carano, Richard A. D.] Genentech Inc, Biomed Imaging, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Sonoda, J (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	junichis@gene.com						Bai XY, 2004, ENDOCRINOLOGY, V145, P5269, DOI 10.1210/en.2004-0233; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bhatia A, 2012, J MECH BEHAV BIOMED, V5, P1, DOI 10.1016/j.jmbbm.2011.08.026; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Brown AP, 2005, TOXICOL PATHOL, V33, P449, DOI 10.1080/01926230590961845; Brownstein CA, 2010, ENDOCRINOLOGY, V151, P492, DOI 10.1210/en.2009-0564; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Gattineni J, 2011, AM J PHYSIOL-RENAL, V301, pF371, DOI 10.1152/ajprenal.00740.2010; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Ito M, 2005, AM J PHYSIOL-ENDOC M, V288, pE1101, DOI 10.1152/ajpendo.00502.2004; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Levy-Litan V, 2010, AM J HUM GENET, V86, P273, DOI 10.1016/j.ajhg.2010.01.010; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/ng0501-37; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Razzaque MS, 2009, NAT REV ENDOCRINOL, V5, P611, DOI 10.1038/nrendo.2009.196; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200	42	81	84	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57322	10.1371/journal.pone.0057322	http://dx.doi.org/10.1371/journal.pone.0057322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451204	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800098
J	Rana, S; Lattoo, SK; Dhar, N; Razdan, S; Bhat, WW; Dhar, RS; Vishwakarma, R				Rana, Satiander; Lattoo, Surrinder K.; Dhar, Niha; Razdan, Sumeer; Bhat, Wajid Waheed; Dhar, Rekha S.; Vishwakarma, Ram			NADPH-Cytochrome P450 Reductase: Molecular Cloning and Functional Characterization of Two Paralogs from Withania somnifera (L.) Dunal	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; CDNA CLONING; ARABIDOPSIS-THALIANA; STRUCTURE PREDICTION; SQUALENE SYNTHASE; ELECTRON-TRANSFER; ESCHERICHIA-COLI; GENE-EXPRESSION; WITHAFERIN-A; BIOSYNTHESIS	Withania somnifera (L.) Dunal, a highly reputed medicinal plant, synthesizes a large array of steroidal lactone triterpenoids called withanolides. Although its chemical profile and pharmacological activities have been studied extensively during the last two decades, limited attempts have been made to decipher the biosynthetic route and identification of key regulatory genes involved in withanolide biosynthesis. Cytochrome P450 reductase is the most imperative redox partner of multiple P450s involved in primary and secondary metabolite biosynthesis. We describe here the cloning and characterization of two paralogs of cytochrome P450 reductase from W. somnifera. The full length paralogs of WsCPR1 and WsCPR2 have open reading frames of 2058 and 2142 bp encoding 685 and 713 amino acid residues, respectively. Phylogenetic analysis demonstrated that grouping of dual CPRs was in accordance with class I and class II of eudicotyledon CPRs. The corresponding coding sequences were expressed in Escherichia coli as glutathione-S-transferase fusion proteins, purified and characterized. Recombinant proteins of both the paralogs were purified with their intact membrane anchor regions and it is hitherto unreported for other CPRs which have been purified from microsomal fraction. Southern blot analysis suggested that two divergent isoforms of CPR exist independently in Withania genome. Quantitative real-time PCR analysis indicated that both genes were widely expressed in leaves, stalks, roots, flowers and berries with higher expression level of WsCPR2 in comparison to WsCPR1. Similar to CPRs of other plant species, WsCPR1 was un-inducible while WsCPR2 transcript level increased in a time-dependent manner after elicitor treatments. High performance liquid chromatography of withanolides extracted from elicitor-treated samples showed a significant increase in two of the key withanolides, withanolide A and withaferin A, possibly indicating the role of WsCPR2 in withanolide biosynthesis. Present investigation so far is the only report of characterization of CPR paralogs from W. somnifera.	[Rana, Satiander; Lattoo, Surrinder K.; Dhar, Niha; Razdan, Sumeer; Bhat, Wajid Waheed; Dhar, Rekha S.; Vishwakarma, Ram] Indian Inst Integrat Med CSIR, Jammu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM)	Lattoo, SK (corresponding author), Indian Inst Integrat Med CSIR, Canal Rd, Jammu, India.	sklattoo@iiim.ac.in	Rana, Satiander/G-3696-2012; Bhat, Wajid Waheed/E-6645-2012	Rana, Satiander/0000-0001-9197-8378; Bhat, Wajid Waheed/0000-0002-7049-8671; DHAR, NIHA/0000-0002-3295-8016	Council of Scientific and Industrial Research, Government of India, New Delhi [NWP 0008]	Council of Scientific and Industrial Research, Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The financial grant from Council of Scientific and Industrial Research, Government of India, New Delhi under Network Project NWP 0008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigrain L, 2009, ACTA CRYSTALLOGR F, V65, P210, DOI 10.1107/S1744309109000700; ANDERSEN JF, 1994, BIOCHEMISTRY-US, V33, P2171, DOI 10.1021/bi00174a025; BENVENISTE I, 1991, BIOCHEM BIOPH RES CO, V177, P105, DOI 10.1016/0006-291X(91)91954-B; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Dhar RS, 2006, PHYTOCHEMISTRY, V67, P2269, DOI 10.1016/j.phytochem.2006.07.014; Duan Hui, 2006, Phytochemistry Reviews, V5, P507, DOI 10.1007/s11101-006-9009-1; Eberle D, 2009, PLANT MOL BIOL, V69, P239, DOI 10.1007/s11103-008-9420-7; ELSAKKA M, 1990, Revista Medico-Chirurgicala Societatii di Medici si Naturalisti din Iasi, V94, P385; Feldmann KA, 2001, CURR OPIN PLANT BIOL, V4, P162, DOI 10.1016/S1369-5266(00)00154-0; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Hrycay EG, 2012, ARCH BIOCHEM BIOPHYS, V522, P71, DOI 10.1016/j.abb.2012.01.003; Huang FC, 2012, PLANT SCI, V190, P16, DOI 10.1016/j.plantsci.2012.03.007; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Jayaprakasam B, 2010, PHYTOTHER RES, V24, P859, DOI 10.1002/ptr.3033; Jennewein S, 2005, BIOTECHNOL BIOENG, V89, P588, DOI 10.1002/bit.20390; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim OT, 2010, PLANT CELL REP, V29, P403, DOI 10.1007/s00299-010-0831-y; Koduru S, 2010, MOL CANCER THER, V9, P202, DOI 10.1158/1535-7163.MCT-09-0771; Koopmann E, 1997, P NATL ACAD SCI USA, V94, P14954, DOI 10.1073/pnas.94.26.14954; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lattoo SK, 2007, CURR SCI INDIA, V92, P1390; Lee MH, 2004, PLANT CELL PHYSIOL, V45, P976, DOI 10.1093/pcp/pch126; McLean KJ, 2005, BIOCHEM SOC T, V33, P796, DOI 10.1042/BST0330796; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Pal S, 2011, J HORTIC SCI BIOTECH, V86, P391, DOI 10.1080/14620316.2011.11512779; Pritchard MP, 1998, PHARMACOGENETICS, V8, P33, DOI 10.1097/00008571-199802000-00005; Ranathunga S., 2012, INTERFACING COGNITIV, P1; Razdan S, 2012, MOL BIOL REP, P1; Ro DK, 2002, PLANT PHYSIOL, V130, P1837, DOI 10.1104/pp.008011; Rosco A, 1997, ARCH BIOCHEM BIOPHYS, V348, P369, DOI 10.1006/abbi.1997.0374; Sambrook J, 2001, MOL CLONING LAB MANU; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Schwarz H, 2009, PLANT BIOLOGY, V11, P300, DOI 10.1111/j.1438-8677.2008.00137.x; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SHEN A, 1993, PROTEIN ENG, V6, P50; SHET MS, 1993, P NATL ACAD SCI USA, V90, P2890, DOI 10.1073/pnas.90.7.2890; SIMMONS DL, 1985, J BIOL CHEM, V260, P515; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Varadarajan J, 2010, NEW PHYTOL, V187, P67, DOI 10.1111/j.1469-8137.2010.03254.x; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Yang CQ, 2010, PHYTOCHEMISTRY, V71, P27, DOI 10.1016/j.phytochem.2009.09.026	57	43	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57068	10.1371/journal.pone.0057068	http://dx.doi.org/10.1371/journal.pone.0057068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437311	Green Published, Green Submitted, gold			2022-12-25	WOS:000315186000072
J	Cheng, PH; Rao, XM; McMasters, KM; Zhou, HS				Cheng, Pei-Hsin; Rao, Xiao-Mei; McMasters, Kelly M.; Zhou, Heshan Sam			Molecular Basis for Viral Selective Replication in Cancer Cells: Activation of CDK2 by Adenovirus-Induced Cyclin E	PLOS ONE			English	Article							E1B 55-KILODALTON PROTEIN; P53 TUMOR-SUPPRESSOR; BREAST-CANCER; RETINOBLASTOMA PROTEIN; DEPENDENT KINASES; IN-VIVO; DNA-REPLICATION; WEIGHT FORMS; RNA OVEREXPRESSION; REPRESSES P53	Adenoviruses (Ads) with deletion of E1b55K preferentially replicate in cancer cells and have been used in cancer therapies. We have previously shown that Ad E1B55K protein is involved in induction of cyclin E for Ad replication, but this E1B55K function is not required in cancer cells in which deregulation of cyclin E is frequently observed. In this study, we investigated the interaction of cyclin E and CDK2 in Ad-infected cells. Ad infection significantly increased the large form of cyclin E (cyclin EL), promoted cyclin E/CDK2 complex formation and increased CDK2 phosphorylation at the T160 site. Activated CDK2 caused pRb phosphorylation at the S612 site. Repression of CDK2 activity with the chemical inhibitor roscovitine or with specific small interfering RNAs significantly decreased pRb phosphorylation, with concomitant repression of viral replication. Our results suggest that Ad-induced cyclin E activates CDK2 that targets the transcriptional repressor pRb to generate a cellular environment for viral productive replication. This study reveals a new molecular basis for oncolytic replication of E1b-deleted Ads and will aid in the development of new strategies for Ad oncolytic virotherapies.	[Cheng, Pei-Hsin; McMasters, Kelly M.] Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McMasters, Kelly M.; Zhou, Heshan Sam] Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA; [Rao, Xiao-Mei; Zhou, Heshan Sam] Univ Louisville, Sch Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Zhou, Heshan Sam] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Zhou, HS (corresponding author), Univ Louisville, Sch Med, Dept Surg, Louisville, KY 40292 USA.	hszhou01@louisville.edu			NIH Grant [R01 CA129975]; K. C. Huang Scholarship from the University of Louisville; NATIONAL CANCER INSTITUTE [R01CA129975] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); K. C. Huang Scholarship from the University of Louisville; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grant R01 CA129975 (to HSZ http://www.nih.gov/). PHC is partially supported by the K. C. Huang Scholarship from the University of Louisville (http://louisville.edu/medschool/pharmacology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akli S, 2004, CANCER RES, V64, P3198, DOI 10.1158/0008-5472.CAN-03-3672; Akli S, 2010, CLIN CANCER RES, V16, P1179, DOI 10.1158/1078-0432.CCR-09-1787; Avvakumov N, 2002, J GEN VIROL, V83, P517, DOI 10.1099/0022-1317-83-3-517; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; Ben-Israel H, 2002, FRONT BIOSCI-LANDMRK, V7, pD1369, DOI 10.2741/ben; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; BRAITHWAITE A, 1990, VIROLOGY, V177, P595, DOI 10.1016/0042-6822(90)90525-V; Chou MM, 2003, J BIOL CHEM, V278, P35241, DOI 10.1074/jbc.M305246200; ConnellCrowley L, 1997, MOL BIOL CELL, V8, P287, DOI 10.1091/mbc.8.2.287; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Dix BR, 2001, J VIROL, V75, P5443, DOI 10.1128/JVI.75.12.5443-5447.2001; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; DYSON N, 1992, CANCER SURV, V12, P161; Freemantle SJ, 2010, CANCER PREV RES, V3, P1513, DOI 10.1158/1940-6207.CAPR-10-0297; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Geisen C, 2002, J BIOL CHEM, V277, P39909, DOI 10.1074/jbc.M205919200; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Geoerger B, 2002, CANCER RES, V62, P764; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Goodrum FD, 1998, J VIROL, V72, P9479, DOI 10.1128/JVI.72.12.9479-9490.1998; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Harwell RM, 2004, J BIOL CHEM, V279, P12695, DOI 10.1074/jbc.M313407200; HAYFLICK L, 1962, AM J HYG, V75, P240, DOI 10.1093/oxfordjournals.aje.a120247; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hobom U, 2004, J VIROL, V78, P7685, DOI 10.1128/JVI.78.14.7685-7697.2004; Hsieh WS, 2009, CLIN CANCER RES, V15, P1435, DOI 10.1158/1078-0432.CCR-08-1748; HUI Z, 1993, MOL BIOL CELL, V4, P897, DOI 10.1091/mbc.4.9.897; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; KAO CC, 1990, VIROLOGY, V179, P806, DOI 10.1016/0042-6822(90)90148-K; KEYOMARSI K, 1994, CANCER RES, V54, P380; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Loeb KR, 2005, CANCER CELL, V8, P35, DOI 10.1016/j.ccr.2005.06.010; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; LUDLOW JW, 1995, VIRUS RES, V35, P113, DOI 10.1016/0168-1702(94)00094-S; Marone M, 1998, INT J CANCER, V75, P34, DOI 10.1002/(SICI)1097-0215(19980105)75:1<34::AID-IJC6>3.0.CO;2-2; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Minella AC, 2002, CURR BIOL, V12, P1817, DOI 10.1016/S0960-9822(02)01225-3; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Nevels M, 1997, P NATL ACAD SCI USA, V94, P1206, DOI 10.1073/pnas.94.4.1206; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Pelka P, 2011, J VIROL, V85, P8841, DOI 10.1128/JVI.00539-11; Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Querido E, 1997, J VIROL, V71, P3788, DOI 10.1128/JVI.71.5.3788-3798.1997; Rao XM, 2006, VIROLOGY, V350, P418, DOI 10.1016/j.virol.2006.02.009; Rao XM, 2004, CANCER GENE THER, V11, P585, DOI 10.1038/sj.cgt.7700739; Raynaud FI, 2005, CLIN CANCER RES, V11, P4875, DOI 10.1158/1078-0432.CCR-04-2264; Rogulski KR, 2000, CANCER RES, V60, P1193; Rothmann T, 1998, J VIROL, V72, P9470, DOI 10.1128/JVI.72.12.9470-9478.1998; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Sawasaki T, 2001, J SOC GYNECOL INVEST, V8, P179, DOI 10.1016/S1071-5576(01)00102-2; Schmitz NMR, 2005, LEUKEMIA, V19, P1783, DOI 10.1038/sj.leu.2403900; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shenk T, 2001, VIROLOGY, P2265; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wienzek S, 2000, J VIROL, V74, P193, DOI 10.1128/JVI.74.1.193-202.2000; Wingate H, 2009, CELL CYCLE, V8, P1062, DOI 10.4161/cc.8.7.8119; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhao TJ, 2003, CANCER RES, V63, P3073; Zheng X, 2006, CANCER GENE THER, V13, P572, DOI 10.1038/sj.cgt.7700923; Zheng X, 2008, J VIROL, V82, P3415, DOI 10.1128/JVI.01708-07; Zhu HY, 2005, J BIOL CHEM, V280, P29282, DOI 10.1074/jbc.M407352200	93	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57340	10.1371/journal.pone.0057340	http://dx.doi.org/10.1371/journal.pone.0057340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437375	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200247
J	Telwala, Y; Brook, BW; Manish, K; Pandit, MK				Telwala, Yasmeen; Brook, Barry W.; Manish, Kumar; Pandit, Maharaj K.			Climate-Induced Elevational Range Shifts and Increase in Plant Species Richness in a Himalayan Biodiversity Epicentre	PLOS ONE			English	Article							MOUNTAIN PLANTS; INDIAN HIMALAYA; VASCULAR PLANTS; NEPAL HIMALAYA; ALPS; DISTRIBUTIONS; VEGETATION; DIVERSITY; MIGRATION; RESPONSES	Global average temperature increase during the last century has induced species geographic range shifts and extinctions. Montane floras, in particular, are highly sensitive to climate change and mountains serve as suitable observation sites for tracing climate-induced biological response. The Himalaya constitute an important global biodiversity hotspot, yet studies on species' response to climate change from this region are lacking. Here we use historical (1849-50) and the recent (2007-2010) data on temperature and endemic species' elevational ranges to perform a correlative study in the two alpine valleys of Sikkim. We show that the ongoing warming in the alpine Sikkim Himalaya has transformed the plant assemblages. This study lends support to the hypothesis that changing climate is causing species distribution changes. We provide first evidence of warmer winters in the region compared to the last two centuries, with mean temperatures of the warmest and the coldest months may have increased by 0.76 +/- 0.25 degrees C and 3.65 +/- 2 degrees C, respectively. Warming-driven geographical range shifts were recorded in 87% of 124 endemic plant species studied in the region; upper range extensions of species have resulted in increased species richness in the upper alpine zone, compared to the 19th century. We recorded a shift of 23998 m in species' upper elevation limit and a mean upward displacement rate of 27.53 +/- 22.04 m/decade in the present study. We infer that the present-day plant assemblages and community structure in the Himalaya is substantially different from the last century and is, therefore, in a state of flux under the impact of warming. The continued trend of warming is likely to result in ongoing elevational range contractions and eventually, species extinctions, particularly at mountaintops.	[Telwala, Yasmeen; Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Delhi 110007, India; [Telwala, Yasmeen; Manish, Kumar; Pandit, Maharaj K.] Univ Delhi, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India; [Brook, Barry W.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Brook, Barry W.] Univ Adelaide, Inst Environm, Adelaide, SA, Australia; [Pandit, Maharaj K.] Natl Univ Singapore, Univ Scholars Programme, Singapore 117548, Singapore	University of Delhi; University of Delhi; University of Adelaide; University of Adelaide; National University of Singapore	Pandit, MK (corresponding author), Univ Delhi, Dept Environm Studies, Delhi 110007, India.	rajkpandit@gmail.com	Pandit, Maharaj K/A-4065-2014; Brook, Barry W./G-2686-2011; Manish, Kumar/M-5034-2019	Pandit, Maharaj K/0000-0001-6611-560X; Brook, Barry W./0000-0002-2491-1517; Manish, Kumar/0000-0002-0373-0426	Research Fellowship award of the University Grants Commission (UGC), Government of India	Research Fellowship award of the University Grants Commission (UGC), Government of India	The study was supported by Research Fellowship award of the University Grants Commission (UGC), Government of India to YT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann D., 1995, P81; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bluemle P, 1999, ENV GEOSCI, V6, P63; CISMHE, 2007, CARR CAP STUD TEEST, VII; DAS SM, 1966, NATURE, V212, P1327, DOI 10.1038/2121327a0; Diaz HF, 2003, CLIMATIC CHANGE, V59, P1, DOI 10.1023/A:1024416227887; Folland CK, 2001, CLIMATE CHANGE 2001; Gansser A., 1964, GEOLOGY HIMALAYA; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Grumbine RE, 2013, SCIENCE, V339, P36, DOI 10.1126/science.1227211; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Guisan A, 2000, INTEGRAT ASS, V1, P307; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Harris SA, 2007, ERDKUNDE, V61, P344, DOI 10.3112/erdkunde.2007.04.05; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holzinger B, 2008, PLANT ECOL, V195, P179, DOI 10.1007/s11258-007-9314-9; HOOKER JD, 1854, HIMALAYAN J; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; KORNER C, 1988, SYM SOC EXP BIOL, V42, P25; Korner C, 1999, ALPINE PLANT LIFE FU; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Liu X., 1998, CHINESE GEOGR SCI, V8, P289, DOI DOI 10.1007/S11769-997-0034-9; Meehl GA, 1996, GEOPHYS RES LETT, V23, P3755, DOI 10.1029/96GL03478; Miehe G, 1996, PALAEOGEOGR PALAEOCL, V120, P5, DOI 10.1016/0031-0182(95)00031-3; OHSAWA M, 1986, MT RES DEV, V6, P143, DOI 10.2307/3673268; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Pandit MK, 2009, CONSERV BIOL, V23, P1346, DOI 10.1111/j.1523-1739.2009.01359.x; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parolo G, 2008, BASIC APPL ECOL, V9, P100, DOI 10.1016/j.baae.2007.01.005; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Price LW, 1981, MOUNTAINS MAN; Rowley DB, 1996, EARTH PLANET SC LETT, V145, P1, DOI 10.1016/S0012-821X(96)00201-4; Salick J, 2009, GLOBAL ENVIRON CHANG, V19, P147, DOI 10.1016/j.gloenvcha.2009.01.008; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Shrestha AB, 2000, INT J CLIMATOL, V20, P317, DOI 10.1002/(SICI)1097-0088(20000315)20:3&lt;317::AID-JOC476&gt;3.0.CO;2-G; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; SINGH JS, 1987, BOT REV, V53, P80, DOI 10.1007/BF02858183; Smith WW, 1911, VEGETATION ZEMU LHON; STOHLGREN TJ, 1995, VEGETATIO, V117, P113, DOI 10.1007/BF00045503; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	49	176	180	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57103	10.1371/journal.pone.0057103	http://dx.doi.org/10.1371/journal.pone.0057103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437322	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200215
J	Ryberg, WA; Hill, MT; Painter, CW; Fitzgerald, LA				Ryberg, Wade A.; Hill, Michael T.; Painter, Charles W.; Fitzgerald, Lee A.			Landscape Pattern Determines Neighborhood Size and Structure within a Lizard Population	PLOS ONE			English	Article							DYNAMICS; MODELS	Although defining population structure according to discrete habitat patches is convenient for metapopulation theories, taking this approach may overlook structure within populations continuously distributed across landscapes. For example, landscape features within habitat patches direct the movement of organisms and define the density distribution of individuals, which can generate spatial structure and localized dynamics within populations as well as among them. Here, we use the neighborhood concept, which describes population structure relative to the scale of individual movements, to illustrate how localized dynamics within a population of lizards (Sceloporus arenicolus) arise in response to variation in landscape pattern within a continuous habitat patch. Our results emphasize links between individual movements at small scales and the emergence of spatial structure within populations which resembles metapopulation dynamics at larger scales. We conclude that population dynamics viewed in a landscape context must consider the explicit distribution and movement of individuals within continuous habitat as well as among habitat patches.	[Ryberg, Wade A.; Hill, Michael T.; Fitzgerald, Lee A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Painter, Charles W.] New Mexico Dept Game & Fish, Endangered Species Program, Santa Fe, NM USA	Texas A&M University System; Texas A&M University College Station; New Mexico Department of Game and Fish	Ryberg, WA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	waryberg@tamu.edu	Fitzgerald, Lee A/I-5193-2013	Ryberg, Wade/0000-0003-2548-8113; Fitzgerald, Lee/0000-0001-5648-9480	Bureau of Land Management	Bureau of Land Management	This study was funded by the Bureau of Land Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1987, OIKOS, V49, P340, DOI 10.2307/3565770; AMARASEKARE P, 1994, OECOLOGIA, V100, P166, DOI 10.1007/BF00317143; Chan LM, 2009, CONSERV GENET, V10, P131, DOI 10.1007/s10592-008-9537-x; Clobert Jean, 2004, P307, DOI 10.1016/B978-012323448-3/50015-5; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Degenhardt W. G., 1996, AMPHIBIANS REPTILES; Diez J. M., 2011, Sources, sinks and sustainability, P291; Fitzgerald L.A., 2009, LIZARDS AM SW, P128; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; FRANKLIN AB, 1992, WILDLIFE 2001 : POPULATIONS, P815; Fraterrigo JM, 2009, LANDSCAPE ECOL, V24, P863, DOI 10.1007/s10980-009-9364-6; Gilpin ME, 1987, VIABLE POPULATIONS C, P126; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski I., 1999, METAPOPULATION ECOLO; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; JOHNSON AR, 1992, LANDSCAPE ECOL, V7, P63, DOI 10.1007/BF02573958; KERSTER HW, 1964, EVOLUTION, V18, P445, DOI 10.2307/2406355; Laurencio LR, 2010, ATLAS DISTRIBUTION H; McCauley David E., 1995, IALE Studies in Landscape Ecology, V2, P178; McGarigal K., 2002, FRAGSTATS SPATIAL PA; Neville P, 2005, NATURAL HERITAGE NEW, V05-GTR-285; PACALA SW, 1985, AM NAT, V125, P385, DOI 10.1086/284349; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ritchie M.E., 2009, SCALE HETEROGENEITY; Roy M, 2008, J THEOR BIOL, V255, P152, DOI 10.1016/j.jtbi.2008.07.022; Ryberg WA, W N AM NAT IN PRESS; Smolensky NL, 2011, SOUTHWEST NAT, V56, P315, DOI 10.1894/F03-MLK-21.1; Smolensky NL, 2010, J HERPETOL, V44, P372, DOI 10.1670/10-008.1; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Turchin Peter, 1998; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wiens J. A., 2011, Sources, sinks and sustainability, P507; Wiens John A., 1997, P43, DOI 10.1016/B978-012323445-2/50005-5; With Kimberly A., 2004, P23, DOI 10.1016/B978-012323448-3/50004-0; WRIGHT S, 1946, GENETICS, V31, P39	35	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56856	10.1371/journal.pone.0056856	http://dx.doi.org/10.1371/journal.pone.0056856			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441217	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200074
J	Schneider, RM; Thurtell, MJ; Eisele, S; Lincoff, N; Bala, E; Leigh, RJ				Schneider, Rosalyn M.; Thurtell, Matthew J.; Eisele, Sylvia; Lincoff, Norah; Bala, Elisa; Leigh, R. John			Neurological Basis for Eye Movements of the Blind	PLOS ONE			English	Article							HEIMANN-BIELSCHOWSKY PHENOMENON; OCULOMOTOR BURST GENERATOR; MONOCULAR VISUAL-LOSS; NEURAL-NETWORK MODEL; VESTIBULOOCULAR REFLEX; OCULAR OSCILLATIONS; VERTICAL NYSTAGMUS; ON-DIRECTIONS; NEURONS; VISION	When normal subjects fix their eyes upon a stationary target, their gaze is not perfectly still, due to small movements that prevent visual fading. Visual loss is known to cause greater instability of gaze, but reported comparisons with normal subjects using reliable measurement techniques are few. We measured binocular gaze using the magnetic search coil technique during attempted fixation (monocular or binocular viewing) of 4 individuals with childhood-onset of monocular visual loss, 2 individuals with late-onset monocular visual loss due to age-related macular degeneration, 2 individuals with bilateral visual loss, and 20 healthy control subjects. We also measured saccades to visual or somatosensory cues. We tested the hypothesis that gaze instability following visual impairment is caused by loss of inputs that normally optimize the performance of the neural network (integrator), which ensures both monocular and conjugate gaze stability. During binocular viewing, patients with early-onset monocular loss of vision showed greater instability of vertical gaze in the eye with visual loss and, to a lesser extent, in the normal eye, compared with control subjects. These vertical eye drifts were much more disjunctive than upward saccades. In individuals with late monocular visual loss, gaze stability was more similar to control subjects. Bilateral visual loss caused eye drifts that were larger than following monocular visual loss or in control subjects. Accurate saccades could be made to somatosensory cues by an individual with acquired blindness, but voluntary saccades were absent in an individual with congenital blindness. We conclude that the neural gaze-stabilizing network, which contains neurons with both binocular and monocular discharge preferences, is under adaptive visual control. Whereas monocular visual loss causes disjunctive gaze instability, binocular blindness causes both disjunctive and conjugate gaze instability (drifts and nystagmus). Inputs that bypass this neural network, such as projections to motoneurons for upward saccades, remain conjugate.	[Schneider, Rosalyn M.; Eisele, Sylvia; Leigh, R. John] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Thurtell, Matthew J.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Thurtell, Matthew J.] Vet Affairs Med Ctr, Neurol Serv, Iowa City, IA 52242 USA; [Thurtell, Matthew J.] Vet Affairs Med Ctr, Ctr Prevent & Treatment Visual Loss, Iowa City, IA 52242 USA; [Lincoff, Norah] SUNY Buffalo, Jacobs Neurol Inst, Buffalo, NY 14260 USA; [Bala, Elisa] Cleveland Clin Fdn, Dept Ophthalmol, Cleveland, OH 44195 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Cleveland Clinic Foundation	Leigh, RJ (corresponding author), Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA.	rjl4@case.edu		Thurtell, Matthew/0000-0002-1546-5463	National Institutes of Health [NIH R01 EY06717]; Department of Veterans Affairs; Evenor Armington Fund of Case Medical Center; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Evenor Armington Fund of Case Medical Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health (NIH R01 EY06717), the Department of Veterans Affairs, and the Evenor Armington Fund of Case Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold DB, 1997, EXP BRAIN RES, V113, P57, DOI 10.1007/BF02454142; Bielschowsky A, 1931, ARCH OPHTHALMOL-CHIC, V125, P493; Carpenter RHS, 1991, EYE MOVEMENTS, V8, P1; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P183, DOI 10.1113/jphysiol.1988.sp017285; Das VE, 2000, EXP BRAIN RES, V133, P189, DOI 10.1007/s002210000367; Davey K, 1998, AUST NZ J OPHTHALMOL, V26, P237, DOI 10.1111/j.1442-9071.1998.tb01318.x; FERMAN L, 1987, VISION RES, V27, P811, DOI 10.1016/0042-6989(87)90078-2; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Garbutt S, 2003, VISION RES, V43, P347, DOI 10.1016/S0042-6989(02)00387-5; Gonzalez EG, 2012, INVEST OPHTH VIS SCI, V53, P5386, DOI 10.1167/iovs.12-9941; Gottlob I, 1996, GRAEF ARCH CLIN EXP, V234, P369, DOI 10.1007/BF00190713; Hall EC, 2000, OPTOMETRY VISION SCI, V77, P511, DOI 10.1097/00006324-200010000-00005; Heimann E, 1902, KLIN MONATSBLAT AUGE, V49, P99; Helmchen C, 1998, EXP BRAIN RES, V119, P436, DOI 10.1007/s002210050359; Jeong S-H, 2008, Br J Ophthalmol, V92, P1402, DOI 10.1136/bjo.2007.135624; KOMPF D, 1987, J NEUROL, V234, P337, DOI 10.1007/BF00314291; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; LEIGH RJ, 1980, INVEST OPHTH VIS SCI, V19, P328; LEIGH RJ, 1989, INVEST OPHTH VIS SCI, V30, P288; Liao K, 2008, EXP BRAIN RES, V185, P553, DOI 10.1007/s00221-007-1181-z; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; Migliaccio AA, 2010, J PHYSIOL-LONDON, V588, P3855, DOI 10.1113/jphysiol.2010.196287; MOSCHOVAKIS AK, 1991, J NEUROPHYSIOL, V65, P203, DOI 10.1152/jn.1991.65.2.203; MOSCHOVAKIS AK, 1990, SCIENCE, V248, P1118, DOI 10.1126/science.2343316; MOSCHOVAKIS AK, 1991, J NEUROPHYSIOL, V65, P218, DOI 10.1152/jn.1991.65.2.218; Nau A, 2012, BRAIN STRUCT FUNCT, V217, P761, DOI 10.1007/s00429-012-0392-7; Navarro-Lopez JD, 2005, J NEUROSCI, V25, P9902, DOI 10.1523/JNEUROSCI.2061-05.2005; Ono S, 2012, INVEST OPHTH VIS SCI, V53, P2038, DOI 10.1167/iovs.11-9011; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Rahman W, 2006, AM J OPHTHALMOL, V141, P221, DOI 10.1016/j.ajo.2005.08.022; Ramat S, 1999, INVEST OPHTH VIS SCI, V40, P1681; ROBINSON DA, 1975, INVEST OPHTH VISUAL, V14, P413; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROBINSON DA, 1974, BRAIN RES, V71, P195, DOI 10.1016/0006-8993(74)90961-5; Schor CM, 2009, OPTOMETRY VISION SCI, V86, P788, DOI 10.1097/OPX.0b013e3181ae00a5; Schubert MC, 2010, RESTOR NEUROL NEUROS, V28, P9, DOI 10.3233/RNN-2010-0523; SHERMAN KR, 1986, INVEST OPHTH VIS SCI, V27, P1154; SKAVENSKI AA, 1973, J NEUROPHYSIOL, V36, P724, DOI 10.1152/jn.1973.36.4.724; SMITH JL, 1982, J CLIN NEURO-OPHTHAL, V2, P85; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; STRAUMANN D, 1991, INT J BIOMED COMPUT, V29, P61, DOI 10.1016/0020-7101(91)90013-5; Surachatkumtonekul Thammanoon, 2009, Journal of the Medical Association of Thailand, V92, P373; Sylvestre PA, 2003, J NEUROPHYSIOL, V90, P739, DOI 10.1152/jn.00123.2003; Tarita-Nistor L, 2011, INVEST OPHTH VIS SCI, V52, P1887, DOI 10.1167/iovs.10-6059; WALLS GL, 1962, VISION RES, V2, P69, DOI 10.1016/0042-6989(62)90064-0; YEE RD, 1979, OPHTHALMOLOGY, V86, P511; YGGE J, 1995, VISION RES, V35, P3169, DOI 10.1016/0042-6989(95)00125-J; ZEE DS, 1984, AM J OPHTHALMOL, V97, P587, DOI 10.1016/0002-9394(84)90377-5	50	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56556	10.1371/journal.pone.0056556	http://dx.doi.org/10.1371/journal.pone.0056556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441203	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200060
J	Shoemaker, CJ; Schornberg, KL; Delos, SE; Scully, C; Pajouhesh, H; Olinger, GG; Johansen, LM; White, JM				Shoemaker, Charles J.; Schornberg, Kathryn L.; Delos, Sue E.; Scully, Corinne; Pajouhesh, Hassan; Olinger, Gene G.; Johansen, Lisa M.; White, Judith M.			Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection	PLOS ONE			English	Article							ATOMIC PHYSICOCHEMICAL PARAMETERS; SMALL-MOLECULE INHIBITORS; ACID SPHINGOMYELINASE; QUANTITATIVE STRUCTURE; CATHEPSIN-L; LOG-P; GLYCOPROTEIN; PROTEIN; CELLS; PATHOGENESIS	Ebola virus (EBOV) is an enveloped RNA virus that causes hemorrhagic fever in humans and non-human primates. Infection requires internalization from the cell surface and trafficking to a late endocytic compartment, where viral fusion occurs, providing a conduit for the viral genome to enter the cytoplasm and initiate replication. In a concurrent study, we identified clomiphene as a potent inhibitor of EBOV entry. Here, we screened eleven inhibitors that target the same biosynthetic pathway as clomiphene. From this screen we identified six compounds, including U18666A, that block EBOV infection (IC50 1.6 to 8.0 mu M) at a late stage of entry. Intriguingly, all six are cationic amphiphiles that share additional chemical features. U18666A induces phenotypes, including cholesterol accumulation in endosomes, associated with defects in Niemann-Pick C1 protein (NPC1), a late endosomal and lysosomal protein required for EBOV entry. We tested and found that all six EBOV entry inhibitors from our screen induced cholesterol accumulation. We further showed that higher concentrations of cationic amphiphiles are required to inhibit EBOV entry into cells that overexpress NPC1 than parental cells, supporting the contention that they inhibit EBOV entry in an NPC1-dependent manner. A previously reported inhibitor, compound 3.47, inhibits EBOV entry by blocking binding of the EBOV glycoprotein to NPC1. None of the cationic amphiphiles tested had this effect. Hence, multiple cationic amphiphiles (including several FDA approved agents) inhibit EBOV entry in an NPC1-dependent fashion, but by a mechanism distinct from that of compound 3.47. Our findings suggest that there are minimally two ways of perturbing NPC1-dependent pathways that can block EBOV entry, increasing the attractiveness of NPC1 as an anti-filoviral therapeutic target.	[Shoemaker, Charles J.; Schornberg, Kathryn L.; Delos, Sue E.; White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA; [Scully, Corinne; Olinger, Gene G.] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Pajouhesh, Hassan; Johansen, Lisa M.] Zalicus Inc, Cambridge, MA USA; [White, Judith M.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; Zalicus Inc; University of Virginia	White, JM (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22903 USA.	jw7g@virginia.edu	Shoemaker, Charles J/F-5575-2019; Shoemaker, Charles/L-9283-2019	Shoemaker, Charles J/0000-0002-8974-7033; Shoemaker, Charles/0000-0002-8974-7033; Olinger, Gene/0000-0001-7338-0292	DTRA [4.10007_08_RD_B, W81XWH-08-0051, W81XWH-12-P-0007]; National Institutes of Health [U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, T32AI055432, U54AI057168] Funding Source: NIH RePORTER	DTRA(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work was supported by: DTRA project 4.10007_08_RD_B (G.G.O) and subcontracts W81XWH-08-0051 (L.M.J) and W81XWH-12-P-0007(JMW) as well as a grant from the National Institutes of Health: U54 AI057168 (J.M.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBOUZ S, 1986, LIFE SCI, V38, P357, DOI 10.1016/0024-3205(86)90083-4; Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Arenz C, 2010, CELL PHYSIOL BIOCHEM, V26, P1, DOI 10.1159/000315100; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; Beniac DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029608; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brecher M, 2012, J VIROL, V86, P364, DOI 10.1128/JVI.05708-11; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Cenedella RJ, 2004, J LIPID RES, V45, P1232, DOI 10.1194/jlr.M300469-JLR200; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Dube D, 2009, J VIROL, V83, P2883, DOI 10.1128/JVI.01956-08; Duvvuri M, 2005, BIOCHEMISTRY-US, V44, P15743, DOI 10.1021/bi051759w; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Ertl P, 1997, QUANT STRUCT-ACT REL, V16, P377, DOI 10.1002/qsar.19970160505; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Haines KM, 2012, VIROLOGY, V432, P20, DOI 10.1016/j.virol.2012.05.018; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Johnson RF, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-31; Ko DC, 2001, MOL BIOL CELL, V12, P601, DOI 10.1091/mbc.12.3.601; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Konig G, 2008, MONATSH CHEM, V139, P401, DOI 10.1007/s00706-007-0819-7; Kolter T, 2010, FEBS LETT, V584, P1700, DOI 10.1016/j.febslet.2009.10.021; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Liu RH, 2009, J BIOL CHEM, V284, P1840, DOI 10.1074/jbc.M803741200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Manicassamy B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-75; Martinez O, 2010, CELL MICROBIOL, V12, P148, DOI 10.1111/j.1462-5822.2009.01385.x; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Miller ME, 2012, J VIROL, V86, P7473, DOI 10.1128/JVI.00136-12; Mulherkar N, 2011, VIROLOGY, V419, P72, DOI 10.1016/j.virol.2011.08.009; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Owens CM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.32; Ponce-Balbuena D, 2009, J PHARMACOL EXP THER, V331, P563, DOI 10.1124/jpet.109.156075; REKKER RF, 1993, QUANT STRUCT-ACT REL, V12, P152, DOI 10.1002/qsar.19930120207; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Shoemaker CJ, 2012, MECH EBOLAVIRUS ENTR; Simmons G, 2003, J VIROL, V77, P13433, DOI 10.1128/JVI.77.24.13433-13438.2003; SLATER B, 1994, J PHARM SCI, V83, P1280, DOI 10.1002/jps.2600830918; Smith DR, 2010, ANTIVIR RES, V87, P187, DOI 10.1016/j.antiviral.2010.04.015; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; SOKOL J, 1988, J BIOL CHEM, V263, P3411; Sullivan NJ, 2009, NAT REV MICROBIOL, V7, P393, DOI 10.1038/nrmicro2129; Towner JS, 2005, VIROLOGY, V332, P20, DOI 10.1016/j.virol.2004.10.048; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; White JM, 2012, NAT REV MICROBIOL, V10, P317, DOI 10.1038/nrmicro2764; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	63	114	120	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56265	10.1371/journal.pone.0056265	http://dx.doi.org/10.1371/journal.pone.0056265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441171	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200028
J	Toniolo, A; Buccellati, C; Pinna, C; Gaion, RM; Sala, A; Bolego, C				Toniolo, Alice; Buccellati, Carola; Pinna, Christian; Gaion, Rosa Maria; Sala, Angelo; Bolego, Chiara			Cyclooxygenase-1 and Prostacyclin Production by Endothelial Cells in the Presence of Mild Oxidative Stress	PLOS ONE			English	Article							CARDIOVASCULAR RISK; HYDROGEN-PEROXIDE; COX-2 INHIBITORS; TEA POLYPHENOL; H SYNTHASE-1; NITRIC-OXIDE; (-)-EPIGALLOCATECHIN-3-GALLATE; BIOSYNTHESIS; EXPRESSION	This study aimed at evaluating the relative contribution of endothelial cyclooxygenase-1 and -2 (COX-1 and COX-2) to prostacyclin (PGI(2)) production in the presence of mild oxidative stress resulting from autooxidation of polyphenols such as (-)-epigallocatechin 3-gallate (EGCG), using both endothelial cells in culture and isolated blood vessels. EGCG treatment resulted in an increase in hydrogen peroxide formation in human umbilical vein endothelial cells. In the presence of exogenous arachidonic acid and EGCG, PGI(2) production was preferentially inhibited by a selective COX-1 inhibitor. This effect of selective inhibition was also substantially reversed by catalase. In addition, EGCG caused vasorelaxation of rat aortic ring only partially abolished by a nitric oxide synthase inhibitor. Concomitant treatment with a selective COX-1 inhibitor completely prevented the vasorelaxation as well as the increase in PGI(2) accumulation in the perfusate observed in EGCG-treated aortic rings, while a selective COX-2 inhibitor was completely uneffective. Our data strongly support the notions that H2O2 generation affects endothelial PGI(2) production, making COX-1, and not COX-2, the main source of endothelial PGI(2) under altered oxidative tone conditions. These results might be relevant to the reappraisal of the impact of COX inhibitors on vascular PGI(2) production in patients undergoing significant oxidative stress.	[Toniolo, Alice; Gaion, Rosa Maria; Bolego, Chiara] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Buccellati, Carola; Pinna, Christian; Sala, Angelo] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Sala, Angelo] CNR, IBIM, Palermo, Italy	University of Padua; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Sala, A (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	angelo.sala@unimi.it	Sala, Angelo/H-5478-2019	Sala, Angelo/0000-0001-9290-0257	University of Padova; University of Milan	University of Padova; University of Milan	Chiara Bolego acknowledges support from institutional funding of the University of Padova. Angelo Sala acknowledges support from institutional funding of the University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander LD, 2004, KIDNEY INT, V65, P551, DOI 10.1111/j.1523-1755.2004.00405.x; Alvarez E, 2006, BRIT J PHARMACOL, V147, P269, DOI 10.1038/sj.bjp.0706507; Auger C, 2010, BIOCHEM BIOPH RES CO, V393, P162, DOI 10.1016/j.bbrc.2010.01.112; Bolego C, 2009, FASEB J, V23, P605, DOI 10.1096/fj.08-106591; Camacho M, 1998, CIRC RES, V83, P353, DOI 10.1161/01.RES.83.4.353; Cannon CP, 2012, SCIENCE, V336, P1386, DOI 10.1126/science.1224398; Carnini C, 2011, FASEB J, V25, P3519, DOI 10.1096/fj.10-177030; Chen W, 1999, J BIOL CHEM, V274, P20301, DOI 10.1074/jbc.274.29.20301; Elbling L, 2010, FREE RADICAL BIO MED, V49, P1444, DOI 10.1016/j.freeradbiomed.2010.08.008; Folco G, 2006, PHARMACOL REV, V58, P375, DOI 10.1124/pr.58.3.8; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Karim S, 1996, J BIOL CHEM, V271, P12042, DOI 10.1074/jbc.271.20.12042; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Konstam MA, 2001, CIRCULATION, V104, P2280, DOI 10.1161/hc4401.100078; Li ZM, 2011, BASIC CLIN PHARMACOL, V109, P47, DOI 10.1111/j.1742-7843.2011.00683.x; Long LH, 2010, ARCH BIOCHEM BIOPHYS, V501, P162, DOI 10.1016/j.abb.2010.06.012; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Okahara K, 1998, ARTERIOSCL THROM VAS, V18, P1922, DOI 10.1161/01.ATV.18.12.1922; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; SHATOS MA, 1991, ARTERIOSCLER THROMB, V11, P594, DOI 10.1161/01.ATV.11.3.594; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sun L, 2004, ANN BIOMED ENG, V32, P1193, DOI 10.1114/B:ABME.0000039353.97347.28; WHORTON AR, 1985, J CLIN INVEST, V76, P295, DOI 10.1172/JCI111960; Zou MH, 1996, FEBS LETT, V382, P101, DOI 10.1016/0014-5793(96)00160-3	27	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56683	10.1371/journal.pone.0056683	http://dx.doi.org/10.1371/journal.pone.0056683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441213	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200070
J	Kim, S; Gross, DS				Kim, Sunyoung; Gross, David S.			Mediator Recruitment to Heat Shock Genes Requires Dual Hsf1 Activation Domains and Mediator Tail Subunits Med15 and Med16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TRANSCRIPTION FACTOR HSF1; GENOME-WIDE ANALYSIS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; INDEPENDENT RECRUITMENT; NUCLEOSOME DISPLACEMENT; PREINITIATION COMPLEX; NEGATIVE REGULATION; YEAST MEDIATOR	The evolutionarily conserved Mediator complex is central to the regulation of gene transcription in eukaryotes because it serves as a physical and functional interface between upstream regulators and the Pol II transcriptional machinery. Nonetheless, its role appears to be context-dependent, and the detailed mechanism by which it governs the expression of most genes remains unknown. Here we investigate Mediator involvement in HSP (heat shock protein) gene regulation in the yeast Saccharomyces cerevisiae. We find that in response to thermal upshift, subunits representative of each of the four Mediator modules (Head, Middle, Tail, and Kinase) are rapidly, robustly, and selectively recruited to the promoter regions of HSP genes. Their residence is transient, returning to near-background levels within 90 min. Hsf1 (heat shock factor 1) plays a central role in recruiting Mediator, as indicated by the fact that truncation of either its N- or C-terminal activation domain significantly reduces Mediator occupancy, whereas removal of both activation domains abolishes it. Likewise, ablation of either of two Mediator Tail subunits, Med15 or Med16, reduces Mediator recruitment to HSP promoters, whereas deletion of both abolishes it. Accompanying the loss of Mediator, recruitment of RNA polymerase II is substantially diminished. Interestingly, Mediator antagonizes Hsf1 occupancy of non-induced promoters yet facilitates enhanced Hsf1 association with activated ones. Collectively, our observations indicate that Hsf1, via its dual activation domains, recruits holo-Mediator to HSP promoters in response to acute heat stress through cooperative physical and/or functional interactions with the Tail module.	[Kim, Sunyoung; Gross, David S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Gross, DS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Hwy, Shreveport, LA 71130 USA.	dgross@lsuhsc.edu			National Science Foundation [MCB-0747227, MCB-1025025]; Direct For Biological Sciences [1025025] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grants MCB-0747227 and MCB-1025025 (to D. S. G.).	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Ansari S. A., 2013, CELL MOL LI IN PRESS; Ansari SA, 2012, EMBO J, V31, P44, DOI 10.1038/emboj.2011.362; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Baidoobonso SM, 2007, J BIOL CHEM, V282, P5551, DOI 10.1074/jbc.M609484200; Balakrishnan SK, 2008, ONCOGENE, V27, P2661, DOI 10.1038/sj.onc.1210935; Baumli S, 2005, J BIOL CHEM, V280, P18171, DOI 10.1074/jbc.M413466200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Erkina TY, 2008, MOL CELL BIOL, V28, P1207, DOI 10.1128/MCB.01069-07; Erkine AM, 1996, MOL CELL BIOL, V16, P7004; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Galdieri L, 2012, J MOL BIOL, V415, P464, DOI 10.1016/j.jmb.2011.11.020; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghosh S, 2011, MOL CELL BIOL, V31, P190, DOI 10.1128/MCB.00317-10; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Gromoller A, 2000, FEBS LETT, V484, P48, DOI 10.1016/S0014-5793(00)02123-2; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; Hashimoto S, 2011, SCIENCE, V333, P1161, DOI 10.1126/science.1206638; Herbig E, 2010, MOL CELL BIOL, V30, P2376, DOI 10.1128/MCB.01046-09; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jedidi I, 2010, J BIOL CHEM, V285, P2438, DOI 10.1074/jbc.M109.071589; Kim S., 2012, THESIS LOUISIANA STA; Kremer SB, 2012, GENETICS, V191, P95, DOI 10.1534/genetics.111.135806; Kremer SB, 2009, J BIOL CHEM, V284, P32914, DOI 10.1074/jbc.M109.058610; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Larschan E, 2005, MOL CELL BIOL, V25, P114, DOI 10.1128/MCB.25.1.114-123.2005; Lee DK, 1999, GENE DEV, V13, P2934, DOI 10.1101/gad.13.22.2934; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Lee YC, 1999, MOL CELL BIOL, V19, P2967; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mehta S, 2009, FEBS LETT, V583, P3115, DOI 10.1016/j.febslet.2009.08.036; Miller C, 2012, J BIOL CHEM, V287, P44017, DOI 10.1074/jbc.M112.430140; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Singh H, 2006, GENETICS, V172, P2169, DOI 10.1534/genetics.105.052738; SORGER PK, 1990, CELL, V62, P793, DOI 10.1016/0092-8674(90)90123-V; SORGER PK, 1989, CELL, V59, P807, DOI 10.1016/0092-8674(89)90604-1; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Soutourina J, 2011, SCIENCE, V331, P1451, DOI 10.1126/science.1200188; Tabtiang RK, 1998, MOL CELL BIOL, V18, P4707, DOI 10.1128/MCB.18.8.4707; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005; Zhu XF, 2011, NUCLEIC ACIDS RES, V39, P8342, DOI 10.1093/nar/gkr551; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	75	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2013	288	17					12197	12213		10.1074/jbc.M112.449553	http://dx.doi.org/10.1074/jbc.M112.449553			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	133RP	23447536	Green Published, hybrid			2022-12-25	WOS:000318157600051
J	Nordholm, J; da Silva, DV; Damjanovic, J; Dou, D; Daniels, R				Nordholm, Johan; da Silva, Diogo V.; Damjanovic, Justina; Dou, Dan; Daniels, Robert			Polar Residues and Their Positional Context Dictate the Transmembrane Domain Interactions of Influenza A Neuraminidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX INTERACTIONS; VIRUS NEURAMINIDASE; DRIVE ASSOCIATION; MEMBRANE-PROTEINS; MOTIFS; SEQUENCE; SIGNAL; OLIGOMERIZATION; RECOGNITION; MATURATION	Interactions that facilitate transmembrane domain (TMD) dimerization have been identified mainly using synthetic TMDs. Here, we investigated how inherent properties within natural TMDs modulate their interaction strength by exploiting the sequence variation in the nine neuraminidase subtypes (N1-N9) and the prior knowledge that a N1 TMD oligomerizes. Initially, consensus TMDs were created from the influenza A virus database, and their interaction strengths were measured in a biological membrane system. The TMD interactions increased with respect to decreasing hydrophobicity across the subtypes (N1-N9) and within the human N1 subtype where the N1 TMDs from the pandemic H1N1 strain of swine origin were found to be significantly less hydrophobic. The hydrophobicity correlation was attributed to the conserved amphipathicity within the TMDs as the interactions were abolished by mutating residues on the polar faces that are unfavorably positioned in the membrane. Similarly, local changes enhanced the interactions only when a larger polar residue existed on the appropriate face in an unfavorable membrane position. Together, the analysis of this unique natural TMD data set demonstrates how polar-mediated TMD interactions from bitopic proteins depend on which polar residues are involved and their positioning with respect to the helix and the membrane bilayer.	[Nordholm, Johan; da Silva, Diogo V.; Damjanovic, Justina; Dou, Dan; Daniels, Robert] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden	Stockholm University	Daniels, R (corresponding author), Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	robertd@dbb.su.se		nordholm, johan/0000-0002-5864-8489; daniels, Robert/0000-0002-5988-2920	Swedish Research Council; Swedish Foundation for Strategic Research; Carl Trygger Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Carl Trygger Foundation	This work was supported by grants from the Swedish Research Council, Swedish Foundation for Strategic Research, and the Carl Trygger Foundation (to R. D.).	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; BOS TJ, 1984, P NATL ACAD SCI-BIOL, V81, P2327, DOI 10.1073/pnas.81.8.2327; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; da Silva DV, 2013, J BIOL CHEM, V288, P644, DOI 10.1074/jbc.M112.424150; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; Escher C, 2009, J MOL BIOL, V389, P10, DOI 10.1016/j.jmb.2009.04.002; Fagerberg L, 2010, PROTEOMICS, V10, P1141, DOI 10.1002/pmic.200900258; Finger C, 2006, J MOL BIOL, V358, P1221, DOI 10.1016/j.jmb.2006.02.065; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; GOTTSCHALK A, 1957, BIOCHIM BIOPHYS ACTA, V23, P645, DOI 10.1016/0006-3002(57)90389-X; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hirst GK, 1942, J EXP MED, V76, P195, DOI 10.1084/jem.76.2.195; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Hubert P, 2010, CELL ADHES MIGR, V4, P313, DOI 10.4161/cam.4.2.12430; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Kundu A, 1996, J VIROL, V70, P6508, DOI 10.1128/JVI.70.9.6508-6515.1996; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mellroth P, 2012, J BIOL CHEM, V287, P11018, DOI 10.1074/jbc.M111.318584; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Oates J, 2010, BBA-BIOMEMBRANES, V1798, P605, DOI 10.1016/j.bbamem.2009.12.016; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; Palese P, 2011, MBIO, V2, DOI 10.1128/mBio.00150-11; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Partridge AW, 2002, BIOPOLYMERS, V66, P350, DOI 10.1002/bip.10313; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Rath A, 2012, ANNU REV BIOPHYS, V41, P135, DOI [10.1146/annurev-biophys-050511-102310, 10.1146/annurev-biophys-050591-102310]; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; SAITO T, 1995, J VIROL, V69, P5011, DOI 10.1128/JVI.69.8.5011-5017.1995; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Schneider D, 2004, J MOL BIOL, V343, P799, DOI 10.1016/j.jmb.2004.08.083; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Wang N, 2008, J BIOL CHEM, V283, P33826, DOI 10.1074/jbc.M806897200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, P NATL ACAD SCI USA, V93, P2985, DOI 10.1073/pnas.93.7.2985; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	51	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10652	10660		10.1074/jbc.M112.440230	http://dx.doi.org/10.1074/jbc.M112.440230			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23447533	hybrid, Green Published			2022-12-25	WOS:000317565000043
J	Wei, ZK; Seldin, MM; Natarajan, N; Djemal, DC; Peterson, JM; Wong, GW				Wei, Zhikui; Seldin, Marcus M.; Natarajan, Niranjana; Djemal, David C.; Peterson, Jonathan M.; Wong, G. William			C1q/Tumor Necrosis Factor-related Protein 11 (CTRP11), a Novel Adipose Stroma-derived Regulator of Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; SHORT-CHAIN COLLAGEN; INSULIN SENSITIVITY; FAMILY; OBESITY; CLONING; GLUCOSE; EXPRESSION; TISSUE; BRAIN	C1q/TNF-related proteins (CTRPs) are a family of secreted regulators of glucose and lipid metabolism. Here, we describe CTRP11, a novel and phylogenetically conserved member of the C1q family. Our studies revealed that white and brown adipose are major tissues that express CTRP11, and its expression is acutely regulated by changes in metabolic state. Within white adipose tissue, CTRP11 is primarily expressed by stromal vascular cells. As a secreted multimeric protein, CTRP11 forms disulfide-linked oligomers. Although the conserved N-terminal Cys-28 and Cys-32 are dispensable for the assembly of higher-order oligomeric structures, they are unexpectedly involved in modulating protein secretion. When co-expressed, CTRP11 forms heteromeric complexes with closely related CTRP10, CTRP13, and CRF (CTRP14) via the C-terminal globular domains, combinatorial associations that potentially generate functionally distinct complexes. Functional studies revealed a role for CTRP11 in regulating adipogenesis. Ectopic expression of CTRP11 or exposure to recombinant protein inhibited differentiation of 3T3-L1 adipocytes. The expression of peroxisome proliferator-activated receptor-gamma and CAAT/enhancer binding protein-alpha, which drive the adipogenic gene program, was markedly suppressed by CTRP11. Impaired adipogenesis was caused by a CTRP11-mediated decrease in p42/44-MAPK signaling and inhibition of mitotic clonal expansion, a process essential for adipocyte differentiation in culture. These results implicate CTRP11 as a novel secreted regulator of adipogenesis and highlight the potential paracrine cross-talk between adipocytes and cells of the stromal vascular compartment in maintaining adipose tissue homeostasis.	[Wong, G. William] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506	National Institutes of Health [DK084171]; American Heart Association [SDG2260721, PRE3790034]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, P30DK079637, R01DK084171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.) and American Heart Association Grant SDG2260721.; Supported by American Heart Association Fellowship PRE3790034.; Supported by National Institutes of Health National Research Service Award F32DK084607. Present address: Dept. of Health Sciences, School of Public Health, East Tennessee State University, Johnson City, TN 37614.	Aerbajinai W, 2004, J BIOL CHEM, V279, P1916, DOI 10.1074/jbc.M305634200; BALL EG, 1960, J BIOL CHEM, V235, P584; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; BERNARD M, 1988, J BIOL CHEM, V263, P17159; Berube NG, 1999, MOL BRAIN RES, V63, P233, DOI 10.1016/S0169-328X(98)00278-2; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; GERSHONI JM, 1985, ANAL BIOCHEM, V146, P59, DOI 10.1016/0003-2697(85)90395-1; Green A, 2004, DIABETES, V53, P74, DOI 10.2337/diabetes.53.1.74; GRIES FA, 1967, J CLIN INVEST, V46, P1413, DOI 10.1172/JCI105633; Hayward C P, 1995, Curr Opin Hematol, V2, P339; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huang HY, 2005, BIOCHEM BIOPH RES CO, V338, P1185, DOI 10.1016/j.bbrc.2005.10.057; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Iijima T, 2010, EUR J NEUROSCI, V31, P1606, DOI 10.1111/j.1460-9568.2010.07202.x; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kee HJ, 2004, FEBS LETT, V569, P307, DOI 10.1016/j.febslet.2004.06.011; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee K, 2003, J CLIN INVEST, V111, P453, DOI 10.1172/JCI15924; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; Park SY, 2009, J BIOL CHEM, V284, P27780, DOI 10.1074/jbc.M109.005611; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; ROSS SE, 2000, SCIENCE, V0289, P00950, DOI [DOI 10.1126/SCIENCE.289.5481.950, DOI 10.1126/science.289.5481.950, 10.1126/science.289.5481.950]; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Seldin MM, 2012, J BIOL CHEM, V287, P11968, DOI 10.1074/jbc.M111.336834; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shiratsuchi T, 1997, CYTOGENET CELL GENET, V79, P103, DOI 10.1159/000134693; Smas CM, 1997, MOL CELL BIOL, V17, P977, DOI 10.1128/MCB.17.2.977; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; THOMAS JT, 1991, BIOCHEM J, V280, P617, DOI 10.1042/bj2800617; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wei ZK, 2012, J BIOL CHEM, V287, P10301, DOI 10.1074/jbc.M111.303651; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wolfing B, 2008, OBESITY, V16, P1481, DOI 10.1038/oby.2008.206; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wright WS, 2007, DIABETES, V56, P295, DOI 10.2337/db06-1339; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3	64	55	63	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2013	288	15					10214	10229		10.1074/jbc.M113.458711	http://dx.doi.org/10.1074/jbc.M113.458711			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	125TU	23449976	Green Published, hybrid			2022-12-25	WOS:000317565000004
J	Bajwa, UI; Taj, IA; Anwar, MW; Wang, X				Bajwa, Usama Ijaz; Taj, Imtiaz Ahmad; Anwar, Muhammad Waqas; Wang, Xuan			A Multifaceted Independent Performance Analysis of Facial Subspace Recognition Algorithms	PLOS ONE			English	Article							FACE-RECOGNITION; 2-DIMENSIONAL PCA; COMPONENT; REPRESENTATION; LAPLACIANFACES; EIGENFACES	Face recognition has emerged as the fastest growing biometric technology and has expanded a lot in the last few years. Many new algorithms and commercial systems have been proposed and developed. Most of them use Principal Component Analysis (PCA) as a base for their techniques. Different and even conflicting results have been reported by researchers comparing these algorithms. The purpose of this study is to have an independent comparative analysis considering both performance and computational complexity of six appearance based face recognition algorithms namely PCA, 2DPCA, A2DPCA, (2D)(2)PCA, LPP and 2DLPP under equal working conditions. This study was motivated due to the lack of unbiased comprehensive comparative analysis of some recent subspace methods with diverse distance metric combinations. For comparison with other studies, FERET, ORL and YALE databases have been used with evaluation criteria as of FERET evaluations which closely simulate real life scenarios. A comparison of results with previous studies is performed and anomalies are reported. An important contribution of this study is that it presents the suitable performance conditions for each of the algorithms under consideration.	[Bajwa, Usama Ijaz; Anwar, Muhammad Waqas] COMSATS Inst Informat Technol, Dept Comp Sci, Abbottabad, Pakistan; [Bajwa, Usama Ijaz; Taj, Imtiaz Ahmad] Muhammad Ali Jinnah Univ, Vis & Pattern Recognit Syst Res Grp, Islamabad, Pakistan; [Bajwa, Usama Ijaz] CASE, Islamabad, Pakistan; [Wang, Xuan] Shenzen Grad Sch, Harbin Inst Technol, Dept Comp Sci & Technol, Shenzhen, Peoples R China	COMSATS University Islamabad (CUI); Mohammad Ali Jinnah University; Harbin Institute of Technology	Bajwa, UI (corresponding author), COMSATS Inst Informat Technol, Dept Comp Sci, Abbottabad, Pakistan.	usama@ciit.net.pk		Bajwa, Usama/0000-0001-5755-1194; Taj, Imtiaz Ahmad/0000-0003-1813-5563	DOD Counterdrug Technology Development Program Office	DOD Counterdrug Technology Development Program Office	Portions of the research in this paper use the FERET database of facial images collected under the FERET programme, sponsored by the DOD Counterdrug Technology Development Program Office. The authors are thankful to Mr. Xiaofei He [23] for valuable comments and suggestions regarding Laplacianfaces and to Mr. Kresimir Delac [18] for valuable comments regarding FERET training set.	Abate AF, 2007, PATTERN RECOGN LETT, V28, P1885, DOI 10.1016/j.patrec.2006.12.018; Baek K, 2002, PROCEEDINGS OF THE 6TH JOINT CONFERENCE ON INFORMATION SCIENCES, P824; Bajwa U, 2011, FACERECEVAL MATLAB B; Bajwa UI, 2011, IMAGING SCI J, V59, P32, DOI 10.1179/136821910X12816888370061; Bartlett MS, 2002, IEEE T NEURAL NETWOR, V13, P1450, DOI 10.1109/TNN.2002.804287; Bartlett MS, 1998, P SOC PHOTO-OPT INS, V3299, P528, DOI 10.1117/12.320144; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Beveridge JR, 2001, PROC CVPR IEEE, P535; Bhatti Z E, 2009, P IEEE INT MUL C, P1; Bhatti Z E, 2009, FACEREC PROVIDES BAS; Chakrabarty A, 2012, ENG APPL AR IN PRESS; CSU, 2003, CSU FAC ID EV SYST; Delac K, 2005, INT J IMAG SYST TECH, V15, P252, DOI 10.1002/ima.20059; He XF, 2005, IEEE T PATTERN ANAL, V27, P328, DOI 10.1109/TPAMI.2005.55; Kelly MD, 1971, AAI7112934; Kumar R, 2009, PROC CVPR IEEE, P150, DOI 10.1109/CVPRW.2009.5206837; Manjunath B. S., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P373, DOI 10.1109/CVPR.1992.223162; Nefian AV, 1998, INT CONF ACOUST SPEE, P2721, DOI 10.1109/ICASSP.1998.678085; NIST, 2004, FERET DAT; Niu B, 2008, PATTERN RECOGN, V41, P3237, DOI 10.1016/j.patcog.2007.12.001; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Ruiz-Del-Solar J, 2005, IEEE T SYST MAN CY C, V35, P315, DOI 10.1109/TSMCC.2005.848201; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Wiskott L, 1997, IEEE T PATTERN ANAL, V19, P775, DOI 10.1109/34.598235; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Zhang DQ, 2005, NEUROCOMPUTING, V69, P224, DOI 10.1016/j.neucom.2005.06.004; Zhao W, 2003, ACM COMPUT SURV, V35, P399, DOI 10.1145/954339.954342	29	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56510	10.1371/journal.pone.0056510	http://dx.doi.org/10.1371/journal.pone.0056510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451054	gold, Green Published			2022-12-25	WOS:000316849500017
J	Malcolm, KC; Nichols, EM; Caceres, SM; Kret, JE; Martiniano, SL; Sagel, SD; Chan, ED; Caverly, L; Solomon, GM; Reynolds, P; Bratton, DL; Taylor-Cousar, JL; Nichols, DP; Saavedra, MT; Nick, JA				Malcolm, Kenneth C.; Nichols, E. Michelle; Caceres, Silvia M.; Kret, Jennifer E.; Martiniano, Stacey L.; Sagel, Scott D.; Chan, Edward D.; Caverly, Lindsay; Solomon, George M.; Reynolds, Paul; Bratton, Donna L.; Taylor-Cousar, Jennifer L.; Nichols, David P.; Saavedra, Milene T.; Nick, Jerry A.			Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; CYSTIC-FIBROSIS; BIOFILM DEVELOPMENT; LUNG-DISEASE; INFECTION; OUTBREAK	Mycobacterium abscessus is a rapidly growing mycobacterium increasingly detected in the neutrophil-rich environment of inflamed tissues, including the cystic fibrosis airway. Studies of the immune reaction to M. abscessus have focused primarily on macrophages and epithelial cells, but little is known regarding the neutrophil response despite the predominantly neutrophillic inflammation typical of these infections. In the current study, human neutrophils released less superoxide anion in response to M. abscessus than to Staphylococcus aureus, a pathogen that shares common sites of infection. Exposure to M. abscessus induced neutrophil-specific chemokine and proinflammatory cytokine genes. Although secretion of these protein products was confirmed, the quantity of cytokines released, and both the number and level of gene induction, was reduced compared to S. aureus. Neutrophils mediated killing of M. abscessus, but phagocytosis was reduced when compared to S. aureus, and extracellular DNA was detected in response to both bacteria, consistent with extracellular trap formation. In addition, M. abscessus did not alter cell death compared to unstimulated cells, while S. aureus enhanced necrosis and inhibited apoptosis. However, neutrophils augment M. abscessus biofilm formation. The response of neutrophils to M. abscessus suggests that the mycobacterium exploits neutrophil-rich settings to promote its survival and that the overall neutrophil response was reduced compared to S. aureus. These studies add to our understanding of M. abscessus virulence and suggest potential targets of therapy.	[Malcolm, Kenneth C.; Nichols, E. Michelle; Caceres, Silvia M.; Kret, Jennifer E.; Chan, Edward D.; Solomon, George M.; Reynolds, Paul; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Caverly, Lindsay; Reynolds, Paul; Bratton, Donna L.; Nichols, David P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Malcolm, Kenneth C.; Chan, Edward D.; Solomon, George M.; Taylor-Cousar, Jennifer L.; Saavedra, Milene T.; Nick, Jerry A.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Martiniano, Stacey L.; Sagel, Scott D.; Nichols, David P.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA; [Sagel, Scott D.; Caverly, Lindsay] Childrens Hosp Colorado, Dept Pediat, Aurora, CO USA; [Chan, Edward D.] Denver Vet Affair Med Ctr, Denver, CO USA; [Reynolds, Paul] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Reynolds, Paul] Univ Colorado, Denver, CO 80202 USA	National Jewish Health; National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; National Jewish Health; University of Colorado System; University of Colorado Denver	Malcolm, KC (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	malcolmk@njhealth.org	Reynolds, Paul/ABD-9094-2020	Nichols, David/0000-0001-8611-7960; Malcolm, Kenneth/0000-0002-8097-6059	Cystic Fibrosis Foundation; National Institutes of Health (NIH) [HL090991, HL34303]; Rebecca Runyon Bryan Chair for Cystic Fibrosis; Wonsowicz Family; Ira and Libbie Pink Charitable Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090991, P01HL034303] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rebecca Runyon Bryan Chair for Cystic Fibrosis; Wonsowicz Family; Ira and Libbie Pink Charitable Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Cystic Fibrosis Foundation, the National Institutes of Health (NIH, HL090991), the Rebecca Runyon Bryan Chair for Cystic Fibrosis, Wonsowicz Family, and Ira and Libbie Pink Charitable Fund (JAN); and NIH HL34303 (DLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOXERBAUM B, 1980, J PEDIATR-US, V96, P689, DOI 10.1016/S0022-3476(80)80743-8; Carter G, 2003, J MED MICROBIOL, V52, P747, DOI 10.1099/jmm.0.05224-0; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Cullen AR, 2000, AM J RESP CRIT CARE, V161, P641, DOI 10.1164/ajrccm.161.2.9903062; Daley CL, 2002, CLIN CHEST MED, V23, P623, DOI 10.1016/S0272-5231(02)00021-7; Davidson LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029148; Esteban J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-184; Garcia-Perez BE, 2011, IMMUNOBIOLOGY, V216, P925, DOI 10.1016/j.imbio.2011.01.004; Fauroux B, 1997, PEDIATR INFECT DIS J, V16, P354, DOI 10.1097/00006454-199704000-00004; Freeman R, 2006, APPL ENVIRON MICROB, V72, P7554, DOI 10.1128/AEM.01633-06; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; Giron RM, 2008, ARCH BRONCONEUMOL, V44, P679, DOI 10.1016/S1579-2129(09)60006-9; Gomez MI, 2007, CURR OPIN PHARMACOL, V7, P244, DOI 10.1016/j.coph.2006.12.005; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; HASLETT C, 1985, AM J PATHOL, V119, P101; HJELTE L, 1990, THORAX, V45, P397, DOI 10.1136/thx.45.5.397; Howard ST, 2000, MICROBES INFECT, V2, P1845, DOI 10.1016/S1286-4579(00)01338-1; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kapur N, 2012, PEDIATR PULM, V47, P300, DOI 10.1002/ppul.21550; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; King P, 2011, PAEDIATR RESPIR REV, V12, P104, DOI 10.1016/j.prrv.2010.10.011; Lee HM, 2012, IMMUNOL CELL BIOL, V90, P601, DOI 10.1038/icb.2011.72; Malcolm KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021958; MOORE M, 1953, J INVEST DERMATOL, V20, P133, DOI 10.1038/jid.1953.18; Oberley-Deegan RE, 2010, FREE RADICAL BIO MED, V49, P1666, DOI 10.1016/j.freeradbiomed.2010.08.026; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Parks QM, 2009, J MED MICROBIOL, V58, P492, DOI 10.1099/jmm.0.005728-0; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Robertson DM, 2011, INVEST OPHTH VIS SCI, V52, P2844, DOI 10.1167/iovs.10-6469; Rodriguez G, 1997, BRIT J DERMATOL, V137, P214, DOI 10.1046/j.1365-2133.1997.18081891.x; Roux AL, 2011, CELL MICROBIOL, V13, P692, DOI 10.1111/j.1462-5822.2010.01565.x; Saavedra MT, 2008, AM J RESP CRIT CARE, V178, P929, DOI 10.1164/rccm.200803-387OC; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sampaio EP, 2008, AM J RESP CELL MOL, V39, P431, DOI 10.1165/rcmb.2007-0413OC; Schorey JS, 2008, GLYCOBIOLOGY, V18, P832, DOI 10.1093/glycob/cwn076; Shin DM, 2008, CELL MICROBIOL, V10, P1608, DOI 10.1111/j.1462-5822.2008.01151.x; Shin JH, 2008, J MICROBIOL, V46, P608, DOI 10.1007/s12275-008-0102-6; Song JY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-6; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; WALLACE RJ, 1983, REV INFECT DIS, V5, P657; Williams MM, 2009, APPL ENVIRON MICROB, V75, P2091, DOI 10.1128/AEM.00166-09; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; ZHANG Y, 1991, MOL MICROBIOL, V5, P381, DOI 10.1111/j.1365-2958.1991.tb02120.x	54	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57402	10.1371/journal.pone.0057402	http://dx.doi.org/10.1371/journal.pone.0057402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451220	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500098
J	Masse, V; Valiquette, L; Boukhoudmi, S; Bonenfant, F; Talab, Y; Carvalho, JC; Alarie, I; Carrier, N; Farand, P				Masse, Vincent; Valiquette, Louis; Boukhoudmi, Soraya; Bonenfant, Francis; Talab, Yasmine; Carvalho, Jean-Christophe; Alarie, Isabelle; Carrier, Nathalie; Farand, Paul			Impact of Methicillin Resistant Staphylococcus aureus Contact Isolation Units on Medical Care	PLOS ONE			English	Article							OF-THE-LITERATURE; PRECAUTIONS	Background: Patient isolation using contact precautions has gained widespread use to halt MRSA transmission, however supportive data is scarce and concerns regarding patient safety and satisfaction have been raised. At our institution, MRSA patients are isolated on a dedicated ward (cohort isolation), rather than in separate rooms. Our objectives were (1) to determine the proportion of bedside medical visits to patients on an isolation ward, (2) to quantify complications in those patients and (3) to determine if those complications are related to isolation and if they can be prevented. Methods: This retrospective case-control study was performed on the two sites of a tertiary teaching hospital in Sherbrooke, QC, Canada. We matched MRSA patients with an admission diagnosis of heart failure or chronic obstructive pulmonary disease to similar non-isolated controls. The proportion of bedside visits was ascertained through the number of progress notes with subjective elements or with a physical examination. Complications were sought through an extensive file review, and events were analysed according to Baker's CAES causality and preventability scales. Results: Overall, 111 patient pairs were analysed (35 with heart failure and 76 with COPD). Isolated patients received less bedside visits (subjective notes/1,000 patient-days: 849.6 vs. 983.3, p = 0,001). Attending physicians (454.5 vs. 451.4, p = 0,02) and residents (347.0 vs. 416.9, p = 0.01) are responsible for this discrepancy, while medical students appear to visit isolated and non-isolated patients equally (116.5 vs. 114.9, p = 0.90). Isolated patients showed a tendency towards longer stay and more preventable complications, although no difference in the total number of complications was observed. Conclusion: Isolated patients have less documented care that suggests less bedside visits from the medical staff, which could hamper the therapeutical relationship. Further studies are needed to explain this finding.	[Masse, Vincent; Valiquette, Louis; Boukhoudmi, Soraya; Alarie, Isabelle] Ctr Hosp Univ Sherbrooke, Div Infect Dis, Sherbrooke, PQ, Canada; [Bonenfant, Francis; Talab, Yasmine; Carvalho, Jean-Christophe; Farand, Paul] Ctr Hosp Univ Sherbrooke, Div Internal Med, Sherbrooke, PQ, Canada; [Valiquette, Louis; Farand, Paul] Ctr Hosp Univ Sherbrooke, Etienne Lessel Res Ctr, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Farand, P (corresponding author), Ctr Hosp Univ Sherbrooke, Div Internal Med, Sherbrooke, PQ, Canada.	Paul.Farand@USherbrooke.ca			University of Sherbrooke	University of Sherbrooke	Funding for the chart review process came from institutional scholarships grants from the University of Sherbrooke. Y.T. received salary support from these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2010, J HOSP INFECT, V76, P97, DOI 10.1016/j.jhin.2010.04.027; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Charlson ME, 2008, J CLIN EPIDEMIOL, V61, P1234, DOI 10.1016/j.jclinepi.2008.01.006; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Edmond M, 2008, PUBLIC HEALTH ETH-UK, V1, P235, DOI 10.1093/phe/phn014; Evans HL, 2003, SURGERY, V134, P180, DOI 10.1067/msy.2003.222; Kirkland KB, 2009, CLIN INFECT DIS, V48, P766, DOI 10.1086/597090; Marshall C, 2004, J HOSP INFECT, V56, P253, DOI 10.1016/j.jhin.2004.02.001; Morgan DJ, 2009, AM J INFECT CONTROL, V37, P85, DOI 10.1016/j.ajic.2008.04.257; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saint S, 2003, AM J INFECT CONTROL, V31, P354, DOI 10.1016/S0196-6553(02)48250-8; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899	13	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57057	10.1371/journal.pone.0057057	http://dx.doi.org/10.1371/journal.pone.0057057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451144	Green Submitted, gold, Green Published			2022-12-25	WOS:000316849500057
J	Kazem, AJN; Widdig, A				Kazem, Anahita J. N.; Widdig, Anja			Visual Phenotype Matching: Cues to Paternity Are Present in Rhesus Macaque Faces	PLOS ONE			English	Article							KIN RECOGNITION SIGNALS; INBREEDING AVOIDANCE; SOCIAL RELATIONSHIPS; MACACA-MULATTA; RESEMBLANCE; RELATEDNESS; KINSHIP; EVOLUTION; DISCRIMINATION; FATHER	The ability to recognize kin and thus behaviourally discriminate between conspecifics based on genetic relatedness is of importance both in acquiring inclusive fitness benefits and to enable optimal inbreeding. In primates, mechanisms allowing recognition of paternal relatives are of particular interest, given that in these mating systems patrilineal information is unlikely to be available via social familiarity. Humans use visual phenotype matching based on facial features to identify their own and other's close relatives, and recent studies suggest similar abilities may be present in other species. However it is unclear to what extent familial resemblances remain detectable against the background levels of relatedness typically found within demes in the wild - a necessary condition if facial cues are to function in kin recognition under natural conditions. Here, we experimentally investigate whether parent-offspring relationships are discernible in rhesus macaque (Macaca mulatta) faces drawn from a large free-ranging population more representative of the latter scenario, and in which genetic relatedness has been well quantified from pedigrees determined via molecular markers. We used the human visual system as a means of integrating multiple types of facial cue simultaneously, and demonstrate that paternal, as well as maternal, resemblance to both sons and daughters can be detected even by human observers. Experts performed better than participants who lacked previous experience working with nonhuman primates. However the finding that even naive individuals succeeded at the task underlines the strength of the phenotypic cues present in faces.	[Kazem, Anahita J. N.; Widdig, Anja] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, Leipzig, Germany; [Kazem, Anahita J. N.] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway; [Widdig, Anja] Univ Leipzig, Behav Ecol Res Grp, Inst Biol, D-04109 Leipzig, Germany	Max Planck Society; Norwegian University of Science & Technology (NTNU); Leipzig University	Kazem, AJN (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Jr Res Grp Primate Kin Select, Leipzig, Germany.	anahita.kazem@bio.ntnu.no			National Center for Research Resources [8 P40 OD012217-25]; Office of Research Infrastructure Programs of the National Institutes of Health; German Research Foundation within the Emmy-Noether Program [WI 1808/3-1]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation within the Emmy-Noether Program(German Research Foundation (DFG)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Maintenance of the Cayo Santiago population is supported by grant number 8 P40 OD012217-25 from the National Center for Research Resources, and the Office of Research Infrastructure Programs of the National Institutes of Health (http://www.nih.gov). This project was funded by the German Research Foundation (http://www.dfg.de), within the Emmy-Noether Program (grant No. WI 1808/3-1 to AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 1999, P ROY SOC B-BIOL SCI, V266, P1501, DOI 10.1098/rspb.1999.0807; Alvergne A, 2009, INT J PRIMATOL, V30, P199, DOI 10.1007/s10764-009-9339-0; Alvergne A, 2009, ANIM BEHAV, V78, P61, DOI 10.1016/j.anbehav.2009.03.019; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2009, LANGUAGER DATA SETS; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bateson P., 1983, P257; Bercovitch FB, 2003, NATURWISSENSCHAFTEN, V90, P309, DOI 10.1007/s00114-003-0436-1; BLOUIN SF, 1988, TRENDS ECOL EVOL, V3, P230, DOI 10.1016/0169-5347(88)90164-4; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bower S, 2012, J COMP PSYCHOL, V126, P318, DOI 10.1037/a0025081; Brandvain Y, 2011, TRENDS GENET, V27, P251, DOI 10.1016/j.tig.2011.04.005; Bressan P, 2004, EVOL HUM BEHAV, V25, P133, DOI 10.1016/j.evolhumbehav.2004.03.001; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Burch RL, 2000, EVOL HUM BEHAV, V21, P429, DOI 10.1016/S1090-5138(00)00056-8; Carson EA, 2006, AM J PHYS ANTHROPOL, V131, P169, DOI 10.1002/ajpa.20424; Celerier A, 2010, J EXP BIOL, V213, P1399, DOI 10.1242/jeb.038349; Chapais B., 2004, KINSHIP BEHAV PRIMAT; Charpentier M, 2005, BEHAV ECOL, V16, P614, DOI 10.1093/beheco/ari034; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Charpentier MJE, 2007, ANIM BEHAV, V73, P37, DOI 10.1016/j.anbehav.2006.02.026; Charpentier MJE, 2010, ANIM BEHAV, V80, P101, DOI 10.1016/j.anbehav.2010.04.005; Cheney DL, 1999, ANIM BEHAV, V58, P67, DOI 10.1006/anbe.1999.1131; CHEVERUD JM, 1982, AM J PHYS ANTHROPOL, V59, P151, DOI 10.1002/ajpa.1330590205; Dal Martello MF, 2006, J VISION, V6, P1356, DOI 10.1167/6.12.2; DASSER V, 1988, ANIM BEHAV, V36, P225, DOI 10.1016/S0003-3472(88)80265-3; de Ruiter JR, 1998, P ROY SOC B-BIOL SCI, V265, P79, DOI 10.1098/rspb.1998.0267; DeBruine LM, 2008, ARCH SEX BEHAV, V37, P64, DOI 10.1007/s10508-007-9266-0; DeBruine LM, 2009, VISION RES, V49, P38, DOI 10.1016/j.visres.2008.09.025; Dubuc C, 2011, BEHAV ECOL SOCIOBIOL, V65, P1615, DOI 10.1007/s00265-011-1172-8; Dufour V, 2010, J ETHOL, V28, P231, DOI 10.1007/s10164-009-0174-8; Fletcher D. J. C., 1987, KIN RECOGNITION; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fox M, 2010, P ROY SOC B-BIOL SCI, V277, P567, DOI 10.1098/rspb.2009.1660; Gaulin SJC, 1997, HUM NATURE-INT BIOS, V8, P139, DOI 10.1007/s12110-997-1008-4; Haig D, 2011, P NATL ACAD SCI USA, V108, P10878, DOI 10.1073/pnas.1100295108; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hepper PG., 1991, KIN RECOGNITION; Holmes WG, 2004, ANN ZOOL FENN, V41, P691; HOLMES WG, 1982, AM ZOOL, V22, P491; Jelenkovic A, 2010, HOMO, V61, P191, DOI 10.1016/j.jchb.2009.10.003; Jeon J, 2007, P R SOC B, V274, P1181, DOI 10.1098/rspb.2006.0366; Johnstone RA, 1997, P ROY SOC B-BIOL SCI, V264, P1547, DOI 10.1098/rspb.1997.0215; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaminski G, 2009, P ROY SOC B-BIOL SCI, V276, P3193, DOI 10.1098/rspb.2009.0677; KUESTER J, 1994, ANIM BEHAV, V48, P1183, DOI 10.1006/anbe.1994.1350; Kulik L, 2012, MOL ECOL, V21, P699, DOI 10.1111/j.1365-294X.2011.05250.x; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lukas D, 2005, MOL ECOL, V14, P2181, DOI 10.1111/j.1365-294X.2005.02560.x; Mateo JM, 2002, P ROY SOC B-BIOL SCI, V269, P721, DOI 10.1098/rspb.2001.1947; Muniz L, 2006, CURR BIOL, V16, pR156, DOI 10.1016/j.cub.2006.02.055; Nurnberg P, 1998, AM J PRIMATOL, V44, P1; Pagel M, 1997, ANIM BEHAV, V53, P973, DOI 10.1006/anbe.1996.0317; Parr LA, 2011, PHILOS T R SOC B, V366, P1764, DOI 10.1098/rstb.2010.0358; Parr LA, 2010, J COMP PSYCHOL, V124, P343, DOI 10.1037/a0020545; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; R Development Core Team, 2009, R FDN STAT COMP; Rawlins RG., 1986, CAYO SANTIAGO MACAQU; Rice WR, 2010, P ROY SOC B-BIOL SCI, V277, P2727, DOI 10.1098/rspb.2010.0409; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schino G, 2006, ANIM BEHAV, V71, P1069, DOI 10.1016/j.anbehav.2005.07.019; Scott LS, 2009, PSYCHOL SCI, V20, P676, DOI 10.1111/j.1467-9280.2009.02348.x; SHERMAN PW, 1980, AM NAT, V116, P604, DOI 10.1086/283652; Sherwood RJ, 2011, ANAT REC, V294, P664, DOI 10.1002/ar.21337; SILK J, 1993, INT J PRIMATOL, V14, P95, DOI 10.1007/BF02196505; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P183, DOI 10.1007/s00265-006-0249-2; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Silk JB, 2009, PHILOS T R SOC B, V364, P3243, DOI 10.1098/rstb.2009.0118; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Smith K, 2003, P ROY SOC B-BIOL SCI, V270, P503, DOI 10.1098/rspb.2002.2277; Stewart-Williams S, 2007, EVOL HUM BEHAV, V28, P193, DOI 10.1016/j.evolhumbehav.2007.01.002; Todrank J, 2003, ADV STUD BEHAV, V32, P77, DOI 10.1016/S0065-3454(03)01002-7; Vokey JR, 2004, J COMP PSYCHOL, V118, P194, DOI 10.1037/0735-7036.118.2.194; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Widdig A, 2004, P ROY SOC B-BIOL SCI, V271, P819, DOI 10.1098/rspb.2003.2666; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848	85	26	26	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e55846	10.1371/journal.pone.0055846	http://dx.doi.org/10.1371/journal.pone.0055846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451032	Green Submitted, Green Published, gold			2022-12-25	WOS:000316658800005
J	Konno-Shimizu, M; Yamamichi, N; Inada, K; Kageyama-Yahara, N; Shiogama, K; Takahashi, Y; Asada-Hirayama, I; Yamamichi-Nishina, M; Nakayama, C; Ono, S; Kodashima, S; Fujishiro, M; Tsutsumi, Y; Ichinose, M; Koike, K				Konno-Shimizu, Maki; Yamamichi, Nobutake; Inada, Ken-ichi; Kageyama-Yahara, Natsuko; Shiogama, Kazuya; Takahashi, Yu; Asada-Hirayama, Itsuko; Yamamichi-Nishina, Mitsue; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Fujishiro, Mitsuhiro; Tsutsumi, Yutaka; Ichinose, Masao; Koike, Kazuhiko			Cathepsin E Is a Marker of Gastric Differentiation and Signet-Ring Cell Carcinoma of Stomach: A Novel Suggestion on Gastric Tumorigenesis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; GENE-EXPRESSION; CADHERIN EXPRESSION; DIFFUSE-TYPE; RISK-FACTORS; E DEFICIENCY; GENOME-WIDE; CANCER; EPIDEMIOLOGY; METAPLASIA	Gastric cancer (GC) presents various histological features, though the mechanism underlying its diversity is seldom elucidated. It is mainly classified into well differentiated tubular adenocarcinoma (tub1), moderately differentiated tubular adenocarcinoma (tub2), poorly differentiated adenocarcinoma (por), signet-ring cell carcinoma (sig), mucinous adenocarcinoma (muc), and papillary adenocarcinoma (pap). By screening, we found cathepsin E (CTSE) expresses universally in sig-type, occasionally in por-type, and rarely in tub1/tub2-type GC cell lines. In surgically-resected specimens, CTSE was immunostained in 50/51 sig-type (98.0%), 3/10 tub1-type (30.0%), 7/18 tub2-type (38.9%), 15/26 por-type (57.7%), 4/10 pap-type (40.0%), and 0/3 muc-type (0.0%) GC. In endoscopically-resected specimens, 6/7 sig-type (85.7%), 7/52 tub1-type (13.7%), 5/12 tub2-type (41.7%), 2/7 pap-type (28.6%) GC and 0/6 adenoma (0.0%) expressed CTSE. For non-malignant tissues, CTSE is universally expressed in normal fundic, pyloric, and cardiac glands of stomach, but hardly in other digestive organs. In the precancerous intestinal metaplasia of stomach, CTSE is mostly observed in mixed gastric-and-intestinal type and deficient in solely-intestinal type. CTSE expression is positively correlated with gastric marker MUC5AC (p<0.0001) and negatively correlated with intestinal marker MUC2 (p = 0.0019). For sig-type GC, in both tumors and background mucosa, expression of MUC5AC and CTSE is high whereas that of MUC2 is low, indicating that sig-type GC reflects the features of background mucosa. For gastric adenoma and tub1/tub2-type GC, more undifferentiated tumors tend to show higher expression of CTSE with MUC5AC and lower expression of MUC2 in tumors, but they tend to present lower expression of CTSE, MUC5AC and MUC2 in background mucosa. These suggest that more malignant gastric adenocarcinoma with stronger gastric and weaker intestinal properties tend to arise from background mucosa with decreased both gastric and intestinal features. In conclusion, CTSE is a marker of both gastric differentiation and signet-ring cell carcinoma, which should shed light on the mechanism of gastric tumorigenesis.	[Konno-Shimizu, Maki; Yamamichi, Nobutake; Kageyama-Yahara, Natsuko; Takahashi, Yu; Asada-Hirayama, Itsuko; Yamamichi-Nishina, Mitsue; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Fujishiro, Mitsuhiro; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Inada, Ken-ichi; Shiogama, Kazuya; Tsutsumi, Yutaka] Fujita Hlth Univ, Sch Med, Dept Pathol 1, Aichi, Japan; [Ichinose, Masao] Wakayama Med Coll, Dept Internal Med 2, Wakayama 640, Japan	University of Tokyo; Fujita Health University; Wakayama Medical University	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	Ichinose, Masao/HAB-1645-2022; 藤城, 光弘/AAN-3131-2020; Ono, Satoshi/AFP-6208-2022; Ono, Satoshi/H-7900-2019; Takahashi, Yu/I-4665-2015	Ono, Satoshi/0000-0002-9864-348X; Takahashi, Yu/0000-0002-3066-9501	Sato Memorial Foundation for Cancer Research; Nakayama Cancer Research Institute; Foundation for promotion of Cancer Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Grants-in-Aid for Scientific Research [25460381] Funding Source: KAKEN	Sato Memorial Foundation for Cancer Research; Nakayama Cancer Research Institute; Foundation for promotion of Cancer Research; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from Sato Memorial Foundation for Cancer Research, in part by a research grant from Nakayama Cancer Research Institute, in part by a research grant from Foundation for promotion of Cancer Research, and also in part by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). But all the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 1997, CANCER, V80, P179, DOI 10.1002/(SICI)1097-0142(19970715)80:2<179::AID-CNCR2>3.0.CO;2-P; BECKER KF, 1994, CANCER RES, V54, P3845; Boussioutas A, 2003, CANCER RES, V63, P2569; Chu PG, 2004, AM J CLIN PATHOL, V121, P884, DOI 10.1309/A09ERYMFR64NERDW; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dohchin A, 2000, CANCER, V89, P482, DOI 10.1002/1097-0142(20000801)89:3<482::AID-CNCR2>3.0.CO;2-5; Farinati F, 1996, CARCINOGENESIS, V17, P2581, DOI 10.1093/carcin/17.12.2581; Fenoglio-Preiser C., 2000, WHO CLASSIFICATION T, P37; FILIPE MI, 1994, INT J CANCER, V57, P324, DOI 10.1002/ijc.2910570306; Fuccio L, 2009, ANN INTERN MED, V151, P121, DOI 10.7326/0003-4819-151-2-200907210-00009; Grotzinger C, 2001, GUT, V49, P73, DOI 10.1136/gut.49.1.73; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hippo Y, 2002, CANCER RES, V62, P233; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jiang CG, 2011, J SURG ONCOL, V103, P700, DOI 10.1002/jso.21878; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kakehashi H, 2007, J IMMUNOL, V179, P5728, DOI 10.4049/jimmunol.179.9.5728; Kawakubo T, 2007, CANCER RES, V67, P10869, DOI 10.1158/0008-5472.CAN-07-2048; Kelley JR, 2003, J CLIN EPIDEMIOL, V56, P1, DOI 10.1016/S0895-4356(02)00534-6; KUBOTA K, 1977, J NATL CANCER I, V59, P1599, DOI 10.1093/jnci/59.6.1599; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2010, BRIT J SURG, V97, P732, DOI 10.1002/bjs.6941; Machado JC, 2001, ONCOGENE, V20, P1525, DOI 10.1038/sj.onc.1204234; MAEHARA Y, 1992, CANCER, V69, P1645, DOI 10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X; Matsuo K, 1996, HUM PATHOL, V27, P184, DOI 10.1016/S0046-8177(96)90373-1; Matsushita M, 1986, JPN J GASTROENTEROL, V19, P1925; MAYER B, 1993, CANCER RES, V53, P1690; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; Otsuji E, 1998, J SURG ONCOL, V67, P216, DOI 10.1002/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.0.CO;2-B; Otsuki S, 2011, ONCOL REP, V25, P1235, DOI 10.3892/or.2011.1185; SAKU T, 1990, GUT, V31, P1250, DOI 10.1136/gut.31.11.1250; Saqui-Salces M, 2010, BBA-MOL CELL RES, V1803, P786, DOI 10.1016/j.bbamcr.2010.03.008; Tong JH, 2011, SURGERY, V149, P356, DOI 10.1016/j.surg.2010.07.006; Tsukamoto Tetsuya, 2006, Gastric Cancer, V9, P156, DOI 10.1007/s10120-006-0375-6; Tsukuba T, 2003, J BIOCHEM, V134, P893, DOI 10.1093/jb/mvg216; Tsukuba T, 2000, MOL CELLS, V10, P601, DOI 10.1007/s100590000019; Wakatsuki K, 2008, J SURG ONCOL, V98, P124, DOI 10.1002/jso.21093; WATANABE M, 1989, BIOCHEM MED METAB B, V42, P21, DOI 10.1016/0885-4505(89)90037-6; Wu CY, 2009, GASTROENTEROLOGY, V137, P1641, DOI 10.1053/j.gastro.2009.07.060; Yamamichi N, 2005, ONCOGENE, V24, P5471, DOI 10.1038/sj.onc.1208716; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yamamichi N, 2009, EXP CELL RES, V315, P1779, DOI 10.1016/j.yexcr.2009.01.006; Yamamichi-Nishina M, 2003, J BIOL CHEM, V278, P7422, DOI 10.1074/jbc.M208458200; Yanagawa M, 2007, J BIOL CHEM, V282, P1851, DOI 10.1074/jbc.M604143200; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Yokota T, 1998, TOHOKU J EXP MED, V186, P121, DOI 10.1620/tjem.186.121; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V367, P517, DOI 10.1016/j.bbrc.2007.12.163; Zhang M, 2010, J GASTROINTEST SURG, V14, P601, DOI 10.1007/s11605-009-1127-9	49	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e56766	10.1371/journal.pone.0056766	http://dx.doi.org/10.1371/journal.pone.0056766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451082	Green Published, gold, Green Submitted			2022-12-25	WOS:000316658800034
J	Rodriguez, M; Rau, D; Angioi, SA; Bellucci, E; Bitocchi, E; Nanni, L; Knupffer, H; Negri, V; Papa, R; Attene, G				Rodriguez, Monica; Rau, Domenico; Angioi, Simonetta A.; Bellucci, Elisa; Bitocchi, Elena; Nanni, Laura; Knuepffer, Helmut; Negri, Valeria; Papa, Roberto; Attene, Giovanna			European Phaseolus coccineus L. landraces: Population Structure and Adaptation, as Revealed by cpSSRs and Phenotypic Analyses	PLOS ONE			English	Article							GENETIC DIVERSITY; VULGARIS L.; COMMON; DIFFERENTIATION; CHLOROPLAST; GERMPLASM; RESISTANCE; SOFTWARE; DISEASE; TRAITS	Relatively few studies have extensively analysed the genetic diversity of the runner bean through molecular markers. Here, we used six chloroplast microsatellites (cpSSRs) to investigate the cytoplasmic diversity of 331 European domesticated accessions of the scarlet runner bean (Phaseolus coccineus L.), including the botanical varieties albiflorus, bicolor and coccineus, and a sample of 49 domesticated and wild accessions from Mesoamerica. We further explored the pattern of diversity of the European landraces using 12 phenotypic traits on 262 individuals. For 158 European accessions, we studied the relationships between cpSSR polymorphisms and phenotypic traits. Additionally, to gain insights into the role of gene flow and migration, for a subset of 115 accessions, we compared and contrasted the results obtained by cpSSRs and phenotypic traits with those obtained in a previous study with 12 nuclear microsatellites (nuSSRs). Our results suggest that both demographic and selective factors have roles in the shaping of the population genetic structure of the European runner bean. In particular, we infer the existence of a moderate-to-strong cytoplasmic bottleneck that followed the expansion of the crop into Europe, and we deduce multiple domestication events for this species. We also observe an adaptive population differentiation in the phenology across a latitudinal gradient, which suggests that selection led to the diversification of the runner bean in Europe. The botanical varieties albiflorus, bicolor and coccineus, which are based solely on flower colour, cannot be distinguished based on these cpSSRs and nuSSRs, nor according to the 12 quantitative traits.	[Rodriguez, Monica; Rau, Domenico; Angioi, Simonetta A.; Attene, Giovanna] Univ Sassari, Sez Agron Coltivazioni Erbacee & Genet, Dipartimento Agr, I-07100 Sassari, Italy; [Bellucci, Elisa; Bitocchi, Elena; Nanni, Laura; Papa, Roberto] Univ Politecn Marche, Dipartimento Sci Agr Alimentari & Ambientali, Ancona, Italy; [Knuepffer, Helmut] Leibniz Inst Plant Genet & Crop Plant Res, Genebank Dept, Gatersleben, Germany; [Negri, Valeria] Univ Perugia, Dipartimento Biol Applicata, I-06100 Perugia, Italy; [Papa, Roberto] Agr Res Council, Cereal Res Ctr, Foggia, Italy; [Attene, Giovanna] Univ Sassari, Ctr Conservaz & Valorizzaz Biodiversita Vegetale, Surigheddu Alghero, Italy	University of Sassari; Marche Polytechnic University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Perugia; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Sassari	Attene, G (corresponding author), Univ Sassari, Sez Agron Coltivazioni Erbacee & Genet, Dipartimento Agr, I-07100 Sassari, Italy.	attene@uniss.it	Rodriguez, Monica/G-6731-2012; papa, roberto/F-9510-2014; Bitocchi, Elena/J-7996-2019; negri, valeria/G-5598-2013; Bellucci, Elisa/AAS-9237-2021; Nanni, Laura/HDN-7936-2022	Rodriguez, Monica/0000-0001-8926-2987; papa, roberto/0000-0001-9598-3131; Bitocchi, Elena/0000-0002-2152-4634; Negri, Valeria/0000-0003-2941-121X; Bellucci, Elisa/0000-0002-1636-0719; Knupffer, Helmut/0000-0002-0525-9244; Rau, Domenico/0000-0002-5294-9053	Italian Government (MIUR) Grant [2005071310]	Italian Government (MIUR) Grant	This study was supported by the Italian Government (MIUR) Grant no. # 2005071310, Project PRIN 2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora A, 2007, EUPHYTICA, V157, P69, DOI 10.1007/s10681-007-9397-3; Alvarez MT, 1998, GENET RESOUR CROP EV, V45, P243, DOI 10.1023/A:1008604127933; Angioi SA, 2011, PLANT GENET RESOUR-C, V9, P197, DOI 10.1017/S1479262111000190; Angioi SA, 2010, THEOR APPL GENET, V121, P829, DOI 10.1007/s00122-010-1353-2; Angioi SA, 2009, PLANT BIOLOGY, V11, P598, DOI 10.1111/j.1438-8677.2008.00143.x; [Anonymous], 1981, HDB LEGUMES WORLD EC; Bitocchi E, 2012, NEW PHYTOLO IN PRESS; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Boczkowska M, 2012, GENET RESOUR CROP EV, V59, P473, DOI 10.1007/s10722-012-9798-6; Busogoro JP, 1999, PLANT BREEDING, V118, P417, DOI 10.1046/j.1439-0523.1999.00413.x; CAMPION B, 1991, Journal of Genetics and Breeding, V45, P173; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Debouck D. G., 1995, EVOLUTION CROP PLANT, P287; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; ESCALANTE AM, 1994, AM J BOT, V81, P1096, DOI 10.2307/2445471; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J, 1996, GENETICS, V144, P1933; Hadado TT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-121; Hammer K, 2011, COLLECTING PLANT GEN; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; LLACA V, 1994, THEOR APPL GENET, V88, P646, DOI 10.1007/BF01253966; MANSFELD R., 1951, ZUCHTER, V21, P41, DOI 10.1007/BF00710527; MANTEL N, 1967, CANCER RES, V27, P209; Negri V, 2002, GENET RESOUR CROP EV, V49, P511, DOI 10.1023/A:1020902508166; NEI M, 1974, GENETICS, V76, P379; Nowosielski J, 2002, CELL MOL BIOL LETT, V7, P753; Olsson K, 2002, J EVOLUTION BIOL, V15, P983, DOI 10.1046/j.1420-9101.2002.00457.x; Papa R, 2006, DARWINS HARVEST; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Rodino AP, 2007, EUPHYTICA, V155, P63, DOI 10.1007/s10681-006-9301-6; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Salinas A. D., 1988, Genetic resources of Phaseolus beans., P441; Santalla M, 2004, EUPHYTICA, V135, P205, DOI 10.1023/B:EUPH.0000014912.07993.e7; *SAS I INC, 2007, JMP; Shannon CE., 1949, MATH THEORY COMMUNIC; Sicard D, 2005, PLANT BREEDING, V124, P464, DOI 10.1111/j.1439-0523.2005.01137.x; Singh SP, 1999, CROP SCI, V39, P80, DOI 10.2135/cropsci1999.0011183X003900010013x; Spataro G, 2011, THEOR APPL GENET, V122, P1281, DOI 10.1007/s00122-011-1530-y; Stinchcombe JR, 2005, AM J BOT, V92, P1701, DOI 10.3732/ajb.92.10.1701; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Wallace D. H., 1985, Plant Breeding Reviews, V3, P21; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Westphal E, 1974, PULSES ETHIOPIA THEI; WHITE JW, 1989, FIELD CROP RES, V22, P113, DOI 10.1016/0378-4290(89)90062-2; ZEVEN AC, 1993, EUPHYTICA, V68, P155, DOI 10.1007/BF00024164	47	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2013	8	2							e57337	10.1371/journal.pone.0057337	http://dx.doi.org/10.1371/journal.pone.0057337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	113IC	23451209	gold, Green Submitted, Green Published			2022-12-25	WOS:000316658800100
J	Brandt, J; Sullivan, C; Burrell, LE; Rogerson, M; Anderson, A				Brandt, Jason; Sullivan, Campbell; Burrell, Larry E., II; Rogerson, Mark; Anderson, Allan			Internet-Based Screening for Dementia Risk	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VERBAL-LEARNING TEST; INFORMANT QUESTIONNAIRE; ELDERLY IQCODE; PERFORMANCE-CHARACTERISTICS; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; POPULATION; DECLINE; HUNTINGTONS	The Dementia Risk Assessment (DRA) is an online tool consisting of questions about known risk factors for dementia, a novel verbal memory test, and an informant report of cognitive decline. Its primary goal is to educate the public about dementia risk factors and encourage clinical evaluation where appropriate. In Study 1, more than 3,000 anonymous persons over age 50 completed the DRA about themselves; 1,000 people also completed proxy reports about another person. Advanced age, lower education, male sex, complaints of severe memory impairment, and histories of cerebrovascular disease, Parkinson's disease, and brain tumor all contributed significantly to poor memory performance. A high correlation was obtained between proxy-reported decline and actual memory test performance. In Study 2, 52 persons seeking first-time evaluation at dementia clinics completed the DRA prior to their visits. Their responses (and those of their proxy informants) were compared to the results of independent evaluation by geriatric neuropsychiatrists. The 30 patients found to meet criteria for probable Alzheimer's disease, vascular dementia, or frontotemporal dementia differed on the DRA from the 22 patients without dementia (most other neuropsychiatric conditions). Scoring below criterion on the DRA's memory test had moderately high predictive validity for clinically diagnosed dementia. Although additional studies of larger clinical samples are needed, the DRA holds promise for wide-scale screening for dementia risk.	[Brandt, Jason; Sullivan, Campbell; Anderson, Allan] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Brandt, Jason] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Brandt, Jason; Burrell, Larry E., II; Anderson, Allan] Copper Ridge Inst, Sykesville, MD USA; [Anderson, Allan] William Hill Manor, Samuel & Alexia Bratton Memory Clin, Easton, MD USA	Johns Hopkins University; Johns Hopkins University	Brandt, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	jbrandt@jhmi.edu		Brandt, Jason/0000-0001-7381-6244	Geoffrey Beene Gives Back Alzheimer's Initiative	Geoffrey Beene Gives Back Alzheimer's Initiative	Development of the Dementia Risk Assessment was supported by the Geoffrey Beene Gives Back Alzheimer's Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford JW, 2007, ALZHEIMERS DEMENT, V3, P75, DOI 10.1016/j.jalz.2006.02.005; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; BRANDT J, 1988, ANN NEUROL, V23, P555, DOI 10.1002/ana.410230605; Brandt J, 2001, AM FAM PHYSICIAN, V63, P620; BRANDT J, 1992, J CLIN EXP NEUROPSYC, V14, P773, DOI 10.1080/01688639208402862; Brandt J., 2001, HOPKINS VERBAL LEARN; Brandt Jason, 2011, Alzheimers Dement, V7, pe94, DOI 10.1016/j.jalz.2010.08.229; Brodaty H, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI 10.1097/01.JGP.0000216181.20416.b2; Brodaty H, 1998, ALZ DIS ASSOC DIS, V12, P1, DOI 10.1097/00002093-199803000-00001; Cherbuin N, 2008, INT PSYCHOGERIATR, V20, P431, DOI 10.1017/S104161020800673X; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Dickerson BC, 2011, NEUROLOGY, V76, P1395, DOI 10.1212/WNL.0b013e3182166e96; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank RM, 2000, INT J GERIATR PSYCH, V15, P317, DOI 10.1002/(SICI)1099-1166(200004)15:4<317::AID-GPS116>3.3.CO;2-Z; GALLO JJ, 1995, PSYCHOL MED, V25, P1211, DOI 10.1017/S0033291700033183; Galvin JE, 2006, NEUROLOGY, V67, P1942, DOI 10.1212/01.wnl.0000247042.15547.eb; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Gifford DR, 1999, NEUROLOGY, V52, P224, DOI 10.1212/WNL.52.2.224; Hogervorst E, 2002, DEMENT GERIATR COGN, V13, P13, DOI 10.1159/000048628; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; JORM AF, 1991, PSYCHOL MED, V21, P785, DOI 10.1017/S0033291700022418; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Khachaturian AS, 2000, J CLIN EPIDEMIOL, V53, P531, DOI 10.1016/S0895-4356(99)00196-1; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Larner AJ, 2007, AGE AGEING, V36, P326, DOI 10.1093/ageing/afl183; Luszcz MA, 1997, PSYCHOL AGING, V12, P340, DOI 10.1037/0882-7974.12.2.340; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; Mayes AR, 2004, HIPPOCAMPUS, V14, P763, DOI 10.1002/hipo.10211; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Nunes PV, 2008, INT J GERIATR PSYCH, V23, P1127, DOI 10.1002/gps.2038; Parra MA, 2009, BRAIN, V132, P1057, DOI 10.1093/brain/awp036; Patterson C, 2008, CAN MED ASSOC J, V178, P548, DOI 10.1503/cmaj.070796; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Roe CM, 2011, ARCH NEUROL-CHICAGO, V68, P1145, DOI 10.1001/archneurol.2011.192; Selverstein SM, 2007, BEHAV RES METHODS, V39, P940, DOI 10.3758/BF03192989; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54	39	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57476	10.1371/journal.pone.0057476	http://dx.doi.org/10.1371/journal.pone.0057476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IT	23437393	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000106
J	Dustan, P; Doherty, O; Pardede, S				Dustan, Phillip; Doherty, Orla; Pardede, Shinta			Digital Reef Rugosity Estimates Coral Reef Habitat Complexity	PLOS ONE			English	Article							FISH ASSEMBLAGES; ABUNDANCE; FLORIDA	Ecological habitats with greater structural complexity contain more species due to increased niche diversity. This is especially apparent on coral reefs where individual coral colonies aggregate to give a reef its morphology, species zonation, and three dimensionality. Structural complexity is classically measured with a reef rugosity index, which is the ratio of a straight line transect to the distance a flexible chain of equal length travels when draped over the reef substrate; yet, other techniques from visual categories to remote sensing have been used to characterize structural complexity at scales from microhabitats to reefscapes. Reef-scale methods either lack quantitative precision or are too time consuming to be routinely practical, while remotely sensed indices are mismatched to the finer scale morphology of coral colonies and reef habitats. In this communication a new digital technique, Digital Reef Rugosity (DRR) is described which utilizes a self-contained water level gauge enabling a diver to quickly and accurately characterize rugosity with non-invasive millimeter scale measurements of coral reef surface height at decimeter intervals along meter scale transects. The precise measurements require very little post-processing and are easily imported into a spreadsheet for statistical analyses and modeling. To assess its applicability we investigated the relationship between DRR and fish community structure at four coral reef sites on Menjangan Island off the northwest corner of Bali, Indonesia and one on mainland Bali to the west of Menjangan Island; our findings show a positive relationship between DRR and fish diversity. Since structural complexity drives key ecological processes on coral reefs, we consider that DRR may become a useful quantitative community-level descriptor to characterize reef complexity.	[Dustan, Phillip] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Dustan, Phillip; Doherty, Orla] Biosphere Fdn, Coral Reef Projects, Big Pine, CA USA; [Pardede, Shinta] Wildlife Conservat Soc, Indonesia Marine Program, Bogor, Jawa Barat, Indonesia	College of Charleston; Wildlife Conservation Society - Indonesia	Dustan, P (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	dustanp@cofc.edu			Biosphere Foundation; Wildlife Conservation Society; Marisla Foundation; Kopcho Family Foundation; Roy A Hunt Foundation; Ward Family Foundation; Threshold Foundation; Yayasan Dwi Asih Sejahtera; Menjangan Beach Resort	Biosphere Foundation; Wildlife Conservation Society; Marisla Foundation; Kopcho Family Foundation; Roy A Hunt Foundation; Ward Family Foundation; Threshold Foundation; Yayasan Dwi Asih Sejahtera; Menjangan Beach Resort	Support for this research was provided by the Biosphere Foundation, Wildlife Conservation Society, Marisla Foundation, the Kopcho Family Foundation, Roy A Hunt Foundation, Ward Family Foundation, Threshold Foundation, Yayasan Dwi Asih Sejahtera and the Menjangan Beach Resort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Carpenter K.E., 1982, Proceedings of the International Coral Reef Symposium, P497; Dustan P, 1999, POINTCOUNT 99 USER M; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; GOREAU TF, 1959, ECOLOGY, V40, P67, DOI 10.2307/1929924; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Green S. J., 2011, Conservation and Society, V9, P173, DOI 10.4103/0972-4923.86986; Grenander U., 1959, PROBABILITY STAT HAR; He H., 2012, P 12 INT COR REEF S, P1; Hoeksema BW, 2000, P 9 INT COR REEF S, V1, P173; Knudby A, 2007, P AM ACAD UNDERWATER, P181; Kuffner IB, 2007, ENVIRON BIOL FISH, V78, P71, DOI 10.1007/s10641-006-9078-4; Kulbicki M, 2005, CYBIUM, V29, P235; Lambin EF, 1999, GLOBAL ECOL BIOGEOGR, V8, P191, DOI 10.1046/j.1365-2699.1999.00123.x; Lieske E., 2001, CORAL REEF FISHES, V2nd ed.; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Munk W.H., 1948, EOS T AM GEOPHYS UN, V29, P855, DOI [10.1029/TR029i006p00855, DOI 10.1029/TR029I006P00855]; POLUNIN NVC, 1983, BIOL CONSERV, V25, P171, DOI 10.1016/0006-3207(83)90059-9; Purkis SJ, 2008, CORAL REEFS, V27, P167, DOI 10.1007/s00338-007-0306-y; Randall JE, 1990, FISHES GREAT BARRIER; Risk MJ, 1972, ATOLL RES B, P153; ROBINSON A, 1981, B MAR SCI, V31, P774; Shumway CA, 2007, FRESHWATER BIOL, V52, P1065, DOI 10.1111/j.1365-2427.2007.01754.x; Turnigan RG, 1991, P 44 GULF CAR FISH I, P759; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; Wildlife Conservation Society CS, 2010, WCS FIJ MAR BIOL HDB; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Zawada DG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043789; Zawada DG, 2009, J COASTAL RES, V25, P6, DOI [10.2112/SI53-002.1, 10.2112/S153-002.1]	32	59	61	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57386	10.1371/journal.pone.0057386	http://dx.doi.org/10.1371/journal.pone.0057386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437380	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000099
J	Kirk-Ballard, H; Wang, ZQ; Acharya, P; Zhang, XH; Yu, YM; Kilroy, G; Ribnicky, D; Cefalu, WT; Floyd, ZE				Kirk-Ballard, Heather; Wang, Zhong Q.; Acharya, Priyanka; Zhang, Xian H.; Yu, Yongmei; Kilroy, Gail; Ribnicky, David; Cefalu, William T.; Floyd, Z. Elizabeth			An Extract of Artemisia dracunculus L. Inhibits Ubiquitin-Proteasome Activity and Preserves Skeletal Muscle Mass in a Murine Model of Diabetes	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; GENE-EXPRESSION; ATROPHY; PATHWAYS; PROTEOLYSIS; MECHANISMS; ATROGIN-1; LIGASES; MURF1	Impaired insulin signaling is a key feature of type 2 diabetes and is associated with increased ubiquitin-proteasome-dependent protein degradation in skeletal muscle. An extract of Artemisia dracunculus L. (termed PMI5011) improves insulin action by increasing insulin signaling in skeletal muscle. We sought to determine if the effect of PMI5011 on insulin signaling extends to regulation of the ubiquitin-proteasome system. C2C12 myotubes and the KK-A(y) murine model of type 2 diabetes were used to evaluate the effect of PMI5011 on steady-state levels of ubiquitylation, proteasome activity and expression of Atrogin-1 and MuRF-1, muscle-specific ubiquitin ligases that are upregulated with impaired insulin signaling. Our results show that PMI5011 inhibits proteasome activity and steady-state ubiquitylation levels in vitro and in vivo. The effect of PMI5011 is mediated by PI3K/Akt signaling and correlates with decreased expression of Atrogin-1 and MuRF-1. Under in vitro conditions of hormonal or fatty acid-induced insulin resistance, PMI5011 improves insulin signaling and reduces Atrogin-1 and MuRF-1 protein levels. In the KK-A(y) murine model of type 2 diabetes, skeletal muscle ubiquitylation and proteasome activity is inhibited and Atrogin-1 and MuRF-1 expression is decreased by PMI5011. PMI5011-mediated changes in the ubiquitin-proteasome system in vivo correlate with increased phosphorylation of Akt and FoxO3a and increased myofiber size. The changes in Atrogin-1 and MuRF-1 expression, ubiquitin-proteasome activity and myofiber size modulated by PMI5011 in the presence of insulin resistance indicate the botanical extract PMI5011 may have therapeutic potential in the preservation of muscle mass in type 2 diabetes.	[Kirk-Ballard, Heather; Acharya, Priyanka; Kilroy, Gail; Floyd, Z. Elizabeth] Pennington Biomed Res Ctr, Ubiquitin Biol Lab, Baton Rouge, LA USA; [Wang, Zhong Q.; Acharya, Priyanka; Zhang, Xian H.; Yu, Yongmei; Cefalu, William T.] Pennington Biomed Res Ctr, Diabet & Nutr Lab, Baton Rouge, LA USA; [Ribnicky, David] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Rutgers State University New Brunswick	Floyd, ZE (corresponding author), Pennington Biomed Res Ctr, Ubiquitin Biol Lab, Baton Rouge, LA USA.	elizabeth.floyd@pbrc.edu	Floyd, Elizabeth/N-1962-2017; Floyd, Elizabeth/W-2758-2019	Floyd, Elizabeth/0000-0002-3002-6186; Floyd, Elizabeth/0000-0002-3002-6186	Botanical Research Center of Pennington Biomedical Research Center; The Biotech Center of Rutgers University; National Center for Complementary and Alternative Medicine; Office of Dietary Supplements [P50AT002776-01]; American Diabetes Association [1-10-BS-55]; Centers of Biomedical Research Excellence [NIH P20-RR021945]; Nutrition Obesity Research Centers [NIH P30-DK072476]; National Institutes of Health; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Botanical Research Center of Pennington Biomedical Research Center; The Biotech Center of Rutgers University; National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nutrition Obesity Research Centers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by pilot funding (ZEF and ZQW) from the Botanical Research Center of Pennington Biomedical Research Center and The Biotech Center of Rutgers University, which is funded by the National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements P50AT002776-01, and the American Diabetes Association (grant 1-10-BS-55, awarded to ZEF). This project used Genomics Core and Cell Biology and Imaging Core facilities that are supported in part by Centers of Biomedical Research Excellence (NIH P20-RR021945) and Nutrition Obesity Research Centers (NIH P30-DK072476) center grants from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2011, J NUTR HEALTH AGING, V15, P890, DOI 10.1007/s12603-011-0366-0; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bennett RG, 2000, ENDOCRINOLOGY, V141, P2508, DOI 10.1210/en.141.7.2508; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Carballo-Jane E, 2004, J STEROID BIOCHEM, V88, P191, DOI 10.1016/j.jsbmb.2003.11.012; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Edstrom E, 2006, J GERONTOL A-BIOL, V61, P663, DOI 10.1093/gerona/61.7.663; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; IKEDA H, 1994, DIABETES RES CLIN PR, V24, pS313, DOI 10.1016/0168-8227(94)90268-2; KETTELHUT IC, 1994, BRAZ J MED BIOL RES, V27, P981; Kim TN, 2012, CLIN ENDOCRINOLOGY; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Koyama S, 2008, J MOL BIOL, V376, P1224, DOI 10.1016/j.jmb.2007.11.049; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Levine ME, 2012, IMPACT INSULIN RESIS; Logendra S, 2006, PHYTOCHEMISTRY, V67, P1539, DOI 10.1016/j.phytochem.2006.05.015; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MUNOZ KA, 1993, METABOLISM, V42, P1006, DOI 10.1016/0026-0495(93)90014-F; Park SW, 2009, DIABETES CARE, V32, P1993, DOI 10.2337/dc09-0264; Ribnicky DM, 2006, PHYTOMEDICINE, V13, P550, DOI 10.1016/j.phymed.2005.09.007; Ribnicky DM, 2009, INT J PHARMACEUT, V370, P87, DOI 10.1016/j.ijpharm.2008.11.012; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt B, 2008, METABOLISM, V57, pS3, DOI 10.1016/j.metabol.2008.03.001; Sishi B, 2010, EXP PHYSL; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sultan KR, 2006, AM J PHYSIOL-CELL PH, V290, pC650, DOI 10.1152/ajpcell.00163.2005; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wang ZQ, 2008, METABOLISM, V57, pS58, DOI 10.1016/j.metabol.2008.04.003; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015; Wang ZQ, 2009, DIABETES, V58, P1488, DOI 10.2337/db08-0977; Wing SS, 2011, CRIT REV CL LAB SCI, V48, P49, DOI 10.3109/10408363.2011.586171; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Zuberi AR, 2008, METABOLISM, V57, pS10, DOI 10.1016/j.metabol.2008.03.002	49	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57112	10.1371/journal.pone.0057112	http://dx.doi.org/10.1371/journal.pone.0057112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IE	23437325	Green Submitted, Green Published, gold			2022-12-25	WOS:000315184200218
J	Ji, XM; Xie, CH; Hu, DS; Fan, X; Zhou, YJ; Zheng, YJ				Ji, Xuemei; Xie, Conghua; Hu, Desheng; Fan, Xia; Zhou, Yajuan; Zheng, Yingjie			Survival Benefit of Adding Chemotherapy to Intensity Modulated Radiation in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; IN-VIVO; RADIOTHERAPY; CANCER; EXPERIENCE; RADIOSENSITIZATION; CHEMORADIOTHERAPY; GEMCITABINE; POPULATION	Background: To evaluate the contribution of chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by intensity modulated radiotherapy (IMRT) and to identify the optimal combination treatment strategy. Patients and Methods: Between 2006 and 2010, 276 patients with stage II-IVb NPC were treated by IMRT alone or IMRT plus chemotherapy. Cisplatin-based chemotherapy included neoadjuvant or concurrent, or neoadjuvant plus concurrent protocols. The IMRT alone and chemoradiotherapy groups were well-matched for prognostic factors, except N stage, with more advanced NPC in the chemoradiotherapy arm. Results: With a mean follow-up of 33.8 months, the 3-year actuarial rates of overall survival (OS), metastasis-free survival (MFS), relapse-free survival (RFS), and disease-free survival (DFS) were 90.3%, 84.2%, 80.3%, and 69.2% for all of the patients, respectively. Compared with the IMRT alone arm, patients treated by concurrent chemoradiotherapy had a significantly better DFS (HR = 2.64; 95% CI, 1.12-6.22; P = 0.03), patients with neoadjuvant-concurrent chemoradiotherapy had a significant improvement in RFS and DFS (HR = 4.03; 95% CI, 1.35-12.05; P = 0.01 and HR = 2.43; 95% CI, 1.09-5.44; P = 0.03), neoadjuvant chemoradiotherapy provided no significant benefit in OS, MFS, RFS, and DFS. Stage group and alcohol consumption were prognostic factors for OS and N stage was a significant predictor for DFS. Conclusions: Addition of concurrent or neoadjuvant-concurrent chemotherapy to IMRT is available to prolong RFS or DFS for locoregionally advanced NPC. Such work could be helpful to guide effective individualized therapy.	[Ji, Xuemei; Zheng, Yingjie] Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiat Oncol, Beijing, Peoples R China; [Ji, Xuemei; Xie, Conghua; Fan, Xia] Wuhan Univ, Dept Radiat & Med Oncol, Zhongnan Hosp, Wuhan 430072, Peoples R China; [Hu, Desheng; Zhou, Yajuan] Tumor Hosptal Hubei Prov, Dept Radiat Oncol, Wuhan, Peoples R China	Capital Medical University; Wuhan University	Ji, XM (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Radiat Oncol, Beijing, Peoples R China.	xuemei.ji@yahoo.com; chxie65@hotmail.com	Ji, Xuemei/B-9774-2015	Ji, Xuemei/0000-0001-7416-9122	National Natural Science Foundation of China [81101561]; UICC American Cancer Society Beginning Investigators Fellowship; American Cancer Society; Scientific Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UICC American Cancer Society Beginning Investigators Fellowship; American Cancer Society(American Cancer Society); Scientific Research Foundation	This work was supported by National Natural Science Foundation of China (81101561); a UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society; the Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry, China to Xuemei Ji. URL of National Natural Science Foundation of China: http://www.nsfc.gov.cn/Portal0/default152.htm, URL of the American Cancer Society: http://www.cancer.org/, and URL of State Education Ministry, China: http://www.moe.edu.cn/. There are no grant numbers for a UICC American Cancer Society Beginning Investigators Fellowship funded by the American Cancer Society, whose certification is available if needed or can be found in URL: http://www.uicc.org/fellowships/beginning-investigators. There are also no grant numbers for the Scientific Research Foundation for the Returned Overseas Chinese Scholars from State Education Ministry to Xuemei Ji, which is available if needed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; BEGG AC, 1986, INT J RADIAT BIOL, V50, P871, DOI 10.1080/09553008614551291; Chinese Center for Disease Control and Prevention, 2010, 2008 CAUS DEATH DAT, P57; Fang FM, 2008, INT J RADIAT ONCOL, V72, P356, DOI 10.1016/j.ijrobp.2007.12.054; FERLITO A, 1993, ANN OTO RHINOL LARYN, V102, P666, DOI 10.1177/000348949310200903; Fields MT, 2000, INT J RADIAT ONCOL, V47, P785, DOI 10.1016/S0360-3016(00)00447-8; Ji XM, 2011, INT J CANCER, V129, P724, DOI 10.1002/ijc.25696; Kam MKM, 2007, J CLIN ONCOL, V25, P4873, DOI 10.1200/JCO.2007.11.5501; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Laskar S, 2008, INT J RADIAT ONCOL, V72, P728, DOI 10.1016/j.ijrobp.2008.01.032; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lee N, 2002, INT J RADIAT ONCOL, V53, P12, DOI 10.1016/S0360-3016(02)02724-4; LEVINE PH, 1992, CANCER, V70, P1024, DOI 10.1002/1097-0142(19920901)70:5<1024::AID-CNCR2820700503>3.0.CO;2-4; Lin SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-39; Lu HM, 2008, CANCER TREAT REV, V34, P27, DOI 10.1016/j.ctrv.2007.08.004; Miles EA, 2005, RADIOTHER ONCOL, V77, P241, DOI 10.1016/j.radonc.2005.10.011; National Marine Fisheries Service Southeast Fisheries Science Center, 2008, NOAA TECHNICAL MEMOR, P92; Ng WT, 2011, INT J RADIAT ONCOL, V79, P420, DOI 10.1016/j.ijrobp.2009.11.024; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Rosier JF, 1999, INT J RADIAT BIOL, V75, P245, DOI 10.1080/095530099140708; Su Sheng-Fa, 2011, Chin J Cancer, V30, P565, DOI 10.5732/cjc.010.10547; Teicher BA, 1998, INT J ONCOL, V13, P437; Tham IWK, 2010, AM J CLIN ONCOL-CANC, V33, P294, DOI 10.1097/COC.0b013e3181d2edab; Tham IWK, 2009, INT J RADIAT ONCOL, V75, P1481, DOI 10.1016/j.ijrobp.2009.01.018; Vaughan TL, 1996, CANCER EPIDEM BIOMAR, V5, P587; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; YU MC, 1988, CANCER RES, V48, P1954; Zhou GQ, 2012, INT J RADIAT ONCOL, V82, pE359, DOI 10.1016/j.ijrobp.2011.06.1967; ZHU KM, 1995, CANCER CAUSE CONTROL, V6, P507, DOI 10.1007/BF00054158	32	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56208	10.1371/journal.pone.0056208	http://dx.doi.org/10.1371/journal.pone.0056208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441169	gold, Green Published, Green Submitted			2022-12-25	WOS:000315159200026
J	Mamrut, S; Harony, H; Sood, R; Shahar-Gold, H; Gainer, H; Shi, YJ; Barki-Harrington, L; Wagner, S				Mamrut, Shimrat; Harony, Hala; Sood, Rapita; Shahar-Gold, Hadar; Gainer, Harold; Shi, Yi-Jun; Barki-Harrington, Liza; Wagner, Shlomo			DNA Methylation of Specific CpG Sites in the Promoter Region Regulates the Transcription of the Mouse Oxytocin Receptor	PLOS ONE			English	Article							GENE-EXPRESSION; MAMMARY-GLAND; ESTROGEN; AUTISM; RAT; VASOPRESSIN; SP1; CANCER; BEHAVIOR; ELEMENTS	Oxytocin is a peptide hormone, well known for its role in labor and suckling, and most recently for its involvement in mammalian social behavior. All central and peripheral actions of oxytocin are mediated through the oxytocin receptor, which is the product of a single gene. Transcription of the oxytocin receptor is subject to regulation by gonadal steroid hormones, and is profoundly elevated in the uterus and mammary glands during parturition. DNA methylation is a major epigenetic mechanism that regulates gene transcription, and has been linked to reduced expression of the oxytocin receptor in individuals with autism. Here, we hypothesized that transcription of the mouse oxytocin receptor is regulated by DNA methylation of specific sites in its promoter, in a tissue-specific manner. Hypothalamus-derived GT1-7, and mammary-derived 4T1 murine cell lines displayed negative correlations between oxytocin receptor transcription and methylation of the gene promoter, and demethylation caused a significant enhancement of oxytocin receptor transcription in 4T1 cells. Using a reporter gene assay, we showed that methylation of specific sites in the gene promoter, including an estrogen response element, significantly inhibits transcription. Furthermore, methylation of the oxytocin receptor promoter was found to be differentially correlated with oxytocin receptor expression in mammary glands and the uterus of virgin and post-partum mice, suggesting that it plays a distinct role in oxytocin receptor transcription among tissues and under different physiological conditions. Together, these results support the hypothesis that the expression of the mouse oxytocin receptor gene is epigenetically regulated by DNA methylation of its promoter.	[Mamrut, Shimrat; Harony, Hala; Shahar-Gold, Hadar; Wagner, Shlomo] Univ Haifa, Dept Neurobiol, IL-31999 Haifa, Israel; [Sood, Rapita; Barki-Harrington, Liza] Univ Haifa, Dept Human Biol, IL-31999 Haifa, Israel; [Gainer, Harold; Shi, Yi-Jun] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA	University of Haifa; University of Haifa; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wagner, S (corresponding author), Univ Haifa, Dept Neurobiol, IL-31999 Haifa, Israel.	shlomow@research.haifa.ac.il		Wagner, Shlomo/0000-0002-7618-0752	Legacy Heritage Bio-Medical Program of the Israel Science Foundation [1901/08]; Autism Speaks Foundation [3613]	Legacy Heritage Bio-Medical Program of the Israel Science Foundation; Autism Speaks Foundation	This research was supported by the Legacy Heritage Bio-Medical Program of the Israel Science Foundation (grant #1901/08 to SW and LBH) and by the Autism Speaks Foundation (grant #3613 to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 1997, ENDOCRINOLOGY, V138, P1151, DOI 10.1210/en.138.3.1151; Bartz JA, 2008, PROG BRAIN RES, V170, P451, DOI 10.1016/S0079-6123(08)00435-4; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Breton C, 2001, J MOL ENDOCRINOL, V27, P175, DOI 10.1677/jme.0.0270175; Breton C, 1997, ENDOCRINOLOGY, V138, P1857, DOI 10.1210/en.138.5.1857; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Daniel FI, 2011, CANCER-AM CANCER SOC, V117, P677, DOI 10.1002/cncr.25482; Douet V, 2007, BIOCHEM BIOPH RES CO, V354, P66, DOI 10.1016/j.bbrc.2006.12.151; Fleming JGW, 2006, ENDOCRINOLOGY, V147, P899, DOI 10.1210/en.2005-1120; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Gurrieri F, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-63; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Harony H, 2010, NEUROSIGNALS, V18, P82, DOI 10.1159/000321035; Hoare S, 1999, J BIOL CHEM, V274, P28682, DOI 10.1074/jbc.274.40.28682; Horn S, 1998, HUM REPROD UPDATE, V4, P605, DOI 10.1093/humupd/4.5.605; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Israel S, 2008, PROG BRAIN RES, V170, P435, DOI 10.1016/S0079-6123(08)00434-2; Ivell R, 2001, EXP PHYSIOL, V86, P289, DOI 10.1113/eph8602185; Ivell R, 1999, MOL CELL ENDOCRINOL, V151, P95, DOI 10.1016/S0303-7207(99)00025-8; Kimura T, 2003, J MOL ENDOCRINOL, V30, P109, DOI 10.1677/jme.0.0300109; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kubota Y, 1996, MOL CELL ENDOCRINOL, V124, P25, DOI 10.1016/S0303-7207(96)03923-8; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Kusui C, 2001, BIOCHEM BIOPH RES CO, V289, P681, DOI 10.1006/bbrc.2001.6024; LARCHER A, 1995, ENDOCRINOLOGY, V136, P5350, DOI 10.1210/en.136.12.5350; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Leung ST, 2000, J REPROD FERTIL, V119, P287, DOI 10.1530/reprod/119.2.287; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Michelotti GA, 2007, FASEB J, V21, P1979, DOI 10.1096/fj.06-7118com; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Neo SJ, 2009, ANAL CHEM, V81, P3344, DOI 10.1021/ac802543x; Petz LN, 2000, MOL ENDOCRINOL, V14, P972, DOI 10.1210/me.14.7.972; QuinonesJenab V, 1997, NEUROENDOCRINOLOGY, V65, P9, DOI 10.1159/000127160; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; SOLOFF MS, 1983, CAN J BIOCHEM CELL B, V61, P631, DOI 10.1139/o83-079; SOLOFF MS, 1979, SCIENCE, V204, P1313, DOI 10.1126/science.221972; Strakova Z, 1998, AM J PHYSIOL-ENDOC M, V274, pE634, DOI 10.1152/ajpendo.1998.274.4.E634; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Unternaehrer E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.77; Veenema AH, 2008, PROG BRAIN RES, V170, P261, DOI 10.1016/S0079-6123(08)00422-6; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Zelko IN, 2010, FREE RADICAL BIO MED, V48, P895, DOI 10.1016/j.freeradbiomed.2010.01.007; Zhong M, 2003, ENDOCRINOLOGY, V144, P2947, DOI 10.1210/en.2002-221039; Zingg HH, 2003, TRENDS ENDOCRIN MET, V14, P222, DOI 10.1016/S1043-2760(03)00080-8; ZINGG HH, 1995, RECENT PROG HORM RES, V50, P255	49	71	73	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56869	10.1371/journal.pone.0056869	http://dx.doi.org/10.1371/journal.pone.0056869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441222	Green Published, gold, Green Submitted			2022-12-25	WOS:000315159200079
J	Walter, SD; Riddell, CA; Rabachini, T; Villa, LL; Franco, EL				Walter, Stephen D.; Riddell, Corinne A.; Rabachini, Tatiana; Villa, Luisa L.; Franco, Eduardo L.			Accuracy of p53 Codon 72 Polymorphism Status Determined by Multiple Laboratory Methods: A Latent Class Model Analysis	PLOS ONE			English	Article							TESTS; METAANALYSIS; NEOPLASIA; STANDARD; CANCER; ERROR; RISK	Introduction: Studies on the association of a polymorphism in codon 72 of the p53 tumour suppressor gene (rs1042522) with cervical neoplasia have inconsistent results. While several methods for genotyping p53 exist, they vary in accuracy and are often discrepant. Methods: We used latent class models (LCM) to examine the accuracy of six methods for p53 determination, all conducted by the same laboratory. We also examined the association of p53 with cytological cervical abnormalities, recognising potential test inaccuracy. Results: Pairwise disagreement between laboratory methods occurred approximately 10% of the time. Given the estimated true p53 status of each woman, we found that each laboratory method is most likely to classify a woman to her correct status. Arg/Arg women had the highest risk of squamous intraepithelial lesions (SIL). Test accuracy was independent of cytology. There was no strong evidence for correlations of test errors. Discussion: Empirical analyses ignore possible laboratory errors, and so are inherently biased, but test accuracy estimated by the LCM approach is unbiased when model assumptions are met. LCM analysis avoids ambiguities arising from empirical test discrepancies, obviating the need to regard any of the methods as a "gold'' standard measurement. The methods we presented here to analyse the p53 data can be applied in many other situations where multiple tests exist, but where none of them is a gold standard.	[Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Riddell, Corinne A.; Franco, Eduardo L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Rabachini, Tatiana; Villa, Luisa L.] Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, Sao Paulo, Brazil; [Franco, Eduardo L.] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McMaster University; McGill University; Ludwig Institute for Cancer Research; McGill University	Walter, SD (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	walter@mcmaster.ca	USP, Oncologia/F-9053-2014; Papilomavirus, Inct/I-2406-2013; VILLA, LUISA/AAH-4761-2019; Walter, Stephen/AAB-5548-2022; Rabachini, Tatiana/B-1460-2014; Franco, Eduardo/C-6445-2014	VILLA, LUISA/0000-0003-4074-2335; Walter, Stephen/0000-0003-4157-8928; Rabachini, Tatiana/0000-0003-0636-2558; Franco, Eduardo/0000-0002-4409-8084	National Institutes of Health [CA70269]; Canadian Institutes of Health Research [MOP-53111, CRN-83320, 49396]; NATIONAL CANCER INSTITUTE [R01CA070269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the study was provided by grants from the National Institutes of Health (CA70269) and Canadian Institutes of Health Research (MOP-53111, CRN-83320, 49396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PS, 2009, STAT MED, V28, P780, DOI 10.1002/sim.3514; Chu HT, 2009, J AM STAT ASSOC, V104, P512, DOI 10.1198/jasa.2009.0017; Cicchetti DV, 1971, AM J EEG TECHNOLOGY; ESPELAND MA, 1989, BIOMETRICS, V45, P587, DOI 10.2307/2531499; Fleiss JL, 2013, STAT METHODS RATES P; Formann A K, 1996, Stat Methods Med Res, V5, P179, DOI 10.1177/096228029600500205; Franco E, 1999, Rev Panam Salud Publica, V6, P223, DOI 10.1590/S1020-49891999000900001; Glauser W, 2010, CAN MED ASSOC J, V182, pE705, DOI 10.1503/cmaj.109-3669; Hui S L, 1998, Stat Methods Med Res, V7, P354, DOI 10.1191/096228098671192352; KALDOR J, 1985, STAT MED, V4, P327, DOI 10.1002/sim.4780040312; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Koushik A, 2004, CANCER EPIDEM BIOMAR, V13, P11, DOI 10.1158/1055-9965.EPI-083-3; Lau TS, 1997, STAT MED, V16, P2283, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2283::AID-SIM658>3.0.CO;2-T; Rabachini T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-44; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; SZATMARI P, 1995, J AM ACAD CHILD PSY, V34, P216, DOI 10.1097/00004583-199502000-00017; Team R. D. C, 2011, R LANG ENV STAT COMP; TorranceRynard VL, 1997, STAT MED, V16, P2157, DOI 10.1002/(SICI)1097-0258(19971015)16:19<2157::AID-SIM653>3.0.CO;2-X; Vermunt JK, 1997, LEM GEN PROGRAM ANAL; WALTER SD, 1988, J CLIN EPIDEMIOL, V41, P923, DOI 10.1016/0895-4356(88)90110-2; WALTER SD, 1984, REV EPIDEMIOL SANTE, V32, P206; Walter SD, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-51	23	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56430	10.1371/journal.pone.0056430	http://dx.doi.org/10.1371/journal.pone.0056430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441193	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200050
J	Zheng, SQ; Ding, AJ; Li, GP; Wu, GS; Luo, HR				Zheng, Shan-Qing; Ding, Ai-Jun; Li, Guo-Ping; Wu, Gui-Sheng; Luo, Huai-Rong			Drug Absorption Efficiency in Caenorhbditis elegans Delivered by Different Methods	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; CALORIC RESTRICTION; DIETARY RESTRICTION; SMALL MOLECULES; MODEL; IDENTIFICATION; INCREASE; WORM; BIOACTIVITY	Background: Caenorhbditis elegans has being vigorously used as a model organism in many research fields and often accompanied by administrating with various drugs. The methods of delivering drugs to worms are varied from one study to another, which make difficult in comparing results between studies. Methodology/Principal Findings: We evaluated the drug absorption efficiency in C. elegans using five frequently used methods with resveratrol with low aqueous solubility and water-soluble 5-Fluoro-2'-deoxyuridine (FUDR) as positive compounds. The drugs were either applied to the LB medium with bacteria OP50, before spreading onto Nematode Growth Medium (NGM) plates (LB medium method), or to the NGM with live (NGM live method) or dead bacteria (NGM dead method), or spotting the drug solution to the surface of plates directly (spot dead method), or growing the worms in liquid medium (liquid growing method). The concentration of resveratrol and FUDR increased gradually within C. elegans and reached the highest during 12 hours to one day and then decreased slowly. At the same time point, the higher the drug concentration, the higher the metabolism rate. The drug concentrations in worms fed with dead bacteria were higher than with live bacteria at the same time point. Consistently, the drug concentration in medium with live bacteria decreased much faster than in medium with dead bacteria, reach to about half of the original concentration within 12 hours. Conclusion: Resveratrol with low aqueous solubility and water-soluble FUDR have the same absorption and metabolism pattern. The drug metabolism rate in worms was both dosage and time dependent. NGM dead method and liquid growing method achieved the best absorption efficiency in worms. The drug concentration within worms was comparable with that in mice, providing a bridge for dose translation from worms to mammals.	[Zheng, Shan-Qing; Ding, Ai-Jun; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Zheng, Shan-Qing; Ding, Ai-Jun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Li, Guo-Ping] Beijing Inst Geriatr, Minist Hlth, Beijing, Peoples R China; [Wu, Gui-Sheng] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Hospital; Chinese Academy of Sciences; Kunming Institute of Zoology	Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.	luohuairong@mail.kib.ac.cn	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Yunnan provincial government [20080A007]; 100 Talents Program of the Chinese Academy of Sciences; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany [P2008-ZZ21, T2009-KF05]	Yunnan provincial government; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany	This work was partially supported by the Yunnan provincial government (20080A007), the 100 Talents Program of the Chinese Academy of Sciences, and the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany (P2008-ZZ21 and T2009-KF05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg AT, 2010, RAPID COMMUN MASS SP, V24, P1447, DOI 10.1002/rcm.4535; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Anastassopoulou CG, 2011, CURR PHARM DESIGN, V17, P1225, DOI 10.2174/138161211795703753; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; BRENNER S, 1974, GENETICS, V77, P71; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Desalermos A, 2011, EXPERT OPIN DRUG DIS, V6, P645, DOI 10.1517/17460441.2011.573781; Dexter PM, 2012, NEUROTHERAPEUTICS, V9, P393, DOI 10.1007/s13311-012-0109-x; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Fonseca-Kelly Zoe, 2012, Front Neurol, V3, P84, DOI 10.3389/fneur.2012.00084; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Keaney M, 2003, FREE RADICAL BIO MED, V34, P277, DOI 10.1016/S0891-5849(02)01290-X; Kim S, 2008, BIOCHEM BIOPH RES CO, V368, P588, DOI 10.1016/j.bbrc.2008.01.131; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2003, GENETICS, V163, P159; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; Masuda M, 2004, ANAL CHEM, V76, P728, DOI 10.1021/ac034840i; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Nass R, 2001, PARKINSONISM RELAT D, V7, P185, DOI 10.1016/S1353-8020(00)00056-0; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Sellers WR, 2011, CELL, V147, P26, DOI 10.1016/j.cell.2011.09.016; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Stiernagle Theresa, 2006, WormBook, P1; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wypijewska A, 2010, FEBS J, V277, P3003, DOI 10.1111/j.1742-4658.2010.07709.x; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zheng J, 2012, INT J OBESITY, V36, P186, DOI 10.1038/ijo.2011.93	50	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e56877	10.1371/journal.pone.0056877	http://dx.doi.org/10.1371/journal.pone.0056877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24058503	gold, Green Submitted, Green Published			2022-12-25	WOS:000316849500039
J	Ding, Y; Song, LR; Sedmak, B				Ding, Yi; Song, Lirong; Sedmak, Bojan			UVB Radiation as a Potential Selective Factor Favoring Microcystin Producing Bloom Forming Cyanobacteria	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; LIGHT; SOLAR; BIOSYNTHESIS; AERUGINOSA; EVOLUTION; GROWTH; DAMAGE; GENES	Due to the stratospheric ozone depletion, several organisms will become exposed to increased biologically active UVB (280-320nm) radiation, not only at polar but also at temperate and tropical latitudes. Bloom forming cyanobacteria are exposed to UVB radiation on a mass scale, particularly during the surface bloom and scum formation that can persist for long periods of time. All buoyant species of cyanobacteria are at least periodically exposed to higher irradiation during their vertical migration to the surface that usually occurs several times a day. The aim of this study is to assess the influence on cyanobacteria of UVB radiation at realistic environmental intensities. The effects of two UVB intensities of 0.5 and 0.99 W/m(2) in up to 0.5 cm water depth were studied in vitro on Microcystis aeruginosa strains, two microcystin producing and one non-producing. After UVB exposure their ability to proliferate was estimated by cell counting, while cell fitness and integrity were evaluated using light microscopy, autofluorescence and immunofluorescence. Gene damage was assessed by TUNEL assay and SYBR Green staining of the nucleoide area. We conclude that UVB exposure causes damage to the genetic material, cytoskeletal elements, higher sedimentation rates and consequent cell death. In contrast to microcystin producers (PCC7806 and FACHB905), the microcystin non-producing strain PCC7005 is more susceptible to the deleterious effects of radiation, with weak recovery ability. The ecological relevance of the results is discussed using data from eleven years' continuous UVB radiation measurements within the area of Ljubljana city (Slovenia, Central Europe). Our results suggest that increased solar radiation in temperate latitudes can have its strongest effect during cyanobacterial bloom formation in spring and early summer. UVB radiation in this period may significantly influence strain composition of cyanobacterial blooms in favor of microcystin producers.	[Ding, Yi; Song, Lirong] Chinese Acad Sci, Inst Hydrobiol, Key Lab Algal Biol, Wuhan, Peoples R China; [Ding, Yi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sedmak, Bojan] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Institute of Biology - Slovenia	Sedmak, B (corresponding author), Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia.	bojan.sedmak@nib.si	Luo, Huai-Rong/ABE-7525-2021	Zheng, Shanqing/0000-0002-5039-0196	Slovenian Research Agency	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was supported by Slovenian Research Agency (http://www.arrs.gov.si/en/dobrodoslica.asp), Research Program P1-0245ARRS: Ecotoxicology, Toxicogenomics and Carcinogenesis - (BS salary, reagents, materials, analysis tools), and Ministry of Defence Administration for Civil Protection and Dosaster Relief (Contract No URSZR 4300-1117/2009-1) "Cyanobacterial toxins in surface waters,'' which co-financed the Laminar Flow Cabinet. Chinese grants from the Natural Science Foundation of China-Yunnan Project (U0833604) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and '973' Program (2008CB418000) funded the nine-month stay of Ding Yi at the National Institute of Biology in Ljubljana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2; Codd GA, 2000, ECOL ENG, V16, P51, DOI 10.1016/S0925-8574(00)00089-6; Ding Y, 2012, PHYCOLOGIA, V51, P567, DOI 10.2216/11-107.1; DONKOR V, 1991, FEMS MICROBIOL ECOL, V86, P159; Dziallas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025569; EKELUND NGA, 1991, J PLANT PHYSIOL, V138, P274, DOI 10.1016/S0176-1617(11)80287-7; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Gan NQ, 2012, ENVIRON MICROBIOL, V14, P730, DOI 10.1111/j.1462-2920.2011.02624.x; Gumbo JR, 2011, AFR J BIOTECHNOL, V10, P8054; Hader DP, 2005, MUTAT RES-FUND MOL M, V571, P221, DOI 10.1016/j.mrfmmm.2004.11.017; Harel M, 2012, ENV MICROBIOL REP, V4, P342, DOI 10.1111/j.1758-2229.2012.00339.x; He YY, 2002, J PHOTOCH PHOTOBIO B, V66, P73, DOI 10.1016/S1011-1344(01)00278-0; Hessen DO, 2008, SOLAR RAD HUMAN HLTH, P123, DOI DOI 10.1038/NRG2897; Jungblut AD, 2006, ARCH MICROBIOL, V185, P107, DOI 10.1007/s00203-005-0073-5; Kaebernick M, 2000, APPL ENVIRON MICROB, V66, P3387, DOI 10.1128/AEM.66.8.3387-3392.2000; Kulandaivelu G, 1989, PHOTOSYNTHESIS MOL B, P305; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P787, DOI 10.1128/AEM.69.2.787-795.2003; Ma ZL, 2009, ENVIRON EXP BOT, V66, P265, DOI 10.1016/j.envexpbot.2009.02.006; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Morris DP, 1995, LIMNOL OCEANOGR, V40, P1381, DOI 10.4319/lo.1995.40.8.1381; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pereira S, 2009, FEMS MICROBIOL REV, V33, P917, DOI 10.1111/j.1574-6976.2009.00183.x; Phelan RR, 2011, J PHYCOL, V47, P1241, DOI 10.1111/j.1529-8817.2011.01056.x; QUESADA A, 1995, J PHYCOL, V31, P242, DOI 10.1111/j.0022-3646.1995.00242.x; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; SCHERER S, 1988, PLANT PHYSIOL, V88, P1055, DOI 10.1104/pp.88.4.1055; Schopf JW., 2000, ECOLOGY CYANOBACTERI, P13; Sedmak B, 2005, MICROB ECOL, V50, P298, DOI 10.1007/s00248-004-0189-1; Sedmak B, 1998, J PLANKTON RES, V20, P691, DOI 10.1093/plankt/20.4.691; Sedmak B, 2009, J PLANKTON RES, V31, P1321, DOI 10.1093/plankt/fbp076; Shi L, 1999, J BIOL CHEM, V274, P10039, DOI 10.1074/jbc.274.15.10039; Sinha RP, 1998, J PHOTOCH PHOTOBIO B, V47, P83, DOI 10.1016/S1011-1344(98)00198-5; UTKILEN H, 1992, APPL ENVIRON MICROB, V58, P1321, DOI 10.1128/AEM.58.4.1321-1325.1992; WALSBY AE, 1987, CYANOBACTERIA, P377; Weatherhead EC, 2006, NATURE, V441, P39, DOI 10.1038/nature04746; Zilliges Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017615	36	83	85	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2013	8	9							e73919	10.1371/journal.pone.0073919	http://dx.doi.org/10.1371/journal.pone.0073919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218BU	24058503	Green Published, gold, Green Submitted			2022-12-25	WOS:000324408400043
J	Kim, HS; Park, SH; Gunzl, A; Cross, GAM				Kim, Hee-Sook; Park, Sung Hee; Guenzl, Arthur; Cross, George A. M.			MCM-BP Is Required for Repression of Life-Cycle Specific Genes Transcribed by RNA Polymerase I in the Mammalian Infectious Form of Trypanosoma brucei	PLOS ONE			English	Article							VSG EXPRESSION SITE; ORIGIN RECOGNITION COMPLEX; BLOOD-STREAM FORMS; POLO-LIKE KINASE; DNA-REPLICATION; ANTIGENIC VARIATION; TOPOISOMERASE-II; DISTINCT ROLES; PROTEIN; TELOMERES	Trypanosoma brucei variant surface glycoprotein (VSG) expression is a classic example of allelic exclusion. While the genome of T. brucei contains >2,000 VSG genes and VSG pseudogenes, only one allele is expressed at the surface of each infectious trypanosome and the others are repressed. Along with recombinatorial VSG switching, allelic exclusion provides a major host evasion mechanism for trypanosomes, a phenomenon known as antigenic variation. To extend our understanding of how trypanosomes escape host immunity by differential expression of VSGs, we attempted to identify genes that contribute to VSG silencing, by performing a loss-of-silencing screen in T. brucei using a transposon-mediated random insertional mutagenesis. One identified gene, which we initially named LOS1, encodes a T. brucei MCM-Binding Protein (TbMCM-BP). Here we show that TbMCM-BP is essential for viability of infectious bloodstream-form (BF) trypanosome and is required for proper cell-cycle progression. Tandem affinity purification of TbMCM-BP followed by mass spectrometry identified four subunits (MCM4-MCM7) of the T. brucei MCM complex, a replicative helicase, and MCM8, a subunit that is uniquely co-purified with TbMCM-BP. TbMCM-BP is required not only for repression of subtelomeric VSGs but also for silencing of life-cycle specific, insect-stage genes, procyclin and procyclin-associated genes (PAGs), that are normally repressed in BF trypanosomes and are transcribed by RNA polymerase I. Our study uncovers a functional link between chromosome maintenance and RNA pol I-mediated gene silencing in T. brucei.	[Kim, Hee-Sook; Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA; [Park, Sung Hee; Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Storrs, CT 06269 USA; [Guenzl, Arthur] Univ Connecticut, Ctr Hlth, Dept Mol Microbial & Struct Biol, Storrs, CT 06269 USA	Rockefeller University; University of Connecticut; University of Connecticut	Kim, HS (corresponding author), Rockefeller Univ, Mol Parasitol Lab, New York, NY 10021 USA.	khee-sook@rockefeller.edu	; Cross, George/B-7444-2011	Gunzl, Arthur/0000-0002-7487-2261; Cross, George/0000-0003-1374-6955	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH) [R01 AI021729, R01 AI059377]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021729, R01AI059377] Funding Source: NIH RePORTER	Rockefeller University Women in Science Fellowship; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Rockefeller University Women in Science Fellowship to HK and by grants R01 AI021729 (GAMC) and R01 AI059377 (AG) from the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases (NIAID) or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON CM, 1994, MOL CELL BIOL, V14, P5579, DOI 10.1128/MCB.14.8.5579; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Alsford S, 2012, NUCLEIC ACIDS RES, V40, P10150, DOI 10.1093/nar/gks813; Becker M, 2004, GENOME RES, V14, P2319, DOI 10.1101/gr.2955304; Benmerzouga I, 2013, MOL MICROBIOL, V87, P196, DOI 10.1111/mmi.12093; Biebinger S, 1996, NUCLEIC ACIDS RES, V24, P1202, DOI 10.1093/nar/24.7.1202; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; BRUN R, 1979, ACTA TROP, V36, P289; CROSS GAM, 1973, PARASITOLOGY, V67, P315, DOI 10.1017/S0031182000046540; DaFonseca CJ, 2001, P NATL ACAD SCI USA, V98, P3034, DOI 10.1073/pnas.061487598; Dang HQ, 2011, J BIOL CHEM, V286, P32424, DOI 10.1074/jbc.M111.240143; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Denninger V, 2010, MOL MICROBIOL, V78, P459, DOI 10.1111/j.1365-2958.2010.07350.x; Ding L, 2011, J BIOL CHEM, V286, P32918, DOI 10.1074/jbc.M111.282541; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fox CA, 1997, SCIENCE, V276, P1547, DOI 10.1126/science.276.5318.1547; Germe T, 2009, EMBO J, V28, P2803, DOI 10.1038/emboj.2009.223; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; GueirosFilho FJ, 1996, MOL CELL BIOL, V16, P5655; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Horn D, 1997, EMBO J, V16, P7422, DOI 10.1093/emboj/16.24.7422; HORN D, 1995, CELL, V83, P555, DOI 10.1016/0092-8674(95)90095-0; Horn D, 2010, CURR OPIN MICROBIOL, V13, P700, DOI 10.1016/j.mib.2010.08.009; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Jagannathan M, 2012, J CELL SCI, V125, P133, DOI 10.1242/jcs.089938; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kawahara T, 2008, MOL MICROBIOL, V69, P1054, DOI 10.1111/j.1365-2958.2008.06346.x; Kim HS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000992; Kim H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Landeira D, 2009, J CELL BIOL, V186, P243, DOI 10.1083/jcb.200902119; Leal S, 2004, J BIOL CHEM, V279, P28979, DOI 10.1074/jbc.M403479200; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li JJ, 2011, FEBS LETT, V585, P3850, DOI 10.1016/j.febslet.2011.10.033; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Mancio-Silva L, 2008, J CELL SCI, V121, P2046, DOI 10.1242/jcs.026427; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; NAGOSHI YL, 1995, MOL BIOCHEM PARASIT, V72, P33, DOI 10.1016/0166-6851(95)00062-6; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Nishiyama A, 2011, GENE DEV, V25, P165, DOI 10.1101/gad.614411; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032; Peacock L, 2011, P NATL ACAD SCI USA, V108, P3671, DOI 10.1073/pnas.1019423108; Ploubidou A, 1999, J CELL SCI, V112, P4641; Pospiech H, 2010, SUBCELL BIOCHEM, V50, P79, DOI 10.1007/978-90-481-3471-7_5; Povelones ML, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003010; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Sakwe AM, 2007, MOL CELL BIOL, V27, P3044, DOI 10.1128/MCB.02384-06; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Takahashi N, 2008, EMBO J, V27, P1840, DOI 10.1038/emboj.2008.107; Takahashi N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000817; Tiengwe C, 2012, CELL REP, V2, P185, DOI 10.1016/j.celrep.2012.06.007; Tiengwe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032674; Nguyen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035931; Tu XM, 2005, EUKARYOT CELL, V4, P755, DOI 10.1128/EC.4.4.755-764.2005; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Vanhamme L, 2000, MOL MICROBIOL, V36, P328, DOI 10.1046/j.1365-2958.2000.01844.x; Wang QP, 2010, MOL MICROBIOL, V77, P1237, DOI 10.1111/j.1365-2958.2010.07284.x; Wickstead B, 2004, GENOME RES, V14, P1014, DOI 10.1101/gr.2227704; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037	80	100	102	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57001	10.1371/journal.pone.0057001	http://dx.doi.org/10.1371/journal.pone.0057001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	24086697	gold, Green Published, Green Submitted			2022-12-25	WOS:000316849500052
J	Kim, BJ; Zaveri, HP; Shchelochkov, OA; Yu, ZY; Hernandez-Garcia, A; Seymour, ML; Oghalai, JS; Pereira, FA; Stockton, DW; Justice, MJ; Lee, B; Scott, DA				Kim, Bum Jun; Zaveri, Hitisha P.; Shchelochkov, Oleg A.; Yu, Zhiyin; Hernandez-Garcia, Andres; Seymour, Michelle L.; Oghalai, John S.; Pereira, Fred A.; Stockton, David W.; Justice, Monica J.; Lee, Brendan; Scott, Daryl A.			An Allelic Series of Mice Reveals a Role for RERE in the Development of Multiple Organs Affected in Chromosome 1p36 Deletions	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; HISTONE DEACETYLASE; CALRETININ IMMUNOREACTIVITY; SKI PROTOONCOGENE; DENTATE GYRUS; MONOSOMY 1P36; GENE; ZEBRAFISH; DEFECTS; MODELS	Individuals with terminal and interstitial deletions of chromosome 1p36 have a spectrum of defects that includes eye anomalies, postnatal growth deficiency, structural brain anomalies, seizures, cognitive impairment, delayed motor development, behavior problems, hearing loss, cardiovascular malformations, cardiomyopathy, and renal anomalies. The proximal 1p36 genes that contribute to these defects have not been clearly delineated. The arginine-glutamic acid dipeptide (RE) repeats gene (RERE) is located in this region and encodes a nuclear receptor coregulator that plays a critical role in embryonic development as a positive regulator of retinoic acid signaling. Rere-null mice die of cardiac failure between E9.5 and E11.5. This limits their usefulness in studying the role of RERE in the latter stages of development and into adulthood. To overcome this limitation, we created an allelic series of RERE-deficient mice using an Rere-null allele, om, and a novel hypomorphic Rere allele, eyes3 (c.578T>C, p.Val193Ala), which we identified in an N-ethyl-N-nitrosourea (ENU)-based screen for autosomal recessive phenotypes. Analyses of these mice revealed microphthalmia, postnatal growth deficiency, brain hypoplasia, decreased numbers of neuronal nuclear antigen (NeuN)-positive hippocampal neurons, hearing loss, cardiovascular malformations-aortic arch anomalies, double outlet right ventricle, and transposition of the great arteries, and perimembranous ventricular septal defects-spontaneous development of cardiac fibrosis and renal agenesis. These findings suggest that RERE plays a critical role in the development and function of multiple organs including the eye, brain, inner ear, heart and kidney. It follows that haploinsufficiency of RERE may contribute-alone or in conjunction with other genetic, environmental, or stochastic factors-to the development of many of the phenotypes seen in individuals with terminal and interstitial deletions that include the proximal region of chromosome 1p36.	[Kim, Bum Jun; Zaveri, Hitisha P.; Yu, Zhiyin; Hernandez-Garcia, Andres; Justice, Monica J.; Lee, Brendan; Scott, Daryl A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shchelochkov, Oleg A.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Seymour, Michelle L.; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Seymour, Michelle L.; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Oghalai, John S.] Stanford Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA USA; [Pereira, Fred A.] Baylor Coll Med, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Stockton, David W.] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Stockton, David W.] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Lee, Brendan] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Scott, Daryl A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; University of Iowa; Baylor College of Medicine; Baylor College of Medicine; Stanford University; Baylor College of Medicine; Wayne State University; Wayne State University; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Scott, DA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	dscott@bcm.edu	wu, mingming/GXN-1864-2022; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; KIM, BEUM JUN/G-6829-2011	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; KIM, BEUM JUN/0000-0003-1797-5026; Hannanta-anan, Pimkhuan/0000-0002-9450-0799; Pereira, Fred/0000-0003-2100-0280	National Institutes of Health (NIH) [R01HD064667, U01HD39372, R03EY014854]; BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [5P30HD024064]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BCM IDDRC from the Eunice Kennedy Shriver National Institute of Child Health and Human Development	This project was supported by National Institutes of Health (NIH; http://www.nih.gov/) grants R01HD064667 to DAS, U01HD39372 to MJJ and R03EY014854 to DWS. The project described was also supported by the BCM IDDRC grant number 5P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (http://www.nichd.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2006, P NATL ACAD SCI USA, V103, P9069, DOI 10.1073/pnas.0603453103; Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929; Beck TF, 2012, HUM MOL GENET; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Choudhary R, 2008, AM J PHYSIOL-HEART C, V294, pH633, DOI 10.1152/ajpheart.01301.2007; Colmenares C, 2002, NAT GENET, V30, P106, DOI 10.1038/ng770; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Doetschman Thomas, 2009, V530, P423, DOI 10.1007/978-1-59745-471-1_23; Gajecka M, 2005, EUR J HUM GENET, V13, P139, DOI 10.1038/sj.ejhg.5201302; Giraudeau F, 2001, J MED GENET, V38, P121, DOI 10.1136/jmg.38.2.121; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Heilstedt HA, 2001, EPILEPSIA, V42, P1103, DOI 10.1046/j.1528-1157.2001.08801.x; Hentges KE, 2006, GENE EXPR PATTERNS, V6, P653, DOI 10.1016/j.modgep.2005.11.015; Kang SHL, 2007, CLIN GENET, V72, P329, DOI 10.1111/j.1399-0004.2007.00876.x; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Liu Y, 1996, EXP BRAIN RES, V108, P389; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Monaghan AP, 1997, NATURE, V390, P515, DOI 10.1038/37364; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Murakawa R, 1999, J COMP NEUROL, V411, P413; Nicoulaz A, 2011, AM J MED GENET A, V155A, P1964, DOI 10.1002/ajmg.a.33210; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Pan J, 2007, VITAM HORM, V75, P257, DOI 10.1016/S0083-6729(06)75010-5; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; Probst FJ, 2010, METHOD ENZYMOL, V477, P297, DOI 10.1016/S0076-6879(10)77015-4; Restivo A, 2006, ANAT REC PART A, V288A, P936, DOI 10.1002/ar.a.20367; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rosenfeld JA, 2010, AM J MED GENET A, V152A, P1951, DOI 10.1002/ajmg.a.33516; Rudnik-Schoneborn S, 2008, AM J MED GENET A, V146A, P2018, DOI 10.1002/ajmg.a.32405; Sanford LP, 2000, METH MOL B, V158, P217; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Schilling TF, 1996, DEVELOPMENT, V123, P329; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Slavotinek A, 1999, J MED GENET, V36, P657; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Stojanovska J, 2012, J THORAC IMAG, V27, P73, DOI 10.1097/RTI.0b013e318218923c; Szabadics J, 2010, J NEUROSCI, V30, P8296, DOI 10.1523/JNEUROSCI.5602-09.2010; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Vilhais-Neto GC, 2010, NATURE, V463, P953, DOI 10.1038/nature08763; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Windpassinger C, 2002, GENE, V292, P25, DOI 10.1016/S0378-1119(02)00649-2; Wu YQ, 1999, HUM MOL GENET, V8, P313, DOI 10.1093/hmg/8.2.313; Xia AP, 2010, DIS MODEL MECH, V3, P209, DOI 10.1242/dmm.004135; Yanagisawa H, 2000, HUM MOL GENET, V9, P1433, DOI 10.1093/hmg/9.9.1433; ZHOU MD, 1995, P NATL ACAD SCI USA, V92, P7391, DOI 10.1073/pnas.92.16.7391; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	60	106	111	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57460	10.1371/journal.pone.0057460	http://dx.doi.org/10.1371/journal.pone.0057460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23451234	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500107
J	Zhao, QH; Guo, QH; Li, F; Zhou, Y; Wang, B; Hong, Z				Zhao, Qianhua; Guo, Qihao; Li, Fang; Zhou, Yan; Wang, Bei; Hong, Zhen			The Shape Trail Test: Application of a New Variant of the Trail Making Test	PLOS ONE			English	Article							NORMATIVE DATA; ELDERLY-PEOPLE; AGE; EQUIVALENCE; EDUCATION; VALIDITY; PROJECT; NORMS	Objective: The Trail making test (TMT) is culture-loaded because of reliance on the Latin alphabet, limiting its application in Eastern populations. The Shape Trail Test (STT) has been developed as a new variant. This study is to examine the applicability of the STT in a senile Chinese population and to evaluate its potential advantages and disadvantages. Method: A total of 2470 participants were recruited, including 1151 cognitively normal control (NC), 898 amnestic mild cognitive impairment (aMCI), and 421 mild Alzheimer disease (AD) patients. Besides the STT, the Mini mental state examination and a comprehensive neuropsychological battery involving memory, language, attention, executive function and visuospatial ability were administered to all the participants. In a subgroup of 100 NC and 50 AD patients, both the STT and the Color Trail Test (CTT) were performed. Results: In NC, the time consumed for Part A and B (STT-A and STT-B) significantly correlated with age and negatively correlated with education (p<0.01). STT-A and B significantly differed among the AD, aMCI and NC. The number that successfully connected within one minute in Part B (STT-B-1 min) correlated well with STT-B (r = 0.71, p<0.01) and distinguished well among NC, aMCI and AD. In the receiver operating characteristic curve analysis, the AUCs (area under the curve) for STT-A, STT-B, and STT-B-1min in identifying AD were 0.698, 0.694 and 0.709, respectively. The STT correlated with the CTT, but the time for completion was longer. Conclusion: The TMT is a sensitive test of visual search and sequencing. The STT is a meaningful attempt to develop a "culture-fair" variant of the TMT in addition to the CTT.	[Zhao, Qianhua; Guo, Qihao; Zhou, Yan; Wang, Bei; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Li, Fang] Capital Med Univ, Fuxing Hosp, Dept Gerontol, Beijing, Peoples R China	Fudan University; Capital Medical University	Guo, QH (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	dr.guoqihao@126.com; lifangwa@sina.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Science and Technology Commission of Shanghai Municipality, China [09DZ1950400, 08411951000]; National Natural Science Foundation of China [81200835]	Science and Technology Commission of Shanghai Municipality, China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Science and Technology Commission of Shanghai Municipality, China (09DZ1950400, 08411951000) and National Natural Science Foundation of China (81200835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NB, 2005, J GERONTOL A-BIOL, V60, P1558, DOI 10.1093/gerona/60.12.1558; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Barncord S W, 2001, Appl Neuropsychol, V8, P99, DOI 10.1207/S15324826AN0802_4; DAVIES ADM, 1968, J CLIN PSYCHOL, V24, P98; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Dugbartey AT, 2000, ARCH CLIN NEUROPSYCH, V15, P425, DOI 10.1016/S0887-6177(99)00034-7; Elkin-Frankston S, 2007, ARCH CLIN NEUROPSYCH, V22, P631, DOI 10.1016/j.acn.2007.04.004; Fernandez AL, 2008, SCAND J PSYCHOL, V49, P239, DOI 10.1111/j.1467-9450.2008.00637.x; Hartman-Maeir A, 2008, BRAIN INJURY, V22, P994, DOI 10.1080/02699050802491305; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; KENNEDY KJ, 1981, PERCEPT MOTOR SKILL, V52, P671, DOI 10.2466/pms.1981.52.2.671; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P529, DOI 10.1076/1380-3395(200008)22:4;1-0;FT529; Lee TMC, 2000, J CLIN EXP NEUROPSYC, V22, P772, DOI 10.1076/jcen.22.6.772.954; Lu JC, 2006, CHIN J CLIN PSYCHOL, V14, P118; Lu L, 2000, Appl Neuropsychol, V7, P243, DOI 10.1207/S15324826AN0704_6; Lu Lei, 2002, Appl Neuropsychol, V9, P219, DOI 10.1207/S15324826AN0904_4; Martin TA, 2003, APPL NEUROPSYCHOL, V10, P163, DOI 10.1207/S15324826AN1003_05; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Oosterman JM, 2010, CLIN NEUROPSYCHOL, V24, P203, DOI 10.1080/13854040903482848; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Petersen R. C., 1999, ARCH NEUROL-CHICAGO, V56, P6; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Seo EH, 2006, INT J GERIATR PSYCH, V21, P844, DOI 10.1002/gps.1570; Spreen O, 1998, COMPENDIUM NEUROPSYC; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8	29	170	179	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2013	8	2							e57333	10.1371/journal.pone.0057333	http://dx.doi.org/10.1371/journal.pone.0057333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	093IE	23613798	gold, Green Published, Green Submitted			2022-12-25	WOS:000315184200244
J	Zhang, Y; Tan, XJ; Cui, AL; Mao, NY; Xu, ST; Zhu, Z; Zhou, JH; Shi, J; Zhao, YP; Wang, XJ; Huang, XY; Zhu, SL; Zhang, Y; Tang, W; Ling, H; Xu, WB				Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Zhou, Jianhui; Shi, Jing; Zhao, Yueping; Wang, Xianjun; Huang, Xueyong; Zhu, Shuangli; Zhang, Yong; Tang, Wei; Ling, Hua; Xu, Wenbo			Complete Genome Analysis of the C4 Subgenotype Strains of Enterovirus 71: Predominant Recombination C4 Viruses Persistently Circulating in China for 14 Years	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; HAND; FOOT; COXSACKIEVIRUS; EMERGENCE; EVOLUTION; INFECTION; OUTBREAK; SINGAPORE	Genetic recombination is a well-known phenomenon for enteroviruses. To investigate the genetic characterization and the potential recombination of enterovirus 71 (EV71) circulating in China, we determined the 16 complete genome sequences of EV71 isolated from Hand Foot Mouth Disease (HFMD) patients during the large scale outbreak and non-outbreak years since 1998 in China. The full length genome sequences of 16 Chinese EV71 in present study were aligned with 186 genome sequences of EV71 available from GenBank, including 104 China mainland and 82 international sequences, covering the time period of 1970-2011. The oldest strains of each subgenotype of EV71 and prototype strains of HEV-A were included to do the phylogenetic and Simplot analysis. Phylogenetic analysis indicated that all Chinese strains were clustered into C4 subgenotype of EV71, except for HuB/CHN/2009 clustered into A and Xiamen/CHN/2009 clustered into B5 subgenotype. Most of C4 EV71 were clustered into 2 predominant evolutionary branches: C4b and C4a evolutionary brunches. Our comprehensive recombination analysis showed the evidence of genome recombination of subgenotype C4 (including C4a and C4b) sequences between structural genes from genotype C EV71 and non-structural genes from the prototype strains of CAV16, 14 and 4, but the evidence of intratypic recombination between C4 strains and B subgenotype was not enough strong. This intertypic recombination C4 viruses were first seen in 1998 and became the predominant endemic viruses circulating in China mainland for at least 14 years. A shift between C4a and C4b evolutionary brunches of C4 recombination viruses were observed, and C4a viruses have been associated with large scale nationwide HFMD outbreak with higher morbidity and mortality since 2007.	[Zhang, Yan; Tan, Xiaojuan; Cui, Aili; Mao, Naiying; Xu, Songtao; Zhu, Zhen; Shi, Jing; Zhu, Shuangli; Zhang, Yong; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Zhou, Jianhui] Jilin Prov Ctr Dis Control & Prevent, Changchun, Peoples R China; [Shi, Jing] Capital Univ Med Sci, Beijing Children Hosp, Beijing, Peoples R China; [Zhao, Yueping] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Wang, Xianjun] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Huang, Xueyong] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Peoples R China; [Tang, Wei] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Ling, Hua] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Shanghai Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	wenbo_xu1@yahoo.com.cn		Zhang, Yong/0000-0002-2692-5437	National Basic Research Program of China (973 Program) [2011CB504902]; National Natural Science Foundation of China [30901259]; Key Technologies R&D Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003]; Science and Technology Development Plan of Shandong Province [2009GG10002055]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of National Ministry of Science; Science and Technology Development Plan of Shandong Province	This study was supported by National Basic Research Program of China (973 Program): (Grant No. 2011CB504902); Projects of the National Natural Science Foundation of China (Grant No. 30901259); Key Technologies R&D Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003); and Science and Technology Development Plan of Shandong Province (2009GG10002055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Huang SW, 2011, EXP BIOL MED, V236, P899, DOI 10.1258/ebm.2010.010233; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; Melnick J.L., 1996, FIELDS VIROLOGY, Vthird, P655; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yamayoshi S, 2012, J VIROL, V86, P5686, DOI 10.1128/JVI.00020-12; Yang F, 2001, SCI CHINA SER C, V44, P178, DOI 10.1007/BF02879323; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034401; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09	38	67	107	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56341	10.1371/journal.pone.0056341	http://dx.doi.org/10.1371/journal.pone.0056341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23516601	Green Published, Green Submitted, gold			2022-12-25	WOS:000315159200036
J	Kim, BJ; Hannanta-Anan, P; Chau, M; Kim, YS; Swartz, MA; Wu, MM				Kim, Beum Jun; Hannanta-Anan, Pimkhuan; Chau, Michelle; Kim, Yoon Soo; Swartz, Melody A.; Wu, Mingming			Cooperative Roles of SDF-1 alpha and EGF Gradients on Tumor Cell Migration Revealed by a Robust 3D Microfluidic Model	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; CANCER; CHEMOTAXIS; MACROPHAGES; EXPRESSION; MECHANISM; INVASION; DEVICE	Chemokine-mediated directed tumor cell migration within a three dimensional (3D) matrix, or chemoinvasion, is an important early step in cancer metastasis. Despite its clinical importance, it is largely unknown how cytokine and growth factor gradients within the tumor microenvironment regulate chemoinvasion. We studied tumor cell chemoinvasion in well-defined and stable chemical gradients using a robust 3D microfluidic model. We used CXCL12 (also known as SDF-1 alpha) and epidermal growth factor (EGF), two well-known extracellular signaling molecules that co-exist in the tumor microenvironment (e. g. lymph nodes or intravasation sites), and a malignant breast tumor cell line, MDA-MB-231, embedded in type I collagen. When subjected to SDF-1 alpha gradients alone, MDA-MB-231 cells migrated up the gradient, and the measured chemosensitivity (defined as the average cell velocity along the direction of the gradient) followed the ligand - receptor (SDF-1 alpha - CXCR4) binding kinetics. On the other hand, when subjected to EGF gradients alone, tumor cells increased their overall motility, but without statistically significant chemotactic (directed) migration, in contrast to previous reports using 2D chemotaxis assays. Interestingly, we found that the chemoinvasive behavior to SDF-1 alpha gradients was abrogated or even reversed in the presence of uniform concentrations of EGF; however, the presence of SDF-1 alpha and EGF together modulated tumor cell motility cooperatively. These findings demonstrate the capabilities of our microfluidic model in re-creating complex microenvironments for cells, and the importance of cooperative roles of multiple cytokine and growth factor gradients in regulating cell migration in 3D environments.	[Kim, Beum Jun; Hannanta-Anan, Pimkhuan; Chau, Michelle; Kim, Yoon Soo; Wu, Mingming] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland	Cornell University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Wu, MM (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA.	mw272@cornell.edu	wu, mingming/GXN-1864-2022; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; KIM, BEUM JUN/G-6829-2011	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; KIM, BEUM JUN/0000-0003-1797-5026; Hannanta-anan, Pimkhuan/0000-0002-9450-0799; Pereira, Fred/0000-0003-2100-0280	National Cancer Institute [R21CA138366]; Swiss National Science Foundation [IZK0Z3-129723-1]; Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute [U54CA143876]; Cornell NanoScale Science and Technology; Cornell Nanobiotechnology Center	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cornell NanoScale Science and Technology; Cornell Nanobiotechnology Center	This work was supported by the National Cancer Institute (Award No R21CA138366), the Swiss National Science Foundation (Award No IZK0Z3-129723-1, International Cooperation), the Cornell Center on the Microenvironment & Metastasis (Award No U54CA143876 from the National Cancer Institute), and the Cornell NanoScale Science and Technology and the Cornell Nanobiotechnology Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheng SY, 2007, LAB CHIP, V7, P763, DOI 10.1039/b618463d; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; Haessler U, 2012, INTEGR BIOL-UK, V4, P401, DOI 10.1039/c1ib00128k; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hughes-Alford SK, 2012, CURR OPIN CELL BIOL, V24, P284, DOI 10.1016/j.ceb.2012.01.001; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim BJ, 2012, ANN BIOMED ENG, V40, P1316, DOI 10.1007/s10439-011-0489-9; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LEBRUN L, 1993, ENZYME MICROB TECH, V15, P1057, DOI 10.1016/0141-0229(93)90054-6; Maheshwari G, 2001, J CELL BIOL, V155, P1123, DOI 10.1083/jcb.200109060; Mosadegh B, 2008, BIOTECHNOL BIOENG, V100, P1205, DOI 10.1002/bit.21851; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Price JT, 1999, CANCER RES, V59, P5475; Raja WK, 2010, INTEGR BIOL-UK, V2, P696, DOI 10.1039/c0ib00044b; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sawyer C, 2003, CANCER RES, V63, P1667; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; Shamloo A, 2008, LAB CHIP, V8, P1292, DOI 10.1039/b719788h; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Soon L, 2005, CELL MOTIL CYTOSKEL, V62, P27, DOI 10.1002/cm.20082; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Taylor Anne M., 2006, V321, P167; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Wang WG, 2002, CANCER RES, V62, P6278; White JB, 2011, INTEGR BIOL-UK, V3, P1003, DOI 10.1039/c1ib00040c; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	49	106	111	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2013	8	7							e68422	10.1371/journal.pone.0068422	http://dx.doi.org/10.1371/journal.pone.0068422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200ZN	23451234	Green Submitted, Green Published, gold			2022-12-25	WOS:000323110600016
J	Kumar, AHS; Martin, K; Turner, EC; Buneker, CK; Dorgham, K; Deterre, P; Caplice, NM				Kumar, Arun H. S.; Martin, Kenneth; Turner, Elizebeth C.; Buneker, Chirlei K.; Dorgham, Karim; Deterre, Philippe; Caplice, Noel M.			Role of CX(3)CR1 Receptor in Monocyte/Macrophage Driven Neovascularization	PLOS ONE			English	Article							MUSCLE-CELL DIFFERENTIATION; PLAQUE RUPTURE; ANTIANGIOGENIC THERAPY; PROGENITOR CELLS; ANGIOGENESIS; MACROPHAGES; FRACTALKINE; ATHEROSCLEROSIS; MICE; COLLAGEN	Monocyte/Macrophages are implicated in initiation of angiogenesis, tissue/organ perfusion and atherosclerosis biology. We recently showed that chemokine receptor CX(3)CR1 is an essential regulator of monocyte/macrophage derived smooth muscle cell differentiation in the vessel wall after injury. Here we hypothesised the contribution of CX(3)CR1- CX(3)CL1 interaction to in vivo neovascularization and studied the functional consequences of genetic and pharmacologic targeting of CX(3)CR1 in formation, maturation and maintenance of microvascular integrity. Cells functionally deficient in CX(3)CR1 lacked matrix tunnelling and tubulation capacity in a 3D Matrigel assay. These morphogenic and cytokinetic responses were driven by CX(3)CL1-CX(3)CR1 interaction and totally abrogated by a Rho antagonist. To evaluate the role of CX(3)CR1 system in vivo, Matrigel plugs were implanted in competent CX(3)CR1(+/gfp) and functionally deficient CX(3)CR1(gfp/gfp) mice. Leaky microvessels (MV) were formed in the Matrigel implanted in CX(3)CR1(gfp/gfp) but not in CX(3)CR1(+/gfp) mice. In experimental plaque neovascularization immature MV phenotype was observed in CX(3)CR1(gfp/gfp) mice, lacking CX(3)CR1 positive smooth muscle-like cells, extracellular collagen and basement membrane (BM) laminin compared to competent CX(3)CR1(+/gfp) mice. This was associated with increased extravasation of platelets into the intima of CX(3)CR1(gfp/gfp) but not functionally competent CX(3)CR1 mice. Pharmacologic targeting using CX(3)CR1 receptor antagonist in wild type mice resulted in formation of plaque MV with poor BM coverage and a leaky phenotype. Our data indicate a hitherto unrecognised role for functional CX(3)CR1 in Matrigel and experimental plaque neovascularization in vivo, which may buttress MV collectively in favour of a more stable non-leaky phenotype.	[Kumar, Arun H. S.; Martin, Kenneth; Turner, Elizebeth C.; Buneker, Chirlei K.; Caplice, Noel M.] Natl Univ Ireland Univ Coll Cork, Biosci Inst, Ctr Res Vasc Biol CRVB, Cork, Ireland; [Dorgham, Karim; Deterre, Philippe] UPMC, INSERM, UMR S 945, Lab Immunite & Infect, Paris, France	University College Cork; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Caplice, NM (corresponding author), Natl Univ Ireland Univ Coll Cork, Biosci Inst, Ctr Res Vasc Biol CRVB, Cork, Ireland.	n.caplice@ucc.ie	Kumar, Arun/C-9149-2009; Dorgham, karim/A-2241-2016; Deterre, Philippe/O-8984-2017; Singh, Aditya/N-4130-2016	Kumar, Arun/0000-0001-8422-0219; Dorgham, karim/0000-0001-9539-3203; Deterre, Philippe/0000-0001-9303-0791; Singh, Aditya/0000-0003-3031-5225; Caplice, Noel/0000-0001-5445-1016	Science Foundation Ireland (PI); Science Foundation Ireland (RFP-NMC); ANR (France) [ANR-09-PIRI-0003]	Science Foundation Ireland (PI)(Science Foundation Ireland); Science Foundation Ireland (RFP-NMC)(Science Foundation Ireland); ANR (France)(French National Research Agency (ANR))	This work was supported by grants from Science Foundation Ireland (PI and RFP-NMC) and from ANR (France) (noANR-09-PIRI-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo-Scherrer A, 2012, CIRC RES, V110, P356, DOI 10.1161/CIRCRESAHA.110.233403; Anghelina M, 2004, STEM CELLS DEV, V13, P665, DOI 10.1089/scd.2004.13.665; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Bell SE, 2001, J CELL SCI, V114, P2755; Bryan BA, 2007, CELL MOL LIFE SCI, V64, P2053, DOI 10.1007/s00018-007-7008-z; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Daher IN, 2008, NAT CLIN PRACT CARD, V5, P797, DOI 10.1038/ncpcardio1375; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; Doyle B, 2007, J AM COLL CARDIOL, V49, P2073, DOI 10.1016/j.jacc.2007.01.089; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Finn AV, 2010, JACC-CARDIOVASC IMAG, V3, P41, DOI 10.1016/j.jcmg.2009.11.001; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Haskell CA, 1999, J BIOL CHEM, V274, P10053, DOI 10.1074/jbc.274.15.10053; Jain RK, 2007, NAT CLIN PRACT CARD, V4, P491, DOI 10.1038/ncpcardio0979; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu P, 2006, ARTERIOSCL THROM VAS, V26, P2056, DOI 10.1161/01.ATV.0000234947.47788.8c; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Lucerna M, 2007, BLOOD, V109, P122, DOI 10.1182/blood-2006-07-031773; Martin K, 2009, CIRC RES, V105, P214, DOI 10.1161/CIRCRESAHA.109.199984; Metharom P, 2010, ARTERIOSCL THROM VAS, V30, P533, DOI 10.1161/ATVBAHA.109.200097; Moldovan NI, 2000, CIRC RES, V87, P378; Moldovan NI, 2002, J HEMATOTH STEM CELL, V11, P179, DOI 10.1089/152581602753658394; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Pedraza C, 2000, J IMMUNOL, V165, P5831, DOI 10.4049/jimmunol.165.10.5831; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Sasaki T, 2006, ARTERIOSCL THROM VAS, V26, P1304, DOI 10.1161/01.ATV.0000219687.71607.f7; Sasaki Takeshi, 2007, V139, P67; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Sinclair P R, 2001, Curr Protoc Toxicol, VChapter 8, DOI 10.1002/0471140856.tx0803s00; Sprague L, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-35; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Weber C, 2008, NAT REV IMMUNOL, V8, P802, DOI 10.1038/nri2415; White GE, 2010, CARDIOVASC RES, V85, P825, DOI 10.1093/cvr/cvp341	47	72	75	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57230	10.1371/journal.pone.0057230	http://dx.doi.org/10.1371/journal.pone.0057230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23437346	Green Submitted, gold, Green Published			2022-12-25	WOS:000315186000087
J	Wang, YP; Hu, YJ; Chao, C; Yuksel, M; Colle, I; Flavell, RA; Ma, Y; Yan, HP; Wen, L				Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Colle, Isabelle; Flavell, Richard A.; Ma, Yun; Yan, Huiping; Wen, Li			Role of IRAK-M in Alcohol Induced Liver Injury	PLOS ONE			English	Article							INNATE IMMUNITY; KUPFFER CELLS; T-CELLS; NEGATIVE REGULATOR; DISEASE; MICE; LIPOPOLYSACCHARIDE; INTERLEUKIN-1; INFLAMMATION; PERMEABILITY	Increasing evidence suggests that innate immunity plays an important role in alcohol-induced liver injury and most studies have focused on positive regulation of innate immunity. The main objective of this study was to investigate the negative regulator of innate immunity, IL-1/Toll-like receptor (TLR) signaling pathways and interleukin receptor-associated kinase-M (IRAK-M) in alcoholic liver injury. We established an alcohol-induced liver injury model using wild type and IRAK-M deficient B6 mice and investigated the possible mechanisms. We found that in the absence of IRAK-M, liver damage by alcohol was worse with higher alanine transaminase (ALT), more immune cell infiltration and increased numbers of IFN gamma producing cells. We also found enhanced phagocytic activity in CD68(+) cells. Moreover, our results revealed altered gut bacteria after alcohol consumption and this was more striking in the absence of IRAK-M. Our study provides evidence that IRAK-M plays an important role in alcohol-induced liver injury and IRAK-M negatively regulates the innate and possibly the adaptive immune response in the liver reacting to acute insult by alcohol. In the absence of IRAK-M, the hosts developed worse liver injury, enhanced gut permeability and altered gut microbiota.	[Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Wen, Li] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Wang, Yipeng; Yan, Huiping] Capital Med Univ, Beijing You An Hosp, Clin Res Ctr Autoimmune Liver Dis, Beijing, Peoples R China; [Yuksel, Muhammed; Colle, Isabelle] Ghent Univ Hosp, Dept Gastroenterol, Ghent, Belgium; [Yuksel, Muhammed; Colle, Isabelle; Ma, Yun] Univ London, Inst Liver Study, Kings Coll, Sch Med, London, England	Yale University; Yale University; Capital Medical University; Ghent University; Ghent University Hospital; University of London; King's College London	Wen, L (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA.	li.wen@yale.edu	yuksel, muhammed/AAT-4783-2021; yuksel, muhammed/F-1706-2019; yuksel, muhammed/C-7861-2017; Wang, Yilong/E-3536-2015; Chen, Bingdi/I-5857-2012	yuksel, muhammed/0000-0002-3390-6007; Wen, Li/0000-0002-8805-2934; Wang, Yilong/0000-0001-7483-9296; Chen, Bingdi/0000-0002-2086-0898	National Institutes of Health [RC1DK087699]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (RC1DK087699 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye M, 2011, MOL MED REP, V4, P597, DOI 10.3892/mmr.2011.471; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Aziz-Seible RS, 2011, ALCOHOL CLIN EXP RES, V35, P717, DOI 10.1111/j.1530-0277.2010.01389.x; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, p51S, DOI 10.1097/00000374-200106001-00012; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; FOX ES, 1989, GASTROENTEROLOGY, V96, P456, DOI 10.1016/0016-5085(89)91571-0; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Hubbard L. L., 2010, INFECT DIS REP, V2; Kim SK, 2011, DIGESTION, V84, P43, DOI 10.1159/000333212; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kirpich IA, 2012, ALCOHOL CLIN EXP RES, V36, P835, DOI 10.1111/j.1530-0277.2011.01673.x; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Koop DR, 2006, ALCOHOL RES HEALTH, V29, P274; Laso FJ, 1999, ALCOHOL CLIN EXP RES, V23, P1306, DOI 10.1097/00000374-199908000-00003; Lech M, 2011, ANN RHEUM DIS, V70, P2207, DOI 10.1136/ard.2011.155515; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Mehal WZ, 2001, GASTROENTEROLOGY, V120, P250, DOI 10.1053/gast.2001.20947; Miller AM, 2011, ALCOHOL CLIN EXP RES, V35, P787, DOI 10.1111/j.1530-0277.2010.01399.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Szabo G, 2011, ALCOHOL CLIN EXP RES, V35, P782, DOI 10.1111/j.1530-0277.2010.01398.x; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	38	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57085	10.1371/journal.pone.0057085	http://dx.doi.org/10.1371/journal.pone.0057085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23776514	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000074
J	Park, SG; Long, MX; Kang, JA; Kim, WS; Lee, CR; Im, SH; Strickland, I; Schulze-Luehrmann, J; Hayden, MS; Ghosh, S				Park, Sung-Gyoo; Long, Meixiao; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar			The Kinase PDK1 Is Essential for B-Cell Receptor Mediated Survival Signaling	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; ANTIGEN-RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; ACTIVATION; PHOSPHORYLATION; IMMUNODEFICIENCY; PROLIFERATION; REGULATOR; RICTOR	Phosphoinositide-dependent kinase 1 (PDK1) plays an important role in integrating the T cell antigen receptor (TCR) and CD28 signals to achieve efficient NF-kappa B activation. PDK1 is also an important regulator of T cell development, mediating pre-TCR induced proliferation signals. However, the role of PDK1 in B cell antigen receptor (BCR) signaling and B cell development remains largely unknown. In this study we provide genetic evidence supporting the role of PDK1 in B cell survival. We found PDK1 is required for BCR mediated survival in resting B cells, likely through regulation of Foxo activation. PDK1-dependent signaling to NF-kappa B is not crucial to resting B cell viability. However, PDK1 is necessary for triggering NF-kappa B during B cell activation and is required for activated B cell survival. Together these studies demonstrate that PDK1 is essential for BCR-induced signal transduction to Foxo and NF-kappa B and is indispensable for both resting and activated B cell survival.	[Park, Sung-Gyoo; Long, Meixiao; Strickland, Ian; Schulze-Luehrmann, Jan; Hayden, Matthew S.; Ghosh, Sankar] Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Sch Life Sci, Kwangju, South Korea; [Park, Sung-Gyoo; Kang, Jung-Ah; Kim, Woo-Seok; Lee, Cho-Rong; Im, Sin-Hyeog] GIST, Immune Synapse Res Ctr, Kwangju, South Korea; [Hayden, Matthew S.] Columbia Univ, Coll Phys & Surg, Dept Dermatol, New York, NY USA	Columbia University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Columbia University	Park, SG (corresponding author), Columbia Univ, Dept Microbiol & Immunol, Coll Phys & Surg, New York, NY 10027 USA.	sgpark@gist.ac.kr; sg2715@columbia.edu	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013; Park, Sung-Gyoo/H-8652-2019	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; Hayden, Matthew/0000-0003-1670-6430; Park, Sung-Gyoo/0000-0003-3702-5765	National Institutes of Health [NIH R37-AI33443, RO1-AI068977]; National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0029942, 2011-0005477]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI068977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work in this study was supported by grants from the National Institutes of Health (NIH R37-AI33443 and RO1-AI068977) and by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0029942 and 2011-0005477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; delPeso L, 1997, SCIENCE, V278, P687; Donahue AC, 2004, SEMIN CELL DEV BIOL, V15, P183, DOI 10.1016/j.semcdb.2003.12.024; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hayashi T, 2007, P NATL ACAD SCI USA, V104, P18619, DOI 10.1073/pnas.0709261104; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hess KL, 2004, EUR J IMMUNOL, V34, P2968, DOI 10.1002/eji.200425326; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Kloo B, 2011, P NATL ACAD SCI USA, V108, P272, DOI 10.1073/pnas.1008969108; Kurosaki T, 2002, CURR OPIN IMMUNOL, V14, P341, DOI 10.1016/S0952-7915(02)00344-8; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Mok CL, 1999, J EXP MED, V189, P575, DOI 10.1084/jem.189.3.575; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki Y, 2007, ADV EXP MED BIOL, V596, P149; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Suzuki H, 2003, NAT IMMUNOL, V4, P280, DOI 10.1038/ni890; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Yusuf I, 2004, BLOOD, V104, P784, DOI 10.1182/blood-2003-09-3071	33	64	64	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2013	8	2							e55378	10.1371/journal.pone.0055378	http://dx.doi.org/10.1371/journal.pone.0055378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	086NV	23437331	Green Published, Green Submitted, gold			2022-12-25	WOS:000314692800025
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200037
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400011
J	Hu, YF; Jiang, HS; Wang, Q; Xie, ZS; Pan, SY				Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue			Identification of a Novel Nonsense Mutation p.Tyr1957Ter of CACNA1A in a Chinese Family with Episodic Ataxia 2	PLOS ONE			English	Article							CALCIUM-CHANNEL; CLINICAL SPECTRUM; TYPE-2; GENE; SCA6	Type 2 episodic ataxia (EA2) is the most common subtype among a group of rare hereditary syndromes characterized by recurrent attacks of ataxia. More than 60 mutations and several gene rearrangements due to large deletions in CACNA1A gene have been reported so far for the cause of EA2. Because CACNA1A gene is a large gene containing 47 exons and there is no hot spot mutation, direct sequencing will be a challenge in clinical genetic testing. In this study, we used next generation sequencing technology to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncated protein without 305 amino acids in the c-terminus. Sanger sequencing confirmed the heterozygous mutation of CACNA1A in a Chinese family with 11 affected individuals. Affected individuals experienced recurrent attacks with or without nystagmus, dysarthria, seizure, myokymia, dystonia, weakness, blurred vision, visual field defects, diplopia, migraine, dizziness, nausea and vomiting, sweating and abdominal pain. This is the first report of EA2 in a Chinese family that carries a novel mutation in CACNA1A gene and had abdominal pain as a novel phenotype associated with EA2.	[Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue] So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Pan, SY (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	pansuyue82@yahoo.com.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Nanfang Hospital, Southern Medical University, China	Nanfang Hospital, Southern Medical University, China	This work was supported by the chief program funding of Nanfang Hospital, Southern Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Eunson LH, 2005, NEUROLOGY, V65, P308, DOI 10.1212/01.wnl.0000169020.82223.dd; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Jen J, 2004, NEUROLOGY, V62, P17, DOI 10.1212/01.WNL.0000101675.61074.50; Jen JC, 2007, BRAIN, V130, P2484, DOI 10.1093/brain/awm126; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Labrum RW, 2009, J MED GENET, V46, P786, DOI 10.1136/jmg.2009.067967; Mantuano E, 2010, J NEUROL SCI, V291, P30, DOI 10.1016/j.jns.2010.01.010; Matsuyama Z, 2003, J NEUROL SCI, V210, P91, DOI 10.1016/S0022-510X(03)00008-X; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Riant F, 2008, ARCH NEUROL-CHICAGO, V65, P817, DOI 10.1001/archneur.65.6.817; Riant F, 2010, NEUROGENETICS, V11, P101, DOI 10.1007/s10048-009-0208-y; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wan Jijun, 2011, Front Neurol, V2, P51, DOI 10.3389/fneur.2011.00051; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	25	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56362	10.1371/journal.pone.0056362	http://dx.doi.org/10.1371/journal.pone.0056362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441182	Green Submitted, gold, Green Published			2022-12-25	WOS:000315159200039
J	Hu, YJ; Rillig, MC; Xiang, D; Hao, ZP; Chen, BD				Hu, Yajun; Rillig, Matthias C.; Xiang, Dan; Hao, Zhipeng; Chen, Baodong			Changes of AM Fungal Abundance along Environmental Gradients in the Arid and Semi-Arid Grasslands of Northern China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SOIL ORGANIC-CARBON; PARTICLE-SIZE; NITROGEN; GROWTH; TEMPERATURE; PLANT; PHOSPHORUS; DISTRIBUTIONS; COMMUNITIES	Arbuscular mycorrhizal (AM) fungi are ubiquitous symbionts of higher plants in terrestrial ecosystems, while the occurrence of the AM symbiosis is influenced by a complex set of abiotic and biotic factors. To reveal the regional distribution pattern of AM fungi as driven by multiple environmental factors, and to understand the ecological importance of AM fungi in natural ecosystems, we conducted a field investigation on AM fungal abundance along environmental gradients in the arid and semi-arid grasslands of northern China. In addition to plant parameters recorded in situ, soil samples were collected, and soil chemo-physical and biological parameters were measured in the lab. Statistical analyses were performed to reveal the relative contribution of climatic, edaphic and vegetation factors to AM fungal abundance, especially for extraradical hyphal length density (HLD) in the soil. The results indicated that HLD were positively correlated with mean annual temperature (MAT), soil clay content and soil pH, but negatively correlated with both soil organic carbon (SOC) and soil available N. The multiple regressions and structural equation model showed that MAT was the key positive contributor and soil fertility was the key negative contributor to HLD. Furthermore, both the intraradical AM colonization (IMC) and relative abundance of AM fungi, which was quantified by real-time PCR assay, tended to decrease along the increasing SOC content. With regard to the obvious negative correlation between MAT and SOC in the research area, the positive correlation between MAT and HLD implied that AM fungi could potentially mitigate soil carbon losses especially in infertile soils under global warming. However, direct evidence from long-term experiments is still expected to support the AM fungal contribution to soil carbon pools.	[Hu, Yajun; Xiang, Dan; Hao, Zhipeng; Chen, Baodong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, Berlin, Germany; [Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Free University of Berlin	Chen, BD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bdchen@rcees.ac.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-JC403, KZCX2-YW-BR-17]; Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences [STSN-21-04]; State Key Laboratory of Urban and Regional Ecology, P.R. China [SKLURE2008-1-03]; Alexander-von-Humboldt Foundation fellowship	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Urban and Regional Ecology, P.R. China; Alexander-von-Humboldt Foundation fellowship(Alexander von Humboldt Foundation)	The study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-JC403 and KZCX2-YW-BR-17), Joint Project of Ministry of Environmental Protection, P.R. China and the Chinese Academy of Sciences (STSN-21-04) and State Key Laboratory of Urban and Regional Ecology, P.R. China (Project SKLURE2008-1-03). BC was supported by an Alexander-von-Humboldt Foundation fellowship during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; Cai Xiaobu, 2005, Yingyong Shengtai Xuebao, V16, P859; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Gaur A, 2000, MYCORRHIZA, V10, P43, DOI 10.1007/s005720050286; Gavito ME, 2005, NEW PHYTOL, V168, P179, DOI 10.1111/j.1469-8137.2005.01481.x; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; HAYMAN DS, 1982, PHYTOPATHOLOGY, V72, P1119; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; Hooper D, 2008, ELECT J BUSINESS RES, V6, P53, DOI DOI 10.21427/D7CF7R; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jennings D.H., 1995, PHYSL FUNGAL NUTR; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KOSKE RE, 1987, MYCOLOGIA, V79, P55, DOI 10.2307/3807744; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liu A, 2000, PLANT SOIL, V221, P157, DOI 10.1023/A:1004777821422; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; SOEDARJO M, 1995, MYCORRHIZA, V5, P337, DOI 10.1007/BF00207406; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tian H, 2009, LAND DEGRAD DEV, V20, P41, DOI 10.1002/ldr.876; Treseder KK, 2006, ECOSYSTEMS, V9, P305, DOI 10.1007/s10021-005-0110-x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot A., 1986, PHYSL GENETICAL ASPE, V39, P217, DOI DOI 10.1177/004057368303900411; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Verbruggen E, 2013, NEW PHYTOL, V197, P366, DOI 10.1111/nph.12079; Wan YF, 2011, AGR ECOSYST ENVIRON, V141, P23, DOI 10.1016/j.agee.2011.02.004; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Yang HS, 2011, CATENA, V87, P70, DOI 10.1016/j.catena.2011.05.009; [周涛 Zhou Tao], 2003, [地理学报, Acta Geographica Sinica], V58, P727; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	55	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57593	10.1371/journal.pone.0057593	http://dx.doi.org/10.1371/journal.pone.0057593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23441182	Green Published, Green Submitted, gold			2022-12-25	WOS:000316849500118
